<SEC-DOCUMENT>0001213900-13-005463.txt : 20130930
<SEC-HEADER>0001213900-13-005463.hdr.sgml : 20130930
<ACCEPTANCE-DATETIME>20130930165526
ACCESSION NUMBER:		0001213900-13-005463
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20130930
DATE AS OF CHANGE:		20130930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-191468
		FILM NUMBER:		131123900

	BUSINESS ADDRESS:	
		STREET 1:		501 FIFTH AVENUE, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		212-300-2131

	MAIL ADDRESS:	
		STREET 1:		501 FIFTH AVENUE, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>fs12013_actiniumpharma.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<html>
<head>
    <title>fs12013_actiniumpharma.htm</title>
    <!--Licensed to: Edgar Agents LLC-->
    <!--Document Created using EDGARizerAgent 5.4.5.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 7%; FONT-SIZE: 10pt; MARGIN-RIGHT: 7%">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">As filed with the Securities and Exchange Commission on&#160; September 30, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registration No. 333-________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

<div>
<hr style="COLOR: black" align="center" noshade size="2" width="100%">
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM S-1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;REGISTRATION STATEMENT UNDER THE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES ACT OF 1933</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

<div>
<hr style="COLOR: black" align="center" noshade size="2" width="100%">
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACTINIUM PHARMACEUTICALS, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(FORMERLY CACTUS VENTURES, INC.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="31%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>
</td>
<td align="left" valign="middle" width="4%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2834</font></div>
</td>
<td align="left" valign="middle" width="4%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="31%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-52446</font></div>
</td>
</tr><tr>
<td valign="middle" width="31%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of incorporation or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">organization)</font></div>
</td>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Primary Standard</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Industrial Classification</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Code Number)</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="31%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification Number)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">501 Fifth Avenue, 3<font style="DISPLAY: inline; FONT-SIZE: 10pt">rd</font> Floor</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">New York, NY 10017</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(212) 300-2131</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address, including zip code, and telephone number,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">including area code, of registrant&#8217;s principal executive offices)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Action Stock Transfer Corporation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2469 E. Fort Union Blvd., Suite 214</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Salt Lake City, UT 84121</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(801) 274-1088</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;(Name, address, including zip code, and telephone number,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">including area code, of agent for service)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Copies to:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="29%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Thomas Slusarczyk, Esq.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hiscock &amp; Barclay LLP</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">One Park Place</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">300 South State Street</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Syracuse, New York 13202</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Tel No.: (315) 235-2299</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fax No.: (315) 624-7359</font></div>
</td>
<td align="left" valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Approximate date of commencement of proposed sale to the public:</font> As soon as practicable after this Registration Statement becomes effective.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:<font style="DISPLAY: inline;" face="Wingdings">&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings">x</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.<font style="DISPLAY: inline;" face="Wingdings">&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings">o</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.<font style="DISPLAY: inline;" face="Wingdings">&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings">o</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.<font style="DISPLAY: inline;" face="Wingdings">&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings">o</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b2 of the Exchange Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Large accelerated filer</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#168;</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated filer</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#168;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-accelerated filer</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt">&#168;</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Smaller reporting company</font></div>
</td>
<td align="left" valign="top" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: wingdings; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Do not check if a smaller reporting company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: white" align="left" noshade size="2" width="100%">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CALCULATION OF REGISTRATION FEE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Title of Each Class Of Securities to be Registered</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount to</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">be</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registered</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(1)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Proposed </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Maximum </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Offering</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Price</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">per share</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(2)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Proposed </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Maximum </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aggregate Offering</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Price</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fee</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,329,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,793,675</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,199.46</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,832,819</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.78</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,449,599</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,152.52</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share, issuable upon exercise of the Series B warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,559,438</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.48</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,867,406</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">527.51</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share, issuable upon exercise of the Stock Offering warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,673,652</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.78</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,085,449</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284.46</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share, issuable upon exercise of&#160;&#160;consulting firm warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,755,562</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,556</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.12</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share, issuable upon exercise of&#160;&#160;placement agent warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,120,499</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.78</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">873,990</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">119.21</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $0.001 par value per share, issuable upon exercise of&#160;&#160;placement agent warrants</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">464,027</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.48</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,150,787</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156.97</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,735,497</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,445.25</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*&#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This registration statement includes an indeterminate number of additional shares of common stock issuable for no additional consideration pursuant to any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration, which results in an increase in the number of outstanding shares of our common stock. In the event of a stock split, stock dividend or similar transaction involving our common stock, in order to prevent dilution, the number of shares registered shall be automatically increased to cover the additional shares in accordance with Rule 416(a) under the Securities Act of 1933, as amended.</font></div>
</td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Calculated based upon the sales price of the common stock held by the selling stockholders named in this Registration Statement.</font></div>
</td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Calculated based upon the exercise price of the warrants held by the selling stockholders named in this Registration Statement.</font></div>
</td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Filing fee previously paid.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the commission, acting pursuant to said Section 8(a), may determine.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font color="red" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="33%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font color="red" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PRELIMINARY PROSPECTUS</font></div>
</td>
<td valign="bottom" width="34%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font color="red" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SUBJECT TO COMPLETION</font></div>
</td>
<td valign="top" width="33%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font color="red" style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">DATED&#160;September 30, 2013</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">25,735,497 Shares of Common Stock</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACTINIUM PHARMACEUTICALS, INC.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This prospectus covers the sale by the selling stockholders of up to (i) 16,162,319 shares of common stock, par value $0.001 per share, held by the selling stockholders, (ii) 1,559,438 shares of our common stock issuable upon exercise of Series B warrants held by the selling stockholders at an exercise price of $2.48 per share, (iii) 2,673,652 shares of our common stock issuable upon exercise of the 2011 stock offering (the &#8220;Stock Offering&#8221;) warrants held by the selling stockholders at an exercise price of $0.78 per share, (iv) 3,755,562 shares of our common stock issuable upon exercise of consulting firm warrants held by the selling stockholders at an exercise price of $0.01 per share, (v) 1,120,499 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $0.78 per share, (vi) 464,027 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $2.48 per share. Our common stock issuable upon the exercise of Series A Warrants are not being offered because they have been either exercised and converted into common stock or expired as of May 28, 2013.&#160;&#160;The shares being sold by the selling stockholders were issued to them in private placement transactions which were exempt from the registration and prospectus delivery requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Our common stock and warrants are more fully described in &#8220;Description of Securities.&#8221;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These shares will be offered for sale by the selling shareholders in accordance with the &#8220;Plan of Distribution.&#8221; We will not receive any proceeds from sales of shares of our common stock or warrants by the selling stockholders. However, to the extent the warrants are exercised for cash, if at all, we will receive the exercise price of the warrants. We will pay the expenses incurred in connection with the offering described in this prospectus, with the exception of brokerage expenses, fees, discounts and commissions, which will be paid by selling stockholders.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock is presently traded on the OTCQB under the symbol ATNM. On&#160;September 25, 2013, the last sale price of our shares as reported by the OTCQB was $5.75 per share. The prices at which the selling stockholders may sell the shares of common stock that are part of this offering may be market prices prevailing at the time of sale, at negotiated prices, at fixed prices, or at varying prices determined at the time of sale. See &#8220;Plan of Distribution.&#8221;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are an &#8220;emerging growth company&#8221; under the federal securities laws and will be subject to reduced public company reporting requirements. An investment in our common stock may be considered speculative and involves a high degree of risk, including the risk of a substantial loss of your investment. See &#8220;Risk Factors&#8221; beginning on page 6 to read about the risks you should consider before buying shares of our common stock.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The date of this prospectus is&#160; __________,&#160;2013</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#prospectus">PROSPECTUS SUMMARY</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#riskfactors">RISK FACTORS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#cautionarynote">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#dividendpolicy">DIVIDEND POLICY</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#useofproceeds">USE OF PROCEEDS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#dilution">DILUTION</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#pennystock">PENNY STOCK CONSIDERATIONS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#sellingstockholders">SELLING STOCKHOLDERS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#description">DESCRIPTION OF BUSINESS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#marketprice">MARKET PRICE OF AND DIVIDENDS ON OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#managementsdiscussion">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#changesin">CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#directors">DIRECTORS AND EXECUTIVE OFFICERS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#executive">EXECUTIVE COMPENSATION</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#securityownership">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#certainrelationships">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#descriptionof">DESCRIPTION OF SECURITIES</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#planofdistribution">PLAN OF DISTRIBUTION</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#shareseligible">SHARES ELIGIBLE FOR FUTURE SALE</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#legalmatters">LEGAL MATTERS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#experts">EXPERTS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#whereyoucan">WHERE YOU CAN FIND MORE INFORMATION</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION OF&#160; SECURITIES ACT LIABILITIES</font></div>
</td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#financialstatements">INDEX TO FINANCIAL STATEMENTS</a></font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-1</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Please read this prospectus carefully. It describes our business, our financial condition and results of operations. We have prepared this prospectus so that you will have the information necessary to make an informed investment decision.</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">You should rely only on information contained in this prospectus. We have not authorized any other person to provide you with different information. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the offer or sale is not permitted. The information in this prospectus is complete and accurate as of the date on the front cover, but the information may have changed since that date.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.3pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="PROSPECTUS">PROSPECTUS</a> SUMMARY</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider before investing in the common stock. You should carefully read the entire prospectus, including &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the consolidated financial statements, before making an investment decision. Our actual results may differ significantly from the results discussed in these forward-looking statements as a result of certain factors, including those described in &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; All references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company&#8221; mean Actinium Pharmaceuticals, Inc. and its subsidiary Actinium Corporation.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Business Overview</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a biopharmaceutical company focused on the $54 billion market for cancer drugs. Our most advanced products are Actimab&#8482;-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia (AML) and Iomab&#8482;-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. The Company is currently designing a trial which the Company intends to submit for registration approval in HSCT in the settings of refractory and relapsed acute myeloid leukemia in older patients. The Company is developing its cancer drugs using its expertise in radioimmunotherapy. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center, whose indirect subsidiary, Actinium Holdings Ltd., is a significant stockholder of the Company.&#160;The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213. The final drug construct is designed to specifically target and kill cancer cells while minimizing side effects. The Company intends to develop a number of products for different types of cancer and derive revenue from partnering relationships with large pharmaceutical companies and/or direct sales of its products in specialty markets in the U.S.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our inception on June 13, 2000, we have not generated any revenues, and as of December 31, 2012, we have incurred net losses of $55,743,463. As of December 31, 2012 and June 30, 2013 our cash balance was $5,618,669, and $5,650,328, respectively, and we need up to $25 million in cash to finance research and development and to cover our ongoing working capital needs. If we do not raise any additional funding, we will be able to continue our operations through&#160;August of 2014<font style="DISPLAY: inline; FONT-WEIGHT: bold">. </font>If we raise 25% of the needed funds,&#160;we will be able to conduct our planned operations through the end of 2014 and into 2015. If we raise 50% of the needed funds, we will be able to conduct our planned development programs through the first half of 2015. If we raise 75% or more of the needed funds, we will be able to accelerate our planned development programs through 2015 and into the first quarter of 2016.&#160;&#160;Our first product is not expected to be commercialized until at least 2017. In the second quarter of 2013 we issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,457,087 for the Company.&#160;&#160;As the remainder of the outstanding warrants are exercisable on a cashless basis there can be no assurance that we will be able to realize any proceeds from their exercise.</font></font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Corporate Information</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our principal executive offices are located at 501 Fifth Avenue, 3rd Floor, New York, NY 10017 and our telephone number is (212) 300-2131. Our website address is<font style="FONT-STYLE: italic; DISPLAY: inline"> www.actiniumpharmaceuticals.com</font> . The information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus or the registration statement of which it forms a part. The information on our website is not part of this prospectus.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<!--EFPlaceholder--></div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.3pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">THE OFFERING</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common stock offered by selling stockholders</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,735,497 shares of our common stock including: up to (i) 16,162,319 shares of common stock, par value $0.001 per share, held by the selling stockholders, (ii) 1,559,438 shares of our common stock issuable upon exercise of Series B warrants held by the selling stockholders at an exercise price of $2.48 per share, (iii) 2,673,652 shares of our common stock issuable upon exercise of the 2011 stock offering (the &#8220;Stock Offering&#8221;) warrants held by the selling stockholders at an exercise price of $0.78 per share, (iv) 3,755,562 shares of our common stock issuable upon exercise of consulting firm warrants held by the selling stockholders at an exercise price of $0.01 per share, (v) 1,120,499 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $0.78 per share, (vi) 464,027 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $2.48 per share.&#160;&#160;Our common stock issuable upon the exercise of Series A Warrants are not being offered because they have been either exercised and converted into common stock or expired as of May 28, 2013.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common stock outstanding before the offering</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,581,189 shares of common stock (1)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common stock outstanding after the offering</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,154,367 shares of common stock (2)</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Use of proceeds</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We will not receive any proceeds from the sale of the common stock by the selling stockholders. However, we may receive up to approximately $8,015,188 in the aggregate upon the exercise of the warrants if the holders exercise them for cash. The registration of common stock pursuant to this prospectus does not necessarily mean that any of those shares will ultimately be offered or sold by the selling stockholders.&#160; We intend to use the proceeds received from any cash exercise of the warrants for working capital and general corporate purposes.&#160;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Trading Symbol</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ATNM</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risk Factors</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The common stock offered hereby involves a high degree of risk and should not be purchased by investors who cannot afford the loss of their entire investment. See &#8220;Risk Factors&#8221;.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<hr style="COLOR: black" align="left" noshade size="2" width="20%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based upon the total number of issued and outstanding shares as of&#160;September 26, 2013</font></div>
</td>
</tr></table>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based upon the total number of issued and outstanding shares as of&#160;September 26, 2013, and including (i) 1,559,438 shares of our common stock issuable upon exercise of Series B warrants held by the selling stockholders at an exercise price of $2.48 per share, (ii) 2,673,652 shares of our common stock issuable upon exercise of the Stock Offering warrants held by the selling stockholders at an exercise price of $0.78 per share, (iii) 3,755,562 shares of our common stock issuable upon exercise of consulting firm warrants held by the selling stockholders at an exercise price of $0.01 per share, (iv) 1,120,499 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $0.78 per share, (v) 464,027 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $2.48 per share.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="RISKFACTORS">RISK FACTORS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">An investment in our common stock involves a high degree of risk. You should carefully consider the risks described below, together with all of the other information included in this Registration Statement, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the trading price of our shares of common stock could decline and you may lose all or part of your investment. See &#8220;Cautionary Note Regarding Forward Looking Statements&#8221; above for a discussion of forward-looking statements and the significance of such statements in the context of this Registration Statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Business</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have generated no revenue from commercial sales to date and our future profitability is uncertain.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have a limited operating history and our business is subject to all of the risks inherent in the establishment of a new business enterprise. Our likelihood of success must be considered in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with this development and expansion. Since we began our business, we have focused on research, development and clinical trials of product candidates, and have incurred losses since inception. As of December 31, 2012 and June 30, 2013, we had a deficit accumulated during development stage of approximately $55.7 million and $59.2 million, respectively. If we continue to incur operating losses and fail to become a profitable company, we may be unable to continue our operations. We expect to continue to operate at a net loss as we continue our research and development efforts, continue to conduct clinical trials and develop manufacturing, sales, marketing and distribution capabilities. There can be no assurance that the products under development by us will be approved for sale in the U.S. or elsewhere. Furthermore, there can be no assurance that if such products are approved they will be successfully commercialized, and the extent of our future losses and the timing of our profitability are highly uncertain.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to obtain the capital necessary to fund our operations, we will be unable to continue or complete our product development and you will likely lose your entire investment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not currently have sufficient capital for the development and commercialization of our lead product and we will need to continue to seek capital from time to time to continue development of our lead drug candidates and to acquire and develop other product candidates. Our first product is not expected to be commercialized until at least 2017 and we do not expect that the partnering revenues it will generate will be sufficient to fund our ongoing operations. Our cash balance as of June30, 2012 was $5.7 million. We expect that we will need approximately $4.6 million over the next 12 months to finance research and development and to cover our ongoing working capital needs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our business or operations may change in a manner that would consume available funds more rapidly than anticipated and substantial additional funding may be required to maintain operations, fund expansion, develop new or enhanced products, acquire complementary products, business or technologies or otherwise respond to competitive pressures and opportunities, such as a change in the regulatory environment or a change in preferred cancer treatment modalities. However, we may not be able to secure funding when we need it or on favorable terms.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If we cannot raise adequate funds to satisfy our capital requirements, we will have to delay, scale-back or eliminate our research and development activities, clinical studies or future operations.&#160;&#160;We may also be required to obtain funds through arrangements with collaborators, which arrangements may require us to relinquish rights to certain technologies or products that we otherwise would not consider relinquishing, including rights to future product candidates or certain major geographic markets.&#160;&#160;We may further have to license our technology to others.&#160;&#160;This could result in sharing revenues which we might otherwise have retained for ourselves.&#160;&#160;Any of these actions may harm our business, financial condition and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The amount of capital we may need depends on many factors, including the progress, timing and scope of our product development programs; the progress, timing and scope of our preclinical studies and clinical trials; the time and cost necessary to obtain regulatory approvals; the time and cost necessary to further develop manufacturing processes and arrange for contract manufacturing; our ability to enter into and maintain collaborative, licensing and other commercial relationships; and our partners&#8217; commitment of time and resources to the development and commercialization of our products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have limited access to the capital markets and even if we can raise additional funding, we may be required to do so on terms that are dilutive to you.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have limited access to the capital markets to raise capital.&#160;&#160;The capital markets have been unpredictable in the recent past for radio-immunotherapy and other oncology companies and unprofitable companies such as ours.&#160;&#160;In addition, it is generally difficult for development stage companies to raise capital under current market conditions.&#160;&#160;The amount of capital that a company such as ours is able to raise often depends on variables that are beyond our control.&#160;&#160;As a result, we may not be able to secure financing on terms attractive to us, or at all.&#160;&#160;If we are able to consummate a financing arrangement, the amount raised may not be sufficient to meet our future needs.&#160;&#160;If adequate funds are not available on acceptable terms, or at all, our business, including our technology licenses, results of operations, financial condition and our continued viability will be materially adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to obtain or maintain necessary U.S. Food and Drug Administration clearances for our radio-immunotherapy products, or if such clearances are delayed, we will be unable to commercially distribute and market our products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our products are subject to rigorous regulation by the U.S Food and Drug Administration (FDA) and numerous other federal, state and foreign governmental authorities.&#160;&#160;The process of seeking regulatory clearance or approval to market a radio-immunotherapy product is expensive and time-consuming and, notwithstanding the effort and expense incurred, clearance or approval is never guaranteed.&#160;&#160;If we are not successful in obtaining timely clearance or approval of API products from the FDA, we may never be able to generate significant revenue and may be forced to cease operations.&#160;&#160;In particular, the FDA permits commercial distribution of a new radio-immunotherapy product only after the product has received approval of a Biologics License Application (&#8220;BLA&#8221;) filed with the FDA pursuant to 21 C.F.R. &#167; 314, seeking permission to market the product in interstate commerce in the United States.&#160;&#160;The BLA process is costly, lengthy and uncertain.&#160;&#160;Any BLA application filed by the Company will have to be supported by extensive data, including, but not limited to, technical, preclinical, clinical trial, manufacturing and labeling data, to demonstrate to the FDA&#8217;s satisfaction the safety and efficacy of the product for its intended use.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Obtaining clearances or approvals from the FDA and from the regulatory agencies in other countries could result in unexpected and significant costs for us and consume management&#8217;s time and other resources.&#160;&#160;The FDA and other agencies could ask us to supplement our submissions, collect non-clinical data, conduct additional clinical trials or engage in other time-consuming actions, or it could simply deny our applications.&#160;&#160;In addition, even if we obtain a BLA approval or pre-market approvals in other countries, the approval could be revoked or other restrictions imposed if post-market data demonstrates safety issues or lack of effectiveness.&#160;&#160;We cannot predict with certainty how, or when, the FDA will act.&#160;&#160;If we are unable to obtain the necessary regulatory approvals, our financial condition and cash flow may be materially adversely affected, and our ability to grow domestically and internationally may be limited.&#160;&#160;Additionally, even if cleared or approved, the Company&#8217;s products may not be approved for the specific indications that are most necessary or desirable for successful commercialization or profitability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our radio-immunotherapy product candidates are in the early stages of development; and we have not demonstrated that any of our products actually cure cancer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Only two product candidates of the Company are currently in clinical development by the Company.&#160;&#160;There is an ongoing physician sponsored Phase I AML trial at MSKCC with a single dose of Actimab&#8482;-A.&#160;&#160;The Company has also commenced a Phase I/II multi-center AML trial with fractionated doses of Actimab&#8482;-A under its own federal Investigational New Drug Application (IND).&#160;&#160;Additionally, there are a number of physician IND trials that have been conducted or are currently ongoing at FHCRC with single doses of Iomab&#8482;-B.&#160;&#160;Neither the Company nor any relevant collaborative partner(s) has yet undertaken any clinical assessment or investigation of Company radio-immunotherapy product candidates for other indications, including colon cancer or prostate cancer.&#160;&#160;Significant further investment may be required to acquire antibody rights and to undertake necessary research and continued development.&#160;&#160;Further laboratory and specific clinical testing will be required prior to regulatory approval of any product candidates.&#160;&#160;Adverse or inconclusive results from pre-clinical testing or clinical trials of product candidates may substantially delay, or halt entirely, any further development of one or more of our products.&#160;&#160;The projected timetables for continued development of the technologies and related product candidates by us may otherwise be subject to delay or suspension.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Modifications to our product candidates may require federal New Drug Application (NDA) approvals.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The NDA application is the vehicle through which the company may formally propose that the FDA approve a new pharmaceutical for sale and marketing in the United States&#160;&#160;Once a particular Company product candidate receives FDA approval or clearance, expanded uses or uses in new indications of our products may require additional human clinical trials and new regulatory approvals or clearances, including additional IND and NDA submissions and premarket approvals before we can begin clinical development, and/or prior to marketing and sales.&#160; If the FDA requires new clearances or approvals for a particular use or indication, we may be required to conduct additional clinical studies, which would require additional expenditures and harm our operating results.&#160;&#160;If the products are already being used for these new indications, we may also be subject to significant enforcement actions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Conducting clinical trials and obtaining clearances and approvals can be a time-consuming process, and delays in obtaining required future clearances or approvals could adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">There is no guarantee that the FDA will grant NDA approval of our future product candidates and failure to obtain necessary clearances or approvals for our future product candidates would adversely affect our ability to grow our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have recently commenced a multi-center Phase I/II clinical trial for our lead drug candidate, Actimab&#8482;-A, in AML and in the future expect to submit an NDA to the FDA for approval of this product.&#160;&#160;This drug candidate is also the subject of an ongoing human safety trial being conducted under a physician IND at MSKCC in New York City.&#160;&#160;We are in the early stages of evaluating other drug candidates consisting of conjugates of Ac-225 with human or humanized antibodies for pre-clinical and clinical development in other types of cancer.&#160;&#160;In June 2012, the Company acquired rights to Iomab&#8482;, a Phase II clinical stage monoclonal antibody with safety and efficacy data in more than 250 patients in need of HSCT.&#160;&#160;Product candidates utilizing this antibody would also require FDA approval of a NDA.&#160;&#160;The FDA may not approve or clear these products for the indications that are necessary or desirable for successful commercialization.&#160;&#160;Indeed, the FDA may refuse our requests for NDA market approval of new products, new intended uses or indications to existing or future product candidates.&#160;&#160;Failure to receive approval for our new products would have an adverse effect on our ability to expand our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Clinical trials necessary to support NDA approval of our future product candidates will be time consuming and expensive.&#160;&#160;Delays or failures in our clinical trials will prevent us from commercializing our product candidates and will adversely affect our business, operating results and prospects and could cause us to cease operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Initiating and completing clinical trials necessary to support NDA approval of Actimab&#8482;-A and other product candidates, will be time-consuming and expensive and the outcome uncertain.&#160;&#160;Moreover, the results of early clinical trials are not necessarily predictive of future results, and any product candidate we advance into clinical trials may not have favorable results in later clinical trials.&#160;&#160;We have worked with the FDA to develop a clinical trial designed to support initial safety and efficacy of Actimab&#8482;-A and on October 6, 2008, and January 5, 2009, we submitted IND amendments to the FDA for the conduct of a multi-center Phase I/II clinical trial for treatment of AML.&#160;&#160;The trial is now underway with the purpose of examining the use of Actimab&#8482;-A in AML patients who are not eligible for approved forms of treatment with curative intent.&#160;&#160;The trial is not designed to support final NDA approval of the product candidate and one or more additional trials will have to be conducted in the future before we file a NDA.&#160;&#160;In addition, there can be no assurance that the data generated during the trial will meet our chosen safety and effectiveness endpoints or otherwise produce results that will eventually support the filing or approval of a BLA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The issued patents, which are licensed by the Company for the HuM-195 antibody, our acute myeloid leukemia targeting antibody, will begin to expire before we have commercialized Actimab&#8482;-A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The humanized antibody which we use in the conjugated Actimab&#8482;-A product candidate is covered by the claims of issued patents that we license from Facet Biotech Corporation, a wholly-owned subsidiary of Abbott Laboratories (&#8220;Facet&#8221;).&#160;&#160;Some of those patents will begin to expire in 2013.&#160;&#160;After these patents expire, others may be eventually able to use an antibody with the same sequence in alpha particle drug products based on alpha particle emitters other than actinium 225 and bismuth 213.&#160;&#160;Any process that would enable such a competition as described above is likely to require several years of development before achieving our product candidate&#8217;s current status and may be subject to significant regulatory hurdles, but is nevertheless a possibility that can affect the Company&#8217;s business in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additionally, because we expect that certain of these patents will expire prior to commercialization of Actimab&#8482;-A, the Company expects that in order to attract a commercialization partner for that product candidate, it will may need to reach an agreement with Facet to reduce the milestone payments and royalties currently required to be paid under our license agreement for HuM-195.&#160;&#160;There can be no assurance that the parties will be able to agree on an amendment to the terms of the license.&#160;&#160;Failure to reach such an agreement could materially adversely affect the Company&#8217;s ability to find a commercialization partner for Actimab&#8482;-A which may materially harm our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The BC8 antibody utilized in Iomab&#8482;-B is not patent protected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The antibody we use in the conjugated Iomab&#8482; product candidate is not covered by the claims of any issued or pending patents.&#160;&#160;Accordingly, others may be eventually able to use an antibody with the same sequence in alpha particle drug products based on alpha particle emitters.&#160;&#160;Any process that would enable such a competition as described above is likely to require several years of development before achieving our product candidate&#8217;s current status and may be subject to significant regulatory hurdles, but is nevertheless a possibility that could negatively impact the Company&#8217;s business in the future.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be unable to obtain a sufficient supply of Ac-225 medical grade isotope in order to continue clinical trials and to allow for the manufacture of commercial quantities of Actimab&#8482;-A</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are limited quantities of Ac-225 available today.&#160;&#160;The existing supplier of Ac-225 to the Company is Oak Ridge National Laboratory (ORNL).&#160;&#160;It manufactures Ac-225 by eluting it from its supply of Thorium-229.&#160;&#160;Although this has proven to be a very reliable source of production for a number of years, it is limited by the quantity of Thorium-229 at ORNL.&#160;&#160;We believe that the current approximate maximum of Ac-225 production from this source is sufficient for approximately 1,000 - 2,000 patient treatments per year.&#160;&#160;Since our needs are significantly below that amount at this time, and will continue to be below that for as long as we do not have a commercial product with a potential of selling more than 2,000 patient doses per year, we believe that this supply will be sufficient for completion of clinical trials and early commercialization.&#160;&#160;To secure supplies beyond this amount, the Company has developed what it believes to be a scalable cost-effective process for manufacturing Ac-225 in a cyclotron at an estimated cost in excess of $5 million.&#160;&#160;This work has been conducted at Technical University Munich (TUM) in Germany.&#160;&#160;The Company is now in possession of detailed descriptions of all the developed manufacturing procedures and has rights to all relevant patent applications and other intellectual property.&#160;&#160;However, we do not currently have access to a commercial cyclotron capable of producing medical grade Ac-225.&#160;&#160;Although beam time on such cyclotrons is commercially available, the Company does not currently have a relationship with any entity that owns or controls a suitable cyclotron.&#160;&#160;It has identified possible sources and estimates that it could secure the necessary beam time when needed at a cost of approximately $2 million per year.&#160;&#160;The Company&#8217;s contract for supply of this isotope from ORNL extends through the end of 2013, is renewable for future years.&#160;&#160;However, there can be no assurance that ORNL will decide to renew the contract or that the U.S.&#160;&#160;Department of Energy will not change its policies that allow for the sale of isotope to the Company.&#160;&#160;Failure to acquire sufficient quantities of medical grade Ac-225 would make it impossible to effectively complete clinical trials and to commercialize Actimab&#8482;-A and would materially harm our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Conducting successful clinical studies may require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patient enrollment in clinical trials and completion of patient participation and follow-up depends on many factors, including the size of the patient population; the nature of the trial protocol; the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects; the availability of appropriate clinical trial investigators; support staff; and proximity of patients to clinical sites and ability to comply with the eligibility and exclusion criteria for participation in the clinical trial and patient compliance.&#160;&#160;For example, patients may be discouraged from enrolling in our clinical trials if the trial protocol requires them to undergo extensive post-treatment procedures or follow-up to assess the safety and effectiveness of our product candidates or if they determine that the treatments received under the trial protocols are not attractive or involve unacceptable risks or discomforts.&#160;&#160;Patients may also not participate in our clinical trials if they choose to participate in contemporaneous clinical trials of competitive product candidates.&#160;&#160;In addition, patients participating in refractory AML clinical trials are seriously and often terminally ill and therefore may not complete the clinical trial due to reasons including comorbid conditions or occurrence of adverse medical events related or unrelated to the investigational products, or death.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Development of sufficient and appropriate clinical protocols to demonstrate safety and efficacy are required and we may not adequately develop such protocols to support clearance and approval.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The FDA may require us to submit data on a greater number of patients than we originally anticipated and/or for a longer follow-up period or change the data collection requirements or data analysis applicable to our clinical trials.&#160;&#160;They may also require additional data on certain categories of patients, should it emerge during the conduct of our clinical trials that certain categories of patients are likely to be affected in different and/or additional manner than most of the patients.&#160;&#160;In addition to FDA requirements, our clinical trial requires the approval of the institutional review board, or IRB, at each site selected for participation in our current Actimab&#8482;-A clinical trial.&#160;&#160;We have submitted our clinical trial to the IRBs at participating sites for approval and we have thus far obtained approval from five IRBs.&#160;&#160;The Company&#8217;s clinical trial protocols have not been rejected by any IRB.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Additional delays to the completion of clinical studies may result from modifications being made to the protocol during the clinical trial, if such modifications are warranted and/or required by the occurrences in the given trial</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each such modification has to be submitted to the FDA.&#160;&#160;This could result in the delay or halt of a clinical trial while the modification is evaluated.&#160;&#160;In addition, depending on the quantity and nature of the changes made, FDA could take the position that some or all of the data generated by the clinical trial is not usable because the same protocol was not used throughout the trial.&#160;&#160;This might require the enrollment of additional subjects, which could result in the extension of the clinical trial and the FDA delaying clearance or approval of a product candidate.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">There can be no assurance that the data generated using modified protocols will be acceptable to FDA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There can be no assurance that the data generated using modified protocols will be acceptable to FDA or that if future modifications during the trial are necessary, that any such modifications will be acceptable to FDA.&#160;&#160;If the FDA believes that its prior approval is required for a particular modification, it can delay or halt a clinical trial while it evaluates additional information regarding the change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Serious injury or death resulting from a failure of one of our drug candidates during current or future clinical trials could also result in the FDA delaying our clinical trials or denying or delaying clearance or approval of a product.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The ongoing Phase I clinical trial for Actimab&#8482;-A conducted at MSKCC was designed to establish the maximum tolerated dose of the product.&#160;&#160;As the Company expected, patients receiving highest dose of the drug administered in the trial so far had prolonged bone marrow suppression which could lead to fatal infections and other severe consequences.&#160;&#160;Consequently, the dose levels of our drug in that trial were reduced as we continue our work on establishing maximum tolerated dose.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even though an adverse event may not be the result of the failure of our drug candidate, FDA or an IRB could delay or halt a clinical trial for an indefinite period of time while an adverse event is reviewed, and likely would do so in the event of multiple such events.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any delay or termination of our current or future clinical trials as a result of the risks summarized above, including delays in obtaining or maintaining required approvals from IRBs, delays in patient enrollment, the failure of patients to continue to participate in a clinical trial, and delays or termination of clinical trials as a result of protocol modifications or adverse events during the trials, may cause an increase in costs and delays in the filing of any submissions with the FDA, delay the approval and commercialization of our product candidates or result in the failure of the clinical trial, which could adversely affect our business, operating results and prospects.&#160;&#160;Lengthy delays in the completion of our Actimab&#8482;-A clinical trials would adversely affect our business and prospects and could cause us to cease operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If the third parties on which we rely to conduct our clinical trials and to assist us with pre-clinical development do not perform as contractually required or expected, we may not be able to obtain regulatory approval for or commercialize our product candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have the ability to independently conduct our pre-clinical and clinical trials for our product candidates and we must rely on third parties, such as contract research organizations, medical institutions, clinical investigators and contract laboratories to conduct such trials.&#160;&#160;If these third parties do not successfully carry out their contractual duties or regulatory obligations or meet expected deadlines, if these third parties need to be replaced, or if the quality or accuracy of the data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other reasons, our pre-clinical development activities or clinical trials may be extended, delayed, suspended or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize, our product candidates on a timely basis, if at all, and our business, operating results and prospects may be adversely affected.&#160;&#160;Furthermore, our third-party clinical trial investigators may be delayed in conducting our clinical trials for reasons outside of their control.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The future results of our current or future clinical trials may not support our product candidate claims or may result in the discovery of unexpected adverse side effects.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if our clinical trials are completed as planned, we cannot be certain that their results will support our product candidate claims or that the FDA or foreign authorities will agree with our conclusions regarding them.&#160;&#160;Success in pre-clinical studies and early clinical trials does not ensure that later clinical trials will be successful, and we cannot be sure that the later trials will replicate the results of prior trials and pre-clinical studies.&#160;&#160;The clinical trial process may fail to demonstrate that our product candidates are safe and effective for the proposed indicated uses.&#160;&#160;If FDA concludes that the clinical trials for Actimab&#8482;-A, or any other product candidate for which we might seek clearance, have failed to demonstrate safety and effectiveness, we would not receive FDA clearance to market that product candidate in the United States for the indications sought.&#160;&#160;In addition, such an outcome could cause us to abandon the product candidate and might delay development of others.&#160;&#160;Any delay or termination of our clinical trials will delay the filing of any submissions with the FDA and, ultimately, our ability to commercialize our product candidates and generate revenues.&#160;&#160;It is also possible that patients enrolled in clinical trials will experience adverse side effects that are not currently part of a product candidate&#8217;s profile.&#160;&#160;In addition, our clinical trials for Actimab&#8482;-A involve a relatively small patient population.&#160;&#160;Because of the small sample size, their results may not be indicative of future results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actimab&#8482;-A and future product candidates may never achieve market acceptance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actimab&#8482;-A and future product candidates that we may develop may never gain market acceptance among physicians, patients and the medical community.&#160;&#160;The degree of market acceptance of any of product will depend on a number of factors, including the actual and perceived effectiveness and reliability of the product; the results of any long&#8722;term clinical trials relating to use of the product; the availability, relative cost and perceived advantages and disadvantages of alternative technologies; the degree to which treatments using the product are approved for reimbursement by public and private insurers; the strength of our marketing and distribution infrastructure; and the level of education and awareness among physicians and hospitals concerning the product.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Failure of Actimab&#8482;-A or any of our other product candidates to significantly penetrate current or new markets would negatively impact our business financial condition and results of operations<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To be commercially successful, physicians must be persuaded that using our product candidates for treatment of AML and other cancers are effective alternatives to existing therapies and treatments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that oncologists and other physicians will not widely adopt a product candidate unless they determine, based on experience, clinical data, and published peer-reviewed journal articles, that the use of that product candidate provides an effective alternative to other means of treating specific cancers.&#160;&#160;Patient studies or clinical experience may indicate that treatment with our product candidates does not provide patients with sufficient benefits in extension of life or quality of life.&#160;&#160;We believe that recommendations and support for the use of each product candidate from influential physicians will be essential for widespread market acceptance.&#160;&#160;Our product candidates are still in the development stage and it is premature to attempt to gain support from physicians at this time.&#160;&#160;We can provide no assurance that such support will ever be obtained.&#160;&#160;If our product candidates do not receive such support from these physicians and from long-term data, physicians may not use or continue to use, and hospitals may not purchase or continue to purchase, them.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Even if our product candidates are approved by regulatory authorities, if we or our suppliers fail to comply with ongoing FDA regulation or if we experience unanticipated problems with our products, these products could be subject to restrictions or withdrawal from the market.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any product candidate for which we obtain FDA clearance or approval, and the manufacturing processes, reporting requirements, post-approval clinical data and promotional activities for such product candidate, will be subject to continued regulatory review, oversight and periodic inspections by the FDA.&#160;&#160;In particular, we and our suppliers are required to comply with FDA&#8217;s Quality System Regulations, or QSR, and International Standards Organization, or ISO, regulations for the manufacture of products and other regulations which cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage and shipping of any product candidate for which we obtain clearance or approval.&#160;&#160;Additionally, because our product candidates include radio-active isotopes, they will be subject to additional regulation and oversight from the United States Nuclear Regulatory Commission (NRC) and similar bodies in other jurisdictions.&#160;&#160;Regulatory bodies, such as the FDA, enforce these regulations through periodic inspections.&#160;&#160;The failure by us or one of our suppliers to comply with applicable statutes and regulations administered by the FDA and other regulatory bodies, or the failure to timely and adequately respond to any adverse inspectional observations or safety issues, could result in, among other things, enforcement actions by the FDA and/or other regulatory bodies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If any of these actions were to occur, it would harm our reputation and cause our future product sales and profitability to suffer and may prevent us from generating revenue.&#160;&#160;Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with all applicable regulatory requirements which could result in our failure to produce our product candidates on a timely basis and in the required quantities, if at all.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if regulatory clearance or approval of a product candidate is granted, such clearance or approval may be subject to limitations on the intended uses for which a product may be marketed and reduce the potential to successfully commercialize that product and generate revenue from that product.&#160;&#160;If the FDA determines that the product promotional materials, labeling, training or other marketing or educational activities constitute promotion of an unapproved use, it could request that we or our commercialization partners cease or modify our training or promotional materials or subject us to regulatory enforcement actions.&#160;&#160;It is also possible that other federal, state or foreign enforcement authorities might take action if they consider such training or other promotional materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, we may be required to conduct costly post-market testing and surveillance to monitor the safety or effectiveness of our products, and we must comply with adverse event and pharmacovigilance reporting requirements, including the reporting of adverse events which occur in connection with, and whether or not directly related to, our products.&#160;&#160;Later discovery of previously unknown problems with our products, including unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements, may result in changes to labeling, restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls, a requirement to recall, replace or refund the cost of any product we manufacture or distribute, fines, suspension of regulatory approvals, product seizures, injunctions or the imposition of civil or criminal penalties which would adversely affect our business, operating results and prospects.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our revenue stream will depend upon third party reimbursement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The commercial success of our product candidates in both domestic and international markets will be substantially dependent on whether third-party coverage and reimbursement is available for patients that use our products.&#160;&#160;However, the availability of insurance coverage and reimbursement for newly approved cancer therapies is uncertain, and therefore, third-party coverage may be particularly difficult to obtain even if our products are approved by the FDA as safe and efficacious.&#160;&#160;Patients using existing approved therapies are generally reimbursed all or part of the product cost by Medicare or other third-party payors. Medicare, Medicaid, health maintenance organizations and other third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of new drugs, and, as a result, they may not cover or provide adequate payment for these products.&#160;&#160;Submission of applications for reimbursement approval generally does not occur prior to the filing of an NDA for that product and may not be granted until many months after NDA approval.&#160;&#160;In order to obtain reimbursement arrangements for these products, we or our commercialization partners may have to agree to a net sales price lower than the net sales price we might charge in other sales channels.&#160;&#160;The continuing efforts of government and third-party payors to contain or reduce the costs of healthcare may limit our revenue.&#160;&#160;Initial dependence on the commercial success of our products may make our revenues particularly susceptible to any cost containment or reduction efforts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Business as a &#8220;Going Concern&#8221;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In expressing an opinion on our financial statements, our auditor has expressed its opinion as to our business being a &#8220;going concern&#8221;. Such an opinion indicates that the business lacks sufficient liquidity to remain operating as a business entity for the next 12 months. Our ability to continue operations is dependent on the successful execution of our plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. We may need to issue additional equity and incur additional liabilities with related parties to sustain our existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are dependent on third parties for manufacturing and marketing of our proposed proprietary products.&#160;&#160;If we are not able to secure favorable arrangements with such third parties, our business and financial condition would be harmed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will not manufacture any of our proposed proprietary products for commercial sale nor do we have the resources necessary to do so.&#160;&#160;In addition, we currently do not have the capability to market drug products ourselves.&#160;&#160;We intend to contract with specialized manufacturing companies to manufacture our proposed proprietary products and partner with larger pharmaceutical companies for their commercialization.&#160;&#160;In connection with our efforts to commercialize our proposed proprietary products, we will seek to secure favorable arrangements with third parties to distribute, promote, market and sell them.&#160;&#160;If we are not able to secure favorable commercial terms or arrangements with third parties for distribution, marketing, promotion and sales of our proposed proprietary products, we may have to retain promotional and marketing rights and seek to develop the commercial resources necessary to promote or co-promote or co-market certain or all of our proprietary product candidates to the appropriate channels of distribution in order to reach the specific medical market that we are targeting.&#160;&#160;We may not be able to enter into any partnering arrangements on this or any other basis.&#160;&#160;If we are not able to secure favorable partnering arrangements, or are unable to develop the appropriate resources necessary for the commercialization of our proposed proprietary products, our business and financial condition could be harmed.&#160;&#160;In addition, we will have to hire additional employees or consultants, since our current employees have limited experience in these areas.&#160;&#160;Sufficient employees with relevant skills may not be available to us.&#160;&#160;Any increase in the number of our employees would increase our expense level, and could have an adverse effect on our financial position.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, we, or our potential commercial partners, may not successfully introduce our proposed proprietary products or they may not achieve acceptance by patients, health care providers and insurance companies.&#160;&#160;Further, it is possible that we may not be able to secure arrangements to manufacture, market, distribute, promote and sell our proposed proprietary products at favorable commercial terms that would permit us to make a profit.&#160;&#160;To the extent that corporate partners conduct clinical trials, we may not be able to control the design and conduct of these clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may have conflicts with our partners that could delay or prevent the development or commercialization of our product candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may have conflicts with our partners, such as conflicts concerning the interpretation of preclinical or clinical data, the achievement of milestones, the interpretation of contractual obligations, payments for services, development obligations or the ownership of intellectual property developed during our collaboration.&#160;&#160;If any conflicts arise with any of our partners, such partner may act in a manner that is adverse to our best interests.&#160;&#160;Any such disagreement could result in one or more of the following, each of which could delay or prevent the development or commercialization of our product candidates, and in turn prevent us from generating revenues: unwillingness on the part of a partner to pay us milestone payments or royalties we believe are due under a collaboration; uncertainty regarding ownership of intellectual property rights arising from our collaborative activities, which could prevent us from entering into additional collaborations; unwillingness by the partner to cooperate in the development or manufacture of the product, including providing us with product data or materials; unwillingness on the part of a partner to keep us informed regarding the progress of its development and commercialization activities or to permit public disclosure of the results of those activities; initiating litigation or alternative dispute resolution options by either party to resolve the dispute; or attempts by either party to terminate the agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Upon commercialization of our product candidates, we may be dependent on third parties to market, distribute and sell them.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our ability to receive revenues may be dependent upon the sales and marketing efforts of any future co-marketing partners and third-party distributors.&#160;&#160;At this time, we have not entered into an agreement with any commercialization partner and only plan to do so after the successful completion of Phase II clinical trials and prior to commercialization.&#160;&#160;If we fail to reach an agreement with any commercialization partner, or if upon reaching such an agreement that partner fails to sell a large volume of our products, it may have a negative impact on our business, financial condition and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our product candidates will face significant competition in the markets for them, and if they are unable to compete successfully, our business will suffer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our product candidates face, and will continue to face, intense competition from large pharmaceutical companies, as well as academic and research institutions.&#160;&#160;We compete in an industry that is characterized by (i) rapid technological change, (ii) evolving industry standards, (iii) emerging competition and (iv) new product introductions.&#160;&#160;Our competitors have existing products and technologies that will compete with our product candidates and technologies and may develop and commercialize additional products and technologies that will compete with our product candidates and technologies.&#160;&#160;Because several competing companies and institutions have greater financial resources than us, they may be able to (i) provide broader services and product lines, (ii) make greater investments in research and development, or R&amp;D, and (iii) carry on broader R&amp;D initiatives.&#160;&#160;Our competitors also have greater development capabilities than we do and have substantially greater experience in undertaking preclinical and clinical testing of product candidates, obtaining regulatory approvals, and manufacturing and marketing pharmaceutical products.&#160;&#160;They also have greater name recognition and better access to customers than us.&#160;&#160;Our chief competitors include companies such as Bayer Schering Pharma AG, GlaxoSmithKline Plc, Spectrum Pharmaceuticals, Inc. and Algeta ASA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Adverse events involving our products may lead the FDA to delay or deny clearance for our product candidates or result in product recalls that could harm our reputation, business and financial results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Once a product candidate receives FDA clearance or approval, the agency has the authority to require the recall of commercialized products in the event of adverse side effects, material deficiencies or defects in design or manufacture.&#160;&#160;The authority to require a recall must be based on an FDA finding that there is a reasonable probability that the device would cause serious injury or death.&#160;&#160;Manufacturers may, under their own initiative, recall a product if any material deficiency in a product is found.&#160;&#160;A government-mandated or voluntary recall by us or one of our distributors could occur as a result of adverse side effects, impurities or other product contamination, manufacturing errors, design or labeling defects or other deficiencies and issues.&#160;&#160;Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our financial condition and results of operations.&#160;&#160;The FDA requires that certain classifications of recalls be reported to FDA within 10 working days after the recall is initiated.&#160;&#160;Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA.&#160;&#160;We may initiate voluntary recalls involving our products in the future that we determine do not require notification of the FDA.&#160;&#160;If the FDA disagrees with our determinations, they could require us to report those actions as recalls.&#160;&#160;A future recall announcement could harm our reputation with customers and negatively affect our sales.&#160;&#160;In addition, the FDA could take enforcement action for failing to report the recalls when they were conducted.</font></div>
</div>

<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our business depends upon securing and protecting critical intellectual property.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our commercial success will depend in part on our obtaining and maintaining patent, trade secret, copyright and trademark protection of our technologies in the United States and other jurisdictions, as well as successfully enforcing this intellectual property and defending this intellectual property against third-party challenges.&#160;&#160;We will only be able to protect our technologies from unauthorized use by third parties to the extent that valid and enforceable intellectual property protection, such as patents or trade secrets law, cover them.&#160;&#160;In particular, we place considerable emphasis on obtaining patent and trade secret protection for significant new technologies, products and processes.&#160;&#160;Furthermore, the degree of future protection of our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage.&#160;&#160;Moreover, the degree of future protection of our proprietary rights is uncertain for product candidates that are currently in the early stages of development because we cannot predict which of these product candidates will ultimately reach the commercial market or whether the commercial versions of these product candidates will incorporate proprietary technologies.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our patent position is highly uncertain and involves complex legal and factual questions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accordingly, we cannot predict the breadth of claims that may be allowed or enforced under our patents or in third-party patents.&#160;&#160;For example, we or our licensors might not have been the first to make the inventions covered by each of our pending patent applications and issued patents; we or our licensors might not have been the first to file patent applications for these inventions; others may independently develop similar or alternative technologies or duplicate any of our technologies; it is possible that none of our pending patent applications or the pending patent applications of our licensors will result in issued patents; our issued patents and issued patents of our licensors may not provide a basis for commercially viable technologies, or may not provide us with any competitive advantages, or may be challenged and invalidated by third parties; and, we may not develop additional proprietary technologies that are patentable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result, our owned and licensed patents may not be valid and we may not be able to obtain and enforce patents and to maintain trade secret protection for the full commercial extent of our technology.&#160;&#160;The extent to which we are unable to do so could materially harm our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We or our licensors have applied for and will continue to apply for patents for certain products.&#160;&#160;Such applications may not result in the issuance of any patents, and any patents now held or that may be issued may not provide us with adequate protection from competition.&#160;&#160;Furthermore, it is possible that patents issued or licensed to us may be challenged successfully.&#160;&#160;In that event, if we have a preferred competitive position because of such patents, such preferred position would be lost.&#160;&#160;If we are unable to secure or to continue to maintain a preferred position, we could become subject to competition from the sale of generic products.&#160;&#160;Failure to receive, inability to protect, or expiration of our patents for medical use, manufacture, conjugation and labeling of Ac-225, the antibodies that we license from third parties, or subsequent related filings, would adversely affect our business and operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patents issued or licensed to us may be infringed by the products or processes of others.&#160;&#160;The cost of enforcing our patent rights against infringers, if such enforcement is required, could be significant, and the Company does not currently have the financial resources to fund such litigation.&#160;&#160;Further, such litigation can go on for years and the time demands could interfere with our normal operations.&#160;&#160;There has been substantial litigation and other proceedings regarding patent and other intellectual property rights in the pharmaceutical industry.&#160;&#160;We may become a party to patent litigation and other proceedings.&#160;&#160;The cost to us of any patent litigation, even if resolved in our favor, could be substantial.&#160;&#160;Some of our competitors may be able to sustain the costs of such litigation more effectively than we can because of their substantially greater financial resources.&#160;&#160;Litigation may also absorb significant management time.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unpatented trade secrets, improvements, confidential know-how and continuing technological innovation are important to our scientific and commercial success.&#160;&#160;Although we attempt to and will continue to attempt to protect our proprietary information through reliance on trade secret laws and the use of confidentiality agreements with our partners, collaborators, employees and consultants and other appropriate means, these measures may not effectively prevent disclosure of our proprietary information, and, in any event, others may develop independently, or obtain access to, the same or similar information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain of our patent rights are licensed to us by third parties.&#160;&#160;If we fail to comply with the terms of these license agreements, our rights to those patents may be terminated, and we will be unable to conduct our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we are found to be infringing on patents or trade secrets owned by others, we may be forced to cease or alter our product development efforts, obtain a license to continue the development or sale of our products, and/or pay damages.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our manufacturing processes and potential products may violate proprietary rights of patents that have been or may be granted to competitors, universities or others, or the trade secrets of those persons and entities.&#160;&#160;As the pharmaceutical industry expands and more patents are issued, the risk increases that our processes and potential products may give rise to claims that they infringe the patents or trade secrets of others.&#160;&#160;These other persons could bring legal actions against us claiming damages and seeking to enjoin clinical testing, manufacturing and marketing of the affected product or process.&#160;&#160;If any of these actions are successful, in addition to any potential liability for damages, we could be required to obtain a license in order to continue to conduct clinical tests, manufacture or market the affected product or use the affected process.&#160;&#160;Required licenses may not be available on acceptable terms, if at all, and the results of litigation are uncertain.&#160;&#160;If we become involved in litigation or other proceedings, it could consume a substantial portion of our financial resources and the efforts of our personnel.</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our ability to protect and enforce our patents does not guaranty that we will secure the right to commercialize our patents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A patent is a limited monopoly right conferred upon an inventor, and his successors in title, in return for the making and disclosing of a new and non-obvious invention.&#160;&#160;This monopoly is of limited duration but, while in force, allows the patent holder to prevent others from making and/or using its invention.&#160;&#160;While a patent gives the holder this right to exclude others, it is not a license to commercialize the invention where other permissions may be required for commercialization to occur.&#160;&#160;For example, a drug cannot be marketed without the appropriate authorization from the FDA, regardless of the existence of a patent covering the product.&#160;&#160;Further, the invention, even if patented itself, cannot be commercialized if it infringes the valid patent rights of another party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We rely on confidentiality agreements to protect our trade secrets.&#160;&#160;If these agreements are breached by our employees or other parties, our trade secrets may become known to our competitors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We rely on trade secrets that we seek to protect through confidentiality agreements with our employees and other parties.&#160;&#160;If these agreements are breached, our competitors may obtain and use our trade secrets to gain a competitive advantage over us.&#160;&#160;We may not have any remedies against our competitors and any remedies that may be available to us may not be adequate to protect our business or compensate us for the damaging disclosure.&#160;&#160;In addition, we may have to expend resources to protect our interests from possible infringement by others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may undertake international operations, which will subject us to risks inherent with operations outside of the United States.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Although we do not have any foreign operations at this time, we intend to seek market clearances in foreign markets that we believe will generate significant opportunities.&#160;&#160;However, even with the cooperating of a commercialization partner, conducting drug development in foreign countries involves inherent risks, including, but not limited to difficulties in staffing, funding and managing foreign operations; unexpected changes in regulatory requirements; export restrictions; tariffs and other trade barriers; difficulties in protecting, acquiring, enforcing and litigating intellectual property rights; fluctuations in currency exchange rates; and potentially adverse tax consequences.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If we were to experience any of the difficulties listed above, or any other difficulties, any international development activities and our overall financial condition may suffer and cause us to reduce or discontinue our international development and registration efforts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may not be successful in hiring and retaining key employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our future operations and successes depend in large part upon the continued service of key members of our senior management team whom we are highly dependent upon to manage our business, in particular, Dr. Dragan Cicic, our Chief Operating Officer and Chief Medical Officer.&#160;&#160;If any member of our current senior management terminates his or her employment with us, such a departure may have a material adverse effect on our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our future success also depends on our ability to identify, attract, hire or engage, retain and motivate other well-qualified managerial, technical, clinical and regulatory personnel.&#160;&#160;There can be no assurance that such professionals will be available in the market, or that we will be able to retain existing professionals or meet or continue to meet their compensation requirements.&#160;&#160;Furthermore, the cost base in relation to such compensation, which may include equity compensation, may increase significantly, which could have a material adverse effect on us.&#160;&#160;Failure to establish and maintain an effective management team and work force could adversely affect our ability to operate, grow and manage our business. </font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We do not yet know what the consequences may be on our business of the Patient Protection and Affordable Care Act.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2010, President Obama signed the Patient Protection and Affordable Care Act ("PPACA"), which makes changes that are expected to significantly impact the pharmaceutical industries. One of the principal aims of the PPACA as currently enacted is to expand health insurance coverage to approximately 32 million Americans who are currently uninsured. The consequences of this significant coverage expansion on the sales of our products, once they are developed, are unknown and speculative at this point.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The PPACA contains a number of provisions designed to generate the revenues necessary to fund the coverage expansions among other things. This includes new fees or taxes on certain health-related industries.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The PPACA provisions on comparative clinical effectiveness research extend the initiatives of the American Recovery and Reinvestment Act of 2009, also known as the stimulus package, which included $1.1 billion in funding to study the comparative effectiveness of health care treatments and strategies. This stimulus funding was designated for, among other things, conducting, supporting or synthesizing research that compares and evaluates the risks and benefits, clinical outcomes, effectiveness and appropriateness of products. The PPACA appropriates additional funding to comparative clinical effectiveness research. Although Congress has indicated that this funding is intended to improve the quality of health care, it remains unclear how the research will impact current Medicare coverage and reimbursement or how new information will influence other third-party payor policies.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, other legislative changes have been proposed and adopted since the PPACA was enacted. Most recently, on August 2, 2011, the President Obama signed into law the Budget Control Act of 2011, which, among other things, creates the Joint Select Committee on Deficit Reduction to recommend proposals in spending reductions to Congress. The Joint Select Committee did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, which threatened to trigger the legislation&#8217;s automatic reduction to several government programs, including aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, starting in 2013. Congress passed and President Obama signed, however, the American Taxpayer Relief Act of 2012 which delays these required cuts for one year. We expect that the PPACA, as well as other federal or state health care reform measures that may be adopted in the future, could have a material adverse effect on our industry generally and our ability to successfully commercialize our products or could limit or eliminate our spending on certain development projects. The taxes imposed by the PPACA and the expansion in the government&#8217;s role in the U.S. healthcare industry may result in decreased profits to us, lower reimbursement by payors for our products, and/or reduced medical procedure volumes, all of which may adversely affect our business, financial condition and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Managing our growth as we expand operations may strain our resources.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect to need to grow rapidly in order to support additional, larger, and potentially international, pivotal clinical trials of our drug candidates, which will place a significant strain on our financial, managerial and operational resources.&#160;&#160;In order to achieve and manage growth effectively, we must continue to improve and expand our operational and financial management capabilities.&#160;&#160;Moreover, we will need to increase staffing and to train, motivate and manage our employees.&#160;&#160;All of these activities will increase our expenses and may require us to raise additional capital sooner than expected.&#160;&#160;Failure to manage growth effectively could materially harm our business, financial condition or results of operations.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may expand our business through the acquisition of rights to new product candidates that could disrupt our business, harm our financial condition and may also dilute current stockholders&#8217; ownership interests in our company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our business strategy includes expanding our products and capabilities, and we may seek acquisitions of drug candidates, antibodies or technologies to do so.&#160;&#160;Acquisitions involve numerous risks, including substantial cash expenditures; potentially dilutive issuance of equity securities; incurrence of debt and contingent liabilities, some of which may be difficult or impossible to identify at the time of acquisition; difficulties in assimilating acquired technologies or the operations of the acquired companies; diverting our management&#8217;s attention away from other business concerns; risks of entering markets in which we have limited or no direct experience; and the potential loss of our key employees or key employees of the acquired companies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We can make no assurances that any acquisition will result in short-term or long-term benefits to us.&#160;&#160;We may incorrectly judge the value or worth of an acquired product, company or business.&#160;&#160;In addition, our future success would depend in part on our ability to manage the rapid growth associated with some of these acquisitions.&#160;&#160;We cannot assure that we will be able to make the combination of our business with that of acquired products, businesses or companies work or be successful.&#160;&#160;Furthermore, the development or expansion of our business or any acquired products, business or companies may require a substantial capital investment by us.&#160;&#160;We may not have these necessary funds or they might not be available to us on acceptable terms or at all.&#160;&#160;We may also seek to raise funds by selling shares of our preferred or common stock, which could dilute each current stockholder&#8217;s ownership interest in the Company.</font></div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Ownership of Our Common Stock</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our shareholders will not be able to use the Rule 144 safe harbor until one year after we ceased to be a shell company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Rule 144 under the Securities Act of 1933 provides a safe harbor under which holders of restricted securities and affiliates of an issuer may resell their securities into the public market. Effective February 15, 2008, Rule 144 was amended to make it unavailable for securities of former shell companies until, among other things, twelve months have elapsed since the former &#8220;shell company&#8221; has filed &#8220;Form 10 information&#8221; with the Securities and Exchange Commission. The Company was a &#8220;shell company&#8221; until December 28, 2012, when it completed its share exchanges with Actinium. On January 2, 2013, we filed a Form 8-K report that was intended to satisfy the &#8220;Form 10 information&#8221; requirement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The unavailability of the Rule 144 resale exemption for our securities may adversely affect our ability to attract additional capital through unregistered offerings, and may adversely affect the ability of shareholders who acquired our shares pursuant to unregistered offerings to resell their securities into the public market, all of which could have a material adverse effect on us and our shareholders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because we became public by means of a &#8220;reverse merger,&#8221; we may not be able to attract the attention of major brokerage firms.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional risks may exist since we became public through a &#8220;reverse merger.&#8221; Securities analysts of major brokerage firms may not provide coverage of us since there is little incentive to brokerage firms to recommend the purchase of our common stock. We cannot assure you that brokerage firms will want to conduct any secondary offerings on behalf of our company in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because we were formerly an SEC-reporting shell company, we are subject to SEC rules on seasoning requirements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company, since it was formerly an SEC-reporting shell company, is also subject to SEC rules which require such companies to trade in the over-the-counter markets (or some other national exchanges) for one full fiscal year and to file all periodic reports with the SEC before seeking to &#8220;uplist&#8221; to a national securities exchange like NASDAQ or NYSE MKT. The Company can only bypass the one year over-the-counter trading requirement if it can complete a firm commitment underwritten public offering with gross proceeds of at least $40 million. As a result, our stockholders may find it more difficult to dispose of shares or obtain accurate quotations as to the market value of our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The sale of securities by us in any equity or debt financing could result in dilution to our existing stockholders and have a material adverse effect on our earnings.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe we need up to $25 million in cash to finance research and development and to cover our ongoing working capital needs through the first quarter of 2016, and we have not completed efforts to establish a stable recurring source of revenues sufficient to cover our operating costs for the next twelve months, We have financed our operations primarily through sales of stock and the issuance of convertible promissory notes.&#160;&#160;It is likely that during the next twelve months we will seek to raise capital through the sales of stock and/or issuance of convertible promissory notes in order to expand our level of operations to continue our research and development efforts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any sale of common stock by us in a future private placement offering could result in dilution to the existing stockholders as a direct result of our issuance of additional shares of our capital stock.&#160;&#160;In addition, our business strategy may include expansion through internal growth, by acquiring subscribers email lists, or by establishing strategic relationships with targeted customers and vendor.&#160;&#160;In order to do so, or to finance the cost of our other activities, we may issue additional equity securities that could dilute our stockholders&#8217; stock ownership.&#160;&#160;We may also assume additional debt and incur impairment losses related to goodwill and other tangible assets if we acquire another company and this could negatively impact our earnings and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The filing of our Registration Statement on Form S-1 on March 15, 2013 could have potentially affected our exemption from registration with the SEC for the share exchange that commenced on December 28, 2012, in connection with our exchange of common stock with the shareholders of Actinium Corporation (fka, Actinium Pharmaceuticals, Inc.).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, we completed a share exchange, that was approved by 78% of our shareholders (100% of those voting approved the share exchange),&#160;&#160;with Cactus Ventures, Inc. (&#8220;Cactus&#8221;), whereby Cactus acquired 21% of the issued and outstanding capital stock of Actinium Corporation from the shareholders of Actinium Corporation (the &#8220;Actinium Shareholders&#8221;) in exchange for the issuance of 4,309,015 shares of Common Stock of the Company to the Actinium Shareholders (the &#8220;Share Exchange&#8221;).&#160;&#160; We continued the physical process of exchanging shares with the Actinium Shareholders with closings on March 11, 2013 (with a total of 55.5% shares of Actinium Corporation exchanged) and August 22, 2013 (with a total of 93.7% shares of Actinium Corporation exchanged).&#160; On September 25, 2013 all of the remaining Actinium Shareholders shares were exchanged for our common stock pursuant to a merger under Delaware law whereby we merged into our self Actinium Corporation (our subsidiary that was 93.7% owned by us). Under Section 5 of the Securities Act of 1933, unless there is a valid exemption from registration of the securities sold in an offering. all issuers must register non-exempt securities with the SEC. The securities in the Share Exchange were offered and sold in reliance upon exemptions from registration pursuant to Section 4(2) of the Securities Act and Rule 506 of Regulation D &#160;(&#8220;Regulation D&#8221;) promulgated under the Securities Act.&#160;&#160;On March 15, 2013, we filed a Registration Statement on Form S-1 (the &#8220;Registration Statement&#8221;) with SEC to register shares of certain selling shareholders who had purchased shares of the Company in various private placements (the &#8220;2013 offering&#8221;).&#160; If the 2013 Offering were deemed integrated with the Share Exchange we may not be able to rely upon the exemptions from registration pursuant to Section 4(2) of the Securities Act and/or Regulation D, since the filing of the &#160;Registration Statement may be deemed general solicitation, which is prohibited for reliance on an exemption from registration under Regulation D.&#160; As a result, investors in the Share Exchange may potentially be entitled to bring suit against the Company for offering a non-exempt security without registering it, and such investor may be able to obtain rescission with interest, or damages if the investor sold the securities for less that he or she purchased them.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Future sales of our common stock in the public market could lower the price of our common stock and impair our ability to raise funds in future securities offerings.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could adversely affect the then prevailing market price of our common stock and could make it more difficult for us to raise funds in the future through a public offering of our securities. We believe we need up to $25 million in cash to finance research and development and to cover our ongoing working capital needs through the first quarter of 2016, and we have not completed efforts to establish a stable recurring source of revenues sufficient to cover our operating costs for the next twelve months, We have financed our operations primarily through sales of stock and the issuance of convertible promissory notes. It is likely that during the next twelve months we will to continue to finance our operations through sales of stock and/or issuance of convertible promissory notes.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Common Stock is quoted on the OTCQB which may have an unfavorable impact on our stock price and liquidity.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock is quoted on the OTCQB, which is a significantly more limited trading market than the New York Stock Exchange or The NASDAQ Stock Market.&#160;&#160;The quotation of the Company&#8217;s shares on the OTCQB may result in a less liquid market available for existing and potential stockholders to trade shares of our common stock, could depress the trading price of our common stock and could have a long-term adverse impact on our ability to raise capital in the future.</font></font></div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">There is limited liquidity on the OTCQB which may result in stock price volatility and inaccurate quote information.</font></font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font size="3" style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">When fewer shares of a security are being traded on the OTCQB, volatility of prices may increase and price movement may outpace the ability to deliver accurate quote information.&#160;&#160;Due to lower trading volumes in shares of our common stock, there may be a lower likelihood of one&#8217;s orders for shares of our common stock being executed, and current prices may differ significantly from the price one was quoted at the time of one&#8217;s order entry.</font></font></font></font></div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our common stock is extremely thinly traded, so you may be unable to sell at or near asking prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate your shares.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Currently, the Company&#8217;s common stock is quoted in the OTCQB and future trading volume may be limited by the fact that many major institutional investment funds, including mutual funds, as well as individual investors follow a policy of not investing in OTCQB stocks and certain major brokerage firms restrict their brokers from recommending OTCQB stocks because they are considered speculative, volatile and thinly traded.&#160;&#160;The OTCQB market is an inter-dealer market much less regulated than the major exchanges and our common stock is subject to abuses, volatility and shorting.&#160;&#160;Thus, there is currently no broadly followed and established trading market for the Company&#8217;s common stock.&#160;&#160;An established trading market may never develop or be maintained. Active trading markets generally result in lower price volatility and more efficient execution of buy and sell orders. Absence of an active trading market reduces the liquidity of the shares traded there.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Common Stock is subject to price volatility unrelated to our operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The trading volume of our common stock has been and may continue to be extremely limited and sporadic.&#160;&#160;As a result of such trading activity, the quoted price for the Company&#8217;s common stock on the OTCQB may not necessarily be a reliable indicator of its fair market value.&#160;&#160;Further, if we cease to be quoted, holders would find it more difficult to dispose of our common stock or to obtain accurate quotations as to the market value of the Company&#8217;s common stock and as a result, the market value of our common stock likely would decline.</font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect the market price of our Common Stock to fluctuate substantially due to a variety of factors, including market perception of our ability to achieve our planned growth, quarterly operating results of other companies in the same industry, trading volume in our common stock, changes in general conditions in the economy and the financial markets or other developments affecting the Company&#8217;s competitors or the Company itself. In addition, the OTCQB is subject to extreme price and volume fluctuations in general.&#160;&#160;This volatility has had a significant effect on the market price of securities issued by many companies for reasons unrelated to their operating performance and could have the same effect on our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are an "emerging growth company" under the JOBS Act of 2012 and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are an &#8220;emerging growth company&#8221;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, Section 107 of the JOBS Act also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing to take advantage of the extended transition period for complying with new or revised accounting standards.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will remain an &#8220;emerging growth company&#8221; for up to five years, although we will lose that status sooner if our revenues exceed $1 billion, if we issue more than $1 billion in non-convertible debt in a three year period, or the date on which the issuer qualifies as a large accelerated filer under SEC rules.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our status as an &#8220;emerging growth company&#8221; under the JOBS Act of 2012 may make it more difficult to raise capital as and when we need it.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Because of the exemptions from various reporting requirements provided to us as an &#8220;emerging growth company&#8221; and because we will have an extended transition period for complying with new or revised financial accounting standards, we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are subject to penny stock regulations and restrictions and you may have difficulty selling shares of our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to the provisions of Section 15(g) and Rule 15g-9 of the Exchange Act, commonly referred to as the &#8220;penny stock rule.&#8221;&#160;&#160;Section 15(g) sets forth certain requirements for transactions in penny stock, and Rule 15g-9(d) incorporates the definition of &#8220;penny stock&#8221; that is found in Rule 3a51-1 of the Exchange Act.&#160;&#160;The SEC generally defines a penny stock to be any equity security that has a market price less than $5.00 per share, subject to certain exceptions. We will be subject to the SEC&#8217;s penny stock rules.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our Common Stock is deemed to be penny stock, trading in the shares of our common stock is subject to additional sales practice requirements on broker-dealers who sell penny stock to persons other than established customers and accredited investors.&#160;&#160;&#8220;Accredited investors&#8221; are persons with assets in excess of $1,000,000 (excluding the value of such person&#8217;s primary residence) or annual income exceeding $200,000 or $300,000 together with their spouse. For transactions covered by these rules, broker-dealers must make a special suitability determination for the purchase of such security and must have the purchaser&#8217;s written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt the rules require the delivery, prior to the first transaction of a risk disclosure document, prepared by the SEC, relating to the penny stock market.&#160;&#160;A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative and current quotations for the securities.&#160;&#160;Finally, monthly statements must be sent disclosing recent price information for the penny stocks held in an account and information to the limited market in penny stocks. Consequently, these rules may restrict the ability of broker-dealer to trade and/or maintain a market in our common stock and may affect the ability of the Company&#8217;s stockholders to sell their shares of common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There can be no assurance that our shares of common stock will qualify for exemption from the Penny Stock Rule. In any event, even if our common stock was exempt from the Penny Stock Rule, we would remain subject to Section 15(b)(6) of the Exchange Act, which gives the SEC the authority to restrict any person from participating in a distribution of penny stock if the SEC finds that such a restriction would be in the public interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because we do not intend to pay dividends, stockholders will benefit from an investment in our Common Stock only if it appreciates in value.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have never declared or paid any cash dividends on our Preferred Stock or Common Stock.&#160;&#160;For the foreseeable future, it is expected that earnings, if any, generated from our operations will be used to finance the growth of our business, and that no dividends will be paid to holders of the Company&#8217;s Preferred Stock or Common Stock.&#160;&#160;As a result, the success of an investment in our Preferred Stock or Common Stock will depend upon any future appreciation in its value.&#160;&#160;There is no guarantee that our Preferred Stock or Common Stock will appreciate in value.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certain provisions of our Articles of Incorporation and Bylaws and Delaware law make it more difficult for a third party to acquire us and make a takeover more difficult to complete, even if such a transaction were in the stockholders&#8217; interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Articles of Incorporation and Bylaws and certain provisions of Delaware State law could have the effect of making it more difficult or more expensive for a third party to acquire, or from discouraging a third party from attempting to acquire, control of the Company, even when these attempts may be in the best interests of our stockholders.&#160;&#160;For example, we are governed by Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years, did own, 15% or more of the corporation&#8217;s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compliance with the reporting requirements of federal securities laws can be expensive.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to the information and reporting requirements of the Exchange Act and other federal securities laws, and the compliance obligations of the Sarbanes-Oxley Act.&#160;The costs of preparing and filing annual and quarterly reports and other information with the SEC and furnishing audited reports to stockholders are substantial.&#160;In addition, we will incur substantial expenses in connection with the preparation of registration statements and related documents with respect to the registration of resale of the Common Stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applicable regulatory requirements, including those contained in and issued under the Sarbanes-Oxley Act, may make it difficult for us to retain or attract qualified officers and directors, which could adversely affect the management of its business and its ability to obtain or retain listing of our Common Stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may be unable to attract and retain those qualified officers, directors and members of board committees required to provide for effective management because of the rules and regulations that govern publicly held companies, including, but not limited to, certifications required by principal executive officers. The enactment of the Sarbanes-Oxley Act has resulted in the issuance of a series of related rules and regulations and the strengthening of existing rules and regulations by the SEC, as well as the adoption of new and more stringent rules by the stock exchanges. The perceived increased personal risk associated with these changes may deter qualified individuals from accepting roles as directors and executive officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Further, some of these changes heighten the requirements for board or committee membership, particularly with respect to an individual&#8217;s independence from the corporation and level of experience in finance and accounting matters. We may have difficulty attracting and retaining directors with the requisite qualifications. If we are unable to attract and retain qualified officers and directors, the management of our business and our ability to obtain or retain listing of our shares of Common Stock on any stock exchange (assuming we elect to seek and are successful in obtaining such listing) could be adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or detect fraud.&#160;&#160;Investors could lose confidence in our financial reporting and this may decrease the trading price of our Common Stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We must maintain effective internal controls to provide reliable financial reports and detect fraud. We have been assessing our internal controls to identify areas that need improvement. Failure to maintain an effective system of internal controls could harm our operating results and cause investors to lose confidence in our reported financial information.&#160;Any such loss of confidence would have a negative effect on the trading price of our Common Stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2012, management concluded that our disclosure controls and procedures and our internal control over financial reporting were not effective due to several material weaknesses.&#160;&#160;&#160;To address these weaknesses, management is seeking a full time Chief Financial Officer who is familiar with the public company reporting rules. The Company in December 2012 also established an Audit Committee to address these issues. In September 2013, we hired a VP of Finance who has served in a variety of core finance and business development functions over the span of 12 years at three NASDAQ listed biopharmaceutical companies<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>who is being tasked with remediating such weaknesses.&#160;&#160;&#160;We expect to&#160;remediate such weaknesses by the end of the fiscal year 2013.&#160;&#160;In May 2013, we also engaged an outside third party financial reporting consulting firm to assist with our public company&#160;reporting requirements.&#160;&#160;&#160;We expect to incur costs of $200,000 in connection with our remediation plan.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The price of our common stock may become volatile, which could lead to losses by investors and costly securities litigation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The trading price of our Common Stock may be highly volatile and could fluctuate in response to factors such as:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">actual or anticipated variations in our operating results;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">announcements of developments by us or our competitors;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the timing of IND and/or NDA approval, the completion and/or results of our clinical trials;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">regulatory actions regarding our products;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">adoption of new accounting standards affecting the our industry;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">additions or departures of key personnel;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">introduction of new products by us or our competitors;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">sales of the our Common Stock or other securities in the open market; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">other events or factors, many of which are beyond our control.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The stock market is subject to significant price and volume fluctuations. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been initiated against such a company. Litigation initiated against us, whether or not successful, could result in substantial costs and diversion of our management&#8217;s attention and Company resources, which could harm our business and financial condition.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold"><a name="CAUTIONARYNOTE">CAUTIONARY NOTE</a></font>&#160;REGARDING FORWARD-LOOKING STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This prospectus contains forward looking statements that involve risks and uncertainties, principally in the sections entitled &#8220;Description of Business,&#8221; &#8220;Risk Factors,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; All statements other than statements of historical fact contained in this prospectus, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;should,&#8221; or &#8220;will&#8221; or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under &#8220;Risk Factors&#8221; or elsewhere in this prospectus, which may cause our or our industry&#8217;s actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assumes no obligation to update any such forward-looking statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. Before you invest in our securities, you should be aware that the occurrence of the events described in the section entitled &#8220;Risk Factors&#8221; and elsewhere in this prospectus could negatively affect our business, operating results, financial condition and stock price. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this prospectus to conform our statements to actual results or changed expectations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;<a name="item_1_3_3"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="DIVIDENDPOLICY">DIVIDEND POLICY</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We plan to retain any earnings for the foreseeable future for our operations. We have never paid any dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends will be at the discretion of our Board of Directors and will depend on our financial condition, operating results, capital requirements and such other factors as our Board of Directors deems relevant. In addition, our credit facility restricts our ability to pay dividends.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;<a name="item_1_3_4"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="USEOFPROCEEDS">USE OF PROCEEDS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will not receive any proceeds from the sale of the common stock by the selling stockholders. However, we may receive up to approximately $14.8 million in the aggregate upon the exercise of the warrants if the holders exercise them for cash. However, as these warrants also include a cashless exercise feature there can be no assurance that we will receive any capital from the exercise of such warrants. The registration of common stock pursuant to this prospectus does not necessarily mean that any of those shares will ultimately be offered or sold by the selling stockholders.&#160;&#160;We intend to use the proceeds received from any cash exercise of the warrants for working capital and general corporate purposes.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="DILUTION">DILUTION</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are not selling any of the shares of our common stock in this offering. All of the shares sold in this offering will be held by the selling stockholders at the time of the sale, so that no dilution will result from the sale of the shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="PENNYSTOCK">PENNY STOCK</a> CONSIDERATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock will be a penny stock, therefore, trading in our securities is subject to penny stock considerations. Broker-dealer practices in connection with transactions in &#8220;penny stocks&#8221; are regulated by certain penny stock rules adopted by the SEC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Penny stocks generally are equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or quoted on the NASDAQ system). Penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer&#8217;s account. The broker-dealer must also make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#8217;s written agreement to the transaction. These requirements may have the effect of reducing the level of trading activity, if any, in the secondary market for a security that becomes subject to the penny stock rules. The additional burdens imposed upon broker-dealers by such requirements may discourage broker-dealers from effecting transactions in our securities, which could severely limit their market price and liquidity of our securities. These requirements may restrict the ability of broker-dealers to sell our common stock and may affect your ability to resell our common stock.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>&#160;</div>
</div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="SELLINGSTOCKHOLDERS">SELLING STOCKHOLDERS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The common shares being offered for resale by the selling stockholders consist of 25,735,497 shares of our common stock that are issued and outstanding, including up to (i) 16,162,319 shares of common stock, par value $0.001 per share, held by the selling stockholders, (ii) 1,559,438 shares of our common stock issuable upon exercise of Series B warrants held by the selling stockholders at an exercise price of $2.48 per share, (iii) 2,673,652 shares of our common stock issuable upon exercise of the Stock Offering warrants held by the selling stockholders at an exercise price of $0.78 per share, (iv) 3,755,562 shares of our common stock issuable upon exercise of consulting firm warrants held by the selling stockholders at an exercise price of $0.01 per share, (v) 1,120,499 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $0.78 per share, (vi) 464,027 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $2.48 per share. Our common stock issuable upon the exercise of Series A Warrants are not being offered because they have been either exercised and converted into common stock or expired as of May 28, 2013.&#160;&#160;These holders include investors in private placement and notes offerings of our subsidiary Actinium that closed (A) on December 19, 2012 for the sale of units consisting of an aggregate of (i) 3,118,968 shares of common stock, (ii) Series A warrants to purchase 3,118,968 shares of common stock, and (iii) Series B warrants to purchase up to 1,559,484 shares of common stock, (B) during 2011 and January 2012 for the sale of units consisting of an aggregate of (i) 15,922,760 shares of common stock (after conversion of preferred stock and dividends), and (ii) Stock Offering warrants to purchase 2,682,140 shares of common stock, and (C) on December 27, 2011, whereby Actinium completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes in the amount of $900,000 and received net proceeds of $750,000, and the notes have converted to 1,148,275 shares of common stock.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth certain information regarding the selling stockholders and the shares offered by them in this prospectus. Each selling stockholder&#8217;s percentage of ownership is based upon 25,581,139 shares of common stock outstanding as of&#160;September 26, 2013 and all securities which the person has the right to acquire within 60 days through the exercise of any option or warrant or through the conversion of a convertible security.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="39%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name of Selling Stockholder</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Owned prior to </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Offering</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Percentage </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(%) </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Owned prior </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">to Offering</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="3" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares to </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Offer (1)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Owned&#160;</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">After </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Offering</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Percentage</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Beneficially </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Owned after </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Offering</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adam Baker</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111,300</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111,300</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Alan Aranha</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,533</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Albert H. Konetzni, Jr. and Shirley A. Konetzni (JTTEN)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94,764</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94,764</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Alexander Sepulveda IRA (Sterne Agee &amp; Leach Inc. C/F Alexander Sepulveda IRA)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amrosan LLC</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99,617</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">475,173</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andres Wawrla</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">378,407</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4792</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">378,407</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andrew Bellamy</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,409</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,409</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andrew Chandler</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,073</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,073</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andrew Charles Good&#160;&#160;&amp; Fiona McPhee (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,244</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,244</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Anthony D'Amato</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,198</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,198</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aparna Beeram</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,657</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,657</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Benjamin Hasty</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,434</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,434</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Billy W. Harris</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bioche Asset Management LLC</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">721,068</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bohdan Chaban</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,588</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,588</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Brendan Sullivan</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,129</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,129</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Brian E. Jones and Peggy A. Jones (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">342,351</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3383</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">342,351</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Brian Miller IRA, (Robert W. Baird &amp; Co., Inc. TTEE, FBO Brian Miller IRA Acct # 6144 2867)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Brian Murray</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,636</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,636</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Brian Robertson</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,116</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105,983</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bruce Porter</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,420</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,420</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bruno Donnou</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bruno J. Casatelli</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">137,380</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">137,380</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bryan J. Hanks &amp; Michelle B. Hanks (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">81,189</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">81,189</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Buff Trust</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274,091</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0715</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274,091</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Burton Mark Paull</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C.S. Leslie, Malcolm</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carl F. Muckenhin</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(28</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carnegie Hill Asset Partners</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353,023</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(29</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carol A. Wilson IRA - Sterne Agee Leach Inc. C/F Carol A.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,135</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,135</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chad A. Elms</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,120</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,120</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charles J. Magolske</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(32</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charles L Weidner TTEE &amp; Alice N Barrett Weidner TTEE FBO The Weidner Family Revocable Trust DTD 8/13/07</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">301,781</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.1797</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">301,781</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charles L. Vinn</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charles W. Ganse</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,409</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,409</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(35</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chris Marshall</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chris McHugh</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,491</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,491</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(37</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc C/F Christina G. Einstein IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,784</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,784</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Christopher J. Mehos</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,784</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,784</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(39</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Christopher Kane</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,435</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,435</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(40</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Christopher M. Johnston</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(41</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Christopher Oppito</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,355</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,355</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(42</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clayton A. and Stephanie S., Reed</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(43</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clint N. Duty</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conor Gilligan</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(45</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conor Stanley</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,005</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,005</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(46</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Craig Bonn</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,382</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,382</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(47</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Daniel P. Wikel</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(48</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Daniel W. Kuhar</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,392</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,392</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(49</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David A. Kuhar</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(50</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Cantwell</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">181,176</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">181,176</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Hicks Pension Fund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Patterson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(53</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David W. Frost</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241,228</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241,228</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David W. Frost IRA - Sterne Agee &amp; Leach Inc. C/F</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,052</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,052</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dean L. Fox</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346,800</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3557</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346,800</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(56</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deborah L. Katz</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(57</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denis O'Brien</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">867,043</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.3894</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">867,043</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(58</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dianne M. Scheck</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(59</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Donald K. Coffey</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(60</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Douglas A. Alcott</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(61</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Douglas E. Eckert</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(62</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Douglas J Amos &amp; Carol A. Amos (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,655</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,655</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(63</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Douglas R. Holroyd &amp; Jill K. Holroyd (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,854</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67,854</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(64</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. John M. Ferriter</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,891</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,891</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Richard &amp; Anita Matter (JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94,551</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94,551</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(66</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Earl R. Richardson</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">130,049</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">130,049</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(67</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Edward C. Moore</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,560</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,560</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Edwin A. Schermerhorn Roth IRA -Sterne Agee &amp; Leach Inc. C/F</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(69</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eitner Family Trust</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">174,634</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(70</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eliana Cardenas and Roberto Mendez,&#160;&#160;(JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(71</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Enguerrand de Ponteves</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,163</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,163</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(72</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eugene E. Eubank</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(73</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Evan Stern</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(74</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Francis Smith</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,548</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,548</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(75</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Frank Davis</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(76</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Garnett Trust</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274,091</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0715</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274,091</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gary M. Higdem</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(78</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gary A.Washauer</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(79</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gene R. Carlson &amp; Cynthia L Carlson ( JTWROS)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(80</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">George B. Beam</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(81</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">George Elefther&#160;&#160;&amp; Karin Alexa&#160;&#160;Elefther (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(82</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc.&#160;&#160;C/F George Elefther IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,281</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,281</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(83</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">George M Zelinski</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233,945</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233,945</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(84</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gerhard Plaschka</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,235</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,235</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(85</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gonzalo A Salgueiro</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,830</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,830</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(86</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant L. Hanby</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(87</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gregory F. Sullivan MD &amp; Gene M. Sullivan (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">168,280</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">168,280</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(88</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Harold O. LaFlash and Greta G. LaFlash (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(89</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Harvest&#160;&#160;Financial Services Ltd. as Qualifying Fund Manager of the Chris McHugh ARF</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">212,131</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">212,131</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(90</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Helmut Koehler</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(91</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hicks Foods Ltd.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,970</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,970</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(92</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hochman Family LLP</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,244</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,244</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(93</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hugh J. Marasa Jr.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,306</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,306</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(94</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hugh Regan</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,045</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,045</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(95</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ian H. Murray</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">400,489</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5656</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">400,489</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(96</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Immotrend Inc.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">408,772</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5979</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">408,772</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(97</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Island Capital Nominees Ltd.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">416,250</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.6272</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">416,250</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(98</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">J. Brian Boulter</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(99</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James Ahern</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">128,436</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,001,604</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(100</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James G. Markey and Carolyn L. Markey (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,135</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,135</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(101</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James L. Payne</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,545</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,545</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(102</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James M. Wimberly</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(103</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James Payne</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,507</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,507</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(104</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James Provenzano</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">531</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">531</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(105</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James T. Dietz &amp; Barbara J. Dietz (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(106</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Holly J. Thompson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,913</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,913</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(107</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James W. Lees</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,909</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,909</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(108</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jan J. Laskowski and Sofia M. Laskowski (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(109</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jared Sullivan &amp; Shannan Sullivan (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,253</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,253</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(110</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jason Russo</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,789</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,789</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(111</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jeff C. Kleinschmidt</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(112</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jeff L. Stevens</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(113</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F Jimmy R. Hasley IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">243,980</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">243,980</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(114</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John Pimpinella &amp; Bernadette Mueller (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(115</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F John H. Welsh Roth IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(116</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John L. Sommer IRA, SAL C/F</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,099</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.0168</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,099</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(117</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John M. Duffy</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,162</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,162</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(118</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John M. Harrington</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,022</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(119</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John Malfer &amp; Toni Malfer (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,120</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,120</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(120</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John W. Eilers, Jr</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(121</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John-Paul Eitner</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,738</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91,605</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(122</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jonathan Smith</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(123</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jorge Borbolla</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,136</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(124</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Joseph Fedorko</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,306</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,306</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(125</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Joseph P. Acquavella</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(126</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Joseph Rozof</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,550</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,550</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(127</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Joseph T. Oppito</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(128</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Justin McKenna</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(129</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Keith A. Zar</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,539</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,539</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(130</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ken. R. Klimitchek</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(131</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kenneth G. Williamson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,507</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,507</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(132</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kenneth N. Larsen Trust U/A/D 9/25/09, Kenneth N. Larsen Trustee</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(133</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kerston Coombs</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(134</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kevin J. Poor</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,796</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,796</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(135</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kevin Lynch</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,108</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,108</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(136</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kevin O'Connor</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,913</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,913</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(137</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kevin P. McCarthy</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">189,529</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">189,529</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(138</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kevin R. Wilson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,868</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,935</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(139</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kimberly J. Macurdy IRA - Sterne Agee &amp; Leach Inc. C/F</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(140</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lachewitz Jr. IRA (Sterne Agee &amp; Leach Inc. C/F Walter J. Lachewitz Jr. IRA)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(141</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laidlaw Holdings Limited</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,612</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,612</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(142</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lance Ziaks &amp; Janet Ziaks JTWROS</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,963</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,963</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(143</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lark Enterprises, Ltd.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(144</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Larry G. Majerus</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,129</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,129</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(145</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laurence B. Jacobs</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,327</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,327</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(146</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lindsay Aranha</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,022</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(147</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jon H. Lytle and Carrie M. Lytle (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,325</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(148</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gary J Mabie, Janelle L Mabie (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,509</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,509</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(149</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Maree Casatelli</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,081</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,081</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(150</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Maree Casatelli SEP IRA - Sterne Agee &amp; Leach Inc. C/F Maree</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,621</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,621</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(151</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark A. Maki &amp; Sara L. Maki (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(152</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark C. Jasek</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark Suwyn Roth IRA - Sterne Agee &amp; Leach Inc. C/F</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225,317</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225,317</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(154</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Marvin S. Rosen</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,818</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,818</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(155</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Matthew Eitner</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">128,436</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">826,970</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(156</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Matthew Reid</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86,699</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(157</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Matura Family Trust UA 05-26-1998</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(158</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael Ahern</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,145</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,145</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(159</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael B. Carroll &amp; Sheila J. Carroll (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">471,515</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.8432</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">471,515</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(160</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael D. Watson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(161</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael E. Whitley</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(162</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael Engdall &amp; Susan Engdall (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">139,665</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">139,665</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(163</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael K. Barber&#160;&#160;&amp; Julia Barber (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,701</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,701</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(164</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael L. Turner</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,679</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,679</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(165</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael M. Hart</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,199</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,199</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(166</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael Murray</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,058</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100,925</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(167</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael R. Chambers</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(168</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Michael Stanley</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,470</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,470</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(169</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Minta Group LLC</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,663</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(170</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nabil M. Yazgi</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,955</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,955</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(171</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nabil Yazgi MD PA 401(K) Profit Sharing Plan and Trust</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,621</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,621</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(172</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nabil Yazgi MD PA Cash Balance Plan &amp; Trust 12-28-2008</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,567</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(173</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nicholas Gupta</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">909</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">909</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(174</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patrick Maddren</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">455</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">455</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(175</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patrick S. Thomas</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(176</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paul&#160;&#160;A. Wildberger &amp; Janice Wildberger (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(177</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Peter H. Colettis</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(178</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Peter H. Silverman</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,637</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,637</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(179</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Peter J. and Tiffany B. Zaborowski, (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">249,082</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">249,082</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(180</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Peter Malone</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(181</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Philip Stephenson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(182</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phillip Todd Herndon</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,989</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,989</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(183</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rafael Penunuri</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,272</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,272</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(184</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raja Appachi</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,407</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,407</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(185</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Randall L &amp; Kathy S Payne (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(186</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Randy Payne IRA (Sterne Agee &amp; Leach Inc. C/F Randy Payne IRA)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(187</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ray Sinnott</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,665</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,665</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(188</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ray Sinnott Pension Fund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,053</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,053</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(189</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reed Family Trust DTD 06-24-1999 Clayton A Reed &amp; Stephanie S. Reed TTEES</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,409</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(190</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rex A. Jones</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343,136</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3414</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343,136</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(191</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard A. Levine</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">950,291</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7148</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">950,291</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(192</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard Brewster</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,913</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,913</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(193</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard Burgess</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,702</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(194</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard Buttine</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,136</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,136</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(195</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard G. Michalski</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,412</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,746</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(196</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Richard L. Herweck</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,339</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(197</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rikin Jobanputra</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,318</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,318</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(198</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rippee Mineral Management LLC</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,905</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,905</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(199</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert Bonaventura</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,458</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35,458</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(200</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert Dunn</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(201</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert H. Krauch</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346,800</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3557</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">346,800</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(202</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert Hair</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(203</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert J Laubenthal</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,415</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,415</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(204</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert LeBoyer</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,665</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,665</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(205</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert N. Blank</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(206</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert Rotunno</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,255</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,255</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(207</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. Stapell</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(208</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Roger Conan</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242,630</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242,630</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(209</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F Roger K. Cady R/O IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,658</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,658</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(210</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ron D. Craig</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">345,393</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3502</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">345,393</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ron Zuckerman</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,090</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,090</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(212</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ronald J. Woodward</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(213</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ronald A. Soicher</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,689</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,689</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(214</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ryan Turcotte</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,609</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,609</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(215</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,958</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,958</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(216</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandra F. Tomlinson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,402</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64,402</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(217</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F Pat Schneider IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,504</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,504</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(218</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Scott L. Byer</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(219</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Seal Rock 1, LLC</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,545</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,545</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(220</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sepulveda Roth IRA (Sterne Agee &amp; Leach Inc. C/F Mercedes Sepulveda Roth IRA)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(221</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sharon M. Smith</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,874</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,874</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(222</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Simon C. Guscott</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,353</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,353</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(223</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sohin Shah</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">832</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">832</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(224</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Srinivasa Rajan</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,481</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,481</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(225</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stephen and Tracy Park, (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,764</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,764</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(226</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stephen Fischgrund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,009</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(227</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stephen Hamilton</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,798</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,798</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(228</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F JB Trahern Bene Owner Ann Trahern DCSD IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,614</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,614</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(229</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Steven De Decker &amp; Diop Diatou (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(230</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Steven K. Nelson</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(231</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Steven W. Poe and Judith L. Poe (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,118</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,118</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(232</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F Gregory F. Sullivan II Roth IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,481</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,481</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(233</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Susan H. Lu</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(234</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Syntec Scientific Ltd. by Ray Sinnott</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167,987</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167,987</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(235</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas and Lillian Murray, (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,156</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,156</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(236</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas C Pugh</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,253</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(237</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas G. Hoffman</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,512</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,512</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(238</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas J. Moore &amp; Cathleen Moore (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89,093</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89,093</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(239</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas N. Metz</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(240</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Thomas Turley</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(241</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy A. Kippenhan</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,682</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(242</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy C. Behr</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,171</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,171</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(243</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy E. Lemaster</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,369</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,369</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(244</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy J. and Catherine A. Pellegrini (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(245</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy J. Kane &amp; Annette K. Kane (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,353</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51,353</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(246</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy J. Rinker</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(247</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy P. Johnston</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,364</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,364</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(248</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timothy Wieghaus</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126,599</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126,599</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(249</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Tracy N. Poe</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93,155</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93,155</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(250</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sterne Agee &amp; Leach Inc. C/F Tracy N. Poe Roth IRA</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,890</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,890</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(251</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Uday Dandamudi</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(252</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Variety Investments Limited</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">515,980</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.0170</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">515,980</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(253</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Velcro LLC</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,817</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(254</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vinod Moras</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">832</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">832</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(255</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Willard L Simons</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,802</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,802</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(256</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Willard L. Simons IRA - Sterne Agee &amp; Leach Inc. C/F</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,794</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(257</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William A. and Barbara B. Valka, (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(258</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William H. Hieronymus</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151,362</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(259</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William J. Diamond&#160;&#160;&amp; Andrea Sullivan (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,163</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(260</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William L. Lane &amp; Leann Lane (JTWROS)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,840</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(261</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William Wade Brawley</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,349</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(262</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">William Woodford</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,704</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(263</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wilson, William, III and Wilson, Patricia White COTTEE of The Wilson Family Restated Living Trust UTA dtd 04/2004</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173,400</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(264</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Wojciech Rybacki</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,975</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,975</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(265</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Xiaowei Zhou</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,359</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,359</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(266</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yogesh Desai</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,407</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45,407</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(267</font></div>
</td>
<td valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="39%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,979,935</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,735,497</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 89,367 shares of common stock and (ii) 21,953 shares of common stock issuable upon the exercise of the Stock Offering warrants (Adam Baker).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 22,533 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;(Alan Aranha).</font></div>
</td>
</tr></table>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 76,525 shares of common stock and (ii) 18,239 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Albert H. Konetzni, Jr. and Shirley A. Konetzni may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;Albert H. Konetzni Jr. and Shirley A. Konetzni JT TEN. &#160; (Albert H. Konetzni Jr. &amp; Shirley A. Konetzni JT TEN).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants. Alexander Sepulveda may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F Alexander Sepulveda IRA. &#160; (Sterne Agee &amp; Leach Inc. C/F Alexander Sepulveda IRA),</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 99,617 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78, exercisable on a cashless basis issued to Amrosan, LLC, a partnership in which the majority member interest is owned by the family of Mr. Seth, a Director of Actinium and (ii) 375,556 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;Mr. Alan Aranha has voting and/or investment power over the common stock of Actinium owned by Amrosan, LLC.&#160;&#160;(Amrosan, LLC).</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 302,726 shares of common stock and (ii) 75,681 shares of common stock issuable upon exercise of the Series B warrants (Andres Wawrla).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 40,273 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants (Andrew Bellamy).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,458 shares of common stock and (ii) 8,615 shares of common stock issuable upon the exercise of the Stock Offering warrants (Andrew Chandler).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 18,163 shares of common stock and (ii) 9,081 shares of common stock issuable upon exercise of the Series B warrants. Andrew Charles Good&#160;&#160;&amp; Fiona McPhee&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by Andrew Charles Good&#160;&#160;&amp; Fiona McPhee (JTWROS). &#160; (Andrew Charles Good&#160;&#160;&amp; Fiona McPhee (JTWROS)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 51,359 &#160;shares of common stock, (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 6,785 shares of common stock issuable upon exercise of the Stock Offering warrants&#160;&#160;(Anthony D'Amato).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 11,305 shares of common stock and (ii) 19,352 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Ms. Beeram is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Aparna Beeram).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 83,461 shares of common stock and (ii) 19,973 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;(Benjamin Hasty).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Billy W. Harris).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 721,068 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;Ms. Lindsay Aranha has voting and/or investment power over the common stock of Actinium owned by Bioche Asset Management, LLC (Bioche Asset Management LLC).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,470 &#160;shares of common stock and (ii) 17,118 shares of common stock issuable upon the exercise of the Stock Offering warrants (Bohdan Chaban).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 31,616 shares of common stock and (ii) 1,513 shares of common stock issuable upon exercise of the Series B warrants (Brendan Sullivan).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 273,881 shares of common stock and (ii) 68,470 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Brian E.&#160;&#160;Jones and Peggy A. Jones may be deemed to be the beneficial owner of the shares of our common stock held by Brian E.&#160;&#160;Jones and Peggy A. Jones (JTWROS). &#160; (Brian E.&#160;&#160;Jones and Peggy A. Jones).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 138,720 shares of common stock and (ii) 34,680 shares of common stock issuable upon exercise of the Stock Offering warrants. Brian Miller may be deemed to be the beneficial owner of the shares of our common stock held by Miller, Brian IRA (Robert W. Baird &amp; Co., Inc. TTEE, FBO Brian Miller IRA Acct # 6144 2867.&#160;&#160; (Robert W. Baird &amp; Co., Inc. TTEE, FBO Brian Miller IRA Acct # 6144 2867)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 3,636 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. Mr. Murray is affiliated with the Placement Agent of the Stock Offering (Brian Murray).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 20,874 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 78,867 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such. and (iii) 6,242 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Robertson is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering.&#160;&#160;(Brian Robertson).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,420 shares of common stock.&#160;&#160;Mr. Porter is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Bruce Porter).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (Bruno Donnou).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 110,761 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 11,483 shares of common stock issuable upon the exercise of the Stock Offering warrants (Bruno J. Casatelli).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 64,951 shares of common stock, (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrant, and (iii) 8,670 shares of common stock issuable upon the exercise of the&#160;Stock Offering&#160;warrants.&#160;&#160;Bryan J. Hanks &amp; Michelle B. Hanks&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;Bryan J. Hanks &amp; Michelle B. Hanks (JTWROS). &#160; (Bryan J. Hanks &amp; Michelle B. Hanks (JTWROS)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 199,236 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. (ii) 74,855 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Buff Trust is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Buff Trust).&#160;&#160;John Tesse has voting and/or investment power over the common stock of Actinium owned by the Buff Trust.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17,340 shares of common stock issuable upon exercise of the Stock Offering warrants (Burton Mark Paull).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,546 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants (Malcolm C.S. Leslie).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Carl F. Muckenhin).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 353,023 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise that the Holder&#160;&#160;may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;Mr. Alan Aranha has voting and/or investment power over the common stock of Actinium owned by Carnegie Hill Asset Partners (Carnegie Hill Asset Partners).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,108 shares of common stock and (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Carol A. Wilson may be deemed to be the beneficial owner of the shares of our common stock held by the Carol A. Wilson IRA - Sterne Agee Leach Inc. C/F Carol A. (Carol A. Wilson IRA - Sterne Agee Leach Inc. C/F Carol A.).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 90,848 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (Chad A. Elms).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,871 shares of common stock and (ii) 3,468 shares of common stock issuable upon exercise of the Stock Offering warrants (Charles J. Magolske).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 241,425 shares of common stock and (ii) 60,356 shares of common stock issuable upon exercise of the Stock Offering warrants (Charles L Weidner TTEE &amp; Alice N Barrett Weidner TTEE FBO The Weidner Family Revocable Trust DTD 8/13/07).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Charles L. Vinn).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 33,927 shares of common stock and (ii) 8,482 shares of common stock issuable upon the exercise of the Stock Offering warrants (Charles W. Ganse).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,109 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants (Chris Marshall).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 189,993 shares of common stock and (ii) 47,498 shares of common stock issuable upon exercise of the Stock Offering warrants (Chris McHugh).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,627 shares of common stock and (ii) 17,157 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Christina Einstein may be deemed to be the beneficial owner of the shares of our common stock held by Sterne Agee &amp; Leach Inc. C/F Christina G. Einstein IRA. &#160; (Sterne Agee &amp; Leach Inc C/F Christina G. Einstein IRA).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,627 shares of common stock and (ii) 17,157 shares of common stock issuable upon exercise of the Stock Offering warrants (Christopher J. Mehos).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 1,435 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Kane is affiliated with the Placement Agent of the Stock Offering Offering (Christopher Kane).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Christopher M. Johnston).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 23,627 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 and (ii) 2,728 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Oppito is affiliated with the Placement Agent of the Stock Offering Offering and the 2012 Common Stock Offering.&#160;&#160;(Christopher Oppito.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Clayton A. and Stephanie S., Reed).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17,340 shares of common stock issuable upon the exercise of the Stock Offering warrants (Clint N. Duty).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,054 shares of common stock and (ii) 1,513 shares of common stock issuable upon exercise of the Series B warrants (Conor Gilligan).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 110,404 shares of common stock and (ii) 27,601 shares of common stock issuable upon exercise of the Stock Offering warrants (Conor Stanley).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 3,382 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Bonn is affiliated with the Placement Agent of the 2012 Common Stock Offering (Craig Bonn).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17,340 shares of common stock issuable upon exercise of the Stock Offering warrants (Daniel P. Wikel).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 574 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 and&#160;(ii) 1,818 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Kuhar is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Daniel W. Kuhar).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 20,807 shares of common stock and (ii) 5,202 shares of common stock issuable upon the exercise of the Stock Offering warrants (David A. Kuhar).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 144,941 shares of common stock and (ii) 36,235 shares of common stock issuable upon the exercise of the Stock Offering warrants (David Cantwell).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,109 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;David Hicks&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by the David Hicks Pension Fund. &#160; (David Hicks Pension Fund).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (David Patterson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 193,331 shares of common stock, (ii) 28,759 shares of common stock issuable upon exercise of the Series B warrants and (iii) 19,138 shares of common stock issuable upon exercise of the Stock Offering Warrants (David W. Frost).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 4,842 shares of common stock and (ii) 1,210 shares of common stock issuable upon exercise of the Series B warrants. David Frost may be deemed to be the beneficial owner of the shares of our common stock held by Frost IRA - Sterne Agee &amp; Leach Inc. C/F David W. &#160; (David W. Frost IRA - Sterne Agee &amp; Leach Inc. C/F David W.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 277,440 shares of common stock and (ii) 69,360 shares of common stock issuable upon the exercise of the Stock Offering warrants (Dean L. Fox).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,130 &#160;shares of common stock and (ii) 8,533 shares of common stock issuable upon the exercise of the Stock Offering warrants (Deborah L. Katz).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 693,634 shares of common stock and (ii) 173,409 shares of common stock issuable upon the exercise of the Stock Offering warrants (Denis O'Brien).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 138,720 shares of common stock and (ii) 34,680 shares of common stock issuable upon exercise of the Stock Offering warrants (Dianne M. Scheck).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Donald K. Coffey).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Douglas A. Alcott).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Dougles E. Eckert).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 55,024 shares of common stock and (ii) 12,631 shares of common stock issuable upon the exercise of the Stock Offering warrants&#160;&#160;(Douglas J Amos &amp; Carol A Amos, JTWROS).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 54,283 shares of common stock and (ii) 13,571 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Douglas R. Holroyd &amp; Jill K. Holroyd may be deemed to be the beneficial owner of the shares of our common stock held by Douglas R. Holroyd &amp; Jill K. Holroyd (JTWROS). &#160; (Douglas R. Holroyd &amp; Jill K. Holroyd (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,313 shares of common stock and (ii) 8,578 shares of common stock issuable upon the exercise of the Stock Offering warrants (Dr. John M. Ferriter).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 76,355 shares of common stock and (ii) 18,196 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Dr. Richard and Anita Matter may be deemed to be the beneficial owner of the shares of our common stock held by Dr. Richard and Anita Matter (JTWROS).&#160;&#160;&#160;&#160;(Dr. Richard and Anita Matter (JTWROS)).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 104,039 shares of common stock and (ii) 26,010 shares of common stock issuable upon exercise of the Stock Offering warrants (Earl R. Richardson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 45,424 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants&#160;&#160;(Edward C. Moore).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">69</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Edwin A. Schermerhorn may be deemed to be the beneficial owner of the shares of our common stock held by the Schermerhorn Roth IRA -Sterne Agee &amp; Leach Inc. C/F Edwin A. &#160; (Edwin A. Schermerhorn Roth IRA -Sterne Agee &amp; Leach Inc. C/F). &#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">70</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 174,634 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;John Coolong has voting and/or investment power over the common stock of Actinium owned by the Eitner Family Trust (Eitner Family Trust).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">71</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,509 shares of common stock and (ii) 8,627 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Eliana Cardenas Mendez and Roberto Mendez may be deemed to be the beneficial owner of the shares of our common stock held by Mendez, Eliana Cardenas and Roberto (JTWROS).&#160;&#160;&#160;(Eliana Cardenas and Roberto Mendez, (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">72</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 18,109 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants (Enguerrand de Ponteves).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Eugene E. Eubank).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 287 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. Mr. Stern is affiliated with the Placement Agent of the Stock Offering (Evan Stern).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 20,174 shares of common stock and&#160;(ii) 10,374 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Smith is affiliated with the Placement Agent of the Stock Offering&#160;&#160;and the 2012 Common Stock Offering (Francis Smith.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">76</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 &#160;shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Frank Davis).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 199,236 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 74,855 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Garnett Trust is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Garnett Trust.).&#160;&#160;John Tesse has voting and/or investment power over the common stock of Actinium owned by the Garnett Trust.</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Gary M. Higdem).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Gary A. Washauer).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">80</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,684 shares of common stock and (ii) 9,569 shares of common stock issuable upon the exercise of the Stock Offering warrants (Gene R Carlson &amp; Cynthia L Carlson (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">81</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,871 &#160;shares of common stock and (ii) 3,468 shares of common stock issuable upon the exercise of the Stock Offering warrants (George B. Beam).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,546 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants. George Elefther&#160;&#160;&amp; Karin Alexa&#160;&#160;Elefther may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;George Elefther&#160;&#160;&amp; Karin Alexa&#160;&#160;Elefther (JTWROS). &#160; (George Elefther&#160;&#160;&amp; Karin Alexa&#160;&#160;Elefther (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">83</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 170,625 shares of common stock and (ii) 42,656 shares of common stock issuable upon the exercise of the Stock Offering warrants (Sterne Agee &amp; Leach Inc.&#160;&#160;C/F George Elefther IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">84</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 184,129 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 34,680 shares of common stock issuable upon exercise of the Stock Offering warrants (George M Zelinski).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 37,788 shares of common stock, (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 3,393 shares of common stock issuable upon exercise of the Stock Offering warrants (Gerhard Plaschka).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">86</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 83,692 shares of common stock and (ii) 19,138 shares of common stock issuable upon the exercise of the Stock Offering warrants (Gonzalo A Salgueiro).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">87</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Grant L. Hanby).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">88</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 134,624 shares of common stock, (ii) 13,017 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 20,639 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Gregory F. Sullivan &amp; Gene M. Sullivan may be deemed to be the beneficial owner of the shares of our common stock held by Gregory F. Sullivan MD &amp; Gene M. Sullivan (JTWROS). (Gregory F. Sullivan MD &amp; Gene M. Sullivan (JTWROS)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Harold O. LaFlash and Greta G. LaFlash may be deemed to be the beneficial owner of the shares of our common stock held by Harold O. LaFlash and Greta G. LaFlash (JTWROS). &#160; (Harold O. LaFlash and Greta G. LaFlash (JTWROS)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 169,705 shares of common stock and (ii) 42,426 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Chris McHugh may be deemed to be the beneficial owner of the shares of our common stock held by Harvest Financial Services Ltd. as Qualifying Fund Manager of the Chris McHugh ARF &#160; (Harvest Financial Services Ltd as Qualifying Fund Manager of the Chris McHugh ARF ).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,273 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants (Helmut Koehler).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 19,980 shares of common stock and (ii) 9,990 shares of common stock issuable upon exercise of the Series B warrants. David Hicks&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by the Hicks Foods Ltd. &#160; (Hicks Foods Ltd.).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 18,163 shares of common stock and (ii) 9,081 shares of common stock issuable upon exercise of the Series B warrants. Lawrence Hochman&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by the Hochman Family LLP . &#160; Lawrence D. Hochman has voting/and or investment power over the common stock of Actinium owned by Hochman Family LLP.&#160;&#160;(Hochman Family LLP).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 19,988 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 and&#160;(ii) 5,318 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Marasa is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Hugh J. Marasa Jr.).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 23,607 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 and&#160;(ii) 20,438 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Regan is affiliated with the Placement Agent of the Stock Offering&#160;&#160;and the 2012 Common Stock Offering (Hugh Regan).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">96</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 312,528 shares of common stock, (ii) 37,840 shares of common stock issuable upon exercise of the Series B warrants and (iii) 50,121 shares of common stock issuable upon exercise of the Stock Offering warrants (Ian H. Murray).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">97</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 302,818 shares of common stock and (ii) 105,954 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Stephan Herrmann may be deemed to be the beneficial owner of the shares of our common stock held by Immotrend Inc.&#160;&#160; (Immotrend Inc.).&#160;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">98</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 333,000 shares of common stock and (ii) 83,250 shares of common stock issuable upon exercise of the Series B warrants. David Sykes&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by Island Capital Nominees Ltd.&#160;&#160;David Sykes has voting and/or investment power over the common stock of Actinium owned by Island Capital Nominees Ltd. (Island Capital Nominees Ltd.).&#160;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 121,090 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (J. Brian Boulter).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 97,001 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 (ii) 873,168 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;and (iii) 31,435 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Ahern is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering&#160;&#160;(James Ahern.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,108 shares of common stock and (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants (James G. Markey and Carolyn L. Markey (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 48,436 shares of common stock and (ii) 12,109 shares of common stock issuable upon exercise of the Series B warrants (James L. Payne).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (James M. Wimberly).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">104</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 83,369 shares of common stock from notes conversion and (ii) 19,138 shares of common stock issuable upon the exercise of the Stock Offering warrants (James Payne).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 531 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Provenzano is affiliated with the Placement Agent of the Stock Offering (James Provenzano).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">106</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;James T. Dietz &amp; Barbara J. Dietz may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;James T. Dietz &amp; Barbara J. Dietz (JTWROS). &#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 1,913 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Thompson is affiliated with the Placement Agent of the Stock Offering (Holly J. Thompson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 80,103 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants and (iii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (James W. Lees).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">109</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17,340 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Jan J. Laskowski &amp; Sofia M. Laskowski may be deemed to be the beneficial owner of the shares of our common stock held by Jan J. Laskowski and Sofia M. Laskowski (JTWROS (Jan J. Laskowski and Sofia M. Laskowski (JTWROS)).</font></div>
</td>
</tr></table>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">110</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 25,802 shares of common stock, (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 3,424 shares of common stock issuable upon exercise of the Stock Offering warrants (Jared Sullivan &amp; Shannan Sullivan (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 10,789 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Russo is affiliated with the Placement Agent of the 2012 Common Stock Offering (Jason Russo).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 121,090 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (Jeff C. Kleinschmidt).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (Jeff L. Stevens).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">114</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 196,411 shares of common stock and (ii) 47,569 shares of common stock issuable upon the exercise of the Stock Offering warrants (Sterne Agee &amp; Leach Inc. C/F Jimmy R. Hasley IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,871 shares of common stock and (ii) 3,468 shares of common stock issuable upon exercise of the Stock Offering warrants. John Pimpinella and Bernadette Mueller may be deemed to be beneficial owner of the shares of our common stock held by John Pimpinella &amp; Bernadette Mueller (JTWROS).&#160;&#160;(John Pimpinella &amp; Bernadette Mueller (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">116</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,130 shares of common stock and (ii) 8,533 shares of common stock issuable upon exercise of the Stock Offering warrants. John H. Welsh may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F John H. Welsh Roth IRA. (Sterne Agee &amp; Leach Inc. C/F John H. Welsh Roth IRA).</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">117</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 208,079 shares of common stock and (ii) 52,020 shares of common stock issuable upon exercise of the Stock Offering warrants (John L. Sommer IRA, SAL C/F).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">118</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 33,318 shares of common stock, (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants and (iii) 6,817 shares of common stock issuable upon the exercise of the Stock Offering warrants (John M. Duffy).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">119</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,022 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver. (John M. Harrington).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">120</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 90,848 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants. John Malfer &amp; Toni Malfer may be deemed to be the beneficial owner of the shares of our common stock held by the John Malfer &amp; Toni Malfer (JTWROS). &#160; (John Malfer &amp; Toni Malfer (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,509 shares of common stock and (ii) 8,627 shares of common stock issuable upon the exercise of the Stock Offering warrants (John W. Eilers, Jr.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">122</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 10,334 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 78,867 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;and (iii) 2,404 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Eitner is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (John-Paul Eitner.).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">123</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,273 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants (Jonathan Smith).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,509&#160;shares of common stock and (ii) 8,627 shares of common stock issuable upon the exercise of the Stock Offering warrants (Jorge Borbolla).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 4,306 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Fedorko is affiliated with the Placement Agent of the Stock Offering (Joseph Fedorko.).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,054 shares of common stock and (ii) 1,513 shares of common stock issuable upon exercise of the Series B warrants (Joseph P. Acquavella).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 5,550 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Rozof is affiliated with the Placement Agent of the Stock Offering (Joseph Rozof).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">128</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 20,807 shares of common stock and (ii) 5,202 shares of common stock issuable upon exercise of the Stock Offering warrants (Joseph T. Oppito).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Includes (i) 18,162 shares of common stock and (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants. (Justin McKenna).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">130</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 99,631 shares of common stock, (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 17,340 shares of common stock issuable upon exercise of the Stock Offering warrants (Keith A. Zar).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">131</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,260 shares of common stock and (ii) 17,065 shares of common stock issuable upon the exercise of the Stock Offering warrants (Ken R. Klimitchek).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 83,369 shares of common stock and (ii) 19,138 shares of common stock issuable upon the exercise of the Stock Offering warrants (Kenneth G. Williamson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">133</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17.340 shares of common stock issuable upon the exercise of the Stock Offering warrants (Kenneth N. Larsen Trust U/A/D 9/25/09, Kenneth N. Larsen Trustee).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">134</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Kerston Coombs).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">135</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 14,531 shares of common stock and (ii) 7,265 shares of common stock issuable upon exercise of the Series B warrants (Kevin J. Poor).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">136</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 9,081 shares of common stock and (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants (Kevin Lynch).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">137</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 22,913 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. O'Connor is affiliated with the Placement Agent of the Stock Offering&#160;&#160;(Kevin O'Connor.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 153,051 shares of common stock and (ii) 36,478 shares of common stock issuable upon exercise of the Stock Offering warrants (Kevin P. McCarthy).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">139</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,477 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. (ii) 45,067 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;and (iii) 5,391 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48. Mr. Wilson is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering. (Kevin R. Wilson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">140</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 18,162 shares of common stock and (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Kimberly J. Macurdy&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by Macurdy IRA - Sterne Agee &amp; Leach Inc. C/F Kimberly J. &#160; (Kimberly J. Macurdy IRA - Sterne Agee &amp; Leach Inc. C/F ).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">141</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Walter J. Lachewitz Jr. may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;Sterne Agee &amp; Leach Inc. C/F Walter J. Lachewitz Jr. IRA.&#160;&#160; (Sterne Agee &amp; Leach Inc. C/F Walter J. Lachewitz Jr. IRA).&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">142</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 62,958 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 23,654 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;The stakeholders of Laidlaw Holdings Limited may be deemed to be the beneficial owners of the shares of our common stock held by Laidlaw Holdings Limited.&#160;&#160; Laidlaw Holdings Limited is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering.&#160;&#160;The chairman of Laidlaw Holdings Limited has voting and/or investment power over the common stock of Actinium owned by Laidlaw Holdings Limited. (Laidlaw Holdings Limited).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">143</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,570 shares of common stock and (ii) 3,393 shares of common stock issuable upon exercise of the Stock Offering warrants (Lance Ziaks &amp; Janet Ziaks JTWROS).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">144</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,260 shares of common stock and (ii) 17,065 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Ralph W. Kettell may be deemed to be the beneficial owner of the shares of our common stock held by Lark Enterprises, Ltd.&#160;&#160; (Lark Enterprises, Ltd.).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">145</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 50,322 shares of common stock (ii) 4,238 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 9,569 shares of common stock issuable upon the exercise of the Stock Offering warrants (Larry G. Majerus).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">146</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 24,218 shares of common stock and (ii) 12,109 shares of common stock issuable upon exercise of the Series B warrants (Laurence B. Jacobs).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">147</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,022 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver. Excluded from calculation of beneficial ownership as such.&#160;&#160;(Lindsay Aranha).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">148</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,260 shares of common stock and (ii) 17,065 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Jon H. Lytle and Carrie M. Lytle may be deemed to be the beneficial owner of the shares of our common stock held by Jon H. Lytle and Carrie M. Lytle (JTWROS).&#160;&#160; (Jon H. Lytle and Carrie M. Lytle (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">149</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,064 shares of common stock and (ii) 3,445 shares of common stock issuable upon exercise of the Stock Offering warrants ( Gary J Mabie, Janelle L Mabie (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,054 shares of common stock and (ii) 3,027 shares of common stock issuable upon exercise of the Series B warrants (Maree Casatelli).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">151</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 9,081 shares of common stock and (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Maree Casatelli&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by Casatelli SEP IRA - Sterne Agee &amp; Leach Inc. C/F Maree. &#160; (Maree Casatelli SEP IRA - Sterne Agee &amp; Leach Inc. C/F Maree).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">152</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,546 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Mark A. Maki &amp; Sara L. Maki may be deemed to be the beneficial owner of the shares of our common stock held by Mark A. Maki &amp; Sara L. Maki (JTWROS). &#160; (Mark A. Maki &amp; Sara L. Maki (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">153</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Mark C. Jasek).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">154</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 179,908 shares of common stock and (ii) 45,409 shares of common stock issuable upon exercise of the Series B warrants. Mr. Suwyn may be deemed to be the beneficial owner of the shares of our common stock held by the Mark Suwyn Roth IRA - Sterne Agee &amp; Leach Inc. C/F. (Mark Suwyn Roth IRA - Sterne Agee &amp; Leach Inc. C/F).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 37,454 shares of common stock and (ii) 9,364 shares of common stock issuable upon exercise of the Stock Offering warrants (Marvin S. Rosen).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 97,001 shares of common stock issuable upon exercise of the warrants at an exercise price of 0.78 (ii) 698,534 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownerhip as such.&#160;&#160;and (iii) 31,435 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Eitner is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Matthew Eitner).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">157</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 69,359 shares of common stock and (ii) 17,340 shares of common stock issuable upon exercise of the Stock Offering warrants (Matthew Reid).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">158</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants. Gary D. Matura and Margaret I. Curtin Matura may be deemed to be the beneficial owners of the shares of our common stock held by the Matura Family Trust UA 05-26-1998. &#160; (Matura Family Trust UA 05-26-1998).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 2,145 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Ahern is affiliated with the Placement Agent of the 2012 Common Stock Offering (Michael Ahern).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">160</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 372,985 shares of common stock, (ii) 37,840 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 60,690 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Michael B. Carroll &amp; Sheila J. Carroll may be deemed to be the beneficial owner of the shares of our common stock held by Michael B. Carroll &amp; Sheila J. Carroll (JTWROS). &#160; (Michael B. Carroll &amp; Sheila J. Carroll (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 24,226 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Michael D. Watson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">162</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Michael E. Whitley).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">163</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 111,730 shares of common stock and (ii) 10,595 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 17,340 shares of common stock issuable upon the exercise of the Stock Offering warrants . Michael Engdall &amp; Susan Engdall may be deemed to be the beneficial owner of the shares of our common stock held by Michael Engdall &amp; Susan Engdall (JTWROS). &#160; (Michael Engdall &amp; Susan Engdall (JTWROS)).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">164</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 102,161 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 10,404 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Michael K. Barber&#160;&#160;&amp; Julia Barber&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by Michael K. Barber&#160;&#160;&amp; Julia Barber (JTWROS). &#160; (Michael K. Barber&#160;&#160;&amp; Julia Barber (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">165</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 27,743 shares of common stock and (ii) 6,936 shares of common stock issuable upon exercise of the Stock Offering warrants (Michael L. Turner).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">166</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,759 &#160;shares of common stock and (ii) 3,440 shares of common stock issuable upon the exercise of the Stock Offering warrants (Michael M. Hart)</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 17,802 shares of common stock, (ii) 78,867 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;and (iii) 4,256 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Murray is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Michael Murray).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">168</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Michael R. Chambers).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,176 shares of common stock and (ii) 10,294 shares of common stock issuable upon exercise of the Stock Offering warrants (Michael Stanley).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">170</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,130 shares of common stock and (ii) 8,533 shares of common stock issuable upon exercise of the Stock Offering warrants. Howard S. Ziment may be deemed to be the beneficial owner of the shares of our common stock held by Minta Group LLC.&#160;&#160; Howard Ziment has voting and/or investment power over the common stock of Actinium owned by Minta Group LLC.&#160;&#160;(Minta Group LLC).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">171</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 59,846 shares of common stock, (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants and (iii) 9,569 shares of common stock issuable upon exercise of the Stock Offering warrants (Nabil M. Yazgi).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">172</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 9,081 shares of common stock and (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Nabil Yazgi may be deemed to be the beneficial owner of the shares of our common stock held by the Nabil Yazgi MD PA 401(K) Profit Sharing Plan and Trust. (Nabil Yazgi MD PA 401(K) Profit Sharing Plan and Trust).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">173</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,054 shares of common stock and (ii) 1,513 shares of common stock issuable upon exercise of the Series B warrants. Nabil Yazgi may be deemed to be the beneficial owner of the shares of our common stock held by the Nabil Yazgi MD PA Cash Balance Plan &amp; Trust 12-28-2008. (Nabil Yazgi MD PA Cash Balance Plan &amp; Trust 12-28-2008).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">174</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 909 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Gupta is affiliated with the Placement Agent of the 2012 Common Stock Offering (Nicholas Gupta).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 455 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Maddren is affiliated with the Placement Agent of the 2012 Common Stock Offering (Patrick Maddren).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Patrick Thomas).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">177</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 121,090 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants. Paul&#160;&#160;A. Wildberger &amp; Janice Wildberger may be deemed to be the beneficial owner of the shares of our common stock held by Paul&#160;&#160;A. Wildberger &amp; Janice Wildberger&#160;&#160;(JTWROS). &#160; (Paul&#160;&#160;A. Wildberger &amp; Janice Wildberger (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Peter H. Colettis).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 1,637 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Silverman is affiliated with the Placement Agent of the 2012 Common Stock Offering (Peter Silverman).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 199,266 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants and (iii) 34,680 shares of common stock issuable upon the exercise of the Stock Offering warrants. (Peter J. and Tiffany B. Zaborowski, (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">181</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 287 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. Mr. Malone is affiliated with the Placement Agent of the Stock Offering (Peter Malone).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">182</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Philip Stephenson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">183</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 102,391 shares of common stock and (ii) 25,598 shares of common stock issuable upon the exercise of the Stock Offering warrants (Phillip Todd Herndon).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">184</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 24,218 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants (Rafael Penunuri).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">185</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 36,326 shares of common stock and (ii) 9,081 shares of common stock issuable upon exercise of the Series B warrants (Raja Appachi).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">186</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,684 shares of common stock and (ii) 9,569 shares of common stock issuable upon the exercise of the Stock Offering warrants (Randall L &amp; Kathy S Payne, JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">187</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;Randy Payne&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F Randy Payne IRA. &#160; (Sterne Agee &amp; Leach Inc. C/F Randy Payne IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">188</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 46,932 shares of common stock,&#160;&#160;(ii) 6,652 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 5,081 shares of common stock issuable upon exercise of the Stock Offering warrants (Ray Sinnott).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">189</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 17,642 shares of common stock and (ii) 4,411 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Ray Sinnott may be deemed to be the beneficial owner of the shares of our common stock held by the Ray Sinnott Pension Fund.&#160;&#160; (Ray Sinnott Pension Fund).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,273 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants. Clayton A Reed &amp; Stephanie S. Reed&#160;&#160;may be deemed to be the beneficial owner of the shares of our common stock held by the Reed Family Trust DTD 06-24-1999 Clayton A Reed &amp; Stephanie S. Reed TTEES (Reed Family Trust DTD 06-24-1999 Clayton A Reed &amp; Stephanie S. Reed TTEES).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">191</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 274,509 shares of common stock and (ii) 68,627 shares of common stock issuable upon the exercise of the Stock Offering warrants (Rex A. Jones).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">192</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 748,124 shares of common stock, (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 171,895 shares of common stock issuable upon exercise of the Stock Offering warrants (Richard A. Levine).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">193</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 22,913 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Brewster is affiliated with the Placement Agent of the Stock Offering&#160;&#160;(Richard Brewster).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">194</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 18,162 shares of common stock and (ii) 4,540 shares of common stock issuable upon exercise of the Series B warrants (Richard Burgess).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 3,136 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Buttine is affiliated with the Placement Agent of the 2012 Common Stock Offering (Richard Buttine).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 21,156 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. (ii) 225,334 shares of common stock issuable upon exercise of the warrants pursuant to the transaction management agreement with Jamess Capital Group, LLC.&#160;&#160;Warrant may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;Excluded from calculation of beneficial ownership as such.&#160;&#160;and (iii) 4,256 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Michalski is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Richard G. Michalski).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">197</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,871 shares of common stock and (ii) 3,468 shares of common stock issuable upon the exercise of the Stock Offering warrants (Richard L. Herweck).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">198</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 7,318 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Jobanputra is affiliated with the Placement Agent of the 2012 Common Stock Offering (Rikin Jobanputra).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">199</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,336 shares of common stock and (ii) 9,569 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;David and Mimi Rippee have voting and/or investment power over the common stock of Actinium owned by Rippee Mineral Managemenet LLC (Rippee Mineral Management LLC).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 19,988 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;and (ii) 15,470 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Bonaventura is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Robert Bonaventura.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 138,720 shares of common stock and (ii) 34,680 shares of common stock issuable upon the exercise of the Stock Offering warrants (Robert Dunn).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">202</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 277,440 shares of common stock and (ii) 69,360 shares of common stock issuable upon the exercise of the Stock Offering warrants (Robert A. Krauch).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Robert Hair).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">204</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,846 shares of common stock and (ii) 9,569 shares of common stock issuable upon the exercise of the Stock Offering warrants (Robert J Laubenthal).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">205</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 1,665 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. LeBoyer is affiliated with the Placement Agent of the Stock Offering (Robert LeBoyer).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Robert N. Blank).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">207</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 2,255 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Rotunno is affiliated with the Placement Agent of the 2012 Common Stock Offering. (Robert Rotunno).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Robert T. Stapell).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">209</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 194,104 shares of common stock, (ii) 22,704 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 25,822 shares of common stock issuable upon the exercise of the Stock Offering warrants. (Roger Conan).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 68,470 &#160;shares of common stock and (ii) 17,188 shares of common stock issuable upon the exercise of the Stock Offering warrants (Sterne Agee &amp; Leach Inc. C/F Roger K. Cady R/O IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">211</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 276,314 shares of common stock and (ii) 69,079 shares of common stock issuable upon the exercise of the Stock Offering warrants (Ron D. Craig).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">212</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 7,090 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Zuckerman is affiliated with the Placement Agent of the 2012 Common Stock Offering. (Ron Zuckerman).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Ronald J. Woodward).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">214</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 48,551 shares of common stock and (ii) 12,138 shares of common stock issuable upon exercise of the Stock Offering warrants (Ronald A. Soicher).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">215</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 16,235 shares of common stock and (ii) 10,374 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Turcotte is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Ryan Turcotte).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">216</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 64,746 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 57,212 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;&#160;Mr. Seth is affiliated with the Placement Agent of the Stock Offering, the 2012 Common Stock Offering and is also a Director of the Company (Sandesh Seth.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">217</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 51,522 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 6,826 shares of common stock issuable upon exercise of the Stock Offering warrants (Sandra F. Tomlinson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">218</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 50,021 shares of common stock and (ii) 11,483 shares of common stock issuable upon exercise of the Stock Offering warrants (Sterne Agee &amp; Leach Inc. C/F&#160;&#160;Pat Schneider IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">219</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (Scott L. Byer).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">220</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock.&#160;&#160;Brian M. Miller may be deemed to be the beneficial owner of the shares of our common stock held by Seal Rock 1, LLC.&#160;&#160;Brian M. Miller has voting and/or investment power over the common stock of Actinium owned by Seal Rock 1, LLC.&#160;&#160;(Seal Rock 1, LLC).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">221</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants. Alexander Sepulveda may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F Mercedes Sepulveda Roth IRA. &#160; (Sterne Agee &amp; Leach Inc. C/F Mercedes Sepulveda Roth IRA),</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">222</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 16,874 shares of common stock (Sharon M. Smith).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">223</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,082 shares of common stock and (ii) 10,271 shares of common stock issuable upon the exercise of the Stock Offering warrants (Simon C. Guscott).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">224</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 832 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78. Mr.&#160;&#160;Shah is affiliated with the Placement Agent of the Stock Offering&#160;&#160;(Sohin Shah).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,785 shares of common stock, (ii)1,696 shares of common stock issuable upon exercise of the Stock Offering warrants (Srinivasa Rajan).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">226</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,411 shares of common stock, and (ii) 10,353 shares of common stock issuable upon exercise of the Stock Offering warrants .&#160;&#160;Stephen Park and Tracy Park may be deemed to be beneficial owner of the shares of our common stock held by Park, Stephen and Tracy (JTWROS).&#160;&#160; (Stephen and Tracy Park, (JTWROS)).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">227</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 20,807 shares of common stock and (ii) 5,202 shares of common stock issuable upon the exercise of the Stock Offering warrants (Stephen Fischgrund).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">228</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 77,535 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78 and&#160;(ii) 13,263 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Hamilton is affiliated with the Placement Agent of the Stock Offering Offering and the 2012 Common Stock Offering.&#160;&#160;(Stephen Hamilton).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">229</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 35,691 shares of common stock and (ii) 8,923 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;JB Trahern and/or Ann Trahern may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F JB Trahern Bene Owner Ann Trahern DCSD IRA.&#160;&#160; (Sterne Agee &amp; Leach Inc. C/F JB Trahern Bene Owner Ann Trahern DCSD IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">230</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,546 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants. Steven De Decker &amp; Diop Diatou may be deemed to be the beneficial owner of the shares of our common stock held by Steven De Decker &amp; Diop Diatou (JTWROS). &#160; (Steven De Decker &amp; Diop Diatou (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">231</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Steven K. Nelson).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">232</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,694 shares of common stock and (ii) 3,424 shares of common stock issuable upon exercise of the Stock Offering warrants (Steven W. Poe and Judith L. Poe (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 6,785 shares of common stock and (ii) 1,696 shares of common stock issuable upon exercise of the Stock Offering warrants. Gregory F. Sullivan may be deemed to be the beneficial owner of the shares of our common stock held by the Sterne Agee &amp; Leach Inc. C/F Gregory F.&#160;Sullivan II IRA&#160; (Sterne Agee &amp; Leach Inc. C/F Gregory F. Sullivan II Roth IRA).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">234</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,109 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants (Susan H. Lu).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">235</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 134,390 shares of common stock, (ii) 16,642 shares of common stock issuable upon exercise of the Series B warrants, and (iii)16,955 shares of common stock issuable upon exercise of the Stock Offering warrants. Ray Sinott may be deemed to be the beneficial owner of the shares of our common stock held by Syntec Scientific LTD. &#160; (Syntec Scientific LTD). &#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">236</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 13,725 shares of common stock and (ii) 3,431 shares of common stock issuable upon exercise of the Stock Offering warrants. Thomas Murray and Lillian Murray may be deemed to be the beneficial owner of the shares of our common stock held by Murray, Thomas and Lillian (JTWROS).&#160;&#160; (Thomas and Lillian Murray, (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,684 shares of common stock and (ii) 9,569 shares of common stock issuable upon exercise of the Stock Offering warrants. (Thomas C. Pugh).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">238</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 144,238 shares of common stock, (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants and (iii) 19,138 shares of common stock issuable upon exercise of the Stock Offering warrants (Thomas G. Hoffman).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">239</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 71,956 shares of common stock, (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants and (iii) 9,569 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Thomas J. Moore &amp; Cathleen Moore may be deemed to be the beneficial owner of the shares of our common stock held by the Thomas J. Moore &amp; Cathleen Moore (JTWROS). &#160; (Thomas J. Moore &amp; Cathleen Moore (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">240</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 24,226 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Thomas N. Metz).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">241</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 121,090 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (Thomas Turley).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,546 shares of common stock and (ii) 15,136 shares of common stock issuable upon exercise of the Series B warrants (Timothy A. Kippenhan).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">243</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 3,444 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;(ii) 2,727 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Mr. Behr is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering (Timothy C. Behr).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">244</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 76,295 shares of common stock and (ii) 19,074 shares of common stock issuable upon exercise of the Stock Offering warrants (Timothy E. Lemaster).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">245</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants. Timothy J. Pellegrini and Catherine A. Pellegrini may be deemed to be beneficial owner of the shares of our common stock held by Pellegrini, Timothy J. and Catherine A. (JTWROS)&#160;&#160; (Pellegrini, Timothy J. and Catherine A. (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">246</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 41,082 shares of common stock and (ii) 10,271 shares of common stock issuable upon the exercise of the Stock Offering warrants.&#160;&#160;Timothy J. Kane and Annette K. Kane may be deemed to be the beneficial owner of the shares of our common stock held by Timothy J. Kane and Annette K. Kane (JTWROS). &#160; (Timothy J. Kane and Annette K. Kane (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">247</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Timothy J. Rinker).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">248</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 65,891 shares of common stock and (ii) 16,473 shares of common stock issuable upon the exercise of the Stock Offering warrants (Timothy P. Johnston).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">249</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 101,279 shares of common stock, (ii) 16,650 shares of common stock issuable upon exercise of the Series B warrants, and (iii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants (Timothy Wieghaus).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 74,524 shares of common stock, (ii) 1,513 shares of common stock issuable upon exercise of the Series B warrants and (iii) 17,118 shares of common stock issuable upon exercise of the Stock Offering warrants (Tracy N. Poe).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">251</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 40,712 shares of common stock and (ii) 10,178 shares of common stock issuable upon the exercise of the Stock Offering warrants (Sterne Agee &amp; Leach Inc. C/F Tracy N. Poe Roth IRA)</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (Uday Dandamudi).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">253</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 412,784 shares of common stock and (ii) 103,196 shares of common stock issuable upon exercise of the Stock Offering warrants. Xiongwei Ju may be deemed to be the beneficial owner of the shares of our common stock held by Variety Investments Limited.&#160;&#160;Xiongwei Ju has voting and/or investment power over the common stock of Actinium owned by Variety Investments Ltd. (Variety Investments Limited).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">254</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 60,545 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants. Brian M. Miller may be deemed to be the beneficial owner of the shares of our common stock held by Velcro LLC. &#160; Brian M. Miller has sole voting and/or investment power over the common stock owned by Velcro LLC&#160;&#160;(Velcro LLC).&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">255</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 832 shares of common stock issuable upon exercise of the placement agent warrants at an exercise price of 0.78.&#160;&#160;Mr. Moras is affiliated with the Placement Agent of the Stock Offering (Vinod Moras.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">256</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 26,678 shares of common stock and (ii) 6,124 shares of common stock issuable upon the exercise of the Stock Offering warrants (Willard L Simons).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">257</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 24,226 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants Willard L. Simons may be deemed to be the beneficial owner of the shares of our common stock held by the Simons IRA - Sterne Agee &amp; Leach Inc. C/F Willard L. &#160; (Willard L. Simons IRA - Sterne Agee &amp; Leach Inc. C/F).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">258</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon exercise of the Stock Offering warrants. William A. Valka and Barbara B. Valka may be deemed to be&#160;&#160;the beneficial owner of the shares of our common stock held by Valka, William A. and Barbara B. (JTWROS).&#160;&#160; (William A. and Barbara B. Valka, (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 121,090 shares of common stock and (ii) 30,272 shares of common stock issuable upon exercise of the Series B warrants (William H. Hieronymus).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 12,109 shares of common stock and (ii) 6,054 shares of common stock issuable upon exercise of the Series B warrants. William J. Diamond&#160;&#160;&amp; Andrea Sullivan may be deemed to be the beneficial owner of the shares of our common stock held by&#160;&#160;William J. Diamond&#160;&#160;&amp; Andrea Sullivan (JTWROS). &#160; (William J. Diamond&#160;&#160;&amp; Andrea Sullivan (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 30,272 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants.&#160;&#160;William L. Lane &amp; Leann Lane may be deemed to be the beneficial owner of the shares of our common stock held by the William L. Lane &amp; Leanne Lane (JTWROS). &#160; (William L. Lane &amp; Leanne Lane (JTWROS)).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">262</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 34,679 shares of common stock and (ii) 8,670 shares of common stock issuable upon the exercise of the Stock Offering warrants (William Wade Brawley).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 15,136 shares of common stock and (ii) 7,568 shares of common stock issuable upon exercise of the Series B warrants (William Woodford).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">264</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 138,720 shares of common stock and (ii) 34,680 shares of common stock issuable upon exercise of the Stock Offering warrants.&#160;&#160;Patricia White and/or William Wilson III may be deemed to be the beneficial owner of the shares of our common stock held by Wilson, William, III and Wilson, Patricia White COTTEE of The Wilson Family Restated Living Trust UTA dtd 04/2004.&#160;&#160; (Wilson, William, III and Wilson, Patricia White COTTEE of The Wilson Family Restated Living Trust UTA dtd 04/2004).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">265</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 19,980 shares of common stock and (ii) 4,995 shares of common stock issuable upon exercise of the Series B warrants (Wojciech Rybacki).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 11,305 shares of common stock and&#160;(ii) 7,054 shares of common stock issuable upon exercise of the 2012 Common Stock placement agent warrants at an exercise price of 2.48.&#160;&#160;Ms. Zhou is affiliated with the Placement Agent of the Stock Offering and the 2012 Common Stock Offering&#160;&#160;(Xiaowei Zhou.).</font></div>
</td>
</tr><tr>
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">267</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Includes (i) 36,326 shares of common stock and (ii) 9,081 shares of common stock issuable upon exercise of the Series B warrants (Yogesh Desai).</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Except as disclosed in the table above, to our knowledge, none of the selling stockholders or beneficial owners:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">has had a material relationship with us other than as a stockholder at any time within the past three years;</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">has ever been one of our officers or directors or an officer or director of our affiliates; or</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">are broker-dealers or affiliated with broker-dealers.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With respect to those selling stockholders noted above who are or were affiliated with registered broker-dealers, each has represented to us that the shares being registered for resale were purchased in the ordinary course of business and, at the time of purchase, such selling stockholder had no agreements or understandings, directly or indirectly, with any person to distribute the shares.</font></div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="DESCRIPTION">DESCRIPTION</a> OF BUSINESS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Business Overview</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a biopharmaceutical company focused on the $50 billion market for cancer drugs. Our most advanced products are Actimab&#8482;-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia (AML) and Iomab&#8482;-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. The Company is currently designing a trial which the Company intends to submit for registration approval in HSCT in the settings of refractory and relapsed acute myeloid leukemia in older patients. The Company is developing its cancer drugs using its expertise in radioimmunotherapy. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center, whose indirect subsidiary, Actinium Holdings Ltd., is a significant stockholder of the Company. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213. The final drug construct is designed to specifically target and kill cancer cells while minimizing side effects. The Company intends to develop a number of products for different types of cancer and derive revenue from partnering relationships with large pharmaceutical companies and/or direct sales of its products in specialty markets in the U.S.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Corporate History and Background</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We were formed as a Nevada corporation on October 6, 1997, originally under the name Zurich U.S.A., Inc. On July 10, 2006, we changed our name to Cactus Ventures, Inc. and began pursuing our business of marketing sunglasses. The Company encountered numerous problems with various vendors and ceased its operations. The Company shifted its efforts to seeking a business combination opportunity with a business entity, and negotiated a merger of a target company into the Company.&#160;&#160;Upon ceasing its operations, the Company was considered a &#8220;blank check&#8221; or &#8220;Shell&#8221; company as such term is defined under the Securities Act. &#160;Upon completing the Share Exchange (as defined below), the Company ceased being considered a &#8220;blank check&#8221; or &#8220;Shell&#8221; company and is now a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 11, 2013, the change of domicile from the State of Nevada to the State of Delaware and the change of Cactus Ventures, Inc.&#8217;s name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc. became effective in accordance with Articles of Merger filed with the State of Nevada and a Certificate of Merger filed with the State of Delaware.&#160;&#160;In connection with the name change we also changed the name of our subsidiary Actinium Pharmaceuticals, Inc. to Actinium Corporation.&#160;Effective April 18, 2013 our new trading symbol became ATNM. On September 25, 2013, we merged into our self our subsidiary, Actinium Corporation.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Acquisition of Actinium</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, Actinium Pharmaceuticals, Inc. (&#8220;Actinium&#8221;) completed a share exchange with Cactus, whereby Cactus acquired 21% of the issued and outstanding capital stock of Actinium Corporation from the shareholders of Actinium Corporation (the &#8220;Actinium Shareholders&#8221;) in exchange for the issuance of 4,309,015 shares of Common Stock of the Company to the Actinium Shareholders (the &#8220;Share Exchange&#8221;).&#160;As part of the Share Exchange, Actinium Corporation paid $250,000 to the shareholders of Cactus before the consummation of the Share Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Share Exchange was treated as a recapitalization effected through a share exchange, with Actinium Corporation as the accounting acquirer and the Company the accounting acquiree.&#160;&#160;Unless the context suggests otherwise, when we refer in this Registration Statement to business and financial information for periods prior to the consummation of the Share Exchange, we are referring to the business and financial information of Actinium Corporation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective following the expiration of the ten day period following the mailing of the information statement required by Rule 14f-1 under the Exchange Act, Diane S. Button resigned from her position as member of the Board of Directors of the Company.&#160;&#160;&#160;Effective upon the closing of the Share Exchange, Diane S. Button resigned as an officer of the Company.&#160;&#160;Also effective upon the closing of the Share Exchange, Jack V. Talley was appointed to our Board of Directors.&#160;&#160;Effective as of the expiration of the ten day period following the mailing of the information statement required by Rule 14f-1 under the Exchange Act Dr. Rosemary Mazanet, David Nicholson, Sandesh Seth and Sergio Traversa were appointed to our Board of Directors.&#160; In addition, our Board of Directors appointed Jack V. Talley to serve as our President and Chief Executive Officer, Dragan Cicic to serve as our Chief Operating Officer and Chief Medical Officer, and Enza Guagenti to serve as our Chief Financial Officer, effective immediately upon the closing of the Share Exchange.&#160;&#160;On February 28, 2013, Mr. Talley resigned as the President and Chief Executive Officer, and Director of the Company and Actinium.&#160;&#160;&#160;On March 1, 2013, the Board of Directors of the Company unanimously approved the appointment of Sergio Traversa as the Company&#8217;s interim President and Chief Executive Officer. Dr. Traversa is also currently a member of the Board of the Company.&#160;&#160;On September 16, 2013 Dr. Kaushik J. Dave was appointed by the board as President, Chief Executive Officer and Director of the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 9, 2013, Ms. Guagenti resigned as the Chief Financial Officer of the Company and Actinium.&#160;&#160;On March 11, 2013, the Board of Directors of the Company unanimously approved the appointment of Sergio Traversa as the Company&#8217;s interim Chief Financial Officer. The Board is actively looking for a candidate to fill the Chief Financial Officer position of the Company. On March 13, 2013, the Board approved the appointment of Brio Financial Group as the Company&#8217;s interim Controller, responsible for the Company&#8217;s treasury and accounting functions.&#160;&#160;On September 16, 2013 Corey Sohmer was hired as the Company&#8217;s Vice President of Finance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the Share Exchange, the Company assumed the business and operations of Actinium Corporation.&#160;On April 11, 2013, the change of domicile from the State of Nevada to the State of Delaware and the change of Cactus Ventures, Inc.&#8217;s name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc. became effective in accordance with Articles of Merger filed with the State of Nevada and a Certificate of Merger filed with the State of Delaware.&#160;&#160;&#160;Effective April 18, 2013 the Company&#8217;s new trading symbol is ATNM.</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As the Company is a &#8220;reporting company&#8221; under the Exchange Act of 1934, it is required to file periodic filings with the SEC, which include Actinium Corporation&#8217;s quarterly and annual financial information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 11, 2013, Actinium Corporation&#160;continued its Share Exchange with the Company, whereby the Company acquired an additional 36% of the issued and outstanding capital stock of Actinium Corporation from the Actinium Corporation Shareholders in exchange for the issuance of 7,344,390 shares of Common Stock of the Company to the Actinium Shareholders.&#160;&#160;On August 22, 2013, Actinium Corporation&#160;&#160;continued its Share Exchange with the Company, whereby the Company acquired an additional 38.2% of the issued and outstanding capital stock of Actinium Corporation from the Actinium Corporation Shareholders in exchange for the issuance of 8,009,550 shares of Common Stock of the Company to the Actinium Shareholders.&#160;&#160;On September 25, 2013 in accordance with a Certificate of Ownership Merging Actinium Corporation into the Company, the Company merged into itself Actinium Corporation, and Actinium Corporation ceased to exist. As a result of the merger, Actinium Corporation stock owned by the Company has been cancelled and each share of Actinium Corporation not owned by the Company was exchanged for 0.333 shares of Company common stock.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Corporate History of Actinium</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium Corporation was incorporated in 2000 in the state of Delaware. Until the Share Exchange, Actinium Corporation was a clinical-stage, privately held biopharmaceutical company with:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Two clinical-stage products, Iomab&#8482;-B and Actimab&#8482;-A, in development for blood borne cancers;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preclinical data in additional cancer indications;</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A proprietary technology platform for novel radioimmunotherapy cancer treatments; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A proprietary process for manufacturing of the alpha particle emitting radioactive isotope actinium 225 (Ac-225).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Iomab&#8482;-B has completed a Phase I/II design trial as a preparatory regimen in conjunction with fludarabine and reduced intensity radiation conditioning in patients who are ineligible for&#160;standard myeloablative conditioning for hematopoietic stem cell transplantation (HSCT) and the Company expects it to enter a regulatory approval trial in 2014, subject to input from the FDA concerning the design and conduct of a pivotal trial. This trial was conducted in 68 human subjects at the Fred Hutchinson Cancer Research Center in Seattle, WA, USA.&#160; Currently, the IND for this drug is held by the licensor, Fred Hutchinson Cancer Research Center.&#160; The Company intends to file its own separate IND for the purpose of conducting a Phase III trial in 2014. Actimab&#8482;-A is currently in a Phase I/II trial in newly diagnosed elderly acute myeloid leukemia (AML). In addition, using its patented Alpha Particle Immunotherapy Technology (APIT) platform and via its collaboration with the Memorial Sloan Kettering Cancer Center (MSKCC), the Company has preclinical data on potential drug candidates in several other cancer indications and expects to further develop these into clinical stage drug candidates</font>.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium Corporation has one wholly owned subsidiary, MedActinium, Inc., a Delaware corporation, which is party to certain isotope related licenses and contracts on which the Company relies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon Actinium Corporation&#8217;s formation in 2000, it acquired Pharmactinium, Inc. and MedActinium, Inc., and through Pharmactinium, Inc. acquired certain rights to the APIT platform. Core technology patents were in-licensed from N.V. Organon which also provided seed funding. Pharmactinium, Inc. was party to a research and development agreement with MSKCC beginning in 1996. In 2002, this agreement and relationship was significantly expanded and now includes research and development, preclinical development, clinical trials and commercial technology licenses. In 2007, Pharmactinium, Inc. was merged with and into the Company. In 2007, the Company also acquired its sister company, Actinium Pharmaceuticals, Limited (Bermuda) (the &#8220;Bermuda Company&#8221;), by a merger of the Bermuda Company into the Company and thereby also acquired certain patent licenses relating to APIT previously licensed by the Bermuda Company to the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2000, the Company also began what has become a long term relationship with General Atlantic Investments Limited (GAIL), an entity which provided most of the Company&#8217;s investment capital since 2000, totaling $50.7 million. In 2010, the parent of GAIL contributed and transferred its ownership of GAIL (now renamed Actinium Holdings, Limited), whose only asset at that time was the shares of API, to an indirect subsidiary of Memorial Sloan-Kettering Cancer Center. In January 2012, the Company closed on $6,685,418 in net funding through the sale of&#160;the Company's&#160;stock and a Senior Convertible Note financing. On December 19, 2012, Actinium completed a private offering of units, consisting of common stock, Series A warrants and Series B warrants.&#160;&#160;The price per unit was $1.65 for aggregate net proceeds of $4,469,776.&#160;&#160;The Series A Warrants had a 120 day term from January 28, 2013 and were exercisable for an aggregate of up to 3,118,968 shares of the Company&#8217;s common stock at an initial per share exercise price of $1.65, subject to adjustment.&#160;&#160;The Series A Warrants expired on May 28, 2013.&#160;&#160;The Series B Warrants have a five year term from January 28, 2013 and are exercisable for an aggregate of up to 1,59,484 shares of the Company&#8217;s common stock at an initial per share exercise price of $2.48, subject to adjustment.&#160;&#160;In the second quarter of 2013, we issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,457,087 for the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 25, 2013 in accordance with a Certificate of Ownership Merging Actinium Corporation into the Company, the Company merged into itself Actinium Corporation, and Actinium Corporation ceased to exist. As a result of the merger, Actinium Corporation stock owned by the Company has been cancelled and each share of Actinium Corporation not owned by the Company was exchanged for 0.333 shares of Company common stock.</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our executive office is located at 501 Fifth Avenue, 3rd Floor, New York, NY 10017 and our telephone number is (212) 300-2131. Our website address is http://www.actiniumpharmaceuticals.com. Except as set forth below, the information on our website is not part of this Registration Statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Summary of Scientific and Business Achievements:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s scientific and business achievements to date include:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In-licensing a Phase II clinical stage monoclonal antibody, BC8, with safety and efficacy data in more than 250 patients in need of Hematopoietic Stem Cell Transplantation (HSCT), currently in 7 active Phase I and Phase II clinical trials;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commencing a Company sponsored multi-center Phase I/II clinical trial for Actimab&#8482;-A in elderly Acute Myeloid Leukemia;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Developing and organizing manufacturing of Actinium&#8217;s lead drug candidate Actimab&#8482;-A&#160;&#160;which was accepted by the FDA for multi-center human use;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supporting three physician sponsored clinical trials, including a Phase I and a Phase I/II trial with the alpha emitting radioactive isotope bismuth 213 (Bi-213) based AML drug and a Phase I clinical trial with the alpha emitting radioactive isotope actinium 225 (Ac-225) based AML drug;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In-licensing the AML targeting monoclonal antibody known as HuM195 or Lintuzumab;</font></div>
</td>
</tr></table>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">37</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Establishing clinical and preclinical development relationships with world-class institutions such as MSKCC, Fred Hutchinson Cancer Research Center (FHCRC) and University of Texas MD Anderson Cancer Center (the MD Anderson Cancer Center relationship includes clinical trials only), as well as leading clinical experts in the fields of AML and HSCT;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Securing rights to an intellectual property estate that covers key aspects of the Company&#8217;s proprietary technology platform;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supporting a number of pipeline projects, including preclinical experiments in metastatic prostate cancer, metastatic colon cancer, antiangiogenesis and breast cancer models;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Maintaining contractual relationship with Oak Ridge National Laboratory (ORNL) of the Department of Energy (DOE) which gives API access to most of the current world supply of Ac-225; and</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Successfully developing commercial production methods for actinium 225.</font></td>
</tr></table>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Business Strategy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">API intends to potentially develop its most advanced clinical stage drug candidates through approval in the case of Iomab&#8482;-B and up to and including a Phase II proof of concept human clinical trial (a trial designed to provide data on the drug&#8217;s efficacy) in the case of Actimab&#8482;-A. If these efforts are successful, API may elect to commercialize Iomab&#8482;-B on its own or with a partner in the United States and/or outside of the U.S. to out-license the rights to develop and commercialize the product to a strategic partner. In the case of Actimab&#8482;-A, API will most likely seek to enter into strategic partnerships whereby the strategic partner(s) co-fund(s) further human clinical trials of the drug that are needed to obtain regulatory approvals for commercial sale within and outside of the U.S. In parallel, the Company intends to identify and begin initial human trials with additional actinium-225 drug candidates in other cancer indications. API intends to retain marketing rights for its products in the United States whenever possible and outlicense marketing rights to its partners for the rest of the world.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market Opportunity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">API is competing in the marketplace for cancer treatments estimated at over $54 billion in 2011 sales per IMS Health and projected to exceed $76 billion per year by 2015, according to the Global Academy for Medical Education. While surgery, radiation and chemotherapy remain staple treatments for cancer, their use is limited by the fact that they often cause substantial damage to normal cells. On the other hand, targeted monoclonal antibody therapies exert most or all of their effect directly on cancer cells, but often lack sufficient killing power to eradicate all cancer cells with just the antibody. A new approach for treating cancer is to combine the precision of antibody-based targeting agents with the killing power of radiation or chemotherapy by attaching powerful killing agents to precise molecular carriers called monoclonal antibodies (mAb). The Company uses monoclonal antibodies labeled with radioisotopes to deliver potent doses of radiation directly to cancer cells while sparing healthy tissues. The radioisotopes we use are the alpha emitter Ac-225 and the beta emitter I-131. I-131 is among the best known and well characterized radioisotopes. It is used very successfully in treatment of papillary and follicular thyroid cancer as well as other thyroid conditions. It is also attached to a monoclonal antibody in treatment of Non-Hodgkin&#8217;s Lymphoma (NHL). It is also used experimentally with different carriers in other cancers. Ac-225 has many unique properties and the Company is a leader in developing this alpha emitter for clinical applications using its proprietary APIT technology.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s most advanced products are Actimab&#8482;-A, Ac-225 labeled mAb for treatment of newly diagnosed AML, a cancer of the blood, in patients ineligible for currently approved therapies, and Iomab&#8482;-B, I-131 labeled mAb for preparation of relapsed and refractory AML patients for hematopoietic stem cell transplantation (HSCT). Iomab&#8482;-B offers a potentially curative treatment for these patients most of whom do not survive beyond a year after being diagnosed with this condition. Iomab&#8482;-B has also demonstrated efficacy in HSCT preparation for other blood cancer indications, including Myelodysplastic Syndrome (MDS), acute lymphoblastic leukemia (ALL), Hodgkin&#8217;s Lymphoma, and Non-Hodgkin&#8217;s Lymphoma (NHL). These are all follow-on indications for which Iomab&#8482;-B can be developed and it is the Companies intention to explore these opportunities</font>.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are currently no FDA approved treatments for either Actimab&#8482;-A or Iomab&#8482;-B targeted patients.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other potential product opportunities in which a significant amount of preclinical work is being undertaken include metastatic colorectal cancer, metastatic prostate cancer and antiangiogenesis which reduces the blood supply to solid tumors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company believes that its biggest market opportunity lies in the applicability of the Company&#8217;s APIT platform technology to a wide variety of cancers. A broad range of solid and blood borne cancers can be potentially targeted by monoclonal (mAbs) to enable treatment with its APIT technology. The APIT technology could potentially be applied to mAbs that are already FDA approved to create more efficacious and/or safer drugs (&#8220;biobetters&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Clinical Trials</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has completed a Phase I and Phase I/II physician trial in AML at MSKCC using Bismab&#174;-A, The Company&#8217;s first generation AML drug that consists of bismuth-213 attached to the antibody Lintuzumab&#8482;. The Phase II arm of the Bismab&#174;-A drug study has shown signs of the drug&#8217;s efficacy and safety, including reduction in peripheral blast counts and complete responses in some patients. Bi-213 is a daughter, i.e., product of the degradation of Ac-225, with cancer cell killing properties similar to Ac-225 but is less potent.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has commenced its first company sponsored Phase I/II multi-center trial with fractionated (two) doses of Actimab&#8482;-A, Actinium&#8217;s lead product for treatment of elderly AML that consists of an AML specific monoclonal antibody (HuM195, also known as Lintuzumab&#8482;) and the actinium 225 radioactive isotope attached to it. The Company intends to conduct these trials at world-class cancer institutions such as MSKCC, Johns Hopkins Medicine, University of Pennsylvania Health System, Fred Hutchinson Cancer Center and MD Anderson Cancer Center.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">38</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company also continues to sponsor a Phase I AML trial at MSKCC with a single-dose administration of Actimab&#8482;-A. Initial data shows elimination of leukemia cells from blood in 67% of all evaluable patients who received a full dose and in 83% of those treated at dose levels above 0.5 microcuries (&#181;Ci/kg), and eradication of leukemia cells in both blood and bone marrow in 20% of all evaluable patients and 25% of those treated at dose levels above 0.5 &#181;Ci/kg. Dose levels in that trial have been reduced as we continue our work on establishing a maximum tolerated dose.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Phase I trial builds on the experience with Company&#8217;s first generation drug Bismab&#174;-A that contains the same antibody used in Actimab&#8482;-A but labeled with bismuth 213, a less potent alpha emitting daughter of actinium 225 used in Actimab&#8482;-A. Bismab&#174;-A trials and the Phase I Actimab&#8482;-A trial were focused on relapsed, refractory and other difficult to treat acute myeloid leukemia patients. The new multicenter Phase I/II trial is focused on newly diagnosed AML patients who have historically had better outcomes. In addition, the new trial includes low doses of chemotherapy with the goal of further improving patient outcomes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s current operations are primarily focused on furthering the development of its lead clinical drug candidates Actimab&#8482;-A and Iomab&#8482;-B. In the case of Actimab&#8482;-A, key ongoing activities include progressing a multi-center Phase I/II trial, support for an ongoing Phase I clinical trial at Memorial Sloan Kettering Cancer Center in New York, managing isotope and other materials supply chain, and managing the manufacturing of the finished drug candidate product. The Company has secured access to much of the currently available world reserves of Ac-225 and Bi-213 through a renewable contractual arrangement with the U.S. Department of Energy (DOE). The Company projects that these quantities are sufficient to support early stages of commercialization of alpha isotopes based products. The Company has also developed its own proprietary process for industrial scale Ac-225 production in a cyclotron in quantities adequate to support full product commercialization.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Operations related to Iomab&#8482;-B include planning for a registration trial which will include development of commercial scale manufacturing to be suitable for an approval trial and preparation of appropriate regulatory submissions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the fiscal years ended December 31, 2012 and December 31, 2011, we spent approximately&#160;$3.4 million $0.3 million, respectively, on research and development activities.&#160; These expenditures consisted of materials maintenance and purchases, supply chain development and implementation, drug candidate manufacturing expenditures, clinical trials costs and intellectual property portfolio related expenses.&#160; Since we have no customers, none of the costs of such research and development activities were borne by our customers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of the end of the second quarter 2013, we believe that we have sufficient cash to continue our operations for the balance of the year.&#160;&#160;In the second quarter of 2013 we issued shares of common stock pursuant to the exercise of Series A Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,457,087 for the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We estimate that we will need approximately up to $25 million cash for the period of 2014 to 2016, i.e. until we receive our first product approval.&#160;&#160;We intend to fund these expenses from a combination of equity and/or debt funding raises and payments obtained from licensing partners.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Failure to raise additional equity or debt funding in the amounts necessary to complete our programs and/or failure to out license our programs on the projected terms may result in a slowing down of our projected development plan or our inability to complete one or more of the planned programs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our business plan has not been impacted by our accountants&#8217; going concern opinion.&#160; Due to our receipt of gross proceeds of $3,457,087 from the exercise of Series A Warrants described above, we believe that we have sufficient funds to fund our operations through 2013 and will seek to raise additional funds through equity and/or debt offerings to fund our operations in 2014 to 2016.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Summary of Material Agreements Related to Our Business</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Abbott Biotherapeutics Corp.</font> We entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, we made a license fee payment of $3,000,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5) First commercial sale</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">39</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="96%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Under the agreement, we agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As of December 31, 2012, we met our first milestone and upon reaching the milestone we paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Memorial Sloan Kettering Cancer Center (MSKCC)</font>.&#160;&#160;In February 2002, we entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">&#160;</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval </font>for each licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) upon the receipt of regulatory approval from the U.S. FDA for each </font>licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Under the agreement, we agreed to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.&#160;&#160;We expect to file the NDA for regulatory approval in 2016.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Oak Ridge National Laboratory (ORNL)</font> &#8211; We have contracted to purchase radioactive material to be used for research and development through December 2012. We contracted to purchase $233,100 of radioactive material to be used for research and development, with a renewal option at the contract end.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Aptiv Solutions.</font>&#160;&#160;AptivSolutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab&#8482;-A) used in our clinical trials, Phase I and Phase II. &#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &#160;The down payment totaling $239,000 was paid in 2007 and 2012. &#160;The agreement was amended to provide for additional services on August 6, 2012, October 22, 2012 and May 16, 2013. &#160;The total project is now estimated at $2,173,955.&#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Fred Hutchinson Cancer Research Center (FHCRC)</font>.&#160;&#160;On June 15, 2012, we entered into a license and sponsored research agreement with FHCRC. We will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and we intend to start preparation for a pivotal trial leading to an FDA approval. &#160;We have been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &#160;Under the terms of the sponsored research agreement, we will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">MSKCC</font>.&#160;&#160;On March 27, 2012, we entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &#160;The amount due of $79,623 was paid on July 10, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">40</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">g.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">FHCRC</font>.&#160;&#160;On July 19, 2012, we entered into a clinical trial agreement with FHCRC. &#160;We will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, we are required to pay a start-up fee of $19,749. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">h.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">The University of Texas M.D. Anderson Cancer Center</font>.&#160;&#160;On August 28, 2012, we entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &#160;The estimated cost is based on treating 24 patients through 2013. &#160;Upon execution of the agreement, we were required to make a payment of $33,946. &#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">i.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Johns Hopkins University</font>.&#160;&#160;On September 26, 2012, we entered into a clinical trial agreement with Johns Hopkins University. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $38,501 per patient, who has completed the clinical trial. We are required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">j.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">University of Pennsylvania</font>.&#160;&#160;&#160;On November 21, 2012, we entered into a clinical trial agreement with the University of Pennsylvania. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $31,771 per patient, who has completed the clinical trial. We will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Intellectual Property Portfolio</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has a patent portfolio with 8 issued patents and 60 pending patents in various jurisdictions as follows:&#160;&#160;United States: 17 and international: 51.&#160;&#160;Most of the patents are in-licensed from third parties and some are held by Actinium Corporation.&#160;&#160;These patents cover key areas of the Company&#8217;s activity, including use of the actinium 225 and other alpha emitting isotopes attached (labeled) to cancer specific carriers like monoclonal antibodies, methods for manufacturing key components of the Company&#8217;s drug candidates including actinium 225 alpha emitting radioisotope and carrier antibodies, methods for manufacturing finished drug candidates for use in cancer treatment, and methods for mitigating potential toxicities of the Company&#8217;s drug candidates.&#160;&#160;These patents are classified in families of related patents per the table below: &#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="white">
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Area</font></div>
</td>
<td valign="top" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims</font></div>
</td>
<td valign="top" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expiration</font></div>
</td>
<td valign="top" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Status</font></div>
</td>
<td valign="top" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="17%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Licensor</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Platform technology</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Metastases larger than 1 mm</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2020</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowed</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MSKCC</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Platform technology</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Use of the DOTA chelator for drug manufacturing</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2021</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MSKCC</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Drug preparation methods</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Actinium 225 labeling method</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2029</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pending</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Owned</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Drug preparation methods</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bismuth 213 labeling method</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017/2020</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MSKCC</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Isotope production methods</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Actinium 225 manufacturing in a cyclotron</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2023/2025</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pending/Allowed</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Owned</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Monoclonal antibody composition and production</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Manufacturing of leukemia targeting antibody</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Abbott Laboratories</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Methods of treatment</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="23%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Protection from actinium 225 toxicity</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2023</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pending</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="17%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MSKjCC</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Key Strengths</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company believes that the key elements for its market success include:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Clinical results to date imply lower development risk for its lead drug candidates:</font> The Company&#8217;s lead drug candidates have been tested in over 300 patients and demonstrated favorable safety and efficacy profiles. Iomab&#8482;-B has been administered to more than 250 patients in a number of Phase I and Phase II trials and has shown a clear survival benefit in the indication for which it is being developed.&#160;&#160;Bismab&#174;-A and Actimab&#8482;-A, drugs based on the APIT platform have so far been tested in over 60 patients in 3 clinical trials. In each trial they exhibited few side effects and have shown indications of efficacy. The current proof-of-concept Actimab&#8482;-A Phase I/II clinical trial is directed at a patient population that is generally easier to treat (newly diagnosed vs. relapsed/refractory in previous trials), and employs a more potent treatment regimen (low dose chemotherapy plus two doses of Actimab&#8482;-A plus low dose chemotherapy vs. a single dose of Actimab&#8482;-A in the physician sponsored trial).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Additional product opportunities from the APIT platform:</font> The Company&#8217;s Alpha Particle Immunotherapy technology has the potential for broad applicability for the treatment of many cancer types, which allows the Company to add new product candidates to its pipeline based on well-defined patent protected methods</font>.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Collaboration with Memorial Sloan-Kettering Cancer Center (MSKCC):</font> The Company&#8217;s collaboration with MSKCC includes licensing, research and clinical trial arrangements involving MSKCC labs and clinicians and included&#160;financial support with respect to certain pre-2012 R&amp;D-related expenses.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Scientific backing of leading experts:</font> The Company&#8217;s clinical advisory board and collaborators include some of the best recognized clinicians and scientists working at some of the highest regarded medical institutions in the U.S. and the world, including MSKCC, Johns Hopkins University, University of Pennsylvania, Fred Hutchinson Cancer Center and MD Anderson Cancer Center. This is expected to be beneficial to the Company both in clinical development and market acceptance assuming its drug candidates are approved.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">41</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Isotope supply secured for clinical trials:</font>&#160;The Company has a contractual relationship with ORNL (Oak Ridge National Laboratory of the Department of Energy (DOE)) that provides the Company access to the largest known supply reserves of actinium 225. Iodine 131 is readily available from a number of qualified pharmaceutical supply vendors.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Proprietary alpha emitting isotope manufacturing technology fully developed:</font> The Company has developed its own proprietary technology for commercial scale manufacturing of actinium 225. This is expected to ensure commercial supply of Ac-225 for Actimab&#8482;-A, Actimab&#8482;-B and other actinium-linked products should they be approved.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">cGMP Actimab&#8482;-A manufacturing developed:</font> The Company has developed at a contractor&#8217;s site full cGMP (current good manufacturing practices) manufacturing&#160;&#160;processes for its drug candidate Actimab&#8482;-A.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Substantial IP portfolio:</font>&#160;The Company has an intellectual property portfolio in excess of 60 patents and patent applications, both in the U.S. and other countries, which cover clinical applications of the APIT technology and methods of manufacturing actinium 225 thus giving the Company control over both the applications of its technology and a supply chain of its key ingredients, actinium 225 and bismuth 213 alpha emitting isotopes.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Competition Overview</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the Company&#8217;s knowledge, there are no other commercial entities that have significant programs in place for developing Ac-225- or Bi-213-based drugs. In the wider field of medical oncology, the Company faces competition from: developers of other alpha emitter based drug candidates, other radioimmunotherapy based technologies, technologies for labeling antibodies with toxic drugs (antibody-drug conjugates), and for each disease indication from all drugs available and/or in development.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For Company&#8217;s lead indication, acute myeloid leukemia, there are a number of companies developing drugs for AML induction in the elderly. These drugs are most often small molecules. Until recently, our leukemia targeting monoclonal antibody HuM195 was under development as a native i.e. unconjugated mAb by Seattle Genetics, Inc., but its development has been discontinued due to lack of efficacy of the native mAb in that company&#8217;s pivotal trial in AML. To our knowledge, there are no clinical trials that have shown significant efficacy in this indication.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the field of hematopoietic stem cell transplantation, pharmaceuticals currently used for bone marrow ablation/conditioning are generic drugs and to our knowledge there are no significant industry efforts to enter this area, especially not in older patients.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Government Regulation</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Governmental authorities in the United States and other countries extensively regulate, among other things, the research, development, testing, manufacture, labeling, promotion, advertising, distribution and marketing of radioimmunotherapy pharmaceutical products such as those being developed by the Company. In the United States, the U.S. Food and Drug Administration (FDA) regulates such products under the Federal Food, Drug and Cosmetic Act (FDCA) and implements regulations. Failure to comply with applicable FDA requirements, both before and after approval, may subject us to administrative and judicial sanctions, such as a delay in approving or refusal by the FDA to approve pending applications, warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions and/or criminal prosecution.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">United States FDA Regulation</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research, development and clinical programs, as well as our manufacturing and marketing operations, are subject to extensive regulation in the United States and other countries. Most notably, all of our products sold in the United States are subject to the FDA as implemented and enforced by the FDA. Certain of our product candidates in the United States require FDA pre-marketing approval of a Biologics License Application (BLA) pursuant to 21 C.F.R. &#167; 314. Foreign countries may require similar or more onerous approvals to manufacture or market these products.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Failure by us or by our suppliers to comply with applicable regulatory requirements can result in enforcement action by the FDA, the Nuclear Regulatory Commission or other regulatory authorities, which may result in sanctions, including but not limited to, untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; customer notifications or repair, replacement, refunds, recall, detention or seizure of our products; operating restrictions or partial suspension or total shutdown of production; refusing or delaying our requests for BLA premarket approval of new products or modified products; withdrawing BLA approvals that have already been granted; and refusal to grant export.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><a name="item_1_3_6"><!--EFPlaceholder--></a><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Properties</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company does not own any property. The Company has office space at 501 Fifth Avenue, 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> Floor, New York, NY 10017. The space is month to month and pays $4,376 per month.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">42</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Employees</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of September 27, 2013, we have 5 full-time employees. None of these employees are covered by a collective bargaining agreement, and we believe our relationship with our employees is good. We also engage consultants on an as-needed basis to supplement existing staff.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Legal Proceedings</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. We are currently not aware of any such legal proceedings or claims that will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="MARKETPRICE">MARKET PRICE </a>OF AND DIVIDENDS ON OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market Information</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Common Stock is listed on OTCQB, under the symbol &#8220;ATNM&#8221;.&#160; Our Common Stock ceased trading on the OTCBB on May 29, 2013.&#160;&#160;&#160;However, there is no active market for our Common Stock and trading has been extremely limited.&#160;&#160;The last quoted price for our Common Stock was $5.75 for a trade on September 25, 2013, as reported on www.otcbb.com.&#160;&#160;However, as there is currently little to no market for our Common Stock, we believe that this last reported price does not accurately reflect the value of the Common Stock or the Company, and it may not be possible to sell Common Stock at this price. &#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Holders</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of&#160;September 26, 2013 there were 25,581,139 shares of common stock issued and outstanding, which were held by 342 holders of record.&#160;&#160;There are no shares of preferred stock outstanding.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Of the 25,581,139 shares of common stock issued and outstanding, 25,181,139 of such shares are restricted shares under the Securities Act.&#160;&#160;None of these restricted shares are eligible for resale absent registration or an exemption from registration under the Securities Act.&#160;&#160;As of the date hereof, until the provisions of Rule 144 are complied with, the exemption from registration provided by Rule 144 under the Securities Act is not available for these shares pursuant to Rule 144(i).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Registration Rights</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain shareholders are entitled to certain registration rights, including piggy-back registration rights, with respect to the shares of common stock purchased in the offerings conducted by Actinium in 2011 and 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following shares are subject to registration rights:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="list"><!--EFPlaceholder--></a><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,281,952 shares of common stock, par value $0.001 per share, held by the selling stockholders issued pursuant to the 2011 Stock Offering and a private placement that closed on December 28, 2012;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,118,968 shares of our common stock issuable upon exercise of Series A warrants held by the selling stockholders at an exercise price of $1.65 per share issued pursuant to a private placement that closed on December 28, 2012;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,559,437 shares of our common stock issuable upon exercise of Series B warrants held by the selling stockholders at an exercise price of $2.48 per share issued pursuant to a private placement that closed on December 28, 2012;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,700,971 shares of our common stock issuable upon exercise of the 2011 Stock Offering warrants held by the selling stockholders at an exercise price of $0.78 per share;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,755,562 shares of our common stock issuable upon exercise of consulting firm warrants held by the selling stockholders at an exercise price of $0.001 per share issued pursuant to a consulting firm agreement, dated&#160;&#160;May 9, 2011;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,245,210 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $0.78 per share issued pursuant to the 2011 Stock Offering) ; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">467,845 shares of our common stock issuable upon exercise of placement agent warrants held by the selling stockholders at an exercise price of $1.65 per share issued pursuant to a private placement that closed on December 28, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have never declared or paid a cash dividend. Any future decisions regarding dividends are made by our Board of Directors. We currently intend to retain and use any future earnings for the development and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. Our Board of Directors has complete discretion on whether to pay dividends. Even if our Board of Directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that the Board of Directors may deem relevant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Authorized for Issuance Under Equity Compensation Plans</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2013 the Board approved the Company&#8217;s 2013 Stock Plan.&#160;&#160;The expiration date of the plan is September&#160;9, 2023&#160;&#160;and the total number of underlying shares of the Company&#8217;s common stock available for grant to employees, directors and consultants of the Company under the plan is 2,750,000 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2013 the Board approved the Company&#8217;s 2013 Equity Incentive Plan.&#160;&#160;The expiration date of the plan is September&#160;9, 2023&#160;&#160;and the total number of shares of the Company&#8217;s common stock available for grant to employees, directors and consultants of the Company under the plan is 450,000 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">43</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="MANAGEMENTSDISCUSSION">MANAGEMENT&#8217;S DISCUSSION</a>&#160;AND ANALYSIS OF FINANCIAL CONDITION </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RESULTS OF OPERATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information and financial data discussed below is derived from the unaudited consolidated financial statements of the Company for its quarterly period ended&#160;June 30, 2013 and of Actinium Corporation for the quarterly period ended June&#160;30, 2012, and audited consolidated financial statements of Actinium Corporation&#160;&#160;for its fiscal years ended December 31, 2012 and 2011.&#160;&#160;&#160;The consolidated financial statements of the Company and Actinium Corporation were prepared and presented in accordance with generally accepted accounting principles in the United States. The information and financial data discussed below is only a summary and should be read in conjunction with the historical financial statements and related notes contained elsewhere in the&#160;Registration Statement of which this prospectus is a part. The financial statements contained elsewhere in the Registration Statement of which this prospectus is a part fully represent the Company&#8217;s&#8217; financial condition and results of operations; however, they are not indicative of the Company&#8217;s future performance. See &#8220;Cautionary Note Regarding Forward Looking Statements&#8221; above for a discussion of forward-looking statements and the significance of such statements in the context of this Registration Statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled &#8220;Risk Factors&#8221; and elsewhere herein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company acquired 21% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;Actinium&#8221;), in exchange for the issuance of 4,309,015 shares of common stock, par value $0.001 per share, of the Company (the &#8220;Common Stock&#8221;), which were issued to the shareholders of Actinium. As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;Actinium&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &#160;Actinium&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We develop drugs for treatment of cancer with intent to cure or significantly improve survival of the affected patients. As of now none of our drugs have been approved for sale in the United States or elsewhere. We have no commercial operations in sales or marketing of our products. All our product candidates are under development. In order to market and sell our products we must conduct clinical trials on patients and obtain regulatory approvals from appropriate regulatory agencies like the Food and Drug Administration (FDA) in the United States and similar agencies elsewhere in the world.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our products under development are monoclonal antibodies labeled with radioisotopes. We have one program with an antibody labeled with a beta emitter and several programs based on a proprietary patent protected platform technology called alpha particle immunotherapy or APIT. Our APIT technology is based on attaching actinium 225 (Ac-225) or bismuth 213 (Bi-213) alpha emitting radioisotopes to monoclonal antibodies. Alpha emitting radioisotopes are unstable chemical elements that decay by releasing alpha particles. Alpha particles can kill any cell in whose immediate proximity they are released. Monoclonal antibodies are genetically engineered proteins that target specifically certain cells, and can target cancer cells. It is crucial for the success of our drug candidates to contain monoclonal antibodies that can successfully seek cancer cells and can kill them with the attached isotope while not harming nearby normal cells. We do not have technology and operational capabilities to develop and manufacture such monoclonal antibodies and we therefore rely on collaboration with third parties to gain access to such monoclonal antibodies. We have secured rights to two monoclonal antibodies, HuM195 (Lintuzumab), in 2003 through a collaborative licensing agreement with Abbott Laboratories and BC8 in 2012 with the Fred Hutchinson Cancer Research Center. We expect to negotiate collaborative agreements with other potential partners that would provide us with access to additional monoclonal antibodies. Establishing and maintaining such collaborative agreements is a key to our success as a company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">44</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under our own sponsorship as well as activity at FHCRC, we have four product candidates in active clinical trials: Actimab&#8482;-A (HuM195-Ac-225), Iomab&#8482;-B (BC8-I-131), BC8-Y-90 and BC8-SA. At this time, the Company is actively pursuing development of Actimab&#8482;-A and Iomab&#8482;-B while BC8-Y-90 and BC8-SA are in physician sponsored clinical phase I trials at the Fred Hutchinson Cancer Research Center.&#160;&#160;Actimab&#8482;-A is a combination of the monoclonal antibody we have in-licensed, Lintuzumab (HuM195), and the alpha emitting isotope actinium 225. Actimab&#8482;-A has shown promising results throughout preclinical development and an ongoing clinical trial started in 2006 in treating acute myeloid leukemia (AML) in the elderly. We have expanded the number of patients and number of clinical centers by commencing a new AML clinical trial which we have launched in 2012. This trial targets newly diagnosed AML patients over the age of 60. In order to conduct the trial we are engaged in funding, monitoring and quality assurance and control of the Lintuzumab antibody; procurement of actinium 225 isotope; funding, monitoring and quality assurance and control of the drug candidate Actimab&#8482;-A manufacturing and organizing and monitoring clinical trials. We estimate that the direct costs to completion of both parts of the ongoing Phase I/II trial will be approximately US $7 million.&#160;&#160;&#160;Assuming a successful trial we intend to explore out-licensing the Actimab&#8482;-A product and potentially receiving payments for co-developing the product with a partner.&#160;&#160;Iomab&#8482;-B is a combination of the in-licensed monoclonal antibody BC8 and the beta emitting radioisotope iodine 131. This construct has been extensively tested in Phase I and Phase II clinical trials in approximately 250 patients with different blood cancer indications who were in need of a hematopoietic stem cell transplantation (HSCT). Iomab&#8482;-B is used to condition the bone marrow of these patients by destroying blood cancer cells in their bone marrow and elsewhere thus allowing for a subsequent transplant containing healthy donor bone marrow stem cells. We have decided to develop this drug candidate by initially focusing on the patients over 50 with active acute myeloid leukemia in relapse and/or refractory to existing treatments. Our intention is to request the FDA to allow us to enter into a pivotal trial with Iomab&#8482;-B. We estimate the direct costs of such a trial to completion anticipated in 2016 will be approximately US $15 million, and up to approximately $25 million for both trials.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have primarily management position employees and consultants who direct, organize and monitor the activities described above through contractors. Much of the<font style="FONT-STYLE: italic; DISPLAY: inline"> in vivo</font> laboratory and clinical work contracted for by the Company has been conducted at Memorial Sloan-Kettering Cancer Center in New York. The Company has also made clinical trial arrangements with other well known cancer centers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Actimab&#8482;-A drug candidate and its components are contract manufactured and maintained under our supervision by specialized contract manufacturers and suppliers in the U.S., including IsoTex Diagnostics, Oak Ridge National Laboratory, Pacific GMP, Fischer Bioservices, BioReliance and others.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a development stage company and have never generated revenue. Currently we do not have a stable recurring source of revenues sufficient to cover our operating costs. As of December 31, 2012, we had an accumulated deficit of $55.7 million. We incurred net losses of $8.3 million and $3.4 million in the years ending December 31, 2012 and 2011, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Emerging Growth Company</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are an &#8220;emerging growth company&#8221; under the federal securities laws and will be subject to reduced public company reporting requirements. In addition, Section 107 of the JOBS Act also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing to take advantage of the extended transition period for complying with new or revised accounting standards.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Opportunities, Challenges and Risks</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market for drugs for cancer treatment is a large market in need of novel products, in which successful products can command multibillion dollars in annual sales. A number of large pharmaceutical and biotechnology company regularly acquire products in development, with preference given to products in Phase II or later clinical trials. These deals are typically structured to include an upfront payment that ranges from several million dollars to tens of million dollars or more and additional milestone payments tied to regulatory submissions and approvals and sales milestones. Our goal is to develop our product candidates through Phase II clinical trials and enter into partnership agreements with one or more large pharmaceutical and/or biotechnology companies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe our future success will be heavily dependent upon our ability to successfully conduct clinical trials and preclinical development of our drug candidates. This will in turn depend on our ability to continue our collaboration with Memorial Sloan-Kettering Cancer Center and our Clinical Advisory Board members plan to continue and expand other research and clinical trial collaborations. In addition, we will have to maintain sufficient supply of actinium 225 and successfully maintain and if and when needed replenish or obtain our reserves of monoclonal antibodies. We will have to maintain and improve manufacturing procedures we have developed for production of our drug candidates from the components that include the iodine 131 and actinium 225 isotopes, monoclonal antibodies and other materials. It is possible that despite our best efforts our clinical trials results may not meet regulatory requirements for approval. If our efforts are successful, we will be able to partner our development stage products on commercially favorable terms only if they enjoy appropriate patent coverage and/or considerable know-how and other protection that ensures market exclusivity. For that reason we intend to continue our efforts to maintain existing and generate new intellectual property. Intellectual property is a key factor in the success of our business as well as market exclusivity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To achieve the goals discussed above we intend to continue to invest in research and development at high and constantly increasing rates thus incurring further losses until one or more of our products are sufficiently developed to partner them to large pharmaceutical and biotechnology companies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our inception on June 13, 2000, we have not generated any revenues, and that as of December 31, 2012, we have incurred net losses of $55.7 million.&#160;&#160;As of December 31, 2012 and March 31, 2013 our cash balance was $5.6 million and $3.2 million, respectively, and we need approximately $25 million in cash to finance research and development and to cover our ongoing working capital needs through the first quarter of 2016. If we do not raise any additional funding, we will be able to continue our operations through&#160;August of 2014. If we raise 25% of the needed funds,&#160;we will be able to conduct our planned operations through the end of 2014 and into 2015. If we raise 50% of the needed funds, we will be able to conduct our planned development programs through the first half of 2015. If we raise 75% or more of the needed funds, we will be able to accelerate our planned development programs through 2015 and into the first quarter of 2016<font style="DISPLAY: inline; FONT-SIZE: 10pt">.&#160;&#160;</font>Our first product is not expected to be commercialized until at least 2017. In the second quarter of 2013 we issued shares of common stock pursuant to the exercise of Series A Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,457,087 for the Company. We believe that we have enough cash on hand to fund our business through 2013.&#160;&#160;In order to fund our business beyond 2013 we will likely need to raise money through private offerings of debt and/or equity.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">45</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six Months Ended June 30, 2013 Compared to the Six Months Ended June 30, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth, for the periods indicated, data derived from our statements of operations:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">For the six months ended&#160;</font> </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">June 30,</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Research and development, net of reimbursements</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,594,968</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,046,158 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;General and administrative</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,899,503</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">798,184 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Other expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">317 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Total operating expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,498,593</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,844,659 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other (income) expense:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Interest expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,209</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">633,618 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Gain on change in fair value of derivative liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,764</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,777</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Total other (income) expense</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25,555</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">626,841 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,473,038</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,471,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded no commercial revenues for the six months ended June 30, 2013 and 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development Expense</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses increased by $548,810 to $1,594,968 for the six months ended June 30, 2013 compared to $1,046,158 for the six months ended June 30, 2012. The increase is primarily attributable to the costs related to continuing the multi-center clinical trial for Actimab&#8482;-A which commenced in the third quarter of 2012 and the manufacturing of BC8, the antibody that is the key component of Iomab-B inlicensed by the Company in 2012. The increased expenses also reflect development work on significantly improving the efficacy and cost structure of the Actimab&#8482;-A manufacturing and costs related to Iomab-B&#8217;s clinical development and regulatory submissions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General and Administrative Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overall, total general and administrative expenses increased by $1,101,319 to $1,899,503 for the six months ended June 30, 2013 compared to $798,184 for the six months ended June 30, 2012. The increase was largely attributable to increases in professional fees, financing related fees&#160;and the stock-based compensation incurred by the Company as discussed below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other (Income) Expense</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other income increased by $652,396 for the six months ended June 30, 2013 compared to the six months ended June 30, 2012. The increase is primarily attributable a decrease in interest expense&#160;due to the amortization of the convertible debt discount and deferred financing costs related to the convertible debt during the six months ended June 30, 2012, and an&#160;&#160;increase in the gain on the change in fair value of the derivative liability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">46</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Loss</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss increased by $1,001,538 to $3,473,038&#160;for the six months ended June 30, 2013 compared to $2,471,500 for the six months ended June 30, 2012. The increase was primarily due to an increase in research and development efforts and in professional fees and payroll related expense, offset by a decrease in interest expense associated with the amortization of debt discount to interest expense and a gain from change in fair value of the derivative liability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have financed our operations primarily through sales of the Company&#8217;s stock and the issuance of convertible promissory notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We did not have any cash or cash equivalents held in financial institutions located outside of the United States as of June 30, 2013 and December 31, 2012. We do not anticipate this practice will change in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables sets forth selected cash flow information for the periods indicated:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the six months ended</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) operating activities</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,327,820</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,862,232</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) investing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,112</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,157</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) financing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,360,591</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">660,163</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="77%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="77%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net&#160;change in cash</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,659</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,203,226)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash used in operating activities was $3,327,820 for the six months ended June 30, 2013 compared to $1,862,232 used in operations for the same period in 2012. Cash used in operations increased due to the increase in spending related to preparations and eventual launch and conduct of a multicenter trial and an increase in spending related to professional fees combined with an increase in payroll-related expenses.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash provided by financing activities was $3,360,591 for the six months ended June 30, 2013 compared to net cash provided by financing activities of $660,163 for the same period in 2012. During the six months ended June 30, 2013, the Company received proceeds from the exercise of warrants as more discussed below. During the six months ended June 30, 2012, the Company received net proceeds of $660,163 from sale of its stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have experienced cumulative losses of $59,216,501 from inception (June 13, 2000) through June 30, 2013, and have stockholders' equity of $1,914,856 at June 30, 2013. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">47</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year Ended December 31, 2012 Compared to Year Ended December 31, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth, for the periods indicated, data derived from our statements of operations:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the Years ended</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Decrease)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development, net of reimbursements</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,440,485</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">323,788</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,116,697</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,506,232</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,959,246</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,546,986</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">581</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">633</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total operating expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,947,298</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,283,667</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,633,631</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other (income) expense:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,099,327</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175,094</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">924,233</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of derivative liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(685,420</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,966</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(671,454)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total other (income) expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">413,907</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161,128</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,779</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,361,205</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,444,795</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,916,410</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded no commercial revenues for the year ended December 31, 2012 and 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and Development Expense</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses increased by $3,116,697 to $3,440,485 for the year ended December 31, 2012 compared to $323,788 for the year ended December 31, 2011. The increase is attributable to the costs incurred on initiation of the multi-center clinical trial for Actimab&#8482;-A. The Company also made its first milestone payment of $750,000 to Abbott Biotherapeutics Corp. upon reaching the milestone. The increase also reflected an agreement the Company made with MSKCC as of April 2010, in which MSKCC agreed to pay or reimburse the Company for certain costs and expenses related to the Company&#8217;s drug development and clinical study program. This agreement expired on October 5, 2011. No reimbursement was due for the year ended December 31, 2012 and $237,834 was due for the year ended December 31, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and Administrative Expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overall, total general and administrative expenses increased by $1,546,986 to $4,506,232 for the year ended December 31, 2012 compared to $2,959,246 for the year ended December 31, 2011. The increase was largely attributable to increases in professional fees and the stock-based compensation incurred by the Company as discussed below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Company&#8217;s stock offering, in January 2012, we issued warrants to purchase 400,013 shares of common stock to the transaction manager for consulting services related to assisting the Company in preparing to become a publicly traded company. The fair value of $144,463, or $0.36 per share, was a noncash charge to general and administrative expenses for the year ended December 31, 2012. In February 2012, the Company granted options to purchase 2,125,000 shares of common stock to its employees and consultants with a fair value of $531,913. In July 2012, the Company granted options to purchase 90,000 shares of common stock to its consultants with a fair value of $23,770. In August 2012, the Company granted options to purchase 2,875,000 shares of common stock to its employees and consultants with a fair value of $724,784. During the fourth quarter, the Company granted options to purchase 1,085,000 shares of common stock to its employees and consultants with a fair value of $239,310.&#160;&#160;For the year ended December 31, 2012, the Company recorded amortization of stock-based compensation of $266,172 as a noncash charge to general and administrative expenses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The increase can also be attributed to additional professional fees of $549,383 related to the year-end audit, the quarterly review, legal fees, and management fees associated with the Company going public. In addition to the professional fees incurred, we increased our personnel. As such, payroll-related expenses for the year ended December 31, 2012 increased compared to the same period in 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest Expense</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest expense increased by $924,233 for the year ended December 31, 2012 compared to the year ended December 31, 2011. The increase in interest expense is directly attributable to interest accrued on the convertible debt, amortization of the convertible debt discount and deferred financing costs related to the convertible debt.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net Loss</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss increased by $4,916,410 to $8,361,205 for the year ended December 31, 2012 compared to $3,444,795 for to the year ended December 31, 2011. The increase was primarily due to additional costs incurred by the Company in research and development expenses, non-cash stock-based compensation costs and professional fees as discussed above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">48</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have financed our operations primarily through sales of the Company&#8217;s stock and the issuance of Convertible Promissory Notes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We did not have any cash or cash equivalents held in financial institutions located outside of the United States as of December 31, 2012 and 2011. We do not anticipate this practice will change in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables sets forth selected cash flow information for the periods indicated:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the years ended </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,212,710</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(517,592</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) investing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,359</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash provided by (used in) financing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,129,940</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,025,255</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase (decrease) in cash</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(85,129</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,507,663</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash used in operating activities was $5,212,710 for the year ended December 31, 2012 compared to $517,592 used in operations for the same period in 2011. Cash used in operations increased due to the increase in spending related to preparations and eventual launch and conduct of a multicenter trial and an increase in spending related to professional fees combined with an increase in payroll-related expenses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash provided by financing activities was $5,129,940 for the year ended December 31, 2012 compared to $6,025,255 for the same period in 2011. In January 2012, we sold 968,759 shares of our stock at $0.78 per share. In 2012, we also sold 3,118,988 shares of our common stock at $1.65 per share. We raised funds through sale of the Company&#8217;s stock to finance the expansion of our research and development efforts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have experienced cumulative losses of approximately $55,743,463 from inception (June 13, 2000) through December 31, 2012, and have stockholders' equity of $1,145,635 at December 31, 2012. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Debt and Equity Offerings</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2011, the Company raised $6,184,967 by selling 7,891,141 shares of the Company&#8217;s stock and warrants to purchase 19,972,785 shares of the Company&#8217;s stock through an offering (&#8220;Stock Offering&#8221;).&#160;&#160;A net amount of $5,379,367 was received by the Company in 2011. The Company paid Laidlaw &amp; Company (UK) Ltd. (&#8220;Laidlaw &amp; Co.&#8221;), the placement agent, total cash fees of $742,196, which consisted of placement agent commission of $618,497 and expense reimbursement of $123,699. In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien <font style="DISPLAY: inline; FONT-SIZE: 10pt">LLP</font>, $60,904 for its services as the placement agent&#8217;s legal counsel and Signature Bank $2,500 for the bank escrow fee.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 27, 2011, the Company completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes (&#8220;Convertible Notes&#8221;) in the amount of $900,000 and received net proceeds of $750,000. The convertible notes were issued at 83.33% of the principal amount resulting in an original issue discount of $150,000. The Convertible Notes mature one year from the date of issuance. Interest accrues at the rate of 8% per year on the outstanding principal amount, accrued semi-annually and to be paid at maturity. On December&#160;19, 2012, in connection with the Share Exchange, the Convertible Notes were converted into 1,252,550 share of common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2012, the Company raised $759,300 by selling 968,759 shares and warrants to purchase 242,190 shares of the Company&#8217;s common stock under the Company&#8217;s Stock Offering.&#160;&#160;A net amount of $660,164 was received by the Company in 2012. The Company paid Laidlaw &amp; Co. total cash fees of $91,116, which consisted of placement agent commission of $75,930 and expense reimbursement of $15,186. In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien PLLC, $8,020 for its services as the placement agent&#8217;s legal counsel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2012, the Company also raised $5,151,450 through an offering of 3,118,988 shares of its common stock and &#8220;A Warrants&#8221; to purchase 3,118,988 shares of the Company&#8217;s common stock, exercisable at a price of $1.65 per share for a period of 120 days from the day of the final closing of the offering, and &#8220;B Warrants&#8221; to purchase 1,559,505 shares of the Company&#8217;s common stock, exercisable at a price of $2.48 per share for a period of 5 years from the date of the final closing of the offering. (&#8220;2012 Common Stock Offering&#8221;)&#160;&#160;A net amount of $4,469,776 was received by the Company. Pursuant to the 2012 Common Stock Offering agreement, the Company paid Laidlaw &amp; Co. total cash fees of $618,174, which consisted of placement agent commission of $515,145 and expense reimbursement of $103,029. The Company also issued the placement agent warrants to purchase an aggregate of 467,845 shares of the Company&#8217;s common stock, with an exercise price of $0.78 per share and a term of 5 years. These placement agent warrants were valued at $499,707 and recorded as derivative liabilities.&#160;&#160;In addition, the Company paid the Laidlaw &amp; Co.&#8217;s outside counsel, Richardson &amp; Patel, LLP, $60,000 for its services as the Laidlaw &amp; Co.&#8217;s legal counsel and Signature Bank $3,500 for the bank escrow fee.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium intends to increase funds available to continue our research and development efforts, which include material supply, manufacturing, clinical development and pre-clinical trials and working capital. For the balance of 2013 and in 2014, we expect cash needs of up to $20,000,000 to finance research and development, which include material supply, manufacturing, clinical trials and pre-clinical trials and to cover our ongoing working capital needs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">49</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the second quarter of 2013 we issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,457,087 for the Company.&#160;The proceeds from these exercised warrants will be used for the Company&#8217;s clinical and preclinical programs and for general working capital.&#160;&#160;This capital will allow us to continue to develop our drug candidates for treatment of the most difficult forms of cancer, including Acute Myeloid Leukemia, where the Company has&#160;&#160;made significant advances and already helped a number of patients. The Company intends to advance its programs and add new programs by the end of 2013. Shareholders exercised 2,095,204 (67.2%) of the 3,118,988 originally issued A-warrants. The A-warrants expired on May 28, 2013.&#160;&#160;With exercise of the A-warrants we believe that we have the needed capital for 2013.&#160;&#160;We do not expect proceeds from the exercise of the outstanding B- warrants, Stock Offering warrants, consulting firm warrants, and placement agent warrants since these warrants contain cash-less exercise provisions. To meet our capital needs beyond 2013 we intend to conduct offerings of either stock and/or debt and also engage in licensing activities.&#160;&#160;We are currently sponsoring conduct of two clinical trials with Actimab-A (Phase I Physician trial at MSKCC and Phase I/II multicenter trial) and preparing for a Phase III trial with Iomab-B. If we do not raise any additional funding, we will be able to continue our operations through&#160;August of 2014. If we raise 25% of the needed funds,&#160;we will be able to conduct our planned operations through the end of 2014 and into 2015. If we raise 50% of the needed funds, we will be able to conduct our planned development programs through the first half of 2015. If we raise 75% or more of the needed funds, we will be able to accelerate our planned development programs through 2015 and into the first quarter of 2016<font style="DISPLAY: inline; FONT-SIZE: 10pt">.&#160;&#160;</font>There can be no assurance that we will be successful in obtaining additional capital through offerings of our securities in the future.</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the event we do not meet our cash needs of $25,000,000 through the first quarter of 2016, it may be necessary for us to delay the timing of various product development efforts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-Balance Sheet Arrangements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Seasonality</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have a seasonal business cycle. Our revenues and operating results are generally derived evenly throughout the calendar year.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Critical Accounting Policies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our financial statements have been prepared in accordance with accounting principles generally accepted in the United States. To prepare these financial statements, we must make estimates and assumptions that affect the reported amounts of assets and liabilities. These estimates also affect our expenses. Judgments must also be made about the disclosure of contingent liabilities. Actual results could be significantly different from these estimates. We believe that the following discussion addresses the accounting policies that are necessary to understand and evaluate our reported financial results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Derivatives</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All derivatives are recorded at fair value and recorded on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Financial Instruments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;&#160;&#160;&#160;&#160;&#160; Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;&#160;&#160;&#160;&#160;&#160; Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#9679;&#160;&#160;&#160;&#160;&#160; Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Taxes</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">50</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development Costs</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Share-Based Payments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Accounting Pronouncements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were various accounting standards and interpretations issued during 2012 and 2011, none of which are expected to have a material impact on the Company&#8217;s financial position, operations or cash flows.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">51</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="CHANGESIN">CHANGES IN</a> REGISTRANT'S CERTIFYING ACCOUNTANT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, we dismissed R.R. Hawkins and Associates International, A PC, (&#8220;Hawkins&#8221;), as our independent registered public accounting firm. The dismissal was approved by the audit committee ("Audit Committee") of our board of directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the fiscal years ended December 31, 2011 and 2010, Hawkins&#8217; reports on our financial statements did not contain an adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the fiscal years ended December 31, 2011 and 2010 and the subsequent periods through September 30, 2012, (i) there were no disagreements between us and Hawkins on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Hawkins, would have caused Hawkins to make reference to the subject matter of the disagreements in connection with its reports on the Registrant's financial statements, and (ii) there were no reportable events as that term is described in Item 304(a)(1)(v) of Regulation S-K.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, we provided Hawkins with a copy of the disclosures it is making in response to Item 4.01 on Form 8-K, and requested that Hawkins furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statements. A copy of the letter, dated December 28, 2012, was filed as Exhibit 16 to the Current Report on Form 8-K filed on January 2, 2013.&#160;&#160;A revised letter is attached to this Form S-1as Exhibit 16.1 that corrects the name of the registrant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, we engaged GBH CPAs, PC as our new independent registered public accounting firm beginning with our fiscal year ended December 31, 2012. The change in our independent registered public accounting firm was approved by the Audit Committee. During the two most recent fiscal years and through December 28, 2012, neither the Company nor anyone on its behalf consulted with GBH CPAs, PC regarding any of the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i) The application of accounting principles to a specific transaction, either completed or proposed;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii) The type of audit opinion that might be rendered on the Company&#8217;s financial statements, and none of the following was provided to the Company:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a) a written report; or (b) oral advice that GBH CPAs, PC concluded was an important factor considered by the Company in reaching a decision as to an accounting, auditing or financial reporting issue; or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii) Any matter that was subject of a disagreement, as that term is defined in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as described in Item 304(a)(1)(v) of Regulation S-K.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">52</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="DIRECTORS">DIRECTORS</a> AND EXECUTIVE OFFICERS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following sets forth information about our directors and executive officers:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Age</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Position</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kaushik Dave, PhD, MBA</font></font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President, Chief Executive Officer and Director</font></font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sergio Traversa, MBA</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interim Chief Financial Officer and Director</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dragan Cicic, MD</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Operating Officer and Chief Medical Officer</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Nicholson, PhD</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth, MS, MBA</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the Company&#8217;s charter, Mr. Traversa and Mr. Seth were appointed as directors of the Company by the former Series E preferred stock holders of Actinium Corporation. During 2011, Actinium Corporation raised $6,184,967 through an offering of 23,697,119 shares (pre-Actinium Share Exchange) of the 2011 Series E preferred shares and 5,924,285 warrants (pre-Actinium share exchange). In January 2012, the Actinium Corporation raised $759,300 through its final offering of the 2011 Series E preferred shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are no other&#160;arrangements or understanding between any of our directors and any other persons pursuant to which they were selected as a director.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Kaushik J. Dave, PhD, MBA, President, Chief Executive Officer and Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dr. Kaushik J. Dave has been our President, Chief Executive Officer and Director since September 2013.&#160;&#160;From March 2008 to September 2013, Dr. Dave was the Executive Vice President of Product Development for Antares Pharmaceuticals Inc. (Antares).&#160;&#160;As part of the core management team at Antares, he was instrumental in setting strategy, vision, product portfolio development and business development.&#160;&#160;Dr. Dave led the clinical and regulatory approval of Anturol&#8482; and was also a key contributor to the change in company vision to combination products using Antares&#8217; medical device technology which resulted in a robust pipeline that included development and New Drug Application submission for Otrexup, which has an October 14, 2013 PDUFA date.&#160;&#160;From January 2001 to June 2006, Dr. Dave was Vice President Product Development at Palatin Technologies Inc. where he obtained approval of NeutroSpec<font style="DISPLAY: inline; FONT-SIZE: 10pt">TM</font> (a radiopharmaceutical monoclonal antibody product).&#160;&#160;From January 1997 to December 2000,&#160;Dr. Dave was employed at Schering-Plough Inc. and Merck &amp; Co. Inc., responsible for steering the development of several pharmaceutical product development programs.&#160;&#160;Dr. Dave received his pharmacy degree from the University of Bath, UK and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas.&#160;&#160;Dr. Dave also received an MBA from the Wharton School of the University of Pennsylvania.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As President and Chief Executive Officer of the Company, Dr. Dave is the most senior executive of the Company and as such provides our Board with the greatest insight into the Company&#8217;s business and the challenges and material risks it faces. Dr. Dave has more than 23 years of healthcare industry experience&#160;and is especially qualified to understand the risks and leadership challenges facing a growing pharmaceutical company from a senior management and financial expertise perspective led us to conclude that Dr. Dave should serve as President, Chief Executive Officer and Director of the Company.</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sergio Traversa, Interim Chief Financial Officer and Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dr. Traversa has been a Director of the Company since August, 2012.&#160;&#160;Dr. Traversa is also the Chief Executive Officer of Relmada Therapeutics Inc.&#160;&#160;Previously, he was the co-founder and CEO of Medeor Inc. a spinoff pharmaceutical company from Cornell University.&#160;&#160;Dr. Traversa has over 25 years of experience in the healthcare sector in the United States and Europe, ranging from management positions in the pharmaceutical industry to investing and strategic advisory roles. He has held financial analyst, portfolio management and strategic advisory positions at large U.S. investment firms specializing in healthcare, including Mehta and Isaly and Mehta partners, ING Barings, Merlin BioMed and Rx Capital. Dr. Traversa was a founding partner of Ardana Capital, a pharmaceutical and biotechnology investment advisory firm. In Europe, he held the position of Area Manager for Southern Europe (Italy, Spain, Greece and Portugal) of Therakos Inc., a cancer and immunology division of Johnson &amp; Johnson. Prior to Therakos, Dr. Traversa was at Eli Lilly, where he served as Marketing Manager of the Hospital Business Unit. He was also a member of the CNS team at Eli Lilly, where he participated in the launch of Prozac and the early development of Zyprexa and Cymbalta. Dr. Traversa started his career as a sales representative at Farmitalia Carlo Erba, the largest pharmaceutical company in Italy later sold to Pharmacia and now part of Pfizer. Dr. Traversa holds a Laurea degree in Pharmacy from the University of Turin (Italy) and an MBA in Finance and International Business from the New York University Leonard Stern School of Business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As Interim Chief Financial Officer of the Company, Mr.&#160;Traversa is a senior executive of the Company and as such provides our Board with great insight into the Company&#8217;s business and the challenges and material risks it faces. That Mr.&#160;Traversa serves in such executive officer positions with the Company and has more than 25 years of healthcare and financial industry experience in the United States and Europe and is especially qualified to understand the risks and leadership challenges facing a growing pharmaceutical company from a senior management and financial expertise perspective led us to conclude that Mr. Traversa should serve as a director.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Traversa devotes a minimum of 40 hours per week to the Company.&#160;&#160;Relmada Therapeutics, Inc., of which Mr. Traversa also serves as Chief Executive Officer, is not related to the Company and specializes in pain management, which is not related to our business.&#160;&#160;We do not believe that Mr. Traversa&#8217;s employment by Relmada Therapeutics creates a material risk of conflicts of interest.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">53</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dragan Cicic, MD, MBA, Chief Operating Officer and Chief Medical Officer</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dragan Cicic is the COO and CMO of the Company. He joined the Company in 2005 and previously held the position of the CEO and prior to that of the Medical Director at Actinium. Dr. Cicic joined Actinium from the position of Project Director of QED Technologies Inc., a life sciences strategic consulting and transactional group focused on emerging biotech, pharmaceuticals and medical devices companies. Dr. Cicic prepared business and strategic plans on behalf of those clients and assisted them in raising funding. He also represented corporate and private investors in identifying acquisition and/or investment targets and negotiating, structuring and consummating deals. Prior to joining QED Technologies, Dr. Cicic was an investment banker with SG Cowen Securities.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dr. Cicic graduated as a Medical Doctor from the School of Medicine at The Belgrade University, and received his MBA from Wharton School at The University of Pennsylvania. He was also a Nieman Fellow at Harvard University.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">C. David Nicholson, BS, PhD, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C. David Nicholson is a Director of the Company and joined the Executive Committee of Bayer CropScience on March 5, 2012 as Head of Research &amp; Development responsible for the integration of the company&#8217;s R&amp;D activities into one global organization. Dr. Nicholson graduated in pharmacology, earning his B.Sc. from the University of Manchester (1975) and his Ph.D. from the University of Wales (1980). Between 1978 and 1988, Dr. Nicholson worked in the pharmaceutical industry for the British company Beecham-W&#252;lfing in Gronau, Germany. The main emphasis of his activities as group leader in a multidisciplinary project group was the development of cardiovascular drugs.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From 1988-2007, Dr, Nicholson held various positions of increasing seniority in the UK, the Netherlands and the USA with Organon a Business Unit of Akzo Nobel. Ultimately he became Executive Vice President, Research &amp; Development, and member of the Organon Executive Management Committee. He implemented change programs, leading to maximizing effectiveness in research &amp; development, ensuring customer focus and the establishment of a competitive pipeline of innovative drugs. In 2007, Dr. Nicholson transferred to Schering-Plough, Kenilworth, New Jersey, USA, as Senior Vice President, responsible for Global Project Management and Drug Safety. From 2009 to December 2011, he was Vice President Licensing and Knowledge Management at Merck in Rahway, New Jersey, USA, reporting to the President of Merck R&amp;D. As an integration team member, David Nicholson played a role in the strategic mergers of Organon BioSciences, the human and animal health business of Dutch chemical giant Akzo-Nobel, and Schering-Plough in 2007 as well as of Schering-Plough and Merck in 2009. C. David Nicholson is presently on the Board of multiple biotechnology companies, including Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">That Mr.&#160;Nicholson brings over 25 years of pharmaceutical experience to our Board, Having served in various pharmaceutical research and development executive-level positions over the course of his career, and that Mr.&#160;Nicholson has developed significant management and leadership skills relating to the pharmaceutical industry.&#160;&#160;and is well accustomed to interfacing with&#160;&#160;investors, analysts, auditors, outside advisors and governmental officials, led us to conclude that Mr. Nicholson should serve as a director.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Sandesh Seth, MS, MBA, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Sandesh Seth is a Director of the Company and also&#160;the Head of Healthcare Investment Banking at Laidlaw &amp; Company (UK) Ltd. (the &#8220;Placement Agent&#8221;) which has served as the company&#8217;s Placement Agent. Mr. Seth has over 20 years of experience which includes prior investment banking at Cowen &amp; Co., equity research at Bear Stearns and Commonwealth Associates and in the pharmaceutical industry at Pfizer, Warner-Lambert, and SmithKline Beecham in strategic planning, business development and R&amp;D project management respectively. Mr. Seth&#8217;s financial services experience includes 100+ completed transactions in which $5 billion+ in capital was raised. Transactions included venture investments, private placements, IPOs, FOs, PIPEs, Convertible and High-Yield Debt. Mr. Seth was also involved with various strategic initiatives such as mergers and acquisitions, leveraged and management buy-outs, and licensing and joint ventures, including the $100 billion merger of Pfizer and Warner-Lambert and the $20 billion merger of Pharmacia &amp; Upjohn with Monsanto. Mr. Seth has an MBA in Finance from New York University; an M.S. in the Pharmaceutical Sciences from the University of Oklahoma Health Center and a B.Sc. in Chemistry from Bombay University. He has published several scientific articles and was awarded the University Regents Award for Research Excellence at the University of Oklahoma. Mr. Seth was designated as Regulatory Affairs Certified (R.A.C.) by the Regulatory Affairs Professionals Society which signifies proficiency with U.S. FDA regulations. He also holds the following Securities Industry Licenses: Series 7, 79 and 63.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">That Mr. Seth has served in various business executive-level positions over the course of his career, has significant investment banking experience, has developed significant management and leadership skills and is well accustomed to interfacing with investors, analysts, auditors, C-level executives, and outside advisors, led us to conclude that Mr. Seth should serve as a director.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Corporate Governance</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The business and affairs of the Company are managed under the direction of the Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Term of Office</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our directors are divided into three classes, designated Class I, Class II and Class III.&#160;&#160;Class I shall consists of two independent directors, Class II shall consist of two directors that were appointed as directors to Actinium Corporation by the holders of the former Series E preferred stock holders of Actinium Corporation, and Class III shall consist of the chief executive officer.&#160;&#160;Each director shall serve a term ending on the date of the third annual meeting of shareholders following the annual meeting at which the director was elected.&#160;&#160;Notwithstanding the foregoing, each director shall serve until his successor is duly elected and qualified, or until his or her retirement, death, resignation or removal. In order to implement a staggered board of directors, Class I shall serve a six month term from the date of incorporation; Class II shall serve a 18 month term from the date of incorporation; and Class II shall serve a 30 month term from the date of incorporation.&#160;&#160;Directors elected at each annual meeting commencing in 2013 shall be elected for a three year term as specified above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Director Independence</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use the definition of &#8220;independence&#8221; of The NASDAQ Stock Market to make this determination.&#160;&#160;We are not listed on NASDAQ, so although we use its definition of &#8220;independence&#8221;, its &#8220;independence&#8221; rules are inapplicable to us.&#160;&#160;NASDAQ Listing Rule 5605(a)(2) provides that an &#8220;independent director&#8221; is a person other than an officer or employee of the company or any other individual having a relationship which, in the opinion of the Company&#8217;s Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.&#160;&#160;The NASDAQ listing rules provide that a director cannot be considered independent if:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">54</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the director is, or at any time during the past three years was, an employee of the company;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the director or a family member of the director accepted any compensation from the company in excess of $120,000 during any period of 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including, among other things, compensation for board or board committee service);</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a family member of the director is, or at any time during the past three years was, an executive officer of the company;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity to which the company made, or from which the company received, payments in the current or any of the past three fiscal years that exceed 5% of the recipient&#8217;s consolidated gross revenue for that year or $200,000, whichever is greater (subject to certain exclusions);</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three years, any of the executive officers of the company served on the compensation committee of such other entity; or</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the director or a family member of the director is a current partner of the company&#8217;s outside auditor, or at any time during the past three years was a partner or employee of the company&#8217;s outside auditor, and who worked on the company&#8217;s audit.</font></div>
</td>
</tr></table>
</div>

<div align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Common Stock is not currently quoted or listed on any national exchange or interdealer quotation system with a requirement that a majority of our board of directors be independent and, therefore, the Company is not subject to any director independence requirements. Under the following three NASDAQ director independence rules a director is not considered independent: (a) NASDAQ Rule 5605(a)(2)(A), a director is not considered to be independent if he or she also is an executive officer or employee of the corporation, (b) NASDAQ Rule 5605(a)(2)(B), a director is not consider independent if he or she accepted any compensation from the company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, and (c) NASDAQ Rule 5605(a)(2)(D), a director is not considered to be independent if he or she is a partner in, or a controlling shareholder or an executive officer of, any organization to which the company made, or from which the company received, payments for property or services in the current or any of the past three fiscal years that exceed 5% of the recipient's consolidated gross revenues for that year, or $200,000. Under such definitions, David Nicholson and Sergio Traversa are the only independent directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Committees of the Board of Directors</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, our board of directors formed two standing committees: audit and&#160;&#160;compensation. Actions taken by our committees are reported to the full board. Each of our committees has a charter and each charter is posted on our website.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="48%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Audit Committee</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="48%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation&#160;Committee</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="48%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Sergio Traversa*</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="48%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. David Nicholson*</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="48%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. David Nicholson</font></div>
</td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="48%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">*</font> Indicates committee chair</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Audit Committee</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our audit committee, which currently consists of two directors, provides assistance to our board in fulfilling its legal and fiduciary obligations with respect to matters involving the accounting, financial reporting, internal control and compliance functions of the company. Our audit committee employs an independent registered public accounting firm to audit the financial statements of the company and perform other assigned duties. Further, our audit committee provides general oversight with respect to the accounting principles employed in financial reporting and the adequacy of our internal controls. In discharging its responsibilities, our audit committee may rely on the reports, findings and representations of the company&#8217;s auditors, legal counsel, and responsible officers. Our board has determined that all members of the audit committee are financially literate within the meaning of SEC rules and under the current listing standards of the Nasdaq Capital Market. Our board has also determined that Dr. Traversa qualifies as an &#8220;audit committee financial expert.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation Committee</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our compensation committee, which currently consists of two directors, establishes executive compensation policies consistent with the company&#8217;s objectives and stockholder interests. Our compensation committee also reviews the performance of our executive officers and establishes, adjusts and awards compensation, including incentive-based compensation, as more fully discussed below. In addition, our compensation committee generally is responsible for:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">establishing and periodically reviewing our compensation philosophy and the adequacy of compensation plans and programs for our directors, executive officers and other employees;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">overseeing our compensation plans, including the establishment of performance goals under the company&#8217;s incentive compensation arrangements and the review of performance against those goals in determining incentive award payouts;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">overseeing our executive employment contracts, special retirement benefits, severance, change in control arrangements and/or similar plans;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">acting as administrator of any company stock option plans; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">overseeing the outside consultant, if any, engaged by the compensation committee.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our compensation committee periodically reviews the compensation paid to our non-employee directors and the principles upon which their compensation is determined. The compensation committee also periodically reports to the board on how our non-employee director compensation practices compare with those of other similarly situated public corporations and, if the compensation committee deems it appropriate, recommends changes to our director compensation practices to our board for approval.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Outside consulting firms retained by our compensation committee and management also will, if requested, provide assistance to the compensation committee in making its compensation-related decisions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">55</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Family Relationships</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are no family relationships among any of our officers or directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Involvement in Certain Legal Proceedings</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To our knowledge, none of our current directors or executive officers has, during the past ten years:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Except as set forth in our discussion below in &#8220;Certain Relationships and Related Transactions,&#8221; none of our directors or executive officers has been involved in any transactions with us or any of our directors, executive officers, affiliates or associates which are required to be disclosed pursuant to the rules and regulations of the SEC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Code of Ethics</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has adopted a code of ethics, a copy of which is attached as Exhibit 14.1 to the Form 8-K filed on January 2, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">56</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="EXECUTIVE">EXECUTIVE</a> COMPENSATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Summary Compensation Table</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides information regarding the compensation earned during the fiscal years ended December 31, 2012, December 31, 2011 and December 31, 2010 by our Chief Executive Officer and the two next most highly compensated executive officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name/Position</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Salary</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bonus</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Awards</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All Other</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Compensation</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jack Talley, former CEO, resigned on February 28, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,000</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,412</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">308,412</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dragan Cicic, COO</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,658</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,658</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">190,658</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,000</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,426</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,717</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,717</font></div>
</td>
<td align="left" nowrap valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)(2)(2)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">249,084</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,375</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200,375</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Enza Guagenti, former CFO, resigned on March 9, 2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">90,000</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,394</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93,394</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diane&#160;Button,CEO, CFO (1)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)&#160;&#160;&#160; Ms. Diane Button resigned as the Company's CEO and CFO on December 28, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)&#160;&#160;&#160;Dr. Cicic&#8217;s options awards were determined by taking into consideration the following factors: (i) Dr Cicic's responsibilities at the Company; (ii) his performance historically and as an incentive for future efforts; (iii) compensation data taken from peer group companies (newly public biotech firms); and (iv) the level of his past awards.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of Dr. Cicic&#8217;s employment contract and the agreed upon written terms of employment for Ms. Guagenti, these employees are entitled to receive severance of twelve months, twelve months and three months base salary, respectively, upon termination by the Company without cause, or upon resignation within thirty days after a change in job responsibilities and a reduction in base salary. On February 28, 2013, Mr. Talley resigned as Chief Executive Officer and Director of the Company and Actinium. On March 9, 2013, Ms. Guagenti resigned as Chief Financial Officer of the Company and Actinium.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As an &#8220;emerging growth company&#8221; we will not be required to provide information relating to the ratio of total compensation of our Chief Executive Officer to the median of the annual total compensation of all of our employees, as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Wall Street Reform and Consumer Protection Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Director Compensation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Historical non-management Directors of the Company do not receive any cash compensation. Commencing October 1, 2012, non-management Directors of Actinium Corporation (and now the Company) began to receive a quarterly cash retainer of $7,500 per calendar quarter for their service on the Board of Directors. They also receive reimbursement for out-of-pocket expenses and certain directors have received stock option grants for shares of Company Common Stock as described below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth the compensation of our directors for the 2012 fiscal year:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="43%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name(1)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fees&#160;Earned&#160;or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Paid in Cash</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock&#160;Awards</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Option&#160;Awards</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All Other</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Rosemary Mazanet (resigned on May 31, 2013)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49,950</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Nicholson</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">333,000</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49,950</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jack Tally (resigned as CEO&#160;&#160;on March 9, 2013)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="43%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sergio Traversa</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49,950</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,500</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">57</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Employment Agreements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective September 16, 2013, the Company and Dr. Kaushik J. Dave entered into an agreement (the &#8220;Employment Agreement&#8221;), to employ Dr. Dave as the Company&#8217;s Chief Executive Officer.&#160;&#160;Dr. Dave shall have such responsibilities, duties and authority as are assigned to him by the Board, or its designee.&#160;&#160;These responsibilities shall include implementation of the overall direction of the Company as set by the Board, including, planning, corporate policies, research and development, staffing, finance and operations.&#160;&#160;Dr. Dave shall perform such other duties and shall have authority consistent with his&#160;&#160;position as may be from time to time specified by the Board&#160;&#160;and subject to the discretion of the Board.&#160;&#160;Dr. Dave reports directly to the Board.&#160;Dr. Dave also agreed to devote his best efforts and substantially all of his business time to advance the interests of the Company and to discharge adequately his duties under the Employment Agreement.&#160;&#160;Dr. Dave may hold up to two board seats on for-profit and not-for-profit boards that do not represent a conflict with the Company and subject to Board approval after review of the time commitment involved.&#160;Dr. Dave may&#160;&#160;also be employed or enter into a consulting arrangement with Antares Pharma Inc. until December 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the Employment Agreement, Dr. Dave is entitled to the following compensation and benefits:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#9679;</font></div>
</td>
<td align="left" colspan="2" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A base salary at an annual rate of $350,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="93%" style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Upon the six month anniversary of the start date, the Board will review Dr. Dave&#8217;s base salary with the help of an independent compensation consultant to adjust the base salary to be competitively aligned to a range between the 25<font style="DISPLAY: inline; FONT-SIZE: 10pt">th</font> (twenty-fifth) and 75<font style="DISPLAY: inline; FONT-SIZE: 10pt">th</font> (seventy-fifth) percentile of the relevant market data of CEO positions of similarly situated publicly traded Biotech companies. The Board shall review the amount of the base salary and performance bonus, and shall determine the appropriate adjustments to each component of Dr. Dave&#8217;s compensation within 60 days of the start of each calendar year.</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="93%" style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="93%" style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In addition, for the duration that the Company maintains its primary office in New York City, the Company will reimburse Dr. Dave for up to $500 per month in travel expenses plus the dollar amount of the difference between Dr. Dave&#8217;s New York State and New Jersey State taxes based on income from the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#9679;</font></div>
</td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Dave shall be entitled to participate in an executive bonus program, which shall be established by the Board pursuant to which the Board shall award bonuses to Dr. Dave, based upon the achievement of written individual and corporate objectives such as the Board shall determine.&#160;&#160;Upon the attainment of such performance objectives, Dr. Dave shall be entitled to a cash bonus in an amount to be determined by the Board with a target of forty percent (40%) of the base salary.&#160;&#160;Within thirty (30) days after the start date, the Board shall establish written individual and corporate performance objectives for the balance of 2013 and the amount of the performance pro-rata bonus payable upon the attainment of each objective.&#160;&#160;At least thirty (30) days before each subsequent calendar year, the Board shall establish written individual and corporate performance objectives for such calendar year and the amount of the performance bonus payable upon the attainment of such objectives.&#160;&#160;Within sixty (60) days after the end of each calendar year, the Board shall determine the amount of any performance bonus payable thereunder.&#160;&#160;Any such performance bonus shall be due and payable within ninety (90) days after the end of the calendar year to which it relates.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#9679;</font></div>
</td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Board has agreed to grant to Dr. Dave an option to purchase common shares of the Company and restricted stock (the &#8220;Grant&#8221;).&#160;&#160;The Grant will consist of (A) an option grant to purchase 675,000 common shares of the Company; (B) 125,000 shares of restricted and (C) 100,000 shares of restricted stock as a sign-on bonus of which fifty percent will vest at the one year anniversary of the start date upon starting work.&#160;&#160;An additional twenty-five percent each will vest at eighteen months and twenty-four months after the start date.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Options</font>.&#160;&#160;Such options will have an exercise price equal to the prior day closing price of the Company&#8217;s common stock which is equal to fair market value as determined by the Board on the date of the grant (the &#8220;Grant date&#8221;).&#160;&#160;The Grant Date shall occur no later than 90 days from the start date.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Restricted Stock Grant (excluding the sign-on bonus)</font>.&#160;&#160;One third (33.33%) of the restricted stock shall be granted upon the next closing of a financing of the Company of at least $5 million, and shall vest per the vesting schedule below.&#160;&#160;The remaining two thirds (66.66%) of the restricted stock shall be granted upon the treatment of the first patient in 2014 for the Iomab&#8482;-B trial and subject to the vesting schedule below.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Vesting Schedule</font>. Twenty-eight percent (28%) of the initial options or restricted stock granted shall vest twelve months after the date of grant and two percent (2%) of the remainder shall vest each month thereafter until fully vested. Such additional options or restricted stock will have an exercise price per share which is equal to fair market value as determined by the Board on the date of the grant. Two percent (2%) of such additional options or stock shall vest each month thereafter until fully vested. The term of all options granted under this Agreement will be for 10 years from the date of grant, subject to Dr. Dave&#8217;s continuing service with the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Dave is also eligible to participate in the Company&#8217;s benefit plans that are generally provided for executive employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The employment agreement also contains a non-solicitation provision that provides that during the term of employment and for a period of 24 months following the cessation of employment with the company you Dr. Dave shall not directly or indirectly solicit, induce, recruit or encourage any of the Company&#8217;s employees or consultants to terminate their relationship with the Company, or attempt any of the foregoing, either for himself or any other person or entity</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">58</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 23, 2012, Actinium Corporation entered into an employment agreement with Jack Talley, as our, Chief Executive Officer. The initial term of employment was for a period of three (3) years, provided that Mr. Talley&#8217;s employment with the company will be on an &#8220;at will&#8221; basis.&#160;&#160;Actinium Corporation agreed to pay a base salary of $250,000 per annum.&#160;&#160;The board will review Mr. Talley&#8217;s base salary with help of an independent compensation consultant to adjust his base salary to be competitively aligned to a range between the 25th and 75th percentile of the relevant market data of CEO positions of similarly situated publicly traded biotech companies.&#160;&#160;Mr. Talley was also entitled to participate in an executive bonus program, which shall be established by the board pursuant to which the board shall award bonuses to Mr. Tally, based on achievement of written individual and corporate objectives such as the board shall determine.&#160;&#160;Upon the attainment of such performance objectives, in addition to base salary, Mr. Talley was entitled to a cash bonus in an amount to be determined by the Board up to fifty percent (50%) of his base salary. Actinium Corporation also agreed to grant to Mr. Talley an option grant to purchase common shares of the Company equal to three percent (3.0%) of the Company's issued and outstanding equity (common and preferred shares) on a fully diluted basis. Such options had an exercise price of $0.261 cents per share which is equal to fair market value as determined by the board on the date of the grant. Twenty-eight percent (28%) of the initial options granted shall vest twelve months after the date of grant and two percent (2%) of the remainder shall vest each month thereafter until fully vested. Additional options were to be granted upon the final closing of the Company's next financing so that total options granted wiould equal three percent (3%) of fully diluted shares on that date. Such additional options will have an exercise price per share which is equal to fair market value as determined by the Board on the date of the grant. Two percent (2%) of such additional options shall vest each month thereafter until fully vested. The term of all options granted under this Agreement will be for 10 years from the date of grant, subject to your continuing service with the Company. On February 28, 2013, Mr. Talley resigned as Chief Executive Officer and Director of the Company and Actinium Corporation as per the terms of the Severance Agreement&#160;(as described below).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 2, 2006, Actinium Corporation entered into an employment agreement with Dragan Cicic, as our, Chief Operating Officer and Chief Medical Officer. The term of the employment agreement is one year; provided that the term shall be automatically extended for successive one year periods thereafter, unless, no later than 60 days prior to the expiration of any successive one-year renewal term, either party thereto provides the other party written notice of its desire not to extend the term.&#160;&#160;Actinium agreed to pay a base salary of $144,758 per annum during the term with an annual percentage increase of not less than an amount equal to the aggregate preceding 12 months annual percentage increase of the U.S. Department of Labor Consumer Price Index for All Urban Consumers (CPI-U) for the New York area.&#160;&#160;Mr. Cicic is also entitled to participate in any incentive compensation or bonus program which is instituted or maintained for company executives generally during the term of the agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">59</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 21, 2012, Actinium entered into an employment agreement with Enza Guagenti, as our Chief Financial Officer. Ms. Guagenti&#8217;s employment with the Company is on an "at will" basis, meaning that either Ms. Guagenti or the Company may terminate your employment at any time for any reason or no reason, without further obligation or liability, except that upon termination of Ms. Guagenti&#8217;s employment by the Company other than for cause Ms. Guagenti will be entitled to severance equal to 3 months base salary. In the event that a) the Company hires a CFO other than yourself, and 2) within two years thereafter Ms. Guagenti&#8217;s base salary is reduced below $115,000 per year,&#160;&#160;Ms. Guagenti may then within thirty days after the base salary reduction resign her position with the Company and collect the severance.&#160;&#160;Actinium Corporation&#160;&#160;agreed to pay an initial base salary of $90,000.&#160;&#160;Ms. Guagenti&#8217;s&#160;&#160;annual base salary will be increased to one hundred fifteen thousand dollars ($115,000) on the six month anniversary of the start date. Thereafter, before the beginning of each calendar year during the term of her employment, beginning in January 2014, the board shall review the amount of Ms. Guagenti&#8217;s base salary and performance bonus, and shall determine the appropriate adjustments to each component of her compensation for the following calendar year.&#160;The Company also agreed to grant to Ms. Guagenti an option grant to purchase 75,000 common shares of the Company. Such options will have an exercise price of $0.261 cents per share which is equal to fair market value as determined by the board on the date of the grant. Two percent (2%) of the options granted shall vest each month after the date of grant until fully vested. The term of all options granted under this Agreement will be for 10 years from the date of initial grant, subject to Ms. Guagenti&#8217;s continuing service with the Company. On March 9, 2013, Ms. Guagenti resigned as Chief Financial Officer of the Company and Actinium Corporation. Purusant to the terms of the employment agreement, Ms. Guagenti did not receive any severance payments upon resignation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Severance Agreement</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 28, 2013, the Company entered into a Separation and Settlement Agreement with Mr. Talley (the &#8220;Separation Agreement&#8221;). The Separation Agreement, among other things, provides for a cash payment in two (2) equal installments the aggregate amount of two hundred fifty thousand dollars ($250,000), with the first payment of $125,000 occurring on March 8, 2013 and the second payment of $125,000 occurring on September 1, 2013.&#160;&#160;The Company will also pay Mr. Talley (i) a discretionary performance bonus of $60,000 for the period of August 15, 2012 to December 31, 2012 and (ii) COBRA continuation coverage under the Company&#8217;s group health plan for six months.&#160;&#160;As part of the settlement Mr. Talley agreed to resign as a director from the Company and Actinium Corporation. The Separation Agreement also includes, subject to limited exceptions,&#160;mutual releases.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Agreement with Dr. Mazanet.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 31, 2013, Dr. Rosemary Mazanet resigned as a director of the Company and Actinium Corporation, a subsidiary of the Company, to pursue other opportunities.&#160;&#160;Dr. Mazanet&#8217;s decision to resign from the board of directors of the Company was not based upon any disagreement with the Company on any matter relating to the Company's operations, policies or practices as contemplated by Item 5.02(a) of Form 8-K.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 31, 2013, the Company and Actinium Corporation also entered into an agreement with Dr. Mazanet (the &#8220;Agreement&#8221;) which, among other things, provides for a cash payment to Dr. Mazanet of $25,000 in full satisfaction for all amounts owed under the Consulting Agreement.&#160;&#160;The parties also agreed that Dr. Mazanet is entitled to a total of 83,250 vested Company options (the Options&#8221;) which will be exercisable until the ten year anniversary of the grants, respectively.&#160;&#160;Dr. Mazanet agreed not to sell or otherwise transfer any shares of Company common stock underlying the Options or other securities of the Company owned by Dr. Mazanet until (i) the date that is the earlier of twelve (12) months from December 28, 2012; or (ii) six (6) months following the effective date of the Registration Statement filed by the Company with the Securities and Exchange Commission on March 15, 2013.&#160;&#160;Dr. Mazanet also resigned as a director from the Company and Actinium Corporation. The Agreement also includes, subject to limited exceptions,&#160;mutual releases, mutual non-disparagement clauses, and a non-solicitation provision.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">60</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;<a name="item_1_3_9"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="SECURITYOWNERSHIP">SECURITY OWNERSHIP</a> OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows the beneficial ownership of our Common Stock as of September 23, 2013 held by (i) each person known to us to be the beneficial owner of more than five percent (5%) of any class of our shares; (ii) each director; (iii) each executive officer; and (iv) all directors and executive officers as a group.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Beneficial ownership is determined in accordance with the rules of the SEC, and generally includes voting power and/or investment power with respect to the securities held.&#160;&#160;Shares of Common Stock subject to options and warrants currently exercisable or which may become exercisable within 60 days of September 23, 2013, are deemed outstanding and beneficially owned by the person holding such options or warrants for purposes of computing the number of shares and percentage beneficially owned by such person, but are not deemed outstanding for purposes of computing the percentage beneficially owned by any other person.&#160;&#160;Except as indicated in the footnotes to this table, the persons or entities named have sole voting and investment power with respect to all shares of our Common Stock shown as beneficially owned by them.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The percentages below are based on fully diluted shares of our Common Stock equivalents as of September 26, 2013.&#160;&#160; Unless otherwise indicated, the principal address of each of the persons below is c/o Actinium Pharmaceuticals, Inc., 501 Fifth Avenue, New York, NY 10017.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Executive Officers and Directors</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Shares of Common Stock and Preferred Stock Beneficially Owned</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Percentage of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ownership(a)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kaushik Dave, PhD</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dragan Cicic, MD</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">249,755</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.98</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Nicholson</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,979</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180,348</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.71</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sergio Traversa</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,984</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All Directors and Officers as a Group (4 persons)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">467,066</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.8</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All other 5% holders</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Actinium Holdings Ltd. (5)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c/o Sterling Management Limited</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">P.O. Box HM 1029</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hamilton HM CX</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,702,387</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22.3</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;(a)&#160;&#160;</font></div>
</td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Based on 25,581,139 shares of Common Stock outstanding as of September 26, 2013, and includes 400,000 shares of common stock of the Company that remained outstanding after the closing of the Share Exchange.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) Options granted to purchase an aggregate of 333,000 shares of Common Stock of the Company at an exercise price of $0.784 per share, options to purchase an aggregate of 99,900 shares of Common Stock of the Company at an exercise price of $1.50 per share, and options to purchase an aggregate of 81,784 shares of Common Stock of the Company at an exercise price of $1.35 per share. All shares are subject to vesting. 249,755 shares of Common Stock will have vested within 60 days of September 23, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) Options to purchase an aggregate of 49,950 shares of Common Stock of the Company at an exercise price of $0.784 per share and options to purchase an aggregate of 49,950 shares of Common Stock of the Company at an exercise price of $1.50 per share.&#160;&#160;All shares are subject to vesting. 20,979 shares of Common Stock will have vested within 60 days of September 23, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">61</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) Warrants to purchase an aggregate of 64,747 shares of Common Stock of the Company at an exercise price of $0.784 per share, exercisable on a cashless basis and warrants to purchase an aggregate of 99,617 of Common Stock of the Company at an exercise price of $0.784 per share, exercisable on a cashless basis issued to Amrosan, LLC, a partnership in which the majority member interest is owned by the family of Mr. Seth.&#160;&#160;Excludes warrants to purchase an aggregate of 375,556 shares of Common Stock of the Company at par value per share, exercisable on a cashless basis issued to Amrosan, LLC as the warrants are not exercisable upon less than 90 days notice.&#160; The holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.&#160; The shares available by exercise of this Warrant are&#160;also restricted and may not be sold or otherwise transferred until the earlier of twelve months from December 28, 2012, the closing date of the going Share Exchange; or for six months after the Registration Statement of which this prospectus is a part is declared effective. Excludes 353,023 warrants issued to Carnegie Hill Asset Partners and irrevocable trust linked to Mr. Seth&#8217;s family and 721,068 warrants issued to Bioche Asset Management, LLC, a partnership in which the majority member interest is owned by the family of Mr. Seth whose terms are the same as those issued to Amrosan LLC. Also excludes warrants held by the Placement Agent or its affiliates in connection with the offering of common stock and Series A and Series B warrants that closed on December 19, 2012 (the &#8220;2012 Offering&#8221;), the Bridge Notes Financing, the Series E financing and by designees of Jamess Capital Group, LLC in connection with the Share Exchange. Also includes options to purchase an aggregate of 49,950 shares of Common Stock of the Company at an exercise price of $1.50 per share. All shares are subject to vesting. 15,984 shares of Common Stock will have vested within 60 days September 23, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) Options to purchase an aggregate of 49,950 shares of Common Stock of the Company at an exercise price of $1.50 per share.&#160;&#160;13,986 shares of Common Stock will have vested within 60 days of September 23, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium Holdings Ltd., a Bermuda corporation (&#8220;AHL&#8221;), has entered the Share Exchange and a related Lock-up Agreement and is the record holder of the number of shares of Common Stock of the Company listed opposite its name.&#160;&#160;Michael Sheffrey&#160; has sole voting and investment power over the securities beneficially owned by Actinium Holdings Ltd.&#160;&#160;&#160;AHL is wholly owned by AHLB Holdings, LLC (&#8220;AHLB&#8221;), which in turn, is wholly owned by MSKCC.&#160;&#160; AHL, AHLB and MSKCC may be deemed to share investment and voting power and beneficial ownership of such shares.&#160;Investment power with respect to such shares is limited by AHL&#8217;s agreement not to transfer its shares of Common Stock, subject to exceptions for certain related-party transfers, transfers to trusts and other private transfers, until, in general, the earlier of (i) December 28, 2013 (the first anniversary of the closing of the Share Exchange); or (ii) six (6) months following the effective date of the Registration Statement of which this prospectus is a part.&#160;&#160;&#160;AHL is entitled to certain demand and &#8220;piggyback&#8221; registration rights with respect to its shares of Common Stock.&#160;&#160;The shares to be registered by AHL will, however, in certain circumstances, be subject to &#8220;cutback&#8221; (or reduction of the number of shares includible in an underwritten registration) prior to the &#8220;cutback&#8221; of the shares being registered on behalf of investors in certain recent private placements of the Company<!--EFPlaceholder--></font>.<a name="ref_id0e5b"><!--EFPlaceholder--></a>&#160;&#160;</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">62</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="item_1_3_10"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="CERTAINRELATIONSHIPS">CERTAIN RELATIONSHIPS</a>&#160;AND RELATED TRANSACTIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Transactions with Related Persons</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 18, 2001, Actinium Corporation entered into a Clinical Trial Agreement with Memorial Sloan-Kettering Cancer Center (MSKCC) and Sloan-Kettering Institute of Cancer Research (SKI),&#160;an entity related to MSKCC.&#160;&#160;Through an indirect subsidiary, Actinium Holdings Ltd. (AHL), MSKCC&#160;has been a principal stockholder of the Company since April 2010.&#160;&#160;The agreement provided for the conduct by SKI/MSKCC of Phase I/II clinical trials of the use of 213Bi-Hu195and cytarabine for the treatment of acute myeloid leukemia and for Actinium Corporation&#8217;s partial sponsorship of the study in exchange for access to data resulting from the study.&#160;&#160;Actinium Corporation was obligated to pay SKI (a) $10,000 for each completed case report on a completed subject, and (b) $2,500 for each case report on an incomplete subject. The trial enrolled 31 patients, was completed in 2007 and all the money due to Memorial Sloan-Kettering Cancer Center (MSKCC) and Sloan-Kettering Institute of Cancer Research (&#8220;SKI&#8221;) were paid in full.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 11, 2002, Actinium Corporation entered into a License, Development and Commercialization Agreement with SKI.&#160;&#160;The agreement was amended in August 2006.&#160;&#160;Pursuant to the agreement, Actinium Corporation licenses certain intellectual property from SKI, including critical patents with respect to Actinium Corporation&#8217;s core technology, and also supports ongoing research and clinical development of Actinium Corporation related drug candidates.&#160;&#160;Certain amounts due under this agreement were deferred and then forgiven under the forbearance-related arrangements described below.&#160;&#160;On June 19, 2011, Actinium Corporation nonetheless agreed to pay SKI (a) $50,000 in 2011, (b) $200,000 in 2012 and (c) $250,000 in 2013 under this agreement, in respect of the $50,000 annual maintenance fees and research payments. Since January 1, 2011, the Company has paid $100,000 for 2012 under this Agreement and as of December 31, 2012, the Company agreed to pay an additional $150,000 for research to be conducted in 2013 under this agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 25, 2006, Actinium Corporation entered into a Clinical Trial Agreement with MSKCC and SKI.&#160;&#160; The agreement provides for the conduct by SKI/MSKCC of a Phase I clinical trials of the use of Actinium 225-HuM195 for the treatment of advanced myeloid malignancy and for Actinium Corporation&#8217;s partial sponsorship of the study in exchange for access to data resulting from the study.&#160;&#160;Actinium Corporation is obligated to pay SKI (a) $10,000 for each completed case report on a completed subject, and (b) $2,500 for each case report on an incomplete subject. As of December 21, 2012, 18 subjects had been enrolled in this study, and the parties intend to attempt to enroll and additional 3 subjects. The maximum compensation for which Actinium Corporation is responsible for under the agreement is $328,000. Since the inception of the trial in 2006, Actinium Corporation has paid $180,000 and since January 1, 2011, Actinium Corporation has paid $70,000 under the agreement.&#160;&#160;As of December 31, 2012, no monies were due under this agreement.&#160;&#160;The trial is ongoing and further fees are likely to be accrued as patients are enrolled.&#160;&#160;In January and February 2012, two additional patients were treated in this trial.&#160;&#160;We anticipate enrollment of one more additional patient under this agreement in 2013 and closing the trial after that.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In April 2010, SKI agreed, on behalf of itself and its related or affiliated entities, including MSKCC, to forbear from collecting or otherwise enforcing Actinium Corporation&#8217;s then outstanding obligations to those entities and similar obligations arising during a defined forbearance period.&#160;&#160;The initial outstanding obligations consisted of approximately $260,000 due under Actinium Corporation&#8217;s license and clinical trials agreements with those entities. In June 2011, SKI agreed to forgive all current and future obligations subject to the forbearance in order to facilitate Actinium Corporation&#8217;s financing efforts.&#160;&#160;The forbearance period terminated on October 30, 2011, when the Company satisfied a financing condition to the termination of the forbearance period by raising in excess of $3,000.000 in new equity financing.&#160;&#160;The total amount forgiven was approximately $360,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MSKCC agreed, subject to certain conditions, to utilize donated funds for certain clinical and preclinical programs and activities related to Actinium Corporation&#8217;s drug development and clinical study programs, including the payment of certain costs and expenses that would otherwise have been borne by Actinium Corporation. The following is a summary of activities related to the MSKCC arrangements at December 31, 2011 and 2010:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Qualified R&amp;D costs incurred by Actinium Corporation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">655,786</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash received from MSKCC</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,834</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">966,341</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2011 and 2010, the Company had reimbursement receivables for costs incurred of $237,834 and $279,401 from MSKCC, respectively.&#160;&#160;These amounts have since been paid.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From&#160;July through October 2011, AHL agreed, in connection with Actinium Corporation&#8217;s Stock offering, to waive its rights to anti-dilution adjustments in respect of its outstanding stock and its preemptive rights to purchase the Company's stock from the Stock Offering.&#160;&#160;AHL also agreed to the restructuring of its registration rights in favor of the private placement purchasers, the amendment of the stockholders agreement of Actinium Corporation (to permit, among other transactions, the share exchange) and the relinquishment of its rights to Board representation, although one director originally nominated by AHL continued to serve.&#160;&#160;Actinium agreed (i) not to reduce the indemnification, advancement of expenses and similar rights of present and former directors and officers of Actinium Corporation, (ii) until April 30, 2016 to maintain directors&#8217; and officers&#8217; liability insurance at least in the same manner and to the same extent as then in effect, and (iii) following any merger, asset transfer and certain other transactions to provide for the parity of such directors and officers in respect of indemnification, advancement of expenses and D&amp;O liability insurance with such rights applicable to the non-continuing directors following such transactions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">63</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 27, 2012, Actinium Corporation entered into an additional clinical trial agreement with Memorial Sloan-Kettering Cancer Center with respect to conducting a Phase I/II trial of combination therapy of low dose cytarabine and fractionated dose of Lintuzumab-Ac225.&#160;&#160;Actinium Corporation will pay $31,185 for each patient that has completed the clinical trial.&#160;&#160;Upon execution of the agreement, Actinium Corporation was required to pay a start-up fee of $79,623, which was paid on July 10, 2012. The total number of patients anticipated to be enrolled at MSKCC in this trial is 15.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AHL has agreed not to transfer its shares of Common Stock, subject to exceptions for certain related-party transfers, transfers to trusts and other private transfers, until, in general, the earlier of (i) December 28, 2013 (the first anniversary of the closing date of the Share Exchange); or (ii) six (6) months following the effective date of the Registration Statement of which this prospectus is a part.&#160;&#160;&#160;AHL will be entitled to certain demand and &#8220;piggyback&#8221; registration rights with respect to the shares of Common Stock that it may acquire.&#160;&#160;The shares to be registered by AHL will, however, in certain circumstances, be subject to &#8220;cutback&#8221; (or reduction of the number of shares includible in an underwritten registration) prior to the &#8220;cutback&#8221; of the shares being registered on behalf of investors in certain recent private placements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 1, 2012, Actinium Corporation entered into a Consulting Services Agreement with Dr. Rosemary Mazanet, a former director of Cactus.&#160;&#160;Pursuant to the agreement, Dr. Mazanet provided, among other things, consulting services in the areas of implementation of the Actimab&#8482;-A trial including all aspects of study initiation until first patient in at each clinical site.&#160;&#160;Dr. Mazanet received compensation of $100,000 per year.&#160;&#160;Since January 1, 2011, Dr. Mazanet has received options to purchase 225,000 shares of common stock of Actinium. Dr. Mazanet resigned as a director of the Company on May 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 7, 2012, Actinium Corporation entered into an engagement agreement with Laidlaw &amp; Company (UK) Ltd. (the &#8220;Placement Agent&#8221;) for the 2012 Offering,&#160;of which Mr. Seth, a director of the Company. is Head of Healthcare Investment Banking.&#160;&#160;&#160;Pursuant to the agreement, the Placement Agent was engaged as the exclusive agent for the 2012 Offering.&#160;&#160;None of the Company&#8217;s current officers or directors had a prior relationship or affiliation with the Company prior to the closing of the Share Exchange.&#160;&#160;In consideration for its services, the Placement Agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the Placement Agent.&#160;&#160;The Placement Agent or its designees have also received warrants to purchase shares of the Company&#8217;s Common Stock in an amount equal to 10% of the shares of Common Stock issued as part of the Units sold in the 2012 Offering and the shares of Common Stock issuable upon exercise of the B Warrants included in such Units.&#160;&#160;The Placement Agent will also receive the same fee and expense schedule for any cash exercise of Warrants within 6 months of the final closing of the 2012 Offering and a 5% solicitation fee for any Warrants exercised as a result of being called for redemption by the Company.&#160;&#160;Upon the final closing of the 2012 Offering the Placement Agent has been engaged by the Company to provide certain financial advisory services to the Company for a period of at least 6 months for a monthly fee of $25,000.&#160;&#160;The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the Placement Agent, the Placement Agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the Placement Agent will have the right to act as the Company&#8217;s financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.&#160;&#160;For a period ending one year after the expiration of all lock-up agreements entered into in connection with the Share Exchange, any change in the size of the Company board of directors must be approved by the Placement Agent.&#160;&#160;The Placement Agent also was engaged by Actinium Corporation as placement agent for its Stock Offering&#160;and notes financing in 2011 and, as a part of the fee for that engagement, designees of the Placement Agent also hold warrants to purchase 1,245,226 shares of the Company&#8217;s Common Stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 9, 2011, Actinium Corporation entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of the Company.&#160; Mr. Seth is a Managing Partner of the consulting firm some of whose member interests are held by entities owned by officers and employees of the Placement Agent.&#160; None of the Company&#8217;s current officers or directors had a prior relationship or affiliation with the Company prior to the closing of the Share Exchange.&#160; Pursuant to the agreement, the management firm was engaged to provide consulting services to Actinium Corporation related to the consummation of a going public transaction for Actinium.&#160; The management firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&#160; Jamess Capital Group does not retain&#160;beneficial ownership of the warrants as they were&#160;issued to designess of the members in amounts which do not qualify either Jamess or the warrant holders for inclusion in the beneficial ownership table.&#160; The warrants contain&#160;a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.&#160; The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transferred until the earlier of twelve months from December 28, 2012, the closing date of the Share Exchange; or for six months after the Registration Statement of which this prospectus is a party declared effective.&#160;The consulting firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.&#160;&#160;The transaction management agreement was terminated on March 31, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2010, Actinium Corporation entered into an agreement with Guagenti &amp; Associates LLC (&#8220;G&amp;A&#8221;).&#160;&#160;G&amp;A is affiliated with Enza Guagenti, the former Chief Financial Officer of the Company.&#160;&#160;Pursuant to the agreement, API leases storage space in Newark, NJ from G&amp;A.&#160;&#160;The rent is $300 per month.&#160;&#160;The agreement is on a month-to-month basis and requires a 45-day notice by either party to cancel. Since January 1, 2011, the Company has paid $7,200 pursuant to this agreement.&#160;&#160;&#160;Ms. Guagenti resigned as our Chief Financial Officer on March 9, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Non-Competition Agreements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our executive officers have signed non-competition agreements, which provide that all inventions become the immediate property of the Company and require invention assignments. The agreements provide that the executive officers will hold proprietary information in the strictest confidence and not use the confidential information for any purpose not expressly authorized by us.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">64</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="DESCRIPTIONOF">DESCRIPTION OF&#160;</a>SECURITIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Authorized Capital Stock</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Introduction</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the discussion that follows, we have summarized selected provisions of our certificate of incorporation, bylaws and Delaware law relating to our capital stock. This summary is not complete. This discussion is subject to the relevant provisions of Delaware law and is qualified in its entirety by reference to our articles of incorporation and our bylaws. You should read the provisions of our certificate of incorporation and our bylaws as currently in effect for provisions that may be important to you.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Authorized Capital Stock</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The total authorized shares of capital stock of the Company currently consists of 100,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share.&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Holders of our common stock are entitled to receive notice of and to attend all meetings of our stockholders, and to one vote for each share on all matters submitted to a stockholder vote.&#160;&#160;Holders of common stock do not have cumulative voting rights.&#160;&#160;Therefore, holders of a majority of the shares of common stock voting for the election of directors can elect all of the directors.&#160;&#160;Holders of our common stock representing a majority of the voting power of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of our stockholders.&#160;&#160;A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to our articles of incorporation.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the event of liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common stock.&#160;&#160;Holders of our common stock have no pre-emptive rights, no conversion rights and there are no redemption provisions applicable to our common stock.</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of September 26, 2013 there were 25,581,139 shares of Common Stock issued and outstanding, which were held by 342 holders of record.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dividends</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Holders of common stock are entitled to share in all dividends that the board of directors, in its discretion, declares from legally available funds.&#160;&#160;We have not paid any cash dividends on our Common Stock and do not plan to pay any such dividends in the foreseeable future. We currently intend to use all available funds to develop our business. We can give no assurances that we will ever have excess funds available to pay dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Preferred Stock</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are authorized to issue up to 10,000,000 shares of preferred stock, par value $0.001 per share, in one or more series as may be determined by our Board of Directors, who may establish, from time to time, the number of shares to be included in each series, may fix the designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereof. Any preferred stock so issued by the Board may rank senior to the common stock with respect to the payment of dividends or amounts upon liquidation, dissolution or winding up of us, or both. Moreover, while providing desirable flexibility in connection with possible acquisitions and other corporate purposes, under certain circumstances, the issuance of preferred stock or the existence of the unissued preferred stock might tend to discourage or render more difficult a merger or other change of control. We currently do not have any preferred stock outstanding.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Series A &amp; Series B Warrants</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Series A Warrants had a 120 day term from January 28, 2013 and were exercisable for an aggregate of up to 3,118,968 shares of the Company&#8217;s common stock at an initial per share exercise price of $1.65, subject to adjustment as set forth below (anti-dilution).&#160;&#160;The Company also had a right of first refusal on the holder&#8217;s sale of the warrant shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">65</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Series B Warrants have a five year term from January 28, 2013 and are exercisable for an aggregate of up to 1,59,484 shares of the Company&#8217;s common stock at an initial per share exercise price of $2.48, subject to adjustment as set forth below.&#160;&#160;These warrants have a cashless exercise provision.&#160;&#160;The Company also has a right of first refusal on the holder&#8217;s sale of the warrant shares.&#160;&#160;The Company may also call this warrant for redemption upon written notice to all warrant holders at any time the closing price of the common stock exceeds $1.50 (as may be adjusted pursuant to warrant agreement) for 20 consecutive trading days, as reported by Bloomberg, provided at such time there is an effective registration statement covering the resale of the shares underlying the warrants.&#160;&#160;In the 60 business days following the date the redemption notice is deemed given in accordance with the agreement, investors may choose to exercise this warrant or a portion of the warrant by paying the then applicable exercise price per share for every share exercised.&#160;&#160;Any shares not exercised on the last day of the exercise period will be redeemed by the Company at $0.001 per share.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The exercise prices of the Series A Warrants and Series B Warrants are subject to adjustment upon certain events. If the Company at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, for so long as there are any warrants outstanding, if and whenever at any time and from time to time after the warrant issue date, as applicable, the Company shall issue any shares of common stock for no consideration or a consideration per share less than the exercise price, as applicable, then, forthwith upon such issue or sale, the warrants shall be subject to a proportional adjustment determined by multiplying such warrant exercise price by the following fraction:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="10%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="100%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(1)</font></div>
</td>
</tr><tr>
<td valign="top" width="100%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(2)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Where:</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(0) = the number of shares of common stock outstanding (calculated on a Fully Diluted Basis) immediately prior to the issuance of such additional shares of common stock or common stock Equivalents;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(1) = the number of shares of common stock which the aggregate consideration, if any (including the aggregate Net Consideration Per Share with respect to the issuance of common stock equivalents), received or receivable by the Company for the total number of such additional shares of common stock so issued or deemed to be issued would purchase at the warrant exercise price, as applicable, in effect immediately prior to such issuance; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(2) = the number of such additional shares of common stock so issued or deemed to be issued.</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock Offering Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Stock Offering Warrants have a term ending on January 31, 2019 and are exercisable for an aggregate of up to 2,700,971 shares of the Company&#8217;s common stock at an initial per share exercise price of $0.78, subject to adjustment as set forth below (anti-dilution).&#160;&#160;The Company also has a right of first refusal on the holder&#8217;s sale of the warrant shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These warrants have a cashless exercise provision.&#160;&#160;The Company also has a right of first refusal on the holder&#8217;s sale of the warrant shares.&#160;&#160;&#160;The exercise prices of the Stock Offering Warrants are subject to adjustment upon certain events. If the Company at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">66</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, for so long as there are any warrants outstanding, if and whenever at any time and from time to time after the warrant issue date, as applicable, the Company shall issue any shares of common stock for no consideration or a consideration per share less than the exercise price, as applicable, then, forthwith upon such issue or sale, the warrants shall be subject to a proportional adjustment determined by multiplying such warrant exercise price by the following fraction:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="10%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(1)</font></div>
</td>
</tr><tr>
<td valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(2)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Where:</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(0) = the number of shares of common stock outstanding (calculated on a Fully Diluted Basis) immediately prior to the issuance of such additional shares of common stock or common stock Equivalents;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(1) = the number of shares of common stock which the aggregate consideration, if any (including the aggregate Net Consideration Per Share with respect to the issuance of common stock equivalents), received or receivable by the Company for the total number of such additional shares of common stock so issued or deemed to be issued would purchase at the warrant exercise price, as applicable, in effect immediately prior to such issuance; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(2) = the number of such additional shares of common stock so issued or deemed to be issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consulting Firm Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Consulting Firm Warrants have a term ending on December 17, 2019 and are exercisable for an aggregate of up to 3,755,562 shares of the Company&#8217;s common stock.&#160;&#160;These warrants may not be exercised by the Holder upon less than 90 days prior written notice of such exercise and provided further that that the Holder may elect, in its sole discretion, to waive the Prior Notice Requirement, in whole or in part, upon 65 days prior written notice of such waiver.&#160;&#160;&#160;&#160;These warrants have a cashless exercise provision and were issued at an initial per share exercise price of $0.001, subject to adjustment as if the Company at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination.&#160;&#160;The warrants are also subject to piggy-back registration rights.&#160;&#160;The holder has also agreed that following the consummation of the pubco transaction (which occurred on December 28, 2012), the holder will not sell or otherwise transfer any shares of common stock of the Company owned by holder, as a result of the exercise of the warrant until the date that is the earlier of&#160;&#160;(i) twelve (12) months from the closing date of the pubco transaction; or (ii) six (6) months following the effective date of the Registration Statement of which this prospectus is a part.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">67</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Placement Agent Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company issued two types of warrants to the Placement Agent, Placement Agent Stock Offering Warrants and Placement Agent Common Stock Warrants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="TAB1"><!--EFPlaceholder--></a><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Placement Agent Stock Offering Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Placement Agent Stock Offering Warrants have a term ending on January 31, 2019 and are exercisable for an aggregate of up to 1,245,210 shares of the Company&#8217;s common stock at an initial per share exercise price of $0.78, subject to adjustment as set forth below (anti dilution).&#160;&#160;These warrants have a cashless exercise provision.&#160;&#160; The exercise prices of the warrants are subject to adjustment upon certain events. If the Company at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, for so long as there are any warrants outstanding, if and whenever at any time and from time to time after the warrant issue date, as applicable, the Company shall issue any shares of common stock for no consideration or a consideration per share less than the exercise price, as applicable, then, forthwith upon such issue or sale, the warrants shall be subject to a proportional adjustment determined by multiplying such warrant exercise price by the following fraction:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="10%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="59%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(1)</font></div>
</td>
</tr><tr>
<td valign="top" width="59%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(2)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Where:</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(0) = the number of shares of common stock outstanding (calculated on a Fully Diluted Basis) immediately prior to the issuance of such additional shares of common stock or common stock Equivalents;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(1) = the number of shares of common stock which the aggregate consideration, if any (including the aggregate Net Consideration Per Share with respect to the issuance of common stock equivalents), received or receivable by the Company for the total number of such additional shares of common stock so issued or deemed to be issued would purchase at the warrant exercise price, as applicable, in effect immediately prior to such issuance; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(2) = the number of such additional shares of common stock so issued or deemed to be issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Placement Agent Common Stock Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Placement Agent Common Stock Warrants have a five year term from January 28, 2013 and are exercisable for an aggregate of up to 467,845 shares of the Company&#8217;s common stock at an initial per share exercise price of $2.48, subject to adjustment as set forth below.&#160;&#160;These warrants have a cashless exercise provision.&#160;&#160; The Company may also call this warrant for redemption upon written notice to all warrant holders at any time the closing price of the common stock exceeds $1.50 (as may be adjusted pursuant to warrant agreement) for 20 consecutive trading days, as reported by Bloomberg, provided at such time there is an effective registration statement covering the resale of the shares underlying the warrants.&#160;&#160;In the 60 business days following the date the redemption notice is deemed given in accordance with the agreement, investors may choose to exercise this warrant or a portion of the warrant by paying the then applicable exercise price per share for every share exercised.&#160;&#160;Any shares not exercised on the last day of the exercise period will be redeemed by the Company at $0.001 per share.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The exercise prices of the warrants are subject to adjustment upon certain events. If the Company at any time while the warrants remain outstanding and unexpired shall declare a dividend or make a distribution on the outstanding Common Stock payable in shares of its capital stock, or split, subdivide or combine the securities as to which purchase rights under this Warrant exist into a different number of securities of the same class, the exercise price for such securities shall be proportionately decreased in the case of a dividend, split or subdivision or proportionately increased in the case of a combination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">68</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, for so long as there are any warrants outstanding, if and whenever at any time and from time to time after the warrant issue date, as applicable, the Company shall issue any shares of common stock for no consideration or a consideration per share less than the exercise price, as applicable, then, forthwith upon such issue or sale, the warrants shall be subject to a proportional adjustment determined by multiplying such warrant exercise price by the following fraction:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="10%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="100%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(1)</font></div>
</td>
</tr><tr>
<td valign="top" width="100%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">N(0) + N(2)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Where:</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(0) = the number of shares of common stock outstanding (calculated on a Fully Diluted Basis) immediately prior to the issuance of such additional shares of common stock or common stock Equivalents;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(1) = the number of shares of common stock which the aggregate consideration, if any (including the aggregate Net Consideration Per Share with respect to the issuance of common stock equivalents), received or receivable by the Company for the total number of such additional shares of common stock so issued or deemed to be issued would purchase at the warrant exercise price, as applicable, in effect immediately prior to such issuance; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 135pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">N(2) = the number of such additional shares of common stock so issued or deemed to be issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Anti-takeover Effects of Our Articles of Incorporation and By-laws</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our certificate of incorporation and bylaws include provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us. These provisions encourage persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">No Cumulative Voting Rights.</font>&#160;&#160;According to our Bylaws and Articles of Incorporation, neither the holders of our common stock nor the holders of our preferred stock have cumulative voting rights in the election of our directors. The combination of the present ownership by a few stockholders of a significant portion of our issued and outstanding common stock and lack of cumulative voting makes it more difficult for other stockholders to replace our Board of Directors or for a third party to obtain control of our Company by replacing our Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Undesignated preferred stock.</font>&#160;&#160;We believe the availability of the preferred stock under our certificate of incorporation provides us with flexibility in addressing corporate issues that may arise. The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could issue shares of preferred stock without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation grants our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. Our board of directors will make any determination to issue shares based on its judgment as to our and our stockholders&#8217; best interests.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Staggered Board.</font>&#160;&#160;Pursuant to our Articles of Incorporation our directors are divided into three classes, designated Class I, Class II and Class III.&#160;&#160;Class I shall consists of two independent directors, Class II shall consist of two directors that were appointed as directors to Actinium Corporation by the holders of the former Series E preferred stock holders of Actinium Corporation, and Class III shall consist of the chief executive officer.&#160;&#160;Each director shall serve a term ending on the date of the third annual meeting of shareholders following the annual meeting at which the director was elected.&#160;&#160;Notwithstanding the foregoing, each director shall serve until his successor is duly elected and qualified, or until his or her retirement, death, resignation or removal.&#160;&#160;In order to implement a staggered board of directors, Class I shall serve a six month term from the date of incorporation; Class II shall serve a 18 month term from the date of incorporation; and Class II shall serve a 30 month term from the date of incorporation.&#160;&#160;Directors elected at each annual meeting commencing in 2013 shall be elected for a three year term as specified above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Anti-takeover Effects of Delaware Law</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are governed by Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years, did own, 15% or more of the corporation&#8217;s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">69</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Listing</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock is listed on the OTCQB under the symbol &#8220;ATNM.&#8221; &#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Transfer Agent</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The transfer agent and registrar for our common stock is Action Stock Transfer Corporation. The transfer agent&#8217;s address is 2469 E. Fort Union Boulevard, Suite 214, Salt Lake City, UT 84121, and its telephone number is (801) 274-1088.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="PLANOFDISTRIBUTION">PLAN OF DISTRIBUTION</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The common shares being offered for resale by the selling stockholders consist of 25,735,497 shares. We will pay any fees and expenses incurred by us incident to the registration of the securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each selling stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the OTCQB or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A selling stockholder may use any one or more of the following methods when selling securities:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</font></font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</font></font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</font></font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">an exchange distribution in accordance with the rules of the applicable exchange;</font></font></div>
</div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">privately negotiated transactions;</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in transactions through broker-dealers that agree with the selling stockholders to sell a specified number of such securities at a stipulated price per security;</font></font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a combination of any such methods of sale; or</font></font></div>
</td>
</tr><tr>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#9679;</font></font></td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">any other method permitted pursuant to applicable law.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The selling stockholders may also sell securities under Rule 144 under the Securities Act, if available, rather than under this prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The selling stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The selling stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each selling stockholder has informed us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">70</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under applicable rules and regulations under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of securities of the common stock by the selling stockholders or any other person. We will make copies of this prospectus available to the selling stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="SHARESELIGIBLE">SHARES ELIGIBLE</a> FOR FUTURE SALE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Prior to this offering there has been a limited public market for our common stock, and a significant public market for our common stock may never develop or be sustained after this offering. We cannot predict the effect, if any, that market sales of shares or the availability of shares for sale will have on the market price prevailing from time to time. Only a limited number of shares will be available for sale shortly after this offering due to contractual and legal restrictions on resale. However, sales of our common stock in the public market after the restrictions lapse, or the perception that these sales may occur, could adversely affect the market price of our common stock and our ability to raise equity capital in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon completion of this offering, we expect to have 35,154,367&#160;shares of common stock outstanding. The&#160;25,735,497 shares of common stock being sold in this offering will be freely tradable without restriction or further registration under the Securities Act, unless the shares are purchased by "affiliates" of our company, as that term is defined in Rule&#160;144 of the Securities Act. All remaining shares were issued and sold by us in private transactions and are eligible for public sale only if registered under the Securities Act, or if they qualify for an exemption from registration, including, among others, the exemption provided by Rules&#160;144 promulgated by the SEC under the Securities Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Rule 144 is not available for resale of securities issued by any shell companies (other than business combination-related shell companies) or any issuer that has been at any time previously a shell company. The SEC has provided an exception to this prohibition, however, if the following conditions are met:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the issuer of the securities that was formerly a shell company has ceased to be a shell company;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and</font></div>
</td>
</tr><tr>
<td valign="top" width="5%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#9679;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result, none of our stockholders is currently able to sell shares of our common stock in reliance on Rule 144. Assuming we continue to meet the requirements set forth above, Rule 144 will become available to our stockholders one year from the date we filed the information required in SEC Form 10. Our stockholders may currently sell their shares of our common stock only pursuant to a registration statement that has been declared effective under the Securities Act or pursuant to another exemption from registration.</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="item_1_3_11"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="LEGALMATTERS">LEGAL MATTERS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The validity of the shares of common stock offered by this prospectus and certain other legal matters as to Delaware law will be passed upon for us by Hiscock &amp; Barclay, LLP, Syracuse, New York. &#160;<a name="item_1_3_12"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="EXPERTS">EXPERTS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our audited consolidated financial statements appearing in this prospectus and registration statement have been audited by GBH CPAs, PC, an independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein and in the registration statement, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="WHEREYOUCAN">WHERE YOU&#160;CAN</a> FIND MORE INFORMATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We filed with the SEC a registration statement under the Securities Act for the common stock in this offering. This prospectus does not contain all of the information in the registration statement and the exhibits and schedule that were filed with the registration statement. For further information with respect to us and our common stock, we refer you to the registration statement and the exhibits that were filed with the registration statement. Statements contained in this prospectus about the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and we refer you to the full text of the contract or other document filed as an exhibit to the registration statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We file annual, quarterly, and current reports and other information with the SEC. Our filings with the SEC are available to the public on the SEC&#8217;s website at www.sec.gov. Those filings are also available to the public on our corporate website at&#160;&#160;www.actinium pharmaceuticals.com. The information we file with the SEC or contained on, or linked to through, our corporate website or any other website that we may maintain is not part of this prospectus or the registration statement of which this prospectus is a part. You may also read and copy, at the SEC&#8217;s prescribed rates, any document we file with the SEC, including the registration statement (and its exhibits) of which this prospectus is a part, at the SEC&#8217;s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. You can call the SEC at 1-800-SEC-0330 to obtain information on the operation of the Public Reference Room.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">71</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="FINANCIALSTATEMENTS">FINANCIAL STATEMENTS</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For period ended June 30, 2013</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying financial statements have been prepared by the Company and are unaudited. &#160;In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at June 30, 2013 and 2012 and for the periods then ended have been made. &#160;Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. &#160;It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company&#8217;s audited financial statements for the year ended December 31, 2012. &#160;The results of operations for the period ended June 30, 2013 are not necessarily indicative of the operating results for the full year.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>
</td>
</tr><tr>
<td valign="bottom" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>
</td>
</tr><tr>
<td valign="bottom" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Balance Sheets</font></div>
</td>
</tr><tr>
<td valign="bottom" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Assets:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,650,328</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">84,270</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167,143</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Current Assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,734,598</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,785,812</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net of accumulated depreciation</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,734,598</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,788,822</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liabilities and Stockholders' Equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Current Liabilities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">793,630</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">897,044</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued expenses - related party</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes payable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,950</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">140,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivative liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,957,977</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Current Liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,819,742</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,643,187</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,819,742</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,643,187</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commitments and contingencies</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stockholders' Equity:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Preferred stock, $0.01 par value; 10,000,000 authorized </font>none issued and outstanding</div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Common stock, $0.01 par value; 100,000,000 shares authorized;</font>&#160;23,584,424 and 21,391,665&#160;&#160;shares issued and outstanding, respectively</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">235,844</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,916</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60,895,513</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,675,182</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit accumulated during the development stage</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(59,216,501</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55,743,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Stockholders' Equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,914,856</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,145,635</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Liabilities and Stockholders' Equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,734,598</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,788,822</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the three months ended</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;June 30,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the six months ended</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;June 30,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Period from June 13, 2000 (Inception) to June 30,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Operating expenses:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development, net of reimbursements</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">509,262</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">601,272 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,594,968 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,046,158 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,015,488</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">966,367</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,908 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,899,503 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">798,184 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,404,478</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">317 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,262,462</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss on disposition of equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,122</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">554,307</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total operating expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,475,629</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">839,339</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,498,593</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,844,659 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,236,735</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss from operations</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,475,629</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(839,339</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,498,593</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,844,659</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(56,236,735</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Income (Expense):</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(634</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(320,728</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,209</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(633,618</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,965,916</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on extinguishment of liability</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">260,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value - derivative liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,307,748</font></div>
</td>
<td align="left" nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(402,524</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,764 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,777 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">726,150</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total other income (expense)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,308,382</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(723,252</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,555 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(626,841</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(979,766</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(2,784,011</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(1,562,591</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(3,473,038</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(2,471,500</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(59,216,501</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net loss per common share&#160;&#160;- basic and diluted</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.13</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></font></div>
</div>
</div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.09</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.16</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted average common shares outstanding&#160;- basic and diluted</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,178,637 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,020,192 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,791,673 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,020,192 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Cash Flows</font></div>
</td>
</tr><tr>
<td valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Period</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Six</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Six</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">from June 13, 2000</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Months Ended</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Months Ended</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Inception) to</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash Flows From Operating Activities:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,473,038</font></div>
</td>
<td align="left" nowrap valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,471,500</font></div>
</td>
<td align="left" nowrap valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(59,216,501</font></div>
</td>
<td align="left" nowrap valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">188,400</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">240,400 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,240,436</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Depreciation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">317 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,262,462</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Loss on disposition of equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,122</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">554,307</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Amortization of debt discount</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">451,267 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Amortization of deferred financing costs</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">145,951 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">292,692</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Gain on extinguishment of liability</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(260,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Gain on change in fair value of derivative</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,764</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,777</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(726,150</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Increase) decrease in:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;R&amp;D reimbursable receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,126</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,069 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,872</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Prepaid expenses and other current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85,000 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,494</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,604</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase (decrease) in:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Accounts payable and accrued liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(103,414</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(263,465</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,135,359</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Accounts payable and accrued liabilities - related party</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Used In Operating Activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,327,820</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,862,232</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(47,730,478</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash Flows From Investing Activities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payment made for patent rights</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,112</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,157</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(816,771</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Used In Investing Activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,112</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,157</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,816,771</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash Flows From Financing Activities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Borrowings on convertible debt, net of offering costs</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">645,888</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments on note payable</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(103,050</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(103,050</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales of stock, net of offering costs</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">- </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">660,163 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,191,098</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from the exercise of warrants for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,463,641 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,463,641</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Cash Provided By Financing Activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,360,591 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">660,163 </font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,197,577</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net change&#160;&#160;in cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,659 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,203,226</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) &#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,650,328</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash at beginning of period</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,703,798 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash at end of period</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,650,328</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4,500,572</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5,650,328</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental disclosures of cash flow information:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid for interest</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">561</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,243</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid for taxes</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental disclosure of non-cash investing and financing activities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beneficial conversion feature discount</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants issued with debt</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants issued with stock</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">318,087</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,985,238</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants issued to the placement agent</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,044</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,170,282</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversion of notes payable and accrued interest to stock</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">981,729</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transfer from liability classification to equity classification</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">590,217</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,821,542</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Unaudited)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Nature of Business &#8211;</font> Actinium Pharmaceuticals, Inc. formerly known as Cactus Ventures, Inc. (the &#8220;Company&#8221;, &#8220;Actinium&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that&#160;was in the market for a merger with an appropriate operating company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;API&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange closed on December 28, 2012.&#160;&#160;As a result of the Share Exchange, the former shareholders of API became the controlling shareholders of the Company. At the closing, each API shareholder received 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Actinium common stock for each API share exchanged. At the closing, all of the API shareholders&#8217; options and warrants to purchase API common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Actinium common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein API is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; API, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. API, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;API&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, API launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. API&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of API&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that API&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through API, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On March 20, 2013, in anticipation of the Company changing its name to Actinium Pharmaceuticals, Inc. and its domicile from Nevada to Delaware, the Company&#8217;s subsidiary, Actinium Pharmaceuticals, Inc., changed its name to Actinium Corporation.&#160;&#160;On April 11, 2013, the Company changed its domicile from the State of Nevada to the State of Delaware and changed its name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Basis of Presentation - Unaudited Interim Financial Information &#8211;</font> The accompanying unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary&#160;for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2012 and notes thereto contained in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2012, as filed with the SEC March 29, 2013.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At June 30, 2013 and December 31, 2012, all of the Company&#8217;s cash was deposited in one bank.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of June 30, 2013 and December 31. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;At June 30, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,957,977</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,957,977</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been antidilutive. For the six months ended June 30, 2013, potentially issuable shares included stock options to purchase 2,280,184 shares and warrants to purchase 9,535,694 shares of the Company&#8217;s common stock. For the six months ended June 30, 2012, potentially issuable shares includes options and warrants&#160;to purchase 6,842,528 shares of the Company&#8217;s common stock and notes payable convertible to 815,275 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events through the date the consolidated financial statements were issued for subsequent event disclosure consideration.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 2 &#8211; Going Concern</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $3,473,038 and net cash used in operations of $3,327,820, for the six months ended June 30,&#160;2013; and an accumulated deficit of $59,216,501 at June 30, 2013. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, and research and development grants until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 3 &#8211; Property and Equipment</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160;Property and equipment consisted of the following at June 30, 2013 and December 31, 2012:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="67%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lives</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office equipment</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;5 years</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">157,274</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156,162</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and fixture</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;7 years</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,292</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,292</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">158,566</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">157,454</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: accumulated depreciation</font></div>
</td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(154,444</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(154,444</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss on disposition of equipment</font></div>
</td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,122</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net</font></div>
</td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Depreciation expense for the three months ended June 30, 2013 and 2012 were $0&#160;and $159, respectively. Depreciation expense for the six months ended June 30, 2013 and 2012 were $0 and $317 respectively. The Company wrote off its remaining underpreciated property and equipment during the six months ended June 30, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 4 &#8211; Note Payable</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a premium finance agreement to pay a&#160;$140,000 premium&#160;for its director and officer&#160;liability insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of June 30, 2013, the&#160;outstanding balance related to the premium finance agreement was $36,950.&#160;&#160;The Company has paid $103,050 of the principal during 2013.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 5 &#8211; Derivatives</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&#8217;s common stock at prices below such warrants&#8217; respective exercise prices and these provisions could result in modification of the warrants&#8217; exercise price based on a variable that is not an input to the fair value of a &#8220;fixed-for-fixed&#8221; option as defined under FASB ASC Topic No. 815 &#8211; 40. The warrants granted in connection with the issuance of the Company&#8217;s Stock Offering and 2012 Common Stock Offering, the Convertible Notes (previously issued and converted) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &#8220;Lower Price&#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Activities for derivative warrant instruments during the six months ended June 30, 2013 were as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,146,338</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reclassification to paid in capital</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,122,821</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(590,217</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,764</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, June 30, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,023,517</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,957,977</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at June 30, 2013 and December 31, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30,</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Market value of common stock on measurement date (1)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.17</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted exercise price</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.48 - $0.81</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.50 - $2.475</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rate (2)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10 - $0.77</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.05</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant lives in years</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4 months/5 years</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.5 years</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility (3)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125% - 161</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">154</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield (4)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The risk-free interest rate was determined by management using the Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)&#160;&#160;</font></div>
</td>
<td align="left" valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 6 &#8211; Commitments and Contingencies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt">The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Abbott Biotherapeutics Corp.</font> We entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, we made a license fee payment of $3,000,000.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5) First commercial sale</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the agreement, we agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2012, we met our first milestone and upon reaching the milestone we paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012.</font></div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Memorial Sloan Kettering Cancer Center (MSKCC)</font>.&#160;&#160;In February 2002, we entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval </font>for each licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) upon the receipt of regulatory approval from the U.S. FDA for each </font>licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the agreement, we agreed to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.&#160;&#160;We expect to file the NDA for regulatory approval in 2016.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Oak Ridge National Laboratory (ORNL)</font> &#8211; We have contracted to purchase radioactive material to be used for research and development through December 2013. We contracted to purchase $ 337,500 of radioactive material to be used for research and development, with a renewal option at the contract end. &#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; d.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Aptiv Solutions.</font>&#160;&#160;AptivSolutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab-A) used in our clinical trials, Phase I and Phase II. &#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &#160;The down payment totaling $239,000 was paid in 2007 and 2012. &#160;The agreement was amended to provide for additional services on August 6, 2012, October 22, 2012 and May 16, 2013. &#160;The total project is now estimated at $ 2,173,955. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Fred Hutchinson Cancer Research Center (FHCRC)</font>.&#160;&#160;On June 15, 2012, we entered into a license and sponsored research agreement with FHCRC. We will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and we intend to start preparation for a pivotal trial leading to an FDA approval. &#160;We have been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &#160;Under the terms of the sponsored research agreement, we will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.&#160;On August 12, 2013, the Company paid $37,500 to FHCRC.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">MSKCC</font>.&#160;&#160;On March 27, 2012, we entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &#160;The amount due of $79,623 was paid on July 10, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">g.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">FHCRC</font>.&#160;&#160;On July 19, 2012, we entered into a clinical trial agreement with FHCRC. &#160;We will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, we are required to pay a start-up fee of $19,749. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">h.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">The University of Texas M.D. Anderson Cancer Center</font>.&#160;&#160;On August 28, 2012, we entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &#160;The estimated cost is based on treating 24 patients through 2013. &#160;Upon execution of the agreement, we were required to make a payment of $33,946. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">i.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Johns Hopkins University</font>.&#160;&#160;On September 26, 2012, we entered into a clinical trial agreement with Johns Hopkins University. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $38,501 per patient, who has completed the clinical trial. We are required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="4%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;j.&#160;&#160;</font></div>
</td>
<td valign="top" width="96%" style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">University of Pennsylvania</font>.&#160;&#160;&#160;On November 21, 2012, we entered into a clinical trial agreement with the University of Pennsylvania. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $31,771 per patient, who has completed the clinical trial. We will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3rd Floor, New York, NY 10017. &#160;The agreement terminated May 31, 2013. On June 1, 2013The Company entered into a rental agreement for office space at 546 Fifth Avenue, 14 th&#160;&#160;Floor, New York, NY 10036.&#160;&#160;The agreement terminates on December 31, 2013.&#160;&#160;Upon the expiration of the term, the agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &#160;The Company paid a one month refundable deposit.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company paid Mr. Talley $125,000 on March 8, 2013 and a second payment of $125,000 is due to be paid to Mr. Talley on September 1, 2013. The Company also paid Mr. Talley a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 7 &#8211; Equity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock Option Plan</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The following is a summary of stock options:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></font></font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,330,134</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.91</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">685,800</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cancellation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(49,950</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,280,184</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.42</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,609,035</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; All options issued and outstanding are being amortized over their respective&#160;service periods. The unrecognized compensation expense at June 30, 2013 was $1,086,848.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the three months ended June 30, 2013 and 2012, the Company recorded option expense of $94,200, and $40,410, respectively. During the six months ended June 30, 2013 and 2012, the Company recorded option expense of $188,400 and $240,400, respectively.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 31, 2013, the Company entered into an agreement with its former director and consultant, Dr. Rosemary Mazanet. Pursuant to the agreement, the Company terminated the consulting agreement with Dr. Mazanet and Dr. Mazanet resigned as a director. The Company paid Mazanet cash of $25,000 and cancelled options to purchase 49,950 shares of the Company&#8217;s common stock at $1.50 per share previously granted.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The following is a summary of warrants:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></font></font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="0%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="0%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="3" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,770,636</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.97</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.48 </font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,114,768</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants exercised</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,211,158</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants expired</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,023,784</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.65</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,535,694</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.77</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.341</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,691,302</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the six months ended June 30, 2013, the Company issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,463,641 received by the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 8 &#8211; Subsequent Events</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Management has evaluated subsequent events and has concluded no events warrant disclosure.&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACTINIUM PHARMACEUTICALS, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2012 and 2011 and for the period</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">from June 13, 2000 (inception) to December 31, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the Board of Directors</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Newark, NJ</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the accompanying consolidated balance sheets of Actinium Pharmaceuticals, Inc. (Formerly Cactus Ventures, Inc.) (a Development Stage Company) (the &#8220;Company&#8221;) as of December 31, 2012 and 2011, and the related consolidated statements of operations, changes in stockholders&#8217; equity and cash flows for the years then ended and for the period from June 13, 2000 (Inception) to December 31, 2012. These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Actinium Pharmaceuticals, Inc. (Formerly Cactus Ventures, Inc.) as of December 31, 2012 and 2011 and the results of their operations and their cash flows for the years then ended and for the period from June 13, 2000 (Inception) to December 31, 2012, in conformity with accounting principles generally accepted in the United States of America.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has not generated any revenue since its inception, has a history of operating losses, and has an accumulated deficit since its inception. Those conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to those matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/ GBH CPAs, PC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GBH CPAs, PC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">www.gbhcpas.com</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Houston, Texas</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">March 15, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Balance Sheets</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ASSETS</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Cash</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,703,798</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;R&amp;D reimbursement receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,834</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167,143</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,384</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Deferred financing costs, net of accumulated amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,248</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,785,812</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,199,264</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net of accumulated depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,233</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL ASSETS</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,788,822</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,200,497</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td colspan="8" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LIABILITIES AND STOCKHOLDERS' EQUITY</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Accounts payable and accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">897,044</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">644,511</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Accounts payable and accrued expenses &#8211; related party</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Note payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">140,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Convertible notes payable, net&#160;of unamortized discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,363</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Derivative liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,439,613</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,643,187</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,208,487</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitments and contingencies</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217; equity:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Preferred stock, $0.01 par value; 100,000,000 shares authorized;</font>&#160;0 shares issued and outstanding</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Common stock, $0.01 par value, 100,000,000 shares authorized; </font>21,391,665 and 13,664,802 shares issued and outstanding, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,916</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">136,648</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Additional paid-in capital</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,675,182</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,237,620</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Deficit accumulated during the development stage</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55,743,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(47,382,258</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total stockholders' equity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,145,635</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">992,010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,788,822</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,200,497</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statements of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Period</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the Years Ended</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">from June 13,</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" nowrap valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2000 (Inception) to</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Research and development, net of reimbursements</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,440,485</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">323,788</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,420,519</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;General and administrative</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,506,232</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,959,246</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,504,975</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Depreciation and amortization expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">581</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">633</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,262,462</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Loss on disposition of equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">550,186</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total operating expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,947,298</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,283,667</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54,738,142</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from operations</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7,947,298</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,283,667</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54,738,142</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other (income) expense:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Interest expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,099,327</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175,094</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,964,707</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Gain on extinguishment of liability</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(260,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on change in fair value of derivative&#160;liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(685,420</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,966</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(699,386</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Total other (income) expense</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">413,907</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161,128</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,005,321</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,361,205</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,444,795</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55,743,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per common share - basic and diluted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7.58</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4.30</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average number of common shares </font>outstanding - basic and diluted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,103,521</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">801,799</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statement of Changes in Stockholders&#8217; Equity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Period From June 13, 2000 (Inception)&#160;to December 31, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid-in</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders'</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capital</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity (Deficit)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of founder shares</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">999,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,990</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of&#160;stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">145,687</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,457</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,748,543</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(672,286</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(672,286</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2000</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,144,687</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,447</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,768,553</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(672,286</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,107,714</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">187,313</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,873</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,248,127</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,250,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,090,621</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,090,621</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2001</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,332,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,320</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,016,680</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,762,907</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,732,907</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180,375</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,804</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,248,196</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,250,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,192,384</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,192,384</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2002</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,512,375</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,124</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,264,876</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,955,291</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,675,291</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">208,992</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,090</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,779,160</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,781,250</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,532,044</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,532,044</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2003</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,721,367</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,214</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,044,036</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,487,335</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,573,915</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">765,900</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,659</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,592,341</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,600,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,734,791</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,734,791</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2004</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,487,267</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,873</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,636,377</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18,222,126</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">439,124</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">649,350</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,494</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,893,506</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">315,388</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">315,388</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,580,237</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,580,237</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2005</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,136,617</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,367</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,845,271</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,802,363</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,275</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statement of Changes in Stockholders&#8217; Equity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Period From June 13, 2000 (Inception)&#160;to December 31, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Continued)</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid-in</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders'</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capital</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity (Deficit)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2005</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,136,617</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,367</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,845,271</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,802,363</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,275</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">839,042</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,390</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,542,151</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,550,541</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,308</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,308</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,053,362</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,053,362</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2006</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,975,659</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,757</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,639,730</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(28,855,725</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,823,762</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">732,600</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,326</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,592,674</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,600,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued for services</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,402</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">664</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">398,146</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">398,810</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">255,061</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">255,061</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,617,581</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,617,581</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2007</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,774,661</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,747</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,885,611</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34,473,306</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,460,052</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">999,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,990</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,990,010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269,618</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269,618</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,570,905</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,570,905</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2008</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,773,661</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,737</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,145,239</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(40,044,211</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,158,765</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,382</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,382</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,425,986</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,425,986</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,773,661</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,737</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,257,621</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(43,470,197</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">845,161</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,166</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,166</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(467,266</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(467,266</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,773,661</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,737</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,278,787</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(43,937,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">399,061</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Consolidated Statement of Changes in Stockholders&#8217; Equity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Period From June 13, 2000 (Inception)&#160;to December 31, 2012</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Continued)</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid-in</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders'</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capital</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity (Deficit)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,773,661</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,737</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,278,787</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(43,937,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">399,061</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,891,141</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78,911</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,300,456</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,379,367</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,935</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,935</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,153,442</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,153,442</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of derivative warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,887,850</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,887,850</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beneficial conversion feature discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,444,795</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,444,795</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,664,802</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">136,648</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,237,620</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(47,382,258</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">992,010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,087,747</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,877</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,089,063</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,129,940</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversion of notes payable and accrued interest to stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,252,550</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,525</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">969,204</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">981,729</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares issued at the reverse merger</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,386,566</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,866</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23,866</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266,172</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266,172</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,957,754</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,957,754</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of derivative warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,052,089</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,052,089</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transfer&#160;from liability&#160;classification to equity classification</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,231,324</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,231,324</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,361,205</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,361,205</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balances, December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,391,665</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,916</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,675,182</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55,743,463</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,145,635</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Statements of Cash Flows</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the Year Ended December 31,</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" nowrap valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the Period </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">from June 13, </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2000 (Inception) to</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">December 31,</div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CASH FLOWS FROM OPERATING ACTIVITIES:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,361,205</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,444,795</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(55,743,463</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Adjustments to reconcile net loss to net cash used in operating activities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stock-based compensation expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,223,926</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,173,377</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,052,036</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Depreciation expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">581</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">633</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,262,462</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss on disposition of equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">550,186</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amortization of debt discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">775,637</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,363</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amortization of deferred financing costs</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,248</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,444</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">292,692</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Gain on extinguishment of liability</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(260,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Gain on change in fair value of derivative liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(685,420</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,966</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(699,386</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in operating assets and liabilities:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;R&amp;D reimbursement receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">234,088</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41,567</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,746</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Prepaid expenses and other current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18,013</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,766</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23,397</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">334,263</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">556,019</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,238,773</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued expenses - related parties</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,185</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net cash used in operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,212,710</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(517,592</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44,402,658</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CASH FLOWS FROM INVESTING ACTIVITIES:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment made for patent rights</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,000,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Purchases of property and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,359</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(815,659</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net cash used in investing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,359</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,815,659</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CASH FLOWS FROM FINANCING ACTIVITIES:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Borrowings on convertible debt, net of offering costs</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">645,888</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">645,888</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Sales of stock, net of offering costs</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,129,940</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,379,367</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,191,098</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net cash provided by financing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,129,940</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,025,255</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,836,986</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase (decrease) in cash</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(85,129</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,507,663</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash at beginning of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,703,798</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196,135</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash at end of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,703,798</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,618,669</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">SUPPLEMENTAL CASH FLOWS INFORMATION:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash paid for:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Income tax</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Interest</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">682</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" colspan="4" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NONCASH INVESTING AND FINANCING ACTIVITIES:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Beneficial conversion feature discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Fair value of warrants issued with debt</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Fair value of warrants issued with stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,393,338</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,591,900</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,985,238</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Fair value of warrants issued to the placement agent</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">658,753</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,484,529</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,170,282</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Conversion of notes payable and accrued interest to stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">981,729</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">981,729</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Transfer&#160;from liability&#160;classification to equity classification</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,231,324</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,231,324</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying summary of accounting policies and notes to consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Nature of Business &#8211; Actinium Pharmaceuticals, Inc (Formerly</font> Cactus Ventures, Inc.) (the &#8220;Company&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;Actinium&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012 when shareholders representing over 20% of the issued and outstanding shares of Actinium had finished the exchange process.&#160;&#160;On August 22, 2013, shareholders representing 38% of the issued and outstanding shares of Actinium completed the exchange.&#160;&#160;As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. At the closing, each Actinium shareholder shall receive 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Cactus common stock for each Actinium share exchanged. At the closing, all of the Actinium shareholders&#8217; options and warrants to purchase Actinium common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Cactus common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;Actinium&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &#160;Actinium&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At December 31, 2012 and 2011, all of the Company&#8217;s cash was deposited in one bank.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of December 31, 2012 and 2011. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;At December 31, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,439,613</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,439,613</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been anti dilutive. For the year ended December 31, 2012, potentially issuable shares included stock options to purchase 2,330,134 shares and warrants to purchase 12,770,596 shares of the Company&#8217;s common stock. For the year ended December 31, 2011, potentially issuable shares includes options and warrants&#160;to purchase 273,859 shares of the Company&#8217;s common stock and notes payable convertible to 3,448,276 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events from January 1, 2013 through March 15, 2013.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Note 2 &#8211; Going Concern</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $8,361,205 and net cash used in operations of $5,212,710, for the year ended December 31,&#160;2012; and an accumulated deficit of $55,743,463 at December 31, 2012. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 3 &#8211; Related Party Transactions</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MSKCC:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2010, General Atlantic Group Limited donated all of the equity shares of its wholly owned subsidiary, Actinium Holdings Ltd. (formerly named General Atlantic Investments Limited) to Memorial Sloan Kettering Cancer Center (MSKCC), a principal owner of the Company.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On February 11, 2002, the Company entered into a License, Development and Commercialization Agreement with Sloan-Kettering Institute of Cancer Research (SKI),&#160;an entity related to MSKCC.&#160;&#160;The agreement was amended in August 2006.&#160;&#160;Pursuant to the agreement, the Company licenses certain intellectual property from SKI, including critical patents with respect to the Company&#8217;s core technology, and also supports ongoing research and clinical development of related drug candidates.&#160;&#160;Certain amounts due under this agreement were deferred and then forgiven under the forbearance-related arrangements described above.&#160;&#160;On June 19, 2011, the Company nonetheless agreed to pay SKI (a) $50,000 in 2011, (b) $200,000 in 2012 and (c) $250,000 in 2013 under this agreement, in respect of the $50,000 annual maintenance fees and research payments. Since January 1, 2011, the Company has paid $100,000 under this agreement and as of December 31, 2012, the Company agreed to pay an additional $150,000 for research to be conducted in 2013.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On March 27, 2012, the Company entered into an additional clinical trial agreement with MSKCC Cancer Center with respect to conducting a Phase I/II trial of combination therapy of low dose cytarabine and fractionated dose of Lintuzumab-Ac225.&#160;&#160;The Company will pay $31,185 for each patient that has completed the clinical trial.&#160;&#160;Upon execution of the agreement, the Company was required to pay a start-up fee of $79,623, which was paid on July 10, 2012.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; MSKCC agreed, subject to certain conditions, to utilize the donated funds for certain clinical and preclinical programs and activities related to the Company&#8217;s drug development and clinical study programs, including the payment of certain costs and expenses that would otherwise have been borne by the Company. The following is a summary of activities related to the MSKCC arrangements for years ended December 31, 2012 and 2011:</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Qualified R&amp;D costs incurred by the Company</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">655,786</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reimbursements received from MSKCC</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237,834</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">966,341</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2012 and 2011, the Company received total R&amp;D reimbursement payments of $237,834 and $299,200, respectively, from MSKCC.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As of December 31, 2012 and 2011, the Company had a net receivable of $0 and $237,834, respectively, from MSKCC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dr. Rosemary Mazanet:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On January 1, 2012, the Company entered into a Consulting Services Agreement with Dr. Rosemary Mazanet, a director of Cactus.&#160;&#160;Pursuant to the agreement, Dr. Mazanet is to provide, among other things, consulting services in the areas of implementation of the Actimab&#8482;-A trial including all aspects of study initiation until first patient in at each clinical site.&#160;&#160;Dr. Mazanet receives compensation of $100,000 per year and may receive additional compensation in the form of options at determined by the board of the Company.&#160;&#160;Since January 1, 2011, Dr. Mazanet has also received options to purchase 99,900 shares of common stock of the Company. These options have exercise price ranging from $0.78 to $1.5 and have a life of 10 years.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Jamess Capital Group, LLC:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On May 9, 2011, the Company entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of the Company&#160;(&#8220;Management Firm&#8221;).&#160; The Management Firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&#160; The Management Firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Placement Agent:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On August 7, 2012, the Company entered into an engagement agreement with its placement agent for the 2012 Common Stock Offering,&#160;of which Mr. Seth, a director of the Company is Head of Healthcare Investment Banking.&#160;&#160;&#160;Pursuant to the agreement, the placement agent was engaged as the exclusive agent for the 2012 Common Stock Offering. &#160;&#160;In consideration for its services, the placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent.&#160;&#160;The placement agent or its designees have also received warrants to purchase shares of the Company&#8217;s Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units.&#160;&#160;The placement agent will also receive the same fee and expense schedule for any cash exercise of warrants within 6 months of the final closing of the 2012 Common Stock Offering and a 5% solicitation fee for any warrants exercised as a result of being called for redemption by the Company.&#160;&#160;Upon the final closing of the 2012 Common Stock Offering of the units, the placement agent has been engaged by the Company to provide certain financial advisory services to the Company for a period of at least 6 months for a monthly fee of $25,000.&#160;&#160;The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company&#8217;s financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.&#160;&#160;For a period ending one year after the expiration of all lock-up agreements entered into in connection with the Share Exchange, any change in the size of the Company board of directors must be approved by the placement agent.&#160;&#160;The placement agent also was engaged by the Company as placement agent for its Stock Offering and Convertible Notes financing in 2011 and, as a part of the fee for that engagement, designees of the placement agent also hold warrants to purchase 1,251,015 shares of the Company&#8217;s Common Stock.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Guagenti &amp; Associates LLC:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2010, the Company entered into an agreement with Guagenti &amp; Associates LLC (&#8220;G&amp;A&#8221;).&#160;&#160;G&amp;A is affiliated with Enza Guagenti, the former Chief Financial Officer of Cactus.&#160;&#160;Pursuant to the agreement, the Company leases storage space in Newark, NJ from G&amp;A.&#160;&#160;The rent is $300 per month.&#160;&#160;Since January 1, 2011, the Company has paid $7,200 pursuant to this agreement.&#160;&#160;&#160;Ms. Guagenti resigned as the Company&#8217;s Chief Financial Officer on March 9, 2013.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 4 &#8211; Property and Equipment</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Property and equipment consisted of the following at December 31, 2012 and 2011:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;Lives</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office equipment</font></div>
</td>
<td valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;5 years</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156,162</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">153,804</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furniture and fixture</font></div>
</td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;7 years</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,292</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,292</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total property, plant and equipment</font></div>
</td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">157,454</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">155,096</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: accumulated depreciation</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(154,444</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153,863</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="67%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="67%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,233</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Depreciation expense for the years ended December 31, 2012 and 2011 were $581 and $633, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 5 &#8211; Note Payable and Convertible Notes</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Note Payable</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a premium finance agreement to pay $140,000 premium of its director and officer insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of December 31, 2012, outstanding balance related to the premium finance agreement was $140,000.&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Convertible Notes</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 27, 2011, the Company completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes (&#8220;Convertible Notes&#8221;) in the amount of $900,000 and received net proceeds of $750,000. The convertible notes were issued at 83.33% of the principal amount resulting in an original issue discount of $150,000.&#160;The Convertible Notes mature one year from the date of issuance. Interest accrues at the rate of 8% per year on the outstanding principal amount, accrued semi-annually and to be paid at maturity.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The principal amount of the Convertible Notes and accrued interest are automatically converted to common stock at the earlier of: (1) the effective date of a Qualified Public Offering, (2) a Public Company Transaction, defined as (i) a reverse merger or similar transaction between the Company and a corporation whose securities are publicly traded in the United States or other jurisdiction mutually agreed between the Company and Placement Agent, or (ii) the quotation of the Company&#8217;s securities for purchase and sale on a U.S. quotation service, or (iii) the filing with an applicable regulatory body which will result in the Company becoming an entity whose securities are traded on a public exchange in the U.S. or other mutually agreed upon jurisdiction, or (3) the acquisition or receipt by the Company of no less than $4,000,000 of gross proceeds in subsequent offerings of its common stock or equivalents following the issuance of the Company&#8217;s stock (See Note 9) and the Convertible Notes.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In connection with the issuance of the Convertible Notes, warrants to purchase a total of 287,061 shares of common stock were issued to investors. The Placement Agent and the Management Firm (See Note 9) were issued warrants to purchase 143,532 shares and 126,829 shares of common stock, respectively. The warrants issued to the Placement Agent are exercisable at $0.78 per share and expire on January 31, 2019. &#160;The warrants issued to the Management Firm are exercisable at $0.01 per share and expire on January 31, 2019.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company analyzed the Convertible Notes and the Warrants for derivative accounting consideration under FASB ASC 470 and determined that the investor warrants and the placement agent warrants, with a grant date fair value of $565,729 (See Note 6), qualified for accounting treatment as a financial derivative (See Note 6) and the Convertible Notes were determined to also have a beneficial conversion feature discount of $372,850 resulting from the conversion price of $0.78 per share which is below the fair value of $1.11 per share on the date of the Convertible Notes.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; The total fees, including cash payments and the fair value of the warrants issued to the Placement Agent, incurred in connection with the financing were $292,692. These fees were amortized over the life (one year) of the Convertible Notes using the straight-line method as it approximates the effective interest method. &#160;The $150,000 original issue discount on the Convertible Notes was also amortized over the life of the Notes on a straight line basis.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160;On October 23, 2012, the investors extended the note maturity date for 90 days. The maturity date of the notes has been extended to January 31, 2013, February 18, 2013 or March 27, 2013 for the 24 notes.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 19, 2012, the Convertible Notes and the accrued interests were automatically converted to common stock when the Company closed on an offering of its common stock in which the gross proceeds exceeded the $4,000,000 threshold.&#160;&#160;The Convertible Notes and accrued interest were converted into 1,252,550 shares of the Company&#8217;s common stock.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the years ended December 31, 2012, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $252,248 and $775,637, respectively.&#160;&#160;During the years ended December 31, 2011, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $40,444 and $124,363, respectively.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; A summary of the 8% Senior Subordinated Unsecured Convertible Promissory Notes as of December 31, 2012 and 2011 are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Principal amount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: original issuance discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(150,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(150,000</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: discount related to fair value of derivative warrants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: discount related to the beneficial conversion feature</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(372,850</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Add: amortization of discount</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,363</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: principal amount converted to stock</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(900,000</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying value at December 31, 2012 and 2011, respectively</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">124,363</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 6 &#8211; Derivatives</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&#8217;s common stock at prices below such warrants&#8217; respective exercise prices and these provisions could result in modification of the warrants&#8217; exercise price based on a variable that is not an input to the fair value of a &#8220;fixed-for-fixed&#8221; option as defined under FASB ASC Topic No. 815 &#8211; 40. The warrants granted in connection with the issuance of the Company&#8217;s Stock Offering and 2012 Common Stock Offering&#160;(See Note 9), the Convertible Notes (See Note 5) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &#8220;Lower Price&#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Activities for derivative warrant instruments during the years ended December 31, 2012 and 2011 were as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair Value</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287,061</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">377,150</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to issuance of Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">143,532</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">188,579</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,972,785</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,591,900</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to issuance of stock (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">986,393</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,295,950</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,966</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,389,771</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,439,613</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242,190</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">318,087</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to Stock Offering (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,095</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">159,044</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with 2012 Common Stock Offering-A (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,118,988</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,409,554</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with 2012 Common Stock Offering-B (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,559,505</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,665,697</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to 2012 Common Stock Offering (See Note 9)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">467,845</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,707</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transfer from liability classification to equity classification</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,753,056</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,231,324</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(685,420</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance, December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,146,338</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,574,958</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 19, 2012, as the result of the Share Exchange, it was determined that the floor for resetting the exercise price was met and the exercise price of the certain warrants was set to be $0.26 (before Exchange Ratio adjustment).&#160;Therefore, these warrants were considered indexed to the Company&#8217;s stock and qualified for the scope exception under FASB ASC 815-10 allowing for a transfer from liability classification to equity classification.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The fair values of the warrants issued in the Company&#8217;s stock and Convertible Notes Offering and the warrants issued to the Company&#8217;s placement agent were recognized as derivative warrant instruments at issuance and are measured at fair value at each reporting period. The Company determined the fair values of these warrants using a modified binomial valuation model.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at each balance sheet date, the transfer date on December 19, 2012, and the date for the new grants in January and December 2012. (The market value of common stock, adjusted exercise price and offering price presented does not reflect the impact of the Share Exchange.)</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">January 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 19,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 27,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Market value of common stock on measurement date (1)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjusted exercise price</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.24 - $0.26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.23 - $0.26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.41 - $0.83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.22 - $0.26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.41 - $0.83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk free interest rate (2)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.24</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10% - 0.77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10% - 0.77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrant lives in years</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7 years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7 years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4 months/5years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6 years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4 months/5years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">157</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125% - 161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125% - 161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield (4)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Probability of stock offering in any period over 5 years (5)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Range of percentage of existing shares offered (6)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Offering price range (7)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.18 - $0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13 - $0.56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01 - $0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.12 - $0.60</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.01 - $0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)&#160;&#160;</font></div>
</td>
<td align="left" valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5)&#160;&#160;</font></div>
</td>
<td align="left" valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management has determined that the probability of a stock offering is 25% for each quarter of the next five years.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management estimates that the range of percentages of existing shares offered in each stock offering will be between 35% of the shares outstanding.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7)&#160;&#160;</font></div>
</td>
<td valign="top" width="96%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Represents the estimated offering price range in future offerings as determined by management.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 7 &#8211; Income Taxes</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities at December 31, 2012 and 2011 are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net operating losses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,609,036</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,089,314</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Share-based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,497,556</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">741,420</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Other differences in tax basis</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233,043</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,749</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,339,635</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,835,483</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: valuation allowance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,339,635</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,835,483</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; As of December 31, 2012, for U.S. federal income tax reporting purposes, the Company has approximately $43 million of unused net operating losses (&#8220;NOLs&#8221;) available for carry forward to future years. The benefit from the carry forward of such NOLs will begin expiring during the year ended December 31, 2020. Because United States tax laws limit the time during which NOL carry forwards may be applied against future taxable income, the Company may be unable to take full advantage of its NOL for federal income tax purposes should the Company generate taxable income. Further, the benefit from utilization of NOLs carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; The difference between the income tax provision and the amount that would result if the U.S. Federal statutory rate of 34% were applied to pre-tax income (loss) for the years ended December 31, 2012 and 2011 are as follows:</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">For the years ended</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal income taxes at 34%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,842,810</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-34.00</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,171,230</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-34.00</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share-based compensation costs</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">756,136</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.04</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">736,796</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.39</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in fair value of derivatives</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233,043</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.79</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,748</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.13</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization of debt discounts</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">349,480</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.18</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56,033</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.63</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in valuation allowance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,504,151</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17.99</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">373,653</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.85</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Provision for income tax</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 8 &#8211; Commitments and Contingencies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Abbott Biotherapeutics Corp &#8211; The Company entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, the Company made a license fee payment of $3,000,000.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5) First commercial sale</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the agreement, the Company shall pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2012, the Company met its first milestone and upon reaching the milestone the Company paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012. &#160;The milestone payment for the Phase I Clinical Trial was recorded as research and development expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MSKCC &#8211; In February 2002, the Company entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payments</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for each licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) upon the receipt of regulatory approval from the U.S. FDA for each</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company expects to file the NDA for regulatory approval in 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oak Ridge National Laboratory (ORNL) &#8211; API has contracted to purchase radioactive material to be used for research and development through December 2012. API is contracted to purchase $233,100 of radioactive material to be used for research and development, with a renewal option at the contract end. &#160;The Company is currently negotiating the 2013 agreement.&#160;&#160;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">AptivSolutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab&#8482;-A) used in the Company clinical trials, Phase I and Phase II. &#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &#160;The down payment totaling $239,000 was paid in 2007 and 2012. &#160;On August 6, 2012, the agreement was amended to provide for additional services. &#160;The total project is now estimated at $1,997,732. &#160;AptivSolutions bills the Company when services are rendered and the Company records the related expense to research and development costs.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On June 15, 2012, the Company entered into a license and sponsored research agreement with Fred Hutchinson Cancer Research Center (FHCRC). The Company will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and the Company intends to start preparation for a pivotal trial leading to an FDA approval. &#160;The Company has been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &#160;Under the terms of the sponsored research agreement, the Company will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On March 27, 2012, the Company entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &#160;The amount due of $79,623 was paid on July 10, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">g.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On May 9, 2011, Actinium entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of Cactus&#160;Ventures, Inc.&#160;by virtue of his position as a director of Actinium Pharmaceuticals.&#160; Mr. Seth is a Managing Partner of the consulting firm some of whose member interests are held by entities owned by officers and employees of the Placement Agent.&#160; None of Cactus&#8217; current officers or directors had a prior relationship or affiliation with Cactus prior to the closing of the Share Exchange.&#160; Pursuant to the agreement, the management firm was engaged to provide consulting services to Actinium related to the consummation of a going public transaction for Actinium.&#160; The management firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&#160; Jamess Capital Group does not retain&#160;beneficial ownership of the warrants as they were&#160;issued to designees of the members in amounts which do not qualify either Jamess or the warrant holders for inclusion in the beneficial ownership table.&#160; The warrants contain&#160;a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.&#160; The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transferred until the earlier of twelve months from the closing date of the Pubco Transaction; or for six months after the planned Registration Statement is declared effective.&#160;The consulting firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">h.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On July 19, 2012, the Company entered into a clinical trial agreement with FHCRC. &#160;The Company will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $19,749. &#160;During the clinical trial additional fees apply and will be invoiced when applicable. &#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">i.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On August 28, 2012, the Company entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &#160;The estimated cost is based on treating 24 patients through 2013. &#160;Upon execution of the agreement, the Company is required to make a payment of $33,946. &#160;&#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">j.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On September 26, 2012, the Company entered into a clinical trial agreement with Johns Hopkins University. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &#160;The Company will pay $38,501 per patient, who has completed the clinical trial. The Company is required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">k.&#160;&#160;</font></div>
</td>
<td valign="top" width="95%" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On November 21, 2012, the Company entered into a clinical trial agreement with the University of Pennsylvania. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &#160;The Company will pay $31,771 per patient, who has completed the clinical trial. The Company will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3<font style="DISPLAY: inline; FONT-SIZE: 10pt">rd</font> Floor, New York, NY 10017. &#160;The agreement terminates January 31, 2013 unless a Notice of Termination is provided to the landlord 60 days prior to January 1, 2013. &#160;The agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &#160;The Company paid a two month refundable deposit.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 9 &#8211; Equity</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; From inception to December 31, 2010, the Company raised $42,711,791 by issuing 5,707,259 shares of the Company&#8217;s stock and issued 66,402 shares, valued at $398,810, for services.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During 2011, the Company raised $6,184,967 by selling 7,891,141 shares of the Company&#8217;s stock and warrants to purchase 19,972,785 shares of the Company&#8217;s stock through an offering (&#8220;Stock Offering&#8221;).&#160;&#160;A net amount of $5,379,367 was received by the Company in 2011. The Company paid Laidlaw &amp; Company (UK) Ltd. (&#8220;Laidlaw &amp; Co.&#8221;), the placement agent, total cash fees of $742,196, which consisted of placement agent commission of $618,497 and expense reimbursement of $123,699. The Company also issued Laidlaw &amp; Co. warrants to purchase an aggregate of 986,393 shares of the Company&#8217;s common stock, with an exercise price of $0.78 per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $188,579.&#160;In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien PLLC, $60,904 for its services as the placement agent&#8217;s legal counsel and Signature Bank $2,500 for the bank escrow fee.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During 2012, the Company raised $759,300 by selling 968,759 shares and warrants to purchase 242,190 shares of the Company&#8217;s common stock under the Company&#8217;s Stock Offering.&#160;&#160;A net amount of $660,164 was received by the Company in 2012. The Company paid Laidlaw &amp; Co. total cash fees of $91,116, which consisted of placement agent commission of $75,930 and expense reimbursement of $15,186. The Company also issued Laidlaw &amp; Co. warrants to purchase an aggregate of 121,095 shares of the Company&#8217;s common stock, with an exercise price of $0.78&#160;per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $159,044. In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien PLLC, $8,020 for its services as the placement agent&#8217;s legal counsel.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; In 2012, the Company also raised $5,151,450 through an offering of 3,118,988 shares of its common stock and &#8220;A Warrants&#8221; to purchase 3,118,988 shares of the Company&#8217;s common stock, exercisable at a price of $1.65 per share for a period of 120 days from the day of the final closing of the offering, and &#8220;B Warrants&#8221; to purchase 1,559,505 shares of the Company&#8217;s common stock, exercisable at a price of $2.48 per share for a period of 5 years from the date of the final closing of the offering. (&#8220;2012 Common Stock Offering&#8221;)&#160;&#160;A net amount of $4,469,776 was received by the Company. Pursuant to the 2012 Common Stock Offering agreement, the Company paid Laidlaw &amp; Co. total cash fees of $618,174, which consisted of placement agent commission of $515,145 and expense reimbursement of $103,029. The Company also issued the placement agent warrants to purchase an aggregate of 467,845 shares of the Company&#8217;s common stock, with an exercise price of $0.78 per share and a term of 5 years. These placement agent warrants were valued at $499,707 and recorded as derivative liabilities.&#160;&#160;In addition, the Company paid the Laidlaw &amp; Co.&#8217;s outside counsel, Richardson &amp; Patel, LLP, $60,000 for its services as the Laidlaw &amp; Co.&#8217;s legal counsel and Signature Bank $3,500 for the bank escrow fee.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During 2012, the Company&#8217;s convertible notes, plus accrued interest, were converted to 1,252,550 shares of the Company&#8217;s common stock as a result of the 2012 Common Stock Offering.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; As a result of the Share Exchange described in Note 1, the Company issued 400,000 shares to the original shareholders of the Company and 1,986,566 shares to the former shareholders of Actinium.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;&#160;&#160; Placement Agent &#8211;</font> In connection with the money raised in 2011, the Company issued Laidlaw &amp; Co. warrants to purchase an aggregate of 1,129,925 shares of common stock, with an exercise price of $0.78 per share.&#160;&#160;With the money raised in 2012, the Company issued Laidlaw &amp; Co. warrants to purchase an aggregate of 588,940 shares of common stock, with an exercise price of $0.78 per share.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;&#160;&#160; Management Firm &#8211;</font> In 2011, the Company entered into a&#160;management agreement with Jamess Capital Group, LLC (formerly, AmerAsia Inc., &#8220;Jamess&#8221;) for Jamess to provide consulting services related to funding and Actinium becoming a publicly traded entity.&#160;In 2011, the Company incurred $96,744 in management fees. In addition, Actinium issued Jamess warrants to purchase an aggregate of 1,974,774 shares of common stock, with an exercise price of $0.01 per share. The warrants have a fair value of $2,153,442 (see Note 11) and included a cashless exercise provision.&#160;&#160;In 2012, the Company issued Jamess warrants to purchase 1,716,340 shares of common stock with an exercise price of $0.01 per share. The warrants have a fair value of $1,957,754 (see Note 11) and included a cashless exercise provision.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 10 &#8211; Stock Option Plan</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company has adopted a 2003 Stock Plan under which it may grant up to 757,575 options to purchase common stock. The 2003 Stock Plan was amended in 2008 to increase the number of shares that it may grant up to 978,154. Option awards are generally granted with an exercise price equal to the market price of the Company&#8217;s stock at the date of the grant. However, since the Company is not publicly traded, the fair market value of the stock represents the Board of Directors&#8217; best estimate, based on the information available, on the date of the grant. The awards generally vest over a four or five year period at a rate of approximately 2% per month.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2011, the 2003 Stock Plan was amended to increase the number of shares by 3,217,880.&#160;&#160;Total shares reserved for issuance under the Plan will be increased to 6,155,280.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In accordance with the terms of the 2012 Common Stock Offering, the Company adopted a 2012 Employee Stock Option Plan (&#8220;2012 ESOP&#8221;) and reserved 15% of the total issued and outstanding shares as of the final closing of the 2012 Common Stock Offering.&#160;&#160;Total shares reserved for issuance under the 2012 ESOP was 9,455,776 shares.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2006, options to purchase 206,060 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $1,051,281 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 4.29% (2) expected life of 5 years, (3) expected volatility of 156%, and (4) zero expected dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2007, options to purchase 113,220 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $137,652 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 143%, and (4) zero expected dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2008, options to purchase 69,941 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $44,159 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 139%, and (4) zero expected dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2009, 20,613 options to one employee were cancelled as the result of termination of the employment and 128,050 options to one employee were forfeited as the employee deceased during the year.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the year of 2010, options to purchase 33,300 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $24,996 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 2.16% (2) expected life of 5 years, (3) expected volatility of 171%, and (4) zero expected dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In February 2012, the Company re-priced 273,859 units of employee stock options to reflect the current per share fair market value of the Company&#8217;s common stock. The exercise prices of all of the current outstanding stock options were reduced to $1.28 per share. The Company recorded an incremental compensation cost of $34,879 as a result of the re-pricing of options.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2012, options to purchase 2,056,275 shares of common stock were issued to several employees and consultants at an exercise price ranging from $0.78 to $1.5 per share.&#160;&#160;These options have a term of 10 years and vest over a 4 year period. The fair value of $1,519,777 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 1.8% (2) expected life of 7 years, (3) expected volatility of 160.44% ~ 162.49%, and (4) zero expected dividends.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; The following is a summary of stock option activities for the years ended December 31, 2012 and 2011:</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: center">Number of</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">273,859</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.29</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.51</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">273,859</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.29</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.51</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,056,275</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.89</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,330,134</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0. 96</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.91</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">685,800</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160; All options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at December 31, 2012 and 2011 were $1,998,435 and $14,528, respectively. During the years ended December 31, 2012 and 2011, the Company recorded option expense of $266,172 and $19,935, respectively.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 11 &#8211; Warrants</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During the year ended December 31, 2011, warrants to purchase 1,974,774 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $2,153,442 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate ranging from 1.92% to 3.17%, (2) warrant life of 10 years, (3) expected volatility ranging from 64.77% to 70.72%, and (4) zero expected dividends. The management firm receives warrants equal to ten (10%) percent of the issued and outstanding capital stock of the Company on a fully-diluted basis on the effective date of the agreement.&#160;&#160;The warrants are subject to weighted average non-dilution provisions to be calculated on the basis of the post-money fully diluted capitalization of the Company upon closing of any transaction, financing or otherwise, up to and including the Public Company transaction, provided that such anti-dilution provisions shall not extend beyond the date of any exercise of the warrants by the management firm prior to the closing of the Public Company transaction. Since these warrants vest immediately, the Company recorded the entire fair value of $2,153,442 as stock-based compensation expense during the year on these warrants issued by the Company.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During the year ended December 31, 2011, the Company also issued the following warrants:</font><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued with convertible notes (See Note 5)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">287,061</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued to investors with Stock Offering (See Note 9)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,972,766</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Convertible Notes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">143,532</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note 9)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">986,383</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,389,742</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-37</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Actinium Pharmaceuticals, Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Formerly Cactus Ventures, Inc.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A Development Stage Company)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notes to Consolidated Financial Statements</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During the year ended December 31, 2012, warrants to purchase an aggregate of 1,716,340 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $1,957,754 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 1.82%, (2) warrant life of 7 years, (3) expected volatility of 60.64%, and (4) zero expected dividends.&#160;&#160;Since these warrants vest immediately, the Company recorded the entire fair value of $1,957,754 as stock-based compensation expense during the year on these warrants issued by the Company.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; During the year ended December 31, 2012, the Company also issued the following warrants:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued to investors with Stock Offering (See Note 6)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">242,189</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued to investors with Common Stock</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,678,491</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note 9)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121,094</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;2012 Common Stock Offering</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">467,845</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Warrants issued to investors with stock &#8211; accrued dividend</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180,115&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,689,734</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160; The following is a summary of warrant activities for the years ended December 31, 2011 and 2012:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Units</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,364,557</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.51</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.76</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,364,557</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.51</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.76</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,261,367</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,406,079</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.32</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.76</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,770,636</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0. 97</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.48</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,114,768</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 12 &#8211; Employee Defined Contribution Plan</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; In 2004, the Company established an employee deferred contribution plan. The plan requires 12 consecutive months of service and a minimum of 500 hours of service for participation. The Plan provides for employer matching of 50% of the employee contribution and discretionary contributions. Employees can contribute up to the maximum allowable under the Internal Revenue Service Code Section 401(k). The amount contributed by the Company for the years ended December 31, 2012 and 2011 was $8,942 and $8,885, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note 13 &#8211; Subsequent Events</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company will pay Mr. Talley in 2 equal installments the aggregate amount of $250,000 and a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012. The $60,000 bonus was included in the accounts payable and accrued liabilities on the Company&#8217;s balance sheet at December 31, 2012.</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-38</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">25,735,497 Shares of Common Stock</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACTINIUM PHARMACEUTICALS, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(FORMERLY CACTUS VENTURES, INC.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROSPECTUS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS DOCUMENT OR THAT WE HAVE REFERRED YOU TO. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT. THIS PROSPECTUS IS NOT AN OFFER TO SELL COMMON STOCK AND IS NOT SOLICITING AN OFFER TO BUY COMMON STOCK IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Until _____________, all dealers that effect transactions in these securities whether or not participating in this offering may be required to deliver a prospectus. This is in addition to the dealer&#8217;s obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The date of this prospectus is __________, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="part_1_2_2"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART II&#8212; INFORMATION NOT REQUIRED IN THE PROSPECTUS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="item_1_3_14"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 13. Other Expenses Of Issuance And Distribution.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Securities and Exchange Commission registration fee</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,950</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transfer Agent Fees</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">800</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounting fees and expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Legal fees and expense</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Blue Sky fees and expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113,750</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All amounts are estimates other than the SEC&#8217;s registration fee. We are paying all expenses of the offering listed above. No portion of these expenses will be borne by the selling stockholders. The selling stockholders, however, will pay any other expenses incurred in selling their common stock, including any brokerage commissions or costs of sale.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="item_1_3_15"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 14. Indemnification of Directors and Officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Section 102(b)(7) of the Delaware General Corporation Law allows a corporation to provide in its certificate of incorporation that a director of the corporation will not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except where the directors breached the duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our certificate of incorporation provides for this limitation of liability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Section 145 of the General Corporation Law of the State of Delaware provides that a Delaware corporation may indemnify any person who was, is or is threatened to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was an officer, director, employee or agent of such corporation or is or was serving at the request of such corporation as a director, officer employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation&#8217;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his conduct was illegal. A Delaware corporation may indemnify any persons who are, or were, a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person is or was a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit, provided such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the corporation&#8217;s best interests, provided that no indemnification is permitted without judicial approval if the officer, director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him against the expenses which such officer or directors has actually and reasonably incurred.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Section 145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or enterprise, against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the corporation would otherwise have the power to indemnify him under Section 145.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our bylaws provide that we will indemnify our directors and officers to the fullest extent authorized by the General Corporation Law of the State of Delaware.&#160;&#160;Expenses (including attorneys&#8217; fees) incurred by an officer or director of the Corporation in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the Company in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Company as authorized under Delaware law.&#160;&#160;Such expenses (including attorneys&#8217; fees) incurred by former directors and officers or other employees and agents of the Company or by persons serving at the request of the Company as directors, officers, employees or agents of another corporation, partnership, joint venture, trust or other enterprise may be so paid upon such terms and conditions, if any, as the Company deems appropriate.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter acquire under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such person.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We maintain a general liability insurance policy that covers liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">II-1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Actinium Holdings Ltd. Indemnification</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to a letter Agreement dated, July 2011, between API and Actinium Holdings Ltd., API agreed to indemnify certain officers and directors of a predecessor company.&#160;&#160;Pursuant to the agreement, API will not, and will not permit any of its subsidiaries to, eliminate or otherwise reduce the right of any present or former director or officer of API, Actinium Pharmaceuticals Limited, a Bermuda corporation that merged into the Company (&#8220;APL&#8221;), and/or the present and former subsidiaries of API or APL (all such entities, collectively, the &#8220;Company Group&#8221;) who currently serves, or at any time prior to the date thereof served, in any such capacity (all such directors and officers, collectively &#8220;Company Group Managers&#8221;) to be indemnified against any costs or expenses (including reasonable attorneys&#8217; fees), judgments, fines, losses, claims, damages or liabilities of any nature whatsoever, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to matters existing or occurring on, prior to or after the date thereof, whether asserted or claimed prior to, on or after the date thereof, arising, in whole or in part, out of or pertaining to the fact that he or she is or was, or at any time in the future will have been, a Company Group Manager or is or was, or at any time in the future will have been, serving at the request of any entity in the Company Group (or at the request of any present or former affiliate (as such term is defined in Rule 405 under the Securities Act of 1933, as amended) of API for and on behalf of any entity in the Company Group as a director, officer, employee, fiduciary or agent of another corporation, partnership, joint venture, trust, other entity or otherwise, or to be advanced expenses, in any of the foregoing cases, to the fullest extent that such Company Group Manager would be entitled to be indemnified or advanced expenses under applicable law, API&#8217;s or any such subsidiaries&#8217; certificate or articles of incorporation or bylaws or equivalent documents or any applicable contract (collectively, the &#8220;Applicable Documents&#8221;), in each case, as in effect on the date thereof.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter acquire under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#8217;s official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such person.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We maintain a general liability insurance policy that covers liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At the present time, there is no pending litigation or proceeding involving a director, officer, employee, or other agent of ours in which indemnification would be required or permitted. We are not aware of any threatened litigation or proceeding that may result in a claim for such indemnification.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><a name="item_1_3_16"><!--EFPlaceholder--></a><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 15. Recent Sales of Unregistered Securities.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2011, Actinium Corporation raised $6,184,967 through an offering of 23,697,119 shares (pre-Actinium Share Exchange) of the 2011 Series E preferred shares and 5,924,285 warrants (pre-Actinium share exchange).&#160;&#160;A net amount of $5,379,367 was received by the Company in 2011.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 27, 2011, Actinium Corporation completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes (&#8220;Convertible Notes&#8221;) in the amount of $900,000 and received net proceeds of $750,000.&#160;&#160;The convertible notes were issued at 83.33% of the principal amount resulting in an original issue discount of $150,000.The Convertible Notes mature one year from the date of issuance. Interest accrues at the rate of 8% per year on the outstanding principal amount, accrued semi-annually and to be paid at maturity.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In January 2012, the Actinium raised $759,300 through its final offering of the 2011 Series E preferred shares.&#160;&#160;A net amount of $660,163 was received by Actinium Corporation .</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 19, 2012, Actinium Corporation completed a private offering of units.&#160;&#160;Upon taking into account the exchange ratio in the Share Exchange that closed on December 28, 2012 the units consisted of an aggregate of (i) 3,118,968 shares of its common stock, (ii) Series A warrants to purchase 3,118,969 shares of its common stock which have a 120 day term from December 19, 2012 and an initial per share exercise price of $1.65, subject to adjustment, (iii) Series B warrants to purchase up to 1,559,484 shares of common stock which have a 5 year term and an initial per share exercise price of $2.48, subject to adjustment.&#160;&#160;The price per unit was $1.65 for aggregate gross proceeds of $5,151,448.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 28, 2012, we entered into a Share Exchange Agreement with (i) Actinium Corporation and (ii) the former shareholders of Actinium Corporation pursuant to which we acquired 12,939,986 shares of capital stock of Actinium from the Actinium Corporation Shareholders in exchange for the issuance of 4,309,015 shares of common stock to the Actinium Corporation shareholders.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 11, 2013, we entered into a second Share Exchange Agreement with (i) Actinium Corporation and (ii) the former shareholders of Actinium Corporation pursuant to which we acquired 22,055,225 shares of capital stock of Actinium Corporation from the Actinium Corporation Shareholders in exchange for the issuance of 7,344,390 shares of common stock to the Actinium Corporation shareholders.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On August 22, 2013, we entered into a third Share Exchange Agreement with (i) Actinium Corporation and (ii) the former shareholders of Actinium Corporation pursuant to which we acquired 24,052,702 shares of capital stock of Actinium Corporation from the Actinium Corporation Shareholders in exchange for the issuance of 8,009,550 shares of common stock to the Actinium Corporation shareholders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">II-2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The above securities were offered and sold in reliance upon exemptions from registration pursuant to Section 4(2) of the Securities Act and Rule 506 of Regulation D (&#8220;Regulation D&#8221;) promulgated under the Securities Act.&#160;&#160;The Company made this determination based on the representations of the investors which included, in pertinent part, that each such investor was an &#8220;accredited investor&#8221; within the meaning of Rule 501 of Regulation D (there were no non-accredited investors in any of the offerings) and upon such further representations from each investor that (i) such investor is acquiring the securities for its own account for investment and not for the account of any other person and not with a view to or for distribution, assignment or resale in connection with any distribution within the meaning of the Securities Act, (ii) such investor agrees not to sell or otherwise transfer the purchased securities or shares underlying such securities unless they are registered under the Securities Act and any applicable state securities laws, or an exemption or exemptions from such registration are available, (iii) such investor has knowledge and experience in financial and business matters such that such investor is capable of evaluating the merits and risks of an investment in us, (iv) such investor&#160;&#160;had access to all of the Company&#8217;s documents, records, and books pertaining to the investment and was provided the opportunity to ask questions and receive answers regarding the terms and conditions of the Offering and to obtain any additional information which the Company possessed or was able to acquire without unreasonable effort and expense, and (v) such investor has no need for the liquidity in its investment in us and could afford the complete loss of such investment. In addition, there was no general solicitation or advertising for securities issued in reliance upon Regulation D.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="item_1_3_17"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 16. Exhibits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See Exhibit Index following the signature page.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;<a name="item_1_3_18"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 17. Undertakings.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The undersigned registrant hereby undertakes:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i. To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5) Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">II-3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;<a name="part_1_2_3"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereonto duly authorized, in the City of New York, State of New York, on September 30, 2013.</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACTINIUM PHARMACEUTICALS, INC.</font></div>
</td>
<td align="left" valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="bottom" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Kaushik J. Dave</font></div>
</td>
<td align="left" valign="bottom" width="12%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kaushik J. Dave</font></div>
</td>
<td align="left" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Duly Authorized Officer and Principal Executive Officer)</font></div>
</td>
<td align="left" valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="bottom" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Sergio Traversa</font></div>
</td>
<td align="left" valign="bottom" width="12%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sergio Traversa</font></div>
</td>
<td align="left" valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interim Chief Financial Officer (Duly Authorized Officer and </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Principal Financial and Accounting Officer)</font></div>
</td>
<td align="left" valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POWER OF ATTORNEY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Sergio Traversa and Sandesh Seth, and each of them, his true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to sign any registration statement for the same offering covered by the registration statement that is to be effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done or by virtue hereof.</font></div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Signature</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capacity</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Kaushik J. Dave</font></div>
</td>
<td valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President, Chief Executive Officer and Director</font></div>
</td>
<td valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="15%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2013</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="26%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kaushik J. Dave</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Executive officer)</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="15%">&#160;</td>
</tr><tr>
<td align="left" valign="bottom" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="32%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="15%">&#160;</td>
</tr><tr>
<td align="left" valign="top" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Sergio Traversa</font></font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="32%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interim Chief Financial Officer</font></font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="15%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2013</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sergio Traversa</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Financial and Accounting Officer)</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="32%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ David Nicholson</font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2013</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David Nicholson</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Sandesh Seth</font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2013</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sandesh Seth</font></div>
</td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="32%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">II-4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<a name="part_1_2_4"><!--EFPlaceholder--></a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="2" valign="top" width="5%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="94%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Description</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share Exchange Agreement, dated December 28, 2012, by and among Cactus Ventures, Inc., Actinium Pharmaceuticals, Inc., Diane S. Button, and the shareholders of Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 2.1 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.2</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share Exchange Agreement, dated March 11, 2013, by and among Cactus Ventures, Inc., Actinium Pharmaceuticals, Inc, and the shareholders of Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.1 to Form 8-K filed on March 11, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.3</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share Exchange Agreement, dated August 22, 2013, by and among&#160;&#160;Actinium Pharmaceuticals, Inc, Actinium Corporation, and the shareholders of Actinium Corporation&#160;&#160;(incorporated by reference to Exhibit 2.3 to Form S-1/A filed on August&#160; 22, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Articles of Incorporation of Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 of the Company&#8217;s Form 8-K filed with the SEC on April 17, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fifth Restated Certificate of Incorporation of Actinium Corporation (fka, Actinium Pharmaceuticals, Inc.) (incorporated by reference to Exhibit 3.5 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.3</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bylaws of Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.2 of the Company&#8217;s Form filed with the SEC on April 17, 2007).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bylaws of Actinium Corporation (fka, Actinium Pharmaceuticals, Inc.)(incorporated by reference to Exhibit 3.7 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of A Warrant, dated December 19, 2012 (incorporated by reference to Exhibit 4.1 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of B Warrant, dated December 19, 2012 (incorporated by reference to Exhibit 4.2 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.3</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Lock Up Agreement, dated December ____, 2012 (incorporated by reference to Exhibit 4.3 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.4</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Stock Offering Warrant, dated April 12, 2013.</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.5</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Placement Agent Warrant, dated December 19, 2012.</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.6</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Consulting Firm Warrant, dated December 17, 2012.</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.7</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lock-up Agreement, dated August 22, 2013&#160;&#160;(incorporated by reference to Exhibit 4.7 to Form S-1/A filed on August&#160; 22, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Opinion of Hiscock &amp; Barclay, LLP *</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Rights Agreement, by and among Actinium Pharmaceuticals, Inc., General Atlantic Investments Limited, and Certain Stockholders, dated June 30, 2000 (incorporated by reference to Exhibit 10.1 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.2</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amendment No. 1 to June 30, 2000 Registration Rights Agreement, dated September 29, 2011 (incorporated by reference to Exhibit 10.2 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.3</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Amended and Restated Stockholders Agreement, by and among Actinium Pharmaceuticals, Inc., Actinium Holdings Limited, N.V. Organon, and the Stockholders Listed Therein, dated October 5, 2011(incorporated by reference to Exhibit 10.3 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.4</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Second Amended and Restated Investor Rights Agreement, by and among Actinium Pharmaceuticals, Inc., Actinium Holdings Limited, and the Investors Listed Therein, dated October 5, 2011 (incorporated by reference to Exhibit 3.5 to Form 8-K filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.5</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intentionally left blank.</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.6</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Subscription Agreement, dated December 19, 2012 (incorporated by reference to Exhibit 10.6 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.7</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Form of Unit Purchase Agreement, dated December 19, 2012&#160;&#160;(incorporated by reference to Exhibit 10.7 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.8</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Employment Agreement, dated January 2, 2006,&#160;&#160;between Actinium Pharmaceuticals, Inc. and Dragan Cicic (incorporated by reference to Exhibit 10.8 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.9</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">License, Development and Commercialization Agreement between Sloan-Kettering Institute of Cancer Research, and Actinium Pharmaceuticals, Inc., dated February 11, 2002; as amended by the First Amendment dated August 7, 2006 (incorporated by reference to Exhibit 10.9 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.10</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phase I/II Study on the safety and efficiency of 225ACAc-HuM195 in patients with advanced Myeloid malignancies with Millennix Oncology, Averion Project, dated December 6, 2006 (incorporated by reference to Exhibit 3.5 to Form 8-K filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.11</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Product Development and Patent License Agreement, dated February 27, 2003, by and between Abbott Biotherapeutics and Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.11 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.12</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement, dated July 19, 2012, by and between Fred Hutchinson Cancer Center and Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.12 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.13</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Employment Letter between Jack V. Talley and Actinium Pharmaceuticals, Inc., effective August 15, 2012 (incorporated by reference to Exhibit 3.5 to Form 8-K filed on January&#160;4, 2013).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"><a href="#TABLEOFCONTENTS">TABLE OF CONTENTS</a></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.14</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Employment Letter between Enza Guagenti and Actinium Pharmaceuticals, Inc., effective August 15, 2012 (incorporated by reference to Exhibit 10.14 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.15</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement, dated January 18, 2001, between Actinium Pharmaceuticals, Inc. and Memorial Sloan Kettering Cancer Center for the purpose of conducting a clinical trial entitled &#8220;Phase I/II trial of 213Bi-M195 and cytarabine for Acute Myeloid Leukemia.&#8221; (incorporated by reference to Exhibit 10.15 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.16</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement with The Trustees of the University of Pennsylvania, dated November 8, 2012 (incorporated by reference to Exhibit 10.16 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.17</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement, dated March 27, 2012, with Memorial Sloan-Kettering Cancer Center (incorporated by reference to Exhibit 10.17 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.18</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement, dated September 22, 2012, with Johns Hopkins University, dated September 24, 2012 (incorporated by reference to Exhibit 10.18 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.19</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">License Agreement, dated June 14, 2012, for BC8 antibody with Fred Hutchinson Cancer Research Center&#160;&#160;(incorporated by reference to Exhibit 10.19 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.20</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012 Unit Investor Rights Agreement, dated December 19, 2012, by and among Actinium Pharmaceuticals, Inc., the persons identified on Exhibit A attached thereto hereto, and the Placement Agent (incorporated by reference to Exhibit 10.20 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.21</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Project Agreement, dated September 30, 2011, between Actinium Pharmaceuticals, Inc. and Aptiv Solutions, Inc. (incorporated by reference to Exhibit 10.21 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.22</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proposal, dated March 30, 2007, with IsoTherapeutics Group, LLC (incorporated by reference to Exhibit 10.22 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.23</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement with The University of Texas M.D. Anderson Cancer, dated March 1, 2012 (incorporated by reference to Exhibit 10.23 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.24</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amendment No. 1 to Research Agreement, dated November 7, 2012, between Actinium Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer&#160;&#160;(incorporated by reference to Exhibit 10.24 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr></table>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.25</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Letter Agreement, dated June 19, 2011, between Actinium Pharmaceuticals, Inc. and Sloan-Kettering Institute for Cancer Research&#160;&#160;(incorporated by reference to Exhibit 10.25 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.26</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Letter Agreement, dated April 9, 2010, between Actinium Pharmaceuticals, Inc. and Sloan-Kettering Institute for Cancer Research (incorporated by reference to Exhibit 10.26 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.27</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Letter Agreement, dated July __, 2010, between Actinium Pharmaceuticals, Inc. and Actinium Holdings Limited (Waiver of Anti-Dilution Rights) (incorporated by reference to Exhibit 10.27 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.28</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical Trial Agreement, dated April 12, 2006, with Sloan-Kettering Institute for Cancer Research and Memorial Hospital for Cancer and Allied Diseases (incorporated by reference to Exhibit 10.28 to Form 8-K /A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.29</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Letter Agreement, dated __, 2011, between Actinium Pharmaceuticals, Inc. and Actinium Holdings Limited (Waiver of Registration Rights) (incorporated by reference to Exhibit 10.29 to Form 8-K/A filed on January&#160;4, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.30</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Agreement, dated November 29, 2012, by and between Oak Ridge National Laboratory and Actinium Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.30 to Form S-1/A filed on August&#160; 22, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.31</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction Management Agreement, dated May 9, 2011, by and between Jamess Capital Group, LLC (fka, AmerAsia Capital Group LLC) and Actinium Corporation (fka, Actinium Pharmaceuticals Inc.).**</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Code of Ethics (incorporated by reference to Exhibit 14.1 to Form 8-K filed on January&#160;2, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Letter from R.R. Hawkins (prior auditor) (incorporated by reference to Exhibit 16.1 to Form S-1/A filed on August&#160; 22, 2013).</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">List of Subsidiaries (incorporated by reference to Exhibit 21.1 to Form 10-K filed on March&#160;29, 2013).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23.1</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consent of GBH CPAs, PC **</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23.2</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consent of Hiscock &amp; Barclay, LLP (included in Exhibit 5.1).</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101</font></div>
</td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interactive Data File for six month period ended June 30, 2013 furnished XBRL and Interative Data&#160;File for the six month period ended June 30, 2012, and the Interactive Data File for&#160;the year ended December 31, 2012 furnished in XBRL and Interactive Data File for the year ended December 31, 2011 furnished in XBLR. **</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*&#160; &#160;&#160;&#160; To be filed by amendment.</font></div>
</td>
</tr><tr bgcolor="white">
<td align="right" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">**&#160;&#160;&#160; Filed herewith.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>2
<FILENAME>fs12013ex10xxxi_actinium.htm
<DESCRIPTION>TRANSACTION MANAGEMENT AGREEMENT
<TEXT>
<html>
<head>
    <title>fs12013ex10xxxi_actinium.htm</title>
    <!--Licensed to: Edgar Efile Solutions Pvt Ltd.-->
    <!--Document Created using EDGARizerAgent 5.4.5.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Exhibit 10.31</font></div>

<div>&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TRANSACTION MANAGEMENT AGREEMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Transaction Management ("<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Agreement</font>") is made as of the 9<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> day of May, 2011 (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Effective Date</font>&#8221;) by and between AmerAsia Capital Group LLC (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Transaction Manager</font>&#8221;), a Delaware Limited Liability Company, with principal office at 244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001 and Actinium Pharmaceuticals Inc. (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Company</font>&#8221;) a Delaware corporation, with principal office at 391 Lafayette Street, Newark, NJ 07105.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">WHEREAS, Transaction Manager has experience in, among other matters, corporate structuring and reverse mergers and acquisitions; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">WHEREAS, the Company is desirous of retaining Transaction Manager to provide consulting services (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Services</font>&#8221;) to the Company related to: <font style="DISPLAY: inline; FONT-SIZE: 10pt">(i) a possible reverse merger or similar transaction between the Company and a corporation whose securities are publicly traded in the United States or other jurisdiction mutually agreed between API and Placement Agent (&#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Pubco</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#8221;), (ii) the&#160;&#160;quotation (a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Public Quotation</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#8221;) of the Company&#8217;s securities for purchase and sale on a U.S. quotation service or (iii) any filing with an applicable regulatory body which will result in the Company becoming an entity whose securities are traded on a public exchange in the U.S. or other mutually agreed upon jurisdiction (any of the foregoing, a &#8220;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Pubco Transaction</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#8221;).&#160;&#160;</font>, and Transaction Manager is willing to provide such Services to the Company, all on and subject to the terms and conditions hereinafter set forth.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOW, THEREFORE, in consideration of the mutual covenants and terms contained in this Agreement, and for good and valuable consideration, the Company and Transaction Manager agree as follows:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ARTICLE 1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ENGAGEMENT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.1.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Company hereby engages and retains Transaction Manager, on an exclusive basis, under the terms and conditions set forth herein and during the Term (hereinafter defined), to render the Services to the Company relating to the Pubco Transaction.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.2.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction Manager is hereby engaged and retained by the Company to provide, as and when requested by the Company, the Services to the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">Page <font style="FONT-WEIGHT: bold">1</font> of <font style="FONT-WEIGHT: bold">11</font></font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If required, restructure the balance sheet and operating condition of the Company in preparation of a public offering via a reverse merger or other similar transaction.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Manage the structuring, negotiations and execution of the public offering via a reverse merger or other similar transaction (collectively with 1.2.1 the &#8220;Transaction&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For more detailed descriptions and deliverables on the above please refer to the Statement of Work provided under Exhibit A.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Services to be rendered by Transaction Manager to the Company shall under no circumstances include the following:&#160;&#160;(i) Any activities which could be deemed to constitute investment banking or any other activities requiring Transaction Manager to be registered as a broker-dealer under the 1934 Act; and/or (ii) any activities which could be deemed to be in connection with the offer or sale of securities in a capital raising transaction.&#160;&#160;It is specifically understood and agreed by the parties hereto that all capital raising transactions associated with the Company will be processed and completed through a FINRA registered broker dealer and the Transaction Manager will have no involvement therewith.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.3. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Company will provide Transaction Manager with all financial and business information and documentation concerning the Company which is reasonably requested by Transaction Manager hereunder.&#160;&#160;In addition, the Company will make its executive officers, members of its Board of Directors, Scientific Advisory Board and other persons available to Transaction Manager, upon reasonable advance notice and request of Transaction Manager, for the purpose of providing information to Transaction Manager in connection with its contemplated Services hereunder.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction Manager will only be required to devote such of its time and efforts as it may reasonably determine is necessary for the performance of its Services hereunder. Transaction Manager will perform its Services hereunder in good faith and in the highest professional manner and will provide such of its staff and personnel as it may reasonably deem necessary for the performance of its services hereunder.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.5. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Company acknowledges that Transaction Manager does not guarantee that its Services will result in a Pubco Transaction closing.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 2 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ARTICLE 2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">COMPENSATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.1. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In consideration of Transaction Manager performing the Services for the Company under this Agreement, Transaction Manager shall be entitled to the following compensation:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="TEXT-DECORATION: underline">Cash Compensation</font>.&#160;&#160;A monthly fee of Twelve Thousand Five Hundred Dollars ($12,500) (the "<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Management Fee</font>") to Transaction Manager, which fee shall be calculated from the Effective Date and payable to Transaction Manager (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Accrued Management Fee</font>&#8221;) upon and only upon the Company receiving an aggregate of $250,000 from a proposed $750,000 financing for the primary purpose of funding transaction costs for completing the Pubco Transaction (&#8220;Bridge Financing&#8221;) to be completed by entities other than Amerasia.&#160;&#160;After the Accrued Management Fees are paid, the Management Fee will be payable on the first business day of each month, in advance, during the remainder of the term of this Agreement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Expenses</font>.&#160;&#160;The Company shall reimburse Transaction Manager for all ordinary and necessary out-of-pocket expenses incurred by it after the Effective Date in the performance of its services under this Agreement, subject to and upon receipt by the Company of invoices or other documentation in support thereof, provided, however, that such amount shall not exceed five thousand dollars per month ($5,000), and, further provided that no such expenses shall be payable unless and until the Company shall have received the first $100,000 of the Bridge Financing, whereupon all accrued out-of-pocket expenses will be paid.&#160;&#160;After the accrued out-of-pocket expenses are paid, the out-of-pocket expenses will be payable as provided for above.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Post Closing Compensation</font>.&#160;&#160;If, during the term of this Agreement, there is a successful closing of a Pubco Transaction, it is agreed that the monthly Management Fee shall continue for a minimum period of three (3) months thereafter, during which period the Transaction Manager will provide advisory services to the post-merger entity.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrants</font>.&#160;&#160;The Company shall issue to the Transaction Manager, or its designees, warrants (&#8220;Warrants&#8221;) to purchase common stock equal to ten (10%) percent of the issued and outstanding capital stock of the Company on a fully-diluted basis (&#8220;Capital Stock&#8221;) on the Effective Date.&#160;&#160;Such Warrants will be issued in three equal monthly installments with the first installment due no later than thirty (30) days of the Effective Date of this Agreement and then every thirty (30) days thereafter.&#160;&#160;Such Warrants will be&#160;&#160;non-dilutive and be calculated on the basis of the post-money fully diluted capitalization of the Company upon closing of any transaction, financing or otherwise, up to and including of the Pubco Transaction, provided that such anti-dilution provisions shall not extend beyond the date of any exercise of the Warrants by Transaction Manager prior to the closing of the Pubco Transaction.&#160;&#160;The exercise price of the Warrants will equal the par value of the Capital Stock.&#160;&#160;The Warrants shall provide for cashless exercise and expire seven years after the date of issuance.&#160;&#160;The Warrants shall only be redeemable or callable under the terms of Article 3.6.&#160;&#160;The Company must issue to the Transaction Manager any additional warrants due within thirty (30) days of the closing of any eligible financing or transaction. Otherwise the warrants shall not be callable or redeemable and shall have unlimited piggyback registration rights with respect to the resale of the underlying shares should the Company file a registration statement on Form S-3, S-1, or other applicable form and will be subject to lock-ups as required under SEC regulations or other applicable law or investors in the financing related to the Pubco Transaction.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 3 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="MARGIN-LEFT: 36pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Warrants shall be exercisable in accordance with the following schedule:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25% of the Warrants shall be exercisable upon the submission of&#160;&#160;a registration statement for the registration of a class of the Company&#8217;s securities pursuant to the Securities Exchange Act of 1934, as amended (a &#8220;34 Act Registrations Statement&#8221;), or the receipt by the Company of at least one initial bona fide term sheet from a Pubco for a Pubco Transaction;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50% of the Warrants shall be exercisable upon the effectiveness of a 34 Act Registration Statement or the receipt by the Company of a final bona fide term mutually agreeable term sheet for a Pubco Transaction; and,</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100% of the Warrants shall be exercisable upon the first quotation of the Company&#8217;s securities for purchase and sale on a U.S. securities exchange or quotation service or the filing of a Super 8-K or other equivalent documentation required by the SEC or other applicable regulatory body for the Pubco Transaction (&#8220;Pubco Filing Documents&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Notwithstanding the above exercise schedule, all warrants issued/issuable to the Transaction Manager shall be immediately exercisable in the event the Company enters into an agreement for a transaction in which it can be deemed to have:</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">merged;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">acquired;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 78px">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 78px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;3)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">been acquired or purchased;</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">entered into licensing transaction or its equivalent other than those conducted in the ordinary course of its business; or</font></div>
</td>
</tr></table>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="5%" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5)</font></div>
</td>
<td width="90%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">sold, assigned or exchanged its assets (other than those sold, assigned or exchanged in the ordinary course of its business) or shares for cash (other than cash raised in a financing transaction) or for other consideration.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 4 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ARTICLE 3</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MISCELLANEOUS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.1. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Independent Contractor Relationship.&#160;&#160;Nothing herein or attached shall be construed to create the relationship of employer and employee between the Company and Transaction Manager. Transaction Manager recognizes, understands and agrees that it is an independent contractor.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.2. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Authority.&#160;&#160;Under this Agreement Transaction Manager will have no authority whatsoever to assume or create any obligation, liability, or undertake and responsibility whatsoever, express or implied on behalf of or in the name of the Company or any affiliate other than those required to perform the services identified under this Agreement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.3. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Confidential Information and Other Restrictions.&#160;&#160;Either during or after the term of this Agreement Transaction Manager agrees not to communicate, disclose, or utilize to the Transaction Manager&#8217;s own benefit or the benefit of any other entity or persons, any techniques, plans, designs, programs, customer information, scientific data or other information not in the public domain pertaining to the business or affairs of the Company or of any of its affiliates.&#160;&#160;Information shall not be considered to be in the public domain if revealed or disclosed in contravention of this Agreement or the agreements made between the Company and other parties except in accordance with the Company&#8217;s privacy notice provisions and in furtherance of the Company&#8217;s business.&#160;&#160;Upon termination of this Agreement the Transaction Manager agrees to immediately surrender to the Company all originals, software, and computer systems programs, and copies any other documents and material received by Transaction Manager while retained under this Agreement.&#160;&#160;Transaction Manager shall not retain or deliver to any other entity or person any of the foregoing or a summary or memorandum thereof.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.4. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contracts or Other Agreements with Former Employer or Business.&#160;&#160;The Transaction Manager hereby represents and warrants that Transaction Manager is not subject to any employment agreement or similar document, except as previously disclosed and delivered to the Company, with a former employer or any business with which the Transaction Manager has been associated, which on its face prohibits the Transaction Manager during a period of time which extends through any portion of the term of this Agreement from any of the following: (i)&#160;competing with, or in any way participating in a business which competes with the Executive&#8217;s former employer or business; (ii)&#160;soliciting personnel of such former employer or business to leave such former employer&#8217;s employment or to leave such business; or (iii) soliciting customers of such former employer or business on behalf of another business.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.5. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Termination.&#160;&#160;This Agreement may be terminated by the Transaction Manager or the Company; (i) by giving ninety days (90) written notice; or (ii) for Cause, as defined, at any time.&#160;&#160;For this Agreement, &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Cause</font>&#8221; means the occurrence of any of the following events: (i) willful and continued failure of the Transaction Manager to substantially perform duties with the Company; (ii) conduct by the Transaction Manager or its personnel that amounts to willful misconduct or gross negligence; (iii)&#160;any act by Transaction Manager or its personnel of fraud, misappropriation, dishonesty, embezzlement or similar conduct against the Company; or (iv) commission by Transaction Manager of a felony or any other crime involving dishonesty.&#160;&#160;This Agreement also may be terminated by either party if non-terminating party has committed a material breach of the Agreement and such material breach is not cured within ten (10) days after receipt by the non-terminating party of notice of such material breach.&#160;&#160;Upon termination of this Agreement, all accrued but unpaid fees and expenses which are then due and payable to the Transaction Manager shall be paid and, unless terminated by Company for Cause or material breach, all Warrants then due and owing must be issued, if not previously issued.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 5 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company agrees to pay all costs of collection, including, reasonable attorney's fees as and when incurred, in the case that any payments due here-in-under are not paid in a timely manner, or in case it becomes necessary to protect the interests hereof, whether suit be brought or not.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%">3.6. </td>
<td width="95%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Redemption.&#160;&#160;Unless the Transaction Manager has advised the Company to pursue a Public Quotation, the Company shall have the right to redeem that percentage of the Warrants or, to the extent exercised, the shares of Capital Stock relating to the Warrants, for a redemption price of $0.01 per share in the event that the following milestones are not met by the timeline specified below, but only if written notice of such redemption is received by Transaction Manager no later than thirty days after the relevant milestone date:</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1) If the Company does not receive at least one initial bona fide term sheet from a Pubco for a Pubco Transaction within 6 months after the closing of the Bridge Financing, 100% of the Warrants may be redeemed;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2) If the Company does not receive a final bona fide term mutually agreeable term sheet for a Pubco Transaction within eight months after closing of the Bridge Financing fifty percent of the Warrants may be redeemed; and,</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3)&#160;&#160;If the Pubco Filing Documents are not filed within ten months from the closing of the Bridge Financing, twenty-five percent of the Warrants may be redeemed.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The above schedule is contingent upon the Company providing the Transaction Manager and legal or other advisors required for the Pubco Transaction with documentation required to complete on a timely basis the Super 8-K or other documents required to be filed with the SEC or other regulatory body including acceptable audited financials, all within two months after the closing of the Bridge Financing.&#160;&#160;If such documentation is delayed or causes delays in the filing of the Pubco Filing Documents, other than due to the gross negligence or willful acts or omissions of Transaction Manager, the above redemption schedule will be extended by a period commensurate with the delay in providing such documentation.&#160;&#160;The Company&#8217;s right to redemption of the Warrants will expire should the Company decide during the term of this Agreement not to complete a Pubco Transaction on an appropriate stock exchange (which unless mutually agreed upon by the Client and Transaction Manager shall be a U.S. stock exchange and no less than the OTC BB) with an entity introduced to Company by Transaction Manager&#160;&#160;which must, among other criteria, be fully reporting, have no material liabilities or contingent liabilities, be DTC eligible, have no mature or unmatured rescission rights, has not been late in any SEC filing for the last one (1) year, and is in good standing it its place of incorporation and on such other terms and conditions (including normal and customary due diligence) reasonably satisfactory to Company .&#160;&#160;The Warrants shall not be exercisable unless the Bridge Financing has been completed by December, 31, 2011, and if not completed by such date the Warrants shall be cancelled by their terms unless otherwise mutually agreed by the parties.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 6 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Notwithstanding the provisions in the paragraph above, or any other provision of this Agreement to the contrary, in the event that this Agreement is terminated by Transaction Manager pursuant to the provisions of Section 3.5 for Cause or material breach, the Company&#8217;s right of redemption shall terminate on the date of any such termination of the Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Transaction Manager hereby agrees that the certificates for the Shares will bear a legend with respect to such redemption right and any assignee or transferee of the Shares from Transaction Manager will be required to agree to be bound by the aforementioned redemption rights of the Company as a condition of any transfer or assignment of shares.&#160;&#160;The Company&#8217;s right to redeem the Shares shall automatically terminate on the date, if any, that the Company files the Pubco Filing Documents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.7.</font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Indemnification.&#160;&#160;In no event shall the Transaction Manager and/or any of its affiliates, employees, equity and/or debtholders, agents, attorneys, partners, officers and/or directors (collectively, &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Personnel</font>&#8221;) be liable for any damages consequential, special, indirect, incidental, punitive, or exemplary loss, damage, cost or expense (including, without limitation, lost profits and opportunity costs) except to the extent due to gross negligence or willful acts or omissions on the part of the Transaction Manager.&#160;&#160;The Company<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>agrees to indemnify and hold harmless the Transaction Manager and its Personnel from and against any and all actions, losses, damages, claims, liabilities, costs and expenses (including without limitation, reasonable legal fees and expenses) in any way arising directly and/or indirectly out of or relating to this Agreement (&#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Damages</font>&#8221;), except to the extent that such Damages to the Company resulted directly from the gross negligence or willful acts or omissions on the part of the Transaction Manager or Personnel.&#160;&#160;The provision of this paragraph shall apply regardless of the form of action, loss, damage, claim, liability, cost, or expense, whether in contract, statute, tort (including without limitation, negligence), or otherwise.&#160;&#160;The provisions of this paragraph shall survive the expiration or any termination of this Agreement.&#160;&#160;Except as set forth above, the Company further agrees to pay any and all reasonable legal or other professional services fees and expenses on behalf of Transaction Manager and/or the Personnel if claims and/or investigations are made or commenced against Transaction Manager and/or any of its Personnel by a third party arising directly and/or indirectly out of this Agreement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.8. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This Agreement constitutes the sole and entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements, representations, warranties, statements, promises, arrangements and understandings, whether oral or written, express or implied, between the parties hereto with respect to the subject matter hereof and may not be amended or modified except by an instrument in writing signed by the party to be bound hereby.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 7 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.9. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All notices, consents, requests, demands and other communications required or permitted to be given under this Agreement (collectively, the "<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Notices</font>") shall be in writing and delivered personally, receipt acknowledged, or mailed by registered or certified mail, postage prepaid, return receipt requested, addressed to the parties hereto identified above (or to such other addresses as either of the parties hereto shall specify by notice given in accordance with this provision).&#160;&#160;All such Notices shall be deemed given when personally delivered as aforesaid, or, if mailed as aforesaid, on the third business day after the mailing thereof or on the day actually received, if earlier, except for a notice of a change of address which shall be effective only upon receipt.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.10. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Neither party hereto may assign this Agreement or its or their respective rights, benefits or obligations hereunder without the written consent of the other party hereto, except that Transaction Manager may assign its rights to the Warrants and/or underlying shares upon notice to the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.11. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.12. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">No waiver of any provision of this Agreement or of any breach thereof shall be effective unless in writing and signed by the party to be bound thereby.&#160;&#160;The waiver by either party hereto of a breach of any provision of this Agreement, or of any representation, warranty, obligation or covenant in this Agreement by the other party hereto, shall not be construed as a waiver of any subsequent breach or of any other provision, representation, warranty, obligation or covenant of such other party, unless the instrument of waiver expressly so provides.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.13. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This Agreement shall be governed by and construed solely and exclusively in accordance with the internal laws of the State of New York without regard to the conflicts of law principles thereof. The Parties hereto hereby expressly and irrevocably agree that any suit or proceeding arising directly and/or indirectly pursuant to or under this Agreement shall be brought solely in a federal or state court located in the City, County and State of New York. By its execution hereof, the Parties hereby covenant and irrevocably submit to the in personam jurisdiction of the federal and state courts located in the City, County and State of New York and agree that any process in any such action may be served upon any of them personally, or by certified mail or registered mail upon them or their agent, return receipt requested, with the same full force and effect as if personally served upon them in New York City. The Parties hereto expressly and irrevocably waive any claim that any such jurisdiction is not a convenient forum for any such suit or proceeding and any defense or lack of in personam jurisdiction with respect thereto. In the event of any such action or proceeding, the party prevailing therein shall be entitled to payment from the other party hereto of all of its reasonable counsel fees and disbursements.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 8 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.14. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision(s) shall be excluded from this Agreement and the balance of this Agreement shall remain in full force and effect.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.15. </font></td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This Agreement may be executed in one or more counterparts, each of which, when executed and delivered, shall be deemed an original, but all of which when taken together, shall constitute one and the same instrument.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">THIS AGREEMENT UPDATES AND SUPERCEDES THE ORIGINAL AGREEMENT DATED MAY </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TH</font>, 2011 AND UPDATED JULY 12<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TH</font>, 2011 AND REFLECTS CLARIFICATION OF LANGUAGE </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RELATED TO ISSUANCE OF WARRANTS.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">IN WITNESS WHEREOF, the parties have executed this Agreement of the day and year first above written.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">AMERASIA CAPITAL GROUP LLC</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">By:</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">/s/ Sandesh Seth</td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="35%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:&#160;&#160;Sandesh Seth</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:&#160;&#160;&#160;&#160;Managing Partner</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">&#160;</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="3%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ACTINIUM PHARMACEUTICALS, INC.</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></td>
<td valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;/s/ Dragan Cicic</font></td>
<td valign="top" width="12%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:&#160;&#160;Dragan Cicic, MD</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:&#160;&#160;&#160;&#160;CEO</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">This agreement replaces the one signed July 12</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">, 2011.</font><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 18pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 9 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit A &#8211; Statement of Work</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Restructuring of Balance Sheet and operating condition of the Company in preparation of a Transaction.&#160;&#160;Structuring, negotiating and execution of the Public Offering (the &#8220;Transaction&#8221;):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overall Company due diligence file preparation for Transaction completion and future reference.&#160;&#160;Transaction Manager to complete overall due diligence questionnaire and organize supporting documentation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Balance sheet restructuring and workout, if required</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iii.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Review and make recommendations with respect to the Company's capital structure and&#160;&#160;&#160;complete roll-forward of capitalization table from inception, basic and diluted.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iv.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounting and financial organization, preparation and coordination of the completion of required audit reports and stub period financials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">v.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assist the Company in acquiring a properly structured publicly trading company and who files reports with the SEC under the Securities Exchange Act of 1934, as amended (the &#8220;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">1934 Act</font>&#8221;), within which to merge into;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">vi.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Corporate governance and other required legal organization to position company to complete a Transaction;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">vii.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Make introductions to, assist in discussions and negotiate compensation packages with Board of Director and Board of Advisor Members.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">viii.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consider other pre-public needs; directors &amp; officers insurance,</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ix.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Introduce to and/or coordinate with legal, auditors and others the preparation of appropriate draft Transaction documents:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 48px">
<div><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 120px">&#160;</td>
<td width="35" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></td>
<td width="1362">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If a Public Quotation, such will include:</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 216px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 47px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td width="1302">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Draft Exchange Act Registration Statement;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 216px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 47px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td width="1302" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Identify market makers to quote the Company&#8217;s securities on a quotation service;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 216px">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 48px">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td width="1301" style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assist the Company in connection with the Market Makers&#8217; initiation of quotation of the Company&#8217;s securities pursuant to Rule 15c-211 of the Exchange Act.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: right; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">Page</font> 10 <font style="FONT-WEIGHT: normal">of</font> 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><img src="img001.jpg" alt=""></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If public company-merger without simultaneous financing, such will include;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Draft Share Exchange;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Exchange disclosure schedule preparation; capitalization, legal actions, off-balance sheet liabilities, related entities, insurance, employment matters, intellectual property, benefit plans, material contracts and transactions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board of Director closing and other resolutions;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Draft &#8220;Super&#8221; 8K Filing;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Super 8K exhibit preparation; employment contracts, investor documents and necessary financial documents.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If public company-merger with simultaneous financing, such will include;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All those noted in Item 1; and</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Investor related documents; convertible notes, warrant, pledge and security agreements, registration rights.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Transaction closing.&#160;&#160;Duties, responsibility and deliverables to include:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Coordinate with management, legal, auditors and other professionals the closing of the Transaction, including, if applicable funding;</font></font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Coordinate the compilation of all Transaction documents for future reference and due diligence.</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td width="5%" style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C.</font></div>
</td>
<td width="95%">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Post-Transaction closing.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This agreement replaces the one signed July 12<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, 2011. </font>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AmerAsia Capital Group, LLC.</font> <font style="FONT-STYLE: normal; DISPLAY: inline; FONT-SIZE: 10pt">244 Fifth Avenue, 2nd Floor, Suite S217, New York, NY 10001. T: 646-827-2460, F: 646-895-7678.</font></font></font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font> </font>

<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: right"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal"><font style="FONT-STYLE: normal">Page</font> <font style="FONT-WEIGHT: bold">11</font> of <font style="FONT-WEIGHT: bold">11</font></font> </font>

<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fs12013ex23i_actiniumpharma.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<html>
<head>
    <title>fs12013ex23i_actiniumpharma.htm</title>
    <!--Licensed to: Edgar Agents LLC-->
    <!--Document Created using EDGARizerAgent 5.4.5.0-->
    <!--Copyright 1995 - 2013 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="TEXT-INDENT: 0pt; DISPLAY: inline; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 7%; FONT-SIZE: 10pt; MARGIN-RIGHT: 7%">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 23.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 43.2pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We hereby consent to the inclusion in this Registration Statement on Form S-1 of our report dated March 15, 2013 relating to the consolidated financial statements of Actinium Pharmaceuticals, Inc. as of December 31, 2012 and 2011 for the years ended December 31, 2012 and 2011 and for the period from </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">June 13, 2000 (inception) to December 31, 2012. We also consent to the reference to our firm under the heading <font style="FONT-STYLE: italic; DISPLAY: inline">"Experts" </font>appearing therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/ GBH CPAs, PC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GBH CPAs, PC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 421.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">www.gbhcpas.com</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 421.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Houston, Texas</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">September 30, 2013</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>4
<FILENAME>fil-20130630.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated using Ez-XBRL version 7.0.2.7 [09/27/2013 08:32:22 PM] -->
<!-- Based on XBRL 2.1 -->
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<xbrli:xbrl xmlns:fil="http://cactusventuresinc.com/20130630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="fil-20130630.xsd"/>
<!-- Context Section  -->
<xbrli:context id="Context_As_Of__13-Jun-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-06-13
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2000-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2000">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2000-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2000-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2000-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2000-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2001">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-01-01
</xbrli:startDate>
<xbrli:endDate>
2001-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-01-01
</xbrli:startDate>
<xbrli:endDate>
2001-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-01-01
</xbrli:startDate>
<xbrli:endDate>
2001-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2001-01-01
</xbrli:startDate>
<xbrli:endDate>
2001-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2001">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2001-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Feb-2002_28-Feb-2002_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-02-01
</xbrli:startDate>
<xbrli:endDate>
2002-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2002">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-01-01
</xbrli:startDate>
<xbrli:endDate>
2002-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-01-01
</xbrli:startDate>
<xbrli:endDate>
2002-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-01-01
</xbrli:startDate>
<xbrli:endDate>
2002-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2002-01-01
</xbrli:startDate>
<xbrli:endDate>
2002-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2002">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2002-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2003">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-01-01
</xbrli:startDate>
<xbrli:endDate>
2003-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-01-01
</xbrli:startDate>
<xbrli:endDate>
2003-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-01-01
</xbrli:startDate>
<xbrli:endDate>
2003-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2003-01-01
</xbrli:startDate>
<xbrli:endDate>
2003-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2003">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2003-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2004-01-01
</xbrli:startDate>
<xbrli:endDate>
2004-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2004">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2004-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2005">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2005-01-01
</xbrli:startDate>
<xbrli:endDate>
2005-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2005">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2005-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2006_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2006-01-01
</xbrli:startDate>
<xbrli:endDate>
2006-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2006">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2006-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_StatementClassOfStockAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2007_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AptivSolutionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2007-01-01
</xbrli:startDate>
<xbrli:endDate>
2007-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2007">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2007-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2008_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-01-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2008">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2009">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2009_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2009-01-01
</xbrli:startDate>
<xbrli:endDate>
2009-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2009">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2009-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:SloanKetteringInstituteOfCancerResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-04-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:SloanKetteringInstituteOfCancerResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2010_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-01-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2010">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2010_StatementClassOfStockAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:JamessCapitalGroupMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:TransactionManagementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-04-10
</xbrli:startDate>
<xbrli:endDate>
2011-05-09
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_20-May-2011_19-Jun-2011_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:SloanKetteringInstituteOfCancerResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-05-20
</xbrli:startDate>
<xbrli:endDate>
2011-06-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__27-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_RangeAxis_MaximumMember_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_RangeAxis_MinimumMember_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">fil:LaidlawAndCoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_SubsidiarySaleOfStockAxis_ManagementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:ManagementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">fil:LaidlawAndCoMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fil:PlacementAgentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:ManagementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-01-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">fil:SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2011_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2011_31-Dec-2011">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-12-01
</xbrli:startDate>
<xbrli:endDate>
2011-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Jan-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Jan-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Jan-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Jan-2012_31-Jan-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Jan-2012_31-Jan-2012_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Jan-2012_31-Jan-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:RosemaryMazanetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ConsultingServicesAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Feb-2012_29-Feb-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-02-01
</xbrli:startDate>
<xbrli:endDate>
2012-02-29
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Feb-2012_29-Feb-2012_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-02-01
</xbrli:startDate>
<xbrli:endDate>
2012-02-29
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Feb-2012_29-Feb-2012_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-02-01
</xbrli:startDate>
<xbrli:endDate>
2012-02-29
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__27-Mar-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-03-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-15
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-15
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-15
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Jun-2012_15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-06-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-15
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2012_15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-06-14
</xbrli:startDate>
<xbrli:endDate>
2012-06-15
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-04-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_OptionsAndWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">fil:OptionsAndWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__19-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-07-19
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_28-Jul-2012_01-Aug-2012_AgreementAxis_RentalAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:RentalAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-28
</xbrli:startDate>
<xbrli:endDate>
2012-08-01
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_05-Aug-2012_06-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AptivSolutionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-05
</xbrli:startDate>
<xbrli:endDate>
2012-08-06
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_07-Jul-2012_06-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AptivSolutionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-07
</xbrli:startDate>
<xbrli:endDate>
2012-08-06
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_08-Jul-2012_07-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:LaidlawAndCompanyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:EngagementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-07-08
</xbrli:startDate>
<xbrli:endDate>
2012-08-07
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:UniversityOfTexasMDAndersonCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-08-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:UniversityOfTexasMDAndersonCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-01
</xbrli:startDate>
<xbrli:endDate>
2012-08-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_27-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:UniversityOfTexasMDAndersonCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-27
</xbrli:startDate>
<xbrli:endDate>
2012-08-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Aug-2012_31-Aug-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-08-01
</xbrli:startDate>
<xbrli:endDate>
2012-08-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:JohnsHopkinsUniversityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-09-26
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:JohnsHopkinsUniversityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-09-01
</xbrli:startDate>
<xbrli:endDate>
2012-09-26
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_25-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:JohnsHopkinsUniversityMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-09-25
</xbrli:startDate>
<xbrli:endDate>
2012-09-26
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Oct-2012_23-Oct-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-10-01
</xbrli:startDate>
<xbrli:endDate>
2012-10-23
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__21-Nov-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfPennsylvaniaMember_AgreementAxis_ClinicalTrialAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:UniversityOfPennsylvaniaMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ClinicalTrialAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-11-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__19-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-19
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__19-Dec-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-19
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__19-Dec-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-19
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_19-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_19-Dec-2012_StatementClassOfStockAxis_SeriesEPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-19
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__21-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:SloanKetteringInstituteOfCancerResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-21
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__27-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__27-Dec-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__27-Dec-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-27
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_27-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-27
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__28-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__28-Dec-2012_LegalEntityAxis_ActiniumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">fil:ActiniumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_28-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Dec-2012_28-Dec-2012_LegalEntityAxis_ActiniumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">fil:ActiniumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-12-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AptivSolutionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:SloanKetteringInstituteOfCancerResearchMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseDevelopmentAndCommercializationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">fil:LaidlawAndCoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">fil:LaidlawAndCoMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">fil:PlacementAgentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:ManagementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:RosemaryMazanetMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ConsultingServicesAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:LaidlawAndCompanyMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:EngagementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:PlacementAgentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ManagementFirmMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:ManagementFirmMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseSecondClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseSecondClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseThirdClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseThirdClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_BiologicalLicenseApplicationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:BiologicalLicenseApplicationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_FirstCommercialSaleMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:FirstCommercialSaleMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:AfterFirstNetSalesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseFirstClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandThreeStockPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandThreeStockPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandThreeStockPlanMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_NewDrugApplicationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:NewDrugApplicationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_ReceiptOfRegulatoryApprovalFromUSFdaMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:ReceiptOfRegulatoryApprovalFromUSFdaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ProductDevelopmentAndPatentLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:AfterFirstNetSalesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ProductDevelopmentAndPatentLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseFirstClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ProductDevelopmentAndPatentLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_OakRidgeNationalLaboratoryMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:OakRidgeNationalLaboratoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_GuagentiAndAssociatesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:GuagentiAndAssociatesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandTwelveEmployeeStockOptionPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandTwelveEmployeeStockOptionPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantsBMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fil:WarrantsBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-01-01
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">fil:SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:PlacementAgentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandThreeStockPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Dec-2012_PlanNameAxis_TwoThousandTwelveEmployeeStockOptionPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:TwoThousandTwelveEmployeeStockOptionPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2012">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2012-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__31-Jan-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Jan-2013_31-Jan-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">fil:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-02-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__28-Feb-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-02-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_27-Feb-2013_28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">fil:FormerChiefExecutiveOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-02-27
</xbrli:startDate>
<xbrli:endDate>
2013-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Feb-2013_28-Feb-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-02-01
</xbrli:startDate>
<xbrli:endDate>
2013-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-Mar-2013_31-Mar-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-03-01
</xbrli:startDate>
<xbrli:endDate>
2013-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01-May-2013_31-May-2013_TitleOfIndividualAxis_FormerDirectorAndConsultantsMember_FinancialInstrumentAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">fil:FormerDirectorAndConsultantsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-05-01
</xbrli:startDate>
<xbrli:endDate>
2013-05-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-04-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AptivSolutionsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_OptionsAndWarrantsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">fil:OptionsAndWarrantsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_AgreementAxis_RentalAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:RentalAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseSecondClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseSecondClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseThirdClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseThirdClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_BiologicalLicenseApplicationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:BiologicalLicenseApplicationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_FirstCommercialSaleMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:FirstCommercialSaleMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:AfterFirstNetSalesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:PhaseFirstClinicalTrialOfLicensedProductMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_NewDrugApplicationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:NewDrugApplicationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_ReceiptOfRegulatoryApprovalFromUSFdaMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:MemorialSloanKetteringCancerCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:ReceiptOfRegulatoryApprovalFromUSFdaMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ProductDevelopmentAndPatentLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:AbbottBiotherapeuticsCorpMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">fil:AfterFirstNetSalesMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:ProductDevelopmentAndPatentLicenseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_OakRidgeNationalLaboratoryMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:OakRidgeNationalLaboratoryMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:SeparationAndSettlementAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_FinancialInstrumentAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME__30-Jun-2013_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_AwardTypeAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of__30-Jun-2013_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_14-Jun-2000_30-Jun-2013">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2000-06-14
</xbrli:startDate>
<xbrli:endDate>
2013-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_10-Aug-2013_12-Aug-2013_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">fil:FredHutchinsonCancerResearchCenterMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="fil:AgreementAxis">fil:LicenseAndSponsoredResearchAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-08-10
</xbrli:startDate>
<xbrli:endDate>
2013-08-12
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>IhkevEkirxw6=c444c555cT{h>J==J:FEF1F67J18E<41E<5:15488;5G445I< -->
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Note"><xbrli:measure>fil:Note</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_6ME__30-Jun-2013">Actinium Pharmaceuticals, Inc.</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_6ME__30-Jun-2013">0001388320</dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="Context_6ME__30-Jun-2013">false</dei:AmendmentFlag>
<dei:DocumentType contextRef="Context_6ME__30-Jun-2013">S-1</dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="Context_6ME__30-Jun-2013">2013-06-30</dei:DocumentPeriodEndDate>
<dei:EntityFilerCategory contextRef="Context_6ME__30-Jun-2013">Smaller Reporting Company</dei:EntityFilerCategory>
<us-gaap:Cash contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">5703798</us-gaap:Cash>
<us-gaap:Cash contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">5618669</us-gaap:Cash>
<us-gaap:Cash contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">5650328</us-gaap:Cash>
<us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">237834</us-gaap:AccountsAndOtherReceivablesNetCurrent>
<us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">5384</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">167143</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">84270</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:DeferredFinanceCostsCurrentNet contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">252248</us-gaap:DeferredFinanceCostsCurrentNet>
<us-gaap:DeferredFinanceCostsCurrentNet contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:DeferredFinanceCostsCurrentNet contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:AssetsCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">6199264</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">5785812</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">5734598</us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">1233</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">3010</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:Assets contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">6200497</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">5788822</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">5734598</us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">644511</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">897044</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">793630</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">31185</us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">31185</us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:NotesPayableCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:NotesPayableCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">140000</us-gaap:NotesPayableCurrent>
<us-gaap:NotesPayableCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">36950</us-gaap:NotesPayableCurrent>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">124363</us-gaap:ConvertibleNotesPayableCurrent>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">124363</us-gaap:ConvertibleNotesPayableCurrent>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ConvertibleNotesPayableCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">4439613</us-gaap:DerivativeLiabilitiesCurrent>
<us-gaap:DerivativeLiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">3574958</us-gaap:DerivativeLiabilitiesCurrent>
<us-gaap:DerivativeLiabilitiesCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">2957977</us-gaap:DerivativeLiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">5208487</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">4643187</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">3819742</us-gaap:LiabilitiesCurrent>
<us-gaap:Liabilities contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">4643187</us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">3819742</us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommitmentsAndContingencies contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:CommonStockValue contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">136648</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">213916</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">235844</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">48237620</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">56675182</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">60895513</us-gaap:AdditionalPaidInCapital>
<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">47382258</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">55743463</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
<us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">59216501</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2000" unitRef="USD" decimals="0">1107714</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">11447</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1768553</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-672286</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2001" unitRef="USD" decimals="0">-1732907</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">13320</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4016680</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-5762907</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2002" unitRef="USD" decimals="0">-1675291</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">15124</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7264876</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-8955291</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2003" unitRef="USD" decimals="0">1573915</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">17214</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14044036</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-12487335</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2004" unitRef="USD" decimals="0">439124</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">24873</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">18636377</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-18222126</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2005" unitRef="USD" decimals="0">74275</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">31367</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">22845271</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-22802363</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2006" unitRef="USD" decimals="0">1823762</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">39757</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">30639730</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-28855725</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2007" unitRef="USD" decimals="0">3460052</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">47747</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">37885611</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-34473306</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2008" unitRef="USD" decimals="0">4158765</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">57737</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">44145239</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-40044211</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2009" unitRef="USD" decimals="0">845161</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">57737</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">44257621</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-43470197</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2010" unitRef="USD" decimals="0">399061</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">57737</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">44278787</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-43937463</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">992010</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">136648</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">48237620</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-47382258</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">-1145635</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">213916</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">56675181</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-55713465</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">1914856</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">6200497</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">5788822</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">5734598</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of__31-Dec-2011" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of__30-Jun-2013" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" xsi:nil="true"/>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of__31-Dec-2011" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of__28-Dec-2012_LegalEntityAxis_ActiniumMember" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of__30-Jun-2013" unitRef="USD_per_Share" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="INF">13664802</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">21391665</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">23584424</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="INF">13664802</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="INF">21391665</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="INF">23584424</us-gaap:CommonStockSharesOutstanding>
<us-gaap:SalesRevenueNet contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_3ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_3ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:SalesRevenueNet contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">323788</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">601272</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">1046158</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">3440485</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">26420519</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">509262</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">1594968</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ResearchAndDevelopmentExpense contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">28015488</us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">2959246</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">237908</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">798184</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">4506232</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">24504975</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">966367</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">1899503</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">26404478</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:DepreciationAndAmortization contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">633</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">159</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">317</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">581</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">3262462</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_3ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DepreciationAndAmortization contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DepreciationAndAmortization contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">3262462</us-gaap:DepreciationAndAmortization>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_3ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-550186</us-gaap:GainLossOnDispositionOfAssets>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_3ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-4122</us-gaap:GainLossOnDispositionOfAssets>
<us-gaap:GainLossOnDispositionOfAssets contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-554307</us-gaap:GainLossOnDispositionOfAssets>
<us-gaap:OperatingExpenses contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">3283667</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">839339</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">1844659</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">7947298</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">54738142</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">1475629</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">3498593</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">56236735</us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-3283667</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">-839339</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-1844659</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-7947298</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-54738142</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">-1475629</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-3498593</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-56236735</us-gaap:OperatingIncomeLoss>
<us-gaap:InterestExpense contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-175094</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">320728</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">633618</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-1099327</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-1964707</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">634</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">1209</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">1965916</us-gaap:InterestExpense>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_3ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">260000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_3ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">260000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-13966</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">-402524</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">6777</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-685420</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-699386</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">-1307748</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">26764</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">726150</us-gaap:DerivativeGainLossOnDerivativeNet>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">161128</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">-723252</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-626841</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">413907</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">1005321</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">-1308382</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">25555</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-979766</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NetIncomeLoss contextRef="Context_Custom_14-Jun-2000_31-Dec-2000" unitRef="USD" decimals="0">-672286</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-672286</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2001" unitRef="USD" decimals="0">-5090621</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-5090621</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2002" unitRef="USD" decimals="0">-3192384</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-3192384</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2003" unitRef="USD" decimals="0">-3532044</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-3532044</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2004" unitRef="USD" decimals="0">-5734791</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-5734791</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2005" unitRef="USD" decimals="0">-4580237</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-4580237</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2006" unitRef="USD" decimals="0">-6053362</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-6053362</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2007" unitRef="USD" decimals="0">-5617581</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-5617581</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2008" unitRef="USD" decimals="0">-5570905</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-5570905</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2009" unitRef="USD" decimals="0">-3425986</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-3425986</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2010" unitRef="USD" decimals="0">-467266</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-467266</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-3444795</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-3444795</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">-1562591</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-2471500</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-8361205</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" decimals="0">-8361205</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-55743463</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">-2784011</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-3473038</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-59216501</us-gaap:NetIncomeLoss>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_FYE__31-Dec-2011" unitRef="USD_per_Share" decimals="2">-4.30</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME__30-Jun-2012" unitRef="USD_per_Share" decimals="2">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_6ME__30-Jun-2012" unitRef="USD_per_Share" decimals="2">-0.15</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_FYE__31-Dec-2012" unitRef="USD_per_Share" decimals="2">-7.58</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_3ME__30-Jun-2013" unitRef="USD_per_Share" decimals="2">-0.13</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_6ME__30-Jun-2013" unitRef="USD_per_Share" decimals="2">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="INF">801799</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME__30-Jun-2012" unitRef="shares" decimals="INF">17020192</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_6ME__30-Jun-2012" unitRef="shares" decimals="INF">17020192</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="INF">1103521</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_3ME__30-Jun-2013" unitRef="shares" decimals="INF">22178637</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Context_6ME__30-Jun-2013" unitRef="shares" decimals="INF">21791673</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1144687</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1332000</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1512375</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1721367</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">2487267</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">3136617</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">3975659</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">4774661</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">5773661</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">5773661</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">5773661</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">13664802</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">21391665</us-gaap:SharesOutstanding>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_14-Jun-2000_31-Dec-2000" unitRef="USD" decimals="0">30000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">9990</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">20010</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">999000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2000" unitRef="USD" decimals="0">1750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">1457</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1748543</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2001" unitRef="USD" decimals="0">2250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">1873</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2248127</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2002" unitRef="USD" decimals="0">3250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">1804</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3248196</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2003" unitRef="USD" decimals="0">6781250</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">2090</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6779160</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2004" unitRef="USD" decimals="0">4600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">7659</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4592341</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2005" unitRef="USD" decimals="0">3900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">6494</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3893506</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2006" unitRef="USD" decimals="0">7550541</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">8390</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7542151</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2007" unitRef="USD" decimals="0">6600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">7326</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6592674</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2008" unitRef="USD" decimals="0">6000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">9990</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5990010</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">5379367</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">78911</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5300456</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">5129940</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">40877</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5089063</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">23017827</us-gaap:ProceedsFromIssuanceOfCommonStock>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_Custom_14-Jun-2000_31-Dec-2000_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">145687</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2001_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">187313</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2002_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">180375</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2003_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">208992</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2004_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">765900</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">649350</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">839042</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">732600</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">999000</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">7891141</fil:ProceedsFromIssuanceOfCommonStockShares>
<fil:ProceedsFromIssuanceOfCommonStockShares contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">4087747</fil:ProceedsFromIssuanceOfCommonStockShares>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE__31-Dec-2007" unitRef="USD" decimals="0">398810</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">664</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">398146</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">398810</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_Custom_14-Jun-2000_31-Dec-2010" unitRef="USD" decimals="0">398810</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">66402</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_FYE__31-Dec-2007_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">66402</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_14-Jun-2000_31-Dec-2010" unitRef="shares" decimals="0">66402</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<fil:ConversionOfNotesPayableAndAccruedInterestToStockValue contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">981729</fil:ConversionOfNotesPayableAndAccruedInterestToStockValue>
<fil:ConversionOfNotesPayableAndAccruedInterestToStockValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">12525</fil:ConversionOfNotesPayableAndAccruedInterestToStockValue>
<fil:ConversionOfNotesPayableAndAccruedInterestToStockValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">969204</fil:ConversionOfNotesPayableAndAccruedInterestToStockValue>
<fil:ConversionOfNotesPayableAndAccruedInterestToStockValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:ConversionOfNotesPayableAndAccruedInterestToStockShares contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">1252550</fil:ConversionOfNotesPayableAndAccruedInterestToStockShares>
<fil:SharesIssuedAtReverseMergerValue contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<fil:SharesIssuedAtReverseMergerValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">23866</fil:SharesIssuedAtReverseMergerValue>
<fil:SharesIssuedAtReverseMergerValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-23866</fil:SharesIssuedAtReverseMergerValue>
<fil:SharesIssuedAtReverseMergerValue contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:SharesIssuedAtReverseMergerShares contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="0">2386566</fil:SharesIssuedAtReverseMergerShares>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2005" unitRef="USD" decimals="0">315388</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">315388</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2005_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2006" unitRef="USD" decimals="0">252308</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">252308</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2006_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2007" unitRef="USD" decimals="0">255061</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">255061</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2007_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2008" unitRef="USD" decimals="0">269618</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">269618</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2008_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2009" unitRef="USD" decimals="0">112382</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">112382</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2009_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2010" unitRef="USD" decimals="0">21166</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">21166</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2010_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">19935</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">19935</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">266172</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">266172</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">2153442</fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2153442</fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">1957754</fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1957754</fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense>
<fil:AdjustmentsToAdditionalPaidInCapitalWarrantExpense contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-3887850</fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-3887850</fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-4052089</fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-4052089</fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants>
<fil:AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">4231324</fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4231324</fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_FYE__31-Dec-2012_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">4231324</fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">590217</fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification>
<fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">4821542</fil:FairValueOfTransferFromLiabilityClassificationToEquityClassification>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">372850</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">372850</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="Context_FYE__31-Dec-2011_StatementEquityComponentsAxis_AccumulatedDeficitDuringDevelopmentStageMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">2173377</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">240400</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">2223926</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">6052036</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">188400</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">6240436</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">633</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">317</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">581</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">3262462</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DepreciationDepletionAndAmortization contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">3262462</us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">124363</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">451267</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">775637</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">900000</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">900000</us-gaap:AmortizationOfDebtDiscountPremium>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">40444</us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">145951</us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">252248</us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">292692</us-gaap:AmortizationOfFinancingCosts>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:AmortizationOfFinancingCosts contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">292692</us-gaap:AmortizationOfFinancingCosts>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">13966</fil:GainOnChangeInFairValueOfDerivatives>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">6777</fil:GainOnChangeInFairValueOfDerivatives>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">685420</fil:GainOnChangeInFairValueOfDerivatives>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">699386</fil:GainOnChangeInFairValueOfDerivatives>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">26764</fil:GainOnChangeInFairValueOfDerivatives>
<fil:GainOnChangeInFairValueOfDerivatives contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">726150</fil:GainOnChangeInFairValueOfDerivatives>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-41567</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-50069</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-234088</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">3746</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">2126</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">5872</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-4766</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">8494</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">18013</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">23397</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-85000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-61604</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">556019</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-263465</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">334263</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">1238773</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-103414</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">1135359</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">31185</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">31185</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">31185</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-517592</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-1862232</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-5212710</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-44402658</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-3327820</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-47730478</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">3000000</us-gaap:PaymentsToAcquireIntangibleAssets>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsToAcquireIntangibleAssets contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">3000000</us-gaap:PaymentsToAcquireIntangibleAssets>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">1157</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">2359</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">815659</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">1112</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">816771</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-1157</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-2359</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">-3815659</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-1112</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">-3816771</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">645888</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">645888</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">645888</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
<us-gaap:RepaymentsOfNotesPayable contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:RepaymentsOfNotesPayable contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">103050</us-gaap:RepaymentsOfNotesPayable>
<us-gaap:RepaymentsOfNotesPayable contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">103050</us-gaap:RepaymentsOfNotesPayable>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2000" unitRef="USD" decimals="0">1750000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2001" unitRef="USD" decimals="0">2250000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2006" unitRef="USD" decimals="0">7533741</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2007" unitRef="USD" decimals="0">6600000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2008" unitRef="USD" decimals="0">6000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">5379367</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">660163</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">5129940</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">53191098</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">53191098</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfWarrants contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfWarrants contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">3463641</us-gaap:ProceedsFromIssuanceOfWarrants>
<us-gaap:ProceedsFromIssuanceOfWarrants contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">3463641</us-gaap:ProceedsFromIssuanceOfWarrants>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">6025255</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">660163</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">5129940</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">53836986</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">3360591</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">57197577</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">5507663</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">-1203226</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-85129</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">5618669</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">31659</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">5650328</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__13-Jun-2000" unitRef="USD" xsi:nil="true"/>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__31-Dec-2010" unitRef="USD" decimals="0">196135</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">5703798</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__30-Jun-2012" unitRef="USD" decimals="0">4500572</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">5618669</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">5650328</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:InterestPaid contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">682</us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">561</us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">1243</us-gaap:InterestPaid>
<us-gaap:IncomeTaxesPaid contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">372850</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">372850</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">372850</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">377150</fil:FairValueOfWarrantsIssuedWithDebt>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">377150</fil:FairValueOfWarrantsIssuedWithDebt>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfWarrantsIssuedWithDebt contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">377150</fil:FairValueOfWarrantsIssuedWithDebt>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">2591900</fil:FairValueOfWarrantsIssuedWithStock>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">318087</fil:FairValueOfWarrantsIssuedWithStock>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">3393338</fil:FairValueOfWarrantsIssuedWithStock>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">5985238</fil:FairValueOfWarrantsIssuedWithStock>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfWarrantsIssuedWithStock contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">5985238</fil:FairValueOfWarrantsIssuedWithStock>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">1484529</fil:FairValueOfWarrantsIssuedToPlacementAgent>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">159044</fil:FairValueOfWarrantsIssuedToPlacementAgent>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">658753</fil:FairValueOfWarrantsIssuedToPlacementAgent>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">2170282</fil:FairValueOfWarrantsIssuedToPlacementAgent>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<fil:FairValueOfWarrantsIssuedToPlacementAgent contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">2170282</fil:FairValueOfWarrantsIssuedToPlacementAgent>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_6ME__30-Jun-2012" unitRef="USD" xsi:nil="true"/>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">981729</fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2012" unitRef="USD" decimals="0">981729</fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_6ME__30-Jun-2013" unitRef="USD" xsi:nil="true"/>
<fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock contextRef="Context_Custom_14-Jun-2000_30-Jun-2013" unitRef="USD" decimals="0">981729</fil:ConversionOfNotesPayableAndAccruedInterestToCommonStock>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 1 &amp;#8211; Description of Business and Summary of Significant Accounting Policies&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Nature of Business &amp;#8211; Actinium Pharmaceuticals, Inc (Formerly&lt;/font&gt; Cactus Ventures, Inc.) (the &amp;#8220;Company&amp;#8221;, &amp;#8220;Cactus&amp;#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a transaction (the &amp;#8220;Share Exchange&amp;#8221;), pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&amp;#8220;Actinium&amp;#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012 when shareholders representing over 20% of the issued and outstanding shares of Actinium had finished the exchange process.&amp;#160;&amp;#160;On August 22, 2013, shareholders representing 38% of the issued and outstanding shares of Actinium completed the exchange.&amp;#160;&amp;#160;As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. At the closing, each Actinium shareholder shall receive 0.333 shares (the &amp;#8220;Exchange Ratio&amp;#8221;) of Cactus common stock for each Actinium share exchanged. At the closing, all of the Actinium shareholders&amp;#8217; options and warrants to purchase Actinium common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Cactus common stock.&amp;#160;&amp;#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &amp;#8220;Actinium&amp;#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &amp;#160;Actinium&amp;#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&amp;#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&amp;#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Development Stage Company &amp;#8211;&lt;/font&gt; The Company is considered a development stage company and has had no commercial revenue to date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font
  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Principles of Consolidation &amp;#8211;&lt;/font&gt; The consolidated financial statements include the Company&amp;#8217;s accounts and those of the Company&amp;#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Use of Estimates in Financial Statement Presentation &amp;#8211;&lt;/font&gt; The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Reclassification &amp;#8211;&lt;/font&gt; Certain prior period amounts have been reclassified to conform to current period presentation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Cash and Cash Equivalents &amp;#8211;&lt;/font&gt; The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At December 31, 2012 and 2011, all of the Company&amp;#8217;s cash was deposited in one bank.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Property and Equipment &amp;#8211;&lt;/font&gt; Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Impairment of Long-Lived Assets &amp;#8211;&lt;/font&gt; Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&amp;#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Derivatives &amp;#8211;&lt;/font&gt; All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Fair Value of Financial Instruments &amp;#8211;&lt;/font&gt; Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div
 style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1 Inputs &amp;#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2 Inputs &amp;#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3 Inputs &amp;#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of December 31, 2012 and 2011. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income Taxes &amp;#8211;&lt;/font&gt; The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&amp;#8217;s assessment as to their realization.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Research and Development Costs &amp;#8211;&lt;/font&gt; Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Share-Based Payments &amp;#8211;&lt;/font&gt; The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&amp;#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Earnings (Loss) Per Common Share &amp;#8211;&lt;/font&gt; The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&amp;#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &amp;#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been anti dilutive. For the year ended December 31, 2012, potentially issuable shares included stock options to purchase 2,330,134 shares and warrants to purchase 12,770,596 shares of the Company&amp;#8217;s common stock. For the year ended December 31, 2011, potentially issuable shares includes options and warrants&amp;#160;to purchase 273,859 shares of the Company&amp;#8217;s common stock and notes payable convertible to 3,448,276 shares of the Company&amp;#8217;s common stock have been excluded from the calculation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Recent Accounting Pronouncements &amp;#8211;&lt;/font&gt; The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Subsequent Events &amp;#8211;&lt;/font&gt; The Company&amp;#8217;s management reviewed all material events from January 1, 2013 through March 15, 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 1 &amp;#8211; Description of Business and Summary of Significant Accounting Policies&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Nature of Business &amp;#8211;&lt;/font&gt; Actinium Pharmaceuticals, Inc. formerly known as Cactus Ventures, Inc. (the &amp;#8220;Company&amp;#8221;, &amp;#8220;Actinium&amp;#8221;, &amp;#8220;Cactus&amp;#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that&amp;#160;was in the market for a merger with an appropriate operating company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a transaction (the &amp;#8220;Share Exchange&amp;#8221;), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&amp;#8220;API&amp;#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange closed on December 28, 2012.&amp;#160;&amp;#160;As a result of the Share Exchange, the former shareholders of API became the controlling shareholders of the Company. At the closing, each API shareholder received 0.333 shares (the &amp;#8220;Exchange Ratio&amp;#8221;) of Actinium common stock for each API share exchanged. At the closing, all of the API shareholders&amp;#8217; options and warrants to purchase API common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Actinium common stock.&amp;#160;&amp;#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein API is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; API, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. API, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &amp;#8220;API&amp;#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, API launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. API&amp;#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of API&amp;#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that API&amp;#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As a result of the Share Exchange, the Company is now a holding company operating through API, a clinical-stage biopharmaceutical company developing certain cancer treatments.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On March 20, 2013, in anticipation of the Company changing its name to Actinium Pharmaceuticals, Inc. and its domicile from Nevada to Delaware, the Company&amp;#8217;s subsidiary, Actinium Pharmaceuticals, Inc., changed its name to Actinium Corporation.&amp;#160;&amp;#160;On April 11, 2013, the Company changed its domicile from the State of Nevada to the State of Delaware and changed its name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Basis of Presentation - Unaudited Interim Financial Information &amp;#8211;&lt;/font&gt; The accompanying unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary&amp;#160;for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2012 and notes thereto contained in the Company&amp;#8217;s annual report on Form 10-K for the year ended December 31, 2012, as filed with the SEC March 29, 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Development Stage Company &amp;#8211;&lt;/font&gt; The Company is considered a development stage company and has had no commercial revenue to date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Principles of Consolidation &amp;#8211;&lt;/font&gt; The consolidated financial statements include the Company&amp;#8217;s accounts and those of the Company&amp;#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Use of Estimates in Financial Statement Presentation &amp;#8211;&lt;/font&gt; The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Reclassification &amp;#8211;&lt;/font&gt; Certain prior period amounts have been reclassified to conform to current period presentation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Cash and Cash Equivalents &amp;#8211;&lt;/font&gt; The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At June 30, 2013 and December 31, 2012, all of the Company&amp;#8217;s cash was deposited in one bank.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Property and Equipment &amp;#8211;&lt;/font&gt; Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Impairment of Long-Lived Assets &amp;#8211;&lt;/font&gt; Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&amp;#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Derivatives &amp;#8211;&lt;/font&gt; All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Fair Value of Financial Instruments &amp;#8211;&lt;/font&gt; Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1 Inputs &amp;#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2 Inputs &amp;#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3 Inputs &amp;#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of June 30, 2013 and December 31. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%"
 valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Income Taxes &amp;#8211;&lt;/font&gt; The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&amp;#8217;s assessment as to their realization.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Research and Development Costs &amp;#8211;&lt;/font&gt; Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and
 development costs.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Share-Based Payments &amp;#8211;&lt;/font&gt; The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&amp;#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Earnings (Loss) Per Common Share &amp;#8211;&lt;/font&gt; The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&amp;#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &amp;#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been antidilutive. For the six months ended June 30, 2013, potentially issuable shares included stock options to purchase 2,280,184 shares and warrants to purchase 9,535,694 shares of the Company&amp;#8217;s common stock. For the six months ended June 30, 2012, potentially issuable shares includes options and warrants&amp;#160;to purchase 6,842,528 shares of the Company&amp;#8217;s common stock and notes payable convertible to 815,275 shares of the Company&amp;#8217;s common stock have been excluded from the calculation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&lt;font style="font-weight: bold; display: inline;"&gt;Recent Accounting Pronouncements &amp;#8211;&lt;/font&gt; The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Subsequent Events &amp;#8211;&lt;/font&gt; The Company&amp;#8217;s management reviewed all material events through the date the consolidated financial statements were issued for subsequent event disclosure consideration.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
<fil:GoingConcernTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;font style="font-weight: bold; display: inline;"&gt;Note 2 &amp;#8211; Going Concern&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $8,361,205 and net cash used in operations of $5,212,710, for the year ended December 31,&amp;#160;2012; and an accumulated deficit of $55,743,463 at December 31, 2012. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&amp;#8217;s ability to continue as a going concern.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&amp;#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:GoingConcernTextBlock>
<fil:GoingConcernTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 2 &amp;#8211; Going Concern&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $3,473,038 and net cash used in operations of $3,327,820, for the six months ended June 30,&amp;#160;2013; and an accumulated deficit of $59,216,501 at June 30, 2013. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&amp;#8217;s ability to continue as a going concern.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, and research and development grants until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&amp;#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/font&gt;&lt;/div&gt;</fil:GoingConcernTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 3 &amp;#8211; Related Party Transactions&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;"&gt;MSKCC:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In 2010, General Atlantic Group Limited donated all of the equity shares of its wholly owned subsidiary, Actinium Holdings Ltd. (formerly named General Atlantic Investments Limited) to Memorial Sloan Kettering Cancer Center (MSKCC), a principal owner of the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On February 11, 2002, the Company entered into a License, Development and Commercialization Agreement with Sloan-Kettering Institute of Cancer Research (SKI),&amp;#160;an entity related to MSKCC.&amp;#160;&amp;#160;The agreement was amended in August 2006.&amp;#160;&amp;#160;Pursuant to the agreement, the Company licenses certain intellectual property from SKI, including critical patents with respect to the Company&amp;#8217;s core technology, and also supports ongoing research and clinical development of related drug candidates.&amp;#160;&amp;#160;Certain amounts due under this agreement were deferred and then forgiven under the forbearance-related arrangements described above.&amp;#160;&amp;#160;On June 19, 2011, the Company nonetheless agreed to pay SKI (a) $50,000 in 2011, (b) $200,000 in 2012 and (c) $250,000 in 2013 under this agreement, in respect of the $50,000 annual maintenance fees and research payments. Since January 1, 2011, the Company has paid $100,000 under this agreement and as of December 31, 2012, the Company agreed to pay an additional $150,000 for research to be conducted in 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On March 27, 2012, the Company entered into an additional clinical trial agreement with MSKCC Cancer Center with respect to conducting a Phase I/II trial of combination therapy of low dose cytarabine and fractionated dose of Lintuzumab-Ac225.&amp;#160;&amp;#160;The Company will pay $31,185 for each patient that has completed the clinical trial.&amp;#160;&amp;#160;Upon execution of the agreement, the Company was required to pay a start-up fee of $79,623, which was paid on July 10, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; MSKCC agreed, subject to certain conditions, to utilize the donated funds for certain clinical and preclinical programs and activities related to the Company&amp;#8217;s drug development and clinical study programs, including the payment of certain costs and expenses that would otherwise have been borne by the Company. The following is a summary of activities related to the MSKCC arrangements for years ended December 31, 2012 and 2011:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Qualified R&amp;amp;D costs incurred by the Company&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;655,786&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Reimbursements received from MSKCC&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;237,834&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;966,341&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In 2012 and 2011, the Company received total R&amp;amp;D reimbursement payments of $237,834 and $299,200, respectively, from MSKCC.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As of December 31, 2012 and 2011, the Company had a net receivable of $0 and $237,834, respectively, from MSKCC.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;"&gt;Dr. Rosemary Mazanet:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On January 1, 2012, the Company entered into a Consulting Services Agreement with Dr. Rosemary Mazanet, a director of Cactus.&amp;#160;&amp;#160;Pursuant to the agreement, Dr. Mazanet is to provide, among other things, consulting services in the areas of implementation of the Actimab&amp;#8482;-A trial including all aspects of study initiation until first patient in at each clinical site.&amp;#160;&amp;#160;Dr. Mazanet receives compensation of $100,000 per year and may receive additional compensation in the form of options at determined by the board of the Company.&amp;#160;&amp;#160;Since January 1, 2011, Dr. Mazanet has also received options to purchase 99,900 shares of common stock of the Company. These options have exercise price ranging from $0.78 to $1.5 and have a life of 10 years.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;font style="font-weight: bold; font-style: italic; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;"&gt;Jamess Capital Group, LLC:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On May 9, 2011, the Company entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of the Company&amp;#160;(&amp;#8220;Management Firm&amp;#8221;).&amp;#160; The Management Firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&amp;#160; The Management Firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;"&gt;Placement Agent:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On August 7, 2012, the Company entered into an engagement agreement with its placement agent for the 2012 Common Stock Offering,&amp;#160;of which Mr. Seth, a director of the Company is Head of Healthcare Investment Banking.&amp;#160;&amp;#160;&amp;#160;Pursuant to the agreement, the placement agent was engaged as the exclusive agent for the 2012 Common Stock Offering. &amp;#160;&amp;#160;In consideration for its services, the placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent.&amp;#160;&amp;#160;The placement agent or its designees have also received warrants to purchase shares of the Company&amp;#8217;s Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units.&amp;#160;&amp;#160;The placement agent will also receive the same fee and expense schedule for any cash exercise of warrants within 6 months of the final closing of the 2012 Common Stock Offering and a 5% solicitation fee for any warrants exercised as a result of being called for redemption by the Company.&amp;#160;&amp;#160;Upon the final closing of the 2012 Common Stock Offering of the units, the placement agent has been engaged by the Company to provide certain financial advisory services to the Company for a period of at least 6 months for a monthly fee of $25,000.&amp;#160;&amp;#160;The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company&amp;#8217;s financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.&amp;#160;&amp;#160;For a period ending one year after the expiration of all lock-up agreements entered into in connection with the Share Exchange, any change in the size of the Company board of directors must be approved by the placement agent.&amp;#160;&amp;#160;The placement agent also was engaged by the Company as placement agent for its Stock Offering and Convertible Notes financing in 2011 and, as a part of the fee for that engagement, designees of the placement agent also hold warrants to purchase 1,251,015 shares of the Company&amp;#8217;s Common Stock.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;"&gt;Guagenti &amp;amp; Associates LLC:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;In 2010, the Company entered into an agreement with Guagenti &amp;amp; Associates LLC (&amp;#8220;G&amp;amp;A&amp;#8221;).&amp;#160;&amp;#160;G&amp;amp;A is affiliated with Enza Guagenti, the former Chief Financial Officer of Cactus.&amp;#160;&amp;#160;Pursuant to the agreement, the Company leases storage space in Newark, NJ from G&amp;amp;A.&amp;#160;&amp;#160;The rent is $300 per month.&amp;#160;&amp;#160;Since January 1, 2011, the Company has paid $7,200 pursuant to this agreement.&amp;#160;&amp;#160;&amp;#160;Ms. Guagenti resigned as the Company&amp;#8217;s Chief Financial Officer on March 9, 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 4 &amp;#8211; Property and Equipment&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; Property and equipment consisted of the following at December 31, 2012 and 2011:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;Lives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156,162&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;153,804&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Furniture and fixture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom:
 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total property, plant and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,454&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;155,096&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(153,863&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Property and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,233&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Depreciation expense for the years ended December 31, 2012 and 2011 were $581 and $633, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 3 &amp;#8211; Property and Equipment&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Property and equipment consisted of the following at June 30, 2013 and December 31, 2012:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Lives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,274&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156,162&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Furniture and fixture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div
 align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total property and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;158,566&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,454&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Loss on disposition of equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4,122&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Property and equipment, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Depreciation expense for the three months ended June 30, 2013 and 2012 were $0&amp;#160;and $159, respectively. Depreciation expense for the six months ended June 30, 2013 and 2012 were $0 and $317 respectively. The Company wrote off its remaining underpreciated property and equipment during the six months ended June 30, 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<us-gaap:DebtDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 5 &amp;#8211; Note Payable and Convertible Notes&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Note Payable&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a premium finance agreement to pay $140,000 premium of its director and officer insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of December 31, 2012, outstanding balance related to the premium finance agreement was $140,000.&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 27, 2011, the Company completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes (&amp;#8220;Convertible Notes&amp;#8221;) in the amount of $900,000 and received net proceeds of $750,000. The convertible notes were issued at 83.33% of the principal amount resulting in an original issue discount of $150,000.&amp;#160;The Convertible Notes mature one year from the date of issuance. Interest accrues at the rate of 8% per year on the outstanding principal amount, accrued semi-annually and to be paid at maturity.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The principal amount of the Convertible Notes and accrued interest are automatically converted to common stock at the earlier of: (1) the effective date of a Qualified Public Offering, (2) a Public Company Transaction, defined as (i) a reverse merger or similar transaction between the Company and a corporation whose securities are publicly traded in the United States or other jurisdiction mutually agreed between the Company and Placement Agent, or (ii) the quotation of the Company&amp;#8217;s securities for purchase and sale on a U.S. quotation service, or (iii) the filing with an applicable regulatory body which will result in the Company becoming an entity whose securities are traded on a public exchange in the U.S. or other mutually agreed upon jurisdiction, or (3) the acquisition or receipt by the Company of no less than $4,000,000 of gross proceeds in subsequent offerings of its common stock or equivalents following the issuance of the Company&amp;#8217;s stock (See Note 9) and the Convertible Notes.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In connection with the issuance of the Convertible Notes, warrants to purchase a total of 287,061 shares of common stock were issued to investors. The Placement Agent and the Management Firm (See Note 9) were issued warrants to purchase 143,532 shares and 126,829 shares of common stock, respectively. The warrants issued to the Placement Agent are exercisable at $0.78 per share and expire on January 31, 2019. &amp;#160;The warrants issued to the Management Firm are exercisable at $0.01 per share and expire on January 31, 2019.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The Company analyzed the Convertible Notes and the Warrants for derivative accounting consideration under FASB ASC 470 and determined that the investor warrants and the placement agent warrants, with a grant date fair value of $565,729 (See Note 6), qualified for accounting treatment as a financial derivative (See Note 6) and the Convertible Notes were determined to also have a beneficial conversion feature discount of $372,850 resulting from the conversion price of $0.78 per share which is below the fair value of $1.11 per share on the date of the Convertible Notes.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The total fees, including cash payments and the fair value of the warrants issued to the Placement Agent, incurred in connection with the financing were $292,692. These fees were amortized over the life (one year) of the Convertible Notes using the straight-line method
 as it approximates the effective interest method. &amp;#160;The $150,000 original issue discount on the Convertible Notes was also amortized over the life of the Notes on a straight line basis.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;On October 23, 2012, the investors extended the note maturity date for 90 days. The maturity date of the notes has been extended to January 31, 2013, February 18, 2013 or March 27, 2013 for the 24 notes.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 19, 2012, the Convertible Notes and the accrued interests were automatically converted to common stock when the Company closed on an offering of its common stock in which the gross proceeds exceeded the $4,000,000 threshold.&amp;#160;&amp;#160;The Convertible Notes and accrued interest were converted into 1,252,550 shares of the Company&amp;#8217;s common stock.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During the years ended December 31, 2012, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $252,248 and $775,637, respectively.&amp;#160;&amp;#160;During the years ended December 31, 2011, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $40,444 and $124,363, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; A summary of the 8% Senior Subordinated Unsecured Convertible Promissory Notes as of December 31, 2012 and 2011 are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Principal amount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left"
 style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: original issuance discount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(150,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(150,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: discount related to fair value of derivative warrants&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: discount related to the beneficial conversion feature&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(372,850&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(372,850&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Add: amortization of discount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;124,363&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: principal amount converted to stock&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Carrying value at December 31, 2012 and 2011, respectively&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;124,363&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
<us-gaap:DebtDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 4 &amp;#8211; Note Payable&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a premium finance agreement to pay a&amp;#160;$140,000 premium&amp;#160;for its director and officer&amp;#160;liability insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of June 30, 2013, the&amp;#160;outstanding balance related to the premium finance agreement was $36,950.&amp;#160;&amp;#160;The Company has paid $103,050 of the principal during 2013.&lt;/font&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 6 &amp;#8211; Derivatives&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&amp;#8217;s common stock at prices below such warrants&amp;#8217; respective exercise prices and these provisions could result in modification of the warrants&amp;#8217; exercise price based on a variable that is not an input to the fair value of a &amp;#8220;fixed-for-fixed&amp;#8221; option as defined under FASB ASC Topic No. 815 &amp;#8211; 40. The warrants granted in connection with the issuance of the Company&amp;#8217;s Stock Offering and 2012 Common Stock Offering&amp;#160;(See Note 9), the Convertible Notes (See Note 5) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &amp;#8220;Lower Price&amp;#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; Activities for derivative warrant instruments during the years ended December 31, 2012 and 2011 were as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div
 align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Convertible Notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;287,061&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of Convertible Notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;143,532&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;188,579&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,972,785&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,591,900&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of stock (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;986,393&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,295,950&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%"
 valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(13,966&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,389,771&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;242,190&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;318,087&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;121,095&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;159,044&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with 2012 Common Stock Offering-A (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,118,988&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,409,554&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with 2012 Common Stock Offering-B (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,559,505&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,665,697&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to 2012 Common Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;467,845&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;499,707&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Transfer from liability classification to equity classification&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3,753,056&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4,231,324&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(685,420&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,146,338&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 19, 2012, as the result of the Share Exchange, it was determined that the floor for resetting the exercise price was met and the exercise price of the certain warrants was set to be $0.26 (before Exchange Ratio adjustment).&amp;#160;Therefore, these warrants were considered indexed to the Company&amp;#8217;s stock and qualified for the scope exception under FASB ASC 815-10 allowing for a transfer from liability classification to equity classification.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The fair values of the warrants issued in the Company&amp;#8217;s stock and Convertible Notes Offering and the warrants issued to the Company&amp;#8217;s placement agent were recognized as derivative warrant instruments at issuance and are measured at fair value at each reporting period. The Company determined the fair values of these warrants using a modified binomial valuation model.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at each balance sheet date, the transfer date on December 19, 2012, and the date for the new grants in January and December 2012. (The market value of common stock, adjusted exercise price and offering price presented does not reflect the impact of the Share Exchange.)&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;January 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 19,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 27,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times
 new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Market value of common stock on measurement date (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.37&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.37&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Adjusted exercise price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.24 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.23 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.41 - $0.83&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.22 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.41 - $0.83&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Risk free interest rate (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.24&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10% - 0.77&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%"
 nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.94&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10% - 0.77&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrant lives in years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected volatility (3)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected dividend yield (4)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Probability of stock offering in any period over 5 years (5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Range of percentage of existing shares offered (6)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Offering price range (7)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.18 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.13 - $0.56&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.01 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.12 - $0.60&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.01 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table
 style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="3%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="80%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The market value of common stock is based on an enterprise valuation.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="96%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(5)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="96%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management has determined that the probability of a stock offering is 25% for each quarter of the next five years.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(6)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management estimates that the range of percentages of existing shares offered in each stock offering will be between 35% of the shares outstanding.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(7)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Represents the estimated offering price range in future offerings as determined by management.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 5 &amp;#8211; Derivatives&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&amp;#8217;s common stock at prices below such warrants&amp;#8217; respective exercise prices and these provisions could result in modification of the warrants&amp;#8217; exercise price based on a variable that is not an input to the fair value of a &amp;#8220;fixed-for-fixed&amp;#8221; option as defined under FASB ASC Topic No. 815 &amp;#8211; 40. The warrants granted in connection with the issuance of the Company&amp;#8217;s Stock Offering and 2012 Common Stock Offering, the Convertible Notes (previously issued and converted) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &amp;#8220;Lower Price&amp;#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Activities for derivative warrant instruments during the six months ended June 30, 2013 were as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="border-bottom: black 2px solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,146,338&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new
 roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Reclassification to paid in capital&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3,122,821&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(590,217&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(26,764&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td
 align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,023,517&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at June 30, 2013 and December 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;June 30,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Market value of common stock on measurement date (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.17&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Adjusted exercise price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.48 - $0.81&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.50 - $2.475&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Risk free interest rate (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10 - $0.77&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.05&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrant lives in years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="text-align: center;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="text-align: center;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected volatility (3)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;154&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected dividend yield (4)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The market value of common stock is based on an enterprise valuation.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The risk-free interest rate was determined by management using the Treasury Bill as of the respective measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;
&lt;div
 align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 7 &amp;#8211; Income Taxes&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&amp;#8217;s deferred tax assets and liabilities at December 31, 2012 and 2011 are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net operating losses&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,609,036&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,089,314&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Share-based compensation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,497,556&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;741,420&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other differences in tax basis&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;233,043&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,749&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;15,339,635&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,835,483&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: valuation allowance&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(15,339,635&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;(13,835,483&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Deferred tax assets, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; As of December 31, 2012, for U.S. federal income tax reporting purposes, the Company has approximately $43 million of unused net operating losses (&amp;#8220;NOLs&amp;#8221;) available for carry forward to future years. The benefit from the carry forward of such NOLs will begin expiring during the year ended December 31, 2020. Because United States tax laws limit the time during which NOL carry forwards may be applied against future taxable income, the Company may be unable to take full advantage of its NOL for federal income tax purposes should the Company generate taxable income. Further, the benefit from utilization of NOLs carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; The difference between the income tax provision and the amount that would result if the U.S. Federal statutory rate of 34% were applied to pre-tax income (loss) for the years ended December 31, 2012 and 2011 are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="14"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;For the years ended&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;
 &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="6"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="6"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Federal income taxes at 34%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2,842,810&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-34.00&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1,171,230&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-34.00&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Share-based compensation costs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;
 &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;756,136&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9.04&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;736,796&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;21.39&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value of derivatives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;233,043&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2.79&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,748&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.13&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Amortization of debt discounts&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;349,480&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font
 style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.18&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;56,033&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.63&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,504,151&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;17.99&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;373,653&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;10.85&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left"
 width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Provision for income tax&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 8 &amp;#8211; Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;a.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Abbott Biotherapeutics Corp &amp;#8211; The Company entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, the Company made a license fee payment of $3,000,000.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The Company agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) when Company initiates a Phase I Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) when Company initiates a Phase II Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3) when Company initiates a Phase III Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new
 roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4) Biological License Application filing with U.S. FDA&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(5) First commercial sale&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(6) after the first $10,000,000 in net sales&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Under the agreement, the Company shall pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;As of December 31, 2012, the Company met its first milestone and upon reaching the milestone the Company paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012. &amp;#160;The milestone payment for the Phase I Clinical Trial was recorded as research and development expense.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;b.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;MSKCC &amp;#8211; In February 2002, the Company entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1) filing of an
 New Drug Application (&amp;#8220;NDA&amp;#8221;) or regulatory approval&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;for each licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) upon the receipt of regulatory approval from the U.S. FDA for each&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The Company expects to file the NDA for regulatory approval in 2015.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;c.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Oak Ridge National Laboratory (ORNL) &amp;#8211; API has contracted to purchase radioactive material to be used for research and development through December 2012. API is contracted to purchase $233,100 of radioactive material to be used for research and development, with a renewal option at the contract end. &amp;#160;The Company is currently negotiating the 2013 agreement.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;d.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;AptivSolutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab&amp;#8482;-A) used in the Company clinical trials, Phase I and Phase II. &amp;#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &amp;#160;The down payment totaling $239,000 was paid in 2007 and 2012. &amp;#160;On August 6, 2012, the agreement was amended to provide for additional services. &amp;#160;The total project is now estimated at $1,997,732. &amp;#160;AptivSolutions bills the Company when services are rendered and the Company records the related expense to research and development costs.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%;
 font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;e.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On June 15, 2012, the Company entered into a license and sponsored research agreement with Fred Hutchinson Cancer Research Center (FHCRC). The Company will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &amp;#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and the Company intends to start preparation for a pivotal trial leading to an FDA approval. &amp;#160;The Company has been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &amp;#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &amp;#160;Under the terms of the sponsored research agreement, the Company will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &amp;#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &amp;#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &amp;#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;f.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On March 27, 2012, the Company entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &amp;#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &amp;#160;The amount due of $79,623 was paid on July 10, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;g.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On May 9, 2011, Actinium entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of Cactus&amp;#160;Ventures, Inc.&amp;#160;by virtue of his position as a director of Actinium Pharmaceuticals.&amp;#160; Mr. Seth is a Managing Partner of the consulting firm some of whose member interests are held by entities owned by officers and employees of the Placement Agent.&amp;#160; None of Cactus&amp;#8217; current officers or directors had a prior relationship or affiliation with Cactus prior to the closing of the Share Exchange.&amp;#160; Pursuant to the agreement, the management firm was engaged to provide consulting services to Actinium related to the consummation of a going public transaction for Actinium.&amp;#160; The management firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&amp;#160; Jamess Capital Group does not retain&amp;#160;beneficial ownership of the warrants as they were&amp;#160;issued to designees of the members in amounts which do not qualify either Jamess or the warrant holders for inclusion in the beneficial ownership table.&amp;#160; The warrants contain&amp;#160;a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.&amp;#160; The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transferred until the earlier of twelve months from the closing date of the Pubco Transaction; or for six months after the planned Registration Statement is declared effective.&amp;#160;The consulting firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;h.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On July 19, 2012, the Company entered into a clinical trial agreement with FHCRC. &amp;#160;The Company will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $19,749.
 &amp;#160;During the clinical trial additional fees apply and will be invoiced when applicable. &amp;#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;i.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On August 28, 2012, the Company entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &amp;#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &amp;#160;The estimated cost is based on treating 24 patients through 2013. &amp;#160;Upon execution of the agreement, the Company is required to make a payment of $33,946. &amp;#160;&amp;#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;j.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On September 26, 2012, the Company entered into a clinical trial agreement with Johns Hopkins University. &amp;#160;The Phase I/II clinical trial will be conducted with Actinium 225. &amp;#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &amp;#160;The Company will pay $38,501 per patient, who has completed the clinical trial. The Company is required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &amp;#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="5%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;k.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top" style="text-align: justify;"&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On November 21, 2012, the Company entered into a clinical trial agreement with the University of Pennsylvania. &amp;#160;The Phase I/II clinical trial will be conducted with Actinium 225. &amp;#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &amp;#160;The Company will pay $31,771 per patient, who has completed the clinical trial. The Company will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3&lt;font style="font-size: 10pt; display: inline;"&gt;rd&lt;/font&gt; Floor, New York, NY 10017. &amp;#160;The agreement terminates January 31, 2013 unless a Notice of Termination is provided to the landlord 60 days prior to January 1, 2013. &amp;#160;The agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &amp;#160;The Company paid a two month refundable deposit.&lt;/font&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 6 &amp;#8211; Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;a.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;Abbott Biotherapeutics Corp.&lt;/font&gt; We entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, we made a license fee payment of $3,000,000.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; We agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) when Company initiates a Phase I Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) when Company initiates a Phase II Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3) when Company initiates a Phase III Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4) Biological License Application filing with U.S. FDA&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(5) First commercial sale&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(6) after the first $10,000,000 in net sales&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Under the agreement, we agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As of December 31, 2012, we met our first milestone and upon reaching the milestone we paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;b.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;Memorial Sloan Kettering Cancer Center (MSKCC)&lt;/font&gt;.&amp;#160;&amp;#160;In February 2002, we entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="border-bottom: black 2px;" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) filing of an New Drug Application (&amp;#8220;NDA&amp;#8221;) or regulatory approval &lt;/font&gt;for each licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) upon the receipt of regulatory approval from the U.S. FDA for each &lt;/font&gt;licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Under the agreement, we agreed to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.&amp;#160;&amp;#160;We expect to file the NDA for regulatory approval in 2016.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;c.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;Oak Ridge National Laboratory (ORNL)&lt;/font&gt; &amp;#8211; We have contracted to purchase radioactive material to be used for research and development through December 2013. We contracted to purchase $ 337,500 of radioactive material to be used for research and development, with a renewal option at the contract end. &amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; d.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;AptivSolutions.&lt;/font&gt;&amp;#160;&amp;#160;Aptiv Solutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab-A) used in our clinical trials, Phase I and Phase II. &amp;#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &amp;#160;The down payment totaling $239,000 was paid in 2007 and 2012. &amp;#160;The agreement was amended to provide for additional services on August 6, 2012, October 22, 2012 and May 16, 2013. &amp;#160;The total project is now estimated at $ 2,173,955. &amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;e.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;Fred Hutchinson Cancer Research Center (FHCRC)&lt;/font&gt;.&amp;#160;&amp;#160;On June 15, 2012, we entered into a license and sponsored research agreement with FHCRC. We will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &amp;#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and we intend to start preparation for a pivotal trial leading to an FDA approval. &amp;#160;We have been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &amp;#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &amp;#160;Under the terms of the sponsored research agreement, we will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &amp;#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &amp;#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &amp;#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.&amp;#160;On August 12, 2013, the Company paid $37,500 to FHCRC.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;f.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;MSKCC&lt;/font&gt;.&amp;#160;&amp;#160;On March 27, 2012, we entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &amp;#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &amp;#160;The amount due of $79,623 was paid on July 10, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;g.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;FHCRC&lt;/font&gt;.&amp;#160;&amp;#160;On July 19, 2012, we entered into a clinical trial agreement with FHCRC. &amp;#160;We will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, we are required to pay a start-up fee of $19,749. &amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;h.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="80%"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;The University of Texas M.D. Anderson Cancer Center&lt;/font&gt;.&amp;#160;&amp;#160;On August 28, 2012, we entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &amp;#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &amp;#160;The estimated cost is based on treating 24 patients through 2013. &amp;#160;Upon execution of the agreement, we were required to make a payment of $33,946. &amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" valign="top" width="3%"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;i.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: justify;" valign="top" width="80%"&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;Johns Hopkins University&lt;/font&gt;.&amp;#160;&amp;#160;On September 26, 2012, we entered into a clinical trial agreement with Johns Hopkins University. &amp;#160;The Phase I/II clinical trial will be conducted with Actinium 225. &amp;#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &amp;#160;We will pay $38,501 per patient, who has completed the clinical trial. We are required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="text-align: left; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" valign="top" width="4%"&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;j.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" valign="top" width="96%"&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-style: italic; display: inline;"&gt;University of Pennsylvania&lt;/font&gt;.&amp;#160;&amp;#160;&amp;#160;On November 21, 2012, we entered into a clinical trial agreement with the University of Pennsylvania. &amp;#160;The Phase I/II clinical trial will be conducted with Actinium 225. &amp;#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &amp;#160;We will pay $31,771 per patient, who has completed the clinical trial. We will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3rd Floor, New York, NY 10017. &amp;#160;The agreement terminated May 31, 2013. On June 1, 2013The Company entered into a rental agreement for office space at 546 Fifth Avenue, 14 th&amp;#160;&amp;#160;Floor, New York, NY 10036.&amp;#160;&amp;#160;The agreement terminates on December 31, 2013.&amp;#160;&amp;#160;Upon the expiration of the term, the agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &amp;#160;The Company paid a one month refundable deposit.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company paid Mr. Talley $125,000 on March 8, 2013 and a second payment of $125,000 is due to be paid to Mr. Talley on September 1, 2013. The Company also paid Mr. Talley a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 9 &amp;#8211; Equity&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; From inception to December 31, 2010, the Company raised $42,711,791 by issuing 5,707,259 shares of the Company&amp;#8217;s stock and issued 66,402 shares, valued at $398,810, for services.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During 2011, the Company raised $6,184,967 by selling 7,891,141 shares of the Company&amp;#8217;s stock and warrants to purchase 19,972,785 shares of the Company&amp;#8217;s stock through an offering (&amp;#8220;Stock Offering&amp;#8221;).&amp;#160;&amp;#160;A net amount of $5,379,367 was received by the Company in 2011. The Company paid Laidlaw &amp;amp; Company (UK) Ltd. (&amp;#8220;Laidlaw &amp;amp; Co.&amp;#8221;), the placement agent, total cash fees of $742,196, which consisted of placement agent commission of $618,497 and expense reimbursement of $123,699. The Company also issued Laidlaw &amp;amp; Co. warrants to purchase an aggregate of 986,393 shares of the Company&amp;#8217;s common stock, with an exercise price of $0.78 per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $188,579.&amp;#160;In addition, the Company paid Laidlaw &amp;amp; Co.&amp;#8217;s outside counsel, McCormick &amp;amp; O&amp;#8217;Brien PLLC, $60,904 for its services as the placement agent&amp;#8217;s legal counsel and Signature Bank $2,500 for the bank escrow fee.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During 2012, the Company raised $759,300 by selling 968,759 shares and warrants to purchase 242,190 shares of the Company&amp;#8217;s common stock under the Company&amp;#8217;s Stock Offering.&amp;#160;&amp;#160;A net amount of $660,164 was received by the Company in 2012. The Company paid Laidlaw &amp;amp; Co. total cash fees of $91,116, which consisted of placement agent commission of $75,930 and expense reimbursement of $15,186. The Company also issued Laidlaw &amp;amp; Co. warrants to purchase an aggregate of 121,095 shares of the Company&amp;#8217;s common stock, with an exercise price of $0.78&amp;#160;per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $159,044. In addition, the Company paid Laidlaw &amp;amp; Co.&amp;#8217;s outside counsel, McCormick &amp;amp; O&amp;#8217;Brien PLLC, $8,020 for its services as the placement agent&amp;#8217;s legal counsel.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; In 2012, the Company also raised $5,151,450 through an offering of 3,118,988 shares of its common stock and &amp;#8220;A Warrants&amp;#8221; to purchase 3,118,988 shares of the Company&amp;#8217;s common stock, exercisable at a price of $1.65 per share for a period of 120 days from the day of the final closing of the offering, and &amp;#8220;B Warrants&amp;#8221; to purchase 1,559,505 shares of the Company&amp;#8217;s common stock, exercisable at a price of $2.48 per share for a period of 5 years from the date of the final closing of the offering. (&amp;#8220;2012 Common Stock Offering&amp;#8221;)&amp;#160;&amp;#160;A net amount of $4,469,776 was received by the Company. Pursuant to the 2012 Common Stock Offering agreement, the Company paid Laidlaw &amp;amp; Co. total cash fees of $618,174, which consisted of placement agent commission of $515,145 and expense reimbursement of $103,029. The Company also issued the placement agent warrants to purchase an aggregate of 467,845 shares of the Company&amp;#8217;s common stock, with an exercise price of $0.78 per share and a term of 5 years. These placement agent warrants were valued at $499,707 and recorded as derivative liabilities.&amp;#160;&amp;#160;In addition, the Company paid the Laidlaw &amp;amp; Co.&amp;#8217;s outside counsel, Richardson &amp;amp; Patel, LLP, $60,000 for its services as the Laidlaw &amp;amp; Co.&amp;#8217;s legal counsel and Signature Bank $3,500 for the bank escrow fee.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During 2012, the Company&amp;#8217;s convertible notes, plus accrued interest, were converted to 1,252,550 shares of the Company&amp;#8217;s common stock as a result of the 2012 Common Stock Offering.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; As a result of the Share Exchange described in Note 1, the Company issued 400,000 shares to the original shareholders of the Company and 1,986,566 shares to the former shareholders of Actinium.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; Placement Agent &amp;#8211;&lt;/font&gt; In connection with the money raised in 2011, the Company issued Laidlaw &amp;amp; Co. warrants to purchase an aggregate of 1,129,925 shares of common stock, with an exercise price of $0.78 per share.&amp;#160;&amp;#160;With the money raised in 2012, the Company issued Laidlaw &amp;amp; Co. warrants to purchase an aggregate of 588,940 shares of common stock, with an exercise price of $0.78 per share.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; Management Firm &amp;#8211;&lt;/font&gt; In 2011, the Company entered into a&amp;#160;management agreement with Jamess Capital Group, LLC (formerly, AmerAsia Inc., &amp;#8220;Jamess&amp;#8221;) for Jamess to provide consulting services related to funding and Actinium becoming a publicly traded entity.&amp;#160;In 2011, the Company incurred $96,744 in management fees. In addition, Actinium issued Jamess warrants to purchase an aggregate of 1,974,774 shares of common stock, with an exercise price of $0.01 per share. The warrants have a fair value of $2,153,442 (see Note 11) and included a cashless exercise provision.&amp;#160;&amp;#160;In 2012, the Company issued Jamess warrants to purchase 1,716,340 shares of common stock with an exercise price of $0.01 per share. The warrants have a fair value of $1,957,754 (see Note 11) and included a cashless exercise provision.&lt;/font&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 7 &amp;#8211; Equity&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Stock Option Plan&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The following is a summary of stock options:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid; text-align: center; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size:
 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,330,134&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.91&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;685,800&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Cancellation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(49,950&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right"
 width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,280,184&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.42&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,609,035&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; All options issued and outstanding are being amortized over their respective&amp;#160;service periods. The unrecognized compensation expense at June 30, 2013 was $1,086,848.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During the three months ended June 30, 2013 and 2012, the Company recorded option expense of $94,200, and $40,410, respectively. During the six months ended June 30, 2013 and 2012, the Company recorded option expense of $188,400 and $240,400, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;On May 31, 2013, the Company entered into an agreement with its former director and consultant, Dr. Rosemary Mazanet. Pursuant to the agreement, the Company terminated the consulting agreement with Dr. Mazanet and Dr. Mazanet resigned as a director. The Company paid Mazanet cash of $25,000 and cancelled options to purchase 49,950 shares of the Company&amp;#8217;s common stock at $1.50 per share previously granted.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Warrants&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The following is a summary of warrants:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display:
 block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td
 align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;12,770,636&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.97&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.48 &lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6,114,768&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants exercised&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2,211,158&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants expired&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times
 new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1,023,784&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9,535,694&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.77&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.341&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9,691,302&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During the six months ended June 30, 2013, the Company issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&amp;#160;&amp;#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,463,641 received by the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 10 &amp;#8211; Stock Option Plan&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; The Company has adopted a 2003 Stock Plan under which it may grant up to 757,575 options to purchase common stock. The 2003 Stock Plan was amended in 2008 to increase the number of shares that it may grant up to 978,154. Option awards are generally granted with an exercise price equal to the market price of the Company&amp;#8217;s stock at the date of the grant. However, since the Company is not publicly traded, the fair market value of the stock represents the Board of Directors&amp;#8217; best estimate, based on the information available, on the date of the grant. The awards generally vest over a four or five year period at a rate of approximately 2% per month.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In 2011, the 2003 Stock Plan was amended to increase the number of shares by 3,217,880.&amp;#160;&amp;#160;Total shares reserved for issuance under the Plan will be increased to 6,155,280.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In accordance with the terms of the 2012 Common Stock Offering, the Company adopted a 2012 Employee Stock Option Plan (&amp;#8220;2012 ESOP&amp;#8221;) and reserved 15% of the total issued and outstanding shares as of the final closing of the 2012 Common Stock Offering.&amp;#160;&amp;#160;Total shares reserved for issuance under the 2012 ESOP was 9,455,776 shares.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During 2006, options to purchase 206,060 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $1,051,281 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 4.29% (2) expected life of 5 years, (3) expected volatility of 156%, and (4) zero expected dividends.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During 2007, options to purchase 113,220 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $137,652 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 143%, and (4) zero expected dividends.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During 2008, options to purchase 69,941 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $44,159 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 139%, and (4) zero expected dividends.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During 2009, 20,613 options to one employee were cancelled as the result of termination of the employment and 128,050 options to one employee were forfeited as the employee deceased during the year.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During the year of 2010, options to purchase 33,300 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $24,996 was calculated using the Black-Scholes option-pricing
 model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 2.16% (2) expected life of 5 years, (3) expected volatility of 171%, and (4) zero expected dividends.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; In February 2012, the Company re-priced 273,859 units of employee stock options to reflect the current per share fair market value of the Company&amp;#8217;s common stock. The exercise prices of all of the current outstanding stock options were reduced to $1.28 per share. The Company recorded an incremental compensation cost of $34,879 as a result of the re-pricing of options.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; During 2012, options to purchase 2,056,275 shares of common stock were issued to several employees and consultants at an exercise price ranging from $0.78 to $1.5 per share.&amp;#160;&amp;#160;These options have a term of 10 years and vest over a 4 year period. The fair value of $1,519,777 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 1.8% (2) expected life of 7 years, (3) expected volatility of 160.44% &amp;#126; 162.49%, and (4) zero expected dividends.&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; The following is a summary of stock option activities for the years ended December 31, 2012 and 2011:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="text-align: center;" colspan="2"&gt;Number of&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;273,859&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.29&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"
 style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;273,859&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.29&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;2,056,275&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.89&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,330,134&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0. 96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.91&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;685,800&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160; All options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at December 31, 2012 and 2011 were $1,998,435 and $14,528, respectively. During the years ended December 31, 2012 and 2011, the Company recorded option expense of $266,172 and $19,935, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<fil:WarrantsTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 11 &amp;#8211; Warrants&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During the year ended December 31, 2011, warrants to purchase 1,974,774 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $2,153,442 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate ranging from 1.92% to 3.17%, (2) warrant life of 10 years, (3) expected volatility ranging from 64.77% to 70.72%, and (4) zero expected dividends. The management firm receives warrants equal to ten (10%) percent of the issued and outstanding capital stock of the Company on a fully-diluted basis on the effective date of the agreement.&amp;#160;&amp;#160;The warrants are subject to weighted average non-dilution provisions to be calculated on the basis of the post-money fully diluted capitalization of the Company upon closing of any transaction, financing or otherwise, up to and including the Public Company transaction, provided that such anti-dilution provisions shall not extend beyond the date of any exercise of the warrants by the management firm prior to the closing of the Public Company transaction. Since these warrants vest immediately, the Company recorded the entire fair value of $2,153,442 as stock-based compensation expense during the year on these warrants issued by the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During the year ended December 31, 2011, the Company also issued the following warrants:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with convertible notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;287,061&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,972,766&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Convertible Notes&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;143,532&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock Offering (See Note 6 and Note
 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;986,383&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,389,742&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During the year ended December 31, 2012, warrants to purchase an aggregate of 1,716,340 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $1,957,754 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 1.82%, (2) warrant life of 7 years, (3) expected volatility of 60.64%, and (4) zero expected dividends.&amp;#160;&amp;#160;Since these warrants vest immediately, the Company recorded the entire fair value of $1,957,754 as stock-based compensation expense during the year on these warrants issued by the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During the year ended December 31, 2012, the Company also issued the following warrants:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Stock Offering (See Note 6)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;242,189&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Common Stock&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,678,491&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;Placement agent warrants related to issuance of:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock Offering (See Note 6 and Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;121,094&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2012 Common Stock Offering&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;467,845&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with stock &amp;#8211; accrued dividend&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;180,115&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,689,734&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160; The following is a summary of warrant activities for the years ended December 31, 2011 and 2012:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"
 style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,364,557&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,364,557&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,261,367&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7,406,079&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.32&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%"
 valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;12,770,636&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0. 97&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.48&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6,114,768&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:WarrantsTextBlock>
<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 12 &amp;#8211; Employee Defined Contribution Plan&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; In 2004, the Company established an employee deferred contribution plan. The plan requires 12 consecutive months of service and a minimum of 500 hours of service for participation. The Plan provides for employer matching of 50% of the employee contribution and discretionary contributions. Employees can contribute up to the maximum allowable under the Internal Revenue Service Code Section 401(k). The amount contributed by the Company for the years ended December 31, 2012 and 2011 was $8,942 and $8,885, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 13 &amp;#8211; Subsequent Events&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company will pay Mr. Talley in 2 equal installments the aggregate amount of $250,000 and a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012. The $60,000 bonus was included in the accounts payable and accrued liabilities on the Company&amp;#8217;s balance sheet at December 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;Note 8 &amp;#8211; Subsequent Events&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Management has evaluated subsequent events and has concluded no events warrant disclosure.&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
<us-gaap:BusinessCombinationsPolicy contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Nature of Business &amp;#8211; Actinium Pharmaceuticals, Inc (Formerly&lt;/font&gt; Cactus Ventures, Inc.) (the &amp;#8220;Company&amp;#8221;, &amp;#8220;Cactus&amp;#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a transaction (the &amp;#8220;Share Exchange&amp;#8221;), pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&amp;#8220;Actinium&amp;#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012 when shareholders representing over 20% of the issued and outstanding shares of Actinium had finished the exchange process.&amp;#160;&amp;#160;On August 22, 2013, shareholders representing 38% of the issued and outstanding shares of Actinium completed the exchange.&amp;#160;&amp;#160;As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. At the closing, each Actinium shareholder shall receive 0.333 shares (the &amp;#8220;Exchange Ratio&amp;#8221;) of Cactus common stock for each Actinium share exchanged. At the closing, all of the Actinium shareholders&amp;#8217; options and warrants to purchase Actinium common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Cactus common stock.&amp;#160;&amp;#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &amp;#8220;Actinium&amp;#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &amp;#160;Actinium&amp;#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&amp;#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&amp;#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.&lt;/font&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
<us-gaap:BusinessCombinationsPolicy contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Nature of Business &amp;#8211;&lt;/font&gt; Actinium Pharmaceuticals, Inc. formerly known as Cactus Ventures, Inc. (the &amp;#8220;Company&amp;#8221;, &amp;#8220;Actinium&amp;#8221;, &amp;#8220;Cactus&amp;#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that&amp;#160;was in the market for a merger with an appropriate operating company.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On December 28, 2012, the Company entered into a transaction (the &amp;#8220;Share Exchange&amp;#8221;), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&amp;#8220;API&amp;#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange closed on December 28, 2012.&amp;#160;&amp;#160;As a result of the Share Exchange, the former shareholders of API became the controlling shareholders of the Company. At the closing, each API shareholder received 0.333 shares (the &amp;#8220;Exchange Ratio&amp;#8221;) of Actinium common stock for each API share exchanged. At the closing, all of the API shareholders&amp;#8217; options and warrants to purchase API common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Actinium common stock.&amp;#160;&amp;#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein API is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; API, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. API, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &amp;#8220;API&amp;#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, API launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. API&amp;#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of API&amp;#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that API&amp;#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; As a result of the Share Exchange, the Company is now a holding company operating through API, a clinical-stage biopharmaceutical company developing certain cancer treatments.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font  style="letter-spacing: 9pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; On March 20, 2013, in anticipation of the Company changing its name to Actinium Pharmaceuticals, Inc. and its domicile from Nevada to Delaware, the Company&amp;#8217;s subsidiary, Actinium Pharmaceuticals, Inc., changed its name to Actinium Corporation.&amp;#160;&amp;#160;On April 11, 2013, the Company changed its domicile from the State of Nevada to the State of Delaware and changed its name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Basis of Presentation - Unaudited Interim Financial Information &amp;#8211;&lt;/font&gt; The accompanying unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the &amp;#8220;SEC&amp;#8221;) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary&amp;#160;for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2012 and notes thereto contained in the Company&amp;#8217;s annual report on Form 10-K for the year ended December 31, 2012, as filed with the SEC March 29, 2013.&lt;/font&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<fil:DevelopmentStageCompanyPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Development Stage Company &amp;#8211;&lt;/font&gt; The Company is considered a development stage company and has had no commercial revenue to date.&lt;/div&gt;</fil:DevelopmentStageCompanyPolicyTextBlock>
<fil:DevelopmentStageCompanyPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Development Stage Company &amp;#8211;&lt;/font&gt; The Company is considered a development stage company and has had no commercial revenue to date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:DevelopmentStageCompanyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Principles of Consolidation &amp;#8211;&lt;/font&gt; The consolidated financial statements include the Company&amp;#8217;s accounts and those of the Company&amp;#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Principles of Consolidation &amp;#8211;&lt;/font&gt; The consolidated financial statements include the Company&amp;#8217;s accounts and those of the Company&amp;#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.&lt;/font&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Use of Estimates in Financial Statement Presentation &amp;#8211;&lt;/font&gt; The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
<us-gaap:UseOfEstimates contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Use of Estimates in Financial Statement Presentation &amp;#8211;&lt;/font&gt; The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Reclassification &amp;#8211;&lt;/font&gt; Certain prior period amounts have been reclassified to conform to current period presentation.&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Reclassification &amp;#8211;&lt;/font&gt; Certain prior period amounts have been reclassified to conform to current period presentation.&lt;/font&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Cash and Cash Equivalents &amp;#8211;&lt;/font&gt; The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At December 31, 2012 and 2011, all of the Company&amp;#8217;s cash was deposited in one bank.&lt;/font&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Cash and Cash Equivalents &amp;#8211;&lt;/font&gt; The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At June 30, 2013 and December 31, 2012, all of the Company&amp;#8217;s cash was deposited in one bank.&lt;/font&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Property and Equipment &amp;#8211;&lt;/font&gt; Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Property and Equipment &amp;#8211;&lt;/font&gt; Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Impairment of Long-Lived Assets &amp;#8211;&lt;/font&gt; Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&amp;#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.&lt;/font&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Impairment of Long-Lived Assets &amp;#8211;&lt;/font&gt; Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&amp;#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.&lt;/font&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:DerivativesPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Derivatives &amp;#8211;&lt;/font&gt; All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.&lt;/font&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
<us-gaap:DerivativesPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Derivatives &amp;#8211;&lt;/font&gt; All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.&lt;/font&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Fair Value of Financial Instruments &amp;#8211;&lt;/font&gt; Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1 Inputs &amp;#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2 Inputs &amp;#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3 Inputs &amp;#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of December 31, 2012 and 2011. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size:
 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Fair Value of Financial Instruments &amp;#8211;&lt;/font&gt; Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1 Inputs &amp;#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2 Inputs &amp;#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3 Inputs &amp;#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of June 30, 2013 and December 31. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new
 roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Income Taxes &amp;#8211;&lt;/font&gt; The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&amp;#8217;s assessment as to their realization.&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Income Taxes &amp;#8211;&lt;/font&gt; The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&amp;#8217;s assessment as to their realization.&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Research and Development Costs &amp;#8211;&lt;/font&gt; Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.&lt;/font&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="Context_6ME__30-Jun-2013">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Research and Development Costs &amp;#8211;&lt;/font&gt; Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Share-Based Payments &amp;#8211;&lt;/font&gt; The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&amp;#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.&lt;/font&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Share-Based Payments &amp;#8211;&lt;/font&gt; The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&amp;#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.&lt;/font&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; Earnings (Loss) Per Common Share &amp;#8211;&lt;/font&gt; The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&amp;#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &amp;#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been anti dilutive. For the year ended December 31, 2012, potentially issuable shares included stock options to purchase 2,330,134 shares and warrants to purchase 12,770,596 shares of the Company&amp;#8217;s common stock. For the year ended December 31, 2011, potentially issuable shares includes options and warrants&amp;#160;to purchase 273,859 shares of the Company&amp;#8217;s common stock and notes payable convertible to 3,448,276 shares of the Company&amp;#8217;s common stock have been excluded from the calculation.&lt;/font&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;&amp;#160; Earnings (Loss) Per Common Share &amp;#8211;&lt;/font&gt; The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&amp;#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &amp;#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been antidilutive. For the six months ended June 30, 2013, potentially issuable shares included stock options to purchase 2,280,184 shares and warrants to purchase 9,535,694 shares of the Company&amp;#8217;s common stock. For the six months ended June 30, 2012, potentially issuable shares includes options and warrants&amp;#160;to purchase 6,842,528 shares of the Company&amp;#8217;s common stock and notes payable convertible to 815,275 shares of the Company&amp;#8217;s common stock have been excluded from the calculation.&lt;/font&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Recent Accounting Pronouncements &amp;#8211;&lt;/font&gt; The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Recent Accounting Pronouncements &amp;#8211;&lt;/font&gt; The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.&lt;/font&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Subsequent Events &amp;#8211;&lt;/font&gt; The Company&amp;#8217;s management reviewed all material events from January 1, 2013 through March 15, 2013.&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
<us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt;Subsequent Events &amp;#8211;&lt;/font&gt; The Company&amp;#8217;s management reviewed all material events through the date the consolidated financial statements were issued for subsequent event disclosure consideration.&lt;/font&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
<us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;
 &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
<us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Derivative liabilities:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;At December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
<us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Qualified R&amp;amp;D costs incurred by the Company&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;655,786&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Reimbursements received from MSKCC&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;237,834&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;966,341&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;Lives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156,162&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;153,804&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Furniture and fixture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total property, plant and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,454&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;155,096&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(153,863&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Property and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,233&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Lives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,274&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156,162&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Furniture and fixture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="9%" valign="bottom"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,292&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new
 roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total property and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;158,566&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157,454&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: accumulated depreciation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(154,444&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Loss on disposition of equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4,122&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="67%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Property and equipment, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
<us-gaap:ScheduleOfDebtTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Principal amount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: original issuance discount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(150,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(150,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: discount related to fair value of derivative warrants&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;(377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: discount related to the beneficial conversion feature&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(372,850&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(372,850&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Add: amortization of discount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;124,363&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: principal amount converted to stock&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(900,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%"
 valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Carrying value at December 31, 2012 and 2011, respectively&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;124,363&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
<us-gaap:ScheduleOfDerivativeInstrumentsTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Convertible Notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;287,061&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;377,150&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of Convertible Notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;143,532&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;188,579&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,972,785&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,591,900&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of stock (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;986,393&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,295,950&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(13,966&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,389,771&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,439,613&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;242,190&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;318,087&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;121,095&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;159,044&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;Warrants issued with 2012 Common Stock Offering-A (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,118,988&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,409,554&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with 2012 Common Stock Offering-B (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,559,505&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,665,697&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to 2012 Common Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;467,845&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;499,707&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Transfer from liability classification to equity classification&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3,753,056&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4,231,324&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family:
 times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(685,420&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,146,338&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
<us-gaap:ScheduleOfDerivativeInstrumentsTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="border-bottom: black 2px solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Fair Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,146,338&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,574,958&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Reclassification to paid in capital&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3,122,821&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(590,217&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(26,764&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Balance, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,023,517&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,957,977&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
<fil:FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;January 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 19,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 27,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td
 nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Market value of common stock on measurement date (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.37&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.37&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.39&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Adjusted exercise price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.24 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.23 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.41 - $0.83&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.22 - $0.26&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.41 - $0.83&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Risk free interest rate (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.24&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10% - 0.77&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.94&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10% - 0.77&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrant lives in years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected volatility (3)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;156&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;157&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected dividend yield (4)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%"
 valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Probability of stock offering in any period over 5 years (5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;25&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Range of percentage of existing shares offered (6)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;35&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="40%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Offering price range (7)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td
 width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.18 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.13 - $0.56&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.01 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.12 - $0.60&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="9%" valign="bottom" style="text-align: right;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.01 - $0.55&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="3%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="80%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The market value of common stock is based on an enterprise valuation.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="96%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman;
 display: inline;"&gt;(5)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="96%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management has determined that the probability of a stock offering is 25% for each quarter of the next five years.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(6)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management estimates that the range of percentages of existing shares offered in each stock offering will be between 35% of the shares outstanding.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="right" width="4%" valign="top"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(7)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="96%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Represents the estimated offering price range in future offerings as determined by management.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</fil:FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock>
<fil:FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock contextRef="Context_6ME__30-Jun-2013">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;June 30,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="10%" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Market value of common stock on measurement date (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.17&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Adjusted exercise price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.48 - $0.81&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;
 &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.50 - $2.475&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Risk free interest rate (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.10 - $0.77&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.05&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrant lives in years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="text-align: center;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4 months/5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" valign="bottom" style="text-align: center;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected volatility (3)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;125% - 161&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;154&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Expected dividend yield (4)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The market value of common stock is based on an enterprise valuation.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;The risk-free interest rate was determined by management using the Treasury Bill as of the respective measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td width="95%" valign="top"&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" width="5%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="95%" valign="top"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock>
<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net operating losses&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,609,036&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,089,314&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Share-based compensation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,497,556&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;741,420&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other differences in tax basis&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px
 solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;233,043&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,749&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;15,339,635&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;13,835,483&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Less: valuation allowance&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(15,339,635&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(13,835,483&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="76%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family:
 times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Deferred tax assets, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
<us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="14"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;For the years ended&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="6"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="6"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Federal income taxes at 34%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2,842,810&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-34.00&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1,171,230&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td
 align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-34.00&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Share-based compensation costs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;756,136&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9.04&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;736,796&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;21.39&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in fair value of derivatives&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;233,043&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2.79&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,748&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.13&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left"
 style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Amortization of debt discounts&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;349,480&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.18&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;56,033&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.63&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,504,151&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;17.99&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;373,653&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;10.85&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Provision for income tax&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
<fil:MilestonePaymentsMilestoneMethodTableTextBlock contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1) filing of an New Drug Application (&amp;#8220;NDA&amp;#8221;) or regulatory approval&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;for each licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) upon the receipt of regulatory approval from the U.S. FDA for each&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</fil:MilestonePaymentsMilestoneMethodTableTextBlock>
<fil:MilestonePaymentsMilestoneMethodTableTextBlock contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) when Company initiates a Phase I Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) when Company initiates a Phase II Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3) when Company initiates a Phase III Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4) Biological License Application filing with U.S. FDA&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(5) First commercial sale&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(6) after the first $10,000,000 in net
 sales&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;</fil:MilestonePaymentsMilestoneMethodTableTextBlock>
<fil:MilestonePaymentsMilestoneMethodTableTextBlock contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) filing of an New Drug Application (&amp;#8220;NDA&amp;#8221;) or regulatory approval &lt;/font&gt;for each licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) upon the receipt of regulatory approval from the U.S. FDA for each &lt;/font&gt;licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:MilestonePaymentsMilestoneMethodTableTextBlock>
<fil:MilestonePaymentsMilestoneMethodTableTextBlock contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember">&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Milestones&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Payments&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1) when Company initiates a Phase I Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2) when Company initiates a Phase II Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(3) when Company initiates a Phase III Clinical Trial of a licensed product&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(4) Biological License Application filing with U.S. FDA&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,750,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(5) First commercial sale&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;(6) after the first $10,000,000 in net sales&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,500,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:MilestonePaymentsMilestoneMethodTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="text-align: center;" colspan="2"&gt;Number of&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family:
 times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;273,859&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;1.29&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size:
 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;273,859&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.29&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,056,275&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.89&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%"
 valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,330,134&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0. 96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.91&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;685,800&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid; text-align: center; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" colspan="2"&gt;
&lt;div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new
 roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,330,134&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.91&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;685,800&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Cancellation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(49,950&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;2,280,184&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.96&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;8.42&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,609,035&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember">&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"
 colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="3"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;12,770,636&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.97&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.48 &lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6,114,768&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants exercised&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(2,211,158&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants expired&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;(1,023,784&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.65&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, June 30, 2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9,535,694&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.77&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5.341&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;9,691,302&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<fil:ScheduleOfWarrantsIssuedTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;During the year ended December 31, 2011, the Company also issued the following warrants:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued with convertible notes (See Note 5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;287,061&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Stock Offering (See Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1,972,766&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Convertible Notes&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;143,532&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock Offering (See Note 6 and Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;986,383&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,389,742&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160; During the year ended December 31, 2012, the Company also issued the following warrants:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Stock Offering (See Note 6)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;242,189&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with Common Stock&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4,678,491&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Placement agent warrants related to issuance of:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stock Offering (See Note 6 and Note 9)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;121,094&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2012 Common Stock Offering&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;467,845&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Warrants issued to investors with stock &amp;#8211; accrued dividend&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%"
 valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;180,115&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,689,734&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:ScheduleOfWarrantsIssuedTableTextBlock>
<fil:SummaryOfWarrantActivitiesTableTextBlock contextRef="Context_FYE__31-Dec-2012">&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Remaining&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Number of&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Average&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times
 new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Contractual&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Intrinsic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Units&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Exercise Price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Term (in years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" style="border-bottom: black 2px solid;" colspan="2"&gt;
&lt;div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2010&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left"
 width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,364,557&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display:
 inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;5,364,557&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0.51&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3,261,367&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Granted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;7,406,079&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;1.32&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;3.76&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" width="52%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt;
 font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;Outstanding, December 31, 2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;12,770,636&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;0. 97&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;4.48&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom"&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;"&gt;
&lt;div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;6,114,768&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"&gt;&lt;font style="font-size: 10pt; font-family: times new roman; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;</fil:SummaryOfWarrantActivitiesTableTextBlock>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">4439613</us-gaap:DerivativeLiabilities>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2011_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="USD" decimals="0">4439613</us-gaap:DerivativeLiabilities>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">3574958</us-gaap:DerivativeLiabilities>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__31-Dec-2012_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="USD" decimals="0">3574958</us-gaap:DerivativeLiabilities>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">2957977</us-gaap:DerivativeLiabilities>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeLiabilities contextRef="Context_As_Of__30-Jun-2013_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="USD" decimals="0">2957977</us-gaap:DerivativeLiabilities>
<fil:PercentageOfOwnershipInterestToBeAcquired contextRef="Context_As_Of__28-Dec-2012_LegalEntityAxis_ActiniumMember" unitRef="pure" decimals="2">1.00</fil:PercentageOfOwnershipInterestToBeAcquired>
<fil:CommonStockIssuableInConsiderationForEquityInterestAcquisition contextRef="Context_Custom_01-Dec-2012_28-Dec-2012_LegalEntityAxis_ActiniumMember" unitRef="pure" decimals="2">0.99</fil:CommonStockIssuableInConsiderationForEquityInterestAcquisition>
<fil:CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage contextRef="Context_Custom_01-Dec-2012_28-Dec-2012_LegalEntityAxis_ActiniumMember">Approximately 99% of the issued and outstanding common stock immediately after the closing of the Share Exchange, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012.</fil:CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage>
<us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">Seven years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
<us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">Five years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
<us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">Seven years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
<us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_MachineryAndEquipmentMember">Five years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="Context_Custom_01-Dec-2012_28-Dec-2012" unitRef="shares" decimals="3">0.333</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_FYE__31-Dec-2011_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">273859</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_FYE__31-Dec-2011_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertibleNotesPayableMember" unitRef="shares" decimals="0">3448276</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_6ME__30-Jun-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">815275</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_6ME__30-Jun-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_OptionsAndWarrantsMember" unitRef="shares" decimals="0">6842528</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_FYE__31-Dec-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">2330134</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_FYE__31-Dec-2012_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">12770596</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_6ME__30-Jun-2013_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="shares" decimals="0">9535694</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Context_6ME__30-Jun-2013_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_OptionsAndWarrantsMember" unitRef="shares" decimals="0">2280184</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<fil:PercentageOfSharesExchangedInShareExchangeProgramme contextRef="Context_6ME__30-Jun-2013_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="pure" decimals="2">0.38</fil:PercentageOfSharesExchangedInShareExchangeProgramme>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">55743463</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">59216501</us-gaap:RetainedEarningsAccumulatedDeficit>
<fil:QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">655786</fil:QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty>
<fil:QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<fil:ReimbursementsReceivedFromRelatedParty contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">966341</fil:ReimbursementsReceivedFromRelatedParty>
<fil:ReimbursementsReceivedFromRelatedParty contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">237834</fil:ReimbursementsReceivedFromRelatedParty>
<fil:NumberOfPatients contextRef="Context_Custom_01-Jan-2012_31-Jan-2012_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="Note" decimals="INF">2</fil:NumberOfPatients>
<fil:NumberOfPatients contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="Note" decimals="INF">2</fil:NumberOfPatients>
<fil:NumberOfPatients contextRef="Context_Custom_01-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="Note" decimals="INF">24</fil:NumberOfPatients>
<fil:NumberOfPatients contextRef="Context_Custom_27-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="Note" decimals="INF">24</fil:NumberOfPatients>
<fil:AmountPaidUnderAgreementInYearTwoThousandEleven contextRef="Context_Custom_20-May-2011_19-Jun-2011_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">50000</fil:AmountPaidUnderAgreementInYearTwoThousandEleven>
<fil:AmountPaidUnderAgreementInYearTwoThousandTwelve contextRef="Context_Custom_20-May-2011_19-Jun-2011_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">200000</fil:AmountPaidUnderAgreementInYearTwoThousandTwelve>
<fil:AmountPaidUnderAgreementInYearTwoThousandThirteen contextRef="Context_Custom_20-May-2011_19-Jun-2011_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">250000</fil:AmountPaidUnderAgreementInYearTwoThousandThirteen>
<fil:MaintenanceFeesAndResearchPayments contextRef="Context_Custom_20-May-2011_19-Jun-2011_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">50000</fil:MaintenanceFeesAndResearchPayments>
<fil:AmountPaidUnderAgreement contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">100000</fil:AmountPaidUnderAgreement>
<fil:AdditionalAmountDueUnderAgreement contextRef="Context_As_Of__21-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">150000</fil:AdditionalAmountDueUnderAgreement>
<fil:DescriptionOfConditionForTerminationOfForbearancePeriod contextRef="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">The forbearance period terminated on October 30, 2011, when the Company satisfied a financing condition to the termination of the forbearance period by raising in excess of $3,000.000 in new equity financing.</fil:DescriptionOfConditionForTerminationOfForbearancePeriod>
<fil:TerminationDateOfForbearanceAgreement contextRef="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember">2011-10-30</fil:TerminationDateOfForbearanceAgreement>
<fil:TerminationDateOfForbearanceAgreement contextRef="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember">2011-10-30</fil:TerminationDateOfForbearanceAgreement>
<fil:MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod contextRef="Context_As_Of__30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="3">3000.000</fil:MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod>
<fil:ForgivenAmountOfObligations contextRef="Context_Custom_01-Apr-2010_30-Apr-2010_RelatedPartyTransactionsByRelatedPartyAxis_SloanKetteringInstituteOfCancerResearchMember_AgreementAxis_LicenseDevelopmentAndCommercializationAgreementMember" unitRef="USD" decimals="0">360000</fil:ForgivenAmountOfObligations>
<fil:ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty contextRef="Context_FYE__31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember" unitRef="USD" decimals="0">299200</fil:ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty>
<fil:ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember" unitRef="USD" decimals="0">237834</fil:ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty>
<us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="Context_As_Of__31-Dec-2011_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember" unitRef="USD" decimals="0">237834</us-gaap:AccountsReceivableRelatedPartiesCurrent>
<us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="Context_As_Of__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableRelatedPartiesCurrent>
<fil:AmountPaidToEachPatient contextRef="Context_As_Of__27-Mar-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">31185</fil:AmountPaidToEachPatient>
<fil:AmountPaidToEachPatient contextRef="Context_As_Of__19-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">31366</fil:AmountPaidToEachPatient>
<fil:AmountPaidToEachPatient contextRef="Context_As_Of__28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">481204</fil:AmountPaidToEachPatient>
<fil:AmountPaidToEachPatient contextRef="Context_As_Of__26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">38501</fil:AmountPaidToEachPatient>
<fil:AmountPaidToEachPatient contextRef="Context_As_Of__21-Nov-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfPennsylvaniaMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">31771</fil:AmountPaidToEachPatient>
<fil:StartUpFeeForClinicalTrial contextRef="Context_As_Of__27-Mar-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">79623</fil:StartUpFeeForClinicalTrial>
<fil:StartUpFeeForClinicalTrial contextRef="Context_As_Of__19-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">19749</fil:StartUpFeeForClinicalTrial>
<fil:StartUpFeeForClinicalTrial contextRef="Context_As_Of__28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">33946</fil:StartUpFeeForClinicalTrial>
<fil:StartUpFeeForClinicalTrial contextRef="Context_As_Of__26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">22847</fil:StartUpFeeForClinicalTrial>
<fil:StartUpFeeForClinicalTrial contextRef="Context_As_Of__21-Nov-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfPennsylvaniaMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">16000</fil:StartUpFeeForClinicalTrial>
<fil:StartUpDueCostPaidDate contextRef="Context_As_Of__27-Mar-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">2012-07-10</fil:StartUpDueCostPaidDate>
<fil:StartUpDueCostPaidDate contextRef="Context_As_Of__19-Jul-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_ClinicalTrialAgreementMember">2013-06-30</fil:StartUpDueCostPaidDate>
<fil:StartUpDueCostPaidDate contextRef="Context_As_Of__28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember">2013-06-30</fil:StartUpDueCostPaidDate>
<us-gaap:OfficersCompensation contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember" unitRef="USD" decimals="0">100000</us-gaap:OfficersCompensation>
<fil:OptionExercisePriceRange contextRef="Context_Custom_01-Jan-2012_31-Jan-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember">0.78 to 1.5</fil:OptionExercisePriceRange>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE__31-Dec-2011">P7Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01-Jan-2012_31-Jan-2012">P7Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01-Jan-2012_31-Jan-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember">P10Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MaximumMember">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MinimumMember">P4M</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_Custom_01-Dec-2012_27-Dec-2012">P6Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember">P4M</us-gaap:FairValueAssumptionsExpectedTerm>
<us-gaap:FairValueAssumptionsExpectedTerm contextRef="Context_6ME__30-Jun-2013">P4Y6M</us-gaap:FairValueAssumptionsExpectedTerm>
<fil:OptionsReceivedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_RosemaryMazanetMember_AgreementAxis_ConsultingServicesAgreementMember" unitRef="shares" decimals="0">99900</fil:OptionsReceivedToPurchaseCommonStock>
<fil:DescriptionOfReceivablesOfPlacementAgentForServices contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">Placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent.</fil:DescriptionOfReceivablesOfPlacementAgentForServices>
<fil:DescriptionOfWarrantsReceivablesByPlacement contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">The placement agent or its designees have also received warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units.</fil:DescriptionOfWarrantsReceivablesByPlacement>
<fil:PeriodOfExerciseOfWarrants contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">Within 6 months of the final closing of the 2012 common stock Offering.</fil:PeriodOfExerciseOfWarrants>
<fil:PercentageOfSolicitationFee contextRef="Context_Custom_08-Jul-2012_07-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember" unitRef="pure" decimals="2">0.05</fil:PercentageOfSolicitationFee>
<fil:PeriodicFeeForFinancialAdvisoryServices contextRef="Context_Custom_08-Jul-2012_07-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember" unitRef="USD" decimals="0">25000</fil:PeriodicFeeForFinancialAdvisoryServices>
<fil:DescriptionOfAdditionalReceivableByPlacementAgent contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember">The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company's financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.</fil:DescriptionOfAdditionalReceivableByPlacementAgent>
<fil:CommonStockPurchaseByHoldingOfWarrant contextRef="Context_Custom_08-Jul-2012_07-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_LaidlawAndCompanyMember_AgreementAxis_EngagementAgreementMember" unitRef="shares" decimals="0">1251015</fil:CommonStockPurchaseByHoldingOfWarrant>
<fil:PeriodicFeeReceivedByManagementFirm contextRef="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember" unitRef="USD" decimals="0">12500</fil:PeriodicFeeReceivedByManagementFirm>
<fil:PercentageOfFullyDilutedCapitalStockEqualToCommonStock contextRef="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember" unitRef="pure" decimals="2">0.10</fil:PercentageOfFullyDilutedCapitalStockEqualToCommonStock>
<fil:MaximumAmountOfOutOfPocketExpenses contextRef="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember" unitRef="USD" decimals="0">5000</fil:MaximumAmountOfOutOfPocketExpenses>
<fil:PeriodicAmountOfRent contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_GuagentiAndAssociatesMember" unitRef="USD" decimals="0">300</fil:PeriodicAmountOfRent>
<fil:AmountPaidToPursuantLeaseAgreement contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_GuagentiAndAssociatesMember" unitRef="USD" decimals="0">7200</fil:AmountPaidToPursuantLeaseAgreement>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_FYE__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_6ME__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">155096</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2011_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember" unitRef="USD" decimals="0">153804</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2011_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="USD" decimals="0">1292</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">157454</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember" unitRef="USD" decimals="0">156162</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__31-Dec-2012_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="USD" decimals="0">1292</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">158566</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_OfficeEquipmentMember" unitRef="USD" decimals="0">157274</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of__30-Jun-2013_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="USD" decimals="0">1292</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">153863</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">154444</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">154444</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<fil:LossOnDispositionOfPropertyAndEquipment contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">4122</fil:LossOnDispositionOfPropertyAndEquipment>
<us-gaap:Depreciation contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">633</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">159</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">317</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">581</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">0</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">0</us-gaap:Depreciation>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of__27-Dec-2011" unitRef="USD" decimals="0">900000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">900000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">900000</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentFaceAmount contextRef="Context_As_Of__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember" unitRef="USD" decimals="0">292691</us-gaap:DebtInstrumentFaceAmount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="Context_As_Of__27-Dec-2011" unitRef="USD" decimals="0">-150000</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">150000</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">150000</us-gaap:DebtInstrumentUnamortizedDiscount>
<us-gaap:DebtInstrumentUnamortizedDiscount contextRef="Context_As_Of__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember" unitRef="USD" decimals="0">150000</us-gaap:DebtInstrumentUnamortizedDiscount>
<fil:DiscountRelatedToFairValueOfDerivativeWarrants contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">377150</fil:DiscountRelatedToFairValueOfDerivativeWarrants>
<fil:DiscountRelatedToFairValueOfDerivativeWarrants contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">377150</fil:DiscountRelatedToFairValueOfDerivativeWarrants>
<fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">372850</fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature>
<fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">372850</fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature>
<fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">372850</fil:DebtInstrumentDiscountRelatedToBeneficialConversionFeature>
<fil:DebtInstrumentAmortizationOfDiscount contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">124363</fil:DebtInstrumentAmortizationOfDiscount>
<fil:DebtInstrumentAmortizationOfDiscount contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">900000</fil:DebtInstrumentAmortizationOfDiscount>
<fil:DebtInstrumentPrincipalAmountConvertedToCommonStock contextRef="Context_As_Of__31-Dec-2011_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" xsi:nil="true"/>
<fil:DebtInstrumentPrincipalAmountConvertedToCommonStock contextRef="Context_As_Of__31-Dec-2012_MajorTypesOfDebtAndEquitySecuritiesAxis_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">-900000</fil:DebtInstrumentPrincipalAmountConvertedToCommonStock>
<fil:CommonStockPurchaseDueToIssuanceOfWarrants contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember" unitRef="shares" decimals="0">143532</fil:CommonStockPurchaseDueToIssuanceOfWarrants>
<fil:CommonStockPurchaseDueToIssuanceOfWarrants contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ManagementFirmMember" unitRef="shares" decimals="0">126829</fil:CommonStockPurchaseDueToIssuanceOfWarrants>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_StatementClassOfStockAxis_SeriesEPreferredStockMember" unitRef="USD_per_Share" decimals="2">0.26</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ManagementFirmMember" unitRef="USD_per_Share" decimals="2">0.01</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.65</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantsBMember" unitRef="USD_per_Share" decimals="2">2.48</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD_per_Share" decimals="2">0.78</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExpirationDate contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember">2019-01-31</invest:InvestmentWarrantsExpirationDate>
<invest:InvestmentWarrantsExpirationDate contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_ManagementFirmMember">2019-01-31</invest:InvestmentWarrantsExpirationDate>
<fil:AmortizationPeriodOfNote contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_PlacementAgentMember">One year</fil:AmortizationPeriodOfNote>
<fil:PremiumFinanceAgreementPrincipalAmount contextRef="Context_As_Of__28-Dec-2012" unitRef="USD" decimals="0">140000</fil:PremiumFinanceAgreementPrincipalAmount>
<fil:PaymentUnderPremiumFinanceAgreement contextRef="Context_Custom_01-Jan-2013_31-Jan-2013" unitRef="USD" decimals="0">28000</fil:PaymentUnderPremiumFinanceAgreement>
<fil:PeriodicPaymentUnderPremiumFinanceAgreement contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">12636</fil:PeriodicPaymentUnderPremiumFinanceAgreement>
<fil:DurationOfPeriodicPaymentsForPremiumFinanceAgreement contextRef="Context_FYE__31-Dec-2012">P9M</fil:DurationOfPeriodicPaymentsForPremiumFinanceAgreement>
<fil:PremiumFinanceAgreementOutstandingAmount contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">140000</fil:PremiumFinanceAgreementOutstandingAmount>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="Context_As_Of__27-Dec-2011" unitRef="pure" decimals="2">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
<fil:ProceedsFromConvertibleNotes contextRef="Context_As_Of__27-Dec-2011" unitRef="USD" decimals="0">750000</fil:ProceedsFromConvertibleNotes>
<fil:PercentageOfPrincipleAmountInWhichConvertibleNoteIssued contextRef="Context_As_Of__27-Dec-2011" unitRef="pure" decimals="4">0.8333</fil:PercentageOfPrincipleAmountInWhichConvertibleNoteIssued>
<us-gaap:DebtInstrumentMaturityDateDescription contextRef="Context_Custom_01-Dec-2011_31-Dec-2011">One year</us-gaap:DebtInstrumentMaturityDateDescription>
<fil:GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">4000000</fil:GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents>
<fil:DerivativeWarrantsIssuedWithConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">287061</fil:DerivativeWarrantsIssuedWithConvertibleNotes>
<fil:InvestmentWarrantGrantDateFairValue contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">565729</fil:InvestmentWarrantGrantDateFairValue>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="2">0.78</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<fil:DebtInstrumentFairValuePerShare contextRef="Context_FYE__31-Dec-2012" unitRef="USD_per_Share" decimals="2">1.11</fil:DebtInstrumentFairValuePerShare>
<fil:ExtendedMaturityPeriodOfConvertibleNotes contextRef="Context_Custom_01-Oct-2012_23-Oct-2012">P90D</fil:ExtendedMaturityPeriodOfConvertibleNotes>
<fil:DescriptionOfExtendedMaturityDate contextRef="Context_Custom_01-Oct-2012_23-Oct-2012">Company was seeking approval to extend the note maturity date for 90 days. The Company was able to obtain approvals from all note holders and the maturity date of the notes has been extended to January 31, 2013, February 18, 2013 or March 27, 2013 for the 24 notes.</fil:DescriptionOfExtendedMaturityDate>
<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="Context_Custom_01-Dec-2012_19-Dec-2012" unitRef="USD" decimals="0">4000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">1252550</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
<fil:InsurancePolicyDownPayment contextRef="Context_As_Of__31-Jan-2013" unitRef="USD" decimals="0">28000</fil:InsurancePolicyDownPayment>
<fil:InsurancePolicyInstallmentPayment contextRef="Context_As_Of__31-Jan-2013" unitRef="USD" decimals="0">12636</fil:InsurancePolicyInstallmentPayment>
<us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">103050</us-gaap:DebtInstrumentAnnualPrincipalPayment>
<fil:DerivativeWarrantsUnits contextRef="Context_As_Of__31-Dec-2010" unitRef="shares" xsi:nil="true"/>
<fil:DerivativeWarrantsUnits contextRef="Context_As_Of__31-Dec-2011" unitRef="shares" decimals="0">3389771</fil:DerivativeWarrantsUnits>
<fil:DerivativeWarrantsUnits contextRef="Context_As_Of__31-Dec-2012" unitRef="shares" decimals="0">5146338</fil:DerivativeWarrantsUnits>
<fil:DerivativeWarrantsUnits contextRef="Context_As_Of__30-Jun-2013" unitRef="shares" decimals="0">2023517</fil:DerivativeWarrantsUnits>
<fil:DerivativeWarrantUnitsReclassificationToPaidInCapital contextRef="Context_6ME__30-Jun-2013" unitRef="shares" decimals="0">-3122821</fil:DerivativeWarrantUnitsReclassificationToPaidInCapital>
<fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">143532</fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes>
<fil:DerivativeWarrantsIssuedWithStockOffering contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">1972785</fil:DerivativeWarrantsIssuedWithStockOffering>
<fil:DerivativeWarrantsIssuedWithStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">242190</fil:DerivativeWarrantsIssuedWithStockOffering>
<fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">986393</fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock>
<fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">121095</fil:DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock>
<fil:DerivativeWarrantsIssuedWithCommonStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">3118988</fil:DerivativeWarrantsIssuedWithCommonStockOffering>
<fil:DerivativeWarrantsIssuedWithCommonStockOfferingOne contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">1559505</fil:DerivativeWarrantsIssuedWithCommonStockOfferingOne>
<fil:DerivativePlacementAgentWarrantsRelatedToStock contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">467845</fil:DerivativePlacementAgentWarrantsRelatedToStock>
<fil:TransferFromLiabilityClassificationToEquityClassification contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">-3753056</fil:TransferFromLiabilityClassificationToEquityClassification>
<us-gaap:DerivativeFairValueOfDerivativeNet contextRef="Context_As_Of__31-Dec-2010" unitRef="USD" xsi:nil="true"/>
<us-gaap:DerivativeFairValueOfDerivativeNet contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">4439613</us-gaap:DerivativeFairValueOfDerivativeNet>
<us-gaap:DerivativeFairValueOfDerivativeNet contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">3574958</us-gaap:DerivativeFairValueOfDerivativeNet>
<us-gaap:DerivativeFairValueOfDerivativeNet contextRef="Context_As_Of__30-Jun-2013" unitRef="USD" decimals="0">2957977</us-gaap:DerivativeFairValueOfDerivativeNet>
<fil:DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-590217</fil:DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue>
<fil:FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">377150</fil:FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes>
<fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">188579</fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes>
<fil:FairValueOfDerivativeWarrantsIssuedWithStockOffering contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">2591900</fil:FairValueOfDerivativeWarrantsIssuedWithStockOffering>
<fil:FairValueOfDerivativeWarrantsIssuedWithStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">318087</fil:FairValueOfDerivativeWarrantsIssuedWithStockOffering>
<fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">1295950</fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock>
<fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">159044</fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock>
<fil:FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">1409554</fil:FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering>
<fil:FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">1665697</fil:FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne>
<fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">499707</fil:FairValueOfDerivativePlacementAgentWarrantsRelatedToStock>
<fil:ChangeInFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-13966</fil:ChangeInFairValueOfDerivativeWarrants>
<fil:ChangeInFairValueOfDerivativeWarrants contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-685420</fil:ChangeInFairValueOfDerivativeWarrants>
<fil:ChangeInFairValueOfDerivativeWarrants contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">-26764</fil:ChangeInFairValueOfDerivativeWarrants>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__31-Dec-2011" unitRef="USD_per_Share" decimals="2">0.37</fil:MarketValueOfCommonStockOnMeasurementDate>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__31-Jan-2012" unitRef="USD_per_Share" decimals="2">0.37</fil:MarketValueOfCommonStockOnMeasurementDate>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__19-Dec-2012" unitRef="USD_per_Share" decimals="2">0.39</fil:MarketValueOfCommonStockOnMeasurementDate>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__27-Dec-2012" unitRef="USD_per_Share" decimals="2">0.39</fil:MarketValueOfCommonStockOnMeasurementDate>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__31-Dec-2012" unitRef="USD_per_Share" decimals="2">0.39</fil:MarketValueOfCommonStockOnMeasurementDate>
<fil:MarketValueOfCommonStockOnMeasurementDate contextRef="Context_As_Of__30-Jun-2013" unitRef="USD_per_Share" decimals="2">1.65</fil:MarketValueOfCommonStockOnMeasurementDate>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Dec-2011_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.26</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Dec-2011_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.24</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Jan-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.26</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Jan-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.23</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__19-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.83</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__19-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.41</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__27-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.26</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__27-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.22</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.83</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__31-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.41</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__30-Jun-2013_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="3">2.475</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsExercisePrice contextRef="Context_As_Of__30-Jun-2013_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">1.50</us-gaap:FairValueAssumptionsExercisePrice>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">0.0135</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_Custom_01-Jan-2012_31-Jan-2012" unitRef="pure" decimals="4">0.0124</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MaximumMember" unitRef="pure" decimals="4">0.0077</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MinimumMember" unitRef="pure" decimals="4">0.0010</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_Custom_01-Dec-2012_27-Dec-2012" unitRef="pure" decimals="4">0.0094</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember" unitRef="pure" decimals="4">0.0077</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember" unitRef="pure" decimals="4">0.0010</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="Context_6ME__30-Jun-2013" unitRef="pure" decimals="4">0.0105</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="2">1.56</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_Custom_01-Jan-2012_31-Jan-2012" unitRef="pure" decimals="2">1.57</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MaximumMember" unitRef="pure" decimals="2">1.61</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_Custom_01-Dec-2012_19-Dec-2012_RangeAxis_MinimumMember" unitRef="pure" decimals="2">1.25</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_Custom_01-Dec-2012_27-Dec-2012" unitRef="pure" decimals="2">1.61</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember" unitRef="pure" decimals="2">1.61</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember" unitRef="pure" decimals="2">1.25</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="Context_6ME__30-Jun-2013" unitRef="pure" decimals="4">1.5400</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2011" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_Custom_01-Jan-2012_31-Jan-2012" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_Custom_01-Dec-2012_19-Dec-2012" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_Custom_01-Dec-2012_27-Dec-2012" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2012" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="Context_6ME__30-Jun-2013" unitRef="pure" xsi:nil="true"/>
<us-gaap:FairValueInputsProbabilityOfDefault contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="2">0.25</us-gaap:FairValueInputsProbabilityOfDefault>
<us-gaap:FairValueInputsProbabilityOfDefault contextRef="Context_Custom_01-Jan-2012_31-Jan-2012" unitRef="pure" decimals="2">0.25</us-gaap:FairValueInputsProbabilityOfDefault>
<us-gaap:FairValueInputsProbabilityOfDefault contextRef="Context_Custom_01-Dec-2012_19-Dec-2012" unitRef="pure" decimals="2">0.25</us-gaap:FairValueInputsProbabilityOfDefault>
<us-gaap:FairValueInputsProbabilityOfDefault contextRef="Context_Custom_01-Dec-2012_27-Dec-2012" unitRef="pure" decimals="2">0.25</us-gaap:FairValueInputsProbabilityOfDefault>
<us-gaap:FairValueInputsProbabilityOfDefault contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="2">0.25</us-gaap:FairValueInputsProbabilityOfDefault>
<fil:RangeOfPercentageOfExistingSharesOffered contextRef="Context_As_Of__31-Dec-2011" unitRef="pure" decimals="2">0.35</fil:RangeOfPercentageOfExistingSharesOffered>
<fil:RangeOfPercentageOfExistingSharesOffered contextRef="Context_As_Of__31-Jan-2012" unitRef="pure" decimals="2">0.35</fil:RangeOfPercentageOfExistingSharesOffered>
<fil:RangeOfPercentageOfExistingSharesOffered contextRef="Context_As_Of__19-Dec-2012" unitRef="pure" decimals="2">0.35</fil:RangeOfPercentageOfExistingSharesOffered>
<fil:RangeOfPercentageOfExistingSharesOffered contextRef="Context_As_Of__27-Dec-2012" unitRef="pure" decimals="2">0.35</fil:RangeOfPercentageOfExistingSharesOffered>
<fil:RangeOfPercentageOfExistingSharesOffered contextRef="Context_As_Of__31-Dec-2012" unitRef="pure" decimals="2">0.35</fil:RangeOfPercentageOfExistingSharesOffered>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Dec-2011_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.55</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Dec-2011_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.18</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Jan-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.56</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Jan-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.13</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__19-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.55</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__19-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.01</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__27-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.60</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__27-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.12</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Dec-2012_RangeAxis_MaximumMember" unitRef="USD_per_Share" decimals="2">0.55</fil:FairValueAssumptionOfferingPrice>
<fil:FairValueAssumptionOfferingPrice contextRef="Context_As_Of__31-Dec-2012_RangeAxis_MinimumMember" unitRef="USD_per_Share" decimals="2">0.01</fil:FairValueAssumptionOfferingPrice>
<fil:DescriptionOfRiskFreeInterestRateDetermination contextRef="Context_FYE__31-Dec-2012">Risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.</fil:DescriptionOfRiskFreeInterestRateDetermination>
<fil:DescriptionOfProbabilityOfStockOffering contextRef="Context_FYE__31-Dec-2012">Probability of a stock offering is 25% for each quarter of the next five years.</fil:DescriptionOfProbabilityOfStockOffering>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">13089314</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">13609036</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">741420</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">1497556</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">4749</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
<us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">233043</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
<us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">13835483</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
<us-gaap:DeferredTaxAssetsTaxDeferredExpense contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">15339635</us-gaap:DeferredTaxAssetsTaxDeferredExpense>
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" decimals="0">13835483</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="0">15339635</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredTaxAssetsNet contextRef="Context_As_Of__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:DeferredTaxAssetsNet contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">-1171230</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">-2842810</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">-0.3400</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="4">-0.3400</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
<us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">736796</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
<us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">756136</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">0.2139</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="4">0.0904</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">4748</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">233043</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">0.0013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="4">0.0279</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
<us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">56033</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
<us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">349480</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">0.0163</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization>
<us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="4">0.0418</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization>
<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">373653</us-gaap:IncomeTaxReconciliationOtherAdjustments>
<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">1504151</us-gaap:IncomeTaxReconciliationOtherAdjustments>
<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="Context_FYE__31-Dec-2011" unitRef="pure" decimals="4">0.1085</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
<us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="4">0.1799</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_FYE__31-Dec-2011" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_FYE__31-Dec-2012" unitRef="USD" xsi:nil="true"/>
<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="Context_FYE__31-Dec-2011" unitRef="pure" xsi:nil="true"/>
<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="Context_FYE__31-Dec-2012" unitRef="pure" xsi:nil="true"/>
<us-gaap:OperatingLossCarryforwards contextRef="Context_As_Of__31-Dec-2012" unitRef="USD" decimals="-6">43000000</us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="Context_FYE__31-Dec-2012">2020-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseSecondClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseThirdClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_BiologicalLicenseApplicationMember" unitRef="USD" decimals="0">1750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_FirstCommercialSaleMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_NewDrugApplicationMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_ReceiptOfRegulatoryApprovalFromUSFdaMember" unitRef="USD" decimals="0">1750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">7750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseSecondClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseThirdClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_BiologicalLicenseApplicationMember" unitRef="USD" decimals="0">1750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_FirstCommercialSaleMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember" unitRef="USD" decimals="0">1500000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_PhaseFirstClinicalTrialOfLicensedProductMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_NewDrugApplicationMember" unitRef="USD" decimals="0">750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_ReceiptOfRegulatoryApprovalFromUSFdaMember" unitRef="USD" decimals="0">1750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:LongTermPurchaseCommitmentMilestonesPayment contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">7750000</fil:LongTermPurchaseCommitmentMilestonesPayment>
<fil:PaymentOfLicenseFee contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">3000000</fil:PaymentOfLicenseFee>
<fil:PaymentOfLicenseFee contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">3000000</fil:PaymentOfLicenseFee>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_Custom_01-Jun-2012_15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember" unitRef="USD" decimals="-6">1000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_Custom_14-Jun-2012_15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember" unitRef="USD" decimals="-6">1000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">10000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_AfterFirstNetSalesMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="USD" decimals="0">10000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
<fil:MilestonePaymentDate contextRef="Context_Custom_28-Jul-2012_01-Aug-2012_AgreementAxis_RentalAgreementMember">2013-01-31</fil:MilestonePaymentDate>
<fil:MilestonePaymentDate contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">2012-07-24</fil:MilestonePaymentDate>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_Custom_01-Jun-2012_15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">Royalty payments of 2% of net sales will be due to FHCRC.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">Company shall pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember">We agrees to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember">Royalty payments of 2% of net sales will be due to FHCRC.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:DescriptionOfRoyaltyPaymentToRelatedParty contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">We agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</fil:DescriptionOfRoyaltyPaymentToRelatedParty>
<fil:RoyaltyOfNetSalesPercentage contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember" unitRef="pure" decimals="2">0.12</fil:RoyaltyOfNetSalesPercentage>
<fil:FirstCommercialSalePeriod contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AbbottBiotherapeuticsCorpMember_AgreementAxis_ProductDevelopmentAndPatentLicenseAgreementMember">P12Y6M</fil:FirstCommercialSalePeriod>
<us-gaap:TechnologyServicesCosts contextRef="Context_Custom_01-Feb-2002_28-Feb-2002_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</us-gaap:TechnologyServicesCosts>
<us-gaap:TechnologyServicesCosts contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</us-gaap:TechnologyServicesCosts>
<us-gaap:MaintenanceCosts contextRef="Context_Custom_01-Feb-2002_28-Feb-2002_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</us-gaap:MaintenanceCosts>
<us-gaap:MaintenanceCosts contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</us-gaap:MaintenanceCosts>
<fil:ResearchAndDevelopmentArrangement contextRef="Context_Custom_01-Feb-2002_28-Feb-2002_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</fil:ResearchAndDevelopmentArrangement>
<fil:ResearchAndDevelopmentArrangement contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_RelatedPartyTransactionsByRelatedPartyAxis_MemorialSloanKetteringCancerCenterMember_AgreementAxis_LicenseAgreementMember" unitRef="USD" decimals="0">50000</fil:ResearchAndDevelopmentArrangement>
<fil:PurchaseOfRadioactiveMaterial contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_OakRidgeNationalLaboratoryMember" unitRef="USD" decimals="0">233100</fil:PurchaseOfRadioactiveMaterial>
<fil:PurchaseOfRadioactiveMaterial contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_OakRidgeNationalLaboratoryMember" unitRef="USD" decimals="0">337500</fil:PurchaseOfRadioactiveMaterial>
<fil:ProjectEstimatedCost contextRef="Context_Custom_07-Jul-2012_06-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">1997732</fil:ProjectEstimatedCost>
<fil:ProjectEstimatedCost contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">1859333</fil:ProjectEstimatedCost>
<fil:ProjectEstimatedCost contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">1859333</fil:ProjectEstimatedCost>
<fil:DownPaymentOfProjectEstimatedCostPercentage contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="pure" decimals="3">0.125</fil:DownPaymentOfProjectEstimatedCostPercentage>
<fil:DownPaymentOfProjectEstimatedCostPercentage contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="pure" decimals="3">0.125</fil:DownPaymentOfProjectEstimatedCostPercentage>
<fil:DownPaymentForProject contextRef="Context_FYE__31-Dec-2007_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">239000</fil:DownPaymentForProject>
<fil:DownPaymentForProject contextRef="Context_Custom_05-Aug-2012_06-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">2173955</fil:DownPaymentForProject>
<fil:DownPaymentForProject contextRef="Context_FYE__31-Dec-2012_RelatedPartyTransactionsByRelatedPartyAxis_AptivSolutionsMember" unitRef="USD" decimals="0">239000</fil:DownPaymentForProject>
<fil:ClinicalTrialCostForApprovalForFoodAndDrugAdministration contextRef="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember_RangeAxis_MaximumMember" unitRef="USD" decimals="-5">23500000</fil:ClinicalTrialCostForApprovalForFoodAndDrugAdministration>
<fil:ClinicalTrialCostForApprovalForFoodAndDrugAdministration contextRef="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember_RangeAxis_MinimumMember" unitRef="USD" decimals="-5">13200000</fil:ClinicalTrialCostForApprovalForFoodAndDrugAdministration>
<fil:FundToRelatedPartyUnderAgreementForFirstTwoYear contextRef="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember" unitRef="USD" decimals="0">150000</fil:FundToRelatedPartyUnderAgreementForFirstTwoYear>
<fil:FundToRelatedPartyUnderAgreementAfterYearTwo contextRef="Context_As_Of__15-Jun-2012_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember" unitRef="USD" decimals="0">250000</fil:FundToRelatedPartyUnderAgreementAfterYearTwo>
<us-gaap:RoyaltyExpense contextRef="Context_Custom_10-Aug-2013_12-Aug-2013_RelatedPartyTransactionsByRelatedPartyAxis_FredHutchinsonCancerResearchCenterMember_AgreementAxis_LicenseAndSponsoredResearchAgreementMember" unitRef="USD" decimals="0">37500</us-gaap:RoyaltyExpense>
<fil:WarrantExercisableNoticePeriodDescription contextRef="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember">The warrants contain a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.</fil:WarrantExercisableNoticePeriodDescription>
<fil:DescriptionOfSharesAvailabilityByExerciseOfWarrant contextRef="Context_Custom_10-Apr-2011_09-May-2011_RelatedPartyTransactionsByRelatedPartyAxis_JamessCapitalGroupMember_AgreementAxis_TransactionManagementAgreementMember">The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transfered until the earlier of twelve months from the closing date of the Pubco Transaction; or for six months after the planned Registration Statement is declared effective.</fil:DescriptionOfSharesAvailabilityByExerciseOfWarrant>
<fil:NonRefundableInstitutionalFee contextRef="Context_Custom_01-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">14500</fil:NonRefundableInstitutionalFee>
<fil:NonRefundableInstitutionalFee contextRef="Context_Custom_27-Aug-2012_28-Aug-2012_RelatedPartyTransactionsByRelatedPartyAxis_UniversityOfTexasMDAndersonCancerCenterMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">14500</fil:NonRefundableInstitutionalFee>
<fil:PharmacyFee contextRef="Context_Custom_01-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">2025</fil:PharmacyFee>
<fil:PharmacyFee contextRef="Context_Custom_25-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">2025</fil:PharmacyFee>
<fil:AmendmentProcessingFee contextRef="Context_Custom_01-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">500</fil:AmendmentProcessingFee>
<fil:AmendmentProcessingFee contextRef="Context_Custom_25-Sep-2012_26-Sep-2012_RelatedPartyTransactionsByRelatedPartyAxis_JohnsHopkinsUniversityMember_AgreementAxis_ClinicalTrialAgreementMember" unitRef="USD" decimals="0">500</fil:AmendmentProcessingFee>
<fil:AmendmentProcessingFee contextRef="Context_6ME__30-Jun-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">0</fil:AmendmentProcessingFee>
<fil:AmountPayableInInstallmentsUnderAgreement contextRef="Context_As_Of__28-Feb-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">250000</fil:AmountPayableInInstallmentsUnderAgreement>
<fil:NumberOfInstallments contextRef="Context_Custom_01-Feb-2013_28-Feb-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="Note" decimals="INF">2</fil:NumberOfInstallments>
<fil:PerformanceBonusPayableUnderAgreementForService contextRef="Context_As_Of__28-Feb-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">60000</fil:PerformanceBonusPayableUnderAgreementForService>
<fil:AgreementRenewalDescription contextRef="Context_6ME__30-Jun-2013_AgreementAxis_RentalAgreementMember">The agreement automatically renews on a month-to-month basis and requires a two month notice of termination.</fil:AgreementRenewalDescription>
<fil:PaymentOfFirstInstallmentForServicesByCompany contextRef="Context_Custom_01-Mar-2013_31-Mar-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">125000</fil:PaymentOfFirstInstallmentForServicesByCompany>
<fil:PaymentOfFinalInstallmentForServicesByCompany contextRef="Context_Custom_01-Mar-2013_31-Mar-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">125000</fil:PaymentOfFinalInstallmentForServicesByCompany>
<fil:PaymentOfPerformanceBonusForServicesByCompany contextRef="Context_Custom_01-Mar-2013_31-Mar-2013_RelatedPartyTransactionsByRelatedPartyAxis_ChiefExecutiveOfficerMember_AgreementAxis_SeparationAndSettlementAgreementMember" unitRef="USD" decimals="0">60000</fil:PaymentOfPerformanceBonusForServicesByCompany>
<us-gaap:LeaseExpirationDate1 contextRef="Context_Custom_28-Jul-2012_01-Aug-2012_AgreementAxis_RentalAgreementMember">2013-01-31</us-gaap:LeaseExpirationDate1>
<us-gaap:LeaseExpirationDate1 contextRef="Context_Custom_01-Aug-2012_31-Aug-2012">2013-01-31</us-gaap:LeaseExpirationDate1>
<fil:NoticePeriodForTerminationOfAgreement contextRef="Context_Custom_01-Aug-2012_31-Aug-2012">60 days prior to January 1, 2013</fil:NoticePeriodForTerminationOfAgreement>
<fil:NoticePeriodForTerminationOfAgreement contextRef="Context_6ME__30-Jun-2013_AgreementAxis_RentalAgreementMember">The agreement terminated May 31, 2013.</fil:NoticePeriodForTerminationOfAgreement>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">273859</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">273859</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="INF">5364557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">2330134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="INF">12770636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">2280184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="INF">9535694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_FYE__31-Dec-2009_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">128050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">-49950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">-2211158</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="Context_FYE__31-Dec-2009_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">20613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">-1023784</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember">P5Y6M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember">P5Y6M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember">P6Y9M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">P8Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember">P4Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember">P8Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Context_6ME__30-Jun-2013_AwardTypeAxis_WarrantMember">P5Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="USD" decimals="0">3261367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">685800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="USD" decimals="0">6114768</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">1609035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="Context_As_Of__30-Jun-2013_AwardTypeAxis_WarrantMember" unitRef="USD" decimals="0">9691302</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<fil:WarrantsIssuedToPurchaseCommonStockOffering contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">19972785</fil:WarrantsIssuedToPurchaseCommonStockOffering>
<fil:WarrantsIssuedToPurchaseCommonStockOffering contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">242190</fil:WarrantsIssuedToPurchaseCommonStockOffering>
<fil:IncreaseOfferingOfCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2010_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">42711791</fil:IncreaseOfferingOfCommonStock>
<fil:IncreaseOfferingOfCommonStock contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">6184967</fil:IncreaseOfferingOfCommonStock>
<fil:IncreaseOfferingOfCommonStock contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">5151450</fil:IncreaseOfferingOfCommonStock>
<fil:IncreaseOfferingOfCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">759300</fil:IncreaseOfferingOfCommonStock>
<fil:CommonStockSharesIssuedInStockOffering contextRef="Context_Custom_14-Jun-2000_31-Dec-2010_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">5707259</fil:CommonStockSharesIssuedInStockOffering>
<fil:CommonStockSharesIssuedInStockOffering contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">7891141</fil:CommonStockSharesIssuedInStockOffering>
<fil:CommonStockSharesIssuedInStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">3118988</fil:CommonStockSharesIssuedInStockOffering>
<fil:CommonStockSharesIssuedInStockOffering contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">968759</fil:CommonStockSharesIssuedInStockOffering>
<fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">5379367</fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet>
<fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">4469776</fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet>
<fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">660164</fil:ProceedsFromIssuanceOfStockUnderStockOfferingNet>
<fil:PlacementAgentCashFees contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">742196</fil:PlacementAgentCashFees>
<fil:PlacementAgentCashFees contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">91116</fil:PlacementAgentCashFees>
<fil:PlacementAgentCashFees contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">618174</fil:PlacementAgentCashFees>
<fil:PlacementAgentCommission contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">618497</fil:PlacementAgentCommission>
<fil:PlacementAgentCommission contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">75930</fil:PlacementAgentCommission>
<fil:PlacementAgentCommission contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">515145</fil:PlacementAgentCommission>
<fil:PlacementAgentExpenseReimbursement contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">123699</fil:PlacementAgentExpenseReimbursement>
<fil:PlacementAgentExpenseReimbursement contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">15186</fil:PlacementAgentExpenseReimbursement>
<fil:PlacementAgentExpenseReimbursement contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">103029</fil:PlacementAgentExpenseReimbursement>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="shares" decimals="0">986393</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember" unitRef="shares" decimals="0">1129925</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="shares" decimals="0">1974774</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="shares" decimals="0">121095</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember_SubsidiarySaleOfStockAxis_PlacementAgentMember" unitRef="shares" decimals="0">588940</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="shares" decimals="0">1716340</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantMember" unitRef="shares" decimals="0">3118988</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantsBMember" unitRef="shares" decimals="0">1559505</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsIssuedToPurchaseCommonStock contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="shares" decimals="0">467845</fil:WarrantsIssuedToPurchaseCommonStock>
<fil:WarrantsExpirationTerm contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember">P7Y</fil:WarrantsExpirationTerm>
<fil:WarrantsExpirationTerm contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember">P7Y</fil:WarrantsExpirationTerm>
<fil:WarrantsExpirationTerm contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantMember">P120D</fil:WarrantsExpirationTerm>
<fil:WarrantsExpirationTerm contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_FinancialInstrumentAxis_WarrantsBMember">P5Y</fil:WarrantsExpirationTerm>
<fil:WarrantsExpirationTerm contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember">P5Y</fil:WarrantsExpirationTerm>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">188579</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="USD" decimals="0">2153442</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">159044</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="USD" decimals="0">1957754</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">499707</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<fil:PlacementAgentServicesFees contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">60904</fil:PlacementAgentServicesFees>
<fil:PlacementAgentServicesFees contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">8020</fil:PlacementAgentServicesFees>
<fil:PlacementAgentServicesFees contextRef="Context_Custom_14-Jun-2000_31-Dec-2012_StatementClassOfStockAxis_CommonStockMember" unitRef="USD" decimals="0">60000</fil:PlacementAgentServicesFees>
<fil:BankEscrowFee contextRef="Context_FYE__31-Dec-2011_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">2500</fil:BankEscrowFee>
<fil:BankEscrowFee contextRef="Context_FYE__31-Dec-2012_StatementClassOfStockAxis_CommonStockMember_TypeOfArrangementAxis_LaidlawAndCoMember" unitRef="USD" decimals="0">3500</fil:BankEscrowFee>
<fil:AccruedManagementFees contextRef="Context_FYE__31-Dec-2011_SubsidiarySaleOfStockAxis_ManagementMember" unitRef="USD" decimals="0">96744</fil:AccruedManagementFees>
<fil:CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">400000</fil:CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement>
<fil:CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">1986566</fil:CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement>
<fil:UnrecognizedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">14528</fil:UnrecognizedShareBasedCompensationExpense>
<fil:UnrecognizedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">1998435</fil:UnrecognizedShareBasedCompensationExpense>
<fil:UnrecognizedShareBasedCompensationExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">1086848</fil:UnrecognizedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">19935</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="USD" decimals="0">2153442</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_3ME__30-Jun-2012" unitRef="USD" decimals="0">40410</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_6ME__30-Jun-2012" unitRef="USD" decimals="0">240400</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">266172</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="USD" decimals="0">1957754</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_3ME__30-Jun-2013" unitRef="USD" decimals="0">94200</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">188400</us-gaap:AllocatedShareBasedCompensationExpense>
<fil:AmountPaidForCancellationOfSharesByCompany contextRef="Context_Custom_01-May-2013_31-May-2013_TitleOfIndividualAxis_FormerDirectorAndConsultantsMember_FinancialInstrumentAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">25000</fil:AmountPaidForCancellationOfSharesByCompany>
<fil:SharesPurchasedAfterCancelationOfOptions contextRef="Context_Custom_01-May-2013_31-May-2013_TitleOfIndividualAxis_FormerDirectorAndConsultantsMember_FinancialInstrumentAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">49950</fil:SharesPurchasedAfterCancelationOfOptions>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_Custom_01-May-2013_31-May-2013_TitleOfIndividualAxis_FormerDirectorAndConsultantsMember_FinancialInstrumentAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_6ME__30-Jun-2013_FinancialInstrumentAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ProceedsFromWarrantExercises contextRef="Context_6ME__30-Jun-2013" unitRef="USD" decimals="0">3463641</us-gaap:ProceedsFromWarrantExercises>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">5364557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="INF">2056275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">7406079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember">P6Y9M4D</fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm>
<fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">P8Y10M21D</fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm>
<fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember">P3Y9M4D</fil:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="Context_As_Of__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember" unitRef="shares" decimals="0">757575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
<fil:MaximumGrantedOptionToPurchaseCommonStockAfterAmendment contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember" unitRef="shares" decimals="0">978154</fil:MaximumGrantedOptionToPurchaseCommonStockAfterAmendment>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2006_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2006_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2007_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2007_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2008_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2008_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2010_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2010_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember_RangeAxis_MinimumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember_RangeAxis_MaximumMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<fil:ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember" unitRef="pure" decimals="2">0.02</fil:ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="2">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
<fil:PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandTwelveEmployeeStockOptionPlanMember" unitRef="pure" decimals="2">0.15</fil:PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering>
<us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="Context_As_Of__31-Dec-2012_PlanNameAxis_TwoThousandTwelveEmployeeStockOptionPlanMember" unitRef="shares" decimals="0">9455776</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease contextRef="Context_FYE__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember" unitRef="shares" decimals="0">3217880</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease>
<fil:ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance contextRef="Context_As_Of__31-Dec-2012_PlanNameAxis_TwoThousandThreeStockPlanMember" unitRef="shares" decimals="0">6155280</fil:ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">206060</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">113220</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">69941</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">33300</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">1974774</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">2056275</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStock contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="shares" decimals="0">1716340</fil:StockOptionGrantedToPurchaseCommonStock>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.35</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.35</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.90</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.90</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.01</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">0.78</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="1">1.5</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockExercisePrice contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.01</fil:StockOptionGrantedToPurchaseCommonStockExercisePrice>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember">P10Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember">P10Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember">P10Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember">P10Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember">P7Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">P10Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember">P7Y</fil:StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">1051281</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">137652</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">44159</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">24996</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">1519777</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">0.0216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2011_RangeAxis_MaximumMember_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.0317</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2011_RangeAxis_MinimumMember_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.0192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="3">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.0182</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">1.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">1.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">1.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2011_RangeAxis_MaximumMember_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.7072</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2011_RangeAxis_MinimumMember_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.6477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MinimumMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">1.6044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2012_RangeAxis_MaximumMember_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="4">1.6149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="4">0.6064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2006_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2007_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2008_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2010_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2011_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE__31-Dec-2012_AwardTypeAxis_WarrantMember" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<fil:EmployeeStockOptionUnitsReprised contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="shares" decimals="0">273859</fil:EmployeeStockOptionUnitsReprised>
<fil:OutstandingStockOptionExercisePriceAfterRepricingOfStockOption contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD_per_Share" decimals="2">1.28</fil:OutstandingStockOptionExercisePriceAfterRepricingOfStockOption>
<fil:ShareBasedCompensationCostAfterRepricingOfStockOptions contextRef="Context_Custom_01-Feb-2012_29-Feb-2012_AwardTypeAxis_EmployeeStockOptionMember" unitRef="USD" decimals="0">34879</fil:ShareBasedCompensationCostAfterRepricingOfStockOptions>
<fil:WarrantsIssuedWithConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">287061</fil:WarrantsIssuedWithConvertibleNotes>
<fil:WarrantsIssuedWithConvertibleNotes contextRef="Context_FYE__31-Dec-2012" unitRef="shares" xsi:nil="true"/>
<fil:WarrantsIssuedToInvestorsWithStockOffering contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">1972766</fil:WarrantsIssuedToInvestorsWithStockOffering>
<fil:WarrantsIssuedToInvestorsWithStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">242189</fil:WarrantsIssuedToInvestorsWithStockOffering>
<fil:WarrantsIssuedToInvestorsWithCommonStock contextRef="Context_FYE__31-Dec-2011" unitRef="shares" xsi:nil="true"/>
<fil:WarrantsIssuedToInvestorsWithCommonStock contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">4678491</fil:WarrantsIssuedToInvestorsWithCommonStock>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">143532</fil:PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes contextRef="Context_FYE__31-Dec-2012" unitRef="shares" xsi:nil="true"/>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfStockOffering contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">986383</fil:PlacementAgentWarrantsRelatedToIssuanceOfStockOffering>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfStockOffering contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">121094</fil:PlacementAgentWarrantsRelatedToIssuanceOfStockOffering>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2011" unitRef="shares" xsi:nil="true"/>
<fil:PlacementAgentWarrantsRelatedToIssuanceOfCommonStock contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">467845</fil:PlacementAgentWarrantsRelatedToIssuanceOfCommonStock>
<fil:WarrantIssuedToInvestorsWithStockAccruedDividend contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">180115</fil:WarrantIssuedToInvestorsWithStockAccruedDividend>
<fil:WarrantsIssued contextRef="Context_FYE__31-Dec-2011" unitRef="shares" decimals="0">3389742</fil:WarrantsIssued>
<fil:WarrantsIssued contextRef="Context_FYE__31-Dec-2012" unitRef="shares" decimals="0">5689734</fil:WarrantsIssued>
<us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans contextRef="Context_FYE__31-Dec-2012">The plan requires 12 consecutive months of service and a minimum of 500 hours of service for participation.</us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans>
<us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="Context_FYE__31-Dec-2012" unitRef="pure" decimals="2">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="Context_FYE__31-Dec-2011" unitRef="USD" decimals="0">8885</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="Context_FYE__31-Dec-2012" unitRef="USD" decimals="0">8942</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
<fil:NumberOfInstallmentsInWhichConsiderationIsPayable contextRef="Context_Custom_27-Feb-2013_28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="Note" decimals="INF">2</fil:NumberOfInstallmentsInWhichConsiderationIsPayable>
<fil:ConsiderationPayableUnderAgreement contextRef="Context_As_Of__28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="0">250000</fil:ConsiderationPayableUnderAgreement>
<fil:AmountOfPerformanceBonus contextRef="Context_Custom_27-Feb-2013_28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember" unitRef="USD" decimals="0">60000</fil:AmountOfPerformanceBonus>
<fil:PeriodOfService contextRef="Context_Custom_27-Feb-2013_28-Feb-2013_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_SeparationAndSettlementAgreementMember_TitleOfIndividualAxis_FormerChiefExecutiveOfficerMember">August 15, 2012 to December 31, 2012</fil:PeriodOfService>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fil-20130630.xsd
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<schema targetNamespace="http://cactusventuresinc.com/20130630" elementFormDefault="qualified" xmlns:fil="http://cactusventuresinc.com/20130630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:us-types="http://fasb.org/us-types/2013-01-31">
<annotation><appinfo>
<link:roleType roleURI="http://cactusventuresinc.com/role/DocumentAndEntityInformation1" id="DocumentAndEntityInformation1">
<link:definition>001 - Document - Document and Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
<link:definition>002 - Statement - Consolidated Balance Sheets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical" id="ConsolidatedBalanceSheetsparenthetical">
<link:definition>003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
<link:definition>004 - Statement - Consolidated Statements of Operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit" id="Consolidatedstatementofchangesinstockholdersequitydeficit">
<link:definition>005 - Statement - Consolidated Statement of Changes in Stockholders' Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
<link:definition>006 - Statement - Statements of Cash Flows</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" id="DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies">
<link:definition>007 - Disclosure - Description of Business and Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Notes11" id="Notes11">
<link:definition>008 - Disclosure - Going Concern</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/RelatedPartyTransaction" id="RelatedPartyTransaction">
<link:definition>009 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
<link:definition>010 - Disclosure - Property and Equipment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotes" id="NotePayableAndConvertibleNotes">
<link:definition>011 - Disclosure - Note Payable and Convertible Notes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Derivatives" id="Derivatives">
<link:definition>012 - Disclosure - Derivatives</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>013 - Disclosure - Income Taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>014 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Equity" id="Equity">
<link:definition>015 - Disclosure - Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/StockOptionPlan" id="StockOptionPlan">
<link:definition>016 - Disclosure - Stock Option Plan</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Warrants" id="Warrants">
<link:definition>017 - Disclosure - Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlan" id="EmployeeDefinedContributionPlan">
<link:definition>018 - Disclosure - Employee Defined Contribution Plan</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Notes13" id="Notes13">
<link:definition>019 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" id="DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies">
<link:definition>020 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables" id="DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables">
<link:definition>021 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/RelatedPartyTransactiontables" id="RelatedPartyTransactiontables">
<link:definition>022 - Disclosure - Related Party Transactions (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentTables" id="PropertyandEquipmentTables">
<link:definition>023 - Disclosure - Property and Equipment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesTables" id="NotePayableAndConvertibleNotesTables">
<link:definition>024 - Disclosure - Note Payable and Convertible Notes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DerivativesTables" id="DerivativesTables">
<link:definition>025 - Disclosure - Derivatives (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>026 - Disclosure - Income Taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesTables" id="CommitmentsandContingenciesTables">
<link:definition>027 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/StockOptionPlanTables" id="StockOptionPlanTables">
<link:definition>028 - Disclosure - Stock Option Plan (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/EquityTables" id="EquityTables">
<link:definition>029 - Disclosure - Equity (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/WarrantsTables" id="WarrantsTables">
<link:definition>030 - Disclosure - Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails" id="DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails">
<link:definition>031 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1" id="DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1">
<link:definition>032 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/GoingconcernDetails" id="GoingconcernDetails">
<link:definition>033 - Disclosure - Going concern (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/RelatedPartyTransactiondetails" id="RelatedPartyTransactiondetails">
<link:definition>034 - Disclosure - Related Party Transactions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual" id="Relatedpartytransactiondetailstextual">
<link:definition>035 - Disclosure - Related Party Transactions (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentDetails" id="PropertyandEquipmentDetails">
<link:definition>036 - Disclosure - Property and Equipment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Propertyandequipmentdetailstesxtual" id="Propertyandequipmentdetailstesxtual">
<link:definition>037 - Disclosure - Property and Equipment (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails" id="NotePayableAndConvertibleNotesDetails">
<link:definition>038 - Disclosure - Note Payable and Convertible Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual" id="NotePayableAndConvertibleNotesDetailsTextual">
<link:definition>039 - Disclosure - Note Payable and Convertible Notes (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DerivativesDetails" id="DerivativesDetails">
<link:definition>040 - Disclosure - Derivatives (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DerivativesDetails1" id="DerivativesDetails1">
<link:definition>041 - Disclosure - Derivatives (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/DerivativesDetailsTextual" id="DerivativesDetailsTextual">
<link:definition>042 - Disclosure - Derivatives (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
<link:definition>043 - Disclosure - Income Taxes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
<link:definition>044 - Disclosure - Income Taxes (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/IncometaxesdetailsTextual" id="IncometaxesdetailsTextual">
<link:definition>045 - Disclosure - Income Taxes (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails" id="CommitmentsandContingenciesDetails">
<link:definition>046 - Disclosure - Commitments and Contingencies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual" id="Commitmentsandcontingenciesdetailstextual">
<link:definition>047 - Disclosure - Commitments and Contingencies (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Equitydetails" id="Equitydetails">
<link:definition>048 - Disclosure - Equity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/Equitydetailstextual" id="Equitydetailstextual">
<link:definition>049 - Disclosure - Equity (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetails" id="StockOptionPlanDetails">
<link:definition>050 - Disclosure - Stock Option Plan (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual" id="StockOptionPlanDetailsTextual">
<link:definition>051 - Disclosure - Stock Option Plan (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/WarrantsDetails" id="WarrantsDetails">
<link:definition>052 - Disclosure - Warrants (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/WarrantsDetails1" id="WarrantsDetails1">
<link:definition>053 - Disclosure - Warrants (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/WarrantsDetailsTextual" id="WarrantsDetailsTextual">
<link:definition>054 - Disclosure - Warrants (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlanDetails" id="EmployeeDefinedContributionPlanDetails">
<link:definition>055 - Disclosure - Employee Defined Contribution Plan (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://cactusventuresinc.com/role/SubsequenteventsDetails" id="SubsequenteventsDetails">
<link:definition>056 - Disclosure - Subsequent Events (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="fil-20130630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="fil-20130630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="fil-20130630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="fil-20130630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo></annotation>
<import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd"/>
<import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2013-01-31" schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="fil_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesCTwoPreferredStockMember" id="fil_SeriesCTwoPreferredStockMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesCThreePreferredStockMember" id="fil_SeriesCThreePreferredStockMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeriesCFourPreferredStockMember" id="fil_SeriesCFourPreferredStockMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromIssuanceOfCommonStockShares" id="fil_ProceedsFromIssuanceOfCommonStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfNotesPayableAndAccruedInterestToStockValue" id="fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfNotesPayableAndAccruedInterestToStockShares" id="fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharesIssuedAtReverseMergerValue" id="fil_SharesIssuedAtReverseMergerValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharesIssuedAtReverseMergerShares" id="fil_SharesIssuedAtReverseMergerShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdjustmentsToAdditionalPaidInCapitalWarrantExpense" id="fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" id="fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfTransferFromLiabilityClassificationToEquityClassification" id="fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RetireOfDerivativeLiability" id="fil_RetireOfDerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GainOnChangeInFairValueOfDerivatives" id="fil_GainOnChangeInFairValueOfDerivatives" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CashPaidForAbstract" id="fil_CashPaidForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfWarrantsIssuedWithDebt" id="fil_FairValueOfWarrantsIssuedWithDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfWarrantsIssuedWithStock" id="fil_FairValueOfWarrantsIssuedWithStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfWarrantsIssuedToPlacementAgent" id="fil_FairValueOfWarrantsIssuedToPlacementAgent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConversionOfNotesPayableAndAccruedInterestToCommonStock" id="fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GoingConcernAbstract" id="fil_GoingConcernAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GoingConcernTextBlock" id="fil_GoingConcernTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsAbstract" id="fil_WarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsTextBlock" id="fil_WarrantsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DevelopmentStageCompanyPolicyTextBlock" id="fil_DevelopmentStageCompanyPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" id="fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MilestonePaymentsMilestoneMethodTable" id="fil_MilestonePaymentsMilestoneMethodTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="AbbottBiotherapeuticsCorpMember" id="fil_AbbottBiotherapeuticsCorpMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MemorialSloanKetteringCancerCenterMember" id="fil_MemorialSloanKetteringCancerCenterMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MilestonePaymentsMilestoneMethodLineItems" id="fil_MilestonePaymentsMilestoneMethodLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MilestonePaymentsMilestoneMethodTableTextBlock" id="fil_MilestonePaymentsMilestoneMethodTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfWarrantsIssuedTableTextBlock" id="fil_ScheduleOfWarrantsIssuedTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfWarrantActivitiesTableTextBlock" id="fil_SummaryOfWarrantActivitiesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" id="fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" id="fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="ActiniumMember" id="fil_ActiniumMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OptionsAndWarrantsMember" id="fil_OptionsAndWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" id="fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" id="fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfOwnershipInterestToBeAcquired" id="fil_PercentageOfOwnershipInterestToBeAcquired" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockIssuableInConsiderationForEquityInterestAcquisition" id="fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" id="fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfSharesExchangedInShareExchangeProgramme" id="fil_PercentageOfSharesExchangedInShareExchangeProgramme" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GoingConcernTextualAbstract" id="fil_GoingConcernTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" id="fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReimbursementsReceivedFromRelatedParty" id="fil_ReimbursementsReceivedFromRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SloanKetteringInstituteOfCancerResearchMember" id="fil_SloanKetteringInstituteOfCancerResearchMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" id="fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RosemaryMazanetMember" id="fil_RosemaryMazanetMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LaidlawAndCompanyMember" id="fil_LaidlawAndCompanyMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="JamessCapitalGroupMember" id="fil_JamessCapitalGroupMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GuagentiAndAssociatesMember" id="fil_GuagentiAndAssociatesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementAxis" id="fil_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
<element name="AgreementDomain" id="fil_AgreementDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClinicalTrialAgreementMember" id="fil_ClinicalTrialAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LicenseDevelopmentAndCommercializationAgreementMember" id="fil_LicenseDevelopmentAndCommercializationAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConsultingServicesAgreementMember" id="fil_ConsultingServicesAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EngagementAgreementMember" id="fil_EngagementAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TransactionManagementAgreementMember" id="fil_TransactionManagementAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RelatedPartyTransactionsTextualAbstract" id="fil_RelatedPartyTransactionsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfPatients" id="fil_NumberOfPatients" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidUnderAgreementInYearTwoThousandEleven" id="fil_AmountPaidUnderAgreementInYearTwoThousandEleven" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidUnderAgreementInYearTwoThousandTwelve" id="fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidUnderAgreementInYearTwoThousandThirteen" id="fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MaintenanceFeesAndResearchPayments" id="fil_MaintenanceFeesAndResearchPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidUnderAgreement" id="fil_AmountPaidUnderAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalAmountDueUnderAgreement" id="fil_AdditionalAmountDueUnderAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfConditionForTerminationOfForbearancePeriod" id="fil_DescriptionOfConditionForTerminationOfForbearancePeriod" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TerminationDateOfForbearanceAgreement" id="fil_TerminationDateOfForbearanceAgreement" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" id="fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NewEquityFinanceRaisedByCompany" id="fil_NewEquityFinanceRaisedByCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ForgivenAmountOfObligations" id="fil_ForgivenAmountOfObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" id="fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidToEachPatient" id="fil_AmountPaidToEachPatient" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StartUpFeeForClinicalTrial" id="fil_StartUpFeeForClinicalTrial" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StartUpDueCostPaidDate" id="fil_StartUpDueCostPaidDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfSharesTransferTerm" id="fil_DescriptionOfSharesTransferTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OptionExercisePriceRange" id="fil_OptionExercisePriceRange" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OptionsReceivedToPurchaseCommonStock" id="fil_OptionsReceivedToPurchaseCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfReceivablesOfPlacementAgentForServices" id="fil_DescriptionOfReceivablesOfPlacementAgentForServices" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfWarrantsReceivablesByPlacement" id="fil_DescriptionOfWarrantsReceivablesByPlacement" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodOfExerciseOfWarrants" id="fil_PeriodOfExerciseOfWarrants" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfSolicitationFee" id="fil_PercentageOfSolicitationFee" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodicFeeForFinancialAdvisoryServices" id="fil_PeriodicFeeForFinancialAdvisoryServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfAdditionalReceivableByPlacementAgent" id="fil_DescriptionOfAdditionalReceivableByPlacementAgent" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockPurchaseByHoldingOfWarrant" id="fil_CommonStockPurchaseByHoldingOfWarrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodicFeeReceivedByManagementFirm" id="fil_PeriodicFeeReceivedByManagementFirm" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfFullyDilutedCapitalStockEqualToCommonStock" id="fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MaximumAmountOfOutOfPocketExpenses" id="fil_MaximumAmountOfOutOfPocketExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodicAmountOfRent" id="fil_PeriodicAmountOfRent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidToPursuantLeaseAgreement" id="fil_AmountPaidToPursuantLeaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LossOnDispositionOfPropertyAndEquipment" id="fil_LossOnDispositionOfPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PropertyAndEquipmentTextualAbstract" id="fil_PropertyAndEquipmentTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" id="fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfConvertiblePromissoryNotesAbstract" id="fil_SummaryOfConvertiblePromissoryNotesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DiscountRelatedToFairValueOfDerivativeWarrants" id="fil_DiscountRelatedToFairValueOfDerivativeWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentDiscountRelatedToBeneficialConversionFeature" id="fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentAmortizationOfDiscount" id="fil_DebtInstrumentAmortizationOfDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentPrincipalAmountConvertedToCommonStock" id="fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentMember" id="fil_PlacementAgentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ManagementFirmMember" id="fil_ManagementFirmMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NotePayableAndConvertibleNotesTextualAbstract" id="fil_NotePayableAndConvertibleNotesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockPurchaseDueToIssuanceOfWarrants" id="fil_CommonStockPurchaseDueToIssuanceOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmortizationPeriodOfNote" id="fil_AmortizationPeriodOfNote" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PremiumFinanceAgreementPrincipalAmount" id="fil_PremiumFinanceAgreementPrincipalAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentUnderPremiumFinanceAgreement" id="fil_PaymentUnderPremiumFinanceAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodicPaymentUnderPremiumFinanceAgreement" id="fil_PeriodicPaymentUnderPremiumFinanceAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DurationOfPeriodicPaymentsForPremiumFinanceAgreement" id="fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PremiumFinanceAgreementOutstandingAmount" id="fil_PremiumFinanceAgreementOutstandingAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromConvertibleNotes" id="fil_ProceedsFromConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" id="fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" id="fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantsIssuedWithConvertibleNotes" id="fil_DerivativeWarrantsIssuedWithConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InvestmentWarrantGrantDateFairValue" id="fil_InvestmentWarrantGrantDateFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtInstrumentFairValuePerShare" id="fil_DebtInstrumentFairValuePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ExtendedMaturityPeriodOfConvertibleNotes" id="fil_ExtendedMaturityPeriodOfConvertibleNotes" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfExtendedMaturityDate" id="fil_DescriptionOfExtendedMaturityDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InsurancePolicyDownPayment" id="fil_InsurancePolicyDownPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="InsurancePolicyInstallmentPayment" id="fil_InsurancePolicyInstallmentPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" id="fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantsUnits" id="fil_DerivativeWarrantsUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantUnitsReclassificationToPaidInCapital" id="fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" id="fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantsIssuedWithStockOffering" id="fil_DerivativeWarrantsIssuedWithStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" id="fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantsIssuedWithCommonStockOffering" id="fil_DerivativeWarrantsIssuedWithCommonStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantsIssuedWithCommonStockOfferingOne" id="fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativePlacementAgentWarrantsRelatedToStock" id="fil_DerivativePlacementAgentWarrantsRelatedToStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TransferFromLiabilityClassificationToEquityClassification" id="fil_TransferFromLiabilityClassificationToEquityClassification" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" id="fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" id="fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" id="fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativeWarrantsIssuedWithStockOffering" id="fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" id="fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" id="fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" id="fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" id="fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ChangeInFairValueOfDerivativeWarrants" id="fil_ChangeInFairValueOfDerivativeWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" id="fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MarketValueOfCommonStockOnMeasurementDate" id="fil_MarketValueOfCommonStockOnMeasurementDate" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RangeOfPercentageOfExistingSharesOffered" id="fil_RangeOfPercentageOfExistingSharesOffered" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FairValueAssumptionOfferingPrice" id="fil_FairValueAssumptionOfferingPrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DerivativeTextualAbstract" id="fil_DerivativeTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfRiskFreeInterestRateDetermination" id="fil_DescriptionOfRiskFreeInterestRateDetermination" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfProbabilityOfStockOffering" id="fil_DescriptionOfProbabilityOfStockOffering" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncomeTaxesTextualAbstract" id="fil_IncomeTaxesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PhaseFirstClinicalTrialOfLicensedProductMember" id="fil_PhaseFirstClinicalTrialOfLicensedProductMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PhaseSecondClinicalTrialOfLicensedProductMember" id="fil_PhaseSecondClinicalTrialOfLicensedProductMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PhaseThirdClinicalTrialOfLicensedProductMember" id="fil_PhaseThirdClinicalTrialOfLicensedProductMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BiologicalLicenseApplicationMember" id="fil_BiologicalLicenseApplicationMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FirstCommercialSaleMember" id="fil_FirstCommercialSaleMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AfterFirstNetSalesMember" id="fil_AfterFirstNetSalesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NewDrugApplicationMember" id="fil_NewDrugApplicationMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReceiptOfRegulatoryApprovalFromUSFdaMember" id="fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MilestonePaymentAbstract" id="fil_MilestonePaymentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LongTermPurchaseCommitmentMilestonesPayment" id="fil_LongTermPurchaseCommitmentMilestonesPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesTable" id="fil_CommitmentsAndContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="OakRidgeNationalLaboratoryMember" id="fil_OakRidgeNationalLaboratoryMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AptivSolutionsMember" id="fil_AptivSolutionsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FredHutchinsonCancerResearchCenterMember" id="fil_FredHutchinsonCancerResearchCenterMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" id="fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UniversityOfTexasMDAndersonCancerCenterMember" id="fil_UniversityOfTexasMDAndersonCancerCenterMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="JohnsHopkinsUniversityMember" id="fil_JohnsHopkinsUniversityMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LaidlawAndCoMember" id="fil_LaidlawAndCoMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UniversityOfPennsylvaniaMember" id="fil_UniversityOfPennsylvaniaMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProductDevelopmentAndPatentLicenseAgreementMember" id="fil_ProductDevelopmentAndPatentLicenseAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LicenseAgreementMember" id="fil_LicenseAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="LicenseAndSponsoredResearchAgreementMember" id="fil_LicenseAndSponsoredResearchAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentAgreementMember" id="fil_PlacementAgentAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RentalAgreementMember" id="fil_RentalAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeparationAndSettlementAgreementMember" id="fil_SeparationAndSettlementAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesLineItems" id="fil_CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommitmentsAndContingenciesTextualAbstract" id="fil_CommitmentsAndContingenciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentOfLicenseFee" id="fil_PaymentOfLicenseFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MilestonePaymentDate" id="fil_MilestonePaymentDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfRoyaltyPaymentToRelatedParty" id="fil_DescriptionOfRoyaltyPaymentToRelatedParty" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RoyaltyOfNetSalesPercentage" id="fil_RoyaltyOfNetSalesPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FirstCommercialSalePeriod" id="fil_FirstCommercialSalePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ResearchAndDevelopmentArrangement" id="fil_ResearchAndDevelopmentArrangement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PurchaseOfRadioactiveMaterial" id="fil_PurchaseOfRadioactiveMaterial" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProjectEstimatedCost" id="fil_ProjectEstimatedCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DownPaymentOfProjectEstimatedCostPercentage" id="fil_DownPaymentOfProjectEstimatedCostPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DownPaymentForProject" id="fil_DownPaymentForProject" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ClinicalTrialCostForApprovalForFoodAndDrugAdministration" id="fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FundToRelatedPartyUnderAgreementForFirstTwoYear" id="fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FundToRelatedPartyUnderAgreementAfterYearTwo" id="fil_FundToRelatedPartyUnderAgreementAfterYearTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantExercisableNoticePeriodDescription" id="fil_WarrantExercisableNoticePeriodDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DescriptionOfSharesAvailabilityByExerciseOfWarrant" id="fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NonRefundableInstitutionalFee" id="fil_NonRefundableInstitutionalFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PharmacyFee" id="fil_PharmacyFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmendmentProcessingFee" id="fil_AmendmentProcessingFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementConsideration" id="fil_AgreementConsideration" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPayableInInstallmentsUnderAgreement" id="fil_AmountPayableInInstallmentsUnderAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfInstallments" id="fil_NumberOfInstallments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PerformanceBonusPayableUnderAgreementForService" id="fil_PerformanceBonusPayableUnderAgreementForService" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementRenewalDescription" id="fil_AgreementRenewalDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentOfFirstInstallmentForServicesByCompany" id="fil_PaymentOfFirstInstallmentForServicesByCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentOfFinalInstallmentForServicesByCompany" id="fil_PaymentOfFinalInstallmentForServicesByCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PaymentOfPerformanceBonusForServicesByCompany" id="fil_PaymentOfPerformanceBonusForServicesByCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NoticePeriodForTerminationOfAgreement" id="fil_NoticePeriodForTerminationOfAgreement" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MccormickOBrienPllcMember" id="fil_MccormickOBrienPllcMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgencyAgreementMember" id="fil_PlacementAgencyAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="JamessCapitalGroupLlcMember" id="fil_JamessCapitalGroupLlcMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsBMember" id="fil_WarrantsBMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FormerDirectorAndConsultantsMember" id="fil_FormerDirectorAndConsultantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EquityTextualAbstract" id="fil_EquityTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedToPurchaseCommonStockOffering" id="fil_WarrantsIssuedToPurchaseCommonStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseOfferingOfCommonStock" id="fil_IncreaseOfferingOfCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockSharesIssuedInStockOffering" id="fil_CommonStockSharesIssuedInStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ProceedsFromIssuanceOfStockUnderStockOfferingNet" id="fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentCashFees" id="fil_PlacementAgentCashFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentCommission" id="fil_PlacementAgentCommission" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentExpenseReimbursement" id="fil_PlacementAgentExpenseReimbursement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedToPurchaseCommonStock" id="fil_WarrantsIssuedToPurchaseCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExpirationTerm" id="fil_WarrantsExpirationTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentServicesFees" id="fil_PlacementAgentServicesFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BankEscrowFee" id="fil_BankEscrowFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AccruedManagementFees" id="fil_AccruedManagementFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" id="fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" id="fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="UnrecognizedShareBasedCompensationExpense" id="fil_UnrecognizedShareBasedCompensationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountPaidForCancellationOfSharesByCompany" id="fil_AmountPaidForCancellationOfSharesByCompany" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SharesPurchasedAfterCancelationOfOptions" id="fil_SharesPurchasedAfterCancelationOfOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" id="fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoThousandThreeStockPlanMember" id="fil_TwoThousandThreeStockPlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoThousandTwelveEmployeeStockOptionPlanMember" id="fil_TwoThousandTwelveEmployeeStockOptionPlanMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EmployeesAndConsultantsMember" id="fil_EmployeesAndConsultantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConsultantsMember" id="fil_ConsultantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionPlanTextualAbstract" id="fil_StockOptionPlanTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" id="fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" id="fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" id="fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" id="fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionGrantedToPurchaseCommonStock" id="fil_StockOptionGrantedToPurchaseCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionGrantedToPurchaseCommonStockExercisePrice" id="fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" id="fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EmployeeStockOptionUnitsReprised" id="fil_EmployeeStockOptionUnitsReprised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" id="fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationCostAfterRepricingOfStockOptions" id="fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedAbstract" id="fil_WarrantsIssuedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedWithConvertibleNotes" id="fil_WarrantsIssuedWithConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedToInvestorsWithStockOffering" id="fil_WarrantsIssuedToInvestorsWithStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssuedToInvestorsWithCommonStock" id="fil_WarrantsIssuedToInvestorsWithCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" id="fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" id="fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" id="fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantIssuedToInvestorsWithStockAccruedDividend" id="fil_WarrantIssuedToInvestorsWithStockAccruedDividend" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsIssued" id="fil_WarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantTextualAbstract" id="fil_WarrantTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="EmployeeDefinedContributionPlanTextualAbstract" id="fil_EmployeeDefinedContributionPlanTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FormerChiefExecutiveOfficerMember" id="fil_FormerChiefExecutiveOfficerMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SubsequentEventsTextualAbstract" id="fil_SubsequentEventsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NumberOfInstallmentsInWhichConsiderationIsPayable" id="fil_NumberOfInstallmentsInWhichConsiderationIsPayable" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConsiderationPayableUnderAgreement" id="fil_ConsiderationPayableUnderAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AmountOfPerformanceBonus" id="fil_AmountOfPerformanceBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PeriodOfService" id="fil_PeriodOfService" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fil-20130630_cal.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedBalanceSheets" roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_Cash" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_NotesPayableCurrent" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent" order="50" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="40" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_LiabilitiesCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" order="20" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" order="30" use="optional" weight="1"/></calculationLink>





<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets" order="10" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_DepreciationAndAmortization" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SalesRevenueNet" order="50" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_SalesRevenueNet" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" order="10" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_OperatingIncomeLoss" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" order="20" use="optional" weight="1"/></calculationLink>



<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StatementsOfCashFlows" roleURI="http://cactusventuresinc.com/role/StatementsOfCashFlows"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_NetIncomeLoss" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium" order="50" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts" order="60" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" order="70" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GainOnChangeInFairValueOfDerivatives" xlink:label="loc_fil_GainOnChangeInFairValueOfDerivatives"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_fil_GainOnChangeInFairValueOfDerivatives" order="80" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" order="90" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="100" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="110" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" order="120" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets" order="10" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" order="20" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" order="30" use="optional" weight="1"/></calculationLink>



<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#PropertyandEquipmentDetails" roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="20" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LossOnDispositionOfPropertyAndEquipment" xlink:label="loc_fil_LossOnDispositionOfPropertyAndEquipment"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_fil_LossOnDispositionOfPropertyAndEquipment" order="30" use="optional" weight="-1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesDetails" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount" order="20" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DiscountRelatedToFairValueOfDerivativeWarrants" xlink:label="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants" order="30" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:label="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" order="40" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentAmortizationOfDiscount" xlink:label="loc_fil_DebtInstrumentAmortizationOfDiscount"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_fil_DebtInstrumentAmortizationOfDiscount" order="50" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xlink:label="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" order="60" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxesDetails" roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance" order="20" use="optional" weight="-1"/></calculationLink>

<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxesDetails1" roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails1"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" order="50" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="50" use="optional" weight="1"/></calculationLink>

<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetails" roleURI="http://cactusventuresinc.com/role/WarrantsDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetails">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssued" xlink:label="loc_fil_WarrantsIssued"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedWithConvertibleNotes" xlink:label="loc_fil_WarrantsIssuedWithConvertibleNotes"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_WarrantsIssuedWithConvertibleNotes" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithStockOffering" xlink:label="loc_fil_WarrantsIssuedToInvestorsWithStockOffering"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_WarrantsIssuedToInvestorsWithStockOffering" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithCommonStock" xlink:label="loc_fil_WarrantsIssuedToInvestorsWithCommonStock"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_WarrantsIssuedToInvestorsWithCommonStock" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" order="40" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" order="50" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" order="60" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xlink:label="loc_fil_WarrantIssuedToInvestorsWithStockAccruedDividend"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fil_WarrantsIssued" xlink:to="loc_fil_WarrantIssuedToInvestorsWithStockAccruedDividend" order="70" use="optional" weight="1"/>
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fil-20130630_def.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedBalanceSheets" roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedBalanceSheetsparenthetical" roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Consolidatedstatementofchangesinstockholdersequitydeficit" roleURI="http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StatementsOfCashFlows" roleURI="http://cactusventuresinc.com/role/StatementsOfCashFlows"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#CommitmentsandContingenciesTables" roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#EquityTables" roleURI="http://cactusventuresinc.com/role/EquityTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Relatedpartytransactiondetailstextual" roleURI="http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#PropertyandEquipmentDetails" roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesDetails" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesDetailsTextual" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesDetails1" roleURI="http://cactusventuresinc.com/role/DerivativesDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesDetailsTextual" roleURI="http://cactusventuresinc.com/role/DerivativesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#CommitmentsandContingenciesDetails" roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Commitmentsandcontingenciesdetailstextual" roleURI="http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Equitydetails" roleURI="http://cactusventuresinc.com/role/Equitydetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Equitydetailstextual" roleURI="http://cactusventuresinc.com/role/Equitydetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlanDetails" roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlanDetailsTextual" roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetails1" roleURI="http://cactusventuresinc.com/role/WarrantsDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetailsTextual" roleURI="http://cactusventuresinc.com/role/WarrantsDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#SubsequenteventsDetails" roleURI="http://cactusventuresinc.com/role/SubsequenteventsDetails"/>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AssetsAbstract_12" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_12" xlink:to="loc_us-gaap_AssetsCurrentAbstract_13" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13" xlink:to="loc_us-gaap_Cash_14" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_15" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_17" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13" xlink:to="loc_us-gaap_AssetsCurrent_18" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_19" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_12" xlink:to="loc_us-gaap_Assets_20" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_22" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_23" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_24" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_NotesPayableCurrent_25" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_26" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_27" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_LiabilitiesCurrent_28" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_22" xlink:to="loc_us-gaap_Liabilities_29" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_CommitmentsAndContingencies_30" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_StockholdersEquityAbstract_31" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_31" xlink:to="loc_us-gaap_PreferredStockValue_32" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_31" xlink:to="loc_us-gaap_CommonStockValue_33" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_31" xlink:to="loc_us-gaap_AdditionalPaidInCapital_34" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_31" xlink:to="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_35" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_31" xlink:to="loc_us-gaap_StockholdersEquity_36" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_21" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_37" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_12" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_13" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_14" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_15" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_16" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_17" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_18" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_19" order="80" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_12" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_CommonStockMember_13" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="loc_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_15" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_16" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_17" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_19" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_20" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfCommonStockShares" xlink:label="loc_fil_ProceedsFromIssuanceOfCommonStockShares_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_ProceedsFromIssuanceOfCommonStockShares_21" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_22" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_23" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue_24" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares_25" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerValue" xlink:label="loc_fil_SharesIssuedAtReverseMergerValue_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_SharesIssuedAtReverseMergerValue_26" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerShares" xlink:label="loc_fil_SharesIssuedAtReverseMergerShares_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_SharesIssuedAtReverseMergerShares_27" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_28" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xlink:label="loc_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense_29" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xlink:label="loc_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants_30" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_31" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RetireOfDerivativeLiability" xlink:label="loc_fil_RetireOfDerivativeLiability_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_RetireOfDerivativeLiability_32" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_33" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_34" order="190" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetIncomeLoss_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_5" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_7" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_8" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_10" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GainOnChangeInFairValueOfDerivatives" xlink:label="loc_fil_GainOnChangeInFairValueOfDerivatives_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_fil_GainOnChangeInFairValueOfDerivatives_11" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_12" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_12" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_13" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_12" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_14" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_15" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_15" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_16" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_15" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_17" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_20" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_19" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_24" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_25" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_26" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_27" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_28" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_29" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CashPaidForAbstract" xlink:label="loc_fil_CashPaidForAbstract_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_fil_CashPaidForAbstract_31" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CashPaidForAbstract_31" xlink:to="loc_us-gaap_InterestPaid_32" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CashPaidForAbstract_31" xlink:to="loc_us-gaap_IncomeTaxesPaid_33" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_35" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithDebt" xlink:label="loc_fil_FairValueOfWarrantsIssuedWithDebt_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_fil_FairValueOfWarrantsIssuedWithDebt_36" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithStock" xlink:label="loc_fil_FairValueOfWarrantsIssuedWithStock_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_fil_FairValueOfWarrantsIssuedWithStock_37" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedToPlacementAgent" xlink:label="loc_fil_FairValueOfWarrantsIssuedToPlacementAgent_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_fil_FairValueOfWarrantsIssuedToPlacementAgent_38" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock_39" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_34" xlink:to="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_40" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/CommitmentsandContingenciesTables">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodLineItems" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodLineItems_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTable" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodLineItems_0" xlink:to="loc_fil_MilestonePaymentsMilestoneMethodTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTableTextBlock" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodTableTextBlock_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodLineItems_0" xlink:to="loc_fil_MilestonePaymentsMilestoneMethodTableTextBlock_6" order="10" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/EquityTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6" order="10" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xlink:label="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_7" xlink:to="loc_us-gaap_DerivativeLiabilities_8" order="0" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_0" xlink:to="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ActiniumMember" xlink:label="loc_fil_ActiniumMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_fil_ActiniumMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_EmployeeStockOptionMember_11" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_WarrantMember_12" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_13" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_14" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsAndWarrantsMember" xlink:label="loc_fil_OptionsAndWarrantsMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_fil_OptionsAndWarrantsMember_15" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_16" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_17" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_17_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_17_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_17" xlink:to="loc_us-gaap_SubsequentEventMember_18" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_0" xlink:to="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfOwnershipInterestToBeAcquired" xlink:label="loc_fil_PercentageOfOwnershipInterestToBeAcquired_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_fil_PercentageOfOwnershipInterestToBeAcquired_20" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xlink:label="loc_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition_21" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xlink:label="loc_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage_22" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_23" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_24" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_25" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_26" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSharesExchangedInShareExchangeProgramme" xlink:label="loc_fil_PercentageOfSharesExchangedInShareExchangeProgramme_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_19" xlink:to="loc_fil_PercentageOfSharesExchangedInShareExchangeProgramme_27" order="70" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_fil_SloanKetteringInstituteOfCancerResearchMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_SloanKetteringInstituteOfCancerResearchMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RosemaryMazanetMember" xlink:label="loc_fil_RosemaryMazanetMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_RosemaryMazanetMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCompanyMember" xlink:label="loc_fil_LaidlawAndCompanyMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_LaidlawAndCompanyMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupMember" xlink:label="loc_fil_JamessCapitalGroupMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JamessCapitalGroupMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GuagentiAndAssociatesMember" xlink:label="loc_fil_GuagentiAndAssociatesMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_GuagentiAndAssociatesMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementAxis" xlink:label="loc_fil_AgreementAxis_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_fil_AgreementAxis_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_fil_AgreementAxis_11" xlink:to="loc_fil_AgreementDomain_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_12_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_fil_AgreementAxis_11" xlink:to="loc_fil_AgreementDomain_12_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialAgreementMember" xlink:label="loc_fil_ClinicalTrialAgreementMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_ClinicalTrialAgreementMember_13" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseDevelopmentAndCommercializationAgreementMember" xlink:label="loc_fil_LicenseDevelopmentAndCommercializationAgreementMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_LicenseDevelopmentAndCommercializationAgreementMember_14" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultingServicesAgreementMember" xlink:label="loc_fil_ConsultingServicesAgreementMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_ConsultingServicesAgreementMember_15" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EngagementAgreementMember" xlink:label="loc_fil_EngagementAgreementMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_EngagementAgreementMember_16" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransactionManagementAgreementMember" xlink:label="loc_fil_TransactionManagementAgreementMember_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_TransactionManagementAgreementMember_17" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RelatedPartyTransactionsTextualAbstract" xlink:label="loc_fil_RelatedPartyTransactionsTextualAbstract_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_fil_RelatedPartyTransactionsTextualAbstract_18" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfPatients" xlink:label="loc_fil_NumberOfPatients_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_NumberOfPatients_19" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandEleven_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandEleven_20" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve_21" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen_22" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaintenanceFeesAndResearchPayments" xlink:label="loc_fil_MaintenanceFeesAndResearchPayments_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_MaintenanceFeesAndResearchPayments_23" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreement" xlink:label="loc_fil_AmountPaidUnderAgreement_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidUnderAgreement_24" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdditionalAmountDueUnderAgreement" xlink:label="loc_fil_AdditionalAmountDueUnderAgreement_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AdditionalAmountDueUnderAgreement_25" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xlink:label="loc_fil_DescriptionOfConditionForTerminationOfForbearancePeriod_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_DescriptionOfConditionForTerminationOfForbearancePeriod_26" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TerminationDateOfForbearanceAgreement" xlink:label="loc_fil_TerminationDateOfForbearanceAgreement_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_TerminationDateOfForbearanceAgreement_27" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xlink:label="loc_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod_28" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewEquityFinanceRaisedByCompany" xlink:label="loc_fil_NewEquityFinanceRaisedByCompany_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_NewEquityFinanceRaisedByCompany_29" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ForgivenAmountOfObligations" xlink:label="loc_fil_ForgivenAmountOfObligations_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_ForgivenAmountOfObligations_30" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xlink:label="loc_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty_31" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_32" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToEachPatient" xlink:label="loc_fil_AmountPaidToEachPatient_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidToEachPatient_33" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpFeeForClinicalTrial" xlink:label="loc_fil_StartUpFeeForClinicalTrial_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_StartUpFeeForClinicalTrial_34" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpDueCostPaidDate" xlink:label="loc_fil_StartUpDueCostPaidDate_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_StartUpDueCostPaidDate_35" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesTransferTerm" xlink:label="loc_fil_DescriptionOfSharesTransferTerm_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_DescriptionOfSharesTransferTerm_36" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaap_OfficersCompensation_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_us-gaap_OfficersCompensation_37" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionExercisePriceRange" xlink:label="loc_fil_OptionExercisePriceRange_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_OptionExercisePriceRange_38" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_39" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsReceivedToPurchaseCommonStock" xlink:label="loc_fil_OptionsReceivedToPurchaseCommonStock_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_OptionsReceivedToPurchaseCommonStock_40" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfReceivablesOfPlacementAgentForServices" xlink:label="loc_fil_DescriptionOfReceivablesOfPlacementAgentForServices_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_DescriptionOfReceivablesOfPlacementAgentForServices_41" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfWarrantsReceivablesByPlacement" xlink:label="loc_fil_DescriptionOfWarrantsReceivablesByPlacement_42"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_DescriptionOfWarrantsReceivablesByPlacement_42" order="230" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfExerciseOfWarrants" xlink:label="loc_fil_PeriodOfExerciseOfWarrants_43"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PeriodOfExerciseOfWarrants_43" order="240" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSolicitationFee" xlink:label="loc_fil_PercentageOfSolicitationFee_44"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PercentageOfSolicitationFee_44" order="250" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeForFinancialAdvisoryServices" xlink:label="loc_fil_PeriodicFeeForFinancialAdvisoryServices_45"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PeriodicFeeForFinancialAdvisoryServices_45" order="260" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfAdditionalReceivableByPlacementAgent" xlink:label="loc_fil_DescriptionOfAdditionalReceivableByPlacementAgent_46"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_DescriptionOfAdditionalReceivableByPlacementAgent_46" order="270" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseByHoldingOfWarrant" xlink:label="loc_fil_CommonStockPurchaseByHoldingOfWarrant_47"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_CommonStockPurchaseByHoldingOfWarrant_47" order="280" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeReceivedByManagementFirm" xlink:label="loc_fil_PeriodicFeeReceivedByManagementFirm_48"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PeriodicFeeReceivedByManagementFirm_48" order="290" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:label="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_49"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_49" order="300" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumAmountOfOutOfPocketExpenses" xlink:label="loc_fil_MaximumAmountOfOutOfPocketExpenses_50"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_MaximumAmountOfOutOfPocketExpenses_50" order="310" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicAmountOfRent" xlink:label="loc_fil_PeriodicAmountOfRent_51"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_PeriodicAmountOfRent_51" order="320" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToPursuantLeaseAgreement" xlink:label="loc_fil_AmountPaidToPursuantLeaseAgreement_52"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_18" xlink:to="loc_fil_AmountPaidToPursuantLeaseAgreement_52" order="330" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_OfficeEquipmentMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LossOnDispositionOfPropertyAndEquipment" xlink:label="loc_fil_LossOnDispositionOfPropertyAndEquipment_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" xlink:to="loc_fil_LossOnDispositionOfPropertyAndEquipment_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_11" order="40" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xlink:label="loc_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3" xlink:to="loc_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfConvertiblePromissoryNotesAbstract" xlink:label="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0" xlink:to="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DiscountRelatedToFairValueOfDerivativeWarrants" xlink:label="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:label="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_9" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentAmortizationOfDiscount" xlink:label="loc_fil_DebtInstrumentAmortizationOfDiscount_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_fil_DebtInstrumentAmortizationOfDiscount_10" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xlink:label="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock_11" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_5" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_12" order="60" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentMember" xlink:label="loc_fil_PlacementAgentMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_PlacementAgentMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ManagementFirmMember" xlink:label="loc_fil_ManagementFirmMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_ManagementFirmMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NotePayableAndConvertibleNotesTextualAbstract" xlink:label="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_0" xlink:to="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseDueToIssuanceOfWarrants" xlink:label="loc_fil_CommonStockPurchaseDueToIssuanceOfWarrants_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_fil_CommonStockPurchaseDueToIssuanceOfWarrants_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate" xlink:label="loc_invest_InvestmentWarrantsExpirationDate_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_invest_InvestmentWarrantsExpirationDate_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmortizationPeriodOfNote" xlink:label="loc_fil_AmortizationPeriodOfNote_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_6" xlink:to="loc_fil_AmortizationPeriodOfNote_12" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0" xlink:to="loc_us-gaap_DerivativeTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xlink:label="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0" xlink:to="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MarketValueOfCommonStockOnMeasurementDate" xlink:label="loc_fil_MarketValueOfCommonStockOnMeasurementDate_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_fil_MarketValueOfCommonStockOnMeasurementDate_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_12" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsProbabilityOfDefault" xlink:label="loc_us-gaap_FairValueInputsProbabilityOfDefault_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_us-gaap_FairValueInputsProbabilityOfDefault_13" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RangeOfPercentageOfExistingSharesOffered" xlink:label="loc_fil_RangeOfPercentageOfExistingSharesOffered_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_fil_RangeOfPercentageOfExistingSharesOffered_14" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueAssumptionOfferingPrice" xlink:label="loc_fil_FairValueAssumptionOfferingPrice_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_6" xlink:to="loc_fil_FairValueAssumptionOfferingPrice_15" order="80" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeTextualAbstract" xlink:label="loc_fil_DerivativeTextualAbstract_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0" xlink:to="loc_fil_DerivativeTextualAbstract_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_DerivativeTextualAbstract_5" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_6" order="0" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_8" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseSecondClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseSecondClinicalTrialOfLicensedProductMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseSecondClinicalTrialOfLicensedProductMember_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseThirdClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseThirdClinicalTrialOfLicensedProductMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseThirdClinicalTrialOfLicensedProductMember_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BiologicalLicenseApplicationMember" xlink:label="loc_fil_BiologicalLicenseApplicationMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_BiologicalLicenseApplicationMember_11" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSaleMember" xlink:label="loc_fil_FirstCommercialSaleMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_FirstCommercialSaleMember_12" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AfterFirstNetSalesMember" xlink:label="loc_fil_AfterFirstNetSalesMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_AfterFirstNetSalesMember_13" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewDrugApplicationMember" xlink:label="loc_fil_NewDrugApplicationMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_NewDrugApplicationMember_14" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xlink:label="loc_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember_15" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentAbstract" xlink:label="loc_fil_MilestonePaymentAbstract_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_0" xlink:to="loc_fil_MilestonePaymentAbstract_16" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:label="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_MilestonePaymentAbstract_16" xlink:to="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_17" order="0" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesLineItems" xlink:label="loc_fil_CommitmentsAndContingenciesLineItems_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTable" xlink:label="loc_fil_CommitmentsAndContingenciesTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fil_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_fil_CommitmentsAndContingenciesTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OakRidgeNationalLaboratoryMember" xlink:label="loc_fil_OakRidgeNationalLaboratoryMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_OakRidgeNationalLaboratoryMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AptivSolutionsMember" xlink:label="loc_fil_AptivSolutionsMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AptivSolutionsMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FredHutchinsonCancerResearchCenterMember" xlink:label="loc_fil_FredHutchinsonCancerResearchCenterMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_FredHutchinsonCancerResearchCenterMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xlink:label="loc_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfTexasMDAndersonCancerCenterMember" xlink:label="loc_fil_UniversityOfTexasMDAndersonCancerCenterMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_UniversityOfTexasMDAndersonCancerCenterMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JohnsHopkinsUniversityMember" xlink:label="loc_fil_JohnsHopkinsUniversityMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JohnsHopkinsUniversityMember_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCoMember" xlink:label="loc_fil_LaidlawAndCoMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_LaidlawAndCoMember_12" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfPennsylvaniaMember" xlink:label="loc_fil_UniversityOfPennsylvaniaMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_UniversityOfPennsylvaniaMember_13" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupMember" xlink:label="loc_fil_JamessCapitalGroupMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JamessCapitalGroupMember_14" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_15" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AfterFirstNetSalesMember" xlink:label="loc_fil_AfterFirstNetSalesMember_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" xlink:to="loc_fil_AfterFirstNetSalesMember_18" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" xlink:to="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_19" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementAxis" xlink:label="loc_fil_AgreementAxis_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_fil_AgreementAxis_20" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_fil_AgreementAxis_20" xlink:to="loc_fil_AgreementDomain_21" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_21_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_fil_AgreementAxis_20" xlink:to="loc_fil_AgreementDomain_21_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProductDevelopmentAndPatentLicenseAgreementMember" xlink:label="loc_fil_ProductDevelopmentAndPatentLicenseAgreementMember_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_ProductDevelopmentAndPatentLicenseAgreementMember_22" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAgreementMember" xlink:label="loc_fil_LicenseAgreementMember_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_LicenseAgreementMember_23" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAndSponsoredResearchAgreementMember" xlink:label="loc_fil_LicenseAndSponsoredResearchAgreementMember_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_LicenseAndSponsoredResearchAgreementMember_24" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialAgreementMember" xlink:label="loc_fil_ClinicalTrialAgreementMember_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_ClinicalTrialAgreementMember_25" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentAgreementMember" xlink:label="loc_fil_PlacementAgentAgreementMember_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_PlacementAgentAgreementMember_26" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransactionManagementAgreementMember" xlink:label="loc_fil_TransactionManagementAgreementMember_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_TransactionManagementAgreementMember_27" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RentalAgreementMember" xlink:label="loc_fil_RentalAgreementMember_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_RentalAgreementMember_28" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeparationAndSettlementAgreementMember" xlink:label="loc_fil_SeparationAndSettlementAgreementMember_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_SeparationAndSettlementAgreementMember_29" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_RangeAxis_30" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_30" xlink:to="loc_us-gaap_RangeMember_31" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_31_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_30" xlink:to="loc_us-gaap_RangeMember_31_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_31" xlink:to="loc_us-gaap_MaximumMember_32" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_31" xlink:to="loc_us-gaap_MinimumMember_33" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTextualAbstract" xlink:label="loc_fil_CommitmentsAndContingenciesTextualAbstract_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfLicenseFee" xlink:label="loc_fil_PaymentOfLicenseFee_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PaymentOfLicenseFee_35" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:label="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_36" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_37" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentDate" xlink:label="loc_fil_MilestonePaymentDate_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_MilestonePaymentDate_38" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfRoyaltyPaymentToRelatedParty" xlink:label="loc_fil_DescriptionOfRoyaltyPaymentToRelatedParty_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_DescriptionOfRoyaltyPaymentToRelatedParty_39" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RoyaltyOfNetSalesPercentage" xlink:label="loc_fil_RoyaltyOfNetSalesPercentage_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_RoyaltyOfNetSalesPercentage_40" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSalePeriod" xlink:label="loc_fil_FirstCommercialSalePeriod_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_FirstCommercialSalePeriod_41" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="loc_us-gaap_TechnologyServicesCosts_42"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_us-gaap_TechnologyServicesCosts_42" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaap_MaintenanceCosts_43"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_us-gaap_MaintenanceCosts_43" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentArrangement" xlink:label="loc_fil_ResearchAndDevelopmentArrangement_44"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_ResearchAndDevelopmentArrangement_44" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PurchaseOfRadioactiveMaterial" xlink:label="loc_fil_PurchaseOfRadioactiveMaterial_45"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PurchaseOfRadioactiveMaterial_45" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProjectEstimatedCost" xlink:label="loc_fil_ProjectEstimatedCost_46"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_ProjectEstimatedCost_46" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentOfProjectEstimatedCostPercentage" xlink:label="loc_fil_DownPaymentOfProjectEstimatedCostPercentage_47"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_DownPaymentOfProjectEstimatedCostPercentage_47" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentForProject" xlink:label="loc_fil_DownPaymentForProject_48"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_DownPaymentForProject_48" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xlink:label="loc_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration_49"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration_49" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xlink:label="loc_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear_50"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear_50" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xlink:label="loc_fil_FundToRelatedPartyUnderAgreementAfterYearTwo_51"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_FundToRelatedPartyUnderAgreementAfterYearTwo_51" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_52"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_us-gaap_RoyaltyExpense_52" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfPatients" xlink:label="loc_fil_NumberOfPatients_53"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_NumberOfPatients_53" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToEachPatient" xlink:label="loc_fil_AmountPaidToEachPatient_54"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_AmountPaidToEachPatient_54" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpFeeForClinicalTrial" xlink:label="loc_fil_StartUpFeeForClinicalTrial_55"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_StartUpFeeForClinicalTrial_55" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpDueCostPaidDate" xlink:label="loc_fil_StartUpDueCostPaidDate_56"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_StartUpDueCostPaidDate_56" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeReceivedByManagementFirm" xlink:label="loc_fil_PeriodicFeeReceivedByManagementFirm_57"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PeriodicFeeReceivedByManagementFirm_57" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:label="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_58"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_58" order="230" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantExercisableNoticePeriodDescription" xlink:label="loc_fil_WarrantExercisableNoticePeriodDescription_59"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_WarrantExercisableNoticePeriodDescription_59" order="240" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xlink:label="loc_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant_60"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant_60" order="250" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumAmountOfOutOfPocketExpenses" xlink:label="loc_fil_MaximumAmountOfOutOfPocketExpenses_61"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_MaximumAmountOfOutOfPocketExpenses_61" order="260" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NonRefundableInstitutionalFee" xlink:label="loc_fil_NonRefundableInstitutionalFee_62"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_NonRefundableInstitutionalFee_62" order="270" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PharmacyFee" xlink:label="loc_fil_PharmacyFee_63"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PharmacyFee_63" order="280" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmendmentProcessingFee" xlink:label="loc_fil_AmendmentProcessingFee_64"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_AmendmentProcessingFee_64" order="290" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementConsideration" xlink:label="loc_fil_AgreementConsideration_65"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_AgreementConsideration_65" order="300" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPayableInInstallmentsUnderAgreement" xlink:label="loc_fil_AmountPayableInInstallmentsUnderAgreement_66"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_AmountPayableInInstallmentsUnderAgreement_66" order="310" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallments" xlink:label="loc_fil_NumberOfInstallments_67"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_NumberOfInstallments_67" order="320" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PerformanceBonusPayableUnderAgreementForService" xlink:label="loc_fil_PerformanceBonusPayableUnderAgreementForService_68"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PerformanceBonusPayableUnderAgreementForService_68" order="330" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementRenewalDescription" xlink:label="loc_fil_AgreementRenewalDescription_69"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_AgreementRenewalDescription_69" order="340" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFirstInstallmentForServicesByCompany" xlink:label="loc_fil_PaymentOfFirstInstallmentForServicesByCompany_70"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PaymentOfFirstInstallmentForServicesByCompany_70" order="350" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFinalInstallmentForServicesByCompany" xlink:label="loc_fil_PaymentOfFinalInstallmentForServicesByCompany_71"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PaymentOfFinalInstallmentForServicesByCompany_71" order="360" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfPerformanceBonusForServicesByCompany" xlink:label="loc_fil_PaymentOfPerformanceBonusForServicesByCompany_72"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_PaymentOfPerformanceBonusForServicesByCompany_72" order="370" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_73"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_us-gaap_LeaseExpirationDate1_73" order="380" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NoticePeriodForTerminationOfAgreement" xlink:label="loc_fil_NoticePeriodForTerminationOfAgreement_74"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_34" xlink:to="loc_fil_NoticePeriodForTerminationOfAgreement_74" order="390" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Equitydetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_12" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_13" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15" order="80" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Equitydetailstextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_CommonStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_12" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:label="loc_us-gaap_SeriesAMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAMember_13" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_us-gaap_SeriesBMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBMember_14" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_15" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_15" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_15" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCoMember" xlink:label="loc_fil_LaidlawAndCoMember_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" xlink:to="loc_fil_LaidlawAndCoMember_17" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MccormickOBrienPllcMember" xlink:label="loc_fil_MccormickOBrienPllcMember_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" xlink:to="loc_fil_MccormickOBrienPllcMember_18" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_19" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_19" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_19" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentMember" xlink:label="loc_fil_PlacementAgentMember_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_fil_PlacementAgentMember_21" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ManagementMember" xlink:label="loc_us-gaap_ManagementMember_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_us-gaap_ManagementMember_22" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_23" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgencyAgreementMember" xlink:label="loc_fil_PlacementAgencyAgreementMember_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_PlacementAgencyAgreementMember_25" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupLlcMember" xlink:label="loc_fil_JamessCapitalGroupLlcMember_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_JamessCapitalGroupLlcMember_26" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_us-gaap_WarrantMember_27" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsBMember" xlink:label="loc_fil_WarrantsBMember_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_WarrantsBMember_28" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_us-gaap_EmployeeStockOptionMember_29" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_30" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_30" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_30" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerDirectorAndConsultantsMember" xlink:label="loc_fil_FormerDirectorAndConsultantsMember_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31" xlink:to="loc_fil_FormerDirectorAndConsultantsMember_32" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EquityTextualAbstract" xlink:label="loc_fil_EquityTextualAbstract_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_fil_EquityTextualAbstract_33" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_34" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_35" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStockOffering" xlink:label="loc_fil_WarrantsIssuedToPurchaseCommonStockOffering_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_WarrantsIssuedToPurchaseCommonStockOffering_36" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_IncreaseOfferingOfCommonStock" xlink:label="loc_fil_IncreaseOfferingOfCommonStock_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_IncreaseOfferingOfCommonStock_37" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInStockOffering" xlink:label="loc_fil_CommonStockSharesIssuedInStockOffering_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_CommonStockSharesIssuedInStockOffering_38" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xlink:label="loc_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet_39" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCashFees" xlink:label="loc_fil_PlacementAgentCashFees_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_PlacementAgentCashFees_40" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCommission" xlink:label="loc_fil_PlacementAgentCommission_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_PlacementAgentCommission_41" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentExpenseReimbursement" xlink:label="loc_fil_PlacementAgentExpenseReimbursement_42"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_PlacementAgentExpenseReimbursement_42" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStock" xlink:label="loc_fil_WarrantsIssuedToPurchaseCommonStock_43"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_WarrantsIssuedToPurchaseCommonStock_43" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_44"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_44" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsExpirationTerm" xlink:label="loc_fil_WarrantsExpirationTerm_45"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_WarrantsExpirationTerm_45" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_46"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_46" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentServicesFees" xlink:label="loc_fil_PlacementAgentServicesFees_47"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_PlacementAgentServicesFees_47" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BankEscrowFee" xlink:label="loc_fil_BankEscrowFee_48"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_BankEscrowFee_48" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_49"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_49" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AccruedManagementFees" xlink:label="loc_fil_AccruedManagementFees_50"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_AccruedManagementFees_50" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xlink:label="loc_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement_51"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement_51" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xlink:label="loc_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement_52"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement_52" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UnrecognizedShareBasedCompensationExpense" xlink:label="loc_fil_UnrecognizedShareBasedCompensationExpense_53"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_UnrecognizedShareBasedCompensationExpense_53" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_54"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_54" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidForCancellationOfSharesByCompany" xlink:label="loc_fil_AmountPaidForCancellationOfSharesByCompany_55"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_AmountPaidForCancellationOfSharesByCompany_55" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesPurchasedAfterCancelationOfOptions" xlink:label="loc_fil_SharesPurchasedAfterCancelationOfOptions_56"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_fil_SharesPurchasedAfterCancelationOfOptions_56" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_57"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_57" order="230" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_58"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_EquityTextualAbstract_33" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_58" order="240" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlanDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_10" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_11" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_12" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_13" order="70" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_2" xlink:to="loc_us-gaap_PlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_2" xlink:to="loc_us-gaap_PlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandThreeStockPlanMember" xlink:label="loc_fil_TwoThousandThreeStockPlanMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_fil_TwoThousandThreeStockPlanMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xlink:label="loc_fil_TwoThousandTwelveEmployeeStockOptionPlanMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_fil_TwoThousandTwelveEmployeeStockOptionPlanMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RangeAxis_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_6" xlink:to="loc_us-gaap_RangeMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_7_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_6" xlink:to="loc_us-gaap_RangeMember_7_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_7" xlink:to="loc_us-gaap_MinimumMember_8" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_7" xlink:to="loc_us-gaap_MaximumMember_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" xlink:to="loc_us-gaap_EmployeeStockOptionMember_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_13" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_13" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_13" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeesAndConsultantsMember" xlink:label="loc_fil_EmployeesAndConsultantsMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" xlink:to="loc_fil_EmployeesAndConsultantsMember_15" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultantsMember" xlink:label="loc_fil_ConsultantsMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" xlink:to="loc_fil_ConsultantsMember_16" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionPlanTextualAbstract" xlink:label="loc_fil_StockOptionPlanTextualAbstract_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_fil_StockOptionPlanTextualAbstract_17" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_18" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xlink:label="loc_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment_19" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_20" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting_21" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_22" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xlink:label="loc_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering_23" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_25" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xlink:label="loc_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance_26" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStock" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStock_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStock_27" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_28" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_29" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_30" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_31" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_32" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_33" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_34" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_35" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_36" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeeStockOptionUnitsReprised" xlink:label="loc_fil_EmployeeStockOptionUnitsReprised_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_EmployeeStockOptionUnitsReprised_37" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xlink:label="loc_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption_38" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xlink:label="loc_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions_39" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UnrecognizedShareBasedCompensationExpense" xlink:label="loc_fil_UnrecognizedShareBasedCompensationExpense_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_fil_UnrecognizedShareBasedCompensationExpense_40" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_StockOptionPlanTextualAbstract_17" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_41" order="230" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_10" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_11" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_12" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_13" order="70" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7" xlink:to="loc_us-gaap_WarrantMember_8" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantTextualAbstract" xlink:label="loc_fil_WarrantTextualAbstract_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_fil_WarrantTextualAbstract_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStock" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStock_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStock_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_12" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_13" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_14" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_15" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_16" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_17" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_18" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_WarrantTextualAbstract_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_19" order="90" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/SubsequenteventsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeparationAndSettlementAgreementMember" xlink:label="loc_fil_SeparationAndSettlementAgreementMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_fil_SeparationAndSettlementAgreementMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_8" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_8" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerChiefExecutiveOfficerMember" xlink:label="loc_fil_FormerChiefExecutiveOfficerMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9" xlink:to="loc_fil_FormerChiefExecutiveOfficerMember_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SubsequentEventsTextualAbstract" xlink:label="loc_fil_SubsequentEventsTextualAbstract_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_fil_SubsequentEventsTextualAbstract_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xlink:label="loc_fil_NumberOfInstallmentsInWhichConsiderationIsPayable_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SubsequentEventsTextualAbstract_11" xlink:to="loc_fil_NumberOfInstallmentsInWhichConsiderationIsPayable_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsiderationPayableUnderAgreement" xlink:label="loc_fil_ConsiderationPayableUnderAgreement_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SubsequentEventsTextualAbstract_11" xlink:to="loc_fil_ConsiderationPayableUnderAgreement_13" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountOfPerformanceBonus" xlink:label="loc_fil_AmountOfPerformanceBonus_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SubsequentEventsTextualAbstract_11" xlink:to="loc_fil_AmountOfPerformanceBonus_14" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfService" xlink:label="loc_fil_PeriodOfService_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fil_SubsequentEventsTextualAbstract_11" xlink:to="loc_fil_PeriodOfService_15" order="30" use="optional"/>
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fil-20130630_lab.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DocumentAndEntityInformationAbstract" xlink:label="loc_659926H556J3_fil_DocumentAndEntityInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DocumentAndEntityInformationAbstract" xlink:to="lab_871148J778L5_fil_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_K44K1GFGG78K9F35F361_dei_EntityRegistrantName"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_dei_EntityRegistrantName" xlink:to="lab_M66M3IHII90M1H57H583_dei_EntityRegistrantName"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_659926H556J3_dei_EntityCentralIndexKey"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_dei_EntityCentralIndexKey" xlink:to="lab_871148J778L5_dei_EntityCentralIndexKey"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_K44K1GFGG78K9F35F361_dei_AmendmentFlag"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_dei_AmendmentFlag" xlink:to="lab_M66M3IHII90M1H57H583_dei_AmendmentFlag"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="loc_659926H556J3_dei_DocumentType"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_dei_DocumentType" xml:lang="en-US">Document Type</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_dei_DocumentType" xlink:to="lab_871148J778L5_dei_DocumentType"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_K44K1GFGG78K9F35F361_dei_DocumentPeriodEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_dei_DocumentPeriodEndDate" xlink:to="lab_M66M3IHII90M1H57H583_dei_DocumentPeriodEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_659926H556J3_dei_EntityFilerCategory"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_dei_EntityFilerCategory" xlink:to="lab_871148J778L5_dei_EntityFilerCategory"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfFinancialPositionAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Balance Sheets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_659926H556J3_us-gaap_StatementTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StatementTable" xlink:to="lab_871148J778L5_us-gaap_StatementTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StatementClassOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class Of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StatementClassOfStockAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StatementClassOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_659926H556J3_us-gaap_ClassOfStockDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class Of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ClassOfStockDomain" xlink:to="lab_871148J778L5_us-gaap_ClassOfStockDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesAPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SeriesAPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_659926H556J3_us-gaap_SeriesBPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_871148J778L5_us-gaap_SeriesBPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesCPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US">Series C Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US">Series C-1 Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SeriesCPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_659926H556J3_fil_SeriesCTwoPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SeriesCTwoPreferredStockMember" xml:lang="en-US">Series C Two Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SeriesCTwoPreferredStockMember" xml:lang="en-US">Series C-2 Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SeriesCTwoPreferredStockMember" xml:lang="en-US">Outstanding nonredeemable series C two preferred stock or outstanding series C two preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SeriesCTwoPreferredStockMember" xlink:to="lab_871148J778L5_fil_SeriesCTwoPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_SeriesCThreePreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_SeriesCThreePreferredStockMember" xml:lang="en-US">Series C Three Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_SeriesCThreePreferredStockMember" xml:lang="en-US">Series C-3 Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_SeriesCThreePreferredStockMember" xml:lang="en-US">Outstanding nonredeemable series C three preferred stock or outstanding series C three preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_SeriesCThreePreferredStockMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_SeriesCThreePreferredStockMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_659926H556J3_fil_SeriesCFourPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SeriesCFourPreferredStockMember" xml:lang="en-US">Series C Four Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SeriesCFourPreferredStockMember" xml:lang="en-US">Series C-4 Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SeriesCFourPreferredStockMember" xml:lang="en-US">Outstanding nonredeemable series C four preferred stock or outstanding series C four preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SeriesCFourPreferredStockMember" xlink:to="lab_871148J778L5_fil_SeriesCFourPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesDPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesDPreferredStockMember" xml:lang="en-US">Series D Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesDPreferredStockMember" xml:lang="en-US">Series D Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SeriesDPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_659926H556J3_us-gaap_SeriesEPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SeriesEPreferredStockMember" xml:lang="en-US">Series E Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SeriesEPreferredStockMember" xml:lang="en-US">Series E Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_871148J778L5_us-gaap_SeriesEPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StatementLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StatementLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_659926H556J3_us-gaap_AssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AssetsAbstract" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AssetsAbstract" xlink:to="lab_871148J778L5_us-gaap_AssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AssetsCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AssetsCurrentAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AssetsCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="loc_659926H556J3_us-gaap_Cash"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_Cash" xml:lang="en-US">Cash In Bank</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_Cash" xml:lang="en-US">Cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_Cash" xlink:to="lab_871148J778L5_us-gaap_Cash"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US">Accounts and Other Receivables, Net, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US">R&amp;D reimbursement receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_659926H556J3_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_871148J778L5_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredFinanceCostsCurrentNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredFinanceCostsCurrentNet" xml:lang="en-US">Deferred Finance Costs, Current, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredFinanceCostsCurrentNet" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DeferredFinanceCostsCurrentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_659926H556J3_us-gaap_AssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_AssetsCurrent" xml:lang="en-US">Total Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AssetsCurrent" xlink:to="lab_871148J778L5_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net of accumulated depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_659926H556J3_us-gaap_Assets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_Assets" xml:lang="en-US">Total assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_Assets" xlink:to="lab_871148J778L5_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Stockholders' Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_659926H556J3_us-gaap_LiabilitiesCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_871148J778L5_us-gaap_LiabilitiesCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xml:lang="en-US">Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xml:lang="en-US">Accounts payable and accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_659926H556J3_us-gaap_AccountsPayableRelatedPartiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AccountsPayableRelatedPartiesCurrent" xml:lang="en-US">Accounts Payable, Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AccountsPayableRelatedPartiesCurrent" xml:lang="en-US">Accounts payable and accrued expenses - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="lab_871148J778L5_us-gaap_AccountsPayableRelatedPartiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NotesPayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NotesPayableCurrent" xml:lang="en-US">Notes Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NotesPayableCurrent" xml:lang="en-US">Notes payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NotesPayableCurrent" xml:lang="en-US">Notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NotesPayableCurrent" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NotesPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_659926H556J3_us-gaap_ConvertibleNotesPayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ConvertibleNotesPayableCurrent" xml:lang="en-US">Convertible Notes Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ConvertibleNotesPayableCurrent" xml:lang="en-US">Convertible notes payable, net of unamortized discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_ConvertibleNotesPayableCurrent" xml:lang="en-US">Carrying value at December 31, 2012 and 2011, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_871148J778L5_us-gaap_ConvertibleNotesPayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeLiabilitiesCurrent" xml:lang="en-US">Derivative Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeLiabilitiesCurrent" xml:lang="en-US">Derivative liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_659926H556J3_us-gaap_LiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_LiabilitiesCurrent" xlink:to="lab_871148J778L5_us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_Liabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_Liabilities" xml:lang="en-US">Total Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_Liabilities" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_659926H556J3_us-gaap_CommitmentsAndContingencies"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CommitmentsAndContingencies" xlink:to="lab_871148J778L5_us-gaap_CommitmentsAndContingencies"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Shareholders' Deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Shareholders' deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StockholdersEquityAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_659926H556J3_us-gaap_PreferredStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, 100,000,000 Shares .01 Par Authorized, 0 Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock, 100,000,000 shares $.01 par authorized, 0 outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PreferredStockValue" xlink:to="lab_871148J778L5_us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, 100,000,000 shares, $.01 par authorized, 11,155,008 outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockValue" xml:lang="en-US">Common stock value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockValue" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_659926H556J3_us-gaap_AdditionalPaidInCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid In Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Paid in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AdditionalPaidInCapital" xlink:to="lab_871148J778L5_us-gaap_AdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xml:lang="en-US">Development Stage Enterprise, Deficit Accumulated During Development Stage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xml:lang="en-US">Deficit accumulated during development stage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xml:lang="en-US">Deficit accumulated during the development stage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_659926H556J3_us-gaap_StockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable To Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholder's Deficiency</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Total shareholders' equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Total Stockholders' Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquity" xml:lang="en-US">Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StockholdersEquity" xlink:to="lab_871148J778L5_us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_LiabilitiesAndStockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and shareholders' equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total Liabilities and Stockholders' Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_659926H556J3_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par Or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_871148J778L5_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PreferredStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_659926H556J3_us-gaap_PreferredStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PreferredStockSharesIssued" xlink:to="lab_871148J778L5_us-gaap_PreferredStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PreferredStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">No. of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PreferredStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_659926H556J3_us-gaap_CommonStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par Or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_871148J778L5_us-gaap_CommonStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_659926H556J3_us-gaap_CommonStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock shares issued in exchange of equity securities of company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CommonStockSharesIssued" xlink:to="lab_871148J778L5_us-gaap_CommonStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_659926H556J3_us-gaap_IncomeStatementAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Statements Of Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeStatementAbstract" xlink:to="lab_871148J778L5_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SalesRevenueNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SalesRevenueNet" xml:lang="en-US">Sales</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SalesRevenueNet" xml:lang="en-US">Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SalesRevenueNet" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SalesRevenueNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_659926H556J3_us-gaap_OperatingExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_OperatingExpensesAbstract" xlink:to="lab_871148J778L5_us-gaap_OperatingExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ResearchAndDevelopmentExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development, net of reimbursements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_659926H556J3_us-gaap_GeneralAndAdministrativeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_871148J778L5_us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DepreciationAndAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DepreciationAndAmortization" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_659926H556J3_us-gaap_GainLossOnDispositionOfAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US">Loss on disposition of equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US">Loss on disposition of equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_GainLossOnDispositionOfAssets" xml:lang="en-US">Loss on disposition of equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_871148J778L5_us-gaap_GainLossOnDispositionOfAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_OperatingExpenses"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OperatingExpenses" xml:lang="en-US">Total expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_OperatingExpenses" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_659926H556J3_us-gaap_OperatingIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Net loss from operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Loss from operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_OperatingIncomeLoss" xlink:to="lab_871148J778L5_us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NonoperatingIncomeExpenseAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other Income (Expense):</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpenseAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_659926H556J3_us-gaap_InterestExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_InterestExpense" xml:lang="en-US">Interest Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_InterestExpense" xlink:to="lab_871148J778L5_us-gaap_InterestExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gains (Losses) On Extinguishment Of Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain on extinguishment of liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain on extinguishment of liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_GainsLossesOnExtinguishmentOfDebt" xml:lang="en-US">Gain on extinguishment of liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_659926H556J3_us-gaap_DerivativeGainLossOnDerivativeNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Derivative, Gain (Loss) On Derivative, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Loss on change in fair value of the derivatives</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Change in fair value - derivative liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US">Gain/loss on change in fair value of the derivatives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_871148J778L5_us-gaap_DerivativeGainLossOnDerivativeNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NonoperatingIncomeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Net Other income (expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total other income (expense)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_659926H556J3_us-gaap_NetIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income (loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_NetIncomeLoss" xlink:to="lab_871148J778L5_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EarningsPerShareBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Loss Per Common Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net loss per common share - basic and diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerShareBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_659926H556J3_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number Of Shares Outstanding, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted average common shares outstanding - basic and diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_871148J778L5_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement Of Changes In Stockholders' Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_659926H556J3_us-gaap_StatementEquityComponentsAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_871148J778L5_us-gaap_StatementEquityComponentsAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EquityComponentDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EquityComponentDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EquityComponentDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_659926H556J3_us-gaap_RetainedEarningsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RetainedEarningsMember" xlink:to="lab_871148J778L5_us-gaap_RetainedEarningsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_659926H556J3_us-gaap_AdditionalPaidInCapitalMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-In Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_871148J778L5_us-gaap_AdditionalPaidInCapitalMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xml:lang="en-US">Accumulated Deficit During Development Stage [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xml:lang="en-US">Deficit Accumulated During the Development Stage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_659926H556J3_us-gaap_SharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SharesOutstanding" xml:lang="en-US">Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SharesOutstanding" xml:lang="en-US">Balance (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_us-gaap_SharesOutstanding" xml:lang="en-US">Beginning Balance, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_us-gaap_SharesOutstanding" xml:lang="en-US">Balance, Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SharesOutstanding" xlink:to="lab_871148J778L5_us-gaap_SharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of founder shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of founder shares, Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds From Issuance Of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Sales of common stock, net of offering costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from issuance of - stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfCommonStockShares" xlink:label="loc_659926H556J3_fil_ProceedsFromIssuanceOfCommonStockShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ProceedsFromIssuanceOfCommonStockShares" xml:lang="en-US">Proceeds From Issuance Of Common Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ProceedsFromIssuanceOfCommonStockShares" xml:lang="en-US">Proceeds from issuance of - stock, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ProceedsFromIssuanceOfCommonStockShares" xml:lang="en-US">Proceeds from issuance of common stock shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ProceedsFromIssuanceOfCommonStockShares" xlink:to="lab_871148J778L5_fil_ProceedsFromIssuanceOfCommonStockShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Stock Issued During Period, Value, Issued For Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Common stock issued for services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock Issued During Period, Shares, Issued For Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Common stock issued for services, Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xml:lang="en-US">Conversion Of Notes Payable and Accrued Interest To Stock Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xml:lang="en-US">Conversion of notes payable and accrued interest to stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xml:lang="en-US">Conversion of notes payable and accrued interest to stock, Value.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xlink:to="lab_M66M3IHII90M1H57H583_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xlink:label="loc_659926H556J3_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xml:lang="en-US">Conversion Of Notes Payable and Accrued Interest To Stock Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xml:lang="en-US">Conversion of notes payable and accrued interest to stock, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xml:lang="en-US">Conversion of notes payable and accrued interest to stock, shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xlink:to="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerValue" xlink:label="loc_K44K1GFGG78K9F35F361_fil_SharesIssuedAtReverseMergerValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_SharesIssuedAtReverseMergerValue" xml:lang="en-US">Shares Issued At Reverse Merger Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_SharesIssuedAtReverseMergerValue" xml:lang="en-US">Shares issued at the reverse merger</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_SharesIssuedAtReverseMergerValue" xml:lang="en-US">Shares issued at the reverse merger value.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_SharesIssuedAtReverseMergerValue" xlink:to="lab_M66M3IHII90M1H57H583_fil_SharesIssuedAtReverseMergerValue"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerShares" xlink:label="loc_659926H556J3_fil_SharesIssuedAtReverseMergerShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SharesIssuedAtReverseMergerShares" xml:lang="en-US">Shares Issued At Reverse Merger Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SharesIssuedAtReverseMergerShares" xml:lang="en-US">Shares issued at the reverse merger, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SharesIssuedAtReverseMergerShares" xml:lang="en-US">Shares issued at the reverse merger shares.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="lab_871148J778L5_fil_SharesIssuedAtReverseMergerShares" xml:lang="en-US">Reverse merger transaction, Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SharesIssuedAtReverseMergerShares" xlink:to="lab_871148J778L5_fil_SharesIssuedAtReverseMergerShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">Adjustments To Additional Paid In Capital, Share-Based Compensation, Stock Options, Requisite Service Period Recognition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">Option expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xlink:label="loc_659926H556J3_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xml:lang="en-US">Adjustments To Additional Paid In Capital Warrant Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xml:lang="en-US">Warrant expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xml:lang="en-US">Adjustments to additional paid in capital warrant expense.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xlink:to="lab_871148J778L5_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xml:lang="en-US">Adjustments To Additional Paid In Capital Fair Value Of Derivative Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xml:lang="en-US">Fair value of derivative warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xml:lang="en-US">Adjustments to additional paid in capital fair value of derivative warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xlink:to="lab_M66M3IHII90M1H57H583_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_659926H556J3_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Fair Value Of Transfer From Liability Classification To Equity Classification</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Transfer from liability classification to equity classification</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Transfer from liability classification to equity classification, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Fair value of Transfer from liability classification to equity classification.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:to="lab_871148J778L5_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RetireOfDerivativeLiability" xlink:label="loc_K44K1GFGG78K9F35F361_fil_RetireOfDerivativeLiability"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_RetireOfDerivativeLiability" xml:lang="en-US">Retire Of Derivative Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_RetireOfDerivativeLiability" xml:lang="en-US">Retire of derivative liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_RetireOfDerivativeLiability" xml:lang="en-US">Retire of derivative liability.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_RetireOfDerivativeLiability" xlink:to="lab_M66M3IHII90M1H57H583_fil_RetireOfDerivativeLiability"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_659926H556J3_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xml:lang="en-US">Adjustments To Additional Paid In Capital, Convertible Debt With Conversion Feature</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xml:lang="en-US">Beneficial conversion feature discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="lab_871148J778L5_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfCashFlowsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement Of Cash Flows [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided By (Used In) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash Flows From Operating Activities:</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_659926H556J3_us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xml:lang="en-US">Employee Benefits and Share-Based Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xml:lang="en-US">Stock-based compensation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_871148J778L5_us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DepreciationDepletionAndAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DepreciationDepletionAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_659926H556J3_us-gaap_AmortizationOfDebtDiscountPremium"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US">Amortization Of Debt Discount (Premium)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US">Add: amortization of discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AmortizationOfDebtDiscountPremium" xml:lang="en-US">Amortization of debt discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_871148J778L5_us-gaap_AmortizationOfDebtDiscountPremium"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AmortizationOfFinancingCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US">Amortization Of Financing Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US">Amortization of deferred financing costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AmortizationOfFinancingCosts"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GainOnChangeInFairValueOfDerivatives" xlink:label="loc_659926H556J3_fil_GainOnChangeInFairValueOfDerivatives"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_GainOnChangeInFairValueOfDerivatives" xml:lang="en-US">Gain On Change In Fair Value Of Derivatives</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_GainOnChangeInFairValueOfDerivatives" xml:lang="en-US">Gain on change in fair value of the derivatives</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_GainOnChangeInFairValueOfDerivatives" xml:lang="en-US">Gain on change in fair value of the derivatives.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_fil_GainOnChangeInFairValueOfDerivatives" xml:lang="en-US">Gain on change in fair value of derivative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_GainOnChangeInFairValueOfDerivatives" xlink:to="lab_871148J778L5_fil_GainOnChangeInFairValueOfDerivatives"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xml:lang="en-US">(Increase) decrease in:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_659926H556J3_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xml:lang="en-US">Increase (Decrease) In Accounts Receivable, Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xml:lang="en-US">R&amp;D reimbursement receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xml:lang="en-US">R&amp;D reimbursable receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) In Prepaid Expense and Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Prepaid expenses and other current assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_659926H556J3_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xml:lang="en-US">Increase (Decrease) in Operating Liabilities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xml:lang="en-US">Increase (decrease) in:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="lab_871148J778L5_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase (Decrease) In Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Accounts payable and accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_659926H556J3_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xml:lang="en-US">Increase (Decrease) In Accounts Payable, Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xml:lang="en-US">Accounts payable and accrued liabilities - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="lab_871148J778L5_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided By Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Used In Operating Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash Flows From Investing Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PaymentsToAcquireIntangibleAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Payments To Acquire Intangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Payment made for patent rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PaymentsToAcquireIntangibleAssets" xml:lang="en-US">Payment made for patent rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PaymentsToAcquireIntangibleAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_659926H556J3_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments To Acquire Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchases of property, plant and equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchase of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_871148J778L5_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided By (Used In) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Used In Investing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash Flows From Financing Activities:</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_871148J778L5_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xml:lang="en-US">Proceeds From Debt, Net Of Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xml:lang="en-US">Borrowings on convertible debt, net of offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_659926H556J3_us-gaap_RepaymentsOfNotesPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US">Repayments of Notes Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US">Payments on note payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US">Payments on note payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_871148J778L5_us-gaap_RepaymentsOfNotesPayable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Proceeds From Issuance Of Preferred Stock and Preference Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Sales of stock, net of offering costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xml:lang="en-US">Proceeds from issuance of preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_659926H556J3_us-gaap_ProceedsFromIssuanceOfWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from the exercise of warrants for cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_871148J778L5_us-gaap_ProceedsFromIssuanceOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided By (Used In) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided By Financing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_659926H556J3_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net increase (decrease) in cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">INCREASE IN CASH AND CASH EQUIVALENTS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net change in cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_871148J778L5_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, At Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents at the beginning of the year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CashPaidForAbstract" xlink:label="loc_659926H556J3_fil_CashPaidForAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CashPaidForAbstract" xml:lang="en-US">Cash Paid For [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_CashPaidForAbstract" xml:lang="en-US">Supplemental disclosures of cash flow information:</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CashPaidForAbstract" xml:lang="en-US">Cash paid for:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CashPaidForAbstract" xlink:to="lab_871148J778L5_fil_CashPaidForAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_InterestPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_InterestPaid" xml:lang="en-US">Interest Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_InterestPaid" xml:lang="en-US">Cash paid for interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_InterestPaid" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_InterestPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxesPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income Taxes Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Cash paid for taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxesPaid" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxesPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_659926H556J3_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xml:lang="en-US">Debt Instrument, Convertible, Beneficial Conversion Feature</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xml:lang="en-US">Beneficial conversion feature discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithDebt" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfWarrantsIssuedWithDebt"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedWithDebt" xml:lang="en-US">Fair Value Of Warrants Issued With Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedWithDebt" xml:lang="en-US">Fair value of warrants issued with debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedWithDebt" xml:lang="en-US">Fair value of warrants issued with debt.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfWarrantsIssuedWithDebt" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedWithDebt"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithStock" xlink:label="loc_659926H556J3_fil_FairValueOfWarrantsIssuedWithStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FairValueOfWarrantsIssuedWithStock" xml:lang="en-US">Fair Value Of Warrants Issued With Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfWarrantsIssuedWithStock" xml:lang="en-US">Fair value of warrants issued with stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FairValueOfWarrantsIssuedWithStock" xml:lang="en-US">Fair value of warrants issued with stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FairValueOfWarrantsIssuedWithStock" xlink:to="lab_871148J778L5_fil_FairValueOfWarrantsIssuedWithStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedToPlacementAgent" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfWarrantsIssuedToPlacementAgent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedToPlacementAgent" xml:lang="en-US">Fair Value Of Warrants Issued To Placement Agent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedToPlacementAgent" xml:lang="en-US">Fair value of warrants issued to the placement agent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedToPlacementAgent" xml:lang="en-US">Fair value of warrants issued to the placement agent.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfWarrantsIssuedToPlacementAgent" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfWarrantsIssuedToPlacementAgent"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xlink:label="loc_659926H556J3_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xml:lang="en-US">Conversion Of Notes Payable and Accrued Interest To Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xml:lang="en-US">Conversion of notes payable and accrued interest to stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xml:lang="en-US">Conversion of notes payable and accrued interest to common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xlink:to="lab_871148J778L5_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_659926H556J3_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xml:lang="en-US">Organization, Consolidation and Presentation Of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xml:lang="en-US">Description of Business and Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_871148J778L5_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_GoingConcernAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_GoingConcernAbstract" xml:lang="en-US">Going Concern [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_GoingConcernAbstract" xml:lang="en-US">Going Concern [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_GoingConcernAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_GoingConcernAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernTextBlock" xlink:label="loc_659926H556J3_fil_GoingConcernTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_GoingConcernTextBlock" xml:lang="en-US">Going Concern [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_GoingConcernTextBlock" xml:lang="en-US">Going Concern</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_GoingConcernTextBlock" xml:lang="en-US">Going Concern assumption.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_GoingConcernTextBlock" xlink:to="lab_871148J778L5_fil_GoingConcernTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property and Equipment [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DebtDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Note Payable and Convertible Notes [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Debt Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DebtDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DebtDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_DebtDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Note Payable and Convertible Notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_DebtDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xml:lang="en-US">Derivatives [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xml:lang="en-US">Derivatives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_IncomeTaxDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Taxes [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Former CEO [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EquityAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_659926H556J3_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Stock Option Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_871148J778L5_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_WarrantsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsAbstract" xml:lang="en-US">Warrants [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsAbstract" xml:lang="en-US">Warrants [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_WarrantsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_WarrantsAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsTextBlock" xlink:label="loc_659926H556J3_fil_WarrantsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsTextBlock" xml:lang="en-US">Warrants [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsTextBlock" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsTextBlock" xlink:to="lab_871148J778L5_fil_WarrantsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CompensationAndRetirementDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US">Employee Defined Contribution Plan [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CompensationAndRetirementDisclosureAbstract" xml:lang="en-US">Compensation and Retirement Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CompensationAndRetirementDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_659926H556J3_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US">Employee Defined Contribution Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_871148J778L5_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventsAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_659926H556J3_us-gaap_SubsequentEventsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_871148J778L5_us-gaap_SubsequentEventsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_BusinessCombinationsPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_BusinessCombinationsPolicy" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_BusinessCombinationsPolicy" xml:lang="en-US">Nature of Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_BusinessCombinationsPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Presentation - Unaudited Interim Financial Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DevelopmentStageCompanyPolicyTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DevelopmentStageCompanyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DevelopmentStageCompanyPolicyTextBlock" xml:lang="en-US">Development Stage Company [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DevelopmentStageCompanyPolicyTextBlock" xml:lang="en-US">Development Stage Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DevelopmentStageCompanyPolicyTextBlock" xml:lang="en-US">Development Stage Company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DevelopmentStageCompanyPolicyTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_fil_DevelopmentStageCompanyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_ConsolidationPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principles of Consolidation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_ConsolidationPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_UseOfEstimates"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_UseOfEstimates" xml:lang="en-US">Use Of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates in Financial Statement Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_UseOfEstimates" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_UseOfEstimates"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_659926H556J3_us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_871148J778L5_us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment Or Disposal Of Long-Lived Assets, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment of Long-Lived Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_DerivativesPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivatives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_DerivativesPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value Of Financial Instruments, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Share-Based Payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EarningsPerSharePolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings (Loss) Per Common Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EarningsPerSharePolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_659926H556J3_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recent Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_871148J778L5_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xml:lang="en-US">Subsequent Events, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_659926H556J3_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured On Recurring and Nonrecurring Basis [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xml:lang="en-US">Summary of set forth assets and liabilities measured at fair value on a recurring and non-recurring basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_871148J778L5_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Schedule Of Related Party Transactions [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US">Summary of activities related to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Summary of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfDebtTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfDebtTableTextBlock" xml:lang="en-US">Schedule Of Debt [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfDebtTableTextBlock" xml:lang="en-US">Summary of senior subordinated unsecured convertible promissory notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfDebtTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_659926H556J3_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xml:lang="en-US">Schedule Of Derivative Instruments [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xml:lang="en-US">Schedule of derivative warrant instruments activity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_871148J778L5_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xml:lang="en-US">Fair Value Of Derivative Warrants On Basis Of Valuation Model [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xml:lang="en-US">Summary of fair values of derivative warrants on basis of valuation model</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xml:lang="en-US">Fair value of derivative warrants on basis of valuation model.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_659926H556J3_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Schedule Of Deferred Tax Assets and Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Components of deferred tax assets and liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_871148J778L5_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US">Schedule Of Components Of Income Tax Expense (Benefit) [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xml:lang="en-US">Schedule of difference between the income tax provision and the U.S. Federal statutory rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTable" xlink:label="loc_659926H556J3_fil_MilestonePaymentsMilestoneMethodTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTable" xml:lang="en-US">Milestone Payments Milestone Method [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTable" xml:lang="en-US">Milestone Payments Milestone Method [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTable" xml:lang="en-US">Milestone payments milestone method.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MilestonePaymentsMilestoneMethodTable" xlink:to="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_659926H556J3_us-gaap_RelatedPartyDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RelatedPartyDomain" xlink:to="lab_871148J778L5_us-gaap_RelatedPartyDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AbbottBiotherapeuticsCorpMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AbbottBiotherapeuticsCorpMember" xml:lang="en-US">Abbott Biotherapeutics Corp [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AbbottBiotherapeuticsCorpMember" xml:lang="en-US">Abbott Biotherapeutics Corp [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AbbottBiotherapeuticsCorpMember" xml:lang="en-US">Abbott biotherapeutics corp.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AbbottBiotherapeuticsCorpMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_AbbottBiotherapeuticsCorpMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_659926H556J3_fil_MemorialSloanKetteringCancerCenterMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MemorialSloanKetteringCancerCenterMember" xml:lang="en-US">Memorial Sloan Kettering Cancer Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_MemorialSloanKetteringCancerCenterMember" xml:lang="en-US">Memorial Sloan Kettering Cancer Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MemorialSloanKetteringCancerCenterMember" xml:lang="en-US">MSKCC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MemorialSloanKetteringCancerCenterMember" xml:lang="en-US">Memorial sloan kettering cancer center.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MemorialSloanKetteringCancerCenterMember" xlink:to="lab_871148J778L5_fil_MemorialSloanKetteringCancerCenterMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentsMilestoneMethodLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentsMilestoneMethodLineItems" xml:lang="en-US">Milestone Payments Milestone Method [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentsMilestoneMethodLineItems" xml:lang="en-US">Milestone Payments Milestone Method [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentsMilestoneMethodLineItems" xml:lang="en-US">Milestone payments milestone method.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentsMilestoneMethodLineItems" xlink:to="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentsMilestoneMethodLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTableTextBlock" xlink:label="loc_659926H556J3_fil_MilestonePaymentsMilestoneMethodTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTableTextBlock" xml:lang="en-US">Milestone Payments Milestone Method [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTableTextBlock" xml:lang="en-US">Summary of milestone payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTableTextBlock" xml:lang="en-US">Milestone payments milestone method.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MilestonePaymentsMilestoneMethodTableTextBlock" xlink:to="lab_871148J778L5_fil_MilestonePaymentsMilestoneMethodTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Summary of stock option activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_659926H556J3_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_871148J778L5_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AwardTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AwardTypeAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AwardTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Equity Award [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Award Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EmployeeStockOptionMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Employee Stock Option [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Stock Options [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EmployeeStockOptionMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EmployeeStockOptionMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_659926H556J3_us-gaap_WarrantMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_WarrantMember" xml:lang="en-US">A Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_WarrantMember" xlink:to="lab_871148J778L5_us-gaap_WarrantMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ScheduleOfWarrantsIssuedTableTextBlock" xlink:label="loc_659926H556J3_fil_ScheduleOfWarrantsIssuedTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ScheduleOfWarrantsIssuedTableTextBlock" xml:lang="en-US">Schedule Of Warrants Issued [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ScheduleOfWarrantsIssuedTableTextBlock" xml:lang="en-US">Summary of warrant issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ScheduleOfWarrantsIssuedTableTextBlock" xml:lang="en-US">Tabular disclosure of warrant issued.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ScheduleOfWarrantsIssuedTableTextBlock" xlink:to="lab_871148J778L5_fil_ScheduleOfWarrantsIssuedTableTextBlock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfWarrantActivitiesTableTextBlock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_SummaryOfWarrantActivitiesTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfWarrantActivitiesTableTextBlock" xml:lang="en-US">Summary Of Warrant Activities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfWarrantActivitiesTableTextBlock" xml:lang="en-US">Summary of warrant activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfWarrantActivitiesTableTextBlock" xml:lang="en-US">Summary of warrant activities.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_SummaryOfWarrantActivitiesTableTextBlock" xlink:to="lab_M66M3IHII90M1H57H583_fil_SummaryOfWarrantActivitiesTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_659926H556J3_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value, Hierarchy [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_659926H556J3_us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_871148J778L5_us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsLevel1Member"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Level 1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel1Member"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_659926H556J3_us-gaap_FairValueInputsLevel2Member"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Level 2 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_871148J778L5_us-gaap_FairValueInputsLevel2Member"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsLevel3Member"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Level 3 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsLevel3Member"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_659926H556J3_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US">Fair Value, Assets and Liabilities Measured On Recurring and Nonrecurring Basis [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_871148J778L5_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xml:lang="en-US">Summary Of Assets and Liabilities Measured At Fair Value On Recurring and Non Recurring Basis [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xml:lang="en-US">Summary of forth assets and liabilities measured at fair value on a recurring and non recurring basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_659926H556J3_us-gaap_DerivativeLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativeLiabilities" xml:lang="en-US">Derivative Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeLiabilities" xml:lang="en-US">Derivative liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativeLiabilities" xlink:to="lab_871148J778L5_us-gaap_DerivativeLiabilities"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Description of business and summary of significant accounting policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_659926H556J3_dei_LegalEntityAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_dei_LegalEntityAxis" xlink:to="lab_871148J778L5_dei_LegalEntityAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_K44K1GFGG78K9F35F361_dei_EntityDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_dei_EntityDomain" xlink:to="lab_M66M3IHII90M1H57H583_dei_EntityDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ActiniumMember" xlink:label="loc_659926H556J3_fil_ActiniumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ActiniumMember" xml:lang="en-US">Actinium [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ActiniumMember" xml:lang="en-US">Actinium [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ActiniumMember" xml:lang="en-US">Actinium</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ActiniumMember" xlink:to="lab_871148J778L5_fil_ActiniumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_MachineryAndEquipmentMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MachineryAndEquipmentMember" xml:lang="en-US">Machinery and Equipment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MachineryAndEquipmentMember" xml:lang="en-US">Machinery and equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_MachineryAndEquipmentMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_659926H556J3_us-gaap_FurnitureAndFixturesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Fixtures [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and fixtures [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_871148J778L5_us-gaap_FurnitureAndFixturesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_659926H556J3_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesNameDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ConvertiblePreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ConvertiblePreferredStockMember" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ConvertiblePreferredStockMember" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ConvertiblePreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_659926H556J3_us-gaap_ConvertibleNotesPayableMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ConvertibleNotesPayableMember" xml:lang="en-US">Convertible Notes Payable [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_871148J778L5_us-gaap_ConvertibleNotesPayableMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsAndWarrantsMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_OptionsAndWarrantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_OptionsAndWarrantsMember" xml:lang="en-US">Options And Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_OptionsAndWarrantsMember" xml:lang="en-US">Options And Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_OptionsAndWarrantsMember" xml:lang="en-US">Options and warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_OptionsAndWarrantsMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_OptionsAndWarrantsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_659926H556J3_us-gaap_SubsequentEventTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_871148J778L5_us-gaap_SubsequentEventTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_659926H556J3_us-gaap_SubsequentEventMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SubsequentEventMember" xlink:to="lab_871148J778L5_us-gaap_SubsequentEventMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Description of business and summary of significant accounting policies.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:label="loc_659926H556J3_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xml:lang="en-US">Description Of Business and Summary Of Significant Accounting Policies Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xml:lang="en-US">Description of Business and Summary of Significant Accounting Policies (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:to="lab_871148J778L5_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfOwnershipInterestToBeAcquired" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PercentageOfOwnershipInterestToBeAcquired"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfOwnershipInterestToBeAcquired" xml:lang="en-US">Percentage Of Ownership Interest To Be Acquired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfOwnershipInterestToBeAcquired" xml:lang="en-US">Percentage of ownership interest to be acquired by company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfOwnershipInterestToBeAcquired" xml:lang="en-US">Percentage of ownership interest to be acquired by company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PercentageOfOwnershipInterestToBeAcquired" xlink:to="lab_M66M3IHII90M1H57H583_fil_PercentageOfOwnershipInterestToBeAcquired"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xlink:label="loc_659926H556J3_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xml:lang="en-US">Common Stock Issuable In Consideration For Equity Interest Acquisition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xml:lang="en-US">Common Stock issuable in consideration for equity interest acquisition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xml:lang="en-US">Common Stock issuable in consideration for equity interest acquisition.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xlink:to="lab_871148J778L5_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xlink:label="loc_K44K1GFGG78K9F35F361_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xml:lang="en-US">Common Stock Shares Issued In Exchange Of Equity Securities In Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xml:lang="en-US">Common stock shares issued in exchange of equity securities in percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xml:lang="en-US">Common stock shares issued in exchange of equity securities in percentage.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xlink:to="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xml:lang="en-US">Estimated useful lives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Shares received by each API shareholder of Actinium common stock for each API share exchanged</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_659926H556J3_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Potentially issuable shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_871148J778L5_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSharesExchangedInShareExchangeProgramme" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PercentageOfSharesExchangedInShareExchangeProgramme"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfSharesExchangedInShareExchangeProgramme" xml:lang="en-US">Percentage Of Shares Exchanged In Share Exchange Programme</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfSharesExchangedInShareExchangeProgramme" xml:lang="en-US">Percentage Of Shares Exchanged In Share Exchange Programme</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfSharesExchangedInShareExchangeProgramme" xml:lang="en-US">Percentage of shares exchanged in share exchange programme.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PercentageOfSharesExchangedInShareExchangeProgramme" xlink:to="lab_M66M3IHII90M1H57H583_fil_PercentageOfSharesExchangedInShareExchangeProgramme"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernTextualAbstract" xlink:label="loc_659926H556J3_fil_GoingConcernTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_GoingConcernTextualAbstract" xml:lang="en-US">Going Concern Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_GoingConcernTextualAbstract" xml:lang="en-US">Going Concern (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_GoingConcernTextualAbstract" xlink:to="lab_871148J778L5_fil_GoingConcernTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Deficit accumulated during development stage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract" xlink:label="loc_659926H556J3_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract" xml:lang="en-US">Related Party Transaction, Due From (To) Related Party, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract" xml:lang="en-US">Summary of activities related to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract" xlink:to="lab_871148J778L5_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xlink:label="loc_K44K1GFGG78K9F35F361_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xml:lang="en-US">Qualified Research and Development Costs Incurred By Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xml:lang="en-US">Qualified R&amp;D costs incurred by the Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xml:lang="en-US">Qualified research and development costs incurred by related party.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xlink:to="lab_M66M3IHII90M1H57H583_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ReimbursementsReceivedFromRelatedParty" xlink:label="loc_659926H556J3_fil_ReimbursementsReceivedFromRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ReimbursementsReceivedFromRelatedParty" xml:lang="en-US">Reimbursements Received From Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ReimbursementsReceivedFromRelatedParty" xml:lang="en-US">Reimbursements received from MSKCC</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ReimbursementsReceivedFromRelatedParty" xml:lang="en-US">Reimbursements received from related party.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ReimbursementsReceivedFromRelatedParty" xlink:to="lab_871148J778L5_fil_ReimbursementsReceivedFromRelatedParty"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule Of Related Party Transactions, By Related Party [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_659926H556J3_fil_SloanKetteringInstituteOfCancerResearchMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">Sloan Kettering Institute Of Cancer Research [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">SKI [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">Sloan kettering institute of cancer research.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SloanKetteringInstituteOfCancerResearchMember" xlink:to="lab_871148J778L5_fil_SloanKetteringInstituteOfCancerResearchMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">Memorial Sloan Kettering Cancer Center Sloan Kettering Institute Of Cancer Research [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">MSKCC and SKI [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xml:lang="en-US">Memorial sloan kettering cancer center sloan kettering institute of cancer research.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RosemaryMazanetMember" xlink:label="loc_659926H556J3_fil_RosemaryMazanetMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_RosemaryMazanetMember" xml:lang="en-US">Rosemary Mazanet [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_RosemaryMazanetMember" xml:lang="en-US">Dr. Rosemary Mazanet [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_RosemaryMazanetMember" xml:lang="en-US">Rosemary mazanet.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_RosemaryMazanetMember" xlink:to="lab_871148J778L5_fil_RosemaryMazanetMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCompanyMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_LaidlawAndCompanyMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_LaidlawAndCompanyMember" xml:lang="en-US">Laidlaw and Company [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_LaidlawAndCompanyMember" xml:lang="en-US">Laidlaw and Company [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_LaidlawAndCompanyMember" xml:lang="en-US">Laidlaw and company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_LaidlawAndCompanyMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_LaidlawAndCompanyMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupMember" xlink:label="loc_659926H556J3_fil_JamessCapitalGroupMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_JamessCapitalGroupMember" xml:lang="en-US">Jamess Capital Group [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_JamessCapitalGroupMember" xml:lang="en-US">Jamess Capital Group LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_JamessCapitalGroupMember" xml:lang="en-US">Jamess capital group.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_JamessCapitalGroupMember" xlink:to="lab_871148J778L5_fil_JamessCapitalGroupMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GuagentiAndAssociatesMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_GuagentiAndAssociatesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_GuagentiAndAssociatesMember" xml:lang="en-US">Guagenti and Associates [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_GuagentiAndAssociatesMember" xml:lang="en-US">Guagenti &amp; Associates LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_GuagentiAndAssociatesMember" xml:lang="en-US">Guagenti and associates.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_GuagentiAndAssociatesMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_GuagentiAndAssociatesMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementAxis" xlink:label="loc_659926H556J3_fil_AgreementAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AgreementAxis" xml:lang="en-US">Agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AgreementAxis" xlink:to="lab_871148J778L5_fil_AgreementAxis"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AgreementDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementDomain" xml:lang="en-US">Agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AgreementDomain" xlink:to="lab_M66M3IHII90M1H57H583_fil_AgreementDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialAgreementMember" xlink:label="loc_659926H556J3_fil_ClinicalTrialAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ClinicalTrialAgreementMember" xml:lang="en-US">Clinical Trial Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ClinicalTrialAgreementMember" xml:lang="en-US">Clinical Trial Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ClinicalTrialAgreementMember" xml:lang="en-US">Clinical trial agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ClinicalTrialAgreementMember" xlink:to="lab_871148J778L5_fil_ClinicalTrialAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseDevelopmentAndCommercializationAgreementMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_LicenseDevelopmentAndCommercializationAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseDevelopmentAndCommercializationAgreementMember" xml:lang="en-US">License Development and Commercialization Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseDevelopmentAndCommercializationAgreementMember" xml:lang="en-US">License, Development and Commercialization Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseDevelopmentAndCommercializationAgreementMember" xml:lang="en-US">License development and commercialization agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_LicenseDevelopmentAndCommercializationAgreementMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_LicenseDevelopmentAndCommercializationAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultingServicesAgreementMember" xlink:label="loc_659926H556J3_fil_ConsultingServicesAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ConsultingServicesAgreementMember" xml:lang="en-US">Consulting Services Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ConsultingServicesAgreementMember" xml:lang="en-US">Consulting Services Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ConsultingServicesAgreementMember" xml:lang="en-US">Consulting services agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ConsultingServicesAgreementMember" xlink:to="lab_871148J778L5_fil_ConsultingServicesAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EngagementAgreementMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_EngagementAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_EngagementAgreementMember" xml:lang="en-US">Engagement Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_EngagementAgreementMember" xml:lang="en-US">Engagement agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_EngagementAgreementMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_EngagementAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransactionManagementAgreementMember" xlink:label="loc_659926H556J3_fil_TransactionManagementAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_TransactionManagementAgreementMember" xml:lang="en-US">Transaction Management Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_TransactionManagementAgreementMember" xml:lang="en-US">Transaction management agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_TransactionManagementAgreementMember" xml:lang="en-US">Transaction management agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_TransactionManagementAgreementMember" xlink:to="lab_871148J778L5_fil_TransactionManagementAgreementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RelatedPartyTransactionLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RelatedPartyTransactionsTextualAbstract" xlink:label="loc_659926H556J3_fil_RelatedPartyTransactionsTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_RelatedPartyTransactionsTextualAbstract" xml:lang="en-US">Related Party Transactions Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_RelatedPartyTransactionsTextualAbstract" xml:lang="en-US">Related Party Transactions (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_RelatedPartyTransactionsTextualAbstract" xlink:to="lab_871148J778L5_fil_RelatedPartyTransactionsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfPatients" xlink:label="loc_K44K1GFGG78K9F35F361_fil_NumberOfPatients"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfPatients" xml:lang="en-US">Number Of Patients</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfPatients" xml:lang="en-US">Number of Patients enrolled</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfPatients" xml:lang="en-US">Number of Patients</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfPatients" xml:lang="en-US">Number of patients.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_NumberOfPatients" xlink:to="lab_M66M3IHII90M1H57H583_fil_NumberOfPatients"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xlink:label="loc_659926H556J3_fil_AmountPaidUnderAgreementInYearTwoThousandEleven"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xml:lang="en-US">Amount Paid Under Agreement In Year Two Thousand Eleven</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xml:lang="en-US">Amount paid under agreement in 2011</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xml:lang="en-US">Amount paid under agreement in year two thousand eleven.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xlink:to="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandEleven"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xml:lang="en-US">Amount Paid Under Agreement In Year Two Thousand Twelve</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xml:lang="en-US">Amount paid under agreement in 2012</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xml:lang="en-US">Amount paid under agreement in year two thousand twelve.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xlink:to="lab_M66M3IHII90M1H57H583_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xlink:label="loc_659926H556J3_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xml:lang="en-US">Amount Paid Under Agreement In Year Two Thousand Thirteen</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xml:lang="en-US">Amount paid under agreement in 2013</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xml:lang="en-US">Amount paid under agreement in year two thousand thirteen.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xlink:to="lab_871148J778L5_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaintenanceFeesAndResearchPayments" xlink:label="loc_K44K1GFGG78K9F35F361_fil_MaintenanceFeesAndResearchPayments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_MaintenanceFeesAndResearchPayments" xml:lang="en-US">Maintenance Fees and Research Payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_MaintenanceFeesAndResearchPayments" xml:lang="en-US">Maintenance fees and research payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_MaintenanceFeesAndResearchPayments" xml:lang="en-US">Maintenance fees and research payments.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_MaintenanceFeesAndResearchPayments" xlink:to="lab_M66M3IHII90M1H57H583_fil_MaintenanceFeesAndResearchPayments"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreement" xlink:label="loc_659926H556J3_fil_AmountPaidUnderAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreement" xml:lang="en-US">Amount Paid Under Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreement" xml:lang="en-US">Amount paid under agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmountPaidUnderAgreement" xml:lang="en-US">Amount paid under agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmountPaidUnderAgreement" xlink:to="lab_871148J778L5_fil_AmountPaidUnderAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdditionalAmountDueUnderAgreement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AdditionalAmountDueUnderAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdditionalAmountDueUnderAgreement" xml:lang="en-US">Additional Amount Due Under Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdditionalAmountDueUnderAgreement" xml:lang="en-US">Additional amount due under agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AdditionalAmountDueUnderAgreement" xml:lang="en-US">Additional amount due under agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AdditionalAmountDueUnderAgreement" xlink:to="lab_M66M3IHII90M1H57H583_fil_AdditionalAmountDueUnderAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xlink:label="loc_659926H556J3_fil_DescriptionOfConditionForTerminationOfForbearancePeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xml:lang="en-US">Description Of Condition For Termination Of Forbearance Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xml:lang="en-US">Condition for termination of forbearance period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xml:lang="en-US">Description of condition for termination of forbearance period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xlink:to="lab_871148J778L5_fil_DescriptionOfConditionForTerminationOfForbearancePeriod"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TerminationDateOfForbearanceAgreement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_TerminationDateOfForbearanceAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_TerminationDateOfForbearanceAgreement" xml:lang="en-US">Termination Date Of Forbearance Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_TerminationDateOfForbearanceAgreement" xml:lang="en-US">Termination date of forbearance agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_TerminationDateOfForbearanceAgreement" xml:lang="en-US">Termination date of forbearance agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_TerminationDateOfForbearanceAgreement" xlink:to="lab_M66M3IHII90M1H57H583_fil_TerminationDateOfForbearanceAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xlink:label="loc_659926H556J3_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xml:lang="en-US">Minimum New Equity Financing Needed Under Condition For Termination Forbearance Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xml:lang="en-US">Minimum new equity financing needed under condition for termination forbearance period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xml:lang="en-US">Minimum new Equity Financing needed under condition for termination Forbearance period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xlink:to="lab_871148J778L5_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewEquityFinanceRaisedByCompany" xlink:label="loc_K44K1GFGG78K9F35F361_fil_NewEquityFinanceRaisedByCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_NewEquityFinanceRaisedByCompany" xml:lang="en-US">New Equity Finance Raised By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_NewEquityFinanceRaisedByCompany" xml:lang="en-US">New equity finance raised by company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_NewEquityFinanceRaisedByCompany" xml:lang="en-US">New equity finance raised by company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_NewEquityFinanceRaisedByCompany" xlink:to="lab_M66M3IHII90M1H57H583_fil_NewEquityFinanceRaisedByCompany"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ForgivenAmountOfObligations" xlink:label="loc_659926H556J3_fil_ForgivenAmountOfObligations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ForgivenAmountOfObligations" xml:lang="en-US">Forgiven Amount Of Obligations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ForgivenAmountOfObligations" xml:lang="en-US">Forgiven amount of obligations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ForgivenAmountOfObligations" xml:lang="en-US">Forgiven amount of obligations.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ForgivenAmountOfObligations" xlink:to="lab_871148J778L5_fil_ForgivenAmountOfObligations"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xml:lang="en-US">Research and Development Prepayments Amount Received By Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xml:lang="en-US">Research and development reimbursement payments received from MSKCC</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xml:lang="en-US">Research and development prepayments amount received by related party.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xlink:to="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_659926H556J3_us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AccountsReceivableRelatedPartiesCurrent" xml:lang="en-US">Accounts Receivable, Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AccountsReceivableRelatedPartiesCurrent" xml:lang="en-US">Net receivable from MSKCC</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="lab_871148J778L5_us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToEachPatient" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AmountPaidToEachPatient"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidToEachPatient" xml:lang="en-US">Amount Paid To Each Patient</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidToEachPatient" xml:lang="en-US">Amount paid to each patient after Completing clinical trial</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidToEachPatient" xml:lang="en-US">Amount to be paid for each Patient that has completed the clinical trial.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AmountPaidToEachPatient" xlink:to="lab_M66M3IHII90M1H57H583_fil_AmountPaidToEachPatient"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpFeeForClinicalTrial" xlink:label="loc_659926H556J3_fil_StartUpFeeForClinicalTrial"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_StartUpFeeForClinicalTrial" xml:lang="en-US">Start Up Fee For Clinical Trial</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_StartUpFeeForClinicalTrial" xml:lang="en-US">Start-up fee for clinical trial</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_StartUpFeeForClinicalTrial" xml:lang="en-US">Start-up fee for clinical trial.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_StartUpFeeForClinicalTrial" xlink:to="lab_871148J778L5_fil_StartUpFeeForClinicalTrial"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpDueCostPaidDate" xlink:label="loc_K44K1GFGG78K9F35F361_fil_StartUpDueCostPaidDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_StartUpDueCostPaidDate" xml:lang="en-US">Start Up Due Cost Paid Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_StartUpDueCostPaidDate" xml:lang="en-US">Due date of start-up fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_StartUpDueCostPaidDate" xml:lang="en-US">Start-up due cost paid date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_StartUpDueCostPaidDate" xml:lang="en-US">Start-up due cost paid date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_StartUpDueCostPaidDate" xlink:to="lab_M66M3IHII90M1H57H583_fil_StartUpDueCostPaidDate"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesTransferTerm" xlink:label="loc_659926H556J3_fil_DescriptionOfSharesTransferTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfSharesTransferTerm" xml:lang="en-US">Description Of Shares Transfer Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfSharesTransferTerm" xml:lang="en-US">Description of shares transfer term transfer by AHLB on behalf of AHL</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfSharesTransferTerm" xml:lang="en-US">Description of shares transfer term.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfSharesTransferTerm" xlink:to="lab_871148J778L5_fil_DescriptionOfSharesTransferTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_OfficersCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OfficersCompensation" xml:lang="en-US">Officers' Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OfficersCompensation" xml:lang="en-US">Officers' Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_OfficersCompensation" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_OfficersCompensation"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionExercisePriceRange" xlink:label="loc_659926H556J3_fil_OptionExercisePriceRange"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_OptionExercisePriceRange" xml:lang="en-US">Option Exercise Price Range</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_OptionExercisePriceRange" xml:lang="en-US">Option Exercise Price Range</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_OptionExercisePriceRange" xml:lang="en-US">Option exercise price range.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_OptionExercisePriceRange" xlink:to="lab_871148J778L5_fil_OptionExercisePriceRange"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExpectedTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US">Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US">Term of options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US">Warrant lives in years</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedTerm"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsReceivedToPurchaseCommonStock" xlink:label="loc_659926H556J3_fil_OptionsReceivedToPurchaseCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_OptionsReceivedToPurchaseCommonStock" xml:lang="en-US">Options Received To Purchase Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_OptionsReceivedToPurchaseCommonStock" xml:lang="en-US">Options received to purchase common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_OptionsReceivedToPurchaseCommonStock" xml:lang="en-US">Options received to purchase common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_OptionsReceivedToPurchaseCommonStock" xlink:to="lab_871148J778L5_fil_OptionsReceivedToPurchaseCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfReceivablesOfPlacementAgentForServices" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfReceivablesOfPlacementAgentForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfReceivablesOfPlacementAgentForServices" xml:lang="en-US">Description Of Receivables Of Placement Agent For Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfReceivablesOfPlacementAgentForServices" xml:lang="en-US">Description of receivables of placement agent for services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfReceivablesOfPlacementAgentForServices" xml:lang="en-US">Description of receivables of placement agent for services.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfReceivablesOfPlacementAgentForServices" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfReceivablesOfPlacementAgentForServices"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfWarrantsReceivablesByPlacement" xlink:label="loc_659926H556J3_fil_DescriptionOfWarrantsReceivablesByPlacement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfWarrantsReceivablesByPlacement" xml:lang="en-US">Description Of Warrants Receivables By Placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfWarrantsReceivablesByPlacement" xml:lang="en-US">Description of warrants receivables by placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfWarrantsReceivablesByPlacement" xml:lang="en-US">Description of warrants receivables by placement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfWarrantsReceivablesByPlacement" xlink:to="lab_871148J778L5_fil_DescriptionOfWarrantsReceivablesByPlacement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfExerciseOfWarrants" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PeriodOfExerciseOfWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodOfExerciseOfWarrants" xml:lang="en-US">Period Of Exercise Of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodOfExerciseOfWarrants" xml:lang="en-US">Period of exercise of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodOfExerciseOfWarrants" xml:lang="en-US">Period of exercise of warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PeriodOfExerciseOfWarrants" xlink:to="lab_M66M3IHII90M1H57H583_fil_PeriodOfExerciseOfWarrants"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSolicitationFee" xlink:label="loc_659926H556J3_fil_PercentageOfSolicitationFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PercentageOfSolicitationFee" xml:lang="en-US">Percentage Of Solicitation Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PercentageOfSolicitationFee" xml:lang="en-US">Percentage of solicitation fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PercentageOfSolicitationFee" xml:lang="en-US">Percentage of solicitation fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PercentageOfSolicitationFee" xlink:to="lab_871148J778L5_fil_PercentageOfSolicitationFee"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeForFinancialAdvisoryServices" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PeriodicFeeForFinancialAdvisoryServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicFeeForFinancialAdvisoryServices" xml:lang="en-US">Periodic Fee For Financial Advisory Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicFeeForFinancialAdvisoryServices" xml:lang="en-US">Monthly fee for financial advisory services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicFeeForFinancialAdvisoryServices" xml:lang="en-US">Periodic fee for financial advisory services.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PeriodicFeeForFinancialAdvisoryServices" xlink:to="lab_M66M3IHII90M1H57H583_fil_PeriodicFeeForFinancialAdvisoryServices"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfAdditionalReceivableByPlacementAgent" xlink:label="loc_659926H556J3_fil_DescriptionOfAdditionalReceivableByPlacementAgent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfAdditionalReceivableByPlacementAgent" xml:lang="en-US">Description Of Additional Receivable By Placement Agent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfAdditionalReceivableByPlacementAgent" xml:lang="en-US">Description of additional receivable by placement agent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfAdditionalReceivableByPlacementAgent" xml:lang="en-US">Description of additional receivable by placement agent.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfAdditionalReceivableByPlacementAgent" xlink:to="lab_871148J778L5_fil_DescriptionOfAdditionalReceivableByPlacementAgent"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseByHoldingOfWarrant" xlink:label="loc_K44K1GFGG78K9F35F361_fil_CommonStockPurchaseByHoldingOfWarrant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockPurchaseByHoldingOfWarrant" xml:lang="en-US">Common Stock Purchase By Holding Of Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockPurchaseByHoldingOfWarrant" xml:lang="en-US">Warrant held by placement agent to purchase common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockPurchaseByHoldingOfWarrant" xml:lang="en-US">Common stock purchase by holding of warrant.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_CommonStockPurchaseByHoldingOfWarrant" xlink:to="lab_M66M3IHII90M1H57H583_fil_CommonStockPurchaseByHoldingOfWarrant"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeReceivedByManagementFirm" xlink:label="loc_659926H556J3_fil_PeriodicFeeReceivedByManagementFirm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PeriodicFeeReceivedByManagementFirm" xml:lang="en-US">Periodic Fee Received By Management Firm</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PeriodicFeeReceivedByManagementFirm" xml:lang="en-US">Monthly fee received by management firm</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PeriodicFeeReceivedByManagementFirm" xml:lang="en-US">Periodic fee received by management firm.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PeriodicFeeReceivedByManagementFirm" xlink:to="lab_871148J778L5_fil_PeriodicFeeReceivedByManagementFirm"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xml:lang="en-US">Percentage Of Fully Diluted Capital Stock Equal To Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xml:lang="en-US">Percentage of fully diluted capital stock equal to common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xml:lang="en-US">Percentage of fully diluted capital stock equal to common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumAmountOfOutOfPocketExpenses" xlink:label="loc_659926H556J3_fil_MaximumAmountOfOutOfPocketExpenses"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MaximumAmountOfOutOfPocketExpenses" xml:lang="en-US">Maximum Amount Of Out Of Pocket Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MaximumAmountOfOutOfPocketExpenses" xml:lang="en-US">Maximum amount of out of pocket expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MaximumAmountOfOutOfPocketExpenses" xml:lang="en-US">Maximum amount of out of pocket expenses.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MaximumAmountOfOutOfPocketExpenses" xlink:to="lab_871148J778L5_fil_MaximumAmountOfOutOfPocketExpenses"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicAmountOfRent" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PeriodicAmountOfRent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicAmountOfRent" xml:lang="en-US">Periodic Amount Of Rent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicAmountOfRent" xml:lang="en-US">Operating lease monthly amount of rent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PeriodicAmountOfRent" xml:lang="en-US">Periodic amount of rent.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PeriodicAmountOfRent" xlink:to="lab_M66M3IHII90M1H57H583_fil_PeriodicAmountOfRent"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToPursuantLeaseAgreement" xlink:label="loc_659926H556J3_fil_AmountPaidToPursuantLeaseAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmountPaidToPursuantLeaseAgreement" xml:lang="en-US">Amount Paid To Pursuant Lease Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AmountPaidToPursuantLeaseAgreement" xml:lang="en-US">Amount paid to pursuant lease agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmountPaidToPursuantLeaseAgreement" xml:lang="en-US">Amount paid to pursuant lease agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmountPaidToPursuantLeaseAgreement" xlink:to="lab_871148J778L5_fil_AmountPaidToPursuantLeaseAgreement"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Schedule Of Property, Plant and Equipment [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_659926H556J3_us-gaap_OfficeEquipmentMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_OfficeEquipmentMember" xml:lang="en-US">Office Equipment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_OfficeEquipmentMember" xml:lang="en-US">Office equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_OfficeEquipmentMember" xlink:to="lab_871148J778L5_us-gaap_OfficeEquipmentMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xml:lang="en-US">Property, Plant and Equipment, Net, By Type [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xml:lang="en-US">Summary of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Useful Lives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Total property, plant and equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Equipment and parts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_871148J778L5_us-gaap_PropertyPlantAndEquipmentGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">(Less) Accumulated depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">(Less) Accumulated depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LossOnDispositionOfPropertyAndEquipment" xlink:label="loc_659926H556J3_fil_LossOnDispositionOfPropertyAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_LossOnDispositionOfPropertyAndEquipment" xml:lang="en-US">Loss On Disposition Of Property And Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_LossOnDispositionOfPropertyAndEquipment" xml:lang="en-US">Loss on disposition of property and equipment.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_fil_LossOnDispositionOfPropertyAndEquipment" xml:lang="en-US">Loss on disposition of equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_LossOnDispositionOfPropertyAndEquipment" xlink:to="lab_871148J778L5_fil_LossOnDispositionOfPropertyAndEquipment"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PropertyAndEquipmentTextualAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PropertyAndEquipmentTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PropertyAndEquipmentTextualAbstract" xml:lang="en-US">Property and Equipment Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PropertyAndEquipmentTextualAbstract" xml:lang="en-US">Property and Equipment (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PropertyAndEquipmentTextualAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_PropertyAndEquipmentTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_659926H556J3_us-gaap_Depreciation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_Depreciation" xml:lang="en-US">Depreciation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_Depreciation" xlink:to="lab_871148J778L5_us-gaap_Depreciation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xml:lang="en-US">Schedule Of Trading Securities and Other Trading Assets [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xml:lang="en-US">Schedule of Trading Securities and Other Trading Assets [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_659926H556J3_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xml:lang="en-US">Major Types Of Debt and Equity Securities [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xml:lang="en-US">Major Types of Debt and Equity Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="lab_871148J778L5_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xml:lang="en-US">Major Types Of Debt and Equity Securities [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xml:lang="en-US">Major Types of Debt and Equity Securities [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xlink:label="loc_659926H556J3_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xml:lang="en-US">Senior Subordinated Unsecured Convertible Promissory Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xml:lang="en-US">8% Senior Subordinated Unsecured Convertible Promissory Notes [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xml:lang="en-US">Senior subordinated unsecured convertible promissory notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xlink:to="lab_871148J778L5_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xml:lang="en-US">Schedule Of Trading Securities and Other Trading Assets [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xml:lang="en-US">Schedule of Trading Securities and Other Trading Assets [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfConvertiblePromissoryNotesAbstract" xlink:label="loc_659926H556J3_fil_SummaryOfConvertiblePromissoryNotesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SummaryOfConvertiblePromissoryNotesAbstract" xml:lang="en-US">Summary Of Convertible Promissory Notes [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SummaryOfConvertiblePromissoryNotesAbstract" xml:lang="en-US">Summary of senior subordinated unsecured convertible promissory notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SummaryOfConvertiblePromissoryNotesAbstract" xlink:to="lab_871148J778L5_fil_SummaryOfConvertiblePromissoryNotesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DebtInstrumentFaceAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Convertible promissory note amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Principal amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentFaceAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_659926H556J3_us-gaap_DebtInstrumentUnamortizedDiscount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">Amount of original issue discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">Less: original issuance discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_871148J778L5_us-gaap_DebtInstrumentUnamortizedDiscount"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DiscountRelatedToFairValueOfDerivativeWarrants" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DiscountRelatedToFairValueOfDerivativeWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DiscountRelatedToFairValueOfDerivativeWarrants" xml:lang="en-US">Discount Related To Fair Value Of Derivative Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DiscountRelatedToFairValueOfDerivativeWarrants" xml:lang="en-US">Discount Related To Fair Value Of Derivative Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DiscountRelatedToFairValueOfDerivativeWarrants" xml:lang="en-US">Discount related to fair value of derivative warrants.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DiscountRelatedToFairValueOfDerivativeWarrants" xml:lang="en-US">Less: discount related to fair value of derivative warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DiscountRelatedToFairValueOfDerivativeWarrants" xlink:to="lab_M66M3IHII90M1H57H583_fil_DiscountRelatedToFairValueOfDerivativeWarrants"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:label="loc_659926H556J3_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xml:lang="en-US">Debt Instrument Discount Related To Beneficial Conversion Feature</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xml:lang="en-US">Beneficial conversion feature discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xml:lang="en-US">Debt Instrument Discount Related To Beneficial Conversion Feature</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xml:lang="en-US">Debt instrument discount related to the beneficial conversion feature.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xml:lang="en-US">Less: discount related to the beneficial conversion feature</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:to="lab_871148J778L5_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentAmortizationOfDiscount" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DebtInstrumentAmortizationOfDiscount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentAmortizationOfDiscount" xml:lang="en-US">Debt Instrument Amortization Of Discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentAmortizationOfDiscount" xml:lang="en-US">Add: amortization of discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentAmortizationOfDiscount" xml:lang="en-US">Debt instrument amortization of discount.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DebtInstrumentAmortizationOfDiscount" xlink:to="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentAmortizationOfDiscount"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xlink:label="loc_659926H556J3_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xml:lang="en-US">Debt Instrument Principal Amount Converted To Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xml:lang="en-US">Less: principal amount converted to stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xml:lang="en-US">Debt instrument principal amount converted to common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xlink:to="lab_871148J778L5_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentMember" xml:lang="en-US">Placement Agent [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentMember" xml:lang="en-US">Placement Agent [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentMember" xml:lang="en-US">Placement agent.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_PlacementAgentMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ManagementFirmMember" xlink:label="loc_659926H556J3_fil_ManagementFirmMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ManagementFirmMember" xml:lang="en-US">Management Firm [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ManagementFirmMember" xml:lang="en-US">Management firm.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ManagementFirmMember" xlink:to="lab_871148J778L5_fil_ManagementFirmMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NotePayableAndConvertibleNotesTextualAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_NotePayableAndConvertibleNotesTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_NotePayableAndConvertibleNotesTextualAbstract" xml:lang="en-US">Note Payable and Convertible Notes Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_NotePayableAndConvertibleNotesTextualAbstract" xml:lang="en-US">Note Payable and Convertible Notes (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_NotePayableAndConvertibleNotesTextualAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_NotePayableAndConvertibleNotesTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseDueToIssuanceOfWarrants" xlink:label="loc_659926H556J3_fil_CommonStockPurchaseDueToIssuanceOfWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CommonStockPurchaseDueToIssuanceOfWarrants" xml:lang="en-US">Common Stock Purchase Due To Issuance Of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CommonStockPurchaseDueToIssuanceOfWarrants" xml:lang="en-US">Common stock shares purchasable through warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_CommonStockPurchaseDueToIssuanceOfWarrants" xml:lang="en-US">Common stock shares purchase due to issuance of warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CommonStockPurchaseDueToIssuanceOfWarrants" xlink:to="lab_871148J778L5_fil_CommonStockPurchaseDueToIssuanceOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_K44K1GFGG78K9F35F361_invest_InvestmentWarrantsExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_invest_InvestmentWarrantsExercisePrice" xml:lang="en-US">Investment Warrants, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_invest_InvestmentWarrantsExercisePrice" xml:lang="en-US">Exercise price of warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_invest_InvestmentWarrantsExercisePrice" xlink:to="lab_M66M3IHII90M1H57H583_invest_InvestmentWarrantsExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate" xlink:label="loc_659926H556J3_invest_InvestmentWarrantsExpirationDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_invest_InvestmentWarrantsExpirationDate" xml:lang="en-US">Investment Warrants Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_invest_InvestmentWarrantsExpirationDate" xml:lang="en-US">Warrants expiration date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_invest_InvestmentWarrantsExpirationDate" xlink:to="lab_871148J778L5_invest_InvestmentWarrantsExpirationDate"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmortizationPeriodOfNote" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AmortizationPeriodOfNote"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmortizationPeriodOfNote" xml:lang="en-US">Amortization Period Of Note</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmortizationPeriodOfNote" xml:lang="en-US">Amortization period of note</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmortizationPeriodOfNote" xml:lang="en-US">Amortization period of note.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AmortizationPeriodOfNote" xlink:to="lab_M66M3IHII90M1H57H583_fil_AmortizationPeriodOfNote"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PremiumFinanceAgreementPrincipalAmount" xlink:label="loc_659926H556J3_fil_PremiumFinanceAgreementPrincipalAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementPrincipalAmount" xml:lang="en-US">Premium Finance Agreement Principal Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementPrincipalAmount" xml:lang="en-US">Premium finance agreement principal amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementPrincipalAmount" xml:lang="en-US">Premium finance agreement principal amount.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PremiumFinanceAgreementPrincipalAmount" xlink:to="lab_871148J778L5_fil_PremiumFinanceAgreementPrincipalAmount"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentUnderPremiumFinanceAgreement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PaymentUnderPremiumFinanceAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Payment Under Premium Finance Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Payment under premium finance agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Payment under premium finance agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PaymentUnderPremiumFinanceAgreement" xlink:to="lab_M66M3IHII90M1H57H583_fil_PaymentUnderPremiumFinanceAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicPaymentUnderPremiumFinanceAgreement" xlink:label="loc_659926H556J3_fil_PeriodicPaymentUnderPremiumFinanceAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PeriodicPaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Periodic Payment Under Premium Finance Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PeriodicPaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Monthly amount payable under premium finance agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PeriodicPaymentUnderPremiumFinanceAgreement" xml:lang="en-US">Periodic amount payable under premium finance agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PeriodicPaymentUnderPremiumFinanceAgreement" xlink:to="lab_871148J778L5_fil_PeriodicPaymentUnderPremiumFinanceAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xml:lang="en-US">Duration Of Periodic Payments For Premium Finance Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xml:lang="en-US">Duration of periodic payments for premium finance agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xml:lang="en-US">Duration of periodic payments for premium finance agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xlink:to="lab_M66M3IHII90M1H57H583_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PremiumFinanceAgreementOutstandingAmount" xlink:label="loc_659926H556J3_fil_PremiumFinanceAgreementOutstandingAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementOutstandingAmount" xml:lang="en-US">Premium Finance Agreement Outstanding Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementOutstandingAmount" xml:lang="en-US">Premium finance agreement outstanding amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PremiumFinanceAgreementOutstandingAmount" xml:lang="en-US">Premium finance agreement outstanding amount.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PremiumFinanceAgreementOutstandingAmount" xlink:to="lab_871148J778L5_fil_PremiumFinanceAgreementOutstandingAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Promissory note interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromConvertibleNotes" xlink:label="loc_659926H556J3_fil_ProceedsFromConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ProceedsFromConvertibleNotes" xml:lang="en-US">Proceeds From Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ProceedsFromConvertibleNotes" xml:lang="en-US">Net proceeds of promissory note</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ProceedsFromConvertibleNotes" xml:lang="en-US">Proceeds from senior subordinated unsecured convertible promissory notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ProceedsFromConvertibleNotes" xlink:to="lab_871148J778L5_fil_ProceedsFromConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xml:lang="en-US">Percentage Of Principle Amount In Which Convertible Note Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xml:lang="en-US">Percentage of principle amount in which convertible note issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xml:lang="en-US">Percentage of principle amount in which convertible note issued.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xlink:to="lab_M66M3IHII90M1H57H583_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_659926H556J3_us-gaap_DebtInstrumentMaturityDateDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentMaturityDateDescription" xml:lang="en-US">Debt Instrument, Maturity Date, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentMaturityDateDescription" xml:lang="en-US">Convertible note maturity term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_871148J778L5_us-gaap_DebtInstrumentMaturityDateDescription"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xlink:label="loc_K44K1GFGG78K9F35F361_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xml:lang="en-US">Gross Proceeds In Subsequent Offerings Of Common Stock Or Equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xml:lang="en-US">Gross proceeds in subsequent offerings of common stock or equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xml:lang="en-US">Gross proceeds in subsequent offerings of common stock or equivalents.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xlink:to="lab_M66M3IHII90M1H57H583_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithConvertibleNotes" xlink:label="loc_659926H556J3_fil_DerivativeWarrantsIssuedWithConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Derivative Warrants Issued With Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Common stock issued to investors</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Warrants issued with Convertible Notes (See Note 5), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Derivative warrants Issued With Convertible Notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativeWarrantsIssuedWithConvertibleNotes" xlink:to="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InvestmentWarrantGrantDateFairValue" xlink:label="loc_K44K1GFGG78K9F35F361_fil_InvestmentWarrantGrantDateFairValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_InvestmentWarrantGrantDateFairValue" xml:lang="en-US">Investment Warrant Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_InvestmentWarrantGrantDateFairValue" xml:lang="en-US">Investment warrant grant date fair value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_InvestmentWarrantGrantDateFairValue" xml:lang="en-US">Investment warrant grant date fair value.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_InvestmentWarrantGrantDateFairValue" xlink:to="lab_M66M3IHII90M1H57H583_fil_InvestmentWarrantGrantDateFairValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_659926H556J3_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Conversion price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_871148J778L5_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentFairValuePerShare" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DebtInstrumentFairValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentFairValuePerShare" xml:lang="en-US">Debt Instrument Fair Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentFairValuePerShare" xml:lang="en-US">Convertible note fair value per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentFairValuePerShare" xml:lang="en-US">Debt instrument fair value per share.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DebtInstrumentFairValuePerShare" xlink:to="lab_M66M3IHII90M1H57H583_fil_DebtInstrumentFairValuePerShare"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ExtendedMaturityPeriodOfConvertibleNotes" xlink:label="loc_659926H556J3_fil_ExtendedMaturityPeriodOfConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ExtendedMaturityPeriodOfConvertibleNotes" xml:lang="en-US">Extended Maturity Period Of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ExtendedMaturityPeriodOfConvertibleNotes" xml:lang="en-US">Extended maturity Period of convertible notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ExtendedMaturityPeriodOfConvertibleNotes" xml:lang="en-US">Extended maturity Period of convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ExtendedMaturityPeriodOfConvertibleNotes" xlink:to="lab_871148J778L5_fil_ExtendedMaturityPeriodOfConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfExtendedMaturityDate" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfExtendedMaturityDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfExtendedMaturityDate" xml:lang="en-US">Description Of Extended Maturity Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfExtendedMaturityDate" xml:lang="en-US">Description of extended maturity date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfExtendedMaturityDate" xml:lang="en-US">Description of extended maturity date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfExtendedMaturityDate" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfExtendedMaturityDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_659926H556J3_us-gaap_DebtConversionConvertedInstrumentAmount1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US">Convertible notes and the accrued interest converted into common shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_871148J778L5_us-gaap_DebtConversionConvertedInstrumentAmount1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xml:lang="en-US">Common stock issued by conversion of note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InsurancePolicyDownPayment" xlink:label="loc_659926H556J3_fil_InsurancePolicyDownPayment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_InsurancePolicyDownPayment" xml:lang="en-US">Insurance Policy Down Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_InsurancePolicyDownPayment" xml:lang="en-US">Down payment under insurance policy</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_InsurancePolicyDownPayment" xml:lang="en-US">Amount of down payment of insurance policy.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_InsurancePolicyDownPayment" xlink:to="lab_871148J778L5_fil_InsurancePolicyDownPayment"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InsurancePolicyInstallmentPayment" xlink:label="loc_K44K1GFGG78K9F35F361_fil_InsurancePolicyInstallmentPayment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_InsurancePolicyInstallmentPayment" xml:lang="en-US">Insurance Policy Installment Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_InsurancePolicyInstallmentPayment" xml:lang="en-US">Premium monthly installment for nine months</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_InsurancePolicyInstallmentPayment" xml:lang="en-US">Amount of monthly installment payment of insurance policy.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_InsurancePolicyInstallmentPayment" xlink:to="lab_M66M3IHII90M1H57H583_fil_InsurancePolicyInstallmentPayment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_659926H556J3_us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentAnnualPrincipalPayment" xml:lang="en-US">Debt Instrument, Annual Principal Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DebtInstrumentAnnualPrincipalPayment" xml:lang="en-US">Principal payment of notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_871148J778L5_us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xml:lang="en-US">Schedule Of Derivative Warrant Instruments Activity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xml:lang="en-US">Schedule of derivative warrant instruments activity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xml:lang="en-US">Schedule of derivative warrant instruments activity.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsUnits" xlink:label="loc_659926H556J3_fil_DerivativeWarrantsUnits"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Derivative Warrants Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Derivative Warrants Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Total warrants issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Beginning balance, Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Balance, Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsUnits" xml:lang="en-US">Derivative warrants units.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativeWarrantsUnits" xlink:to="lab_871148J778L5_fil_DerivativeWarrantsUnits"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xml:lang="en-US">Derivative Warrant Units Reclassification To Paid In Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xml:lang="en-US">Reclassification to paid in capital, Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xml:lang="en-US">Reclassification to paid in capital.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xlink:to="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_659926H556J3_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Derivative Placement Agent Warrants Related To Issuance Of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Placement agent warrants related to issuance of Convertible Notes (See Note 5), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Derivative placement Agent warrants related to issuance of convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:to="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithStockOffering" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantsIssuedWithStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Derivative Warrants Issued With Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Warrants issued with Stock Offering (See Note 9), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Derivative warrants issued with Stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantsIssuedWithStockOffering" xlink:to="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:label="loc_659926H556J3_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Derivative Placement Agent Warrants Related To Issuance Of Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Placement agent warrants related to issuance of Stock Offering (See Note 9), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Derivative Placement Agent warrants related to issuance of stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:to="lab_871148J778L5_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithCommonStockOffering" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantsIssuedWithCommonStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Derivative Warrants Issued With Common Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Warrants issued with 2012 Common Stock Offering - A (See Note 9), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Derivative warrants issued with Common Stock Offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DerivativeWarrantsIssuedWithCommonStockOffering" xlink:to="lab_M66M3IHII90M1H57H583_fil_DerivativeWarrantsIssuedWithCommonStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:label="loc_659926H556J3_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Derivative Warrants Issued With Common Stock Offering One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Warrants issued with 2012 Common Stock Offering - B (See Note 9), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Derivative warrants issued with Common Stock Offering one.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:to="lab_871148J778L5_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DerivativePlacementAgentWarrantsRelatedToStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Derivative Placement Agent Warrants Related To Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Placement agent warrants related to 2012 Common Stock Offering (See Note 9), Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Derivative placement agent warrants related to stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DerivativePlacementAgentWarrantsRelatedToStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_DerivativePlacementAgentWarrantsRelatedToStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_659926H556J3_fil_TransferFromLiabilityClassificationToEquityClassification"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_TransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Transfer From Liability Classification To Equity Classification</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_TransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Transfer from liability classification to equity classification, Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_TransferFromLiabilityClassificationToEquityClassification" xml:lang="en-US">Transfer from liability classification to equity classification.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_TransferFromLiabilityClassificationToEquityClassification" xlink:to="lab_871148J778L5_fil_TransferFromLiabilityClassificationToEquityClassification"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeFairValueOfDerivativeNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeFairValueOfDerivativeNet" xml:lang="en-US">Derivative, Fair Value, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeFairValueOfDerivativeNet" xml:lang="en-US">Derivative, Fair Value, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeFairValueOfDerivativeNet" xml:lang="en-US">Beginning balance, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeFairValueOfDerivativeNet" xml:lang="en-US">Balance, Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeFairValueOfDerivativeNet"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xlink:label="loc_659926H556J3_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xml:lang="en-US">Derivative Warrant Units Reclassification To Paid In Capital Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xml:lang="en-US">Reclassification to paid in capital, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xml:lang="en-US">Reclassification to paid in capital, fair value.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xlink:to="lab_871148J778L5_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Fair Value Of Derivative Warrants Issued With Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Warrants issued with Convertible Notes (See Note 5), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Fair value of derivative warrants issued with convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_659926H556J3_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Fair Value Of Derivative Placement Agent Warrants Related To Issuance Of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Placement agent warrants related to issuance of Convertible Notes (See Note 5), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Fair value of derivative placement agent warrants related to issuance of convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:to="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Fair Value Of Derivative Warrants Issued With Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Warrants issued with Stock Offering (See Note 9), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xml:lang="en-US">Fair value of derivative warrants issued with stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:label="loc_659926H556J3_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Fair Value Of Derivative Placement Agent Warrants Related To Issuance Of Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Placement agent warrants related to issuance of Stock Offering (See Note 9), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xml:lang="en-US">Fair value of derivative placement agent warrants related to issuance of Stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:to="lab_871148J778L5_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Fair Value Of Derivative Warrants Issued With Common Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Warrants issued with 2012 Common Stock Offering - A (See Note 9), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xml:lang="en-US">Fair value of derivative warrants issued with Common Stock Offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:label="loc_659926H556J3_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Fair Value Of Derivative Warrants Issued With Common Stock Offering One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Warrants issued with 2012 Common Stock Offering - B (See Note 9), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xml:lang="en-US">Fair value of derivative warrants issued with Common Stock Offering one.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:to="lab_871148J778L5_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Fair Value Of Derivative Placement Agent Warrants Related To Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Placement agent warrants related to 2012 Common Stock Offering (See Note 9), Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xml:lang="en-US">Fair value of derivative placement agent warrants related to stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ChangeInFairValueOfDerivativeWarrants" xlink:label="loc_659926H556J3_fil_ChangeInFairValueOfDerivativeWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ChangeInFairValueOfDerivativeWarrants" xml:lang="en-US">Change In Fair Value Of Derivative Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ChangeInFairValueOfDerivativeWarrants" xml:lang="en-US">Change in fair value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ChangeInFairValueOfDerivativeWarrants" xml:lang="en-US">Change in fair value of derivative warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ChangeInFairValueOfDerivativeWarrants" xlink:to="lab_871148J778L5_fil_ChangeInFairValueOfDerivativeWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeTable" xml:lang="en-US">Derivative [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeTable" xml:lang="en-US">Derivative [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_659926H556J3_us-gaap_RangeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RangeAxis" xlink:to="lab_871148J778L5_us-gaap_RangeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RangeMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RangeMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RangeMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_659926H556J3_us-gaap_MaximumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_MaximumMember" xlink:to="lab_871148J778L5_us-gaap_MaximumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_MinimumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_MinimumMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_MinimumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_659926H556J3_us-gaap_DerivativeLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativeLineItems" xml:lang="en-US">Derivative [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeLineItems" xml:lang="en-US">Derivative [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativeLineItems" xlink:to="lab_871148J778L5_us-gaap_DerivativeLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xml:lang="en-US">Summary Of Fair Value Of Derivative Warrants On Basis Of Valuation Model [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xml:lang="en-US">Summary of fair values of derivative warrants on basis of valuation model</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MarketValueOfCommonStockOnMeasurementDate" xlink:label="loc_659926H556J3_fil_MarketValueOfCommonStockOnMeasurementDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MarketValueOfCommonStockOnMeasurementDate" xml:lang="en-US">Market Value Of Common Stock On Measurement Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MarketValueOfCommonStockOnMeasurementDate" xml:lang="en-US">Market value of common stock on measurement date (1)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MarketValueOfCommonStockOnMeasurementDate" xml:lang="en-US">Market value of common stock on measurement date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MarketValueOfCommonStockOnMeasurementDate" xlink:to="lab_871148J778L5_fil_MarketValueOfCommonStockOnMeasurementDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExercisePrice" xml:lang="en-US">Fair Value Assumptions, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExercisePrice" xml:lang="en-US">Adjusted exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExercisePrice" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_659926H556J3_us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Fair Value Assumptions, Risk Free Interest Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk free interest rate (2)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_871148J778L5_us-gaap_FairValueAssumptionsRiskFreeInterestRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Expected volatility (3)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueAssumptionsExpectedVolatilityRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_659926H556J3_us-gaap_FairValueAssumptionsExpectedDividendRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield (4)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="lab_871148J778L5_us-gaap_FairValueAssumptionsExpectedDividendRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsProbabilityOfDefault" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsProbabilityOfDefault"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsProbabilityOfDefault" xml:lang="en-US">Fair Value Inputs, Probability Of Default</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsProbabilityOfDefault" xml:lang="en-US">Probability of stock offering in any period over 5 years (5)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_FairValueInputsProbabilityOfDefault" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_FairValueInputsProbabilityOfDefault"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RangeOfPercentageOfExistingSharesOffered" xlink:label="loc_659926H556J3_fil_RangeOfPercentageOfExistingSharesOffered"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_RangeOfPercentageOfExistingSharesOffered" xml:lang="en-US">Range Of Percentage Of Existing Shares Offered</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_RangeOfPercentageOfExistingSharesOffered" xml:lang="en-US">Range of percentage of existing shares offered</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_RangeOfPercentageOfExistingSharesOffered" xml:lang="en-US">Range of percentage of existing shares offered (6)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_RangeOfPercentageOfExistingSharesOffered" xml:lang="en-US">Range of percentage of existing shares offered.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_RangeOfPercentageOfExistingSharesOffered" xlink:to="lab_871148J778L5_fil_RangeOfPercentageOfExistingSharesOffered"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueAssumptionOfferingPrice" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FairValueAssumptionOfferingPrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueAssumptionOfferingPrice" xml:lang="en-US">Fair Value Assumption Offering Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueAssumptionOfferingPrice" xml:lang="en-US">Offering price range (7)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FairValueAssumptionOfferingPrice" xml:lang="en-US">Fair value assumption offering price.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FairValueAssumptionOfferingPrice" xlink:to="lab_M66M3IHII90M1H57H583_fil_FairValueAssumptionOfferingPrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_659926H556J3_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xml:lang="en-US">Derivative Instruments, Gain (Loss) By Hedging Relationship, By Income Statement Location, By Derivative Instrument Risk [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_871148J778L5_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeInstrumentsGainLossLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsGainLossLineItems" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsGainLossLineItems" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DerivativeInstrumentsGainLossLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeTextualAbstract" xlink:label="loc_659926H556J3_fil_DerivativeTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DerivativeTextualAbstract" xml:lang="en-US">Derivative Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DerivativeTextualAbstract" xml:lang="en-US">Derivative (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DerivativeTextualAbstract" xlink:to="lab_871148J778L5_fil_DerivativeTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfRiskFreeInterestRateDetermination" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfRiskFreeInterestRateDetermination"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfRiskFreeInterestRateDetermination" xml:lang="en-US">Description Of Risk Free Interest Rate Determination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfRiskFreeInterestRateDetermination" xml:lang="en-US">Description of risk free interest rate determination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfRiskFreeInterestRateDetermination" xml:lang="en-US">Description of risk free interest rate determination.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfRiskFreeInterestRateDetermination" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfRiskFreeInterestRateDetermination"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfProbabilityOfStockOffering" xlink:label="loc_659926H556J3_fil_DescriptionOfProbabilityOfStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfProbabilityOfStockOffering" xml:lang="en-US">Description Of Probability Of Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfProbabilityOfStockOffering" xml:lang="en-US">Description of probability of stock offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfProbabilityOfStockOffering" xml:lang="en-US">Description of probability of stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfProbabilityOfStockOffering" xlink:to="lab_871148J778L5_fil_DescriptionOfProbabilityOfStockOffering"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US">Components Of Deferred Tax Assets and Liabilities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US">Components of deferred tax assets and liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_659926H556J3_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Components Of Deferred Tax Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Deferred tax assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_871148J778L5_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Net operating losses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_659926H556J3_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US">Share-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xml:lang="en-US">Other differences in tax basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_659926H556J3_us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xml:lang="en-US">Total deferred tax assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xml:lang="en-US">Total deferred tax assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:to="lab_871148J778L5_us-gaap_DeferredTaxAssetsTaxDeferredExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsValuationAllowance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Less: valuation allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Less: valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_659926H556J3_us-gaap_DeferredTaxAssetsNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred Tax Assets, Net Of Valuation Allowance, Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred tax assets, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred tax assets, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_871148J778L5_us-gaap_DeferredTaxAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xml:lang="en-US">Schedule of difference between the income tax provision and the U.S. Federal statutory rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Income Tax Reconciliation, Income Tax Expense (Benefit), At Federal Statutory Income Tax Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Federal income taxes at 34%</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Effective Income Tax Rate Reconciliation, At Federal Statutory Income Tax Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">U.S. Federal statutory rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Federal income taxes at 34%, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">U.S. Federal statutory rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Income Tax Reconciliation, Nondeductible Expense, Share-Based Compensation Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Share-based compensation costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Compensation Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Share-based compensation costs, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Income Tax Reconciliation, Change In Deferred Tax Assets Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in fair value of derivatives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Deferred Tax Assets Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in fair value of derivatives, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xml:lang="en-US">Income Tax Reconciliation, Nondeductible Expense, Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xml:lang="en-US">Amortization of debt discounts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xml:lang="en-US">Amortization of debt discounts, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US">Income Tax Reconciliation, Other Adjustments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxReconciliationOtherAdjustments" xml:lang="en-US">Change in valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xml:lang="en-US">Change in valuation allowance, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_659926H556J3_us-gaap_IncomeTaxExpenseBenefit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_871148J778L5_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_871148J778L5_us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Provision for income tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Provision for income tax, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_IncomeTaxesTextualAbstract" xlink:label="loc_659926H556J3_fil_IncomeTaxesTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_IncomeTaxesTextualAbstract" xml:lang="en-US">Income Taxes Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_IncomeTaxesTextualAbstract" xml:lang="en-US">Income Taxes (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_IncomeTaxesTextualAbstract" xlink:to="lab_871148J778L5_fil_IncomeTaxesTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_OperatingLossCarryforwards"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Net operating losses ("NOLs")</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_OperatingLossCarryforwards" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_OperatingLossCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_659926H556J3_us-gaap_OperatingLossCarryforwardsExpirationDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_OperatingLossCarryforwardsExpirationDate" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_OperatingLossCarryforwardsExpirationDate" xml:lang="en-US">Expiration dates of operating loss carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="lab_871148J778L5_us-gaap_OperatingLossCarryforwardsExpirationDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_LongTermPurchaseCommitmentTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentTable" xml:lang="en-US">Long-Term Purchase Commitment [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentTable" xml:lang="en-US">Long-term Purchase Commitment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_659926H556J3_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xml:lang="en-US">Category Of Item Purchased [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xml:lang="en-US">Category of Item Purchased [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xml:lang="en-US">Long-Term Purchase Commitment, Category Of Item Purchased [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:label="loc_659926H556J3_fil_PhaseFirstClinicalTrialOfLicensedProductMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PhaseFirstClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase First Clinical Trial Of Licensed Product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PhaseFirstClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase I Clinical Trial of a licensed product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PhaseFirstClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase first clinical trial of a licensed product.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:to="lab_871148J778L5_fil_PhaseFirstClinicalTrialOfLicensedProductMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseSecondClinicalTrialOfLicensedProductMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PhaseSecondClinicalTrialOfLicensedProductMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseSecondClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase Second Clinical Trial Of Licensed Product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseSecondClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase II Clinical Trial of a licensed product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseSecondClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase second clinical trial of licensed product.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PhaseSecondClinicalTrialOfLicensedProductMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_PhaseSecondClinicalTrialOfLicensedProductMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseThirdClinicalTrialOfLicensedProductMember" xlink:label="loc_659926H556J3_fil_PhaseThirdClinicalTrialOfLicensedProductMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PhaseThirdClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase Third Clinical Trial Of Licensed Product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PhaseThirdClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase III Clinical Trial of a licensed product [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PhaseThirdClinicalTrialOfLicensedProductMember" xml:lang="en-US">Phase III clinical trial of licensed product.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PhaseThirdClinicalTrialOfLicensedProductMember" xlink:to="lab_871148J778L5_fil_PhaseThirdClinicalTrialOfLicensedProductMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BiologicalLicenseApplicationMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_BiologicalLicenseApplicationMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_BiologicalLicenseApplicationMember" xml:lang="en-US">Biological License Application [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_BiologicalLicenseApplicationMember" xml:lang="en-US">Biological License Application filing with U.S. FDA [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_BiologicalLicenseApplicationMember" xml:lang="en-US">Biological license application.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_BiologicalLicenseApplicationMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_BiologicalLicenseApplicationMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSaleMember" xlink:label="loc_659926H556J3_fil_FirstCommercialSaleMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FirstCommercialSaleMember" xml:lang="en-US">First Commercial Sale [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FirstCommercialSaleMember" xml:lang="en-US">First Commercial Sale [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FirstCommercialSaleMember" xml:lang="en-US">First commercial sale.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FirstCommercialSaleMember" xlink:to="lab_871148J778L5_fil_FirstCommercialSaleMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AfterFirstNetSalesMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AfterFirstNetSalesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AfterFirstNetSalesMember" xml:lang="en-US">After First Net Sales [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AfterFirstNetSalesMember" xml:lang="en-US">After First Net Sales [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AfterFirstNetSalesMember" xml:lang="en-US">After first net sales.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AfterFirstNetSalesMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_AfterFirstNetSalesMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewDrugApplicationMember" xlink:label="loc_659926H556J3_fil_NewDrugApplicationMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_NewDrugApplicationMember" xml:lang="en-US">New Drug Application [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_NewDrugApplicationMember" xml:lang="en-US">New Drug Application [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_NewDrugApplicationMember" xml:lang="en-US">New drug application.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_NewDrugApplicationMember" xlink:to="lab_871148J778L5_fil_NewDrugApplicationMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xml:lang="en-US">Receipt Of Regulatory Approval From U S Fda [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xml:lang="en-US">Receipt of Regulatory Approval From U.S. FDA [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xml:lang="en-US">Receipt of regulatory approval from U.S. FDA.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_659926H556J3_us-gaap_LongTermPurchaseCommitmentLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentLineItems" xml:lang="en-US">Long-Term Purchase Commitment [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentLineItems" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_871148J778L5_us-gaap_LongTermPurchaseCommitmentLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentAbstract" xml:lang="en-US">Milestone Payment [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentAbstract" xml:lang="en-US">Summary of milestone payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:label="loc_659926H556J3_fil_LongTermPurchaseCommitmentMilestonesPayment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_LongTermPurchaseCommitmentMilestonesPayment" xml:lang="en-US">Long Term Purchase Commitment Milestones Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_LongTermPurchaseCommitmentMilestonesPayment" xml:lang="en-US">Milestones payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_LongTermPurchaseCommitmentMilestonesPayment" xml:lang="en-US">Long term purchase commitment milestones payment.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:to="lab_871148J778L5_fil_LongTermPurchaseCommitmentMilestonesPayment"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTable" xlink:label="loc_K44K1GFGG78K9F35F361_fil_CommitmentsAndContingenciesTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesTable" xml:lang="en-US">Commitments and Contingencies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesTable" xml:lang="en-US">Commitments and Contingencies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesTable" xml:lang="en-US">Commitments and contingencies.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_CommitmentsAndContingenciesTable" xlink:to="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesTable"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OakRidgeNationalLaboratoryMember" xlink:label="loc_659926H556J3_fil_OakRidgeNationalLaboratoryMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_OakRidgeNationalLaboratoryMember" xml:lang="en-US">Oak Ridge National Laboratory [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_OakRidgeNationalLaboratoryMember" xml:lang="en-US">Oak Ridge National Laboratory [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_OakRidgeNationalLaboratoryMember" xml:lang="en-US">Oak ridge national laboratory.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_OakRidgeNationalLaboratoryMember" xlink:to="lab_871148J778L5_fil_OakRidgeNationalLaboratoryMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AptivSolutionsMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AptivSolutionsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AptivSolutionsMember" xml:lang="en-US">Aptiv Solutions [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AptivSolutionsMember" xml:lang="en-US">Aptiv Solutions [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AptivSolutionsMember" xml:lang="en-US">Aptiv solutions.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AptivSolutionsMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_AptivSolutionsMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FredHutchinsonCancerResearchCenterMember" xlink:label="loc_659926H556J3_fil_FredHutchinsonCancerResearchCenterMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FredHutchinsonCancerResearchCenterMember" xml:lang="en-US">Fred Hutchinson Cancer Research Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FredHutchinsonCancerResearchCenterMember" xml:lang="en-US">Fred Hutchinson Cancer Research Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FredHutchinsonCancerResearchCenterMember" xml:lang="en-US">Fred hutchinson cancer research center.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FredHutchinsonCancerResearchCenterMember" xlink:to="lab_871148J778L5_fil_FredHutchinsonCancerResearchCenterMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xml:lang="en-US">Phase I and Ii Clinical Trial For Actimab In Elderly Acute Myeloid Leukemia [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xml:lang="en-US">Phase I/II Clinical Trial For Actimab In Elderly Acute Myeloid Leukemia [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xml:lang="en-US">Phase I and II clinical trial for actimab in elderly acute myeloid leukemia.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfTexasMDAndersonCancerCenterMember" xlink:label="loc_659926H556J3_fil_UniversityOfTexasMDAndersonCancerCenterMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_UniversityOfTexasMDAndersonCancerCenterMember" xml:lang="en-US">University Of Texas M D Anderson Cancer Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_UniversityOfTexasMDAndersonCancerCenterMember" xml:lang="en-US">University of Texas M.D. Anderson Cancer Center [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_UniversityOfTexasMDAndersonCancerCenterMember" xml:lang="en-US">University of texas M.D. anderson cancer center.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_UniversityOfTexasMDAndersonCancerCenterMember" xlink:to="lab_871148J778L5_fil_UniversityOfTexasMDAndersonCancerCenterMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JohnsHopkinsUniversityMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_JohnsHopkinsUniversityMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_JohnsHopkinsUniversityMember" xml:lang="en-US">Johns Hopkins University [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_JohnsHopkinsUniversityMember" xml:lang="en-US">Johns Hopkins University [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_JohnsHopkinsUniversityMember" xml:lang="en-US">Johns hopkins university.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_JohnsHopkinsUniversityMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_JohnsHopkinsUniversityMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCoMember" xlink:label="loc_659926H556J3_fil_LaidlawAndCoMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_LaidlawAndCoMember" xml:lang="en-US">Laidlaw and Co [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_LaidlawAndCoMember" xml:lang="en-US">Laidlaw &amp; Co [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_LaidlawAndCoMember" xml:lang="en-US">Laidlaw and company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_LaidlawAndCoMember" xlink:to="lab_871148J778L5_fil_LaidlawAndCoMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfPennsylvaniaMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_UniversityOfPennsylvaniaMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_UniversityOfPennsylvaniaMember" xml:lang="en-US">University Of Pennsylvania [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_UniversityOfPennsylvaniaMember" xml:lang="en-US">University of Pennsylvania [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_UniversityOfPennsylvaniaMember" xml:lang="en-US">University of pennsylvania.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_UniversityOfPennsylvaniaMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_UniversityOfPennsylvaniaMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_659926H556J3_us-gaap_ChiefExecutiveOfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_ChiefExecutiveOfficerMember" xml:lang="en-US">Former CEO [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ChiefExecutiveOfficerMember" xlink:to="lab_871148J778L5_us-gaap_ChiefExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProductDevelopmentAndPatentLicenseAgreementMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ProductDevelopmentAndPatentLicenseAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProductDevelopmentAndPatentLicenseAgreementMember" xml:lang="en-US">Product Development and Patent License Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProductDevelopmentAndPatentLicenseAgreementMember" xml:lang="en-US">Product development and patent license agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ProductDevelopmentAndPatentLicenseAgreementMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_ProductDevelopmentAndPatentLicenseAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAgreementMember" xlink:label="loc_659926H556J3_fil_LicenseAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_LicenseAgreementMember" xml:lang="en-US">License Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_LicenseAgreementMember" xml:lang="en-US">License agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_LicenseAgreementMember" xml:lang="en-US">License agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_LicenseAgreementMember" xlink:to="lab_871148J778L5_fil_LicenseAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAndSponsoredResearchAgreementMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_LicenseAndSponsoredResearchAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseAndSponsoredResearchAgreementMember" xml:lang="en-US">License and Sponsored Research Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseAndSponsoredResearchAgreementMember" xml:lang="en-US">license and sponsored research agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_LicenseAndSponsoredResearchAgreementMember" xml:lang="en-US">License and sponsored research agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_LicenseAndSponsoredResearchAgreementMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_LicenseAndSponsoredResearchAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentAgreementMember" xlink:label="loc_659926H556J3_fil_PlacementAgentAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgentAgreementMember" xml:lang="en-US">Placement Agent Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgentAgreementMember" xml:lang="en-US">Placement Agent Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgentAgreementMember" xml:lang="en-US">Placement agent agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgentAgreementMember" xlink:to="lab_871148J778L5_fil_PlacementAgentAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RentalAgreementMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_RentalAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_RentalAgreementMember" xml:lang="en-US">Rental Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_RentalAgreementMember" xml:lang="en-US">Rental agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_RentalAgreementMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_RentalAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeparationAndSettlementAgreementMember" xlink:label="loc_659926H556J3_fil_SeparationAndSettlementAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SeparationAndSettlementAgreementMember" xml:lang="en-US">Separation and Settlement Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SeparationAndSettlementAgreementMember" xml:lang="en-US">Separation and Settlement Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SeparationAndSettlementAgreementMember" xml:lang="en-US">Separation and Settlement Agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SeparationAndSettlementAgreementMember" xlink:to="lab_871148J778L5_fil_SeparationAndSettlementAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_fil_CommitmentsAndContingenciesLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesLineItems" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesLineItems" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesLineItems" xml:lang="en-US">Commitments and contingencies.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_CommitmentsAndContingenciesLineItems" xlink:to="lab_M66M3IHII90M1H57H583_fil_CommitmentsAndContingenciesLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTextualAbstract" xlink:label="loc_659926H556J3_fil_CommitmentsAndContingenciesTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CommitmentsAndContingenciesTextualAbstract" xml:lang="en-US">Commitments and Contingencies (Textual) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CommitmentsAndContingenciesTextualAbstract" xml:lang="en-US">Commitments and Contingencies (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CommitmentsAndContingenciesTextualAbstract" xlink:to="lab_871148J778L5_fil_CommitmentsAndContingenciesTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfLicenseFee" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PaymentOfLicenseFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfLicenseFee" xml:lang="en-US">Payment Of License Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfLicenseFee" xml:lang="en-US">License fee payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfLicenseFee" xml:lang="en-US">License fee payment.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PaymentOfLicenseFee" xlink:to="lab_M66M3IHII90M1H57H583_fil_PaymentOfLicenseFee"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="loc_659926H556J3_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xml:lang="en-US">Revenue Recognition, Milestone Method, Revenue Recognized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xml:lang="en-US">Net sales in milestones payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="lab_871148J778L5_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentDate" xlink:label="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentDate" xml:lang="en-US">Milestone Payment Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentDate" xml:lang="en-US">Milestone payment date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentDate" xml:lang="en-US">Milestone payment date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_MilestonePaymentDate" xlink:to="lab_M66M3IHII90M1H57H583_fil_MilestonePaymentDate"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfRoyaltyPaymentToRelatedParty" xlink:label="loc_659926H556J3_fil_DescriptionOfRoyaltyPaymentToRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DescriptionOfRoyaltyPaymentToRelatedParty" xml:lang="en-US">Description Of Royalty Payment To Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DescriptionOfRoyaltyPaymentToRelatedParty" xml:lang="en-US">Description of royalty payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DescriptionOfRoyaltyPaymentToRelatedParty" xml:lang="en-US">Description of royalty payment to related party.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DescriptionOfRoyaltyPaymentToRelatedParty" xlink:to="lab_871148J778L5_fil_DescriptionOfRoyaltyPaymentToRelatedParty"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RoyaltyOfNetSalesPercentage" xlink:label="loc_K44K1GFGG78K9F35F361_fil_RoyaltyOfNetSalesPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_RoyaltyOfNetSalesPercentage" xml:lang="en-US">Royalty Of Net Sales Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_RoyaltyOfNetSalesPercentage" xml:lang="en-US">Royalty of Net Sales Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_RoyaltyOfNetSalesPercentage" xml:lang="en-US">Royalty of net sales percentage.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_RoyaltyOfNetSalesPercentage" xlink:to="lab_M66M3IHII90M1H57H583_fil_RoyaltyOfNetSalesPercentage"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSalePeriod" xlink:label="loc_659926H556J3_fil_FirstCommercialSalePeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FirstCommercialSalePeriod" xml:lang="en-US">First Commercial Sale Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FirstCommercialSalePeriod" xml:lang="en-US">First commercial sale period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FirstCommercialSalePeriod" xml:lang="en-US">First commercial sale period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FirstCommercialSalePeriod" xlink:to="lab_871148J778L5_fil_FirstCommercialSalePeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_TechnologyServicesCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TechnologyServicesCosts" xml:lang="en-US">Technology Services Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TechnologyServicesCosts" xml:lang="en-US">Technology access fee</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_TechnologyServicesCosts" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_TechnologyServicesCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_659926H556J3_us-gaap_MaintenanceCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_MaintenanceCosts" xml:lang="en-US">Maintenance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_MaintenanceCosts" xml:lang="en-US">Annual maintenance fee</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_MaintenanceCosts" xlink:to="lab_871148J778L5_us-gaap_MaintenanceCosts"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentArrangement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ResearchAndDevelopmentArrangement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentArrangement" xml:lang="en-US">Research and Development Arrangement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentArrangement" xml:lang="en-US">Annual research funding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentArrangement" xml:lang="en-US">Research and development arrangement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ResearchAndDevelopmentArrangement" xlink:to="lab_M66M3IHII90M1H57H583_fil_ResearchAndDevelopmentArrangement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PurchaseOfRadioactiveMaterial" xlink:label="loc_659926H556J3_fil_PurchaseOfRadioactiveMaterial"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PurchaseOfRadioactiveMaterial" xml:lang="en-US">Purchase Of Radioactive Material</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PurchaseOfRadioactiveMaterial" xml:lang="en-US">Purchase of radioactive material used for research and development</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PurchaseOfRadioactiveMaterial" xml:lang="en-US">Purchase of radioactive material.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PurchaseOfRadioactiveMaterial" xlink:to="lab_871148J778L5_fil_PurchaseOfRadioactiveMaterial"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProjectEstimatedCost" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ProjectEstimatedCost"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProjectEstimatedCost" xml:lang="en-US">Project Estimated Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProjectEstimatedCost" xml:lang="en-US">Project estimated cost for clinical trials of drug Ac-225-HuM195</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProjectEstimatedCost" xml:lang="en-US">Project estimated cost.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ProjectEstimatedCost" xlink:to="lab_M66M3IHII90M1H57H583_fil_ProjectEstimatedCost"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentOfProjectEstimatedCostPercentage" xlink:label="loc_659926H556J3_fil_DownPaymentOfProjectEstimatedCostPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_DownPaymentOfProjectEstimatedCostPercentage" xml:lang="en-US">Down Payment Of Project Estimated Cost Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_DownPaymentOfProjectEstimatedCostPercentage" xml:lang="en-US">Down payment of project estimated cost percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_DownPaymentOfProjectEstimatedCostPercentage" xml:lang="en-US">Percentage of total estimated project cost required for down payment.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_DownPaymentOfProjectEstimatedCostPercentage" xlink:to="lab_871148J778L5_fil_DownPaymentOfProjectEstimatedCostPercentage"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentForProject" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DownPaymentForProject"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DownPaymentForProject" xml:lang="en-US">Down Payment For Project</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DownPaymentForProject" xml:lang="en-US">Down payment for project</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DownPaymentForProject" xml:lang="en-US">Down payment for project.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DownPaymentForProject" xlink:to="lab_M66M3IHII90M1H57H583_fil_DownPaymentForProject"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xlink:label="loc_659926H556J3_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xml:lang="en-US">Clinical Trial Cost For Approval For Food and Drug Administration</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xml:lang="en-US">Clinical trial cost for approval of food and drug administration</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xml:lang="en-US">Clinical trial cost for approval of food and drug administration.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xlink:to="lab_871148J778L5_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xml:lang="en-US">Fund To Related Party Under Agreement For First Two Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xml:lang="en-US">Fund for Fred Hutchinson Cancer Research Center lab ( Per year for the first two years )</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xml:lang="en-US">Fund to related party under agreement for first two Year.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xlink:to="lab_M66M3IHII90M1H57H583_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xlink:label="loc_659926H556J3_fil_FundToRelatedPartyUnderAgreementAfterYearTwo"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xml:lang="en-US">Fund To Related Party Under Agreement After Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xml:lang="en-US">Fund for Fred Hutchinson Cancer Research Center lab ( thereafter )</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xml:lang="en-US">Fund to related party under agreement after year two.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xlink:to="lab_871148J778L5_fil_FundToRelatedPartyUnderAgreementAfterYearTwo"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_RoyaltyExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RoyaltyExpense" xml:lang="en-US">Royalty Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_RoyaltyExpense" xml:lang="en-US">Royalty payment for the commercial use of drugs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_RoyaltyExpense" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_RoyaltyExpense"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantExercisableNoticePeriodDescription" xlink:label="loc_659926H556J3_fil_WarrantExercisableNoticePeriodDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantExercisableNoticePeriodDescription" xml:lang="en-US">Warrant Exercisable Notice Period Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantExercisableNoticePeriodDescription" xml:lang="en-US">Warrant exercisable notice period description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantExercisableNoticePeriodDescription" xml:lang="en-US">Warrant exercisable notice period description.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantExercisableNoticePeriodDescription" xlink:to="lab_871148J778L5_fil_WarrantExercisableNoticePeriodDescription"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xlink:label="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xml:lang="en-US">Description Of Shares Availability By Exercise Of Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xml:lang="en-US">Description of period of shares availability by exercise of warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xml:lang="en-US">Description of shares availability by exercise of warrant.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xlink:to="lab_M66M3IHII90M1H57H583_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NonRefundableInstitutionalFee" xlink:label="loc_659926H556J3_fil_NonRefundableInstitutionalFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_NonRefundableInstitutionalFee" xml:lang="en-US">Non Refundable Institutional Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_NonRefundableInstitutionalFee" xml:lang="en-US">Non - refundable institutional fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_NonRefundableInstitutionalFee" xml:lang="en-US">Non refundable institutional fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_NonRefundableInstitutionalFee" xlink:to="lab_871148J778L5_fil_NonRefundableInstitutionalFee"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PharmacyFee" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PharmacyFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PharmacyFee" xml:lang="en-US">Pharmacy Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PharmacyFee" xml:lang="en-US">Annual pharmacy fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PharmacyFee" xml:lang="en-US">Pharmacy fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PharmacyFee" xlink:to="lab_M66M3IHII90M1H57H583_fil_PharmacyFee"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmendmentProcessingFee" xlink:label="loc_659926H556J3_fil_AmendmentProcessingFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmendmentProcessingFee" xml:lang="en-US">Amendment Processing Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AmendmentProcessingFee" xml:lang="en-US">Amendment processing fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmendmentProcessingFee" xml:lang="en-US">Amendment processing fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmendmentProcessingFee" xlink:to="lab_871148J778L5_fil_AmendmentProcessingFee"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementConsideration" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AgreementConsideration"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementConsideration" xml:lang="en-US">Agreement Consideration</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementConsideration" xml:lang="en-US">Consideration pursuant to agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementConsideration" xml:lang="en-US">Consideration under agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AgreementConsideration" xlink:to="lab_M66M3IHII90M1H57H583_fil_AgreementConsideration"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPayableInInstallmentsUnderAgreement" xlink:label="loc_659926H556J3_fil_AmountPayableInInstallmentsUnderAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AmountPayableInInstallmentsUnderAgreement" xml:lang="en-US">Amount Payable In Installments Under Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_AmountPayableInInstallmentsUnderAgreement" xml:lang="en-US">Amount payable in installments under agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AmountPayableInInstallmentsUnderAgreement" xml:lang="en-US">Amount payable in installments under agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AmountPayableInInstallmentsUnderAgreement" xlink:to="lab_871148J778L5_fil_AmountPayableInInstallmentsUnderAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallments" xlink:label="loc_K44K1GFGG78K9F35F361_fil_NumberOfInstallments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallments" xml:lang="en-US">Number Of Installments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallments" xml:lang="en-US">Number of installments.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_NumberOfInstallments" xlink:to="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallments"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PerformanceBonusPayableUnderAgreementForService" xlink:label="loc_659926H556J3_fil_PerformanceBonusPayableUnderAgreementForService"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PerformanceBonusPayableUnderAgreementForService" xml:lang="en-US">Performance Bonus Payable Under Agreement For Service</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_PerformanceBonusPayableUnderAgreementForService" xml:lang="en-US">Performance bonus payable under agreement for service</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PerformanceBonusPayableUnderAgreementForService" xml:lang="en-US">Performance bonus payable under agreement for service.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PerformanceBonusPayableUnderAgreementForService" xlink:to="lab_871148J778L5_fil_PerformanceBonusPayableUnderAgreementForService"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementRenewalDescription" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AgreementRenewalDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementRenewalDescription" xml:lang="en-US">Agreement Renewal Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementRenewalDescription" xml:lang="en-US">Rental agreement renewal description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AgreementRenewalDescription" xml:lang="en-US">Description regarding renewal of agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AgreementRenewalDescription" xlink:to="lab_M66M3IHII90M1H57H583_fil_AgreementRenewalDescription"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFirstInstallmentForServicesByCompany" xlink:label="loc_659926H556J3_fil_PaymentOfFirstInstallmentForServicesByCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PaymentOfFirstInstallmentForServicesByCompany" xml:lang="en-US">Payment Of First Installment For Services By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_PaymentOfFirstInstallmentForServicesByCompany" xml:lang="en-US">Payment of first installment for services by company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PaymentOfFirstInstallmentForServicesByCompany" xml:lang="en-US">Payment of first installment for services by company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PaymentOfFirstInstallmentForServicesByCompany" xlink:to="lab_871148J778L5_fil_PaymentOfFirstInstallmentForServicesByCompany"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFinalInstallmentForServicesByCompany" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PaymentOfFinalInstallmentForServicesByCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfFinalInstallmentForServicesByCompany" xml:lang="en-US">Payment Of Final Installment For Services By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfFinalInstallmentForServicesByCompany" xml:lang="en-US">Payment Of Performance Bonus For Services By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfFinalInstallmentForServicesByCompany" xml:lang="en-US">Outstanding payment of final installment for services by company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PaymentOfFinalInstallmentForServicesByCompany" xml:lang="en-US">Outstanding payment of final installment for services by company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PaymentOfFinalInstallmentForServicesByCompany" xlink:to="lab_M66M3IHII90M1H57H583_fil_PaymentOfFinalInstallmentForServicesByCompany"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfPerformanceBonusForServicesByCompany" xlink:label="loc_659926H556J3_fil_PaymentOfPerformanceBonusForServicesByCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PaymentOfPerformanceBonusForServicesByCompany" xml:lang="en-US">Payment Of Performance Bonus For Services By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_PaymentOfPerformanceBonusForServicesByCompany" xml:lang="en-US">Payment of performance bonus for services by company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PaymentOfPerformanceBonusForServicesByCompany" xml:lang="en-US">Payment of Performance bonus for Services by Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PaymentOfPerformanceBonusForServicesByCompany" xlink:to="lab_871148J778L5_fil_PaymentOfPerformanceBonusForServicesByCompany"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_LeaseExpirationDate1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LeaseExpirationDate1" xml:lang="en-US">Lease Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_LeaseExpirationDate1" xml:lang="en-US">Rent agreement termination date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_LeaseExpirationDate1" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_LeaseExpirationDate1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NoticePeriodForTerminationOfAgreement" xlink:label="loc_659926H556J3_fil_NoticePeriodForTerminationOfAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_NoticePeriodForTerminationOfAgreement" xml:lang="en-US">Notice Period For Termination Of Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_NoticePeriodForTerminationOfAgreement" xml:lang="en-US">Notice period for termination of agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_NoticePeriodForTerminationOfAgreement" xml:lang="en-US">Notice Period for termination of agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_NoticePeriodForTerminationOfAgreement" xlink:to="lab_871148J778L5_fil_NoticePeriodForTerminationOfAgreement"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Summary of warrants activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Summary of stock option activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Number of Units, Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Number of Units, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Cancellation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Stock option forfeitures during period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">warrants exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_871148J778L5_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US">Warrants expired</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US">Stock option cancelled during period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Weighted Average Remaining Contractual Term (in years), Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfStockByClassTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule Of Stock By Class [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ScheduleOfStockByClassTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:label="loc_659926H556J3_us-gaap_SeriesAMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SeriesAMember" xml:lang="en-US">Series [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SeriesAMember" xlink:to="lab_871148J778L5_us-gaap_SeriesAMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesBMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SeriesBMember" xml:lang="en-US">Series B [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SeriesBMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SeriesBMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_659926H556J3_us-gaap_TypeOfArrangementAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Type Of Arrangement and Non-Arrangement Transactions [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_TypeOfArrangementAxis" xlink:to="lab_871148J778L5_us-gaap_TypeOfArrangementAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Arrangements and Non-Arrangement Transactions [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Arrangements and Non-arrangement Transactions [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MccormickOBrienPllcMember" xlink:label="loc_659926H556J3_fil_MccormickOBrienPllcMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MccormickOBrienPllcMember" xml:lang="en-US">Mccormick O Brien Pllc [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MccormickOBrienPllcMember" xml:lang="en-US">McCormick &amp; O'Brien PLLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MccormickOBrienPllcMember" xml:lang="en-US">McCormick O Brien PLLC.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MccormickOBrienPllcMember" xlink:to="lab_871148J778L5_fil_MccormickOBrienPllcMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsidiarySaleOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Subsidiary, Sale Of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Subsidiary, Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsidiarySaleOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_659926H556J3_us-gaap_SaleOfStockNameOfTransactionDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale Of Stock, Name Of Transaction [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock, Name of Transaction [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_871148J778L5_us-gaap_SaleOfStockNameOfTransactionDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ManagementMember" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ManagementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ManagementMember" xml:lang="en-US">Management [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ManagementMember" xml:lang="en-US">Management Firm [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ManagementMember" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ManagementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_659926H556J3_us-gaap_FinancialInstrumentAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_FinancialInstrumentAxis" xlink:to="lab_871148J778L5_us-gaap_FinancialInstrumentAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Types Of Financial Instruments [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Types of Financial Instruments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgencyAgreementMember" xlink:label="loc_659926H556J3_fil_PlacementAgencyAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgencyAgreementMember" xml:lang="en-US">Placement Agency Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgencyAgreementMember" xml:lang="en-US">Placement Agency Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgencyAgreementMember" xml:lang="en-US">Placement agency agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgencyAgreementMember" xlink:to="lab_871148J778L5_fil_PlacementAgencyAgreementMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupLlcMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_JamessCapitalGroupLlcMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_JamessCapitalGroupLlcMember" xml:lang="en-US">Jamess Capital Group Llc [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_JamessCapitalGroupLlcMember" xml:lang="en-US">Jamess Capital Group, LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_JamessCapitalGroupLlcMember" xml:lang="en-US">Jamess capital group LLC.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_JamessCapitalGroupLlcMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_JamessCapitalGroupLlcMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsBMember" xlink:label="loc_659926H556J3_fil_WarrantsBMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsBMember" xml:lang="en-US">Warrants B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsBMember" xml:lang="en-US">B Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantsBMember" xml:lang="en-US">Warrant B.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsBMember" xlink:to="lab_871148J778L5_fil_WarrantsBMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_TitleOfIndividualAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_TitleOfIndividualAxis" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_TitleOfIndividualAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_659926H556J3_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title of Individual with Relationship to Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_871148J778L5_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerDirectorAndConsultantsMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_FormerDirectorAndConsultantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_FormerDirectorAndConsultantsMember" xml:lang="en-US">Former Director And Consultants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_FormerDirectorAndConsultantsMember" xml:lang="en-US">Former director and consultants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_FormerDirectorAndConsultantsMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_FormerDirectorAndConsultantsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_659926H556J3_us-gaap_ClassOfStockLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class Of Stock [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ClassOfStockLineItems" xlink:to="lab_871148J778L5_us-gaap_ClassOfStockLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EquityTextualAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_EquityTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_EquityTextualAbstract" xml:lang="en-US">Equity (Textual) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_EquityTextualAbstract" xml:lang="en-US">Equity (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_EquityTextualAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_EquityTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStockOffering" xlink:label="loc_659926H556J3_fil_WarrantsIssuedToPurchaseCommonStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToPurchaseCommonStockOffering" xml:lang="en-US">Warrants Issued To Purchase Common Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToPurchaseCommonStockOffering" xml:lang="en-US">Warrants issued to purchase common stock offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToPurchaseCommonStockOffering" xml:lang="en-US">Warrants Issued To Purchase Common Stock Offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsIssuedToPurchaseCommonStockOffering" xlink:to="lab_871148J778L5_fil_WarrantsIssuedToPurchaseCommonStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_IncreaseOfferingOfCommonStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_IncreaseOfferingOfCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_IncreaseOfferingOfCommonStock" xml:lang="en-US">Increase Offering Of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_IncreaseOfferingOfCommonStock" xml:lang="en-US">Raised offering of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_IncreaseOfferingOfCommonStock" xml:lang="en-US">Increase offering of common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_IncreaseOfferingOfCommonStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_IncreaseOfferingOfCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInStockOffering" xlink:label="loc_659926H556J3_fil_CommonStockSharesIssuedInStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedInStockOffering" xml:lang="en-US">Common Stock Shares Issued In Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedInStockOffering" xml:lang="en-US">Common stock issued in stock offering, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedInStockOffering" xml:lang="en-US">Common stock shares issued in stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CommonStockSharesIssuedInStockOffering" xlink:to="lab_871148J778L5_fil_CommonStockSharesIssuedInStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xml:lang="en-US">Proceeds From Issuance Of Stock Under Stock Offering Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xml:lang="en-US">Sale of common stock, net offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xml:lang="en-US">Proceeds from issuance of stock under stock offering, net.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xlink:to="lab_M66M3IHII90M1H57H583_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCashFees" xlink:label="loc_659926H556J3_fil_PlacementAgentCashFees"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgentCashFees" xml:lang="en-US">Placement Agent Cash Fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgentCashFees" xml:lang="en-US">Placement agent cash fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgentCashFees" xml:lang="en-US">Placement agent cash fees.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgentCashFees" xlink:to="lab_871148J778L5_fil_PlacementAgentCashFees"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCommission" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentCommission"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentCommission" xml:lang="en-US">Placement Agent Commission</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentCommission" xml:lang="en-US">Placement agent commission</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentCommission" xml:lang="en-US">Placement agent commission.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentCommission" xlink:to="lab_M66M3IHII90M1H57H583_fil_PlacementAgentCommission"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentExpenseReimbursement" xlink:label="loc_659926H556J3_fil_PlacementAgentExpenseReimbursement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgentExpenseReimbursement" xml:lang="en-US">Placement Agent Expense Reimbursement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgentExpenseReimbursement" xml:lang="en-US">Placement agent expense reimbursement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgentExpenseReimbursement" xml:lang="en-US">Placement agent expense reimbursement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgentExpenseReimbursement" xlink:to="lab_871148J778L5_fil_PlacementAgentExpenseReimbursement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedToPurchaseCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToPurchaseCommonStock" xml:lang="en-US">Warrants Issued To Purchase Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToPurchaseCommonStock" xml:lang="en-US">Warrants issued to purchase common stock, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToPurchaseCommonStock" xml:lang="en-US">Warrants Issued To Purchase Aggregate Shares Of Common Stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedToPurchaseCommonStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToPurchaseCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsExpirationTerm" xlink:label="loc_659926H556J3_fil_WarrantsExpirationTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsExpirationTerm" xml:lang="en-US">Warrants Expiration Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsExpirationTerm" xml:lang="en-US">Warrants expiration term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantsExpirationTerm" xml:lang="en-US">Warrants Expiration Term.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsExpirationTerm" xlink:to="lab_871148J778L5_fil_WarrantsExpirationTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments To Additional Paid In Capital, Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Warrants issued to purchase common stock, fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentServicesFees" xlink:label="loc_659926H556J3_fil_PlacementAgentServicesFees"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgentServicesFees" xml:lang="en-US">Placement Agent Services Fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgentServicesFees" xml:lang="en-US">Placement agent services fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgentServicesFees" xml:lang="en-US">Placement agent services fees.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgentServicesFees" xlink:to="lab_871148J778L5_fil_PlacementAgentServicesFees"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BankEscrowFee" xlink:label="loc_K44K1GFGG78K9F35F361_fil_BankEscrowFee"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_BankEscrowFee" xml:lang="en-US">Bank Escrow Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_BankEscrowFee" xml:lang="en-US">Bank escrow fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_BankEscrowFee" xml:lang="en-US">Bank escrow fee.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_BankEscrowFee" xlink:to="lab_M66M3IHII90M1H57H583_fil_BankEscrowFee"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AccruedManagementFees" xlink:label="loc_659926H556J3_fil_AccruedManagementFees"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_AccruedManagementFees" xml:lang="en-US">Accrued Management Fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_AccruedManagementFees" xml:lang="en-US">Accrued management fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_AccruedManagementFees" xml:lang="en-US">Accrued management fees.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_AccruedManagementFees" xlink:to="lab_871148J778L5_fil_AccruedManagementFees"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xlink:label="loc_K44K1GFGG78K9F35F361_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common Stock Shares Issued To Original Shareholder Under Share Exchange Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common stock issued to former shareholder under share exchange agreement, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common stock shares issued to original shareholder under share exchange agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xlink:to="lab_M66M3IHII90M1H57H583_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xlink:label="loc_659926H556J3_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common Stock Shares Issued To Former Shareholder Under Share Exchange Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common stock issued to former shareholders under share exchange agreement, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xml:lang="en-US">Common stock shares issued to former shareholder under share exchange agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xlink:to="lab_871148J778L5_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UnrecognizedShareBasedCompensationExpense" xlink:label="loc_K44K1GFGG78K9F35F361_fil_UnrecognizedShareBasedCompensationExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_UnrecognizedShareBasedCompensationExpense" xml:lang="en-US">Unrecognized Share Based Compensation Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_UnrecognizedShareBasedCompensationExpense" xml:lang="en-US">Unrecognized share based compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_UnrecognizedShareBasedCompensationExpense" xml:lang="en-US">Unrecognized share based compensation expense.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_UnrecognizedShareBasedCompensationExpense" xlink:to="lab_M66M3IHII90M1H57H583_fil_UnrecognizedShareBasedCompensationExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_659926H556J3_us-gaap_AllocatedShareBasedCompensationExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Recorded option expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Fair value of warrants recorded as stock-based compensation expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Recorded option expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_871148J778L5_us-gaap_AllocatedShareBasedCompensationExpense"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidForCancellationOfSharesByCompany" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AmountPaidForCancellationOfSharesByCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidForCancellationOfSharesByCompany" xml:lang="en-US">Amount Paid For Cancellation Of Shares By Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountPaidForCancellationOfSharesByCompany" xml:lang="en-US">Amount paid for cancellation of shares by company.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AmountPaidForCancellationOfSharesByCompany" xlink:to="lab_M66M3IHII90M1H57H583_fil_AmountPaidForCancellationOfSharesByCompany"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesPurchasedAfterCancelationOfOptions" xlink:label="loc_659926H556J3_fil_SharesPurchasedAfterCancelationOfOptions"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SharesPurchasedAfterCancelationOfOptions" xml:lang="en-US">Shares Purchased After Cancelation Of Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SharesPurchasedAfterCancelationOfOptions" xml:lang="en-US">Shares purchased after cancelation of options.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SharesPurchasedAfterCancelationOfOptions" xlink:to="lab_871148J778L5_fil_SharesPurchasedAfterCancelationOfOptions"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_659926H556J3_us-gaap_ProceedsFromWarrantExercises"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US">Proceeds from Warrant Exercises</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_871148J778L5_us-gaap_ProceedsFromWarrantExercises"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Number of Units, Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_659926H556J3_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Option Granted Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xml:lang="en-US">Weighted Average Remaining Contractual Term (in years), Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xml:lang="en-US">Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:to="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_659926H556J3_us-gaap_PlanNameAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_PlanNameAxis" xlink:to="lab_871148J778L5_us-gaap_PlanNameAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_PlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_PlanNameDomain" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_PlanNameDomain"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandThreeStockPlanMember" xlink:label="loc_659926H556J3_fil_TwoThousandThreeStockPlanMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_TwoThousandThreeStockPlanMember" xml:lang="en-US">Two Thousand Three Stock Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_TwoThousandThreeStockPlanMember" xml:lang="en-US">2003 Stock Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_TwoThousandThreeStockPlanMember" xml:lang="en-US">Two thousand three stock plan.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_TwoThousandThreeStockPlanMember" xlink:to="lab_871148J778L5_fil_TwoThousandThreeStockPlanMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_TwoThousandTwelveEmployeeStockOptionPlanMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xml:lang="en-US">Two Thousand Twelve Employee Stock Option Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xml:lang="en-US">2012 Employee Stock Option Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xml:lang="en-US">Two thousand twelve employee stock option plan.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_TwoThousandTwelveEmployeeStockOptionPlanMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeesAndConsultantsMember" xlink:label="loc_659926H556J3_fil_EmployeesAndConsultantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_EmployeesAndConsultantsMember" xml:lang="en-US">Employees and Consultants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_EmployeesAndConsultantsMember" xml:lang="en-US">Employees and Consultants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_EmployeesAndConsultantsMember" xml:lang="en-US">Employees and consultants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_EmployeesAndConsultantsMember" xlink:to="lab_871148J778L5_fil_EmployeesAndConsultantsMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultantsMember" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ConsultantsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConsultantsMember" xml:lang="en-US">Consultants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConsultantsMember" xml:lang="en-US">Consultants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ConsultantsMember" xml:lang="en-US">Consultants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ConsultantsMember" xlink:to="lab_M66M3IHII90M1H57H583_fil_ConsultantsMember"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionPlanTextualAbstract" xlink:label="loc_659926H556J3_fil_StockOptionPlanTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_StockOptionPlanTextualAbstract" xml:lang="en-US">Stock Option Plan Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_StockOptionPlanTextualAbstract" xml:lang="en-US">Stock Option Plan (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_StockOptionPlanTextualAbstract" xlink:to="lab_871148J778L5_fil_StockOptionPlanTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US">Maximum granted option to purchase common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xlink:label="loc_659926H556J3_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xml:lang="en-US">Maximum Granted Option To Purchase Common Stock After Amendment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xml:lang="en-US">Maximum granted option after amendment in 2008</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xml:lang="en-US">Maximum granted option to purchase common stock after amendment.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xlink:to="lab_871148J778L5_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Share based payment award vesting period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xlink:label="loc_659926H556J3_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xml:lang="en-US">Share Based Compensation Arrangement By Share Base Payment Award Periodic Percentage Of Award Vesting</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xml:lang="en-US">Share based payment award monthly vesting percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xml:lang="en-US">Share based compensation arrangement by share base payment award periodic percentage of award vesting.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xlink:to="lab_871148J778L5_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Stock Maximum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xml:lang="en-US">Warrants percentage of total issued and outstanding shares of capital stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xml:lang="en-US">Percentage of total issued and outstanding shares of Series E Preferred</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xlink:label="loc_659926H556J3_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xml:lang="en-US">Percentage Of Aggregate Issued and Outstanding Common Shares Reserved Under Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xml:lang="en-US">Percentage of aggregate issued and outstanding common shares reserved under offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xml:lang="en-US">Percentage of aggregate issued and outstanding common shares reserved under offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xlink:to="lab_871148J778L5_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US">Stock reserved for future issuance under ESOP</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Other Share Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xml:lang="en-US">Increment in number of shares under plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xlink:label="loc_K44K1GFGG78K9F35F361_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xml:lang="en-US">Share Based Compensation Share Based Arrangement Award Shares Reserved For Issuance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xml:lang="en-US">Total shares reserved for issuance under plan</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xml:lang="en-US">Share based compensation share based arrangement award shares reserved for issuance.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xlink:to="lab_M66M3IHII90M1H57H583_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStock" xlink:label="loc_659926H556J3_fil_StockOptionGrantedToPurchaseCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStock" xml:lang="en-US">Stock Option Granted To Purchase Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStock" xml:lang="en-US">Warrant granted to Management Firm to purchase common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStock" xml:lang="en-US">Stock option granted to employees to purchase common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStock" xml:lang="en-US">Stock option granted to purchase common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_StockOptionGrantedToPurchaseCommonStock" xlink:to="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:label="loc_K44K1GFGG78K9F35F361_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xml:lang="en-US">Stock Option Granted To Purchase Common Stock Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xml:lang="en-US">Warrants granted to Management Firm to purchase common stock, exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xml:lang="en-US">Stock option granted to purchase common stock, exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xml:lang="en-US">Stock option granted to purchase common stock exercise price.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:to="lab_M66M3IHII90M1H57H583_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:label="loc_659926H556J3_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xml:lang="en-US">Stock Option Granted To Purchase Common Stock Weighted Average Contractual Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xml:lang="en-US">Warrants granted to purchase common stock, term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xml:lang="en-US">Stock option granted to purchase common stock, term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xml:lang="en-US">Stock option granted to purchase common stock weighted average contractual life.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:to="lab_871148J778L5_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US">Fair value of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xml:lang="en-US">Fair value of stock option</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Discount For Postvesting Restrictions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xml:lang="en-US">Discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected life</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Expected volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_871148J778L5_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividends</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeeStockOptionUnitsReprised" xlink:label="loc_659926H556J3_fil_EmployeeStockOptionUnitsReprised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_EmployeeStockOptionUnitsReprised" xml:lang="en-US">Employee Stock Option Units Reprised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_EmployeeStockOptionUnitsReprised" xml:lang="en-US">Employee stock option units repriced</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_EmployeeStockOptionUnitsReprised" xml:lang="en-US">Employee stock option units reprised.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_EmployeeStockOptionUnitsReprised" xlink:to="lab_871148J778L5_fil_EmployeeStockOptionUnitsReprised"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xlink:label="loc_K44K1GFGG78K9F35F361_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xml:lang="en-US">Outstanding Stock Option Exercise Price After Repricing Of Stock Option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xml:lang="en-US">Outstanding stock option exercise price after repricing of stock option</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xml:lang="en-US">Outstanding stock option exercise price after repricing of stock option.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xlink:to="lab_M66M3IHII90M1H57H583_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xlink:label="loc_659926H556J3_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xml:lang="en-US">Share Based Compensation Cost After Repricing Of Stock Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xml:lang="en-US">Share based compensation cost after repricing of stock options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xml:lang="en-US">Share based compensation cost after repricing of stock options.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xlink:to="lab_871148J778L5_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedAbstract" xml:lang="en-US">Warrants Issued [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedAbstract" xml:lang="en-US">Summary of warrant issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedWithConvertibleNotes" xlink:label="loc_659926H556J3_fil_WarrantsIssuedWithConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Warrants Issued With Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Warrants issued with convertible notes (See Note 5)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantsIssuedWithConvertibleNotes" xml:lang="en-US">Warrants issued with convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsIssuedWithConvertibleNotes" xlink:to="lab_871148J778L5_fil_WarrantsIssuedWithConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithStockOffering" xlink:label="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedToInvestorsWithStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToInvestorsWithStockOffering" xml:lang="en-US">Warrants Issued To Investors With Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToInvestorsWithStockOffering" xml:lang="en-US">Warrants issued to investors with Stock Offering (See Note 6 and Note 9)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToInvestorsWithStockOffering" xml:lang="en-US">Warrants issued to investors with Stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssuedToInvestorsWithStockOffering" xlink:to="lab_M66M3IHII90M1H57H583_fil_WarrantsIssuedToInvestorsWithStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithCommonStock" xlink:label="loc_659926H556J3_fil_WarrantsIssuedToInvestorsWithCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToInvestorsWithCommonStock" xml:lang="en-US">Warrants Issued To Investors With Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToInvestorsWithCommonStock" xml:lang="en-US">Warrants issued to investors with Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantsIssuedToInvestorsWithCommonStock" xml:lang="en-US">Warrants issued to investors with common Stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantsIssuedToInvestorsWithCommonStock" xlink:to="lab_871148J778L5_fil_WarrantsIssuedToInvestorsWithCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Placement Agent Warrants Related To Issuance Of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Placement agent warrants related to issuance of Convertible Notes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xml:lang="en-US">Placement agent warrants related to issuance of convertible notes.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:to="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xlink:label="loc_659926H556J3_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xml:lang="en-US">Placement Agent Warrants Related To Issuance Of Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xml:lang="en-US">Placement agent warrants related to issuance of Stock Offering (See Note 6 and Note 9)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xml:lang="en-US">Placement agent warrants related to issuance of stock offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xlink:to="lab_871148J778L5_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xlink:label="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xml:lang="en-US">Placement Agent Warrants Related To Issuance Of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xml:lang="en-US">Placement agent warrants related to issuance of 2012 Common Stock Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xml:lang="en-US">Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xml:lang="en-US">Placement agent warrants related to issuance of common stock.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xlink:to="lab_M66M3IHII90M1H57H583_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xlink:label="loc_659926H556J3_fil_WarrantIssuedToInvestorsWithStockAccruedDividend"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xml:lang="en-US">Warrant Issued To Investors With Stock Accrued Dividend</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xml:lang="en-US">Warrant issued to investors with stock - accrued dividend</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xml:lang="en-US">Warrant issued to investors with stock accrued dividend.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xlink:to="lab_871148J778L5_fil_WarrantIssuedToInvestorsWithStockAccruedDividend"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssued" xlink:label="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssued" xml:lang="en-US">Warrants Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssued" xml:lang="en-US">Total warrants issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssued" xml:lang="en-US">Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_WarrantsIssued" xml:lang="en-US">Warrants issued.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_WarrantsIssued" xlink:to="lab_M66M3IHII90M1H57H583_fil_WarrantsIssued"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantTextualAbstract" xlink:label="loc_659926H556J3_fil_WarrantTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_WarrantTextualAbstract" xml:lang="en-US">Warrant Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_WarrantTextualAbstract" xml:lang="en-US">Warrant (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_WarrantTextualAbstract" xlink:to="lab_871148J778L5_fil_WarrantTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeeDefinedContributionPlanTextualAbstract" xlink:label="loc_K44K1GFGG78K9F35F361_fil_EmployeeDefinedContributionPlanTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_EmployeeDefinedContributionPlanTextualAbstract" xml:lang="en-US">Employee Defined Contribution Plan Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_EmployeeDefinedContributionPlanTextualAbstract" xml:lang="en-US">Employee Defined Contribution Plan (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_EmployeeDefinedContributionPlanTextualAbstract" xlink:to="lab_M66M3IHII90M1H57H583_fil_EmployeeDefinedContributionPlanTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="loc_659926H556J3_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xml:lang="en-US">Description Of Defined Contribution Pension and Other Postretirement Plans</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xml:lang="en-US">Description of employee deferred contribution plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:to="lab_871148J778L5_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US">Percentage of employer matching contribution</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_659926H556J3_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xml:lang="en-US">Contribution of the company in employee deferred contribution plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_871148J778L5_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventTable" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventTable"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerChiefExecutiveOfficerMember" xlink:label="loc_659926H556J3_fil_FormerChiefExecutiveOfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_FormerChiefExecutiveOfficerMember" xml:lang="en-US">Former Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_FormerChiefExecutiveOfficerMember" xml:lang="en-US">Former Chief Executive Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_FormerChiefExecutiveOfficerMember" xml:lang="en-US">former chief executive officer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_FormerChiefExecutiveOfficerMember" xlink:to="lab_871148J778L5_fil_FormerChiefExecutiveOfficerMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_us-gaap_SubsequentEventLineItems" xlink:to="lab_M66M3IHII90M1H57H583_us-gaap_SubsequentEventLineItems"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SubsequentEventsTextualAbstract" xlink:label="loc_659926H556J3_fil_SubsequentEventsTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_SubsequentEventsTextualAbstract" xml:lang="en-US">Subsequent Events Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_SubsequentEventsTextualAbstract" xml:lang="en-US">Subsequent Events (Textual)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_SubsequentEventsTextualAbstract" xml:lang="en-US">Subsequent events textual.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_SubsequentEventsTextualAbstract" xlink:to="lab_871148J778L5_fil_SubsequentEventsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xlink:label="loc_K44K1GFGG78K9F35F361_fil_NumberOfInstallmentsInWhichConsiderationIsPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xml:lang="en-US">Number Of Installments In Which Consideration Is Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xml:lang="en-US">Number of installments in which consideration is payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xml:lang="en-US">Number of installments in which consideration is payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xlink:to="lab_M66M3IHII90M1H57H583_fil_NumberOfInstallmentsInWhichConsiderationIsPayable"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsiderationPayableUnderAgreement" xlink:label="loc_659926H556J3_fil_ConsiderationPayableUnderAgreement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_ConsiderationPayableUnderAgreement" xml:lang="en-US">Consideration Payable Under Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_ConsiderationPayableUnderAgreement" xml:lang="en-US">Consideration payable under agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_ConsiderationPayableUnderAgreement" xml:lang="en-US">Consideration payable under agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_ConsiderationPayableUnderAgreement" xlink:to="lab_871148J778L5_fil_ConsiderationPayableUnderAgreement"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountOfPerformanceBonus" xlink:label="loc_K44K1GFGG78K9F35F361_fil_AmountOfPerformanceBonus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountOfPerformanceBonus" xml:lang="en-US">Amount Of Performance Bonus</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountOfPerformanceBonus" xml:lang="en-US">Performance bonus included in accounts payable and accrued liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M66M3IHII90M1H57H583_fil_AmountOfPerformanceBonus" xml:lang="en-US">Amount of performance bonus.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K44K1GFGG78K9F35F361_fil_AmountOfPerformanceBonus" xlink:to="lab_M66M3IHII90M1H57H583_fil_AmountOfPerformanceBonus"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfService" xlink:label="loc_659926H556J3_fil_PeriodOfService"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_871148J778L5_fil_PeriodOfService" xml:lang="en-US">Period Of Service</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_871148J778L5_fil_PeriodOfService" xml:lang="en-US">Period of service</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_871148J778L5_fil_PeriodOfService" xml:lang="en-US">Period of service.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_659926H556J3_fil_PeriodOfService" xlink:to="lab_871148J778L5_fil_PeriodOfService"/>
</labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fil-20130630_pre.xml
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.0.6.8 on Monday, September 30, 2013 02:53:50 PM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DocumentAndEntityInformation1" roleURI="http://cactusventuresinc.com/role/DocumentAndEntityInformation1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedBalanceSheets" roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedBalanceSheetsparenthetical" roleURI="http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Consolidatedstatementofchangesinstockholdersequitydeficit" roleURI="http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StatementsOfCashFlows" roleURI="http://cactusventuresinc.com/role/StatementsOfCashFlows"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies" roleURI="http://cactusventuresinc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Notes11" roleURI="http://cactusventuresinc.com/role/Notes11"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#RelatedPartyTransaction" roleURI="http://cactusventuresinc.com/role/RelatedPartyTransaction"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#PropertyAndEquipment" roleURI="http://cactusventuresinc.com/role/PropertyAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotes" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotes"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Derivatives" roleURI="http://cactusventuresinc.com/role/Derivatives"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxes" roleURI="http://cactusventuresinc.com/role/IncomeTaxes"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#CommitmentsAndContingencies" roleURI="http://cactusventuresinc.com/role/CommitmentsAndContingencies"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Equity" roleURI="http://cactusventuresinc.com/role/Equity"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlan" roleURI="http://cactusventuresinc.com/role/StockOptionPlan"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Warrants" roleURI="http://cactusventuresinc.com/role/Warrants"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#EmployeeDefinedContributionPlan" roleURI="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlan"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Notes13" roleURI="http://cactusventuresinc.com/role/Notes13"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#RelatedPartyTransactiontables" roleURI="http://cactusventuresinc.com/role/RelatedPartyTransactiontables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#PropertyandEquipmentTables" roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesTables" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesTables" roleURI="http://cactusventuresinc.com/role/DerivativesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxesTables" roleURI="http://cactusventuresinc.com/role/IncomeTaxesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#CommitmentsandContingenciesTables" roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlanTables" roleURI="http://cactusventuresinc.com/role/StockOptionPlanTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#EquityTables" roleURI="http://cactusventuresinc.com/role/EquityTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsTables" roleURI="http://cactusventuresinc.com/role/WarrantsTables"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1" roleURI="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#GoingconcernDetails" roleURI="http://cactusventuresinc.com/role/GoingconcernDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#RelatedPartyTransactiondetails" roleURI="http://cactusventuresinc.com/role/RelatedPartyTransactiondetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Relatedpartytransactiondetailstextual" roleURI="http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#PropertyandEquipmentDetails" roleURI="http://cactusventuresinc.com/role/PropertyandEquipmentDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Propertyandequipmentdetailstesxtual" roleURI="http://cactusventuresinc.com/role/Propertyandequipmentdetailstesxtual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesDetails" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#NotePayableAndConvertibleNotesDetailsTextual" roleURI="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesDetails" roleURI="http://cactusventuresinc.com/role/DerivativesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesDetails1" roleURI="http://cactusventuresinc.com/role/DerivativesDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#DerivativesDetailsTextual" roleURI="http://cactusventuresinc.com/role/DerivativesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxesDetails" roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncomeTaxesDetails1" roleURI="http://cactusventuresinc.com/role/IncomeTaxesDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#IncometaxesdetailsTextual" roleURI="http://cactusventuresinc.com/role/IncometaxesdetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#CommitmentsandContingenciesDetails" roleURI="http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Commitmentsandcontingenciesdetailstextual" roleURI="http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Equitydetails" roleURI="http://cactusventuresinc.com/role/Equitydetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#Equitydetailstextual" roleURI="http://cactusventuresinc.com/role/Equitydetailstextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlanDetails" roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#StockOptionPlanDetailsTextual" roleURI="http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetails" roleURI="http://cactusventuresinc.com/role/WarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetails1" roleURI="http://cactusventuresinc.com/role/WarrantsDetails1"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#WarrantsDetailsTextual" roleURI="http://cactusventuresinc.com/role/WarrantsDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#EmployeeDefinedContributionPlanDetails" roleURI="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlanDetails"/>
<roleRef xlink:type="simple" xlink:href="fil-20130630.xsd#SubsequenteventsDetails" roleURI="http://cactusventuresinc.com/role/SubsequenteventsDetails"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DocumentAndEntityInformation1">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DocumentAndEntityInformationAbstract" xlink:label="loc_fil_DocumentAndEntityInformationAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_3" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_4" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_5" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_6" order="50" use="optional"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_AssetsAbstract_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_13" xlink:to="loc_us-gaap_AssetsCurrentAbstract_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14" xlink:to="loc_us-gaap_Cash_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_14" xlink:to="loc_us-gaap_AssetsCurrent_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_13" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_13" xlink:to="loc_us-gaap_Assets_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_NotesPayableCurrent_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_LiabilitiesCurrent_29" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23" xlink:to="loc_us-gaap_Liabilities_30" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22" xlink:to="loc_us-gaap_CommitmentsAndContingencies_31" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22" xlink:to="loc_us-gaap_StockholdersEquityAbstract_32" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_PreferredStockValue_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_CommonStockValue_34" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_AdditionalPaidInCapital_35" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_36" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_StockholdersEquity_37" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_22" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_38" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_PreferredStockSharesIssued_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_18" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_CommonStockSharesIssued_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_SalesRevenueNet_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_DepreciationAndAmortization_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2" xlink:to="loc_us-gaap_OperatingExpenses_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_InterestExpense_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_StatementTable_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17" xlink:to="loc_us-gaap_StatementLineItems_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_CommonStockMember_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="loc_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockholdersEquity_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_SharesOutstanding_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfCommonStockShares" xlink:label="loc_fil_ProceedsFromIssuanceOfCommonStockShares_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_ProceedsFromIssuanceOfCommonStockShares_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockValue" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue_25" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToStockShares" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares_26" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerValue" xlink:label="loc_fil_SharesIssuedAtReverseMergerValue_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_SharesIssuedAtReverseMergerValue_27" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesIssuedAtReverseMergerShares" xlink:label="loc_fil_SharesIssuedAtReverseMergerShares_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_SharesIssuedAtReverseMergerShares_28" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_29" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense" xlink:label="loc_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense_30" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants" xlink:label="loc_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants_31" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_32" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RetireOfDerivativeLiability" xlink:label="loc_fil_RetireOfDerivativeLiability_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_fil_RetireOfDerivativeLiability_33" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_34" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_NetIncomeLoss_35" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_StockholdersEquity_36" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_16" xlink:to="loc_us-gaap_SharesOutstanding_37" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_NetIncomeLoss_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GainOnChangeInFairValueOfDerivatives" xlink:label="loc_fil_GainOnChangeInFairValueOfDerivatives_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_fil_GainOnChangeInFairValueOfDerivatives_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_13" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_16" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_30" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_31" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CashPaidForAbstract" xlink:label="loc_fil_CashPaidForAbstract_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_fil_CashPaidForAbstract_33" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CashPaidForAbstract_33" xlink:to="loc_us-gaap_InterestPaid_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CashPaidForAbstract_33" xlink:to="loc_us-gaap_IncomeTaxesPaid_35" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_37" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithDebt" xlink:label="loc_fil_FairValueOfWarrantsIssuedWithDebt_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_fil_FairValueOfWarrantsIssuedWithDebt_38" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedWithStock" xlink:label="loc_fil_FairValueOfWarrantsIssuedWithStock_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_fil_FairValueOfWarrantsIssuedWithStock_39" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfWarrantsIssuedToPlacementAgent" xlink:label="loc_fil_FairValueOfWarrantsIssuedToPlacementAgent_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_fil_FairValueOfWarrantsIssuedToPlacementAgent_40" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock" xlink:label="loc_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock_41" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_36" xlink:to="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_42" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Notes11">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernAbstract" xlink:label="loc_fil_GoingConcernAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernTextBlock" xlink:label="loc_fil_GoingConcernTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_GoingConcernAbstract_0" xlink:to="loc_fil_GoingConcernTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/RelatedPartyTransaction">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/PropertyAndEquipment">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotes">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Derivatives">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Equity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlan">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Warrants">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_fil_WarrantsAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsTextBlock" xlink:label="loc_fil_WarrantsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_fil_WarrantsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlan">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Notes13">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DevelopmentStageCompanyPolicyTextBlock" xlink:label="loc_fil_DevelopmentStageCompanyPolicyTextBlock_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_fil_DevelopmentStageCompanyPolicyTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsPolicyPolicyTextBlock_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/RelatedPartyTransactiontables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/PropertyandEquipmentTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock" xlink:label="loc_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/CommitmentsandContingenciesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTable" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_fil_MilestonePaymentsMilestoneMethodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodLineItems" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodTable_1" xlink:to="loc_fil_MilestonePaymentsMilestoneMethodLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentsMilestoneMethodTableTextBlock" xlink:label="loc_fil_MilestonePaymentsMilestoneMethodTableTextBlock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_MilestonePaymentsMilestoneMethodLineItems_6" xlink:to="loc_fil_MilestonePaymentsMilestoneMethodTableTextBlock_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlanTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/EquityTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_fil_WarrantsAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ScheduleOfWarrantsIssuedTableTextBlock" xlink:label="loc_fil_ScheduleOfWarrantsIssuedTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_fil_ScheduleOfWarrantsIssuedTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfWarrantActivitiesTableTextBlock" xlink:label="loc_fil_SummaryOfWarrantActivitiesTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_fil_SummaryOfWarrantActivitiesTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract" xlink:label="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7" xlink:to="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract_8" xlink:to="loc_us-gaap_DerivativeLiabilities_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_dei_LegalEntityAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2" xlink:to="loc_dei_EntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ActiniumMember" xlink:label="loc_fil_ActiniumMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3" xlink:to="loc_fil_ActiniumMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_EmployeeStockOptionMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_WarrantMember_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsAndWarrantsMember" xlink:label="loc_fil_OptionsAndWarrantsMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_10" xlink:to="loc_fil_OptionsAndWarrantsMember_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_16" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_17" xlink:to="loc_us-gaap_SubsequentEventMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable_1" xlink:to="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract" xlink:label="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems_19" xlink:to="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfOwnershipInterestToBeAcquired" xlink:label="loc_fil_PercentageOfOwnershipInterestToBeAcquired_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_fil_PercentageOfOwnershipInterestToBeAcquired_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition" xlink:label="loc_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage" xlink:label="loc_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSharesExchangedInShareExchangeProgramme" xlink:label="loc_fil_PercentageOfSharesExchangedInShareExchangeProgramme_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract_20" xlink:to="loc_fil_PercentageOfSharesExchangedInShareExchangeProgramme_28" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/GoingconcernDetails">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernAbstract" xlink:label="loc_fil_GoingConcernAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GoingConcernTextualAbstract" xlink:label="loc_fil_GoingConcernTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_GoingConcernAbstract_0" xlink:to="loc_fil_GoingConcernTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_GoingConcernTextualAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_GoingConcernTextualAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_GoingConcernTextualAbstract_1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/RelatedPartyTransactiondetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty" xlink:label="loc_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract_1" xlink:to="loc_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ReimbursementsReceivedFromRelatedParty" xlink:label="loc_fil_ReimbursementsReceivedFromRelatedParty_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract_1" xlink:to="loc_fil_ReimbursementsReceivedFromRelatedParty_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_fil_SloanKetteringInstituteOfCancerResearchMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_SloanKetteringInstituteOfCancerResearchMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterSloanKetteringInstituteOfCancerResearchMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RosemaryMazanetMember" xlink:label="loc_fil_RosemaryMazanetMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_RosemaryMazanetMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCompanyMember" xlink:label="loc_fil_LaidlawAndCompanyMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_LaidlawAndCompanyMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupMember" xlink:label="loc_fil_JamessCapitalGroupMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JamessCapitalGroupMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GuagentiAndAssociatesMember" xlink:label="loc_fil_GuagentiAndAssociatesMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_GuagentiAndAssociatesMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementAxis" xlink:label="loc_fil_AgreementAxis_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_fil_AgreementAxis_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementAxis_11" xlink:to="loc_fil_AgreementDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialAgreementMember" xlink:label="loc_fil_ClinicalTrialAgreementMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_ClinicalTrialAgreementMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseDevelopmentAndCommercializationAgreementMember" xlink:label="loc_fil_LicenseDevelopmentAndCommercializationAgreementMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_LicenseDevelopmentAndCommercializationAgreementMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultingServicesAgreementMember" xlink:label="loc_fil_ConsultingServicesAgreementMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_ConsultingServicesAgreementMember_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EngagementAgreementMember" xlink:label="loc_fil_EngagementAgreementMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_EngagementAgreementMember_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransactionManagementAgreementMember" xlink:label="loc_fil_TransactionManagementAgreementMember_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_12" xlink:to="loc_fil_TransactionManagementAgreementMember_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RelatedPartyTransactionsTextualAbstract" xlink:label="loc_fil_RelatedPartyTransactionsTextualAbstract_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_18" xlink:to="loc_fil_RelatedPartyTransactionsTextualAbstract_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfPatients" xlink:label="loc_fil_NumberOfPatients_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_NumberOfPatients_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandEleven" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandEleven_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandEleven_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandTwelve" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreementInYearTwoThousandThirteen" xlink:label="loc_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaintenanceFeesAndResearchPayments" xlink:label="loc_fil_MaintenanceFeesAndResearchPayments_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_MaintenanceFeesAndResearchPayments_24" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidUnderAgreement" xlink:label="loc_fil_AmountPaidUnderAgreement_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidUnderAgreement_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AdditionalAmountDueUnderAgreement" xlink:label="loc_fil_AdditionalAmountDueUnderAgreement_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AdditionalAmountDueUnderAgreement_26" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfConditionForTerminationOfForbearancePeriod" xlink:label="loc_fil_DescriptionOfConditionForTerminationOfForbearancePeriod_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_DescriptionOfConditionForTerminationOfForbearancePeriod_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TerminationDateOfForbearanceAgreement" xlink:label="loc_fil_TerminationDateOfForbearanceAgreement_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_TerminationDateOfForbearanceAgreement_28" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod" xlink:label="loc_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod_29" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewEquityFinanceRaisedByCompany" xlink:label="loc_fil_NewEquityFinanceRaisedByCompany_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_NewEquityFinanceRaisedByCompany_30" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ForgivenAmountOfObligations" xlink:label="loc_fil_ForgivenAmountOfObligations_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_ForgivenAmountOfObligations_31" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty" xlink:label="loc_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty_32" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_33" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToEachPatient" xlink:label="loc_fil_AmountPaidToEachPatient_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidToEachPatient_34" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpFeeForClinicalTrial" xlink:label="loc_fil_StartUpFeeForClinicalTrial_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_StartUpFeeForClinicalTrial_35" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpDueCostPaidDate" xlink:label="loc_fil_StartUpDueCostPaidDate_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_StartUpDueCostPaidDate_36" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesTransferTerm" xlink:label="loc_fil_DescriptionOfSharesTransferTerm_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_DescriptionOfSharesTransferTerm_37" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaap_OfficersCompensation_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_us-gaap_OfficersCompensation_38" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionExercisePriceRange" xlink:label="loc_fil_OptionExercisePriceRange_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_OptionExercisePriceRange_39" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_40" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OptionsReceivedToPurchaseCommonStock" xlink:label="loc_fil_OptionsReceivedToPurchaseCommonStock_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_OptionsReceivedToPurchaseCommonStock_41" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfReceivablesOfPlacementAgentForServices" xlink:label="loc_fil_DescriptionOfReceivablesOfPlacementAgentForServices_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_DescriptionOfReceivablesOfPlacementAgentForServices_42" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfWarrantsReceivablesByPlacement" xlink:label="loc_fil_DescriptionOfWarrantsReceivablesByPlacement_43"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_DescriptionOfWarrantsReceivablesByPlacement_43" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfExerciseOfWarrants" xlink:label="loc_fil_PeriodOfExerciseOfWarrants_44"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PeriodOfExerciseOfWarrants_44" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfSolicitationFee" xlink:label="loc_fil_PercentageOfSolicitationFee_45"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PercentageOfSolicitationFee_45" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeForFinancialAdvisoryServices" xlink:label="loc_fil_PeriodicFeeForFinancialAdvisoryServices_46"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PeriodicFeeForFinancialAdvisoryServices_46" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfAdditionalReceivableByPlacementAgent" xlink:label="loc_fil_DescriptionOfAdditionalReceivableByPlacementAgent_47"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_DescriptionOfAdditionalReceivableByPlacementAgent_47" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseByHoldingOfWarrant" xlink:label="loc_fil_CommonStockPurchaseByHoldingOfWarrant_48"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_CommonStockPurchaseByHoldingOfWarrant_48" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeReceivedByManagementFirm" xlink:label="loc_fil_PeriodicFeeReceivedByManagementFirm_49"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PeriodicFeeReceivedByManagementFirm_49" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:label="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_50"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_50" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumAmountOfOutOfPocketExpenses" xlink:label="loc_fil_MaximumAmountOfOutOfPocketExpenses_51"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_MaximumAmountOfOutOfPocketExpenses_51" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicAmountOfRent" xlink:label="loc_fil_PeriodicAmountOfRent_52"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_PeriodicAmountOfRent_52" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToPursuantLeaseAgreement" xlink:label="loc_fil_AmountPaidToPursuantLeaseAgreement_53"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_RelatedPartyTransactionsTextualAbstract_19" xlink:to="loc_fil_AmountPaidToPursuantLeaseAgreement_53" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_OfficeEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LossOnDispositionOfPropertyAndEquipment" xlink:label="loc_fil_LossOnDispositionOfPropertyAndEquipment_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" xlink:to="loc_fil_LossOnDispositionOfPropertyAndEquipment_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Propertyandequipmentdetailstesxtual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PropertyAndEquipmentTextualAbstract" xlink:label="loc_fil_PropertyAndEquipmentTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_fil_PropertyAndEquipmentTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_PropertyAndEquipmentTextualAbstract_1" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember" xlink:label="loc_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_3" xlink:to="loc_fil_SeniorSubordinatedUnsecuredConvertiblePromissoryNotesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfConvertiblePromissoryNotesAbstract" xlink:label="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_5" xlink:to="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DiscountRelatedToFairValueOfDerivativeWarrants" xlink:label="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_fil_DiscountRelatedToFairValueOfDerivativeWarrants_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:label="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentAmortizationOfDiscount" xlink:label="loc_fil_DebtInstrumentAmortizationOfDiscount_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_fil_DebtInstrumentAmortizationOfDiscount_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentPrincipalAmountConvertedToCommonStock" xlink:label="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfConvertiblePromissoryNotesAbstract_6" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentMember" xlink:label="loc_fil_PlacementAgentMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_PlacementAgentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ManagementFirmMember" xlink:label="loc_fil_ManagementFirmMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_ManagementFirmMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_1" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NotePayableAndConvertibleNotesTextualAbstract" xlink:label="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_6" xlink:to="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockPurchaseDueToIssuanceOfWarrants" xlink:label="loc_fil_CommonStockPurchaseDueToIssuanceOfWarrants_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_fil_CommonStockPurchaseDueToIssuanceOfWarrants_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExpirationDate" xlink:label="loc_invest_InvestmentWarrantsExpirationDate_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_invest_InvestmentWarrantsExpirationDate_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmortizationPeriodOfNote" xlink:label="loc_fil_AmortizationPeriodOfNote_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_NotePayableAndConvertibleNotesTextualAbstract_7" xlink:to="loc_fil_AmortizationPeriodOfNote_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PremiumFinanceAgreementPrincipalAmount" xlink:label="loc_fil_PremiumFinanceAgreementPrincipalAmount_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_PremiumFinanceAgreementPrincipalAmount_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentUnderPremiumFinanceAgreement" xlink:label="loc_fil_PaymentUnderPremiumFinanceAgreement_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_PaymentUnderPremiumFinanceAgreement_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicPaymentUnderPremiumFinanceAgreement" xlink:label="loc_fil_PeriodicPaymentUnderPremiumFinanceAgreement_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_PeriodicPaymentUnderPremiumFinanceAgreement_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement" xlink:label="loc_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PremiumFinanceAgreementOutstandingAmount" xlink:label="loc_fil_PremiumFinanceAgreementOutstandingAmount_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_PremiumFinanceAgreementOutstandingAmount_18" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromConvertibleNotes" xlink:label="loc_fil_ProceedsFromConvertibleNotes_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_ProceedsFromConvertibleNotes_20" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued" xlink:label="loc_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued_21" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_22" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents" xlink:label="loc_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents_23" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithConvertibleNotes" xlink:label="loc_fil_DerivativeWarrantsIssuedWithConvertibleNotes_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_DerivativeWarrantsIssuedWithConvertibleNotes_24" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InvestmentWarrantGrantDateFairValue" xlink:label="loc_fil_InvestmentWarrantGrantDateFairValue_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_InvestmentWarrantGrantDateFairValue_25" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature" xlink:label="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature_26" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_27" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DebtInstrumentFairValuePerShare" xlink:label="loc_fil_DebtInstrumentFairValuePerShare_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_DebtInstrumentFairValuePerShare_28" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ExtendedMaturityPeriodOfConvertibleNotes" xlink:label="loc_fil_ExtendedMaturityPeriodOfConvertibleNotes_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_ExtendedMaturityPeriodOfConvertibleNotes_29" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfExtendedMaturityDate" xlink:label="loc_fil_DescriptionOfExtendedMaturityDate_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_DescriptionOfExtendedMaturityDate_30" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_31" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_32" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_33" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_34" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InsurancePolicyDownPayment" xlink:label="loc_fil_InsurancePolicyDownPayment_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_InsurancePolicyDownPayment_35" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_InsurancePolicyInstallmentPayment" xlink:label="loc_fil_InsurancePolicyInstallmentPayment_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_fil_InsurancePolicyInstallmentPayment_36" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaap_NotesPayableCurrent_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_NotesPayableCurrent_37" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_38" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract" xlink:label="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsUnits" xlink:label="loc_fil_DerivativeWarrantsUnits_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsUnits_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithConvertibleNotes" xlink:label="loc_fil_DerivativeWarrantsIssuedWithConvertibleNotes_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsIssuedWithConvertibleNotes_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantUnitsReclassificationToPaidInCapital" xlink:label="loc_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithStockOffering" xlink:label="loc_fil_DerivativeWarrantsIssuedWithStockOffering_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsIssuedWithStockOffering_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:label="loc_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithCommonStockOffering" xlink:label="loc_fil_DerivativeWarrantsIssuedWithCommonStockOffering_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsIssuedWithCommonStockOffering_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:label="loc_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativePlacementAgentWarrantsRelatedToStock" xlink:label="loc_fil_DerivativePlacementAgentWarrantsRelatedToStock_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativePlacementAgentWarrantsRelatedToStock_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_TransferFromLiabilityClassificationToEquityClassification_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_TransferFromLiabilityClassificationToEquityClassification_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantsUnits" xlink:label="loc_fil_DerivativeWarrantsUnits_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantsUnits_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_13" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue" xlink:label="loc_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue_14" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes" xlink:label="loc_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes_15" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_16" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering" xlink:label="loc_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering_17" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock" xlink:label="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock_18" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering" xlink:label="loc_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering_19" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne" xlink:label="loc_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne_20" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock" xlink:label="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock_21" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification" xlink:label="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification_22" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ChangeInFairValueOfDerivativeWarrants" xlink:label="loc_fil_ChangeInFairValueOfDerivativeWarrants_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_fil_ChangeInFairValueOfDerivativeWarrants_23" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract_1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_24" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_us-gaap_DerivativeTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1" xlink:to="loc_us-gaap_DerivativeLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract" xlink:label="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6" xlink:to="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MarketValueOfCommonStockOnMeasurementDate" xlink:label="loc_fil_MarketValueOfCommonStockOnMeasurementDate_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_fil_MarketValueOfCommonStockOnMeasurementDate_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_FairValueAssumptionsExercisePrice_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueAssumptionsExercisePrice_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueAssumptionsRiskFreeInterestRate_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedTerm_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedTerm_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedVolatilityRate_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsProbabilityOfDefault" xlink:label="loc_us-gaap_FairValueInputsProbabilityOfDefault_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_us-gaap_FairValueInputsProbabilityOfDefault_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RangeOfPercentageOfExistingSharesOffered" xlink:label="loc_fil_RangeOfPercentageOfExistingSharesOffered_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_fil_RangeOfPercentageOfExistingSharesOffered_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FairValueAssumptionOfferingPrice" xlink:label="loc_fil_FairValueAssumptionOfferingPrice_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract_7" xlink:to="loc_fil_FairValueAssumptionOfferingPrice_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/DerivativesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DerivativeTextualAbstract" xlink:label="loc_fil_DerivativeTextualAbstract_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_5" xlink:to="loc_fil_DerivativeTextualAbstract_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_DerivativeTextualAbstract_6" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfRiskFreeInterestRateDetermination" xlink:label="loc_fil_DescriptionOfRiskFreeInterestRateDetermination_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_fil_DescriptionOfRiskFreeInterestRateDetermination_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_us-gaap_FairValueAssumptionsExpectedDividendRate_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfProbabilityOfStockOffering" xlink:label="loc_fil_DescriptionOfProbabilityOfStockOffering_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_fil_DescriptionOfProbabilityOfStockOffering_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RangeOfPercentageOfExistingSharesOffered" xlink:label="loc_fil_RangeOfPercentageOfExistingSharesOffered_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0" xlink:to="loc_fil_RangeOfPercentageOfExistingSharesOffered_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpense_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_2" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_8" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncomeTaxesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_13" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/IncometaxesdetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_IncomeTaxesTextualAbstract" xlink:label="loc_fil_IncomeTaxesTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_fil_IncomeTaxesTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_IncomeTaxesTextualAbstract_1" xlink:to="loc_us-gaap_OperatingLossCarryforwards_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_IncomeTaxesTextualAbstract_1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_IncomeTaxesTextualAbstract_1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_6" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseSecondClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseSecondClinicalTrialOfLicensedProductMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseSecondClinicalTrialOfLicensedProductMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseThirdClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseThirdClinicalTrialOfLicensedProductMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_PhaseThirdClinicalTrialOfLicensedProductMember_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BiologicalLicenseApplicationMember" xlink:label="loc_fil_BiologicalLicenseApplicationMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_BiologicalLicenseApplicationMember_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSaleMember" xlink:label="loc_fil_FirstCommercialSaleMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_FirstCommercialSaleMember_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AfterFirstNetSalesMember" xlink:label="loc_fil_AfterFirstNetSalesMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_AfterFirstNetSalesMember_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NewDrugApplicationMember" xlink:label="loc_fil_NewDrugApplicationMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_NewDrugApplicationMember_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ReceiptOfRegulatoryApprovalFromUSFdaMember" xlink:label="loc_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7" xlink:to="loc_fil_ReceiptOfRegulatoryApprovalFromUSFdaMember_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentAbstract" xlink:label="loc_fil_MilestonePaymentAbstract_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_16" xlink:to="loc_fil_MilestonePaymentAbstract_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:label="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_MilestonePaymentAbstract_17" xlink:to="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTable" xlink:label="loc_fil_CommitmentsAndContingenciesTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_fil_CommitmentsAndContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2" xlink:to="loc_us-gaap_RelatedPartyDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AbbottBiotherapeuticsCorpMember" xlink:label="loc_fil_AbbottBiotherapeuticsCorpMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AbbottBiotherapeuticsCorpMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MemorialSloanKetteringCancerCenterMember" xlink:label="loc_fil_MemorialSloanKetteringCancerCenterMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_MemorialSloanKetteringCancerCenterMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OakRidgeNationalLaboratoryMember" xlink:label="loc_fil_OakRidgeNationalLaboratoryMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_OakRidgeNationalLaboratoryMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AptivSolutionsMember" xlink:label="loc_fil_AptivSolutionsMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_AptivSolutionsMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FredHutchinsonCancerResearchCenterMember" xlink:label="loc_fil_FredHutchinsonCancerResearchCenterMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_FredHutchinsonCancerResearchCenterMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember" xlink:label="loc_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_PhaseIAndIiClinicalTrialForActimabInElderlyAcuteMyeloidLeukemiaMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfTexasMDAndersonCancerCenterMember" xlink:label="loc_fil_UniversityOfTexasMDAndersonCancerCenterMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_UniversityOfTexasMDAndersonCancerCenterMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JohnsHopkinsUniversityMember" xlink:label="loc_fil_JohnsHopkinsUniversityMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JohnsHopkinsUniversityMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCoMember" xlink:label="loc_fil_LaidlawAndCoMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_LaidlawAndCoMember_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UniversityOfPennsylvaniaMember" xlink:label="loc_fil_UniversityOfPennsylvaniaMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_UniversityOfPennsylvaniaMember_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupMember" xlink:label="loc_fil_JamessCapitalGroupMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_fil_JamessCapitalGroupMember_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaap_ChiefExecutiveOfficerMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_3" xlink:to="loc_us-gaap_ChiefExecutiveOfficerMember_15" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_16" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AfterFirstNetSalesMember" xlink:label="loc_fil_AfterFirstNetSalesMember_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" xlink:to="loc_fil_AfterFirstNetSalesMember_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PhaseFirstClinicalTrialOfLicensedProductMember" xlink:label="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_17" xlink:to="loc_fil_PhaseFirstClinicalTrialOfLicensedProductMember_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementAxis" xlink:label="loc_fil_AgreementAxis_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_fil_AgreementAxis_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementDomain" xlink:label="loc_fil_AgreementDomain_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementAxis_20" xlink:to="loc_fil_AgreementDomain_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProductDevelopmentAndPatentLicenseAgreementMember" xlink:label="loc_fil_ProductDevelopmentAndPatentLicenseAgreementMember_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_ProductDevelopmentAndPatentLicenseAgreementMember_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAgreementMember" xlink:label="loc_fil_LicenseAgreementMember_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_LicenseAgreementMember_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LicenseAndSponsoredResearchAgreementMember" xlink:label="loc_fil_LicenseAndSponsoredResearchAgreementMember_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_LicenseAndSponsoredResearchAgreementMember_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialAgreementMember" xlink:label="loc_fil_ClinicalTrialAgreementMember_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_ClinicalTrialAgreementMember_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentAgreementMember" xlink:label="loc_fil_PlacementAgentAgreementMember_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_PlacementAgentAgreementMember_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TransactionManagementAgreementMember" xlink:label="loc_fil_TransactionManagementAgreementMember_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_TransactionManagementAgreementMember_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RentalAgreementMember" xlink:label="loc_fil_RentalAgreementMember_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_RentalAgreementMember_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeparationAndSettlementAgreementMember" xlink:label="loc_fil_SeparationAndSettlementAgreementMember_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_AgreementDomain_21" xlink:to="loc_fil_SeparationAndSettlementAgreementMember_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_RangeAxis_30" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_30" xlink:to="loc_us-gaap_RangeMember_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_31" xlink:to="loc_us-gaap_MaximumMember_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_31" xlink:to="loc_us-gaap_MinimumMember_33" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesLineItems" xlink:label="loc_fil_CommitmentsAndContingenciesLineItems_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTable_1" xlink:to="loc_fil_CommitmentsAndContingenciesLineItems_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommitmentsAndContingenciesTextualAbstract" xlink:label="loc_fil_CommitmentsAndContingenciesTextualAbstract_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesLineItems_34" xlink:to="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfLicenseFee" xlink:label="loc_fil_PaymentOfLicenseFee_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PaymentOfLicenseFee_36" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LongTermPurchaseCommitmentMilestonesPayment" xlink:label="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_LongTermPurchaseCommitmentMilestonesPayment_37" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:label="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_38" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MilestonePaymentDate" xlink:label="loc_fil_MilestonePaymentDate_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_MilestonePaymentDate_39" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfRoyaltyPaymentToRelatedParty" xlink:label="loc_fil_DescriptionOfRoyaltyPaymentToRelatedParty_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_DescriptionOfRoyaltyPaymentToRelatedParty_40" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_RoyaltyOfNetSalesPercentage" xlink:label="loc_fil_RoyaltyOfNetSalesPercentage_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_RoyaltyOfNetSalesPercentage_41" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FirstCommercialSalePeriod" xlink:label="loc_fil_FirstCommercialSalePeriod_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_FirstCommercialSalePeriod_42" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TechnologyServicesCosts" xlink:label="loc_us-gaap_TechnologyServicesCosts_43"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_us-gaap_TechnologyServicesCosts_43" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaap_MaintenanceCosts_44"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_us-gaap_MaintenanceCosts_44" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ResearchAndDevelopmentArrangement" xlink:label="loc_fil_ResearchAndDevelopmentArrangement_45"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_ResearchAndDevelopmentArrangement_45" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PurchaseOfRadioactiveMaterial" xlink:label="loc_fil_PurchaseOfRadioactiveMaterial_46"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PurchaseOfRadioactiveMaterial_46" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProjectEstimatedCost" xlink:label="loc_fil_ProjectEstimatedCost_47"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_ProjectEstimatedCost_47" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentOfProjectEstimatedCostPercentage" xlink:label="loc_fil_DownPaymentOfProjectEstimatedCostPercentage_48"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_DownPaymentOfProjectEstimatedCostPercentage_48" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DownPaymentForProject" xlink:label="loc_fil_DownPaymentForProject_49"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_DownPaymentForProject_49" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration" xlink:label="loc_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration_50"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration_50" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementForFirstTwoYear" xlink:label="loc_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear_51"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear_51" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FundToRelatedPartyUnderAgreementAfterYearTwo" xlink:label="loc_fil_FundToRelatedPartyUnderAgreementAfterYearTwo_52"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_FundToRelatedPartyUnderAgreementAfterYearTwo_52" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_53"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_us-gaap_RoyaltyExpense_53" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfPatients" xlink:label="loc_fil_NumberOfPatients_54"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_NumberOfPatients_54" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidToEachPatient" xlink:label="loc_fil_AmountPaidToEachPatient_55"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_AmountPaidToEachPatient_55" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpFeeForClinicalTrial" xlink:label="loc_fil_StartUpFeeForClinicalTrial_56"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_StartUpFeeForClinicalTrial_56" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StartUpDueCostPaidDate" xlink:label="loc_fil_StartUpDueCostPaidDate_57"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_StartUpDueCostPaidDate_57" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodicFeeReceivedByManagementFirm" xlink:label="loc_fil_PeriodicFeeReceivedByManagementFirm_58"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PeriodicFeeReceivedByManagementFirm_58" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock" xlink:label="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_59"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock_59" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantExercisableNoticePeriodDescription" xlink:label="loc_fil_WarrantExercisableNoticePeriodDescription_60"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_WarrantExercisableNoticePeriodDescription_60" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant" xlink:label="loc_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant_61"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant_61" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumAmountOfOutOfPocketExpenses" xlink:label="loc_fil_MaximumAmountOfOutOfPocketExpenses_62"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_MaximumAmountOfOutOfPocketExpenses_62" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NonRefundableInstitutionalFee" xlink:label="loc_fil_NonRefundableInstitutionalFee_63"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_NonRefundableInstitutionalFee_63" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PharmacyFee" xlink:label="loc_fil_PharmacyFee_64"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PharmacyFee_64" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmendmentProcessingFee" xlink:label="loc_fil_AmendmentProcessingFee_65"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_AmendmentProcessingFee_65" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementConsideration" xlink:label="loc_fil_AgreementConsideration_66"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_AgreementConsideration_66" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPayableInInstallmentsUnderAgreement" xlink:label="loc_fil_AmountPayableInInstallmentsUnderAgreement_67"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_AmountPayableInInstallmentsUnderAgreement_67" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallments" xlink:label="loc_fil_NumberOfInstallments_68"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_NumberOfInstallments_68" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PerformanceBonusPayableUnderAgreementForService" xlink:label="loc_fil_PerformanceBonusPayableUnderAgreementForService_69"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PerformanceBonusPayableUnderAgreementForService_69" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AgreementRenewalDescription" xlink:label="loc_fil_AgreementRenewalDescription_70"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_AgreementRenewalDescription_70" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFirstInstallmentForServicesByCompany" xlink:label="loc_fil_PaymentOfFirstInstallmentForServicesByCompany_71"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PaymentOfFirstInstallmentForServicesByCompany_71" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfFinalInstallmentForServicesByCompany" xlink:label="loc_fil_PaymentOfFinalInstallmentForServicesByCompany_72"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PaymentOfFinalInstallmentForServicesByCompany_72" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PaymentOfPerformanceBonusForServicesByCompany" xlink:label="loc_fil_PaymentOfPerformanceBonusForServicesByCompany_73"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_PaymentOfPerformanceBonusForServicesByCompany_73" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_74"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_us-gaap_LeaseExpirationDate1_74" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NoticePeriodForTerminationOfAgreement" xlink:label="loc_fil_NoticePeriodForTerminationOfAgreement_75"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_CommitmentsAndContingenciesTextualAbstract_35" xlink:to="loc_fil_NoticePeriodForTerminationOfAgreement_75" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Equitydetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_14" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_15" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_17" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_18" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_19" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/Equitydetailstextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_CommonStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCTwoPreferredStockMember" xlink:label="loc_fil_SeriesCTwoPreferredStockMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCTwoPreferredStockMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCThreePreferredStockMember" xlink:label="loc_fil_SeriesCThreePreferredStockMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCThreePreferredStockMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeriesCFourPreferredStockMember" xlink:label="loc_fil_SeriesCFourPreferredStockMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_fil_SeriesCFourPreferredStockMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAMember" xlink:label="loc_us-gaap_SeriesAMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAMember_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBMember" xlink:label="loc_us-gaap_SeriesBMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBMember_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_15" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_LaidlawAndCoMember" xlink:label="loc_fil_LaidlawAndCoMember_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" xlink:to="loc_fil_LaidlawAndCoMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MccormickOBrienPllcMember" xlink:label="loc_fil_MccormickOBrienPllcMember_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_16" xlink:to="loc_fil_MccormickOBrienPllcMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_19" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentMember" xlink:label="loc_fil_PlacementAgentMember_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_fil_PlacementAgentMember_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ManagementMember" xlink:label="loc_us-gaap_ManagementMember_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_us-gaap_ManagementMember_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_23" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_23" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgencyAgreementMember" xlink:label="loc_fil_PlacementAgencyAgreementMember_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_PlacementAgencyAgreementMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_JamessCapitalGroupLlcMember" xlink:label="loc_fil_JamessCapitalGroupLlcMember_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_JamessCapitalGroupLlcMember_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_us-gaap_WarrantMember_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsBMember" xlink:label="loc_fil_WarrantsBMember_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_fil_WarrantsBMember_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24" xlink:to="loc_us-gaap_EmployeeStockOptionMember_29" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_30" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_30" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerDirectorAndConsultantsMember" xlink:label="loc_fil_FormerDirectorAndConsultantsMember_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_31" xlink:to="loc_fil_FormerDirectorAndConsultantsMember_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_33" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EquityTextualAbstract" xlink:label="loc_fil_EquityTextualAbstract_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_33" xlink:to="loc_fil_EquityTextualAbstract_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_35" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_36" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStockOffering" xlink:label="loc_fil_WarrantsIssuedToPurchaseCommonStockOffering_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_WarrantsIssuedToPurchaseCommonStockOffering_37" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_IncreaseOfferingOfCommonStock" xlink:label="loc_fil_IncreaseOfferingOfCommonStock_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_IncreaseOfferingOfCommonStock_38" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedInStockOffering" xlink:label="loc_fil_CommonStockSharesIssuedInStockOffering_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_CommonStockSharesIssuedInStockOffering_39" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet" xlink:label="loc_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet_40" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCashFees" xlink:label="loc_fil_PlacementAgentCashFees_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_PlacementAgentCashFees_41" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentCommission" xlink:label="loc_fil_PlacementAgentCommission_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_PlacementAgentCommission_42" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentExpenseReimbursement" xlink:label="loc_fil_PlacementAgentExpenseReimbursement_43"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_PlacementAgentExpenseReimbursement_43" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToPurchaseCommonStock" xlink:label="loc_fil_WarrantsIssuedToPurchaseCommonStock_44"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_WarrantsIssuedToPurchaseCommonStock_44" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_45"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_45" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsExpirationTerm" xlink:label="loc_fil_WarrantsExpirationTerm_46"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_WarrantsExpirationTerm_46" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_47"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_47" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentServicesFees" xlink:label="loc_fil_PlacementAgentServicesFees_48"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_PlacementAgentServicesFees_48" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_BankEscrowFee" xlink:label="loc_fil_BankEscrowFee_49"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_BankEscrowFee_49" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_50"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_50" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AccruedManagementFees" xlink:label="loc_fil_AccruedManagementFees_51"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_AccruedManagementFees_51" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement" xlink:label="loc_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement_52"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement_52" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement" xlink:label="loc_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement_53"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement_53" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UnrecognizedShareBasedCompensationExpense" xlink:label="loc_fil_UnrecognizedShareBasedCompensationExpense_54"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_UnrecognizedShareBasedCompensationExpense_54" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_55"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_55" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountPaidForCancellationOfSharesByCompany" xlink:label="loc_fil_AmountPaidForCancellationOfSharesByCompany_56"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_AmountPaidForCancellationOfSharesByCompany_56" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SharesPurchasedAfterCancelationOfOptions" xlink:label="loc_fil_SharesPurchasedAfterCancelationOfOptions_57"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_fil_SharesPurchasedAfterCancelationOfOptions_57" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_58"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_58" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_59"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EquityTextualAbstract_34" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_59" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlanDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_PlanNameAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_2" xlink:to="loc_us-gaap_PlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandThreeStockPlanMember" xlink:label="loc_fil_TwoThousandThreeStockPlanMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_fil_TwoThousandThreeStockPlanMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_TwoThousandTwelveEmployeeStockOptionPlanMember" xlink:label="loc_fil_TwoThousandTwelveEmployeeStockOptionPlanMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3" xlink:to="loc_fil_TwoThousandTwelveEmployeeStockOptionPlanMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RangeAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_6" xlink:to="loc_us-gaap_RangeMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_7" xlink:to="loc_us-gaap_MinimumMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_7" xlink:to="loc_us-gaap_MaximumMember_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" xlink:to="loc_us-gaap_EmployeeStockOptionMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_13" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeesAndConsultantsMember" xlink:label="loc_fil_EmployeesAndConsultantsMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" xlink:to="loc_fil_EmployeesAndConsultantsMember_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsultantsMember" xlink:label="loc_fil_ConsultantsMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_14" xlink:to="loc_fil_ConsultantsMember_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionPlanTextualAbstract" xlink:label="loc_fil_StockOptionPlanTextualAbstract_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17" xlink:to="loc_fil_StockOptionPlanTextualAbstract_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment" xlink:label="loc_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering" xlink:label="loc_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance" xlink:label="loc_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStock" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStock_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStock_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_33" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_34" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_35" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_36" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_37" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeeStockOptionUnitsReprised" xlink:label="loc_fil_EmployeeStockOptionUnitsReprised_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_EmployeeStockOptionUnitsReprised_38" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption" xlink:label="loc_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption_39" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationCostAfterRepricingOfStockOptions" xlink:label="loc_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions_40" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_UnrecognizedShareBasedCompensationExpense" xlink:label="loc_fil_UnrecognizedShareBasedCompensationExpense_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_fil_UnrecognizedShareBasedCompensationExpense_41" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_StockOptionPlanTextualAbstract_18" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_42" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetails">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_fil_WarrantsAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedAbstract" xlink:label="loc_fil_WarrantsIssuedAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_fil_WarrantsIssuedAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedWithConvertibleNotes" xlink:label="loc_fil_WarrantsIssuedWithConvertibleNotes_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_WarrantsIssuedWithConvertibleNotes_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithStockOffering" xlink:label="loc_fil_WarrantsIssuedToInvestorsWithStockOffering_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_WarrantsIssuedToInvestorsWithStockOffering_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssuedToInvestorsWithCommonStock" xlink:label="loc_fil_WarrantsIssuedToInvestorsWithCommonStock_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_WarrantsIssuedToInvestorsWithCommonStock_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock" xlink:label="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantIssuedToInvestorsWithStockAccruedDividend" xlink:label="loc_fil_WarrantIssuedToInvestorsWithStockAccruedDividend_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_WarrantIssuedToInvestorsWithStockAccruedDividend_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsIssued" xlink:label="loc_fil_WarrantsIssued_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsIssuedAbstract_1" xlink:to="loc_fil_WarrantsIssued_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetails1">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_fil_WarrantsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/WarrantsDetailsTextual">
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantsAbstract" xlink:label="loc_fil_WarrantsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7" xlink:to="loc_us-gaap_WarrantMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_WarrantTextualAbstract" xlink:label="loc_fil_WarrantTextualAbstract_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9" xlink:to="loc_fil_WarrantTextualAbstract_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStock" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStock_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStock_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockExercisePrice" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife" xlink:label="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_19" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_WarrantTextualAbstract_10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_20" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/EmployeeDefinedContributionPlanDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_EmployeeDefinedContributionPlanTextualAbstract" xlink:label="loc_fil_EmployeeDefinedContributionPlanTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0" xlink:to="loc_fil_EmployeeDefinedContributionPlanTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="loc_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EmployeeDefinedContributionPlanTextualAbstract_1" xlink:to="loc_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EmployeeDefinedContributionPlanTextualAbstract_1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_EmployeeDefinedContributionPlanTextualAbstract_1" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://cactusventuresinc.com/role/SubsequenteventsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_PlanNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5" xlink:to="loc_us-gaap_PlanNameDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SeparationAndSettlementAgreementMember" xlink:label="loc_fil_SeparationAndSettlementAgreementMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6" xlink:to="loc_fil_SeparationAndSettlementAgreementMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_8" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_FormerChiefExecutiveOfficerMember" xlink:label="loc_fil_FormerChiefExecutiveOfficerMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_9" xlink:to="loc_fil_FormerChiefExecutiveOfficerMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventLineItems_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_SubsequentEventsTextualAbstract" xlink:label="loc_fil_SubsequentEventsTextualAbstract_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11" xlink:to="loc_fil_SubsequentEventsTextualAbstract_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_NumberOfInstallmentsInWhichConsiderationIsPayable" xlink:label="loc_fil_NumberOfInstallmentsInWhichConsiderationIsPayable_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SubsequentEventsTextualAbstract_12" xlink:to="loc_fil_NumberOfInstallmentsInWhichConsiderationIsPayable_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_ConsiderationPayableUnderAgreement" xlink:label="loc_fil_ConsiderationPayableUnderAgreement_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SubsequentEventsTextualAbstract_12" xlink:to="loc_fil_ConsiderationPayableUnderAgreement_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_AmountOfPerformanceBonus" xlink:label="loc_fil_AmountOfPerformanceBonus_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SubsequentEventsTextualAbstract_12" xlink:to="loc_fil_AmountOfPerformanceBonus_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="fil-20130630.xsd#fil_PeriodOfService" xlink:label="loc_fil_PeriodOfService_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fil_SubsequentEventsTextualAbstract_12" xlink:to="loc_fil_PeriodOfService_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img001.jpg
<TEXT>
begin 644 img001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`%@`
M^@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/RJ/[7>K:9H]GIFD6-O'#9PI;QRRJ6DE"@*&*YP,XS@$XSU-3Z;
MX_\`B_XMQ)I^EZLL;<ATT\K&?^!.-M>Z?LZ?!2PO-*T./0]&@.J:G;PR%UC,
MDI=U4GYCEL9.`,]P*_8']AO_`()#>&_`&BV/B/XB6=KX@\03`2IIUPZ26MCW
M&4W8D?UW94>AZU_97%WB!D_#V$A*I!-R7N0>LFNC=W9+S^ZY^>9?1^M5G##4
ME9/5O^OU/Q:^$'[-'[67QFNX%\*^!?$&MQS-A9X["U^S_P#`IN%7\6!KTS4_
MV3/VC/A;XE_L/Q1X/\+G5!&))K2#7H_MB9&0I822PHQ'.TKGH<<BOVD_;9_;
M3L_V9_#_`/PA_ABW,7BB>W&U%LW%MI4)!`<O&DB%^,K&<8&&/&`WP-X?\6I/
MXE74+O6+%[JZN'EDGNKV7=,Y!+,2RAB23DG!]\5^58;Q6S;&1>)>%ITX.[BD
MI<S2UNVFK+HM+OIIO[.*P>%@_963DK7=E97Z==>_8\=TC]C+XS?\(W9ZXOP_
MUZ.UN$$\$]K+#>PG_<N+=V&X$')F6`*1CKQ7E7Q7^%WA_P"*>HWFG^/=!N(=
M>A?9-J447V/6[1\9S*64>?V.)PQ*XVNF=U?I1\"OVHKW]F[QN)(Y%UKP;K3^
M;?65E.K?9)3P9HVD*8;U`#!A[X(^F_VB?V1_AG^WCX$M;[5+6.>YD@(TSQ-I
MB&.\M%.3@2;0)$#9S&X*YSP&Y'+_`,18Q6"Q4(YS03HR?NSC=2B_*[;NNJYM
M=UV,89#3K4W6RR7+-;QZ/_@/TTZG\Q?[07[,6M?`.[M[J2:/6O#.I.4T_6K6
M,K%,P&3%*AR89U')C8GC)5G7#'F/@Y_R5SPKP/\`D+VG_HY*_37]I[]F#5_V
M3?B#J7P_\?6,6O\`A;Q%`2LT(,=OK=H&XFB)SY5S$Q![M&^#\RM\WP%XE^"M
MU\`_VL=%\/37'VZS75;&[TZ^";%U"SEE1X9@.Q*G#+D[75UR2IK^B^'^)J68
M82T9J<9Q;A/^9):IKI)=>ZUZ,Y\-6E*3I5ERSB]5^J\C^UI?NT4+THK^"3[@
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#\
M%/\`@@]\(K77=1T7Q-=:>NI?V1I"7<4;1AU#JL<<6<GL6E;ORB^E?<_[6_[>
M'@_X7:7=>%X9+&W\;74!"%G#'20XXD(.1O[JA&.A(QPWY_\`_!([]K*;]GCX
M++'9P0R7NJ:5'I:S2\K92.L<L$Q7^+[MPHSQN*`]<'%M_P!F_P`,?&GX@ZU-
MH^L:EJWBB\9]1U!IIYI+B<LWSRGS#\PW,`2.`2!QP*_0.+,LIK.ZN<<0U84\
M-3Y4E.3BFE&+5^B6OS9\O@<9*6$C@,KA*5>5W>,;VNVM.M]'Z&M_PB>I7UQ+
M?#QQKUS>O+YAGNKF"Y$NXY+M(P`3'.2P``[XR1N:!H'B:PET^9?'%I8V,F?,
MOY+%[CRVQ@[&BV;4&.I90W;K7F>J?LSW7@[7HK*X\3>(]#W2F.5QI;3B`#_E
MIL5O-DCZ#?&CC/?J1>T;X>?$F^\61V/A/Q3J&M:2A"_;]0L/[,"OM8X,<Y#`
M9&.<$\X'3.?U[*L=2K8NGC'[%PM&?+3E"&MM).*C*/\`<E=O=,QE@<=AG3H3
MH1]IS7<7*492TZI-R3_O*UNJ/;M>\+6_B3P?<+KOC)]?MX0TD=L?!]UY5P<#
M.-]P,;L\%POW220,$T/V5?VZ;C]EGQ$='N_"NL6W@N\N5ENETNY%PL.X8\Y$
M5Y(U;&"R`Y.,'!&:T/A]^Q-^U'XCC@N5CT/[+(VT7(U2VFB=`?O`QAMPZXQS
MP>E7?B_\$OBY^S?X7O=<\:?\(Y_8=BA>:Z^TJ58#&<(4#$\]`#7#_;/"M:+P
M5?,E54U:S5)>]T:Y%&S\M6:8?!9U2?MJ.&C%IZ-.>W5-.]_P]#W3_@J9X`\*
M_M'_`+`NK>+M`U*SU9O"L4?B72;M-JR;%($Z8"@_-"7!4\AE7(RM?BC^U#I<
M6IR_!+6B`UY8^(YM$=SU:W$UK<PK]%DFN3_VTK[B\7?MT:=J7[,_Q`\,Z;'8
MW":Q;-HJ-;JZQK-,P21D/"-B)922,@XZ\BO@W]ICQ3';^+?@]X95A]I76SK<
MZC^%)9K>"'/H?]'F./1E/>OUSPCRS$83!U*"FYTU5O3;WMROF_#<SS'$1K9C
M3FH\LN5J:6RMMT6ES^OA>E%`Z45_.I]<%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110!_*;^S[XRF\$>%-!N(U\ZWFTR"*Y@+
M%1/'L4XR.58$!E8<JR@CI7U!X=^)>B^.[*PO+VZO$N=,/^C:M:W+V<]GNP"L
MQC92F<`$_P"K?CD$[1\0_"KXU^$_$>B6=CINI+:O:PI"EEJ4BPW2!0``'.(Y
M>G52&;_GFO2O1+'79M#O8YH;B>PNARIR89,'\C@_K7]GYCD.&QU!8?$Q2GRJ
M,HS5U)+I*+TDNS5_F?CM>C7H5.=W5FVI1;33[IK\C[(\%>/+?1K6RTKPOX9T
M'5M0FPU_XF#"WMA$WSJBG<TLTL<;*K`!8P^X`\8KJ]?U+Q%X:OX-5T'6KVZA
MAD5I/#LOV7[#J'!#`L\9=6(Y!W@;@.V:^-O#WQKUC0&#0M&&_O1@PD_4(0I^
MI!KHE_:R\311J%F^Z0PW"-N1_P``K\VH^#.6?V77R7&477HUI.34IN48MW_A
MJ3_=I7]U12L=N,XHS.684LQPLXTYTTHIJ-G)*WQM)\][:W>I]1V&M>/_`(A>
M(+?Q)KGB#Q%X-DL6_P")5IFB^('AATM<`;F6$JDCL=Q;?O4!\`8!)\[_`&D+
M?3=(T/2(OB)XI\1>/=)T52EEI6H:U)=:@,EB3$\KO@DL0792P7Y0P'!\`\=_
MMA^(I+"0:AXF73;9@0P61(>/J`#7S?\`$[]LW2]-FF_LKSM=U"3.;B5B(0?4
ML?F;\,?6O8R/P3X?PN"IY?A<+&,::M&22=1;Z\]KWU;NV]11SO/L9CI8RK4;
M<G=I:0]+:)+T/7OC+\4_#?A1;K7);-M#\.VKL-/TM;CSIG8@?NPY^_(V!N;&
M%'L.?C[2_B)J'Q5_:5T77M2VBYOM;LR(T^Y!&LL:QQ+_`+*(JJ.^!SS7,^/?
MB)J_Q*UG[=JUT]Q*!MC4?+'"O]U%Z*/Y]ZM?!^WDB^*WA.1D8(^L6H5B/E8B
M9,X/MD?F*_:,MX?H9;A.2.G+%I+>VG?=R?5GN82@X-U*CO*3U?Z+R/[CU^[1
M0OW:*_SY/N@HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`/XK=9_8H\6+ID-YH<NGZ\)(EDDLXYOLVH6K$9,;P2[27'0B,OR*
MX^YN?'WP;?['<?\`"4>'5!YMYUFMXV_X`V%/Y5^XWAK_`(-./B1X5ACA@_:8
MM;BWB&$AO/"ANXXQZ*)+AMO_``'%=]X?_P"#:;XA:5;>1-\=-$DM^ZP>';F+
M?]0UVZ?^.U_7D?%G*J45"KBH5EYPFF__`"5+\SY?ZCBU]E/YV_S/Y_[?]I#Q
ME`O&L*W&,M:P,?SV9JOJ'QY\6ZFI$FM3!3VC1(__`$%17]!UU_P:^7&JG=>_
M$/PC<R'J\O@^"1B?J3G]:H2?\&L$D7-K\0/!,+=C_P`(7$,?D]:4O%WAE;QB
MG_AE_P#(&?U#$7O[+\4?SR>;J_B^\Q_IVI3L>``TS'\.:ZK0/V;?%&L0^==6
MD>C6@Y:?4)!"JCUP?F_2OW>U7_@US\?7,+16'QX\/Z7&W&(/"+#'Y7`'Z5P7
MB3_@SR\8>+Y=^H_M'6]W_LOX9D*CZ#[3BO2I^+W#\E;ZS&"\H3?_`+;87U#&
MO114?G?_`"/QJNM,\#_#1?WEQ)XPU6/I''F&QC;W;J_T'!]JI>#?'FH>-OC)
MX0:\D1;>UU>U6VM85\NWM5,T>0B#@9P,GJ<#)-?L7_Q!:ZQ_T7W3/_"6?_Y)
MK3\&?\&:NL>$_&&DZH?CQILRZ;>0W1C'A=U\S8ZMC/VCC.,9K2?BCPCR2;Q?
M-*SLW"?;I[MD:TLLKQ=VKOO='[MK]VB@#`HK^*3Z@****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HK\M?^"W/[:'Q7T/X_Z7
MX!^">N:KI5[\.?#%SXX\6R:=,5_T<.@5)0.JQQ@.5/!%PM?4'Q+_`."KO@OX
M/?L&^!/CQJFEZQJF@^-#9V_V72A')-9W$T4C2(WF.H(B>&5#@DY7@&O<J</X
MI4*%:"YG5T45NGT3_P`2U7D9^UC=KL?55%?"\'_!<C19/B5-X)D^"GQG@\;W
MUI'?^'M"?2HOMNNV[AG$H7S/W2B-6<EL@!7'WE*UTGA[_@M=\*-8_8PN/C)<
M6?B:QMK?6SX8/A][56U6;50BR"UC4-L8F-@^[<`%SG##;6<^'\QBDW2>K25K
M.]]MGL[/7;1]@]K%]3[$HKY%^'W_``5W\+^(--^)5GXH\"^//`/C+X8>%[CQ
MA?\`AK6K6..\O].AB\UI+=M^QC@H,,5P7'4!B)_V'?\`@K-X?_;I\3WT.B?#
M_P`?>&_#>GZ3-JC^(]<MX8=-<PR(DL2R+(P++OSP3@*V<8YSJ9+C80E4E3?+
M&UWI;756=];]+7N-5(O1'UG17X^_L9?\%._B=XH_X*-:-XP\6:MK'_"C_C=X
M@U7PMX5LKF4_9;*2%X!;.B'A7+M!$3GDRS''%?:?[2__``5;T/X%_M"ZC\+_
M``]\/_'?Q,\7:!IBZOK5KX?@B8:;;LJN,[V#2-L=&PBD8=><Y`[,9PUC*%>.
M'BE)N/-H]%9V:;=DG&7NOS)C6BU<^KZ*^%OVJ/VY-$\:>%?V;/%EGJWQ@\!V
MOQ`\80V4.FV5G%97%S)Y\<9MM1CF<'R"W>,MN5B5R"">A_:-_P""P^D_L_>.
M_&FGQ_"7XJ>*-`^',D47B/Q#8:?''I]DTAVC8974R*&R-W`RIYQ\QYZ>1XNI
MRJG&[=]-K6?+N[)ZZ:==!^TBMS[(HKF?A?\`%O1?B_\`"+0O&VB323:#XBTN
M'5[.1XRCM!+&)%W*>0VT\CJ#Q7YL_LAZ?\:/^"Q/AGQY\5V^.'C3X4Z';ZU/
MI'A'0/#L@BM[/RHXY%>ZVD&8?O4!R0S$.<JNU:SP65NM&=6M-4X0:3;3>KO9
M62;OH_2P2J6LEJ?J917R#X?_`&H?B=^PM^QEH-Y\?-(N_B)\1+C5UT.QA\%6
MS7UQJ_F`&!YLI&D<F=R,0-I(3&6?%4_"'_!9OPEJ?A+XL3>(O`?CSP?XI^#E
MA'J6N>'-2@A%X\$C(JM$PDV$_O(SABN0ZE=P.:?]BXJ2E.C'GBG:Z:L]4KKK
M9MI7M:[0>TCU/LJBOASP!_P73\$^+M9\!W&K?#CXF^$?!?Q%NUTW1_%>KV,,
M>FRW9(4QEED;Y`_R[QD95CC:I8>=?$?_`(*!ZK\#]7_:^U3PCJ7Q,\8>(O`%
MS:6\6GZO!;W&B^&WE-T!/;(LF_[.NS+[P#PG!Y%=-/AS'.?LYQY7I:^VLE#=
M:*S>M]MA.M&US]***^"?V=_^"L6LZ5^PY\-_$_B[X<_%+Q5XZ\67::+9V]EH
M\8?Q).(8I&OHBI$:6K-,$5C@ED8!<*2.-_;$_P""KTGQQ_X)R_'J_P#`]KXX
M^%?Q,^%.H:-8:I:7P6WOM->XU6"'*21L00RI.A'!X/&""2GPWC9UE2Y=.=0<
MKII-RY;Z:VOI>V^FXW6BE?YGZ445YC\(?B8VC?L<^%_&6O7%U>M:^#;36=1G
M8[YIRMDDTKGU8X8^Y-?GS^S-9_%;_@I#\%O$'QV\>?M'>)/@MX>U'5+BR\-:
M7HE['8:;IB1N$1IW9D\W]YE,,0S;<[OF"KC@\I=93J5)J$(-1NTW>3O9))-O
M9OT02J6V/U4HKX)^&_\`P4"\1?L-?L%2^+/CIXD\/_%S5-%\0)HL=_X(U*WO
M[B>":,O";DDQQK*"D@)!R5V$Y;<3M6__``7"\%V_P97Q=JOP[^)FCW&L:U%H
MGA70[G3H_P"U/%DDL4<J/:QA_P#5[9826)VYE0*7+`54L@QK;]E#FCS.*:V;
M7:]GY[:+</:1/MRBOD_X/?\`!6CPE\1;WX@Z'X@\'^-/A_X\^'&A7'B/4/#&
MNVT<5Y=V<,7FL]NP?:_RE."5^^",KDBOXB_X+!^!?#G[&/PY^-TOAKQ;)X?^
M)7B'_A'+"Q1+?[;;3>9>1[Y09=FS-E(?E8G#KQUQC+)<:I\CIN]TNFK:NK/9
MW2;36@_:1W/KBBOBWXE_\%G]"\'_`!\\>_#7P_\`"GXH^.?%7P_W/?IHMG!+
M`8(U#23[O,W*BAE`RN69@`.:^@OV/_VMO"?[;/P*TKX@>#9+O^R=29X7M[M!
M'<V4\9VO#*H)`8<'@D$,I!((K/$97BZ%)5ZL&HNVOJKKTNM5?<<:D6[(]0HK
MP'_@J1\0-;^%?_!/_P"*7B+PWJEYHNN:5HYFM+VUD,<UN_FQC<K#H<$U:_X)
MG>.M8^)O[!?PK\0>(-2O-8UK5M`@N+R]NI#)-<R'.69CU)]:S^IR^J?6[Z<W
M+;K>U[^@<WO<I[I17P?_`,$P_CUXT^*7_!03]K;P[XB\3:OK.A^#_$,-MHEC
M=3F2'3(S=7ZE(E/W05C0<=E%7/\`@K/^U1\0?#/Q<^#?P-^&&M_\(CXB^,&I
MM#>^(Q&'FTNS1XT/DAN-[;W8D88"(`$%\CN_L2K]=6"YE?E4F];)<G.V^NB_
MX!/M%R\Q]R45\7_!;]CS]H3]ES]J'P[=:/\`&35/BA\*=4MVC\367C6\:2^M
M)!P)+1E5CNSA@N57`96SE67[0KAQF'IT9)4JBFFKW5U\FG9IE1DWN?E[\$/^
M"1GQ#_:E^,'QD^*/QB\2?$3X0Z]X^U>>RMM*\.:Y:[[O1F10L-R\1E62+8(X
MA&2,^025P5->3^+?^":7[1UO_P`$]/%7P%C\$W&O6OA?XEQ:QX2O?[7L$74M
M*9+Q)6`:<>6`_ER['"L3=-Q\I`**^BCQ5C>>SY;1<7%6TCRZ*VM]M-6]#'V,
M;'V7XB_96\<7W_!;;P_\6H_#^[X>Z?X#;1WU7[5`%BNR9\1B+?YN<./F";<-
MUZU\=3?\$?OC1XE_8'\1:+-X7AM?&VB_%V[\9Z;HEQJT"KKFG26=O"0DT4NV
M.0LA(W.C`(W0LI)17+A>),70473M[J@MGM'FMUZ\SO\`A8ITHO<]`^&'[`7C
MCQSX>^.FN+^SU9_#*\UCX;ZIX:\+Q:AXWO-;U[4;VZLS&86EFO'ME@+EL,\<
M9&Y,'[Q'HWAW]G#XX?"/_@A%8?"3P[X+FE^*VH6-YHEUIJ:E9Q_8+>ZU"Y>>
M4S&81'-LY`VN2&E7T."BJK9_B*E1*2349QDD^9ZQ5DM9-M=]05)6/)/CC_P0
M)\5>&?V*-!A\$_$#XA>(OB%X-CM=3TOPO=:O`FBVM^\B/>&T5@BPL&:5U8OR
M5Y))S4_[</[''Q8_:0^(^A^,O%7[.,6O:EJ7A6SCDU/PCXJBT?Q%I.KK`JR1
MW3O-);31+*)-C)$3Y;1#S`5*$HKHPW%6.E.,ZMI-.5GJG[UFU>+CI=7^;"5&
M-M"]J'_!/[]HW7/V>/V5]-\6PW7C#Q1X`^(2Z[KK3:Q!/-H>F"XA9$>:20>>
M41'.$+D`A1D**XO]L;]A']IC]H+XL?&S3_$'@OQ9\0+?6K^6Y\!ZG_PGD5CH
M.B6*RN\<8L2X#S-'Y<05PH#Y9N,N2BC#<48FG/VJA"_O-:-6O+FTLU;7ILUH
M[DNC%K^NQ^DW[!_PXUKX9_L1_#'PCXJTN32=<T'PS9Z5J5C)-'*898HA$XWQ
MLR,#MR"K'@BOBSX`_L_?M3?\$M;+QU\._A3\./#OQ8\">(=5GU7PSJTVOP:?
M-H<DJI&!<Q3,K2A4CC)1,`LK$/\`,5!17E87-)TYU5*$91J.[C).UTVT]&GI
M=]=GJ:NFFD2_M!_LM?M?Z=^PS\.-$/C+Q)\0?%D7B-M0\;6>B:]%I6H3::P0
M)8P7I"%E4*X9CN.^;($B(,?/&N_L1?$?]F_X8?M6>,/$7PWU#P+X-\8>`HTT
MR.[\2P:Y/;RK=6A,4\PD,KS-M>0DKL!RH;A<E%>WE?$->3CAN2*4YJ]DUO.,
MMDTM&M-+I:&52DE[QO\`PL^!GQT_;^_8I_9M^$Y^&UIX=^'_`(;U&U\0W'CI
M]9@EANK*)9DC"6X/FK+LGD4H0<NJ'Y4)(]N?_@G_`/%;5?%'[=K'PVMO#\8K
M6)?"$TM_;;=79/M3;>)"8B=Z#,H09<=@2"BIS#/J]*O4HTHQC%-Z6>_M%.^K
M>K<5?I;1)!&FFDW_`%I8\]\3?`S]JS7?V.?@3X4M?AUXTT'0?AW<R:+XM\-:
M)XSMM.U+Q/9I';&&Y$Z,-D;'[3'Y>6*E0Q!!#+Q?AO\`X):_'#1OV9OVL/#-
MM\++G1[GXI2^&KSPOII\3V>HDI:ZK]IF@>Z>8%I(XI.7DVAVC?:3E<E%5'BC
M$4ERTX07O<VBENIJ:O[VNNE][:7#V*>_]:'ZN?"+X7.?V4_#'@OQ+9M%(/"=
MIHFJVOF`E3]C6&:/<I(./F&02.X)K\[OA[^RW\>/V*O@[XF^!%_\!=#_`&D_
MA3=:J^I>';QM?M]-$)9PX2YAD);A@KX``5R^'8$%2BO%R_-*E&4H.*E&34K.
M^DE>S3BTTU=]>II*FF><:C_P1Z^.>@?\$T/&WA6'PGH\OC/QMX[L?$4'AO3-
M4@VZ3:10S*R-+(ZQ?*9``J._`')YQ]:?\%'?V-/B1\0HOV>?B1\.='L/$'B_
MX%WT=Y-X:NKJ.W75(B+5I$CD<^6KJUJ%&2.'+*<J`2BNRKQ+BZE:->:C=2F[
M6=GSI1DGKM96[^=R51BE;T_`X?PO^QU\9/VR?VKOB5\9/'O@VR^%$>I?#R^\
M#^&=$NM3BOKJ>6XMY(O/N'ARJQ@RRYX#<H`"%)/S[J7[%G[4?C;]A/X3_`N7
MX)K86OPJ\9G6[G6'\2V#-J8:>\D!BB\P#8@O)-Q+$G";1RP!16]'B2O3DTH1
MM%QY5:5H\J<5;WKO1O=L7LDSHOA/\5_B?\'_`/@L%^U1J/PS^&J_$Z\F06]U
MIZZI%82VC$Q^3.#(<21AQM=%^;#@@@*:]7_92\/_`!/_`."/_P"Q[\)_#.H>
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M=.DFUR['>LXX95*[??CLOVLOV9?CG^V'H?PI^-VD>`]+^'/QL^$>LSSP>$=2
MU^'4;?5[/S(W53=1!8PS%"-I*?+(X+@A:**[*V>U.>.*5.*FDDW[VL>7ELTY
M-6<='9)^9,::MRWT.L^#X_:X_:._:V\)^*/&^AVOP+^&?A.VD&H>'[77;;6)
M_$TS@'#F,,H7<J<D*R+O"DLQ(^WJ**\?'XKVTU:$8**LE%67XMMO7=MFD8V1
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsTextBlock', window );">Warrants</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 11 &#8211; Warrants</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During the year ended December 31, 2011, warrants to purchase 1,974,774 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $2,153,442 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate ranging from 1.92% to 3.17%, (2) warrant life of 10 years, (3) expected volatility ranging from 64.77% to 70.72%, and (4) zero expected dividends. The management firm receives warrants equal to ten (10%) percent of the issued and outstanding capital stock of the Company on a fully-diluted basis on the effective date of the agreement.&#160;&#160;The warrants are subject to weighted average non-dilution provisions to be calculated on the basis of the post-money fully diluted capitalization of the Company upon closing of any transaction, financing or otherwise, up to and including the Public Company transaction, provided that such anti-dilution provisions shall not extend beyond the date of any exercise of the warrants by the management firm prior to the closing of the Public Company transaction. Since these warrants vest immediately, the Company recorded the entire fair value of $2,153,442 as stock-based compensation expense during the year on these warrants issued by the Company.</font></div>
<div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During the year ended December 31, 2011, the Company also issued the following warrants:</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with convertible notes (See Note 5)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">287,061</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Stock Offering (See Note 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,972,766</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Convertible Notes</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">143,532</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note
 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">986,383</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,389,742</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During the year ended December 31, 2012, warrants to purchase an aggregate of 1,716,340 shares of common stock were granted to the Management Firm at an exercise price of $0.01 per share. These warrants have a term of 7 years and vest immediately. Fair value of $1,957,754 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 1.82%, (2) warrant life of 7 years, (3) expected volatility of 60.64%, and (4) zero expected dividends.&#160;&#160;Since these warrants vest immediately, the Company recorded the entire fair value of $1,957,754 as stock-based compensation expense during the year on these warrants issued by the Company.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During the year ended December 31, 2012, the Company also issued the following warrants:</font></div>
<div align="justify" style="margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Stock Offering (See Note 6)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">242,189</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Common Stock</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,678,491</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">121,094</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;2012 Common Stock Offering</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">467,845</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with stock &#8211; accrued dividend</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">180,115&#160;</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,689,734</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160; The following is a summary of warrant activities for the years ended December 31, 2011 and 2012:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="text-align: center;" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom"
 style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,364,557</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.51</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6.76</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,364,557</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6.76</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,261,367</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7,406,079</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.32</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3.76</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%"
 valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">12,770,636</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0. 97</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.48</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6,114,768</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUYAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants (Details 1) (Warrant [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of warrants activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Beginning balance</a></td>
        <td class="nump">12,770,636<span></span></td>
        <td class="nump">5,364,557<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Units, Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,406,079<span></span></td>
        <td class="nump">5,364,557<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Ending Balance</a></td>
        <td class="nump">9,535,694<span></span></td>
        <td class="nump">12,770,636<span></span></td>
        <td class="nump">5,364,557<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance</a></td>
        <td class="nump">$ 0.97<span></span></td>
        <td class="nump">$ 0.51<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.32<span></span></td>
        <td class="nump">$ 0.51<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance</a></td>
        <td class="nump">$ 0.77<span></span></td>
        <td class="nump">$ 0.97<span></span></td>
        <td class="nump">$ 0.51<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term (in years), Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years 9 months 4 days<span></span></td>
        <td class="text">6 years 9 months 4 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years), Outstanding</a></td>
        <td class="text">5 years 4 months 2 days<span></span></td>
        <td class="text">4 years 5 months 23 days<span></span></td>
        <td class="text">6 years 9 months 4 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning balance</a></td>
        <td class="nump">$ 6,114,768<span></span></td>
        <td class="nump">$ 3,261,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
        <td class="nump">$ 9,691,302<span></span></td>
        <td class="nump">$ 6,114,768<span></span></td>
        <td class="nump">$ 3,261,367<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EM6BG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="1">157 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Statements Of Operations [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenue</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net of reimbursements</a></td>
        <td class="nump">509,262<span></span></td>
        <td class="nump">601,272<span></span></td>
        <td class="nump">1,594,968<span></span></td>
        <td class="nump">1,046,158<span></span></td>
        <td class="nump">3,440,485<span></span></td>
        <td class="nump">323,788<span></span></td>
        <td class="nump">26,420,519<span></span></td>
        <td class="nump">28,015,488<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">966,367<span></span></td>
        <td class="nump">237,908<span></span></td>
        <td class="nump">1,899,503<span></span></td>
        <td class="nump">798,184<span></span></td>
        <td class="nump">4,506,232<span></span></td>
        <td class="nump">2,959,246<span></span></td>
        <td class="nump">24,504,975<span></span></td>
        <td class="nump">26,404,478<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">159<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">317<span></span></td>
        <td class="nump">581<span></span></td>
        <td class="nump">633<span></span></td>
        <td class="nump">3,262,462<span></span></td>
        <td class="nump">3,262,462<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposition of equipment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">4,122<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">550,186<span></span></td>
        <td class="nump">554,307<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">1,475,629<span></span></td>
        <td class="nump">839,339<span></span></td>
        <td class="nump">3,498,593<span></span></td>
        <td class="nump">1,844,659<span></span></td>
        <td class="nump">7,947,298<span></span></td>
        <td class="nump">3,283,667<span></span></td>
        <td class="nump">54,738,142<span></span></td>
        <td class="nump">56,236,735<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(1,475,629)<span></span></td>
        <td class="num">(839,339)<span></span></td>
        <td class="num">(3,498,593)<span></span></td>
        <td class="num">(1,844,659)<span></span></td>
        <td class="num">(7,947,298)<span></span></td>
        <td class="num">(3,283,667)<span></span></td>
        <td class="num">(54,738,142)<span></span></td>
        <td class="num">(56,236,735)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="num">(634)<span></span></td>
        <td class="num">(320,728)<span></span></td>
        <td class="num">(1,209)<span></span></td>
        <td class="num">(633,618)<span></span></td>
        <td class="nump">1,099,327<span></span></td>
        <td class="nump">175,094<span></span></td>
        <td class="nump">1,964,707<span></span></td>
        <td class="num">(1,965,916)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">260,000<span></span></td>
        <td class="nump">260,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value - derivative liabilities</a></td>
        <td class="num">(1,307,748)<span></span></td>
        <td class="num">(402,524)<span></span></td>
        <td class="nump">26,764<span></span></td>
        <td class="nump">6,777<span></span></td>
        <td class="num">(685,420)<span></span></td>
        <td class="num">(13,966)<span></span></td>
        <td class="num">(699,386)<span></span></td>
        <td class="nump">726,150<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
        <td class="num">(1,308,382)<span></span></td>
        <td class="num">(723,252)<span></span></td>
        <td class="nump">25,555<span></span></td>
        <td class="num">(626,841)<span></span></td>
        <td class="nump">413,907<span></span></td>
        <td class="nump">161,128<span></span></td>
        <td class="nump">1,005,321<span></span></td>
        <td class="num">(979,766)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,784,011)<span></span></td>
        <td class="num">$ (1,562,591)<span></span></td>
        <td class="num">$ (3,473,038)<span></span></td>
        <td class="num">$ (2,471,500)<span></span></td>
        <td class="num">$ (8,361,205)<span></span></td>
        <td class="num">$ (3,444,795)<span></span></td>
        <td class="num">$ (55,743,463)<span></span></td>
        <td class="num">$ (59,216,501)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share - basic and diluted</a></td>
        <td class="num">$ (0.13)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.16)<span></span></td>
        <td class="num">$ (0.15)<span></span></td>
        <td class="num">$ (7.58)<span></span></td>
        <td class="num">$ (4.30)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding - basic and diluted</a></td>
        <td class="nump">22,178,637<span></span></td>
        <td class="nump">17,020,192<span></span></td>
        <td class="nump">21,791,673<span></span></td>
        <td class="nump">17,020,192<span></span></td>
        <td class="nump">1,103,521<span></span></td>
        <td class="nump">801,799<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4A<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4C<br><br><br><br> -Subparagraph (a),(c),(d),(e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624171-113959<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeGainLossOnDerivativeNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2941-110230<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDispositionOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 40<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12317-112629<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 40<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12355-112629<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainsLossesOnExtinguishmentOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the cost of borrowed funds accounted for as interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SalesRevenueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 3 &#8211; Property and Equipment</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160;Property and equipment consisted of the following at June 30, 2013 and December 31, 2012:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Lives</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2013</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Office equipment</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,274</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156,162</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Furniture and fixture</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;7 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div
 align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total property and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">158,566</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,454</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: accumulated depreciation</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Loss on disposition of equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4,122</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Property and equipment, net</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,010</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Depreciation expense for the three months ended June 30, 2013 and 2012 were $0&#160;and $159, respectively. Depreciation expense for the six months ended June 30, 2013 and 2012 were $0 and $317 respectively. The Company wrote off its remaining underpreciated property and equipment during the six months ended June 30, 2013.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 4 &#8211; Property and Equipment</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; Property and equipment consisted of the following at December 31, 2012 and 2011:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;Lives</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Office equipment</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;5 years</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156,162</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">153,804</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Furniture and fixture</font></div>
</td>
<td width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;7 years</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom:
 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total property, plant and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,454</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">155,096</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: accumulated depreciation</font></div>
</td>
<td align="left" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(153,863</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Property and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,010</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,233</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Depreciation expense for the years ended December 31, 2012 and 2011 were $581 and $633, respectively.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note Payable and Convertible Notes (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Note Payable and Convertible Notes [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of senior subordinated unsecured convertible promissory notes</a></td>
        <td class="text"><div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Principal amount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: original issuance discount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(150,000</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(150,000</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: discount related to fair value of derivative warrants</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">(377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: discount related to the beneficial conversion feature</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(372,850</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(372,850</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Add: amortization of discount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">124,363</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: principal amount converted to stock</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%"
 valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Carrying value at December 31, 2012 and 2011, respectively</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">124,363</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDebtTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events (Details) (Subsequent Event [Member], Separation and Settlement Agreement [Member], Former Chief Executive Officer [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2013

</div>
          <div>Note</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Subsequent Event [Member] | Separation and Settlement Agreement [Member] | Former Chief Executive Officer [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SubsequentEventsTextualAbstract', window );"><strong>Subsequent Events (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfInstallmentsInWhichConsiderationIsPayable', window );">Number of installments in which consideration is payable</a></td>
        <td class="nump">2<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConsiderationPayableUnderAgreement', window );">Consideration payable under agreement</a></td>
        <td class="nump">$ 250,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountOfPerformanceBonus', window );">Performance bonus included in accounts payable and accrued liabilities</a></td>
        <td class="nump">$ 60,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodOfService', window );">Period of service</a></td>
        <td class="text">August 15, 2012 to December 31, 2012<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountOfPerformanceBonus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of performance bonus.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountOfPerformanceBonus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConsiderationPayableUnderAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Consideration payable under agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ConsiderationPayableUnderAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfInstallmentsInWhichConsiderationIsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of installments in which consideration is payable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfInstallmentsInWhichConsiderationIsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodOfService">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period of service.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodOfService</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SubsequentEventsTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SubsequentEventsTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Employee Defined Contribution Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Defined Contribution Plan [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Defined Contribution Plan</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 12 &#8211; Employee Defined Contribution Plan</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; In 2004, the Company established an employee deferred contribution plan. The plan requires 12 consecutive months of service and a minimum of 500 hours of service for participation. The Plan provides for employer matching of 50% of the employee contribution and discretionary contributions. Employees can contribute up to the maximum allowable under the Internal Revenue Service Code Section 401(k). The amount contributed by the Company for the years ended December 31, 2012 and 2011 was $8,942 and $8,885, respectively.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationAndRetirementDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E62BG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="4">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of stock option activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Beginning balance</a></td>
        <td class="nump">2,330,134<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancellation</a></td>
        <td class="num">(49,950)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">128,050<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Warrants expired</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,613<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Ending Balance</a></td>
        <td class="nump">2,280,184<span></span></td>
        <td class="nump">2,330,134<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance</a></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance</a></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years), Outstanding</a></td>
        <td class="text">8 years 5 months 1 day<span></span></td>
        <td class="text">8 years 10 months 28 days<span></span></td>
        <td class="text">5 years 6 months 4 days<span></span></td>
        <td class="text">5 years 6 months 4 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning balance</a></td>
        <td class="nump">$ 685,800<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
        <td class="nump">1,609,035<span></span></td>
        <td class="nump">685,800<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of stock option activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Beginning balance</a></td>
        <td class="nump">12,770,636<span></span></td>
        <td class="nump">5,364,557<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">warrants exercised</a></td>
        <td class="num">(2,211,158)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Warrants expired</a></td>
        <td class="num">(1,023,784)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Ending Balance</a></td>
        <td class="nump">9,535,694<span></span></td>
        <td class="nump">12,770,636<span></span></td>
        <td class="nump">5,364,557<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance</a></td>
        <td class="nump">$ 0.97<span></span></td>
        <td class="nump">$ 0.51<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, exercised</a></td>
        <td class="nump">$ 1.65<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, expired</a></td>
        <td class="nump">$ 1.65<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance</a></td>
        <td class="nump">$ 0.77<span></span></td>
        <td class="nump">$ 0.97<span></span></td>
        <td class="nump">$ 0.51<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years), Outstanding</a></td>
        <td class="text">5 years 4 months 2 days<span></span></td>
        <td class="text">4 years 5 months 23 days<span></span></td>
        <td class="text">6 years 9 months 4 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning balance</a></td>
        <td class="nump">6,114,768<span></span></td>
        <td class="nump">3,261,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
        <td class="nump">$ 9,691,302<span></span></td>
        <td class="nump">$ 6,114,768<span></span></td>
        <td class="nump">$ 3,261,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EF5AE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note Payable and Convertible Notes (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 27, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfConvertiblePromissoryNotesAbstract', window );"><strong>Summary of senior subordinated unsecured convertible promissory notes</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 900,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: original issuance discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">150,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature', window );">Less: discount related to the beneficial conversion feature</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(372,850)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Carrying value at December 31, 2012 and 2011, respectively</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">124,363<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">8% Senior Subordinated Unsecured Convertible Promissory Notes [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfConvertiblePromissoryNotesAbstract', window );"><strong>Summary of senior subordinated unsecured convertible promissory notes</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: original issuance discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(150,000)<span></span></td>
        <td class="num">(150,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DiscountRelatedToFairValueOfDerivativeWarrants', window );">Less: discount related to fair value of derivative warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(377,150)<span></span></td>
        <td class="num">(377,150)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature', window );">Less: discount related to the beneficial conversion feature</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(372,850)<span></span></td>
        <td class="num">(372,850)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentAmortizationOfDiscount', window );">Add: amortization of discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="nump">124,363<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock', window );">Less: principal amount converted to stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(900,000)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Carrying value at December 31, 2012 and 2011, respectively</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 124,363<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtInstrumentAmortizationOfDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt instrument amortization of discount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DebtInstrumentAmortizationOfDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt instrument discount related to the beneficial conversion feature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtInstrumentPrincipalAmountConvertedToCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt instrument principal amount converted to common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DebtInstrumentPrincipalAmountConvertedToCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DiscountRelatedToFairValueOfDerivativeWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Discount related to fair value of derivative warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DiscountRelatedToFairValueOfDerivativeWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SummaryOfConvertiblePromissoryNotesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SummaryOfConvertiblePromissoryNotesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertibleNotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face (par) amount of debt instrument at time of issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentFaceAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentUnamortizedDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentsMilestoneMethodLineItems', window );"><strong>Milestone Payments Milestone Method [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentsMilestoneMethodTableTextBlock', window );">Summary of milestone payment</a></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(5) First commercial sale</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(5) First commercial sale</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(6) after the first $10,000,000 in net
 sales</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">MSKCC [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentsMilestoneMethodLineItems', window );"><strong>Milestone Payments Milestone Method [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentsMilestoneMethodTableTextBlock', window );">Summary of milestone payment</a></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval </font>for each licensed product</font></div>
</div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) upon the receipt of regulatory approval from the U.S. FDA for each </font>licensed product</font></div>
</div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">for each licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) upon the receipt of regulatory approval from the U.S. FDA for each</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MilestonePaymentsMilestoneMethodLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MilestonePaymentsMilestoneMethodLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MilestonePaymentsMilestoneMethodTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Milestone payments milestone method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MilestonePaymentsMilestoneMethodTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of deferred tax assets and liabilities</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Deferred tax assets:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Net operating losses</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,609,036</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,089,314</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Share-based compensation</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,497,556</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">741,420</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Other differences in tax basis</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px
 solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">233,043</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,749</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total deferred tax assets</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">15,339,635</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,835,483</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: valuation allowance</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(15,339,635</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(13,835,483</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family:
 times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Deferred tax assets, net</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of difference between the income tax provision and the U.S. Federal statutory rate</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="14">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">For the years ended</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="6">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="6">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Federal income taxes at 34%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2,842,810</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-34.00</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1,171,230</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td
 align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-34.00</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Share-based compensation costs</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">756,136</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9.04</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">736,796</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">21.39</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value of derivatives</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">233,043</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2.79</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,748</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.13</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left"
 style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Amortization of debt discounts</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">349,480</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.18</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">56,033</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.63</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in valuation allowance</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,504,151</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">17.99</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">373,653</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">10.85</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Provision for income tax</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGVAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | Phase I Clinical Trial of a licensed product [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">$ 750,000<span></span></td>
        <td class="nump">$ 750,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | Phase II Clinical Trial of a licensed product [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">750,000<span></span></td>
        <td class="nump">750,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | Phase III Clinical Trial of a licensed product [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | Biological License Application filing with U.S. FDA [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">1,750,000<span></span></td>
        <td class="nump">1,750,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | First Commercial Sale [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Abbott Biotherapeutics Corp [Member] | After First Net Sales [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Memorial Sloan Kettering Cancer Center [Member] | New Drug Application [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">750,000<span></span></td>
        <td class="nump">750,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Memorial Sloan Kettering Cancer Center [Member] | Receipt of Regulatory Approval From U.S. FDA [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentAbstract', window );"><strong>Summary of milestone payment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="nump">$ 1,750,000<span></span></td>
        <td class="nump">$ 1,750,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongTermPurchaseCommitmentMilestonesPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Long term purchase commitment milestones payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_LongTermPurchaseCommitmentMilestonesPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MilestonePaymentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MilestonePaymentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party Transactions (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract', window );"><strong>Summary of activities related to related party</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty', window );">Qualified R&amp;D costs incurred by the Company</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 655,786<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ReimbursementsReceivedFromRelatedParty', window );">Reimbursements received from MSKCC</a></td>
        <td class="nump">$ 237,834<span></span></td>
        <td class="nump">$ 966,341<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Qualified research and development costs incurred by related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_QualifiedResearchAndDevelopmentCostsIncurredByRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ReimbursementsReceivedFromRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reimbursements received from related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ReimbursementsReceivedFromRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionDueFromToRelatedPartyCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E5VBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Derivatives (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="1">157 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract', window );"><strong>Schedule of derivative warrant instruments activity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsUnits', window );">Beginning balance, Units</a></td>
        <td class="nump">5,146,338<span></span></td>
        <td class="nump">3,389,771<span></span></td>
        <td class="nump">3,389,771<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsIssuedWithConvertibleNotes', window );">Warrants issued with Convertible Notes (See Note 5), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">287,061<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital', window );">Reclassification to paid in capital, Units</a></td>
        <td class="num">(3,122,821)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes', window );">Placement agent warrants related to issuance of Convertible Notes (See Note 5), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">143,532<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsIssuedWithStockOffering', window );">Warrants issued with Stock Offering (See Note 9), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">242,190<span></span></td>
        <td class="nump">1,972,785<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock', window );">Placement agent warrants related to issuance of Stock Offering (See Note 9), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">121,095<span></span></td>
        <td class="nump">986,393<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsIssuedWithCommonStockOffering', window );">Warrants issued with 2012 Common Stock Offering - A (See Note 9), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,118,988<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne', window );">Warrants issued with 2012 Common Stock Offering - B (See Note 9), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,559,505<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativePlacementAgentWarrantsRelatedToStock', window );">Placement agent warrants related to 2012 Common Stock Offering (See Note 9), Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">467,845<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TransferFromLiabilityClassificationToEquityClassification', window );">Transfer from liability classification to equity classification, Units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,753,056)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsUnits', window );">Balance, Units</a></td>
        <td class="nump">2,023,517<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,146,338<span></span></td>
        <td class="nump">3,389,771<span></span></td>
        <td class="nump">5,146,338<span></span></td>
        <td class="nump">2,023,517<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Beginning balance, Fair Value</a></td>
        <td class="nump">$ 3,574,958<span></span></td>
        <td class="nump">$ 4,439,613<span></span></td>
        <td class="nump">$ 4,439,613<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue', window );">Reclassification to paid in capital, Fair Value</a></td>
        <td class="num">(590,217)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes', window );">Warrants issued with Convertible Notes (See Note 5), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">377,150<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes', window );">Placement agent warrants related to issuance of Convertible Notes (See Note 5), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">188,579<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering', window );">Warrants issued with Stock Offering (See Note 9), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">318,087<span></span></td>
        <td class="nump">2,591,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock', window );">Placement agent warrants related to issuance of Stock Offering (See Note 9), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">159,044<span></span></td>
        <td class="nump">1,295,950<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering', window );">Warrants issued with 2012 Common Stock Offering - A (See Note 9), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,409,554<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne', window );">Warrants issued with 2012 Common Stock Offering - B (See Note 9), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,665,697<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock', window );">Placement agent warrants related to 2012 Common Stock Offering (See Note 9), Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">499,707<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification', window );">Transfer from liability classification to equity classification, Fair Value</a></td>
        <td class="nump">590,217<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">4,231,324<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,231,324<span></span></td>
        <td class="nump">4,821,542<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ChangeInFairValueOfDerivativeWarrants', window );">Change in fair value</a></td>
        <td class="num">(26,764)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(685,420)<span></span></td>
        <td class="num">(13,966)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Balance, Fair Value</a></td>
        <td class="nump">$ 2,957,977<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 3,574,958<span></span></td>
        <td class="nump">$ 4,439,613<span></span></td>
        <td class="nump">$ 3,574,958<span></span></td>
        <td class="nump">$ 2,957,977<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ChangeInFairValueOfDerivativeWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Change in fair value of derivative warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ChangeInFairValueOfDerivativeWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative placement Agent warrants related to issuance of convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative Placement Agent warrants related to issuance of stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativePlacementAgentWarrantsRelatedToIssuanceOfStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativePlacementAgentWarrantsRelatedToStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative placement agent warrants related to stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativePlacementAgentWarrantsRelatedToStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsIssuedWithCommonStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants issued with Common Stock Offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsIssuedWithCommonStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants issued with Common Stock Offering one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsIssuedWithCommonStockOfferingOne</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsIssuedWithConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants Issued With Convertible Notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsIssuedWithConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsIssuedWithStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants issued with Stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsIssuedWithStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsUnits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsUnits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantUnitsReclassificationToPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification to paid in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantUnitsReclassificationToPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification to paid in capital, fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantUnitsReclassificationToPaidInCapitalFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative placement agent warrants related to issuance of convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative placement agent warrants related to issuance of Stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToIssuanceOfStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative placement agent warrants related to stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativePlacementAgentWarrantsRelatedToStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative warrants issued with Common Stock Offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative warrants issued with Common Stock Offering one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativeWarrantsIssuedWithCommonStockOfferingOne</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative warrants issued with convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativeWarrantsIssuedWithConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative warrants issued with stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativeWarrantsIssuedWithStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of Transfer from liability classification to equity classification.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ScheduleOfDerivativeWarrantInstrumentsActivityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TransferFromLiabilityClassificationToEquityClassification">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Transfer from liability classification to equity classification.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TransferFromLiabilityClassificationToEquityClassification</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13495-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeFairValueOfDerivativeNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3GFK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">127 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="4">12 Months Ended</th>
        <th class="th" colspan="1">127 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="8">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>A Warrant [Member]</div>
        </th>
        <th class="th">
          <div>May 31, 2013

</div>
          <div>Stock Options [Member]

</div>
          <div>Former Director And Consultants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Management Firm [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]

</div>
          <div>A Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]

</div>
          <div>B Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]

</div>
          <div>Management Firm [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Common Stock [Member]

</div>
          <div>Management Firm [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]

</div>
          <div>Laidlaw &amp; Co [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Common Stock [Member]

</div>
          <div>Laidlaw &amp; Co [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Common Stock [Member]

</div>
          <div>Laidlaw &amp; Co [Member]

</div>
          <div>Placement Agent [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Common Stock [Member]

</div>
          <div>Laidlaw &amp; Co [Member]

</div>
          <div>Placement Agent [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 19, 2012

</div>
          <div>Series E Preferred Stock</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EquityTextualAbstract', window );"><strong>Equity (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">66,402<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">66,402<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 398,810<span></span></td>
        <td class="nump">$ 398,810<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 398,810<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedToPurchaseCommonStockOffering', window );">Warrants issued to purchase common stock offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">242,190<span></span></td>
        <td class="nump">19,972,785<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncreaseOfferingOfCommonStock', window );">Raised offering of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,151,450<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">759,300<span></span></td>
        <td class="nump">6,184,967<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">42,711,791<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockSharesIssuedInStockOffering', window );">Common stock issued in stock offering, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,118,988<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">968,759<span></span></td>
        <td class="nump">7,891,141<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,707,259<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet', window );">Sale of common stock, net offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,469,776<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">660,164<span></span></td>
        <td class="nump">5,379,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentCashFees', window );">Placement agent cash fees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">618,174<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">91,116<span></span></td>
        <td class="nump">742,196<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentCommission', window );">Placement agent commission</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">515,145<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">75,930<span></span></td>
        <td class="nump">618,497<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentExpenseReimbursement', window );">Placement agent expense reimbursement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">103,029<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,186<span></span></td>
        <td class="nump">123,699<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedToPurchaseCommonStock', window );">Warrants issued to purchase common stock, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">467,845<span></span></td>
        <td class="nump">3,118,988<span></span></td>
        <td class="nump">1,559,505<span></span></td>
        <td class="nump">1,716,340<span></span></td>
        <td class="nump">1,974,774<span></span></td>
        <td class="nump">121,095<span></span></td>
        <td class="nump">986,393<span></span></td>
        <td class="nump">588,940<span></span></td>
        <td class="nump">1,129,925<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price of warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 1.65<span></span></td>
        <td class="nump">$ 2.48<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="nump">$ 0.26<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsExpirationTerm', window );">Warrants expiration term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">120 days<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants issued to purchase common stock, fair value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">499,707<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,957,754<span></span></td>
        <td class="nump">2,153,442<span></span></td>
        <td class="nump">159,044<span></span></td>
        <td class="nump">188,579<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentServicesFees', window );">Placement agent services fees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">60,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,020<span></span></td>
        <td class="nump">60,904<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_BankEscrowFee', window );">Bank escrow fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,500<span></span></td>
        <td class="nump">2,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Common stock issued by conversion of note</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,252,550<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AccruedManagementFees', window );">Accrued management fees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">96,744<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement', window );">Common stock issued to former shareholder under share exchange agreement, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement', window );">Common stock issued to former shareholders under share exchange agreement, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,986,566<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnrecognizedShareBasedCompensationExpense', window );">Unrecognized share based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,086,848<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Recorded option expense</a></td>
        <td class="nump">94,200<span></span></td>
        <td class="nump">40,410<span></span></td>
        <td class="nump">188,400<span></span></td>
        <td class="nump">240,400<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidForCancellationOfSharesByCompany', window );">Amount Paid For Cancellation Of Shares By Company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SharesPurchasedAfterCancelationOfOptions', window );">Shares Purchased After Cancelation Of Options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">49,950<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.65<span></span></td>
        <td class="nump">$ 1.50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 3,463,641<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AccruedManagementFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accrued management fees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AccruedManagementFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidForCancellationOfSharesByCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid for cancellation of shares by company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidForCancellationOfSharesByCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_BankEscrowFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Bank escrow fee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_BankEscrowFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockSharesIssuedInStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock shares issued in stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockSharesIssuedInStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock shares issued to former shareholder under share exchange agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockSharesIssuedToFormerShareholderUnderShareExchangeAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock shares issued to original shareholder under share exchange agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockSharesIssuedToOriginalShareholderUnderShareExchangeAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EquityTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_EquityTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncreaseOfferingOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase offering of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IncreaseOfferingOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentCashFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent cash fees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentCashFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentCommission">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent commission.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentCommission</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentExpenseReimbursement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent expense reimbursement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentExpenseReimbursement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentServicesFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent services fees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentServicesFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of stock under stock offering, net.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ProceedsFromIssuanceOfStockUnderStockOfferingNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SharesPurchasedAfterCancelationOfOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Shares purchased after cancelation of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SharesPurchasedAfterCancelationOfOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnrecognizedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized share based compensation expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_UnrecognizedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsExpirationTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Expiration Term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsExpirationTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedToPurchaseCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Issued To Purchase Aggregate Shares Of Common Stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedToPurchaseCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedToPurchaseCommonStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Issued To Purchase Common Stock Offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedToPurchaseCommonStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price of the warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 13<br><br> -Sentence Column A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>invest_InvestmentWarrantsExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Warrant<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtConversionConvertedInstrumentSharesIssued1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromWarrantExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract', window );"><strong>Summary of forth assets and liabilities measured at fair value on a recurring and non recurring basis</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
        <td class="nump">$ 2,957,977<span></span></td>
        <td class="nump">$ 3,574,958<span></span></td>
        <td class="nump">$ 4,439,613<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 1 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract', window );"><strong>Summary of forth assets and liabilities measured at fair value on a recurring and non recurring basis</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 2 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract', window );"><strong>Summary of forth assets and liabilities measured at fair value on a recurring and non recurring basis</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 3 [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract', window );"><strong>Summary of forth assets and liabilities measured at fair value on a recurring and non recurring basis</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
        <td class="nump">$ 2,957,977<span></span></td>
        <td class="nump">$ 3,574,958<span></span></td>
        <td class="nump">$ 4,439,613<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringAndNonRecurringBasisAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13495-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20225523&amp;loc=SL20225862-175312<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28370219&amp;loc=SL20226008-175313<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>28
<FILENAME>0001213900-13-005463-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-13-005463-xbrl.zip
M4$L#!!0````(`/2&/D.]3[J:7E$!`*)'&``0`!P`9FEL+3(P,3,P-C,P+GAM
M;%54"0`#3.5)4DSE25)U>`L``00E#@``!#D!``#L75MOXSB6?A]@_H,GS^/$
MDJ_)5M4@E<1=J<X-<:JW&[N+@)%HAU.RY*:D).X%]K<O*=\D2W8DQY1(Z0"-
MABL22?&<[UQY2'[ZU]O8JKU@ZA+'_GR@'38.:M@V')/8H\\'/Q[Z]=[!O[[\
M_6^?_E&OUW[!-J;(PV;-=]GSVL5?]=^_WE\MFM>ZAXU#_;!;^Z_&\9'>/=(;
M6K/6Z)TT]1-=K]U=_T^M7E]T]16YK!O6)NA`/]16SX*_G#N&/\:V5[MFGS(D
M[-U7XCWS$2],XCFT]MM\3/;%AYW#'N_JVK%--/UG;8`G'AX_85IK-OY9FWV%
M?M)NGK0;["OF`[T]48N<\/_7&`5L]V1(K,\'SYXW.3DZ,I#A^>X+&]^GF$W5
M.#2<<3"?1J?)*#1K81'[Y[+)Z^OK(>_MT*$C]F:C><0?/[%I+E[G3TVR;!!^
MN7,T>[A\-=;U:S-X5SL^/CX*GBY?=4G2BZQ3[>CWZZN!\8S'J$YLUT.V$?D6
MLN7;U]\GKM/2M>ZV%K,W%@T,Q[<].HW.UL7&X<AY.9H_#`A:;VCUIK9LYE/*
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MXQX/:X&V.9G+PG:==#2AS@13C[`IA;1?T`&?Z.<#EXPGUO)OSP$:F.*M+U3K
MX9MK'APMC,298WOXS6,*W?"XKH^H;F/^D#`1GK_X>.H^W@X?'QDQO_LVZ[31
M.%@U8-J<>-/5OXG)_\)L"ZT%LXU.;@&?L\M?#[ZPCK1FK]?4&Y^.UAOS#H^2
M1V"T((X9&C'0JA[[`_^T>J-3UYJKUJNGB[^LVA]%YIR*"$VM?HX-Z8G`%'E3
MRX,(CP./Z7ON4US\Z;,O/'/&$\=F_W1/WXC[R/XY=NR!YQ@_KP/G(1^BS?[F
MXA'_L,4?3#8D,S?$(-[L6VHF8<]G+MI<T9QLG<[!E\5KL7E].DH<(D3@T->H
MS=-3D_F*C&C(ND/$O+3/T(1XR"H5?[?.L4J\-EC`X%O<I3O'0S[7<Y^R(.4<
MOV#+F?!VK(,1+A?S,TU:732<^:[GC!^UUM*N2VO>V(2I=\XX$K;RK1")0\^7
M'VV&&ZS1</54)`W!.HJ3D7)"`HPK0`5LL\RV65HP]?^X"+MVFLP&/$@;-;3T
M5-/RHAJ8[-Q$1UD0@)$&<(!9EMHLRP.?6,Y%+L,<237$B"`L\01V-J_$L3P\
M!;-9(5Z#%2P\<2P,#?.T!1N@CY\X&O1'O;?Z?8\#$MPQ@SM]H,AV4;#0['Z=
MAI\$,&%3=BA!UL!RD/TK]CS,Z77&BV3H&9LLIC.B/)Z.*`XX$#2[(@9C$5[^
M40T4I:?+P9<AL4[2$F<+D-[]-CY.A+:SH9,)G(/?IM?Y?QG\MJ"!WA/N]NM2
M>6UQJF7S=O6<@B4=W+P\14=-$(!?".``1U(N1U):^,0B$;D,<\0!CQ%!6#@&
M=C:O=(H\/`6S62%>@Q4L/)TB#`UK'E%3*H.VY@@TLSH"S9S\R"98P-R\065!
M`"83P`$V5BX;*RU\8DZ:7(8YXIO$B"#,4P4[FU>D*0]/P6Q6B-=@!0N/-(6A
M8<TC:DEET-8<@5961Z"5DQ_9`@N8FS>H+`C`9`(XP,;*96.EA4_,29/+,$=\
MDQ@1A'FJ8&?SBC3EX2F8S0KQ&JQ@X9&F,#2L>41MJ0S:FB/0SNH(M'/R(]M@
M`7/S!I4%`9A,``?86+ELK+3PB3EI<AGFB&\2(X(P3Q7L;%Z1ICP\!;-9(5Z#
M%2P\TA2&AC6/J".505MS!#I9'8%.3GYD!RQ@;MZ@LB``DPG@`!LKEXU5!SZG
MKXB:#],)#N!R,9Y8SA3C0/7>3KC(J8&,R#162-@XGVHS_1[9HQG#KXE-QOYX
M<9Q+.<"PG-X*")%Y;F$^`$XTX-!;-0`7GB<`3C#@8KD'N>+-2,@=(X*P!`R$
MCWDE4.7A*42#%>(U!'>%)U"%H6'-A^I*9=#6'(%N5D>@FY/GV04+F)LWJ"P(
MP&0".,#&RF5CU8%/25(8$J87)&8Z)%`W,1\`)QIPD$`%P.7H%9U9R'5OAP%Y
M%(^9UJ<"\=(F;9/^JHA3)C$O`\?R@Q?4`$36&Q^2YE@I@,0RDW)EHR()N1@1
MA*5G(;F4U_**/#R%7%&%>`VIG\*75X2A8<WGZ4EET-8<@5Y61Z"7DZ?8`PN8
MFS>H+`C`9`(XP,;*96/5@4])$IP2)A\E9CHLKVQB/@!.-.!@>04`)SZ!*E>\
M&0FY8T00EH"!\#&O!*H\/(5HL$*\AN"N\`2J,#2L^5#'4AFT-4?@.*LC<)R3
MYWD,%C`W;U!9$(#)!'"`C97+QJH#GY*D,"1,+\C#])AG+I<W%G%(8T00%IZ`
M<Y57>D$>GH*O5"%>@^M3>'I!.!H:]=,)96C0&EFJT@>6@^Q?L>=A3IM+]DW$
M\SU\.SQ#MH'I/78QHL;S8I5G1'%`^J#M%3$8;W"(H*>VR74JI@9!%OD+\5&7
M;=1`5]:2]TP$_,CR45!?'Z;_;/R=F"`:[5JCWFC5FXW]H_W,=SUG_,C\R27:
M`?F`_$*1'XUV9MC/$.W$A65?T<[^A(51R:&,J%&>SQA]QNB#:3DQGG;>E8)5
M-'.B-:0*H>-4RY1Z8`URR3<Q\8.8.T?141,$$*0#.""JERNJ5P<^L*!10:9#
M1?C.<28`[H.`@XIP`)SP)5O)XLVUM&=.2SX0/N:U9"L13R$:K!"O(;@K>LDV
M5S24Q%N2P9/)AX?SM16M5?_NV[P(HR&MB[)6C<=<NTY=:TG@VFVG(9RL*-K+
MEQ`*R^5)[;%Q7+]&T]GO#$N5W]$8N^[<;_B%.OXD<0D_U,LULIE1"9Z4>\5^
M$VD$+,ZG(6\.8:S&UT"U1GJ`LP;M>N-8&,#UQ@K4VO%<[V4#.!2N0.&**&%I
M,S1F$A9F/@0(R]Q!UKL+9T"3RJ&*>)@:-XEZ=_\>YEJF52X2Q*&3+5VHY92?
MUB!/EJ?^4!,$D%@#<$`F3JY,G#KP@=1=!9D.N:D*,Q\*YU4JG)<82*=L)B;A
MUZ6\X`$VF(GU"'8OW@S+-['9I\Z8&VC?"Q("M\,+1&U&1?<.T\$SHOCK-+D#
MQ0V1.**`6<ODR_PGHDS4%<D";O!?(G.H-G/35>HIQ?0"J_,`6$G`VE)SK#RP
M<JHS!F#M$F4]<D+>#D\Y[4:A!2]$3`N]!@LL:B!OS^%8ZG$3Z3=?L(H1L>*P
M])]<YF$B.AT@"X=AN5KK5@1LFV82MJ?1*56;]2(C-C;H"Z8>>;+PC>-A]PY-
M$?NM!I)RB=JV4JC:P!1A*K<HNCL+&?.:'G64G>*6=1]:G0^:Q#L0GK3"4R+C
M7Y`\@-.Q'9ZQ[0%RE?[$JY]RV2,!E3QY[7B3AZ=0F%,A7D.=3>$[WO)$`Y3-
MJ,]#*(20NA!"$ME6:N&GJ$69PGC51X3^ABP??YTN?WYC9.1;8*97W`X%3%P^
MN[0GON<&#S0U6)INABM>;YDJ<'Y&#KTZG->!\V%R-*O#^68).7]''=:7-[VS
M4+#MD(<G09CQ=;JTU[=#%HG@Y1,U&)YB8BMN)\ZP<GSN^]0FGD\Q>]XG;_R7
M6T)F;YYFJ3A^C?[M4#Y[]W9XCI\69/&F:ZO,`VP3AP[\)X>:Q.81RP_;Y:]@
M,[2\RB@\)J[KT&FPT*H&+%*28+X+?'<ZE`HW&ZI"9>?U!RH_E>91N`A111ZE
M+**4G$>KFS66/))UN2ZVS,E((MDRYW<4G(*B2T6W")`XR00+^X((H)#5XA$H
M9!EXM%+(2Q[)JEC6%+*>M>XD1L/]7Q>51,,RGR2EV$%-RD`FP_K@O>/B,:+3
M:_07LK&WV$$4P1P;U?4MC]BC`:8OC#FN(OC:=?$PD2A;`+8KT-\E;$5!W<=/
M,R#KQZO?`A:]DW5KR<&]AY7Q#RKV0D">+?H*&NCBSJ/<!'*HS@$(@+\GC[\G
M"616!W->(YJ7.3RS6(QJ(.N!MU4$80H:Q6UDSB,QT!1RBNH<L5I[<=9R)L3V
M*3:_^9[QS#['L:/G`Z=PX&QS,&$=.ZR71:LUPBJ;[<N(Z[2$%.CLO<^,CPPN
M4QJT4]?:E98DI7*R($GR)JLK*4D@,7))C.1H#N6`%V@&9`.R<PZ0.UD#Y*@P
MB+K2"H0!A*$(8<ARJ9<P86A>\W,V&DOX2[X,W\JN0IJ-_5.MHQ;5,B_:Y4,U
MH2=UJ;6C41PABCNTLJ+`FZU5N<S0S`FN2&6^4`QR"[R),)6"XJ)045+;$0]'
MPT38=W*%7ZYHY>5U5VF)JD`_N^@EJF[DML,])U#TW@JQ3*.<^J.D=?A[]D,9
MB&U@8^(<\M'4W;K>RZ2I>Q'5ON_2B_:*S4P=+G]G4%BGS/"]#!QN&=D+<L-A
M5XV3-,=\X,*XW\X*EXXXN'1#&@+@(A]<NNP_B>`2-BC=G>`2/I]V/$'V--'[
MN;!'U;A`?0,Y!'@Z&TF:&Y`SF\GN_H&\*#?K[03>'S8+%JG+IGX[?,!OR+T^
M9YQC?UEXK>#0!UC+1*<2>O6]B$^X_V71)78!QX!CT>YJMCQ4%/I[]C_T+D`?
MH)\;]/6LKK=`Z(>U?G/U6ZIT[%[4A\"#(?1.?8`GF57&=^?9=K\YDY_,D*_$
MHO(:8AM92J`0UGVZX[H>"JSW[],MD0DH!91^0.4>9U6Y46#OVV-K`[`!V'L"
MMIXM<RX4V$QCWQK>'-C-Y6^Y_3&MD5$YL`9Z4YP_IM5OG)</A7!WV+;=J?6"
M;((JKQ*V$Z8$2F'-)].TNB[N="[M>''\GEQ2O4X$74@)09P(RFXL+7[_9"$\
M4FK+8O$[\P3Q*':NIRZM8HF["UG/B%BCX?Y=KB0:@EZJ%(M!K963Q9MOS!VP
MX;![<4?Q$%.*315OY-Q\(>Z6V54*'JN8<"7UZ6/"Z.DVE\QX$\_W\.TP6DV\
M;8-C.0ZBVC5VS$1``:&D-"=EQ=U"@3&FWI73%4P@@KB3E$)$`%].+1Z!,R8#
MCQ(\*UD5RU[<#UUH8:B4=$L`DH`*PS@1'J_P"%D7P=?-ROV9&V$3V67>Q.1D
M[<OGE?R1S\])Y(76@JY$7E+H[D?DA596)=$0D%](:"F"T?T_+L*W7TDN'IGW
M?@NZ36F=:JL,S>P*/+YAQ;'9/]WY50KCL6.KF)M)FL[*1XS-*Q?1410$IZ9)
M>)R.K#M$S$O[#$V(AZQ2`6+K'`$<6\!A&/[8#Y)/YWC(B7/N\V13*.?#.ACA
M<J$ETZ2K#1^X!T7Y(]^+O`=%5EC#S2<59/J&)&E9P/"!9"H`3C3@PBL/909<
MRA46`)Q89S]6L*%N*F!SF0:D`79UU>&`(``(U.Z(1!_4[I19/-)&\V5#]1ZR
M&!4`DLBSH94-%G(YH!S"@A39+K7.M4^._Q0XB5["F.^1$_)V>,II-PHY;*$#
M#]5`Q9Z#P]3C)M(O?FHDP%(,+!\'_I/+C`"BTP&R<+C3.PL9\Y,TE8DI5$=Q
M^HEN8MMLT"3>@?"D%9[-,G&-[/GQLB`/.\)SE=>.DK+:\+RC#NO)FS+!#?(*
MO-PBR#%\G2Z]S-OAD!AX^40-!*:8V`H3B3,$8+P'C+[/(CO/I_PBO3YYX[\4
MR4!G0L?F:58;(K";K-Q,A>UGI6%J^GSXO>/B,?.?KM%?R,9>XK(0&\?U+8_8
MHP&F+\QRNB5?`DHDBH"EGG<)6VT8PQ6A<$6H[/H3;N"IY@T\)8#NZ=.3XWE?
MB>,]8XHFF&D'PSUSZ*2<T'QGN@";E+!1,5^?%2N0U_Y(B<TRX]HG5)5X,FLY
M3<(<`2#[,3R/5XX]>L!T?.=3XQFYF"\=$&^6KCMC78T<.KT=7GIX^88YTTS\
M)W-O'>9]A,]2OAW.:^K,.^J8OE%2I;6[@4O]23MR9JY4L[$'Q$D&<7IX)A2D
M259I2LT=$*:"A8GU:#DCSJ;%IMX)9P12IPRT;`+T/D=`:`H6&N9;N]YJZP.O
M\0!9*4)6-C("1*1@$3D=>I@&[+G!'N>+(A4999.037P``9$ABIGI+XABI!.;
M;-RIMC#QXK4;-)Y5ZSR\.@_/CN\BVWQXIO-]4_P--7`<GLL,">],"%B?EO6J
MEG3M$Q+I]2G4D0F`G4KEH=+`#FI2L]2B7R/CF=B83L//%4%<EF+T+?.L-DA$
M'&^Y:XQQ@U_/J3\J?4HW+2$+#RLV,01$1A:1N<<&)A/O=GB/1_Q`7_8:XQ9U
M7I#%ZUE_#/HF`B$J5(C2LPC$:D])KFC5\#SW$3T)ZH[U:'O5.'I98/9J0U5Q
M9I(#]"5=``%94BL3O,,""@AY580\VS(!B+Y:HK^W12!0"+(IA%OT\YZ8(WR#
M9I?\7*$GAP:A1#E%[;WY`G!2`N<7'_&M-X0)XJGK.@9ACTM:VK)EJM6&R\;E
MIU=LO>"$$T/+LO[]_ORJ#8PLAZSUB8UL7K3(3_*F_M(K5.H`@*+.5]M`/#@T
M0"PHW:\`RYU@R17I&@TK!<KYE>.RWLX;O\T[3(0]W[L.E^WF<LN.I#R%NW,K
MQ&NX"O>]29<*#26YA$^&"_(*XR%<V2/UE3V2R+9207I1%YX4QJL^(O0W9/GX
MZW3Y\QLC([\>;7K%[=!L%^_BV:4]\3TW>*"IP=)T,PP=';UYJL#Y&3GTZG!>
M!\Z'R=&L#N>;)>0\7!V1Z]414O,9;H(H$\>OT;\=RF?OW@[/\=."+-YT[<SL
M`;:)0P?^DT--8O.(Y8?M\E>PR7I_860E3Q9F%!X3UW7H],919LT^)0GF-P3O
M3H=2X4;1'9]%;+Z4@4<J;08O8E^V"KDP.'RY!/R&@SQ*STFH4%.7SV>^ZSGC
M1ZU5_^[;C,^-AK0%%=%"E$:CWNC4M5:(Q$45HFRG899:*=GE9,\U4#O+AK10
M6*G-[XA#06M*)4(1G=+DE5P"=4IC101I";)6W-;,6MP6H^&>@:3WZGW\-*,A
MO_\7_^GS8HD7]K]E?FKM[_.JRXBU'N`)HL$N#1;K#[#G64F7"3T^$(]?+'QI
MF^2%F#Z:I[<=.L;T[)G@X<4;B_SYO5JSS*`B:]$;"+?268D4W**W/N!7I./$
M/L9.9.;\A-OW."K<GV%RH]?UGC"_-2PW&2+.+219VV>9CH^R2T:6:'5IX'>"
MS;N?M&&WXH?E17*\SFVEWEWA%70^Z/R2Z/RX>\6DJ)O)O8J*W9Y#-N:\)8H=
MF`PP&7N">\9H0C3<KQ%=1F3+WP!W@/M>X-[,"O>FR(1<`/=I".[SW]M<GG-"
ML>$Y-+C4-[BPG&^ON]Z^DU'9JOQW_85MY-B'P_+NGMM<-PC$`=W."NBV$$`W
MK_G^V\8\ORQ]#JV5E6J=>K.Q?ZIUU*):YLQC/E03<I)JU%6HQLE4>]CBLJN/
M4-C!3A+#&C;659#I68[W8T1[&3B6'[R@!A@R'Y:7,$<`"&S5E':KICI`@KV=
M)68N;`_*=7M0N8`!^XDJ#9$,'D:?8O.;[_%+D5S'GEG8>^QBOCLS13AMFX,)
MZ]AAO2Q:E3S$3DLP@2'V^T2O-OQ/V4Q,8@5+(ZO]9A=OAN6;V.1WK?!#@'PO
M6-&X'5X@ID7LD7N'Z>`94?QUFMR!@EZ6.$*`SY8S\&8)%I<)_^)`1L#@[(CP
M#82I.!0CYOJ>_4"6(I9Y@_5+G$.UF;R_FT1DQ4+^5W0`;'*[@(9I<\<VT]Q1
M`O#,7/;P\1MDTK,'Q$D&<7IX)A2D259I2LT=$*:"A8GU:#DCSJ9%PJ7L]U#+
M+D#O<P2$IF"AF5TWQU[&E-=:\@LG05:*D)6-C``1D?1F79"0?"5DAYMQ04#D
MNY46Q*:`*&8?M\I60)C2U&A<([Z&C.DT_%P-:&<JTM@RSVJ#1,2FAUU5[PU^
M/:?^J/21;AX;)/:B;3<Q!$1&%I&YQP8F$^]V>(]'_-XH]AKC%G5>D,57M7\,
M^B8"(2I4B-*S",1J3[Y_M.Y@[A*&[E!C3L`=Z]'VJK$A3Z!3OZ%,(C/)`?J2
MYH5`EM0*D'?(*X&0RR;DM^CG/3%'^`;-;H*]0D\.#3R'<@K5>_,%X,"I17!J
M46D!ONFX(:6V.;Q[P@]L45@R/--IG[(S?N\G<)8/`(O3XB4]HFC]!-PH$?9]
MTP@<S2("^Y+P4"F3)<7=UGGR"NZVENEN:T4X#W=;5Y7S<+>UTIR'PVN*N]M:
M-C[#631EXCC<4:P4C^".8AEXE'1[HZ0)F8]>>R@LD;6@8:-^ZH]F.-?TU6\X
M\DK<&B$<>;7$=J^N-3()`VN@[RH,_ZC7:S^84U$;X(!!M5J]OOC[W_]V^7_:
M?_=_N_N&W_!YN]/M_7&/_R1?+I]_XI>+GX2^O78^&ZU6RVBWV\;#_SY_^?[Y
M\_>3_D5?ZW>ZW[7>Q:>6=O&I?:*U6[W>?[1_:;7:EY_F`\R^Q.=#<Q'\,3@_
M^#+_XQ@CE[DV7XCKM'2M>\*>+;Y\\6CQ;]X^N;='-NO'X'B?9;_![1#X2^CE
M&W^,@Y7H'8>.M>=_/,>V,R9V4K=SEO*O<K?U&^GB*/KUVV<^ZSM&RK0#)_0X
M\4,DC/;''V7L[<;QXKT%Q<CLP7M]<5!>S%98(WC]9&)R<A$(VCT>$=?C"4Y^
M>5EMCO1[/-QVG\(IZ\HF_KAVQP@T1D90]H,L]Y^U2]LX_'2TJ7O^3:MG7$U1
MOD!HXK=?\33EV&$5O+&OQ4"G;.HFGW[?0J.4`PS91/"L[TCS19_GCA$L9_)P
M(V67@[HVZS#<=KV_NT#K7,RT4<J.5\8]VG^DKRC5^\3"=%$WE?;[Q\ABK6KW
M>.)0QOI1C9\/ANQIF`61COF8RPH#Y#XG#A2[;%X[J''H!B]Q!5<SL4'8V.[G
M@\;!EW:WT>P>]SX=A3O>;2!]^T`=K=?I'']@H!#QM@_4;C3U+3,Z-0S'MSU^
MD-HMK[`+BJ=?T).%W1OLG?F4<M'>`VWU9K?7;*T^)-7`@KXTQIPWEYS8Q/I\
M\/_L75MOX\:2?E]@_X.0!0[.`:*D[Y<,<`!G+H&![-A(YFRP3P%'HCT\D"DO
M*3MQ?OUV4Y;=E"62S:XFJ<1^&8TNK*^JJZJKNZNK-L5=^M6WL&2/#U4#V<LB
MO4VRY?O?;Q\CH8KX65FFFQ)P5#A5SIAT(!H%8[.Q8"$QHZ.A[&AIBA&)>H-\
MEUZEYLWE-JDE?;LNG[YFM`S$_C@AS'$$S12AL?E87`"]7J8&;E0":TV$Z^N.
M#3NXK7"IN,($E'37J492QMW)L\$BC^RP`JDZ)K3F+HY3@T75/#04830@J@!3
M`+$!@A#3<E\;^A)KU7JER`NM]R06IN>'8H;+Y,$&"F;8S#M&V,L?L^1SMJI*
MV3[:A?GLXSI?`#H?LZ3'^&6<Y8ME.'Z:QU9IB=B!N'%R_'14'ZFIH"@J/\Y^
MWO./>^I6A\@XG&J+X\18\:,".T@6%&;'@0V$:7=;=E^.-F2]B;1$Z`R9OV?>
M#Y`)0=%U`(3FW4$8(O=F8LW,IW"BWPM#F#%U9^G=2!$<VZ__G?Q[7=A]H/+B
MZEWZ>1<];![V:LS_G.;9NOCY[O.Z6-H=SG3Y+[-D,5])EPX0$XC<9&6Y+AXJ
M2(]G'M/EWV?%`4)O#'G'X:E7Z/@N+;+[Q-[P>3EQ05@38U0+3-T%['&"L,!:
MIB<NF>9J0&`=_2'17&HI_8'%&4!.D&+*@1,'1/-@,<$HC@:BZT2EL):,]``1
M6P1]R`(P7?=;N\O7Y;8WO#T-2/-%9^Y]XJ%@8GZS3#]B??>/M[MHU660*OL4
M7GR]B?B(S9=(+W'9L5GGP;*JQS]4"'?'=9]&./UF0R>8:BPBT.\Z_U"NW)5[
M$_VSY3+;7D6_3++E>?XVN<TVR0HD<%"$2D'<)?=A8F!XVL[^A.18D>AX.@Z3
M0$IS[D96'?`X-2A^WB37Z7N;#W1;9&7Z+KVR>3AF^7MW<U>M>=_=V4)1^[\`
M&5I)%2'UV"L4UQA<MBB,"3`I$_1$N>RZK:H)%ASA6%Q6?N?+>K5,BW*[+.LT
M-@@U^WB,I,2.DWM)!@3$KX:?395FL_V9S8Y8YU4H496A>':M71;FF#$Y-N0C
M3J8+?"D4YW1T!ASMV^KC827LP-%<2$*4B,U1LS.=8TF)1M$5`\/J,J7NU#X.
MY/ZZS!`60HW/`*`N<Q-L#:!&S7/F')L@BV@<'06L,G-,HL\E;9#[*[,D9KTC
MH[NQ5@8`E=F&Q@.H47-HA+DT*SD>'02L+DL2/RYJ@QP09##$&*+1E;F5`T!E
M-LY%24JC*Q)KGO*,+L?W<@Q4F2O!C0TY0)F5H(+*Z'-R*P>0RFQ6_@23Z`;*
MFZ<\1F1T>^*@NDPQ%=$UH0UR?UTV"R7&B8P^);=R`*C+AB=$:F?E<7@2+5ZB
MVBB-#@)6F[7DT;6Y#7)_;:9(&`YH]`5@*P>0VJP4YY)$=XNR6;),&"..KLT2
M5)N9E/%WYMH@!VBS-$,O<'3?W,H!H#93QDS,C*+'&:I9,3`W*^OH)J5`M9E+
M2:-K<QOD@+TYADVD0?7H'`!J,S-!.B/Q+52WW)7B6,3'<'K*W`8Y1)F)W9@=
M7>B@RDR91%C''A7<?`1(M4;1E1G#G@`.H<RMD(.462JIQN<`5)DUE2SZ&K`E
MHT)K4KNF%@D#\!%@/<]J',P!VOPB06DD#B"U^45F3AR>VDX!300GHF]X8]A3
MP/V\O7$P]]?GQP2WZ%/BD.>`G$M,6;0%6,<<*:PQ,POLKB"<#&M;2BO*A/'B
MGF\;47B`GG>#!P/8]SZQ#\!Z<O1E4EP4E5$LJPS;R[2HZFWU&FBG7)<#F'SU
M3_2-FZ77#4$LS.1T,!]3AX$P5Q^79W>;+^LB^R-=^NO$8R$S!^3YQP_&*:''
MOV-8]RE#8R33Q7APS%LP0D$\+\L[F&$V3JH%U986)*+F01T04>,0=KZVLB5W
M<;>QI667MK[9(./B$`3'%CI"$;#U'2LG/A]C"NU`'A`M4<\!](_I=;)Z7Q77
M>PR9MV47#X7$DV0F-!(8&&U@#-`?[9"S?P-94'3]YOW(Z/K,^`#HX";[+;)J
M2PV1!F`O)]@@4!T&<[LOXJ[!(X'R&</M)4=R^)IC9U#`@4'7,3PR!8?#@QE-
M:'C`XWH$7M4#_*?T/LWOTF-%VC[\[_N^=ZZ[/)[6Z^OZW+;N\G@1]_%[PH%^
M_*&V#-&(T?U*QU%'`OKQ+1TLNA-[JMZ?+YW=U\?BJ+TLI'X$:XL+.SMHC>3"
M<+695GUSU'Q!DD%PM=ED?1\9,8'Y,`)KL^:]I#V&F%M%+2(P/S]0/Z$1C"".
M]1@:U[*9C#01HVA<VQ4FS;081N/\O%9]8!6J.F/TP/E#FJ=%LK+U&Y<W9A%M
M>Q+84DM@3HYHK@ES#G]:*(:"\_)TQ@%KI`;#YN7MI%;8K7(>&9N7PV,<"4+)
M8.!"G)[!RK1[VV58!6RV7"U$[5K+L`K8XOR4UAS140>YJP,4]MZC[&?)[]+;
MPCPLL6D#]OLWMI7'']5_P]V?H+4"*$<IA0#R<GEF2HL.R,O/42RC`_)R;ESA
MZ(`"'!HUD1)S@Z5AM,JOJ&:0OL0D%>!D^@K^AR3+?UR7Y47^+BMOUV65GW1Q
MU5#:/6"?Q9]8P*Z+/[&`/9A@,<8E%F#1<\X1=NOH-%(''6T?4PL>[6;SFC/L
MYCM%E$&`#S!#Q:A;):8SS(M;V^`ORZ\?(Y!^EK_GD!05;O3X@H8_`*]80E%-
MW8M&`/3]-H048X+#`O`*%:1FDKA)<````AP)M_G+V*U6"Z\1+6L&)KD@456B
M99)F6G%-HX](YT9VQ*SOW%3N;GC.\\7Z)K6.)=Q-S(_[B6<R?5!X^8KY46<1
M!L++8<R/>XPP%%Y>8W[<;82A"(I!COL.4"UIF5^/.Q!0-6E!<=R+P`]0Y\CC
MN"LY#.K<T"S2$NZ\:HXE1]K9DMRCX$O<RW]0@J3;$320MI?;$)0*#$?;SUE@
MI#4E$HQZB)/`6C")X+!X^09!X53/;R.4(!U5_)WOT9BIR[UBU0#%KDM*ZQ%2
MLS1Y_[OU$G=9^<6>`FW;O,38>/`G&+CYX$\P<`,B6*3Q"08=$-?3^EH!@"N`
M[WY$L`+$)QATK!$P'L]M<YP]BJ?W^J9X[<T'5`OA;HBVD`S'Y[?F8(AP-QEN
M`(!^@84\W.@H&CJ_T$,HSMP+W@,`#(E.A`F4U*CJV+:XH4A*=K#GUE#ZV.9P
MI!C67`*\HR0"\[[:^7&=K^O+)[!E$A88NRN5HZ3ZX_'S@I)0XI:4BP#(;Q=&
M$*$8C@K(+YW%S&/NJB8"G@"_AA'BE,05E[<?4U0-JE$M?HN;O\''KZNXM-32
M#9.ZP4LW`;M]+?U?7G3NJ%&#A#%B-Y(`GNK>HZT#"4<:U6J4`5(>LEA(/#9:
MY@.*-:%NKB,@Y2%K;L9CHVV_VDP0M7;S@)2'%&`\-IJ+^\]M-1.IH^A^<$G_
MIL;HT&"\RB<-"@RTU4^TP6XNNS]GW%9,EU$H3TG-0.OH#PH,LIA<O,%NKH@_
M%V;!0-U,14#*4U(ST`+W@P*##'OC#79SJ?HY%UC6DJ4!*4])S4`KSP\*#'+2
MC#?8S37D;1%#LS+A42A/2<U`2\(/"@RV8F6LP6XN[CZGC'`=9_\@N*0[Y&B"
M%FL?%!AH>XQ8@]U2=GW.A"0B#N$):1EL%?5!@4&N`**-=5O&+V-FA1O#BX87
M08<<3-#JYH,"@VWU`S;8?@>+F`OC1F%B0K\31,(DYFYJ#)R"MZ:Q"TRB!"CA
M]=@A-1BTT/J@P"#[*`,.=M@%0<EHK<L&G(VW'"T0J1C"46R\-0E?4D15-.%W
M3KS7!`N.NHC@?5+D1M7*75G+[Y,R6]@:+-GJ;G.D?%_SS'ZTQ.:<?>/V7VRA
M'`JR>5XX#A)]XZ9.1P;9/(4T@72[E$<&V3S;'`<IOW$K7PT[W%W+OEI)TK&&
MVP>DZ`7RES2[_F+>.[M/"S.!?+RS$\C%5?4SIZIBH-$?J>RH$);:L:5^8"*Q
MT^`>CI7YE,A\49.),M3@2DZ3H0:W<XPAC"AWTT$FQ4^#ASI6&I5@J81['C<I
MAAJ\V=%2M%)C(2DD0_T*Y[:F>36M7(ZJ'V.BUBNOL7IM/]PAFQE'ZQ=34KNT
M$0-WR$KQ&&Z."77+I,7`W99,U`>W)+A60BT&[I`<GF/6RY0DL7&')(4<P4UM
M@6X<&7=(EL$QW%KRVLW_&+A#CJV/X+:]U46M46L$W"'GH$=PVUZMT7&''*R-
MB#OHJ&9,W%'FR_UZ_S&`PTZ8Z%`?@&;8]LG;C@K;W4BSW,S6VQXH']/?JD_`
ML_QI_?9H)PQ#@`9M.ZJU/D$>^[<IM5%K!(:WVCO2J!YQ#79H.RCP'G27V<MB
MO4C39?FA6-_83Y-\D5Y<.5"@3<Y62-EKAM>"(#9<V)[5C,O3X:V_D6')%&=T
M4%:][AP1,KR>>5Y-\M0L)<<5=SR';59ZF`QK-H/>(FOL)@F`OJTNU.B6`-M'
M'2O$ILQ-?TN@UA*TF#1SD[:$EOI8TO@9/JHEA.SO'0IU]:2YZ6\)0MJM^VDS
M-VE+:+[.R<2+EM1#BS?XUF>-(5G;N9P>-_TM@7%-*,.39F[2EM!\XY3JT2TA
M^&)JW7,R/6IT!'JSM3Y42E..1HV.XMZ.C6T)S9=B)>>(C^MH@N_.UAA2=-SH
M"/3R[=Y0,8+YI(=JVI;0?&]7C!\=!5_OK>L+):.Z3=#[P?6A,M&1D*-.>''O
M&,>VA.:KQ6*_C_WPX@V^@=QP&#8];OI;`K=G07C:S$W9$EIN#'(J=2V+:G#Q
MAE\LK,\)2N,Q(PC8JXE[8V76K'S,&2_R]<;8IM#21`D3K=F8GB;\(F!]BP4I
M.:IEQSM1X$AI),8\.(Q\'1'<%$*Z`U"$I?(^R;S*5NU?W.9PC)UULLUPJ++.
M/5!#,`EXMGZ8+26IO9HU+EO@67A8H2IG?5RV8+/:JX,OI>U-HG'9@DUZ?SS%
ML*NM<=F"S8G?;DE3/CI;L"GSC_N+;'0EA,VH?]PL&E\)81/NT7.NY*AL`>>'
M[Y9Q=M=^7+[`)ZXJ)F?^<4:7M-_MVQ_6Q<]I<9\M.MI9RS&B4EVSCE^0CXL;
M]G31[7YR.DP&'#IJA9DX29YCK:MB<O)VE93EQ55%HH=Z3L@,&]>1+==2(G.Q
M]9:#>Y/#L:%@M:M-7H@'X]5++2?/9V?5C,.)G=$-E/NT*(U+OKCZN-ZDY67R
MD'Q>I6?YTO@MXW*6N]:=G]85A4K9P_<NC3>7MGER?PP#<`";+4TXX:?-</_9
M6PM-;++X27,//8_W8F?$I4"EP;O]@Y[`=WR[;NG,T+3/,I(KKM.BOX<Y(F,0
M6K#YXE39:JM=P`W)1'_[GD^5HQ@VVP!\1.NT(\`[C,'+)?K9\M\F$+%(RD_K
M(SJPJSB6+BW.-"\3^Z4*WL6M?5G^E!HVRFR3/H88V_#CIW2QOLZK)P+D"&-.
ME5-;;B#@4Y55Q"*L)\1FP);"JSI-(:5Z0C)H3LPVX0]%K_H"E2-^(BH1[[KU
MJSI-(8]]0C)H/MJP:R^W;-)?6U]B]MTZ(39#W,^K.DW@$&=",FB^@D"$%OAU
MNH*Z#7$B*A'/_;RJTQ1N;$Q(!LU=[S`F5)%7?8G?I^^$V`RHF_:J3H,U-#P)
M76M)!2$8N_WQ_M+J$K5_XPFQ&1#\O&K34'TN3T/5FN^\8JTI?U67^&T]3XC-
M@-#G59LF<#]X0C)HN4QIFVB\1LI0>4`GHA(1]WU>U6GD_*4N_/^2%$5B0/UN
M>>^4BM52!AQSRG:7]/P!1(8>P:C'0QNR+#GA03HA4VF><+'F4G(VS5&(,?^-
MAS8DB#[A01K-5#XDV3:W]^+JG9DN[\VD>I\^\M?MVFYS%C)52JI=AGHPH&$Y
M&]&PHH,/2"S_$P_IZ9IA\P0V9XC;PB"G.&9CSF_1P0>8X9]X2*.8H8/ZDT%:
M7J6%+9KP8Y9\SE86@[W(FAEJU;KRT_H16>W=@\PU]/L>!8^79V"$8DH>HR8(
M2(.S%\D]3`5_0'N$/_O0GI:;"*B>=WHCV="1_E!]7D2P/"'N#@UE1UZ9(ICO
M-G2@F/791MW>$MYDGU?IN_3SYI=L\^7YXO"'--G<%0";BU02Y;:3@D(V&K<C
M'S(,Q4?`U;V_V(A'.X9\?W.[6C^DZ?=I;IYKJ.7+PT<?$$<`DE*WOF]GVG"`
MVZ+G.F"&F%MS?P2\?B>UA%#M-I@8`7!`W"'L$I.."]\KDL!*C:T?`;&!L.H=
M+.YWZ6UAGEJ];UZO4OO"U@"Y61NW^`>0ZQ#4J9S=A20(1"]G0;$<`:)?O7B%
M1X`8X!$H,4HJR/A#_\*2&F944$%UM.5@0;GOVWVVSYMW6;E8W^6;RR*]R>YN
M`)(8B?$VCAFWD@S'YV7`C&/B]A49`)^7]4K)!1T67X#I[G=S''ZT?6P63CP=
M#190/!^R/,D79BWP=EU"'**:J("Q8\CJQ()`>1DG9ER[??:BH?(+N#DA3`V`
M*J07AED1:#+\>/8WOY[RZ&AYOO*P.V<_)%E^D;_]DN37Z7E^\$`*P/`PU;OR
M75T(!H/S,D`AI1P0FY<9"L4900.B"UGD:DW5B*/<8AQ""C:R(#M"E41@[CGH
M.YL_SQ=%:E:U9L2J?\_SLT4UV98_I8O4_.+S*OTIK7;;+A/C'2"L>\XP=\-+
M?PP1./!R`7..D-`3X\`O,850AMR*;Y-@(62!+-V2^)/@QL_?8#(U_`$NB2OW
M8@,T-V8A<)MD=OL_+8IT^9@.:M;T%YLO:7%6EBE("B63HG%(NL"(Q(B7MU),
MLXGRX9<-KA"F$V4DJ$4?U8VSX73TK-GHYXK75O*3XB3`F<T%%BBR!>T<XHO2
MX;N<!)#(BW.!<*>XI0E')$[\(C`B*!-\HJQXN35*&1&-?FU$3@+\FBTK(^54
M&?/S;!A1AAM=P,3&J.NY+::<\F$]`L!RLF$##8)\C\3BB-RW';9BY>,&^ZP:
MND,/6<!-BI&`+=Q8<NQZ``HFQX_IYFU2?KDLUO?9,EU^__"OTK8RN;A-BV23
MY==GBTUV#Q29S#F6W-V,[DX<$+)?"(*5((2.C=EOVX<33*3;R&T4S`%N8LX8
M0T1P-2U5:8D?*"52D2F*O2L'S(1RB,E@L1NOL\LC7?S?7588A[1)\FN;-AJP
M<=/@COL1#`@!0#B,3S!DJD9[9_:M",`'Q&="AI-/URD85C[&PHQ-;1XN5TF^
M,?&W38NN\IRCFXH?9;\T!LQE@X".4HXGJ;9=.G>9-`K>`(M5F(O1\?ME%&-,
M)BCOCN@5%E+B4/Q'9MCS_#XM`0+P!D\02-DSCJZY@NZDXXFJ]>S4M:51`(=$
MT'3?&XS"@><&7,T=3$;DG>/_?8?0CP/S]46:+DM[6=%F1IJG7%S9UH9)ODB!
MDAX%X\I-#&BG"8`P)-P&D<D`%$-2I28P)EX1-YR$NE[A"9+03^GMXP1=[^`+
MK:LA=%K")421>POT&*7>:$(.&7I@<\=O-VP75Y?%XPGKMNM]OMR^D9H/JW>\
M[0XUE[K'DN\MY'K!BL387N>"EBNGY(18:6X^*3FEDN'38*6YD9T0^SL%$V:E
MN2F6>+'I,5U6VM(DJ-34S5"=%"M^R>H"83>Y8%*<^%W9Q$1K-E7]"@CN.,4:
M(WTD>!F=,Z`P,()\N^:B#B;?QE)L0$N<?M1:]JN9H*)]0G5+U@5`"]E8[P_T
MR(+[Z983Y&&V0(03SEM7^P>(`T(.FB=&01PV'XP".<CO*RJT$M-2DQ8#I`)Q
MW;Z/-;S0NTX&$FO)9?M^<PL']B=FBK#_V*W[^V1EU[/;Q@?[*3<0>;M("M<\
M?<B#PO;<V2>($O=>RVBX_3;XE74N$T`=XET$5D),@0D_!X-K)Q.3DGQ7%R.X
MT7H5BXDSXZZ*XL%XINIFYT'T9^6O%U>__HKI$WJ/:#.8;-=&DE@+[+;?ZD0X
M$M(6_RL1E;IU2*-"[5R[!2'N7KX;4ZH@+FH8J8+8=`/4<T.W2,N-K9D(G_/>
M\NR@A'8_W*#/#CDR4[4+J,^$0@37IB08@&3(00MAM`N"Q?HF_93\;@]>8BAC
M^^/#+ECXHH=^O)]6PHK*\R)"+UYZUGK[O#G/2_.!/=E[^UP,=EM#<9'M*L1&
M+7?<!T44+@(T/)8D1\$05-'A-,9V%"L)V40%DNM>(?7=IJO=ADV7MORS?3"$
MB<NGZC:MY,)PA3<4Z2^$N,2"S'`L^7<Q+%B1=+8@:)$`'5P3KK%&79`]G6@%
M0/,L"JR0>MEK(@XRS_OWFE*J!H(6LJ6G%2>#`8UAC''.=X'%\FE]N4H650."
ML^N^MVSJZS*F&">Z!>$^71B@?I=RN$;L9;N;(7#ZE3GD2G(Z"LZ00C]8(J)>
MMJ`900V"K;FWK#J70PN1U7.\6L\P?2Y>L=L<^;1V.LA`;85`0^@9ET:40DO%
M:X7ESMWU!!&#AY`:WM/DJ*=5QQ9JU\K?,$+=K6,OBNLD?RQ?;!Y7KE?9,GDL
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M\R?G\]`S.ZC5T^]V/URE&V/V\_(VL;DXW\WT$^IG21YZ59-N\U>?7LT^;O?;
M7.5U%=QF`N6V`\+EEZ2X,7''W<:H\:K\>G:>+V9__[`N;M)B]5"C/7N;+#9W
MY>Q_C,S-L[??_>8?L[]OOJ1/#R?HC6TJE.0/3^_@-U_7/JZ>XGSZCZ]GOR6E
MD=UB7=RN"UO!Q[C:95K,[(-7R6^E9<.^KGR<_<_']#Y9)C-CG1>+_V?O79O;
MQI%&X>^IRG]`Y23/<:IHC>Z79&:J'"=Y-K/))"?.[+[[:0HB(8D3BM3P8D?[
MZ]_N!GB3J8LERR8I5.UL+(D$&HV^H]$=>F-XM&^PUF@T:+!O\)R"@(;E+)@)
MQV$`M!TN81@>,AMGHQ&!LKZ+$,C"AP=AR5,8Z@;<*^!TQA<+WUOX-LT95P(!
M24EC-VI.]%L)L;XK9KLRV?'^8I]=T$$FM?UC[:'!4/\:1+$Q;0NR(2Q80^@!
M[8;8^Q,X"S76*D-2OR_V[H=)I=3SG+>(?$PU#AF,<C.SS5EN$C[U!<R!,\B[
M_H#?YHN8'6UR7$@I>E$8A/`'<HB@5H<L$&;DR\1'>'ZCP&FPLPRX\:-Y0(%A
MA5H!L6L,`*9)XP3$K3_`(@N%LV2CT38H3;*\@(*`]``-W&?7E&'QO-EHMABP
M.\@-0)L1#Z-0(@5,'J,D9]#D@FF\@HT#Q`I7#C<#?0&V(?.QDQ.:<0B*=XT/
M;\4K#9!'YHQ;;`)_@HBSZ-4$10O,)@^"1A%U`7%=1%/@2]9N$X0=8P-TG>$>
M@*&4!'VW`E4A-!<HH^']R`D3.9]#KZ3[":FD/)S9&<?"Y'-!CZ(QZWN.D\"6
M>3ZWE1>A?!ZV#IXUF.!`_\F(F5?Q;]`A/I7X%JS9Z'0Z\;)7N2VABJ]HHF>)
M&.=7.C1+?43.!5,G:+-N0XK0J-44P9NHU];@->@NE`K2>+V);S,`2P/KP_B!
MR.U:"A42=0(!XQ*`_.((<A2L\13P,9X!8`R0*<$41N?'R,U8@(5"VEC#:US:
MV@`6*6Y)0.ASP?[S[P+YZ2?8*]G,-6[.)B838>([XR49!5D,&\BBO@`9D^#"
MIGSMP+9(RN+:E0CTY:2IN8]XG<1N&/(.MIZ![V&U"Y`)@109"AK%:<"?M@G3
MXKN"^RX\'Z1"A_$Y#JZ,%)G6J7Q`D9TK2'R^1"0N*!43A\<O//HNQDULW\"*
MD.%"&@V>\<7$`=2H9U?0!C#@6GV+!"W91CE!XQ,AX&AC1\JAV+22L\&#8@&<
MC=6C;VR`P@5WRSI%\^E4#*E']7MB_C7R_@00\F^1"^9+!Q5>LVD@?W,VMH$8
MS9GK.=YT&9OV));L4#&')7LQ(T./?<&_AS/?BZ;$!#YPBI"LY]@3U#WP0"B0
MF1$UF`,=,/2^ILP&%N7.8L;1T@#+QP%E.I]'KB>'6;*SBR\?OKUD@,X0-9W4
ML?@C<"05-:5O`AMV`DR5!&@;Q4NZYM";"GJ)^!0GO0&%`/:0=^/"$$$T!H%F
M<W]IL$_"2M^3-MBGBP]@:)U)2<@G(4TN[Q$B)DP82>`-$C2P>,"VF&Q@G*";
M!18@@8]O\S%N!VI0$,8@)0,))ZP(!(GM`GV'D50D84:D2+GF>Z#OX'\@"J5`
MF6Q&**(+(0BB!0IDH@&!UB>(H`\_?7!`EP)P8(*"Z8RRE!">/G'KYQ`P-O?H
M[RO'X^[Y/XFL<7,O433Z[)),<D#CU3\O+U\J%Q;\2/H,XRX#3$!QF2J,,^6R
M\S@XLS?LK1]-V874EOAU`YY21G^BD1P>N28*6/!4P5BRSTTY84+F+%B@GJ#M
M(D!)=D?PPWP)-&Q;S!'1=S&W.9#;IX]`;3`7:H]&QN59W4JP($"OC_^2.X^V
MF*1_-!`YJ'-"G)4V+"?.0EWO>U9DHD)Q;%F)0V)I@D*)U",]0"2*;@=L/.@<
M`-5S/3!S7-J2T!Y[%O(8;,9W6)9TS?/;+HA7?3(^),=D'?<%7\)N63%(>"^*
M@39<L@5P/KH]2'O*3I7\+-6U)-Q5*LF9G#D,H>P`G0T3S3C0]UB`Q4_0QCC&
M[\E:*-X0Q*)-D8DQ(`S0:<E01>%D*"M247%C@S%(L][8EEP^&5U8T'Q)TLFR
M)W3[%Y:[7$A+7>T&F3W`(W9(>U2,?'@6H(*18'VGH[CKO<['5=*[N7QQ%`*8
MPO5NX!5T;C(QN$Q4+I9*J4KC">N>@R(!_0*Z?I&+/23#9%0\\$3(06PJ]@A1
MH9.!72:ZSV._EF19J5C[VU3[88AZFE)N)N2>#Z5_RY-WQM/D667*).G&A!K;
M-!CV<3VR4X6OO,YKX4:"#%90>YI:JT"M3Y\\#KU^`:O5M!>.M`1RY\N;*79[
M&`(&=B)+9,5WSG)181,9C`IG7B!6@G*YIXN=%^GS@,T39(Y?;32%$S[)S9)&
MQK/&&5A9<UC!B<8BZKWB2FJ1/R0OO`,<XR$&'5$FV1TL2>]@V?R/S>RZP%9N
M/H^S&'8-):+YX[GH6J#_(%VN--JY2(7'5+A@?R&'PN_@DZ>QOS_`>X)/!+3T
MF4!1`:."GJ(8:@`$XH)FHP6!SIKS[P(=?K5R9%L>!-%<A97)$^(4OU5!2N72
MRS@IS<!E^7M\U<DTF5)Q:TL='(<[23$IG(KG49I6/B1D=[R`69$OS5"1#0!3
M+);B,Q'I:#1X4=E'CJ5\,C8!0E:",%G_Z0BD>J^SDF+HJS`=X"72JYM%S*7R
ME>19@SIXB#DE5;1^,F`<1B390G]&/D4EDD.+5+)I'JC'.BO)`U@*@>0[_9$I
MBK";0Q=[<P$=T\Y@L:`B'1N&L5+3E/2J![MB8[1MCNE:2;($'B10,"Z<45C3
MP?0MX)<Q1E$!(I%"U&!7D3EC8^Y@Q`)F]`6+@HBTLDR9P'=AS/=O/UQBC#U"
M)Q-M7WSW(DRS%3HME:V`"\?L\-PI<Y%Y3K#@>:P%*B^PE?['(/J8N]\U!]=C
MG97DX+@G"1%SVAIE+?M^XN8,0/?E"R)Y@=-1.1Y_RQP(TPM"=>(!VLJTX\-%
M#JOT.2+E'%$`#!#8@4SLB<TZ"_A23"('F.]:LOD$3\*6@OO`B>\C'VQF3-F4
MZ00_*,7RN/,':,K&`/P;<Y1B(YIF#6T4%2!^P%JV#&4ZJ^F30TG3C.:1_#L!
M":T&.<3<PX,,9>.*1/C)O`<4E?$X4S0D4-)Y(*WL($Y)4!)%AGE!JC88%ERW
M?6E]SSEZ_2XE)I`E;MDIULP9GNR0Q9%Y?P=>)?[\Y9GBSV<Q^1[.INU!<4RL
MQI*ITR^C:/HP1QHB_@8N^.BYT_./-A*J:J&V04HD3BNX@;:X"8!@X6V'WE;,
M@P=N=CH#YOX)XL-KLB#@5WG&(1UMVP<&PDPZD[ZPT.H6TN$EAE,UF.*,H#E?
M8@(-6@*^H"0=/+;#?*00CX5MUYY'F#S@2@L@XY9.O,@'B^/OB/MX:*S4.C)_
M@WV8X#FUP`1(E?03Q)ZZ8OQ4B$PBDE(1@!K$65AD"$P<#_`!2/"46$IRA0@Q
MDBG1BE#I!,DO*S:%6K#,QJ0$#(!WCD+-)C#MW.X%:/W("?"82*"YPWV5IBE3
MOB@Z@''VS*:0"SZF\94/+\,$ZJ#41-\EO$'WA7`'[RF`\E/*4]M5J,MD^3QJ
M]+V<[/\6O,UK2D/9P.H87[8R#ZXJXBQ)2")1)CA>-Q`A*/3D`2D2,NG0H*FM
M-%8&VLF-[R%(S9Z?%52YU/%_1Y@Y%S]*"812;_LB_R6]AE("1(1E8WCNFMN.
MS,*<9,#"QQ+NLE2FDAI)SHKCT9>>)9SL%0W\,A[=&P?"OY;Y`_)EBX=<F0DH
M1/#AOR)K*BTJM*]TI$NS(KY'3/*O6+"FT>ZTAL\&%DTY#$6_)29$Q3Q0^6+`
M"5*/)L)>I6^3]@GP3A!7%J^!&G2!=<50+^%Y$89F>1)(7M+U`XX6JH77HG*W
M+6)%$;,@Y279"T[.^4564,QLL$-]<[:D0UQY"I7)FT4ID5'![B(*5>A[2L(`
MEX7!!'A'QMSH/I,7RP7%^Y3S13EV$B!ED"`54-*#LE(H9S$3)E<1;]#AJ\-'
M;H;!)512NQ:N#-,J<4H'K8%7!Y+]*I'OI>.>/MF=M8A+RB5#/F(V`&L!2Q`]
M9+B!_>%R"]<!FW\?-)`8G>D)AKHT-U-,%>>4T7T@"BRI-^:"8V")!/P=\P_N
M98]W<MI*N[GMHLU57\F,1M@:]]8>TTD[F1$QC<AS,KSVF7)L?#%`&JR9+0>A
M)FP:W0([WPQ1D_OD@LA/Q.1X:P`QDQSLYX$@PT;E)!<3U2U2-`J&2"ESE_%B
MFDY6BZ8.5^FI]A:TW0U%[$P9^S*_`$4C)MK"(JX]AX<**$.>M"YEQLX"FW@8
MS`0WQX;'[>`[?!(AWI0E_*9B7=I?/JDD=:Q*7AO%2SQ*[/6]L<I@'R]SUM5X
M23]C^(2.=^/<5^#$W<(<FOUB]NL4R]9;6D^FTBI[.7&K,_9T>@I=)%GC6S;H
M:9-8_;\!9K;D#KKYV(O"F!;SQ]\%YH6R;*(`(4QL]8225\$H)564T)@EVX8,
M&$(G4D#``GE+/)RM2S10*K#`.<2L!SSIC.^*N1XL+?E&1FJ!G1TB1@R:V+>B
M#JE]Q8G,UA_:-#"Y-H[=X+`75Y=LV&X:F4R'=:D2&*!)CVHE%``"4JLO0!@F
MGFC&4I10`TC$(\GU^FQJEHKU9):3,1=R%_;SJ6(`91#$<1X<(1U47?E5W!"A
MNE#S;YHKS3Z)O5%#Q9&7V>R2U`;'&'TZTCJT2=,9'EO$!9RV[B)A[2[1:&26
M>V2@\GB]V?6EO\C;"`JF&]L*9Z_HYOE.)5\RX#]C)OAYZL@)"_70YP6W+/4Y
M,Z6?^=O*X_U:?1I[8>C-DWU0XYS+KU^Q]N+'P]0GN(76T*H/\&O@'9/OG8`[
M!E[[CD`SRN7"G?9PH^'%]K-"$I.WI:K"1,JDW\)!M=KX2@.OJ3;CSVJJK0CP
MFFHS;J"FVHH`KZF6W%0OY,[)T.Q/.?M\=UO]T0&O.'RK3//0#F.-4%EV^/16
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M@HYFTMJ66M_FJ@PDM3N+D$6]?3,E`#C6@:""`Q)/T0*^A*FIV(ILV#?W?$R:
M_(YM,:GB#-:C28HIW9XD6<LDPFHOLHXG-7DNFM?`LI=)74OJKJCZ&`(NL6QN
M$!8MQ,C"FS;;2&ASI<("#U3I!-N/"XOJ*OSU66<5Q2O[FNTPFNVQ=ND%F^H"
M?EW3F92J5Z<BP@UDM4`09=B&PFJL?]$7]GP<@1Q)V\-,91OU7%G0\3+7ME#U
M)<<FIZJ8R+J>J1(RS6SU6&<EF8WZ;YZ_(9WQ198RV]&22=LVW2Z5+#@0>Q#"
MIC!O(?7:#?>MN&P@,9'LS31>9HR!-WAU]_S*G'G4HTZ^F:M%2QR43(.-$.&)
M`-<0K)0IXD&8_$Z`I#K6HE85R+0VP(2UA):97U%&^.'&_A?98=5\V493!(]<
MY*V*F1D#S!>J\4V0UMA/2M))=*'%%9"@F;IH*\C*_E2L"-&?])J*"W[+ELI8
M:6R^<+RE$-F*WME6R%CB#`NERE8A5)<\/S?5DZ*%G$N\8@EOD)TICK!V=AZX
M9`-HA(!ALVJD$#!VLK89@IYO]$K"4A%2/#1"DZD^[OD3H:K\)].``1QZ/M4/
M3'^75F0#VZ5=VUX4D*65@)A;A=0+6`4*C+*DI"99C[)DF^Q=0$V\5B9(D"6+
M9.7)6V!+\4G!-C6PT2WU=`%[;2Q<,;'18J/ZYF#BQ4I%P8IZ!'!I639!B[O'
M;>N<NM0N[)`[6G'48YV55!SON(_%$`-V]M$+@I?L"PBF2RD894_GG92(DD?$
MU+8I[2/;B9`/13S!@GK=IY(>D("-Q"0/DYA`;9/O)89FW1L:,AGFS"$X;X\F
MF[A'JM@F$)-MQ0K)%6'L\JK7DY+JLJ59J@BP1S6V?E+&H-P_Y&*0V-C+UXWH
M&/Z6UO*B$-M`T)0;NPF^W8Z7W5:R;0GI)A^REH43!7(O\6YA6@6_P:YLU\QU
MBJ4ZPYY+G:ND34[]8(1T9E?(`A="W6)N+1__(_7+Y^#XIZN@EIA>B)):-L>X
M#10[D\8&S`B"7)GX+JH+%Y8<VK(8:%*;_"6@A+P)58HW:703`UD,("@JK%FH
MJH>;/)+=)[#4H@IM4%W/M(4>P&$GX#;8>Z5SL'D'*AEAW;ZA8.26:@=!)$OJ
MR0U*B@=G;3,*`2PB\$]`L;*VT>DTC5:G&[^#>$B0DGT2)AL,FD9OU$_V?S>;
M::>5M'9:29"L(0MFNO>YE0TZQK`WNB.PJG0GVKD+OB00LE0!$W2,;G=HM`=W
M14.V*?$M2LK0RJ.K^:=/M*(_747_5>!Q"KM((])??,^%OTUQ!V_1\A!!7J@\
M`54(FVQ_'%YQN+#R+8=S\U#XE'B&YUN`PPS8[<=5BE-VVP4F3/M_9:O@4LM"
M^)*:/V0Z&.6Y]M&93K/<Z;+<530.P&E'MGMWO3./Y13-?+5E&;*60PU'P9X$
M-E!MR4CA_,;=B/M+)C5O!_N0>M%TQCY1T++5DU^7B24**Y#__%,4G$\Y7[SZ
M[$^YJ\XR+I.VW_#APK6R?=0_3Y+>,TFC]>"M'9A@P(&K#T]?I8(FE8!?8#P3
MS,9O`-P;!/W7IT]^?JRYT1Q!+'T5DU^>7<J__^Q_>O?GGYWF^6^1>XY[]^S7
M:C'SKGSZ.QAFK)6KX/]6!*9O+^+8^QL,+U++$K#CKJ+Y'`D=OL\@-Z?;%'I+
M1.M:_)^8^/^=4YPQ2[QKY?^%"61K1W/V!7R/.3=%1`U5P.+YX)H-#(_,J7/5
M=U?VG&"7&-`,V+\`^1A-5<^=H>D33])NOEY1*>W6:R/[<SSKNM_E))E?7QK4
M,#IM)(='U"J-0<CC?F5_D2S$#[^+:VYQ-.L^FZ&'GF'?8*W1:)`_U+^AX[9@
MAGV]5-LBM"U3=,IY9;LBV4M#GO4#7J8P*'6KQ#CK`LS-A6_3[-)P!'%@:FNP
M3NM\5+;^[*9!CO8P#M=DXV"4MD8M.+#35J[;W"J#RACK.W5VD^>T1>0'D>K`
M(4^$<L?3ICH.PL8*,=?%SA>>7&2">'AR!`R5"93!\UM$SEE63GSYD`>MZ+R)
M0CMQ:P_DPA_QJ=%HM`W`;#S%P*,\=<SVO-EHMB@"1S$98]6[(Q&2QR%#PTL>
M+-W:ID;1AE[(<WYT-Q/AE1O14`UX401+..(@,6+QRP<*`LZ%.OUS0]]S'%S4
MZJ,YP"]4@V``%IXU9/`;!\N\E78\;#8ZG4X<EUJEH63E7]$@S6Y4;IMS,:LD
MWIY,F6RH=1LX]#C4`E9`3)0#>"N%,;Q<J!%?SH&!0CV9-SYWRZ^'0$6)$(\.
M'^/!#3I<6RS`UI/M47.3%2V\D`(*B(C4D1DW2"9-(\F$\M%8R+\+/,/]"79(
M'N(I3T&%@&7DGJ]@UL#,,U\`\R`B*,SO!K9%LD*>41)+^W*^U)B5+>5O9_+!
M4A=`ZZJ?HP+$4)-2PS39("=WU*""[+(?M52H`=&M\G!$=JX@\6@2-D\.:&S\
MPE/!&HF66!<+.@&EEV\=Q-["F$J3]"T2'DG7Z42^4.PGUVDS-@/D;/"@6(2R
M?]J-'5`_.2#BFJM`K>H?0-4#FQIY8Q?H%7QQ\%4[J%&:34KHY&QL`\V9,]=S
MO.DRMC9)\-BAX@&5+T8]PWS!O\?!&21;8`@A.<RQ)ZA(X(%04),ZP(K@F&PL
MTVNP6SEW%K.X=Q8>:,WGD>O)89;L#&#^]A)[686HL:2FI6Q7:C:H=&_<I#$!
MFD[T:+FA-Y79L<2).-\-B'KL+GF#V2Y!-`:195,NZR=AQ4(V-AH^77P`\^!,
MBCD^"6G>.+L5CRD=%`2@TQQ*L%MO8]!A(@P=RF;T^"*G7HIXX@="%D1@($&$
M=4SEL9X=1LE!6"(O5#MA#P/)>-#I2FDQV8Q&1!)"$$0+E+:T\P(M)9`O'W[Z
MX(!N!.`P926D,!RA.7WBUL\A(&ONT=]7CL?=\W\2'>.67J+<\]DE68V`P:M_
M7EZ^5%X5.#3T&<9=!C:(9!?P3,DH4Q*>,-SOP$%O_6C*+J0>I*,F>$K9I:AI
M'!ZY)@I.\)8PF>=<7JQ@"5VS8('RGS:)8"29',$/\R40K6TQ1T3?Q=SF0%^?
M/@)YP31"=DA.MXT"EM[X+Z%Z><84OBYMDGA')C-AWA`2J"T/YB1&)BAQU`$"
M9F$&R@J.L''G?P$VS_7`1'$)_:$]]BSD(D#\=UB']`?S6RR(&_T@;;>9]187
M?`D[8P79_"I0:TMU?@DZ'^@LE*I:<JS4NY)(5RDB-@Y7CPT7H'=ACO3,D`"-
M\8G?D\8O1CXEDE'2^AAP):@7-A[`K,Z#,B`5`>F!RXUMR463P20O*U!73)6"
M#XM<+J1WH/:`#!;@`ENV="M&.3Q+^?"X-*UWZ['.Q]6[N[EDL2MLXY'D#;R"
M/DDFW),)`,6RB%0<3WCU'+0$*`]0WXN<$YR,D-':P`XAIZP]XHP0=329QIKD
MZ['.QXXJR6,Z[/6*1ST49$$AB]V"XU.0+-43)\0VH4L!"&];4$<JD(!9WAS&
MQ=[9>&ZH0K3P^ENP$6\HT+(N\R5K_VV>S&"Q7U\(X*4R/B@SI@`C@)`+T,P.
M:[5BA-Q:O2A:35'T6?FIR=?Q.F5VV"J8-$QQ@'TKBFO.(Q64!4^?G,Z1TQOJ
M1@T$GCVA9N?L#Y='EHW&ZP>T_.TY2PZMX9LT#7=C?@)&:8CY4.A$R8BV&G%[
M"`F9+?9"92I>:@8O?`%VNK"*PD&Y7")PQ^T%WBN9"A>T.WJF\#OX=&E@Z`^7
M`"-NEW;X7.#]@EQ,^X_&58/][\7%EYS7*6_IR@6E:\AD*AOJ_FQAS,J/'!$O
M<ZK2_I+0;QZJJS06C\\G@4?,O;:#H/"LX-UE#E::%O99)F)YF(TY!Y(__W\T
MXH5R>H8X_]<$''9U_O\UZ*3<1U/)69)8Q<0N2NM2^9C9B&\V39LBD9X7RMW+
M]BE/T$DH1$(!PA>%="#=IGT(:!+YK@P!QA%%A%->^9!/G%%(55[6`/A=A-S)
M-G!/GWT97[-!=:<H!RT]I6K3S!LCO;^;LIH\?*0;00F`,<;BW+7D9$0M4(9.
M@VQR>\R.\2NHDW`?XAEMRJ:VR*^_%NLFP)O(E(1+J`WV0VXPH[3E,0[/B<3A
MG;\B5QY<)32^?:`5.V6R0[IS)CL7O6M!H2(7S>V4JPN;S+MNE(3$,3@7\\`_
M=YJ6S@\F8#E8Z?J`RV)+;'10PA3JM@?(EJIVM<-*:MGL9>8K<B!C6M\IAS9_
M\,-S-XFE/QI[GW$4<L:1.RB>+'QU"'0MW(@L:N1$;7;68YV59(<OJ4T&HC^7
M*[F9(;:KDM@<62O_I64H;:APY@5B1?ODGBX^R)!''Z!`<\GHJ#83-LS-DF9S
M9.U7X=AS6($^>:S-.BO)BW](#GB77.H'XREU]9($Y;Q_N)%)I6.6C4#ME"X@
MS4?T'/"0X7[=..5WY++C01'.^7>1*6=`U8J"()K'M^/HJHJ\H9=>S40-O+WP
M47BK.,!NWNZZ>93ZE@^IJ_+!YGNC%_(">VSZFV2LRX.;..Z%XB]9OQ9#]5AG
M)<705V$ZP$ND33>+F$MUJB+SB51R4<PIJ7KUDP'C1`*2+?0G7C6&A>9OCI?C
MRJ7F@=/E@4N\DXCRG?YX!RKKFCN[W[2,7<2`8EPS6"RH2,>&8:S4("6]ZL&N
MV'@D/\<+!TE^+V81T8E].*.,!X<JEG@8X*'KDB*%J,&N(G/&QMSA21F^*(CD
MC6U*]<5W8<SW;S]<8JH-5?]#BY=20$*9$]51)U>JX-?M6$L:4RR\4XU`8=ZE
M)>ANIS0$J,8/=[]K5J['.BO)RE]\S"0(94`&.5D&:];R\2=NS@!T7[X@DA=R
MY>:XK!NGLJ)`;9EVG&+(894^1Z2<(PJH?$8@BT:EM92B0$PB![CP6O+[!`/$
M&.T$EGR/@7*Z?21SAW_(DDM'G3]`FS8&X-]8W3.VIFG6D$X*0`Z!V6P9::FL
M[*$0R+5H'LF_$Y#HW(&&F'O7V=H*L1241S+R$KI\%^MJDLC#^AU4W(I."Y1$
M2:Z38\G`!;=]:8;/.3K]+IWHD$ENV2G6S!EF?Y'ID7F_=KSZ](F62E612AGY
M]&&.9!P?07WTW.GY1[HW<B$Y<(.@6KE>'@#/P-L.O9VIJ6NG,V#A7D&B0%X]
MQ^,^.KN43K_M`P_CQ1Z3OJ"C*Y'6TUTI-TQEV_#`2QX[X:4`S#/$P[40TU5M
MUYY'<W7.@T5_4A=YXD4^6#]_1]P/916C^+BGP3Y,J'I>6@TP4S]/RIY,3;J(
M!&4$H`;QA8],/0E`@J<D8W)&I(H^^RI2KY*;DU]6S!JU8'FCB3+!5>U`63$N
MBUL4HVB)R0DPKRT^>92'IJK`D$>5YG*;$I_=8>JS*KT7YHHK)S6APUME'C-3
MQ@E">:CK)^BTF*N*F`-/P@<_)20S8ZT@P_B]E7EPU=+)$KQD`>7LX)5C$8+%
ME#P@!5[FKB280E8:E03U[\8WD*7IE)\U*6OY=X3WD.)'Z3J6-(Q\D?\R.?3'
M<W<\\$\JNQD9N&\5?I<70M1(<M9<C=7L-6W\,A[=&V/54)G.+5^V>,B5'88B
M$A_^*[*FTF1%`U;'%.NUSBK*@8Q$(%[]5ZR]LIEL26F_]9(B9734KY:8$#/Q
M0-T3LDUEK-RDV3#J$BZHU@#+$W#EV5#E*:SE2LH?CP4Q%L_31A`JA9>A%,+B
M#=F+X+$VCB4!W5&Q%UQ>JLG*JYD-_H9OSF1]17G8F+D,B<(J8^>XBRA49QU3
MDDFX+(P>P3LRR$JE%;Q8/"D11`EME&(D`5)6'Q(CY<,K4Y!NJ.4;0E#A!^]F
M=?C(S<@9"=6M(LKIRO`2'4Z)71."5S7GOA.1,A\QK86U@"N))#,,B>FH<9GF
M^R##Q+E(3\U4"9&9XNOXLA/68S`IF*G>4*U,2-7I1)K:K%/27KN(]M17\OX?
M]7M9)4%5PQ-H,29A>72,M7Q2F9:462>_*4.1(/:%3:-;X&Z:6!.1DHKC3W&.
MYAPQDV2XY($@"U3=T2VF^5N<8A0,D3+.+N/%+)>L%FU2KBYSVEO0=C<4L3/E
M<\I$&U0>5._=8-<>YBE+H`R9?+"4F7$+(2SXR@1OVX;'[>`[?!*AV7@I\9LJ
M/FDH^Z2T5:8!!0\H<DC9R;[OC=6-[O$R9P:/E_2S4-G2R4U1$!3E"OAM209]
M(#!N99^J2:J2@"HYO%.LI&Y9,/*RK'+!DCA4QD5+4TB*5%22M.XJ_?1_`R;+
M>:59*GSL16',-?G<E0)345FI6(':3EML)#RW"L8V^BTM-1^-N+J]8U(7V;MD
MU-*V("4%+)"ER\+9NFRCI+W:K;@%S]YDH(QY6%KRC3RE`0'F$%%CM-*^%>Y+
M;6Y.Y+KQY):ZAV1O>5Q<7;(AWE!,,YXV=*G+I&Q(0+!$.C7:``V0;_,B'0@)
M.$!%[":I'I:43<Q4<=;,BC(F7&-M'=5,K[2XNTLRJ"I9I1@K0AVIYM\T5YJ%
M%L=*#'6,M,QFF:6N&1[1I2-M:+$G$074)"LF;]U(PMI.NJF:,OI.1FOV$D3Z
MBZQ>H&"B/JFOJ&[:-GA6P7_&3.$X*M[QR[.F_+S`YB[R<V;*3,?3U4ZM*^U9
M8\#4..?RZU>LO?CQ$%B]8\_@J@&_!MXQ1642<,?8LPJ!9I36B3OMX4;#B^UB
M2^>^N],>NSR_<F:VF0!UVOI*`U\5NGT03UY3;46`UU2;<2LUU58$>$VUY*YZ
M(7=.AF9_REGHNUOKCPYXQ>%;99J'=AEKA,JRPZ>W6F^UWNJZP:>W>F\C@XVG
M@#S/_^79_S%-(2:39W=:2J5KO:1YG-F(][9DGTKMMF8<+2/U5NNMUEM=3_CT
M5M^#Y7,SLT.QP>ZAX]E?GO7:+^IG`Q6ELZ]>GS_$(%*X:Q6CKE2L50E0B4H2
M6$<[4J1ZJQHD>:[I38-Z'ZSQ](EFCNIM8\U`K;1U\'P_:CL!)=4V1KV!,1H,
M-#]6"U3-CYH?*TCD!X3M3]!]O57KK:9444E03T`::2M=@ZI90[.&!E6SQNY8
MZ1B]01?LV*%F$0VJ9I%39)&<F_<371+-?*Y%@ZT3*?A2.&:%2II]<$UO+M@W
M_F-3E<-L??@H4,6]TL*=:7F5N0AG7M*F4C5=D;TM:9X0YVFP/UR+JKG8@7K#
MP()HPJ>"IOS'IKO]F4*$R4W^M-AHD-0W2PL%I,699`?-&)#5DK`;&[%@H6=?
MI"429!%$*NCJ<JKPC"/Z20,8A]^HZADWMN-@.3>L9R^OYV,AVY4BJ7)M6$!5
MCN51IQ8_$+G*`DFMW")DR<:0Z;5_CN4?J,B`Q%.TP&Z*,T%596RJ;S#W?,R)
M_"ZP1AR6UL'".TE1J]N3)&O!OH]+53<7NTE>%,UK8)G9I(ZL@1,N?._:ILJ8
M6"D["(L68F3A31OM)+2Y4E6!!ZI<@NW'A7QU!X[ZK+.*XI5]%8&@3IZRK$G:
M9?'2"S:5B,R]E^W.:-)[L8AP`UDX$D09MJ"Q&NM?](4]'T<@1]+64%.?"OCD
M"M6.E[G.J3`V5GRQ(C,N(.)G)GCZY#9LFMWJL<Y*LMO5#(CY_`UIC2^R:MN.
MMDS:M.UV<7+!@=R#$#:%>0NIV6ZX;\4%'(F-9&>V\3)C#KS!N[KG5^;,H[Z4
M\LU<?63BPF0:[*T*3P2XAF"E.!$/PN1W`B35LA;UIT&VM0$FK""TS/R*4L(/
M-S:]R0ZKYLNVF2-XY")OE4_-F&"^4&VO@K2Q1E)]3Z(+;:Z`1,W416M!MO.@
M$D4BR'2:BTOLJ^;8L(CYPO&60F1KZ*.N5T8$PQII6#57-@J27<QS<U,5*5K(
MN<0K%LT'Z9GB"*O5YX%+-H!&"%CD2`H!<R=KG2'H1DYFDKA4A!0/C=!DZOU[
M_D2HUA[)-&`"AYY/I1+3WZ4=V<!FB=>V%P5D:R4@YE8A-0/6?@*S+"EN2O:C
MK/DF&Y90"[^5"1)DR=)8>?(6L&V*%/+;U,"6\=31"2RVL7#%Q$:;C3H*@)$7
MJQ4%*VH2P*5EV00M[AZWK7/LU\`7=L@=K3CJL<Y**HYWW,=JB@$[^^@%P4OV
M!033I12,I%-V4R)*'A%3VZ8TP6PG0CX4\03`.SE)#TC`-H*2ATE,H+;)=Q)$
MP^X-#9D,<^80G+='(X&^B%1=42`FVXH5DBO"V.E5KR=E_F5#PU01@,ZBQF_*
M')3[AUP,$AO;@[L1G;;?TEI>%&+C%9IR8R_1M]OQLMM*MBTAW>1#UK)PHD#N
M)5X>3#LS--B5[9JY[M!4\=ESJ6^=M,JI"920[NP*6>!"J$74K>7C?Z1^^1Q<
M_W05U!#7"U%2RW8TMX%B9]+8@!E!D"LCWT5UX<*20UM6$TT*U;\$E)`_H:H.
M)]VM8B"+`01%A94*52EYDT>RWPL66%3!#2H,FC;0!#CL&-H&>Z]43F#_B#L$
M@J:!V7(W$8S<6NT@B&09/;E#2:'DK'%&48!%!"X*:%;6-MK#IM$:=N-W$!$)
M5K)/CHQ>IV?T1\F3.]I,.RZEO=-2@F0163C3W<\"W#>&W;;1:P_O"+"JVXFV
M[H(O"8@L9<`4PU;/:`]Z=QTWTXK\%BUEJ$4K^GJL\^$5-LN_M8^9\55@021V
MD<:DO_B>"W^;X@[>HN4A@KQ0>0*JYC?9_CB\XF]AY1N.Y^:A`"IQ#,]5E\6.
M6MA?RU6*4_;:!A9,F_YE:]]2GU+XDCJ!9'J&Y7FV3"Q7CJKAVO1-8B;1.`"?
M&KGBW?7.+)#3`O/5'GY(^0YU`P9S#ZA4]>D+9[X736=IB&&W-O9DGBB&HK8$
M*<0T,&+5!",E\D72LWAG3:-.5.M7D/CGGZ+@?,KYXM5G?\I==1IRF6`;/ERX
MUI=,K_+/DZ21T56"_;<);N'IJU10I1+T"XQG@MGY#5;_!G'SZ],G/T]LY]7_
M>O`K3&@*WTU^Q!U"/'T5DU^>7<J__WS_GW=__MEIG;\5YCG:2L]^K<V!]SX"
MX7<PSE@[UPJ`<,D4,F_O^4ZB?15+IRN@'T707JQT`8X;"),\Q=W=*@F-6WYF
M$-&YL96IRB^=3=5I)+$9P,9`/Q4;:^(?Y&3D3Y1G=-:3.*1@0#P?&IU^RV@W
M>])E@)_(PHB"U3;&]#3X#.#E#%I8FU]Y1-@*5?E"V0S]%"G([*]5\^25WLL@
M9NQ0#MPS!MV.T>UW,"9Y*]6_P3ZD@<7;*$(S#9$,>RUD9U'P3SU?>G])&S-J
M.$V^4(K)P`-72\A#+]`SV%T#\8W"3K8!,"F`C4,J5-`F!NH(7@8J?L"3-\+!
M+CGD&L:]=R9@Y7D^D`2WX1.JM)"3<PC&931&13KE?A+P*&PHD':40IEJNU33
M'Q8R]10UH:PHD^FGO:V*BJYOF09F><\B1WT93D"A0,T-L8LY];R0`B^(J/D9
MMFT7/X#3XF/EU(3\OP$VGJ#@%9W_Q.VIXN,4,TR:62#O4*11C*FY$QX-)7T]
MU+&"(7LF!Q0K5$("3T`B&=B38E*VE/)Y^K.4OHD0P',-@H,84OAS&4`Q&)I`
MCFQ?C!LI/4$</)/B,EYFL8*QL[P8P<?9C>=_)[:58,?G7"3W\X*:^E4+>;9#
M5G%V70H%*K\I\K._9=.8""EQLWIJ.R)((`;`#UPIIR*A(W[804C-G+D3SLB:
M=V7<U0ZEM8ZB+\9N&A&:<]A"&7BBMD(^Y2.!(8FG5?0C88X0F1TMSC-*PKQE
MDF?:4CJBN+F3992A-&K8YJNCV[PNE/V)8L%"C@C8!<FI?R9I;"4!4`;B0SN8
M\"019J5U'6E[/,AQ8&#,L\%GQI@-`.(N4?I%H%L>V2BQG*.T&SJ^E3_+1G`H
M=CP%)9D=RWRG+_*D5;,CDQ?!*!MX4<>_L4BS\5@PHSA]5J:/L1=]>J928MNB
M/7AT+WNMIWMW-[C_"=W@YOEOD8MN<"=U@ZLA2H[GW]9*MFJ357O;!=XV>+B#
MCM'L#'?RMCM&ISTP9">\;>>/.7^[L]W?'H$GWS=ZS1;ZV[GS6.UKEUL?:L%5
M><&E?>UUOC:*+7]=?KM*9M?^^`G[XUKF'=0G6+O<57:YMWBB\6'P5RECON`]
M@6_`]8%$;^:<]\"CVO*>I-_)/>WDW%.%-49H8UF\G7**08666+#W<@0<#18.
M*MXVUV#BT]4_+R^W=0FI1;+"W?4;KJOTRJT@(^-13'OPG4%D@BO]O\(%^]-A
M%Z&#CJC)_M?WH@7[:(.=A<XXF(>ARJ%2+H"R(].,7+3_;V8>YA)[-W@!"]U:
MV[+I@O4%R";7CN;L'T#IE%[_,;0:[`QO&@@?7G'Y'%ZY!<8'%Z_X2"6H@'F)
M"NF3F'N4R'7E>&`B_I.01@$[-!M]=DE-)MD9<<I+`SO9P\^FO8!7$#K_?O(1
M[Y_8]`G.<2C]L\O>B[$?H;73HCR-9CL?+B**H<@6T!<':C/QHIR1NR2-=B#>
MPA$^&G"QG7@Q]85,-B2GB4CR/"7)#RYL4!C)"XR*/I-;T6=7__SP,A,/P\N%
M0/GA,O&]D-J1BAM%ZR(K.9T>S;.Y#+6!.7H138$V<*G]PI>_@(D:<>EBAMF!
M\HAQ)"8"!H"3ZP<8$@X&,O'F'CBQ>*%S*9UI6$W663;Q_@=>(%SP4'EKY%4&
M,DG9VY#&C[=-A#ES/<>;+J6KS9T`_<_%@@)XGBOMT)P#;@*]T8193YQB>"JJ
MZ$?H08/S:=$]QB*T7*IEQJ4WK`A-X:0J2`;=PL^4HE`^`MV9FMK7\$?\$EUG
M'`.0N/?G,2ATE6(:V_\B`%R-\>LQ6/:%<`$)4^BS-:+09RN_2Z[G8OT,!^\_
M$HCR0BI?XIZP,_Z2/>\UC6:SB90A7S\;PY=`'9EOV[2,,Q-_R#W>*40![G6R
MG4JBQM-PUT7ZF',D%Y>\^8E0]UV2/5NH.]'QM:7?N"M9M&B)&-#%.YKL>4L!
M7;@M1"JDDFYE9N7'RZ,I<QD4P'[>4LO`:$4"+CPZII1>K#\@F8R"T&71'B6T
MQ[1ZVE$]?2(*:P^**#6OFW*$FDB\D.PAGM=%I#E6C*)5&:S(F:H-L2]TD^O#
M3Q\^J`'E+<2Q[4I=A\%2OJ#`@^/=@&$(3YO+$&0;/"(#>!-?>J)2X'HR"O(1
M0(_^&\WY^/S";+=[:[59O&2*ZR%?/@?F;0U[F:NH``D%1C&8@3(A/>"1$9`L
M0@KG^6-!E^PS$>@-Z@^5:NZ./\H*C-WXX3F8R"#3Z(QJ,#+Z[4X<5[J)196'
M0AOLVY:Z=/>H-P`RR0F;4\+O/X11#N?]P;(SBGA<\J)4.@9Z1W_%#*@,#F1$
M6UVH@J^!.+&&E;R<HMA)'AP@*R0OQ>2.K+?P1?(9#+.IS^>J0!APY+6,`6;L
MRG76%UE)UHK=FPP<A)&U3(;/G8W@56"IT4EN).L*5`Q559^(RX]1T)'.7V[P
M'#2-WXX]/ZXADKIHLM:'AS6\<#+4^8#%^9RK..C:)2K$9^TMQ"#F@@<%R>"I
M'80FR!W"+!6FU[N%DM)?Y*FY@HFJ6B(\S1<[B8T,^,^`6!Q'Z=I?GC7EYP7J
M.?DY,V6V#<&6WH0*,#7.N?P:T+KX\1!8/;"Q8MF!7P/O&.MV^0FX8RPZA$`S
M.KUY?:MAY"T2,\E,J4J\\M#>#E7;]4H#KTE6D6SK9$AVI6W-SJMZ=,`K#E_-
M^@(_?:(W^V0VN^1]M`;]&O;1^G\1`#VQP1?[2JC$_]XJUS&I6Y7W"/?38?D>
M!64LP:_;"=YM#VO99Z+^78HT(Y:(W#0CKL-,'ZL]#/LU9<>UULC-S`[%B=HB
M7_.EZ;&&FGT=%P^D:+(V/4H$Z@D(H79G8`P[W9H*(<TAFD,.Q<JHWS<ZW8/B
MFB7>RCMV93MV?;5J9"[%8SYB:G5ZCKS:DD&9%*&'=_FR(8]<7YPD08YR3)06
MH#&?MT<C`Y/WXE0>&,Y9&AD;I2RI)@\<"]3T>U_E"HHR*-?0\XQ;JGJ`I&Q*
M"T"2;2IBE91[+\1:)4^B'&E/9;BS]-9OL*\>2#5,U_G$_\N!6/05)ITR>TC*
M;#Y;?/-]#JPSC!V3W"F[DMV9@M6+&T4DBE>'+!N$6NCY\OZ&&4;%]P8V7*?`
MD=6`F+>6=HHR\)8!@*2*$,SP:I1!5YT5K$$,:UPQQA<RM]W&G-=Y7"DYSF'%
M>U9S/E;9?-UA^_7YA4KD3=/T\!87)S%,(\E\/MNU0UN.)4L63&P_")-D6[P/
M$<K\VS01T`Z+;RIDEZLLG2#?&PI50YS$CXT\J"XK:@JL7:!>R64Y9U]6J,"[
M8[(.O:J;$.8ZL,JCHK&'G:-6+WL5P+SF_D%V*50B!^^@)-9;48,/,,M&L*KT
M8ER^G]GD5DXC)DBK<2@#4OS`ZT7P+;9FPWY8[C0I5O&\V1@,<;KGK88L@JLJ
M]COVA!1NJRGS&A^]"L+3)P]^A3([^IY::I/HKH,</P0WO_$Y7BZZ5/5'Z(:H
MP3Y^W.DF\B;TZ#+@CZU(/X'4+;Q5MJ)$P[3.0+;'PLJED[6$DKWP^]WU;ER\
MIW4!GWE@\X+GZ>)N1AF"2IHS/IG8CDWYW?**"TCH*Y"$(IB!9@]G^,[;C,:^
ME>2.BSZ+\]W;S=>?TH6\APF27UJO7V8T!66?KSR:*@(N"WS!NN+[(&".]$`-
MJ#)&`9.*B?RBE9:VX0RP%]=)XY-0W1F43:M0#V:;7\H[CXMH#'R:VPY9?@@;
MMPBI=N0N9-/SZ6(IM0PO0B&A+MO9HK`I54Z9B;_QAA_\W&J^B`&D_MOG<:>N
MN%A1D?)3E_3NOE9U$R!*NHWA97.I;F7I->S4EFD&EG3E0L,G[H.#320S_=3B
M9ES8W(/,(Q@&KR[AU3\?=SB]S/DN;OYY18OZ+/NH?G&XNXU<;&4_"!!/<6NK
ML4@C/JJSN"R5-9X#J,I6DI=LF>6946KRX5H]K!*'!HNLT!?7<X&5G7N3\P7`
M)\+TU@7U4/>P&1;>>WS>2\PO(KY#3893$N.'Z%&@%-ES"?P/!$JCO>+:4]VS
MW^GFIG"G:[0FUL]8)*3!D3222I(4>8O;?TJI@X4_8769T@$@)Z2V2<5YWG?-
MP@6BZ!^"DV<$_SKAS,2R<VFY#?:&NUANKM!7VLGGI<M@*^O!:Y$2`Y84L:K+
M8T#NWHY+SC:?3/_ZX.9;+=%`B-/8@UX#$5XSC1U.O"7/5=,R(0K5V]2GWI.^
MAR)4%?!,RKENV":Z;,_QEOZY:L%&ID#<CCD?]$\F;A\^;WR?/S]#UO]&1#EB
MBK4!8T6QFG"Y@K6UEW=7L:NV(+5+I+>:\Z$+S8SMC1YSR\7H1%RPH7#;UGCC
ML3$04(7#^.'();H!J;X=P6EIN&2&/&1Q6\U(W3F6KKV:Z4VZ^L1(@2FIR"%!
ML3.FB8ZSB$UZM1(I9RY?LL"<"2MR9)-ME`5$\%G0$J!0,`$\_=@ZC6T\6]X\
M]Z@`I_IR"XXXZ[V@^S2F'=LO(@4AF3$&0_;G5NT&J8R>D,4O'4<U70/R%'-I
M>ZU<%"W"V1^Q8757V+,T42Q","PDFXPJR;9JWZ=]X>,;L6D-0&Y=VX&')?CB
M0%_^7J[$4-Q^&:^YAL"L'-1-LBGRB57_HTW6W0Y%8XAHDD;1=#'WS'Z)7=.S
M8)`7-I]3G42J,2K\J?!!O)A_1W;<\3$N=9BK&("Z)RZQFG@K9W'`D\M=D3VM
MW_T`[G>GXJ74B-3!FNK;@?;T/6QB+VN:AFODTAH13]>,DZ#B6M'.IU.LNQRN
M].Q+&#(#OZK]>F83HHR83[+[!`25=^FD_Y<K.'!K[U?*P*R>&5,1`F2+M$(M
M=A^TP5K"\&D\7!;1:W4>26*J)4GE(-$Z,<-8*1<)W%LTJVK()A;#&"P&K(BM
MT)6#,0O2(F,S<%A[2#N22"7ZPO/1(I+@Y\VK0@NJD,S?9SE'2#?/<U4/L(R?
M_6-A^VG!3T`-VK18VB$9/LB;<?*JOBOD<HA4;].P(44K_1VO!`W=54,L"5#'
MEEK`YKA<+&F[0+8\7`L3AV=-KQ4!Q8L-3U2"!8+\,M.:^7=JVISNM"HMA,\9
M4H!G]6HL\$G&I-MHY.,6111+*\#^Z<760LMH]UI&L[5+@^BLE'_T(+D^AWQ`
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MK8AQ*[VD`,5I;-\EM9F*NN+N4U&IMEE?NII2>:J[%.Y,M2JZI%CZB+E6AUR"
M.)%-KU])'UV%JBK`:Y)5)*NK4)6^6HV&3Q=.J@8JRPZ?WNJ'K)'5']2P+H4,
MBZ4N^!W5YQVO?U?+G$AIJR=O0.QG6]2M`$&EZ5T7)5J'F5:O;[3Z![E\E2!Q
MS8XE(CK-CNO9L6,,FW4MSW-HC;`B6VRKNUYI3GD?^:X=1KYJB&/_P+_OS5J[
M.^ZJ:LH-CFK*E3MDM+N`N,M!1TF6M%4G''1X4RW=8;1'1S+DUA#XTR>E(W'-
MJYI7-:^6E\"/%Y`K"9'G8%WCHY01U#+Z"Y4$=2<OM22P5@BM&E1-K"5'ZS'"
M&Y6/8'RCNJ1Q<W<#;^2X83X!]![LH')3;MV"SR4!]23BP0.CVZMK/%ASB.:0
MPSFD9S1')]=5Y2!WN=YG)A]%$+QBW#2C>23;=UL"^YG+HJ3',3;*'731X5$=
M'JV44#]K];I&MWLDNZ?>XN_E?DC3DD%+A@I0]QEER/0[6C(<63(<*YA5$I:J
M4/2H]$[*?J`^?5)VJ5I1Q&I0:PBJ)M;*1E6ZM3`>BFMW/&PTI5LR5V-OGZEL
M"SG(9X+%,,N+QHZH`9D?ZVK"81BLE(O6,9JMYL/Z9V7C)RT8M&#0@J$@Z;7S
MP(&;<O#3'9LN5Y`[-M4+T'UT[Z4_R-O,(692@C]N<D&WF[`VM;`V%,R379F>
M]X8MV4RWW^GD&^FN+XN9EJ.\2UW)>ZU'V?^$]2B;Y[]%+M:C[*3U*`L(JAHE
MA]<7I>S<:U'*DF/F*"*E,NM\3*F2_K57;4Y@12#5IJRI2V_>$CYW*-)9WGJR
M)U*G\Y"4H<=V6(YT.%JM"\\'%^VL\/%_#'IS?PJH7V'$QSHG?VQBJ,LZ-%'?
M=X':JA+#SH4_=?[%J1UGK@.U2&B4N'9D!3%<(5`U,90[>Z#R(6!=4_3H-45+
MSQJZAN&V+3R)&WD#HSVH_YW5FH&JN;&FW%CG`K^ZY,:#%PVME3EV4%W0TG-'
M)4&]FTQ^^J2:4OEX]?]*M)4:U,=G$,T>)=M(70&SI*"6D5@J":J^JZ9!K0RH
MFEBU._Z0%3!/K/1EZ4FVDJ">@@O0&QJ]?EWK^FE0-8/HTK`ZR:(*M2T?G18J
M1+:5!/4$A.5Q"TH>"^J"@FWE`E#SA>:+.J>5E*)B8J4Q^-$+`N:Y]*,7V'1Y
MW9OH`(@&M9*B^>F3AQ3.7:/5/N(Q:*4%RYYEKBM$XQ4"]00LI?.:TIM.1R@I
MJ&4DEDJ"JD]X-:B5`543JTY'>(Q"S@:\IYWQBH%::3K45[9.S=6H+:B:#VO)
MAT<L9/[H!+Y?2>+[K]#8[3W,1;\MVZC+$A]<0'1S@>)PY@O!YC#Z+*Y3?+MX
M*!4KEC6*F^G`5*JXU1NME"K>/%]@_[C+;+(><J<U6)GC&PQUZ<T7W%VR&Q\+
M\WJ3";/#`)Z;<]O%.J@1C.\K4&"BXD1?9D4^/KP=MO4UF!^`'8]+J-NY\?`R
MTV_%>.>*TN__@Q6E6^=OA8D5I=NUKBC=RU64IJ^^\"45H$5*!9Q<`[YM_(P_
M;KL373\L':HL2KCT]=2@MO[`E:ZN:\TB\HBM$RX?5?>RSVY:;[L]E/6V#5(Q
ML<ZBL@R@86PW]!@'W23F=C1G$]OEK@F,/P6M3.H)?E[P)>C9;M-H-IO)DY[4
M=I8-^BT$W8JBPJ-*7SX,"B*6QEEXCFV"NOP2^4'$Y7`(1C)^'JH%M\%29I9W
MX^*L!`!,]!S6@'/;+ON-NQ'WEZFRGO$@A;%M]#M]?(RTJ+-$2$+N.#006@"@
MEV-CH\$N`AS\5F%R@WE1"*^Y6.R3C;E#*_&%3*M5"UB/L!L`*,96X]Y$Q\DS
M5'W5T$GKG!+)R0&Q?RLOD4SX%T`2%@E)^YI+2U^0S0[28_B"70G7!M%R%6'!
M91`'^/`?X'*8$0K8+-V"Z3JW@\`#^44DS,YBRZO=+"#P^+?6ZY<HTTANSKU(
MR<114PID%((@@P4X)A;&ZM'/,(6P2+@]'_2D("*'Q<Q,X1(`Y.4`2!$N,&3#
M3J/3>1%W=(#UNJ:]X$X\+;A`D1/BR@$<[C(/:`86[,@1<(/-!+Q6;U4"2I=I
M99%`?520R'-EKQHV`1S1[)9$-8V-(K;!/I#."D*\YN!'\"Y`C$_ZZDG8"_`,
MY#">Q%=6DJ\NQU#C6"P`67[.7=`LCB/=,Y#R8Z'442AAM,,-77"T$*\`MW\K
MHFE%Z[<)$\D@)A`[H3RLG16%L,30-HE:%$])RP"D!1@7L#AT+!5U`C4Z-I"E
M-WG%SEHOY7<@02B4D%`Y9_\/J,^>V##0EV@,5A/[K,2,P<[:+^$!]74LF;Z!
MA15P$X,<!K,$&"+(PR!3;'S8%P!5`+:.\*<XN<\"&W8*."-,WP,:#V^$<',2
MC]8-*_$7GB]#*#<S#T8B@6:'-J(&L+`@:``!,)Y%**)1_G!MQ,55R!&',*T'
MW_I`H+X=6+:<=1Z%BM/0:++60@$>OBEMJHLIF8HPW)EM2Q3^'7DAC[.&,V\F
MONS@=9"%&:V_1>2;8"]*OS;@#HH=6.L?C:M&9KQ`^-=@QL;3J?DFMH-"Y,8.
M9RCZ^&(!RR<GV1=3O'*%4GWL64M`EVW.X$''40(SQDV\MK$`.J%&.2[:X2!8
MBE&L,$LP2G0S\0,6X$Y%@FX$/<'R*F*C!;R;1;U<4T>NB)M_1W:<>>U+';((
MV7B9`Q:PZWK,$0&8V3`U>]Y%L4Z:!WZ:^IC&G6@<@"J(QH'X.Y*6NR3@('86
M<NP!4V(0[!JVP0V#3/L@G#T6^ALWEX8YNQ*28]GHI13=1=RL)7>E)?<'%^6L
M*Z3\(!XLII*5;3?`&_-!WH721TS8'SYAZ05XK3T<&,U^BP4SX#@BU!R19NTC
M&,&&\>$'/Y#VU(J`2LCO$W?Y5/[PWO;G>1K-#ED(7:O;,7J==@P2#MIJ]XUA
M>[0&RM7X-X*6C)P"'Q9!#+"('\(W[4`&_$+VO-D8#,F0HMEDM/K'PB8C+?&_
ME;,\:K"\@;=FWE6,%,_;;.T^;\W=HJVL4[L5/[IIF)H>W%G^5ZS1)`F3_SNF
M=+0L+$&^(5IT8#.B88F:C'KDP4_2KJ#C(/;^XNH-N[BZ9-V!]-TL\"[].5EO
MH&"ES1C+F92=XED7"0/SJ8PVR0<,99F`1L8P&YF5$V[[>+X<D8!\WNOWC`$(
MD50:]5\:8/?$9B>N(P-\Z`L>RIE@>A7HLD%J9M::'6J]\I4B+[M.CW$G\-B,
M([[`'G+!?*6QI34=(+HF0GJ&.:^R,V@;PUXSXXDF_F+F53#RI5)8E672-+,#
MF!*,#6G7Y9'4:K2R0DBYD;&5?I^VQ?T?(6OKX]@GV2@FI.DP$6A=@"_I1!1<
M,'DPBT/6*;?FB2O<62_3R)$O`_2%IH]B1_1(Z*"Z/6H;_5&;E#^>=HN8[<#-
M!6)%<>8!V=*[P._`NG'$Y>5Z%S@*DI-I\$5PY\\="J"+<.996&$7UA&B+^1[
M/^PYN7QY]S9QG.4KJ]9"'"5:'TERUXD4%$HH0]:M3RU*/DTN5+P&1FL8\\`^
MV"W0W%LA[OWLLL]FZ%&LMY,]$TNL>K`W0YEX@5]CA#0)_2F-"BIRU(2_E\H#
MR/^L:$Z&5O%@:HQAC710;]6,!3#>B[%/7[6&*@4%YOC$P1>((]*=)'>EW95C
M:[*M/=GFCB9:H_P1[CJ3=#5<&:N`'0.6-[.5(!SFRJ@`E)L[];@5S+%=95OA
MZRM!(?$#_U5,E0D?8>97,/,<JU&$@.+3@L*@+"TR718=:;>,=J]M],!43'WF
M=8&D[$K*Q%K:KZP\%[]-D_NHGX3*ZRO(.<CRG2],[-UJQ<9-/I-Q)1/!$L"7
M:"FF)J'I!1DCU!+C,.]%(6NTNT.9VS@8](Q^9[`21"I:S8Z+:3WL8KI-K%,C
MU])J=XU.O[.ZEGH3N&;D!V#D"Q9$\SG::4J1'';PSXM3C^+TXY8\:(Q/18)7
MNV_M_9Q49&\KI+_0;8!X(KK#@/O9?+%3HF5F^Y\Q4SB.VKA?GC7E9]5>&3]G
MIMS0T+A2;9JK#KQN,HYC'MIDO&J[7FG@-<DJDFV=#,FN7.S?>56/#GC%X2MS
MQ_"*H;+L\.FM?L@:6H-^#6^6?UE)PMQ//>4OFI?Q+K4N%G"W/:QEL0"5IW^(
M"58)$C\-=GSZI")DIQGR-!GRT-)FM30X9'>47)()Y0W'!PG:`"D1J"<@@LY4
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M6^I].U?W/V'GZN;Y;Y&+G:L[:>=JA<CRM@:G7W=M6MU=V[1Z"T]5`A7[DE6Z
M1#6O+O098VF?NMOWTSJ9IZ.O=E%.?\$2[^OZ*:=/.38?VP[6FZ]4BV401H)U
MFG')>P`G7=+AO98[?6/4:VXH(BX7CJN@Q3]O-3M&L]>\W>;4D@6.$<KU18/O
M*+KCVWP?`$U^1.U!+ESK'\("!IM>H+]-#?]VE>_O_X/RO74.-(KRO5U7^=[/
MR?<4C;NT?2X])@X7[T=;8GOP0&O<UH4+V76U-1;(PI!CJX&D;=[*"ZJI#C(.
M/K?PO6L;;ZL$\GWX'()T9=AT0/B![!TUB:C-5%P39.=.`8P&M/$-V4TJB+#M
M9WQG-WTM$UF+>]Z)^$U5UIR^2&`UO<BQ,KU#YYYE@R+(=3LMFB<_.':XB;N'
M7G/?IMK-A`8[P#8BV-/!=A=1HC#R]Y!YPH!MT$[V#V&=@W0_I[^27X`UO06!
M1;LE>]"N]#G[YBUL$RRT!ANV>CFN[C97>A52[[+U/8]V:0IZ15L3M\Z-PYMM
M?!9W+O]S2GK9#HWKNFRDS_1>;NW'EM`@?+#/+=N)0MF9[!9%7MN6;"R#37NM
M2*Y9M7==V5%8=X[(DL>NR=S``14UYPCU#+O_IJUELUW`R8;!3JR97HP(2_;]
MET@PBK-P*&I?*\<)?6ZJEK.T.?#Z2^0+K@!.&ZF=Y>CIHW<#OWS!9S*T]#(A
MS[3=['8LQ'V640))>DH[.Z-<H&>YA:*2]LG.R17<(1,;%!!A):26V:<\PV6,
M#]F\;R%<*Y"==JGW3T26(\)8W%$T@T@+![+4-R_C=61PDU`9M1`B1DV[K&2?
MVP%EN35D,%8299-3?@]@9.RC;>\Y!O&HJC:U/%?[5\9$8J<&:VP8;VUCDO8O
MD(V'[M3`H)Z1GN+U9<)ZNJ?"T2H5EQUX7:`>Q_S#M?>M<5/-;:\T\)IF<<SW
MZ"O]"WVEDR%<W5KAD22"KK>OMUIO]19QI"_+RS'?R",4XY9O5O\+RQ4"]00N
M`1\I[:VTFUAN6&M?:"5SQKX?X6F6K"Q+'KVFW],G562)?R>G1/+(@0XW-A]K
MU91`*@GJ"0BD]G!@-/L'=:>LX%:6&];*HK66''+TRK_E5-RG[<-_69=3DLF+
MS.;":)U>%5!/0&*UNAVCUSFH27H%M[+<L%86K?7DD.'0Z`U&->4076!_5U=\
M)54UFX):4]JH)*BG()&,T:!M#(:]VM.=UMJ:1_:,51F]$?!);0L_:U_\7GQQ
M=>-"Z_)2@GH"<FHT[!N=45V+;VM-KCGD<&NW/>KAE?&:\H@N4'_G0GDS[D[Q
M,F3F#NS]$,?3)]5*\M8EIW==4[5EX$F6G-:%X3675HI+SUH=8]3O/Q*O5EJE
MEZ3Q7DEXJO0V:R5!U>6]-:B5`543JW:QRW@O;<_L7VW!:PN^`F3?,3K#D3$8
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MMS\PAMWR*_2G3[1*+R6HI\`CHY$Q:)Z<0C]MQ_P;*/``]#.;P%/,L?G8=NQP
MR4R'!X$]L4U.O>M!L8N_H]L_U)18*@GJ"8BHLXXQZ'6,9N](]1,JS\Y[VM7:
M:-`<N2='=HUVIV5TVD<,Z)\.1^H[Z.4I\U:MFW[Z.NMI7&?51=[TI7/-I67G
MTK/^L&=TVT>ZD5-OC:ZKO%74VZD0J/K.L`:U,J!J8BWYN?XZ?=RMA3Y>6^7M
M2/T@MV*S(J2^T=J%Q3#+B\:.*-6:#C/A5Q=5;1N^9[2Z?:/3.5(V_\YD_O1)
MJ8A"<VP-9'J*O.?[4;<6%-EK/[U!UQCU'EM0/+X]]5/(84\SGW/KKSRO;-E?
M7)^:EZ"CM;YB?T5!:$^6R2I*N\YXS'A01X0AL&ZPX";0W2LV2F9/,5+T5PY+
MFQ]-J>RSF]J7K9&T+PW&`Q;.!/-%$#DAMN+#3U<S[@OV[H=)1S\&LS$1-6"6
M`&CGL!P+GN(A/3IQ/,\'9/@X!"P'LU#Q>_%#^*8="+;P;5/0ZW,1,NY:13^K
M>4WAA]QVTZQ7?`U&Q>28L6#/FXUVGYV-!4R7@L>^8IX,XQ:2`:;.OFRDJ_XV
M$SX];N`$@<@,#3\PTW,#&Z0GK`@IX(=,L$50+KWY@KM+.=*PW1J\!D@HV1:7
M\'<$I#>QX7%<.3X?F-X"EV6*!:7S1#"<S]Y?7+UA%U>7;-CJG;>:P)R.=X,H
MPM<X"P]+#6K4G%VT6'@`L?`-F3@YV`UB5KQ9N4X&7+F=+2X]]QI8V`8515GH
M09J9'C/^ZK@;V&VQF@N/'.L+TYNZ@'"+D43R[6O@A>MD8``T"/T(7PL8R*BD
MRR@"@%)M+G@0(</#C^FZ\9/@Y@S&7W@^2;$%C.U9#4*0`B\O`8OPEI4P44`+
M9W//DK)B;+O>W.8.O2)9&WX3CN;C>JRSC'Q\FT-BU<<=,Y)W2G8F5'FIE"C?
MBS49**1H3CHO2)AH+`-:+)@)4-X63$+J-]5W^!7SB@T2)2CHD5B[(NJG2FZX
M[#?N1MQ?TJ/)"/AV@YTA&H`*OL.\DK$!#Z:\*T-RRE"&`JQRQ0;!T;Q87,FO
M%FC3N/BLY2$!>"'(AXDC3&G[V"`4S#5&4V/;(=OQB;T]*`U79YV2C(>&ODP,
M$[EG"$_SQ39X5L%_!H:CXR@V^^594WY6WAQ^SL:CUSN(90ND`WP/#M)=(0+>
M0L3#%^WB.(.)_.-7Q1/-!N#O&&MPO1N?+WYY)O]=&V/(\CIBX7$85)/9HY)9
MK,`TE94*HII16=:XTF16'HCJ2F;M@2:S$D%45S([(:6YDDJSL^MRC!3MIT^.
MZ=D\<E+YON!NR[.N&0_NT7AR1]XKVG=6/H;4A%M9PKUK+ITFW%*"JPE7$ZXF
M7$VXFG`UX6K"+9/3>7RX[YB&7+X(S4:??86-'AG4RL9,-!5H*M!4H*E`4X&F
M`DT%F@KNKXY%MUG#XFF?-N1*8H:F2I>F-&Q*R3QKW;4"XF/>5=]*S]MOA3T<
M*1?<%"R&=L-MP"RT1%''`[?9Z!24,EZ/W\J*#DW#FH8U#>\&W-KR^IJ*CTK%
M(TW%I09.T["F84W#FH;K0<.'UOBJI2M]47RQ4'O+6C:0;&AWV;FL87$2,D+3
M<IUIN:-I6=-R/6BYVY*T/.QH6BXU<)J6M\OEMI;+FI;K0<LG)I?U`74A^K[:
MP7<V\05VH`J%+X*0^70.W=;GT*4!NQPBH]7H%/2?KI"H>*&UG:;AHCZ/FH8U
M#5>'AIN-5O,%V&[-QN`NR15884!3LZ;FTE'S2$ODQR<&3<,/+Y$K1\M[GTO7
MS6O^MZJ&[=C7@FKF+@7W@SLZS.63!?4N<378:Y=*QZ/[[V?Y(-(4IBGL@6]0
MU8OBNFP.+\V"GWJ:\DH&4<THK:]EVZ-#I&7;"5">/J@L1-^['PMA8OKOM>?P
M4#;R.NOH0\K2@%V.4$RK5^W4'!U-U"3<JW4049/P"9!PNX?Q\%:_H)ZUIF1-
MR16B9$W"!-/3)YJ(JTO$)R&.]:W936XSP&_#?!9;VL*QV%E7N\ZE`;L<4N*\
MTL)!WVDI`]B:DDM"+*4&K@HXU91<$F(I-7!5P*FFY)(02ZF!JP).-27K8^A'
M]J>_^-Z8C^7QLS=AJI#S9")\VYUB)C!WEVP!GSR+>=?"9SV9-\/.>MKA+@W8
MY1`D;7V=]O%)05.PIF!-P9J"-05K"M84K"E84_`1*?CIDU.D87TP751XBKM3
M:HD$SC+>2^#RD_AA!R&ZTL&,^S`,N=;"8F=][3Z7!NQR*#Y=C:H$I*`I6%.P
MIF!-P9J"-05K"M84K"E84_##.,^G?0[].3YRIB9(S"=O^FR@G>0C@5VY\NZM
MH2SOWJNV=-")5YJ6&RW5#JGB=_LU+6M:;C1;6BYK6JX'+;=4.Z1^4]-RJ8'3
MM*SE\@:W^J>0CQV1^9SS&3,>,G;@M2?+HSC)><!7(<AL`,*:EB.@S4"$-5]L
M0]@J?I\Q4SA8,<\$1_J79TWY><$M2WW.!AZ*P@RTJB3.T,E0<N@MBF,,ZI5J
M!!G.6B\SV[*!LG:),0R;N^#GF!1V!`Q]FPD$X+L(<6D1I3"8WGSNN>IJ@!VP
M,0^$Q3R\&L"H`./"Q^[5^#P/;<]MW`6?Y>/;!Q9BZY9(P;L5*5$^&=&MGXQH
MWX>,*(K;COJ[(*M*05N4%L#[W\\+&N[=\(!9`KZ9P^,6&R\!5)=/Q1S`8E&`
MH=X07N?7PE>I4CT0*!:3-<?I3_R]<TY%4]DW7_`@\I?LC>TXC&,B%?T.$V)!
M$/L:Y!8](2>P`(1CRB&%Q-7=V,L4T!S_R!S?N4>K8#<FKYC^>B-,'H&*1X:[
M].8+O!-H>?BB%[(9L##CEO@[0K8/?8YTQ68VV`O`KJ&72@%FAX'ZP3:YDSR;
M5L`U:(I,1=P)-^%I$B8@6>PY#S?(DLS0R1`VY5RB#;/@/G$4_>GB][9+KP5\
MCL++@CT!@%'P^&)Z9#M&RX\:R8^NEA^;,?0IY=:,28"\MU+%"Z3%6+#F"^5C
M1`OP,E!H"*KZ1=X%O,9#^!(0!H8`"J`%7R;C!`">3R/#OR(0@IA@$H5@&&A^
MUOR\$S_WM`>P!V?/\@8_L2DRXB)?88"SU1H#`<-RCLBW@ILS!G:$#Z/$!KX+
M:V$3M.^I[H!F8LW$.S%Q7ROEG5DW-JV#E&O]V]>9@DWWF<"6)NY=86Y2TJ#2
MQR*\$<)E'>!TQ=CQ`%$8A&!TP].:MS5O[\3;`\W;6RXCB@5:OVX8$*NEKK-7
ME&8)O"LMY.3G@&V(WMT_F_[\4Q2<3SE?O'H+TU]S#.=]<,$=CW"^X,*U_B$L
MP.;T`B-]Y-2_M0/3\3#>]PVP^@9Q_NO3)S_?QSC,A*7!AZ]B\LNS2_GWG_U/
M[_[\L],\_RURS]O-5N?9KY6A$/KU1LAIQIYCK2&:W[U0L!Z3##5LMUJO68K&
M;>VJ*H&)>SN<J=H2XS'C01T1`F^?*QWSBHT*--]6";OYT>0O]BT3-2QR$DSA
MAQQDT(UL0ASDPHSX@AT$$3R,;(G/@4-Q;0>VYRIS!3Z'P@0'!$A;^`&;`"IB
M@8:O<M<4R7F!&C<A\L'K('_`20/:^,98.-X-"R*P:F+0,J]E3Q[$#S"2\`Q4
MO:D.+^B+!%;3BQP,+0:1$Z+(G7N6/;%-&=10T!7-DQ\\<_H*6LNWR>:0(1$9
MCN4N#+Z(0HRE4!R$VWYZELL3]FXW7T_L'\(Z!\?KG/Y*?@'&]Q8$%NW6A+8J
M`D+UV?N+JS?LXNJ2??,6MLE^]QILV,K+C&ZS05N>;.<4_Y$F(FRABSB#H6_L
M<$8`QENT:8>N:&N2.P*(7Q#";7P6=R[_LZ&&<:^!L&S$#TJV@)V!3KRVO2AP
MEC%)X4"F?%!8+Y-#)^`@4UK&H/+@_Y.EQ"0('^QSRW8B6DH!06(TBEQ:#CMN
M17+)*MZ\LJ%8=2]+8\ECUS@U#:B(.4>G9S!X(,S(ES%N,[-<VX6]1W=:3B1#
M8/`Y^_Y+I!>%!1QJ+.!7.4[H<S.,N*/0A*^_1+;@"F#P"*3QSLYRY/31NX%?
MON`S&5)ZF5"G(P)"T"Y88,H-0?DFR8G/O0B^1QH&L4#/<@OE,.V3G1,KN$.F
MZ?D6T55":9E]RO,;;+,OU(8#"5AB0:%$"C]2#"*:CV5$(O%Z5K,B$D1:.)"E
MOGD9KR.#FX3*0/S3#GOL9F:;LUO/[8"RW!HR&*N#)MO5;#D!_9V:J\3'5F*5
M)9MOIU8NLR(_/A$+[!^JZ2@#B@:R!/-5L$[30/'984!K`F7\Q'-`U06OZH#`
M8Y)-61W^7)!YT%^?@:K&/)=?OV+MQ8^',*S9;13O$"W?D/?[2.O8NHSMD(]!
M*X'E'0,^!DOC.X+/`L^Q+<43*K-6MC=^?:L/\C$6^8=KAP4^7B6WJ2[DMGT=
M,>@%-X)W)+BZ-=E^C^[.O]#=N8?SNLJ1Q,KE\KUTQ:,O8O?-*('$KS:D!9=5
M]/:?%*A%FN,!S(TZHOCPRA[KQ'&E4T3><`?#,`9[*TQ!<91.B_S/]G$T=$E%
M;:DAS9\8K]$*U3XT[AFM;M_H=(95I;J=!65^,\L-ZRYHK;3T*[@WO`NYU8,A
MGS[97.C+Z`VZQJA75Y8\M$ZV]LZT(M;[KT$M*ZB:6+7W>/Q,1M/A09!FRH0>
M6W!;9I/PA1URIZK60W5(5[N1F<O"1JO=-H;MUO'(KM(,>]>*K:4A\OJHDM-B
MR-ZH:;1;`\V.A[.C=EA+HD@K"JEV`32H50%5TZIV5^\??Y>SY$9=<N^BJ@9Q
M=6A5F\,)4LZK2FTG>[Q9$E!/@#?.VGUCT.]J3U%[BJ7GV_I!6H73HJ=/RH/7
M"A%K'4&M`KE6!JW:6]R<&IN[EEE5"[XZU*IMX@0I;:/9[AB]8YZ?E$1(ULUO
MK+3D.^FTV"T,.>H-C-&@K@RY7\./*M'V)CU3A_5]RU452FJIW*Y*$<@"$R9W
MS,BA\G.R5CM7M8^PL)SM>G,;"[;'W6/P-^&D15MD;0IZ+0BB.=4E"K#82;Z4
M!195N77!Z`YU4$JZ`?2KKF91,AE6(7&[I4A`O2[_9P5`3=5GM4`]'=*+M5%-
MR>X^"DN4NW1&74J`Z*HP14[5T6Z;EYX8ZK(.3=0%1'VD6'&YB4$7.2H'J(]>
M.J;V&*X0J"=%#$^?Z-/2QVA8LZ$O-08.5_J_,FSW74]W3)\4;=O"$S@I:C5.
MX-2V9J!J5JPI*_9[-67%8V7Z5IH3+JCSA+!66C+4E`2TB-,B[G6ST1VR<_:\
MV1@>L?1%A>B\0J!JEJPE2[8:O2:R9+O1'9R<^7':L9"O=O"=37Q!S;Z$+X*0
M^13R:.N01^4W5TN\]49(JRF-D-KFQVI02W"OJ]I<TFHTCV@.5%JTOK@+7G3H
MHP"#_U8=!QUL"HV%3I:"^]NZ0U=8;.R0=[)+S[9TS]>_Q$J^]5W52_*G7MTW
MO4*@:OI,Z;/QZ(2I,P,>8^/?_<!.[,)BUY[#0]NQPR4[ZVA/N$2@GH+9W>Z]
M`.>TU=>EH>_!^*XDE5<(U%-@R)ZN]:7=X".;'`"_#?-9;&D+QV)G76UVE`C4
M$Y!R]:_XJ4'5K*%9HZXU5.C74RYQT<M06.@MJF\;X;V+=+-VW;8U@<W13NC!
M=$Q[LJP*AK"$SGS3=18[8&,>@'D)WW"74?QUX6.B:5(H9UMQFX/N3!8AO21Z
M*P=G(7641S:?)/>W-?=OYW[@Y>_G!0E<-SQ@EH!OYO"XQ<9+`-7E4WFK39;/
MPJI8WWRZ[+9D;VS'83PIP@4#H5^*1;A6K\-I>:'E11FY`0]JM+S86"98F#P"
MU8\,?NG-%]Q=,LO#%[V0S3CP.K?$WQ&*C]#G:(.RF0UV!(B'T$NE";/#0/U@
MF]Q)GDT/S0R:(G.(-N$F/$U""224/:<B?NMD4F;H9`A;U@<T$6J?K&_ZT[5E
M[@B^%O`Y"D$+]@0`QCI^OIAJ^T;+JY)R(T9X#Y=7.V]V@JO5W@35P-:G5%)D
MS!JJ%YH/G(.D&@O6?*'\GF@!G@\*+$&!=M7[><9#^!+P!48/"K\%7R;C!`">
MKTJ&@ADD!(F;212"$;2_+*EZ=&7?4,K//T7!^93SQ:NW25W7#RZ(Z`CW,KAP
MK7\("U8PO4!KDP3]6SLP'0]MSF^PDC>XSE^?/ODY'N>#"Z)??.,_"IX#K>#B
M\K^*R2_/+N7??[[_S[L__^RTSM\*\QP+>#W[M1HHWS6@];L'"GO`Y&8,VZW6
M:R9QQ`!)8EL24R95:W6A:U:5W_1U='S_ME%[\$"T7/`7>RLFPO<%]HLGU(:(
M6K`P)@Y(%9(6K@CQ6R8F$_A*>E)BOO!\[J-P@6]]X9KPTEB$-T)(H\7DOK^D
MHL1S+W+E6SP(!/R%%HQC\W%L_J!4FM@N=TVL<^P+&#G$-Q>1O_`"(5_`,>.A
M(I1_^%8*<O)P@UW!+MD3L+(`C6A+>:Y0\V?,PX2F!J_1G50HP('6``ER]5;U
M9'H(_F@Q[@OT,64IYN#5'>.OY>/0$XDO5ZJJ6]6!US4)<<Q#"VU6;=<K#;PF
M646R!R5L5FK7#T@@KUL&U]O;9M$VR^8N=/#H6[V-3DM<G;%BJ"P[?'JK=;FK
M(_K8Z5^_@ROM+83/R<%U/!"J>][%TLW:2K3]NA[%VAL&':/?'!G-3O\>PO_E
MIG+-D26B.\V1&SBR.1P9G=81K_Z4TT`Y[2O`NYHH5S/NBW-YQHCA<^$&=+:H
MS902@7H*<LKHC@9&KZ<-AS+!6EFTUH5'GC[)X670!3YI-VO*(\>(-6P-/Y^$
MEO\<SH2?.[S'9$/^`Y.+[&.%),H=^;][]Z]MYT`E6M)687B7-55.:.:/LSK@
M`75/LC&<YE7-JY7BU:XQZ(Y.D5./%\0H"9&7WO:L)*@[^3PE@;5":-6@:F(M
M.5KUL7S1/6(OY$Y1>K<.9I<(U'H&ZE8*[1F=SLCH=^K:A48SB6:2>SB9'G9Z
M1G=XI-C,H^_F<9RZ>@>T/XH@>)76]($E.-X-=_=M):GC7CKN50&J/SNVP5!O
MH;%GA5DM'+1P*"=UKYSZGQW;5-+BX>B!E9+P5>F-YDJ"JD.;&M3*@*J)M;(^
M?K<6^KC@HK&!56<>V(KOULF*A\4PRXO&CJ@!@1SK-L]A&"R[T_`0E?ZKPDM:
M*&BAH(6"%@JK%MJI5J^\M;Z:536\H()_MRKV&50V\(_&58--!'`W=[(U!&^7
M'C1R):5G/&!\L?"]'U3HV5FRY]T.`Z@=/)F"^2*72A.Z!54>V-G_J)*#[>;K
MWS]_#)*/K=<O&;_FMB/+L0)\5#L1_[KA/M5]E35:9>O>!L/J^&/ABHD=L@G@
M**VWF+P#L`21.6,XD2P&.Q:P65@KUO81*"ORXZK4."H3L&G6*K[:S0:+2VO_
MX=I8VOHJA(4'A"V'WP3,L>>VK!*)VQ8/>S.SY>1YL`*@F246L04D.C:,QJ?<
M=H,P7A^,2CB06Y+'O7HS<ND)P$G(OV/Q6BSN;UUS-^13:A*"%7%Q8BHJ>7N+
MDYJ2P<R+'"LWQ11P2BT&\G`TV/O(Q^LR$J`<YB.LX?U?>3()DQ.Z5Y9LTCP`
M>A"-_Z*2FI[$&KT5`,IH.4A0/M:_]&X`BF!F+Y@YX^X4D8U%?>4PGFE&?EP7
M/(8;J-(.J4"L[4;XO,=\CIU04/SB)#"JR1<PHP/[&3=-(?K(`'*;U`,[+:1)
M*T.<RJWU!<^NFRX.2;P$V)DE<DWAA["WV\H*ZQJM.TFS;U0-.KZKE:NSFJ5M
MW[NV`SHDSQ5,E01T0P3DBR!R0F;+8J@D"-\K+@F`$"*JB4],`-O:Z;Y@-\)/
M^14H:^&+<YQ,S7N&TNUE4EB:)%2Q,+F7<JD5WM>=UZA+INKZDPKX@^M/MKK%
M7DJU"E"^ORU=#G%<*D4%.W>3J-2JR@W\TR</P)K].G#F+1U_,GQ9=>`U_1;1
M[\G6.=YY58\.>,7ATZ5F]5;KK:X;?'JK]5;KK=YF9.R1#-5KU_!:\OM;YQ*R
MP52G^V(_^[-N=RXKO;NZ]/#:6TUM8]B%_UI'K%=8:=(YUKVEBK%_24`]`8X\
M[W0;3<V-Q<C1RKCZ>ZB5\?HKQD9KT#+:'<W^6AF7']03X$BMC.]+&1]Z9[>6
M48=UC3W@0Z`KHCT$J+OD%9R.N!OT^D9+]P4K%:R516LM.634:!ZQ25>EE9GV
MS<L$Z@GPXJ#3-P8CK:W*!&MET5I+#FFW&ITC]6HX+76E3\T+<7A)U^'P\MN$
MVSZ5!*5;2I;P[6OP9*]U*^U2@7H*(N^8K:1*NY7EAK6R:*TGAS0&VB;0+FSY
M03T!7L1F:D.MJTH$:V716DO^:#9:1S3E3D=7Z=/7`@Q>S+&T4%HRQ1+C$)\T
ML4*'=ES+!.H)B+I.=V1TAW5M&U]_#GGZI%2(K26/=!NM(UK+E59FVG4M$Z@G
MP(N]OM'LZ#AKF6"M+%IKR2"M1E_[KJ4]>]U:"J;2"$X/9G6;QKMRUZYUETJT
MI-/NQ):7ND:OV35:O8/*1E6?R#6W:FZM`K<.&J,C'4;76\$?R]W78D&+A<>G
M[LZ@8_1[C]5(M93T4.&%:%ZM,Z^VFHVA[HC^:$&0`P_P2\)/%8I<5@A4W456
M@UH94"M'K$^?5`.Q%:*!"H%:.7*M!EHUJ)I82X[6ASV/K$<[^2])'SQL2Y<6
M67[@*&8YNMW>4V1$=X[6G:-SM>H>-@A3-E[20J&(I$NR)LVGFD\UGVKEK86"
M%@I:*&CEK?FT2N2=BWC\1-W/,Y\W-DVOR+:FJ%B[OS__%`7G4\X7KSY0^.(;
M__'6#DS'"R)??`-(W^`Z?GWZY.?XN4MO/K?#.4`?7+C6)8P)6RM<TQ9!P9O,
MA`?@PU<Q^>79I?S[S_?_>??GGYW6^5MAGF,OWV>_KB#YKR@([<FRA'BF7V^$
MG&;L.=8:U/_NA8(-F=R!8;O5>LTRB&/<M5@.=5L8$'&C`%Y=^9IEYK=^'37?
M/Z([_6-2]+>90#PNN+MD,XXMVD/A"PN>"3WFV*9P`T'(]44@N&_.Z(,EKH7C
M+1#UC$]](>0FW-CAC(4SV[?8@OLA[`*+8!4^NYG9YHP:P<=SV0'SQH`R'L)D
M,-6<?Q?PTE(.9+OT\,3SYWCC/EI,?%QW\CL`>B,<!_^%Q8H@]%P%I;?D3KA,
MGFPPH!L41!A,="(,+:K1`0`3)I]Z_I)Q7[QZ)'HAZ9=1!02KFHCT`.YM\\5.
M7)0AA6?,!/P$"VX"0_SRK"D_*[6!G[.AZ>W*O)=11:&WJ(&"YHW,!FV7ZL5:
M.S9U=D)/>45P<=6+,1H7[(WM`2?Z?"&BT#8#X%]_D1/"60&2$QZ<??$]*S)#
M]C8K+8!)OP#?P9\?E72YB`6(E!\;)FZP,Q0)PG>6[#TWA7Q*@&A)OO[N>C<N
MR@68/!3`Z6]%`.AG'_DX>(F<WVXV.RAP`F&"6F7B!XF%:\$(S0$CR(.%,.V)
M;0*XH3WVK"5(,('M%MR_(BFR"%3N+&:<"5!"J'>8SRW;LP,/2$"`Y/ECX;DP
M/LP35PY!F9:(2R,G#^?<@M\2B3L1B33$%Y]WC&:SB?\U[D*B=S3([E6^J<'H
M9>*`5TQQ0$+8DO1)OY6+]K,T3?N5JJA4W23**`0-X^#^/Q\8@Q[M$AU?T6Z;
M,QNH/]Y'J=3P@AT^GPZ-7(%VG<]-)*YDDD"KI2('Z3Z3:*OD?GQ*Z.(0][)J
MZ>%[[O9JM^=;.V^2NJK*WG]1XN9D=GXE?V+G53TZX!6'3W=)?\@<G^&PAG4;
MSEHOI<&<>/NN'=I@-P?H%<PX&+@?V"4\;YO<8=]\&_X?K*/$_+780KH.]W%@
M5,;<L!.JX:';N*[OHD:^PG%."AZ=Q`^]B51/P=C>+ABU9*P(A6MA57]A=>)V
M7&<'<:7E546(_*3D%=9W*J?$>OI$&UC'DUC=EW@FY'A3$DC)$=-B`0))UK>;
MV!2LIP.</QI7#?;^[8663B4"]22DD[:G3E$Z]5ZR][8?A,STYG/AFV@N!=PY
M5JG-1Z>#"I'LB<F?LEI'VC8ZGO3IOV1\$@J9F3`A.?2\U8PS2S`YQA4AR2/=
MU:9,H&J!5"^!I#.Q=D;P'Y0^O"%O+IAQQ\%<+$RCVI2SB)7-&;7L\I?GX^6Y
M^I.->6!C."O.'/8FK-5^@?\DPI`B6C#+:DP+LYM#VR%X'(Z"U9N\8GCXV6HW
M>FPIN!_<DK@KEI_!/)\EQP+XV(*R(P,F?BQL7VS+]WO0#:XQH5W0+K\5IIB/
M8;\Z+8/A18J5)$V@"!NV1NYD/O,\PFQ/7V#"GSNEM]+?LV,LN&UMSG'EMY,,
M*0<TSBV$>7Z+G"5K=R6,#99NS+=908IBDHVXYNC]A@<`N8GY5!:CO]>D^@-)
M(@/<@29/(BFQ[KGR8YTKOR4O\^J?EY>YK/@/+GLOQG[$0<.TF\T5.;*2)Y]<
ML\DGPLM1PQD/@2/_CD`9H)["='<7`YQ+QDU3!`'EBJ-\4.(ARJ6=&\#$\#\W
M`CZ?<YA0N-C;8_4EY/3TP40`3"(7F2#[),H2D!&.APG,05XUXZT>FVKWF%N%
M1&G,HY(+%YWQK#.>=<;S2>R\SGC6&<]E1^4!)SMUBZ>"GZ_.DC$^X#Y]PGZ'
M-][ZT31WWGP6VX7MYNO?WUXDGUJO7Z+O[XMIY/"0KB$O%KX'6+I'@??H]*)9
M3Q]J'),)T1W!H(M..*O?WNJK`SH;5V>/Y"X/4'`'8RZ^,(6]H,!P@07!)C`0
M/1=GN+%84-:49BH)JJZWKLVCX\H,;165&-03,%1.*M%5YW4<*:]#GH3=(8/C
M\`2.IDK?2`PIG;U18G+*%2'[L1"F+.0UL1V9?/&[,H"+3&6J"=;JZ:2&3<JI
M?DD-IDYJV(R@S_P[^VI;4^`>"F3C=2H^]GS)/F>?O_[^\64NY^'BRP<J(9HI
M9`8\N(A\D]*.J#H>?(VU]N8H;%&(P@-CP2*4R9(_UV0>A3/?BZ:S-$%+)C[A
ME/;:&9^W.QVCA1E3DX-F-U2U/W@`D(8W7!<4V><A"9=X=B9<:S47*U/NU(Q\
M>#]TEH#YJ8?7:.-$,5A+)]6#!]/E?F68*T:=.Z-&B]I'WRM+B]HMR:<@3ZZO
M/(<RM@*T3J]M2]`??X$M`\"Y?"HSK`+A7X,5&R0YG4$86<NXMJ1%AX_F>;O=
M._]']*DUZK&S"Q!Z<SY6DKH[;+\^OW@IA9XJLQP+*3-."PU1.@9&DB]*15O5
M=?]5"4?5+Q-(0<Z)`.=3LMCTZ)*),>R-C$ZGHRI))\ELF"?]@EE8LC63Z1HF
MPZ9CQ1/@@*L@Y-Y/JW&V.R/*6,/T5LJZE=5?!P3$:N+L9Y==1%,@&];/9OYF
M4O)@%`Y_64K)R#V2Z7#`Z4I#QMNS%4NN=Y-9'2<DC48#8]#)@;5"&6,;!$UN
MS\CQ2(B"^Q@91M\*!X5E9A^5*;Z!"A\[-+'*Z,45K=6]B/*@KNE\3Y]H:7^_
MPDQH:;_%L,;\?5>P5J_HCL&ZW&!@RF`!,L##'U->S:<,O\<?_Q&%>`DA``OU
M$G-]??8U?OR21F=G[_]Q^?7R92-7O/L&9`L;1[:C[C(L?'%M>Y%LK>"Y4P^%
MZBT50=.^N1RRLR2X$M?,?DEO@B!QPX@[8/<JH8)1G-PPJNXWZ"G7CN8,E%=6
M!!*LTK%(+&@38'8$"K`B%17KD)595N4A)4-;%"@(0NZ'N.(%]U65")3K;&%?
MD^"6`SB"4S8T%6RF0[4XB+#.[$>HQP(D]-0'K)"\O5UN'&%"#":UQJ62E`)Z
MS@/<,90Q;,S=[S$2X:?QDA%N5B<GG0OCQN@F=:KP#*,`).#345SK>:O3:.-]
M$0>7#*^`SFSTXB\,&`&T@TP`=S/#6+*D.MT4(55.L.#O@),L-&F4#]8P#^)]
MV43'>68@@#$)78Y.E.#PL228YRV5DKZ`23!:E]A$,E87WGCQ'2P8X'E;/8TW
M;@3=RLJ"&B>;RD+LH7?#?2M)?Y?QP;%B$<`PP&Y+"X>>6^TZP;P;:25(B)69
M-85M=PFBG(9?<]NGE>Q+/*L5B71,8M$L"2;EQ6GM:`CF=@(?7PE>9HU&HV`-
MM\.H19#4U3#09L$])VIILV"K6?")9&%[L(-=L*K;5JX.B;E'WU\Y'JBJ?XH0
M(UX@R91!(.V`=5J+V!R/7IYW6D9KV$MR1_!TPY;A./!89*PO5L2W%>X=.V#8
M&76"#A;,SZ5B/H\6R7VEP<CH@Y):@9S/\2R(Y%+Z4.KXQ3<F6TUU8_+XX;0J
M)0GH6%IUQ.A4B]$=Q.B2C8C36T;J5JP(T!#LX``/!$`X9.)K*X+T-S['*Y:7
M?&&C'_"_OA<M#/;QXV6V%5'2<^@"/O/`Y@7/OS3H\-H-(H?B_F"FS1F?X`6"
MM)_0)Q#)5V"LBF#&KD0XPW?>@D`T0P^/IF%8,XR"=-O_A:X5V-`&^^!FS[/`
M&K^V_5!*0^QTMO`"6QY98-3-R@R9H`><)W_.3;J)#IY=9C0)%H##Z)C]$R(+
ME_`%1+-+9^;Q,4AN<8$WI_EO9AYX97-Y;&/3)@2A#%7-A$.N`RS#IFYQ@$?I
M3'B`&5!4TG07H&.\I1")`_'%`4!IDRZF^1,3]CO:T2NH&K9;@]>Q]Y@.#0B(
M,1&`,K/0W_-M.@=RR`D,9O8"GXJW21KC@`<YN'I:>7#8IU'=!<&/5S-<X+L?
MY@S=K2R$7R(_B#A%*HO48886"8TWU)1O"M_EXHX9;"?1/ZR`$6]G[#_&T.'C
M\SF/]3!GTI]?1&/PVW/,@,H^'B8+][<"X"@+]1I]?C8'5IT!,\2*&NR7'@9?
MJ?,?$`YZ@+9+:D(YB['B#V>``/E^MER&F$R$/*^S8"4Q7M>"+:.6Z)@J0I&L
M:\C&?^3&)616R'?$;S=`G0!M$.%/W$>O/<B=*:(/!;.!OV9^9V"NR%/$5O-%
MXG]%CK,\MVPGPN%-)0CD\^J1I+540M!W6ZN,V]!$+)XH0'J+3P6HMZ%C1I*,
M%09PE\"N4XNCH$X4@GTE75SU?J:Q8DA\BQZZCSL<);[\.\6.[(H6]5D>A@)/
MNEER*9*<S/)0@GMXH3WDMIN16,(5P)94/AAD@"]93Z(AV0=YW7Q)FY2^JA9$
M`8_,]A,OD="A.^G20@P4/5H>08';!ZJ-"1N#`C'(*HB@IF4SS[%P$$1MTD0R
M]ND+X29C:)5UDE7@<7%N[5PR-0U[@\$)-;:<&'@.5LR1-O#+41-(!)-<T)&'
M_8%E`._'EC-Q)K#7U+[&3>WW\.%84*E'`3=!!#B@,?U5,&,ZN.:V$S-K,AFA
M%8CKWPHU*.)`5]#9`9C\=`"/A(4@(W['`J\F6XA1*G1R@X,0(4^$[Q-1Q>E7
M@ON.K90)4.!U(A"2!*Q8P&8YY$LT-CWV+66-US@7[E1@_[@M4L!:<%'!?!53
M&P"6W'$5PH!Q]0)+F`Y'R!*.;/S/2G`MK^50)2(&!!A+-N)+YA3`)L['(.B%
ME:;L!]%X#L2J)##L.<:M+,^,</(TZNCYP)!8-P(QZ0HL\8"?@%G/O<GY`EA.
M))58)#/!E.*'B:WDGO>2@!@M7CLZVM&IJ*,STX[.#L=(&-08'1PN*CQ&*(P&
M=?K],D6#8.V#[JCQ]$D&]K>1'\?L5U>=GM-/T$K@BX4CQ6P<V+;=:P]TI"6/
MU;F\Q8W*?'V\"=<M=9UPT_?'48CE>?PH/1O)6WVW*HUI4:U%=45%M:U%]591
MK9*+VL.#A37*GS]<M-T#6]YV^"9^@%#YU'C;8!?HI65._HL#_:O)571B#`.!
M<8O7(M:(3Q#)S[O#EM%N=HW8KY>>)8:%7,\]!Y&-1Z;$=[8+PX=1*F^EP.YB
M5&`5GA5(8*(Q1],9#6=?R$39=C?6-T&2#8R)L[=..??4,-3=F>>;;G>,4;>?
MG:#26D"?IM9'Y/ZE1>Y6D7LE%J&Z+-`_6.K^YLW<@/W#6WP'P9:1OZNB3.4@
M_?3AP^TD)Y4\(H5L''M<E_;T[;8`OCU"&I1;^%[H83$=%*;`A78P*Q`Z8.HN
M,N%G[K(/[C5*WVE\Q2,I8?3NAYC+R-[9A]_?PD8,FX.72<0^,^H.?L,0A'Z+
MHA)*A*/^\'9P&;[=V2-HMXUA=Y"M>KF0!QMI9+IM--N]I.(EIO32-@,&,=9"
MD9VD.&;3T*[`8[.R=@6JHY>^'U,O;;JBNH*[G2^SE@^%H+E^]ZZ5XBHL0WXG
MQ17><A>^"-<-ELXU=VVNU==.8:_!X&#U%:]^EZA6/ZW)G(:LN#6'T>6QQ345
M<`YN*Z>*N0_W;U2V!P^DB@K^8JF?OPO?8C9"CE_I](>R$QBJ&('7@M!P>F]/
MD-.NA1L)@W6V+JP0=-_*T09[[WB>;Q##_,?SO\-?_T&5V!K<,G`2^-01/K9_
M_8V[5-M<F2P=8&4'STXYR*[XE/&;>IR.2Y-;;4E*@@/T[7B^Q?K-["DE_!H/
MKL9>#Q"/0@]S&DRZ7D"W<P-9)H).O\Y#[YS^B$M$Y"^?87ZX_#D]&0U3F-<)
M!LHHS+Z="7I8@C)MUK/ASS]%P?F4\\4K&&YNAY1J?>%:E_`LF!#"-6T1O+4#
M/.R,?/$-2/L-$OZO3Y_\O-^;=-X,'[Z*R2_/+N7??_8_O?OSST[S_+?(/4<4
M/_NU&O8A_7HCY#1CS['6$#L0H6#]W.WT#-:($')XV]VPK)@;?"?;N<)&T^J8
M#F4\GRM+_14;%2BFK8;JYD?S>1/9&S\Y.9^]P+7VBF4BTH+8:+-!,"[`+L!T
M)6DFR8CK2@33`U-I&B=Z40@SN;^ALD@P2Q$E6[28^(B@Y/=,JD^^D\WJ39`&
MRG05TU7I+VITRC,*Q93JJ?CBE6:CW(>R>9TY7THY69T7-?`Z^7UXG478&3;7
MH*=J]%LX)OX-S^%]>7-=98(-C:KR]N2_Q:I]^T46V6)OLX(.KVE2B2R6].;.
M^ZL;6V.E.=?OP3Z63PGL4W,K%1LF#S&1[JV\J_B1CX.7J@!`AVY\"A.LI,+[
MF."1+81I@QV>7LDD/PLLJ;^B:9HVRIW%C#,!9@6=4%&)&3L`1W:!!0"V'D;=
M"'G9,+WDBPY@[@`J[LVI(X+W:M7@NK1)L\FD^;>BU-2NN'5+-<B4VAC$91Z3
M*[C8!P_X/EO28^(YCG>#SZ=#HSS(5&]*)@FT+5&%<'9.:&QM3U2WXKKWTYQ*
M`538DJAT]4X!^#UW6S>GJO;.']*<JM)<?@^NQ3;\/#9+;X)/=^AYC.98V:+T
ME><@+*A,#E1:><?&^I<4A5_3DYCN*-YK]?HU&&Z]>'RZV9$86C6@A<-Z^JQ!
MS*@.0:Q[*)1?8A+?NSM'K05C>[M@U)*Q(A2NA57]A=6)VW&='<25EE<5(?*3
MDE<MO'9TBA+KI,VK[DL\(72\*8FCY,`QTYQ9-7"FX[RX5:*6324"]21DD[:F
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MGIPVW4.$1\RC5CZHNP%>ATL&^GI!'9+,]?4"?;U@BQPH&^`5AT^G]Y_406:E
M%>)1SD%:+^,D$`QDN6D%L6R:R-G_J$HR[>;KW]]>))]:KU\R:A@UQ5X[5`8C
M;L>:(Z6D9/Y=\^!.\:"ETC2J[S?HE.%*'C)7FNN.HAG:+]/>3=3H;D$!VB)A
MGS2IBG,(TR8I.;+1XK_D;'Q2$OFD$@]W#O-5+?2L#PE+=-0N@^AW.%0__#2]
MJ<[2$QVTYU%ZP;JQIM>/A3"IVC)X2;(%Y>]*O14I0JJPU>KO<E99?W8K82R]
M[B>5ICZI/-))Y6?^G7VUK2GP?UQL_2,?>[X4`&>?O_[^,7\^F:N^^V_LCG$M
MLK6^LEV5J70>EQV0L1$4'8G*3JH12D$I;M843XV[024Y'+)H]+_7SO:<=3H#
MZDZ-YOP!4QNJ#J`L/8UW'67)>1[&3;=I>B9<J[B+U%T(4Q]::ME:DNUAEA:S
MQRJX"A+D^LIS*)LB6+&C"G!.S[/DA;C*/OWQ%UIN`".?RG0)[.0.=F7<)1Z9
M)K*6<7E&BX+>YGF[W3O_1_2I->JQ,^SN,>?C\XN74AB">8?Y</D^%X&1%/&A
M\J[J(GAQT\$8+#O(=/T#<4N-_YZWC&%O9'0ZG=5:_9@S^H)96-PUDRL7%O0R
MC"?``5=!R+V?5J]L=T:4:W+#`YFW)^O$#@@(2KU;VX$`7Z$64DK%2.S+K)6T
M=4>">"]I$)%T)/MLAAXIK;;\AB;]!-Y$JU_<_N`6'EWO)K-^T#W/6=MH#3K&
MJ)=KR:*5C58VE=F>8H=4:YC#-<Q[3`7\1Q1BXG*F4^S7V,:-4PZI*?@.*8?4
MA]P5K-7+9$ZO2SD$V18L0$]Y^&-J5A>V(P<#7C9-BFQ'Y5LO?'%M>Y'LX.&Y
M4P_E]RUM1(.\N1RRLR2,$A?R?DEO@@7OAA$UC5'6_.TV6AN[6Q&$L@%4Y&,?
M'Q@I;055I`UC=;7:K`N;CV-CA1!T"-4EQV90N,X%]U6)`M0E;&%?D]R7KSF"
M4Z*D;(*%YPUQ!"8+9>QT43_"J0\X`."**IXC8(BOI-RYU+X.*90Y#Y`>4#ZQ
M,7>_QRB3_;D*6\>3,H=Q8^22GDY[@`$DX$92O.HYZ+<V)L([N%1X!91QHQ=_
M86!#':%R0MW,,):LZLXS+2%55R_`1:XC<!*XP\X^0;P+FVB0Z)?@Q'14.2AM
MM\/'DBJ>MU1R*K8$P^!;8E#)T!NV!E+W6V"`YVWU--X!$'3C)0MAG.DE:\&'
MW@WWK2015H;[QFGK-`#9EA83/;?:JH-Y-](0D1"K%B!3V&V7(,I.?+'F_D$K
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M3QJ8.\E5Y4^WA_M*UCT`*S[I2(\V**P$`ZD&\G&`9`4.L%B?=X<MH]WL&JII
M*O4MM>@@R?7<\VS'9MN%X<-('=0DXK:+H8)5>%8@@8G&'(.+&)KR!2>`VMU8
M2P1)8L+J*<XN>N%&K"@&:L+&\^T!.\:HV]=*8;]N[0?]M8IGK<].2I_9]Z'/
M-B3C%J/NMK*K43[OSAKO-V_F!NP?WN([R.Z,BME)K5V)1:B2Q/K[:K9U`*RJ
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M6'!;&Q]1!5?9B-:7_XZN?#)I[YD\DU@B9<]*5T03YH7E1!*>(WB3B6UB`A*'
M_^<A0T/YO3U!87(MW$@8K.-;[+WC>;Y!G/T?S_\.?_T'C:/68'TF,N8WV2Y%
MIS![6-4Q[318DI\GO_AV*,#=_@K`K2Y@H0A?:U;1Z1?*_C7+H:3IU?*LG<(1
M_HAOZ].51IX-KN%PQDKU0!Z%0'(ABC-G*:_P!/+JYAQ(9'8>>N?T1WQM,Y^1
MCDE>\F?7"Q%#.),"&B9>=XI/)]^<8=*5?#L3B[3$P@,]I0N]:H%U3P(K5PYT
M6)0:MR("KM*\4Z3W*P#;D=QRD;>L[)"ND<PQ>/_NL\%^P_I\WX"3Q++!OF0,
ME@VY)<0+G_R&>@_L@W8O+GTL<VT4R-)B8(%`ZRF?K*C>`/Y4N8%C57L9+V.G
M0WO9T$\B&K.,R9W`NP411YL(ETE%3,>>&U%ZXO-^6IQT!E.K^QTRI376$"H=
M&@&Y55WZ;O[,SS]%P?F4\\4K`'9NAY0F>>%:E_`L4)-P35L$;^W`=+P@\L4W
MH/(WR`._/GWR<_SF%5B8WV>>@^<N[T"(A<O?O5`4O$2W%N'#5S'YY=FE_/O/
M]_]Y]^>?G=8Y+.0<X7_V:V7B%_3KC9#3C`$!:S@6T<%&N4NK$D^[1SC*BX1[
M"^+<_Q+;@\<[`F+OD6%MX&WI-A6P:C,OLGQNXXG?\V[;&+3`:QJUT+6R@R#"
M>&+/&#0'1KLW8L&,^R))-U=O)[0U>`TR`QF2!!N^#6/V^T:WV59O&AA=B-1U
MKLYH:`P1$I0W\5VR.Y18J.B9W:D2Y=N(DD*!^%K%Q-<W6L.N,>H/D/8"X=`M
MQH$Q'+6,5K=U)]J[X3[>"PER]^-;(V,T``(?]G8>*S[JYFAQ3V16:[9H(JD?
M]EG]E/S0>OVR4!5>4.Z_RA^E"+W1&8R,#BSYABY]F,*^3B]]I/V("6MYQ4XZ
M_2/\G\-OI'C'_Y*?S_[XYTOV,;0:.7B+GF]DP98[`WMK*F=B*LT;2EDP>3"C
M.(;,>P5AT1KUXV0$T*_@3J"?!C^N#$`W)4`>*,_E>;\U-+HC>1$5*['@'2I?
MV/,Q&%@B8P1UC/YH5&#/*-%2N)KBO<>CDBF8:U-PO7#PT;!O=$:='0@!00>P
MB1[BP@B4YN";0+9LX2LGZ7FS,1A2K(G&5+8=ND[XZT#>G*&U!+<0G,),^1&I
MC`2@;%_><6(6@C[A\)E^ER@:#HW>8)0A-C"-XQA4@56Z<?]IN5X4!GC5%VO[
M``\:[)-Y"8:B#62>OO0Y\\H;WQ8N^_+QXZ5!!N2HV26!CI9T<D%8E;A?679N
M8@?VQHFGE58Z2$$>@A''WN#]K.=MNN<2WTFB.ULB,'WO!FGR44OS/)A</84U
M;M8=[6+=,<#[]4`=&<TQZ@^-06JSK%4+;9)CS3N*@DR<N^C1O&+831GT@7M:
M_>X.JJ"]HRIH%`INU*>MO>3VH&>,.LUM8KL'>KQ_%*G=:K>,YF@7]7TGJ9WN
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MW77[X/UV[UW=K752>OMIN>?=T0@C1.HHR<06-Q9J#S"0[&MY^NW8?&P[H.`P
MPE-`3IL5('ZQAQ+\"AO.?0L3\M.WO@!RX;>/'[\8N8!WD>K;/N=VKZ5SJ->B
M=,BJ-EH3NSI)Y;?./5CA$?=:^*&-TM;U0@Q&+AQ,13%-/Y)'14#7`=U3\$7\
MN$S\:!GM'KB?O3M["9SJXHH@<I+*7NLEGJ:&>Z&&B]LXOR)I]^X'R`.LT6(A
M!]IC6?F-3DA:J]?#27)W5==XM>E*97FP;%*Q]+4Z?%JA"!(%+0/#3+U^?V4`
M=<"X^GJ<=J7)X(!4OAV.Q+:0SY=$[5V0VLL<G>4V!DUN$!*N,$-9548EY@%?
MBR0PH4*WA=1UB"-LM-HC8]3.V@9[V@#%%;(W+*9]WXOI#<$_Z#;O8RGWYX`^
M?5(V:C^%*.!Q./I36BOTO0VF[B:.OLVM^522=-A,!=+5FS1\CAUE+_D",XK9
M_X*WO4"+\Y*=2='O+`UV`?]>!#:'2<V&D74YY>M9!XS,1S5JIAPG^C*@Y-#T
M22S7N+P95K97U;90%24IO6.PS^?T+3#DV+%-!QPTGZ/%#O#C=9^<45X@O%RJ
M#6>QYZ.^,>AV42ID4(%^UTH\*YE;B0JUD!T%W0A\M\&@NY]T4-=UI'0@!RV9
ME4K(\=6(7-MH]3I&M]MF9X$0RC9HR?)ZZKHM>DSH8CJXB,RLL"?H.:YS;]9*
MSDWH:!F#5M_HK!6.][QZP'9O8`QZW0-6OSW;9^><G?M+].E_PD2?YOEOD8N)
M/IU;B3XES26X4Y;/0&?Y5#)A9-=-5LZBS.D!*]75FUOIG.%XS,=(IB5M,/$<
MQ[M!8X#:]P31?(X9M:`)I'*1;1^"5YK.RGS?<V/;,@588;/LXV-U>U>Z<L&[
M+[A;N[H_7A?W!YSJP3S"`\?\/:),6&]R>[O72X#[!N(/UPZ#+7/>J4&AYG3-
MZ36<JBI"Y1AC_IM\`F%MD5,/)[2.,>;%M?#Y5#SFLM[%88PO&#S10ED+Y2I*
M2CV55C6U'W,?E5@C95F5,7=3ZGIC-H[Y5<RY[6(N9ITQAT<TV$TVXLYC+NT;
MYD">V;*?4/!RR^S:"*R:$<BRYP/2AMB_1-I:>[+@+&+]7%6PB;3Y]3#Z,LYY
MJ("H?_ID_U$_@*RWW<`V'W-I_\)\AY,1\+FJ<7<X.GITP+=A/1'"G3)H)8U*
MC4J-2HW*4@AY-IX"\CS_EV?_QS2%F$R>K5^*JO#;:[\H7%95DJ@*\?<Y"H.0
M4Q:L<;M:V7XF@&KHH-#6*L9:J?BJ$J#FT3K:D1@KU5VC;70Z3:/5Z1YB>U9P
M,\L-ZRYHK;00?'X?<JZ6#-ELC/J:%TL$:V716DOV&#9&+<T>)8)5JZJ3Y<7^
ML&<,F\V:LN-:]_5F9H?B1)U7ZB'J.%2U7+NJ)0+U!,3-67=DC'I'%#>5YLP]
MLP,T.SX>.Y8$ULJBM=RP5A:MFEKO%:U/GU0#VLHA5M.K/J9[H&,Z:NK6:<I>
M1MK0*A&H)^#WM(WVL(EM2&H::*DOCU1:`.JXISZBJPBLE45K+=ECV.CNF<94
MV7TL-ZQ:59TL+[:,?G-D-#N]FC+D'=O/5Y"V,]G`N@#=L0O073A.7&`NKH2*
M94:]-!;`L&;[6-!?<\\/8;7P^[7LNF7[6.)]@<6WKT4Z;-RR6+9*D:TL6.1B
M5XJI2P.8WAP[><AFT'%7#Q[FXP[4P^1YRV@.^\:P.]RS=7EENGH?2.V56>>C
M$KQJ4H$5@,.9+ZBV>C@+F'"QJFZ>_)`3"IK=Q;U5)-\DU$M-W;I&N]F4[8N>
M=YM&%QOKIASB+!M9``+[Q_U.CXTHNTW9&NYY&^=OKLY?<]HZ$1[ZC#WLE_$=
MBLZF4NGN:EUT;+&C>E]8-E!3B%VM7"NN8\ZQT]-;O\&^>H&@2J2?^'^Y*\+;
M7:/6M(;"1D:V*^N?SW+UT5<@P5G4X`1!]C,0+>R([&#$$T`+.B[&+U"_*2H>
MWJ-N(;0DF;R3,$N^K+?,KKAS+YD0&Y_!>VG_IH4OKFTO"IRE[#(HK#+TS]ZM
MW4A)+4/Z=8=JS$E;N,?'=PG%F3:`#ZS`'%?J/TKQY:=/RH%_77[YD:-6Y8)W
M7W!U_;^C2\A['%.77]:<KCF](E-51:@<8TQ=?OEAEG6ZY9<K#7RYX#V61JFO
M:-=3:=U8^S%UO>A*C*GK1=_#F+I>M*X7K0T_'4HHZ515$3!'T6\5JN^LJSN7
M2;SIZLYET"$:E1J5Y8#OZ9,=-[NM-UOSC;[87IZ+[;K^=)E!/84+2FUC,&@:
M_8Z^45LF6/65P9/ER&9C-*@]+VI0M;[:"RO=1G=8@(^:L8=6524B.:VJUA:@
M-EJMKC'H#VO*D+H$]88[3DRH%+V"/`KMLY9$==12[)RUC7:K9;1Z1Y0[E691
M78NZ3*">`$>V&OVZ5KC1H):`.TH":V716FY8*XM63:WZ@/"H#M;"]LOF7CU]
M<I*T>E+FW%G+:+8[QN"8):\KS:+:P2H3J"?`D=K!TJ!JDU6#6G=0-;'JXZL'
M3+_4?87*"NH)V'0CH]?I&?V1[BM4)EAK[[OJ=);UF9<#G7FI0=7JJA`KO4:G
MVZH]>VA552*2TZIJO>W8'[6,3K.NC;Y.JJ_0YBVL>&^(9,QXT,?JK[*YO4F^
M9X3J/93V8LCU7%BL-)Z($V'QP8OSY/C6`X3;+G><9#S;Q?83+G8_@<&HZ01G
M"]^^YJ%@@#I3=J,(9SQDIN,%\I7?N!MA`7@$LU&T2BP:'Y>&9S?"3R&R5'^(
M?B_M#T$=6%0'#!A]ZGM!`$!XIA`6K?5YQ^CV.T:_V\+N+L*^AF'&RRQ^[M!/
M8O?Z\^6@UNU<^?-/47`^Y7SQZ@JI8>8YEO"#=W]'=KC\W0O%6SO`O8M\\0W`
M?H.+^O7IDY_CE]*?/T\N,VVGO@H'>Y1<>D$87.$^O>&P?U_X$DDB2(9"`D)T
M?!637YY=RK__?/^?=W_^V6F=OQ7F.5XB?O9KM00'_;I#>PU$+PS(_B=NA])Z
MS6@3V&?9?>B+P]T#Q>DJ#O9K9U(-O)=08&<;ZLRPV8[E+;!U#P?QU^RHW<9M
M9A$@PV<W,]O$)D*`,]7NAD4+%,R#WL#H#7J%K7:RTESV\%D='%N]\;G4$R`D
MX><ACF"[IB]P!!2&;ERS/M83)+<+0!D-AD:KUVW$5,I!6(.HQ5X]4^$*GU2$
M:M6CM(*;*I4%%D!FXN^(.['"`?KX+D+URX9.04F+('S`0B6C'J;)&NP?WHVX
M%KX!NM$UQ8H&9*X'4T1CQS8!O-#G@`NI)2?<]F,8KK&R4CRLG,\7"\`&2BWZ
M\HT'J\4GWJJN24$&1C860<C@/WL.X!ELC$*/`8[P3=O%QE"R*1^_YK:#9J`1
M_UJP'MQ)A=P4L=<X`W4(Y,`.$6R8SR:@U*A(G^H)B#CBS%<C\@6HPQ\$$;S?
M?D&ZDTR',O4KTQ+H.!+H`[)[JR5)?9-<V"H/P&CJ&$#EQG#8+#;<O!"86CV-
M/..CK05$3P8C=@M34@Z'E_/;C@,\DTQ,4/1!NO2,-DY2'O+4+E-UZ9^;V-21
MZ(_4$;6G%/X\:4N'1B:J"M2BR@";3(1/9ZI9+9+5WO#&N_G"\99"W#;:V%FL
M%-K-U_+9J\]?DN]:KU]2![V$1UJ]%S$L(3'1FFZQBK=X`OD$/3)RKO#GK<LY
MG&V3Q9#L&!E=8-7!H*]>UQQ;CW66(<@!NJIO%-J[;?BAV6^NBV=0R""V/^&]
M`(U"H'"AV#4@\^B624HM7AN=3&B!+#",@R@89AS,+$ZB`Y\&SXT*(Q.79LVR
M[GDO:XTUV'NT,!/3$GLN]UJ@X%K$0R9WS(B<918%<73G#9;J/;\RP1W'%1(`
MYP@G/C#W+.$TV+^X;Z,)&<![TJ[?[4W4MDYD"7;6>HG[;WH1;'5L+78;[=$+
M=M9^2;UO303+L2?TDUQ58+"S3N;7:P^`MQT[I)Y^K5[_A>S0>]9]R?XK?"]]
M$KC"!NJU2B4FM-UY;"X>%'-QJP769+O"7-P9&/U>NXP\W&ET^X?P<+>C>5CS
M<):'A\4\W!\9HVYK5Q9&;HU-YK7,VVR,FL=GWFX7G,Q1'7FW,]*\JWDWR[LC
M/!(T^JU.EH4]5Z3,2(R:MG/G,M(IS]7(J50]Y]&]53ZF?)?.]Y#86NTA&+7-
MS3.`2SD1=IC.D/QL"5.&?ZST@!-I71/JR1!JO.5(8.UFJUFL<#H=H]/<V68L
MD<)I=XW1J+^?PGGZY+@JI]UH':1R!JUJJ1P=&:JHJ/C@LO=B[,?I(^U\=-87
M1/1`=>U!QQB">1=A!VPDT40*2#F1D2R^F#A`JC20&?D^*K1$&*P_&BPZGKQ]
M#)N7-@0)=YQXC'BZ7(`W!Q_),U]8D2GE&7BV[>&*K,HL'Z/<%#26YRFHG#$X
MG,G*@`]!*)-BNL9P,$)%S+.*GM1^(CO@&P6*9M]ZK+,,FEYR;F%@%VS(OM$>
M]#8J>'4V4AP3`BUDPK!`SY0^5JCUP4"8(B`30!7J_\%0,5<V:K0F,VT?TR!O
M&'R+4PZR`>%>:V0,!H/'=4A?%9L'K<9PC74PV,4ZZ#<;W>X+E>34:O=?PU?M
M1O>>W%25EU?:EFZ[YH+=20(=+1FQ/7@@*;LN5VKB.8YW0[F<J)F":#Y'98])
M"!G-R+@9`I&$-DR*YY2Q[Q"GPMYJ0T*4AFD0KTX"NSNOD3+,,QGU*#UBF"B=
M'N%IOMB)R#/@/V,825!*Y9=G3?E9=9?#SYDIZ]//K>SPZ;Y9>JOU5E<1OBV[
M6QUKJ+A`X-K^]7LW-"W#IE49/BT_]BY+4QW`*PZ?IE&]U7JKJPA?O<V9"XQ)
M3N^S/7L9]JS*\&GQH:V9>X3OZ1--I2>SV5K):9^]//#5FZB^BCFW7=N=:JK2
M5'5_]OATZHLI#VMED6LS[>'8H2#?1W+`ZUNL\GM\9[Z*ZRX[?#474SILH&GJ
MGC&!!;5\;H81=S1=:;JZ-TQ\`+*RW<`VZT15^YI4,;`JO>E<?OV*M1<_'B+9
MZ\"@4]F!7P/O&%/=_03<,>:X(M`L\!S;NFV859SA_L"+#/?(;*7?]DH#KVD6
MQWP7)]U_P:1[3;P5`5X3+X[Y#2]UG-FN3"O?LS]F-0F@TL!KZL4Q_X4WBTZ&
M9G4L5*=55!R5A\/W](G>[)/9;+W5%4%EV>'36[VWF9&VG_T_IBG$9/)L_5).
MI@'MZL7;YGY&:-VZEI4$U!-H)*8JOQSB^U1P*\L-:^W[^J4XT1W^UN&HU6AK
MKBP3K)5%:RW9H]?HZ6:T98)5*RVMM%Z?UY0EU[JR-S,[%/LYLEO/""K-+?\K
MB\H>R9TM]_G*[H2]ZW%;B9:T58K=94U:VE68N$^&2TL$ZL[<M[M6T2Q7'4K5
M+/?8.-<L=V(LMVT=3Y_4924E`O5PGBO)0JK-!<<[P:W(]FA0CQ9^+@FL%4*K
M!E43:V70JD'5Q%H9M&I0-;&6'*W'.($JC$U4Z9!I8RKEGND!=3MS+PFH)W#X
MK5,IRP=K9=%:2P[1.8TE@[6R:*TE>^B<QI+!6EFTUI(]3BZY\*!3%IU>J+,H
M='IAQ>3=2J>$I+WS<21?5<C\9/BU1*">>M93LS'J:ZZKQ4(TUU6&ZX:-X9$"
M1'4AUKJLHT2@ZF3#4JSC6"><%=D<#:K.,="@UAI43:P:U,J`JHE5@UH94#6Q
M5O8\JEN+\ZB-F8CM_4(:>P?@NJ7PY^[IF`H6PRPO&CNB5&LZ[)QJ=5'5CMJU
MC4ZG:;0ZW8<-W96-S$^&7RLOK5.<'*N4U]VU7:4XOME@#WT\5C8F*0VWK^0,
MU-$BU8R7'I"-CI0BJOE.:UFM94N%P/ZP9PR;>[8$J#:_YV(0/X4</*7,Y]SZ
M*\\=6_87UZ?F)>AHK:_87U$0VI-ELHH#UMD>/-!"T]V_<!SF+4+;<P-F!T$D
M@&Y=BWEI&(5Q7["QH+_FGA\"$/#[M?!9.!.VSWP1+(09VM>"70M`!3RW$+[M
M64&#?9L)%KF^,+VI2^^9WGPAW(#CA$S\P+\%X^'M2`U!@9='V8V`^9^WC-%H
M:'0[/?KA>:MK]-I#(S.YLVRPMY&/TP-<LOLA$X!8:\/@!CU["4!Q=\D03A]?
MD`A)X/,F['F[WS=:@[::?62,.KV5V==2S\\_1<'YE//%J[=V8#I>$/GB\^0R
M@XFOPN&AL"Z](`RN9H#O-SP0UA>^G`-9!-^`1-X@`?WZ],G/$]MY]6_N8]9U
M^@.@U45"^BHFOSR[E'__^?X_[_[\L],ZA]6?XZ*?_?HP1'Q?S$J_W@@YS=AS
MK#5D_;L7"@9T(HEZV&ZU7K,80P=R].K2UZPS+T!J+S,RTF.%X=;P&_S_C=H0
M%GIL$?GF#`B<`4\/NL9@T&4!$GV`C`8"8@ZL%X1(UL3Z4WG#`-_$>3YQET\%
M,@9[;_MS%!X<656U[%U@RU[BV&:CV4)))`<G602_)X#,.`@L#KB$,>#Q@9(8
MR-\HQI@]GPO+!K9$P?*>@Z"[QMZ44A@8K5['Z';;,%S`3.Z8$3$PBX(8'6\P
MO'A^9<X\!Q=&`N4<@<,'YIXEG`;[%_=M5*@!O`<OV^Z.;\*3IA-9@IVU7N*V
MF5X$V/`!`O@_=XK/36!36:LQ:K]`O'4:K<$+@YVU7\;K9XX]H;6TFG+A\&OG
M)4D\$Q=R[<&";,<.E_DA^]W&8$!C#IJ-01L&182==5^R_PK?2]\'NK>!/F,=
M,$\W;8*;!I)6@-0,TNT0?T?<H3T6+JRK^>(E[ATV+T4H$2]KM)/)%W8(KTJ*
M4<_&$ATHB;-)Y#C+<\MV(H1LS`,[P!_P.3&9*-5E(?;4VWSJ"P*V443TN)X$
M;-2-033^"T9!X*6X0BA!/\**F0M[1S.C/EGXWK4=D*J%9\<B2SD*(`6=A&,!
M^N`<N$$LY1I8O`:U9ON_4H^N+#I:P'>H9Q`]\!M^%P*X`3?Q<0.VP.4ND9/G
M,P]>]6^`=0QX$>%"!$L"BVGY2S1V;#,9/S<6K0F9/IP!)P:1.8,!0KMPT<"(
M8&VX7@AT`ML,>R&6GFO1'#'^<8*$F=7"$FR/E_1YE9J`.6`A2CYD%KX9]@:[
M@F4*?"HK%U:9?XV)0-0#"X7]GZP3#B`;B"K/QZC.BVT?:T6"2CK(`J3H7JU=
M`;+>VMA#[Y`*.06CO-P+/4C!9HF4.X$7DPU^/_$<Q[O!<6*B>O7HKDYYJ"?K
MLF;\=U3,,4SDO",\S1<[6:T9\)\Q4SC8J1+E[2_/FO*S\O7Q\X$G_,-A#0-6
M_UZ1?3=V.$,?!Y1J:..^@`Z!8<ZNA&!D_O?V['.O[\#K._!['K4/!T:S7]<J
M$8=>`3@)J00&I^VBN>B!WT@BZHI\D,_@5)#63N732,NG,H%Z`O()8RMM8]`_
M4G+`HV_FX;F1M9117QQN2L\8/&3X_\2+]&6(F806B"_N4I1LFQ]05>JH)*@Z
M=UI;,(\9;$C_NLRX6FB_;#M'T=9+Z>1$Q:V7;L?H=?9,UR_]5A['=KE[18HZ
MBJZU+EB?#C;PSZ=/CN>/E?MFORY8MNN:JBT^1\.^T1EVCB,^RTWBQ[+[2D+D
MI==ME015>UZ5M6[J<6OUFQ=RYX%-DG+D%^O+J:=R.;4#)LG(&'2/Y-65F\Q/
M.HW^`:=:BTJ5NG*/V*Q`XFU[3>(M=QF?3GTQ54EW+6/0`H^AVZQ:(F[+&/4&
MQJ#7+5TB+F*U,6ROR;H=;$NZA6?ZS4:_NT.";6$4Y"B9C2FV'SFSL4X\?5JK
MW4."W7]FXRX(+7>JZ,YKU%F-Y=F_`_*'^CI_J$R@GL`)7+O;-EK'J@'^Z%NI
MLP/VDD^7TB<@,:4%4HE`/0&!U#7Z@Z'1/5;5E4??S)-/:'SZ1*<TGJ1<*@FL
MI4>K-EJ.FQ>D;VF4"]03,&I:[9;1'!VI7.NC;^7)FS2'B2RJ5)1UN1+QI<54
MB4`]`3'5[0^,8?=(S4\??2N/85?5.QE[>Z1('AO_3Z8D%S=-/\H<7!Z'F,J=
MG*KSKT\C_[HU;!JM5F_G`[M:$KO.`[T[<G4>J,X#K7L>:,_H8Q[H:38I.:D\
MT!--<J**EVEFDATPSH)H#H!27E^<"XA5"*_MT(99)IZ_M6AQ*RY:W+Y#BE-%
M">=NZ\M(B<=(;UHOI,KFZ%8</@;V(^P)?-%^%"*L$2K+#I_>ZEIM]9;=O276
ML>RS\`]27$^?/&0\3)5]/L2B+>&V51D^+4'VCM14!_"*PZ=I5&^UWNHJPO<(
M!LT#FC,7LGF%MF9*`Y\6']J:*3M\FD9KM=7U5G':8]=$=>^8^"KFW';WSL\L
M[:Z5';YZ4]5%7*FE3E2EC;2'8P<%1K:1E^2`UP]BL_T>T3&V-ZD\8LL.7\WE
MH(Y*:)JZ9TQ@KVR?FV&T;]9E:?>M[/#5FZX^`%G9;F";=:*J?6VV<J>I5QWX
M%7B?/MGUFD7-6.X/UP[W[%-3S8VO-/![7@VJ&<V^BXNE?L%BJ9IX*P*\)EX<
M\QL6[#VS79FUOF?IC&H20*6!U]2+8_X+JQJ?#,WJ<*L^$Z\X*LL.G]YJO=5Z
MJ^L&G][JARSXT&O7L-S7YR@,0NZB56C<NM7;W,\$U:6\="FO_;!R?HC/4\%-
M+#>LNZ"UTL+O^7W(-\V(FA%+P(@E`57S1NTVL=RP:B5U2HSX],E)L.*A15^+
M7-6M9P"5YI+_E>T_C^2PEOO\1!=NW75-E9-W*[4)._VNT>L-CB/UJD+D)\.M
M)0)U9R[<7;M4BO6:C=Z16GM5A5@UUSTVSD^/Z_J-05]S72T6<E)<5Y*%5)L)
MCG=@6Y'MT:#JIHX:U%J#JHE5@UH94#6Q:E`K`ZHFUI(?1Q5&)ZITXK0Q<W+/
M8&'=#MY+`FH]S\(?\FRHM)MY%%B?/M%<4DLN.=XQ3FGWL=RP5A:MM62/XYVW
ME'8?RPUK9=%:2_;H&.U^"^RLNMI8QSEQT7F'^G17YQU66>X-C&ZS;S0'H^/(
MO:H0^<EP:XE`/?4,J%:CT]9<5XN%:*ZK#-=U3C[O\%3642)0==IA*=9QK+/.
MBFR.!E5G&VA0:PVJ)E8-:F5`K3*Q/GU2(6`UJ*=.KJ4#]6'/H[JU.(_:F)6X
M9RAQ[Q!<MQ0>W3T=4\%BF.5%8T>4:DV'G5.M+JK:<;M6VQ@,FD:_\\#1N[+1
M^<DP;.7%];&*>]U=R56*T9L--GK@*CAE8XV3XO&2@'KJ;-=M=(>:ZVJQ$*U9
M-8L7IH`;K5;7&/1/DL]S`8>?0@YN4>9S;OT5Y8H4%6OW]^>?)K;SZM_<Q\S6
MX!N`]@8!__7IDY^CX'S*^>+5%^$&MN=>N-;G<";\+UX0^B*T?3&'%;P1KIC8
M8?#6#DS'"R)?)&,P$^:##U_%Y)=GE_+O/]__Y]V??W9:YV^%>8XQBF>_KN#W
MKR@([<FRA"BF7V^$G&;L.=8:K/_NA8*UVDQB?]ANM5ZS=_.%XRV%8&\!6ZZP
M&'7[ML=1")AE7QSN;N%`Q)`">W7]:Q:;W_MUY'S_Z&X/'HBD"_YB'US6;C:[
M!@-*!1S/%]Q=,A$@<]O!#/#.72;BO;#$1/@^?&EF-P/F=!OL&[R/?S%?_!T!
MK0>XH_!<($QX[%JP.;PS"Y@W88'PKVU3P-`P/)O;KCV/YOA#K]ED,R_R<T]-
M/)\MN!_:IKW@.*&<"TF`+7SOVK9@+GQ(@>D#PD-S!N)3#OD"_\'5)<O(08]`
M`.),Y%#/Y?XR]W/02"@Q8";,F/PH6+1@H4<CS_D/6@)W'.\&Q2*+8&]]^NT#
M-E9TN<.^BFOA1H)=J75=>A9^,`F*;K-U]OVE7!F?>Q'00#J3Q<;+W/[@:O$S
M->]D`N:R;@<S:65XUYK=\(`]'QJCKOP._AP.>P9L5+#`Z:^%LVQLD'>'BK6L
M:+R*Q@'0![SP#K"1D9^G+?LZ.=F7(HE)+&E1=T^B[KT8^Q'R>'M(3-)9D7O(
MJ\!+M@N,S8$Y0>[P1$I<B3!TB-C9Q=07\J\;.YPQH'ODR3EPW^6[SP;[#6/'
MWT`:B&6#?0%Y%H&M$`L+'K^;G_O&=AR0<TOVR6^H=P$.UF9`"2`];!=DLN/@
M>X$:!L:9\C"1%R#EGK=[3:,)0E1*UH7P$2KN@K09>VY$8O5Y7SZ",F1F!ZF8
M!<RRBV@*>\Y:/25"`.1;<D4*J7@8.2Y*&-LUG<@B[$D`31/A"G!1)!,)*-/T
M(WC&L?G8=NS0AFWUW"PB$D88O`[8F#L$/6@B$3(>%D"S`V\\!#D7<E0J.]?*
MO?V%8_\3"L?F^6^1B\*Q4U?A.#Q8-I8>'_OZ(K?$/T%'RWW%<%W)$DJ[R'C,
M>%`'A*SPSX,%-\&">\5&!1Q6]%<.19L?337")^[RJ93C,Y!@`KSQB*.]%:14
M)HC*2'CA,\")2LRY7OS;C70&R8R4MD]C)T?R3L+A310`UH(`Q.38=DDK!5\\
MQS:7=S2="DA%<49UJ"4[YBYRA(>P*:C]8BSF9,H%&,&N#?;[EQD'=6D*,/U-
M[@0&F`PF.WM/FMU9YG:277(S!,WW+U@UC"V?;;QD9ZC*XL';S=<K6JW=>FWD
M?J91,K^^-&)EZOD+SR=J3)T)A]\$L3MS%:+RAP^_`]U:'-7H9S/T4#GV#=8:
MC0924R<&!@S+49."G0%`VR'Z%*!2[2#6V+"WWT'-HF4`;IGPIS`4V3?@]_`%
M^%H+WZ8YP;```@0'RY1C[Z*$JTQV6P5.?5?,=A6FQ_N+?793NT\9[NV-AGL(
MXCC@TK->9<@KX''!WOTP9]R=BCSG+3*F^LW,-F>Y2<APM_`W;E*(`_";1A?L
M((@H7&(Q+TTR0NL=.0VC(+XR=R>;!4Z#G67`C1_-`PH,*]0*DF```D#&,DQ`
MW/K#G@.W.DLV&FV#$OAX#K@*0B`]`Z,M&)B.P,IO-IHM]"-`;@#:C'@8A1(I
M8/(8)3F#:A"F\0HV#A`K7#G<#"2V\`/FBP5(4)1)&+.YQH>WXI4&R"-SQBTV
M@3\I;$4!GQ@D0(8)0K]11%U`7,KK:;=CGW`]=)WA'H"AE`2[9@6J0F@N4$;#
M^Y$3)G(^AUY)]\K9S,&9G7$L3#X7]"B%D3S'26#+/)_;RHM0/@];1]EQ@@/]
M)R-F7L6_08?XL+,8UVLV.IU.O.Q5;DNHXBM:+%DBQOF5#LU2GXSDW9XZ09MU
M&U*$1JVF"-Y$O8)+";J++"?:-F6W!<C2P/HP?B!RNY9"A42=0(".*$Z67QQ!
MCH(UG@(^QC,`C`$R)9AKZ`H;N1D+L%!(&VMX3?G9`!8I;DE`P$0P<LB_"^2G
MGV"O^,(.00O]5\8SQ&0B3!59Y"L8-I!%?0$R)L&%389O8%LD9:5W3R+0EY-*
M$)#$$*_`A""(;(XT`C8,?0^K78!,"*3(4-`H3@/^M$V8%M\5W'?A^2`5.G%\
M0QHI`5$TU8X@VRB=*T![2,9'8I$(8]B>A</C%S+\$N,FMF]@1<AP(8T&S_AB
MX@!JU+,K:`,8<*V^18*6;*.<H*%H42Y\'IM6<C9X4"R`LS%^>F,#%"YXN-8I
MFD^G8D@]JG\;\Z^1]R>`D'^+7`P[H\)K-@WD;\[&-A"C.7,]QYLN8].>Q)(=
M*N:P@'D<;X$,/?8%_Q[.?"^:$A/XP"GJ(,:Q)ZA[X(%0(#,C:@1(NH"A]S6E
M<"EW%C.NSG4<4*;S>>1Z<I@E.[OX\N';2SQ."E'321V+/P)'.K0$_":P82?`
M5$F`ME&\I&L.O:F@EY(8[0TH!+"'O!M7^?BV97-_:;!/PDK?DS;8IXL/8&B=
M24G()R%-KHZ_`!,FC!0?GJ#0W6*R4>P`O@UM`A_?YF/<#M2@((Q!2@823E@1
M"!(,]]JA/(+"Z1*1(N6:[X&^@_]A-(($RF0S0N/H11`M4"`3#0BT/D$$??CI
M@P.Z%(`#$Q1,9Y2EA/#TB5L_AX"QN4=_7SD>=\__262-FWN)HM%GEV22`QJO
M_GEY^5*YL.!'TF<8=QG8(+5=0/8UK,V>DGR%X7X'AGKK1U-V(;6E//"C4THT
M^A.-Y/#(->E\DLW!6++/33EA0N8L6*">H.TB0$EVX[G=?`DT;%O,$=%W,;<Y
MD-NGCT!M,!=JCT;&Y5G=2@I*>^._Y,ZC+2;I'PU$#NI<GB9*)I$A?EM:%[YG
M128J%`Q\.Z@`"4L3%$JD'ND!(E%T.V#C0>?0F:D'9HY+6Q+:8\]"'H/-^`[+
MDJYY?ML%\:I/QH?DF*SCON!+V"TK!@F/3AEHPR5;`.>CVX.TI^Q4R<]274O"
M7:62G,F9PQ#*#M#9,-&,`WV/!5C\!&V,8_R>K(7B#4$LVA29&`/"`)V6#%44
M3H:R(A45=(Q"L][8EEP^&5UXV"`/3BT;;!^?EKM<2$M=[0:9/<`C-J6VK$$^
M'@*/T0*']9V.XJ[W.A]72>_F\L51"&`*U[N!5]"YR<3@,E&Y6"JE*HTGK'L.
MB@3T"^CZ12[VD`R34?'`$R$'L:G8(T2%3@;V+MD"Z^/5!T2UUY]YU8'\[C6J
MG8]6;XDX352(FWT'VG+1GBD,;]\UNEU@"94L^IWRH9Q7Q\&U/GAD?5"6:+<,
M\%@/$N3^\J$Z\>T-L>UCA'2_?+C':"X,E@WDJA"N=4@,MSA>FD9QXREW#>#F
M0;QC[!9>?K"P;>'"RQ*X!43HF*V.V6I57VI5#VQZ4J%97.ZC167S-H8.R-Y3
M0!8TS3%CL9EMT\'76\'7%>0<+>ZZ,H\.N6J]6VF]>[R0*ZJX!XNVUH,4-,D_
M3%3I$RG)=C/.<D,E[*;7*E=""(PX(;8)70I`>-N".E*!!,SRYC"NHVX5J1`M
M729R^`T%6M;=^,G:?YLG,UCLUQ<">*F,#S17UN7]@69V6*M5=!4L.W9^-471
M9^6G)E_'ZR2$W`*3ABD.L&]%<<UYY"[7)G8\8>*!'7R>7"3A#OF(_/\];UB5
M[22(T2*1\+[(5%7)T.?L#Y='EHU&)5U#MN?L?1)[^>#2Y4!Z<NVYT3=UD8^8
M`H5!E(QHJQ&WAW:0"6+O$(,G6?-TX>,E2QET60W39$)4P*DP[,*!=Z?"!:V+
M'B/\#KY6&K#YPR7`B`NE?3P'"$V>BS7_T;AJL/^]N/B2\P;12HT7E*[!3E$D
M(UUK8DE^A(#)94XCAZM`XJ0`JJLT1H[/)P'!2_3E@Z`PAO_N,@<K3:LN;Z/`
MP/LI0'/G_X]&O%#.R!#G_YJ`PZ[._S],CD+@`:'.DL0=&"`>;DE\>3,;B<TL
M7D8(/2^4NZ=N^%,,,D$GH3#.="ZD`^G.[$-`D\A7:=UQI`_AY!:*-?G$&84Z
M@U#=^G<1<DI1CGQR@C//OE1N'JDA13EH@2D5.$_NA!G`KY@V#KHHE4OR4'#"
M;3\%,,:8M"C34&:\0!G2#)C*(\<(>,R.\2NH*W`?XAE!:,#K%OG;UV+=!),(
MT(!%``BUP7[(#69>Y%CH8('%220.[_P%'CWM?$+CVP=:L1^R10HVUBB01(5>
MKZ`0CHMF<,K5158"=]TH"55CT"SF@7_N-"W%]2>@T:UT?<!EL84TD@;!3ED.
M.VD7U$=8->9M&IRX0L=`+6T77;3V/M\A>B,##R.`DLW;J!`R?E'FA(%G8R],
M.CZQFQ.'N_"*ANM1X%+XZK1!5L7`""904B./YMV1=@\HWGJANE*5C/8U)<I*
M$Z=M\]Z-$6+I=)G(;!#ECR9EOJ2V&][YR<*TF::VJYS8;%FK)^(:%$ALX<P+
MQ(J6RCU=?!`ACRY`T09`5O8$5#(=;()Z32@Y-TN:C9&U<X5CS]%)B4\.;VF2
M37MUT)Y6QXO1A%)`*)OMCUVIYH]`?)Z\`X$X)R_D?GC_D>CD#[DYZ6K`4$S=
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MM8^;V>203;WDP>S"M?"?=R"UKKF#PN$X/M@C[22NC009_9%9Y6Z1@CA,$%`P
M=P;3@2YP;!C&2@UE4B`>..8VYH3,\<9+DF".:6QI65F?.7@#!G9]C!D^`)%(
M(6JPJ\B<Q>4$9;@U"B)2/S+7'-^%,=^__7")N5Z13T4*08D%E*Z\OKIJ+GNY
MR%D@6##?UP+9'JC@+"5SC;G[?2<C?Q=:NA_BJXP8.27BHXS0CCJWIT471;1+
M1X5??,R/"9=8J3F$-_$MBEX=)`4K'>K;.X(F,2F/#&,TKJ?T3QSK7V-N(=F9
MR0N<\N;Q"%#>AC"](%19DZ`;33M.0>8`H,\1K',$`DB$CI>Q,E-L9UI`PF(2
M.4"GUY(C)GA0116I&^P]'MC1[41YM^`'Y3@<=_X`;>L8@']CD:G8JJ=90SJQ
M!$X%\]TRE"VOID]2ETTSFD?R[P0D.O^D(>8>9D0F22"QG)!'PRA5XG&F:+:@
M4/"`L>T@/K54/">3QJBV^%?PL6Q?N@-SCK$BETZ6R36P[!1KY@RS0\F^R;R_
M0V"\!+5O=Y4#]R8[*J/$-%]KOKX37Q_&5!_F"!4^]-E_"_3H!=SY//GHN=./
M>`OP@M!:9N7<Z9=1.Z=H17)%=)X3/IE$Z"9V3L)8OKBVQ4T`E`5O._2VHG+*
M3$IGP.J)@AA&UA[&I!O*()*A-]L'2L=KKR9]00DD0H;`B#.X[U,:E[J?-^=+
M2CN1R1]X90ZS\#'%)<QTYI#9%F"M9@)5$R_RP3K^.^(^7O50EJ?,1?DPH:XA
MLIHR7<%+<X8DAZ;</HE(G$0N%D]6UR')5ITX'N`#D.`I^9%D:A!B)/>@H:NN
M_B2_K)B]:L'ROB_=DP)XYRA];`+3SNU>@):ZG`"SON/\'YFZ).]>4KP03[HS
MFQ)GT.#%(!G5DX%#=>\!Z^^+\`:C%80[S!Z2`.6GC--G\U#O(@[V8>VCB(;*
MZ%ZFV5:S;=79]JWPP1''%$&MM_?(?DN0MZ%PCN,`[:4/KIJZ6:*09)+K60(F
M<_*`%`J9(AE@"V?ZI8`]Y\:E9Z3MG)\5C&5I1?\=X07T^%&ZAR\M8U_DOTRR
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MCCQ:I5IH7LRIBAOIIHOLVT@`*8L6J8`NL"HSETI*9!(F5.X#&(&KPT=NAN4D
M5-(\*UP95KW`*;&A8O#JP`3@^VF*MS-C$8^4Z^#A(Z8.LQ8P!%%#AA?PBAB=
M9</6WP<%)#Y+FLFBRNW-%$O%A0&HCP8=?:DWYH+CT1<)W#OF?3]<V\/2;FZ[
M:'/55[(8!6R->VN/TYY],8W(?"DL+)GR:WRI1OH[F2T'D29L&MT"-]$,4;/Z
MY,'*3_'%I#EB)LG"S0-!AH8J&%-,5+=(T2@8(J7,7<:+:3I9+9H>7%46L;>@
M[6XH8F?*5Y3)P"@8L2@*+.+:P\MY$BA#9MPMY4V)A1`6?&6"EVS#XW;P'3Z)
M$#M,$7Y3H2[M(9\4DDJO(Z>?PMET)<_WO;$J+S1>YJR=\9)^%NJ*8%*V!#AQ
MM],ES7XQ^W6*9>LMG2?KH2C[-8G*9.S;-!NQ2+(F]Q]=)5;_;\!DQ=8TX9&/
MO2B,:3&?!EE@7"B[)@H0PL1V3BAY%8Q24D4)35FR;,A\(70B!6"O5:HJ&\[6
M)9PJ%5C@K/'L95:Z-`E+2[Z1!VG`S@X1(\;<[%M!J]2ZXH$L4K`NIZF!%5*R
MMWPOKB[9$"M'I!FOZU)F,;Z7YN-)*&R?J-47(`P3SS!C)TJH`23B$1:WI<O>
MHU"APLQR,N9"KM1O_EX'0!D$V4NZZ:"JE*CBA@C5A9I_TUQI%G+L'1KJF&^9
MS3).+7`\0DU'6H<V:3C#8T!*9MI:>-,N$M;ND@10J?N+=ZD*DUU?^HLL*:5@
MNK&M</:*BMEN@V<5_&?,!"]/E6GYY5E3?EYPRU*?,U/ZF;^M/-ZOU:>Q%X;>
M/-D'-<ZY_/H5:R]^/`16V6VTAE9]@%\#[Y@\[P3<L8.-N@%H1CG]N-,>;C2\
MV'Y62&*RLEU5F$B9]%LXJ%8;7VG@-=5F_%E-M14!7E-MQ@W45%L1X#75DIOJ
MA=PY&9K]*6>?[VZK/SK@%8=OE6D>VF&L$2K+#M_N6_WTB=[LBL.G^5IOM=[J
M>S4S*AVT3;.>LL'M;>D;E=I;S29:(NJMUENMM[J>\.FMWMO.8>,I(,_S?WGV
M?TQ3B,GDV?JET''L+\]Z[1?ULX(RVYLV`2TH(;.?641K2A#8*L9?J3BL$J#F
MT3K:D2S56]6@R_-#[/`*;F*Y8:TL6C5OU&`3RPWK+FBMM(GP_#YT?RT9L6/T
M!EUCU!MJABP1K)HA-4/6E"'7.K$W,SL4VH7=Y,+NF5E:-\E7$E!/0!@]HIG^
M](FV"S1W:.XHT2:6&];*HK66O-$UNIV1T6\=E*!=P<TL-ZR51:OFD0IN9L[5
M^XFNAV8^'^,:>UH0:J=23_=3&VI]']/CUH8ZKD=:-.8N93YU;2A=&ZK"9'^7
M:_`57F?="U15<4].B_9T_2Q=/^NQZF<=G6ONJ[3A86#<\H[NOZC3`P@*7>EK
MB\/TV-1\-.+J]HY)716H&+:Q$9TN&E;+HF$5D]%W,EJS@:M,1$O7#=-504ZZ
M*HBN&U8MX#759OQX3;45`5Y3;<:IU%1;$>`UU9*SJNN&[;"J1P?\X>![^D1?
MQSZ9S=9;76Y4EAT^O=5ZJ_56;S,S[E)/HVX7D'0E,<TX6D;JK:X;?'JK]5;K
MK=[=\M&7L&]=PLXE81QB$)7XID8E03V!&T+UOV&J0=6LH5GC%$"MM&V@ZQ6M
MPTS;&/4&QF@PT/Q8+5`U/VI^K""1ZR+8AU00.RA;[RA4\?3)"<OI$Y!'VD[7
MH&K6T*RA0=6LH:O@:E`UBV@6.4;UL&K[;.NV\(""9A]<TYN+;_R'_.D;+.L-
M+KJPAMG[_V`-L]8Y^(M8PZR=U#`[VMJ+QMRAOIA<%8-EB0UUQ#(WS;'^0I"I
M=)*]U+UD<Q'./$L6;#&]R*7Z1%2=1<X3XCP-]@>0`Y9+L0/UAH'%R82/-^_A
MD4WW[..*%'A'/[Y5;]D3>%FX6)LEKC667MI/"R7A>"D@S.2^OZ3OYPAJMJ)%
MT55UG#TI5Q`%<?$)X7(S5'!371?Y,K]1E2QN;,?!TFJ`$R&ORM_,A+SAGH4;
M1Q<_%D*.Y0'4U\(/1.Z6/WYIBYN@$%F(99ZY@L^Q%`-=^)=XBA;P)4Q-%5YL
MJC4P]WS,3_PNL%X;EKG!(CA)@:G;DR1KF4188L87("3^*RRLX58PK\'L"=`M
M5J#B/M:'"]C"]ZYMK#?$I]P&9BM:B)&%%PB>3ZDR0$*;*Q4.L.B5I\H(2(`(
MC/45`E(1L(ZC]^;ZM94+R\;U3+.]9GO-]NO9_JL(!!8<N7"MMWC!U5O@K.]@
MH]Q`;*A=6AF]S^(5JC(XR1J!Z()-)45S[UF9]TQZ+Z9G-Y"%1H'O(MSIQOH7
M?6'/QQ$0O2QFBC]/?2KXA(/YPL2KJ521)\SP!(R-%8*LR(P+SO@;(=N%,G;8
M]?L@$EW@-O.>IL-:%:.\DP]V1WY#E,,O).B_8M%"81&1U,HANYH!M9V_(5WX
M19:#W-%"$T`A<[)$5JIG`4T*#O08A(@=;R'U]0WWK;@R+-$YU81%\DZ-G#=8
M!N#\RIQY6,Q-O1E7WIM[EG"(R)-I0+'.X8D`UQ"L5#WC09C\3H"DMH/EN4+R
ME0TP86FR9>979&,_*6565/`L-ZR:CQ83ES]#>.0B;]5ESAB68#$B[[JAQ""R
M:UK64Z(++<F`9,'411N(>=="/G"-Z`>L`*PVF,)61&7J;F8V"0(FY@O'6PHA
M7U=%YL""4:81P^*+6(X;S<4?)AAE4Y&?F\K3T4+.)5[-##?$HFX%N&0#:(2`
M18ZD$##BLC8G@F[DA!K),T5(\=`(34QB5(E[(NPPRNTS&/:AYU,-UO1W:1TW
MV!>T8KTH(`LR`3&W"BFZL:@<&)M)U62RBF4Q2<*&&4:W)TB0)6ONY<E;P+8I
M4LAO4X.]^T$5DM$.'0M73&RT1,&`!2P8B=Q7L**H!UQ:EDW0XNYQVP*Y"B[%
MP@ZYLXN-L:,0NR^Y5QV75`L^+?BTX-."+R/XWG$?*P\'7X1/TJ%6AAZ+5\?.
M/GI!\)+!*I$.D:%IM;L)/\5'1(RV*7T.VXF0?D0\`>QY3D(!'$`U<TE[1-XH
M)14#*U&`KM(;&C(9YLPA.&^/1H)H$:D*XX!KVXH%J2O"./:F7N?7W':H1"G0
M45:`@:RUA!_$#I9$(5(?2!H.4L&-*//NEK3UHC`(8=TXI9(^^?X(,<F_W8Z7
MW5:R;0FI$W3(6A9.%,B]Q#("`98^EH6MV97M4N>6E`JP]X/G@H2)_5R&R!8R
MJK9"%K@0_/7V\O$_4AM\+AHL7072V\(+4<)0;?D"H-B95)(P(P@@Y3:[*.9<
M6')HR[KBR?':2T`)>>BJ_P!5JY>Q40ED,8`@8+%FL6HJ8W*L!:Y*+:L8*Y4(
MGP&:9?,8@,-.P&VP]TI6+H$$4#@*ZW9&IY%;JAT$D:RG*S<HZ9B0M2DH%KF(
MP),%A<#:1J?3-%J=;OP.XB%!2O9)F&PP:!J]43_9_]UT_4XK:>VTDB!90Q;,
M=.]S*QMTC&%O=$=@5?5NM,\6?$D@9*D")N@8W>[0:`_NBH;,1M^FI`RM[**>
MMNB:0]529>SP3#Z!5E!:06D%=7P%=5L_!?8/\#+=<!8HV9Z[-'\/&JH]!`TU
MW*ZA1D:OTS/ZH^[>"FKC4G93MG=147UCV&T;O?;PWI74L-4#%=6KAHKZ7=Q<
M)"?Q7WS/A3]EAP7E;QW'E=KIO`<KQ;(4.I8';S>E8GFH`KU0N?.J%1(Y\#B\
MHB649^D\B_P\=*A-N\-S33=LF`%&5-$4V.K(D3D"'G`[5R(D33-8>`%YQ=0@
MT>3!C$VPK]\J?11NZ%UWZ=YWN#)6R6E2S2Y"X1`:NHK&@?@[PC.WZQ*(AA0<
M)N'9:5=SHC=-'%%),[B9L&,8N_,1\4(.3"+X-^Y&W%^REFH(%,Y\+YK.V"<Z
MO05Q3U\WBO&^$^[N!]F5X=('W,!XKY*(MPQ<NU2N7`9J$V8#@S6,V5>0$4U,
M3GT'4XAI8%R7":8=1E=Q-'!<_)WU\YU)(LE!_ICFG'U2J6:?W:]QLZL+U_K=
M<Y/>5^CT!-_01-F31X^>V[U;@S/=MD@W)5#`ZZ8$.*9N6U0MX#75IE2KVQ95
M!7A-M2G5ZK9%50%>4RV.J=L65:(<<,7ATY6?]5;KK:X;?'JK]5;KK;Y7(Z/2
MU3)TBR+-)EHBZJVN&WQZJ_56ZZW>9N?H.L^WMO<(=9[S9?/*6!6N3`7LGC[1
M]0A/J9JMY@Y=JU/SQFGP1J6-!-T=Y52+YFJ&+"79:88\58;4G7;W=V+WS"RM
MF^0K":@G((RTF5XF6"N+5LT;-=C$<L-:6;36DC>Z1K<S,OJM@]*S*[B9Y8:U
MLFC5/%+!S;QCNR(%XNH6W>6":D%OH$/OY3[<9=_U->75OJH"XOJ^;QUN1E0=
M>'V;!\?4]WVK!;RFVI1J]7W?J@"OJ3:E6GW?MRK`:ZK%,?5]WTKDUE8</IU&
MK;=:;W7=X--;K;=:;_4V(^,N]V#JEC:D;P!KQM$R4F]UW>#36ZVW6F_U[I:/
M3IV^E3J=Z[=RB$%4X@R+1P'UZ1.=VZ-S0S6H.NU-L\9)@%IIZT#?,UR'F;8Q
MZ@V,T6"@^;%:H&I^U/Q802+7Y:L>H7Q5Z:FBDJ">@#325KH&5;.&9@T-JF8-
M7;M&@ZI91+/(,6[]5MMC6[>%1[Z(?&7.A!4YXO/DJW"P5?(7[H?+;SYW`VY2
MI_+[:"Y\__>-VX.%OG#\Z$*VFL#KZT04)#PP$E2U7:\T\)ID%<F>S@5Y?0%.
M9Q%6')5EAT]O]4.>N0WZ-3QS^W\1`#VQA<6^$BKQO[=`5T$8P'/H@\%/XR4+
M9X)=>G,@MN5^&JQNQ>$JO>LZ]>!T3S0T(Y:(W#0CKL-,O]<S!L-^3=GQT.LK
MM;1%O@I[/H[\0,QAKH#YPA3V-9@?$WB)?;KZY^6E-CU*!.H)"*%V9V`,.]V:
M"B'-(9I##L7*J-\W.MV#HIHEWLK'K-M\UY/-[*GH%]];"'CZB\/=\,*UWOT=
MV0O4J@>>@];O$/*>#BH*&;E:AQ,I/7X$JRLXA*,K=4ZA3Z?T@6KU@-<DJTA6
M'ZB6_NA%PZ=/`:N!RK+#I[?Z(0]\^X,:!ED_3R:V*9B(/<([JL\[QC*J94ZD
MM-5C2\']/9V@ND73*DWO^H1M'69:O;[1ZM?_-K5FQQ(1G6;']>S8,8;-NIXU
M'7K@762+;777*\TI[R/?M</(%XR[%IO8/_#O>[/6[HZ[JIIR@Z.:<N4.&>TN
M(.YRT%&2)6W5"0<=WE1+=QCMT9$,N:H0N.94S:F:4Q^"P/>M>GR\@%Q)R#P'
MZQH?I8R@EM%?J"2H.WFI)8&U0FC5H&IB+3E:CQ'>J'P$@QJ^LH7*1338`K,1
M*9JQ[^E3]11MW8+/)0'U).+!`Z/;JVL\6'.(YI##.:1G-$<G=T7P('>YWF<F
M'T40O&+<-*-Y1'<FF"46OC!MCA<FCF-L5"6NJ`.D.D!:`18^:_6Z1K=[)+NG
MWN+OY7Y(TY)!2X8*4/<99<CTC]3!4DN&HP>S2L)2%8H>E=Y)J22H.O*M0:T,
MJ*=&K$^?U"BJTJV%\1!7DWB(HYNMF"P)J>_M,Y5M(0?Y3+`89GG1V!$U(/-C
M74TX#(.5<M$Z1K/5?%C_K&S\I`6#%@Q:,!2DO78>.'!3#G[2/:"FV:)FVPN3
MW4,9L_XG+&/6//\M<K&,6:=B9<P..;TMXJ,CQ8ZK=1_LX)IF%3X=B4%O[D\!
M]:L;]5C'"(]-#'59AR;J^Z[?5U5BV+DNFCZ>*F&\]U%`+1(:)2ZM54$,5PA4
M30SE/ERIO(>L2ZX=O>1:Z5E#EW@Z.%Q:@RAH;V"T!_6_TE,S4#4WUI0;ZUS_
M4-](?O"::K4RQPXJFU9Z[J@DJ*<@DX]7'JE$&ZE!U>RAV>/!@D=[+NOI$QW:
M+R^Y5!+44TOFUZ!6&%1-K-H=?\@"82=6&:ST)%M)4$_!">@-C5Z_KF6/-*B:
M073E/)UD48727X]."Q4BVTJ">@+"\KCUMHX%=4$]FW(!J/E"\T6=TTI*45"J
MTAC\Z`4!\USZT0MLM%*8-]$!$`VJ%LU;1'/7:+6/>`Q::;&R9PW0"E%XA4`]
M`68\KRF]/5XZPI$KH&E;08.J3W@UJ%4#51.K3D=XC#J7!KRGG?&*@5II.M17
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M((+.6KTCRZ!*L^N>6=F:'S4_:GY\;'[4$8\-)DAL<#!?R&OWH<<FW/9QN9'`
M&VV6\.UK'MK7@MUPW^=NN&=562T-M33<AI6G3];(P\Y@8(!,U/)0VR>E![56
M'*GY\='L$QT@*;).PIE@8^&*B6W:W,&,M&OA!WC]?B+X'@T!M"S4LO!06=@V
MAEH6:MND`J!J?M3\J&,GA^+PPK)>8:*(']K_Y7'I'WUV4T)03T#>U?OX6'.(
MYI"#*PJWNT:GWZDIAQPC?K`UI;[2ZEL&%Q8K*9\JE*#"#$$(<!Y)E9?[PL+N
MI+_K]942+6FKM+O+FJHM%<^.:CC46X(<*ZBA)8.6#(]/W4>JTU%NXCY>J*,D
M!%YZ0W8]J$^?E!A87=E,@UH94#6Q5M3S[M;";K[DOK^$9:GT0AZRM\(4\['P
M6:=E,*QE0>7[L$*`P7P1+(2)J8?.\H$-[FXI;))[,KAA,<SRHK$C:D!"Q[I'
M=A@&M7U?'5[20D$+!2T4'O20I-P<M5_-P"KQQZ;J);?J!6ZJ`+BN4F!\1^2#
M&X1^A,4%@WVK!F;1FZ&UZA?ZJT]-*UW)3&'L#]?>]SI4-;>]TL!KFL4QW^/U
MOG^A_WTRA*MK\#V21-"%V?16ZZW>.6Y\VEG5;[B#17",6S'A^N>V5@C4$\@7
MK7^?DKKE4E=:[J4XT37R3HTE]>7O`NS]6]69H;IXPH*UAC-V*;.S;0P#_NZ%
M,,S9E9!_LIYNFUPB4$]`'+6'`Z/9/ZB)006WLMRP5A:MM>20HQ>(*:?:/FT/
M_HO#P7.'>1B?XO_'!>.R]5N26K?>1.OTRH!Z`A*KU>T8O<Y!O;0JN)7EAO4^
MT/KTB>:1>^.1X=#H#48UY1'MC._JC%_A[6CV>3(1/F9SIUI[I+5VB4`]!8ED
MC`9M8S#LU9[N3DUO:QZYMVB5T1L!G]2V1I#VQN_%&Z>2)UJ7EQ34$Y!3HV'?
MZ(SJ6J=):W+-(8=;N^U1SQB=7EQ=US);=Z-ZQMVI@*\R;5N.0QSE3O'6M8EV
M75.U)>!)UB;2%<0TEU:*2\]:'6/4[S\2KU9:H9>D/GM)>*KT%FLE0=55H#2H
ME0'U(8GUZ9/:(U:[V/=V+VW/_%]MPVL;O@)DWS$ZPY$Q&!PIR[TJ1*ZY57-K
M!;BU:W0[(Z/?>N`"7N4@<NT&:U!+[EF<$%HUJ)I82XY6G>FM,[UK0,8GE?O2
M[K:-UJBNF2\Z.TQSR,$1F];0:`X'->40G>6]=Y:W5N*5`/4$1%2KW3*:(WU9
MJTRP5A:M]>20WLAH=KLUY9#:.][[51LH=+VI&]:E-Y][[HH&/[_0.KRDH)Z`
MA.H8+7`T1L-A[>E.:W'-(_M>U.HV1T:O=W)Z_+2=\;OJ\3=:CY<4U).043WP
M-7I-[8V7"=;*HK6F/-+O]XS^Z.2"ZG7QQX\54E^OU+5*+RFH)R"NNOV!,>QJ
MA5XF6"N+UGIRR&AD#)HGI\Y/VRW_!NH[`.W,)O`4<VP^MAT[7#+3X4%@3VR3
MAS;H<5#KXN_H]@\U)99*@GH"(NJL8PQZ':/9.U+]A,JS\YY6M38:-$?NR9%=
MH]UI&9WV$</YI\.1^@9Z@MZG3W29MR-)2'V=M<H25Y=YTY?.-9>6G4O/^L.>
MT6T?Z4Y.176ZKO-6;W^G0J#J.\,:U,J`JHFUY.?ZZ_1QMQ;Z>&V5MR-UA-R*
MS8J0^D9K%Q;#+"\:.Z)4:SK,A%]=5+5M^)[1ZO:-3N=(V?Q5(?.]/>ZR+>1>
M^;72$CU%WO/]:%N+B>REG]Z@:XQZ)RDF<M;43R&'/<U\SJV_\KRR=G]__BD*
MSJ><+UY=F3-A18[X/'DK?/N:A_:U^.`&H1]ATF3P#:!^@VOZ]>F3G^_Z#C-A
M:OCP54Q^>78I__ZS_^G=GW]VFN>_1>XY6&2=9[^NH/JO*`CMR?(HV,YC9N-F
M9R@?:22&AL@>-Z?Y8MOFK.[E,V8*QPD6W`2N^.594WY67(*?LU;^O5KU58TD
M/](ZMB[CX!BXI$]Z]150`7"&C^3A(77`8.VC+?(/UPZ#FFQ37<AM^SIBT)O[
M'U"L$M<MH2>IL"HZ[CV>G/_K5$_.5R)"^L#@Z!*_VI#J`.RI@UJD.1[`W*@C
MBG5>?BEB[B45M:6&]`32>X\<`G]TZ5/?%/A*2[]C1:6KSY!'#C8_.I$?Z]9]
MA3BW',JM.I#J[!@-:F5`U<2J?<=CVPA?Q>W;VPMN6WA'RN0+.^1.5:V'ZI"N
M=B*SM[9;[;8Q;!^I7V;E&;;\M9!.H/OS:;%D;]0TVJTC%GLY'8;4+FM)5&E%
M(=5.@`:U*J!J6M4.Z_WC[^%*>)14!90:TA,PAX]44^/1Y4U]CS=+`NH)\,99
MNV\,^KJ\E_84R\^W]8-4GQ=I4"L#JB96[2L^6&+L;Y$K6*=)2;&=JMKOU:%6
M;1$G2&D;S7;'Z!WS]*0D0K)N7F.E)9].BEW/D*/>P!@-ZLJ0NLC"=-\B"Q/;
M>86W6^ER:_:%N!_E9_<-#^S@\P2?H'2I3YXEG&^(Y,VE%][_!TLOM,[?"A-+
M+[33T@L*,=E;Z:H,0X+F`S:B/5C4J0!#V9@-X"N?<;7ELN&M+:_6]?/L';<[
MBG#7N_'YXI=G\M^U%\^SK(A8>!Q)ILGL4<GL-^Y&W%]J*BL71#6CLD28M4::
MS$H$45W)K#W09%8BB.I*9B>D-'>N!U2I*D<%I/JX\.X+[HG5YFHW6W>]-[,C
MYQ7M.RL?.VK"K2SAWK58C2;<4H*K"5<3KB9<3;B:<#7A:L(MD\M9!J_R<>$[
M"+R'+=JY%=3*1DPT%=P?J$^?:#K0=*"E@:8"306:"JI.!8??8N@6%%LO='FJ
ME._XB?O?12AONC-O`M0VGWLNS(#)AO#'7/`@\@7F,S*+AX*=M>Y:)*K4EP6V
MMPIY.%(NR*LNAG9#F[LLM$11QP.WV>@4Y#FOQV]E18>F84W#FH8U#9>7AD>:
MADL-G*9A3<.:AC4-UX.&#ZT>4TM'^L+"FW7"8N*'\$T[$&SAV^9=J\=IV5!7
MV=#NLG/V'/[MGX2,T+1<9UKN:%K6M%P/6NZV)"T/"TKW:%J^_SX-FIJ/*IG;
M6C)KR5P/6CXQR:P/J`O1]]4.OK.)+[`J>RA\$83,IW/HMCZ'+@W8Y1`9K4:G
M5VE1\4)K.TW#[8(*YYJ&-0U7AX:;C5;S!=ANS491(41-RYJ6JT3+(RV/'Y\8
M-`UK>;R5EO<^EZZ;SZQ*RC+'OH:G;9<M!?>#.[K+Y9,%]2YP-=AKETK'H_OO
M9_D@TA2F*>R![T_5B^*Z;`XOS8*?>IKR2@91S2BMKV7;HT-T;-GV]$FY:.Y$
MI9L^J"Q$W[L?"V%B`O"UY_#0=NQPR<XZ^I"R-&"7(QC3ZE4[-4?'$S4)]VH=
M1M0D?`(DW.YA1+S5+ZAHK2E94W*%*%F3<`EH09.P%L;'.IT\":<9X+=A/HLM
M;>%8[*RK'>?2@%T.*7%>:>&@;[24`6Q-R24AEE(#5P6<:DHN";&4&K@JX%13
M<DF(I=3`50&GFI*K=@C]]$GM/.HOOC?F8WG\[$V8*N0\F0C?=J>8"\S=)5O`
M)\]BWK7P64]FSK"SGG:Y2P-V.41)6U^G?7Q2T!2L*5A3L*9@3<&:@C4%:PK6
M%*PI6!],'[WL%'>GU!`)7&6\E\#E)_'##D)TI(,9]V$8<JR%Q<[ZVGDN#=CE
M$!JZ%E4)2$%3L*9@3<&:@C4%:PK6%*PI6%.PIN"'<9Y/^S+TY_C`F9H@,9^\
MZ;-!G9SDIT]*)1XJ5]Z]-93EW7O5E@\Z]4K3<J.E&B)5_&Z_IF5-RXUF2\ME
M3<OUH.66:H?4;VI:+C5PFI:U7-[@6/\4\K$C,I]S7F/&1\8>O/9D>10W.0_X
M*@29#4!88P!H*Q!=S1?;T+6*W6?,%`Y6S#/!D?[E65-^7G#+4I^S@8>B,`.M
M*8DS=#)T''J+XAB#>J4:08:SULO,IFR@JUUB#,/F+O@Y)GT=`4/?9@(!^"Y"
M7%I$*0RF-Y][KKH88`=LS`-A,0\O!C`JP+CPL7LU/L]#VW,;=\%G^;CV8478
M0TK+==BD.&'IQ5&W?N*H?1_BJ"A$/.KO@JPJQ8=1,(&8^7Y>T-GOA@?,$O#-
M'!ZWV'@)H+I\*N8`%HL"C"J'\#J_%K[*RNJ![+*8+&].?^+OG7.JSLJ^^8('
MD;]D;VS'81QSMNAWF!!KC]C7("+I"3F!!2`<4^0I)*[NQEXVA^;X1^;XSCT:
M(+LQ><54Y1MA\@BL"62X2V^^P,N'EH<O>B&;`0LS;HF_(V3[T.=(5VQF@VD"
M[!IZJ11@=ABH'VR3.\FS::E=@Z;(E-Z=<!.>)F$"DL6>\W"#+,D,G0QA4WHG
MFDL+[A-'T9\N?F^[]%K`YRB\+-@3`!@%CR^F1S:9M/RHD?SH:OFQ&4.?4F[-
MF`3(>RL%PT!:C`5KOE#N3+0`AP:%AJ`"8^3(P&L\A"\!86`(H`!:\&4R3@#@
M^30R_"L"(8@))E$(AH'F9\W/>=QD6Q'D.+JG?8`]>'N6-_F)49$5%_EB!IRM
MEC,(&-:.1,X5W)PQL"1\&"4V\5U8"YN@A4\E#C0;:S;>22WWM5K>F75CXSI(
MN=:_?7<JV'1Y"JQIXMX5YB8U#4I]+,(;(5S6`4Y7C!T/$(5!"&8W/*UY6_/V
M3KP]T+R]Y>:C6*#]ZX8!L5KJ/'M%.9W`N])&3GX.V(;XW?VSZ<\_36SGU7MN
M^__"$X[/D[<`Q37'N)YJ@QI\=M_PP`X^3_X5GVE\\BSA?,,!OP%>WR#6?WWZ
MY.?[&8F9L#SX\%5,?GEV*?_^L__IW9]_=IKGOT7N>;O9ZCS[]:$LMVK+HYP-
M/.@_1EH#NTVS.]CKCY*!L1W4&+J"I/.:=01\*TPQ'X,ST&D9]^!_E70_*P3J
MZ9`>"'G!.LVZDMW*G9>]Q'8,N%(%Y_+K5ZR]^/$0!_?WQEBE7\<FKE,@C3W?
M$GX"^MCA8,3``EC@.;;UNF[<">97^SB<67IBJ,LZ-%$7$'7G%(GZ/G31HR^B
M0KI_':@[&'7'A;OV&*X0J)H8CB3>]KA>OD[@5?SH<$-.,_RQFM#',%6\GL[8
MW4"M]*X77-G990OS1QH%UWD*$5.I4XU6HU70DOD$Z;M"H&I6K"DK]@LNZ-6"
M%0\M%%M+4^3"PO-=83'Q0_@FWIRBX]&:DH`6<5K$O6XVNJIVS["@8_,)TOEQ
M07WZ1#.E9LKM=D>OB4S9;G0')V>`G'8TY*L=?&<%%RGQ0FH]"4%+/"WQL+Q/
M4YHA`QW\T*#N`^H)<$FKT3RB.5!IT5I0VG?'9&0=_)!CJKQHYMC7\E8TW;.J
MKS#>(>\D6TE+II!LRC59_Q(K^=9W&977"'[JU7W3*P2JIL^4/AOU)DSM"Q?B
M[QW=]Q=6MA0(EFFI)Q%4$M13,+KQ5OHY:_6/&!^O-)O>R?2N))57"-138,A>
M5W.B=H*/:W*LE"3"ZDY:RI4&U!.0<N>:WDX2U*=/-'.<+'/L5W*[I`J6?KT1
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MOSDRFIW^/80%RTWEFB-+1'>:(S=P9',X,CJM(UX***>!<MJ7`W<U4:ZPO>"Y
M/'W`(TKA!A34UF9*B4`]!3EE=$<#H]?3AD.98*TL6FO)(X,N<$F[65,..4:D
M86OP^21T_.=P)GP8@GH0NZ9*0>(_,.G`/E9`HMQQ_[OW!-IV"E2B)6T5A=O6
M]/1)=E75%IKM#GA`W9-L&*6Y]22XM3Z\VC4&W=$I<NKQ@A@E(?+26Y^5!'4G
MGZ<DL%8(K1I43:PE1ZL^EB^Z7^B%W&'6[3PF'<PN$:@G$*AK]8Q.9V3T.W7M
M3J&91#/)/9Q,#SL]HSL\4FSFT7?S.$Y=O4/:'T40O$IK?<`2'.^&N_LVF=-Q
M+QWWJ@#5GQW;8*BWT-BS]J06#EHX5("ZSXYM*&GA</2P2DFXJO0F<R5!/>G`
MYM,G%0)6@WKJY%IM'[];"XU<<-'8@)?"![;BNW6RXF$QS/*BL2-J0"#'NLUS
M&`8KY30<J0)X57A)"P4M%+10T$)AU4([W;IV!U:C*RYHAT59/5=@5;S)!]?T
MY@(&PQY!;B#>"%=,[/`^BMK=?]G:]F"A"]N51+E5#?B#JX2UNL6ZI%IEPMZK
MLJ/4>)8)F-(Z1+U4B@IVK@5<J555'?B#&;-?![X$+2KF8^&S3LM@NOQDA8#7
M]%M$OR=;BW+G53TZX!6'3Y<#U%NMM[IN\.FMUENMMWJ;D;''@76O7<.K8^\%
MV-C<@>\PBHDGT_`2#UFG>Z>F\?6]%U/IW=7E(=<WK32&7?BO=<2J4I4FG6/E
MEE>,_4L"Z@EPY'FGVVAJ;BQ&CE;&U=]#K8S7W_0P6H.6T>YH]K\79?ST25T%
M0$E`/0&>U.KXOM3QH7>K:AEW6%=^'3X$_S][U]J;.)*UOT?*?["B6:E;<FA?
MP$!/=TODMIO93B=O0L]H/D75IH!:&9OU)0G[Z]\JFVM"P!@,=3D?9@0=8S_G
M6J?..3X%<VNX@JJ`LZO7'-V$LUNXPBHL6Z6TD&;%*/$@%:&7,MB;\P15`5NL
MVXY>;\)JQ1-68=DJI8589L4N:9ZV6LL55,V7\O"\C_P>9J>)=!$)T[%M6`NZ
M6@>'Y(GN8Y_@N%.NH*K@\LH\[H-;4?*-55BVRFDAE3K$!+"%Y1^J`K;(#KQI
MP%K%$59AV2JE?1@5L\10;OE:Q0Z_$X(Y4'W=EH.M01#&Y']9Q37=M_Z*V95N
MD/A0?>4*J@+.SJXV]6I#UN-]P4+`0K8.ERMFB=&RT$L9;%UY@JJ`+=8<W;`A
MS\H35F'9*J6!F!5G[WM705C#0>UU[2@8H1D\*\S"45J;6E?>N4L<D02GY<R\
MKEXSJKI9VVILE/A*#M8*UBJ"M=8KS9**T7(O\&5M]\$M@%LXO';;=5MW:H<Z
M[HY+?1"8$+!5F6W5-"H-04ZM/3[BBW5<%/`YL2B!<I<"086S_@"J,%!!60&J
M,%!!60&J,%!!6;F?H/S>7D>.(W_OPN")1*P*V0W"N2'+>\YB\G$BX8XR(W"Z
M)YSNN3"I;K])&-YL"9S",I7FA":P4[!3L%-8O,$I@%,`IP"+-]BI2.J]D/'X
ME)Y]/O=]Y9'I@HAUQHIWY?OE4Q*=]A`:?GYP^[B3>/BV>QX,AH%/X46WW>LT
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MDNU5/_.C1@,>ZD;8?!7D:S_H]1=ATM-:PZ%'W.S5M`\99QN69?S^XZ(U_6;^
M_E$+0BW$O81&,$$XTM!P&`:41SMT=P?7%C"\\@TO9Y-DHR'AV[:LY(J1V]>H
MO;&=24>C-M1)W'@7:3L>*_0*O4D-A^F]?Y:-H1MEGMS%IZ/+W80BI:O[8'W4
MDB&-*.(^IF&#B\DP9H''D@A"Z](;I=?]K#Q4M*N+EC9QE)+JC)!0H74-PJ-R
M?09$11Q#52!0,76%0I7UU:,QQ-<B>D<>B_O6::EF\QH+)Y69UB\FMC,2T,`D
M1$.<Q,2-SH-P"`49@984*,A`0489R4-!!O+"O+,2TB7+TR7F1^VYCWV--;(@
M?T3_2&)"(Y)(0]I='T58N];.Z?7$19[69BTC:1D',LGRZ0)DDB&3##FAN3SR
M.L<(GE$0#0=G);^S4CR.LW.X*_!7@BBY4OZ*S6M6TF,I'5Y5/VIGA/*AE[JC
M[YD/6F@)'#<-/I.X/RW0@V_B"*H2O@FB*16]4^VC=D7"*-;<8##`H<N"I0AY
M91V<<7`]$$AE%?,_$!NIYWV<CQKJQCA,>Q.[J1_ZS4S5@/W'SO3Q<<P.*:8>
M"<ZHY0DJN"2Y7)(*S4K.#6M6,D[_2'S6K&3#:^30M:1.[PIT+4'7TF;>X.#`
M!<<'74M*Y6>$7A!+V=Z5]$+\HBH5?N57Q=VCT#H*;5O0"2%D[DQHJRME9=C)
MN\N+:@/NGW,S5LHC*U5/S3TG\S])%)/N2!0AKMI<B9_2A/<O(9,I9#X+,IF0
MR=P\DRFTE<^M1.O7I,VE?G#!0B85,JGP_B=7)@B)1`6WK0IM6D5,)):5BX/W
M/R''!LZ*+U%"'`?O?X*_DLE?*=50#.'5V%_!^Y^"JK-BO@FB*16]$[S_*0!4
M)?P/Q$9">Y_CH_+>`(7W/[F#"BY)+I>D[E''Q?JWWAZ0_-!'(3Y#$>ZPS!3=
MY*6;NX>8_N!VF/9@M=R8/)%X5&"N_IMFK-UWTEGU`XMBN:K-F1;7#6<'-V?!
M\4&+!X@:1"TBOC72%;S'\B_,'HL[VP2!'`I-9'S@/^#=?][Q@8Z"J$'4(N*3
M.YQI/>$0]0J6=[B5F<CXP'U`-,,[/M!1J40M]Q('.W90JIUSXAX/$/&)WP.M
M`JW:733>ZX6XAV*IXG$(TO9G#F,8J<:F?_JL91;P=M;!CX1-]=""KHAT\XY/
M<C=U^*3!\1%HE61:Q7I=0N3&"?)D6OX$P">W7EU3M2)^1%R9M*IH4,7W/!_1
MP<,8*G;/GSY1:`:5Z.!!9]D]+U_8RTX1UNY"XNXRLN5>_D*#!^5E]VSC<*!]
M(+XVPBB,/H+V"@(>M)?=\T_D)>IX7,B&0LE:<%;RC@]$#:(&4<N&#T2]S^DF
M-8OS^0)%^'>;Q%&,?!85ZMH%=M-S#33;U#7+,`N^U@WS!&">0#&N6'5;;]2:
MV^Q\!!0EWUBE'W4]XPD,O9[CT?'1XJB/B@5VR1-68=DJBX$L<*56J9E@'AQA
MA65+S65K@4>GDIKDMJ/REFUEU]8(A+:6?X;(+_S"RUJ_QW=]);]BYRVW<432
M6B^V"4W@[016;F6LE".HN:TO_ZH")B>.IH+)'9KG8'**F9PJ='`$=7N+XX00
ML76GO`JN(.(!J*4EGSG!*A!;`2HHJS!L!:B@K,*P51FHQT>@KJ+J0!D5J*6Y
M"9&*3"N;*0NV!\A6<^<$J@+%;VBFY`^KL&R5TD*@IY$SK,*R54KS@)Y&SK`*
MRU8IS4.YYL*MZBS07@A=%-!>*+*_LW2CYNA6O5:.WQ-%R96Q5HZ@JM[S9%2:
M#EB=%(2`U0EC=8U*HZ3TD"S**@L='$&%9D,NZ"BKOBF(<#B&>GS$,5CH,0"H
MPD`%906HPD`%906HPD`%916V'E65HAZULA/1*I;4*)R"JW*QH]M1F8H2HW6"
MY)>'N:)INSK5:Z+$SMM9NFT;NFE7]YN\XTW-E;%7X;WUC"=EC?+:?+43RN*-
MBK;O`AEO1J*4M7,"576S:U2:)36(BJ*L2ED=K+$J&[O3J.D-H^"1`&+;^T(&
MXE.,Z#YI[OL"_<);Q[OR_?(IB4Y["`T_/[A]W$D\?-M]Z*,0GZ$(=\Z#P1#[
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M/5N=+[S@E.%1L-3`/7>\)$JT6(IRSWR+.@AFY3WO\0`1GZ[#4G..I0A#Y,8)
M\@Y)6AN'`^T#\;411F'T$8)`R8+`;,U/?_I9RV*(:6@P%SSD"A;>CR?'6/(]
M2X28",*O_:R7O5Z(>RC>:,44SM5?4T]/_(BXAR3L3^0EZNSQ7[5KYZ;JX,#7
M<7WJ@FT>UB1@);!2&58>'P$S.=/+\D[C$;J1YB`OWAQ<&>3LWEVJC$+U[)7\
M)@RWPN0;J_2]MG`@_?X'N7&DW[+9(B=0%3"/\EXHX5:.?&.%I4I96RSU?8^#
MJSB<7[6L,(I\]@I`^MH%;%4Y@JJ`N_E0;>K-6HGN1FC++-@=`.8(XYU$92O?
M6(5E*V@K:"O/4$%;H4BWUR+='XF/-=M("W0VA%D<03W4KN?X:*\E.JMAZ&8#
M2G0\895^0PEY3RC1"8)56+9*:1Z-2K5@&Y.P<N0;*RQ5RMJBJ3M&4S?LDD[D
M/+B2*S5W3;4);'^AD!V:#%/78.J:+&]\*C+VHQ39E'!/F+H&E@Z6+LBC1'$J
M9=P3IJ[MARQUIZX)#9XOO&6M*/*Z=G@4K(W2WQ/&Q`EQ3Q@3MX-[PI@X&!,'
M@1^D$CA]E"@.II3U#<:ZP5@W&.L&,Y^`E2*SDG=\QT>OHQ80-M@-O-'"Q1LM
M,':.9Z@J]"5:>KUNZ(X-C?0\885.864MTJ@TZ]+;(D"%]:H05ZJ5:F,)/R0S
M#UBJ.%(Y6*K>G3NGFV95KSL-20T2)L\MZY[(7@:)-#QNT5O21P%[5DZ6#BG=
MS@=+MTQ3-VLE^AVA311&T/$$50&+-"N.K"^V`E0.K(,3K,*RE6^LPK(5M!4*
MA*5NL(8D%&%[=7PDO:XJ%<Y],'7#LO5ZF9/NA#91V&#Q!%4!BX0-%D"%D!6@
MR@X5E!7*5S!07%F-52JF:^HUNZ8[31@GSA-6Z?>NT,[R?N=E'3HO`2HL5TNY
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MNFK/_%,3_!-/4!7P3Z;>K%MZW9%U<,+VW9E2^J@[#]&M`7V.AGKL_Y.`7PNQ
MA^*QTZ+N"_DNUH+NNGV`J-HA)%3H+H`(9F_[XI6?SN>V6BQ^*7CL$$0O$+T4
MC%ZJMEZSE4@?[RQVF9#R[M17)5S7NULP1T-^I^3=V%H1<.)!UEG(!%Z>DV8X
M(6FM4]R$)K&=9[/AZ':C8,-@7M7@4\7+BOHX47+N5S8AH<*^2]C8IBI%;-,.
MXF4GPY0:DE2Y\-<["DDH,5HG2.AV-1]-QT>\N):-R!([++%I4-+4Z]62=G5\
M*SIT#"VC;]Q/LD,2TQ:>`VU"M7S-.E89S3IY&,IA>Q,TZHAM]%N4Q!THB?,$
M58&DLE6U=+/15"VIK'+!:[U_HLOP(/`S-P4.B2.H"CBDJN[4&WJUJ5P7H=I!
M$_3HB`L5<L40LD"A^_"J(Y"6*Q72F):I&]+.#(&`9BN7Q9*?"QNNJ?L"-\41
M5`7<5-6IZXVJK#,KRXBKY.XN7)\GBE)_E8F@89GF[QIRW9!=2TDF%&+!0=AB
M]UNIU5)X?*1N4Z'9,'33K.4NV$FI[M#<M#ESH;EIS\U-O$2)"K4VU72'M3;9
M)>U[^59SI5J;\HQ%RC_(:#KV*!E0`D?3B\=#D@B.MAI\5#:K%YG!<[_.^U;'
MV]Y-<'Q40YE,Z#]8!VD:DXB5O.,#44LEZC72?>/67;H8X%"4)?POS!Y;]+0R
M;H4F,C[P'X43#^(`%QP?Z"B(&D0M(CZYPYG6$PY1#T,TPPT^<!\0S?".#W14
M*E'+O<3!CAV4:N><N,<#1/S"#8?<2HUW?')K5:O7"W$/Q5+%XQ"D[<\<QC#F
MCUK)+.#WO<1L/Y)T/D70%9ZQO..3W`_RDI4X/@*MDD:K6)]+B-PX*=I&R*W<
M>,<GMUY=4[4B?D1<F;2J:-3&=]^UZ.`+OC4@F<']]$E<\"0!,<4N-'C067;/
MRQ<<NB3"VEU(W%U&MMS+7VCPH+SLGFT<#K0/Q$^G448%9T&(J0!"@P?M9??\
M$WF).AX7TJU0$Q><E;SC`U&#J$'4LN$#4>]S?D'-DG!^U6T21S'R652HOQG7
M;Q0+06$V%<RF*L:5TVWV/`(*D6^L>=@JM//[;1?^#0SQE<8<'XFAWK*9(B=0
MP3JD$R+?6&&9`D.4S!"WG6*Z;*NZM@8@M(W\D\V.*OK&#!QN+M`D4G7GD-9T
MVZGJM5J]'*\GBI(K8ZT<0<UMA?E7%Z%,SZC42CJI2A1E!:L[-,_5LSJG4G?`
MZJ0@1"FKXX00L8V@O(*M(.(!J'!*(4"5&BHH*T`5!BHH*T#=&]3C(U!7CJ"6
M49!:FI\0J>:TLG>R8+I0ML([)U`5J(677!WB5IA\8Q66K5+:2'EE'&[ER#=6
M8=DJI7F45V_A5HY\8Q66K5*:AZU;CDFC+%DCK'(J+M!W"-5=Z#L4V>_5]:KA
MZ$:]68[?$T7)E;%6CJ"JW@%E5FP+K$X*0L#JA+$Z6_F^0U7HX`@JM!UR04=9
ME4Y!A",9U.,C7JQ7,L8"5(&A@K("5&&@@K("5&&@@K(*6X^J2E&/6MF36#"5
M6#@%5^5B1[>C,A4E1NL$R2\/<T73=G6JUT2)G;<S+;U>-W3'WG/VCC<]5\9@
MA7?798WVVGR1$\K0C8K6W/,4'-Y,0RD;YP2JZF97K50;8'52$`(K*YCXTA9P
MW32K>MU1TLX7$@Z?8D2W17/?%^@7U"IFK'A7OE\^=8GW^2$94*"CV^Y?*&0M
MKBTW)D\D)CAJ,[:T*>(S1L^WXZ,O273:0VCX^0*'Y`G1Z_!W@GX1+[U<<^DS
MZ-7WN/OUY#S[_-B*'F^[CX^V>7J!W5/VMN2)EO@DN^CGP\6)UL$N&2`O^GIB
MG'RK5NVF8]I?/JU\TJZ@/%XA$O[)3F`[&TT__HO@$(5N?_0=/V&O]4*BV677
M_C")H_0/YDV:<'E-S4M$/OO$^WH2APD^^<0#4DL8I/9RI(?3$&LE%+M6KS9K
MC3U!$499MT*Z5V7="FD>9=V'AABG?R0^H\9>"<5JUNK->GU/4'A7UMT@W8>R
M[@9I'F7-KR$L;+C#(3MI%?7P;??VV<=AU"?#:W;T*H[B=G"&6^Y_$Q+BSBKJ
MK,;,%+_C'O(N_9C$HY0,%H?X)!F\03Y,0CP/W3KY9E8,(XMF<L.:T'$>#`:!
M_Q#3".<ZBA(6\ES[%&9$.I2S,0G\JR"\I+^)1Y/;I+>("/O;4N+.DXB&NH_&
MG)_9%:%&I=G,"-T.]Q+J'_J(7L3NA3O7_N6+VT<^XV)VCP?L)F&J`-?^C,<E
MD/^M-1R&P0LE.<;>2&LV_Z$%72WN8XVDT#3D=[1@5ONB$!@)-'2F-&AD,,`=
MDOT4=2G9Z2]=+XC8I>,;I91J$PIU;8A"MGM)L/:;43%,;4A_%K%K],DO*)N&
MR!]5M/:;GVO/*$H?0*%1&--"G-7("G&5-^(JPNAY'W(7!A1A/+KS6+3N=]CO
MA@-ZW644IVSK_(QP-_&^4\-=[ENN_KY<7`;?O>79J#T:XLRM)"%53*J2].]7
MY(5]BB8R>Z`^9GP`]\Q];(23`P)OD-NGVZ=P-/_W"857]%D<$>C<7"ZN#;))
ML!"!^Y/@64(="HZB.9>ZZ&O']GT;3ISSCX3!N.W.6W\!]SFW/*0N*II?(&RV
M0-CVW.9H-SCG*6]1S]TA7L+"@IFOHE[,2SJX<Q4&`^8LDSA=@JA30U3G_%Y$
M75EZQ]8@2/PXC]&:CUL^ZFRT_`:IJEP.AEXPPCCUR+=#=H<WZ^];!K,HJ6XW
M:LT9AW?"#PD93!_Z1$V+,)4*8AS=H1%3KWQ,MJO5AE5WA.3R*\]EE<KE<<XN
M'U<;9LVJUX"IZYB:N8.(K@=C]D;Y^.LTJE;-:@C)X#<1$Y_.U[9I+%`%#N_4
M+YA6O6[4FE*X6YL?MC9K=LUIBJFL>^5J47]K60W#;)3!X->9I"P8GFS5Z:X]
M_8?)=[J+Z(5H,%B>#GG#RH?D5X3_F[!=!MUSQ=/=RZM_SY<.LAMO\UXYT<YK
MTCV.$=TH="8L:;EN,D@\M@.ZP%WBDN5JLF'!I%:K5^VJ,[<_6?_<':+,F2FO
M-2W3J1GFIBB9&/XO01[I$MRYQQ%F>5FJU!<L`1NDV\KS@.VX?*J9(>Z<C>YQ
M>H\[1+>@N2+VE;@=RMZ&DZE#<1S[H>2-GBS)F3,4]Y@,?B5AA-DSHWOL8FK:
MJ27OEG=-Q[&K9L:[?,_</<+5MF/9]0:+?#9'.-G1WU&WQZY?DW7X`XU#;'ON
M<ZL7XO1IJ:?Z3JBOB?"<.E#E8!E.ZH0(59O_I0YV^ILWGHQM".?)N_YQ10G,
M:'N-MB`55_C7.'?2G'T6CHI6TIMF@*:?YV7<ILMEA-QT_5RTPI3$GSY5C#`B
M\>BVV\8O*+JYH#32?PG\<^2[.#S'+`^4D?:*/><>\8F+O'9(F;$I%ZJ[8X-5
MEY8-6<!QATCG)X,SO?NU_S=UN>WGH-T/D@CYG4LO3<^NXI)Q>H-&65K';$X6
M.G,3+CUX`?+_C6/*";K(7?M13.(DIO%$QJ/).K"42]O:TI)5V#`F-;T-V;0Q
M=]O/V'M:6<N2CKN648"]&9\V9V^?A#%63'VM(OH[X=2$Q3<TZHRQS_!?8<PV
M2!,J[M!HL-9QRL;3.9:NY\PZ-<V7HQ&65V8.`Y^RJ--)*T-T?4NOO$AP#EY-
M6CBDX-:\M:[CQH1M%SAR0S+,<@F4*]G/KH*PC<,!\<=)!OK]%R6%447WZ"18
M5_1K#4/&3(-M5Z>?N6;L-]84T9V1R?HG&)WQF`U98\2M&P?I"\I&=FB*KCWW
MZ9HPUUVA1?3V$=MR:DCK$F;<67_'F+-:'*27QS/V3OHSECS]UT@+$4G;/HBO
MX1<71Q&[_#=;IZ*NT/_8O[,N:IP61&=/''=L%!3O1#OFKKI`C/]S5ZXV+*%U
M@8GVU#1.[;$UY6(#3SRCA`0LU%_DW=MMPI:DWM!=Q2`9_,#/63W^:J)]/S#N
MX,Q1OZ-T^3S*+.DEAN:\ZY[MDV_VV&+':_\.63<1!_U#C^X1_<SEWW9O?WFD
ME_YD[19=.!M=V;#LS!;"%3R9);^6Y0;O0CP<1V'9;R<9J@(9SU),=W47;-.:
M<&`K\O;&HXWBKMWP:"$7N26/IL4;UV47CM.9K%=D[DJ"HW.6:EX=BQY4;\8\
MV9"<TCBP?ZTP"A&_N$%I!Y>([>'2/-G*;4>=;F[#_V?O6I_;QI'\O\(O6Y=4
M13D^1%'<NTJ58\<SF8UCE^W<U'R:@B7(XH0FM7S8T?[UUPV^)9`$7Q+ER=:6
M1Y%(H/N'1J,!]&,P1ML=`G+TJ:+,]=U=6(')#ABP3;W=&(-+CRY_#0-TE4P/
M0)-9/`P&VFPV%`;C/1'FA*[-%56>#H;$;')'-XV1^,U=._ZO[N8[2$.&2L\2
M,&?7J0/QK4R^NL^=)."&.HZ_M9^)8Y&^9=\PQ#B_"X"T;YM+2L'N*O3W"M2@
M8<Y4+0XW+N6S&Q(GH@P5TYB:PR)Q2BI1T\SI;&`XQJL7574^-0;F?LS:49FE
MFTUA_B]"BKXGJ$?QE.5$E",>%JD3V9@H17YWN&G/ZXC4'_*J3>19>C#6-Z]C
M4W`-&$XV2->KE04]^GCT31V?E,:2=MGKW[H^Q=0>5^0_Q*$!GS%X-;0#$/`[
MZCT#37Z;6Z8JMI)QCKP\/_W`LRF?WGCPX"T+H&SACG1P$#[([XTY7D`H[^/M
M7!D[^5%.(['/?#]\BKQ</_W8T`50B*>28GYK'VZ,/S*(Z]KLW'\U]..BY@B"
M<*/(Q^$_U0"@ZC-M@"(7QS[^P%/QE$Q]G%1&9_<IE=.KXU())D+J??GA9G9(
MS/8U^SC&LHJN8X[>KA\]]O_'K"$%F>9.W6;OW9L0K!WBTUR,_NC78G[$B6DF
M]K0(DUQ'ANS(U@?3WR:+B+Y'^`.6>4)8[_A\`2/))B_1_15Z`W`1^N0\DL>8
MH%V]G)`J$:15>K%L6_(B]J4WY*U$I`7QU]**4KSQAUT3KN9RFEWBT7-]7]IX
M[H+2I<]\!^@2703P1^1&BI"3(OD`2X=M"]Y);QZP;<=U)B0Z]4;L)/H##2`*
M%.1<M;..U>[]8AZ,-XNW.SV@AP-89>CC@%X1DHW9-A)J?&@W\MA']PCL8%-$
MC>?Z("807%E*PGER37S<9@,U.AFZWT=$`@RMP(=YYEN/#@4(UP0$"F:<FTC7
M4GJ)^<21W<3S+,H@XN]D$/DOOSB<,,X$_A\%8O'$,FNEF.<DSH7B8_*2('D8
MM8./U8@%!(C)3[&'(F5Q/@`IW+CH/Q/9N4E/'S.>0:18>!5VZ8>+=40%3Y*J
MQ2$7=V6YR^M58EIG[XU/8'ZW`M@Y2S,)<`O6Z6"C*Y&]FW6&#45A$).A>)^&
M<)4PS@U)<VT,/(K<&FCU+FJ>G0W(1JN]<U>D:J+89)T3Q59DL"@>UB(Z*8I]
M/V!/OGRV?-?;5BY08\2CQ'4X+Q*US'*5;^;'F,VWW'1C"GQ\,PI5,$E=O9B:
MA;7QV0+]"[.(!-(;ZZUD%70J,N%C$M,`GL%_/U'OD7JP0F9)3]Y)#W$F%)R"
M#ZG[H">YT)(G!1E;TIOXJS5Q..FBWH)E$:Q9/QOFH6$Y@><NPP5H0%#=5E"R
MM+[C?2F]N"$HZ\1,(:76"7D$3![C<[$LQ5>J<W/T^[%I8#&@WC%R<9E)'".A
M15!$L<**<V3M>U226,0D/YE02R9<#[CJ/+C/]%UA"#S*LJKY!<]-0->WGBR;
M>%ES>:"Y@*#9QI98_)6ESD4HX`U<[(HKZ2J9#TGSC''+>:9^P)I\(,YW8"\!
MJ4!9GA#02;#8.5%/P''`QL%?K.DRA!60?>%Z,.KQJ@H:`S2)9$09OB2:BG,F
MNKSU3V1&<A*S)9;[Q^VOL+(#^>G"<#)*KB3M@*[(BKZ7'ZV<7\X:D/D571$G
MIN/2JCX`4%)//>5/V<R"))K<#I$GT"7G9`,+E/V+YX8;+C:Y5C+R&AVPXF*P
MMQ:4,<VS$RY#V]Y>8%`\7<;T,I0_H9:Y=^OVO&.'C&M.*/*^.2&.0Q9]PTYA
M4O?'$/[<P.\T^)1LITX1,7Y<31)64\?R[A1,'KT=PIKX)62+@@4:Z,SWW04F
M=MS/#<&Y5=Z=,WDJ>:XF-_$"\(6"WADN1*@M/X:Z'\I31K10&KXDJ]V*OV]H
ME3XQNOO92[M7.+P4(.AH]%=E1RS<>1R(B589$$<T"+VGJ!QD$'YAQV]B/L4U
M(62ZG$^A5-UC[[1UD(YJKK2Y/!TW5Q4R4VU:F>JQ&*M.]:'HQE0_&NA=M'TU
M5S-E=CS$7YDH">8R4O2Y/CNT5NIES:J9(*IQZ`G2WTHVA"@54E)M/(JV)08B
MTHU-61`8F)Q/KA?$,6&E#?>S%&KS?)*OOF@['K]U^GH*_WL%_`HKE>'XQ4W.
M%Y#M:^?"\C=N='H+F]#XG;Y9F2IJG+%)L--B,8^,V1[2MVF%HD99TXVZU'82
MY=8,I-E#E[NY>>L"(GKHLE'F-'VN]`]LM5C)_</:0X</`887>R$[+B2+JOR?
MF0>U6/J\'3_0LKZZTI/?&ER1OUP/EUO_>H5MQ;,T7T$C"K"FCN5Z=R%618_2
M47QS?'R$+L^S'.4PUY\L'Z\H6+9R@97Z\#RK?TN>&YRO%:]2A(*]U9FI=.'G
MFT.BI0W6/LM?]#6A)DE&&N%>>R-Q3'-L#"@<?]:-`X4AYV$K#MG]:OSOF(1[
M-W4"Q:%*RI=5.A"-4.PUPP!$XAOD1AP.B<OQ)T(/N!0$:Z^-C]1A^9R)'='I
M,]\C@IOWTY$==9YBU)K;0^%5LUDX+5Y>]=CG=_#`W:D9$NI4FVD\9/A\]8_!
M\:4C,=Z[87#C6<["VB39$6.*4*3J7$G&(18EB>8'8_+XXSXI'W@A/BM<TBY"
M>N^RRG'.8DA'[1J#DN]>-M5T32WU+BLA?03,%GVZ1'WI9G-UOS*L`+.1N^0_
M/Z=>D\F/A=!6L5QM=P%P@FV<V\0':6<TQ*%-*4VQ#Q-.B.O5&?;UF,MHEW,Y
MY(GVGQMXE3GD[CE]&?/__6\Q9DZ!;58-QEI:Q-O>$9OF&ZW?79T\2N7,9Y.C
M(>.8@.@@C-?$PI;#<`>[%NI_NO'HBF*,5@X082[5V7&&MXJO5SSWAV'[M<W]
M9BB=\MP?T,89Z]#V9]B,=0R;"&\:HI7;7.&3984#JWA6WL_T5\"S_[$1U^K[
MZ:%D.?'4G\9WK++<%H/#S].-Y:69Q@^CBC#+D3D!LT:KGHEYRH[)!%?;M&4B
M]KW/?%CB6%W<@Q\(_FLG*E^?!@)PB4GC,SSZ9(5/T=S,H@-V-OPU6;;$O)^F
MV>F"6*\IC5&&:):PO>1-L9Q`6BXG4+6?A#K/:*WO?3?8I2W!C=Q58"NOS8KA
M*PU(O0B]^!AOYV7_TNU&\X<;\RH^0VK11XU<7H>!'Q`'H_T:E%#N*I=[O99?
MG'X&"CQ0$[<P5=G"L,R"RYI?^/.#X.=E%Z!5G6?`1AE$HBJWZ7$A.R3LPR/!
MT/-PEO?%BT&,Y[\=>U-\=GY?6XOUSIN?HY06G;&<(I9S3=/V8P`;T%$N"5=X
M26(%6UP:<N&]8F<!2C&S6Z;3&_658,R\@)/!^.QD!823S!(^5JY);95K#\^=
MGV%7)7IL6>T[*>?.E;N0DIW![U[;1F.!63:$1+K"WY)?0'INR#,E.1@7[SPA
M>,]R^`7_X&"EE]$]N"_.=",YVA7HL%QP<UQD=W[,UE1:7=;6F+F-B>!?Q:2,
M)56Z6R!:L<52%-Z]R%ZG"6V??@045N%E,C$3TTM(/#-M<+T(XOQS6OH9%UCY
M(J)&M!MNXH_=ETNMZSIZDN0.+\27?$J_LZQ!&TS'$>6GH*PCEA'!03OX*>Y0
M6F*/F'W*E.'SUG\OW>=R16!S++,0-.$^8&7MM%5?6L&2(A';CEI<NS8F:$US
M%15[B%-5.`SP-;3Z@%4F:<P^-@\V84B\K:0I+%6#]DZZI`\>^TJ91U]A+H@K
M3'<KJ4;\#5+.,O9,H[9YN1QX(.].O4S`TXNUPITK+$'\F5=]A"RFE)L2THCX
MJ,)\I"#Y+'0Y41!('*'J>A,>"_1FVML/HU)0F&EH>^&^.+$=6Z,.F^XTRCLJ
M(04)ASG`MD[]493;6-3V5[Z*G#DPI>QT1R="GVA8B:S)NZ-:UV^YZ?"-Y4(3
M6M=DCL"5N@ETZ*?6'M&TN9G6BRCIJA=*U#I*=&4Z`VH&HX0K$GP;358U73':
M4<)^O:4+5#G6REJP;>N]B_D3/CMQ8HVFP1=<*B>:HJISM6SH1.C89Z)X#I1E
MSXM=N++[_$&,X[S_1`\TB1CYT=8@25#8"Q.FH1I)!2;AK@>AM7;.J5-5,>7.
MI`J/D'"BVUJ4S?E,,[76HK*3C'8X1FJ'0%$5V=R3EJZ,\#:4V4ZX3Q'"<F/F
MO%1M5Q+0DFX\PN@%>ETW=5E@IO)I:"P^_0G-=&;,ITV%IB`J[#X`6,'SM"\6
M>;!LV%&<[RP6D<]@\=M>Z)]HA@Z65VP:MJ:E:#(F,'"]\K]20:=9>==@Y)AE
M??=9?0PZG6KF3"E$ZM9U.P21-7[SNC$U]?F1B!0T]U53-\#:;4ID:_NJ^DBN
M4;3M1#=EM=0F;41,PE)E]$I_QZ#5,34MB:CDX6!&+&=#.9^#B%6PUMF8%02L
MDUW+2Q!L*FFB_S8D#$U^70J`N3PW!J)^6.N7FZ\%[98^A*Q@$AR(N=K\$/)T
M>AC>!C&2N;?"IJY7\=3(6&[?0@N[F5=`;Z;/S&9SJ=I^;C/,/4G;U#0-N8J7
M)B;U.4O6_=EI'O?::/I/%#`'8\M9J,O>Z:O&=#*;ZU-5/BB!S4PI=6;,IBWH
MNR+>=QK$C^5EVKFBQ`\])BAUE01+A[GB;E,SDERY@@3T37%:BNTT*"Z]N:JB
MV#PFQ?FB8*=!<9L[^B-37*8?:MRA&U-<71VLSD68$[-Z6U*FK4F(CC!10W-0
M*.@FS,'T2!QD91]/=0QX'+0;`^T8'(B4GA3E8#XF#EJ-P50Y!@>YU>E$YT$)
M!^WF@7I<;7JJ\T"DP.>XYT$^(6^',=!8R)&ACXB%%H.@O,][SG3FX-;ROU]Z
ME.8=SYMNEKE^V<!I#=*\KGLCMZ:V=2WQ=9;/@8CG>04*S`$^4W+^#F;$3)7,
MBA*FE)KI<&BF^'O*$N+-8XJ9<%WJ<0N6<!GK<8M2Q6%:B8Z2!U"P21GM_W-M
M$C"/@#Y6A&C=JC5!>5WW2'#K-2$BOT;&#TA^3ZM"=-12:]*-ABW!R<S84FO-
MO,.S);8RC&-4>E@;QL_(20E4L_4!]-54KMTH="'YPL):O<ZR_?I0X>+5J>.&
M>GYX,FIB>PY.1I4B&HJ,BLO,83NNG3<B'7]V-F&`4:\/L9\D7EBN2&@+A:_7
M!H1SE4MYGWV0V,48.C+!0M-IE`0+6P!'(;AVBG8G$2_UV`+,,DJDX?J?8#D.
M+.<QBMYCSBK5"0(:S"TMODL4[;9G,D5GU#');#"/CDEF@]ESY$$?FDS.@IAX
M>!WTAEO7=YRX2N@9D.Y6]QC*_*!T]W:;G81N')'N=GAKAZ.[SYOK0\IWG_?5
MLG(XNON\I9[MNE<?GNYV\JT>0P^>EGSW>0_=5+X+"3UXQ^(7%#X_82Y^X5B[
M#]C.9`4-25;<DN3A)A2SGBSC]L!2>-A*3VF"0BGTT;D=<XZ09^IA2C%W)>DL
M[8G!$D2E&5"TR1-TO9;N/>;JMI4^6K8M0=MQ,A3H$'?`UC.5GC)G.)8OA9?&
MI)9K+E8%.[Z%@_Z'7`-(.)%\YD+N)JU8OJ3J_V")6"A9K*5_A\0#HM*,+]"J
MM$(>$1MN?I9R$HN1;E&J[7OR`V2%!OXU2!=!`PO+@9X3S]L"#2_$6_93(UZ3
MYZ:FY&[W&A`P*-TU80;:3#9E;=8_W?`A^0Z/;AR?8I8@^"\3OC-G&=6I"7PV
MXS\2'VMA9`^<NWXO49W&5&%>\D/2.0X<ZJ)C3$/7J\;Y\$!<PXSW>@G=-:9F
M(\Y8S\-16ST4JJ;)4VUP>OM1:W--G\Z;$3L(G77A;)IFSO(.2%WI1"LC$GS;
M=E\PU.U`>.YW/`B=G?%L2&?[(/W*Q`!M>]ECOZ*7S\["?:+0QRV%MA=@>3"^
MTZ]C<8K5XUEP29>P8MJ8%BT,7&^;O=_BYHP7F*88BJKEUK1>"3PJYS4A;^I\
MJLZ50W#^"4Q*9FL7GBCVTO-(<RYU)_)[K7"KVP-91^"RQB]N:"Y+A.2KBUD>
MPP6+_8\%I:$-UFC>&MK,,&>ULMN,K*/P63U+#7VF:$/R*2(>PPXNUS]/532S
MF0R?&@3U_JVF/#T4!"5BE40:MS64&DUIV'?,:P6]`46'YZ_93J5?#D7D8\#A
M+/,)UII)\.DP7S]]5:.A!NM7MGG*(%\-I?N$U6>R5B_/=70<B)6:7#M3<SJO
M-X6;\-)687<9HQ)7]UG#63A&-NOGVU29#\=FB4"PHZ2SY5]A5&V@ESQCVDRO
MGU6['0]$:]W!!H"N*YV(%1FHKBASY461YWHS>3D&&[5BKQAFPV5&2'2*>_U6
M8BUR"-2\FR9G37PTL&'+"3&?4W09XSHM)>I@73?R]QWPCFLR`S-=VRV=(':G
M5?Y4BP)W+-^Y/%%45J"N:1?)9>T7UWF\I]Y34OX;<Z18;%)<63;U`]>A?E7B
M_B[%Z\X>'MP@^&BY.!O)AH:!M?#/76\35XLLI^WC]AR:>G2][?7J<T#3)Y91
M43S\>(<3?GEN6XZU(/:]9Q'[>O7%6N!<6]YX+BYZ/*>!BEI6#;!Z]?#>KRVO
M.[J*+O^$=P=>:-%V'Q'6&,^SS<:.4\.*0/I38O<@O;0\/\"',:\!L;%8]$_A
M;(7DV2J@'H/S*PT01_\GD.V5:"27?^,E"KASD>T[VR7.OV@0,+>K<SS>\<XI
M.IIUA/DK?;GPPL=F*O0GH.6`PCZ*6IO@>G5+'T/H'!X[BRNR81F`;W>72_(W
M7Z72FK'11(_F\05]IK:[B<I306,!?$C6]^1Y$=%\Q;@=1I4..SS''9W=2-71
MC,[KV(R-%M[7L1D;([PGOAD;(Z2GN1D;(Y(GN1D;(Y"O9S/6!=V?F[%3`_25
M;,:&5`ECWHS%_TS5S"45S4!U&OBDMV0ES#;%X53E1`2'Y/[N%KIT0G9=_0@M
MHHY,Q.>*!FMW67S@/R69)'+)><(X!%_1L\\-@+OTZ/+7,%BL+<=WG4AYW5*?
M$A#S@A(K(IC`Y"SO-M"P"ZTD;PE#AU>MRNY-:W.`AH-7F?Z$=PAXQWC*5&9L
M#ZHYXN$9V_B,T88_Z?%AI6J2Y^(5HM01)%8^ZASPMZ/Y`7K^+'R,/A?YO84/
MQ-[EZ0..V@3>TN(\"+S.&Q,V9CL%.58GLC%1I_4<%_,>N%MB!]OXL7LW3_K)
MK[T?8NZD3<0>2PZA_@/_.C20?)Q'T@OFC7B@TC*D4N!*E[^>WYYS,T14(-4/
MM`>Y&N.#N0L<AI(09ROY:P+H`'P(S=7=O\[/)=>1")`?.H&WG3QL)_%'Z8'X
ME@\_>3'F'*@QPP4T9\?G#M(F$G0?E%!@V2RC!;*%Z2W^*;U1WDJ*'"6VD%:P
MX6._KU`'0O?)`1MK^9WD>M(;]:WTLJ8.>VS#9HLO470+XR?\&/5P#JXPN`,<
M]2KM="MAOTV&7>D^[NI[/1YY@BO?J0W]0<Y5Q&;R[U0B^)V/`_QS(A]Z-'\N
M<B=TS)%.EF5NLO2D%,,--O8:5&/\S/4JV8ID>3E/;L1K$I`FB>LJ6$YSO^U?
M_,%#EGOX/6;G67"CJ'_,KN(4<F5LY3?>]W2Q=O`J>7M'O6=HU<?P8WXT0K9_
MN*0/P+NLXEXO_7RTA;(R#K*X"RYAMR]$,!&VF7U^)8A<$4P#Z"`MKUHX=OGL
MC,$)B@,/`Z9&$Q/&6>;U$=8SC_,_OC*A$&*Z7W1.2%P:H9.<AX*-0I:62UCL
MW16:1FCO]+W_OB;?;ZWE(_W*+O*)_84\N!Z[@A9@3]4T);T0JR*[/6]=[(=.
MO&D:7@LWX<US_Z*+X),?0",!)BDIR9Z2"+*1._B=90>_30PD,&:?[UP[9`^(
M''2;IF%HL:W'([@Q,YW.?AJ3/]=-3=-Z)+^3>3H8^1?NBY->,/,>K-F(##@H
MN[L'+=H]Q/FC&Q#>%Z\#CN"0O%ZZ7OR.P`C*QJ!RJ6IFNDQQ26Q.?Z+C]$RO
M'4K'J8JAF?K^('5AYZ!:3G@X"EZ.*''P2.HXYGJ7KKM$:P-]]99/\*@?>.5)
M2I+J`R.]XA)+<5_PB]`1RKR;;%N\_NYXEZ?FW\5;T=0>\;X,G67Q9.Z;LZ1>
M2BFV@:<V]R_N'Y@Q_P1A%O#QCH^GFF$A"B%SM\`7X+U7AY_:`+\\$`57F^A`
MM"HG=>)%)B?KF_:GHF:?3P:N>,/#YSP1J-\)[EB#3S_PF-0G#S;]Z@;0?W16
MFCMBKX-JXT4EG&1S<D6V<3DG<:A^(T\4,Z-LK(#8OWANR#\4SK5RE1;?V#L'
MOE]CM0[&6'1412R\[T!-9?G(R\N:>M2*[A;6K@V"(SV1+;R#%2GP2U.6EO`%
MC6"ADL-`D3SZ[]"*"W(\;*5'ZQEK7<QT?-B']BW72QYU5Y(?+M91FUY\92&,
M-O?**BH9=O9,+#LNC/%Q&S<%6]FX[5,;)Y\Q)9&(*YLBKBGLK%J(Y4L);_"H
M!.+M8I&4P+.P3BBKJX*#![CC1:$/PXGW1^R2X04;"9"6J+I;=C<%L\FVXGHD
M+]3&8BN`U3IWS[NP75;3!0NO)&5+;L*'A2OEF/L?[`J+G/C6CZ2%['9K8Q,'
M2\7<TL?,>,!$QI$$65A/9F$3I(PF69EXEUM"`Y^(S%?7@;$']8AH?G9@!Q.$
MT7E)F0-W=A*7&O3JO)5Q_\U!8?=9R99[^H/X5Q=GJ)93[5>A]0K61:-E=9H>
M[%3RWAD@U?A[`'0#XO9$%MMZ>;FCFQB.6?:YB39QUX[_J[OY#@MD!DV_W*MR
MLL//\=60554_?5;/H)$E-@2[S@7H<-!MKV.`4^'F<]B>_Q,9]?[Y[W(&=[ZV
MZ`H6IT6(J]GU:@7F#5^?`9[$2XH.W=$@L+E60A7K@HRC<\L-V48Z#[4>L6WF
M<53<,U16%4PN[D:,1GY_),QTNBJ&V/[U*O^DV+V=-D)PP*PN'/5^_GH)^,1K
M((?3=#V@'EAS3[@4?W2=T(\!W-N;Q]X"IRXQLUP`7#/.T\F5_'1+'?I"[+H=
MXYYJ$8J+P(T"2:<I"4$`@7%0EO86M@+0L1]YM#$+?!*X<8G%V)L--@CQQ@U=
MVX(7-WHNMU/+E4N,[>\*OO;B(]E!34Z:,I1@@!-_Y>JI=$6\"`XM]WFL4J,P
M1;,3-RD"`@<YL#Q_(E</PAYRN]/UM2.7UU1-,,B?_7VAQ*?%?+O*04*YJ@CH
M0F">*"W[W*SS:%N8G4(!BO>9.KQ>59M'=93,Y/S96.!*OQ$G)-Y64MY)JIS4
M#Q?JOSNQ?2P^R5)!E](5V?Y_>U?:VSB.1/^*=SYOITGJ(-G`-I">=`8!)I,@
M2<\@GP+%EF/M.%)6DI/._/HE=3BR)4LD31T^T$`ZL774>RR2Q6*Q:F1D.$XD
M@>2M4ET$IQ!&].W]XY),\T]YXNBK9"Z*KA8Q&SC\"3-Y4[M&+),V>$@><O?^
MDNX)?7]^F0?OKIO6V7VI3`*2>NK*5A4VB%5(]*X=T0#H@D>ZMJ$K\U"*4F09
MMFE9>+\Y0AI5RC#8"&0>%E^2.@41QL`NUJO;(Y**,YHVI4($0+*?2K61+TFE
MHI9AV717.&+VR-3UX@5#<N'7'/%9BU6C6G0J6?P08`%]9%7@Z8.NLE&IJPM^
M,BGMDC`NX444+=S)V8)'T*>7I)N/!?&C?.M1B0_Q+I94`D800JM0/4M>2)TZ
M\;%\ZJ<+(6`7ZQ:V`*</MK1J#`3(P#KGK99)*@SY?[G>TXPM+$]?W=!Y<G,-
MO@X;/,W;+>M^W)X]O+CA0R+EVD%2>(+:6:K401TLNRJKP".[JNQNZO9UC(*3
M8LV_0V=498E9SRYM9_VT%^RJZ2MMQ\VQ2XQN93H?]565735]Q0/7UZC1FDN?
MO+3EI(E5M%;K#0';DJ!5*T;-[)9LY;WD5PIEB>''YB[S*-UE;MQGQ_/YN7?&
M8^B,XX4SY]M/2.0`G/BZX>NU=6]?FF=K='8+:0<8%5\K'!E58W1U(/AZ;=_3
M(XL"1UW%]9+<0W")R)%324[7-=.\MRZ1<:11F^><JZ9U"8^,;F4[\8G'O$0#
M8U'/>N*"O<7S(V_\IS-?M.L\K:UXWS,D18_E+D&J60^LGX=%-C3L=M:OJT@&
M1)>B#W`]^I)8!&C<B=Q%YL05S8;0Q#8Y"+JV==ZMQPC8@`)#9K&^A]2):QJU
M*30`ZHBNP@GV*-V"OPN*]4`"/VWLZ31)P">VJ%L>A_YU[D31U31Y1!I?_O%(
MP0`32C'"Q%HY:R\B:4O@D$YPR$20`F5H%_XXY`'@^>=7T\+%0L64`%BQE=2@
ME5781!A"3+.")[5BJF/1I'550STQ*;<INA,>U1\&A18_[MVI0-K8Q!8U@(SL
MA8_2"*"T1UP(]-56U+NRYUH88,1#OL4EUH"OS8$6$\I,'-@O(M0DI0$AH83T
M+*5.WJE-L)HB)0>CW4G$ZX_R"_F9J4R4Y(3GRDU_N$)9\_2-HI:!J9&/HK*B
MM@FQ?JPU39MB;`]0;'WSFPV@;6Z)<.Z,L_-^7"`GFIWSJBZZ->R!V\]7TX*M
MFR;3<KS)W'D[]9E%+#(%<3,K;])*P;>')=4\>F"Q\1KJ1E4[@VI404@@-A5D
MYQ4*HR3=US!5+;$=<26PI>@ZH/6@;HDAUP*RCE0N-:)5Y,^RZ]VXWO/C(HPV
M'T7M7_T@,FQ*JT!6@=`+MP>59$U**D?`%M!VI*80&`!)MZ"`\V`0&EMM`1/;
MH(:P%V0G,#_<+AXC;^(YX3NO4E1\Z&JK"GK!(*(4B3O!>N5H,_2/M)&BSC]L
MXMQ.Z!YVZR-:-6@$`>VMJ=O!K+D[6(104]QOVBM%&GL#AK:Q*[!Y`AR?%VGC
M27#"Q5(WI`Y^K7A[=AQQ]$VPE2V+6J"[_M^*75.)S+0Q,=6!?43H\B"3'LV9
MK]?X?A7%JFC;"][2Q#,TP<7&"%X!$ISMD-S+GLZ#L33+K;&WBDB7;T&?3O[+
M7LP?'-T%IY.)QR]RYM=,QR[\+'%X]I2T1P]BM5%5W8E8N'`^4QK7P$A1,BZJ
MRO%8AFFB(?/2BW>!`M/<'U(T*0ND%L;6L'CIR#EC4HH!WA)YV;.3)S@<\!8*
M#^&J]-<79=>#KH>>3@"J]&QK`-?5ADHAE68CA&^.__?W:!P&;YN2A?>O<&B9
M`7U%6F4(/6B540_A=#P.V9#P,?9*='\](SFUL9EUZDIA&B(G[H*KT'OBB6Z3
M3].:.^FN,?_[^T^VHN/UR6K3=\H&@)C%VF5ZY&J$>1Z$S]G-W8"$E-B6;3>@
ME!$KQ_C##]UQ\.1[_[B3ZKC2NBI:RN<A&RJ9H,S%(RQ=*W#TA-5#2HEI6+T`
M6C\JU+#31&QBJC"_-'_F\V#,L^8.19,H+8:9BXG7#2#Q\._R6JQ+&,:J!C7$
M2@$3@IX$M64$14Q2T)>DK8PRR+8A[DM)I([*RBTE>]3U^M&2FJ@W#9(;U@E1
MU/5BB1F/9SI/JI?-YUFJ\]3X$"]$\%XH1)#]?N?%W%R]\"?>JS=9./-$7U([
MYLQC,U`<A(EU[4>+><Q=D@T>5\7.8Y5*ZC3CS1E*/\[W*R9)3=+TQNR^[-3-
MSO!3;6:G64IE`&M-.O-;NCNDFF]&CWE1S#VSS>'9?L%VD'-/'\`!\]ISYKV#
MY%@M,90A<WAR/WD=XD13WVA22;'WL]%*F3YD@V@ZS)>FQG#QN$D&8IG8;GO3
MUS!MPS8+$U?=ZW2>%5\EX[<PB`0=N>HIQ%M,YJ$)C52DE_;R,!4@!L"1S@(Q
MP+(1UIA583<8D](J;`(;8(WYN#=PM%PFJ3\Z>;*[/I!N2K&D,[=>Y\(/EC'Y
M/'KPR)]$SCRC3XUK:PA@?_&RBP(Y8H;EE.@*IH9E<QLP\X+1J7?K]-7QYKPT
M,EL")5A%TTE=SQW_#^<YA7;W%MS-@D7D^).[69A!Y%<(SE86_Z=ALFK`EH\?
ME\Y/[WGQG'6EM"DJ([$3E]^R'KM8H^LDAF("K2Q005%H+3J3_/C3C>)EB:+J
M2JYKE8+LAYMD+SZ)SV##$Q,_6TV+3S?FO0:]J)!_,+RDS2K-B[6'O."COC3S
M<M27)2_DJ"_-O!SUI9`(ZZ@OC;P<]45I6;R/>B%GS&[J7$=RUL@I]K"6>XZL
MPZ'XR/0QWIC]/V:?.4\\,+SPFE:70R^+BFUCGANV341:U*GX\$("VC3(/FUZ
MG9L*E41!'=FM!8`LCX84"7UZ"MTG[C%)HK5/_4GAYFR9FJQU;]S(#5_=21*\
M+9>%<*-2O;GS5[=BF!;7,9AG2M(&J:A5A65Z=DIJ]<;S(#Q?\)K&>4JZK=TQ
M4HQ4.R'X_A0N1&Q(@]#CGHMG68Q_GDR5@4_^[]XO8R"("=&20GXCJOKA^^/3
MXED=_L126VA3)06B;&A9B("Z85L!R9*:#W7.W&*J&2^`K;&H-?N7`1:3KP4X
M6%N9>V@@U#L<H@N.36F>Z;<W-$JE6:J'(6.98+H_-%M%/ZSDN>H/@Y[H!%"(
M31@6'KDV*69;:@>#;'BDTO#<$"HIUTBEP*XVT:J,WKN+5F5P;P@OEE/>+M&J
MUN7:4;1Z0O*!W)3=*4*TM4]9N%@UV1$6E#S(`BS`)%IZR"3LF+*O!1$58H=^
M]Z::Y^6OUQ#<2R&KEZYSJ.*3\LY#%9^1=QVJ5*WP'8?:%!:+=QJ=S%[=CC=D
M4[2I]H;455&7;[/PHC[I/LRYXX5),*5@S)22)5%*_6%!1-9/>+8`:2BT*2XE
MUVDSL&VMGRW<8]84EZ2EBDK06C^"L;^DJ5><7LM80DNG@_>8-$VIERQ(,5X_
M1-8%;2I[7LO'G4;1XCE]X9D7C7E"BO,@O`ZB^#7=D+]A_[%U37)%6Y/$^BZP
MF2S"3*3C\)0:TH&3K#*E5)-LF#)Y``Z*9)49Z$BR',E*,U8UR0@>2=ZX[!1S
M#8H&.&5:#74<F=Y_PFL\TG*$0ZJC,/M>$JYBPZV3;*0DDR/'V_G6-R@O&9#R
MJICE5:_F">S&W*GCAL^:72@50<FM2#T<;F2\^X?&C<QVP(%Q([5_<&C<-&TX
M)&[X0R)$9H\"'S@W59L:/?"ART[(W_)GP).'SKWX_<:)6PM]JSC9`$^LMI:H
MU=@&2*4.SU5"I6D<.I4Z_%-I9&);?M9=H5*+%RJA$LMDKMU+*EOQ-6&`VUH]
M[B:QNGQ*MEG:LCHX8G6&CU:0#$_LE4I^1Y*WC4ZM)AF:!S^-;>6ALX&]9UIZ
MQO-+N_ZD8S,?G``=QU)%D0V.1DTF_J'3J,F\/W`:=9GVAT[C5KDP#ILZ'7N3
M1QJ5C9M^J./!WQ4-_8-)&=VX+Z$7U5>3!O#3N?N8XD;TXW==AZ2Q07A@K(B8
M.9SU!#3II2N'GY*\I\E]8W955ALVO:X;L/5'</-2G]LAJ<\*\FL0Q34W-Y7F
MTL=#J3X%P;0N"4B3X#GLK-]EE6#_\N(90_'JAK'W.'?_"&+!.L*-&DHPL+-S
M>,VOU"M<58W<BCS0Y1?>!1<^CS\(PHB_.Z5/(JU2(RN08H3SXKSB[VY'VL92
MPLA$D-!6A)7-D*&I16630#26NK,Q,6FEFF]^<W4U^/SN&UX;+[D]2]5S-6VE
M@T+3L`Q45?9=0I).H$AT9V$Y]'=M2FR#&))\5G:<]D`T%P]'$%"S4Q#MC01M
MB2`V*EC27:LT0&17;QYR3\=CAGAIO.I1`<)(ME9&-&$!JL=@+=W+,`C%)JH:
M:=7?VDB&9;.W&N:FM^9+DC,W&H=>8F==3<_<J>=SVXR7NWA<\`^OF9'&URA^
MFJR.ASF&;NR%B6+P5'""X^#7NYD[>F'7CT+W?PMV?S2"B-\:N6/VHE=WQ%0H
MGD6C8#KB*=]XU@5F)X^<T7.Z,<*_L``8S8)%N'+5-`A'+PX;F,?>2V).GGPL
MN+9'M\I5^0'LFLPJ#B^=>#S+J[`L7Y`DDI1MT<J59+%4H+HH$H!X>"NG(_"=
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MG]_>WDY^/H;SDR!\^HP`,#[SKS_S"W_AC_Y<>G;R*;_%^\)_LC__#U!+`P04
M````"`#TACY#V/2A@X4+``!:I@``%``<`&9I;"TR,#$S,#8S,%]C86PN>&UL
M550)``-,Y4E23.5)4G5X"P`!!"4.```$.0$``-U=[6_;-A/_/F#_@Q[OZQS'
MS=JG#=8-;EZ*`&EB).VV;P,CG6-N,NF14A+OKQ^I%\<O%$G)LD09`]9$X1WO
M[G?B'<DC]?.O+[/0>P+&,24?>\.CXYX'Q*<!)H\?>]^^7O;?]W[]Y?OO?OY?
MO__'I[MK[YSZ\0Q(Y'T1;288`N\91U/OXM_^18`CRKS?4EZ>8'7T[NB])W[\
M0DF`%C]Z]S"/8/8`S#LY_M%[<SP\\8[?G+X].7U[[(V_>/V^["C$Y.\'Q,$3
M@A'^L3>-HOGI8/#\_'ST\L#"(\H>!V^.CT\&><->VO+TA>.UUL\G>=OAX(\O
MU_?^%&:HCPF/$/%?J20;%=WPPX</@^2OHBG'ISRAOZ8^BA)3&>7R"EO(W_IY
ML[Y\U!^^Z9\,CUYXT),V8#2$.YAX2?>GT6(.'WL<S^:A%#MY-F4P^=B;X+`O
MS7C\[N18$O]P1@FG(0Y0!,$G%$I%[Z<`$>]YDN>WNZNEX#[RHY@_"2AC!AP3
M_\BGLX%L-2CF,I#2^2CTXS`QP[6094U*>(F`!!#D<DI^NW69^`3UUWH))0J4
MK1LCZR0Q]03QA\3>,>\_(C0?2"L-((QX_B2Q6_]XF)G]A^SQGR/.1:]G,6-"
MS+R#$#U`F'3[I[K=H&$ISQ"?:H1+_KR)U8BMBX>8G[,0/ZX!M>VR68L!CV>S
MA%L?BU<YIY\P.M.9)^^7*L3T*`N`B:%'C#PQ%S+0N>2/PI[W#/AQ&HD_-6[?
MD>_3F$1\1(+;:`KL#GS`3^@A!'X#D85W6-&[CY"E'3((W[@$X9C!'.'@XF4.
MA$.N@.WK;4/M/GQ6-LC`.W$)O'.8@!`ON,1$AH(SRI<""[_3X&8@=!\RD^89
M6C^YA%:JF#%8"KE:MGWA,*=\(PP1J=G!C,Z!18NQR(PB\1Y?_!/C^<SX-FC)
MG$5#KZQ=K&D2G&N,'G"((PP6@471N%EI\Y`^1@L9QX5]Q1,60[`MF?C;#26^
M=;93FF6++E@,6E$.5-Y@[HTC&[K<02@G7&/$[)S7BKR+H!88PKVQYH9&D`MM
MQDO5NA/P*-6T2U0;G893\B0B%192E@/&0-@)C$S*VV6JS<XJF)B\1O@)2H5L
M+5DGH-(KG@'UUAV@5J2T2Z4<@:'(_AJK.Y0<W$?4_WM*0R$7ESEWM-`87]&X
MZ2E1-E-.)/D-A3%HQ%6U;M%GBDVM6,+95M,]WSFCLQDE5E!L->T$#ML*NI<<
MCH(`IS*,$0ZNR!F:XT@*5)S0%U!T`I)"==U+%,_A"4*:+&+<1^@1+D@$;,XP
MAW.88!]'8CX2S^)D$G(>,TP>-RFT^<G.S#N!=QU&-">E_1:3G1$)2@5A(ZD;
M:9%6K6[F2C(<X$@ZEM1.3(4BX6Y`?'W&JJ/J(%1:(UB&QZ[IK&II&6\&&X43
MOWS_W>M_]=1\B%%.:"T!N9W<SH$E?54O_BA@UT@52$'?#6]M93V3QVP/5?=V
M;[=M>B/N,\+DFG)^2\XQGU.>I$>W$^/^G)ZNU4W30@`V7TR#[N80TF]CFWO.
MP,>I54DPFE$6X7^37[7Y7C%5-[#2ZNUB,<EG($*U4,H:S##!/&+)<EJFJ.[5
M,E!V`S"C_BX6D=P!!V&1J9!Z92)@ADQ/UPW`#+J[6$5RCT+@=T)8$H.^K&&S
M93<@V=+/O.[>0DA:JG-%1%H&,J+:I#PKK5M,ZC7"VZ)AFF-V0#6%1YIC:N/+
M'C>4T'6=S"-S,4VSLE_)E2?@%K%DLV6+'F0T^*8?;6EIF4,W/>/A\F4`D?A?
MO$C=8LRG,MC=3L[A01=&S+1=0LO"$N[M6+QN3*],WY;/3*6^)MHNP6=A"?>V
M-8185FG">KLV85$)7!@_5YLZGAY8*:9Q2LNAH7`)L_KRY>HZGSP0=!G2YW(K
MEFH.>UND5'?7<)HN3]^(OL>,/F&APZ?%-P[!%5FZ[L@7PX:I@*8$DZ:G(55'
MEA8G@N4AV7H_UY5V\6#<A7BCZ0+@$Q"8X&3?YWZ*&'Q"0MDS.I/#B6G]TIY'
MQ_$L82P7%SU75VG%SR%47Z8N).\XPG8F<G%Q]`"WBG:'TVX/R:E5TU5/2^=Y
M0O3D;,.8P0S',PV69MJ.XVEA'+OBYS8Q34^""GV3LZ#6<&Z0'122FR;)0'SG
M$HC[7IGJ-)SVBU7_KP?3K6FG>)!(<4O.IH@\PA6Y1)@EI;U2@GSA1?6^69-V
M%"1[TV08O7?IO1,S*`9(UH2F_UZ1_*S?Z^45Z\?]M,OWI9EU%/1=S)>YP0>W
MW2"[#"._8$%Y*48I5[!B>'#N8&?&Y=J%VSYA<[:[TO"@97AP/F%GQMPGG%K0
M,BI30ZQ0<SIT+RB($D.GUK@*['!%1'ZSZSJZBDG#9R31(MFH^$I'_C\Q9@*D
M2&1T\LBV,=Z9:=O=[BH)V]:Y2K-I'"QWV)*Z\*Z<,L@6,SDLB#7&<K%`2FV`
MY=K'+D.3BDGC-UKY``&_%,#+";\0]'9RQ7F\O/5,Y\%F8O<\5P.<X@8LHW'<
M.Q-W)R8&BVQC?/5&$&VI=0%)I^$K-H2#P\RJK^4N=CM9OW9`C)7I`Y#W\LHG
MEB]G"8:=1KRJ$=TKZ5)K\CMB3,1,VS%907B`\+X:Q;VKCJ3"\DRN^$=F.4\H
ME,/1&!BFP>;,30-J*38M0EQ%747UC?64V/%JP#V:0YE_.W[6>X_F4`XBNYX'
MKUY,F<]PT,KDYAPBA,-R)94Z/GLKK-1UVOCEX?NX;]<1'3XS?4VE@;#5=4L;
M8*SO$\X,X6*=Y>I5-A8U9E66@6KKHG,.49]Q+>=S.U4I*`K2<HD,2)>A[@R(
MI4QBCL0Y/HI@7#T,RTG_ZU[8YD6I50*R'<>]A6:[[IO^",[>;M]MNL[Z(;HB
M/&+)A[4ND0]B](D-5](6D+3Z&ML!LEU#7:2^BX%Y7=IO!*6!0D22K++4&C45
M;>?A4QJDB2B9]Y;M.G^ERIHUS3I6!28=0JN*B>R#YPZPK7G/EH3IR1F1GX6I
MNO++@I>`9(`J@K`ZPZ[!N8/I+*_!K!':C5+\XL'2FK33<!69H][C"!:XC)E(
M]/`<A6G0S?22#K1RX[$53':<.HV:I;&LCR/4.NE(CXY^12_59A@*\KU-)Q1]
MM?2!.2%#6NXC?M@H:=4F<F;JMCZ9MY1IN7$A9\MG(JHO)I0](Q;HUO[*<&GU
M52X!8-$G]JPLY>8<Q*C[ZNEB,6//3R"KCQ_+BI+=O+U\=P?C/+78WLWCWT9-
MDY+_W3PG97'`WI#9R,4SX%O2VWU;=:UYB]NZ.O$K`.5B2=V6V'*ZGEHZ#.ES
M]B%[:\`4U%W%3V4(V^HZY<9[G8GW<,?,>]ADZCUL.O=>BI"]>%F`U#AR$44+
MAX52.>[`IV(F&*8;AP7BC:)+".2UR?+&J%B(M'BE1Y'^UL@Z^VDUN!K`5IPJ
MJM/"+F;O!2K>4/DZQWZR.I&I62E=KX?_`3A-68NZF(07J)8?S-\M/ZB!^0&X
M22E;NIC&EW!_RZN[JG(\`&\P6\W%6Z`*E$F/Y`=_Q3S]2E-YR+<X'`#$VU9Q
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MD^_,C![%_W+1EO7=K_=06`Y=U?DYC-@.1JIW'7<W"&T&O8K,#@$\]6"XSR+Y
M$GYE&A@KL3H$U*K5Q.\<P(K#:78I[3F65W@00Z9IS\9AK,J;Q/K:?=79A8$4
MX`%Q$+_\!U!+`P04````"`#TACY#B.I:AL(_``!W4P0`%``<`&9I;"TR,#$S
M,#8S,%]D968N>&UL550)``-,Y4E23.5)4G5X"P`!!"4.```$.0$``.U]6W/C
MMI;N^ZDZ_Z%/YG4Z'4EV9R<U^TS)MVSO<;=<MCN9>4+1)"1AAR(57FPKOWX`
MDJ(H"5<2($!'+XG;QF6M]8$`U@5K_<=_OJW"#R\P25$<_?V[T?<_?/<!1GX<
MH&CQ]^^^/=U\_-MW__G__^__^8__]_'C?U\\W'VXBOU\!:/LPQ?<9HY@\.$5
M9<L/UW]^O`Y0%B<??BW'^H"'^O[S]W_[@'_\$D>!M_GW#X]PG<'5,TP^3'[X
M]P_C'T:3#S^,?SZ?_'S^PX?[+Q\^?B03A2CZ_=E+X0=,6)3^_;MEEJU__O3I
M]?7U^[?G)/P^3A:?QC_\,/FT;?A=V?+GMQ3MM7Z=;-N./OWWE[M'?PE7WD<4
MI9D7^;M>9!A:O]%//_WTJ?@K;IJBG].B_UWL>UDA*B%='Y@MR+\^;IM])+_Z
M.!I_G(R^?TN#FB[<)LCJ:9H#G'\J__@=$9>7^$D<P@<X_U#]^.WA]K@;BK)/
M`5I]JMI\\L(0ST1H^#G;K.'?OTO1:AW"[>^6"9PS6=S.3R@_)S3_&QGM4P=J
M\,\P(JOF8P#G7AYF&FD['EL3I?'*0Y$90LNA.]%9#/%Q57QN.HG<&[<+A4M,
M3.+GS_!CS;A&.FFC=Z$VBK.IUD^F&K"@:4N0:/`Y"C^27?.'SY,?BD$NXRB-
M0Q1X&0PNO)#L:X]+"+/TNP^'G/F>G^7I"]ZY\P2F*/*_]^/5IX(W]BB&J%M[
M":9C"3/D>Z$>4O>'U$?W8X;_2\Z[=#:?X255;/[MQ<L83A^]Z7:">.XOO6A!
M:$FSV/]]&8<!/IGA'SG*-G@G1#[*6K.A-DLW[IHBN_32Y4T8OZH!0!^AJ\Q7
M*Y05@WI1@&63X0L3OC@AF#YYSR%472*BT;I1>UW@T8*PO8[=:+B"J9^@-5GP
M\?PBQ_/`E'#[F*]67K*)YX]H$>$;I>]%V=3WX[P0PCU><D0,5S#S4*A&O)X9
M'>!ZU#_;HXY\/\"0;!1X6\XV6>)%*:87$Q24HV?P+<L5MWZY$;M1?9_$>%/.
M-EA:9.6OR1?99N7QQNE&X=<X@_?>AGR0TV*GP*I;AO"_R!]:?25R(_9`]5.+
M1:$T<-<O.4$O^+Q^:?U9'O?735$;$;)',79"MEFF$L/II-=O3M!AUY(?5<<)
M'[00['Y/C52T$1=U@*[W1WPOG17'X3U6&-JL/<80)NAJ\P7S1^I&Y6]>@L_:
MK-V6=]19*RUM1,48HB.2^3/1>/!\D$S::GMCC5%01A2I"!%\[S`9>P1B!B"^
M`P5;$LE@W73^P@8;^WNSA,3J&2=44T=AYIA[Z7-AZ\C3CPO/6W\B`OH$PRS=
M_J80V<<?1I69\]^J7X-:.<.LP5O\8[J=)?2>85C,#=B-P0^EB&Q07*A%,M06
M#<'H$,QILD^SE_C;T2JSDY(==Y[$*PEQ;:>,!<1^B!.LRO_].]PC3S$E<;'!
MD.^M-&7]3`XSO/RNPZ(;_E;@@ORP^WL8IS#X^W=9DD-[(%V&7HKU_F*/G+XA
MJ=5UV`>,34#',8!RH*SA$<!(X8&):-_@-&F[VC.C4U`Y;@PF)N!@6?8Y6-!D
M3(>%RL3[P0-<-5TKQG#9]PT9`Z;FQAF`'K&.!M/I/1X2)@DQ(V-RO^SY=FC[
M&;L7.#,"%<WI=`P3_6-@[&=<'AP#Z*(50-1>X'Q0`+%XV`(T<@2ARU8(47N!
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MRK8J1M(LN;-KX4-M[:'@^FT-HQ1N"=]CG(.A1&\PLJF,JR(HR9`.S5P/?E?5
MG>0&1<11>!FG-:%XR7&@XW<$(YOZO"IJ8EYT*/8&K@FRUP,PLJGH*V^#AZ3K
M4.]U;7=E]!\)QLBFC1!`_L?"ZP9&-LT!TE<V$0ON'$DE2\)/`XQMZOB*5V5"
MK#N'QAWRGE&(10;)5>6Q\3J@#/*2T%YDAP!CFUJ^BFZIPI&34,JKGNQ.8&S3
M%*`$@1!%"FO.*4^[`&G\FR2'`87^*/@:1[ZT/J4Z)!C;-#D(\.+K66U8=74)
M5&\H[KVD0;T\W-3N8&S3PJ$#6B9;[EQ7BN<,%;EBV"BMP=BFC:,52@PNW#D6
M#Y^;2./#[PC&-HT9K:`2,^2.;KQ[[W+,*M>4P>X&QC8-&:T0$['CCC:MA!*-
M&9M6C5;8T)EPQY/>H$\."C"V:;WHB@&AWAT7>>-!V?3@'1SWQ&'V`A.;)@X-
MVIB`-W<N<:UL(!R13&Q:/30`QV?-G7O>?DS&KUZ8\U[]4%J#B=W8!ZZ8F3XJ
M&A?.*+;DHX\C*4`.FX*)35M$*S1H++BSKTV#`)53WWLHN(TNO37*O)`#":,'
MF-@T);1"AL.).QO8%7R!85PX8AXS;P&OHPPFZP2E\*I,T3/U_7R5%U:0JSS!
MQ^=A#ZYBU'5P,+%IFV@%NQZFW5&*CX6@="4!$YLFBU8(TIEP4NVEWJ\ZN,W`
MQ!%SA0;_"Y-!P;?U:?]-?=^O[/?3U9V>W,M2?'IR?WIR?WIR?WIR?WIR?WIR
MW\=3I-.3^].3>T<!.CVY=QVATY/[TY-[OLQ/3^Z[R?WTY/[TY-XMB"29<">>
MX/3DWOTG]_L4WGO)+"GTKJ!P!M[#Y''I)?(^:=8`PWFB+\^/.[?A?9H+`M-I
MGBWC!/VYLRP+P3OL:/<Q?WO0:'RXXS&ET7J;IKDR4&4GNUD`NH*TX\$=AR6-
MSEF>D=INI'2=(DJ-GG:3`72%ZH`1=]R9C0B6%N>71&^[*0!4<)-DQIUK?(-@
MA6.+T\ONP_^66-&8<.<:?T2H\+1B]+";!:`3-CL&W+FZ'Q$I=TCQNMG-!=`)
MH0,NMC#]S948#49YOE-\QBD^PU!\1O]K7*UVXVGIGY;^.PI-*N,#\;FTCJ/B
MP9!D>!*MWQ!#E!A\../4/Z!/&!E#;>],L!)+VG206+R\-W!<BUS2@I)[`4P/
MI()8!(-K+XGP?3L5^G3H':R&+3$_"3HV3`Z<`45_5)E-:Z4B/'PVW/'4Z(\L
MLVF:;`42BPUW/#3Z@\MLVB1;@<1BPWBTD\[X,IO61DFI2W%A.M1)>XB932-B
M"\%S^-#A*>DQRLQJ#).ZY'E\N./_,!!J9C.,J=5YP.3#'7>(@6@SFS%+K6!B
M\B%PA]CQ6@G!.6IK-R))$1(J]5L@?K(.!".]A!`4;C^[T4B*``DYV>F-]M%J
M)'TH_2?TW`]B^)0&LANRI(JG,FLUP`Y8!CJFR1A,C!*==H=,-`JQ%)30@Z&$
M'U%)=\@&0U9)&753?L3W^((3EZ%L7^%K\1>^>TVB_W`"DJ39<2>,ED%RN>XZ
M0'@PP'!"EN3Y<2>V]CZ)?0B#]`9S3N@C:69F\\;-EH.?L*_="BAJ\=`2K!BS
M%0EG+Y<0PV8DV=O]0B>*S#AD0.)LWN6O;^($*_`OR&]]IAV-8[<2BJZSC<J6
M0S8GWI:N`5K&0'9+GF@[\ZA\Z;!447?1LI``">"8S9N5!';55VY)ID689D_Q
M+ATJ8U-M-YC=>B:R>VQ[WG08M_1@QST16XYFM\Z),?1VS&DQ=]&]78WO?9H]
M0$(A_`*3!4QX7YFHF]UR)K*(R'"AQ1"E*GKN1R+L9[<RB0;A[]BHI6_?[C$-
M_I6G9<6!IYAAH"X(O_!2&!#3*(S2XBU)\3'/"KK3!Q)IGZ(,5B=K>>H^0#]>
ME$AQ[?N]4&"W>(K*':9'@=0+47M\C0P3OWE)XD5953R:L2^H#V2W1(OL1M&.
MKQHP[;$Y,O3<>*@\0F;S7=&EBDC6OMYY7+M%773"*62S1E>[2:<Q]1.>+IW#
MA)@TMMFG-T6N&31'?K&//,65)VSOMPR`=0QMM_Z++,:Z.*UA[F(JHL+\`#.4
M["VOFC@&>IP>MDN]R($B8*"6M7WCC<P6T:@^>`6?L]]0MMPI6#?0(^\A.]ZE
M9*:P75=&[V5)EN-ZK=B/6OH*L]O(CU?P+DYY=KR]=K9KSLBC=D1V+7J&*:>?
MM\7--_.77KJ\">/7TY/YT[OA]_!N&']R9$G?)_$+PI_&Q>9;2DQS56J(:#'U
M\=E9UB$15_)3'\S,"V,S6Y,Z:^Y$$[4\."R"TT[@4N>*.X\E]ZXIQ`@3^2B$
M>^0^Q?J^3Q/367T]JW.1&!*..WO`]6H=QAL(+V"$L2I*R=+MA9P5)#V&U5>[
MIJ"D+QP5F3BS\US!=0)]5-"%?PYA`5$43%<Q5HG^%*T#F>Y6WP3WNP0DQ>'.
M7O`+EB&1P2RZ0NDZ3@MX9O-IFD*JR5:JG]7WQ?T"+I*#.Q',S25(S&'/&:;8
MC_,HNT_@"N4KWGU!U-?JV^9^$9>1A3M1S_O4WJ#(P\*)%I=QROV\>=VL/J>V
MB?61&-R)BR;;4$J8AW@GNGXC?.8H71(YE6M4L)5S^]I]QMW_?BX4AK'(:C+[
M++HL<A7>1E1_(,N/*M/5[D/O?H!4D84[(=E8!`GT2$GM\O]-IHNKA(12+SV&
MW8?D_7[/2D)Q)Y#[F.RI7]PQ4BPQB-?P<P@?8/&T]-Y+B"B4%H9H,+OOVM4P
MD\5=AF=GM/)C\O'E<NTA\I"XR*=0Q?Q@U7*6+6$BU-?:#6CW^;R9=2#+MSLZ
M.D<.S?+PG4X(RD!VW]H[<TPP).-.!A/V5G<4:M_@I=5YP1O0[HO_%@"J'APB
MYAT^/`Y8T'!SH(YD-]M`?TO@F&MW#@MY3Y@6_[W=E`6:?<,*/+MCUV70?1MA
M)5=7X`9GL.'D.VC'FSM`X\UG&\?H_Y&C!.]+F1<M2-BB\/HO[&LW]T%+:.@X
M2_'JS&%]1"T6`MYRLLU]Z$49OFR0*/%U%2<F#2]S$+MI%<SBS&7:^1.:(@0M
M&[7=Q`M:$5=CVIV=FT%W[4_2<41S!AM.>H9VO+GC;6VF@R'.(LS/;+[-"R/R
MN8H[V\W7T!(<QN8MQ:PSI_0#7%>GS7X6`PZ<K"YVTS9H!9''HCOG+3U'TWYF
M8GQ;*'\!\1_;)1(3#6@W.82QCU=-`.Z<R70>.(^5Y3K:S4+1`\I-1MTY>.49
MUW*SLILL0BO*:DR[$_%$B,9[#/D?T?->O)"<0V46BT,#+@=SE6'<3QS1EBO7
M89WB-9HD&[P<6>F9E/J[GS)"F1UC(6G%YN`ADA:/HYPR6@XC;P.#<)>BP\H,
M:81(KK=NU\Q.<@:>-%F^MGV:G='XRC"#)^^-:#4"L>^UM),;H8WDC\AV1V?;
MOJ[_&D<^_G%GX8L"RLV$!."'<9HG4,)^UG7HX611T,&I.R&1Q$IT&V'*<L)^
M(V='^=S.1]M$'G*I4-H,!R8V33=:X*2OE+;"T+!;B])1;?7-,F4BR<W">,X@
MU0],;!IA#"`HS;6.O5T=*Y8I3:XCF-@TIMA`JV9;AZ%,#:ZG^#[T_.)LF2[H
M[F:E_F!BTT;2-W@T[HT5IU7)J<ROC=%A-#"Q:0TQA&\'61BKBNMZ;L8SF\84
M\]]Y)\$(S#+]I"TC"Q65H?1>%.`E3@0$L6A@6N2N4DAA1EV@7Q`>(XLCN(W(
MJ7_Q!6;+.+CC)"I3ZJ^4NZP5J:P,9=)]>TQ:IBHZRC*796G8J<T:X=J;XFO&
MGPHF/[W8-/\R?4,\YY#\(&92F2UQS\3/G^%'_%L8I8U-76U)U)BR?/H*?#IC
MK6O25I;EE(2RKN%IX@C;`O4QV"/I^!13$[H8N%UETG<#$+B"<R\/,\-`59/T
MCE3-GBF3RO3Y.<ZR"Q235X[>&N89\M/+.%DS*_1*]+*:\XV^X(\/.3$/IF2.
M)X@3Y(6/8>Q%_P4SK#F0["$DD"*YA$21X`I?MKO5%&NR*"@P8\Q4)74T/N%[
MS$7(5I?5!K&2^ZROFV&32P%H_6@ZI1JFJM1HK--\E.IO2HQ$B^)6?+'9-:FD
M.GWU$JYZI&]P&WF?_24,\A#KT$+R4Q;]PI31NN:PD6U:!ZB,.X9.N0Q;^RM9
MP;,(%+R]=A9U.",(TA?)(<O.:`OM.=ZQ%`7D'=A7;P6%^H:)Z6RKE$?8,O8)
M,ZR?5I).<3JB^UI=4CH59+UIM!M5]9CJG+"/54W:U"9`7Q\\&3@#;N7=%0*Z
MU\ZJ(MXOB(=\NQ,Z*+HW-8M@5I[!C5#QUS>XU63H-C4.*=$X846X@JF?H&+B
M>'Z1XS_"E'A.'_/5RDLV\?P1+:+"S8NE4V8&(I7DXQ`1E^H5S#P4]FY^J#W6
M56J\J)F>Z@OTB-,[F$4/T,^3I'20?XVC9/M/#!=*92P16N>Q8)300;_(**%M
M#@M&"=WX,G8+G2(:MGVBEL3%IO[Q'P@F&*WEY@Z^P%!@N)`;P`&+AE;,!<M*
M)`MG+IHUF94`BIO:,>U"S5-I'-O&"7F8!#!+,OM71]L1`T+/L+MG,JAIO8W6
M>986+(^$.B:GEU6S@?)7*$"5RI[3V(U;83=VP%I@$+NQ@T8!&IV35N!5O:RJ
M\0;!V[%G[`5*I49OBV31KX'3;!>"?7@C?-B[$0I>I1N:S6J),\,ZFEFQN;,I
M[*K!R.5%I[:W4OG,,$+T[8+%/O^$'I#);M3Q'42#B%E-Q+0F8L8G@F=\TSAZ
M]S<4W0CAO;#0,'+/[R_T@4+9@_6(PP7K6`K][Q?Q"]X+4+D]XQ\.=V7\*W`'
M%UYXC=E@/L>@M++\WD(32OOPT]G4K`O)HE+2P+1)'#:Q95QBR.Q8L`?$#D6J
MEHTX+<5K_F&#C[\GE*_X[QCV&EFQFM!6WO&>?T2H,_8/9G;UBXU$=*5$;S/V
M$+O[N!K[[JA&3'H)M4+KM$1O0_83:0^$)""*:.[QY_Z7JP],1QP,YE%USZ?P
MQ?.7>*]*-DV2A:9-3B^KIBW)3XN.()\I9Q"[R1,L5Y*$@B2I>"NL&6);-+.3
M%0N4%KRX/+ES&$[Q21^@,">FKT=B-"LL7]=O?I@',"!Y04B<6YY59>*O/<Q5
MM"#I=LM(N`U]`-%[%'.S`B.9>]RX:9D5FSOYZ^ED2CU2$'4E)>[MOETQBZ'*
MPMF7BC-'B%GT';G-N;H,W+L#ZGV*,K*9M%OJ,Z1#Q^7(&:S:O2P9V2SBU@&3
M(R[<N=8UTMSNEZX10B/H"48VZZUU`$N"+W<N0`UBFYD:5<`[[@=&-@/J]$!'
MY\I8,M+MDYXHV&9$Y5KB6<U)/>Y!25[$C#LU51[SYQ3^D6.E_/JETLP%NB>C
M!ZER_VX51P[/[M2YHA`I?I/.ZD,*UUO5\W@BEP9IQXLS5SS=*#FBC^F%RSTM
MZH!:X4V"VAZ,;)IC^=^'%$@[-DQY[#MNX_`MR[U0$/:K=0Y2DMI.D*?+\67'
M,C*6N.\>WP_PTO06<#:?O48P29=HO<O$?@&K"O"T,DU*_<'81C)S,V`<`ZXD
M!E-??R-M?E%5%%_*;B.LOJ0(3U>8\F[BI$SDMR6M("LMT&``W&U0,+9A\>H+
M]>ZR,?9=-T@K3+95,8W;Z/K-7Y*<%+-Y2=A.)[N-=JM8O!C:C`K&MDKG];P:
MV@K')1M0S<R]E\R2HCI:4#QWV'H!N)8@86]2./=]K@5%(;BC`C,C#J[3#*T(
M\=]2.,_#._3"?<VC-`X8V[`+]KD.E,7ACGVKELKNU-H_SJH];I9LS[^O.1%X
ME:FH^BMGJ>B9`(QM6#C[7$/ZY*2CG+$3P3_3%9&FN3"?<GPPMI5FO*^EI4U,
M.JHZ"W74<CEO;U3X<E7\8OMOO-4N$F^U8MU?6XP$QC:"-FWHK0H"$=2N[>=E
M:E4?84WJ(V2[@B%!^>0T*_GO.UD<HXK)'><)JFQ7JWGFY:JSR.>45QC/0JHV
M"2A8)M^6'+KPEO14!ZQ-#GE%G.G+YE0;[%0;S$6`'/&/#K8V6%]UJH90+4R!
M&5-P[$]]&Z49RO(,;^(E%0\PA9CY)1<3I3$&44!,E2-S5<2$*T0'@)IGL9JO
M3-^WI\JSL21F#_@>2_3;+]Z?7@39L2+,ME9?6<H"PJ+<6##IG8>"T'N=1D7J
M>"_:<`7+:&WU0:2L:-FT&RLD_T]O!=/TTENCS`M_2>*<7_N3U=S,ZT'-XN40
MK\.V3)7O+[FWP+L4PIA.TS3V$::4'PS-Z6'J$9Y>,0L8,&9LG2X26)@8&-KZ
M41M#CYIL:.-4WHS==NJ9F)H9I96IYTI"I9DN&X[\=O0:RT_44H"6E=KVDC2N
MKE[B!LCWPB=R5ZSGYVZTO"YVGFNQ5N&QA$6TFQ+S'?+Q(H%7)"UP7(0"E)>5
M%=[Q,"7HS[)XD)3\6XUEYS&6/#"MF3(83Q>E^,O#JM$C3%XP>:GDYR'J9^=U
MEL(W(L.`,67P.EIX9?TL.7$SVQMZ8*5-S%S"C2F%C1O2%R]2DK1,5U//H'0)
M798'8WHCZ[8J]Q)#LK?==S/JKE1%UHQM^=L(JGM\V)`R``P4#IO9>]*B(K1C
MD=/X,'9S+X*&[CT4?(OP!/4G=QO]#_22I]?X:1GG),OX=8BO`,R;O=HH]EZ@
M=`.F!9OF=%996IY>8?C""L-2',7>(Y*>@-NQ:>PB)4_+$B49[/[-;<>Q]^:C
M+_`:C!J[J'W!S&8P(JZ8&PA)%.#6(5/5DF6=3N*.]AYB=`-(CC-C5S?6^E#\
M;NP]?S#S>33?+VAW`TR#`)4CE=-?Y5!.^*)^]AX0=$1!AC%CKH*]`.7+."II
MN8F3)YBL4%0%C.-_/^//DGRG]S!!,>LE<<O1[`7H=X.N`[N"Z.L.YH#=U%<>
M\?TWIA=]8U)][073=P-+FKDM-'_3?@'`XEKEJZ_PM7SW<X/(R8>BQ5<(`UAN
MPHQ5)/L!ZIP"C&T5[^IXJ=`L@^UZ^$F[<6*?0OC@H10&%YLJY(%EJ^#W`N.!
MFB[$;.TT8MU(8-P7".O=Y0D\F\^>0[0H5@3K3L[I`2;#M%$(6*JEK]T@L;WS
MX^M_PUMTG\!UI024%#U`'V+Z@OTP`*9=M<.88#),8T5GIFN,[2<OJ%[#I26Q
M)-:C02R"Z66>)/2;C.((8#(\XT8+%FMHM=LU=FKD4WSM$=6],#X+E>B]UF`R
M3`L&AYU:XMKM%H\9)O;;^@9"O&?O!4`PA,[N`";#M%WP.:I%K]U\4<V+E?3+
M."UP)\H$7^P'C<%DF(8*-C>UN,V:)\K'S07A<UA<VV7,$,>]P.0=F!OH;-5(
M=+$KZ#G`9_,Y\F&2D@L\Q)QFB)J?C-<<3(9G:A#Q4R.DW;Q0IEN^?B/Q52F\
M3Q!1HB)F'C!6<S`9IMK/XZ<6>A<=7E-YJT9U^GQ59LB^?EM#'W/.V-)DNX+)
M\%1_%=YVCE5#6=JWBM%3?)]C-<I+82/_%_<SXG<%9\.T",CR5@.CW32P=^3M
MM)QT-K\//;^*]<+_P9?`;6BCS)U`;B1P-DPS0$M6:Q2U!R[L$;2M!=`@[&)3
M$R:#'G\$<#8\?;X%BS5:VO7YTO(]FV^/TATU#'#8'<#9,+5Z/D>UZ+4K]GNI
MG(HD4&7*+JSFLF7/Z@'.AJG:"UBJI:]=MR]11WYI5*C<1IC<X`6E<;(1'#"2
MO<'9,+5_!?9JA,R:`W:!$[M=LK%)%D><S'$B,PXX>P<F`UE&:_RT!R<TT^E6
M5\F+S3_B,$#1HMYC&9A)]05GP[,8*#%78Z/=?-#XP'<.HMV3BAO$-+=)]`1G
MPS0J2+)6HZ(]1J!Y&-[D8;BY(FD^85"]W2]6S/4?F)&G6*RKMAL,G`W/K-"-
MVUT(L/X8X#<2FU*[V'/\GWL\*\R(L2-*F;<+<4=P/DPC@QQG-20FJJ<4G_B6
M@`?VM8'6%)P/TTC`XJ46M,'G"X4A*<WQD78'\4DG'W?-Z@C.AZGSRW%60\)0
M]?M)U;M-@>\ULM]?E7EZ^T[0R\S&?R>1HE?<V6J27B9Y\GEY^4-82,4K)7*&
M8T"!K6'GWV6R=[%YV@AKDDKT=BKCKAA,^G*0X].9Y*UL-C<252\E>MO.ORN)
MAR*8>_S]E<!T)%>O>53=JV]:!FS4Q`KKFU+;6TWB*_DYT5%CL>,,/C=Y@B6*
MKZ68LQOT5EQ0A2"Q.UG-ZML)*2Y/.K(&&-XMO\+M-L).C:(^B-44OETNN$HL
M#@#>;2&T.4]9D>AM-06P&BB*P.[QZ,S^RB3WER1.6ZD>14>KZ8:-PKAESYUO
M<NK[^2HO#%)7<)U`DG`64X)_#F$A^2B8KN(DJW+O,3GC@*UK"JMIDG4L"XV"
M,)8PY@XOT%ETA=)U7-8;W.G=`K@5>MM-Q=P%2D4F!U#D%3/=\C)E*`.T"_MT
MQ9T@BTP_1O2O<0;OO0VQ<1794*,73#(BI3[Q'U)+YO2=5>XI\8(B2^BVA"0F
M<I8M85+]89JF,$MEK.RMQ[1J?)>C5=X2KS">!;-\%XR$UGHUUH=MNO_B_2M.
MR"Z5SN97\'F[^S2KQ`O,]Y(C.&7"5T28OF#D&7=&49(@66@,EA[#MGU?`9_6
M`+MGZ>\98D>L_GUB;;P,PB.,4)P\YL]X?)+=AR3^20D9L'GMPI?&%4I)`'-Q
M`>,7C6L_HE6W@-(7>*PA=6/;&+S;`MIL&@29MQ5&L.HKT'A+4V?;'=L66;FD
MHEV2%X&WGE]5K>?LP*PN5EP%+61/WV0Y7#ES?N[3^"WR2DL8#*Y0ZBNA1NEK
MQ3%@"#XZ>\92?V_GJ*(6G^+ZV34Y&A+TXF7H!0J>^ZD-8L7^WQFM5GP:L^/N
MKYDCNBY@A(5+7F.5K*;%8SF/6)]8$+8>T(K=7@^<77@VEA1\GZJFQP`O,O9F
M*=O5CG'>`%YL]HQE!]\GX#Y!D8_6VRS-%5=DY8C?W;08R8X]W@!PTMSJR#BN
MY_9R:):O#/;BC(/\CJ;*/O9T<1$S)TA2[I"'I7J=<7*TN,W_R=%R<K3L+2"Y
MRL`"7XO\(._/W:+$NS/FA.-ZVY+PNN%#41.Z&#CW_"6=`7+$`V(**>/>COTD
M'EPW!JVI5?\$?6D?ZQ4,PDV)=#_+`U>DM*96?0:R(F40;JX<)_=R+E<Q56D,
MJZ\"-'MN5!DW6$?[*%G-50Z?XMN4/&#WQ0GCY`>P9NM7%O8Q7DI<:C[*4^A_
MOXA?,.<O,,W*@[S\^?`(+W\+;HO_D9U@2]1>)ET*D'(=K9G_.P(HS9UN#ZD6
MY-8HJ0M=J4'7[&G-UF\.NP/V='ALW'-O6[/Y=\1-AC%W@O#-^KBMF?^-8,C@
MT&1AU]W+FRJ7*Z&?<1]A-;=GL==P_>`Q)?"U]&.IW_G0MV;Y4=\&^1T),J9V
M2FL+1O0=%2+S^$%+"X9ONL286\8AN0,W5I/J$R);]+:-`Z9FBOP9%JX&T>Z8
M(`E1PGP0C5;6K<)-*7($75,[9%&[8M]5E+E[66JJ;)E"Z>^ULVO>W5_$=*D?
MDNN.O,MBPF)Y-]O9M?U*R?N`7&.VPCKTA!L\.8LNO!2ELSEI4=Q8O\0!%%F"
MM8QMU4(L=3_2R:HQG+]XR>\PJRAK6#YGT1?HI?CN7P1=LDLE2O>W'_W=%0*:
M&T:>>6=V1GK%+K[-6+JO_:AQO2BK,.[.FQL:M0\H_?TF@?`6:UY8H\\>Z-^T
MZA#VX\K[`YS!OSO&:),U"NT'I/?Y9>\S[H[QFD?MKW&(&0]1MFGQ;=,'<2":
MO7_4CT6@P]YM'O\K](("&`4=T&\.X4#8>__8'PK`G<<--=6WT3K/TOLD?O:>
MBU5*A+-G/^&!SNX-1K9J_O6%-Y]WP2N(]BI6H=C/YLVR-M=O*,U(8%%1#'PV
MG^/[1$"!3Z4[&-DJ&VA0PU)A?@N@]NIGE`VCF!83P5*89+J!D:V*@@8!DV%Z
M"Q2C%)HM+Z:EQT4[0G9^]_07#"%)<:CFWN0-8-7C22'L8O,/&"SPLBAB7LD9
MO$3KB\UMA!&"CQD^?XL\S(0Z_,>+#6TPHI#).U--$V'53RN`7NBZ[4$XP_8*
MUPQ?AEZ*-\7"T"?P$C/[..4U[@-Z^O+CR<<9>VF3-N$;F>/&MMW57!G38:$R
M\7[P<,2GK0D8]US=CW@S@.GU/1X2)OAN7I`K=,1R>EEU@],_!L9^QN7!U(.G
M1OR/U$,<9GNK[N^V5QD11T[&^6MYH6$K&QI7VOO@2'/"_S;ZT0B)`Q<55*9>
M$;M+K`PP\I&U!-]W<;0@/HCM,Z0=A3)ZH41O"THAFRJ1)B?H:4']DI,PX[`0
MLS-LA>FOE_-!`E'Z4CAE=SAE=W`1($<TI<%F=Y@^/\=9=H%B\F3<6\,\0WYZ
M&2=K;E8"0:]!Y'P0\V`L_0-<Q0GRPL<P]J+_@EE6^!XNR</MY!*2R!U^2@C)
M[L-($R'/C#O!:^Q3]&)SB=E>Q,1S12Y7VQ:!X!+1<D0S"E8_-XKV+`]A(3`X
M$)YQ+4<T%+HL?5/I`*;JZA#)P9F[C4.+PY%;DCNKQ'S6+#+=#4K2[!(W1;X7
M/I%C;C:_0SX6%SX9DSC(?4$^+:5!K)9#[?"]'E\*E/DVBN(C].,HZ`JC_"A6
MZY?JQU&)<6./B`I2GI8HZ0RD]"!VJY?J!U*)<6,%"[#"%L8+0D(U]W2]#E'I
MY>>")^YHMU"I5L#DF#56>J#<NS$#Q(6"E3LO9#_JYK:W$^%M!!(NC^;2U<RQ
M"EU,_15F9$Y^(3)6<SN1UT9PX+&H(Y:>GIT2OEXE^4)VKV(UMQ-`;00&'HOF
MXMRA#]$ZF\T?X((46,<D8P*2^,4+;S"[WQYO`H\+C/P`=D*GC4"EQK2Q&/<O
M"'^K61R1[%5%KEY^#`FK.1C9?);?RA\K8L?8K9E-;4U.6M'#0$%A!#"R]?Z>
M*]MC*!1Y<B]PQ&\&C@1EX$BF^K2`F;^WFF=Z$*!RQXD'D>VJ%`RB2B`KN$.F
M6X^1'0JRHJQ="49.,1W#B.F0A5/L;3X%=/3D)CD%=)P".DX!':>`CE-`A]',
M<#/O]P<4+.!7KQSOSGN.DT)OY>(@ZF8UGYNL_"68,&:;G^)Q7A[C,"^V2OZ&
M0VEJ)?^:\BY#)]R<*3V!P3_RS%^B*(VC\CMZ@"G$["TE]A;9[E:=Q[*R5V#&
MF$&]<(7=XLOV+=KSA=W$R11?$5;>\VUT'>*YP\W4SS/X90/#&`5W,/\=KA#?
MNJAE;*ON8^F"6YHX-6:P_Q:AHE(WR<#R!-^\],L5IA;_9KON)+X]I3'L>HME
M<5-FR9@I_Y_Q,DK_$:]_QWO!CBHN'KPN=GV_LN(7<6#,]G[GH2#T7@L;`U?&
MQPWMNG!E)4NG6Y`&1L_V<@^C*-V$+UXD.![XG>RZ:-ML('0>MC+_2?N.X:U@
MFEYZ:Y1YX2])G/-58E9SNSY8Z9V"0_U.[[)N+KI<(CB_?H/XC,?K8C:?(Y]S
MJ$KTLNMVE4%'DHD:))>CW/M^[F#&==N#M;T#PZ?7#L=A"H8\Q<:?.QS[DS5(
MPAG;OTOKPQ$W@DL+Q;SK05>LX1`?,HP4@PT-/UKH^>G):(AO%NB0J7-NS(\Q
M722P+$M/OTX=M0%C(T8D@Q<D*@OF'!3;F9@G#Z45&)LQ#0EO&W39<.2WH]?8
M%M]2@):/X_:2-/]0L-Q-KN`+#.-U05^$%<BLB`@MGVYLB>)OV*KC@+&MY/FT
M]4K9A]LP9`HE)2A8Y-E*7B\G;S;5YL*+JRFCX'$=1VF<P&#KSE.3M'@`,+:5
M>EY-^G*<&#L@]ZX\<ACPNH"QK?SQ<E(7T6[,JW\?>GYY&"V*_TCM\+P^8&PK
MUZ+D;BXBWIC#OA&]]\6+O$5%A8S$9;J"L:U7"W*"E^7!F"?]`4\CNY=0VX*Q
MK8I]<A)F$FW,]_T(UUY2Q'>1\P)F6:BPJ.4Z@[&MJGER0I?G0H=/W$;5]LG0
M5'DJ"^[4I6M16MR2WD\7)$?8.WJ=\06TD;8C-GMUL;N7X+Y=+?>)U4B=@Y5,
M%_P1P>Z(O%4Y]XG5H!TYD1\2;,P>P#MSI.H&R`\`)K;L`6;>;AYS9RZ54OFT
MN7:(W$#6JUE*2S"Q91%0E!Y%A:5S8\SDV.O;^XDM\T%G6!2Y="><Y@&^P"B'
M#]"/%Z7(:X*_P&P9!_L-_J26WVP_&)C8,EQT@KP;P\8,IX<I)*[H%8Y93<'$
MEHVC\_?'8L>8[?0*IGZ"JKJ=#_'&"[---?=3W(S`9,A?NC^8V+*!=`9%B4=C
MIM=JXME\&_RR*Y++,@"R>X`S&P]DM*`AX,J8Z962<@[/C&)6'6=F>W!FXW6,
M%MES>=)AH=5S&7B"_C(B.1LWCS!YP1?,]#).,YZED-$#G-ERZVLYUCE<N6/(
M_8)%D<&(/'@3H738%)S9B@+0`@^-'6./I&H'>!0THT!(>;;2C<7T(@GZ@3,'
ME7_)HT2&-V-/J+8Z%KY3>`&*B5OQ!7[Q2(X'+V2@P>T#SH9K#A#QI>69%2MF
M[%_0SZY3\E(:W^3(I\@."SMJ"LX&J^RSV-'R6HJN;<2O46WYH4TOO-,JC`#.
M!JF3M^"R!DR[)MX@Y"9.*DK$T.S:@K/!ZN),?FIQ:]?&]T*H",XDA<,V.VR<
MW,1Q0,XJDNHW6.&FA/ZLX77F19,I#`?.!JNK=V&YQE6[[GZ31\&^J>`;2?10
M!U@0RHAJ]?0:_P^^D;`T2K51P/E@=?P6G-;@Z5?\!<04SY((&9B:EL@UAP#G
MPS4/*+)98V;?9%!9E:[?UL0;Q?,-[#4$YX,V$!PS4T.B/>O)UYPP@Z\S>+\E
M5#,^E<-FX'R0.CZ+E5J^VA7\Z2K.H^S>0_@3O/;\934K0\R,UN!\L,H\AZ-:
MZ-IU^,<,[W+?UC<0XB-I[^[!D#N[`S@?K/;.9VKG)C0D_:N\L)\1Z#F>0GIC
M<#Y8]9W-4"UQ_>$JA;4?^1CJHI#%"PPN-KM0>'PI6[%L)^*>X'RP"KLD=S4P
MVA7UG4%@-K_)PW!SA<*<&`O*I$6/6>S_?OT'9N0I)LS&4?$;-E8M!@/G@U7U
MVS-<(ZK=%O";1^S0V?4;\;6E)$K\:YPAOW*X-7S2#!"E^X/SP6K[2CS64&E7
M[_<"!!Z77@+3Z8N',"`H1-GF8E,1B%=71;%,-(740.#S8)7\=LS6*&K7\ZMH
MZ/(>.9O/<F)[Q9\YS"K]B*6RB#N"SX/5Z>68JU'1_CSK:QP]P'D>!>3KOHW2
M#&5Y.3([5);;!WP>I,HNQ5<-@W;M_1Y_GRO/WW#BDW<MP.?!ZNP'7-0"-:"N
MPR@@A-XGL0_3%-/)EBV],?@\8&6=Q5`M<>VZ>FV&Q/2F"$_"<YW0&X//@]71
MV0SM8DM-F:0VY7Y%=BPO#`LF]@W#`B.5L#_X/%@M7HG'&BKMBOW65MF<7V"A
M;38%GP>KNK/8J65M0E>?Q_B4B7QX$4=Y6H%_Y.*J@O;82KK**.#SD+5S54YK
M\+2KY?6$#S""KUXH5L0Y/<#GP:K>`JYJ`/37#-G&Q10>X,97NUL!Z<4&\[?V
M(M:K!:4QP(^#5;&5^:QATZY=-TC!HW6&33P&^'&P.K<RGS5LVM7O713:P2;<
M!C:9,<"/@U7/E?FL8;,?A7\'O11>OZU1J1<03]*(`B>O.?AQD%J_B*4:).TF
M@*:M&B\1\NX6?^^E/52D&DGU!3\.UD`@S5\-#\->T$])\.L_<I1MJNK?\F6_
M]7R[A>W\@N1B)GL+C-(RE=/N&</%9M=D6Y7]U4N".TX5<7V#*]49UR01?PF#
M/(257X%'?LJBGU7!7/L</98[UPHJ8Q_5*9=A5T\O6<&S"-*4[;6S6`/="(+T
M17+(LC.)A]ISO&,I"NY#+_KJK:"P)H>)Z6S793_"EK%/F&']M))TBM.1+')6
MEY1[">FN5^LPWD!81"'-"BJ$F=*8?:R6HS>U"=#7!T\&SH!;Q;H(`=UK9[6:
M?;\@'O+M3@ZJUK?J<BFFLSQ+,R\*L*K\$(?DN1KYHPG=C#LAL.%+[44S,26N
M=[D$2[]H/ZNOG`O8\"&;7QS&%V,M/6?.L*[,8>G-(2K,;+<1,\N2P=F`S:IY
M0UN*=/DYM"F2Z]YMFN8PN,H3+)62QC+DN'$73+<!Q]S%ICP8L%G.K_>UU$8\
M.A))NK%Q[?Q'?6Q<E-G`R$:PPE!W+H8`W:FSH%&@OT&T6&8PF+[`Q%O`[?=W
MG]!#S'JF`(QL1&L,==TJ"%5'/E+;!M&#(Z/^5DTM::V$@)'-0A#.K6SMLM61
M\-69!7YT'-E;XDJD@)'-TAL#7.3*TG4GNV[!V;-8VL_*A]<#)'#CWY.`(1(<
M1%Y<PV0U%JWT?JD!(Z==)B86>_\"=B=!L4:!WV(^490B_U<OS'NZ=>_/"49.
M>XK<O6<?BU&0JME"X&%6AE;V'7]X&7II.IL7UAV9D$)J>[M1@H24BTU!F$+<
MWV$O"Y%\+%F*@_,HQ`\[W.XQ\[+RA6M#)H+0.V8?M\+P:%BQ[*]LAIQQ#S5I
M$P8V'3>V'>#&E3$=%BH3[P</1\+$-`'C7L!7(^F4,"[HJ*W5`"_ZPF=@0:'<
M&0@>L98.T^D]'A(F"0SDP.#TLAJRI0(+GP>'W+P%G1>M$*+VLAH(I8X0BP>'
MO*L%G9>M$*+VLAHQI(X0BP=CU?VJ:9]>8TF9BSM9C8R1$;D4"\:J]&UGQDU@
M"YFSNEF-(5&5.H<)8]7YJKEOXCQ1%SNKE]U@"D6Q\YAPR'E0$'O5Z@B@]K(;
M.*!^!C"9<,C@71!ZW0HC:B^[+G!UC)A,Z*C.IU4=D55`MBS8]-*VT#EV9.NH
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MD/!8<>?V0%+W1CXJT_<FN82U@M$#C(T8[<S?'#C\N//`LEAP<YB0ZVR9HQ=%
MBS+Q\@'M*='Y4OJ?A,>3SFG`V(PM4?HNP@.68;K2S+XS.^\PEX\C]R#KZZC?
M^Y*_J1,7R]^<CCJ!L<VX,>T?LN"V167?%%K_Q%>0-*UJ?OZ2Q/GZ3F"FX?0`
M8YO18SW@).#=G9M8NX1Z8YLF3L/P,3G68<_A%;/EN$TIK<#8IJVSAT^(PJ\[
M-V.]24;'-@/8>OJ<N-R[DX?C"65$D[N-`O2"`E**0>!%I[4'$R,&T1Z\Z"QN
M'`;H-Y0M'V!8)@Q8HO53?!UE*-N(]0:UD<#$C'U.WHO.!$<23#%_[JB.%E%V
M1`$T#[=Q#>\F3E8PN4()]'&'LM9-BB<DQSKWKB/N""8V3;-M/JWC&XX<EZ;`
M*1_''Q0<8N!!;0LFK@1,WK'?=G.I=T<-XV:&+'_?J)/&<_4I#43J2]FI@<7&
MA.'B4^;+F;.,07J1*D,#M/1QP,16,6Y-R++9TO'5<O7P<M:G^#Y/_*67PL;3
MV]D<:TJ81H&.+C$"F-BJRBT+4`N&C)E(;B,_(24(MY/-Y@T*&&!P^X")K9K<
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M#03.7%>8V_-5HZM=9Y[Z?H)GV3U8X.Q!U+;@?`@:,Y/T6K+:-6:&Z>HIGB5H
M@?`$Q6^7<8CG+VTEY-_7;_C&'2U@'5NJ9N13'1V<#T$?U\ALC;=V_9U)9.EH
M-H.VRMC@?`A6`&VLUDAKMQ1\BQ+HQXL(_0D#>AK_RGC!0%.Z/S@?@M5`B9T:
M%?O9DJ9A,;@ZAFH#@'/7C0KJ_.P\C=KO(ZLXCS*BEN'O_9*X$\(RKF<V+[>#
MBPVAR8LVK$N*]`#@?`A&"#5^:F"TN^?+R;86P6`ZSV!%3D5-59>$`8ML=W#N
MND5!E9L:$@<R470M#O9+:1ZV7`!.G@IP[KIMQ))0ZD5I_S%'TX5<6>#J0HN<
M5<3K!LY=M^'(<E'CQ##K]%/)J?%JY#[THJNRI%/?M9Q:5\RZDRC\U'UPNU6B
M6F\?"C6ENLUAH0*5%E!9&[9&N0R[N%7)"IY%\%AKKYU;1:RZ(\C0J`Y8=B<J
MNC7'.Y:B@!P&)#F..`66@>ELE]HZPE;WQ8[+^FDEZ12G(X_.K"XI]TJ+Z7WF
M[71AY):;`'U]\&3@#+AFZNV:N.'S"_P.LF:QS/W6E+@<>O:GC\6ON:CD@NZY
MK%:`,[<XC"_&6GKO9B?<M_S]DL2I$4,'>S:KI>Z&MA3I\GN7FZ(I_X`>"JQ6
M"QS:JI67J4-YU_]RWBZ;B:R<6]%:Y>I.[K."IV>QG)^5O^0'2(#&O[^,H\)O
ME7LA>?`P%JWN?JFQ6_G2RC+O7\#FBM!VDU_QT<+#KY7%"B\6I2\:[!8![6NY
M6A&KCH?DSEV:;S&;*$J17Z1@Z>>:O#^GW9*HSMTCNHC1H>+&FM56_*\K+X.]
MK5:I^>T6D1W:RI46J2#E@<T8I"K2ZA2*=`I%.H4BG4*1MAY20212L]E?(Q#I
M@&-G?!_2<1]NQ?X<BI,O=/>"=EJ+W9%`F7;R-YYQ^>DU?EK&>8HO<4^X61F`
M0:C@IEL6]+(:N"(*.9&COP]YO\+P!5(B7Y3$+Q[$:KR'*AI2[+CC>GPHWO#R
MC^ZZC9GX!]?.[2:[C@$E#,5KM#(4(2!]7N^)D2/IFEIG3NH6HG;DC%:5N7OQ
MIU^PX%;Y2ERXMMG.:EC!P2*F2_V07'?D[;W)R;O9SJK36T[>!^2ZLX^W>[EC
MQO_JVLE[Q/-["&QQY\F%(:]HR]<[H_9AT"V9=V;3?1^+R9$[C^55Y=X52N\3
M'K<=TVUW`OH2X4K!&7SU%&PTX[9U[4;!Y-V=X$)[A?]&9JR<'<L[CMCEWM7Y
M<_>C[1%E1PYJ\W`;=S9L#XA4H;(CMP\8V;1MM_F@CJW?0@9-H2&+`(4HFP_Y
M]$B=RI2Q0G$'C@RY&IK\3F`TR"=L=_S*FV*>W3%%M99!^9YSFPQQ^N*AD%S#
M;N*DB&@S$6<EF!*,;&4?DP"\I3[:012F=MS*K%J%C9=<4TO6%-D9IYCDH`I4
MHNT/+4<#(UM)YY6Q[LCE.]@JBO_\"M.L+G/*JSZ@<QHPMI4DO_\M@<&^L>*D
M*H0VZ2QI0S[^OX]_YRWP/:A).^LB86@Z,+:5B;_53F)2#.[80UI_!$WV&G']
MA:BK3=C$UB,Q+1C;J@+0_U8D*0YSI6.;BWRQ2.""O*\HZAE@_;1!477R%I>H
M!YC"Y`4&17D#0:E??1.`L:U2`ZVV'[V,N_.0L'$%JXJ2[9..+]8W.7D<LRVV
MR]E%E,<"8UN5"EIO#:UX?`^O\K)E5?MD6Z3\"I;_-W&LL&<#8ULU%/H_3?A2
M,%87F$[O[K<-R@LRCSX`SE:A=7PPME6Z0>,-MB7?QJH2-UBKM':5RL22O<'8
M5IF$=LC)<Z6C5'$77$19@MH.!<:#L3%V8=%<$6-)B@ZR43224-RA>4=`^6.#
M\:`LB]IX=JBT<M?<.\2D0<IZEC:/&P\EQ9-ZH='1P)1@,DP#I"%1:"GL;%D%
MJ#F:XGO(JN3Y"J4^*1>&;R?W<9J]E#8U?&?)\(Y:M#"A'K2C!$P&8_"T*"$M
ME;$M;X<T[DDQ09^<$C!9&=D0A9."R3`-H<:$X5`)<:T?VI;17V,2UA*B;//@
M94;L)/*SDY)@0UQ\YJ6BI=2YPZOPB@1:P2BPL0:;<X/)X(R]O<A$2T%XV];A
MFD64E)%\VVNP$>LP<S8P^0M9A[E2T%)VWHU5A>^K<XB*!&T]K"K*;&`R&#NS
M82F8*W%/>7WT#8LZ?8#K!*60AKA,-S`9E*%9AATM!>VI&!Q&+)0$[-E(BS"]
M@AH?MYK-&^T8"'4;%$P&97;NSJRY0O?T+>$R3C,.2=SJZLJ#@<FP3,RMF:Q1
MU/X6X5N40#]>1.A/&-#I(_?,B.J65^H/S@9CP%7FJX;'OC5V&A:#JX.I-@`X
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M5I(CMQVK2\J]JU.[@%ZG8SE:?NST=7#(MZE"/]4\<G6^Z(V'&8_`L;MP6>VC
M\IK!9,16W/)\@5)<ZO+,F/HN;*<@MN)8-H33$6>VOR&+B8>M.%T-X2IFU9TH
MP;YR#UAQ3:K@J\Z/8Q6C.@2@N)0SVE!-;OT+Q:0$WD$HFZ/Y=ZV4F^YU>4G)
MX!W$C@T^%;F5&MRMEV*_@GD'D6.#R0IMI0RY]77(%H:.HEH.KSUG<D%;JUCN
MQ+H[%(6.8EZG^K.L@JO6*J;WMM8DI2"H3=9/,.MC_IS"/W+\)TC^O@UJ[3V:
MM2;CFI!Q)Q.CRNAB(_)TGQ1A$"FEN8UX4+8`65\$G?!A!VP>,B4.)6'T<"&8
MDP&0')PN9GX[)E'LHV?UL1W!R9&W-$`.IE33"Y$CL1`ZL7(OM.&`6&&(`[6]
MW=QEO$]#"B'W8D>W@1>"XZ?9S$SDJ,$SYX!X=T(2I4/`#L)CS%@.I<^40WGR
MI5[3[-R:5Q:[(^=$._GK/!'H409P[95EB*91\`BSK+QZ3Q<)+'Y@[OCRG:WF
MVCI>T)00`5DVG/D8GE!&`L)OHX!8I(B1@G\24-N;B4`T>"2PN'`G,N.(PM]0
MMGR`85GG:XG63_%UE*%L(]S%%$<R%+<H?;HPH9%$4LB=NY]>?Q`[<I*9QMKX
MF7<3)RN87"X1G%^_03_/T`LF<(Y\F'"/.V$_NXFB6GQ4QV>A%(_&+B/[QT$J
M%\DMZ&4YKY&T[522%6/QIF666;)^TLP+P^(5P&WTVQ+YRTN\?A">M5A)M^F]
MMV$8KEN-8R^.5$;<QR"U8M#4)[,W8S7?MPC_HKZ],F`2=[07_]D.%SF.C'T_
MTQ4)D9G-[V$RQYNH%_GP(HYR5B4^5G-[P93MI,[C0\?%G"KK,OYR-G^$R0O[
ML<)!*WMQA.TD2R%?$+Y,\01_(L.2>$/\C_\%4$L#!!0````(`/2&/D.'/=HD
M)98``$Q,"0`4`!P`9FEL+3(P,3,P-C,P7VQA8BYX;6Q55`D``TSE25),Y4E2
M=7@+``$$)0X```0Y`0``[;UY<^1(<B?Z_S-[WR%V]JVFVHS5IWHT/5II+7EU
M4\.JY)+LF96UK8V!0"0)#1+(`9"LROGT+PY<F0#B0@#N;,E,FF:1$0[\''Z%
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M?V5#B_@/A9A_FX5!*5BE?2\R.H+_ZWT][#W_U?MOOGW_W3=??BZBWW`>Y%E"
M[^F&B,?_H3SLZ+_\IHBWNX2_MOC=2TXWP^^0Y/E7?/Y7*7T.2AIQ^C]P^M_\
MCM/_[]6O;X,GFOR&\)$_W]^,POGAB):<]-6_DB7>\([F<19=I6ZO>C)[T7=^
M*(.\G/#6G?D+O?=C5@:)TQMW9B[TKA^I&V^;>4OQE!E"ZL;3=J;'=RW[[VG-
MR):#W%+SGV_9\X_>C'XN:1K1J'XW/E-A+05A866%\<_"(V()-[=9?HQS$R?O
MN?/X^G???2V`L%_\I?9+JY0I?1F7AYMTD^5;8:Q73T69!V%9DQ$O+HC_Y7??
M__##M[_[Z?OO?_=OW_W%F,Y7_UK#/WK;G!;9/@^I%73Y!8Y?+'CZR^__Z9MO
M_O'W__9/__3[V^_-7XP[-4:%^VZ:OO_YX3?_VOCK((V(G$@Z,\DO]=S_^S_E
MN_B#QJ**IZQ1@5\CPJAZM'@0',0O3X&M\F,U"O*P?COVHP99->*K,&-ATJY\
M?R2AFSS;3M&<^K6R*0SZRMA45"`%P(*&7SYGKU]%-/Z*FP_^@[`C[[_^I@J^
M_CO[U5_D<^_I<\P?EY8?@RT=L!Q__,=__.,W/U[_^.,__?Z//UQ_]_WU=[_[
MYB^C\Q>P&!]^][L/W]W\='/SP]<?OOGI^W_ZZ?O??S?^0GTAJ^2J'4?XP*6M
MPC(HEE`0.P$Y40P[-BRA$!=,*_,@N6&^_?,?Z4'G2\<G+NT\51!&I*<:2,1(
MPH:"^L8Y`"SN(;2"-.@2=%(TE\BOF`^*N!^Z3H)G&^-_/!'2ZI]".)64YN^$
M#T!CYJ>]-JA='Q0:K4$?DIBYQ+J.KAX961,#?C0>PFZ?O/!H7,S_#FZCI[PL
MB#T>$H=1,SP@"W.+:9/#NPQ*JQ!\F`"D-1Z#-"HD<B!;[$6$#T5CGWT#`;78
M2D'36FZ5E,T;BU_'"<TOV-.>L]PB$C^>!A>'G[[^2!`KAI%Z'+AY]_CN@-'W
MH.AH8N\AN;$5\$U0/`D,^^+]<Q#LI)33I"SJWYR*>_7KOSR4[,E<S]:;ZS@-
MTC`.DKNLB#69W4&EMZ()Y2\L@9]*X'F0\`U.\O!":5D`)GCG`-=,(]F&-!-)
M/5.!%LS1N,BQTO<X"#&`MCX&3XEVD3$R:VG7-/KRX^+WBQ@"NVGB[[47=TAJ
M<1GT1TI9`1#PBR0HBO7FH<S"OZX^QX6S#^H10N-X!B">BI880M8;(@8Q^\N&
M(?4TQF@R-1H\GF1,!.W<QXC\+:=2W1>XS+9!W-M+'3,?`S.A?,<@")VVR($X
MO(@%@$P'`,R?C(N2TJ>,RM&"?H7F,2U6=XPDS7,:B7?Y(,HEK3V+@A2X;U'"
M[`4N8C1I1M=B)R<@\S,NR%:GV/`Y&[U<FKD;K5`NK6OGAKHV'+@J2(`M7Y2P
M1B3P'(UVS8@)C7\RD#SUXD<K=DMKT84_CS5,"H?'&H,Y(H$7:+1J!FSOO\&@
M7\X"9>^U5(+I7+%<D7[\E+GX(0,*$%7*6E"C^L*FH-$9?[#>?ZM3E<E8K(N0
MK<&L]R4_-,7/A)$T2]EX2K<\^4:*^NN5[.OM&J"%^'I93K+.3-78+XE8@;4'
MRN)4_N$E2R*:%[\E]&][OJ\6;T[>@#VD^SZ,(<F!!"4I7]C?=F)/@*U6^;_B
MHMC3?.A))=WNLCS(#YVG<*);.3\N!(XXHH(.,TLE8_P)6?`(P]RDC!9?&]F3
MR?:.#:%38@8C6E!!@R'0<2O()Z&Q@W-`?/\=N$7T"<O$-HIO:FP=AT;_EWWT
M%B':F")EB&AAAZ;:S&NF`A.#Q%$2@%&B`M:H@>1ST-A'C\#>_R.X6?2`QL`:
M;O@'-#6&0X/_RQ;ZC!5UID47+&KLRM+9J$M_V:AA4CBR46,P1ZS+)1J+N0`V
M-)&&A61:Y*)48KFTMEU-WT$9)@&[@S(&:T0"K]!HUXR8P'V6A>09[*"HQ`Z@
MENPV3ND-^]&]B*RE`.ZAAD`I*A+Y,"+&(?-&_G#`NZ!10;,K%3N5LN549544
MM"Q,.[F,S()R*[V7[YUJ%0.P-&.Q?&TTKF%81I3>8%!`EI;JBSUS1&GI>IAE
MF`BT&QB#-BQ#9Z0:B?6\BBF<&H8<_P=TGD`I<4;.0"5N"]8,!\6+J1<08\'J
M@N6+]N2$_9K<I.0\2/UG^IS*?Q7OR=M.A?P'GO-Z#1+VX?%8_:XDJ(M\6S%8
MT,*'8;9G[%JET;I\H?D]#2ECX5-"BX^TK+3(VN(;$07W`(;0>QZAFB?$3LPD
MG:EGA$UNW`4N'^$(^/X?@NWNGR])3N/MTSXOY((B;V;C<R(V0FWF5"PD>CGE
MO<OI+HBCJ\\[FA:T?K<C!VCJ@TQ(0;DH,YBG4EO-(M6TCK:>A'0HW-LTC%1.
MDR8I$R##*M`+<*V!+$16Z2S-Y74Y=;RL4G;RM#.]R(KF79B1L'6B&FK0WE,+
MMM=QI<[75C.(F-)HH?";J-RE.\*-/.Z>/I-08DRI:`@0A.%^NT]X#V42;+.\
MC/\N-KO1.5`S23;RG$9B#)31L$O30;M!G3/`Z-9T[RS:LVM\U>07+SO=XWV^
M]G$N!8V+M7>FL&[S+L]V-"\/=XS%HK$R6\3OMFY.4TD+VF5J@/:#.SG\C(@)
MLKEV/06?NW1$)V#1%M:`JXSHCBTVXT%7.:]QF!\P.M=OHHU&CM]`%9=V^W;^
M'MC1&^]G`3KV4=>(S)./OB=*UVWALQ=7I-LX>(J3N.1GY5-9G%+5M5Z)>E/7
M34)CNM!.W((!IR+7F=HX<^8/9MQ1+#MW_"P'\V9U?G-[\WAS]4!6'R_)PT^K
M^ZN?UK>75_</OR57__OGF\=_1Q6Y>/RD#T>%WG(Z.A=OJ\-&[MY2@4$LEKZ0
M8=`J*RA`A0A*4`HA7:2.06EUIL.I$23M)!0AD1.(SB208@Q;@3<)3;3ZLOSV
M]EUPX)MUS#*QW^1[&@V\8QI]9+R:MN-M_1SH<&8"@T;WQ2M:PB%6U+IRCLKW
MSX%_U\$?5/CK'3ITP<!4#;':/G=4#S![<4]%!NHNR#MO:)Q%,*$%EF,P`ZK3
M\3-2S2355&3;#Q-1JC29O"=YA7W'",(WT7>1876*P5R`E]/0CUE)ZS=R+$\;
M(@'MAX=AG0JF&-7JWERJYIXVL(%1*1>J<,##^X-[=(6&&#GK<?58L'PZ2]EG
M+&/V"F8*/UQZJZ8"5G*M`]=;++83R$(FP*E$>PJNM*M3S3;@/JWJ9/@V8%P(
M?X1@5\$>:9#G!UX0]!HD>\J;.ES24!SJ)-]]<T:8%GPK@@SV`_LG`[&C81F_
MT@1/6&&FDNH*=Q-]7+)>+X]?`\[F_C+$-J90TH(.+C1`^W5L]7`RE#I$Y;#=
MH2G2A^`NW$0R#:OOM&()F8EWS\`CRKP;9MQ1N&BCMS\NRILSS6[O>2T`#*38
MT3A3O5J;H@=4X@E[_.`N\1B&0G\1%9RIWUD*/;"P&W]_QZUE@(7H=AN7O&R-
M;VNS`+9D43Q-PV'Q'PF<QTG`+4%5L/KKM&:T6*4<C4?AUZ;A"55X`!=<6M'3
MK+9T<K=D)R%?A6*(2\.L*H<>7H*<-I5"EW03AS&F3.X$,-%,8*9U2[*!,U#%
MA:]5AJ?"+42E6L=-S_[$4V6F3G9H*N!YY0$8`V=WNPWLSL@W7W]]]K7\?R(4
MJB!??OT-WU@EJWWYDN4\"WI&OB:=+K8(:K=LT19]M(5$^_]QN#L&-SB"F\T(
MU_&HMCU@F?A%$ULH-$UW['I$S98-R;-4:2*4=K,W'SIN&``T%+%F:6TIQ*@S
M<L/;-4>(8@9S(*-&X&S8"GSSS=DWWW_/QOT>TASX!`]G$.R4PR:4&-&L!<NW
MHDA<+Q\D=T$<W:07P2XN@]ZG'*V<&9D.5J0U"J=7L=2,)'PH[]Q5#4;A,IV`
M\/X>[^.4A#,!<3A,9@Q#?(3Q=X>K#5,KB+H<3*D=2V[;OM(D$T=)'\K@F5ZE
MS&/M\KB@U2IZU9X=OMSGS$^<SK#?W)W\1.@8PPO3^KNIS1`BQI"6[%F=TR`=
MRD22)KV)J#SY3+R2W#@ZV"ZY$76X4?CEQ@^2&RE]Y@]\$]S@%Y%H.0(>)_DS
M0H;[^)XL$&3*US0,&Y@)=N'"$`B3="%9E64>/^U+43_^F/$TSN*ENEX@_;:H
M+#E-PUXU&D@T:81`;H<61XEI.G@>%R"0M$!@<J)X,H(=S>,L8G8B+_WC.*?/
M<9IRTWX>)+P'V$RO?Y6..K@)+S_\RG#7BXQ:5?6M(F,F%4_GB`G5),/TH$-N
M`\!F'2)0!<<.J*0A2TZPP9OF>7#^*EM"N-;KJ#03:E^116+K7%P9$XDLY1W-
MQ7:;VU;C*#4<NX\*L-H-2;[SN,Z)G"TW'0B;+S<G442"'K!6.Q%\PP'S%IU.
M:"UV[302"Z66<LN[W>FVC0<TU*"C`2U8K3I6-0'M)%1QP01\E0I650#!*#YP
M+VDFL(;=$0VD%585Y?:RFU<\HH##$YZ`,E6WF3;9IWL[8SS'ZA4/XD'BY88$
MS\*S#4@=K`IU*K5\N+,N.8S^[!BNJ8:!E;-YQO<Q^Y(?699#T?MFRV]560]%
M\0U*[SR@@,[NN:]](#5O4Y>O)J0@CZ7H8:J+XY9=M=KOOTS"J%NM@L0E7A&1
M'?M6Q="W`CV(8ZA\V@,Y9IH'8EBF+L!5I*"C%35,M4'!O>YV0O9F5MP&XFE;
MF0J^UNZ]B]U">VPZ`I^M69(.J15,%;L?("8+:VB';('D&`BO7J6?PQ<VFO)E
MC=R@(P4-][G<W&*_#+/M+D@Q]2A2JI:I=P;-(_3>8T(204D+G4]6+TF'K<><
MR0.O;MD&W!M8;)M(J9MGAEQFWZ3,HE$1EV\=+@H8FP[EFL?A].O]JC$%66_(
MFJW!Q&U;Q9S7!+AX-G-$<B1IABJ0@+DKC;@IW95:UA8L\PT26MS35YKNJ<.%
M?:?3H9U2'TY/5?@(5+Y&_\[5']%YD1'A,>M;,"@YRPE^9233Y^H.ZL+66XP3
M@/(7*DBG(G4U<J$!B%NP>?%F;-/)'<_%*UJ94KH$G4`MIQOWM*",#R^K-.J<
M0ZE>R]9%J(E!.PP=U+XIEN-%;6CW'%PU!95GF02N<XBKZ>><TWC[M,\+&6NB
M\T=&<FODG4R$=CE]_)&FS#0D_-Z5:!NG,3<+O"GLN$8.FB<=&2B_I8=W*JC5
M#'E%T=$<*#V<`5AP-`>-DS,41J6K,Y/$)<^DMU=4\Y>23>O%/VW=G8H4M+-3
MP^P?\FU'\^/@NX3R'Z72=::>D8]9NLNS:!_.<L7WM+/@KHBE"G;&U_$F.J]G
M(+R&AY1UDKN@QPOB]#8KBG5Z&1>[K!"=*]8;NWO`U43`O)T&6L\EL/'D'9_Q
M!6%2V)G$([+F6GIQ3SMI;FD_8XXP3/8\#4O6L70H/P8%.;K&_C$65UC4OT.P
MB6?+'#Z6<R4ZY@JMV8`C#$`+RJR_!`@HN/C&Q/2HHQL#NP.8Z+*-:/H$H..8
M(4CC>2*H5-=D"/)`ZMC5H].ML_/A6O.7SWK9.G3ATZA^&`5-8\H!H-]R2XD;
M'NL4=F<J>/+Z",:X5O,!*+R[V8M_I"5)N`OD4EFK199BN)/%#,"MP<O#)][[
M.F"6<N\IP)(WHJ;9\6M4IL2UQ;Z>(+3_-H'<T_SRA2U5JK*`=]7X+U#Y='^P
M\'6K-Y92PSM*S41TR=(AMEBEA6*3:Z0$Y'@:7*G0Z>OW"VKD"%0)<HO7'LF^
M@:Q]I[\V8,W2H)QK:I6&A'S99&#!?3-E2^JKS]QH[./BA6<-UIM+^F3M(?4$
MH3VD">2A1&$A,X6T^(*L4W(\D9<&\JF(3NFZPB0B'7\$+MLT+:IP==Q"C]%#
MD]F%,()'0<:6R"@*,C5#$%<J=W*8S>^&ZT,'W8R>$%2D9`)Q_-KA,]+=CF$F
MMOLG-AG!%HH+P#HY7YT78@@W05R?Z&4:*9LZUS1PY%U<<%X,X7O?@3;/=;D3
M0DT7E'SD5\FT3PH6H!J;(&7(:FI_$*1YO*5WP(-6%<1^MY5V[!O-ZHQD>65&
M)ZX@T;D@N>_>V`"J=G&,((%'9UH5FY:;6MYDT-)^3^=X$E24=?KJ0XI2:[V(
MI1`$3B;OG&#9=3)YV5IADWD8;+W1Y,I@L%AD4`&5<<>0]BUG,*Z"G#?J+^IV
M-.=!$8>\A#U.]J5]1Q@=.>AX0P]W<)W#NTG5![8A6B%[QM3L+//.2V'5$()/
M90N;)SY;GN:0\]'Y;$.1-?+<9O*ZG#K^F<;/+^S!*R80P3/]N.?5ENN->+?.
M,7F]E@X:)T?J4!&!,S-.Y;TF1"I*1)+BV>U^1\HS<MZHP.6P"H"X;__<""IN
M="W`40\*+.;`IS";N.1)>K+D?5M5*P#V:MJ;X4T]N!E1:#]N"GVTZP77?9G:
M*_C5J8,7>L%UPI@9.^]9:P<8W.E;R;I9-P$+00?0:?D>+.C<92D_.;OZ'!LO
MZ-5$X&[64T/K]1N00MF.8_+)1N)H2S,7&,!KQ@P$3W/CF%[J%ES8'K_$9;8-
M8NN3F<-$H)W?&#2=S)%?Y%!<[LP[&G!?I10]LV6I0NZ6[.E1LL?2J%XD?Z`\
M#C9U0B.SH;S/*)A^1PLYD-0CR2]RK'^UL4\XVZ.H;@M&XV?40J5T,$J)`FG7
M.:H1IIT4EU,*TY:,HQ+5;5@)I!)>,:!R@MX^`+CS&]4.V]Z@0-J]BB)Q^#9(
M[H(XNDDO@EU<!HF=[U,3@7*!.FBG`M>.)WS"^YN45%,PN<2IJ.(&%1H?:22#
M2E=I(H`+ZE08[K?[A%>R5>'(Y3YG'KS3)XLM'I^IFSNUI`[M:ZV9T1/@ED`=
MW1%)XJB[G"`RGZ).\7:365##/F*%9`$O4NRQ`9V7=-,((Q?JI`X+)C@-.MP/
M)Z@@VMD/)[H,VKLCZ%;O_.[G`?MG2,F[N-X4]%\*M*-YG$5,$//2__O3YSCE
M*T12(3F;ZXH^B>(JM2O0MO@&8V\.ER;6M?XW1+S\O@I;4LC[/:0YO!.?3ES%
M]9%^$G^Q;G-C1A0ZX#"%WM\OY`M-.;'VKG+JF;QDCQ]?^20'X.J4XXJ8_T%8
MOFQ#-MD^C>J+Z?"UH+&29\/]4'-A!M=;:5!4BCNRR65$#6Z'U!"LC:K6D0B<
MKOK%.JZD^)REE?!J-E<M)'?)*["SD-*HN&:,J#_,>M/)XMFZ5#U!:'=J`KE_
MN;*<0_@DTD@PKT&:,R,]Y2YL>Y#B>H[JCKC.97E5'_ALLZ'"+H59T>\##QHN
M3/JBHK]5W+%)[R5P=!&#L:H:7I=MIJ<FIF@3)\*^?/V[[[X6UH7]0O\`:?IT
MGM^&U-)NWPZFFTT!NIQ^#IQCFC;;ZC[*PCU/EPTV=5\*9->8`BY&G)5*%=S8
M*R?XPD,LA^2OK[/\@>:O<>@W<=`G#AWQV++"(9%0_9'1(34A5"'"5!8<W;I;
M7;>[86"+$;#@T8*3^$_.,XS)/KC:=^\'5NN]_4(01.'M%YE3-?WX]F]059\'
MO$['WU9Z0JOD/I@X<8UPD:7L2Q>B5?['K*3%77`(GA+*KR()PYP]K.Y#^)B)
M-Q-&QM193W@"E,>>Q)2^/->$^*)"D"(5+7FACZ1&FL:5CUFUYA`44?CON1C"
M`O-4,&3784A0,22N&5)FP[F`V5<FB'E1A7Q?HHEXIAL29=@SV8HL9QW-,RJN
MI"$R+.YL\&<0D21A9F&%K?IC2=:@8(9,Z(`80V]*K<OP3#,6SN:O&W.N2GYM
M>%[0#S1_IKEU&*BE!1GP&0`=KDZKEV*KDE2SB)R&+(!S!UBMPH)2E(7F%<BM
MF(HG*)L'G^S;B2O.,M5);41EJ)!S&`_S*$E/!"(>,H%F:R^0Q#<3H*DT"4_,
M,A/`L3#$'>!Q^^*/U*S(UQ7B_3&:,@_2(@CE1<-(<FY61F4TE#*U*$L>E_N/
M?5%R(2X>LY%31W5G-1KQ$^V4?1L^2(1ZZYVX%>R>W^E9Q"6M,H,R:WA/P^PY
MC5VNU%[JM:"WYI9C?_\87?-DOLX].55'VK."E0J^%V]`NJ]P5JV.J[<X(\U[
MU#L#U>8!Z;P*BJ@4GOUR*MH+QA<V"V8'HQ:U"<ZAI\EK_CG(F8\SO7G,D2I$
M<.H$WMDTD8H4B@O.O,&O07F__LPU:O7^4<N,!.U'W?&/&J<DK#[JIV/\.))K
M[EH]&@PZJ_2LINDZB.42G-]'5-^>4;V&<9V4GX=!)N5\L,K=KG'*,HDG;W!K
M[JJIJ:.(HN;BT_71K36=FWH^S87>.?4WMYBH+>5&QRA<V4-OYD>;7O1E>YPM
M;8?X(\]F;&C."V1OZVON+I*@*.)-'`J)>\RJAG%'OS4)"[T\!R)0],2@0=/1
M&,Z:LBRQ;VB38S+<%M?-"8_^`-@<9T86-4P1I>K-Q8LD/&8*LSQ4,B6<ERFV
M,39.MIQU?#9\Q#ZG=C7^9B+'<,3U/@WU:*3OT4H[>Z1[6L;YD:]K'F\3U:O(
M0,;K:G@#W379Z)/8^A;57<+.H(XCP?DN2':.F7VBPA7@&NB8-G35*QBNS2%9
M'53&3PGE]Q?_.2Y?VH*A:QJ4^UR;X/3^/+@.C=X8-F&_IO,$<?L[X<\@G2JW
MZBDHCFW,R+)SFHH&:HQ'80M^(\>3*"[";)_BZ:SL6]LT#2:]JAK(I3D70?%R
MG62?"@]WY?1I06\-:X"J;\9A$XB8\08NP;%#EQFB`]]"-1%4VXMNQJ1TT0MJ
M^4O<Y=EK'-'H_/!SP>M_U_7UN:N0A2SB+G6%4H[=O&E+&?"J6WLF#%WB*"2Y
M)D/.#^0=I\2<^1>D(49::G,JL]/EN=.YT-%ED:0;@OT'%(&*'[BKAY_(]>WZ
MSP_D^G[]@:SOKNY7CS<??R2KB\>;/]T\WEP]].!"7H;KJ.RZ&W/=-!UHY<.+
M0](P3NC15;^/V71#:%Z#X^L=H*.:F1BK62TU#R*]6\CYG]^*&<;&V3(C></9
MM+Z4F/V6_QQRINYJICXQINX+<8CJ"Y(U3`W@C/S;8V;%/S/V@<>_<YI0^WI!
MO_9SP6OPMKLD.U`J<QEEL4JCX1I'TS#;G"!4=&T#N7?)7#67U)/%`<ZQ`F84
M<>44N**P]?V3`!9VAD+6%4^4.I,`TE:&EU/72[IC1CP6#V<_)Y3_P`_*;K.\
MC/\^IJE*0VI$$SJN,P3>OPBDG79&FHGR.'YG*JK@P`-6M(7_-@)LY(4MI'?!
MY5WGX7RK[:F\K'8#[G*ZC?=;XQTK+2&PK2@#B+UPM#-';HX_E:2>1MY5$_U?
M)N)P:9@+NBCZ`PFZ$/FF\L@N$,Q>V-1O)G;)V3?#M[=EJG#J32M#;8,R)-=Q
M&K!%1OI\P7MD6^=[5+2@_;L&J,Z2-!/(!;KVX5.@"87;T#SGO0(;C(,MTL%=
MNXFLFBVL]8+J7*;V8Q"GZ_3BA7&<WJ2#-=I&O1N,Z$`4/AL"/)4Z/HVL4R(G
M\G*/L3,B\&T<ID!D.A5*B.P?Q^<;>-^#:$:8UE6VR^"<K:L#]/=L,8*'*;:6
M9[32U\+L+!>DW*1A3H."7E+YWVZ&LRAHZ;Q#94X8.GRQ84'OPJ)J+GE7S_Z"
M"W-G9TA0P%II,P7ZNWKR%TQ;*R[$*;Z]!FL)-XIS;,4;4J-7H5@'%?<TI,S0
M/"7TGHH[9.^"G&]@F"8T'"A#93B<F&"BW"RXJBF1EA1O;R)O*JZHH4@9>&'"
M_3\$V]T_7Y*<QMNG?5[(2KN\(0`:@<R*5/3X'`<*EB]Q5W!E`L59NR%-VUU.
M^<'GRVJ=7?5"6*71FD7*N;3$TR,7HZ?@"V,,F6-H]BIJ=3\5L0TC"%4Q#O+`
MQI$9->IJ3T;N&6<"=KAGA)@M##S#-[.#R.$C#/ML;(5C#&AA*%`L\>KC8PXE
MV994\02"&O#6*[P.&<!EWMS@HPYX/$7(;J)M&089R#6&U5VO\WKG=:>'0$9/
MP1<"&3+'=N4W=#-$AR+R4,B1*0WZH?L/DG'T"$,!&YUQ#`4L%`:1]?"=&!HF
MBR<8T,%W-`QO+1]D"M_4!)#W)*\8L&/$>@TF$`4,1@K@F#A123_&8YFV88(%
M9>C0P(H)1L<QAT[_(#KR,QGPT+&2+,45V\P"\NCLC/\OFI5!`@-6B'!U>LU(
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MSP]7E^3F(_N_/UT]G/0(PY^RLA3K.F5E(LC@4:6].9N2LAJW9>`&O#G[YSUE
MI:*,+&6E9H*E(6\/RB+H-S8?%TY36T.P4;=]M(1[TO;Q^N;CZN/%&VO[:*#L
M+ID\O:8ON)S.LY#2J.`RR=L+L%=>;_AUS>P-J=.A?@.*T'&I$>A^T;"<)-67
M3SL3O177&U)/17C4WPGJ>9;GV2<FH(4XS=IIKA\)V+P_'UML9IL-S?&>_C<7
M;;-4F*E<+Z>\]W17K8#7FX]92>O2#--(9'0^5+RA`-2_):4>RD51#*[KE%!X
M40LH38*.*5O*AM9U2"A24S/@`'/S.GU1.G.-LL"X[-K^K#=W>74\0W1(7*61
M_`5E?Q2_F>+&+9Z"R;5;,4?M[AL/S[Q]0XR(N2+5VM*3OT24B?+&D8<@D?GT
M@@\PC`+0!#]^A$%<_!?7PB`2[K4P%$/?'5409&\LK`,C:TL!;385]WP/[V"H
MJ8!M$.K`J27ZIB/14!=NSX&+-Q:BGVD>QG)[K+XE6NSC\PP[FM#$3#K5NV$F
MHHDQ@>II!VR(,G0X8L4$#XE35.YW,OC>A0IMP\&W5,L\X6N;?&/P&,->TZ=L
M#HVK^7*VC;\7"VGX?WB)P2N+C/G!&!8'9]'IP1G3R,**)E2<80E\<!.$KY?$
M#QT*9T32(`-'T1#L`$V$S54['CQT/AB$@$1:$R'>?+RXOUH]7/'M>['WL_IX
M*7^X^M\_W_QI=7OU\7'A/?RYOF3;W1%5!.EBDY3QI(-!@K;`*^8Q\OS`G(-H
M0FD;6)H1A8XI3:%;&-\5#SWD;-E@%U4<.1FPB"-I.Y4$I5@:/M'G.$TYZ*H)
M[8$&N7?H.Z$Q#V60EP#PRV.4\F5FPGB5NI7E3T5(>?NF,6S@X;&5J3**C&WL
ME'-?<A%[!W%TG>6F%4YCTR"ZC@^__J`$B>ODV3@<54?F+_^PW^T2T;DR2,0%
M&$E6['.9HQ<F;Y-DGUB<LLGRK3CF#%M?9/E51(<V]NKP54(:;1AMC3VN"DOV
M1F&21XN2OX=M.'0T%SKJ.0'2/Q<K_RR4&57THGGQ(UEGRBH'HW-B0W)DV$.H
M)T2+=@;*MO0Q^,QWZP<58*R?RM$TP,X^)Z\_T+F'7^PKAH"(ON-['TM]R4>"
MFWF-T.BZY0Q(S+++85Y<_)'A93^V!?1I-)`OO6QB!==[$"8_#]J=>&#8:(7W
M&:FH=LYV\&7H8*5[2QKK=0HSL&HD<N6!:YJE[P7OXB/>#>W\X+N5P9<:&J\"
M/>C@DE?%/I4W*7NXN'3HHBTKEK?:AG&0R%\6;*UR38.2O:RIRW:B#>77'1G1
MOU[UJ20MG3/2H71&6EJD)48J:BC"!$]LZ``-6Z`;.1[?Q9!3M$`9@TQ0`><D
M4>>^I[K0A)>>T.C/<?G"7\@TL#`C!A4UF$(]%<WC&^OJ:43.(WRB.$B"PMU/
MPMA<<=946,42XR>.,9H#H^[R.@B0O9OKP"(2*^54AALVFCF/'1FK7^\EZ0RH
M0*2BC<`YF(YY*LUM4[KNZ-3Z-%A//;O56!8>B+UP41M=JMM8\_Q;B,?L+@E"
ML9A</0^W?;*WD#VB*"./`>AV9N0Q(PT%(DC@#T5,08^J7YF)O?Y=`SR8!;C_
M^&0FY&\D:!G3<_?@943)W7?,F]75\0G!]I:$>C/D,;O(MMLL-8YL7$F#[+P[
MLZ&746V7\^N3,[Y'EY0TFW_,GDF*2&*C65@ADJ2<%4/7%=0;B%S7D410L$P(
MI3P@"K<FFHGQ<H-)-F*Y-/`Z?P[2^.]"?M@[%UD21^(?\I!@4<O6>E.EL8/D
M@?U&V&GGB[O]/!1ZU\H7Z_J9Y"+,XUU96=KS?1&GM)#W(C[LM]L@/_#?/\3/
M:;R)0]Y$L[H-A._(W+'7"&$OB@/A6I>N2+ZWE.M#X0UM;K`:ZJ0EK^`9^&Z6
M5T4UVM+RJ:5OQ*!U]N72J*-@K7[5ZO5(/Y?GB4'`"/9>4/MI`!]@DBU8C]B"
M3BV`L+PZ<\M?B(@WPG$S)X+OT/5DV8@GR[2>##Q.A#8MRHU&(+OBO"[_,6-4
M+SCW\]0V?AR=#YD0'`%TJ@MB&*G&80O.9L`!FK=2"9DV1:60,"]2;QPZC$^$
MR"2-0=`("!:WZ`P!/F?CQOF@*/9;X7MQ9%J4*C":1U')_Y*]'9OK-0^/>9`6
MO.Z1.5O7!(B6'G1NPP!POP=D>QWM@70G8?-V2X,$SQV8BJ]16L!0=N&5LPUN
MK1?K-B3AVK/:P+80Y&X1/!;O/3=H<`\Y09@UC5)M)7G1)H##%P2YNE4]06B_
M:@)YH(M>>XU4,P&K4YV"L+H`S1@HN&,UEF#3WIU&XHM`0R?X5BN:@"T\;8#;
M"31F!^L)N/H*0\C&GM;RK&OS:2O,RQ[QFGZZ=(0*M"<=!=?K$L:;WW<+E3J'
M<:HR)J2NU!BB.'MF='85W&.J9=+(32H%$DJ[K-W@V'3(8Y!F-KXG;=A\F#D4
MO6U`X[HTXJ8]C(C#(>7Q:U#&K[0]&EDPK_D3C9X]]T28\BAXUS:%37UUK:DA
M=G3S`.Z<QY9%!Q5!ZY8/"-SF9,TQ]*U3U0:U-7'PTA.>`>?*)S'&GS[A"PQF
M8@RF,&&Z4FABB<D:`=!R;'I`H2(%'3"H82K;E"&-"%P1O1%W;B"7AOW\=$()
MJFO6[E9)`[SQGYE7&!%&;+[0&14B9V<B<F:=`C$X*WX,+"YK?WJ1B?I;FH9^
M>@1:$8=V:+:LZ)]-;.;7:9V6`EAGZ5DA7V?YEN;DXFI-?OE`MT\TQ^71Y_VD
M;\/M.VFX6?M!!_5&9MFL@P5+JF"W--F"=Y=\;#'&O-#1A"%NXJV^[L=%MI=3
M:+[-71Y<8Y&3V=#!1@_,J13*`5B7RM-?']PO#HN3D>,;E*7E%$$T;7C)DHC%
M??)5^*[A!*=F3A#*G]E`[K6:[LS]+:D$4VS"8G9C4Q#+\6A<E;6\*KV4K;`N
MN#?4O,-ZPWSICJ:%.&Y5E4-?9$59/+P$.7T*"EX=?9C4SV3BTZ`=X&1F]39&
MCIK(=TF2N@1?$#TC@NQ[09?4A+$ZVK?#)G"'[D?]S':L?>@>0L-TWGU=^WWK
MB8\!V[J>S!Z%DJU-E.S\1,FP!2/^.22\.%G+-AV\D!E-M.))6=3[V5XTQ;DQ
M0-T$TZ451F\N9!N,`2"G@M8TO$7FX/V]/FC3BS%1TC:\&)&CR3)MU>BB/PFB
MR<70JX_+`1;?8/OFX`9>*26CO2#&1&31C8S&0:S2Z)Z6<4Z/C_M,V*`U)@V]
M8+1C0R\ELMTEV8%2<DDW<4IE5C^/G_9-`(+-0?C!?11[\MV,=O[;V;^T%7_3
MW4M+V5_P""Q[,?E:Z_*%YG<L'LR;]Y.7.953=C&=Z8,=C75G2.^TJ"0EE$$0
M(\?42$T.=7K8(T/TIA'<=?O2"_6QVFE*L>#^S_ZIH'_;L[>Z>IV201ZE`^WJ
M%0#[]XC60XD<B]6-SX0)W#WKA-'(%VLD$4ZU[+=21PF`;9TJ(!E('C;'YPB'
MBL%H')E6SM1;H!HA6TY?ZN[*+)A^BE,12Q>B>^_!UADI*$&[(R7(WEVT=;_I
M[FC95OI`?JG^"ZA4_I!^E-?K=GILHW-.>O$T<D]:V5Q0X8(B+M:;DU[9!_F_
MUM[*D!J4ZS(&VU-"/I%+9COU#)$.S@3VZ(:!]^3G--A'<5G?CA5O.U<.W*2;
M+-^*D6A\HIUH*QVDE5P[;SE<LJ`BR43GI8<R>*8\HQ2D!KHXNIMB2!%RR\T8
M=/_@<C.1B)FDFHI!(Q>$B^>:2?_8<%TD::>?VAU+*^5<<GNH<_^&8QR@I`%W
MAD4);.!JP'8X>F]O">XNCYGCWB6TD%5[G<EH_+>)(&K.GVBE<#FU^KF@Z\U5
M4<8L2J*%[6KV9#;T"K8'YE2^V`!>J=8,P:0_TY%E'60D3H>NWCH*GM%X,;4P
M&JU=!R5QR6:^<9;?L=5'%MW3,`F*0MSV)#9=H__8%^*X6>?*+N,=3%NZ<$U]
MK1G0[R!_/`^3<BZ%&8V7<Q5H34=?)VE>,,@,BA=^)I3]AY^Y>0T2GG=V7.G:
M$87VG:;0>_$HFR#/#_,?.E,QJ>^RR-'Y52NQ-JLJLI!I!"WU'=>+QO30M=(W
M66HIVNACTMVY@+^U-OHN2TU+`5ZPH=EV%\0Y?Y-U?AD7NZP(DO7F-DN?;^-7
M&JV*@D[VNT[/@';#CHSIM11KR)!U3FI"?.W+2;T7M(@DADG7%V9--L`.=,Y[
MBJJ8-3ITUQ.(AL0&9D'3O15"Z37]7@WDMC,8D\IZ!8;&"^O%S;"1+[CB7#/=
M_E.0[&GGDO).=V&W*B8SHM"^U!1ZK]T?FT?$1.XPN]4$S5Q,&C@W#[(1'J#S
ME%:B;N0:;>0<H!NPHR<<G0_>!=@@>FMZY6)207^H$/E`G9B9=?^%]G_WM*",
M"SQ;U:ELN/K,#\51-^]G0A+:]YG![F]'R%DB-](M?ZDF8M*Y)>&+3A7H_)V%
M:!O>/FXJUS"GPKMM0YPK@,S(`3:T-82K/`%]TGT'C])Z!CW45@B-_[0475W/
M6@NY7;!9;9"G<?I<W-%<?(N)*5L=.6BOJH?;.W5<S2!LBNR"A4D=YP+[[C8K
MBB\$9MYMF5DD00&=!S447[-NN4:RNYQJ?J2?.@<#\BQE/X:TLVYU=*'6=*%\
MJ0,#>F>_Z*?.V1IR3`23(L_%@'L:\OAWE`=HG*VKM"N]KJ.HPYWC-E5LJZ/N
M8%IM=9;>5*)[9[\QJ?$RB-&Y82LQ=NJT@$-=FW3R;1P\Q8FXRO$##7B;E6C-
MXOIPG^?\GL<T^IBE>?U/<<KOD5^C;>VK_3T0RHG[9-GX'L<9Z9`G-7VRYBOI
MBJ3("76?0>2!U%_$8]#Y_CGY]K#?;H/\P#>&"EJ239:7+R0090*"2TF'E]N:
MEP$;R/G]*O>44A*0_(BW:9:^;W_SQ-\$373A77&588=OK5TP'@E?:+1/Z'I3
M)2GN@KP\/.9!6@2AZ">@M6-J1V%+'SQ*L6=(3]LJ$GPONL[K"2JD2P:!'9J=
M$:W9"=H[L?.*)676_+CCI/$%.8ZZ81;ON"D&@M)L?T79\,&*$4BK0FP$:NT/
M:4>!=]TB;/IVBK`]E5]C\-"7]*GTY8T':.'QO(-`55Z63T"@>%[A=4/V-,YR
M4NR?LCSB;9Z8Q]RG!0\CV4],6]AKE3''SI1T&Q=%QN:E60E3F>(N@&[N<U22
M852T+B/M%)W9]VHTI0?6NM$<L%IMZ\G=*D4$BCP;:*;-40OZDVSA3^(.^"I0
M1G1)GJ5PJQM$VDFV<P>L3AEH^Z#ZQH1U6K7AXB/$!OV'+**)FVOU]#3(SEE>
MF*4NR>YH>G-AR#JM$G+L[PUQ(J@C,`'+<JOC[=N<6S%L+@J>BWNJ>^N]-IS;
M\B?A:>(UGU2]UD7NEKS!U03,GXG2-@CS9I]@0JH-S5F@^QA\E@?;V+*LDV9U
MVV9Q)8\AX+)CASK^DK1X&7MUF%(L[[M;*_"6>&:&\$*]+!6QES`I%4M*QI+A
M'1*4D9F#CA@':O8*`F$GVN^XWC1G&:I2Z.J2#%_)$_M'X<FMN+!)94,ZZL/^
MU1Z+J0\@D'<5U2\0F!(('G&C$F^8#E&FX>2)EI\H34GY0MFR3S"+6YI=GKW&
MS>T__(\_?_GP);FF+,0)$E*P\&M?\K1.'I3XBC(]**%ETL=5`YT7E!_BA!8E
M>V1=M-[\X@,M7[)(/$T7?9@3@KCMT13BJ:0WP]I[@MM?R:F5ZL/?"_D6,>I6
M8#.`W-4@M\VOMF(JR!+*48=488ZM)BYY^G%X-_C\T/W+ZG-LW?K5@C)TN&+%
MA'X%=+?DXA<^"E>@,3LZ\(#`7H@-CSM:2C",VEYFVR`V;A@[,!,JRS`(0B.`
M<AR.I(#']P=;U(\+DG*]/BI%SA'OZNDI*\OS..-W3@8[NB_CL+C(\MT'NGVB
MN:GW,2$%N?FAAWDJ0'(&.9E"^!SRBYR%P]^\(7C.NPS.^)Y.\(5L#JX-`D,%
MU&;_S;3/?65,MUD>!\E#D@7I'VG);W1*GR\"!CJ_H/R"IU&#T0_L36F!K(_-
M@?965M54(N:29C*1LXF</I]Z,>(VB^2W"]0Z'S`!ZL,?+R[@+.(L7ZT07^VO
MS5<+Y5<+Q70D:W]+<S.^_+>S-;-E#F_CE-Z4=&N\GK<C"AE;V4!WRKAQ`D10
MP!-QO6G0SG&8']2X\HX>M,\T1K/5YWGW,8S+*1PHHMW94&WFF:?_T11*>,'=
M*4O;GBHI@HC'WV?%97BFZIB7G0\,-1VB+8]H%M9MI_50LK=:B_N&BE55+NVK
MM,/YB=!;)EZ8IBIBD)W;GD3GMB[A,R)(DXKV&:FI(["(`!SK'-L1;,D$@<[Y
M5S21C']ULRSBF*AK>`S2BE?2/LLV0^>'=DQE7E>?@MRL0,3_`^$+5J>SS,4J
MD>X#R-/A:&#U$"*>@J(VY=?#-@35L)Z4U+`^UH^&+F?,Y*/94UQJ2(XG0\<\
MIU!Z6SU"4/D`C&4@D]\>/'(8%"6C(&!(CA;TY\XJV[YW&O$>`1^#+;4K]YCE
MV6!>?AY&]KK4_FW/UQ.5W\%4<;(0`[JF`%O!RIS*I';!\VG2@NVXM[LD.U#:
M6?78U=?H"4%[:17$GJ978X]R"KBJ:EQ@'65(1N&`^W.M,)JUU=9(XG+*51UQ
M-:L_&9X$Y5E/7_U4HJJ_8R@9,7WE%9G]I5U<^%1.@SG>0>E6>LPAT484=8^Y
M:^L*"8]/A':>7I@V?`F+.ONC2?Y@J[QXP_P"=_O^%--L`\"75CH70;3)N[H)
MQDU1[*E#\8,A)8BB!V.0JM/=3;,>.1?!EIY'G.U67=.(2\R$KVQPQL0&[),@
M)U%<A$G&^T_WX>$H:;#3P=%2!BL%=#<84E2:AZR:W5SWIF'&-"$K."V`CZE7
M:T5(.QN!(9D3<T?GQC?^9S<KBR/$5:5IJ[3:(DU+C06XI62H08_-/02F.1)_
M#P2_I<0#RQ2M#RM*U>UCBJM),!4AO!'>P-\MXDO=S.X6\:1K`&;I_-#\^%-,
M<WYC\>&6WU?L4H)@2!4Z<6,,7G7'43,!8_W"(@C!DR-V0FR4`+&28`!U[1KF
M_@O:E3O8$06/!@RAJR3ZV*UU_%U'U#&5,"#!#N_-;<3>S&-;R#R`FM^DNWU9
M"'OSC5O-@8H4&O\["%,EQ'+"&1%3R#<XJP_LX.F@X/&RXT)IYUI')1)6T;ZU
MJT50D0#WE8.PS!7K6UQE`':P=!#@O=FXT)GYKE&)@U6@[_QYJN\0>ZKO'!3J
MN[?CJ<;AZ:"@]%3?>?)4WT$KVH044Z\68(D<\FE%P-O,(ZM*3[KJ/G)#@]WE
MUXI"E#>;;/;%P&PB`^&]OD\%GCTK?:J]T[?G52^S*MMK<$[?Z_[HO59/19D'
M8>FTF^_Y%5!L_GMGJZ)60*>CJ[*;5QHR>9W?5"I;/QE'8`3#6GZS6):7+R.7
MVI!MS>"@[%Q!QDUB0/(C%J?L=^UOQ&5;:**T!:R!>9G`+*9@N:BPO2JL\_ZF
MT=WP9*@H;0S*J;)TKBFL!_8NX@2)DAP`)&,`P*(4I4`IHPV5-#E'#9>T"/-8
MG$]:;\[W!8M&"JZMC?X^Q,]IO(E#4>H39ONT9#IYER5Q6)?\V$0(/AX'&0WX
M85=?8!NJW/O7=(6CZ40%'=JD)4YJZE#E,__%+"_UB/-SBT4_3UUN%9TV31UN
M!2VW=A5U5*&-1Y.E#6/\V2O;D*6@X9?/V>M7$8UEM,)^.`U2V*_^<DN?@^2*
M/7;T/IPC-S0T9>F`9/BU^TE0-H+((4"5/_.\]>*AAT),!@..<1F92XCE@T:+
M:@9-06\>5%PP`*!WHK^2!Z"2EYE>&\P+C(F,TIR/R(O[U3`A,_7Q?FM^L</)
M#(CS<+V7[IU/KP;@V)=&\LK61]>,WQG<-XQ+\NAILT$Q7BXC<Y=G.YJ7!]ZS
MIF2A&.^+M),G9ET;NIF0A-X@-X-]*F?UK#,BYHFPOYEYAK8KW-)@P3?4+83:
M:&/=7*(1*"Y_([N":A-24&E6,YA.LHNI8GIYF&`I6PO!529PS:5V.:7\$(0O
M<4KS0_=]W,K+5*2@O:<:9N]*A'KTL7SB+"V;`HUJH8%[1@,!-?*(>NE<L-1L
MGZ=QN<]YZ\7K^#/_J;"LB1ZG`%8$I@+5*TBJ!PLQK(?C6'1Z`+31`8(KDM**
MGKKB22=W"[;P3LLXBI,]WQ!]X,4"8C_TZG.8[",:73,V\,Y*>[EH7V^N`O;F
MZ7-Q1W/96.DP3,"I(?B,KP+M.>=E<R\OTAE,VM$8UZB8&0/NM1=03K,6Z[-K
M)K3!LV^^KJ4#%4$8`#14BS/"9^%:,"^&#BRV,!50981A*)W+J=U%EK+/7<9/
M";UC9&F>TTAT=79;)>O(0?M[/=Q3*>W,(,V4JG<YRA7S,A#!?;"AX!KY43.I
M!5'*CUE)B[O@P&MM[!;1:B)07E`'326;8@*I9N!;?!I]-:5W,/EDSCOZ]7U[
M:52WT;0S\4H:D%6K"F"GTE1?S\#&MGUO8?KKOSTXSK6?#HAXFJEJ/HFLY:1.
MC;1%EQH=6K!9__ZIH'_;LR]Z]5IMTYC46.JF@UU4-0JG?UZJ'DG$4,A"@06A
MP%T?I18T]0U02BD#51:[@DX](>BUD0JBH=QAJ@"='Q;X&D@KE&:7-6@D$DS)
M[-8[PY.1>*/Q:\-.)0[5)J%W%%A\D,6B3"570`<3;VUO2_+YR+=[0/%6T4/$
MU[F[6V27)OT7UX".+)JRS?W8(JYUL6>+-O/9Q5-S!G7"G'XN]T&BZ$;3.\[@
M]X$0IW1\LVPFHU0]"+"U#"CGLA'.97K.O:N>]`5X]#>;AHX>'YI#/9V-TQUE
M`LD\WS-=;]:?4IH7+_'N)BTI$];R,3NGJ_!O^SBGD4T<:4X4,E*T@=XKXV_F
M<CO1S";U=/*8D7-*:@IHXCQ/F)F&9PWFN,9<9N2)LC!$4N!788;9=A>D_IOG
M.`=L,/AQA6'6*J\-M&SUW=E:763;;9:*?7=^P1_?^;Q)+[*TB".:"V&XSG)>
MW%X>ZL>+1Q?QD*`,N8*)3X`(EB8SI;^AS@E6U1TU26;:R!%1PJ@22;8U>QW"
MX*'0O'R):[[$*5/S+E\VC"]4\J4Q#<&,?+$^G(V4,3AN)/5C8D:#/R_VQ8?]
M%.6]U36I-^G5Y_"%7[R\WLAGMX6'-VEKW6UBP*F/@HP,I[-)J2&29GV9,K.K
M-5D>2U86M5/AS@:TM-%$DK/QJ!`\*B2/Y%W%W)30FD<L]JJ,2-'RB`W8S<<C
MYW`3,9-PQ:2>#),V4O5CE1"T#+@JRG@;E#3ZN:";?7(;OYIW9;4CBJZ-P`AT
MRY/V#14BR1!!!\66ZE3D+;2]A)8,0</734`ETVY]!10"O9P.-RF^-HX[#O`J
M([3.ZXCPXYYO(*\W71-E6T3DZ:G0%4?>F'>J)$WFND/YK+>>K6*T==ZL@\^(
M?(#8'Q"/0!&2S<ZO*FC-:4B9%HGL%@W"%[*ZNY%QR$N6L"4,CSR:?F1A-U@1
MJ[^C&4VXTLN/@I=-^=59HQHKKPH+?2C3^(#I:LOW-TPC%S\/PW6\TYY5ID>C
M:\J$DR8=VF*=65'G:TMIR,Z(?`**&&@N7MUE)8L+XB!)#FVFJABTX\B.D3JJ
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MC02*`&%.OOQ#L-W]\R4)!1OBF@U/!U*^4)$*1E66/1,7\JYT=,.F/EN.K"6N
M?,=TNZ)->TPV*LY&\Y[&VZ<]6R_PYQ3WU>XBM]4:`]E;WQI2@LB)&(/L1T#=
MB:2>*4,?4(,V&\9F@YEK!OGP\,>+"_B*Z7G`P=L<5R72Y8NL=''!YB'A"XWV
M"5UO1L+$XMBX6=WN/.TAT`DF5];TEB45';[9,KI^*\YZ`1FJNYMG8TJF9LJ3
M(5/`$SR3%,FLX]`$+7(.1AZ2+$C_2,N2\D3;35J4<;DOV3M<!#SU70='YA=>
MVA&$"$UL(?=$F\\G#0'24.`&0-)H%VDH&A=Y0?W'&T27;?KYAG]MOF'<?$-F
MKT+Y#>NE%(XPQ4E11Z,5%RUUMC&,2I;'07+\4/FD"\I+_:9:H=&%I.]'0^:3
M_+.Q=U%8]01R:N(JJR:?TOLK2@,(R4:^@I/M02"-)@9!*D[L;&5:0RE(IW]%
M9X47LRNF6:MY[)E[*HLI(-^2^1#\/4BI86O*\8D@B:H1"+VT1C6.5`/Q1':F
M""[S+\ER*.P33K8?8BL'X@C/E)HPGC12J(&S4MX&<90$GU9I5&UZV(=-8R0@
MPY]Q6*<24HT4'K@:BR\,00K'.:APPX.R6Y!&@;1.6JT]SGK];\&6%L5%L(O+
M(/DQS_8[<W\[.A?"Y2J`G,J*'$JJL40,QN-YIP*YO;U`Y(#MT805FF<^&(<?
MUBG)J"O6:(A[K?L^>.;'KY@U6!5%%L9!J;CX>=0FJ<A`>F4UO%ZQ>#5:V/YV
M/#[O[`A+E*!T@8%J^!P?+6C&X_+9!FJF]=MZ'7.V`JOGG(J=89.[A/H3(+ST
MZ2OW:M#KOV.X(PC%"UM[7.,WQN%;!X5XU*$.2?!T_;&[7FAH*J2W[,-0""FF
M:X/0O+RSS[-X>UR>;43TM=YL6.[=^RBR`7$8)(\\_=S0-E^!*N>#])!5`^IU
MH:N&$S&>=$0=RVH4/2#[KJV.B$J!*,#E/4T4:+R'JEY[W//%<4C3@G:*GV7F
M:DMS%@(G\=_%]]*K_'@^S>D!H+EF1Y;T4IV2SM$QC2J->TP*@3U9BAEG.+CA
MGNCV+!O1"3?"'C=@#9EGM39.HD\P&A.:1:?%/N%WCSS0_)6]0>$2Z6B)P+3,
MUT,;N&:^FD/J20@,U5N&YM"X?A*VHL:&+1@R531%5WDS+7.V!5?I<_`L$QCN
MH<\X$<CP1@6MUUFW&8M!/WQ#0NI:M;*G=9\ZP7-6B\YYA`]!:JPA/0M@1`?"
M41H"/!6JSC32SL/H+CT`W+8``WBCL!1"'*[31@%'O:>%]H%WF+FUO=?9F![T
M"40#P,8-8O!=LKPX2O`S@J8";-@"RDAZ)[0A&#YDZ-"0T9043","4YC&0HCR
M%MQ9<.)JYV@IL8JC^C;BZJQ@=:_Z.Q:W,*=J[+X&YT(N%P>`G,I0>T%$/0A!
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M-EUL[X+#UC;99$`-M.^1"=A>!YIV$N&S1&E=TY2HGH@F:IJ,<5-C;!I`[^;"
MZ-YW:#Z0N*(A<_74-_PQU4WO,<^4T`95!&,7J*`-1>P<,=Y(PPX'[I#!.3*8
MK+11)*Y+#A+YA,L]U6KO^.)-2PPTI6(`M2=0S9SJ@E]Q>PZPIL^%,)`((X80
MV@@L#Q&7XS=62WWBPU`GG2W()2W"/-[)6XXOLE0^[CK+'VF^C=/J^F/V[R<6
M;?#PXX[F<1:91`6NI"&"!G<V]*^O:RB)/J@U+<(FDPXU_L<./2()@H<=_AC1
M(M\PY&4'>;;AOVJ0[^9!;AVIS",#O(6I'2=PQ#H3#<-H*#3-*KC7J[?4+P/>
M![7S!*=HR8P@9,1D"KE7_]P14#[QU%+ABYQ\((T"V6^XJX\((ZC9H>**I*S4
M5AM-V>BL>U(V3N/M?ON1?KKZVSXN#]<Q3]O$Z?-'2B,J%X`C=L\IS/+Z/(C8
MRS/#>IE#29XP^D0^@#1/(/(1U9)P/%9#&*@MQ+64<8U*KFT:KJ62:W(--A[=
M8`SR%F1;3]@,V7:--"*<P["-AHDS6#7W"N[CEZ#W05SPVR"KMKXV4:..%&A]
MMQ9FKUCW5,HID9/X)6=S7;7J7#OM!._(]E&22WA/A[IE-9[(<!Y\N,)!0TW4
M%V,;J:&SP6`6Z#E^I:G,V:TWZZ<D?A8?U*CIIVHZ1("FAG,J5?7H.N7.5H^=
M">!QDR.8*O7,5DW9C&"LPQF?:'!$&0:Z,QHTZ!5GPC')H>NA[W):EQ[(9]87
MOKK?<C_M09#QPU06]0\DCMQPWR%9&YGF?FBTU]W/RIUN\["\>P-Q4QF#XG9I
M>.;L.J)3&<&&,2SH@;^7>B:[8!H8^;`^RW6*6(4A?YOJFFU^#V[G=6):7.SS
MW*"$R9;<TC&8/=S>'GHUD[13SX[L))M]1JKYH"':=*P?::W3?);"W"T>WCB*
M[6"XXR:S'JH#'[.K@%<=BE.L5N5%(R1PG-,ZA:4J%7S,"!]<'[!&$V)8HQ&5
M=F5&:"!J:,5H$FQ*D0O?[A(JF@>&2;>?,IZ@P1HN0_I$)6B><Z6=;TC*EZ`D
M+T$A\AX,..7'%>@)=EP1@48G+0Y5#2FD^U7R);,\/^^N*67+L:.&U2:Y#\5L
MD$OB56!ZMXGSP>3G'3]I(+:0CGNK@Z<^[,&\W^]XM;U0%V`S,"L:'*D/O>:,
M7^2N4YNIZGRYIQ=9(:P%WSJW<?PC%"#]_BBH497FA<-\K(P`^&@DG6V,H7`$
M=>5'T5$'-.&+W4?A;\\+@4/^481/C^;X*,[1B0\TN.(-M270AAM*,^"G?OGA
M)6#?6/3RVE"Q)6P2<NA(@-<C#\+2U!W+.:2>)*I9P`.0::BXW9*HRAH5+YMH
M__5T(*N?;L\)&_M$7X)DPZ>PW\#'*K,`QQ&T&"J@63WPJ/8MEU-<;S9QR#PQ
M7P#3M!C\Q+H&H(,TH+O,C@`[%;QZV&])=R"*(&$6).#=8E4"9]0A5B%MSFYU
M+13RZC._9:6@=WG,:R32YZ&XOV<11N=".%(%D)Z\2&M;CR5B,!&CP3TG4AC6
MCM`>!ZUQ[`2.G(_&X?ET.C+J\C0*LIRONP[B_$]!LJ>KHMAOQ5L55Y]W-"QI
M-!(]*TV9EAZT#S0`W*N985.(F$,ZD\Y(/6V>R-H^%S`!(O^UJ`7:@91H^8;S
MYR!G5J(D2?S*0N:J$U$/%;C?-U4^HQC`4/,FQ@-%O>__F-TQ(7@)"LJO8LO2
MAS(+_VH>&VCHP,4)6H##3JIHZX\>,U+/)'(J$7.11!#.`)LJF3(CNQI@*`$6
MLP!TC"WF0X@IZC#31$T$8J2&?C)S;7E"L=[<)4%8W33#_N<ZR^NKVVQV%5S(
M0VXYN+%#D^7KT!%-]VM*1)`2>Y`U,11>?1Y&L-`E[S""]XYO&!$(1O`=OV(N
M1CAO$4!S`M?VP@1[H=U[<#<6?LQ?%9)VJK2*\T/S:.M-"@TY\`T++5R-6:OG
M']FW\T-KW\"C*7]PF8Y^JN%V=??IT.HN?&RU+%X<D9:#!IOM<ABIK[/AD6=>
MUYLZO]0^SR:\4E"!C**4X$[%3@[F!J5)AG:,"YJ`R`43TZ(F,=K1*#RQC4=0
MN,(4O7IIHQ&M;DW1_9!_K6=&\R%+XC"67^Z:&NW<J*9#!!5J.`-25(T6!1"=
M\;P@$SQD<`;#M_^[8.:HV;(."'RBP>'N#71GU+WK%6>B.X]#6=I9M<$(DE7T
M&A=9?G!)G9B2A'?T)K"'G4D<-E78S612S\:7%'&'^R%+RY?DT!0V;QJT08T6
M7^;#P]<UP(LQ<#!69,,HPE2+_>0QVG:T[=JELW01.13K;(814?"<AB%T36:C
MT\RX)7.4VI"I6_!HQ3=VYO:#%GOG?&9WW2]SE/#!#2!X'+&0L]*;)4`L--[9
M;G5VLNK-K?/#3UD2Q>ESL^"RB9K,"$+&3*:0^YV:VWWJ=O>:&:5J;B=K@B9@
M<L5:%X>\T"0:4#\\V]MS?66!IL7(6/!2?>4VY8(K<++29&W89*/&/A9M;:N,
M#T'*9(Q_\^O8[&2*"1F@O(P!/.7"K-NPIYU)^%3PV,<-7G<AUNTILVW1;>9`
MYY*ZF?+U-/AP!#`6"JA*ZAAJGY=\[?4^20Z7<;(O:701[.(R2(25NOK;/D@>
M,W6AG6K5Z?($X-2/&U/4"6%!BE2T2$6L"GH$.5Z[!UFRMRA#>/MWP9"H8DA8
M,43&!U0PA`5#.&,@+!S!%2A-LR8F"2=W4S+ACM//O!%TT])QS_[GCM&E):]O
M3HO!U'>_=[6>"DCK>Q-P_:LPQ:1N?]6]^(^<2>JIX''4)'2=%J5[\9^=1$?G
M0F??2GY.>#C"*'/E&V_D;JIYDQ=;]2/N+1N3#<['L/=U`F@T(F\-P3VF=F2&
M,-8[F@>BT5A">49B6ZVC6@V9I2GAY+TKTZ]SC`-=Q#"J.L8;4`-ZXZ7/X-T^
M+_9!6MYRL7"\CWB4"NS-Q`IPFL:#]3PB)J*\K]@>7-V'<%>#DY8`Y2W&_M'A
M</7FFF=PR[%&[98[X?P0OM!HG[`5RUV>,4=3\EVFM%RE$;__030W?N2[3Z;Q
M@C5=Z!//%@SH-::JIHJE137YC(CIHJ]V0X#\(DC\7Q21AT_@F2-P\+/%MF)O
M=,;84N:7;MG3O,0'NGVBN2Y.4$^&:O$]!F6XMTU7$N70Q770!PJJ10'6JELI
M6LK&W"JY6DXU1C7U-D[I34FWQH6C%A2A?9X1Z-YZ36WH^50BYN)R<PMC!?=L
MY@)MY-.,I1F!RGZDY?GAD3U^]524>1`:WVMA01'*[UF!MA+G,\)(G/$R`TZ%
M_%+3P>$I)^%^V&^W07X0V>.*CL#>^%,T;M1>II6^U5J@$6COSP7=[)/;>&.]
MUC0AB=;E'L&V5%PYE_#);\/G*L$V:%[[FU=XW6I?;*?YU9[,(E#-'_.LT.XB
M&U)!YT!K<):Z)Z8MV];.#Z['C-=L[!ITNP;=J%O$Y?G'@+4!.@?#;Z@#,2,N
M2C')IW?U:M&KY?;;O;A)ZY+N<AK&8J^`_<QO1<I2]H:K;9:7\=_%[T??WM;9
M>WLN=$3@D8$#M]G5I$F7]AEIJ`L=Z=(_.\WDGAU;/%0!QHR\>W=+B^(+TF5A
MU'F$/S;\(-F0TF?^D#?.!O#XS+<Y,@KB/-LBYZ*`6^8`UNEE7.RR(I8GR.IG
M:4QM;Y?3E!1$>8`YS%-IYC/).B6=N=U-.[*:U=)9;Z9/!,K`11V@H]F/WK[Z
MW,9L?J!X,CL.>CE:-V"GE.YU@@,T'^GG<A\DBHSJ>.V4`3G0*D(CN&/+PI,]
M@6HB8/IT&9SOJIE?H(D`+"577[5G++;++;:ZT85I'N9H#E36Y>3%^ST`YHBL
M)R0=+-ZWKD0']S0J(5%F%`8D!*+P[#$/^-GB!QKN\YA?R<TT;UV^T+SZPZHH
M:%E,K$*S>0AT9L"5-:KZM&H":4D)PRZ(-7^4Y)!7JWGB2>:%)^#KWDEJ9%G5
M9J]#RYF3#\%_9#G?V"S6FTOZ5"^ORT/G;3_'QIL8IN2@_*HYW/[Y*C93;/6+
MCOA\<A/BE8>N+OS"*>"H`O`#-W.`"^;-+05:Z>CMI!F5TEYFVR"VOE_2G#"T
MK[=AP015EC1PN71?T#5J/0(=W'-;"[^1M[:5?/=K[VD:9_G#_BG+F>_G6;^?
MV6*(/8-&%UG*Y**,61S`%M/;N.#M%C]F)2W,*L^GDH?(34]C1R]*%=1(EQQI
MZ)$.0=)2)((DCCIW_QSY_?\@&)EBG=J?14Z*+DOV#4O"#DMV+4M23A+'F3H/
M1F0T:3[=@N!-AMRZ'DYP?Q!TH#2%1=X2([=(#SG,PAS;#(F".>#!UF0%FR55
M<JI=[L&8+'1?;\8MF^F9"%MR(,&6%=RQ4P%,^=5!`XZ3$/X`\YLEG`,&'/&"
MO9R/QP?60K[D?M]3>9.RAXO@\CH(J6P=8.ON1^E`>W,%P/Z>&UO;MV//"!]=
MM?1!=*VX!:*+<36KFN&@"BXLD-WE<1K&.W[7Q"`.\#A`IUA&;EZC55!FXN<T
MD,6&-+J,BW#$7HQL'>L(P140Z"%J+49G&JGG(3BZX8)MU;;%R^/GF%^7P,S'
MGO)"N'EPN951H/]J#A6+4]#Q<NH_''^S@)FQT<\&6$5B:%,TI25F!L7]UIV*
MSCT5Y=>/V740YW\*DCWE>>\\?@W*^)6Z7.QI21GTRG1;)O1TKB)`*@J\@1JG
M0001N:E4D\%W+^BO!+[[]>C>\.<5_C(C&X[_5>!G3B9J\8_>-CJW#9X/OS3*
MD0L7T$2V[L90?RF\BR6<<(]:UV7TGGU.4[J)^05N<OE4B-LC@W*?&]W<.H$Z
MS,UJ$YBAB:S(D-EK*9*6)*EH`L;*WIG1`1JV0#=R/(XH^C^!`#C<..>;'W'+
MCR$/4+Y0\J22%?C34UYY,NX+M9P`7[OX<1^*J_DF^@Y//K%[EI1YX/$<SWB@
M8$(/=$5C!EAGX+H311@/9-9]XUQ%T1](T`7'H].YP+DO3"9\Q8Y9'@.*JT6\
MC8[J0VYS!?5D5)J4O<PL5GL3W*ZI+]32&&`SLO"AM2E\G<5I=SZJ#&U#"?K6
MK)D8(..%W<F&3[V%+",'F$NQYOSB'>NDA@Y^"987_;2+C&QTWOV0^M$ER*,%
MQ>-'A8?F@QY#'P;4VUH]OO\<K,[WS>!PO[_&%@C<O>1V4FX:A"A49,(M==UK
M0<W/`0S.@[F);A!`_V#*T56]B"K/[0'@N:U6)3V*B]5&1<=9C'E9V%UPX$=<
M5VFWCES4BTUHEF)'&-)?V;+@5,#X,%(1$-7$W7(H67F)N)G*`NAQMEAQDGRM
MJW$1>V?E';C9_G)/'[.;JABCN=W>Z,94"VH0_LH*;+]"L5VODGHZ8?/Y8K:F
MP!-K4#4!L\"5]Q@7+P%[87X9&:<B]+1\R;/]\\OHYN_RSGPNN)1$[".S]6M3
MH)1MQG?^06(!>RT>C1"L5=BVM+.@X9?/V>M7,;-K12D+.^7/IR6=\K=_N1'_
MX:)0/_GJ,\W#N*!L<1T.[70/&FQ#:E!AA#'84\EM9S26YXS4DXB8A2)2<`;8
M8-GQ`1WE0Q,+V`FJ,@"PDE(0U=O%N>SH&I3:*A-3,DL'`^;P#+2-M),(GP7J
M]]V1-7!H"R<:@+.X@[.4Q4'/9B>(4VXB;CL;BYN.UQL>M=NL>D=I0"YP%<`&
MJO';'4HYED?%?#0*/S0%SD["82XHG0..<WK6#QY<Z5J=+FG7T1I%FM`2F&[C
M_?8Z3GD\W%Q3?++38[)<-J0$L50V!MD_[B8FDFIF>]EX;SL8?'T\&>.FPMC<
MRMW;`(5?%2\`$L<:V$XM1]>_5CKI;D."@SP$%-%\Y(E6&[@&Y$#W<XW@]B10
MSB)B&ADU+&BBBFDH]P+E;DSK\`0;L\+$%8-8J*E^!]E81]VMBHARXM#-NO0M
MJ@4YD!C%"FY/(*O9!*F9\0SW0Y:6+\FA+LS:5=MMV*S.7!_9#C:2B,9>G<?#
M&FM==J^EW>=5=>[)0XOKS$>PXT0?M(#?C2&]8LN*C+BEZ<1X%821PF.[%F,%
MO\>I9L6N9L4FPV31$/,"5[`UQ6[H#Q&X&PW?B:+UOBS*(!4M[Z:FBOJT$"6+
MAH":IXLZLY$GC&QP]K,I60<G\J21;Z!(PBQ+-;5-'8WI*%1/K)NTI$R*RON@
MI`\E/Z_)3&+(Q>/9^C(A"\JXVNMIF*!MQ%3/)YS`&9$D2$L#1<3E!?K=23>^
MN$:>`VT.^Q)(D]#!6<ZG7#@94AH5UPSO:>VG6:"@F`\3'"@!#8B;&$[X^'XE
M,((8P`K.1\KW2RI(\M;9KC9A</5NGX?KXX36N5A<OU[9%.Y>JVE3,KF5/>'7
MVHJMIZ3JJ'F3_ODE#E].GLC+,VEDM6?D^`C0?21GM@PD!BM*\M+KBE9]4ODF
M)8)<SP`121&%>Y^-(\).U1RI,J=Q2CX)CG2U6@8$\W#$?7\*"TMPI5<FFA3]
M_M8D>P*U&/K`>]+$Y8%7_UW2(LSCG=V%PB;$<#0*'H>J7>W44T5]ZQGIS$;8
M6M<<Y\6IWFYKG"R^WX)'*$X2:]&"5BVNSK'+CWE6%'5P=),^[)\*^K<]3X1L
M-I09AN>"WR_0G#)9Y_PRMM<@H99-:2<]!S**F<B@4RD6Y$@3F+/0I:5(&I+R
M:H_.$;9U3CITT00TLS"G68$QEUVTS,D:YC#WWNU.0MBBAL[('.?8!B-W<(4Y
M/JR/-M;Q8'HFM*HZ[3(K`ZD_Q^5IA&64,+*B!].<R@IP/YCIM:NN%G&$4U@@
MQ63;V742W*.#K'(=(LZNBI,O60Z?0)N(K_F&%;9/@]^0O'N@U8+]^R_XM0DQ
MAA/*_B3YDY$DXTBRN1@L17<M:VOE;&E[I\5^Y/_#H^6FZ;=-O&I"#C(L-8.K
M/Q!)Q#RQ5.S<'(`FP)P,L](]\BS^EQ^1[+3&QQ,JSHL35]!GH:G:V,Y<3:%R
M5AT[UW97%N?"OW'+6ZD(XLA=J2%K\U>=Z6?=5NX@W1&\P^T`V@T!0I*X,A!;
MB^257F8]-0-NM/Z.Y@^\,8R-S]>1PM-7?`BFKL%OYUX@-HN(:6C\O#V\7CJX
M<^/-CN$K9L'GJ:.X\??KM.L=PH?+L1NJHF4/\3$]=+885Y]+FD8TJC/J]7%S
MEWR,,2V(7(P%T'X;'SFUW4QJFT/@*_/Q`71[`E2D48]-#(*DQ%)(<20C;#5U
M-!%AJ:83@I%F8VZ].7WH2`\FA3G5$8,-2/10^RZMF<,-2=_(0'1DF@TATRO:
MT[FA)DV04<E,$+$%)H9J:1":F.GDLMF&=DW57%EP=`?+/BVMD@U&]"!S#8:`
M!T/J=NY9YXZ3;@("P0$F#V!/%TB%Z-;,[T(+PC#G^Q#-X8#VX@_VJ_;J#]%8
M%3P0<!5T;7K"0LH1J;-8`E7[*$-*K3UP84$=PRD@*V8X*KPD@ZE:V!L'AG:8
MGP[=.Q!'^N.A.!QDKPG&!X2LU6#"SF2QS_DAP[LLB</#9?8IK8XSFV08%+,A
M<@I*,/W]J6HPD:,)'UYW00#/&EA!$6^^.VJ+%#?H=H(`?';`"E%U>()?2]C%
MQOY]"@Q',D"O1J/+?ZT.^=)M;D&").&4QU5<L3&J(P9;<:"'JC4`G5E0=L`K
MP/H`_;9JV!1W\/%N'FF<4OE'1'6I+D!;:S$$%9OQF*!BYI4'9LH*57>P2M-]
MD#2=,`TC#BM:.*H-1H%J"PWDS$ZK6PR1R420+9B.3LKE?]5.#=R9N\BK1:V!
M4EB='?U#^$*C?4+7FUY18_OH8A6RW\?EP>4"-<<G0(8$SDPYE=J:D+CJO%<"
MWE':@M34,-ZMYI\?/#KO%1)WJ@(*$E34\(07D%S`%6U,,QK:$&22Q?!XI$44
M[)OD,L:FXCBH4L,P.9,RSQF%Z:<SX#&4&8N#9T#PR.FV1REFZF,@>S(^E$%>
MSH#AG#[':<I;JCT%"5\[S'781<*X2J,Y0,S[ZA[.Z1@H02-'>SX61X)+8U@M
M3METK:H_.R^HWM,P"8HBWL2A^$*/V5T01S?I1;"+F8+:U;>X/`"VYL6-)7IK
M+)6)G)+BMY5R8OR<>$4.3;#KBQD]S&7&EJHQWXLFH9P%96LP8,<5T4XR"@;5
M->X6P8.=NTN"4#0!73VW!XK8XQ/>*JU[J>JTD]ONCX&-DZ>P1V$!&[)$T&WC
MTXKRZ8W-^,J/YV%1RY?@N7/"KR!YQ9>32X[?W+'JF>1I=R)/.KXAK7WV:)8,
M(L>I-FF6!AFR'4?5I&-29#E*%%4TJ8!NVR>CZAI4$<`;,UI`'NPE<8RS8_%^
M`+-X<W_O3^-\J)L`(8\9=2IN'R=J]'O)V%`\?Z:`4-)^(U%@S0B/H9\@^1;#
MO3%>V,9X",T=D*CH."4*7M]L)'=D1'R&;UT+,E-3L[:1FN?(;8@TUOAMF`WV
MW<ZZ+2#?4C!GAG\PI&/B]NTP<O*>K%#8O&5$8C#0&V3,VXGW%.9A4M0W;AN6
MLG+K=.APKV5_M4&J.';'#<![,6^$T4(4XDV`;V_=SE%8M]F%P=RPD2R%.4KL
M0V_M]VT-3<'\R]FQ1:R!S3>BC"-L,V3"Q`4LR*)U/O0F2U:%D<-@X!81C9T!
MG^`6J;X4V3YVL[`/SG;ND=$LF,#QRYYNX^`I3N+R<'&RB<R[?)_^UB2"<R<.
M$<A-846O!*^B)6][:ZB1BU[-BB1X\@?PJ&X67HBKU9*&%_UZ#BIY<?P'-+$=
M(I[@"/0FVX[1>&^JX5CR)%EMK9OF>]T:\X_4^&"+!47X9A,&H,<=_EFGP>89
M8:-1A'QO!IQ!X;5_@`/UV#/V0-<69<\`4`\+09\/4V-CV-O#T-(L6QBMNH1`
MGVRP>P**A*$M4WS62`/>9#`_8XSJI6=DP/3TX2(<`+[]P+=.6R<374R&LTD<
M-+5.-UZ-)B9<'P&9:G1GRZG(=YJW#QZ17OJ6+-?THS^..%TM!6@6EQ(2V2%^
M\,3T,:]PU#U[UW?3C.0T>^+74LYZ\,3S$R&"2^],,S:O;_]PRNR\\WU.!5/H
MNHS@#9ELD^VC-W"*91YS-QH%SV+KYHZ*G8LEG>B_@7A85R-G%PPCK9[TQ`O[
M4S%O.`8V$@SC`+A`?&9FBNGP%?IZK::<9IF-#]7X>,S;BW#'RE&\A;4X#M[,
MPR2O9W!^/<&K4J9\1*P/>$[H>#1.,X6F7LJBC%,>DX[P3'C*&XA-S4YQV*9K
M,1_S\<J8Z2=^WG#X:B$[QD'L&S@/--WL^$OF>C\EY/YDPP-#TQZ`)I:=<'+$
M@S%%<:C(-U^FGR]"'ZU.E9II9A3/Z2,O5L8N-%WJ3))+7&Q]/,G](>A"4L>3
M*9-2`;B.,/EDB]?33&\F-)TB0ZY+?X1GG2:;'K>X=(D34!<O[,/1FU1IVDW"
M3S-"$&&F*<3>C8AB'J\6U0:6X"'C1(QQVBF#A`_Q?*(9">IPA&M6VC<:EMFH
M'L39H$=^FY!I%#8V'<^IGQJ.HA#]%S$&QWTS/@$@.@-R)%26!SZZ$K6<0MQS
M+5U]CK7NM#\!Z@*U[BOWBNN%K?V%_W5Q0??ZLF#WFO4$0GEYV:DT+"RX'^CV
MB>:V5KP[%=J"'\,8D9#+;!O$*2[+/>7%P2WV@/`86>N^Y"PG\!^"S_%VOQT5
M^4%M/IX$9;%/7_U46JJ_DU_D"!R6>^I+@UGP04%16O$A*5E0L.-4*=A*33Z>
M#&W-3Z'T9$;^'4S09WUY<*L^*$A&=GU(BB`6I;=Q2F]*NC6.QH>FPEUL/`1#
MM9[CXX@8B,/D>T4`>#/QJ#AI+B(>DR7W>X?WVVV0']8;919HG9X'15RL-WR$
MR,=]R"+&0)=KB+T\$/168D\LZUU'*^GR7+&^)&&=$D&?_[UY`A&/0'ES\<P\
MRS:=W&TQMB//./0DF,;^_MHP;<N?@<95>E=*_36_'C72V0Y]"/*_TK)Z>K<2
M(/U`@V*?BPVMRZ`TJFDR)P:QL60#M;^DX7-;TW"\;<P,0$N!<!+@.TP>P#;[
M,:$$6YVK88K;`1LQ$N3=-U_`[T(MB1C'=I2U[HYN2=DJ[G(K@,8VKHIBO]UQ
M82BN/M,\C`MZE\>A]4:5GB#T4MD$LJ(,J#/KC-3SB)B((BR9`G,5_<>^X(4G
MM,:U&\(%OMXVEEJC-;BIR,)JY7U<_/4ZI_0F+2F3I?+>(&BPI@>U@K<`;*J:
M?#KA\TE-@-Q#1PX>X`I8&PXKKF'E(D;XMA<C@.4!;,57F1RPE%UHU[FC(3.@
M?\H2%ECQ1K4C:NI@W@8IXW2F(TPP]ZJ2`&DI@.CN?,@;A*\MPG??@6BP+TF<
M[G$5`HY#JR_CUSBB:335]0[2P^1Z1P!;ZV\]?Q[M9;;?@]\UQ-I@BFI,AY@F
M$=IP8AHL\NX?<8<3*I6T#B<4^@A@>&[2W;XL[O+LJ>IUS].6FV"?6'>/-R&)
M)H!0PE98'CGOC'1FRLT%,1=GR&"%M0NLOJ&U:;_#J[N#]$!DDW22L=<CWY,#
M#?*"O/L><4"AEW*[2$(KXLXI?%%ZM=[<428I:1GPGZ\^QT7)N/_P$C`9$L>:
M:&22P3>F!9'`MP`Z7'7'U*Z=S/]53R=R/JD(`$8"7G`R+=RU.-F_:(VSD#BS
MF7#:[E(LAI2\^QV"+8K%X.+8G[`U3*/;$Y96:?J9Y3;VJH^$6NTU&-%"<0)Y
M'*C16JH],8MG?\$17X-$["B07.C;NW]:WFIX_VAR5S-H/UIV!!7IV5V-"IH?
MT57K'T0MXTU:E+F0@>+'($YOLZ(X/_Q$HV?V;N*X,%_SO<2[\\--&F9;^L!D
M1>S`WF;RNH?SPQ`QGG0>.[NG*8>;_8W@*R\78+JB'++S]#/"GT_>\3?X@IP?
M2/42I/L69_P/\D5(\R:D?A7QUT'J<E<)Z#SCV_P"3V-?X$GY!9Y<O@""RM>E
MC(]A0>U"E@>)F;]55+$;'J154H5.EAF#=U%4R*)XG*C!LV5VPFYY[-M`TCW<
M]?=(/Y?[0%52K[CRZW0R[`U]?2@*@:L&`Q:M^T+RKAH-OR%D)%D&5[T-B]4$
M82_"/*Z60$.E*9>4_;R-T\$EJ?I6>2O*D"D/:R;T):XAP%/'(^5;Y(@,"C?E
M'7VV(?E(E5<T*WKGU`D(?%R)%3<CH$VS.%D`/Y;L:"]-U]9\P$Z;D8)QZ:8P
M-4;J9,\9MA/Y3##YGHAJ!QI^VV<9G#CV?"PU5!$,V:CG<LO[BVR[RU*^)A'[
M]S3/:?08?%X5!2V+51K=QO)%8UK8GM*=\@CHA;\;6WH-`1LJ586,H$,8(2(I
MD2"-2(<6MB.WL[%#'*RMV%$R=@0M.Y*6%IJ`PX.V&"4+W%4%B\4P3#O8$8/:
M;3&%:J_W2+(44X%>]G7X#^!NVTE0E>E]&RE=,C-_\B;K'66K-A9%\-3B19#G
MATV6?PKRR"$];TX:VE7;L6%4@EOE/",-!<))D",:9^0Q*X->GP?@A/T4%GRD
M)<D:Q`F;@=#S.@B[87K>5M(!%9S]4/^.E]"G!>66B?U7+-U8?'!.4[J)RT)4
MD9T'!8VZ`RZRPM@QS_)LN*J)61AI9$OXS\T?JH>=D2XU$?76#SR3I;OOQ3./
MA_&GHH@6%F*G9,238$38&8XFP)A3/S7E!K,I)RKKMBY?[/M$&M-%%[B,,V""
MI1$D<$<KYKC%[TD4B_)HIK`%/X[#UQZB'1?^H$4CXFX1BUJ^42FTQ^@#<S`Q
M36-!UA<>H8KW'TKO^3^&Q)^$"1'F4,179`%O5YK.@:LDR3[QBZ<GQP@#)-&%
M!X.PC>Q,V]BSF8H[(C"">DN+X@^=_IN!?VP_2&PI?>9WGF'$AB_&&==.M_!F
M5#4!+=!'ZIY(X7/1Q"X2B)$1X6G"HR;!S?=`';)H$+:^_(RDU']^Q4.(,@T!
MGI"DHS1V,4BK,<NIO#R=P5ZABGJJ!,I%EI9QNN=7"LL\<986S=![ROD4)[$T
M5X[E$AZ?#!W">&7BJ0)49YFXB:K(DW?5`[[@"=;Z&:1]R!GI3#I^$-;*BUE9
M^!"^T&B?R$LJFZ0*>:+E)TI34K[P>E#!,&YD=GGV&A=UPIK_\><O'[XDUS1B
M;Y"0H@S*/=/&@R@=11>G^%=HHW#&NS8#F,#C]QE!M"HK07BHY:"=;]&^S>]#
MH>(LWZQ3V+[C)QQ9N`&SN"H;?6T>=F04L71LG9N#-1=:^T8+$I3DNW_\'V@B
MJ%D44!EZS:%]RQFL*^;!0GG2KO,:)];4VDPIO8J/1T)':7[8UFMT6%,]-2\]
MBP5BDY0=K`#891%*@<:C\Z!76..S3HLS5(D]<#D`#ZD]VENC6-J?L04/HC]F
M:<267@S-4T(KKSJ]:,O/PY`%S=:LL@B6CVBW.[#X2[#FXM58S17[1X%HN].K
M5KE$Q$XJA2L2GFR")OL&?'9ILON9K(#F8?-;L%WP_%0;-%5P^2;"JVD6;^G/
M@R3XNGCAS3!O4K?"$AN'9/,D9&&7'9,L8BY)F)FWP8-Q"$I5EN-2Q8HX[5PZ
M>WSG+/J0RT&77.(M>T7"%6Q-,SF3W00R.S39[TQ3._,8"[VM`N:D@0%[\R'6
M!`NWZ-=!$EP-A82K;9:7\=\'&\QX6.(?D4<61AFP8WJ^JDL0<[3DP(SNGZ5E
M>2I)%!=AMD_?9D)J2!E\I:`&-`%7'.1@'699(R]M,F99:6M49W(J"=*L0#!,
M;6O>?"!C:XSF_P1(0A9Q7%)>Q2ZZ,T\,47KDD(4D`W`M0A!Y!+<S'7/`80"U
M7<(@.6TS2=0FQ!,C8HLK?C!0U<EV$D)_)]M:`TDWCP?`=7P)=B@5_\T[>YUE
M\,]A)"=TK)WWR71P9]V#8W/P!9<SG@1EY`P/@A-ZYOCNFB,SFRSO5#?BBRN&
ME<@LCAC4(.BX8>B$C9]H89`RSAAAA`G&D<%2.N@_'#!$;JJ@\UJ9Y?&]P?A&
MI=`3HAJ%-CM?Z]`\@!8.US$I9D-<WJ`$,^[0:8'Q2B9W,+AN9=)+V.A-!%KQ
M6LYS^VM8C+@_L54O7E7G851>=W*'8?+N-Q_7M\5O0/3)599LW`VB1L+CK\)"
M]U@ZO4N+0]K&]*`6TQ:`;33PC+33R266H](3P';@1&R$N)?C6%%)J#)!8.M6
M6XE6+F0MQ7DYO;W-TN='FF_OF!B]!**I[S86Z;:Q>]&5ADU'#MI3ZN'VVJ2Q
M&>_Y%%+/(>TDJ&O#Y\!86F($=Z*&HFOD2<WD%H-:GA\NF)UXSO+#>L/O]:U'
M1*O/L?&VLBMY*&?KSH[>EDPUFO>9X^,;B8_8&I)-P7%9S@QX,T.\8/YVHL@K
MW>\T><>@]B-O>9EM@]BZI,WU,7B]MXX]5E[]C*BLA*3Y5ER^$V/&0H$.8P;,
MR0AC$,<)1DHU,7XPT2CG+/`=IW4=YT5YP8;&89`\YG&0K#>W<<CWRZ*[/./5
M<1_H]FGPFHM>UL^2(D2VV!IT;\="B+6@0&H21-#@^EY3(149\HLD!)]9]@3\
MYA0TT^6`)#7LW=RPK2\#]H1[(SYX6&,OQ['CN!?83;E'D_).FCW-,CWP<I[(
MT32-7LMN2QHJ:G%CP[#L2A*8K=7L++C!;K=FYT`AA:!OP5#8+V_Z:A)WN=N!
M:1;M\27.70W:L($WIP@6:]F`'I9<00&S]9H+^`UZJS4G<J26:JHB&D5:MGKM
M;)?.XRS)GOE3*O*KW8ZQ67QO^^#*@!ID/&4$]E0@VTFUP2&=:?@BICE`,KI\
MO_537+Y4/?4O5PA#I:G0*_M"@G8:KF#(7%NU\8^QJCJ;%KE:S+9;FH?,@#T$
M"36/;L8G0P0R*BB]5L$R,]0,)GPTGM`$,13K8,,>2]AB*=AH'`&$5E%&8P6=
MECCK[FI3TEQ0_TA+3K:P#P9&:4"&``I@O=/V?&B5Z.4%@F(T/G^/%Y&S'[>&
M)).S*8/$M;K`Y;1UNJ1UU1I%<E;RC_339;Y_-HGX>S9K="Z$>U8`Z5?Z?B)\
M+(H8_NT`L7;-ED@BC@0Z[#87<IU?UFB'L\;>TY#&NW*]N:?/^X1/.K!GY-EK
MD%PS&#\_7$>!O:.VH`KINJW`GPI9-9FG#=OII)Y/.`'R,WD@C`8^%^\%>:9"
MCG=-[PM[WF(/:NR;+G9<08.]IFO#"&LUQU"Y=ANGE)>^>"A.;4GA*T3MPK2L
M(>=31345^NI3+<CQ(G(%2(0EISVA=2PO/958Y[CA0\P6#666TKO@P`G;7OVK
MI`$9$RB`G4I8,Y148['=J&N)YV&_W0:REG+;0-O)::A<F4[XM(Y+(WG.6C&N
M>,T3B^J1)DMB&W(0JV0[N$,&FHQZH99"K5W@:^EI<#N`*IWR?[S9>E'MX0L*
M%[NKOV#8?L%M#S".-;B#DHXNR^TUU-FVM*2+51K)'A[/-`UC6E@=C32B!>F!
M#8#V3A6U4\1-[4>34!V*?%,`G9?8'A"&W4FX5M*FFJ@-0PS5T-EDK(._WL?1
M,_TH/J!HQI3E8IENGI;7TH`(/`R`]9H<!'\E8@ZI)Y%V%IY\_=M!9AUK.$++
M!;2TAI8TLW!$$Z8Z-AI"&"J8^\;[KHQ?'[)D+_I\.6RZ#\T'W7`?!M3;Q^7#
M2#,.7PX>&P[WS74;($4]#I=/5VF)?CM]7$7<:]UR&OVT+\.7."VR]()W:,[O
M:4$9T)<+]I5H;E'Z9DH+I!+.'&BO`HO?3M;.)7(RJ6<3.1V/<W_#4.TKZ29B
M?6FQAA)K7F,-Q70<[M]63<<+[^QT=-JQH1NVW+B)CTX#7&?Y*BSC;?!TDUXE
M$<V3PRK<E_3#@299'-W2_5_I-G:H!?#S0/!#DQY8-G;\F2]W;^+3<SF,.JG(
M\]L8JP<0\012/8+4S\`7W<S,M*_Z!YF0,&S:L<RYQ:QW"(HW20XJKL4IH177
M`L&U;<6UI'H&KIC-JRDS.][IR8XY6^^?TY@I9!&7A_7FD7X.B@^7[(W8;VJ7
M81L:VA&$B`]M(9^*?SN?EVH)"N0#N20UD3J4PA8L>L2=-;B_O/QR<>#6H:-?
MY&6+/*B15Q$EID#22;-'HTD7M78V2O^6O:3%3]GNKRQT;1]L'RDJZ4`&@!J`
MI_(GAI-J/.E(([H@#3TPYV#*"=E+A6S?3,`5\)@HFC:.,=`R]_J7((Z2X)/8
MS#*/009F@52S#+U\K^1!#JHV8?%$"U8O_P_!=O?/L[Z^?2&*+?/#;+L+4B2;
M0.-R/UXY,B;T7M8&=S1-BT/R&J0N*1L-)4A7K`6I#O^[4_"YXRG@LJ7`.;OD
MB>AVG2FXW+*9XFD=LY'6+7>"XN(EIINKSS3<\PNDUIM-')HF%DQ(0)V84,/J
MWYC*1I-F.*G&SZ==;%%F>3K"#M!UEF_YFO]J/8H![/B#@<0ICSWHQ<U]UT1V
M2+JDKS3)=J)D/(WN@E(<J9#-3IYS2D7AI_T.B35QT-T0!U8,W-$GNHQUB(B@
M3I)I&P;5A!!Z,Y]LB$[8L)-L:)H'U81PN3UGG="GVAT5PGW=:JK#_<@?3$'[
M*PI3L5M0O:R7L;88`G@3X1$$DM6LD?::PO:DFFGTL,O2(LMI5)=%3'"Y%E0A
M?:T5^%'I8AZEF=Y6#,%K_SRPDP[LHH'=%`\A,!CS?VX5;EQ!A+UZ:Z,':]UV
M7Q4D02C(K9[%_UA'#VH"(`V6-9!Z(6P]GH@)"*S*6X1DWQ39&5/P+/\75<1A
MI$CC_8T-M&A"@R3V69()H<8P`=BV1\.0^KUN^#@,\N\+"E(GJ)0Q@RX\XP+F
M+/8/=!?(:V"Y'Z5EF50:9NWC#"E!.#MCD+U.&<U$&5TW4S'ZO[>)TMHES@D3
MAY>TT\E1=VFED'.T*[A5=.!R.71]NV0;+I?#W+>*-E6:D_VW<+VX?D5(YVAD
M8`/U;38SZ.GIE(8&ITHZ2Q\4^KG<LU!HO!=9SZ9:4(.(4*S`VBG<NXK`%X!=
MRT#PHO#E]E(\ZL^M1=@]WR4[&347!UU3JZY#0]-!=[('X?12)U5OO_9Z,,(&
MHG'&9B#J-]_0T8Y^@%OIKA!P>5*%=NAWO$=58[F"KWOZ2M,]O:=A]IS&HL5X
MW</L`RU?LNAXP-]I9%H'YD`9JCS,B0G];),80SI4SMJ&AD02.B,GPQ@M%.UV
MO;#@8WUS!C]4VN\$".Z#IPN]LA3-6>*]->2]#$HKYSPX'U,CW@J0O@DO'XC&
M/5NCJ!2$1'.@<';1DV#@<M,J1;%N'-S1$F?-O:1%F,<[_DG6F_OL$"3EH2+_
MF-W3A#TBN@OR\F"RGC4G!K&<M8%Z*EN=N>+.#3F[T?K'C%0$B*``OI3UA97?
M-%%AA8K<%\1&RHSDU7?<<0HX4N_6.CJZ6K=54/>-:TE[O:FO^+JC.3_P'CQ;
MQ04J,J";V$IXO8B\DC)F.-IKZMH9:,(%-U390JC<M^E=8347\)%=,P-7.&&@
M9OH=?*V.^;PREQ&/,^W:73T9R96Y#12S>V;E</#(P![(R26S7!GF`.+CNEPG
M)#B<O%97;&[-/5*4Y9)XCS1\2?D]W(<'FK_&(2TNLJ(TWFG7D8'R^'IXI^+6
MCB3U4"+&HO#UD_`$(1M7\$0X&D]H*'Y*3V@F>\NITH<@3DN:\G9)8SHTF%+L
MS8/*90\`Z"5LVB$PVN'ZXJLTW3,?LNV\/Y`^F,F`2=)X1'`FE"Y7IQ[2J'N4
M,L\9(T6EE]4Z4$L,MJ19#[6_2U,?C4FCHY/(G6DHG(4KP$I'FB-`FWT:Q>DS
MHF7AU*]V='"ZG89LA6BJA@:5WF8ZZ%[@45UCM=[<!U&<\;ZPK_1#4%+>Z-1D
MQ:@F`'*@20.I5^Y1WV3&<\SM#%)/`5\].@/BR=8.H&TUA>P+&HDVP/F(:L&O
M,WUCQK'>--*V\5-/!JHVI=_)?]"PO"IX8^.21CP>L8D6!N<#=RT9`C30D8,/
M(\TX$16CB0(L4=`&1<@&"AT_[OY=<`6)\OTS687OO_WV^_<_[3]\\\/W>"*$
M28!QA0$JE3+IB#*F3^[[SMFGM*D[&WJ`<L.HOT5F00YD[]D*;F_7DLTFG5+0
M84,!N*4T!]YZ3Y9WWQLV*3NXS2;/@-L_BJ;A&3\NVH*MX0O0.?W;/LZKH"GJ
M,`I'6.&@U^.[U=9*[<,<76=Y]2R;F&.8`&30,09):5SX-2;54#1QAQ60VFIP
M[=C-!,0YH)B*!%=,H=09;5"A4ACWXUE)YVX4;B'X_2@[QKU7<57*=99%/'W!
M8LY5M&5#^<F4H8\X>&C&E3;(T2UW1O0.-B5'%QV)2$/<=E21$__@!&4J4\3S
M1S3!@Y$YF"'O+VI6-D'-#.:^-S4OQ-HFF)<7UH$*(F;@B%BFVHSQHW'3#(9[
MU<T^C8ZK^7[FMZ\T1^SYLWG)P..G[-]I8-5.QI8T9/QCSX9>T0BCT"OM)8)*
MIPF%,'^BO(11(IP4FLC)$PNX3AM>`<I>A[SC"U%R8+\7,\L72C:"/R7C#_]U
M07K'8.%B,D\\.JT<)GLA)FW#/\Z*E@V<%*YHSM%J:.,\-Y,QF_%;;9B8\@>Q
MYYE$?5;T0`H3[0"[V3A!1`@M-W+@`9T/S-9&C=FQG`:"$<N;KUE8H+59$JVP
MY,QHX0C77!1\O'327KL7/!(M"[.O/N_XH6S3,&UD-G3M9`_,6-U]-6+9NRW\
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M6I1QN>>/#Y+A;FH]DZ\F`!%(Z2#U>@,Q<6PGD*,9$+W5O`!ZSQ;R#:3X"-+`
MP93E`R,73"I$..(?(VT:C7E,5,F]A)99DVT0'FR;)':F@1;,'KU^KUJJ^BNN
M5HC*5ZY.P^SJ-X?0RJG<AM([(VDU];E]"7?6L15C=L09?I=G_$QLG#X;>M&1
MF1#N<Q1$3X+K@:0=B<)?.B#8M0A0N,?)$'#X0[5"C#I"I3:X:V>=P[_(TB*.
MZ&BAUZAY&:$`Z1='0?4$I=G#.1J)(*MN!>/H[V2WSXM](-MT-9M4>-RH(ZJ3
M33=4'E:M1%IGJ]2@"7XWVS-C$1QDX,Q#YR!)^&.*X]T[,U=L2@S&.YM#[?L*
M/I=4D]E"EW2GGV[Q`]XE[PGHK@(:IV*]V`#5Z!>$MU\**Y:PP%)?%9&"G;*Z
MY\GV_!:B]:;[!)O087`^9.`P`JB7=Q'#>)*^.Q"/B[6#D6V.M`/7XE4E8EK'
MJI`O]Y01S3<96QLS..=9NB\J->M5ZU5]D4R<JRU)D!8-UK`'#N_5%(@@T?C<
MH5+AB@ZPO_6+^DF@KIW24.5K,1-J^V8.,,!Q>&)'%1_O`N&DW].7]/<TI9^"
M1%T0I%_4#)!!L;@?A#>^PJ^&SUKT,W&=;X3H])I<DE?`(&M\/&'K;H;G]#G(
M>2^L!B`+5)!>#FR@<N99@%%]FWXGF#A"T(F&6J-3G!\NLNTN2(UN,+`C"!*O
M6$)6W"@F3RUU2'0#E(*7[51DH(,53Y#Y<40!N;,JZ#KI@A>DA#-!MH]4`%`C
M"5-<M'H\2'%0:1\&*0T2>X.DO]_-B#"*BPT-6:`T4+S>`YV!6@)Z?U&Y%/3)
M=T$Z@E_O2S9%-`GM]O[9"!G`:+'1<@)7".ED$LWOK+2PA].M^NF"=W*8:400
M-,PTA(S2E#F&F1,AR_+ODQP1%J,U)^I^9FS3_=!/HQ\:-LJT46I]E&FAT<L=
M);VE04&O/N]BN0//+P[\QC3Z5-*`/E8Z`JQW?3,?1MIQ>*[IM`3"<V2=#!DS
M<%OF_P2DH3L[P8^6J@3/Z("I0NHFG()HSY8Q]7QLF;C>6!6/F!&".15A!K%?
M>-\]1LK]=&<J=^;S%8S8GY.8!+$ZH27.:G<@=E.Q\,[9SV=48<21\;'22,6)
M"G-U7,[WBH-=Y\R*1=S[T[00;]2Y-^'\T`ZIPHC5IR"/UB)%7G16@_=9PCN'
M\3_:>N^9W@+:_\_&W%.-$E3>/W$RI/NH[GTM/,+MCJM#8_'`,U(]DOW06=__
MPA]+JN?^7P1YK.4YN]]N@_S0.0!:$'&?0%S&%->%:1`\*<HL_"O)Y-;A.%_`
M([UYS9Q1K#BKC7N3#D/6B>E"V?D>#'7YW!PL7,@CG!'Y1!1WX?T7'_M\E`N'
MAS+(2W2\;`M??T[CDC'DG#[':<H#C:<@X3FIF=AQE4;XF7$E0Z[S84Z`7=<X
MF[U7WO<XE[%_.WZ2^?<-C<L]D_J;=/1>\EF#GJ%7>.M+JF&VSFGU.T_D)V)F
MNF@=;BEEQE'1O#1)0%KN(X#_T%TG;3H2$>USL9$^*!5O?MFD,&*+K)G&+=B"
MCH!_^INBV-/H4GQL^1ZRHY+X8_6R=3^E(3L_[)KM*8,M>5R8,*=5KI\SITUV
M6M/X8%23J:K[EX%8%E\R:Q0ONJK"VPD(VVU&L(!PZ!7>>D`XS-9Y34_SQ%]E
M0&C&T3^W-FK';PS\506%AD+5#0I#&2`SN?EUAX0*,[9(2#ANP]Z.*^AD-_Y,
MX^>7DD8K)N[!,ZW=VUUN<`AZZ=?Y%>3;->Q>+'M<OP>I7J1M82Q>!4<H^U]L
M_Q5D\RU9K^'0?XJ<OV^6_?IW!DR\V%+[!08N#%&D4&C#G2K/40<[E@'#M%C0
M[]NA7VKZ_A@N?JV8D`%#%U?@_AQ:PPV:?L.DN5X7>',8E3=ET7L+V$46@;[?
M"^UJT/\'F-F.#Z03T5ERK)_"P(8/IB?Q1MTSV8]IX?<\QF-AJ_VD7U\\6:\O
M[NDVB/EZ^")+RSP(RWV0\+,AWSH%XPN_(HJ(?/'/`I=N:MZ*=%Y+'(+#%YF#
M?Q8+[I%WS'.*R]^_./H$..-V&#MD'KR#&"%$$;QYKNF&08G3(@[_%"1[B/V:
MDQ=`&Y-/8.EBUKIY,A&/?AL1]G\Q%L4NBY:YJ^=GWIFSI*?<^$^QHS*%/;_^
MW9-A+[+4?LF@"UG0&X<O--HG=+T1Y33GAXLD*(I'WNG9>@6E(`6^TE'"[)GB
M:K2X\UA4&?$^5GP&^47,\7^6>])ZP0U<5H-[TH"##]OU0FH67FLE=$'%8TZ!
M%JL/U.H0[]$DL'#SY-5[$B;^3GZ1`T#$R8![1G9^@-]+B\CYJ(BH=>9H,KC]
M/8$R(C+GH$)CP4\KJS/P)983HD?V@/6F$YJL/L=#UQT-:LSP9"B[,P;E5)CX
M.-'.JK-P8L$6^9BE[[N_>V0_%KSK!M_[^8436]RO3\>9#>,,['""V62E>"IM
MLTHVEU.O[B;-*HT8ZSN<[S+>S8K;DH>V\_;LZ"U%NWNX>JV]S'A>$U<\/A,3
MQE5ZA`G@/M-1.8R\JIMF.+>5_!"&6;Z-P[^NSYDW3^^2)#0+W=63(=I'JJ"<
M"F(SEJR)&$WX\-$H;5%W:8_EHL+R#\%V]\]D_=L*T>WMQ7R(K-M"ND%J/@\#
M@Z/MHU9C1EL]ZM1EP178_JF(HSC(#P]!DS88":#5JX=10M`>6P6QW[FN'GM&
M^.@V/P83/<\'+%,#`_>L6L$T6YEJI')!16N?_S'8LA\['EQ&-\8I,CTEL+R9
M"<B>:';U[(SPB?R?G:E@0;!GD-DQR,P,)%PVT5ADU2E&4WE=3AD_!&D@XVBW
M16MO/K2/&P#4BZ2:(6#!K4<(UW&^Q9M*'9,O(Y\U(ES+:0>_DR@-8WDO4;ZW
M3:F.38=R2N-P3N6K&4G:H9C2IK,@`7,O&C%3^A2UC"VX]\!=V8;F/$$C[\F)
MTV=YJ]?)ZQ4\FUL,_VDT_E,:&:_/AG9@GADYM)%0U'<RGBH&TB3K(BS);%D"
M[EOG4#DCOSR#OKE?Z9<$H=P2>J9I>&BN!S'/V&HH@%S:IP/5N[RMGD#DC/9Z
M'SSYVS<!RO[:/7=4@42%[`H?,X4:OS_/1)N<M?W?V+*Y*"Z"75P&R8]YMM_=
M*C9G1J\R59&!O')9#>]4DN1H4@TG8CRY!=RRF1'7&0'=N?&++*R0/<LO!K2+
MXZ0=)F&"F88YVX"Z'>)XL5S/IIU.@?#I_=<>[?,X7AJWN-/6O_4Y:=X;CU<V
M9C8YQ^%U1X1ZU,T.2_2"R_VXY+GLFS2*7^-H'R0N.Z7#1,`7X"/0>LM&/HXO
M&]N1&/=&_<.!7_BJA,]L!:N0/$`E^G-<OMQ3>?5#\1+O'K.KM(S+@]VVJ"U9
ML!I?:_C]6Y3;P:3,B!R.:Y-T.LHAS?S$B!!+^'"%OVYRKBX)=A)RYZ#S.LNW
M-+^,<QJR":LTNF!/V2<E]\'VZT\#:I#+4".PO8T6,8G4LPB;1CKS$*[=IL",
M:IB\8C=LY^%:R9E+K79!9RRRR[E/<:*OJJ>XC5-Z4]*M\=[L\&0H5S@&I7<W
ME#B[V9;B\;%$#,;A[.QP9"8XP+R64KR4ODDE6\X>Z.IO>^;-'NEGWLYE]52(
MSBXV3F>8`*2?&8-T*BUR''E7C?R"K4NJP3B66E.PH/(72AG3N@B5@$W.]LD;
MBQZS._9!7X*"7F3;;9;*^XHV&\KO`;')!)J0@\P2FL$=S2#*Z>0Q(S4!(BE4
M!K>F@2:_.!%O+/&R-="NQAM*O-6UZW/A=<Y,+O2!<64W+918F_DTUV!GVW.3
MACEEI&MZZTWG(3:N5TT(T@7K()X*8#V^$3`>C'8E#XU#MD5V'_#VXXVEX,%I
MUX3@6;8Z?[(Q:+C6K$9*IXU%3#3.V2YT2,EK$Z4MNK$/1PPI040BQB![:[NN
M'Y)3:W=U@R[^F(I2AA=5^!&?AAMGI!!$X<,./S@EFE&X.((-.^T<C3.L5-.]
M?#'/0DJCXIKAX0_@C?>JS,'/:43SHX=]I%8+?FO:D(&(`R-ZE745"<)ID)I(
MFRT3=$X,$&&DT(0L'GA0GZ[K^O<SDM(2;@FTR"?G]D#8)?')&0.D9=J+3WYJ
ME!D[<,4\KE9`&P8YF@`_U=CE15"\7%.JS<DK9H)77W=!J`N42\*'$CX6/*QQ
M@!`(""&'L)D#PK3*:B<,..(1M4Z8%5*?*H0O!65>@AG-@0^BM%9C-$#CAW%@
M6K5M!N.)!%S05-(_'QIW3^\##C*7K5$DO6M6:Y$G#;_ZS%M6TWL:;Y_V>2'^
M8.^.!ZG`N^81<#I]KZ:1HWG(7+8U-*DMM(*6SPIMHBOWB0VCBU?IG*&[5RC<
MG#NI-E&`"3G(@,`,KNL&&YI(82),S<8I6`)SP<_:7HA1):M/=K1PQ1T66JP-
M0<Q5>++1:6\MY#=1V51JG,R$+,KH@1@5LW8DR)5S'A#0%D$Y!P+GP@GGCX`C
M5%`KA+;J85`;%FR!'?W'OBAE9X=L%44Q?Y,@N0OBZ":M3GM6KRJ-BFE$X?X`
MZ.-B+BSI]8!N:7#7U%(AG`S?-JT(G=6'+2M'AB(,\<D)\\!D$\0Y>1VZY0S\
M?)JSEIAUPW94$4\9!=GPA19NB?VCV?`9A!,PNLQ!/1QCDM\8BEQ-%S44C,G^
M*5APN'F]SAAF`@84QEF1SX/TKU<%`_2)4;-9ZQ]/A%S5GT+H=2-@?R=R`%=2
M%/[1^+VI?._-#._MO-ZV?'%<B^5!@=<NBX>DW5GG5F&8,Q_<MC(U]9O#$R%<
MYAB$7A0KQY%N<UH,?M+V_;?M^^-PCA,!X/"(2D48=88J+?!=O_N8K?/X.6:Q
MM/CM2Y9$-)=E,OS?5Y_9,B1]IDU+,QL/ZNN1D+[7']LL2H;9<K@F3SKTZV(^
M_AM2/Z)M$(C&[\_.LZ,"9+9:WLCSZ46'5541G&`5K5G5=!T\JQB.)^18B&?'
MQ<R,=5DM9^;,PQ7N>+9KVD#)KU'S;\YESP)G8VY:66[Y($2'.:Q99&>XJUX9
M>,WVTGS2&^L"J[6&857/1EN[-QS!KU<397MDQ<D^.5OCG].<AMES&O^=1N()
MYT%!(_9JO*)%2%=5W&(3/IL3A0R0;:"?BGUW;F4?Q6S2G5Z7KJ$);[TAENK[
M)!"'7<1T)L3.T>EBD''%EM9JK8T>;75ZP5WN1!"WMU^#?80,J4&UGC(&VV^^
M&&9YQ(_,[V;5U))%179=J)PA73=[ROP(V:=Z+SJOD0:%C$O>+VBH7-IPS?U-
MP7IRV6FFLDF7E5JZI_^WV3XM^=X\B\$N^/&[1+:H7&]DB'9^X$\-TH--.&1!
M%3(>L@+?2V:+R;(`ADTGW?GB3*]<&IP?2$4#3XC@`_>.XV:K'1)V<?.#K1+W
MTT&8'T8#5YQ@+_#:0,%:VIVU59*KRV"CU8;Y'OG`ZGEK81:-]N^,:4'D@RR`
M]DZ82_EKYA(QF71F<^VLYL.G*:8CW35(`X$T["!E^B@])9)--EL!'DTE6$KO
M@K='#WKK%8_4Y`8ALP;MF+O@("II6"@756_\HRQY3^]H'F?1GVG\_,*"@!4+
MLX)G>O69YF%<T+L\#HT3%!"O!EWUNNQG&-3,*@@_RH]T7X"[R.[`ZB6(>(NS
MVD*=D1^K@M.4R'<Y(_7;D.IU2/T^1+S0LBL<Q)]A9K9,J46&98Q&@"J9ZY=O
M@U<N`UA7HYKGY4WK<AZMVZ.EJMNN7\BXF[F2!E1F20-,W<NG/N?0S`"/KVR^
MES+S8/"Q$,535HKU8YX5UM=`S?$*Z.,C)[8.QT$#^T2=!_$,27><)@RZ:<,@
M\=2WY=6]</7CGE]GP==V/Z=Q6;QA;^VNNWZ\LK/B3LO@N+]2]:5/XH-[RJ\0
MBM/GBRP53>WW06)ZC'G9%P++)2W(\D$C.+19/F0$R8`1K&Q@K>;]Y5_S,J3S
M-C@.=D,SWX)7Y!U;8A]HD!=?C)I4H/P@!@8&%0/SAH%AAX'\#+[8#J@VY@+^
M"@5YEH\_X]F+W]ZE_YY^2"\?TY_8?QY^*VJE@O),3*.?@^TN82O/W]Y]\^_?
M?_CFN\O?LB?M&(M%JJ1\X0_>93E_DPU[ILALIE1\+T8A?J5DRU[GA7E#?N-5
M^1*SH30E47#`E/I<VO*K\Z<+F_VWNVA@_[H,2GK#4,5I$8=_XEOPT,N(X9?Z
MM2TLQEB_]%*#K_7YBY#F3<B?A@[W_ZK6'Z;,;UL4G7#G/\_:1&DB0%8K*ONP
M8/:0"<K'8$M'[M\>SF!UYX!E!X]??.",?TKXWX'NU)[CG>%2E@-"HDY1]B5D
M>9$>O?5::7A.9D/[ZQX8A=``75L]]_N#^Z)A@3)R&H/2Y)R=>OR4/;YD^X(M
MH1[9,"J.:O!'C%XAW5OFZ$A`9(#TL'I7FG_*2#V%B#G5&3(A3;-=%6V;7;$'
MQI^U"!3K1(?;1RKKCU2*CR1/9>W8,!R+?D.%&EVFFVF3%WW_1)-7>K7=)=FA
M>HZ,*Y7J/UIF:4D9L@K8F@EJ8R%(D)I&?9V/S(J!6H_Y&,#DZEL0Q,X5T%Z^
M>6M[Y#>G-0>J^WPD!\",D2_=-`E'G%7>_;KQBGBQ2MEZ.2WV2<F7O^:!BIH`
M1)BB@]0K;ZO'BY1W9P:>`.4-0+(.5*9A"ML9.$(4(T4:#5!,M&A"XPR]7BN:
MC0#HM*(5B5Y0,&@P?@`3VO98(<#EL[6::0%[:@G+L3M_I)_Y/M_JJ1!;?D8U
M)VH*($4B.E"]_:9>E%O-(;_4L^#=KP=4[ZI)7Z!P5F:R-[[K;2)X;V";6E8`
MUL<+5Z]!S.`F]#K+Q;;/8CO3NO>`3F[/R.`9]I^KNL[V['#S7''`6#P913P`
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MUS*0GP0Z\A,X(M>Y#:*7DST.UO`-Q+Y=!.M]691!&C$`(IZO`O_%8F&3=WFS
ML;$9HV>(E8_]3>?153ZC>OA;:H3DE\?--:7'=K+,RB"IN]7S:H2LP[I")IW9
ML%!>TCF<2GV;:Q`W-MZY<.^!&5+VTQ6Y8\:0YOFOZ?"3A6F==PEC;E?=KY7M
M.L+Z@)N\L6"51IV'5NDB(0#WE%_V22-Q@<%ZP[Z_X2+&X]-`KJWUR2R%&O+E
M17O8L%7%K@^H4]M2(^N'5%>[U(\!7Y<LQ3$>'C<<&S%>=2)8<BRO.29O+LGF
MXIC]);QOC64XEB+^#=GXW<"^K=ARRXU.TK^ZI/SX[:ZS_'I?[G,!AW>:M5U#
MV#\`>F'@PA+5#5QGI"+3L\V\OD&2(C4M5'&G#T[(I4EC*7C7DXV$'%>3*NMQ
M];"^0Q<R.JN'41SHJAMO(!NQ+E^JJZQNTC"G[,^75/Y7%Q;.^6BH4_7SL'&.
M9B#\>57JNWXB>5<_LU<-N6CXN"PSQ9"Z2B)M>@]6D8\T6?R0$WBLLX"J*IL2
MS*>GGK?EVM]V7DZ\2<_JV@8[?A\*>6+#)^N,=]ZZ?^C:*KFE-A0UH0J7YN;;
MH\C`G:ZY>"1U$D(-V:/9UZN`HC2PI59T_M#=7I-[92H>XCKYXMV$:4_,^+9?
M/D[:5)5J@S5JED=NE*2`S]YH8"J/J]3%KF-5KH`7_TU#6;>:KRLYRXQ\"-*@
MTN?K.-\:U\$O7WTQ\=M65:L=Z+0Y3KL8:/N2"N^H!X'B2"]:6BF3PUD&)FIN
MH^ITTY(S?=!`UXTADVPQOAN+/'*BV7QW,-AGA-:<V:&YM,B[E!C:M]F9X1[1
M`W#CA!G(HO0)5E4?D+N;U+G=Q$D'[$[CZ]MXH\WP^GL0XKA=RZ)IGJ37X;_;
MUY\_X6W$_=9<&O(R(U:T1'$3Q*S28NQ19N'%7`N$>9E!/IW>[="]T2%A3WA3
M"PPS4SQU^6%DAQ?>EGS2[SD\]?8<9--P7MQ-H[II^'40YZ)-N-MAP3G>`[H&
M8D8&N]P::WIIK'QL]])8_NB9KBR86!:]#'<%_E?^5[Y[^:GRGBC65^#<Z#:L
M1+.L6,K$F1<JSV??WD`=2_/.JZ+8;R6JR[@(LWU:7F?Y75:4U0&L>_8?M@03
M(V:O<7%\K3=7_^+,_AEJ8UI70CIO<T;J]Q$;TYTW(MU7>MN5,]X^0\.K/"A[
M'OGME<Y,LP[SE-5,,@UO((0?PG?U>4=#OG9AR]SE@GC]F[S9,-Z$R0N:V/K1
M(+=[XN%PPX9D(,'W=B-68XV>-V8U5><W&K764/Z4)8Q,$I>'>^:#02+5D5?Y
M542GHVR&,)?M2Y#[@8#K[0>AQMQN6/+:C/QUAI]J-5\NY%3J^!LWH9?Q:QS1
M-!HQH/,<0C=^(11!Y\PLAS"F]2N`F%)T'&_8$E7C>BD.'`'I$KH_;],'2\6?
M?+=09TOPYS0NBWNZRV/V3B9E'5H:D#<,*8"-W5YS?*V7F$7J:>"U!5-P'5W6
MM1>X<BHJK/SC<KYKR"<P-@W'OKZIFFDO']+HF+,=.&TL(Q]Q5&8F^@.+YX5L
MU'K3&6=3-#SQ29#EPY.9="K`_79>E=$YKAFNFI8W9,6]"9WA*.*2V1ETI.3'
M!:)51^^\89!FHQ>NFA8KAW"5V/JQ1MIB6R^FR/.!Y8NL*!4/U>XR3Z",IP>P
M`1.,SQES6CH#"KM3.P,?!@[)AIP/&BO@GP^>6O0NS@@<8>,T$V'9-]?0/CC;
MN[J*N^J1-7Z)WJA;&*$`&1*.@AJM8:\Z^<%=G3<=R\-^NPWR0Z>XL&H=ARJ(
M4,N;-CA0"ILG)?AS7+Y<9"G[8&7\E-"/64F-'+P!%0AG;@1.IQA\&NG,(V(B
MN(.>AJWJK/B)8PL[V%(^D;Q[H!(F^=Y_MR5K#SPC4AQ>U5P'1SVHL0)Z,A2/
MV4W*"[BRO.`/DVYYO.6NH4U44L7C537@=0;E,2/-?&E=JM`?J#WNS*@K!2PS
M$C>H/_51=XS.[T3'5_'C#\O;'UAV@+:O]:&F;N&,@>;/8[DL>_D8TX(/=Y1`
M[6W4K.U\I@4_;DA'%7%6I!.C'\]0PPY4C+&07ED-(R*MIKI?59`$H>Q']LS^
MIW[J/4T"<8RU[D>VWABLJT;MK_M#(*.F*:SIM8BO:1%!C#2R79$3%JMN1+C>
MP"_8%N9*(+A2'ZTD><45KO(U5[(EN.(<74&R!<>Z<`;M-PW&IMJ7^:VG;H79
MOWG!C3+(!2ZN3)AJ)&'7G4OPP4S_D:Y$\3"H@%^;^E)P7=PXR6XL$46JUJL^
M7,BB:U@?'DFU!+(/&Z&:UB['"3.59R+Z[7&W+W3Y24^<`5WO8_OLX#UN_9JP
M&0)@;YF#ZBGC"=!5&.;[MKS>(C]I3A,P3VD#?*POMV9+I2+4G)H!#W$]0A]-
MZLE@[3T)*O#17.!=<YD+H#_%CB-D==5X79+35MT];:6X;_0BVLS5;X:@B7>T
M+R[O:&E<_'`-U/0PEC]EII?'$W^92XED,ZY@:5A1+3=E/5F+1_J9]^A4%%B.
M&<K3F8#!2A_$F&>J1@(65$['\*X:VLMY0;K-$3G2.<=A(9I\0/62;N*4%RRG
M91X_[;EY88N(5"_LHSIK21G2A5HS8?2D9$6!=$D03@.!'H'"!U5!7S)JZG><
M1'^Y_AV7M`CS6)PZ6&^&WI&F!3]&G\KK)'EWNYR6L;RZDP,P[L7IX4E0#8R\
M,*G7JK$ERM.SP^HB"8NM&GEU[#%MH4\X>E_.SJ-LTUS212*ZH7DN3AMUN(7J
MNEA_BJ7L*>1-JY8T.8.6L#*4^8>@#%_B]/D8!9/@U#CD\/`DZ"8_DYC45Z,1
M5WQ&:H*DIG@TZ(Q41%'$)[/PIOH+OZ>BM3`YV=;LZ%H8-/&*/U4R:JTS68_0
M&!?>J)?;ORP-\D-WT&K+^_>:QS*3G@(7QTQDCHMA.:)Z/%+211*^>&;-$5!F
M69CW%6>C@_3`[\]X6Z&,#YW2A#$>%&K!KH?[IX+^;<\,W-4K^Y_'X"FQ;U0X
M1`,Z[!@!UC^57`\C8ASY18S$D<:8"0NXLU<)G5F'O'&)<\X97F?YEN87+S'=
M7'VF(5/*5[K>;.*0A05T^T1SG4LU(P*1'C>!UKL`1\PA8A)I9I%J&OE%3H1/
MF[\E;-9[\2[@-A)<*,#1!EPFI^'88S?6M=%]`U-%`_.DMRP*N"GIUO@(D98.
M,H_:!:CW1'PT$<-1NU9OH+#YV)XXNOC94UET[V)V3+=PV'W6D0#I2Z:%I9.I
M`L&.VBRP1G?*EG>JD^!0":>4<W!X4T-M&N_L9:1*SLK^<<_]\7ISDQ9ED"3\
M6Q4WZ9]?XI#W/RGBB.;BV]T4=\'!9OWI1AQR2]Z%%:?"*&GPC;8N%?8/(NB0
M(T+DIB`5*11NUS,3L@V)NTR(4_)),"$\8D)<D-U,3'`N78/D`JXR.&?[H*U8
M<#4.SJ;NB&I%\^>4_6+UG%.Q46D2VAA0@8ANC,`-)(\[(EC-(F(::>:!1S@>
MH%6J1?8"6C`;-.MP9SYL.*(?<YT;#8",%<[9,,CL_GIS1W.>G^''E,ZS=&_5
M7V24!F1$HP!V*E-R*`]<.H.)&(TF-K&`TP7QQ,<POQLF^TC>*A^$XAK5QN6*
MPJ?ZP$L2!T_\HJL84V\/^R_)XH[=*1-PA18ZM=-&$!J=<S]*+JXY7V\>:/X:
MAT,KGOY1^I,I($TP>J\]H!5LA.A;(<>`^W;C=^8M%&9Z9_LF$O8OC<,;CPCV
M>">'(:F60&[9Q']E/[/_\(;L[`__/U!+`P04````"`#TACY#$M)%O$)8```[
M9`8`%``<`&9I;"TR,#$S,#8S,%]P<F4N>&UL550)``-,Y4E23.5)4G5X"P`!
M!"4.```$.0$``.U]6W?C-I;N^UGK_(<ZF=>35"RY*IU>TS/+U[2G[9*/[>K,
M/&'1%"2C0Y$*+RXKO_X`O(F2<"5!;9#Q2^*R"1#?_C9QV=B7?__/MU7PX17'
M"8G"OWUW\L./WWW`H1_-2;C\VW=?GZZ__\MW__D?__M__?O_^?[[_SY_N/UP
M&?G9"H?IASOZS(+@^8=O)'WY</7']U=SDD;QAW\6?7V@7?WP^8>_?*`_WD7A
MW-O\WP^/>)WBU3../TQ__+\?)C^>3#_\./GKI^E?/_WXX?[NP_??LQ<%)/SM
MV4OP!SJP,/G;=R]INO[KQX_?OGW[X>TY#GZ(XN7'R8\_3C]6#WY7//G7MX3L
M//UM6CU[\O&_[VX?_1>\\KXG89)ZH;]MQ;KAM3OY^>>?/^9_I8\FY*])WOXV
M\KTT%Y5R7!^$3[!_?5\]]CW[U?<GD^^G)S^\)?/OF`SB*,`/>/$A?_U?T\T:
M_^V[A*S6`1MV_KN7&"_^]MV"!-\S,?[X>?HC:_QO%3MGX?PJ3$FZN0D74;S*
MAWSRW0?6[]>'FWKPON>G6?)*&V0Q3DCH_^!'JX_LJ8_RGCYV&N5%%"910.9>
MBN?G7L#H>'S!.$V,1BCNI:?1K;V8CN,%I\3W`CM#W>W2WK@?4_I?1E\R6\S6
M.,YI:R]>07?VQIM4+X@6_HL7+ME8DC3R?WN)@CF=4/#O&57!.5X0GZ2M89B]
MI1NZIL@NO.3E.HB^F1'`[Z';J"YQXL=DS>B;+<XS^D*<)/03?\Q6*R_>S!:/
M9!G2:=WWZ)?O^U%&/_UP>4\%Z!-L-OR.K^J&\TN4XN3$;,:KVG1[\P,.F*K=
M>W&Z>8J],*$OI"(P&HFHCVXCNX\C^NFF&S:C4T5?,]4R&A:W@^X\W7L;[SG`
MM%?ZK=*=2$KHOW(RC.F3=-7UNXG)*YWU7HT_@FV[;B.XH9NR%7[RW@Q'T&S7
M=;Y>K4B:3TB%@-GW2O>*IA.#K)]N([S*YV^CP91-NL[U=`V9Y5/=/5W<#6?Y
MW;;=1O*K%]/YPG`C53?J*'WZ3+3!^)*NGR'.B8W)<]9**JJ^;*P.TQ:KP]3>
M^AO5BZ)7+XJ1?%'LN@YW>24D[B<VJ1\3=?G"7G8"J3D8>4]V=@5>8U%O(6])
M-WWN$%J,5*M#:[N%5JJ[W]K:SJ'%:`Y;6]M%>'NK?XO1J7NSNK*W&"&_!QO[
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M-J0)NNCU5J`-B9I==OP6LF?F#T#?C]D@6FF;J`^CD?&\B((X+MX0XB4[@S$?
MHI^9#]')YWSPY:]OO6?,48%]AZ2?=_HJ&GW\CP_'&.$]W:E%\ZNPW5#W6A]U
MS(\I/?=V&'6C_9'&_12E7M!JQ(V61QKK%]Q.MG6[8\F4>0VUD^FVI<6QIH?C
M-!;D5H)TEEK3.8U.7;G#URT=QLX`Z0*!PSF>5T-D'73W+<R=0"-_YTT!<[N,
M8L6<37^!9'V?/2=I3(=5=1,PH'GG2+<I^K&8O;4&6$HBEW*"_1^6T>O'.28?
MV:#9#_GHO__QI'3]_#?Z*U2\^0$O"7MAF'[Q5I@S7M&CJ-Q'-'D[BW?'ZL5^
MU2/]<8>T0U_5\HF/A:?B]_X+"6J^%W&T,A9?-91(">1#%,]Q_+?O:)LLH6.,
M\OUDM2/IF8$+BB3V@ANJWV__P!LI!7O/HLE@.3A$4I%P<F06SBB,.8-R'7A+
M@?1WGD'3`4I]'T$E[<F1I5TA>*+="H3=?`2=#E#6>P`J44^!1%UO7B_I=D`A
M\YUGT:<!"W\?2<7"*<@D?TT"'%_0D2RC6#[%[SR)/@^0`3Z.2OZ?^/+_N+__
MVX=M;4\HCN9HI0<++WG.Y9LEWR\];UTH`P[2I/K-OE:4OT:UV_UL<4U".@[B
M!?=10A0;2)/FK3>1%E#E3A<ZX\\?!-I.&@IS3]N%4(0;R@\4WP+'<6G]D(P_
M'WQ0'I"`*+P(O"29+7(;Z]D;2738W&\#M$<54Z.@D#/^8;/9!'09K3P22F@\
M?!AHMZO%"Y]*+H9A<_A(-S,X.;NOAIICN\LC7&7?I+@5T+Y:3I'@RY2BL,7K
M*XZ?HZV=#(+>\U;T<EL![=S;TRM"(38*#(_?BU;\<EL!G0O:\RM"(39#'(=?
MKF6W'/+3MTB3,74C])/SA&F!$-LR'."+/H);,"9JAOXR*,XD,,2V#WC6KJ,L
M-B=-U`K]/"3.)"C$YI+A+7R7K18^;BMT\J/S!&O"J!C^/`*&KUHQS&V%3F`M
M0>8,"V%4#/\T;(:K$_@M"?$-_5'+#%0_C$X&9@#:&;FU\P>,W>`L27"::!B3
M=Q]$)XX8?7:YX!-W./11V`0*6!=9S`2FS>#>\^@$UL[#X49&(F?TH^"2)562
M&5WIG]$)K,E&3(#`R%J.>13\E%&D+$O,+'W!\0/V,7G-@X:_X+04BNS;TVF/
M3F"--J8,:X,:AXV.;N+6'IE?O:UQF.`*]([0)!J@T1J=P-J`3/G7A`1MP;/#
M_F4YTN+R%U]$20V2*KN$>'E#=`)K0S+E7(T&V@#8P^9*=U.%3F"-2\83^/[@
MK9D!TZ:;_K&GZ2)JG<7?I,W\@/+/5-8,36!M2MJ;9!6(<2S$A3B4'R6:P-J)
M#(\V;+C6EDK`[^^6>,\D("F[D@\+@U>9T[8(7]4XJ>IV@2:.6(YTK!`FH,;Q
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MYC?AA;<F*<,@ME_Q6Z`IK,FJ%:\2+..8>B_Q*PZB_(;U,?66^"I,<;R.29(G
MA/0)JSZ0K;+<4G>9Q73+L=]">@CNVCF:PMK`6BF-'=C=S2?\5)30&SJCC1R:
MPIK&6O'/AS$&SQ35?K;#C3B:.F,4LW`W*H1HS2BZKP4.)!?:K;_\GFGH/=/0
M>Z:A]TQ#[YF&WC,-N<7A>Z:A]TQ#[YF&!L[O>Z:A0Q30)JGW3$/OF8;>,PU!
MLO:>:>@]T]![IJ&!,_R>:>@]TY#@X?=,0X!V@UW-O/?B69SCG.=7_O<X?GRA
M0M3V7!%U,*C,1/J01F%;V(6;8TO.LO0EBLD?VYL4)?7[#:%S&'6@G`=E''8&
M'LZ;),F,>2X:06<_ZLSQ%@:TG:$_?F=9FJ1>."<AKTR69DOH+$B=F=[#`FVF
ML.Z2V&+IUF@-G?S(B'9-//:<5IH5.L&(-UBP):V@,QZU)9J'8QR6D0.0RG5:
MT`(Z_U$W:K<8[`4!.?3=ZBW.LF;0:9"ZT;L'I$>#"(PS62V=9+:8K7&<O^GH
M)>MN0CHX7(]%PW=,T`+"7<P+</*`J:0S+$\6MO<DL,.86((B^]+!\$=A7BBU
M/ER6&2EUTEH+VP#[BAES*@,R#HO"`R6""O'E+)PW//Y+N!**I>V`7<JDK/&)
M5L$9Q:?\"PZI8`*6_6B^(F%>C)UE3U"SK6@)[&S6@F\UH'%\WI>8#M8G!2,4
M["J*4_)'_D\)W9)6P(YG+:B6@QF'W?`7CX2W49+,PDN2K$NW]ME"F=-3V@[8
M!ZW-5ZV`,X[XM0/!F.S$@/W46I#*@S"&P+4:5[$K97JK0^3V:6#WM?:;Z1T(
M8\C.^R4*HUUP5?I^]5E)V1;8X\V89AU`X[B^N6%!U#C1."WM/0GMY*9%$9]=
M#I+.9R,7%E6V=4C8E(3I[N'JC4DF(\E+$3%XB9]EG["R+;3+6P>^M;"-Y:Q4
MI1-L["/KWZGJD2C:0GO)=5`!+6SC.$<)I=1F`8=VFNM`N113;_D"CDDT3K6V
MW3O/0;O$F6_%]D<_AG/3E1>'5"V3RB?DW$N(S^RV),A2Z06[HB6T-YPQO1IX
MQN%+\2LFRQ>*Z(R.PEOB+QESP)\M<M"-&VA]36C7(;03G;&"M(<YDMB5MJE*
M8(UDYE?/!\.WYH@!G*#DMF5(BB/><%L^%,3M#+V'5!8PWC-)!2]:^"]>N&2/
M)HT<5#C/034O,M`!9F=JF>)7H_U[?B;S_$Q2:6K.@$-/!U/!*?!?1*MU%#(O
M--TD3;QV0TO4),`P;&;W0"GS-7&?=R5EDX@AP7%%`&78A#[@E,+`\^HPI@R-
MYC<`=J$1<L.G4HC!%I>`/M[V4W'!FA4,J94#&8>EWWXZ+EC#0"N*14#&8<FW
MGY$+UB;0BF(1$.CK]Z,EY8(U`VARIH7#Y0Q/UO-RP7J\M*!-@@3:`G_$U%S`
M7BWFO,F0C,0";C\_%ZR=J-4Z*$0RD@1.]E-TP9J*6I$L1%*1_)=!D]P(O552
M>_`LM"N*(:'<\5<T_CQ@VX*@=I.24&D[:+<40W*56+8VAB$SW:BG5-QO\<LJ
MJ:DWZ@C:A\54%XS!U<HQ<`M4UPMN1](YM<BY^-F>$1'J<JY;_3`'<S)]%A/(
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MJE="8Z(Z2UDJS3C!=SA>XECVB:N:H<D`#&ZZ0.Q=CAR).>D7JFR')@.PL6DC
M&<GEQ=G\7UF2YEF1GR+!=5X5D(SG[#((ATG.7#X+S7+,R0.+_DI(BLL-2;%9
M><!^M`R)(D'AD4:`)@,R^!U1)K4>.U7554<`OWIQ[,GRV[;K"$T'8!9L#ZWF
MVRF'81TLUQXIUDZ6K*A*65,"%"U*G?M%TP&8"JTAK97#*3MB8]A/=*@)'08S
MHMT2[YD$S$6!58$D"^+GY#Q%I>/"SF\%^F&C:S0=B`72%MA:2SK;)ULY]7!U
MY`&G)-[1ZQJ6@'I)"S0=@!%1`T--U+#MA3I36W%^3@D],K-,=K^2]&5[I+[&
M'DMNT'$3JO,*-!V0C=$FZ%K5ANU^W2Z7V'0`%D;AR&OF.EL/(0-]._IQ30=@
M)I0/OZ:QLQFP<`"Z"H&RMW;SXYH.P#XH'?W6A:</'H^7.ZA9;>O"2UZN@^C;
MT8MM-3+1U&,P2P=TT.P]"Y!Y%B">$(63VSB3_]RV\PUWY&1I[AH^]-P^=)O$
MM/8^CEX)G?W.-U\3=@57USTX\^EIBVZ8M6JHF7?F2E:@'4*%&TIS<"/(+=/N
MJ`![/&S'E<Y!8A3I@G8.Q.R>)/1)@'>`/D7VIH4^7@><H,BF@O4D'FN!$H"*
M>K5:!]$&XW,<X@5)D[-PSK\.E&B?=A_`"9'Z4@.^TIE(912%))LE]>C/`<[I
M;55>4-0<.-W2<15(4R#C2+[63ZU"6#>AXZJ+2A+=([I<J,C45/ZBU!!%ZT=9
MF-['>$6RE6R7I&H+G&+JN/JB(XUQ1(#M(KTFH4<%&RXOHD0ZM<B:06>U@E25
M0TE`QXS96X)&6^SM^&N1=GVX]KX?W18DKO<'&_DLO,CK$MR$7#<GD8>83E/H
M'%K'40,3:70/1'-A6T+%%V-ZL+O$Q?^;`LLW8!I&'.T^H/-V'7<N,1(+=.A:
M7]ITYN<[LX1*&].OYSG`#SA/D'3OQ4R,1FJEZ@PZ=9@9X[I:HX-Z%$5K#Z'3
M#?W:(RR95@ZA*O@8SF?I"XZ59^QV'4(G'>M'BW21=[?*N*E*M0PK]U"]"PJS
MCJ`3F3FSP`ED`QVEV_<J=Q"QVI!#JY5.UB%TYK46])LN>2KXH[A^4,*WL&/B
M]@2=\>UX"G2(>QR7#_IWS59<<Z`SQEGVW3!`;2VK'&R1<![BF_`5)[;\N22=
M.9AKSM2A2X%N'',*G3*K>!C_]XS$=#9-O7#)PE^4!RYE6^BT<RV)Y6N)%MI1
MG,P/D%(!THDRW=P'7IC2[1D+PLCS6YLHA[`3Z(1V_6J)%/8XCM_Z`K2RQ$!G
MO+.J+V:P1[PQJ:]K;6Q,))TYF!3/=&.B0&=/2>#\/9NY0]E%+)7$;%$E$55Y
M1*@;0Z?(:TFL8,G1@CL*X\D#7I?KZV[2.(DRB)I`)\JSJ@(RD./88_"3">]6
MS:*[J^(7F/ZQ7<YL58?0Z?AZFSC,1#"V)6:+7I)>2:\A=-*_(VA($^HX7"_U
MA69E+PJ=FL^JCIC!MN:#"7B"87#IO,C^QT[SKU[`5MXBV>#^Y81$7TRZ<3!'
MG_#48HK+VA3BG$J<T2\CCC?T(Q"E`#9J[V!J/D,EX`"R-B&`EW$ZD@XXDB'!
MG@Y8+/_1.I,//Z$[6]8\PNH.2$Q1@B<=3*EW0)1DZ-8*;P#N\*L$\@R>U(]B
M^QA4.CL9$R(OB-U1C\*^4SBN/7EOS(*A(&WG2:B,=&UX.QCX.&Z2JYQ'7Z+0
MIS]N;S#".><LP(+X@BC)8JQAY>_:M8/9[J2+9E>LXP@O8+;LFY"BRICH&GDY
MBU0%/JF2=>IE/&W3'71V/2O*P->SMN(`7F=4^;(KVU11S()E;Q6$1&JU0U-8
M8UX/_&OCAEZ5S)D6F?SU&J(IK%$.@NL:.'0=73.RGZ+[P//S%?5LR7=#,FJ/
M3F&M:\>FGH<?VI#?N:2:O%1NA][0*:S9K2?MZ"`-Z$0*@RR:<0IKN.M_CNDD
M&FLFP'U[T_$20%_BQ(_)NL@^<I[1/^(D3Z>6K59>O)DM'LDRS$'3:;>(6&%E
M3J.`;K;QT3-%S^*E%Y;)4NA4D-!AS+TR===]0SQU(A4OV&:XUCBS6^D?(/=T
MIW$W/AO*NXSN)ZIEYX'<1>780P'.GVU+8P0'7@!I]G=6/MZLEF\-3D[TIR=^
MOIHH3\04^C@.%7<IO$>-Y@'E`&3?GO!9H(]#(A'.:BP:^1@4L1'5N<FW&O11
MMF4[N@LJ=Q@Z2Z*J*<!J)QK2=K[36:@,>@%>8S0H$"P?9AC'\,%5D4L[`5_'
M=]+D1T]I?&[*M@#?FW!,9A^<23?`7YP."X)/SA#E&+XYMMO:VF$:MS+Y-NS8
M7U^5;57[HI;?`.`[VQV(SB<E:`'\]0@%*KG5&^_7T4QN>72%JEZ]O31EQIV_
MX_FRO6-#AUY!/BKCT>I]>>V[!?\\N_`G_(8[R6,,'WK#2>K8'WK]:J,/6=(*
MX$/EC$;G0Y0U`_[0Y/(5?$@*/&/X4-C%'$FK&8+N%YDI$H<0%PJ2H9@Y^YGT
M`_!Q:8U/YW,SZPCX`S1E1?!)&F,>PT=:UF<^=LFL_*T:']SN@R#E7O?K.[/3
MKMG'I-T'\'=T(&S!AV*"9PS?2(YWE@^<F7N.?KRK!3M;-(N>E5;?/(M&7A;M
MF95%JY(\Z9SP.G4,<<C3'?!Y<\!:Y[QN/4,?];H2*3KM=9;*&#[_.NU"MUO>
MJAO%%?/^8]VOEZL>55?+!\\!7BMSI,"Y4N:->`P:5]6]O,0+$N)\*QJ3YPQJ
M`6I^^G1G_(!3$N/=NPZ]LY-N+Q"77W1HQ<#R*@3W=&J+ZQ%6]4<-+\):=@E_
MFC+@270]UA[[&#[@PC%I>NP/]3%[3O#O&1W1U:OF'E#4!.*HM3<4K:.5J`WP
M1R01J^A0)4$RAD^BX8$<U1[(7NV!',D]D-\]D=WR1*X(I(O%,QU8[FV4<[21
M@!4W&K=WKQ3W*'(CT/,?26:+O>]V4_Q79Q[7ZP#!AJGTK2:Z,G`R^O42O^(@
MREV@*.@E9MM(+]10`?W&"#9K34_T&^&'CH6U=:!L2$]_DI`U0["9LWN>&A3(
MH>-C[6C%UP3/%E=)2E9>*DUFN?L@@DV7W3/S!UBAXUMM^1J3*"[2+CY@?R?B
M<ELYL'%DD/H;FW6%8//M]*PO+:1A+;P5/,43)[.G_N*BTQ[!IMSI>Y71%(&U
M_'O`4Y#`@U]?9W2[0+"9>GJ?<K2E,([D7S=T<TYBAG`67Y)D'25>,%O<1JQ8
MY"N>%Q6W]+6H37<(-A]0SQK54B+CJ.G;""30UR%Q(W0"FS^H9U61`Z\TXN=!
M:T0CCTDMHX;[O=+NJM4>G8S:!JLM@ZUQ;=`Z4_N7&ZQ#@B;H9-1F5QGL6AF&
MG?[V@0J)RIQM[AN6QJLW=L^/E=.'1FMT,DK3K*$$:FT9NG66[^EG8JC5Z@&=
MC-QHJRV%6G.&;<&]\N*0A$M63R5W"]77&$5+=#)J(Z\&^EI#AFWW_8*_->XW
MXRBD/Q;)/A/3*V/3KM#)J`V_;<11*]6P3;_[KE.FFJ35'IV,VO:K+8-:9WJP
M_@[%&^V)Y4!Y]T5SQ!>M/MI7B5TI0W?88W[%\QG=>?E9'!?)9+]$85S],_>V
MR8G4F2*LO6/<GFXVQ30&IU=!8K849/X85W;`1_\%S[,`SQ:BP6E_W*9=#39/
M8`N@8_@*JPM*KW$W";.$_VE2!G:Z/7?E0^LC/>#8OBUY4D"8KVRXJ0&W$S0;
M4HL%[+`9=&BZ89)`!90Q?#*-*VNH[^,]7V!3SSCC-OWJ9%V`?X$]Y`$TP.YX
M4;[M^*ML`K.PC,1A3^1LW45S'"AG8SL=`\<X6=46:Q+I,>())'$DS+P_AO21
MS8FGX)V.K'`(I%K:,#NUVCP9]#C$I)/MH8XB2G4+GUW-1R&;VF:+6I*E/T>9
MG:*%_ACW"CS7=]2A-G!',9$W$D5Z>XDB829V]].;<G=A=X3**J4J5&4.JW]Q
MA].7:)X+4[#1TFH+GTFG2UY2$YBVYN<`R#^1;XT^WS3_<O9&9%&A^IT`3;M&
M?/(G7R.,X]&)RVCE$5D,Z.'#P+D"S(A2DUV#@B*5.X&?/3]':7I.(I;CRUOC
M+"5^<A'%ZSN\>L:Q8.I6M`*.Y.=+_7!F5J-PT?!!!Q?%[%(_B+SP'SA-,;N`
MO_!85;X+S&HJ2ZG3;0X<DZ_+H0$<)W.NJ%83NN/%-RE>\99-H_9`,?,=5DQ3
M>(/D5\LD:=8)4(2[,5TMM\J\,/8A'T7W4I,#W2>])R@_,(YLTV(W!]Z@*RE-
MZ9L6AJ:VG4/?1/64IMR*8,8P&Q3%&&`F@0&5]%"HRQF[FUH6+J_GFX/\]F??
MO%AHFK+^CJ&4!+&(=]AVBP(*?8O"7+7S'/!%@%7V^`JR#W?8)+<7TU8.X9SM
MV+YX*ZPT;_7Q.F`#V8$^".:5?I`/6_NJ\A"-?8W0:J-L`VQNZXM@OCK)I#"*
M*^[2L4:I#CO/`5OKCJL"^\BA#3]'6I!$(I29".UU#IQS\PC[&RLRLJ:+0+LB
MQZT?L`'<=C2D-PN(/7MH`&'ZJ$N!&1H_W"K5MN6QZOLF23*L9^C7:^Q\43=M
M&"[>KY;Y`^JQ;_VE]2C4;`[HP:))HCZ04;@$=LLG<8E3CP3O"25<2RC!<XTV
M26<@D8VU=_Q)$DI8$-.PC3ZU),XW]8]_)SAF>0DWMRPKH<+@K-<!L"7:*M\*
ME5+)823Z4DHM_^`.`2MMST;]`!N5]:E5J(8FUI%HR$VXSM(DE\^)TG(H:05L
M2C9F3Z$$7("CL!+S($Y:,3]QPH+<(_.3D1F*>1BGK:@O6P&;=GND?@MP'%7W
M;.RM=*X+K+X'V&A[S/VH)7%!SU-RNY@,Y%FZ31:PC_=A!Z_",-O3VX#+.%E7
M%(G9SKK@1K%OVB:P:(A%YK_,>QZH=%//]/+G-I$`QN!L:\7D>_)N\^UJ\Q54
MHZ[)F=7DG-7DS#3R.PO6%@L]C]-D:T\X+IA5$NS_L(Q>/\XQ*3XN^L/^-T5_
MA6[QT@NN*`QA?#KG*<#K.TL,[5+/ARBDL5]&BC$([9K[CP"9+`4B.Y3KWE@M
M")4?RNU3GDFVDD=N[SP$9.[C">5P)CH8ZB@VH,*TLN<;C9`#C=9`AKS>9B8S
MZ`/WOQ,G':9O5E[T:+0&MO5IDFBH`3OP7-AZM%>`.X]*,,3QIHE/:=R5M`*V
MOFERQB=<#FL4R\%U%H>$G4PIQ&OREI]1U;9\82-@^U8GMJ6HH$VBEB(+Z8(W
M)T'&S"F/S!"36U.NWOP@F^/Y-94G<_G-JL/;?E&Y\PV_`U6<8G]O!;2$];K9
MZ%=DUBZC@.)CN=BTPB!53:%+G??,NXFR[0IEV+L:N^&.P&7.M>CB,RW%-(K]
M3+OH1>#RY!T8/<`QCHU*HPK,?37J7&F5Q"I:0I<9[T"U!K)Q>)GLEP`JBP.9
M4'_8#KI2N!WB^;@JVCN7_K:2TK,*$@SG5:"/U"(L>ARZ8'<+PE1P*IXZ%^!.
M<>Q(I60-F[&@!50Q[=[/;A*\8!]J;]RK$\^(VD!7PY;1I$WL%LJP#TA[T)1+
M+?=Y=`)K_9/SH\7I%HA36;*[S5>WBAR^EGI')R,SQEF6C;75WZ97;4?!X;<T
M\P*%+ZW5=Z`)C(7.MC+85C6.F%S,;G"/8Y^QML2SQ>Q;2/>Q+V1]P_*DXR1]
MBL[QF?][1N*M+^6>+FFW1Q.X+!7VF3S4%B-!N*@)K+1-F5:&9>=@4_!-[DQ(
MZ%!SMJZCN$@>6L'*(26$_4V@'MTZ19/!>M5IZ4QWZ4!;%U6:E-^"E-E>;L*K
M-_^%I4::+0I0VV/\3;C]?M2JU*97-($Q-`+H4EOQC,5:60OBWHMG<>[H/,^#
M'ZIK.:G-4MD:36`LE\?0)$,Q6+.?N.F">96D9,6`?TWP(@MN67WO-NYVO'[0
M9+!^F=I:9"P0Z".9'7VJ);I=JW<7\7)NGL75JO\E8V:.,M5?^5>)HMEY`9H,
MUN"KK8'V)%6IYJ=!JV9'?Y:S%6.B/]>RHG\T@:M8="S%M":H2B\_NW0":!Z&
MBP^IVH72#6G^B^K?=(E8QMYJ)=KUM^@)36#,WA"6!@.15(KRTY`C='^)J+C\
MB%7S"XU3+')5->_QHNA183?E/=H]KK79JY[]5M(",!6L0#H<!9:/?Q1N;U]P
M6M1/OXT2V9%AYSG`&%(%)?PU;'_PMI@#]*:@D"Z\Y(5.G*^$3D_G&WI`H;/J
M;)W;X\+E-NFMG%3-3H`B5;LPKH_,FFT24!\>V!H3XGFU_Z)K=K;*\MIVEY@N
MXT2V&58W!HJW;<V_%B)K9L1]WH^WS1#4^I[#)'4651[7R-VA:@J0BEDPI,L,
MLU//4]3\^T46,SUN#U2G5^#<'1H4";_&+IA=O(/\?W06HJ<C/'^@5%`QOM"C
MTR5+W!?E9L.\G"C=<C`L=/%IXA-LE=MW")PUN2.WAYON3I)P45<>,%D]9W2%
MR)/8/&`?D]?"<J*A%WJ-@7,?6]<!;=2C*.!08EHS3.G!(IX6>Y[WM=Q.>2C1
MX':G$OT:NP;]#7;];HMVV*[->E@5,0SZG3A3A]>08Z,M'Q_W>/1$&=5P^+";
M:[>`*#79X`4*N'NP.[R*8I9,,(B\\!\XI2=V9E7PF%7A`K,K5FFHF6YSX"H$
M?!X.MU<&<$!-I?QTSCN#O@F3E*192N>M8OS5J4'*IU$?P`4&=$DUQ>2D1Z9:
M,VW0;_DMP*G)['WUIJBA_3#YQVW:$;O"OO/^\$(LCD@3/@N<>$R73M'8H5T=
MN:3<>F0>>-_.PKPTK!=NI+0(G@;.$:9+C'CTT%Z#7&K^RUOA)+GPUB3U@E_B
M*%M+N1$]#I10RY0<R?"A'>?X3A>9MZ3P"=6FLR2)?$)1RM,B2%I`)ZG2)4D!
MP4E/LK-EC'-SI<`@</`,=#8H2P=^+BZP9+9R:H2G<\Y34*F=^/*4R'P[7*=.
MW!?T`>)[P1/;<M:#E<Y<LB90Z9=$HCXD1#5Z%Z^F;HF/PP0WKM>*7<L*QZST
M0EFH08^]5GU!)5?2I[4U+"?/URQF,PN8!]0CCE\IM$3STU2U@TJZ9/!]ZD!P
M\D1[%2[I?BA7/2VRA,]#9D[2(TDZ=+>RE35V2G=>:$203E.H+$?Z7.FB@#[U
M]GH;>*M1E%+5%#S]T5&N_G;@.CG/BM#K!3MHMH9*=F3$#L?:J(_.Q8UN%2QY
M3\7-7(H$'.X_!IDSR$3BAWSQD+AWEU=$!]Y[9/XUI$.K%X^;\'^P%S]]BYY>
MHHP5-KP*Z/Y;>'(WZP4RP4\W4EL`=?(4HHWCZ1L.7D41EX:]0.;H.1+M6Z!.
MKJ_Z.%Y(G.+NWWO5#V1*G6-1WX#JY`W@'3U(I)C5],37&+-0X^HZ^=[;K"1K
MLKHA9)Z;;O3J88,^0!E]S(;?+&1VF7X^S69Z&*>N$L_F<U*,HACZ98;UJ%.U
M@\S/TI%#'6A.7C?NY&^XB,("QW44/^%X1<*JB'(4/]/IA,TO]S@FD2@Y9LO>
M(/.?=".^`^`>TU-T,$9NAWWI,8^MQM!5W[=66\A<)=VHUH97$?L7EXB](R%9
M9:LO^%N1#JHLBQXNOV`\Q\72(]!?W8_?YBO0!"Z5=\>MF&4I5-KTLTO:M(<.
M/W@D85&4I:.:R"HF;X6F@S62J8%M[2<N\4@U;DE><5CL6F:+V7-`EKG<1:<H
M20LT':H]3`&JYLXIXQ<_K/D^QNORR%>@J8)>M:+'._6)ID,UC'6&76O(L#,)
MEPG:RD!I=CO7`$IP4L9<2ZXH-7M`TR$:TEJ`K!7#*1O:UN3P%%UYS$B47^XH
M32X[3Z/I4*UE$D`U7T[9R!Y3"O3K^AICNE+M^`<**!,W0-.AVLGDF&KBG#*5
ME6.^S#!+-\(TCAT=Y:3M/8RF0S6*B?'49'4VA=F[0MZQY!191G/(=##LB*9C
M\#ILA::C,&SQ@=4L0EFP[&QZ9HL%\:D:L<,:IE)B$"0['-[C:#I$HY8*4<VO
M4X:LHKSIU1MSFT[P?4S8<3L4%E$1/8ZF0S4PR1#5E$%9B^Q\DM<>B?/2&V=)
MDJV*>K97;VOL4ZD))F/=INATB$8F$W1;EPUW%M>R)G%U@'Z*[C-ZW/82W"B[
M(OV`Y4W1Z5`M3[KH:E*=,D'M;!*VI^%DMK@//+_TXZ;_H1OV*E9"9Q^EUQ,Z
M':JYJ2786@><<L;:`5-5'&^`.M_4H'2XE_>`3H=H-VH!LN;:*;M1<2LU6U2;
MCRT2`;7B!NATJ-8C.:::.*<,2#L5-/+:&X7`K[%6&9+=%NATJ"8D!:B:.Z=L
M2(6^$;\P?)77R13J_)4D4;Q1+*R:K='I4*U,!@!K?MWUP-HZDFW7AL;2D&\+
M=)91G7[0Z2B,4[I0:_:=<KAJUITLM_[GF[]'P9R$RWIE$3"NU1:=#M$V902O
M9M8I0U5C8MI>'&\#7*^)T*BLT1*=#M5\I0FNYM0IOZ?F!N(Z"X+-):MHA^=E
M'JA<5Z]^IT)XBM26C7:=H4]#-&!UP[L-1'%)&>Z\-^;I5SL-9?0_]W3$.&4F
MN3`1[LG4#=&GH1JT]+#5A#IESJJFIFKP#^+-%N]1]&FH!BD1FIHFIRQ.3?<-
MNC%(,KH-N,5T=Z`?.R1JB#X-U;ZDAZTFM`>STO'J7%15MKU&@6WCVIAV;JJ$
M!;\URELHVX+6MQ".3K^DA;P+X"H6.M(7W,(9(!QV10(AO//-$WVWHF2%1FMG
M:E6HB>2K@A[&D6H!0Z@L5*'1&KARA2:'A@JP`V_8"E`X"-7(A"G)I,\#E[30
MY(E/L@C0*"HW7V=Q2-@FBTKEFKSEVRTEQ>)&P%4N.O$L106=`:?GR?Q6(P&=
MNC%P"8L>%_0FQ)&KPA=<+7T=#C$'G0"7P]`CUE`I>"!'L2@($7]-\"(+;LE"
M=@34:`U<@\.,44.MV$$Y;G7X)8Z25BM&WA"XUD>O2E`!M+96M/+&M187NJUZ
M3T?-"FE0#/3G`.><A?.S512G91)SH4PDBF+K%="E26SHE$U9=$_@]W.A?B%>
ML@%9L>#?TD]C%EZ29!TEI/#BJ$`HU,6@-71=E"Z:8`BS>Z*^;B3WOQ]MN0.%
M*KYRE!6FQ&<MJU\:I5X`?:&#*W1UU?($I&RY.Q<[_*MJSDR@EUY<H^7P;F;T
M@8UB.][<%4CTL/D8T$V+`3'\V6\/0W_T'6^V^Q*E^-[;,#M47@(HI(-)"?T7
M^T,"=)%]B9]3NM?P@RAA]D_U),=O`'IE_11[\[PLCY_%A"5BH>*=I2\X+O]P
MEB0X3?3OKPWZ`YXRA60H;[#-,`[['NO.^U<4LTU7,ELPB9434KIIH)=?:6OV
MX,RUMB&[?&71!SUZ]5#>=FOW`7SG;<!I:Z4`O_WFI^3!(8GBQ^R9#HKEW60I
M.1,V9MQ<BNF>9442%D"4+\K2*EP=>@2^%#<B\7#'W0WX*';BIE.MSBUKZSZ!
MK]XM+SM=Q`!]0<N?>;+5RHLW>9YPP<>A.+L;].#,17P+\C@SC1'P4<PL;#Z^
M"2FF+`^+\GQ<N'@KCF2\)D`W[RV($]D`A+A&2/77T"LN=_"<'>F,..>T!;IH
M[XE\/L#NTWT/EUS5^,JXCJ>H3M[$-ELQ>:54O&)%`@VS3H#NTSMSW0JIDS>;
MN]IZ@.D<AWA!6'Z"0DQ)GGS"8S9"D0*T[A#J)MR.-G2"#7T?JJ$:S0M\JN#B
MB5ZW*=1U=P]TBP$Z6<%L=_#W,0E]LJXJ094284JKC@AOT1/4#7</M&OCA:Z*
M9F?7MW_Q4UX)J7/LRQNB$[@05BL;/C4\:X74X#P>M.X`RTO2]ZO`]ZO`]ZM`
MNYHB"K;?+>VBN`W4[V1<%X)&N,>C)\K+O\.'@6_YS(A2D^WFC=YNJC?I51WO
M4>`[.+Y\#_?*@J$[Q<1N&B\I$[Q'@>^O=)D0#-W:G1/,3.?63>:P;J]ZN\F$
M#S7E?N?RTXN>'[)1'\"QHYT(/)Q`3*$#7W+IYBV]S/!3=).PU%.^.C6X?@>`
M-UC&3!V2;833H>O,!/L_+*/7CX1B3M)B'2E^WE]!BM^BF_Q_;%FL`.W4J.&H
M@5Y#P$NMCO1KXX.>Y*WSOB9Q72C=C/AF2\@;K/ZHWT?8_1[3!6NV37<5P)NL
MCK3K0.M^.0D?$-ZOQPK@E58O_`LPV@O<M%:G:R>LO*QSPI`+]G"BQR'OH"QL
MV62PH.\>!=&@>$6R55'\8IOQ=>]"5603TVJ,3F#-9+K7&F:(H#=>?#:+HO-?
M0SHT`101E>J6Z`36R&;$HQX<Z`V4-)=X!S+U>T`GL/8R(U+-8%G;+5GU^,GB
MTCEI#TUR'1FRW*8K=`)K#C.ANRT^)SV]!..=96F2>F%N_VNQTAXT1R>PR=$L
MK+5<3-![IS[./C<AW7W3,_X#/<T_IOG]45WF1/L0).N$Y?L?@C*T0V;-E<ON
M9Q[Y&,^3:RJ,_0.$\-,6-T$3V)1D9I^S'$?%EU,UU)J%A<I-?E`:7&["7U^(
M_[('A=G>MSY[A_NN-KVAR3#\OCI"K!0`JM1:'W/X'0L<(.F&660;I06UIV]!
M>S2!]?KJ-G-+0%4ZX%1IMCS?9C5]W82/V7."?\_85F1!1T3W(0ES2Z[OXF8Q
MBW1_]0(LOJ+LTB6:P+I^F4P'77%NK2@N*<1AT%@QB_U*TOWI35R57K\+-!F.
M@<P45TTP3!);+KT'5VN_L/^PV:H.'!2PJM$2389C)=.$4W/HE)G,I7C)R7",
M:-U0UJHPGBO(QJRUA9R[5YQH;^,D?:#),"QNK8#5ZN"4K6W_"KV<RNC1Y?'%
MT_S\#UJAR7`L:QI0:N:<NHV\*F/BJA-$=86JN>G2;8XFPS",F6*J277*)M8X
M`LX6^W`$;EY:[=!T.-8Q+3`U?U`V,GOKZW:UJ(.Q=Z+TZ9Y#M;SJ=(&FPS"=
MM<%5:\/P#692R/F:5!XC.^G$3D=H.CP3FAFZ6C^@C&EV]&,O94<IMKPD=7%!
M*%$)95LT'88MS0C0UFME1,07U\`D7%Y$"=>LJM,,38=A2=/%4C/ME)<9G9.R
MF-W9WT<!\3>7T;>P],P0FLU$#=!T2-8R&8J:*J>,9'MC9JN)%P2Y2Z,)8X?M
MT'0X)B\M,#5_4.YB=B95LWQ`O"PYTV'9JP00:CIA7.3[,%2>A6'F!;4KLO@#
M-FF.IL,P:YEBJOGOP;YUO%Q/V]LVN.(NU0BV4F>1RW_'\R7ST//IGXIL[V9I
MGUKWVKT`UC8D^^`RLSF:8@P;55[M5IV!)WKJ(G[."MM:"B[&IQ]><7\-B3C-
M+O]IP*)9[<G0N>ZOT-EB;IW;LQ]3+TX'Z;L!F#*Q5YZED)T,?CK`D*OJ`_8#
M+TG(@O@Y.4_1O4?F-^&%MR8I&[">"NCT!90.JG==T,3N9##5%LQN%JQ*S6O'
MAVU2#>-9HG7/0%FK^E.8+I)P,UQ+,B\6'HVEGV.+I62G/5#:JF.N(_MXG8S3
M:J'+\K3<[;J#K+L".S-4\*$COEIL+K=NSNTG!4XOD&58CK;%Y*%V,L++$,8L
M%+NWF'8$6:,%3A$*X$Y&CVE/;U:6B+*(`6!I%HB5H48-'3[&U8`\-3)]-PMZ
MO"7>,PDH\HN]@U)1&'/WMP)E:-T?:`T7BWK120!.1I?9,2="UFHY@CVQD=.J
M>RA885*\"HV++]F^,N'6(?N"]6Y&1(U!J[184@4SM/9BR'HW-NN8RE1!9MTZ
MA<JVY805<D<*;H:M26L3&E]5M.P-*I67;27I`-]>)%OOVF';<FWW)5`9Q(ZB
M2YVDXF9TG.8WHV/(:M,55`8RH*GG`+N;@7?=E%]FWK#0,U12,[=FF%H4;D;Y
M:2_%NE;R]AU"Y3T#V]UP)0`>3&A93<26]$Y]0J58<T=92B&`AQM:6YAL+T?%
MS`N4I,V%1:@6`'C(H4I';-OC;70-E<RM1\WI)`OP\$6N$EV\>.$2WX32>52@
M)5IMH=*ZV58#;;#@P8O#,.<#)7\#,N<W4L)UCY3D7?1`!N><O$?G'+]R^W:T
MJIKL>T^.*0A'#''@1;396J.JI5X]`UPJG2-[/DG-`8^`'F&Q9LY3T%7-FY*7
MD%,/=MCTW'EO9)6)JVESGX,N:KXK?SY)^P-VJ/AI![9(J,=6\SGHPN=:;.T-
M&#IZS/:^XU:CGCGG:>!*Y=K+%7_HT"3R0[NSU<J+-[.%]'`Z"\^]A"2S!7LB
M%_M=-,>JJN-6^@:N1BZ@\O"0;PNLB_'==U[\&TY+4$U[>'B'/;;-SA,CB_-2
M:K>'#-RPQ=^A:IC`'\6Z7(OP+$FR58Y`69]<NRUD3$<_.F("'7H1Z4]!'DCR
MVW6,<;.*E:&>\+H`#?\XOKZ(1``=:M[GQ++&/KMTP[$L\:6J*6@X",2\L@L=
M.I:\?_WX9Q10H;%KMQ8S"[\3T!@3.)TY%`)T8'K_VG-)7LD<A_,.NM/L`C0D
M!4YS]D4`';)N66]NPG66LN)>S^4%/Q/LPLL"V=V11FO0")4C:8L<O9.![;DI
M+Z^U7!=XO'HC24K"99%Z//<7$]:^U&T.&GK2WZG8!+Z3L>R<B:YR$!0=<G6:
M@4:']$>W#NP>`]8AG1R>:%<9!?'NZ@!XY=`8[2\>"6^C)#G?E(/.W3;9/N6%
MK,\W-R'ELBB@S1Z_C0I'O/,-KS-VWM;WHNA[$.-VT#B"](9]>UT#SEU(RP`8
MA2^(L(TSOB''H)VO>C+9#%M3FH`NHQ45JT1%#A\&=DJ1\L*GDHMAV!P^4J7&
MR=5]-=0<F](70M(*V(^%3Y'@RY2B&#:OTIG/S'-"U@&P'XP+\[NVH*!OW12I
M5,H#AL(=0_B\,VXU*A8.3Y4R3`Y=I2?8_V$9O7XD>?GP8BHH?MZ?!(K?'M89
M5]Z?ZS4$S)(JI6J766TL+CK+[-0MY5W'7F+Z\XJ$LB@ZLTZ`W&9Z*XYAC!YZ
M?A[>_1-T.><>#`4&V*UY0[0J=:6>-G:N0?02)&NUAG*&.<Y,(<<-[>$`>X4T
M(L.@*7!KS@G['_OQ[A2*@\^3]P96U:P>@=%E@:05P&7`1;1:1R%3O?QN.2>>
MCHTN%SC7QBHNG^JA!K86O0&;Y^5LB`QGK6`Z=/;J2U^Z:D@E+%@S>TMZV^C*
M%O`HM.,`X&R-8X^M0,QN<4%/K)M%%'_SXKG<5J?="[#179M<D:W-!.@X-81-
MO>7OV,$D3#`3*OU_P64X/\<A7I`TR?<PYUZ"Y\T'6)%S$U6R\#KH*P'+.F='
M(N.P-F@(9Y:^2.^2=+L`OFKH7XLJE..(LM``W$TI@"\<^M>'QNU#9W-#&J5>
MX(@BU`Y_9T$0?6-95DT4X;`U<'"O;47@`NQN?OBY4(00+UER04=4097%Z_!Q
MX%L*VV07B*Q%,.Q_YI#&I:-GY1J#=:D>3;D&E%O)BRBDAYR,98TM#CQ1F-2/
M/F`_"GUZOBX^!@/(G5\R1%N45?2C.&(*8`H$=99>8XK9"Y@+34:'M-FVE]\K
M6GT/L,G+KA8I--62O$:AK%>+!?:+2Z`&NCW1ME91"[T#6]B.H9AVI#0."XA`
MB%\BMHO*_+PT34E%*X.<E?Z!+7"`DZ6QG,9A?='Y0JVIJ/V7`=OZ7)E#C84&
M[9[2ZY1:94#O9E#JWCFPX1%P,C43TCCR>>A\IW8TT_*;@,VBKLRA9A(;1RX1
M@[W0V2J*4_*'R(V\8X_`UEK']IU[DH%.1P*[T]14/!O=`_NINS(3:H@).D5*
MK]-??K]^-O]75H0#R1RJ-'N`]H0'G-]XHN@Q\XIC$YJ!*K7I#MK3WI49BR>7
M2LF@2N'U>L]G?FD'E3T29`HZA+ZU(0_80X;_*?!$:#S/\#J!2AL)/[N(I%%K
M4>>K"&@'C)0Y8,Q!,X;!NF%P`^0:SBEZ60[$#8;D\:!$,HH+X581$Y*X`;AL
MS'*N^!.=%,C(^:7K!REF<4'9$-,N@*[N[7-_`&L<=^WN^W[`I5ANHT!V$'>_
M,1?Z)A]O^W01K5:D.&5ZX;S8*"XQ%0-8L'1C1&?[(S+961GU`^#R>AN%2U9`
MXCZ+_1<O#Z8JQZM*B:IH";Q5,Y6[X!M5@QQVHKH\.1N>WWMQNLGKVU-IL'/9
M^:;Y%U4M6NU.@-U&-=CDJX$1PO%HA#*MZ.'#T+5NC8A2DPV>9Y1[HCY[?H[2
M])Q$S$+KK7&6$C^YB.*U,'6H1BOH$KA<J1\>J=4H7,PH1P<7Q81NXX+("_^!
MTS3/:73!_![B"\S2HDFITVT.71A7DT,#.-:.3JW2?/6]QSK?7%"!+>FV?K9@
M*3*K)^:*%;=EC\"^<ZV7W_9PK:D/S&(L!BZ`K5RQ6_8([,[600%,-4HE!J<V
M`O=L;-<D3M(+^BCQO>")S:NSQ2WQV>7._#Z.F,^)='$QZP38J:P#<8?KD#%R
M%[<6.8A'9C6:=U4"_5Z`G;KL:X$1=&A[KE@/GEY(W%D-M#N!]L"RKP9&T*&#
ME;AJ0$]&0;1DPR_'?;9>!Z3(LB^E7MT0VC'**MUZ<*%#>OA5Z_(5BX)GF=3I
M*<H+L)19X?/0[DM6"96BA(Z&X9MQ%O10F@_["T[9>!.Y_4;P.+1'D54692"A
MPT.X)'[!WR[C;*D[RXH>AZH/VPN),I#0<1?\'-[8QV2=SA8/>)D%K-&&#CZ.
M7KW@FHKJZ^/UW)/2JM\!5"G87H@V@SV.^`:Q`&\U"CMIM(:J'MNCF6X'FY/;
MYCM"EYHT"O&]MV$C5K@HBAY')ZX:RG8IX-CD)8A<-'N(D=9(DA**@$.#'M`)
MC-5+2<PACX:H^J,6RGO(;_IZE,[8*8PSMOM.1-Q/2_(ZD5.03K-A>P1I(AR/
M\\=XW8%TJ52[A[S[`KW[`KW[`KW[`KW[`HW?%XC+Y<S[[8',E_B+5XR$=AK%
MN1U$RJ&J&;"CCBYW&C"</.R?T3&\/D9!EJ\'\HF2\RBP,XSV[,@?NIM76O2E
M?\]2BCQ,HK#X^A^H=*ED7C3F1-WFP,XKNLP9P''R8BN_2K^A^^H;LG.7?AW%
MK$[DRGN^":\".NY@<^9G*;[;X"`B\UN<_8971&YIM](WL/N*KA[8PNKDQ=G7
MD-#NDKS2ZQ-^\Y*[2XJ4_J;2>(WOWJ@/:&\57=:-03EYI?9?T4N8_#U:_T;G
ML"TB*9NR)M"^)[KDJ3!`WX'Q;>D>F0?>M]P0(F7H\$%H%Q)=7O@CA\Z9I9P8
M[W$8)IO@U0L5RZ*\$;2+2)NICX\".@$5?Z[S5ICE`%B3U`M^B:-,;GP1/0[M
M`Z(]QTG&;R\E%&S=X!>"%U=OF.ZJJ$;.%@OB2[8B&JV@W3YTN-6$83%?TWM,
M%IBW1[=+D`Y@WT.R+(5D.>MJHE8!4Z52"L*M*QE;?KW##+7B^Z7(4+IX2P,1
M6G<RS*@J/N'FV)T,JSI;QACG?E?\Y?_@&32!,3.U6]"YP[=V:6-G.JV&)UQ)
M.4^A"8R]B"]/B<RWPW5J#2L_SDO\BH-HG8,)Z>DAS3U)BWBI"H%\!C3M!TW@
MG()XI'`FMC:0G"+7B$$1)KALC7HTB<?MY#I3#3></ZZC,(GH&*HK/S.>U!V@
M"5RB1#/N]+`XZ6.PL^G18U#6!$U@[$?ZG*E&[Z3?P7W@^<52O<S_H[6DR=J@
M"9PY1W/Y4@W?29>"A@/GG1=ZRQ*!#E\Z3=$$QIBB3YLN"B?O^A^82#5G0>ZS
M:`(7@*/'CW#8UF[GK6S]'C$%7$B/+JXX30.#+TFO,9K`F#'TN=+'8>VZ'LB!
MGU5?5(5K5,^@Z9`,%]SA6]MC`-*EO&5L/(6FP%XQ.\*7$+0=[K`C8NZ\-[+*
M5DJ.=IY#4V`?F3T&^#P=#'D4]2ONZ*%$B[#F<V@*["ZC1]C^D)VT:TAF]EM)
MO@3=IF@*9\MH9VW71>7D,4P&6:NVDWX':`IG\=#FR(A>#D`G;SZ+[`#U1=TU
M%D5\<YY$4S?=63BBYYA&^'A<).FXZ2^F<-:1SJ0:XH1>1&U%;K_B,,N+"2U#
MDAN-*K!W.'V)YKL/_+%-NL&-[#;M#$WAS#6=%*8;9"<O(O;SQPBJM8D>15,X
M:T[G;U\$R,F[B$N<^#')!S);/$0;+T@WY;B?HJ;_KH`][?;HU$U#CQ:E1BB=
MW$.7@YXM*D>X>QS[C(:EZ+N4M$"G<'XNG;E4X'+R*H.39I:.FD2\!53Z/#IU
M,_N-%G-25-#QB':V4$_8?PE9CNC-(XY?Z8$@N8B25&9)%[1`IW"N,E8V0Q)<
MT.&,MJRZ)$QQR()K51SO/XI.W;0_:9/+`^1D6&3M`!3.FZYW<<R,I9)SKK(=
M.G72T*2YA.J@<S)HLCJ/TUV<-R>1EY?"O?-8_A\V,+[!2=8&G0[9]*1"!AY8
M*7(3_A?VTZN$9:.@.V\VA8@]@0\>1:<#-BR)`-F+C[1ZNHR^A;5]DS=TY2G$
MH`=T.E#[3PN<-=U.67T:(*ZCN$2A)G;[+#H=L-U'B*@FRRG+SX[K+-,PEN"G
MRJ,?Q==1-&?K.RNI,%_11QEV-FH=/V*#[M"G`=N%NH"NM<(I.]%U%LYW35I?
M61J@VDN-H6+'\*=OT?_0/:#(_F#6"_HT8'M2"ZPU]6X9F11`\F!:!H$B:<E[
MLPOT:<BF*$.@->/#-D^5MM.KMS6[J9;=WNT\B#X-W!AU"*<FM+,1REY>V"\9
M<\JBVT<J7X97\)'N/X8^#=2:)`)3<^.4*>EL%65A>N\1.G%<>?Y+.6(!28*G
MT:<!FXTDF&K*G+(6/:9T9O^ZOL:8+N([>ST!:^(&Z-.`[41R6%L'!`>YN\QR
M"S-3.HD/`O]A]&G`AB(QI)HOITQ%Q4T>\:F2Y07>7O'\?+,-.J-;Z)7(QJ=N
MB3X-V#2DB:^FU2F3T-9L-5M<9T&PN21!QDQ:12*_QS3R?[OZG0KA*6*"BL+\
M-V*F6W2&/@W8J-0><JT/3EF=?O78+5%Z]<;N\!/FL/XE2HE?7N0W_&P$*J#=
M'GT>L%W)"&5-M%.&I!V7J<<7*K/D[-4CE$X2D'1SOBG!4;TNT>IXF&EUA#X/
MV)S4#FZM`TY9E,KHKF+?/UO,,G:W0:<GG)8G:=$15=T0?1ZP]4@/7LVI4RG6
MOT3A`UYDX9S-2C=ADI(T*T8E#MF0MD&?!VH<TD)6D^A4[O5[.J^L/'\CB;+9
M/H$^#]@^M(>CIL,QTQ`.YPSD?1SY.$DH1C$S_(?1YT$;AD20:KZ<L@O59GZ*
M-2%T@+*+4?[#Z/.`[4%B2-L8!W?,XI79<5/,T6R6]H(@A[][::,PQ2K;H\\#
MMA<9H:QI=J@J7G43T!RYX@:D^2CZ/&`3D0A0S9,;257I\741T>4X]/%Y%&9)
MJ6T']^6EQ[?8"F32"_H\;/./*=::\\YV'XM3<#74!QSB;UZ@MO-(6J"?!FS9
M4>"JR>MLR[%'7NV6F+NQ-*:8K=XEYQLJF;47BL($C?I`/PW8?F.,M*:\L^FF
M%\KI.#I3KNX#_31@<XXQTIIRIRP[6_?CO46G#>DZ?:"?!FSY,49:DP[C,62I
M$`WV$GSUMB;%D8]=*9]P5$'V./IIH.8D%:B:8*=L2\V+(ZJ:+"D)G:6*ZP75
MR5>K+?IIP)8G;80UN3T8HCXV)7=+A[@O3?:['7%2;)@>`6JI[`C4IW"SY)4V
MSF@?)/1_\*-5\>ZKWS.2;N8X]4B0?'?DN:-XN215%_]!]./19[E'_P7/LP"7
M%W#GK.P,F\EQF)3:74<ZTCE^^TRY)IQ]\^)YGHQ-`M+:.Q!L-LX#L@2SIDV\
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M16PE(>@<Y6Y,FML[PV-,FIRWH1/8NX*AS9H"$5I+Y`XY;0YZ)WL"?!LR,#WF
M"M!:FOIB,WL5S@>OR;]BLGQ)\?R,+C/>$E=+V'W,=T8^\@C0">R%S("U7B56
M:TG_W3_8"<V7>_NV>L7KZZ.P.A!TXO@EU;&_#>O2'4=]!0MR.]@2PGT@1D-!
M)XY?XKGWB1C+=QR5*?Y$.RK@6T?7/@E[8K56S<.%T\6S6F3/QB)[P,P-@?Z>
MN2TSWTF6Q`G'JXGJNSCN:-#)0"\[NWPCQQ<Q=+44YU:.&RHC$B;$_Z<79$=:
M*W;?B4[>+TRM"=)>)1GWC]C#4O+WBU1K@K17A(>WZP$*$TJ+0*KW:"&-:"%V
M_WF^N0B\)#&(_]EO-;R('@Z"83O0T^4E+3(<,4PE0D6\CK"-.[$[/)Y$]_QB
M,,.FM@E(&5=S^#!P5(R4%SZ57`P#YW";ZE@9R'#P+'`\"Y\.`76<L8_#D9;N
M;W!R=E^-6(]*22O@"!434N4H1A)MDF,\;\4OMQ5P?(@YOR(4(W&%RS%>M.*7
MVPHXI,*<7Q$*:\YA5HNA%$-^^A9I,J9N!!Q-H$.8%@AK;E!]\$4?P2T8$S4#
M=IHWY4P"PYK#3@^L74=9;$Z:J!6T@[DA:3(8(W$AR8%>MEKZN*V@O;+-USXA
MC)'X/^0@KUHQS&T%[:]LSK`0AK5[?0<8/M,]<%;P84T_+<Z8VX%;NU\&LL<6
M9RK=$V2%>SB6GH.!V[LPA6&,)=V8+1H7:PKK.?=Y<)_%-J9S(9*!)V]HNDZ>
MA?,O=.3;WSS1GQ+/S^](E5^I84_0;GIB0OD*T`(>E#F>>XZY]<@\\+[E&36E
M1Y?#!Z&]Q=J(_O`LP\<%;'CG5UCS_2A>$?^WV3E=/\+[(/"EC`F?AW9VLD.<
M%-Y(+.O9<T+FQ(LWCUZ],*ENID5MP+U_6EU-R]!8,Z\#[7.WB%BJLMFBH?KJ
M))#*QF@"G*U`2IV`;BU43BV@]X'G%QN%)9:DVA,]BB;`8?IZ$C^<?D5@1G%E
MO:VXK=S?[C^*)L`>0&T(E8$9QU+*RG6$/BE*=L29QB%5T`)-@)V"VBRC$BS6
M[C"!3`],N^DHV4:R*,5!PF51G64/<,*.=@G_3\KEUN9KT`365"53!H&5PS)Z
M=Q=P?U-7@M!?R@\:H0FL*<LZ7XKEGRL`%X_0_T57Q"2Y\-8D]8)?XBA;WRH.
MT9(6:`)LJNJ?907Z<6P-VF7)GL`:OWHF7XC9VIG;7@&[<HR2&R/.4V@":P,[
MPL?+00SML.9BQ8,)K%GL2!^R%#^T7YREHP!)V;'H)IR35S)G]<`4MY"\Y]$4
MV&K6ZA92A,0:L4"'NWU<OY+TY0$'1:*6%[)^BJ["E*0;]?G-K"<TA;7*B0G5
M5``U/*?.8-=1O,+Q)8FQ3QL4Y?V2+$C9\B5=U=4-T136'M>&FL.U7`_GP`.]
M&BXTMQJ%2+C/H^D`S7-")$ZZ/A<QPWLU-P7?)_=9-'7'5VM7W(<?GA#`*.XY
MI!F^B]\W2AS+KB.-.F(%6J'*R(H)%5Q)&B,;LV;DZ2\L*`:_'S2%L:A9U`LQ
M,&ACF=1V4HSX*;K/8O_%2W`C&'FVH&.C^!1V%8T>T!3&9F9";PM(T%&>7&)O
M0C]FM<NK@<X6C=$+J)2V05,8@YDI>4H0T#8P+EV-,397EANM3U"O,9K"&+I,
M"=1'`VVVXE\GQI&/\3RYI@)@(_="OSH,?`WI<'=0?,&BC;-I-^@4QFYERFX;
M7$Z>@G;]GRZ\Y.4:<W="XH?1*8R5R9@SX>BAHSQUF*'3"4D2.BH];NK'T2F,
MX:@C.SOCAX[1U.#GZHUEYL,/F*R>LSC)_Z#%%*\A.H6Q_G3C3(0$.OZR[8FA
M_4D!G<)8AGHX(3`H+B7Z3;#_PS)Z_4C"5YRDA2&@^'G?!%#\EFZDV?^8+E9H
M51G=]1JB4_>-/_I([(5N]O&1;LL:L.33BN]R]V%TZKXM1CYZ>QE:02UQ9_-_
M9842)D_1V7Q."@SW'J%GHM(UJQ1",1U)K''&?:%3]TTVG<#52N*4]69W?U!9
M$;4/&,T&Z'08=ALY@IHFIZPVYU[XVU5"I?&-CE/`S,XSZ'08-IB#0=?R'[:+
MT"5^IB<DNJK'[(14_)0RVU+E2-6T.)U()E*SCM`G]XTS[9'5NN&4?>;,]V,Z
MPFU$DV3VY#Z+/@W#.B,<?,V+4]89@7GW*9K%9$GHX/+?OD0!'7MA$63_OGJC
MYZMPB>LX`S-3N&GOZ-,P;#\6X=;:XI2M2`BP<(CJ1U=,^D:?AF%QL@:VUA.G
MK%)?PQC[T3(D?^`YO^Q':603Z()V>_1I&!8J(T`UIRX8JCJ<E(.\<W,-,.L`
M?7+?@&6.:.O%X(1'\-DJRL*4G=WI!'7!;@F#PF5VMBCFK_,-`^*%&]&>3KL#
M]&D8EBXS1#6?1\]`QL^7FX^PLI//SQ8I+C&4$,J:2P(V=9NC3^[;JTSQU$P.
M-<]-U^*\OQ1W+<`EF/5'@3ZY;W(#$DNMRYWM>*WB1^TH=-.'I30HUR76)1HH
M:X8^N6\8U,51<VPSZNQX!?$:$9+W@1=>%I7QCET2[Y(D?A`E='2Y`V/]9>:1
M0^QC3=+DH#9MHE%"KUO'L"7W6L]5!@7ZNKT#N)Q?9W)%JX1%^0P[2*V`0M^B
M""[>><Z=HH#=V1.<,_?@#IOD]F+:RB&<L]6#I6!3YW+LX77`I0L/],'V[E.*
M?-C:9S>]!6RH95\$\]5))H5Q1.6UK6A]JQ%/W;USX,*,1UCGK,@(.A(06!>E
MU=S[T$]Y^7C8)&YV%,JRLJH$]N>>2P^E\R53E:JQ_2[@$IK]:5;OFES+SY82
MKXM\`*D7I\-4Y%T+[B]QE/2R2Q"_#;B\Z-"4F2_!]TT%_*0,7&!C8'K,DY^U
M7`K%K'P5S@>OQWW==]H9`73)V@$KO4JLUA)5N+]#&9T'`'"97^>^"KNBA4[\
M\;Y&&$YFP/=?KGT-]L1J+36*"_NE9[7(GHU%]H#9G0']_444YK?<F1>P".&)
MZKLX[FB@"TZ#?"/'%[&3"6LZRCY?._'^HBD2@\S!]EAC@"[6?2QE!Q$L=,X?
MYS9'-U1$)$R(G^?F/,YV:/>=X*7-A[L!.A2DM:Q([A^+#0W!]%^77HJ/IN]:
M[X<NZ#XTW=<6JDO)I=[G^9*6]VM9:X*TEUF+=[:%CB<HPRW>PPK>PPK>PPK>
MPPHJ#U=%5$'SL?$'%>RA'0?#RF@`I_SX]RF0$P7N@,\UKSU]BYY>HBRA&XTG
M^ECA'<Z&+*TLIF@%[%>O\HC70^!BB>;FJ+_AX!5SG/J-R%-W`NRV;LJE%J!Q
MN(,]Y.F'Y&MB_0RT)W?_"V(3JC6"89;#'(HRK*GQ%+#'\X[H)>S4@QWV;N6.
MA&25K90$[3P'[,>[)W\^2?L#'D4HPYWWIL=6\SE@;U4]MO8&/(Y5K5T,.;2C
MY;&#R!L>D'^ZQ$?NA)$#.S(>JH1M!T0Y]F&OXG8CR5WWXFM+,5^CI'(8Q:Z!
M6V1>HAG\HO30?FO]+TM"W-8<]&%F!\/*]"::H:AQ#^S^)2944P'4\)PR@%93
M64+GOPLZXBQ(F8^!U((F;0/MS]2&D$.;FA*BB^917?XX@&#-8W8XX\(:QZFP
M>R:(/EQ>ZL[!?5L&D=REX;?B5%7BO6N"O62?(I]P:2-T,M"P_5VV#N<8->Q1
M;/];RZ\(UJZ2CI^]>B1@W]5U%.?>BGW,0HI7HA.X[+D:VF)YMM$0AHL[E]*6
M6P8T%!+C5D[-DZ&?4;AS!EDP-[7L#4W@*G$9:TI'G'_R;5'^GW_B)"7ALG"F
MEA5TL_D:-(&K'';\Z4@@`&NV>ZA(NR;&`A?QZ?]]1NB2;D.;N"T$U9F\#DW@
MRI.UFL7Z%(0U*]PPI[FF:!K^]#E-Y>+1Q[2G\5HT@2N-=OQI4%,@3IX.=SZO
MY3+&2Q9QE!>(.POG#33E?B/?>#Y04N-7/,_KQ<T6=.CBB=#>"]`$KOY:JZG/
M+G1K^1Y`)[O&MK6LR[T+FQYEKC,62</DQ*HB268PX[[0!*Y\6^MIJ15*Z&0'
MT!&"Z4M9R/(F]&-,_WR)B__WL2"*WX8F</7ECK\.RN4`G9S`X%2P_6T#=0[Q
MX-.33%-6^T<3N.IV%O?]+9%;"_SOR;!>VFBXUAFUA5W6&DW@"LJUXUT?%W08
M>Q=657G6VG:%)@.R9W<!:2_&&X#]O9P\C50\MV3141WD?:/IP*S8UE#7"C,"
MHW:'[&?,_(7G59*0:X_$>=H$I8&[AU>BZ5"-W3T)HU91*,LW\+&KEL89W;NM
M"GFQ!`*L>#7=T=U'2?I:6&_I/B^E*T'^1!]'LG8C0=,!&=<!953K^0@,[VVF
M`I[DKM[6V&>K&XY7O4S&RI>BZ5"-[KV)HU;4/VFZ:)F0_ADQ!\R`I)L'+^W%
M+J;_=E9R>IBJV[]<:AT>MN&_%VE=,H=B',XA-+CY;C0=X,7"4:12:^^?]2:B
M%@^)"W_WZNC0RTV$\&UH^J>ZB9#*H=;)/W>>9+K'7V"29RT\@DYRWH:F`[K3
MZ%D.M4XZ=<7!B83]&I(T><#KF"28IR\ZS=!T8)<:.H!J!IVZSMCW1RH&OV.-
MS]V'<R0^?6JV:#PGX+=;IV@ZL"N.[G"W'K$NZ09_*F,I/25P>.:Z]IVATZ%=
M9[2&6>L`U/T%5P>^AC'VHV5(_L!S/C:VLP^YCC-&[='I@"X+C)'5Y`[;\G\6
MY)V;JX)9!^AT@'9V?6BU,O1@'C]>\O)?O3BO1U!F+==/5\Z=9ZK>%'&G^X\9
M90>7OKCTN]5[_>[#0"FX!?+@3%7"8;L8#+@[6)8*X"(*Z0M2\AS@+U&*13L,
M=4.@O-AR"E1T"8"X3]U3=!.R"\(H3AB&8F*5!P/H=P"4_+H;E0I`T%&9YIRJ
MW1AUFP,ES;;*YRX<)Z,<Z9;&+WQJE_0_%9JR6`.%4_K4LEH.6G-NZ_Z`$FN;
M\MT%'W3T83<%T)FNVW4&E(R[-^KWP;D9QZ>OR*HIO4U70"FZ>_S<F]"LA=ZE
M.+:[;(OW'6>^'V?;^UCY\JW=#5">[Y;+N`DLZ(@YC<V9UA8,*+=WMXU6([]W
MYSO9-$J]P`6+R<D`3":6;J+?"ZI9LN;TDO)NT(FLVV7,'WV!M'VXPR:YCP3?
M77Q9VN03ATV&?:`/@GFE'^3#UKYR6E;FQ]]Y#K@*7%]$\M5F'_FP^78]W2YL
MANUA9-L=2YF[KNZ$_+K=/?IQ"@N%.ST;:BF496555E:W-(FV,BHYI[U%:MOC
M*&[Q+N"R@OWI5>]Z7,O/E@JO<S_HQ]2+TV$J\B^%,:MTZ/XECI)>]@CBMP$7
M8!R:,O,E^+ZE@)^484M3#DV/>?*SYIA0S,I7X7SP>KR774:5O.G((P"O[SE<
MI5>)U9J/AOL[%.%AG+OD]?5%V!L%=/U1Y[X*NZ*%]F)Y7R,,)S/'2[`.=8V8
MV//N:;U?ZERP@B.!,MG>'O@'S`S]><KQ.L$>RY9C%-37TQC`Z\D>2<5!!`OM
MWN1&\D3QK""2W40U]1]W--#U<T&6@>.+&#I7N7.;HQLJ(Q(FQ,_S_AQG.[3[
M3NC"PP/>`!T*TEH^=?>/Q8:&8/JO2U:EY5CZKO5^Z`+.0]-];:%"9Z!WXQMP
M;)Y_OY:U)DA[2?9Y9ULPS_HR:<.[?_V[?_V[?WU'W7I@.!6^]?4SX_>K;T(=
M`;%*G^;&4\`>[#N2EY!3#W;8]-R1D!4&51*T\QRPT_F>_/DD[0\8.)&));:*
M,JYJMIK/`3MRZ[&U-^!QN$"U"QH#/F0?.VCLLSVR'8WC&$#4&.QA]T`A;+LF
M2)$/>P%O%S7FN)MN2R+Y:K./?!0[`=>#QX#]9P<1/&;11[:';!][*4GE9JF#
M_*4#=27=(>?07T*,UL4\B<>I#`SD'ZF@@^/KHH\'-"3.R7+`0&Y_?9$L=+[K
M?`0Y.N6`-8"!'.7Z4@HU6FO+-6"L[+%RJP-YB!DIASDD:X$<T-'2'9S97"K]
M#.2-U4K+^A2"M3"*(>JEHW5P@;RECJN;6F*P%MHP3)/+X.N1`_E"M=?DX\IF
M1$$-M@3G9'7G$_"LP4!J+);'GSS"8!!%G4_`4RD#J^V^-*R%#0Q3:>G^WV=Z
ML,2SQ7Y-R-*/H@]]U7@MFL"543R>JFH*PII3__Z1['C^SE6]V4N\("&3$_/L
M?L[8.]CEJW%)-CL?S@Y==%;`*8ESPMAN+8@2"D-R:=6BE^[5WQ2"U+MJ,^L$
MR/^YG7@Y1EMCM*.XUK_$B1^3?.2S!0\ZE6DAT5GZ@O-#25R+ELE%=FSLWCE@
M93MS?>!/^U:$,!)=XTJR%'1\YZ64CC(PN19.OO1)=:QMIX"E]NSI5@?PXW!Y
M58B`S?[L<Z*XXDWSH;,5L[.T5RQ%QX!U_XZD7&H!].AL=+PMZ6/VG.#?,_HG
MS/YN7A;8TN&M'L95/@R-#:>H"40@W^Y0E#%YG,>!MY<288J.>WP0PW;^W0>E
M#C40M(".J!.0HT?E:,K/'.)21P.(V@"'T4DXTB9U)'5=]I`I/?6YST/7>9&Q
MHT7HN`+QJM@#Q6S;?`RZGHK1%+LW\(%':&G'5NV%E,!&XNUS(&>J'C+49,EW
M8L44:V4$?,1I&I1U;V.<_R"<#/4;`\>N'<K_T):I#604<^,325GDS4TX9_=V
M[&PKGR2YST-'J!G-EB($UD[<,-/F`2Q6MSBO4LUN9U_(^BFZ"E.2;I3SJF%/
MP-%C0CHUV5>"<VJ*OH[B%8XO7@A>7+UA/TO)*T6S(#Z.I;.SLAUT$%@+7@ZG
M;BV4HYBV]Z:\6YTX44$3\)SY7<P).RBL^?M;C>O;,W[I71\K6H%G=I>QP-E2
MJ=&X&))95,=ADU*2>D&0!R#?A+^^$/_E@DY*A`XX%_Q-<N]M!&;95OU`!FOI
M<'7(<"N(+G*^,]IRK%]#^HMZ_R\@6=T0,LJJ':MZF*#O0KD\%A=IL\4]CA=T
M5^"%/CZ/PHRW0,H>AXQ9:L>9#(F3&0R*"*G9XA''K^)`Z+VG(.-UVO'"`=#C
M?H5[Q_N1#8H%!=%__']02P,$%`````@`](8^0[QU*_IO'```UU$!`!``'`!F
M:6PM,C`Q,S`V,S`N>'-D550)``-,Y4E23.5)4G5X"P`!!"4.```$.0$``.T]
M77/;.)+O6[7_0>>7VZM:QW$\R4U2D]GRYXSG;$MG*S-[3UL0"4G84(2&(&UK
M?OTU0%($"(`$)24&1WE)9*(;0'<#C>X&T/CA'\^+:/"($T9H_/'@^-7K@P&.
M`QJ2>/;QX-/XZO#[@W_\^->__/`?AX?_/+N_&5S0(%O@.!W<`LR4X'#P1-+Y
MX/*/P\N0I#09_)K7-8"J7KU[]?T`?M[2.$2KOP\>\#+%BPE.!B>O_SYX\_KX
M9/#ZS8>W)Q_>OAZ,;@>'A[PA%LSQ`@U2E,QP>H<6F"U1@#\>S--T^>'H*$!!
MFK%'Z$&68$;BX%5`%T>\KM?O3GCG(\R[=T63Q06>HBQ*/Q[\GJ%(]/5@`-3&
M[,.41,X5"HPU]-/3TZNGDU<TF0'(Z^.C?][>/(@.EU5')/ZL0#]/DJB$/SGB
MQ1/$<`G.2\-TC2`#OSW*"]>@44.]_[R!BN5*20,PB5F*XJ#JA-;I@L3C]^_?
M'XG2$C3&,Y3BT%KY^Z.$1OBH`"NQ`IK%:;)2R60X>#6CCT=%H6#YX>OCPY/C
M-5J6)#`8;7A%*4=\HR*&F)AQH,#03HB7"0Y:Z$))($B;PG@YQ,_+",4(QOOJ
M"OXN*\+/P=S<,"\QM$SB1\Q2,TI>9D"*$0F8&4<4<93C&@J-XVQAIBY,DZ-T
MM02AT?@0H'!"@C5>.Y**D."IE8?OCJ"T!&0D,),`!08"6+I,+/!08D#(V.$,
MH>4:9XK81'2D*##PM2@Y1&EJ1X/"A$RR%#,)C7."&7%$B=P65W$HCFF*4M"2
M/_Z`EDL23RG_S.?9!S[&QH`TX#\^W5^WZ"DQ)$N=?!J'EW%*TM4UU)@L1`M`
M'8%AW0RR;CW$4Q(3T3/0;H/#2MU+/U$<#O)*!E(M/QS5:R@KS1@.A_&/XC=,
M-`9U"`RNL@JL`L2$457H!A^@*,@B>P-'"INWXOLYC1F-2,@UQQF*N$I]F&.<
MLISG]F(SO]\`DQ^`-;A@N(P_*"H8Y#5\8W;%S26"92"=XY1`;UHXK\*:Q7#B
M+H;!WT9RA?^UYV)9<XT-I\,E3D0'#)/!`F<6QW=-XJAJ&M#IH*IKSP7!2K;0
M:3!'\8R#LI0&G^<T"L$^Q[]GH+TY,0%)=?ET0S>+[:V3V+C4SO,F!B2&[U4C
M_SFX%,WLH2CE^7&.V/PJHD_%-#(7F47PKB8"=;)P[(%`WT,.7V`6)&3)FQI.
MSS(HQ(R!;?20+18H60VG#V06@\L8(#"9`N&A@$,\@@$<$%R(8LLZS#+[;VYH
M$19$E$&G^1]5*UQJ93O"""M:XM^EM@958X.RM3T4\1T%&_VX,'_+/\Q,_[[.
M])\H9QZHK``G^VC8WN.(ZVDP;M+5.$$Q`U!H-N>EK=#,V_=UWA;H`X$_D"K8
MQT$Z2BC8+.F*NV6PVBVY=LZY;"PQLOCX=9W%)6[NJ978>\A>/NU':(4F$08^
MPGQ^!+80^$OH@THU-,"867Y<9SD''A35"+9+%8G"?1S=%S@AC]#28[5D5A_,
MC'VCKW]KE#WDX'4,/_$8/9<<E#^8.7A2YV".,A`X>\C"<[I8D%28O?G\YH81
MCBL[K@G`S.+OZBR6JB@G?U7)'O(\]]QR]A:_S9Q\6^?D'OM\X/H.A9T_BE!<
M>GOJ1S,3W]69*-`&.=Z`(^XA/W]#"9B692AV_9>9@YK75<+O(>,N%\N(KC"^
MX%W$0A^*#0]E8+8!F=FL^5EE-8.BGH%<T;Z.W-Q7/9$=UQ,+0S7GZB&;\.@<
MC_=<\LKW<0!+$1.ZCLN@=5R&-L=EK#&>;>HR2N^-YK?M)M8S^%OY:Q_W([:3
MV)C[;SN1?5&36?*:^[@KR>>M[J/<+5&I5!)H,XA94IH_:@]?[3/WRX@3DJ)5
M\EQJ*#?S7?-BS3&M?>9Y<^!*YKX3I%D.FJO;'NC:9YE(T2IU*:E_-G-;<X<E
MQ'UFJQ3UDMFJ?S:S57.0Y9#8/O-5BENA6NA+YG,[F)GOFEO=&"?;9T'4`CTR
M\\U%9H9K#K86"=IG)N>Q19FWRA<S2S47.\?99SZ6P3&9D[5O1EZ>:`YOB;7/
MW-S.S;S`*2+13CS6LBJS[+Z8RUHT^TWT&\KK>(>RMQR0.3'LRNY4^(,Q?DZS
M_3Q`*\X:!?E1(V4VFPK,XM&<Y?S\4H&[UU/,$O,)94:WP)AYKCG&38&A;P)8
M<JZD&G/3?-XK<F@!-8M#\YP=Q+'/6L<4D%.T3Q.`602:EVT+V>WQ;)"XBDN&
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M*3K"$=8L!OTN;>OMNKU6*M5=.2RNRJG&B*70S'K]!F[]'MZ?AM/\'Y[`]AY/
M!R(S[`>>XO+C`2,PVGA&6?%M+O*`3DET6";2_1=0].IY$940O.*&%+5"0G4F
M%.V6510969L3UT(E8OL3O,6CLN\'1]N3`^SN2HXJ(9^(B="D*S&`@B/?Z(`Q
MW96.VC38+35'9797^%7E?(4"((0FZ2#6TELWIJG-4V/?T$#4HZ;#-2(>X2AE
MY9?#JJI7SRS,>^C4$2V)[18]$75UZTI3`FM+1W04_M=AB7?(/QT>O]FT_;64
M.[9?XFW7?ELN:I<^14FBU')95<([]YYW[OC=1IT3=:X3@+MV1L;:40\ZL*+$
MV*)E<QIMEP[(F'<YXD[ZL5D?-NF`.6V]X]PH$7B3;UT;:TH>WZ2<3'CE']VT
M4GLN>J=^R(CKOPZK:KKVI)[AWJ43)0[_L043M!SW+FVOD<2O+5HWI,MW:5]"
M*WYOT0<]_;Y+%RJL_.=A54'7#M23Y[LT7^+P']LT7<_#[]1VB21^&5LO'O00
MS3?GL3^=L#01*R#WX,`P_)<;=&Y<BD<S/L`W$L^N4[S@7L_!`!50'P_2)..F
MIX`":X_0<"SPPBS/.7TPB$D4\<-B)2P#)Q`:%>[V3PG-EF4C!*H'X@8:=0]0
M+V;GXR<Z`N,6@S((183U5KR:4M'5!I=3E#_Z\"&D"T1B$TE3%+&O1A.8Z]B-
M*CNDAW1=T2QQ(LL.Z!-5HX0&&(?L*J&+:\8R;BT/IWP3EL:BTP]SE)27_CAU
MS@C*+!/?7HS(_"`G?Z5H.!4'.:NCHZ=!`)6&UW&*H8?IF`H:?D41;ZFD>5-\
MF07`'IRB9+4A$_*R2?X:P<>#`,84S^3^`KRI#XB-*_!H@.1=XL,9AZ?I/>8$
MX5N<S'!2&PKMD'T0>@,5=?$Z@'HDR-/PWQG+3X^,Z6D8BN@;BD:(P"@\1TN2
MHJC8K0`/&,=,$NTFN'T0M@M=5XCDXW<XK<ZQJBD575G44E4?.":1("Z2P1K.
ME[L;@B8D`JOR/$*,B7NNO,XQS0]\J%\KINVFMB_'MQ!/=L.V>YR21!'[FL:*
M&XU`?1@</X&Y-HSS1TRN8^-HEV:,&W0?Z.;OA_")?D43W?$R%OKC9TE\+S51
MOJ+]1M+Y!9ZDQMEJ`^V#M!K)$&:8(\D%;*]I'M-1A`(!>CK#L8NT=90^<*"+
M+2ZY;)L9\TH%?>".R))0//*BJS!SJ3\Z3.X?/UYS%BF2LQ0KL8:T_/YB]GDY
MR73VZR7^L'Z=[$AGNZ'(,Y9?@,L647$'_"%%,PS3=HGBE<C)LC)0Y`KO&9F-
M;L<P/D.,L.&40X@F;VF((Y&$RL""7=3E&7MN201*&Q0S*'3AOZT_W.)T#BWR
MZBL..()_Y2D:IA_F@)D$V01?6]W=R82FZ1FAZ1PG:(FADH"=TV19C].V`OH4
MIX4^T82@Z"&B*/X?G,(BS/4]7R*3<WYJ+:F3YX[A%9TM`^^&Q$+TS'VL2BC^
M+"E.$\R@FKKB>::&'H(Y#K-(-[<MY+K"^T9F^21DT>O3`%80DI;Y4TV$.F/X
M2NHI8UB\J%3&<Z#OMQCQ`[+A:5HMJ?$]YL<>8.X![!VM_A3+JFX8?K$&_%$&
MV[TL6ENZ=U*9EPL[3(F89`MM':]]]VDYRV]*<?:7^JO>>SN$(QW^#U##FKVS
M"O\TDSB_,&,XTK+;:OWAUPBF.S_L/X/%??@4XX3-R;**+IWAT^#WC"3\3.GZ
M[($[2C%Y8.8L<Z1.*B`_-[RCD-PZ2B:.2T!EUS%_')V$Q>/U5S3)MWQ*2@05
MC*B[2-O6LQU#=GL:HW96)#?IKN/+Y_SU^>$TI^.!+]QBF;^.*]$;6;)916Z3
MX>N<PY&&=DY,2030(SZ4?X\2.DO08H'-\\(9V9\!40]=&O5@(Y`_6NU_H5^@
MC7%XCQE&23`'52U%U,XI`Q<F%N=^P[.5G(FV(G6;.GJQ34P6DRQAXAL#ZQR3
M1QSR+7$S.USA^[`%H09CKN,<G1^@$W&94N#:D<)N:#Y9P.UAJ`UYLO.*?>+:
M/87A#N/W%OV!8"37:;<4^T3!#2)AA)Y$=DZQ@5"GP0K@$Q6_\#/PK#C9)%#J
M9-@A?*+CIPSQ76S"]W$9HP$!O:FYHHU`/E%S.DMPOC7_3.33:>KGKQ_#"`FT
MSC?/[3&,LHL7@H.&OI<%/O'[/"(Q.)C1F.O;=4_KPZ<9RB=Z;DC`CV]*-E6N
MA19@"$/?R1_YA1$;H1NB^\0![CAF$8\4/.#D$>AA=K&V@_I$V64\`RV6G]NQ
M4-0`XA,ETAL&MRAN(\H-VB?Z+,]PV$-AS@C^N(-W&>?[<#J"&K%RE%HOD7M-
MP'Z=X>3E5M@%#R3R$YV?XA`GZW%T'?\?V,SC)SJ>TXQG?+R,>+X4:1WKBM@'
MK\V9J/$3CA[Q!MPH$?]<W)B3),4;C8X*M0\<N45\OL:\VBN,>72^]"W+77K)
M;76`[0/--E&V"[LG]*UOM^1T7&382F@[Z-84KW<DOE143MEG`ILO)^F*)F.<
M+$B,\@+X>P*#E;<]$KVS;%1UJ<"C*+S4U0O$(T52=PV"=P27"0P![@4/5\5D
MD2WN\%.^+W)%N!X"AM]A'.)\FEHDUR#XW=;ZQ6;*[E1#C5)\CPCCD?@BCB79
M>&V`/2`61#0C8*GEJFTX'4XB,A/"DQ:U1J`^:'OS3LLHP<MB4<XI*S<?;#LW
M6U;3!TY5J_J87B)NM0C_Q;3LUP#\7P,?H$OIIR7893"@E7"6M!73`-,;"L%"
MX;N(7$A\X=*HT\JW6L)V>)I",3+RK>[R3BU?5BS6B`G0(ZLC/P)V^<S#APR/
M$L)7BE@^Z6"'\(Z,]0;MF(XR4(6(8>--,S=HA;R732V@C*B\V^(-\^%4O2D(
M:J$,E%J&HRNR1[)5^E\>5)3H.%NMZ;`0W8;D$;&Y*3J<EO.MZKQRY,8*XQ<I
MU<D@<28PSTD*RY?E^%`=R)]C0CG+29`OO867`3YW^$@835;ZI'-&Z(/=I4RF
M*N)032=I-M4N.6^`ZM$0EM:#<HDX6_U,HQ`ZM9YUQD.!3>`>+2S2,*T<@VH/
MYXK(=HT3<!_&LZQTKK(H6EV0*`-7J#A)(00(SC/8UN:;ZIOB^Z//;M$SCYNL
M?>8,_AE!'W&97DB)&K?#?CFI[\S]*$=O2<>]HJ?,I3T@2W9Y0>GPI'CI#0;-
MTQ@5M\/V@.0;RM@POB!L2?,3YC`>BW?'3Z47Y*5#$ZX(/8B)F3INW;5V`O9G
MQ_H!QP2<D&Q"DY!':7D`E_'S\UA^9AN(6A#&K2B1)41/@;E%)3Z=45C?LK%W
MN^'&H@N2/Y+G#YKDT4D1DQQ3QZ1P7?'\CY+Q-$_\N'`BD@EK])WA&$\)=R6J
M=#E7&/$79V2C>_,Z^L8A6--@E/]1;/&5M-IX88/N@>)7"1G!;`W(LMSV+68[
MEZ[18MT(N0=,47W'^E)@+O5)QZO>DW;-P%CJ4__Y@E*EZ9+6'+'26.V2CFC^
MK%,&#_\BPV-:9:/6UZ@N.!Z%!F15648<N7@4=\("X5$(9Y3@!<D6Q2[XVM&I
MJ4#99':#]W^=+,YTB3,0%JHDLEV`>Q+;$8Y\-^J[(/6!"Q=%$^#HJJ2Q*]K.
MCLVPE7W:H@;?IOTP2_FLXP%9QXEOP.A!B$1^*:&^O)K?4]"A^F#^28'80D.#
M12'$=!W_-B?!O$96?DO?',GM5,%VH=P=GDH`*,9*05['U6.@P^E4W#UER@L9
M0Y&GX1%%ZLG@[6KIA4;4H@%5GF'[#.F&Y9'U=BV>E^(?BH[_Q/_A!VK6$9**
M2B?@?@A9=G/7G1\5[T78_&$#H#*_Q;>7NU7VG&(P2,);'J$AZ:HTM>VCUAW#
MJS5;V2NNTZ">%7,`]<@'@9&6Y0>-12+;"_H4%P:5/`?M,/[[&K7>\ZF%HD@X
M3BV$FD#]I[?*#:FM$)5:844BQ94A3+\AOC^1$'UE_!23M''I+`"V7"5W>J*S
MUD71PWL<U%Y%4=Z8::#0#=TC*Z&B0`V55@?FBBT#^;6U=EMIB\J\9([E98K2
M-G8S%VLH7A+J+#AM>V'3&KQD@\G6KWR?3E(W(O:7Z&&,-Z9;X'I)>LN@W72P
M^S?$RVL(6[PHMD45'C%BHZ7;X#EO6T\/0HF-)RI<8B@;5]!7YNS`EMIUO7UE
MI;/EM1EV7]FRJ9VVD\KZRK2.5MTV=?RI6:38@%M6TU=&=;,8MZBB!PQJ?&#4
M<!S&#;P/VPWKP[:;/-K5<'9WN^K\B1'>HN0S3@M*9!40%V^GB..I2F"_`\J6
M6S0[C"/>YPG?Y<WDRV?"1-Y"X><(G2?O.[MC>+/1O!Z4IZ#5%\762Z[*Q:5P
M@[JS0OHCNFI^-;R"807Q9ZJIE[P)^WR58%P^QG`/\^4"IU7N&]OE\'8\CW;5
ME*Z/$CHI@A&%H6J*TSDB>$3D=1S0!1ZCYX;3M$TP_HS0$3_X>D42EBJ92X;3
M(J5M"!()LT`_Q-T1K]`M7AR/%GU_P`&-PPV([H+H'=4\B^(F1'?`\XGF,T(C
M.N-]+CI[NEQ&1?BO3J<+K$^TY9-OG6/Z`46X3E(#B$^4G$YA,1-]O<,I[Z1V
M>]`.X1,==_CI(LEF#6/,#N$3'2*-P%)<MYYEX/C29`4]3N@CBOC^PJ>'JQ!I
M[T]TP/&)UOKKJ?HZ;H?P9Q6_H?&,)[&2,R81<71PW7NF'?GIA-2'B,>Z_RR_
MOL3]-AP;'L1LA_S*HG5Z[7*(/M^3<(;O1-VP3*$)3<1,TUZ0;(7T:0J>@NW_
M^$`C@:*K?F.I3_T'WRS\.4N#.3C`-%9?$C(_Q.V.X1.=PA"\A@ES311+\(HF
M_$C<`DVNX\LHQ$FT.@VR%-^N<$1)>(.SSWA!M!5C1]7YQ*%/,1$7M[GS"CX?
M8K<7I_S2TEK(YN'0$<TGBG^A\YC]3)>?82179&@O(C5"^42/_`15T_-4/O9=
M'D8C',=L%3VB6)]X;7`^T53XENK#.B.4PH_22[,]?[(!JD^4MY'7)QKB\&$)
MBS=-I`<LV^ARP?&)5G7CT#XJF\%\HH@GVVIXW,M2[$C!UTE<M$1Y;7PTX32-
M"LY;*'*%]TE(#:Z,X9%U-VA__-HF1\T6=^^"XP^EA:.]CJJJZ5A-A3WPR.NA
MD]JFLK%4)NM%G\90]^#H"D7IJNCIF)J3_7=`\6@SJ^CH<%K&5D>&E]4;@;;;
M#?_"0?'\FF5C4+P$4<;>2]^[-+\<<<J/F\QJF2$<0'N@+<HX)$P=%!**^#4[
M?(OX6\WR_:X6L#X0FM!_XR"]9#S*P1/44J9FAS24]H`LZ7*LV,C7J##IE4Y(
M_N@9J=LB^8KHMY$JN;@'0E1"<9S_/!Q7;N30Y(K2D&L9OHD5+@"4=UD]N[)Y
M#5NSYXM?,+[*XE!=R=5GW412>5A>QD^4/U\H+3I=$?O/"[%G6SSBZ,X(%<M_
M+A3G/XM''U!^MX.4CY=)!F'%@@XH'EF)AN=S3A\1B8K36F<K[=V+QJ=W6G$]
M(OV.QO=X"@.75\,3`138H,]D+ZT%K`?*?P2B6:!@I3J?\L<>$'$*OT/^MTB<
MQ!B,'(4>6WD?2"NU)'^!G8#:K"V]MG*/YE*9['Z53Q(ISPAK>S76`>6+K1<[
M?"JR>.5;)D/2(<92F:R7?@<<5JDI!84`;#FC<<8*N6CF3/&6CI+4K1MB#X2Y
M[O<]CO$3BHSK?2.01U-S[88)2U0:@=(39(8G33NB]4#-2A3!XKT)(US0^L2(
M^MQU9(0;6@\8(1OH]?>K#2N6([A'<_\V"$!0)/@\/$L(CD=1%&AIS^T@/FV(
M*1NLP<IM(]8`YQ--O\"_C!5Y*@3*C2Z?1B"?J"FO3)[5*=`*?.HUS.,%3BY(
M@H.4)OG.(LLB;F!H9Q9=8#W:)\_SPE@W5"W%_NR=JA?;C>_&ZM?..B$IM+YT
M"EDP7\7V1W%A7[Z/J]P^:P+[<FON[HQKJ<-YS"@7U;5-HJ[P'@E33O5=R^@A
M_"*EYW=8W27JB-D#,TL]''6.V/P**YG1+>7](XV?46%,<1/M$+TCKWB!\AZ3
MQ21+6,TZ=H'M`<D."TBGU<8KQ53V%Z1#\EJY$Z/34R_WZ@2%.M!*S[-)I:@P
M/1B$9RC^?,F"A#XI,>[:YQX0<AH$@!E*;VLI8K(4]X`PBU4RIL.$S'B@2'R=
M4W[3)5^Y^=^7SX%(R&,(+NRL0H_4C96FW)/:&8NZ5><1@S[%X$O264S^P*'H
M[ADL'B$/H<'B*5HIUE'YFH<S2@^F4?5(,LA0W(J"&N4-94,<L@M.#UB0][FT
M'$)Q4B*GJB!J*/84)*WICN'14#>/5>DPX]FJ`BGO9#^A),R)$8^DX/`W3&9S
M^/_T$2>P9-QC'F`!5XB?!^?$\&?@%8OF*S?KE:$T?J+C.<T8BL/Q'-1?_BHB
MC-]Z8*L5T*>(G=S9)QP]XLO%,J*KHM>YV-J(=,'SB>:RJZPY0-D"YA-%#51X
MWO/:<+'&5]O@_`FTWJ)GLL@6A:[+NVST9<5*LSYH(^<1W+""GJY/\CJ1;P>2
M0,XN*`I^Q2+#X&9+4;<6BNGAP0%JI8\SL+EGJ'S&#W22]+QC,2B$S/D]A^01
MA\)JUP/`NZS3'TZ91T/U51H70M@J66#YEN'AM@&V495;3LP=YHR4U&BA7UIB
M<LX(/BD?MSZ7YVEK*4`WPU:FPLL^NN=(0,T*EXSO&S+MSH^VZKRRY0W&:O'Z
MQ3(!F8:Z$6B']&C@2]I;ZJ\R4H7-(#H?B`U/"4Y*C;1E/3Y-!J,6YS=N&BBH
M1P<VP.]!J$3=;M%-;ENY/Z9VEZ=<>O8(;GTO+'_GEB:LX2&1+CA](=5IH]".
MX1&9.WA:Y\_Q.&&W1UL,'LR&^'UD@7'X;X;M$?GE<[%6/57L9%Z01Q+B.-1F
M?@=,_\@NU)9-G?G896M8SE;NCXU0&O`7>$IB+%+=)&22M08<N^+Y0W&^?WL^
M)W@*)GN0\=0/H`7!:-=S;+:#>A4L!@S\>\8/1#W"/_;T1JV`_DC+=)GM.OYM
M3H*Y<D'QNKP+UGP/K@55IONE+\DI?31>=%-W,=I@MW:YOL)5.+'9KM_YJ6_'
MFR!ZX%'FL74PO`S7&M4"M_GWA8;A$0OF>(%^_.M?_A]02P$"'@,4````"`#T
MACY#O4^ZFEY1`0"B1Q@`$``8```````!````I($`````9FEL+3(P,3,P-C,P
M+GAM;%54!0`#3.5)4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/2&/D/8
M]*&#A0L``%JF```4`!@```````$```"D@:A1`0!F:6PM,C`Q,S`V,S!?8V%L
M+GAM;%54!0`#3.5)4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/2&/D.(
MZEJ&PC\``'=3!``4`!@```````$```"D@7M=`0!F:6PM,C`Q,S`V,S!?9&5F
M+GAM;%54!0`#3.5)4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/2&/D.'
M/=HD)98``$Q,"0`4`!@```````$```"D@8N=`0!F:6PM,C`Q,S`V,S!?;&%B
M+GAM;%54!0`#3.5)4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/2&/D,2
MTD6\0E@``#MD!@`4`!@```````$```"D@?XS`@!F:6PM,C`Q,S`V,S!?<')E
M+GAM;%54!0`#3.5)4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/2&/D.\
M=2OZ;QP``-=1`0`0`!@```````$```"D@8Z,`@!F:6PM,C`Q,S`V,S`N>'-D
M550%``-,Y4E2=7@+``$$)0X```0Y`0``4$L%!@`````&``8`%`(``$>I`@``
!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Income Taxes (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
        <td class="nump">$ 13,609,036<span></span></td>
        <td class="nump">$ 13,089,314<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
        <td class="nump">1,497,556<span></span></td>
        <td class="nump">741,420<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other differences in tax basis</a></td>
        <td class="nump">233,043<span></span></td>
        <td class="nump">4,749<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense', window );">Total deferred tax assets</a></td>
        <td class="nump">15,339,635<span></span></td>
        <td class="nump">13,835,483<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
        <td class="num">(15,339,635)<span></span></td>
        <td class="num">(13,835,483)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComponentsOfDeferredTaxAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from other provisions, reserves, allowances, and accruals not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ETAAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivatives [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of derivative warrant instruments activity</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="border-bottom: black 2px solid; text-align: center;" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Fair Value</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,146,338</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Reclassification to paid in capital</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3,122,821</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(590,217</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(26,764</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, June 30, 2013</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,023,517</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Fair Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2010</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">287,061</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">143,532</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">188,579</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,972,785</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,591,900</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of stock (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">986,393</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,295,950</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(13,966</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,389,771</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">242,190</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">318,087</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">121,095</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">159,044</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">Warrants issued with 2012 Common Stock Offering-A (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,118,988</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,409,554</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with 2012 Common Stock Offering-B (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,559,505</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,665,697</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to 2012 Common Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">467,845</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">499,707</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Transfer from liability classification to equity classification</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3,753,056</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4,231,324</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family:
 times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(685,420</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,146,338</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock', window );">Summary of fair values of derivative warrants on basis of valuation model</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">June 30,</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2013</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Market value of common stock on measurement date (1)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.17</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Adjusted exercise price</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.48 - $0.81</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;
 </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.50 - $2.475</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Risk free interest rate (2)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10 - $0.77</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.05</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrant lives in years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="text-align: center;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="text-align: center;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected volatility (3)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">154</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected dividend yield (4)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The risk-free interest rate was determined by management using the Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4)&#160;&#160;</font></div>
</td>
<td align="left" width="95%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">January 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 19,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 27,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td
 nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Market value of common stock on measurement date (1)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.37</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.37</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Adjusted exercise price</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.24 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.23 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.41 - $0.83</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.22 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.41 - $0.83</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Risk free interest rate (2)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.24</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10% - 0.77</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.94</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10% - 0.77</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrant lives in years</font></div>
</td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected volatility (3)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected dividend yield (4)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%"
 valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Probability of stock offering in any period over 5 years (5)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Range of percentage of existing shares offered (6)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Offering price range (7)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td
 width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.18 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.13 - $0.56</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.01 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.12 - $0.60</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.01 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="3%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1)&#160;&#160;</font></div>
</td>
<td width="80%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2)&#160;&#160;</font></div>
</td>
<td align="left" width="96%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">(5)&#160;&#160;</font></div>
</td>
<td align="left" width="96%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management has determined that the probability of a stock offering is 25% for each quarter of the next five years.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(6)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management estimates that the range of percentages of existing shares offered in each stock offering will be between 35% of the shares outstanding.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(7)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Represents the estimated offering price range in future offerings as determined by management.</font></div>
</td>
</tr>
</table>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of derivative warrants on basis of valuation model.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfDerivativeWarrantsOnBasisOfValuationModelTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 25<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41678-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41620-113959<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579245-113959<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1B<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5580258-113959<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579240-113959<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41641-113959<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41638-113959<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624171-113959<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4B<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624163-113959<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(n)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVVBI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Statements of Cash Flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="1">157 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (3,473,038)<span></span></td>
        <td class="num">$ (2,471,500)<span></span></td>
        <td class="num">$ (8,361,205)<span></span></td>
        <td class="num">$ (3,444,795)<span></span></td>
        <td class="num">$ (55,743,463)<span></span></td>
        <td class="num">$ (59,216,501)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation expense</a></td>
        <td class="nump">188,400<span></span></td>
        <td class="nump">240,400<span></span></td>
        <td class="nump">2,223,926<span></span></td>
        <td class="nump">2,173,377<span></span></td>
        <td class="nump">6,052,036<span></span></td>
        <td class="nump">6,240,436<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">317<span></span></td>
        <td class="nump">581<span></span></td>
        <td class="nump">633<span></span></td>
        <td class="nump">3,262,462<span></span></td>
        <td class="nump">3,262,462<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposition of equipment</a></td>
        <td class="nump">4,122<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">550,186<span></span></td>
        <td class="nump">554,307<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">451,267<span></span></td>
        <td class="nump">775,637<span></span></td>
        <td class="nump">124,363<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="nump">900,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">145,951<span></span></td>
        <td class="nump">252,248<span></span></td>
        <td class="nump">40,444<span></span></td>
        <td class="nump">292,692<span></span></td>
        <td class="nump">292,692<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(260,000)<span></span></td>
        <td class="num">(260,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GainOnChangeInFairValueOfDerivatives', window );">Gain on change in fair value of derivative</a></td>
        <td class="num">(26,764)<span></span></td>
        <td class="num">(6,777)<span></span></td>
        <td class="num">(685,420)<span></span></td>
        <td class="num">(13,966)<span></span></td>
        <td class="num">(699,386)<span></span></td>
        <td class="num">(726,150)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties', window );">R&amp;D reimbursable receivable</a></td>
        <td class="num">(2,126)<span></span></td>
        <td class="nump">50,069<span></span></td>
        <td class="nump">234,088<span></span></td>
        <td class="nump">41,567<span></span></td>
        <td class="num">(3,746)<span></span></td>
        <td class="num">(5,872)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">85,000<span></span></td>
        <td class="num">(8,494)<span></span></td>
        <td class="num">(18,013)<span></span></td>
        <td class="nump">4,766<span></span></td>
        <td class="num">(23,397)<span></span></td>
        <td class="nump">61,604<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
        <td class="num">(103,414)<span></span></td>
        <td class="num">(263,465)<span></span></td>
        <td class="nump">334,263<span></span></td>
        <td class="nump">556,019<span></span></td>
        <td class="nump">1,238,773<span></span></td>
        <td class="nump">1,135,359<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Accounts payable and accrued liabilities - related party</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">31,185<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">31,185<span></span></td>
        <td class="nump">31,185<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used In Operating Activities</a></td>
        <td class="num">(3,327,820)<span></span></td>
        <td class="num">(1,862,232)<span></span></td>
        <td class="num">(5,212,710)<span></span></td>
        <td class="num">(517,592)<span></span></td>
        <td class="num">(44,402,658)<span></span></td>
        <td class="num">(47,730,478)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payment made for patent rights</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(3,000,000)<span></span></td>
        <td class="num">(3,000,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(1,112)<span></span></td>
        <td class="num">(1,157)<span></span></td>
        <td class="num">(2,359)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(815,659)<span></span></td>
        <td class="num">(816,771)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used In Investing Activities</a></td>
        <td class="num">(1,112)<span></span></td>
        <td class="num">(1,157)<span></span></td>
        <td class="num">(2,359)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(3,815,659)<span></span></td>
        <td class="num">(3,816,771)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Borrowings on convertible debt, net of offering costs</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">645,888<span></span></td>
        <td class="nump">645,888<span></span></td>
        <td class="nump">645,888<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments on note payable</a></td>
        <td class="num">(103,050)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(103,050)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Sales of stock, net of offering costs</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">660,163<span></span></td>
        <td class="nump">5,129,940<span></span></td>
        <td class="nump">5,379,367<span></span></td>
        <td class="nump">53,191,098<span></span></td>
        <td class="nump">53,191,098<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from the exercise of warrants for cash</a></td>
        <td class="nump">3,463,641<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,463,641<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided By Financing Activities</a></td>
        <td class="nump">3,360,591<span></span></td>
        <td class="nump">660,163<span></span></td>
        <td class="nump">5,129,940<span></span></td>
        <td class="nump">6,025,255<span></span></td>
        <td class="nump">53,836,986<span></span></td>
        <td class="nump">57,197,577<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net change in cash</a></td>
        <td class="nump">31,659<span></span></td>
        <td class="num">(1,203,226)<span></span></td>
        <td class="num">(85,129)<span></span></td>
        <td class="nump">5,507,663<span></span></td>
        <td class="nump">5,618,669<span></span></td>
        <td class="nump">5,650,328<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at beginning of period</a></td>
        <td class="nump">5,618,669<span></span></td>
        <td class="nump">5,703,798<span></span></td>
        <td class="nump">5,703,798<span></span></td>
        <td class="nump">196,135<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash at end of period</a></td>
        <td class="nump">5,650,328<span></span></td>
        <td class="nump">4,500,572<span></span></td>
        <td class="nump">5,618,669<span></span></td>
        <td class="nump">5,703,798<span></span></td>
        <td class="nump">5,618,669<span></span></td>
        <td class="nump">5,650,328<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CashPaidForAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
        <td class="nump">561<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">682<span></span></td>
        <td class="nump">1,243<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature discount</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">372,850<span></span></td>
        <td class="nump">372,850<span></span></td>
        <td class="nump">372,850<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfWarrantsIssuedWithDebt', window );">Fair value of warrants issued with debt</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">377,150<span></span></td>
        <td class="nump">377,150<span></span></td>
        <td class="nump">377,150<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfWarrantsIssuedWithStock', window );">Fair value of warrants issued with stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">318,087<span></span></td>
        <td class="nump">3,393,338<span></span></td>
        <td class="nump">2,591,900<span></span></td>
        <td class="nump">5,985,238<span></span></td>
        <td class="nump">5,985,238<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfWarrantsIssuedToPlacementAgent', window );">Fair value of warrants issued to the placement agent</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">159,044<span></span></td>
        <td class="nump">658,753<span></span></td>
        <td class="nump">1,484,529<span></span></td>
        <td class="nump">2,170,282<span></span></td>
        <td class="nump">2,170,282<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock', window );">Conversion of notes payable and accrued interest to stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">981,729<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">981,729<span></span></td>
        <td class="nump">981,729<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification', window );">Transfer from liability classification to equity classification</a></td>
        <td class="nump">$ 590,217<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 4,231,324<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 4,231,324<span></span></td>
        <td class="nump">$ 4,821,542<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CashPaidForAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CashPaidForAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion of notes payable and accrued interest to common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ConversionOfNotesPayableAndAccruedInterestToCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of Transfer from liability classification to equity classification.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfWarrantsIssuedToPlacementAgent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of warrants issued to the placement agent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfWarrantsIssuedToPlacementAgent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfWarrantsIssuedWithDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of warrants issued with debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfWarrantsIssuedWithDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfWarrantsIssuedWithStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of warrants issued with stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfWarrantsIssuedWithStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GainOnChangeInFairValueOfDerivatives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gain on change in fair value of the derivatives.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GainOnChangeInFairValueOfDerivatives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 8<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Beneficial Conversion Feature<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Costs and payments related to employee benefits and equity-based compensation, such as pension expense and contributions, other postretirement benefits expense and payments, stock or unit options expense, and amortization of restricted stock or unit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeBenefitsAndShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2941-110230<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDispositionOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12317-112629<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12355-112629<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainsLossesOnExtinguishmentOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromDebtNetOfIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Going Concern<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GoingConcernAbstract', window );"><strong>Going Concern [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GoingConcernTextBlock', window );">Going Concern</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 2 &#8211; Going Concern</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $3,473,038 and net cash used in operations of $3,327,820, for the six months ended June 30,&#160;2013; and an accumulated deficit of $59,216,501 at June 30, 2013. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, and research and development grants until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</font></div><span></span></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;<font style="font-weight: bold; display: inline;">Note 2 &#8211; Going Concern</font></font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As reflected in the accompanying consolidated financial statements, the Company has suffered recurring losses from operations since its inception. The Company has a net loss of $8,361,205 and net cash used in operations of $5,212,710, for the year ended December 31,&#160;2012; and an accumulated deficit of $55,743,463 at December 31, 2012. In addition, the Company has not completed its efforts to establish a stable recurring source of revenues sufficient to cover its operating costs for the next twelve months. These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The ability of the Company to continue its operations is dependent on the successful execution of management's plans, which include the expectation of raising debt or equity based capital, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to issue additional equity and incur additional liabilities with related parties to sustain the Company&#8217;s existence although no commitments for funding have been made and no assurance can be made that such commitments will be available.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GoingConcernAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GoingConcernAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GoingConcernTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Going Concern assumption.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GoingConcernTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note Payable and Convertible Notes<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Note Payable and Convertible Notes [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note Payable and Convertible Notes</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 4 &#8211; Note Payable</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a premium finance agreement to pay a&#160;$140,000 premium&#160;for its director and officer&#160;liability insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of June 30, 2013, the&#160;outstanding balance related to the premium finance agreement was $36,950.&#160;&#160;The Company has paid $103,050 of the principal during 2013.</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 5 &#8211; Note Payable and Convertible Notes</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Note Payable</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a premium finance agreement to pay $140,000 premium of its director and officer insurance policy. Pursuant to the agreement, the Company paid a down payment of $28,000 in January 2013 and has to pay $12,636 in monthly installment for nine months. As of December 31, 2012, outstanding balance related to the premium finance agreement was $140,000.&#160;</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Convertible Notes</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 27, 2011, the Company completed a private offering of 8% Senior Subordinated Unsecured Convertible Promissory Notes (&#8220;Convertible Notes&#8221;) in the amount of $900,000 and received net proceeds of $750,000. The convertible notes were issued at 83.33% of the principal amount resulting in an original issue discount of $150,000.&#160;The Convertible Notes mature one year from the date of issuance. Interest accrues at the rate of 8% per year on the outstanding principal amount, accrued semi-annually and to be paid at maturity.</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The principal amount of the Convertible Notes and accrued interest are automatically converted to common stock at the earlier of: (1) the effective date of a Qualified Public Offering, (2) a Public Company Transaction, defined as (i) a reverse merger or similar transaction between the Company and a corporation whose securities are publicly traded in the United States or other jurisdiction mutually agreed between the Company and Placement Agent, or (ii) the quotation of the Company&#8217;s securities for purchase and sale on a U.S. quotation service, or (iii) the filing with an applicable regulatory body which will result in the Company becoming an entity whose securities are traded on a public exchange in the U.S. or other mutually agreed upon jurisdiction, or (3) the acquisition or receipt by the Company of no less than $4,000,000 of gross proceeds in subsequent offerings of its common stock or equivalents following the issuance of the Company&#8217;s stock (See Note 9) and the Convertible Notes.</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In connection with the issuance of the Convertible Notes, warrants to purchase a total of 287,061 shares of common stock were issued to investors. The Placement Agent and the Management Firm (See Note 9) were issued warrants to purchase 143,532 shares and 126,829 shares of common stock, respectively. The warrants issued to the Placement Agent are exercisable at $0.78 per share and expire on January 31, 2019. &#160;The warrants issued to the Management Firm are exercisable at $0.01 per share and expire on January 31, 2019.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company analyzed the Convertible Notes and the Warrants for derivative accounting consideration under FASB ASC 470 and determined that the investor warrants and the placement agent warrants, with a grant date fair value of $565,729 (See Note 6), qualified for accounting treatment as a financial derivative (See Note 6) and the Convertible Notes were determined to also have a beneficial conversion feature discount of $372,850 resulting from the conversion price of $0.78 per share which is below the fair value of $1.11 per share on the date of the Convertible Notes.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; The total fees, including cash payments and the fair value of the warrants issued to the Placement Agent, incurred in connection with the financing were $292,692. These fees were amortized over the life (one year) of the Convertible Notes using the straight-line method
 as it approximates the effective interest method. &#160;The $150,000 original issue discount on the Convertible Notes was also amortized over the life of the Notes on a straight line basis.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160;On October 23, 2012, the investors extended the note maturity date for 90 days. The maturity date of the notes has been extended to January 31, 2013, February 18, 2013 or March 27, 2013 for the 24 notes.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 19, 2012, the Convertible Notes and the accrued interests were automatically converted to common stock when the Company closed on an offering of its common stock in which the gross proceeds exceeded the $4,000,000 threshold.&#160;&#160;The Convertible Notes and accrued interest were converted into 1,252,550 shares of the Company&#8217;s common stock.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the years ended December 31, 2012, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $252,248 and $775,637, respectively.&#160;&#160;During the years ended December 31, 2011, the Company recorded amortization expense related to the deferred financing costs and the debt discount of $40,444 and $124,363, respectively.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; A summary of the 8% Senior Subordinated Unsecured Convertible Promissory Notes as of December 31, 2012 and 2011 are as follows:</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Principal amount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left"
 style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: original issuance discount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(150,000</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(150,000</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: discount related to fair value of derivative warrants</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: discount related to the beneficial conversion feature</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(372,850</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(372,850</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Add: amortization of discount</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">124,363</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: principal amount converted to stock</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(900,000</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Carrying value at December 31, 2012 and 2011, respectively</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">124,363</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party Transactions<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 3 &#8211; Related Party Transactions</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;">MSKCC:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;<font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2010, General Atlantic Group Limited donated all of the equity shares of its wholly owned subsidiary, Actinium Holdings Ltd. (formerly named General Atlantic Investments Limited) to Memorial Sloan Kettering Cancer Center (MSKCC), a principal owner of the Company.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On February 11, 2002, the Company entered into a License, Development and Commercialization Agreement with Sloan-Kettering Institute of Cancer Research (SKI),&#160;an entity related to MSKCC.&#160;&#160;The agreement was amended in August 2006.&#160;&#160;Pursuant to the agreement, the Company licenses certain intellectual property from SKI, including critical patents with respect to the Company&#8217;s core technology, and also supports ongoing research and clinical development of related drug candidates.&#160;&#160;Certain amounts due under this agreement were deferred and then forgiven under the forbearance-related arrangements described above.&#160;&#160;On June 19, 2011, the Company nonetheless agreed to pay SKI (a) $50,000 in 2011, (b) $200,000 in 2012 and (c) $250,000 in 2013 under this agreement, in respect of the $50,000 annual maintenance fees and research payments. Since January 1, 2011, the Company has paid $100,000 under this agreement and as of December 31, 2012, the Company agreed to pay an additional $150,000 for research to be conducted in 2013.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On March 27, 2012, the Company entered into an additional clinical trial agreement with MSKCC Cancer Center with respect to conducting a Phase I/II trial of combination therapy of low dose cytarabine and fractionated dose of Lintuzumab-Ac225.&#160;&#160;The Company will pay $31,185 for each patient that has completed the clinical trial.&#160;&#160;Upon execution of the agreement, the Company was required to pay a start-up fee of $79,623, which was paid on July 10, 2012.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;<font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; MSKCC agreed, subject to certain conditions, to utilize the donated funds for certain clinical and preclinical programs and activities related to the Company&#8217;s drug development and clinical study programs, including the payment of certain costs and expenses that would otherwise have been borne by the Company. The following is a summary of activities related to the MSKCC arrangements for years ended December 31, 2012 and 2011:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Qualified R&amp;D costs incurred by the Company</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">655,786</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Reimbursements received from MSKCC</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">237,834</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">966,341</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2012 and 2011, the Company received total R&amp;D reimbursement payments of $237,834 and $299,200, respectively, from MSKCC.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As of December 31, 2012 and 2011, the Company had a net receivable of $0 and $237,834, respectively, from MSKCC.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;">Dr. Rosemary Mazanet:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On January 1, 2012, the Company entered into a Consulting Services Agreement with Dr. Rosemary Mazanet, a director of Cactus.&#160;&#160;Pursuant to the agreement, Dr. Mazanet is to provide, among other things, consulting services in the areas of implementation of the Actimab&#8482;-A trial including all aspects of study initiation until first patient in at each clinical site.&#160;&#160;Dr. Mazanet receives compensation of $100,000 per year and may receive additional compensation in the form of options at determined by the board of the Company.&#160;&#160;Since January 1, 2011, Dr. Mazanet has also received options to purchase 99,900 shares of common stock of the Company. These options have exercise price ranging from $0.78 to $1.5 and have a life of 10 years.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;<font style="font-weight: bold; font-style: italic; display: inline;">&#160;</font></font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;">Jamess Capital Group, LLC:</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On May 9, 2011, the Company entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of the Company&#160;(&#8220;Management Firm&#8221;).&#160; The Management Firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&#160; The Management Firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;">Placement Agent:</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On August 7, 2012, the Company entered into an engagement agreement with its placement agent for the 2012 Common Stock Offering,&#160;of which Mr. Seth, a director of the Company is Head of Healthcare Investment Banking.&#160;&#160;&#160;Pursuant to the agreement, the placement agent was engaged as the exclusive agent for the 2012 Common Stock Offering. &#160;&#160;In consideration for its services, the placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent.&#160;&#160;The placement agent or its designees have also received warrants to purchase shares of the Company&#8217;s Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units.&#160;&#160;The placement agent will also receive the same fee and expense schedule for any cash exercise of warrants within 6 months of the final closing of the 2012 Common Stock Offering and a 5% solicitation fee for any warrants exercised as a result of being called for redemption by the Company.&#160;&#160;Upon the final closing of the 2012 Common Stock Offering of the units, the placement agent has been engaged by the Company to provide certain financial advisory services to the Company for a period of at least 6 months for a monthly fee of $25,000.&#160;&#160;The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company&#8217;s financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.&#160;&#160;For a period ending one year after the expiration of all lock-up agreements entered into in connection with the Share Exchange, any change in the size of the Company board of directors must be approved by the placement agent.&#160;&#160;The placement agent also was engaged by the Company as placement agent for its Stock Offering and Convertible Notes financing in 2011 and, as a part of the fee for that engagement, designees of the placement agent also hold warrants to purchase 1,251,015 shares of the Company&#8217;s Common Stock.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; font-style: italic; display: inline;">Guagenti &amp; Associates LLC:</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">In 2010, the Company entered into an agreement with Guagenti &amp; Associates LLC (&#8220;G&amp;A&#8221;).&#160;&#160;G&amp;A is affiliated with Enza Guagenti, the former Chief Financial Officer of Cactus.&#160;&#160;Pursuant to the agreement, the Company leases storage space in Newark, NJ from G&amp;A.&#160;&#160;The rent is $300 per month.&#160;&#160;Since January 1, 2011, the Company has paid $7,200 pursuant to this agreement.&#160;&#160;&#160;Ms. Guagenti resigned as the Company&#8217;s Chief Financial Officer on March 9, 2013.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph b<br><br> -Article 3A<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph k<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EI5BG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Derivatives (Details 1) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 19, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 27, 2012</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract', window );"><strong>Summary of fair values of derivative warrants on basis of valuation model</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MarketValueOfCommonStockOnMeasurementDate', window );">Market value of common stock on measurement date (1)</a></td>
        <td class="nump">$ 0.39<span></span></td>
        <td class="nump">$ 0.39<span></span></td>
        <td class="nump">$ 0.37<span></span></td>
        <td class="nump">$ 1.65<span></span></td>
        <td class="nump">$ 0.39<span></span></td>
        <td class="nump">$ 0.37<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (2)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.94%<span></span></td>
        <td class="nump">1.24%<span></span></td>
        <td class="nump">1.05%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.35%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Warrant lives in years</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">6 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">4 years 6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (3)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">161.00%<span></span></td>
        <td class="nump">157.00%<span></span></td>
        <td class="nump">154.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">156.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (4)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsProbabilityOfDefault', window );">Probability of stock offering in any period over 5 years (5)</a></td>
        <td class="nump">25.00%<span></span></td>
        <td class="nump">25.00%<span></span></td>
        <td class="nump">25.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25.00%<span></span></td>
        <td class="nump">25.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RangeOfPercentageOfExistingSharesOffered', window );">Range of percentage of existing shares offered (6)</a></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract', window );"><strong>Summary of fair values of derivative warrants on basis of valuation model</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Adjusted exercise price</a></td>
        <td class="nump">$ 0.83<span></span></td>
        <td class="nump">$ 0.26<span></span></td>
        <td class="nump">$ 0.26<span></span></td>
        <td class="nump">$ 2.475<span></span></td>
        <td class="nump">$ 0.83<span></span></td>
        <td class="nump">$ 0.26<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (2)</a></td>
        <td class="nump">0.77%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.77%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Warrant lives in years</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (3)</a></td>
        <td class="nump">161.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">161.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueAssumptionOfferingPrice', window );">Offering price range (7)</a></td>
        <td class="nump">$ 0.55<span></span></td>
        <td class="nump">$ 0.60<span></span></td>
        <td class="nump">$ 0.56<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.55<span></span></td>
        <td class="nump">$ 0.55<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract', window );"><strong>Summary of fair values of derivative warrants on basis of valuation model</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Adjusted exercise price</a></td>
        <td class="nump">$ 0.41<span></span></td>
        <td class="nump">$ 0.22<span></span></td>
        <td class="nump">$ 0.23<span></span></td>
        <td class="nump">$ 1.50<span></span></td>
        <td class="nump">$ 0.41<span></span></td>
        <td class="nump">$ 0.24<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (2)</a></td>
        <td class="nump">0.10%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.10%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Warrant lives in years</a></td>
        <td class="text">4 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (3)</a></td>
        <td class="nump">125.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">125.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueAssumptionOfferingPrice', window );">Offering price range (7)</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.12<span></span></td>
        <td class="nump">$ 0.13<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.18<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueAssumptionOfferingPrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value assumption offering price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueAssumptionOfferingPrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MarketValueOfCommonStockOnMeasurementDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Market value of common stock on measurement date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MarketValueOfCommonStockOnMeasurementDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RangeOfPercentageOfExistingSharesOffered">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Range of percentage of existing shares offered.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_RangeOfPercentageOfExistingSharesOffered</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SummaryOfFairValueOfDerivativeWarrantsOnBasisOfValuationModelAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Agreed upon price for the exchange of the underlying asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExpectedTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Risk-free interest rate assumption used in valuing an instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsProbabilityOfDefault">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of likelihood a loan will not be repaid and instead default, used as an input to measure fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (bbb)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueInputsProbabilityOfDefault</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock Option Plan (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activities</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="text-align: center;" colspan="2">Number of</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family:
 times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size:
 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,056,275</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.89</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%"
 valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,330,134</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0. 96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.91</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">685,800</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXHAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="3">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 28, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Subsequent Event [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Convertible Notes Payable [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Options And Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012

</div>
          <div>Options And Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Machinery and equipment [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Machinery and equipment [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Furniture and fixtures [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Furniture and fixtures [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 28, 2012

</div>
          <div>Actinium [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract', window );"><strong>Description of Business and Summary of Significant Accounting Policies (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfOwnershipInterestToBeAcquired', window );">Percentage of ownership interest to be acquired by company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition', window );">Common Stock issuable in consideration for equity interest acquisition</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">99.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage', window );">Common stock shares issued in exchange of equity securities in percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Approximately 99% of the issued and outstanding common stock immediately after the closing of the Share Exchange, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012.<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Estimated useful lives</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Five years<span></span></td>
        <td class="text">Five years<span></span></td>
        <td class="text">Seven years<span></span></td>
        <td class="text">Seven years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares received by each API shareholder of Actinium common stock for each API share exchanged</a></td>
        <td class="nump">0.333<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,330,134<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="nump">9,535,694<span></span></td>
        <td class="nump">815,275<span></span></td>
        <td class="nump">12,770,596<span></span></td>
        <td class="nump">3,448,276<span></span></td>
        <td class="nump">2,280,184<span></span></td>
        <td class="nump">6,842,528<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfSharesExchangedInShareExchangeProgramme', window );">Percentage Of Shares Exchanged In Share Exchange Programme</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">38.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common Stock issuable in consideration for equity interest acquisition.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockIssuableInConsiderationForEquityInterestAcquisition</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock shares issued in exchange of equity securities in percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockSharesIssuedInExchangeOfEquitySecuritiesInPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfOwnershipInterestToBeAcquired">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of ownership interest to be acquired by company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfOwnershipInterestToBeAcquired</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfSharesExchangedInShareExchangeProgramme">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of shares exchanged in share exchange programme.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfSharesExchangedInShareExchangeProgramme</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of equity interests issued or issuable to acquire entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7488404&amp;loc=d3e6927-128479<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EIJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PropertyAndEquipmentTextualAbstract', window );"><strong>Property and Equipment (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 159<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 317<span></span></td>
        <td class="nump">$ 581<span></span></td>
        <td class="nump">$ 633<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PropertyAndEquipmentTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PropertyAndEquipmentTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Depreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Employee Defined Contribution Plan (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EmployeeDefinedContributionPlanTextualAbstract', window );"><strong>Employee Defined Contribution Plan (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans', window );">Description of employee deferred contribution plan</a></td>
        <td class="text">The plan requires 12 consecutive months of service and a minimum of 500 hours of service for participation.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percentage of employer matching contribution</a></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution of the company in employee deferred contribution plan</a></td>
        <td class="nump">$ 8,942<span></span></td>
        <td class="nump">$ 8,885<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EmployeeDefinedContributionPlanTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_EmployeeDefinedContributionPlanTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the terms and benefits provided by the employer's defined contribution plans. A defined contribution plan provides benefits in return for services rendered, provides an individual account for each participant, and has terms that specify how contributions to the individual's account are to be determined rather than the amount of benefits the individual is to receive. Under a defined contribution pension plan, the benefits a participant will receive depend solely on the amount contributed to the participant's account, the returns earned on investments of those contributions, and forfeitures of other participants' benefits that may be allocated to such participant's account. A description of the plan(s) including employee groups covered, the basis for determining contributions, and the nature and effects of significant matters affecting comparability of information for all periods presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -SubTopic 70<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6414718&amp;loc=d3e28014-114942<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Defined Contribution Postretirement Plan<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510416<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>40
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U
M93ED8V$P8C`B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B
M,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N=%]O9E]#:&%N/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W1A=&5M96YT
M<U]O9E]#87-H7T9L;W=S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&5S8W)I<'1I;VY?;V9?0G5S:6YE<W-?86YD7U-U/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1V]I;F=?0V]N8V5R
M;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E)E;&%T
M961?4&%R='E?5')A;G-A8W1I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^4')O<&5R='E?86YD7T5Q=6EP;65N=#PO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970Q,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?4&%Y86)L95]A
M;F1?0V]N=F5R=&EB;&5?3CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,2YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/D1E<FEV871I=F5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$R+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^26YC;VUE7U1A>&5S/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6ET;65N='-?86YD7T-O;G1I;F=E
M;F-I97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y%
M<75I='D\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3
M=&]C:U]/<'1I;VY?4&QA;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-BYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/E=A<G)A;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^16UP;&]Y965?1&5F:6YE9%]#;VYT<FEB=71I;VY?/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W5B<V5Q=65N
M=%]%=F5N=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,3DN:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y$97-C<FEP=&EO;E]O9E]"=7-I;F5S<U]A;F1?4W4Q/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1&5S8W)I<'1I;VY?;V9?0G5S
M:6YE<W-?86YD7U-U,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/E)E;&%T961?4&%R='E?5')A;G-A8W1I;VYS7U1A8CPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970R,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E!R;W!E<G1Y7V%N9%]%
M<75I<&UE;G1?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(S+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^3F]T95]087EA8FQE7V%N9%]#;VYV97)T:6)L95].,3PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970R-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D1E<FEV871I=F5S
M7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970R-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DEN8V]M95]487AE<U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C8N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y#;VUM:71M96YT<U]A;F1?0V]N=&EN9V5N8VEE<U\\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,C<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:U]/
M<'1I;VY?4&QA;E]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C@N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y%<75I='E?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(Y+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^5V%R<F%N='-?5&%B;&5S/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1&5S8W)I<'1I;VY?;V9?0G5S
M:6YE<W-?86YD7U-U,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D1E<V-R:7!T:6]N7V]F7T)U<VEN97-S7V%N9%]3=30\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y';VEN9U]C;VYC97)N
M7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,S,N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y296QA=&5D7U!A<G1Y7U1R86YS86-T:6]N<U]$970\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,S0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y296QA=&5D7U!A<G1Y7U1R86YS
M86-T:6]N<U]$970Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#,U+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^4')O<&5R='E?86YD7T5Q=6EP;65N=%]$971A:6QS/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#,V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4')O<&5R='E?86YD7T5Q
M=6EP;65N=%]$971A:6QS,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-RYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/DYO=&5?4&%Y86)L95]A;F1?0V]N=F5R=&EB;&5?3C(\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,S@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7U!A>6%B
M;&5?86YD7T-O;G9E<G1I8FQE7TXS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,Y+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^1&5R:79A=&EV97-?1&5T86EL<SPO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970T,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D1E<FEV871I=F5S7T1E=&%I
M;'-?,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970T,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D1E
M<FEV871I=F5S7T1E=&%I;'-?5&5X='5A;#PO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,BYH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/DEN8V]M95]487AE<U]$971A:6QS/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#0S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^26YC;VUE7U1A>&5S
M7T1E=&%I;'-?,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970T-"YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/DEN8V]M95]487AE<U]$971A:6QS7U1E>'1U86P\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M-#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VUM:71M96YT<U]A;F1?0V]N
M=&EN9V5N8VEE<U\Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#0V+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^0V]M;6ET;65N='-?86YD7T-O;G1I;F=E;F-I97-?,CPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970T-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D5Q=6ET>5]$971A:6QS
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#0X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^17%U:71Y
M7T1E=&%I;'-?5&5X='5A;#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T.2YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/E-T;V-K7T]P=&EO;E]0;&%N7T1E=&%I;',\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T-3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=&]C:U]/<'1I;VY?4&QA
M;E]$971A:6QS7U1E>'0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-3$N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y787)R86YT<U]$971A:6QS/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#4R+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^5V%R<F%N='-?1&5T86EL<U\Q/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#4S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^5V%R<F%N='-?1&5T86EL
M<U]497AT=6%L/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#4T+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^16UP;&]Y965?1&5F:6YE9%]#;VYT<FEB=71I;VY?,3PO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970U-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U8G-E<75E;G1?179E;G1S
M7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T-38N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`\+W@Z17AC96Q7;W)K<VAE971S/@T*("`\>#I3='EL
M97-H965T($A2968],T0B5V]R:W-H965T<R]R97!O<G0N8W-S(B\^#0H@(#QX
M.D%C=&EV95-H965T/C`\+W@Z06-T:79E4VAE970^#0H@(#QX.E!R;W1E8W13
M=')U8W1U<F4^1F%L<V4\+W@Z4')O=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O
M=&5C=%=I;F1O=W,^1F%L<V4\+W@Z4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X
M8V5L5V]R:V)O;VL^#0H\+WAM;#X\(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`\<#Y4:&ES('!A9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H
M($UI8W)O<V]F="!%>&-E;"!84"!O<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V
M,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O
M<FMS:&5E=',O4VAE970P,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15-$04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^1&]C=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO
M;CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D1O8W5M96YT(&%N9"!%;G1I='D@26YF;W)M871I;VX@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M;G1I='D@4F5G:7-T<F%N="!.86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#Y!8W1I;FEU;2!0:&%R;6%C975T:6-A;',L($EN8RX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET
M>2!#96YT<F%L($EN9&5X($ME>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^,#`P,3,X.#,R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT($9L86<\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/F9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!4>7!E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y3+3$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT(%!E<FEO
M9"!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2G5N
M(#,P+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL97(@0V%T96=O<GD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/E-M86QL97(@4F5P;W)T:6YG($-O;7!A
M;GD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D
M8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B
M,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#`R+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M3$Q!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYS;VQI9&%T960@0F%L
M86YC92!3:&5E=',@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT($%S
M<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`U+#8U,"PS,C@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L-C$X+#8V.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PW,#,L
M-SDX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y2)F%M<#M$(')E:6UB=7)S96UE;G0@<F5C96EV86)L93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C,W+#@S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<R!A;F0@;W1H97(@8W5R<F5N
M="!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@T+#(W
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$V-RPQ-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU+#,X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5F97)R960@9FEN86YC:6YG(&-O<W1S+"!N970@
M;V8@86-C=6UU;&%T960@86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3(L,C0X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@0W5R<F5N="!!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4L-S,T+#4Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L-S@U+#@Q,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L,3DY+#(V-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R
M='D@86YD(&5Q=6EP;65N="P@;F5T(&]F(&%C8W5M=6QA=&5D(&1E<')E8VEA
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPP,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#(S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L($%S<V5T<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PW,S0L-3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PW.#@L.#(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPR,#`L-#DW/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-U<G)E;G0@3&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A>6%B;&4@86YD
M(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<Y,RPV,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX.3<L,#0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-C0T+#4Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L92!A
M;F0@86-C<G5E9"!E>'!E;G-E<R`M(')E;&%T960@<&%R='D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q+#$X-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q+#$X-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F]T97,@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S8L.34P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,30P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@;F]T
M97,@<&%Y86)L92P@;F5T(&]F('5N86UO<G1I>F5D(&1I<V-O=6YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,C0L,S8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E(&QI86)I;&ET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DU-RPY-S<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4W-"PY-3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#0S
M.2PV,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!#=7)R96YT($QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS+#@Q.2PW-#(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#8T,RPQ.#<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#(P."PT
M.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,RPX,3DL-S0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-"PV-#,L,3@W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM:71M96YT<R!A;F0@
M8V]N=&EN9V5N8VEE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-T;V-K:&]L9&5R<R<@17%U:71Y.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VL@=F%L=64\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('9A;'5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S4L.#0T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$S+#DQ-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S-BPV
M-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%D9&ET:6]N86P@<&%I9"UI;B!C87!I=&%L/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV,"PX.34L-3$S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38L-C<U+#$X,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X+#(S-RPV
M,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E9FEC:70@86-C=6UU;&%T960@9'5R:6YG('1H92!D979E;&]P;65N
M="!S=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3DL,C$V
M+#4P,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@U-2PW-#,L-#8S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0W+#,X,BPR-3@I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@4W1O8VMH;VQD
M97)S)R!%<75I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M.3$T+#@U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$L,30U+#8S-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY.3(L,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@3&EA8FEL:71I97,@
M86YD(%-T;V-K:&]L9&5R<R<@17%U:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4L-S,T+#4Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PW.#@L.#(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V+#(P,"PT.3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB
M,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U
M93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#`S+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%1D-!
M13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VYS;VQI9&%T960@0F%L86YC
M92!3:&5E=',@*%!A<F5N=&AE=&EC86PI("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E
M<G)E9"!S=&]C:RP@<&%R('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@
M<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"PP,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R
M960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@4W1O8VLL('-H
M87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R('9A;'5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"PP,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+#`P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@:7-S=65D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RPU.#0L-#(T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L,SDQ+#8V
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$S+#8V-"PX,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!3=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RPU.#0L-#(T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L
M,SDQ+#8V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S+#8V-"PX,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C
M83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X
M934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#`T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%339"1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!/<&5R871I;VYS("A54T0@)"D\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$U
M,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ-3<@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S
M,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3=&%T96UE;G1S($]F($]P97)A=&EO;G,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y2979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG(&5X<&5N<V5S.CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E87)C:"!A
M;F0@9&5V96QO<&UE;G0L(&YE="!O9B!R96EM8G5R<V5M96YT<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`Y+#(V,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8P,2PR-S(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4Y-"PY
M-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#`T-BPQ-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#0T,"PT.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,C,L-S@X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8L-#(P+#4Q.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(X+#`Q-2PT
M.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D=E;F5R86P@86YD(&%D;6EN:7-T<F%T:79E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY-C8L,S8W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,W+#DP.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#DY+#4P,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Y."PQ
M.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT+#4P-BPR,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#DU.2PR-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-"PU,#0L.3<U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8L-#`T+#0W.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5P
M<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX@97AP96YS93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-3@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPR-C(L-#8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,RPR-C(L-#8R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;W-S(&]N(&1I<W!O
M<VET:6]N(&]F(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PQ,C(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-3`L,3@V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34T+#,P-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O
M=&%L(&]P97)A=&EN9R!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PT-S4L-C(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^.#,Y+#,S.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#DX+#4Y,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#0T+#8U.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L
M.30W+#(Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,L,C@S+#8V-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4T+#<S."PQ-#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-BPR,S8L-S,U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!F
M<F]M(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$L-#<U+#8R.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@X,SDL,S,Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#,L-#DX+#4Y,RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#@T-"PV-3DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-RPY-#<L
M,CDX*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,L,C@S+#8V-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@U-"PW,S@L,30R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4V+#(S-BPW,S4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D]T:&5R($EN8V]M92`H17AP96YS92DZ/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&5X<&5N<V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8S-"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S,C`L-S(X*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,C`Y*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8S
M,RPV,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PP.3DL,S(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3<U+#`Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.38T+#<P-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L.38U+#DQ-BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=A
M:6X@;VX@97AT:6YG=6ES:&UE;G0@;V8@;&EA8FEL:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR-C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C8P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN(&9A:7(@=F%L=64@+2!D97)I
M=F%T:79E(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#,P-RPW-#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-#`R+#4R-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-BPW-C0\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#<W-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8X-2PT,C`I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,L
M.38V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#8Y.2PS.#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-S(V+#$U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&]T:&5R(&EN8V]M92`H97AP
M96YS92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,S`X+#,X
M,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@W,C,L,C4R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(U+#4U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#8R-BPX-#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#$S+#DP-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V,2PQ,C@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P-2PS
M,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Y-SDL-S8V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#(L-S@T+#`Q,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L-38R+#4Y,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#,L-#<S+#`S."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#(L-#<Q+#4P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#@L,S8Q+#(P-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#,L-#0T+#<Y-2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#4U+#<T,RPT
M-C,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@U.2PR,38L-3`Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,@<&5R(&-O;6UO;B!S:&%R92`M
M(&)A<VEC(&%N9"!D:6QU=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#`N,3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@P+C`Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,"XQ-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,34I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@W+C4X*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-"XS
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V5I9VAT960@879E<F%G92!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG
M("T@8F%S:6,@86YD(&1I;'5T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(R+#$W."PV,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-RPP,C`L,3DR/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L-SDQ+#8W,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#`R,"PQ
M.3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#$P,RPU,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX,#$L-SDY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED
M8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?
M.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970P
M-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14XR14L^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^
M0V]N<V]L:61A=&5D(%-T871E;65N="!O9B!#:&%N9V5S(&EN(%-T;V-K:&]L
M9&5R<R<@17%U:71Y("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^5&]T86P\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^0V]M;6]N(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D%D9&ET:6]N86P@4&%I9"UI;B!#87!I=&%L/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E9FEC:70@06-C=6UU;&%T
M960@1'5R:6YG('1H92!$979E;&]P;65N="!3=&%G93QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5G:6YN:6YG($)A;&%N8V4@870@
M2G5N+B`Q,RP@,C`P,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y)<W-U86YC92!O9B!F;W5N9&5R('-H87)E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DL.3DP/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,"PP,3`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A
M;F-E(&]F(&9O=6YD97(@<VAA<F5S+"!3:&%R97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDY.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N
M8V4@;V8@+2!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PW-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PT-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#<T."PU-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N
M8V4@;V8@+2!S=&]C:RP@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-#4L-C@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-C<R+#(X-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@V-S(L,C@V*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N
M(#,Q+"`R,#`P/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$P
M-RPW,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,2PT-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#<V."PU-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@V-S(L,C@V*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92P@4VAA<F5S
M(&%T($1E8RX@,S$L(#(P,#`\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,30T+#8X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T
M;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#(U,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#@W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L,C0X+#$R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U
M86YC92!O9B`M('-T;V-K+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$X-RPS,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@U+#`Y,"PV,C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PP.3`L-C(Q*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A
M="!$96,N(#,Q+"`R,#`Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q+#<S,BPY,#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,L,S(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-"PP,38L-C@P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PW-C(L.3`W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC
M92P@4VAA<F5S(&%T($1E8RX@,S$L(#(P,#$\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,S,R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC
M92!O9B`M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#@P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,L,C0X+#$Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@
M9G)O;2!I<W-U86YC92!O9B`M('-T;V-K+"!3:&%R97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$X,"PS-S4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#$Y,BPS.#0I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPQ.3(L,S@T*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92!A="!$96,N(#,Q+"`R,#`R/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q+#8W-2PR.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,34L,3(T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPR-C0L.#<V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH."PY-34L,CDQ
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC92P@4VAA<F5S(&%T($1E8RX@,S$L(#(P,#(\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-3$R+#,W-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O
M;2!I<W-U86YC92!O9B`M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV+#<X,2PR-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#`Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8L-S<Y+#$V,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K+"!3:&%R97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P."PY.3(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#4S,BPP-#0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPU
M,S(L,#0T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4W,RPY,34\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPR,30\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PP-#0L,#,V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3(L-#@W+#,S-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q+"`R,#`S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<R,2PS-C<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M;V-E961S(&9R;VT@:7-S=6%N8V4@;V8@+2!S=&]C:SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-"PV,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPV-3D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#4Y,BPS-#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N8V4@;V8@+2!S=&]C:RP@
M4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-C4L.3`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PW
M,S0L-SDQ*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L-S,T+#<Y,2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A
M;&%N8V4@870@1&5C+B`S,2P@,C`P-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#,Y+#$R-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(T+#@W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#8S-BPS-S<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q."PR,C(L,3(V*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92P@4VAA<F5S(&%T($1E8RX@,S$L(#(P,#0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-#@W+#(V-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I
M<W-U86YC92!O9B`M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#DP,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV+#0Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L.#DS+#4P-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K+"!3:&%R97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8T.2PS-3`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;B!E>'!E
M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,34L,S@X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S$U+#,X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L-3@P+#(S-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@T+#4X,"PR,S<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L
M(#(P,#4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<T+#(W-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q
M+#,V-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(R+#@T-2PR-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R,BPX,#(L,S8S*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92P@4VAA<F5S(&%T
M($1E8RX@,S$L(#(P,#4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,L,3,V+#8Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#4U,"PU-#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#,Y
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<L-30R+#$U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC
M92!O9B`M('-T;V-K+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@S.2PP-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]P=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR-3(L,S`X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4R+#,P.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8L,#4S+#,V,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+#`U
M,RPS-C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P,#8\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L.#(S+#<V,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y+#<U-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P+#8S.2PW,S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M."PX-34L-S(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0F%L86YC92P@4VAA<F5S(&%T($1E8RX@,S$L(#(P,#8\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L.3<U+#8U.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV+#8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#,R-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L-3DR+#8W-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K+"!3
M:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<S,BPV,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UO;B!S=&]C:R!I<W-U960@9F]R('-E<G9I8V5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS.3@L.#$P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDX+#$T-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N('-T;V-K(&ES<W5E9"!F;W(@<V5R=FEC97,L(%-H87)E
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8L-#`R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4U
M+#`V,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(U-2PP-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#8Q-RPU.#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-2PV,3<L-3@Q*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$
M96,N(#,Q+"`R,#`W/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#0V,"PP-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT-RPW-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS-RPX.#4L-C$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S0L-#<S+#,P-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4L
M(%-H87)E<R!A="!$96,N(#,Q+"`R,#`W/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#<W-"PV-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N8V4@
M;V8@+2!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.2PY.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU+#DY,"PP,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R
M;VT@:7-S=6%N8V4@;V8@+2!S=&]C:RP@4VAA<F5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY.3DL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VX@97AP96YS93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8Y+#8Q.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(V.2PV,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@U+#4W,"PY,#4I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-2PU-S`L.3`U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`X/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#$U."PW-C4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-RPW,S<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M-"PQ-#4L,C,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-#`L,#0T+#(Q,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4L(%-H87)E<R!A="!$96,N
M(#,Q+"`R,#`X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#<W
M,RPV-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]P=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,3(L,S@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$R+#,X,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L
M-#(U+#DX-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#0R-2PY.#8I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"
M86QA;F-E(&%T($1E8RX@,S$L(#(P,#D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@T-2PQ-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU-RPW,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PR-3<L-C(Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#,L-#<P+#$Y-RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q+"`R,#`Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#<W,RPV-C$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;B!E>'!E;G-E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,2PQ-C8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,2PQ-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T-C<L,C8V*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#0V-RPR-C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P,3`\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y.2PP-C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-RPW,S<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PR
M-S@L-S@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-#,L.3,W+#0V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q
M+"`R,#$P/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#<W,RPV
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!R;V-E961S(&9R;VT@:7-S=6%N8V4@;V8@+2!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PS-SDL,S8W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S@L.3$Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PS,#`L
M-#4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M(&ES<W5A;F-E(&]F("T@
M<W1O8VLL(%-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-RPX.3$L,30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/<'1I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3DL.3,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL.3,U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y787)R86YT(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,34S+#0T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,34S+#0T,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F%I<B!V86QU92!O9B!D97)I=F%T:79E('=A<G)A;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#@X-RPX-3`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,RPX.#<L.#4P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5N969I8VEA;"!C;VYV97)S
M:6]N(&9E871U<F4@9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,W,BPX-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S(L.#4P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPT
M-#0L-SDU*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L-#0T+#<Y-2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A
M;&%N8V4@870@1&5C+B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.3DR+#`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$S-BPV-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT."PR,S<L-C(P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#<L,S@R+#(U."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q+"`R,#$Q/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPV-C0L.#`R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M
M(&ES<W5A;F-E(&]F("T@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4L,3(Y+#DT,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0P+#@W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,#@Y+#`V,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')O8V5E9',@9G)O;2!I<W-U86YC92!O9B`M('-T;V-K+"!3:&%R97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,#@W+#<T-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R
M<VEO;B!O9B!N;W1E<R!P87EA8FQE(&%N9"!A8V-R=65D(&EN=&5R97-T('1O
M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.#$L-S(Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3(L-3(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.38Y+#(P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!N;W1E
M<R!P87EA8FQE(&%N9"!A8V-R=65D(&EN=&5R97-T('1O('-T;V-K+"!3:&%R
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C4R+#4U,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4VAA<F5S(&ES<W5E9"!A="!T:&4@<F5V97)S92!M97)G97(\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#@V-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(S+#@V
M-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!I<W-U960@870@=&AE(')E=F5R<V4@
M;65R9V5R+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,S@V+#4V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(V-BPQ-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-C8L,3<R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y787)R86YT(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L.34W+#<U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.34W+#<U-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1F%I<B!V86QU92!O9B!D97)I=F%T:79E('=A<G)A;G1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#`U,BPP.#DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-"PP-3(L,#@Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5')A;G-F97(@9G)O;2!L
M:6%B:6QI='D@8VQA<W-I9FEC871I;VX@=&\@97%U:71Y(&-L87-S:69I8V%T
M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#(S,2PS,C0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#(S,2PS,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X+#,V,2PR,#4I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH."PS-C$L,C`U*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N
M(#,Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L
M,30U+#8S-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(Q,RPY,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#4V+#8W-2PQ.#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#4U+#<Q,RPT-C4I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"
M86QA;F-E+"!3:&%R97,@870@1&5C+B`S,2P@,C`Q,CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C$L,SDQ+#8V-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE
M971S+U-H965T,#8N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$565D))/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E-T871E;65N=',@;V8@0V%S:"!&;&]W<R`H55-$("0I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,34Q($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$U
M-R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^0V%S:"!&;&]W<R!&<F]M($]P97)A=&EN9R!!8W1I=FET:65S.CPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@S+#0W,RPP,S@I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@R+#0W,2PU,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@X+#,V,2PR,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@S+#0T-"PW.34I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U-2PW-#,L
M-#8S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H-3DL,C$V+#4P,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^061J=7-T;65N=',@=&\@<F5C
M;VYC:6QE(&YE="!L;W-S('1O(&YE="!C87-H('!R;W9I9&5D(&)Y("AU<V5D
M(&EN*2!O<&5R871I;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T
M:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X
M."PT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-#`L-#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPR,C,L.3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ-S,L,S<W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP-3(L,#,V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPR-#`L
M-#,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$97!R96-I871I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3@Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C,S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPR-C(L-#8R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPR
M-C(L-#8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y,;W-S(&]N(&1I<W!O<VET:6]N(&]F(&5Q=6EP;65N=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PQ,C(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-3`L,3@V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34T+#,P-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I
M>F%T:6]N(&]F(&1E8G0@9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0U,2PR-C<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-S4L-C,W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(T+#,V,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDP
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!;6]R=&EZ871I;VX@;V8@9&5F97)R960@9FEN86YC
M:6YG(&-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-#4L.34Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C4R+#(T.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0P+#0T-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y,BPV.3(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.3(L-CDR/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M86EN(&]N(&5X=&EN9W5I<VAM96YT(&]F(&QI86)I;&ET>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8P+#`P,"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-C`L,#`P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V%I
M;B!O;B!C:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-BPW-C0I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BPW-S<I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C@U+#0R
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q,RPY-C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-CDY+#,X-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@W,C8L,34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SXH26YC<F5A<V4I
M(&1E8W)E87-E(&EN.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y2)F%M<#M$(')E:6UB=7)S86)L92!R96-E:79A8FQE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#$R-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP-CD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S0L
M,#@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#$L-38W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,RPW-#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-2PX-S(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O
M=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.#4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH."PT.30I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3@L,#$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-S8V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C,L,SDW*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Q+#8P-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY);F-R96%S92`H9&5C<F5A<V4I(&EN.CPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE
M(&%N9"!A8V-R=65D(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,#,L-#$T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(V,RPT-C4I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,T+#(V,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4U-BPP,3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(S
M."PW-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#$S-2PS-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U960@
M;&EA8FEL:71I97,@+2!R96QA=&5D('!A<G1Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2PQ.#4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,2PQ.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,2PQ.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@0V%S:"!5<V5D($EN($]P
M97)A=&EN9R!!8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@S+#,R-RPX,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,2PX-C(L,C,R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L,C$R+#<Q,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,3<L-3DR*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0T
M+#0P,BPV-3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-#<L-S,P+#0W."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!&;&]W<R!&<F]M
M($EN=F5S=&EN9R!!8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y087EM96YT(&UA9&4@9F]R('!A=&5N="!R
M:6=H=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L,#`P
M+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@S+#`P,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A;F0@97%U
M:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#$Q,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M+#$U-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@R+#,U.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,34L-C4Y*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Q-BPW-S$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M($-A<V@@57-E9"!);B!);G9E<W1I;F<@06-T:79I=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ,3(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ-3<I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPS-3DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,RPX,34L-C4Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#,L.#$V+#<W,2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!&;&]W
M<R!&<F]M($9I;F%N8VEN9R!!8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y";W)R;W=I;F=S(&]N(&-O;G9E
M<G1I8FQE(&1E8G0L(&YE="!O9B!O9F9E<FEN9R!C;W-T<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C0U+#@X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8T-2PX.#@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#4L.#@X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y087EM96YT<R!O
M;B!N;W1E('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$P,RPP-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3`S+#`U,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-A;&5S(&]F('-T;V-K
M+"!N970@;V8@;V9F97)I;F<@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8V,"PQ-C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#$R.2PY-#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,W.2PS
M-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,RPQ.3$L,#DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-3,L,3DQ+#`Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!T:&4@97AE
M<F-I<V4@;V8@=V%R<F%N=',@9F]R(&-A<V@\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,L-#8S+#8T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#8S+#8T,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYE="!#87-H(%!R;W9I9&5D($)Y($9I;F%N8VEN9R!!8W1I=FET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#,V,"PU.3$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-C`L,38S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-2PQ,CDL.30P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-BPP,C4L,C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-3,L.#,V+#DX-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W+#$Y-RPU-S<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@
M8VAA;F=E(&EN(&-A<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,Q+#8U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$L,C`S+#(R-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@X-2PQ,CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PU,#<L-C8S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV,3@L-C8Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV
M-3`L,S(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#87-H(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-C$X+#8V.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-S`S+#<Y.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-S`S
M+#<Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$Y-BPQ,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@870@
M96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-2PV-3`L,S(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-"PU,#`L-3<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-2PV,3@L-C8Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PW,#,L-SDX/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV,3@L-C8Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-2PV-3`L,S(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!D:7-C;&]S=7)E<R!O
M9B!C87-H(&9L;W<@:6YF;W)M871I;VXZ/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@<&%I9"!F;W(@:6YT97)E<W0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4V,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C0S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H('!A:60@
M9F]R('1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5P<&QE;65N=&%L
M(&1I<V-L;W-U<F4@;V8@;F]N+6-A<V@@:6YV97-T:6YG(&%N9"!F:6YA;F-I
M;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0F5N969I8VEA;"!C;VYV97)S:6]N(&9E871U<F4@9&ES
M8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,W,BPX-3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S(L.#4P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<R
M+#@U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F%I<B!V86QU92!O9B!W87)R86YT<R!I<W-U960@=VET:"!D96)T
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S<L,34P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<W+#$U,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,W-RPQ-3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9A:7(@=F%L=64@;V8@=V%R<F%N=',@:7-S=65D('=I=&@@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q."PP
M.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#,Y,RPS,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#4Y,2PY,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#DX-2PR,S@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#DX-2PR,S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@
M=F%L=64@;V8@=V%R<F%N=',@:7-S=65D('1O('1H92!P;&%C96UE;G0@86=E
M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$U.2PP-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV-3@L-S4S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PT.#0L-3(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ-S`L,C@R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ-S`L,C@R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M;VYV97)S:6]N(&]F(&YO=&5S('!A>6%B;&4@86YD(&%C8W)U960@:6YT97)E
M<W0@=&\@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDX,2PW,CD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.#$L
M-S(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.3@Q+#<R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^5')A;G-F97(@9G)O;2!L:6%B:6QI='D@8VQA<W-I9FEC
M871I;VX@=&\@97%U:71Y(&-L87-S:69I8V%T:6]N/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#4Y,"PR,3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L,C,Q
M+#,R-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-"PR,S$L,S(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T+#@R,2PU-#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B
M7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S
M9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T
M<R]3:&5E=#`W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%4T<^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^1&5S8W)I<'1I;VX@;V8@0G5S:6YE<W,@86YD(%-U;6UA<GD@;V8@
M4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<SQB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1&5S8W)I<'1I;VX@3V8@0G5S:6YE<W,@86YD(%-U;6UA<GD@3V8@4VEG
M;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<V-R:7!T
M:6]N(&]F($)U<VEN97-S(&%N9"!3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C
M8V]U;G1I;F<@4&]L:6-I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E
M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^3F]T92`Q("8C.#(Q,3L@
M1&5S8W)I<'1I;VX@;V8@0G5S:6YE<W,@86YD(%-U;6UA<GD@;V8@4VEG;FEF
M:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<SPO9F]N=#X\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S
M='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!.871U<F4@;V8@
M0G5S:6YE<W,@)B,X,C$Q.SPO9F]N=#X@06-T:6YI=6T@4&AA<FUA8V5U=&EC
M86QS+"!);F,N(&9O<FUE<FQY(&MN;W=N(&%S($-A8W1U<R!696YT=7)E<RP@
M26YC+B`H=&AE("8C.#(R,#M#;VUP86YY)B,X,C(Q.RP@)B,X,C(P.T%C=&EN
M:75M)B,X,C(Q.RP@)B,X,C(P.T-A8W1U<R8C.#(R,3LI+"!W87,@:6YC;W)P
M;W)A=&5D('5N9&5R('1H92!L87=S(&]F('1H92!3=&%T92!O9B!.979A9&$@
M;VX@3V-T;V)E<B`V+"`Q.3DW+B!4:&4@0V]M<&%N>2!W87,@82!S:&5L;"!E
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF
M(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N
M($1E8V5M8F5R(#(X+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@
M82!T<F%N<V%C=&EO;B`H=&AE("8C.#(R,#M3:&%R92!%>&-H86YG928C.#(R
M,3LI+"!P=7)S=6%N="!T;R!W:&EC:"!T:&4@0V]M<&%N>2!A8W%U:7)E9"`Q
M,#`E(&]F('1H92!I<W-U960@86YD(&]U='-T86YD:6YG(&5Q=6ET>2!S96-U
M<FET:65S(&]F($%C=&EN:75M(%!H87)M86-E=71I8V%L<RP@26YC+B`H)B,X
M,C(P.T%0228C.#(R,3LI+"!I;B!E>&-H86YG92!F;W(@=&AE(&ES<W5A;F-E
M(&]F(&%P<')O>&EM871E;'D@.3DE(&]F('1H92!I<W-U960@86YD(&]U='-T
M86YD:6YG(&-O;6UO;B!S=&]C:RP@<&%R('9A;'5E("0P+C`Q('!E<B!S:&%R
M92P@;V8@=&AE($-O;7!A;GDN(%1H92!3:&%R92!%>&-H86YG92!C;&]S960@
M;VX@1&5C96UB97(@,C@L(#(P,3(N)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0@
M;V8@=&AE(%-H87)E($5X8VAA;F=E+"!T:&4@9F]R;65R('-H87)E:&]L9&5R
M<R!O9B!!4$D@8F5C86UE('1H92!C;VYT<F]L;&EN9R!S:&%R96AO;&1E<G,@
M;V8@=&AE($-O;7!A;GDN($%T('1H92!C;&]S:6YG+"!E86-H($%022!S:&%R
M96AO;&1E<B!R96-E:79E9"`P+C,S,R!S:&%R97,@*'1H92`F(S@R,C`[17AC
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M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP
M=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#L@05!)+"!I;F-O<G!O<F%T960@;VX@2G5N92`Q,RP@,C`P,"P@
M:7,@82!B:6]T96-H;F]L;V=Y(&-O;7!A;GD@8V]M;6ET=&5D('1O(&1E=F5L
M;W!I;F<@8G)E86MT:')O=6=H('1H97)A<&EE<R!F;W(@;&EF92!T:')E871E
M;FEN9R!D:7-E87-E<R!U<VEN9R!I=',@86QP:&$@<&%R=&EC;&4@:6UM=6YO
M=&AE<F%P>2`H05!)5"D@<&QA=&9O<FT@86YD(&]T:&5R(')E;&%T960@86YD
M('-I;6EL87(@=&5C:&YO;&]G:65S+B!!4$DL('1O9V5T:&5R('=I=&@@:71S
M('=H;VQL>2!O=VYE9"!S=6)S:61I87)Y+"!-961!8W1I;FEU;2P@26YC+B`H
M34%)*2P@*&AE<F5I;F%F=&5R(')E9F5R<F5D('1O(&-O;&QE8W1I=F5L>2!A
M<R`F(S@R,C`[05!))B,X,C(Q.RD@:&%S(&EN:71I871E9"!C;VQL86)O<F%T
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M;"!.97<@1')U9R!!<'!L:6-A=&EO;BX@26X@,C`Q,BP@05!)(&QA=6YC:&5D
M(&$@;75L=&DM8V5N=&5R(&-O<G!O<F%T92!S<&]N<V]R960@=')I86P@:6X@
M86-U=&4@;7EE;&]I9"!L975K96UI82`H04U,*2!P871I96YT<RX@05!))B,X
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I
M9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS
M<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S(&$@<F5S=6QT(&]F('1H92!3:&%R92!%
M>&-H86YG92P@=&AE($-O;7!A;GD@:7,@;F]W(&$@:&]L9&EN9R!C;VUP86YY
M(&]P97)A=&EN9R!T:')O=6=H($%022P@82!C;&EN:6-A;"US=&%G92!B:6]P
M:&%R;6%C975T:6-A;"!C;VUP86YY(&1E=F5L;W!I;F<@8V5R=&%I;B!C86YC
M97(@=')E871M96YT<RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y
M.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A
M8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R!/;B!-87)C:"`R,"P@,C`Q,RP@:6X@86YT:6-I
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M,#LF(S$V,#M/;B!!<')I;"`Q,2P@,C`Q,RP@=&AE($-O;7!A;GD@8VAA;F=E
M9"!I=',@9&]M:6-I;&4@9G)O;2!T:&4@4W1A=&4@;V8@3F5V861A('1O('1H
M92!3=&%T92!O9B!$96QA=V%R92!A;F0@8VAA;F=E9"!I=',@;F%M92!F<F]M
M($-A8W1U<R!696YT=7)E<RP@26YC+B!T;R!!8W1I;FEU;2!0:&%R;6%C975T
M:6-A;',L($EN8RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[#0H@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T
M97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C
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M05`F(S@R,C$[*2!F;W(@:6YT97)I;2!F:6YA;F-I86P@:6YF;W)M871I;VXL
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M97-S87)Y)B,Q-C`[9F]R(&$@9F%I<B!S=&%T96UE;G0@;V8@=&AE(')E<W5L
M=',@9F]R('1H92!I;G1E<FEM('!E<FEO9',@<')E<V5N=&5D+B!);G1E<FEM
M(')E<W5L=',@87)E(&YO="!N96-E<W-A<FEL>2!I;F1I8V%T:79E(&]F('1H
M92!R97-U;'1S(&9O<B!T:&4@9G5L;"!Y96%R+B!4:&5S92!U;F%U9&ET960@
M:6YT97)I;2!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@<VAO
M=6QD(&)E(')E860@:6X@8V]N:G5N8W1I;VX@=VET:"!T:&4@8V]N<V]L:61A
M=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&]F('1H92!#;VUP86YY(&9O<B!T
M:&4@>65A<B!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@;F]T97,@=&AE
M<F5T;R!C;VYT86EN960@:6X@=&AE($-O;7!A;GDF(S@R,3<[<R!A;FYU86P@
M<F5P;W)T(&]N($9O<FT@,3`M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB
M97(@,S$L(#(P,3(L(&%S(&9I;&5D('=I=&@@=&AE(%-%0R!-87)C:"`R.2P@
M,C`Q,RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@
M:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[
M)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[($1E=F5L;W!M96YT(%-T86=E($-O;7!A;GD@)B,X,C$Q.SPO9F]N
M=#X@5&AE($-O;7!A;GD@:7,@8V]N<VED97)E9"!A(&1E=F5L;W!M96YT('-T
M86=E(&-O;7!A;GD@86YD(&AA<R!H860@;F\@8V]M;65R8VEA;"!R979E;G5E
M('1O(&1A=&4N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L
M9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS
M<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[(%!R:6YC:7!L97,@;V8@0V]N<V]L:61A=&EO
M;B`F(S@R,3$[/"]F;VYT/B!4:&4@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES
M<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG
M.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[(%5S92!O9B!%<W1I;6%T97,@:6X@1FEN86YC:6%L(%-T
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF
M;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!296-L
M87-S:69I8V%T:6]N("8C.#(Q,3L\+V9O;G0^($-E<G1A:6X@<')I;W(@<&5R
M:6]D(&%M;W5N=',@:&%V92!B965N(')E8VQA<W-I9FEE9"!T;R!C;VYF;W)M
M('1O(&-U<G)E;G0@<&5R:6]D('!R97-E;G1A=&EO;BX\+V9O;G0^/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX\
M9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C
M,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@0V%S
M:"!A;F0@0V%S:"!%<75I=F%L96YT<R`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M
M<&%N>2!C;VYS:61E<G,@86QL(&AI9VAL>2!L:7%U:60@86-C;W5N=',@=VET
M:"!O<FEG:6YA;"!M871U<FET:65S(&]F('1H<F5E(&UO;G1H<R!O<B!L97-S
M('1O(&)E(&-A<V@@97%U:79A;&5N=',N(%-U8V@@8F%L86YC97,@87)E('5S
M=6%L;'D@:6X@97AC97-S(&]F($9$24,@:6YS=7)E9"!L:6UI=',N($%T($IU
M;F4@,S`L(#(P,3,@86YD($1E8V5M8F5R(#,Q+"`R,#$R+"!A;&P@;V8@=&AE
M($-O;7!A;GDF(S@R,3<[<R!C87-H('=A<R!D97!O<VET960@:6X@;VYE(&)A
M;FLN/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES
M<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG
M.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[(%!R;W!E<G1Y(&%N9"!%<75I<&UE;G0@)B,X,C$Q.SPO
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M9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H-"B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L
M87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@
M.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C
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M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($1E<FEV871I
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$
M)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O
M;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($9A:7(@5F%L=64@
M;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S("8C.#(Q,3L\+V9O;G0^($9A:7(@
M=F%L=64@:7,@9&5F:6YE9"!A<R!T:&4@<')I8V4@=&AA="!W;W5L9"!B92!R
M96-E:79E9"!T;R!S96QL(&%N(&%S<V5T+"!O<B!P86ED('1O('1R86YS9F5R
M(&$@;&EA8FEL:71Y+"!I;B!A;B!O<F1E<FQY('1R86YS86-T:6]N(&)E='=E
M96X@;6%R:V5T('!A<G1I8VEP86YT<RX@02!F86ER('9A;'5E(&AI97)A<F-H
M>2!H87,@8F5E;B!E<W1A8FQI<VAE9"!F;W(@=F%L=6%T:6]N(&EN<'5T<R!T
M:&%T(&=I=F5S('1H92!H:6=H97-T('!R:6]R:71Y('1O('%U;W1E9"!P<FEC
M97,@:6X@86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@
M;&EA8FEL:71I97,@86YD('1H92!L;W=E<W0@<')I;W)I='D@=&\@=6YO8G-E
M<G9A8FQE(&EN<'5T<RX@5&AE(&9A:7(@=F%L=64@:&EE<F%R8VAY(&ES(&%S
M(&9O;&QO=W,Z/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY,979E;"`Q($EN<'5T<R`F(S@R,3$[(%5N861J=7-T
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY,979E;"`R($EN<'5T<R`F(S@R,3$[($EN<'5T
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M+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY,979E;"`S($EN<'5T<R`F(S@R,3$[(%5N;V)S97)V86)L92!I;G!U
M=',@9F]R(&1E=&5R;6EN:6YG('1H92!F86ER('9A;'5E<R!O9B!A<W-E=',@
M;W(@;&EA8FEL:71I97,@=&AA="!R969L96-T(&%N(&5N=&ET>2=S(&]W;B!A
M<W-U;7!T:6]N<R!A8F]U="!T:&4@87-S=6UP=&EO;G,@=&AA="!M87)K970@
M<&%R=&EC:7!A;G1S('=O=6QD('5S92!I;B!P<FEC:6YG('1H92!A<W-E=',@
M;W(@;&EA8FEL:71I97,N/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
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M8VAY(&%S(&]F($IU;F4@,S`L(#(P,3,@86YD($1E8V5M8F5R(#,Q+B!!<R!R
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I
M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT
M+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H-"B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,
M979E;"`R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E1O=&%L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY$97)I=F%T:79E(&QI86)I;&ET:65S.CPO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.T%T($IU;F4@,S`L(#(P
M,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)0T*('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F
M9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#LF(S$V,#M!="!$96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXS+#4W-"PY-3@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS+#4W-"PY-3@\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D
M:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($EN
M8V]M92!487AE<R`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M<&%N>2!U<V5S('1H
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M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI
M;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C
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M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B
M;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS
M1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F
M;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!%87)N:6YG<R`H3&]S<RD@
M4&5R($-O;6UO;B!3:&%R92`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M<&%N>2!P
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M92!T:&4@<V%M92X@)B,Q-C`[5&AE('!O=&5N=&EA;&QY(&1I;'5T:79E('-E
M8W5R:71I97,@*&]P=&EO;G,L('=A<G)A;G1S(&%N9"!C;VYV97)T:6)L92!I
M;G-T<G5M96YT<RD@=V5R92!E>&-L=61E9"!F<F]M('1H92!D:6QU=&5D(&QO
M<W,@<&5R(&-O;6UO;B!S:&%R92!C86QC=6QA=&EO;B!B96-A=7-E('1H96ER
M(&5F9F5C="!W;W5L9"!H879E(&)E96X@86YT:61I;'5T:79E+B!&;W(@=&AE
M('-I>"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,RP@<&]T96YT:6%L;'D@
M:7-S=6%B;&4@<VAA<F5S(&EN8VQU9&5D('-T;V-K(&]P=&EO;G,@=&\@<'5R
M8VAA<V4@,BPR.#`L,3@T('-H87)E<R!A;F0@=V%R<F%N=',@=&\@<'5R8VAA
M<V4@.2PU,S4L-CDT('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&-O
M;6UO;B!S=&]C:RX@1F]R('1H92!S:7@@;6]N=&AS(&5N9&5D($IU;F4@,S`L
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[("8C,38P.SQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY2
M96-E;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<R`F(S@R,3$[/"]F;VYT
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M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C
M,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y
M.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="UW96EG:'0Z(&)O
M;&0[(&1I<W!L87DZ(&EN;&EN93LG/DYO=&4@,2`F(S@R,3$[($1E<V-R:7!T
M:6]N(&]F($)U<VEN97-S(&%N9"!3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C
M8V]U;G1I;F<@4&]L:6-I97,\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T
M:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G
M;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N
M=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@3F%T=7)E(&]F($)U<VEN97-S
M("8C.#(Q,3L@06-T:6YI=6T@4&AA<FUA8V5U=&EC86QS+"!);F,@*$9O<FUE
M<FQY/"]F;VYT/B!#86-T=7,@5F5N='5R97,L($EN8RXI("AT:&4@)B,X,C(P
M.T-O;7!A;GDF(S@R,C$[+"`F(S@R,C`[0V%C='5S)B,X,C(Q.RDL('=A<R!I
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.SPO9F]N=#X\+V1I=CX-"CQD
M:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M($]N($1E8V5M8F5R(#(X+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN
M=&\@82!T<F%N<V%C=&EO;B`H=&AE("8C.#(R,#M3:&%R92!%>&-H86YG928C
M.#(R,3LI+"!P=7)S=6%N="!T;R!W:&EC:"!T:&4@0V]M<&%N>2!A9W)E960@
M=&\@86-Q=6ER92`Q,#`E(&]F('1H92!I<W-U960@86YD(&]U='-T86YD:6YG
M(&5Q=6ET>2!S96-U<FET:65S(&]F($%C=&EN:75M(%!H87)M86-E=71I8V%L
M<RP@26YC+B`H)B,X,C(P.T%C=&EN:75M)B,X,C(Q.RDL(&EN(&5X8VAA;F=E
M(&9O<B!T:&4@:7-S=6%N8V4@;V8@87!P<F]X:6UA=&5L>2`Y.24@;V8@=&AE
M(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@8V]M;6]N('-T;V-K+"!P87(@=F%L
M=64@)#`N,#$@<&5R('-H87)E+"!O9B!T:&4@0V]M<&%N>2X@5&AE(%-H87)E
M($5X8VAA;F=E('=A<R!C;&]S960@;VX@1&5C96UB97(@,C@L(#(P,3(@=VAE
M;B!S:&%R96AO;&1E<G,@<F5P<F5S96YT:6YG(&]V97(@,C`E(&]F('1H92!I
M<W-U960@86YD(&]U='-T86YD:6YG('-H87)E<R!O9B!!8W1I;FEU;2!H860@
M9FEN:7-H960@=&AE(&5X8VAA;F=E('!R;V-E<W,N)B,Q-C`[)B,Q-C`[3VX@
M075G=7-T(#(R+"`R,#$S+"!S:&%R96AO;&1E<G,@<F5P<F5S96YT:6YG(#,X
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M96%C:"!!8W1I;FEU;2!S:&%R96AO;&1E<B!S:&%L;"!R96-E:79E(#`N,S,S
M('-H87)E<R`H=&AE("8C.#(R,#M%>&-H86YG92!2871I;R8C.#(R,3LI(&]F
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M;VX@<W1O8VLN)B,Q-C`[)B,Q-C`[5&AE(%-H87)E($5X8VAA;F=E('=A<R!A
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N
M=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I
M;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#L@06-T:6YI=6TL(&EN8V]R<&]R871E9"!O;B!*=6YE
M(#$S+"`R,#`P+"!I<R!A(&)I;W1E8VAN;VQO9WD@8V]M<&%N>2!C;VUM:71T
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M26X@,C`Q,BP@06-T:6YI=6T@;&%U;F-H960@82!M=6QT:2UC96YT97(@8V]R
M<&]R871E('-P;VYS;W)E9"!T<FEA;"!I;B!A8W5T92!M>65L;VED(&QE=6ME
M;6EA("A!34PI('!A=&EE;G1S+B`F(S$V,#M!8W1I;FEU;28C.#(Q-SMS(&]B
M:F5C=&EV92P@=&AR;W5G:"!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0L(&ES
M('1O('!R;V1U8V4@<F5L:6%B;&4@8V%N8V5R(&9I9VAT:6YG('!R;V1U8W1S
M('=H:6-H('5T:6QI>F4@;6]N;V-L;VYA;"!A;G1I8F]D:65S(&QI;FME9"!W
M:71H(&%L<&AA('!A<G1I8VQE(&5M:71T97)S(&]R(&]T:&5R(&%P<')O<')I
M871E('!A>6QO861S('1O('!R;W9I9&4@=F5R>2!P;W1E;G0@=&%R9V5T960@
M=&AE<F%P:65S+B!4:&4@:6YI=&EA;"!C;&EN:6-A;"!T<FEA;',@;V8@06-T
M:6YI=6TF(S@R,3<[<R!C;VUP;W5N9',@:&%V92!B965N('=I=&@@<&%T:65N
M=',@:&%V:6YG(&%C=71E(&UY96QO:60@;&5U:V5M:6$@86YD(&ET(&ES(&)E
M;&EE=F5D('1H870@06-T:6YI=6TF(S@R,3<[<R!!4$E4('!L871F;W)M('=I
M;&P@:&%V92!W:61E<B!A<'!L:6-A8FEL:71Y(&9O<B!D:69F97)E;G0@='EP
M97,@;V8@8V%N8V5R('=H97)E('-U:71A8FQE(&UO;F]C;&]N86P@86YT:6)O
M9&EE<R!C86X@8F4@9F]U;F0N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS
M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T
M>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V
M,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($1E=F5L;W!M96YT
M(%-T86=E($-O;7!A;GD@)B,X,C$Q.SPO9F]N=#X@5&AE($-O;7!A;GD@:7,@
M8V]N<VED97)E9"!A(&1E=F5L;W!M96YT('-T86=E(&-O;7!A;GD@86YD(&AA
M<R!H860@;F\@8V]M;65R8VEA;"!R979E;G5E('1O(&1A=&4N/"]F;VYT/CPO
M9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL
M:6YE.R<^/&9O;G0-"B`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
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M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
M/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#L@57-E(&]F($5S=&EM871E<R!I;B!&:6YA;F-I86P@4W1A=&5M96YT
M(%!R97-E;G1A=&EO;B`F(S@R,3$[/"]F;VYT/B!4:&4@<')E<&%R871I;VX@
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M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T
M>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V
M,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%)E8VQA<W-I9FEC
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S
M='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!#87-H(&%N9"!#
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M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX\
M9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C
M,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@4')O
M<&5R='D@86YD($5Q=6EP;65N="`F(S@R,3$[/"]F;VYT/B!-86-H:6YE<GD@
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M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P
M.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`S-G!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`S-G!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
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M>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD
M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`S-G!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/DQE=F5L(#(@26YP=71S("8C.#(Q,3L@26YP=71S(&]T:&5R('1H86X@<75O
M=&5D('!R:6-E<R!I;F-L=61E9"!I;B!,979E;"`Q('1H870@87)E(&]B<V5R
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M<&QA>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-
M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M('1H92!F86ER('9A;'5E(&AI97)A<F-H>2!A<R!O9B!$96-E;6)E<B`S,2P@
M,C`Q,B!A;F0@,C`Q,2X@07,@<F5Q=6ER960@8GD@05-#(#@R,"P@9FEN86YC
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT
M86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O
M;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,
M979E;"`S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N=`T*('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M1&5R:79A=&EV92!L:6%B:6QI=&EE<SH\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.T%T($1E8V5M8F5R(#,Q
M+"`R,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS+#4W
M-"PY-3@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$
M=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[070@1&5C96UB97(@,S$L(#(P,3$\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M#0H@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+#0S.2PV,3,\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T
M86)L93X-"CPO9&EV/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O
M;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[
M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T
M97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C
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M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T
M>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V
M,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%)E<V5A<F-H(&%N
M9"!$979E;&]P;65N="!#;W-T<R`F(S@R,3$[/"]F;VYT/B!297-E87)C:"!A
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
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M)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R!3:&%R92U"87-E9"!087EM96YT<R`F(S@R,3$[/"]F;VYT/B!4:&4@
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES
M<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG
M.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[($5A<FYI;F=S("A,;W-S*2!097(@0V]M;6]N(%-H87)E
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M86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S)B,Q-C`[8GD@=&AE('=E:6=H
M=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T<W1A;F1I
M;F<@<&QU<R!D:6QU=&EV92!S96-U<FET:65S+B!3:6YC92!T:&4@0V]M<&%N
M>2!H87,@;VYL>2!I;F-U<G)E9"!L;W-S97,L(&)A<VEC(&%N9"!D:6QU=&5D
M(&YE="!L;W-S('!E<B!C;VUM;VX@<VAA<F4@87)E('1H92!S86UE+B`F(S$V
M,#M4:&4@<&]T96YT:6%L;'D@9&EL=71I=F4@<V5C=7)I=&EE<R`H;W!T:6]N
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M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H-"B`P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$
M)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O
M;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%)E8V5N="!!8V-O=6YT:6YG
M(%!R;VYO=6YC96UE;G1S("8C.#(Q,3L\+V9O;G0^(%1H92!#;VUP86YY(&1O
M97,@;F]T(&5X<&5C="!T:&%T(&%N>2!R96-E;G1L>2!I<W-U960@86-C;W5N
M=&EN9R!P<F]N;W5N8V5M96YT<R!W:6QL(&AA=F4@82!S:6=N:69I8V%N="!I
M;7!A8W0@;VX@=&AE(')E<W5L=',@;V8@;W!E<F%T:6]N<RP@9FEN86YC:6%L
M('!O<VET:6]N+"!O<B!C87-H(&9L;W=S(&]F('1H92!#;VUP86YY+CPO9F]N
M=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
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M)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R!3=6)S97%U96YT($5V96YT<R`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M
M<&%N>28C.#(Q-SMS(&UA;F%G96UE;G0@<F5V:65W960@86QL(&UA=&5R:6%L
M(&5V96YT<R!F<F]M($IA;G5A<GD@,2P@,C`Q,R!T:')O=6=H($UA<F-H(#$U
M+"`R,#$S+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970P."YH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P15-'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D=O:6YG($-O;F-E<FX\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D=O:6YG($-O;F-E<FX@6T%B<W1R86-T73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y';VEN9R!#
M;VYC97)N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="UW96EG:'0Z(&)O;&0[
M(&1I<W!L87DZ(&EN;&EN93LG/DYO=&4@,B`F(S@R,3$[($=O:6YG($-O;F-E
M<FX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^
M)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R!!<R!R969L96-T960@:6X@=&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI
M9&%T960@9FEN86YC:6%L('-T871E;65N=',L('1H92!#;VUP86YY(&AA<R!S
M=69F97)E9"!R96-U<G)I;F<@;&]S<V5S(&9R;VT@;W!E<F%T:6]N<R!S:6YC
M92!I=',@:6YC97!T:6]N+B!4:&4@0V]M<&%N>2!H87,@82!N970@;&]S<R!O
M9B`D,RPT-S,L,#,X(&%N9"!N970@8V%S:"!U<V5D(&EN(&]P97)A=&EO;G,@
M;V8@)#,L,S(W+#@R,"P@9F]R('1H92!S:7@@;6]N=&AS(&5N9&5D($IU;F4@
M,S`L)B,Q-C`[,C`Q,SL@86YD(&%N(&%C8W5M=6QA=&5D(&1E9FEC:70@;V8@
M)#4Y+#(Q-BPU,#$@870@2G5N92`S,"P@,C`Q,RX@26X@861D:71I;VXL('1H
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M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!4
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M9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L
M87DZ(&EN;&EN93LG/DYO=&4@,B`F(S@R,3$[($=O:6YG($-O;F-E<FX\+V9O
M;G0^/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=D:7-P;&%Y.B!B;&]C
M:SL@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF
M;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!!<R!R
M969L96-T960@:6X@=&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@9FEN
M86YC:6%L('-T871E;65N=',L('1H92!#;VUP86YY(&AA<R!S=69F97)E9"!R
M96-U<G)I;F<@;&]S<V5S(&9R;VT@;W!E<F%T:6]N<R!S:6YC92!I=',@:6YC
M97!T:6]N+B!4:&4@0V]M<&%N>2!H87,@82!N970@;&]S<R!O9B`D."PS-C$L
M,C`U(&%N9"!N970@8V%S:"!U<V5D(&EN(&]P97)A=&EO;G,@;V8@)#4L,C$R
M+#<Q,"P@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"8C,38P.S(P
M,3([(&%N9"!A;B!A8V-U;75L871E9"!D969I8VET(&]F("0U-2PW-#,L-#8S
M(&%T($1E8V5M8F5R(#,Q+"`R,#$R+B!);B!A9&1I=&EO;BP@=&AE($-O;7!A
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!A8FEL
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M-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[
M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C
M:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[(%1H92!A8V-O;7!A;GEI;F<@8V]N<V]L:61A=&5D
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M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V
M,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O
M<FMS:&5E=',O4VAE970P.2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A8W1I;VYS/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E
M;&%T960@4&%R='D@5')A;G-A8W1I;VYS(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5L871E9"!087)T
M>2!4<F%N<V%C=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="UW96EG:'0Z(&)O
M;&0[(&1I<W!L87DZ(&EN;&EN93LG/DYO=&4@,R`F(S@R,3$[(%)E;&%T960@
M4&%R='D@5')A;G-A8W1I;VYS/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS
M1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M
M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE.B!I=&%L:6,[(&1I<W!L87DZ(&EN
M;&EN93LG/DU32T-#.CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@
M.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R!);B`R,#$P+"!'96YE<F%L($%T;&%N=&EC($=R;W5P($QI
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M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y
M<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[($]N($9E8G)U87)Y(#$Q+"`R,#`R+"!T:&4@0V]M<&%N>2!E
M;G1E<F5D(&EN=&\@82!,:6-E;G-E+"!$979E;&]P;65N="!A;F0@0V]M;65R
M8VEA;&EZ871I;VX@06=R965M96YT('=I=&@@4VQO86XM2V5T=&5R:6YG($EN
M<W1I='5T92!O9B!#86YC97(@4F5S96%R8V@@*%-+22DL)B,Q-C`[86X@96YT
M:71Y(')E;&%T960@=&\@35-+0T,N)B,Q-C`[)B,Q-C`[5&AE(&%G<F5E;65N
M="!W87,@86UE;F1E9"!I;B!!=6=U<W0@,C`P-BXF(S$V,#LF(S$V,#M0=7)S
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M,#M/;B!*=6YE(#$Y+"`R,#$Q+"!T:&4@0V]M<&%N>2!N;VYE=&AE;&5S<R!A
M9W)E960@=&\@<&%Y(%-+22`H82D@)#4P+#`P,"!I;B`R,#$Q+"`H8BD@)#(P
M,"PP,#`@:6X@,C`Q,B!A;F0@*&,I("0R-3`L,#`P(&EN(#(P,3,@=6YD97(@
M=&AI<R!A9W)E96UE;G0L(&EN(')E<W!E8W0@;V8@=&AE("0U,"PP,#`@86YN
M=6%L(&UA:6YT96YA;F-E(&9E97,@86YD(')E<V5A<F-H('!A>6UE;G1S+B!3
M:6YC92!*86YU87)Y(#$L(#(P,3$L('1H92!#;VUP86YY(&AA<R!P86ED("0Q
M,#`L,#`P('5N9&5R('1H:7,@86=R965M96YT(&%N9"!A<R!O9B!$96-E;6)E
M<B`S,2P@,C`Q,BP@=&AE($-O;7!A;GD@86=R965D('1O('!A>2!A;B!A9&1I
M=&EO;F%L("0Q-3`L,#`P(&9O<B!R97-E87)C:"!T;R!B92!C;VYD=6-T960@
M:6X@,C`Q,RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T
M.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R!/;B!-87)C:"`R-RP@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E
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M=VAI8V@@=V%S('!A:60@;VX@2G5L>2`Q,"P@,C`Q,BX\+V9O;G0^/"]D:78^
M#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`R-W!T.R<^)B,Q-C`[/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E
M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($U32T-#(&%G<F5E9"P@<W5B
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M0R!A<G)A;F=E;65N=',@9F]R('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+"`R
M,#$R(&%N9"`R,#$Q.CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T
M:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#(W<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I
M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT
M+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M#0H@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R
M(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/C8U-2PW.#8\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E)E:6UB
M=7)S96UE;G1S(')E8V5I=F5D(&9R;VT@35-+0T,\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,S<L.#,T/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CDV-BPS-#$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L
M;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O
M;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V
M,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($EN(#(P
M,3(@86YD(#(P,3$L('1H92!#;VUP86YY(')E8V5I=F5D('1O=&%L(%(F86UP
M.T0@<F5I;6)U<G-E;65N="!P87EM96YT<R!O9B`D,C,W+#@S-"!A;F0@)#(Y
M.2PR,#`L(')E<W!E8W1I=F5L>2P@9G)O;2!-4TM#0RX\+V9O;G0^/"]D:78^
M#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$
M)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O
M;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S(&]F($1E8V5M8F5R(#,Q
M+"`R,#$R(&%N9"`R,#$Q+"!T:&4@0V]M<&%N>2!H860@82!N970@<F5C96EV
M86)L92!O9B`D,"!A;F0@)#(S-RPX,S0L(')E<W!E8W1I=F5L>2P@9G)O;2!-
M4TM#0RX\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@
M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[
M)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[($]N($IA;G5A<GD@,2P@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E
M9"!I;G1O(&$@0V]N<W5L=&EN9R!397)V:6-E<R!!9W)E96UE;G0@=VET:"!$
M<BX@4F]S96UA<GD@36%Z86YE="P@82!D:7)E8W1O<B!O9B!#86-T=7,N)B,Q
M-C`[)B,Q-C`[4'5R<W5A;G0@=&\@=&AE(&%G<F5E;65N="P@1'(N($UA>F%N
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M86YE="!R96-E:79E<R!C;VUP96YS871I;VX@;V8@)#$P,"PP,#`@<&5R('EE
M87(@86YD(&UA>2!R96-E:79E(&%D9&ET:6]N86P@8V]M<&5N<V%T:6]N(&EN
M('1H92!F;W)M(&]F(&]P=&EO;G,@870@9&5T97)M:6YE9"!B>2!T:&4@8F]A
M<F0@;V8@=&AE($-O;7!A;GDN)B,Q-C`[)B,Q-C`[4VEN8V4@2F%N=6%R>2`Q
M+"`R,#$Q+"!$<BX@36%Z86YE="!H87,@86QS;R!R96-E:79E9"!O<'1I;VYS
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M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H-"B`P<'0[
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M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M="UW96EG:'0Z(&)O;&0[(&9O;G0M<W1Y;&4Z(&ET86QI8SL@9&ES<&QA>3H@
M:6YL:6YE.R<^2F%M97-S($-A<&ET86P@1W)O=7`L($Q,0SH\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&1I<W!L
M87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF
M(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[($]N($UA>2`Y+"`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@
M82!T<F%N<V%C=&EO;B!M86YA9V5M96YT(&%G<F5E;65N="!W:71H($IA;65S
M<R!#87!I=&%L($=R;W5P+"!,3$,N("AF;W)M97)L>2!K;F]W;B!A<R!!;65R
M87-I82!#87!I=&%L($=R;W5P+"!,3$,I+"!A(&-O;G-U;'1I;F<@9FER;2!A
M9F9I;&EA=&5D('=I=&@@37(N(%-A;F1E<V@@4V5T:"P@82!$:7)E8W1O<B!O
M9B!T:&4@0V]M<&%N>28C,38P.R@F(S@R,C`[36%N86=E;65N="!&:7)M)B,X
M,C(Q.RDN)B,Q-C`[(%1H92!-86YA9V5M96YT($9I<FT@<F5C96EV960@82!M
M;VYT:&QY(&9E92!O9B`D,3(L-3`P('=H:6-H(&ES('1E<FUI;F%B;&4@8GD@
M=&AE($-O;7!A;GD@=&AR964@;6]N=&AS(&%F=&5R('1H92!E9F9E8W1I=F4@
M9&%T92!O9B!T:&4@9V]I;F<@<'5B;&EC('1R86YS86-T:6]N(&%N9"!D97-I
M9VYE97,@;V8@2F%M97-S+"!I;F-L=61I;F<@96YT:71I97,@869F:6QI871E
M9"!W:71H($UR+B!3971H+"!W97)E(&ES<W5E9"!W87)R86YT<R!T;R!P=7)C
M:&%S92!C;VUM;VX@<W1O8VL@97%U86P@=&\@,3`E(&]F('1H92!F=6QL>2UD
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M964@4W1O8VL@3W!T:6]N(%!L86XN)B,Q-C`[(%1H92!-86YA9V5M96YT($9I
M<FT@:7,@86QS;R!E;&EG:6)L92!T;R!B92!R96EM8G5R<V5D('5P;VX@=&AE
M('-U8FUI<W-I;VX@;V8@<')O<&5R(&1O8W5M96YT871I;VX@9F]R(&]R9&EN
M87)Y(&%N9"!N96-E<W-A<GD@;W5T+6]F+7!O8VME="!E>'!E;G-E<R!N;W0@
M=&\@97AC965D("0U+#`P,"!P97(@;6]N=&@N/"]F;VYT/CPO9&EV/@T*/&1I
M=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!D:7-P;&%Y.B!B;&]C
M:SL@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M=V5I9VAT.B!B;VQD.R!F
M;VYT+7-T>6QE.B!I=&%L:6,[(&1I<W!L87DZ(&EN;&EN93LG/E!L86-E;65N
M="!!9V5N=#H\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&IU<W1I9GD[(&1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T
M.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E
M<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N($%U9W5S="`W+"`R,#$R+"!T:&4@
M0V]M<&%N>2!E;G1E<F5D(&EN=&\@86X@96YG86=E;65N="!A9W)E96UE;G0@
M=VET:"!I=',@<&QA8V5M96YT(&%G96YT(&9O<B!T:&4@,C`Q,B!#;VUM;VX@
M4W1O8VL@3V9F97)I;F<L)B,Q-C`[;V8@=VAI8V@@37(N(%-E=&@L(&$@9&ER
M96-T;W(@;V8@=&AE($-O;7!A;GD@:7,@2&5A9"!O9B!(96%L=&AC87)E($EN
M=F5S=&UE;G0@0F%N:VEN9RXF(S$V,#LF(S$V,#LF(S$V,#M0=7)S=6%N="!T
M;R!T:&4@86=R965M96YT+"!T:&4@<&QA8V5M96YT(&%G96YT('=A<R!E;F=A
M9V5D(&%S('1H92!E>&-L=7-I=F4@86=E;G0@9F]R('1H92`R,#$R($-O;6UO
M;B!3=&]C:R!/9F9E<FEN9RX@)B,Q-C`[)B,Q-C`[26X@8V]N<VED97)A=&EO
M;B!F;W(@:71S('-E<G9I8V5S+"!T:&4@<&QA8V5M96YT(&%G96YT('=I;&P@
M<F5C96EV92`H82D@82!C87-H(&9E92!E<75A;"!T;R`Q,"4@;V8@=&AE(&=R
M;W-S('!R;V-E961S(')A:7-E9"!I;B!T:&4@,C`Q,B!#;VUM;VX@4W1O8VL@
M3V9F97)I;F<L("AB*2!A(&YO;BUA8V-O=6YT86)L92!E>'!E;G-E(')E:6UB
M=7)S96UE;G0@97%U86P@=&\@,B4@;V8@=&AE(&=R;W-S('!R;V-E961S(')A
M:7-E9"!I;B!T:&4@,C`Q,B!#;VUM;VX@4W1O8VL@3V9F97)I;F<L(&%N9"`H
M8RD@<F5I;6)U<G-E;65N="!O9B`D,3`P+#`P,"!F;W(@;&5G86P@97AP96YS
M97,@:6YC=7)R960@8GD@=&AE('!L86-E;65N="!A9V5N="XF(S$V,#LF(S$V
M,#M4:&4@<&QA8V5M96YT(&%G96YT(&]R(&ET<R!D97-I9VYE97,@:&%V92!A
M;'-O(')E8V5I=F5D('=A<G)A;G1S('1O('!U<F-H87-E('-H87)E<R!O9B!T
M:&4@0V]M<&%N>28C.#(Q-SMS($-O;6UO;B!3=&]C:R!I;B!A;B!A;6]U;G0@
M97%U86P@=&\@,3`E(&]F('1H92!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&ES
M<W5E9"!A<R!P87)T(&]F('1H92!U;FET<R!S;VQD(&EN('1H92`R,#$R($-O
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M(&QE87-T(#8@;6]N=&AS(&9O<B!A(&UO;G1H;'D@9F5E(&]F("0R-2PP,#`N
M)B,Q-C`[)B,Q-C`[5&AE(&%G<F5E;65N="!A;'-O('!R;W9I9&5S('1H870@
M*&DI(&EF('1H92!#;VUP86YY(&-O;G-U;6UA=&5S(&%N>2!M97)G97(L(&%C
M<75I<VET:6]N+"!B=7-I;F5S<R!C;VUB:6YA=&EO;B!O<B!O=&AE<B!T<F%N
M<V%C=&EO;B`H;W1H97(@=&AA;B!T:&4@4VAA<F4@17AC:&%N9V4I('=I=&@@
M86YY('!A<G1Y(&EN=')O9'5C960@=&\@:70@8GD@=&AE('!L86-E;65N="!A
M9V5N="P@=&AE('!L86-E;65N="!A9V5N="!W;W5L9"!R96-E:79E(&$@9F5E
M(&5Q=6%L('1O(#$P)2!O9B!T:&4@86=G<F5G871E(&-O;G-I9&5R871I;VX@
M:6X@<W5C:"!T<F%N<V%C=&EO;G,L(&%N9"`H:6DI(&EF+"!W:71H:6X@82!P
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M;&4@<V5T(&9O<G1H(&EN('1H92!!=6=U<W0@-RP@,C`Q,B!E;F=A9V5M96YT
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M;G9E<G1I8FQE($YO=&5S(&9I;F%N8VEN9R!I;B`R,#$Q(&%N9"P@87,@82!P
M87)T(&]F('1H92!F964@9F]R('1H870@96YG86=E;65N="P@9&5S:6=N965S
M(&]F('1H92!P;&%C96UE;G0@86=E;G0@86QS;R!H;VQD('=A<G)A;G1S('1O
M('!U<F-H87-E(#$L,C4Q+#`Q-2!S:&%R97,@;V8@=&AE($-O;7!A;GDF(S@R
M,3<[<R!#;VUM;VX@4W1O8VLN/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS
M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9F]N="US='EL93H@:71A;&EC.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY'=6%G96YT:2`F86UP.R!!<W-O8VEA=&5S($Q,
M0SH\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q
M-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[
M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#(W<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/DEN(#(P,3`L('1H92!#;VUP86YY(&5N=&5R
M960@:6YT;R!A;B!A9W)E96UE;G0@=VET:"!'=6%G96YT:2`F86UP.R!!<W-O
M8VEA=&5S($Q,0R`H)B,X,C(P.T<F86UP.T$F(S@R,C$[*2XF(S$V,#LF(S$V
M,#M')F%M<#M!(&ES(&%F9FEL:6%T960@=VET:"!%;GIA($=U86=E;G1I+"!T
M:&4@9F]R;65R($-H:65F($9I;F%N8VEA;"!/9F9I8V5R(&]F($-A8W1U<RXF
M(S$V,#LF(S$V,#M0=7)S=6%N="!T;R!T:&4@86=R965M96YT+"!T:&4@0V]M
M<&%N>2!L96%S97,@<W1O<F%G92!S<&%C92!I;B!.97=A<FLL($Y*(&9R;VT@
M1R9A;7`[02XF(S$V,#LF(S$V,#M4:&4@<F5N="!I<R`D,S`P('!E<B!M;VYT
M:"XF(S$V,#LF(S$V,#M3:6YC92!*86YU87)Y(#$L(#(P,3$L('1H92!#;VUP
M86YY(&AA<R!P86ED("0W+#(P,"!P=7)S=6%N="!T;R!T:&ES(&%G<F5E;65N
M="XF(S$V,#LF(S$V,#LF(S$V,#M-<RX@1W5A9V5N=&D@<F5S:6=N960@87,@
M=&AE($-O;7!A;GDF(S@R,3<[<R!#:&EE9B!&:6YA;F-I86P@3V9F:6-E<B!O
M;B!-87)C:"`Y+"`R,#$S+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,C=P
M=#LG/B8C,38P.SPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A
M,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE
M-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,3`N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$531SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY0<F]P
M97)T>2!A;F0@17%U:7!M96YT/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T>2!A
M;F0@17%U:7!M96YT(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD($5Q=6EP;65N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
M/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#M0<F]P97)T>2!A;F0@97%U:7!M96YT(&-O;G-I<W1E9"!O
M9B!T:&4@9F]L;&]W:6YG(&%T($IU;F4@,S`L(#(P,3,@86YD($1E8V5M8F5R
M(#,Q+"`R,#$R.CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z
M(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ
M93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\
M='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C(P,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$P)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D]F9FEC92!E<75I<&UE;G0\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.S4@>65A<G,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ-3<L,C<T/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C$U-BPQ-C(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D9U<FYI='5R92!A
M;F0@9FEX='5R93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[-R!Y96%R<SPO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=@T*(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#(Y,CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C$L,CDR/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R
M/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#8W)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#8W)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXQ-3@L-38V/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0V-R4@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY,97-S.B!A8V-U;75L871E9"!D97!R96-I871I;VX\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B@Q-30L-#0T/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/BD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.PT*
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(]
M,T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,L,#$P/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S
M='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R!$97!R
M96-I871I;VX@97AP96YS92!F;W(@=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!*
M=6YE(#,P+"`R,#$S(&%N9"`R,#$R('=E<F4@)#`F(S$V,#MA;F0@)#$U.2P@
M<F5S<&5C=&EV96QY+B!$97!R96-I871I;VX@97AP96YS92!F;W(@=&AE('-I
M>"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,R!A;F0@,C`Q,B!W97)E("0P
M(&%N9"`D,S$W(')E<W!E8W1I=F5L>2X@5&AE($-O;7!A;GD@=W)O=&4@;V9F
M(&ET<R!R96UA:6YI;F<@=6YD97)P<F5C:6%T960@<')O<&5R='D@86YD(&5Q
M=6EP;65N="!D=7)I;F<@=&AE('-I>"!M;VYT:',@96YD960@2G5N92`S,"P@
M,C`Q,RX\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV
M(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M)B,Q-C`[)B,Q-C`[)B,Q-C`[(%!R;W!E<G1Y(&%N9"!E<75I<&UE;G0@8V]N
M<VES=&5D(&]F('1H92!F;VQL;W=I;F<@870@1&5C96UB97(@,S$L(#(P,3(@
M86YD(#(P,3$Z/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\
M9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P
M)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q
M,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED
M.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[3&EV97,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D]F9FEC92!E<75I<&UE;G0\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.S4@>65A<G,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,2PR.3(\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H-"B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O
M;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0V-R4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY4;W1A;"!P<F]P97)T>2P@<&QA;G0@
M86YD(&5Q=6EP;65N=#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ-3<L-#4T/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-C<E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,G!X.R<^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/DQE<W,Z(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;CPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0-"B!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0V-R4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^4')O<&5R='D@86YD(&5Q=6EP;65N=#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X
M(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U
M8FQE.R<^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,2PR,S,\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y
M<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[($1E<')E8VEA=&EO;B!E>'!E;G-E(&9O<B!T:&4@>65A<G,@
M96YD960@1&5C96UB97(@,S$L(#(P,3(@86YD(#(P,3$@=V5R92`D-3@Q(&%N
M9"`D-C,S+"!R97-P96-T:79E;'DN/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T
M-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7
M;W)K<VAE971S+U-H965T,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$531SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY.;W1E(%!A>6%B;&4@86YD($-O;G9E<G1I8FQE($YO
M=&5S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E(%!A>6%B;&4@86YD($-O;G9E<G1I
M8FQE($YO=&5S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F]T92!087EA8FQE(&%N9"!#;VYV97)T:6)L
M92!.;W1E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A
M;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES
M<&QA>3H@:6YL:6YE.R<^3F]T92`T("8C.#(Q,3L@3F]T92!087EA8FQE/"]F
M;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O
M;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V
M,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N($1E
M8V5M8F5R(#(X+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!P
M<F5M:75M(&9I;F%N8V4@86=R965M96YT('1O('!A>2!A)B,Q-C`[)#$T,"PP
M,#`@<')E;6EU;28C,38P.V9O<B!I=',@9&ER96-T;W(@86YD(&]F9FEC97(F
M(S$V,#ML:6%B:6QI='D@:6YS=7)A;F-E('!O;&EC>2X@4'5R<W5A;G0@=&\@
M=&AE(&%G<F5E;65N="P@=&AE($-O;7!A;GD@<&%I9"!A(&1O=VX@<&%Y;65N
M="!O9B`D,C@L,#`P(&EN($IA;G5A<GD@,C`Q,R!A;F0@:&%S('1O('!A>2`D
M,3(L-C,V(&EN(&UO;G1H;'D@:6YS=&%L;&UE;G0@9F]R(&YI;F4@;6]N=&AS
M+B!!<R!O9B!*=6YE(#,P+"`R,#$S+"!T:&4F(S$V,#MO=71S=&%N9&EN9R!B
M86QA;F-E(')E;&%T960@=&\@=&AE('!R96UI=6T@9FEN86YC92!A9W)E96UE
M;G0@=V%S("0S-BPY-3`N)B,Q-C`[)B,Q-C`[5&AE($-O;7!A;GD@:&%S('!A
M:60@)#$P,RPP-3`@;V8@=&AE('!R:6YC:7!A;"!D=7)I;F<@,C`Q,RX\+V9O
M;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O
M;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.;W1E(#4@)B,X
M,C$Q.R!.;W1E(%!A>6%B;&4@86YD($-O;G9E<G1I8FQE($YO=&5S/"]F;VYT
M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O
M;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[
M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!/
M;B!$96-E;6)E<B`R."P@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O
M(&$@<')E;6EU;2!F:6YA;F-E(&%G<F5E;65N="!T;R!P87D@)#$T,"PP,#`@
M<')E;6EU;2!O9B!I=',@9&ER96-T;W(@86YD(&]F9FEC97(@:6YS=7)A;F-E
M('!O;&EC>2X@4'5R<W5A;G0@=&\@=&AE(&%G<F5E;65N="P@=&AE($-O;7!A
M;GD@<&%I9"!A(&1O=VX@<&%Y;65N="!O9B`D,C@L,#`P(&EN($IA;G5A<GD@
M,C`Q,R!A;F0@:&%S('1O('!A>2`D,3(L-C,V(&EN(&UO;G1H;'D@:6YS=&%L
M;&UE;G0@9F]R(&YI;F4@;6]N=&AS+B!!<R!O9B!$96-E;6)E<B`S,2P@,C`Q
M,BP@;W5T<W1A;F1I;F<@8F%L86YC92!R96QA=&5D('1O('1H92!P<F5M:75M
M(&9I;F%N8V4@86=R965M96YT('=A<R`D,30P+#`P,"XF(S$V,#L\+V9O;G0^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&1I
M<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^0V]N=F5R=&EB;&4@3F]T97,\+V9O;G0^/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS
M1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F
M;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!/;B!$96-E;6)E<B`R-RP@
M,C`Q,2P@=&AE($-O;7!A;GD@8V]M<&QE=&5D(&$@<')I=F%T92!O9F9E<FEN
M9R!O9B`X)2!396YI;W(@4W5B;W)D:6YA=&5D(%5N<V5C=7)E9"!#;VYV97)T
M:6)L92!0<F]M:7-S;W)Y($YO=&5S("@F(S@R,C`[0V]N=F5R=&EB;&4@3F]T
M97,F(S@R,C$[*2!I;B!T:&4@86UO=6YT(&]F("0Y,#`L,#`P(&%N9"!R96-E
M:79E9"!N970@<')O8V5E9',@;V8@)#<U,"PP,#`N(%1H92!C;VYV97)T:6)L
M92!N;W1E<R!W97)E(&ES<W5E9"!A="`X,RXS,R4@;V8@=&AE('!R:6YC:7!A
M;"!A;6]U;G0@<F5S=6QT:6YG(&EN(&%N(&]R:6=I;F%L(&ES<W5E(&1I<V-O
M=6YT(&]F("0Q-3`L,#`P+B8C,38P.U1H92!#;VYV97)T:6)L92!.;W1E<R!M
M871U<F4@;VYE('EE87(@9G)O;2!T:&4@9&%T92!O9B!I<W-U86YC92X@26YT
M97)E<W0@86-C<G5E<R!A="!T:&4@<F%T92!O9B`X)2!P97(@>65A<B!O;B!T
M:&4@;W5T<W1A;F1I;F<@<')I;F-I<&%L(&%M;W5N="P@86-C<G5E9"!S96UI
M+6%N;G5A;&QY(&%N9"!T;R!B92!P86ED(&%T(&UA='5R:71Y+CPO9F]N=#X\
M+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@9&ES
M<&QA>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
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M($]F9F5R:6YG+"`H,BD@82!0=6)L:6,@0V]M<&%N>2!4<F%N<V%C=&EO;BP@
M9&5F:6YE9"!A<R`H:2D@82!R979E<G-E(&UE<F=E<B!O<B!S:6UI;&%R('1R
M86YS86-T:6]N(&)E='=E96X@=&AE($-O;7!A;GD@86YD(&$@8V]R<&]R871I
M;VX@=VAO<V4@<V5C=7)I=&EE<R!A<F4@<'5B;&EC;'D@=')A9&5D(&EN('1H
M92!5;FET960@4W1A=&5S(&]R(&]T:&5R(&IU<FES9&EC=&EO;B!M=71U86QL
M>2!A9W)E960@8F5T=V5E;B!T:&4@0V]M<&%N>2!A;F0@4&QA8V5M96YT($%G
M96YT+"!O<B`H:6DI('1H92!Q=6]T871I;VX@;V8@=&AE($-O;7!A;GDF(S@R
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M('1H92!#;VUP86YY(&]F(&YO(&QE<W,@=&AA;B`D-"PP,#`L,#`P(&]F(&=R
M;W-S('!R;V-E961S(&EN('-U8G-E<75E;G0@;V9F97)I;F=S(&]F(&ET<R!C
M;VUM;VX@<W1O8VL@;W(@97%U:79A;&5N=',@9F]L;&]W:6YG('1H92!I<W-U
M86YC92!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS('-T;V-K("A3964@3F]T92`Y
M*2!A;F0@=&AE($-O;G9E<G1I8FQE($YO=&5S+CPO9F]N=#X\+V1I=CX-"CQD
M:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@9&ES<&QA>3H@8FQO
M8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\
M9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C
M,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@26X@
M8V]N;F5C=&EO;B!W:71H('1H92!I<W-U86YC92!O9B!T:&4@0V]N=F5R=&EB
M;&4@3F]T97,L('=A<G)A;G1S('1O('!U<F-H87-E(&$@=&]T86P@;V8@,C@W
M+#`V,2!S:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@:7-S=65D('1O(&EN
M=F5S=&]R<RX@5&AE(%!L86-E;65N="!!9V5N="!A;F0@=&AE($UA;F%G96UE
M;G0@1FER;2`H4V5E($YO=&4@.2D@=V5R92!I<W-U960@=V%R<F%N=',@=&\@
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M;G0@1FER;2!A<F4@97AE<F-I<V%B;&4@870@)#`N,#$@<&5R('-H87)E(&%N
M9"!E>'!I<F4@;VX@2F%N=6%R>2`S,2P@,C`Q.2X\+V9O;G0^/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS
M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT
M("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!4:&4@0V]M
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M-S(Y("A3964@3F]T92`V*2P@<75A;&EF:65D(&9O<B!A8V-O=6YT:6YG('1R
M96%T;65N="!A<R!A(&9I;F%N8VEA;"!D97)I=F%T:79E("A3964@3F]T92`V
M*2!A;F0@=&AE($-O;G9E<G1I8FQE($YO=&5S('=E<F4@9&5T97)M:6YE9"!T
M;R!A;'-O(&AA=F4@82!B96YE9FEC:6%L(&-O;G9E<G-I;VX@9F5A='5R92!D
M:7-C;W5N="!O9B`D,S<R+#@U,"!R97-U;'1I;F<@9G)O;2!T:&4@8V]N=F5R
M<VEO;B!P<FEC92!O9B`D,"XW."!P97(@<VAA<F4@=VAI8V@@:7,@8F5L;W<@
M=&AE(&9A:7(@=F%L=64@;V8@)#$N,3$@<&5R('-H87)E(&]N('1H92!D871E
M(&]F('1H92!#;VYV97)T:6)L92!.;W1E<RX\+V9O;G0^/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS
M1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F
M;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R!4:&4@=&]T86P@
M9F5E<RP@:6YC;'5D:6YG(&-A<V@@<&%Y;65N=',@86YD('1H92!F86ER('9A
M;'5E(&]F('1H92!W87)R86YT<R!I<W-U960@=&\@=&AE(%!L86-E;65N="!!
M9V5N="P@:6YC=7)R960@:6X@8V]N;F5C=&EO;B!W:71H('1H92!F:6YA;F-I
M;F<@=V5R92`D,CDR+#8Y,BX@5&AE<V4@9F5E<R!W97)E(&%M;W)T:7IE9"!O
M=F5R('1H92!L:69E("AO;F4@>65A<BD@;V8@=&AE($-O;G9E<G1I8FQE($YO
M=&5S('5S:6YG('1H92!S=')A:6=H="UL:6YE(&UE=&AO9`T*(&%S(&ET(&%P
M<')O>&EM871E<R!T:&4@969F96-T:79E(&EN=&5R97-T(&UE=&AO9"X@)B,Q
M-C`[5&AE("0Q-3`L,#`P(&]R:6=I;F%L(&ES<W5E(&1I<V-O=6YT(&]N('1H
M92!#;VYV97)T:6)L92!.;W1E<R!W87,@86QS;R!A;6]R=&EZ960@;W9E<B!T
M:&4@;&EF92!O9B!T:&4@3F]T97,@;VX@82!S=')A:6=H="!L:6YE(&)A<VES
M+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[
M)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[3VX@3V-T;V)E<B`R,RP@,C`Q,BP@=&AE(&EN=F5S=&]R
M<R!E>'1E;F1E9"!T:&4@;F]T92!M871U<FET>2!D871E(&9O<B`Y,"!D87ES
M+B!4:&4@;6%T=7)I='D@9&%T92!O9B!T:&4@;F]T97,@:&%S(&)E96X@97AT
M96YD960@=&\@2F%N=6%R>2`S,2P@,C`Q,RP@1F5B<G5A<GD@,3@L(#(P,3,@
M;W(@36%R8V@@,C<L(#(P,3,@9F]R('1H92`R-"!N;W1E<RX\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF
M;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!/;B!$
M96-E;6)E<B`Q.2P@,C`Q,BP@=&AE($-O;G9E<G1I8FQE($YO=&5S(&%N9"!T
M:&4@86-C<G5E9"!I;G1E<F5S=',@=V5R92!A=71O;6%T:6-A;&QY(&-O;G9E
M<G1E9"!T;R!C;VUM;VX@<W1O8VL@=VAE;B!T:&4@0V]M<&%N>2!C;&]S960@
M;VX@86X@;V9F97)I;F<@;V8@:71S(&-O;6UO;B!S=&]C:R!I;B!W:&EC:"!T
M:&4@9W)O<W,@<')O8V5E9',@97AC965D960@=&AE("0T+#`P,"PP,#`@=&AR
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP
M=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#L@1'5R:6YG('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B`S,2P@
M,C`Q,BP@=&AE($-O;7!A;GD@<F5C;W)D960@86UO<G1I>F%T:6]N(&5X<&5N
M<V4@<F5L871E9"!T;R!T:&4@9&5F97)R960@9FEN86YC:6YG(&-O<W1S(&%N
M9"!T:&4@9&5B="!D:7-C;W5N="!O9B`D,C4R+#(T."!A;F0@)#<W-2PV,S<L
M(')E<W!E8W1I=F5L>2XF(S$V,#LF(S$V,#M$=7)I;F<@=&AE('EE87)S(&5N
M9&5D($1E8V5M8F5R(#,Q+"`R,#$Q+"!T:&4@0V]M<&%N>2!R96-O<F1E9"!A
M;6]R=&EZ871I;VX@97AP96YS92!R96QA=&5D('1O('1H92!D969E<G)E9"!F
M:6YA;F-I;F<@8V]S=',@86YD('1H92!D96)T(&1I<V-O=6YT(&]F("0T,"PT
M-#0@86YD("0Q,C0L,S8S+"!R97-P96-T:79E;'DN/"]F;VYT/CPO9&EV/@T*
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y
M;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P
M.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@02!S=6UM87)Y(&]F
M('1H92`X)2!396YI;W(@4W5B;W)D:6YA=&5D(%5N<V5C=7)E9"!#;VYV97)T
M:6)L92!0<F]M:7-S;W)Y($YO=&5S(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$R
M(&%N9"`R,#$Q(&%R92!A<R!F;VQL;W=S.CPO9F]N=#X\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF
M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE
M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY0<FEN8VEP86P@86UO=6YT/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/CDP,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T#0H@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^.3`P
M+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXH,34P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#$U,"PP
M,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^*#,W-RPQ-3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#,W,BPX-3`\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H-"B!I
M;FQI;F4[)SXY,#`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,97-S.B!P<FEN
M8VEP86P@86UO=6YT(&-O;G9E<G1E9"!T;R!S=&]C:SPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXH.3`P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O
M;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY#87)R>6EN9R!V86QU
M92!A="!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@,C`Q,2P@<F5S<&5C=&EV96QY
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D
M;W5B;&4[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ,C0L,S8S/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R
M,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,3(N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$531SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$97)I=F%T:79E
M<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^1&5R:79A=&EV97,@6T%B<W1R86-T73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T
M:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG
M;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA
M>3H@:6YL:6YE.R<^3F]T92`U("8C.#(Q,3L@1&5R:79A=&EV97,\+V9O;G0^
M/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J
M=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE
M/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\
M+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!#;VUP86YY(&AA
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M:6]N(&%S(&1E9FEN960@=6YD97(@1D%30B!!4T,@5&]P:6,@3F\N(#@Q-2`F
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M:R`H;W(@<V5C=7)I=&EE<R!C;VYV97)T:6)L92!I;G1O(&]R(&5X97)C:7-A
M8FQE(&9O<B!C;VUM;VX@<W1O8VLI(&ES(&ES<W5E9"`H;W(@8F5C;VUE<R!C
M;VYT<F%C='5A;&QY(&ES<W5A8FQE*2!A="!A('!R:6-E('!E<B!S:&%R92`H
M82`F(S@R,C`[3&]W97(@4')I8V4F(S@R,C$[*2!T:&%T(&ES(&QE<W,@=&AA
M;B!T:&4@97AE<F-I<V4@<')I8V4@;V8@<W5C:"!W87)R86YT(&%T('1H92!T
M:6UE+B!4:&4@86UO=6YT(&]F(&%N>2!S=6-H(&%D:G5S=&UE;G0@:7,@9&5T
M97)M:6YE9"!I;B!A8V-O<F1A;F-E('=I=&@@=&AE('!R;W9I<VEO;G,@;V8@
M=&AE('=A<G)A;G0@86=R965M96YT(&%N9"!D97!E;F1S('5P;VX@=&AE(&YU
M;6)E<B!O9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&ES<W5E9"`H;W(@9&5E
M;65D(&ES<W5E9"D@870@=&AE($QO=V5R(%!R:6-E(&%N9"!T:&4@97AT96YT
M('1O('=H:6-H('1H92!,;W=E<B!0<FEC92!I<R!L97-S('1H86X@=&AE(&5X
M97)C:7-E('!R:6-E(&]F('1H92!W87)R86YT(&%T('1H92!T:6UE+CPO9F]N
M=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="UW
M96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^06-T:79I=&EE<R!F;W(@9&5R:79A=&EV92!W87)R86YT(&EN
M<W1R=6UE;G1S(&1U<FEN9R!T:&4@<VEX(&UO;G1H<R!E;F1E9"!*=6YE(#,P
M+"`R,#$S('=E<F4@87,@9F]L;&]W<SH\+V9O;G0^/"]D:78^#0H\9&EV(&%L
M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
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M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
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M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$96-E;6)E
M<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C4L,30V+#,S.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#<V)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C
M8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,RPQ
M,C(L.#(Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@U.3`L,C$W/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@R-BPW-C0\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
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M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0-"B!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^0F%L86YC92P@2G5N92`S,"P@,C`Q,SPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^,BPY-3<L.3<W/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E1H92!F86ER('9A;'5E<R!O9B!T:&4@9&5R:79A
M=&EV92!W87)R86YT<R!W97)E(&-A;&-U;&%T960@=7-I;F<@82!M;V1I9FEE
M9"!B:6YO;6EA;"!V86QU871I;VX@;6]D96P@=VET:"!T:&4@9F]L;&]W:6YG
M(&%S<W5M<'1I;VYS(&%T($IU;F4@,S`L(#(P,3,@86YD($1E8V5M8F5R(#,Q
M+"`R,#$R+CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T
M>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('=I
M9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$96-E
M;6)E<B`S,2P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/DIU;F4@,S`L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X]
M,T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C(P,3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$P)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X
M('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,SPO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C
M965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY-87)K970@=F%L=64@;V8@8V]M;6]N('-T;V-K(&]N(&UE87-U
M<F5M96YT(&1A=&4@*#$I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ+C8U/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY!9&IU<W1E9"!E>&5R8VES
M92!P<FEC93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/C`N-#@@+2`D,"XX,3PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ+C4P("T@)#(N-#<U/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,3`@+2`D,"XW
M-SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C$N,#4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY7
M87)R86YT(&QI=F5S(&EN('EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CLG(&-O;'-P86X],T0R/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M-"!M;VYT:',O-2!Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R<@8V]L<W!A;CTS1#(^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXT+C4@>65A<G,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[#0H@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!V
M;VQA=&EL:71Y("@S*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^,3(U)2`M(#$V,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ
M-30\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!D:79I
M9&5N9"!Y:65L9"`H-"D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE
M9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,2DF(S$V,#LF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.34E('9A;&EG;CTS
M1'1O<#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#DU)2!V86QI9VX],T1T;W`^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4E('9A;&EG;CTS1'1O
M<#X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^*#(I)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W
M:61T:#TS1#DU)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF
M>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#DU)2!V86QI9VX]
M,T1T;W`^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#4E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#,I)B,Q-C`[)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DU)2!V86QI9VX],T1T
M;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
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M)2!V86QI9VX],T1T;W`^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$.34E('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH
M-"DF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#DU)2!V86QI9VX],T1T;W`^#0H\9&EV#0H@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^36%N86=E;65N
M="!D971E<FUI;F5D('1H92!D:79I9&5N9"!Y:65L9"!T;R!B92`P)2!B87-E
M9"!U<&]N(&ET<R!E>'!E8W1A=&EO;B!T:&%T(&ET('=I;&P@;F]T('!A>2!D
M:79I9&5N9',@9F]R('1H92!F;W)E<V5E86)L92!F=71U<F4N/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M
M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.;W1E(#8@)B,X,C$Q
M.R!$97)I=F%T:79E<SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T
M:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!#;VUP86YY(&AA<R!D
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M(&%S(&1E9FEN960@=6YD97(@1D%30B!!4T,@5&]P:6,@3F\N(#@Q-2`F(S@R
M,3$[(#0P+B!4:&4@=V%R<F%N=',@9W)A;G1E9"!I;B!C;VYN96-T:6]N('=I
M=&@@=&AE(&ES<W5A;F-E(&]F('1H92!#;VUP86YY)B,X,C$W.W,@4W1O8VL@
M3V9F97)I;F<@86YD(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG)B,Q-C`[
M*%-E92!.;W1E(#DI+"!T:&4@0V]N=F5R=&EB;&4@3F]T97,@*%-E92!.;W1E
M(#4I(&%N9"!T:&4@<&QA8V5M96YT(&%G96YT('=A<G)A;G1S(&-O;G1A:6X@
M86YT:2UD:6QU=&EO;B!P<F]V:7-I;VYS('1H870@<')O=FED92!F;W(@82!R
M961U8W1I;VX@:6X@=&AE(&5X97)C:7-E('!R:6-E(&]F('-U8V@@=V%R<F%N
M=',@:6X@=&AE(&5V96YT('1H870@9G5T=7)E(&-O;6UO;B!S=&]C:R`H;W(@
M<V5C=7)I=&EE<R!C;VYV97)T:6)L92!I;G1O(&]R(&5X97)C:7-A8FQE(&9O
M<B!C;VUM;VX@<W1O8VLI(&ES(&ES<W5E9"`H;W(@8F5C;VUE<R!C;VYT<F%C
M='5A;&QY(&ES<W5A8FQE*2!A="!A('!R:6-E('!E<B!S:&%R92`H82`F(S@R
M,C`[3&]W97(@4')I8V4F(S@R,C$[*2!T:&%T(&ES(&QE<W,@=&AA;B!T:&4@
M97AE<F-I<V4@<')I8V4@;V8@<W5C:"!W87)R86YT(&%T('1H92!T:6UE+B!4
M:&4@86UO=6YT(&]F(&%N>2!S=6-H(&%D:G5S=&UE;G0@:7,@9&5T97)M:6YE
M9"!I;B!A8V-O<F1A;F-E('=I=&@@=&AE('!R;W9I<VEO;G,@;V8@=&AE('=A
M<G)A;G0@86=R965M96YT(&%N9"!D97!E;F1S('5P;VX@=&AE(&YU;6)E<B!O
M9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&ES<W5E9"`H;W(@9&5E;65D(&ES
M<W5E9"D@870@=&AE($QO=V5R(%!R:6-E(&%N9"!T:&4@97AT96YT('1O('=H
M:6-H('1H92!,;W=E<B!0<FEC92!I<R!L97-S('1H86X@=&AE(&5X97)C:7-E
M('!R:6-E(&]F('1H92!W87)R86YT(&%T('1H92!T:6UE+CPO9F]N=#X\+V1I
M=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#(W<'0[)SXF(S$V,#L\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M
M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A
M;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E5N
M:71S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$96-E;6)E<B`S,2P@,C`Q,#PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LD
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD
M:78-"B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY7
M87)R86YT<R!I<W-U960@=VET:"!#;VYV97)T:6)L92!.;W1E<R`H4V5E($YO
M=&4@-2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C(X-RPP-C$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY0;&%C96UE;G0@86=E;G0@=V%R<F%N=',@<F5L871E9"!T;R!I<W-U86YC
M92!O9B!#;VYV97)T:6)L92!.;W1E<R`H4V5E($YO=&4@-2D\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,3@X+#4W.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#DW,BPW.#4\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,BPU.3$L.3`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E!L86-E;65N="!A
M9V5N="!W87)R86YT<R!R96QA=&5D('1O(&ES<W5A;F-E(&]F('-T;V-K("A3
M964@3F]T92`Y*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#(Y-2PY-3`\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY#:&%N9V4@
M:6X@9F%I<B!V86QU93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24-"B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O
M;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$96-E;6)E<B`S,2P@,C`Q,3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXS+#,X.2PW-S$\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED
M.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXT+#0S.2PV,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.PT*
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C(T,BPQ.3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,S$X+#`X-SPO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C
M965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY0;&%C96UE;G0@86=E;G0@=V%R<F%N=',@<F5L871E9"!T;R!3
M=&]C:R!/9F9E<FEN9R`H4V5E($YO=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$R,2PP.34\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,34Y
M+#`T-#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^5V%R<F%N=',@:7-S=65D('=I=&@@,C`Q
M,B!#;VUM;VX@4W1O8VL@3V9F97)I;F<M02`H4V5E($YO=&4@.2D\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXQ+#0P.2PU-30\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^5V%R<F%N
M=',@:7-S=65D('=I=&@@,C`Q,B!#;VUM;VX@4W1O8VL@3V9F97)I;F<M0B`H
M4V5E($YO=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C$L-34Y+#4P-3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#8V-2PV.3<\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/E!L86-E;65N="!A9V5N="!W87)R86YT<R!R96QA=&5D('1O
M(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG("A3964@3F]T92`Y*3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-#8W+#@T
M-3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H-"B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C0Y.2PW,#<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXH,RPW-3,L,#4V/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH
M-"PR,S$L,S(T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L
M;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B
M;&4[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C4L,30V+#,S.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N=`T*('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I
M=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P
M.R!/;B!$96-E;6)E<B`Q.2P@,C`Q,BP@87,@=&AE(')E<W5L="!O9B!T:&4@
M4VAA<F4@17AC:&%N9V4L(&ET('=A<R!D971E<FUI;F5D('1H870@=&AE(&9L
M;V]R(&9O<B!R97-E='1I;F<@=&AE(&5X97)C:7-E('!R:6-E('=A<R!M970@
M86YD('1H92!E>&5R8VES92!P<FEC92!O9B!T:&4@8V5R=&%I;B!W87)R86YT
M<R!W87,@<V5T('1O(&)E("0P+C(V("AB969O<F4@17AC:&%N9V4@4F%T:6\@
M861J=7-T;65N="DN)B,Q-C`[5&AE<F5F;W)E+"!T:&5S92!W87)R86YT<R!W
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M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN
M9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!F86ER
M('9A;'5E<R!O9B!T:&4@9&5R:79A=&EV92!W87)R86YT<R!W97)E(&-A;&-U
M;&%T960@=7-I;F<@82!M;V1I9FEE9"!B:6YO;6EA;"!V86QU871I;VX@;6]D
M96P@=VET:"!T:&4@9F]L;&]W:6YG(&%S<W5M<'1I;VYS(&%T(&5A8V@@8F%L
M86YC92!S:&5E="!D871E+"!T:&4@=')A;G-F97(@9&%T92!O;B!$96-E;6)E
M<B`Q.2P@,C`Q,BP@86YD('1H92!D871E(&9O<B!T:&4@;F5W(&=R86YT<R!I
M;B!*86YU87)Y(&%N9"!$96-E;6)E<B`R,#$R+B`H5&AE(&UA<FME="!V86QU
M92!O9B!C;VUM;VX@<W1O8VLL(&%D:G5S=&5D(&5X97)C:7-E('!R:6-E(&%N
M9"!O9F9E<FEN9R!P<FEC92!P<F5S96YT960@9&]E<R!N;W0@<F5F;&5C="!T
M:&4@:6UP86-T(&]F('1H92!3:&%R92!%>&-H86YG92XI/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$
M;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY$96-E;6)E<B`S,2P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/DIA;G5A<GD@,S$L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$96-E;6)E
M<B`Q.2P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E
M;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D1E8V5M8F5R(#(W+#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^1&5C96UB97(@,S$L/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<PT*(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R!T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[('1E>'0M86QI9VXZ(&QE9G0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L
M<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$-#`E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,S<\
M+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXD/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,S<\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#0P)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M>3H@:6YL:6YE.R<^,"XR-"`M("0P+C(V/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
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M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+W1D
M/@T*/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXP+C(S("T@)#`N,C8\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C`N-#$@+2`D,"XX,SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M,"XR,B`M("0P+C(V/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+W1D/@T*/'1D('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+C0Q
M("T@)#`N.#,\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#0P)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E)I<VL@9G)E92!I;G1E<F5S="!R871E("@R*3PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^,"XQ,"4@+2`P+C<W/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C`N.30\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO=W)A
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,3`E
M("T@,"XW-SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY787)R86YT(&QI=F5S(&EN
M('EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0@;6]N
M=&AS+S5Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-B!Y96%R<SPO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0@;6]N
M=&AS+S5Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^17AP96-T960@=F]L871I;&ET>2`H,RD\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX]
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E
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M9VXZ(')I9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXQ,C4E("T@,38Q/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI
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M9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,3(U)2`M(#$V,3PO9F]N
M=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0T,"4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!D:79I9&5N
M9"!Y:65L9"`H-"D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N
M=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX]
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-3PO9F]N=#X\+W1D
M/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C(U/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-3PO9F]N=#X\
M+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY286YG92!O9B!P97)C96YT86=E(&]F(&5X:7-T:6YG
M('-H87)E<R!O9F9E<F5D("@V*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C,U/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS-3PO9F]N
M=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,S4\+V9O;G0^/"]T9#X-"CQT9"!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)3PO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C,U/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B4\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,"XQ."`M("0P+C4U/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+C$S("T@)#`N-38\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F
M;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/C`N,#$@+2`D,"XU-3PO9F]N=#X\+W1D/@T*/'1D
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M>3H@:6YL:6YE.R<^,"XQ,B`M("0P+C8P/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
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M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+W1D
M/@T*/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXP+C`Q("T@)#`N-34\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-
M"CPO9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV/@T*/'1A
M8FQE#0H@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#,E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY4:&4@;6%R:V5T('9A;'5E(&]F(&-O;6UO;B!S=&]C:R!I<R!B87-E
M9"!O;B!A;B!E;G1E<G!R:7-E('9A;'5A=&EO;BX\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1J
M=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G
M=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O
M;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#0E('9A;&EG
M;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B@R*28C,38P.R8C,38P.SPO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.38E('9A;&EG;CTS1'1O<#X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\
M9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P
M)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q
M,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$-"4@=F%L:6=N/3-$=&]P/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M*#,I)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T
M:#TS1#DV)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A
M8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0T)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-"DF(S$V,#LF(S$V,#L\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.38E('9A;&EG;CTS1'1O<#X-
M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^36%N86=E;65N="!D971E<FUI;F5D('1H92!D:79I9&5N9"!Y:65L9"!T
M;R!B92`P)2!B87-E9"!U<&]N(&ET<R!E>'!E8W1A=&EO;B!T:&%T(&ET('=I
M;&P@;F]T('!A>2!D:79I9&5N9',@9F]R('1H92!F;W)E<V5E86)L92!F=71U
M<F4N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D
M:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N
M=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT
M86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$-"4@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#4I)B,Q-C`[)B,Q-C`[/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y-B4@
M=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY-86YA9V5M96YT(&AA<R!D971E<FUI;F5D('1H870@
M=&AE('!R;V)A8FEL:71Y(&]F(&$@<W1O8VL@;V9F97)I;F<@:7,@,C4E(&9O
M<B!E86-H('%U87)T97(@;V8@=&AE(&YE>'0@9FEV92!Y96%R<RX\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF
M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE
M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0T)2!V
M86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXH-BDF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D('=I9'1H/3-$.38E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI
M9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-
M"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$-"4@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#<I)B,Q-C`[)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DV)2!V86QI9VX],T1T
M;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/E)E<')E<V5N=',@=&AE(&5S=&EM871E9"!O9F9E<FEN9R!P<FEC
M92!R86YG92!I;B!F=71U<F4@;V9F97)I;F=S(&%S(&1E=&5R;6EN960@8GD@
M;6%N86=E;65N="X\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CPO=&%B
M;&4^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V
M,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#$S+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^26YC;VUE(%1A
M>&5S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DEN8V]M92!487AE<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M92!487AE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^
M3F]T92`W("8C.#(Q,3L@26YC;VUE(%1A>&5S/"]F;VYT/CPO9&EV/@T*/&1I
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($1E9F5R<F5D
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M(&QI86)I;&ET:65S(&%T($1E8V5M8F5R(#,Q+"`R,#$R(&%N9"`R,#$Q(&%R
M92!A<R!F;VQL;W=S.CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z
M(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ
M93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\
M='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X]
M,T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,#$Q/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^1&5F97)R960@=&%X(&%S<V5T<SH\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.R8C,38P.R8C,38P.TYE
M="!O<&5R871I;F<@;&]S<V5S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/C$S+#`X.2PS,30\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[4VAA<F4M8F%S960@8V]M<&5N
M<V%T:6]N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,2PT.3<L-34V/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ#0H@:6YL:6YE.R<^-S0Q+#0R,#PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,S,L,#0S/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S
M;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R
M:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,34L,S,Y+#8S-3PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S(&]F($1E
M8V5M8F5R(#,Q+"`R,#$R+"!F;W(@52Y3+B!F961E<F%L(&EN8V]M92!T87@@
M<F5P;W)T:6YG('!U<G!O<V5S+"!T:&4@0V]M<&%N>2!H87,@87!P<F]X:6UA
M=&5L>2`D-#,@;6EL;&EO;B!O9B!U;G5S960@;F5T(&]P97)A=&EN9R!L;W-S
M97,@*"8C.#(R,#M.3TQS)B,X,C(Q.RD@879A:6QA8FQE(&9O<B!C87)R>2!F
M;W)W87)D('1O(&9U='5R92!Y96%R<RX@5&AE(&)E;F5F:70@9G)O;2!T:&4@
M8V%R<GD@9F]R=V%R9"!O9B!S=6-H($Y/3',@=VEL;"!B96=I;B!E>'!I<FEN
M9R!D=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,C`N($)E
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H
M92!D:69F97)E;F-E(&)E='=E96X@=&AE(&EN8V]M92!T87@@<')O=FES:6]N
M(&%N9"!T:&4@86UO=6YT('1H870@=V]U;&0@<F5S=6QT(&EF('1H92!5+E,N
M($9E9&5R86P@<W1A='5T;W)Y(')A=&4@;V8@,S0E('=E<F4@87!P;&EE9"!T
M;R!P<F4M=&%X(&EN8V]M92`H;&]S<RD@9F]R('1H92!Y96%R<R!E;F1E9"!$
M96-E;6)E<B`S,2P@,C`Q,B!A;F0@,C`Q,2!A<F4@87,@9F]L;&]W<SH\+V9O
M;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#$T/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.PT*(#PO9F]N=#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$-CX-"CQD:78@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$96-E;6)E
M<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0V/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D1E8V5M8F5R(#,Q
M+"`R,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY&
M961E<F%L(&EN8V]M92!T87AE<R!A="`S-"4\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3,T+C`P/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^+3,T+C`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.PT*(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXW-38L,3,V/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/CDN,#0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,C$N,SD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C,S+#`T,SPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXR+C<Y/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+#<T.#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXP+C$S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT#0H@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0N,3@\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/C4V+#`S,SPO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C8S/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,2PU,#0L,34Q/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S
M;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R
M:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T#0H@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^4')O=FES:6]N(&9O<B!I;F-O;64@=&%X
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@
M9&]U8FQE.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X
M.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,30N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$531SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VUM:71M96YT<R!A
M;F0@0V]N=&EN9V5N8VEE<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V]M;6ET;65N=',@
M86YD($-O;G1I;F=E;F-I97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM:71M96YT<R!A;F0@0V]N
M=&EN9V5N8VEE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@9&ES
M<&QA>3H@:6YL:6YE.R<^3F]T92`V("8C.#(Q,3L@0V]M;6ET;65N=',@86YD
M($-O;G1I;F=E;F-I97,\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S
M=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=L971T97(M<W!A8VEN9SH@
M.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\
M9&EV/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,R4^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SYA+B8C,38P.R8C,38P
M.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$.#`E/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]R;65R;'D@:VYO=VX@87,@4')O=&5I;B!$97-I9VX@3&%B<RD@:6X@,C`P
M,R!T;R!S96-U<F4@97AC;'5S:79E(')I9VAT<R!T;R!A('-P96-I9FEC(&%N
M=&EB;V1Y('=H96X@8V]N:G5G871E9"!W:71H(&%L<&AA(&5M:71T:6YG(')A
M9&EO:7-O=&]P97,N(%5P;VX@97AE8W5T:6]N(&]F('1H92!A9W)E96UE;G0L
M('=E(&UA9&4@82!L:6-E;G-E(&9E92!P87EM96YT(&]F("0S+#`P,"PP,#`N
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=L971T
M97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R!792!A9W)E960@=&\@;6%K92!M:6QE
M<W1O;F4@<&%Y;65N=',@=&]T86QI;F<@)#<L-S4P+#`P,"!F;W(@=&AE(&%C
M:&EE=F5M96YT(&]F('1H92!F;VQL;W=I;F<@86=R965D('1O(&%N9"!C;VYT
M<F%C=&5D(&UI;&5S=&]N97,Z/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS
M1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS
M1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M.R`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X
M."4^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B@Q*2!W:&5N($-O;7!A;GD@:6YI=&EA=&5S(&$@4&AA<V4@22!#;&EN
M:6-A;"!4<FEA;"!O9B!A(&QI8V5N<V5D('!R;V1U8W0\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M-S4P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#@X)3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXW-3`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/C$L-3`P+#`P,#PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X)3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C$L-S4P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-2D@1FER
M<W0@8V]M;65R8VEA;"!S86QE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^,2PU,#`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH
M-BD@869T97(@=&AE(&9I<G-T("0Q,"PP,#`L,#`P(&EN(&YE="!S86QE<SPO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD
M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L
M-3`P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CQF;VYT('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF
M(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%5N
M9&5R('1H92!A9W)E96UE;G0L('=E(&%G<F5E9"!T;R!P87D@=&\@06)B;W1T
M($)I;W1H97)A<&5U=&EC<R!#;W)P(&]N(&$@8V]U;G1R>2UB>2UC;W5N=')Y
M(&)A<VES(&$@<F]Y86QT>2!O9B!U<"!T;R`Q,B4@;V8@;F5T('-A;&5S(&]F
M(&%L;"!L:6-E;G-E9"!P<F]D=6-T<R!U;G1I;"!T:&4@;&%T97(@;V8Z("@Q
M*2`Q,BXU('EE87)S(&%F=&5R('1H92!F:7)S="!C;VUM97)C:6%L('-A;&4L
M(&]R("@R*2!W:&5N('1H92!P871E;G1S(&5X<&ER92X\+V9O;G0^/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T
M>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V
M,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S(&]F($1E8V5M
M8F5R(#,Q+"`R,#$R+"!W92!M970@;W5R(&9I<G-T(&UI;&5S=&]N92!A;F0@
M=7!O;B!R96%C:&EN9R!T:&4@;6EL97-T;VYE('=E('!A:60@06)B;W1T($)I
M;W1H97)A<&5U=&EC<R!#;W)P+B!A(&UI;&5S=&]N92!P87EM96YT(&]F("0W
M-3`L,#`P(&]N($IU;'D@,C0L(#(P,3(N/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.SPO9F]N=#X\+V1I=CX-"CQD:78^#0H\=&%B;&4@<W1Y;&4],T0G=VED
M=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M
M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^
M#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1T;W`@=VED=&@]
M,T0S)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/F(N)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!V86QI9VX],T1T;W`@=VED=&@],T0X,"4^#0H\9&EV(&%L:6=N/3-$:G5S
M=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<W1Y;&4Z(&ET86QI8SL@9&ES<&QA>3H@:6YL:6YE.R<^365M;W)I
M86P@4VQO86X@2V5T=&5R:6YG($-A;F-E<B!#96YT97(@*$U32T-#*3PO9F]N
M=#XN)B,Q-C`[)B,Q-C`[26X@1F5B<G5A<GD@,C`P,BP@=V4@96YT97)E9"!I
M;G1O(&$@;&EC96YS92!A9W)E96UE;G0@=VET:"!-4TM#0R!T:&%T(')E<75I
M<F5S(&$@=&5C:&YO;&]G>2!A8V-E<W,@9F5E(&]F("0U,"PP,#`@=7!O;B!E
M>&5C=71I;VXL(&%N(&%N;G5A;"!M86EN=&5N86YC92!F964@;V8@)#4P+#`P
M,"!A;F0@86X@86YN=6%L(')E<V5A<F-H(&9U;F1I;F<@;V8@)#4P+#`P,"!F
M;W(@87,@;&]N9R!A<R!T:&4@86=R965M96YT(&ES(&EN(&9O<F-E+CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S
M='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X.R<@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY-
M:6QE<W1O;F5S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^4&%Y;65N=',\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*
M/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0X."4^#0H\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,2D@9FEL:6YG(&]F(&%N($YE
M=R!$<G5G($%P<&QI8V%T:6]N("@F(S@R,C`[3D1!)B,X,C(Q.RD@;W(@<F5G
M=6QA=&]R>2!A<'!R;W9A;"`\+V9O;G0^9F]R(&5A8V@@;&EC96YS960@<')O
M9'5C=#PO9F]N=#X\+V1I=CX-"CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C<U,"PP,#`\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X
M."4^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXQ+#<U,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L
M:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=L971T97(M
M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P
M.R8C,38P.R8C,38P.R8C,38P.R!5;F1E<B!T:&4@86=R965M96YT+"!W92!A
M9W)E960@=&\@<&%Y('1O($U32T-#(&]N(&$@8V]U;G1R>2UB>2UC;W5N=')Y
M(&)A<VES(&$@<F]Y86QT>2!O9B`R)2!O9B!N970@<V%L97,@;V8@86QL(&QI
M8V5N<V5D('!R;V1U8W1S('5N=&EL('1H92!L871E<B!O9CH@*#$I(#$P('EE
M87)S(&9R;VT@=&AE(&9I<G-T(&-O;6UE<F-I86P@<V%L92P@;W(@*#(I('=H
M96X@=&AE('!A=&5N=',@97AP:7)E+B8C,38P.R8C,38P.U=E(&5X<&5C="!T
M;R!F:6QE('1H92!.1$$@9F]R(')E9W5L871O<GD@87!P<F]V86P@:6X@,C`Q
M-BX\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78^
M#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H
M="!V86QI9VX],T1T;W`@=VED=&@],T0S)3X-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/F,N)B,Q-C`[)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0X
M,"4^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<W1Y;&4Z(&ET86QI8SL@9&ES
M<&QA>3H@:6YL:6YE.R<^3V%K(%)I9&=E($YA=&EO;F%L($QA8F]R871O<GD@
M*$]23DPI/"]F;VYT/B`F(S@R,3$[(%=E(&AA=F4@8V]N=')A8W1E9"!T;R!P
M=7)C:&%S92!R861I;V%C=&EV92!M871E<FEA;"!T;R!B92!U<V5D(&9O<B!R
M97-E87)C:"!A;F0@9&5V96QO<&UE;G0@=&AR;W5G:"!$96-E;6)E<B`R,#$S
M+B!792!C;VYT<F%C=&5D('1O('!U<F-H87-E("0@,S,W+#4P,"!O9B!R861I
M;V%C=&EV92!M871E<FEA;"!T;R!B92!U<V5D(&9O<B!R97-E87)C:"!A;F0@
M9&5V96QO<&UE;G0L('=I=&@@82!R96YE=V%L(&]P=&EO;B!A="!T:&4@8V]N
M=')A8W0@96YD+B`F(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*
M/&1I=CX-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS
M1')I9VAT('9A;&EG;CTS1'1O<"!W:61T:#TS1#,E/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(&0N)B,Q
M-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0X,"4^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M;W1A;"!E<W1I;6%T960@<')O:F5C="!C;W-T+B`F(S$V,#M4:&4@9&]W;B!P
M87EM96YT('1O=&%L:6YG("0R,SDL,#`P('=A<R!P86ED(&EN(#(P,#<@86YD
M(#(P,3(N("8C,38P.U1H92!A9W)E96UE;G0@=V%S(&%M96YD960@=&\@<')O
M=FED92!F;W(@861D:71I;VYA;"!S97)V:6-E<R!O;B!!=6=U<W0@-BP@,C`Q
M,BP@3V-T;V)E<B`R,BP@,C`Q,B!A;F0@36%Y(#$V+"`R,#$S+B`F(S$V,#M4
M:&4@=&]T86P@<')O:F5C="!I<R!N;W<@97-T:6UA=&5D(&%T("0@,BPQ-S,L
M.34U+B`F(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CPO=&%B
M;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=CX-"CQT86)L
M92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG
M;CTS1'1O<"!W:61T:#TS1#,E/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^92XF(S$V,#LF(S$V,#L\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#@P)3X-"CQD
M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M<B`H1DA#4D,I/"]F;VYT/BXF(S$V,#LF(S$V,#M/;B!*=6YE(#$U+"`R,#$R
M+"!W92!E;G1E<F5D(&EN=&\@82!L:6-E;G-E(&%N9"!S<&]N<V]R960@<F5S
M96%R8V@@86=R965M96YT('=I=&@@1DA#4D,N(%=E('=I;&P@8G5I;&0@=7!O
M;B!P<F5V:6]U<R!A;F0@;VYG;VEN9R!C;&EN:6-A;"!T<FEA;',L('=I=&@@
M0D,X("AL:6-E;G-E9"!A;G1I8F]D>2D@86YD(&5V96YT=6%L;'D@9&5V96QO
M<"!A(&-L:6YI8V%L('1R:6%L('=I=&@@06-T:6YI=6T@,C(U+B`F(S$V,#M&
M2$-20R!H87,@8W5R<F5N=&QY(&-O;7!L971E9"!0:&%S92!)(&%N9"!0:&%S
M92!)22!O9B!T:&4@8VQI;FEC86P@=')I86P@86YD('=E(&EN=&5N9"!T;R!S
M=&%R="!P<F5P87)A=&EO;B!F;W(@82!P:79O=&%L('1R:6%L(&QE861I;F<@
M=&\@86X@1D1!(&%P<')O=F%L+B`F(S$V,#M792!H879E(&)E96X@9W)A;G1E
M9"!E>&-L=7-I=F4@<FEG:'1S('1O('1H92!"0S@@86YT:6)O9'D@86YD(')E
M;&%T960@;6%S=&5R(&-E;&P@8F%N:R!D979E;&]P960@8GD@1DA#4D,N("8C
M,38P.U1H92!C;W-T('1O(&1E=F5L;W`@=&AE('1R:6%L('=I;&P@<F%N9V4@
M9G)O;2`D,3,N,B!M:6QL:6]N('1O("0R,RXU(&UI;&QI;VXL(&1E<&5N9&EN
M9R!O;B!T:&4@=')I86P@9&5S:6=N(&%S(')E<75I<F5D(&)Y('1H92!&1$$N
M("8C,38P.U5N9&5R('1H92!T97)M<R!O9B!T:&4@<W!O;G-O<F5D(')E<V5A
M<F-H(&%G<F5E;65N="P@=V4@=VEL;"!F=6YD('1H92!&2$-20R!L86(@=VET
M:"`D,34P+#`P,"!P97(@>65A<B!F;W(@=&AE(&9I<G-T('1W;R!Y96%R<R!A
M;F0@)#(U,"PP,#`@=&AE<F5A9G1E<BX@)B,Q-C`[4&%Y;65N=',@;6%D92!T
M;W=A<F0@9G5N9&EN9R!T:&4@;&%B('=I;&P@8F4@8W)E9&ET960@=&]W87)D
M(')O>6%L='D@<&%Y;65N=',@;W=E9"!T;R!&2$-20R!I;B!T:&4@9VEV96X@
M>65A<BX@)B,Q-C`[02!M:6QE<W1O;F4@<&%Y;65N="!O9B`D,2!M:6QL:6]N
M('=I;&P@8F4@9'5E('1O($9(0U)#('5P;VX@1D1!(&%P<')O=F%L(&]F('1H
M92!F:7)S="!D<G5G+B`F(S$V,#M5<&]N(&-O;6UE<F-I86P@<V%L92!O9B!T
M:&4@9')U9RP@<F]Y86QT>2!P87EM96YT<R!O9B`R)2!O9B!N970@<V%L97,@
M=VEL;"!B92!D=64@=&\@1DA#4D,N)B,Q-C`[3VX@075G=7-T(#$R+"`R,#$S
M+"!T:&4@0V]M<&%N>2!P86ED("0S-RPU,#`@=&\@1DA#4D,N/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+V1I=CX-"CQD:78^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P
M,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@
M,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^
M#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1T;W`@=VED=&@],T0S)3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/F8N)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI
M9VX],T1T;W`@=VED=&@],T0X,"4^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<W1Y;&4Z(&ET86QI8SL@9&ES<&QA>3H@:6YL:6YE.R<^35-+0T,\+V9O;G0^
M+B8C,38P.R8C,38P.T]N($UA<F-H(#(W+"`R,#$R+"!W92!E;G1E<F5D(&EN
M=&\@82!C;&EN:6-A;"!T<FEA;"!A9W)E96UE;G0@=VET:"!-96UO<FEA;"!3
M;&]A;B!+971T97)I;F<@0V%N8V5R($-E;G1E<BX@)B,Q-C`[5&AE($-O;7!A
M;GD@=VEL;"!P87D@)#,Q+#$X-2!F;W(@96%C:"!P871I96YT('1H870@:&%S
M(&-O;7!L971E9"!T:&4@8VQI;FEC86P@=')I86PN(%5P;VX@97AE8W5T:6]N
M(&]F('1H92!A9W)E96UE;G0L('1H92!#;VUP86YY(&ES(')E<75I<F5D('1O
M('!A>2!A('-T87)T+75P(&9E92!O9B`D-SDL-C(S+B`F(S$V,#M4:&4@86UO
M=6YT(&1U92!O9B`D-SDL-C(S('=A<R!P86ED(&]N($IU;'D@,3`L(#(P,3(N
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^
M#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78^#0H\=&%B;&4@<W1Y;&4]
M,T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1T;W`@
M=VED=&@],T0S)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/F<N)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!V86QI9VX],T1T;W`@=VED=&@],T0X,"4^#0H\9&EV(&%L:6=N
M/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M($9(0U)#+B`F(S$V,#M792!W:6QL('!A>2`D,S$L,S8V(&9O<B!E86-H('!A
M=&EE;G0@=&AA="!H87,@8V]M<&QE=&5D('1H92!C;&EN:6-A;"!T<FEA;"X@
M57!O;B!E>&5C=71I;VX@;V8@=&AE(&%G<F5E;65N="P@=V4@87)E(')E<75I
M<F5D('1O('!A>2!A('-T87)T+75P(&9E92!O9B`D,3DL-S0Y+B`F(S$V,#L\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=CX-"CQT86)L92!S='EL93TS1"=W
M:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N
M="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1'1O<"!W:61T
M:#TS1#,E/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^:"XF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#@P)3X-"CQD:78@86QI9VX],T1J
M=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M97(\+V9O;G0^+B8C,38P.R8C,38P.T]N($%U9W5S="`R."P@,C`Q,BP@=V4@
M96YT97)E9"!I;G1O(&$@8VQI;FEC86P@=')I86P@86=R965M96YT('=I=&@@
M5&AE(%5N:79E<G-I='D@;V8@5&5X87,@32Y$+B!!;F1E<G-O;B!#86YC97(@
M0V5N=&5R+B`F(S$V,#M4:&4@=&]T86P@97-T:6UA=&5D(&-O<W0@;V8@8V]N
M9'5C=&EN9R!T:&4@8VQI;FEC86P@=')I86P@:7,@)#0X,2PR,#0L('=H:6-H
M(&EN8VQU9&5S(&$@;F]N+2!R969U;F1A8FQE(&EN<W1I='5T:6]N86P@9F5E
M(&]F("0Q-"PU,#`N("8C,38P.U1H92!E<W1I;6%T960@8V]S="!I<R!B87-E
M9"!O;B!T<F5A=&EN9R`R-"!P871I96YT<R!T:')O=6=H(#(P,3,N("8C,38P
M.U5P;VX@97AE8W5T:6]N(&]F('1H92!A9W)E96UE;G0L('=E('=E<F4@<F5Q
M=6ER960@=&\@;6%K92!A('!A>6UE;G0@;V8@)#,S+#DT-BX@)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1T;W`@
M=VED=&@],T0S)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/FDN)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R<@=F%L:6=N
M/3-$=&]P('=I9'1H/3-$.#`E/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M-C`[5&AE(%!H87-E($DO24D@8VQI;FEC86P@=')I86P@=VEL;"!B92!C;VYD
M=6-T960@=VET:"!!8W1I;FEU;2`R,C4N("8C,38P.U1H92!C;&EN:6-A;"!T
M<FEA;"!W:6QL(&)E(&-O;F1U8W1E9"!U;F1E<B!T:&4@<')O=&]C;VQS(&5S
M=&%B;&ES:&5D(&)Y('5S(&%N9"!P=7)S=6%N="!T;R!A;B!);G9E<W1I9V%T
M:6]N86P@3F5W($1R=6<@17AE;7!T:6]N("A)3D0@,3`X,#<I(&AE;&0@8GD@
M=7,N("8C,38P.U=E('=I;&P@<&%Y("0S."PU,#$@<&5R('!A=&EE;G0L('=H
M;R!H87,@8V]M<&QE=&5D('1H92!C;&EN:6-A;"!T<FEA;"X@5V4@87)E(')E
M<75I<F5D('1O('!A>2!A('-T87)T+75P(&9E92!O9B`D,C(L.#0W+"!A;B!A
M;FYU86P@<&AA<FUA8WD@9F5E(&]F("0R+#`R-2!A;F0@86X@86UE;F1M96YT
M('!R;V-E<W-I;F<@9F5E(&]F("0U,#`L('=H96X@87!P;&EC86)L92X@)B,Q
M-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D
M:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$-"4^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)R!V86QI
M9VX],T1T;W`@=VED=&@],T0Y-B4^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US='EL93H@:71A;&EC.R!D:7-P;&%Y.B!I;FQI;F4[)SY5;FEV97)S:71Y
M(&]F(%!E;FYS>6QV86YI83PO9F]N=#XN)B,Q-C`[)B,Q-C`[)B,Q-C`[3VX@
M3F]V96UB97(@,C$L(#(P,3(L('=E(&5N=&5R960@:6YT;R!A(&-L:6YI8V%L
M('1R:6%L(&%G<F5E;65N="!W:71H('1H92!5;FEV97)S:71Y(&]F(%!E;FYS
M>6QV86YI82X@)B,Q-C`[5&AE(%!H87-E($DO24D@8VQI;FEC86P@=')I86P@
M=VEL;"!B92!C;VYD=6-T960@=VET:"!!8W1I;FEU;2`R,C4N("8C,38P.U1H
M92!C;&EN:6-A;"!T<FEA;"!W:6QL(&)E(&-O;F1U8W1E9"!U;F1E<B!T:&4@
M<')O=&]C;VQS(&5S=&%B;&ES:&5D(&)Y('5S(&%N9"!P=7)S=6%N="!T;R!A
M;B!);G9E<W1I9V%T:6]N86P@3F5W($1R=6<@17AE;7!T:6]N("A)3D0@,3`X
M,#<I(&AE;&0@8GD@=7,N("8C,38P.U=E('=I;&P@<&%Y("0S,2PW-S$@<&5R
M('!A=&EE;G0L('=H;R!H87,@8V]M<&QE=&5D('1H92!C;&EN:6-A;"!T<FEA
M;"X@5V4@=VEL;"!B92!R97%U:7)E9"!T;R!P87D@82!S=&%R="UU<"!F964@
M;V8@)#$V+#`P,"!A;F0@861D:71I;VYA;"!A9&UI;FES=')A=&EV92!F965S
M+"!W:&5N(&%P<&QI8V%B;&4N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^
M#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[
M)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[($]N($%U9W5S="`Q+"`R,#$R+"!T:&4@0V]M<&%N>2!E
M;G1E<F5D(&EN=&\@82!R96YT86P@86=R965M96YT(&9O<B!O9F9I8V4@<W!A
M8V4@870@-3`Q($9I9G1H($%V96YU92P@,W)D($9L;V]R+"!.97<@66]R:RP@
M3ED@,3`P,3<N("8C,38P.U1H92!A9W)E96UE;G0@=&5R;6EN871E9"!-87D@
M,S$L(#(P,3,N($]N($IU;F4@,2P@,C`Q,U1H92!#;VUP86YY(&5N=&5R960@
M:6YT;R!A(')E;G1A;"!A9W)E96UE;G0@9F]R(&]F9FEC92!S<&%C92!A="`U
M-#8@1FEF=&@@079E;G5E+"`Q-"!T:"8C,38P.R8C,38P.T9L;V]R+"!.97<@
M66]R:RP@3ED@,3`P,S8N)B,Q-C`[)B,Q-C`[5&AE(&%G<F5E;65N="!T97)M
M:6YA=&5S(&]N($1E8V5M8F5R(#,Q+"`R,#$S+B8C,38P.R8C,38P.U5P;VX@
M=&AE(&5X<&ER871I;VX@;V8@=&AE('1E<FTL('1H92!A9W)E96UE;G0@875T
M;VUA=&EC86QL>2!R96YE=W,@;VX@82!M;VYT:"UT;RUM;VYT:"!B87-I<R!A
M;F0@<F5Q=6ER97,@82!T=V\@;6]N=&@@;F]T:6-E(&]F('1E<FUI;F%T:6]N
M+B`F(S$V,#M4:&4@0V]M<&%N>2!P86ED(&$@;VYE(&UO;G1H(')E9G5N9&%B
M;&4@9&5P;W-I="X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y
M<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[($EN($9E8G)U87)Y(#(X+"`R,#$S+"!T:&4@0V]M
M<&%N>2!E;G1E<F5D(&EN=&\@82!397!A<F%T:6]N(&%N9"!3971T;&5M96YT
M($%G<F5E;65N="!W:71H(&ET<R!F;W)M97(@0T5/+"!*86-K(%1A;&QE>2X@
M4'5R<W5A;G0@=&\@=&AE(&%G<F5E;65N="P@=&AE($-O;7!A;GD@<&%I9"!-
M<BX@5&%L;&5Y("0Q,C4L,#`P(&]N($UA<F-H(#@L(#(P,3,@86YD(&$@<V5C
M;VYD('!A>6UE;G0@;V8@)#$R-2PP,#`@:7,@9'5E('1O(&)E('!A:60@=&\@
M37(N(%1A;&QE>2!O;B!397!T96UB97(@,2P@,C`Q,RX@5&AE($-O;7!A;GD@
M86QS;R!P86ED($UR+B!486QL97D@82!P97)F;W)M86YC92!B;VYU<R!O9B`D
M-C`L,#`P(&9O<B!H:7,@<V5R=FEC92!F<F]M($%U9W5S="`Q-2P@,C`Q,B!T
M;R!$96-E;6)E<B`S,2P@,C`Q,BXF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L
M9#L@9&ES<&QA>3H@:6YL:6YE.R<^3F]T92`X("8C.#(Q,3L@0V]M;6ET;65N
M=',@86YD($-O;G1I;F=E;F-I97,\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE
M/3-$)V1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[
M/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`S-G!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#4E('9A;&EG;CTS1'1O<#X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/F$N)B,Q
M-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DU
M)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D%B8F]T="!":6]T:&5R87!E=71I8W,@0V]R
M<"`F(S@R,3$[(%1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(%!R;V1U8W0@
M1&5V96QO<&UE;G0@86YD(%!A=&5N="!,:6-E;G-E($%G<F5E;65N="!W:71H
M($%B8F]T="!":6]T:&5R87!E=71I8W,@0V]R<"X@*&9O<FUE<FQY($9A8V5T
M($)I;W1E8V@@9F]R;65R;'D@:VYO=VX@87,@4')O=&5I;B!$97-I9VX@3&%B
M<RD@:6X@,C`P,R!T;R!S96-U<F4@97AC;'5S:79E(')I9VAT<R!T;R!A('-P
M96-I9FEC(&%N=&EB;V1Y('=H96X@8V]N:G5G871E9"!W:71H(&%L<&AA(&5M
M:71T:6YG(')A9&EO:7-O=&]P97,N(%5P;VX@97AE8W5T:6]N(&]F('1H92!A
M9W)E96UE;G0L('1H92!#;VUP86YY(&UA9&4@82!L:6-E;G-E(&9E92!P87EM
M96YT(&]F("0S+#`P,"PP,#`N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^
M#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L
M;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`S-G!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/E1H92!#;VUP86YY(&%G<F5E9"!T;R!M86ME(&UI;&5S=&]N92!P87EM96YT
M<R!T;W1A;&EN9R`D-RPW-3`L,#`P(&9O<B!T:&4@86-H:65V96UE;G0@;V8@
M=&AE(&9O;&QO=VEN9R!A9W)E960@=&\@86YD(&-O;G1R86-T960@;6EL97-T
M;VYE<SH\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L
M;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L
M:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY-:6QE<W1O;F5S/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E
M969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B@Q*2!W:&5N($-O;7!A;GD@:6YI=&EA=&5S(&$@4&AA<V4@22!#
M;&EN:6-A;"!4<FEA;"!O9B!A(&QI8V5N<V5D('!R;V1U8W0\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^-S4P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXW-3`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-3`P+#`P,#PO9F]N=#X\+V1I=CX-
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,2PW-3`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@U
M*2!&:7)S="!C;VUM97)C:6%L('-A;&4\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#4P,"PP,#`\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B@V*2!A9G1E<B!T:&4@9FER<W0@)#$P+#`P,"PP,#`@:6X@;F5T('-A
M;&5S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^,2PU,#`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY5;F1E<B!T:&4@86=R965M96YT+"!T:&4@0V]M<&%N>2!S:&%L;"!P
M87D@=&\@06)B;W1T($)I;W1H97)A<&5U=&EC<R!#;W)P(&]N(&$@8V]U;G1R
M>2UB>2UC;W5N=')Y(&)A<VES(&$@<F]Y86QT>2!O9B`Q,B4@;V8@;F5T('-A
M;&5S(&]F(&%L;"!L:6-E;G-E9"!P<F]D=6-T<R!U;G1I;"!T:&4@;&%T97(@
M;V8Z("@Q*2`Q,BXU('EE87)S(&%F=&5R('1H92!F:7)S="!C;VUM97)C:6%L
M('-A;&4L(&]R("@R*2!W:&5N('1H92!P871E;G1S(&5X<&ER92X\+V9O;G0^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA
M<F=I;BUL969T.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@
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M($-O<G`N(&$@;6EL97-T;VYE('!A>6UE;G0@;V8@)#<U,"PP,#`@;VX@2G5L
M>2`R-"P@,C`Q,BX@)B,Q-C`[5&AE(&UI;&5S=&]N92!P87EM96YT(&9O<B!T
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M<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#4E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/F(N)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DU)2!V86QI9VX],T1T;W`^#0H\9&EV
M(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/DU3
M2T-#("8C.#(Q,3L@26X@1F5B<G5A<GD@,C`P,BP@=&AE($-O;7!A;GD@96YT
M97)E9"!I;G1O(&$@;&EC96YS92!A9W)E96UE;G0@=VET:"!-4TM#0R!T:&%T
M(')E<75I<F5S(&$@=&5C:&YO;&]G>2!A8V-E<W,@9F5E(&]F("0U,"PP,#`@
M=7!O;B!E>&5C=71I;VXL(&%N(&%N;G5A;"!M86EN=&5N86YC92!F964@;V8@
M)#4P+#`P,"!A;F0@86X@86YN=6%L(')E<V5A<F-H(&9U;F1I;F<@;V8@)#4P
M+#`P,"!F;W(@87,@;&]N9R!A<R!T:&4@86=R965M96YT(&ES(&EN(&9O<F-E
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M96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^36EL97-T;VYE<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O
M;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/E!A>6UE;G1S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ*2!F:6QI;F<@;V8@86X-"B!.97<@
M1')U9R!!<'!L:6-A=&EO;B`H)B,X,C(P.TY$028C.#(R,3LI(&]R(')E9W5L
M871O<GD@87!P<F]V86P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SYF;W(@96%C:"!L:6-E;G-E
M9"!P<F]D=6-T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/C<U,"PP,#`\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/FQI8V5N<V5D('!R;V1U
M8W0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXQ+#<U,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO
M='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ
M(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`S
M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E5N9&5R('1H92!A9W)E96UE;G0L('1H92!#;VUP86YY('-H86QL('!A
M>2!T;R!-4TM#0R!O;B!A(&-O=6YT<GDM8GDM8V]U;G1R>2!B87-I<R!A(')O
M>6%L='D@;V8@,B4@;V8@;F5T('-A;&5S(&]F(&%L;"!L:6-E;G-E9"!P<F]D
M=6-T<R!U;G1I;"!T:&4@;&%T97(@;V8Z("@Q*2`Q,"!Y96%R<R!F<F]M('1H
M92!F:7)S="!C;VUM97)C:6%L('-A;&4L(&]R("@R*2!W:&5N('1H92!P871E
M;G1S(&5X<&ER92X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`S-G!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF
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M:6QE('1H92!.1$$@9F]R(')E9W5L871O<GD@87!P<F]V86P@:6X@,C`Q-2X\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K.R!T
M97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$
M;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M;VYT<F%C=&5D('1O('!U<F-H87-E("0R,S,L,3`P(&]F(')A9&EO86-T:79E
M(&UA=&5R:6%L('1O(&)E('5S960@9F]R(')E<V5A<F-H(&%N9"!D979E;&]P
M;65N="P@=VET:"!A(')E;F5W86P@;W!T:6]N(&%T('1H92!C;VYT<F%C="!E
M;F0N("8C,38P.U1H92!#;VUP86YY(&ES(&-U<G)E;G1L>2!N96=O=&EA=&EN
M9R!T:&4@,C`Q,R!A9W)E96UE;G0N)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N
M/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE
M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0U)2!V
M86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SYD+B8C,38P.R8C,38P.SPO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@=VED=&@],T0Y-24@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG
M;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M;6%T960@<')O:F5C="!C;W-T+B`F(S$V,#M4:&4@9&]W;B!P87EM96YT('1O
M=&%L:6YG("0R,SDL,#`P('=A<R!P86ED(&EN(#(P,#<@86YD(#(P,3(N("8C
M,38P.T]N($%U9W5S="`V+"`R,#$R+"!T:&4@86=R965M96YT('=A<R!A;65N
M9&5D('1O('!R;W9I9&4@9F]R(&%D9&ET:6]N86P@<V5R=FEC97,N("8C,38P
M.U1H92!T;W1A;"!P<F]J96-T(&ES(&YO=R!E<W1I;6%T960@870@)#$L.3DW
M+#<S,BX@)B,Q-C`[07!T:793;VQU=&EO;G,@8FEL;',@=&AE($-O;7!A;GD@
M=VAE;B!S97)V:6-E<R!A<F4@<F5N9&5R960@86YD('1H92!#;VUP86YY(')E
M8V]R9',@=&AE(')E;&%T960@97AP96YS92!T;R!R97-E87)C:"!A;F0@9&5V
M96QO<&UE;G0@8V]S=',N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K
M.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L-"B!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0U)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY/;B!*=6YE(#$U+"`R,#$R+"!T:&4@0V]M<&%N
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M;&]P(&$@8VQI;FEC86P@=')I86P@=VET:"!!8W1I;FEU;2`R,C4N("8C,38P
M.T9(0U)#(&AA<R!C=7)R96YT;'D@8V]M<&QE=&5D(%!H87-E($D@86YD(%!H
M87-E($E)(&]F('1H92!C;&EN:6-A;"!T<FEA;"!A;F0@=&AE($-O;7!A;GD@
M:6YT96YD<R!T;R!S=&%R="!P<F5P87)A=&EO;B!F;W(@82!P:79O=&%L('1R
M:6%L(&QE861I;F<@=&\@86X@1D1!(&%P<')O=F%L+B`F(S$V,#M4:&4@0V]M
M<&%N>2!H87,@8F5E;B!G<F%N=&5D(&5X8VQU<VEV92!R:6=H=',@=&\@=&AE
M($)#."!A;G1I8F]D>2!A;F0@<F5L871E9"!M87-T97(@8V5L;"!B86YK(&1E
M=F5L;W!E9"!B>2!&2$-20RX@)B,Q-C`[5&AE(&-O<W0@=&\@9&5V96QO<"!T
M:&4@=')I86P@=VEL;"!R86YG92!F<F]M("0Q,RXR(&UI;&QI;VX@=&\@)#(S
M+C4@;6EL;&EO;BP@9&5P96YD:6YG(&]N('1H92!T<FEA;"!D97-I9VX@87,@
M<F5Q=6ER960@8GD@=&AE($9$02X@)B,Q-C`[56YD97(@=&AE('1E<FUS(&]F
M('1H92!S<&]N<V]R960@<F5S96%R8V@@86=R965M96YT+"!T:&4@0V]M<&%N
M>2!W:6QL(&9U;F0@=&AE($9(0U)#(&QA8B!W:71H("0Q-3`L,#`P('!E<B!Y
M96%R(&9O<B!T:&4@9FER<W0@='=O('EE87)S(&%N9"`D,C4P+#`P,"!T:&5R
M96%F=&5R+B`F(S$V,#M087EM96YT<R!M861E('1O=V%R9"!F=6YD:6YG('1H
M92!L86(@=VEL;"!B92!C<F5D:71E9"!T;W=A<F0@<F]Y86QT>2!P87EM96YT
M<R!O=V5D('1O($9(0U)#(&EN('1H92!G:79E;B!Y96%R+B`F(S$V,#M!(&UI
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M96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*
M/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0U)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SYF+B8C,38P.R8C,38P.SPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@=VED=&@],T0Y-24@=F%L:6=N/3-$=&]P
M/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY/;B!-87)C:"`R-RP@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I
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M;R!P87D@82!S=&%R="UU<"!F964@;V8@)#<Y+#8R,RX@)B,Q-C`[5&AE(&%M
M;W5N="!D=64@;V8@)#<Y+#8R,R!W87,@<&%I9"!O;B!*=6QY(#$P+"`R,#$R
M+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT
M86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^9RXF(S$V,#LF(S$V,#L\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.34E('9A;&EG;CTS1'1O<#X-
M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M<&ET86P@1W)O=7`L($Q,0RX@*&9O<FUE<FQY(&MN;W=N(&%S($%M97)A<VEA
M($-A<&ET86P@1W)O=7`L($Q,0RDL(&$@8V]N<W5L=&EN9R!F:7)M(&%F9FEL
M:6%T960@=VET:"!-<BX@4V%N9&5S:"!3971H+"!A($1I<F5C=&]R(&]F($-A
M8W1U<R8C,38P.U9E;G1U<F5S+"!);F,N)B,Q-C`[8GD@=FER='5E(&]F(&AI
M<R!P;W-I=&EO;B!A<R!A(&1I<F5C=&]R(&]F($%C=&EN:75M(%!H87)M86-E
M=71I8V%L<RXF(S$V,#L@37(N(%-E=&@@:7,@82!-86YA9VEN9R!087)T;F5R
M(&]F('1H92!C;VYS=6QT:6YG(&9I<FT@<V]M92!O9B!W:&]S92!M96UB97(@
M:6YT97)E<W1S(&%R92!H96QD(&)Y(&5N=&ET:65S(&]W;F5D(&)Y(&]F9FEC
M97)S(&%N9"!E;7!L;WEE97,@;V8@=&AE(%!L86-E;65N="!!9V5N="XF(S$V
M,#L@3F]N92!O9B!#86-T=7,F(S@R,3<[(&-U<G)E;G0@;V9F:6-E<G,@;W(@
M9&ER96-T;W)S(&AA9"!A('!R:6]R(')E;&%T:6]N<VAI<"!O<B!A9F9I;&EA
M=&EO;B!W:71H($-A8W1U<R!P<FEO<B!T;R!T:&4@8VQO<VEN9R!O9B!T:&4@
M4VAA<F4@17AC:&%N9V4N)B,Q-C`[(%!U<G-U86YT('1O('1H92!A9W)E96UE
M;G0L('1H92!M86YA9V5M96YT(&9I<FT@=V%S(&5N9V%G960@=&\@<')O=FED
M92!C;VYS=6QT:6YG('-E<G9I8V5S('1O($%C=&EN:75M(')E;&%T960@=&\@
M=&AE(&-O;G-U;6UA=&EO;B!O9B!A(&=O:6YG('!U8FQI8R!T<F%N<V%C=&EO
M;B!F;W(@06-T:6YI=6TN)B,Q-C`[(%1H92!M86YA9V5M96YT(&9I<FT@<F5C
M96EV960@82!M;VYT:&QY(&9E92!O9B`D,3(L-3`P('=H:6-H(&ES('1E<FUI
M;F%B;&4@8GD@=&AE($-O;7!A;GD@=&AR964@;6]N=&AS(&%F=&5R('1H92!E
M9F9E8W1I=F4@9&%T92!O9B!T:&4@9V]I;F<@<'5B;&EC('1R86YS86-T:6]N
M(&%N9"!D97-I9VYE97,@;V8@2F%M97-S+"!I;F-L=61I;F<@96YT:71I97,@
M869F:6QI871E9"!W:71H($UR+B!3971H+"!W97)E(&ES<W5E9"!W87)R86YT
M<R!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL@97%U86P@=&\@,3`E(&]F('1H
M92!F=6QL>2UD:6QU=&5D(&-A<&ET86P@<W1O8VL@;V8@=&AE($-O;7!A;GD@
M87,@;V8@=&AE(&5F9F5C=&EV92!D871E(&]F('1H92!G;VEN9R!P=6)L:6,@
M=')A;G-A8W1I;VXN(%1H92!F=6QL>2!D:6QU=&5D('-H87)E<R!F;W(@=&AI
M<R!C86QC=6QA=&EO;B!I;F-L=61E9"!A;&P@:7-S=65D(&%N9"!O=71S=&%N
M9&EN9R!S:&%R97,@87,@=V5L;"!A<R!T:&]S92!R97-E<G9E9"!U;F1E<B!T
M:&4@16UP;&]Y964@4W1O8VL@3W!T:6]N(%!L86XN)B,Q-C`[($IA;65S<R!#
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M+#`P,"!P97(@;6]N=&@N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI
M9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0U)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY/;B!*=6QY(#$Y+"`R,#$R+"!T:&4@0V]M<&%N
M>2!E;G1E<F5D(&EN=&\@82!C;&EN:6-A;"!T<FEA;"!A9W)E96UE;G0@=VET
M:"!&2$-20RX@)B,Q-C`[5&AE($-O;7!A;GD@=VEL;"!P87D@)#,Q+#,V-B!F
M;W(@96%C:"!P871I96YT('1H870@:&%S(&-O;7!L971E9"!T:&4@8VQI;FEC
M86P@=')I86PN(%5P;VX@97AE8W5T:6]N(&]F('1H92!A9W)E96UE;G0L('1H
M92!#;VUP86YY(&ES(')E<75I<F5D('1O('!A>2!A('-T87)T+75P(&9E92!O
M9B`D,3DL-S0Y+@T*("8C,38P.T1U<FEN9R!T:&4@8VQI;FEC86P@=')I86P@
M861D:71I;VYA;"!F965S(&%P<&QY(&%N9"!W:6QL(&)E(&EN=F]I8V5D('=H
M96X@87!P;&EC86)L92X@)B,Q-C`[5&AE(&%M;W5N="!D=64@:&%S(&YO="!B
M965N(&EN=F]I8V5D(&)U="!A8V-R=65D(&)Y('1H92!#;VUP86YY(&%S(&]F
M($1E8V5M8F5R(#,Q+"`R,#$R+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R
M/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV
M(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T
M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^3VX@075G=7-T(#(X+"`R,#$R+"!T:&4@
M0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!C;&EN:6-A;"!T<FEA;"!A9W)E96UE
M;G0@=VET:"!4:&4@56YI=F5R<VET>2!O9B!497AA<R!-+D0N($%N9&5R<V]N
M($-A;F-E<B!#96YT97(N("8C,38P.U1H92!T;W1A;"!E<W1I;6%T960@8V]S
M="!O9B!C;VYD=6-T:6YG('1H92!C;&EN:6-A;"!T<FEA;"!I<R`D-#@Q+#(P
M-"P@=VAI8V@@:6YC;'5D97,@82!N;VXM(')E9G5N9&%B;&4@:6YS=&ET=71I
M;VYA;"!F964@;V8@)#$T+#4P,"X@)B,Q-C`[5&AE(&5S=&EM871E9"!C;W-T
M(&ES(&)A<V5D(&]N('1R96%T:6YG(#(T('!A=&EE;G1S('1H<F]U9V@@,C`Q
M,RX@)B,Q-C`[57!O;B!E>&5C=71I;VX@;V8@=&AE(&%G<F5E;65N="P@=&AE
M($-O;7!A;GD@:7,@<F5Q=6ER960@=&\@;6%K92!A('!A>6UE;G0@;V8@)#,S
M+#DT-BX@)B,Q-C`[)B,Q-C`[5&AE(&%M;W5N="!D=64@:&%S(&YO="!B965N
M(&EN=F]I8V5D(&)U="!A8V-R=65D(&)Y('1H92!#;VUP86YY(&%S(&]F($1E
M8V5M8F5R(#,Q+"`R,#$R+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*
M/"]T86)L93X-"CPO9&EV/@T*/&1I=B!S='EL93TS1"=D:7-P;&%Y.B!B;&]C
M:SL@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG
M;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#4E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI
M9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/FHN)B,Q-C`[
M)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DU)2!V
M86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/D]N(%-E<'1E;6)E<B`R-BP@,C`Q,BP@=&AE($-O
M;7!A;GD@96YT97)E9"!I;G1O(&$@8VQI;FEC86P@=')I86P@86=R965M96YT
M('=I=&@@2F]H;G,@2&]P:VEN<R!5;FEV97)S:71Y+B`F(S$V,#M4:&4@4&AA
M<V4@22])22!C;&EN:6-A;"!T<FEA;"!W:6QL(&)E(&-O;F1U8W1E9"!W:71H
M($%C=&EN:75M(#(R-2X@)B,Q-C`[5&AE(&-L:6YI8V%L('1R:6%L('=I;&P@
M8F4@8V]N9'5C=&5D('5N9&5R('1H92!P<F]T;V-O;',@97-T86)L:7-H960@
M8GD@=&AE($-O;7!A;GD@86YD('!U<G-U86YT('1O(&%N($EN=F5S=&EG871I
M;VYA;"!.97<@1')U9R!%>&5M<'1I;VX@*$E.1"`Q,#@P-RD@:&5L9"!B>2!T
M:&4@0V]M<&%N>2X@)B,Q-C`[5&AE($-O;7!A;GD@=VEL;"!P87D@)#,X+#4P
M,2!P97(@<&%T:65N="P@=VAO(&AA<R!C;VUP;&5T960@=&AE(&-L:6YI8V%L
M('1R:6%L+B!4:&4@0V]M<&%N>2!I<R!R97%U:7)E9"!T;R!P87D@82!S=&%R
M="UU<"!F964@;V8@)#(R+#@T-RP@86X@86YN=6%L('!H87)M86-Y(&9E92!O
M9B`D,BPP,C4@86YD(&%N(&%M96YD;65N="!P<F]C97-S:6YG(&9E92!O9B`D
M-3`P+"!W:&5N(&%P<&QI8V%B;&4N("8C,38P.U1H92!A;6]U;G0@9'5E(&AA
M<R!N;W0@8F5E;B!I;G9O:6-E9"!B=70@86-C<G5E9"!B>2!T:&4@0V]M<&%N
M>2!A<R!O9B!$96-E;6)E<B`S,2P@,C`Q,BX\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z
M(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ
M93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\
M='(^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#4E('9A;&EG;CTS1'1O
M<#X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/FLN)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W
M:61T:#TS1#DU)2!V86QI9VX],T1T;W`@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M:G5S=&EF>3LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y
M.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D]N($YO=F5M8F5R(#(Q+"`R,#$R+"!T:&4@
M0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!C;&EN:6-A;"!T<FEA;"!A9W)E96UE
M;G0@=VET:"!T:&4@56YI=F5R<VET>2!O9B!096YN<WEL=F%N:6$N("8C,38P
M.U1H92!0:&%S92!)+TE)(&-L:6YI8V%L('1R:6%L('=I;&P@8F4@8V]N9'5C
M=&5D('=I=&@@06-T:6YI=6T@,C(U+B`F(S$V,#M4:&4@8VQI;FEC86P@=')I
M86P@=VEL;"!B92!C;VYD=6-T960@=6YD97(@=&AE('!R;W1O8V]L<R!E<W1A
M8FQI<VAE9"!B>2!T:&4@0V]M<&%N>2!A;F0@<'5R<W5A;G0@=&\@86X@26YV
M97-T:6=A=&EO;F%L($YE=R!$<G5G($5X96UP=&EO;B`H24Y$(#$P.#`W*2!H
M96QD(&)Y('1H92!#;VUP86YY+B`F(S$V,#M4:&4@0V]M<&%N>2!W:6QL('!A
M>2`D,S$L-S<Q('!E<B!P871I96YT+"!W:&\@:&%S(&-O;7!L971E9"!T:&4@
M8VQI;FEC86P@=')I86PN(%1H92!#;VUP86YY('=I;&P@8F4@<F5Q=6ER960@
M=&\@<&%Y(&$@<W1A<G0M=7`@9F5E(&]F("0Q-BPP,#`@86YD(&%D9&ET:6]N
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N($%U9W5S
M="`Q+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!R96YT86P@
M86=R965M96YT(&9O<B!O9F9I8V4@<W!A8V4@870@-3`Q($9I9G1H($%V96YU
M92P@,SQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9&ES<&QA>3H@
M:6YL:6YE.R<^<F0\+V9O;G0^($9L;V]R+"!.97<@66]R:RP@3ED@,3`P,3<N
M("8C,38P.U1H92!A9W)E96UE;G0@=&5R;6EN871E<R!*86YU87)Y(#,Q+"`R
M,#$S('5N;&5S<R!A($YO=&EC92!O9B!497)M:6YA=&EO;B!I<R!P<F]V:61E
M9"!T;R!T:&4@;&%N9&QO<F0@-C`@9&%Y<R!P<FEO<B!T;R!*86YU87)Y(#$L
M(#(P,3,N("8C,38P.U1H92!A9W)E96UE;G0@875T;VUA=&EC86QL>2!R96YE
M=W,@;VX@82!M;VYT:"UT;RUM;VYT:"!B87-I<R!A;F0@<F5Q=6ER97,@82!T
M=V\@;6]N=&@@;F]T:6-E(&]F('1E<FUI;F%T:6]N+B`F(S$V,#M4:&4@0V]M
M<&%N>2!P86ED(&$@='=O(&UO;G1H(')E9G5N9&%B;&4@9&5P;W-I="X\+V9O
M;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S
M7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970Q-2YH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P15-'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D5Q=6ET>3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^17%U:71Y(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17%U:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SY.;W1E(#<@
M)B,X,C$Q.R!%<75I='D\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S
M=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!F;VQL
M;W=I;F<@:7,@82!S=6UM87)Y(&]F('-T;V-K(&]P=&EO;G,Z/"]F;VYT/CPO
M9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F
M=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI
M9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C
M96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O
M;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-
M"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/E=E:6=H=&5D/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9F]N=#X\
M+V1I=CX-"CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E)E;6%I;FEN9SPO9F]N=#X\+V9O
M;G0^/"]F;VYT/CPO9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^5&5R;2`H:6X@>65A<G,I/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N
M=&5R.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG(&-O;'-P86X],T0R/@T*/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97([(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M<VEZ93H-"B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY);G1R:6YS:6,\+V9O;G0^/"]F;VYT/CPO9&EV
M/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY686QU93PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T
M86YD:6YG+"!$96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXX+CDQ/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXV.#4L.#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY#86YC96QL871I;VX\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH
M-#DL.34P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0-"B!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!*
M=6YE(#,P+"`R,#$S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^,BPR.#`L,3@T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP
M+CDV/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C@N-#(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-C`Y
M+#`S-3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO
M=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I
M=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/CQF;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!!
M;&P@;W!T:6]N<R!I<W-U960@86YD(&]U='-T86YD:6YG(&%R92!B96EN9R!A
M;6]R=&EZ960@;W9E<B!T:&5I<B!R97-P96-T:79E)B,Q-C`[<V5R=FEC92!P
M97)I;V1S+B!4:&4@=6YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E
M(&%T($IU;F4@,S`L(#(P,3,@=V%S("0Q+#`X-BPX-#@N/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@
M<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C
M,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@1'5R:6YG('1H
M92!T:')E92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,R!A;F0@,C`Q,BP@
M=&AE($-O;7!A;GD@<F5C;W)D960@;W!T:6]N(&5X<&5N<V4@;V8@)#DT+#(P
M,"P@86YD("0T,"PT,3`L(')E<W!E8W1I=F5L>2X@1'5R:6YG('1H92!S:7@@
M;6]N=&AS(&5N9&5D($IU;F4@,S`L(#(P,3,@86YD(#(P,3(L('1H92!#;VUP
M86YY(')E8V]R9&5D(&]P=&EO;B!E>'!E;G-E(&]F("0Q.#@L-#`P(&%N9"`D
M,C0P+#0P,"P@<F5S<&5C=&EV96QY+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^3VX@36%Y(#,Q+"`R,#$S+"!T
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M,#`@86YD(&-A;F-E;&QE9"!O<'1I;VYS('1O('!U<F-H87-E(#0Y+#DU,"!S
M:&%R97,@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!C;VUM;VX@<W1O8VL@870@
M)#$N-3`@<&5R('-H87)E('!R979I;W5S;'D@9W)A;G1E9"X\+V9O;G0^/"]D
M:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V
M,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M(%1H92!F;VQL;W=I;F<@:7,@82!S=6UM87)Y(&]F('=A<G)A;G1S.CPO9F]N
M=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ#0H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P
M>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/DYU;6)E<B!O9CPO9F]N=#X\
M+V9O;G0^/"]D:78^#0H\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E5N:71S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI
M9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C
M96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P
M>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E)E;6%I;FEN9SPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M5&5R;2`H:6X@>65A<G,I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P
M>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D%G9W)E9V%T93PO9F]N
M=#X\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D#0H@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R
M/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!$96-E
M;6)E<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C$R+#<W,"PV,S8\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C`N.3<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXT+C0X(#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY787)R86YT<R!E>&5R8VES960\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,BPR
M,3$L,34X/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C8U/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!*=6YE(#,P+"`R,#$S
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+C<W/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I
M=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT("!S='EL93TS
M1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F
M;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!$=7)I;F<@=&AE('-I>"!M
M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D
M('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@<'5R<W5A;G0@=&\@=&AE(&5X97)C
M:7-E(&]F($$M5V%R<F%N=',@;W)I9VEN86QL>2!I<W-U960@:6X@8V]N;F5C
M=&EO;B!W:71H(&$@<')I=F%T92!P;&%C96UE;G0@=&AA="!C;&]S960@:6X@
M2F%N=6%R>2`R,#$S+B8C,38P.R8C,38P.U1H92!W87)R86YT<R!W97)E(&5X
M97)C:7-E9"!A="`D,2XV-2!P97(@<VAA<F4L(')E<W5L=&EN9R!I;B!G<F]S
M<R!P<F]C965D<R!O9B`D,RPT-C,L-C0Q(')E8V5I=F5D(&)Y('1H92!#;VUP
M86YY+CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@
M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="UW96EG:'0Z(&)O;&0[(&1I
M<W!L87DZ(&EN;&EN93LG/DYO=&4@.2`F(S@R,3$[($5Q=6ET>3PO9F]N=#X\
M+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&IU
M<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,C=P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[($9R;VT@:6YC97!T:6]N('1O($1E8V5M8F5R(#,Q+"`R,#$P+"!T
M:&4@0V]M<&%N>2!R86ES960@)#0R+#<Q,2PW.3$@8GD@:7-S=6EN9R`U+#<P
M-RPR-3D@<VAA<F5S(&]F('1H92!#;VUP86YY)B,X,C$W.W,@<W1O8VL@86YD
M(&ES<W5E9"`V-BPT,#(@<VAA<F5S+"!V86QU960@870@)#,Y."PX,3`L(&9O
M<B!S97)V:6-E<RX\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-
M"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#(W<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R8C,38P.R8C,38P.R!$=7)I;F<@,C`Q,2P@=&AE($-O;7!A
M;GD@<F%I<V5D("0V+#$X-"PY-C<@8GD@<V5L;&EN9R`W+#@Y,2PQ-#$@<VAA
M<F5S(&]F('1H92!#;VUP86YY)B,X,C$W.W,@<W1O8VL@86YD('=A<G)A;G1S
M('1O('!U<F-H87-E(#$Y+#DW,BPW.#4@<VAA<F5S(&]F('1H92!#;VUP86YY
M)B,X,C$W.W,@<W1O8VL@=&AR;W5G:"!A;B!O9F9E<FEN9R`H)B,X,C(P.U-T
M;V-K($]F9F5R:6YG)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[02!N970@86UO=6YT
M(&]F("0U+#,W.2PS-C<@=V%S(')E8V5I=F5D(&)Y('1H92!#;VUP86YY(&EN
M(#(P,3$N(%1H92!#;VUP86YY('!A:60@3&%I9&QA=R`F86UP.R!#;VUP86YY
M("A52RD@3'1D+B`H)B,X,C(P.TQA:61L87<@)F%M<#L@0V\N)B,X,C(Q.RDL
M('1H92!P;&%C96UE;G0@86=E;G0L('1O=&%L(&-A<V@@9F5E<R!O9B`D-S0R
M+#$Y-BP@=VAI8V@@8V]N<VES=&5D(&]F('!L86-E;65N="!A9V5N="!C;VUM
M:7-S:6]N(&]F("0V,3@L-#DW(&%N9"!E>'!E;G-E(')E:6UB=7)S96UE;G0@
M;V8@)#$R,RPV.3DN(%1H92!#;VUP86YY(&%L<V\@:7-S=65D($QA:61L87<@
M)F%M<#L@0V\N('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E9V%T92!O
M9B`Y.#8L,SDS('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&-O;6UO
M;B!S=&]C:RP@=VET:"!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XW."!P97(@
M<VAA<F4@86YD(&$@=&5R;2!O9B`W('EE87)S+B!4:&5S92!P;&%C96UE;G0@
M86=E;G0@=V%R<F%N=',@=V5R92!V86QU960@870@=&AE:7(@9W)A;G0@9&%T
M92!F86ER('9A;'5E(&]F("0Q.#@L-3<Y+B8C,38P.TEN(&%D9&ET:6]N+"!T
M:&4@0V]M<&%N>2!P86ED($QA:61L87<@)F%M<#L@0V\N)B,X,C$W.W,@;W5T
M<VED92!C;W5N<V5L+"!-8T-O<FUI8VL@)F%M<#L@3R8C.#(Q-SM"<FEE;B!0
M3$Q#+"`D-C`L.3`T(&9O<B!I=',@<V5R=FEC97,@87,@=&AE('!L86-E;65N
M="!A9V5N="8C.#(Q-SMS(&QE9V%L(&-O=6YS96P@86YD(%-I9VYA='5R92!"
M86YK("0R+#4P,"!F;W(@=&AE(&)A;FL@97-C<F]W(&9E92X\+V9O;G0^/"]D
M:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S
M=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#LF
M(S$V,#L@1'5R:6YG(#(P,3(L('1H92!#;VUP86YY(')A:7-E9"`D-S4Y+#,P
M,"!B>2!S96QL:6YG(#DV."PW-3D@<VAA<F5S(&%N9"!W87)R86YT<R!T;R!P
M=7)C:&%S92`R-#(L,3DP('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS
M(&-O;6UO;B!S=&]C:R!U;F1E<B!T:&4@0V]M<&%N>28C.#(Q-SMS(%-T;V-K
M($]F9F5R:6YG+B8C,38P.R8C,38P.T$@;F5T(&%M;W5N="!O9B`D-C8P+#$V
M-"!W87,@<F5C96EV960@8GD@=&AE($-O;7!A;GD@:6X@,C`Q,BX@5&AE($-O
M;7!A;GD@<&%I9"!,86ED;&%W("9A;7`[($-O+B!T;W1A;"!C87-H(&9E97,@
M;V8@)#DQ+#$Q-BP@=VAI8V@@8V]N<VES=&5D(&]F('!L86-E;65N="!A9V5N
M="!C;VUM:7-S:6]N(&]F("0W-2PY,S`@86YD(&5X<&5N<V4@<F5I;6)U<G-E
M;65N="!O9B`D,34L,3@V+B!4:&4@0V]M<&%N>2!A;'-O(&ES<W5E9"!,86ED
M;&%W("9A;7`[($-O+B!W87)R86YT<R!T;R!P=7)C:&%S92!A;B!A9V=R96=A
M=&4@;V8@,3(Q+#`Y-2!S:&%R97,@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!C
M;VUM;VX@<W1O8VLL('=I=&@@86X@97AE<F-I<V4@<')I8V4@;V8@)#`N-S@F
M(S$V,#MP97(@<VAA<F4@86YD(&$@=&5R;2!O9B`W('EE87)S+B!4:&5S92!P
M;&%C96UE;G0@86=E;G0@=V%R<F%N=',@=V5R92!V86QU960@870@=&AE:7(@
M9W)A;G0@9&%T92!F86ER('9A;'5E(&]F("0Q-3DL,#0T+B!);B!A9&1I=&EO
M;BP@=&AE($-O;7!A;GD@<&%I9"!,86ED;&%W("9A;7`[($-O+B8C.#(Q-SMS
M(&]U='-I9&4@8V]U;G-E;"P@36-#;W)M:6-K("9A;7`[($\F(S@R,3<[0G)I
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[
M)B,Q-C`[($EN(#(P,3(L('1H92!#;VUP86YY(&%L<V\@<F%I<V5D("0U+#$U
M,2PT-3`@=&AR;W5G:"!A;B!O9F9E<FEN9R!O9B`S+#$Q."PY.#@@<VAA<F5S
M(&]F(&ET<R!C;VUM;VX@<W1O8VL@86YD("8C.#(R,#M!(%=A<G)A;G1S)B,X
M,C(Q.R!T;R!P=7)C:&%S92`S+#$Q."PY.#@@<VAA<F5S(&]F('1H92!#;VUP
M86YY)B,X,C$W.W,@8V]M;6]N('-T;V-K+"!E>&5R8VES86)L92!A="!A('!R
M:6-E(&]F("0Q+C8U('!E<B!S:&%R92!F;W(@82!P97)I;V0@;V8@,3(P(&1A
M>7,@9G)O;2!T:&4@9&%Y(&]F('1H92!F:6YA;"!C;&]S:6YG(&]F('1H92!O
M9F9E<FEN9RP@86YD("8C.#(R,#M"(%=A<G)A;G1S)B,X,C(Q.R!T;R!P=7)C
M:&%S92`Q+#4U.2PU,#4@<VAA<F5S(&]F('1H92!#;VUP86YY)B,X,C$W.W,@
M8V]M;6]N('-T;V-K+"!E>&5R8VES86)L92!A="!A('!R:6-E(&]F("0R+C0X
M('!E<B!S:&%R92!F;W(@82!P97)I;V0@;V8@-2!Y96%R<R!F<F]M('1H92!D
M871E(&]F('1H92!F:6YA;"!C;&]S:6YG(&]F('1H92!O9F9E<FEN9RX@*"8C
M.#(R,#LR,#$R($-O;6UO;B!3=&]C:R!/9F9E<FEN9R8C.#(R,3LI)B,Q-C`[
M)B,Q-C`[02!N970@86UO=6YT(&]F("0T+#0V.2PW-S8@=V%S(')E8V5I=F5D
M(&)Y('1H92!#;VUP86YY+B!0=7)S=6%N="!T;R!T:&4@,C`Q,B!#;VUM;VX@
M4W1O8VL@3V9F97)I;F<@86=R965M96YT+"!T:&4@0V]M<&%N>2!P86ED($QA
M:61L87<@)F%M<#L@0V\N('1O=&%L(&-A<V@@9F5E<R!O9B`D-C$X+#$W-"P@
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M="!W87)R86YT<R!W97)E('9A;'5E9"!A="`D-#DY+#<P-R!A;F0@<F5C;W)D
M960@87,@9&5R:79A=&EV92!L:6%B:6QI=&EE<RXF(S$V,#LF(S$V,#M);B!A
M9&1I=&EO;BP@=&AE($-O;7!A;GD@<&%I9"!T:&4@3&%I9&QA=R`F86UP.R!#
M;RXF(S@R,3<[<R!O=71S:61E(&-O=6YS96PL(%)I8VAA<F1S;VX@)F%M<#L@
M4&%T96PL($Q,4"P@)#8P+#`P,"!F;W(@:71S('-E<G9I8V5S(&%S('1H92!,
M86ED;&%W("9A;7`[($-O+B8C.#(Q-SMS(&QE9V%L(&-O=6YS96P@86YD(%-I
M9VYA='5R92!"86YK("0S+#4P,"!F;W(@=&AE(&)A;FL@97-C<F]W(&9E92X\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K.R!T
M97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$
M:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V
M,#LF(S$V,#L@1'5R:6YG(#(P,3(L('1H92!#;VUP86YY)B,X,C$W.W,@8V]N
M=F5R=&EB;&4@;F]T97,L('!L=7,@86-C<G5E9"!I;G1E<F5S="P@=V5R92!C
M;VYV97)T960@=&\@,2PR-3(L-34P('-H87)E<R!O9B!T:&4@0V]M<&%N>28C
M.#(Q-SMS(&-O;6UO;B!S=&]C:R!A<R!A(')E<W5L="!O9B!T:&4@,C`Q,B!#
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M>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S(&$@<F5S=6QT(&]F
M('1H92!3:&%R92!%>&-H86YG92!D97-C<FEB960@:6X@3F]T92`Q+"!T:&4@
M0V]M<&%N>2!I<W-U960@-#`P+#`P,"!S:&%R97,@=&\@=&AE(&]R:6=I;F%L
M('-H87)E:&]L9&5R<R!O9B!T:&4@0V]M<&%N>2!A;F0@,2PY.#8L-38V('-H
M87)E<R!T;R!T:&4@9F]R;65R('-H87)E:&]L9&5R<R!O9B!!8W1I;FEU;2X\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K.R!T
M97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$
M:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[(%!L86-E;65N="!!9V5N="`F(S@R,3$[/"]F;VYT
M/B!);B!C;VYN96-T:6]N('=I=&@@=&AE(&UO;F5Y(')A:7-E9"!I;B`R,#$Q
M+"!T:&4@0V]M<&%N>2!I<W-U960@3&%I9&QA=R`F86UP.R!#;RX@=V%R<F%N
M=',@=&\@<'5R8VAA<V4@86X@86=G<F5G871E(&]F(#$L,3(Y+#DR-2!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K+"!W:71H(&%N(&5X97)C:7-E('!R:6-E(&]F
M("0P+C<X('!E<B!S:&%R92XF(S$V,#LF(S$V,#M7:71H('1H92!M;VYE>2!R
M86ES960@:6X@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D($QA:61L87<@)F%M
M<#L@0V\N('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E9V%T92!O9B`U
M.#@L.30P('-H87)E<R!O9B!C;VUM;VX@<W1O8VLL('=I=&@@86X@97AE<F-I
M<V4@<')I8V4@;V8@)#`N-S@@<&5R('-H87)E+CPO9F]N=#X\+V1I=CX-"CQD
M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M#0H@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&IU<W1I9GD@
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M.R8C,38P.R!-86YA9V5M96YT($9I<FT@)B,X,C$Q.SPO9F]N=#X@26X@,C`Q
M,2P@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$F(S$V,#MM86YA9V5M96YT
M(&%G<F5E;65N="!W:71H($IA;65S<R!#87!I=&%L($=R;W5P+"!,3$,@*&9O
M<FUE<FQY+"!!;65R07-I82!);F,N+"`F(S@R,C`[2F%M97-S)B,X,C(Q.RD@
M9F]R($IA;65S<R!T;R!P<F]V:61E(&-O;G-U;'1I;F<@<V5R=FEC97,@<F5L
M871E9"!T;R!F=6YD:6YG(&%N9"!!8W1I;FEU;2!B96-O;6EN9R!A('!U8FQI
M8VQY('1R861E9"!E;G1I='DN)B,Q-C`[26X@,C`Q,2P@=&AE($-O;7!A;GD@
M:6YC=7)R960@)#DV+#<T-"!I;B!M86YA9V5M96YT(&9E97,N($EN(&%D9&ET
M:6]N+"!!8W1I;FEU;2!I<W-U960@2F%M97-S('=A<G)A;G1S('1O('!U<F-H
M87-E(&%N(&%G9W)E9V%T92!O9B`Q+#DW-"PW-S0@<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:RP@=VET:"!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XP,2!P97(@
M<VAA<F4N(%1H92!W87)R86YT<R!H879E(&$@9F%I<B!V86QU92!O9B`D,BPQ
M-3,L-#0R("AS964@3F]T92`Q,2D@86YD(&EN8VQU9&5D(&$@8V%S:&QE<W,@
M97AE<F-I<V4@<')O=FES:6]N+B8C,38P.R8C,38P.TEN(#(P,3(L('1H92!#
M;VUP86YY(&ES<W5E9"!*86UE<W,@=V%R<F%N=',@=&\@<'5R8VAA<V4@,2PW
M,38L,S0P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=VET:"!A;B!E>&5R8VES
M92!P<FEC92!O9B`D,"XP,2!P97(@<VAA<F4N(%1H92!W87)R86YT<R!H879E
M(&$@9F%I<B!V86QU92!O9B`D,2PY-3<L-S4T("AS964@3F]T92`Q,2D@86YD
M(&EN8VQU9&5D(&$@8V%S:&QE<W,@97AE<F-I<V4@<')O=FES:6]N+CPO9F]N
M=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?
M.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#$V+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W1O8VL@3W!T:6]N
M(%!L86X\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^1&ES8VQO<W5R92!O9B!#;VUP96YS871I;VX@4F5L871E9"!#
M;W-T<RP@4VAA<F4M8F%S960@4&%Y;65N=',@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!/<'1I
M;VX@4&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M=V5I9VAT.B!B;VQD
M.R!D:7-P;&%Y.B!I;FQI;F4[)SY.;W1E(#$P("8C.#(Q,3L@4W1O8VL@3W!T
M:6]N(%!L86X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&IU<W1I9GD[(&1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T
M.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E
M<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(%1H92!#;VUP86YY(&AA<R!A9&]P=&5D
M(&$@,C`P,R!3=&]C:R!0;&%N('5N9&5R('=H:6-H(&ET(&UA>2!G<F%N="!U
M<"!T;R`W-3<L-3<U(&]P=&EO;G,@=&\@<'5R8VAA<V4@8V]M;6]N('-T;V-K
M+B!4:&4@,C`P,R!3=&]C:R!0;&%N('=A<R!A;65N9&5D(&EN(#(P,#@@=&\@
M:6YC<F5A<V4@=&AE(&YU;6)E<B!O9B!S:&%R97,@=&AA="!I="!M87D@9W)A
M;G0@=7`@=&\@.3<X+#$U-"X@3W!T:6]N(&%W87)D<R!A<F4@9V5N97)A;&QY
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M-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[
M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C
M:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[($EN(#(P,3$L('1H92`R,#`S(%-T;V-K(%!L86X@
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I
M9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS
M<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[($EN(&%C8V]R9&%N8V4@=VET:"!T:&4@=&5R
M;7,@;V8@=&AE(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG+"!T:&4@0V]M
M<&%N>2!A9&]P=&5D(&$@,C`Q,B!%;7!L;WEE92!3=&]C:R!/<'1I;VX@4&QA
M;B`H)B,X,C(P.S(P,3(@15-/4"8C.#(R,3LI(&%N9"!R97-E<G9E9"`Q-24@
M;V8@=&AE('1O=&%L(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@<VAA<F5S(&%S
M(&]F('1H92!F:6YA;"!C;&]S:6YG(&]F('1H92`R,#$R($-O;6UO;B!3=&]C
M:R!/9F9E<FEN9RXF(S$V,#LF(S$V,#M4;W1A;"!S:&%R97,@<F5S97)V960@
M9F]R(&ES<W5A;F-E('5N9&5R('1H92`R,#$R($533U`@=V%S(#DL-#4U+#<W
M-B!S:&%R97,N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z
M(#EP=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#L@1'5R:6YG(#(P,#8L(&]P=&EO;G,@=&\@<'5R8VAA<V4@
M,C`V+#`V,"!S:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@9W)A;G1E9"!T
M;R!S979E<F%L(&5M<&QO>65E<R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D
M,2XS-2!P97(@<VAA<F4N(%1H97-E(&]P=&EO;G,@:&%V92!A('1E<FT@;V8@
M,3`@>65A<G,@86YD('9E<W0@;W9E<B!A(#0M-2!Y96%R('!E<FEO9"X@1F%I
M<B!V86QU92!O9B`D,2PP-3$L,C@Q('=A<R!C86QC=6QA=&5D('5S:6YG('1H
M92!";&%C:RU38VAO;&5S(&]P=&EO;BUP<FEC:6YG(&UO9&5L+B!687)I86)L
M97,@=7-E9"!I;B!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I;VXM<')I8VEN9R!M
M;V1E;"!I;F-L=61E("@Q*2!D:7-C;W5N="!R871E(&]F(#0N,CDE("@R*2!E
M>'!E8W1E9"!L:69E(&]F(#4@>65A<G,L("@S*2!E>'!E8W1E9"!V;VQA=&EL
M:71Y(&]F(#$U-B4L(&%N9"`H-"D@>F5R;R!E>'!E8W1E9"!D:79I9&5N9',N
M/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T
M:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
M/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#L@1'5R:6YG(#(P,#<L(&]P=&EO;G,@=&\@<'5R8VAA<V4@,3$S+#(R
M,"!S:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@9W)A;G1E9"!T;R!S979E
M<F%L(&5M<&QO>65E<R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D,2XS-2!P
M97(@<VAA<F4N(%1H97-E(&]P=&EO;G,@:&%V92!A('1E<FT@;V8@,3`@>65A
M<G,@86YD('9E<W0@;W9E<B!A(#0M-2!Y96%R('!E<FEO9"X@1F%I<B!V86QU
M92!O9B`D,3,W+#8U,B!W87,@8V%L8W5L871E9"!U<VEN9R!T:&4@0FQA8VLM
M4V-H;VQE<R!O<'1I;VXM<')I8VEN9R!M;V1E;"X@5F%R:6%B;&5S('5S960@
M:6X@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D96P@:6YC
M;'5D92`H,2D@9&ES8V]U;G0@<F%T92!O9B`S+C0V)2`H,BD@97AP96-T960@
M;&EF92!O9B`U('EE87)S+"`H,RD@97AP96-T960@=F]L871I;&ET>2!O9B`Q
M-#,E+"!A;F0@*#0I('IE<F\@97AP96-T960@9&EV:61E;F1S+CPO9F]N=#X\
M+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF
M(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($1U
M<FEN9R`R,#`X+"!O<'1I;VYS('1O('!U<F-H87-E(#8Y+#DT,2!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K('=E<F4@9W)A;G1E9"!T;R!A;B!E;7!L;WEE92!A
M="!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XY,"!P97(@<VAA<F4N(%1H97-E
M(&]P=&EO;G,@:&%V92!A('1E<FT@;V8@,3`@>65A<G,@86YD('9E<W0@;W9E
M<B!A(#0M-2!Y96%R('!E<FEO9"X@1F%I<B!V86QU92!O9B`D-#0L,34Y('=A
M<R!C86QC=6QA=&5D('5S:6YG('1H92!";&%C:RU38VAO;&5S(&]P=&EO;BUP
M<FEC:6YG(&UO9&5L+B!687)I86)L97,@=7-E9"!I;B!T:&4@0FQA8VLM4V-H
M;VQE<R!O<'1I;VXM<')I8VEN9R!M;V1E;"!I;F-L=61E("@Q*2!D:7-C;W5N
M="!R871E(&]F(#,N-#8E("@R*2!E>'!E8W1E9"!L:69E(&]F(#4@>65A<G,L
M("@S*2!E>'!E8W1E9"!V;VQA=&EL:71Y(&]F(#$S.24L(&%N9"`H-"D@>F5R
M;R!E>'!E8W1E9"!D:79I9&5N9',N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G
M;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N
M=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@1'5R:6YG(#(P,#DL(#(P+#8Q
M,R!O<'1I;VYS('1O(&]N92!E;7!L;WEE92!W97)E(&-A;F-E;&QE9"!A<R!T
M:&4@<F5S=6QT(&]F('1E<FUI;F%T:6]N(&]F('1H92!E;7!L;WEM96YT(&%N
M9"`Q,C@L,#4P(&]P=&EO;G,@=&\@;VYE(&5M<&QO>65E('=E<F4@9F]R9F5I
M=&5D(&%S('1H92!E;7!L;WEE92!D96-E87-E9"!D=7)I;F<@=&AE('EE87(N
M/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T
M:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG
M/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#L@1'5R:6YG('1H92!Y96%R(&]F(#(P,3`L(&]P=&EO;G,@=&\@<'5R
M8VAA<V4@,S,L,S`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=V5R92!G<F%N
M=&5D('1O(&%N(&5M<&QO>65E(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F("0P
M+CDP('!E<B!S:&%R92X@5&AE<V4@;W!T:6]N<R!H879E(&$@=&5R;2!O9B`Q
M,"!Y96%R<R!A;F0@=F5S="!O=F5R(&$@-"TU('EE87(@<&5R:6]D+B!&86ER
M('9A;'5E(&]F("0R-"PY.38@=V%S(&-A;&-U;&%T960@=7-I;F<@=&AE($)L
M86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<-"B!M;V1E;"X@5F%R:6%B;&5S
M('5S960@:6X@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D
M96P@:6YC;'5D92`H,2D@9&ES8V]U;G0@<F%T92!O9B`R+C$V)2`H,BD@97AP
M96-T960@;&EF92!O9B`U('EE87)S+"`H,RD@97AP96-T960@=F]L871I;&ET
M>2!O9B`Q-S$E+"!A;F0@*#0I('IE<F\@97AP96-T960@9&EV:61E;F1S+CPO
M9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF
M>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V
M,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M($EN($9E8G)U87)Y(#(P,3(L('1H92!#;VUP86YY(')E+7!R:6-E9"`R-S,L
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I
M9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS
M<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[($1U<FEN9R`R,#$R+"!O<'1I;VYS('1O('!U
M<F-H87-E(#(L,#4V+#(W-2!S:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@
M:7-S=65D('1O('-E=F5R86P@96UP;&]Y965S(&%N9"!C;VYS=6QT86YT<R!A
M="!A;B!E>&5R8VES92!P<FEC92!R86YG:6YG(&9R;VT@)#`N-S@@=&\@)#$N
M-2!P97(@<VAA<F4N)B,Q-C`[)B,Q-C`[5&AE<V4@;W!T:6]N<R!H879E(&$@
M=&5R;2!O9B`Q,"!Y96%R<R!A;F0@=F5S="!O=F5R(&$@-"!Y96%R('!E<FEO
M9"X@5&AE(&9A:7(@=F%L=64@;V8@)#$L-3$Y+#<W-R!W87,@8V%L8W5L871E
M9"!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I;VXM<')I8VEN9R!M;V1E
M;"X@5F%R:6%B;&5S('5S960@:6X@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N
M+7!R:6-I;F<@;6]D96P@:6YC;'5D93H@*#$I(&1I<V-O=6YT(')A=&4@;V8@
M,2XX)2`H,BD@97AP96-T960@;&EF92!O9B`W('EE87)S+"`H,RD@97AP96-T
M960@=F]L871I;&ET>2!O9B`Q-C`N-#0E("8C,3(V.R`Q-C(N-#DE+"!A;F0@
M*#0I('IE<F\@97AP96-T960@9&EV:61E;F1S+CPO9F]N=#X\+V1I=CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E:6=H=#H@8F]L9#L@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A
M;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[(%1H92!F;VQL;W=I;F<@:7,@82!S=6UM87)Y(&]F
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M)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B
M;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^5V5I9VAT960\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.@T*(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY796EG:'1E
M9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY296UA:6YI;F<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^06=G<F5G871E/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-
M"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY!=F5R86=E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D-O;G1R86-T=6%L/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E5N:71S
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X
M('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY497)M("AI;B!Y96%R<RD\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY686QU93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$
M(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P,3`\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-S,L
M.#4Y/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C(Y/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C4N-3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY'<F%N=&5D
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;0T*('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^3W5T<W1A
M;F1I;F<L($1E8V5M8F5R(#,Q+"`R,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C(Y
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C4N-3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.@T*(&EN;&EN93LG/C(L,#4V+#(W-3PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C@N.#D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!$
M96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD
M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(L
M,S,P+#$S-#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R0\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXX+CDQ/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)#PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X
M.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXV.#4L.#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^
M#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF
M(S$V,#L@06QL(&]P=&EO;G,@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!A<F4@
M8F5I;F<@86UO<G1I>F5D(&]V97(@=&AE:7(@<F5S<&5C=&EV92!V97-T:6YG
M('!E<FEO9',N(%1H92!U;G)E8V]G;FEZ960@8V]M<&5N<V%T:6]N(&5X<&5N
M<V4@870@1&5C96UB97(@,S$L(#(P,3(@86YD(#(P,3$@=V5R92`D,2PY.3@L
M-#,U(&%N9"`D,30L-3(X+"!R97-P96-T:79E;'DN($1U<FEN9R!T:&4@>65A
M<G,@96YD960@1&5C96UB97(@,S$L(#(P,3(@86YD(#(P,3$L('1H92!#;VUP
M86YY(')E8V]R9&5D(&]P=&EO;B!E>'!E;G-E(&]F("0R-C8L,3<R(&%N9"`D
M,3DL.3,U+"!R97-P96-T:79E;'DN/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T
M-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7
M;W)K<VAE971S+U-H965T,3<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY787)R86YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY787)R86YT<R!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A
M<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
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M>3L@9&ES<&QA>3H@8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\
M+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,C=P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[($1U<FEN9R!T:&4@
M>65A<B!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,2P@=V%R<F%N=',@=&\@<'5R
M8VAA<V4@,2PY-S0L-S<T('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=V5R92!G
M<F%N=&5D('1O('1H92!-86YA9V5M96YT($9I<FT@870@86X@97AE<F-I<V4@
M<')I8V4@;V8@)#`N,#$@<&5R('-H87)E+B!4:&5S92!W87)R86YT<R!H879E
M(&$@=&5R;2!O9B`W('EE87)S(&%N9"!V97-T(&EM;65D:6%T96QY+B!&86ER
M('9A;'5E(&]F("0R+#$U,RPT-#(@=V%S(&-A;&-U;&%T960@=7-I;F<@=&AE
M($)L86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D96PN(%9A<FEA8FQE
M<R!U<V5D(&EN('1H92!";&%C:RU38VAO;&5S(&]P=&EO;BUP<FEC:6YG(&UO
M9&5L(&EN8VQU9&4@*#$I(&1I<V-O=6YT(')A=&4@<F%N9VEN9R!F<F]M(#$N
M.3(E('1O(#,N,3<E+"`H,BD@=V%R<F%N="!L:69E(&]F(#$P('EE87)S+"`H
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M;G1I<F4@9F%I<B!V86QU92!O9B`D,BPQ-3,L-#0R(&%S('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&1U<FEN9R!T:&4@>65A<B!O;B!T:&5S
M92!W87)R86YT<R!I<W-U960@8GD@=&AE($-O;7!A;GDN/"]F;VYT/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,C=P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`R-W!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N
M=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$
M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F
M;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=A<G)A;G1S(&ES<W5E
M9"!W:71H(&-O;G9E<G1I8FQE(&YO=&5S("A3964@3F]T92`U*3PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(X-RPP-C$\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E=A<G)A;G1S(&ES<W5E9"!T;R!I;G9E<W1O<G,@
M=VET:"!3=&]C:R!/9F9E<FEN9R`H4V5E($YO=&4@.2D\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#DW,BPW-C8\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M0V]N=F5R=&EB;&4@3F]T97,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXQ-#,L-3,R/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#M3=&]C:R!/9F9E<FEN9R`H4V5E($YO=&4@-B!A;F0@3F]T90T*
M(#DI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CDX-BPS.#,\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0X."4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY4;W1A;#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C,L,S@Y+#<T,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE
M/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX]
M,T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#(W<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C
M,38P.R8C,38P.R!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L
M(#(P,3(L('=A<G)A;G1S('1O('!U<F-H87-E(&%N(&%G9W)E9V%T92!O9B`Q
M+#<Q-BPS-#`@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!W97)E(&=R86YT960@
M=&\@=&AE($UA;F%G96UE;G0@1FER;2!A="!A;B!E>&5R8VES92!P<FEC92!O
M9B`D,"XP,2!P97(@<VAA<F4N(%1H97-E('=A<G)A;G1S(&AA=F4@82!T97)M
M(&]F(#<@>65A<G,@86YD('9E<W0@:6UM961I871E;'DN($9A:7(@=F%L=64@
M;V8@)#$L.34W+#<U-"!W87,@8V%L8W5L871E9"!U<VEN9R!T:&4@0FQA8VLM
M4V-H;VQE<R!O<'1I;VXM<')I8VEN9R!M;V1E;"X@5F%R:6%B;&5S('5S960@
M:6X@=&AE($)L86-K+5-C:&]L97,@;W!T:6]N+7!R:6-I;F<@;6]D96P@:6YC
M;'5D92`H,2D@9&ES8V]U;G0@<F%T92!O9B`Q+C@R)2P@*#(I('=A<G)A;G0@
M;&EF92!O9B`W('EE87)S+"`H,RD@97AP96-T960@=F]L871I;&ET>2!O9B`V
M,"XV-"4L(&%N9"`H-"D@>F5R;R!E>'!E8W1E9"!D:79I9&5N9',N)B,Q-C`[
M)B,Q-C`[4VEN8V4@=&AE<V4@=V%R<F%N=',@=F5S="!I;6UE9&EA=&5L>2P@
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#LF(S$V,#L@1'5R:6YG('1H
M92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$R+"!T:&4@0V]M<&%N>2!A
M;'-O(&ES<W5E9"!T:&4@9F]L;&]W:6YG('=A<G)A;G1S.CPO9F]N=#X\+V1I
M=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`R-W!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R(&)G8V]L;W(],T0C8V-E969F
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E=A<G)A;G1S(&ES<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!3=&]C:R!/
M9F9E<FEN9R`H4V5E($YO=&4@-BD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-#(L,3@Y/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0X."4@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R
M/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[#0H@9&ES<&QA>3H@:6YL:6YE.R<^4&QA8V5M96YT(&%G96YT
M('=A<G)A;G1S(')E;&%T960@=&\@:7-S=6%N8V4@;V8Z/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[4W1O8VL@3V9F97)I;F<@*%-E92!.;W1E(#8@86YD
M($YO=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ,C$L,#DT/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B
M9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E=A<G)A;G1S(&ES<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!S=&]C:R`F
M(S@R,3$[(&%C8W)U960@9&EV:61E;F0\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXQ.#`L,3$U)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B
M9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0X
M."4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T
M<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXU+#8X.2PW
M,S0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF
M>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L
M:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.PT*('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/E=E:6=H=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/D%V97)A9V4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/E=E:6=H=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E)E;6%I;FEN9SPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-
M"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY!9V=R96=A=&4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M.R<@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY.=6UB97(@;V8\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/D%V97)A9V4\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^0V]N=')A8W1U86P\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT-"B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY5;FET<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D5X97)C
M:7-E(%!R:6-E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^5&5R;2`H:6X@>65A
M<G,I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*
M/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!$96-E;6)E
M<B`S,2P@,C`Q,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H-"B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXU+#,V-"PU-3<\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,"XU,3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXV+C<V/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B
M9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U
M,B4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY/
M=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXU+#,V-"PU-3<\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXP+C4Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/C8N-S8\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,RPR-C$L,S8W/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY'<F%N=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C<L-#`V+#`W.3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXQ+C,R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,N-S8\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)0T*('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O
M;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[
M)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^3W5T<W1A;F1I;F<L($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L
M93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,3(L-S<P+#8S-CPO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,"X@.3<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-"XT.#PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B0\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#1P>#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO
M=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T
M-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7
M;W)K<VAE971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY%;7!L;WEE92!$969I;F5D($-O;G1R:6)U=&EO;B!0
M;&%N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D5M<&QO>65E($1E9FEN960@0V]N=')I8G5T:6]N(%!L86X@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;7!L;WEE92!$969I;F5D($-O;G1R:6)U=&EO;B!0;&%N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$:G5S=&EF
M>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY.;W1E(#$R("8C.#(Q,3L@16UP;&]Y964@1&5F:6YE9"!#;VYT<FEB=71I
M;VX@4&QA;CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@
M8FQO8VL[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@
M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#(W<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R8C,38P.R8C,38P.R!);B`R,#`T+"!T:&4@0V]M<&%N>2!E<W1A8FQI
M<VAE9"!A;B!E;7!L;WEE92!D969E<G)E9"!C;VYT<FEB=71I;VX@<&QA;BX@
M5&AE('!L86X@<F5Q=6ER97,@,3(@8V]N<V5C=71I=F4@;6]N=&AS(&]F('-E
M<G9I8V4@86YD(&$@;6EN:6UU;2!O9B`U,#`@:&]U<G,@;V8@<V5R=FEC92!F
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M;VX@-#`Q*&LI+B!4:&4@86UO=6YT(&-O;G1R:6)U=&5D(&)Y('1H92!#;VUP
M86YY(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,3(@86YD
M(#(P,3$@=V%S("0X+#DT,B!A;F0@)#@L.#@U+"!R97-P96-T:79E;'DN/"]F
M;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R
M,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,3DN:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$531SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3=6)S97%U96YT
M($5V96YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5B<V5Q=65N="!%=F5N=',@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=6)S97%U96YT(&5V96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7=E
M:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^3F]T92`X("8C.#(Q,3L@
M4W5B<V5Q=65N="!%=F5N=',\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$
M:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z
M(#EP=#LG/B8C,38P.R8C,38P.R8C,38P.SPO9F]N=#XF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#L@36%N86=E;65N="!H87,@979A;'5A=&5D('-U8G-E<75E
M;G0@979E;G1S(&%N9"!H87,@8V]N8VQU9&5D(&YO(&5V96YT<R!W87)R86YT
M(&1I<V-L;W-U<F4N)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1J
M=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN
M;&EN93LG/DYO=&4@,3,@)B,X,C$Q.R!3=6)S97%U96YT($5V96YT<SPO9F]N
M=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E>'0M
M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T
M:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#(W<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.R8C
M,38P.R!);B!&96)R=6%R>2`R."P@,C`Q,RP@=&AE($-O;7!A;GD@96YT97)E
M9"!I;G1O(&$@4V5P87)A=&EO;B!A;F0@4V5T=&QE;65N="!!9W)E96UE;G0@
M=VET:"!I=',@9F]R;65R($-%3RP@2F%C:R!486QL97DN(%!U<G-U86YT('1O
M('1H92!A9W)E96UE;G0L('1H92!#;VUP86YY('=I;&P@<&%Y($UR+B!486QL
M97D@:6X@,B!E<75A;"!I;G-T86QL;65N=',@=&AE(&%G9W)E9V%T92!A;6]U
M;G0@;V8@)#(U,"PP,#`@86YD(&$@<&5R9F]R;6%N8V4@8F]N=7,@;V8@)#8P
M+#`P,"!F;W(@:&ES('-E<G9I8V4@9G)O;2!!=6=U<W0@,34L(#(P,3(@=&\@
M1&5C96UB97(@,S$L(#(P,3(N(%1H92`D-C`L,#`P(&)O;G5S('=A<R!I;F-L
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M=#LG/B8C,38P.SPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A
M,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE
M-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,C`N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$553T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D1E
M<V-R:7!T:6]N(&]F($)U<VEN97-S(&%N9"!3=6UM87)Y(&]F(%-I9VYI9FEC
M86YT($%C8V]U;G1I;F<@4&]L:6-I97,@*%!O;&EC:65S*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1&5S8W)I<'1I;VX@3V8@0G5S:6YE<W,@86YD(%-U;6UA<GD@3V8@
M4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYA='5R
M92!O9B!"=7-I;F5S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY.871U<F4@;V8@0G5S:6YE<W,@)B,X,C$Q.SPO9F]N
M=#X@06-T:6YI=6T@4&AA<FUA8V5U=&EC86QS+"!);F,N(&9O<FUE<FQY(&MN
M;W=N(&%S($-A8W1U<R!696YT=7)E<RP@26YC+B`H=&AE("8C.#(R,#M#;VUP
M86YY)B,X,C(Q.RP@)B,X,C(P.T%C=&EN:75M)B,X,C(Q.RP@)B,X,C(P.T-A
M8W1U<R8C.#(R,3LI+"!W87,@:6YC;W)P;W)A=&5D('5N9&5R('1H92!L87=S
M(&]F('1H92!3=&%T92!O9B!.979A9&$@;VX@3V-T;V)E<B`V+"`Q.3DW+B!4
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU
M<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@('-T>6QE/3-$)VQE='1E
M<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N($1E8V5M8F5R(#(X+"`R,#$R+"!T
M:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!T<F%N<V%C=&EO;B`H=&AE("8C
M.#(R,#M3:&%R92!%>&-H86YG928C.#(R,3LI+"!P=7)S=6%N="!T;R!W:&EC
M:"!T:&4@0V]M<&%N>2!A8W%U:7)E9"`Q,#`E(&]F('1H92!I<W-U960@86YD
M(&]U='-T86YD:6YG(&5Q=6ET>2!S96-U<FET:65S(&]F($%C=&EN:75M(%!H
M87)M86-E=71I8V%L<RP@26YC+B`H)B,X,C(P.T%0228C.#(R,3LI+"!I;B!E
M>&-H86YG92!F;W(@=&AE(&ES<W5A;F-E(&]F(&%P<')O>&EM871E;'D@.3DE
M(&]F('1H92!I<W-U960@86YD(&]U='-T86YD:6YG(&-O;6UO;B!S=&]C:RP@
M<&%R('9A;'5E("0P+C`Q('!E<B!S:&%R92P@;V8@=&AE($-O;7!A;GDN(%1H
M92!3:&%R92!%>&-H86YG92!C;&]S960@;VX@1&5C96UB97(@,C@L(#(P,3(N
M)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0@;V8@=&AE(%-H87)E($5X8VAA;F=E
M+"!T:&4@9F]R;65R('-H87)E:&]L9&5R<R!O9B!!4$D@8F5C86UE('1H92!C
M;VYT<F]L;&EN9R!S:&%R96AO;&1E<G,@;V8@=&AE($-O;7!A;GDN($%T('1H
M92!C;&]S:6YG+"!E86-H($%022!S:&%R96AO;&1E<B!R96-E:79E9"`P+C,S
M,R!S:&%R97,@*'1H92`F(S@R,C`[17AC:&%N9V4@4F%T:6\F(S@R,C$[*2!O
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M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y
M;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P
M.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@05!)+"!I;F-O<G!O
M<F%T960@;VX@2G5N92`Q,RP@,C`P,"P@:7,@82!B:6]T96-H;F]L;V=Y(&-O
M;7!A;GD@8V]M;6ET=&5D('1O(&1E=F5L;W!I;F<@8G)E86MT:')O=6=H('1H
M97)A<&EE<R!F;W(@;&EF92!T:')E871E;FEN9R!D:7-E87-E<R!U<VEN9R!I
M=',@86QP:&$@<&%R=&EC;&4@:6UM=6YO=&AE<F%P>2`H05!)5"D@<&QA=&9O
M<FT@86YD(&]T:&5R(')E;&%T960@86YD('-I;6EL87(@=&5C:&YO;&]G:65S
M+B!!4$DL('1O9V5T:&5R('=I=&@@:71S('=H;VQL>2!O=VYE9"!S=6)S:61I
M87)Y+"!-961!8W1I;FEU;2P@26YC+B`H34%)*2P@*&AE<F5I;F%F=&5R(')E
M9F5R<F5D('1O(&-O;&QE8W1I=F5L>2!A<R`F(S@R,C`[05!))B,X,C(Q.RD@
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M;BX@26X@,C`Q,BP@05!)(&QA=6YC:&5D(&$@;75L=&DM8V5N=&5R(&-O<G!O
M<F%T92!S<&]N<V]R960@=')I86P@:6X@86-U=&4@;7EE;&]I9"!L975K96UI
M82`H04U,*2!P871I96YT<RX@05!))B,X,C$W.W,@;V)J96-T:79E+"!T:')O
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M/&9O;G0@('-T>6QE/3-$)VQE='1E<BUS<&%C:6YG.B`Y<'0[)SXF(S$V,#LF
M(S$V,#LF(S$V,#L\+V9O;G0^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[($%S
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M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF
M;VYT("!S='EL93TS1"=L971T97(M<W!A8VEN9SH@.7!T.R<^)B,Q-C`[)B,Q
M-C`[)B,Q-C`[/"]F;VYT/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R!/;B!-
M87)C:"`R,"P@,C`Q,RP@:6X@86YT:6-I<&%T:6]N(&]F('1H92!#;VUP86YY
M(&-H86YG:6YG(&ET<R!N86UE('1O($%C=&EN:75M(%!H87)M86-E=71I8V%L
M<RP@26YC+B!A;F0@:71S(&1O;6EC:6QE(&9R;VT@3F5V861A('1O($1E;&%W
M87)E+"!T:&4@0V]M<&%N>28C.#(Q-SMS('-U8G-I9&EA<GDL($%C=&EN:75M
M(%!H87)M86-E=71I8V%L<RP@26YC+BP@8VAA;F=E9"!I=',@;F%M92!T;R!!
M8W1I;FEU;2!#;W)P;W)A=&EO;BXF(S$V,#LF(S$V,#M/;B!!<')I;"`Q,2P@
M,C`Q,RP@=&AE($-O;7!A;GD@8VAA;F=E9"!I=',@9&]M:6-I;&4@9G)O;2!T
M:&4@4W1A=&4@;V8@3F5V861A('1O('1H92!3=&%T92!O9B!$96QA=V%R92!A
M;F0@8VAA;F=E9"!I=',@;F%M92!F<F]M($-A8W1U<R!696YT=7)E<RP@26YC
M+B!T;R!!8W1I;FEU;2!0:&%R;6%C975T:6-A;',L($EN8RX\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^
M3F%T=7)E(&]F($)U<VEN97-S("8C.#(Q,3L@06-T:6YI=6T@4&AA<FUA8V5U
M=&EC86QS+"!);F,@*$9O<FUE<FQY/"]F;VYT/B!#86-T=7,@5F5N='5R97,L
M($EN8RXI("AT:&4@)B,X,C(P.T-O;7!A;GDF(S@R,C$[+"`F(S@R,C`[0V%C
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@)B,Q-C`[)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[($]N($1E8V5M8F5R(#(X+"`R,#$R+"!T:&4@
M0V]M<&%N>2!E;G1E<F5D(&EN=&\@82!T<F%N<V%C=&EO;B`H=&AE("8C.#(R
M,#M3:&%R92!%>&-H86YG928C.#(R,3LI+"!P=7)S=6%N="!T;R!W:&EC:"!T
M:&4@0V]M<&%N>2!A9W)E960@=&\@86-Q=6ER92`Q,#`E(&]F('1H92!I<W-U
M960@86YD(&]U='-T86YD:6YG(&5Q=6ET>2!S96-U<FET:65S(&]F($%C=&EN
M:75M(%!H87)M86-E=71I8V%L<RP@26YC+B`H)B,X,C(P.T%C=&EN:75M)B,X
M,C(Q.RDL(&EN(&5X8VAA;F=E(&9O<B!T:&4@:7-S=6%N8V4@;V8@87!P<F]X
M:6UA=&5L>2`Y.24@;V8@=&AE(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@8V]M
M;6]N('-T;V-K+"!P87(@=F%L=64@)#`N,#$@<&5R('-H87)E+"!O9B!T:&4@
M0V]M<&%N>2X@5&AE(%-H87)E($5X8VAA;F=E('=A<R!C;&]S960@;VX@1&5C
M96UB97(@,C@L(#(P,3(@=VAE;B!S:&%R96AO;&1E<G,@<F5P<F5S96YT:6YG
M(&]V97(@,C`E(&]F('1H92!I<W-U960@86YD(&]U='-T86YD:6YG('-H87)E
M<R!O9B!!8W1I;FEU;2!H860@9FEN:7-H960@=&AE(&5X8VAA;F=E('!R;V-E
M<W,N)B,Q-C`[)B,Q-C`[3VX@075G=7-T(#(R+"`R,#$S+"!S:&%R96AO;&1E
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M:&%L;"!R96-E:79E(#`N,S,S('-H87)E<R`H=&AE("8C.#(R,#M%>&-H86YG
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M<F-H87-E($-A8W1U<R!C;VUM;VX@<W1O8VLN)B,Q-C`[)B,Q-C`[5&AE(%-H
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="`@<W1Y
M;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P.R8C,38P
M.SPO9F]N=#XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@06-T:6YI=6TL(&EN
M8V]R<&]R871E9"!O;B!*=6YE(#$S+"`R,#`P+"!I<R!A(&)I;W1E8VAN;VQO
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M1')U9R!!<'!L:6-A=&EO;BX@26X@,C`Q,BP@06-T:6YI=6T@;&%U;F-H960@
M82!M=6QT:2UC96YT97(@8V]R<&]R871E('-P;VYS;W)E9"!T<FEA;"!I;B!A
M8W5T92!M>65L;VED(&QE=6ME;6EA("A!34PI('!A=&EE;G1S+B`F(S$V,#M!
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M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N
M="`@<W1Y;&4],T0G;&5T=&5R+7-P86-I;F<Z(#EP=#LG/B8C,38P.R8C,38P
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M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%S:7,@;V8@4')E<V5N=&%T:6]N("T@56YA=61I=&5D($EN
M=&5R:6T@1FEN86YC:6%L($EN9F]R;6%T:6]N/"]T9#X-"B`@("`@("`@/'1D
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M;FET960@4W1A=&5S(&]F($%M97)I8V$@*"8C.#(R,#M5+E,N($=!05`F(S@R
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M)B,Q-C`[9F]R(&$@9F%I<B!S=&%T96UE;G0@;V8@=&AE(')E<W5L=',@9F]R
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M<B!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@;F]T97,@=&AE<F5T;R!C
M;VYT86EN960@:6X@=&AE($-O;7!A;GDF(S@R,3<[<R!A;FYU86P@<F5P;W)T
M(&]N($9O<FT@,3`M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L
M(#(P,3(L(&%S(&9I;&5D('=I=&@@=&AE(%-%0R!-87)C:"`R.2P@,C`Q,RX\
M+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$979E;&]P;65N="!3=&%G92!#;VUP86YY/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[)SX@1&5V96QO<&UE;G0@
M4W1A9V4@0V]M<&%N>2`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M<&%N>2!I<R!C
M;VYS:61E<F5D(&$@9&5V96QO<&UE;G0@<W1A9V4@8V]M<&%N>2!A;F0@:&%S
M(&AA9"!N;R!C;VUM97)C:6%L(')E=F5N=64@=&\@9&%T92X\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/D1E
M=F5L;W!M96YT(%-T86=E($-O;7!A;GD@)B,X,C$Q.SPO9F]N=#X@5&AE($-O
M;7!A;GD@:7,@8V]N<VED97)E9"!A(&1E=F5L;W!M96YT('-T86=E(&-O;7!A
M;GD@86YD(&AA<R!H860@;F\@8V]M;65R8VEA;"!R979E;G5E('1O(&1A=&4N
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y0<FEN8VEP;&5S(&]F($-O;G-O;&ED871I;VX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#H@
M8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^(%!R:6YC:7!L97,@;V8@0V]N<V]L
M:61A=&EO;B`F(S@R,3$[/"]F;VYT/B!4:&4@8V]N<V]L:61A=&5D(&9I;F%N
M8VEA;"!S=&%T96UE;G1S(&EN8VQU9&4@=&AE($-O;7!A;GDF(S@R,3<[<R!A
M8V-O=6YT<R!A;F0@=&AO<V4@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!W:&]L
M;'D@;W=N960@<W5B<VED:6%R:65S+B!!;&P@<VEG;FEF:6-A;G0@:6YT97)C
M;VUP86YY(&%C8V]U;G1S(&%N9"!T<F%N<V%C=&EO;G,@:&%V92!B965N(&5L
M:6UI;F%T960N/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/E!R:6YC:7!L97,@
M;V8@0V]N<V]L:61A=&EO;B`F(S@R,3$[/"]F;VYT/B!4:&4@8V]N<V]L:61A
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M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5<V4@;V8@17-T:6UA=&5S(&EN
M($9I;F%N8VEA;"!3=&%T96UE;G0@4')E<V5N=&%T:6]N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M
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M=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
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M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E
M8VQA<W-I9FEC871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE
M.R<^4F5C;&%S<VEF:6-A=&EO;B`F(S@R,3$[/"]F;VYT/B!#97)T86EN('!R
M:6]R('!E<FEO9"!A;6]U;G1S(&AA=F4@8F5E;B!R96-L87-S:69I960@=&\@
M8V]N9F]R;2!T;R!C=7)R96YT('!E<FEO9"!P<F5S96YT871I;VXN/"]F;VYT
M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[
M(&1I<W!L87DZ(&EN;&EN93LG/E)E8VQA<W-I9FEC871I;VX@)B,X,C$Q.SPO
M9F]N=#X@0V5R=&%I;B!P<FEO<B!P97)I;V0@86UO=6YT<R!H879E(&)E96X@
M<F5C;&%S<VEF:65D('1O(&-O;F9O<FT@=&\@8W5R<F5N="!P97)I;V0@<')E
M<V5N=&%T:6]N+CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\9F]N="!S='EL
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M>&-E<W,@;V8@1D1)0R!I;G-U<F5D(&QI;6ET<RX@070@2G5N92`S,"P@,C`Q
M,R!A;F0@1&5C96UB97(@,S$L(#(P,3(L(&%L;"!O9B!T:&4@0V]M<&%N>28C
M.#(Q-SMS(&-A<V@@=V%S(&1E<&]S:71E9"!I;B!O;F4@8F%N:RX\+V9O;G0^
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
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M8F%N:RX\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@17%U:7!M96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQF;VYT('-T>6QE
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M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26UP86ER;65N="!O9B!,;VYG
M+4QI=F5D($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[
M)SX@26UP86ER;65N="!O9B!,;VYG+4QI=F5D($%S<V5T<R`F(S@R,3$[/"]F
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M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M=F%L=64N/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M<RX\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T
M:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`S-G!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E(&]F($9I;F%N
M8VEA;"!);G-T<G5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/DQE=F5L(#(@26YP=71S("8C.#(Q,3L@26YP=71S(&]T:&5R('1H86X@<75O
M=&5D('!R:6-E<R!I;F-L=61E9"!I;B!,979E;"`Q('1H870@87)E(&]B<V5R
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF
M(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF
M>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$
M:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/DQE=F5L(#,@26YP
M=71S("8C.#(Q,3L@56YO8G-E<G9A8FQE(&EN<'5T<R!F;W(@9&5T97)M:6YI
M;F<@=&AE(&9A:7(@=F%L=65S(&]F(&%S<V5T<R!O<B!L:6%B:6QI=&EE<R!T
M:&%T(')E9FQE8W0@86X@96YT:71Y)W,@;W=N(&%S<W5M<'1I;VYS(&%B;W5T
M('1H92!A<W-U;7!T:6]N<R!T:&%T(&UA<FME="!P87)T:6-I<&%N=',@=V]U
M;&0@=7-E(&EN('!R:6-I;F<@=&AE(&%S<V5T<R!O<B!L:6%B:6QI=&EE<RX\
M+V9O;G0^/"]D:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>3L@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[
M/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`T-7!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY4:&4@9F]L;&]W:6YG('1A8FQE<R!S970@9F]R=&@@87-S
M971S(&%N9"!L:6%B:6QI=&EE<R!M96%S=7)E9"!A="!F86ER('9A;'5E(&]N
M(&$@<F5C=7)R:6YG(&%N9"!N;VXM<F5C=7)R:6YG(&)A<VES(&)Y(&QE=F5L
M('=I=&AI;B!T:&4@9F%I<B!V86QU92!H:65R87)C:'D@87,@;V8@2G5N92`S
M,"P@,C`Q,R!A;F0@1&5C96UB97(@,S$N($%S(')E<75I<F5D(&)Y($%30R`X
M,C`L(&9I;F%N8VEA;"!A<W-E=',@86YD(&QI86)I;&ET:65S(&%R92!C;&%S
M<VEF:65D(&EN('1H96ER(&5N=&ER971Y(&)A<V5D(&]N('1H92!L;W=E<W0@
M;&5V96P@;V8@:6YP=70@=&AA="!I<R!S:6=N:69I8V%N="!T;R!T:&4@9F%I
M<B!V86QU92!M96%S=7)E;65N="X@5&AE($-O;7!A;GDF(S@R,3<[<R!A<W-E
M<W-M96YT(&]F('1H92!S:6=N:69I8V%N8V4@;V8@82!P87)T:6-U;&%R(&EN
M<'5T('1O('1H92!F86ER('9A;'5E(&UE87-U<F5M96YT(')E<75I<F5S(&IU
M9&=M96YT+"!A;F0@;6%Y(&%F9F5C="!T:&4@=F%L=6%T:6]N(&]F(&9A:7(@
M=F%L=64@87-S971S(&%N9"!L:6%B:6QI=&EE<R!A;F0@=&AE:7(@<&QA8V5M
M96YT('=I=&AI;B!T:&4@9F%I<B!V86QU92!H:65R87)C:'D@;&5V96QS+CPO
M9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG
M;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,979E;"`R/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L
M<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^3&5V96P@,SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E1O
M=&%L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[)B,Q-C`[070@2G5N92`S,"P@,C`Q,SPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^,BPY-3<L.3<W/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C(L.34W+#DW-SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#M!
M="!$96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C,L-3<T+#DU.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY,979E;"`Q($EN<'5T<R`F(S@R,3$[(%5N861J=7-T
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M(&QI86)I;&ET>2`H<W5C:"!A<R!I;G1E<F5S="!R871E<RP@=F]L871I;&ET
M:65S+"!P<F5P87EM96YT('-P965D<RP@8W)E9&ET(')I<VMS+"!E=&,N*2!O
M<B!I;G!U=',@=&AA="!A<F4@9&5R:79E9"!P<FEN8VEP86QL>2!F<F]M(&]R
M(&-O<G)O8F]R871E9"!B>2!M87)K970@9&%T82!B>2!C;W)R96QA=&EO;B!O
M<B!O=&AE<B!M96%N<RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I
M<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY,979E;"`S($EN<'5T<R`F(S@R,3$[(%5N;V)S97)V86)L92!I;G!U
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M+"`R,#$R(&%N9"`R,#$Q+B!!<R!R97%U:7)E9"!B>2!!4T,@.#(P+"!F:6YA
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M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*
M/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,979E;"`Q/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@
M8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^3&5V96P@,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/DQE=F5L(#,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C
M96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY4;W1A;#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.@T*
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY$97)I=F%T:79E(&QI86)I;&ET:65S.CPO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[070@1&5C96UB97(@
M,S$L(#(P,3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,L
M-3<T+#DU.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,RPU-S0L.34X/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#M!="!$96-E;6)E<B`S,2P@,C`Q,3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD
M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[#0H@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+#0S
M.2PV,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K
M.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-O;64@5&%X
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^($EN8V]M92!4
M87AE<R`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M<&%N>2!U<V5S('1H92!A<W-E
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M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY);F-O;64@5&%X97,@)B,X,C$Q.SPO9F]N=#X@5&AE($-O;7!A;GD@=7-E
M<R!T:&4@87-S970@86YD(&QI86)I;&ET>2!M971H;V0@:6X@86-C;W5N=&EN
M9R!F;W(@:6YC;VUE('1A>&5S+B!5;F1E<B!T:&ES(&UE=&AO9"P@9&5F97)R
M960@=&%X(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@87)E(&1E=&5R;6EN960@
M8F%S960@;VX@9&EF9F5R96YC97,@8F5T=V5E;B!F:6YA;F-I86P@<F5P;W)T
M:6YG(&%N9"!I;F-O;64@=&%X(&-A<G)Y:6YG(&%M;W5N=',@;V8@87-S971S
M(&%N9"!L:6%B:6QI=&EE<R!A;F0@87)E(&UE87-U<F5D('5S:6YG('1H92!E
M;F%C=&5D('1A>"!R871E<R!A;F0@;&%W<R!T:&%T('=I;&P@8F4@:6X@969F
M96-T('=H96X@=&AE(&1I9F9E<F5N8V5S(&%R92!E>'!E8W1E9"!T;R!R979E
M<G-E+B!4:&4@0V]M<&%N>2!R979I97=S(&1E9F5R<F5D('1A>"!A<W-E=',@
M9F]R(&$@=F%L=6%T:6]N(&%L;&]W86YC92!B87-E9"!U<&]N('=H971H97(@
M:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA="!T:&4@9&5F97)R960@
M=&%X(&%S<V5T('=I;&P@8F4@9G5L;'D@<F5A;&EZ960N($$@=F%L=6%T:6]N
M(&%L;&]W86YC92P@:68@;F5C97-S87)Y+"!I<R!P<F]V:61E9"!A9V%I;G-T
M(&1E9F5R<F5D('1A>"!A<W-E=',L(&)A<V5D('5P;VX@;6%N86=E;65N="8C
M.#(Q-SMS(&%S<V5S<VUE;G0@87,@=&\@=&AE:7(@<F5A;&EZ871I;VXN/"]F
M;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-O<W1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z(&)O;&0[(&1I<W!L87DZ(&EN;&EN93LG/E)E
M<V5A<F-H(&%N9"!$979E;&]P;65N="!#;W-T<R`F(S@R,3$[/"]F;VYT/B!2
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
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M;G0@8V]S=',N/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F4M0F%S960@4&%Y;65N=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^(%-H87)E+4)A<V5D
M(%!A>6UE;G1S("8C.#(Q,3L\+V9O;G0^(%1H92!#;VUP86YY(&5S=&EM871E
M<R!T:&4@9F%I<B!V86QU92!O9B!E86-H('-T;V-K(&]P=&EO;B!A=V%R9"!A
M="!T:&4@9W)A;G0@9&%T92!B>2!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O
M<'1I;VX@<')I8VEN9R!M;V1E;"!A;F0@=F%L=64@;V8@8V]M;6]N('-H87)E
M<R!B87-E9"!O;B!T:&4@;&%S="!C;VUM;VX@<W1O8VL@=F%L=6%T:6]N(&1O
M;F4@8GD@=&AI<F0@<&%R='D@=F%L=6%T:6]N(&5X<&5R="!O9B!T:&4@0V]M
M<&%N>28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!O;B!T:&4@9&%T92!O9B!T:&4@
M<VAA<F4@9W)A;G0N(%1H92!F86ER('9A;'5E(&1E=&5R;6EN960@<F5P<F5S
M96YT<R!T:&4@8V]S="!F;W(@=&AE(&%W87)D(&%N9"!I<R!R96-O9VYI>F5D
M(&]V97(@=&AE('9E<W1I;F<@<&5R:6]D(&1U<FEN9R!W:&EC:"!A;B!E;7!L
M;WEE92!I<R!R97%U:7)E9"!T;R!P<F]V:61E('-E<G9I8V4@:6X@97AC:&%N
M9V4@9F]R('1H92!A=V%R9"X@07,@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N
M(&5X<&5N<V4@:7,@<F5C;V=N:7IE9"!B87-E9"!O;B!A=V%R9',@=6QT:6UA
M=&5L>2!E>'!E8W1E9"!T;R!V97-T+"!T:&4@0V]M<&%N>2!R961U8V5S('1H
M92!E>'!E;G-E(&9O<B!E<W1I;6%T960@9F]R9F5I='5R97,@8F%S960@;VX@
M:&ES=&]R:6-A;"!F;W)F96ET=7)E(')A=&5S+B!0<F5V:6]U<VQY(')E8V]G
M;FEZ960@8V]M<&5N<V%T:6]N(&-O<W1S(&UA>2!B92!A9&IU<W1E9"!T;R!R
M969L96-T('1H92!A8W1U86P@9F]R9F5I='5R92!R871E(&9O<B!T:&4@96YT
M:7)E(&%W87)D(&%T('1H92!E;F0@;V8@=&AE('9E<W1I;F<@<&5R:6]D+B!%
M>&-E<W,@=&%X(&)E;F5F:71S+"!I9B!A;GDL(&%R92!R96-O9VYI>F5D(&%S
M(&%N(&%D9&ET:6]N('1O('!A:60M:6X@8V%P:71A;"X\+V9O;G0^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=CX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY3:&%R92U"87-E9"!087EM96YT<R`F(S@R,3$[/"]F;VYT/B!4:&4@0V]M
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M/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16%R;FEN9W,@*$QO<W,I(%!E<B!#;VUM;VX@4VAA
M<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[($5A
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M<W1O8VMH;VQD97)S)B,Q-C`[8GD@=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M
M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T<W1A;F1I;F<@<&QU<R!D:6QU=&EV
M92!S96-U<FET:65S+B!3:6YC92!T:&4@0V]M<&%N>2!H87,@;VYL>2!I;F-U
M<G)E9"!L;W-S97,L(&)A<VEC(&%N9"!D:6QU=&5D(&YE="!L;W-S('!E<B!C
M;VUM;VX@<VAA<F4@87)E('1H92!S86UE+B`F(S$V,#M4:&4@<&]T96YT:6%L
M;'D@9&EL=71I=F4@<V5C=7)I=&EE<R`H;W!T:6]N<RP@=V%R<F%N=',@86YD
M(&-O;G9E<G1I8FQE(&EN<W1R=6UE;G1S*2!W97)E(&5X8VQU9&5D(&9R;VT@
M=&AE(&1I;'5T960@;&]S<R!P97(@8V]M;6]N('-H87)E(&-A;&-U;&%T:6]N
M(&)E8V%U<V4@=&AE:7(@969F96-T('=O=6QD(&AA=F4@8F5E;B!A;G1I9&EL
M=71I=F4N($9O<B!T:&4@<VEX(&UO;G1H<R!E;F1E9"!*=6YE(#,P+"`R,#$S
M+"!P;W1E;G1I86QL>2!I<W-U86)L92!S:&%R97,@:6YC;'5D960@<W1O8VL@
M;W!T:6]N<R!T;R!P=7)C:&%S92`R+#(X,"PQ.#0@<VAA<F5S(&%N9"!W87)R
M86YT<R!T;R!P=7)C:&%S92`Y+#4S-2PV.30@<VAA<F5S(&]F('1H92!#;VUP
M86YY)B,X,C$W.W,@8V]M;6]N('-T;V-K+B!&;W(@=&AE('-I>"!M;VYT:',@
M96YD960@2G5N92`S,"P@,C`Q,BP@<&]T96YT:6%L;'D@:7-S=6%B;&4@<VAA
M<F5S(&EN8VQU9&5S(&]P=&EO;G,@86YD('=A<G)A;G1S)B,Q-C`[=&\@<'5R
M8VAA<V4@-BPX-#(L-3(X('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS
M(&-O;6UO;B!S=&]C:R!A;F0@;F]T97,@<&%Y86)L92!C;VYV97)T:6)L92!T
M;R`X,34L,C<U('-H87)E<R!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&-O;6UO
M;B!S=&]C:R!H879E(&)E96X@97AC;'5D960@9G)O;2!T:&4@8V%L8W5L871I
M;VXN/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M(&%V86EL86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S)B,Q-C`[8GD@=&AE
M('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T
M<W1A;F1I;F<@<&QU<R!D:6QU=&EV92!S96-U<FET:65S+B!3:6YC92!T:&4@
M0V]M<&%N>2!H87,@;VYL>2!I;F-U<G)E9"!L;W-S97,L(&)A<VEC(&%N9"!D
M:6QU=&5D(&YE="!L;W-S('!E<B!C;VUM;VX@<VAA<F4@87)E('1H92!S86UE
M+B`F(S$V,#M4:&4@<&]T96YT:6%L;'D@9&EL=71I=F4@<V5C=7)I=&EE<R`H
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M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E8V5N="!!
M8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
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M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY296-E;G0@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<R`F(S@R,3$[
M/"]F;VYT/B!4:&4@0V]M<&%N>2!D;V5S(&YO="!E>'!E8W0@=&AA="!A;GD@
M<F5C96YT;'D@:7-S=65D(&%C8V]U;G1I;F<@<')O;F]U;F-E;65N=',@=VEL
M;"!H879E(&$@<VEG;FEF:6-A;G0@:6UP86-T(&]N('1H92!R97-U;'1S(&]F
M(&]P97)A=&EO;G,L(&9I;F%N8VEA;"!P;W-I=&EO;BP@;W(@8V%S:"!F;&]W
M<R!O9B!T:&4@0V]M<&%N>3PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<V5Q=65N="!%=F5N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=CX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#H@8F]L9#L@9&ES<&QA>3H@:6YL:6YE.R<^4W5B<V5Q=65N
M="!%=F5N=',@)B,X,C$Q.SPO9F]N=#X@5&AE($-O;7!A;GDF(S@R,3<[<R!M
M86YA9V5M96YT(')E=FEE=V5D(&%L;"!M871E<FEA;"!E=F5N=',@9G)O;2!*
M86YU87)Y(#$L(#(P,3,@=&AR;W5G:"!-87)C:"`Q-2P@,C`Q,RX\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB
M,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U
M93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#(Q+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4T<^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^1&5S8W)I<'1I;VX@;V8@0G5S:6YE
M<W,@86YD(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI
M8VEE<R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5S8W)I<'1I;VX@3V8@
M0G5S:6YE<W,@86YD(%-U;6UA<GD@3V8@4VEG;FEF:6-A;G0@06-C;W5N=&EN
M9R!0;VQI8VEE<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@<V5T(&9O<G1H(&%S<V5T
M<R!A;F0@;&EA8FEL:71I97,@;65A<W5R960@870@9F%I<B!V86QU92!O;B!A
M(')E8W5R<FEN9R!A;F0@;F]N+7)E8W5R<FEN9R!B87-I<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@
M,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE
M.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT
M<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS
M1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^3&5V96P@,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG
M;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,979E;"`S/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A
M;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^5&]T86P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E
M969F/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[070@2G5N92`S,"P@,C`Q,SPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ#0H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR+#DU-RPY-S<\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,BPY-3<L.3<W/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R8C,38P.T%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C,L-3<T+#DU.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!A
M;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/DQE
M=F5L(#$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,979E;"`R/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@
M8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^3&5V96P@,SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/E1O=&%L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY$97)I=F%T:79E(&QI86)I;&ET:65S.CPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[
M070@1&5C96UB97(@,S$L(#(P,3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[#0H@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^,RPU-S0L.34X/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS
M+#4W-"PY-3@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P.T%T($1E8V5M
M8F5R(#,Q+"`R,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXT+#0S.2PV,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I
M<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y
M8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q
M-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970R,BYH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A
M8W1I;VYS("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A8W1I;VYS
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W5M;6%R>2!O9B!A8W1I=FET:65S(')E;&%T960@=&\@<F5L
M871E9"!P87)T>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I
M=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,C=P=#LG/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\
M=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K
M(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E
M<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS
M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXR,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/E)E:6UB=7)S96UE;G1S(')E8V5I=F5D(&9R;VT@35-+0T,\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR
M,S<L.#,T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/CDV-BPS-#$\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV('-T>6QE
M/3-$)V1I<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970R,RYH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P15-'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y(&%N9"!%
M<75I<&UE;G0@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y(&%N
M9"!%<75I<&UE;G0@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F('!R;W!E<G1Y(&%N9"!E
M<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@
M86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[
M)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CPO=&0^#0H\=&0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(P
M,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@
M8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E
M969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/D]F9FEC92!E<75I<&UE;G0\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXQ-3<L,C<T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$U
M-BPQ-C(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#8W)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/D9U<FYI='5R92!A;F0@9FEX='5R93PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[-R!Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#(Y,CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXQ-3@L-38V/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0V-R4@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B@Q-30L-#0T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-"PQ
M,C(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E!R
M;W!E<G1Y(&%N9"!E<75I<&UE;G0L(&YE=#PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,L,#$P/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I
M=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@-#5P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE
M('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L
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M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.TQI=F5S/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0V-R4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY/9F9I8V4@97%U
M:7!M96YT/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#LU('EE87)S/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$U
M-BPQ-C(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H
M:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#8W)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY&=7)N:71U
M<F4@86YD(&9I>'1U<F4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#LW('EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXQ-34L,#DV/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,97-S.B!A8V-U;75L871E9"!D97!R
M96-I871I;VX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,34T+#0T-#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,34S+#@V,SPO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD
M:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*3PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET
M93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0V-R4@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.PT*(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-C<E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE
M.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXS+#`Q,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I
M=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q
M-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB
M,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H
M965T,C0N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY.;W1E(%!A>6%B;&4@86YD($-O;G9E<G1I8FQE($YO=&5S("A486)L97,I
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/DYO=&4@4&%Y86)L92!A;F0@0V]N=F5R=&EB;&4@3F]T97,@6T%B<W1R
M86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3=6UM87)Y(&]F('-E;FEO<B!S=6)O<F1I;F%T960@=6YS96-U<F5D(&-O
M;G9E<G1I8FQE('!R;VUI<W-O<GD@;F]T97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E
M>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L
M969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,#$R/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED
M.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY0
M<FEN8VEP86P@86UO=6YT/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CDP,"PP,#`\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/CDP,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#$U,"PP,#`\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B@Q-3`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M#0H@9&ES<&QA>3H@:6YL:6YE.R<^*#,W-RPQ-3`\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B@S-S<L,34P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXH,S<R+#@U,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M*#,W,BPX-3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^.3`P+#`P,#PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ,C0L
M,S8S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R
M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W
M-B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^3&5S<SH@<')I;F-I<&%L(&%M;W5N="!C;VYV97)T960@=&\@<W1O
M8VL\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#DP,"PP,#`\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO
M='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24-"B!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P
M>#LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY#87)R>6EN9R!V86QU92!A="!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@
M,C`Q,2P@<F5S<&5C=&EV96QY/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P
M>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE
M.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^
M#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE
M971S+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5404%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D1E<FEV871I=F5S("A486)L97,I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY$97)I=F%T:79E<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(&1E<FEV871I=F4@
M=V%R<F%N="!I;G-T<G5M96YT<R!A8W1I=FET>3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG;CTS1&IU<W1I9GD@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV
M(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T
M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
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M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$
M,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
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M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$P)2!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$
M96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C4L,30V+#,S.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M,RPU-S0L.34X/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R
M/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
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M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(]
M,T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/E)E8VQA<W-I9FEC871I;VX@=&\@<&%I9"!I;B!C87!I
M=&%L/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@U.3`L,C$W/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@R-BPW
M-C0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/D)A;&%N8V4L($IU;F4@,S`L(#(P,3,\+V9O
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR+#`R,RPU
M,3<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE
M('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI
M9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/E5N:71S/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$
M96-E;6)E<B`S,2P@,C`Q,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#LD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B
M9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR.#<L,#8Q/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,W-RPQ
M-3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ-#,L-3,R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.PT*
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ+#DW,BPW.#4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,BPU.3$L.3`P/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C
M8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/E!L86-E;65N="!A9V5N="!W87)R86YT<R!R96QA=&5D('1O
M(&ES<W5A;F-E(&]F('-T;V-K("A3964@3F]T92`Y*3PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXQ+#(Y-2PY-3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY#:&%N9V4@:6X@9F%I<B!V86QU93PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ#0H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY"86QA;F-E+"!$
M96-E;6)E<B`S,2P@,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS+#,X
M.2PW-S$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+#0S.2PV,3,\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG
M:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-#(L,3DP/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C,Q."PP.#<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ
M,C$L,#DU/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/C$U.2PP-#0\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[#0H@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^5V%R
M<F%N=',@:7-S=65D('=I=&@@,C`Q,B!#;VUM;VX@4W1O8VL@3V9F97)I;F<M
M02`H4V5E($YO=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/C,L,3$X+#DX.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#0P.2PU-30\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^5V%R<F%N=',@:7-S=65D('=I=&@@,C`Q,B!#;VUM
M;VX@4W1O8VL@3V9F97)I;F<M0B`H4V5E($YO=&4@.2D\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R
M:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-34Y+#4P-3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXQ+#8V-2PV.3<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E!L86-E;65N="!A9V5N
M="!W87)R86YT<R!R96QA=&5D('1O(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R
M:6YG("A3964@3F]T92`Y*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT.3DL-S`W/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(]
M,T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#,L-S4S+#`U-CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXI/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C4L,30V+#,S.#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L
M93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,L-3<T+#DU.#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.SPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@9F%I<B!V86QU97,@;V8@9&5R
M:79A=&EV92!W87)R86YT<R!O;B!B87-I<R!O9B!V86QU871I;VX@;6]D96P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/B8C,38P
M.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4],T0G
M=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&9O
M;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q
M,"4@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M2G5N92`S,"P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXR,#$S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q,"4@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY-
M87)K970@=F%L=64@;V8@8V]M;6]N('-T;V-K(&]N(&UE87-U<F5M96YT(&1A
M=&4@*#$I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ
M+C8U/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SY!9&IU<W1E9"!E>&5R8VES92!P<FEC93PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C`N-#@@+2`D,"XX,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.PT*(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C$N-3`@+2`D,BXT-S4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,"XQ,"`M("0P+C<W/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^,2XP-3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#<V)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$P)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R<@8V]L<W!A;CTS1#(^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<CL@;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT(&UO;G1H
M<R\U('EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D('=I9'1H/3-$,3`E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([)R!C;VQS<&%N/3-$,CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0N
M-2!Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0W-B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!V;VQA=&EL:71Y
M("@S*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^,3(U)2`M(#$V,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ-30\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!D:79I9&5N9"!Y:65L
M9"`H-"D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&9O;G0M=V5I9VAT.B!B;VQD.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT
M86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0U)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY4:&4@;6%R:V5T('9A;'5E(&]F(&-O;6UO;B!S=&]C:R!I<R!B87-E9"!O
M;B!A;B!E;G1E<G!R:7-E('9A;'5A=&EO;BX\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U)2!V
M86QI9VX],T1T;W`^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$.34E('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I
M=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,BDF
M(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$
M.34E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M;&EG;CTS1&QE9G0@=VED=&@],T0U)2!V86QI9VX],T1T;W`^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.34E('9A;&EG;CTS1'1O<#X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$-24@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,RDF(S$V,#LF(S$V,#L\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.34E('9A;&EG;CTS1'1O<#X-"CQD
M:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Y
M-24@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0U)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@T*28C,38P
M.R8C,38P.SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$.34E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^36%N86=E;65N="!D971E<FUI
M;F5D('1H92!D:79I9&5N9"!Y:65L9"!T;R!B92`P)2!B87-E9"!U<&]N(&ET
M<R!E>'!E8W1A=&EO;B!T:&%T(&ET('=I;&P@;F]T('!A>2!D:79I9&5N9',@
M9F]R('1H92!F;W)E<V5E86)L92!F=71U<F4N/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I
M=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[(&UA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#(W<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX]
M,T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/D1E8V5M8F5R(#,Q+#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T
M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^2F%N=6%R>2`S,2P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D1E8V5M
M8F5R(#$Y+#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^1&5C96UB97(@,C<L
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$96-E;6)E<B`S,2P\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\
M9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R!T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[('1E>'0M86QI9VXZ(&QE9G0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L
M<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C(P,3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#L@=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0-"B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`],T1N;W=R87`@=F%L
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#0P)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M>3H@:6YL:6YE.R<^,"XR-"`M("0P+C(V/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE
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M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+W1D
M/@T*/'1D('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXP+C(S("T@)#`N,C8\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C`N-#$@+2`D,"XX,SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ#0H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+W1D/@T*/'1D
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXP+C(R("T@)#`N,C8\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N
M-#$@+2`D,"XX,SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C,U/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C(T/"]F;VYT/CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXP+C$P)2`M(#`N-S<\+V9O;G0^/"]T9#X-"CQT9"!W:61T
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C`N.30\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO=W)A
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,3`E
M("T@,"XW-SPO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY787)R86YT(&QI=F5S(&EN
M('EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0@;6]N
M=&AS+S5Y96%R<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.PT*(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-"!M
M;VYT:',O-7EE87)S/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY%>'!E8W1E9"!V;VQA=&EL:71Y("@S*3PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C$R-24@+2`Q-C$\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED
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M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,3(U)2`M(#$V,3PO9F]N
M=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>'!E8W1E9"!D:79I9&5N
M9"!Y:65L9"`H-"D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^+3PO9F]N=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX]
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M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E#0H@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY0<F]B86)I;&ET>2!O9B!S=&]C:R!O9F9E<FEN
M9R!I;B!A;GD@<&5R:6]D(&]V97(@-2!Y96%R<R`H-2D\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(U/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-3PO9F]N=#X\+W1D/@T*/'1D('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(U/"]F;VYT
M/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-3PO9F]N=#X\+W1D/@T*/'1D('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY286YG92!O9B!P97)C96YT86=E(&]F(&5X:7-T:6YG
M('-H87)E<R!O9F9E<F5D("@V*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C,U/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI9VXZ
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXS-3PO9F]N
M=#X\+W1D/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C,U/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B4\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-#`E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+C$X("T@)#`N-34\+V9O;G0^
M/"]T9#X-"CQT9"!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L
M:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXD/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N,3,@+2`D,"XU-CPO9F]N=#X\+W1D
M/@T*/'1D('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M9&ES<&QA>3H@:6YL:6YE.R<^,"XP,2`M("0P+C4U/"]F;VYT/CPO=&0^#0H\
M=&0@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXP+C$R("T@)#`N-C`\+V9O;G0^/"]T9#X-"CQT9"!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@;&5F=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO
M=&0^#0H\=&0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C`N,#$@+2`D,"XU-3PO9F]N=#X\+W1D/@T*/'1D('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=T97AT+6%L:6=N.B!L969T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE
M/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78^#0H\
M=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#,E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
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M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY4:&4@;6%R:V5T('9A;'5E(&]F(&-O;6UO;B!S=&]C:R!I<R!B87-E
M9"!O;B!A;B!E;G1E<G!R:7-E('9A;'5A=&EO;BX\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1J
M=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y;&4]
M,T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#0E('9A
M;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B@R*28C,38P.R8C,38P.SPO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.38E('9A;&EG;CTS1'1O
M<#X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M<W!L87DZ(&)L;V-K.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@
M,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE
M.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT
M<CX-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$-"4@=F%L:6=N/3-$=&]P
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^*#,I)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!W
M:61T:#TS1#DV)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$:G5S=&EF
M>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*
M/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0T)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$<FEG:'0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-"DF(S$V,#LF(S$V,#L\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.38E('9A;&EG;CTS1'1O
M<#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^36%N86=E;65N="!D971E<FUI;F5D('1H92!D:79I9&5N9"!Y:65L
M9"!T;R!B92`P)2!B87-E9"!U<&]N(&ET<R!E>'!E8W1A=&EO;B!T:&%T(&ET
M('=I;&P@;F]T('!A>2!D:79I9&5N9',@9F]R('1H92!F;W)E<V5E86)L92!F
M=71U<F4N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*
M/"]D:78^#0H\9&EV('-T>6QE/3-$)V1I<W!L87DZ(&)L;V-K.R!T97AT+6EN
M9&5N=#H@,'!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-
M"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$-"4@=F%L:6=N/3-$=&]P/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL-"B!D:7-P;&%Y.B!I;FQI;F4[)SXH-2DF(S$V,#LF(S$V,#L\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#DV)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/DUA;F%G96UE;G0@:&%S(&1E=&5R;6EN960@
M=&AA="!T:&4@<')O8F%B:6QI='D@;V8@82!S=&]C:R!O9F9E<FEN9R!I<R`R
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M<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#0E('9A;&EG;CTS1'1O<#X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY-
M86YA9V5M96YT(&5S=&EM871E<R!T:&%T('1H92!R86YG92!O9B!P97)C96YT
M86=E<R!O9B!E>&ES=&EN9R!S:&%R97,@;V9F97)E9"!I;B!E86-H('-T;V-K
M(&]F9F5R:6YG('=I;&P@8F4@8F5T=V5E;B`S-24@;V8@=&AE('-H87)E<R!O
M=71S=&%N9&EN9RX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CPO=&%B
M;&4^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E
M>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L
M969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0T)2!V86QI9VX],T1T;W`^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-RDF(S$V,#LF(S$V
M,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('=I9'1H/3-$.38E('9A;&EG
M;CTS1'1O<#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M/"]T86)L93X-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A
M,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE
M-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,C8N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$4R1CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);F-O
M;64@5&%X97,@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>&5S(%M!8G-T<F%C=%T\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M<&]N96YT<R!O9B!D969E<G)E9"!T87@@87-S971S(&%N9"!L:6%B:6QI=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^)B,Q
M-C`[/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS
M1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@
M8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,C`Q,CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(P
M,3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$969E<G)E9"!T87@@87-S
M971S.CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T
M<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[3F5T(&]P97)A=&EN9R!L;W-S97,\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,3,L-C`Y
M+#`S-CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$
M(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M3:&%R92UB87-E
M9"!C;VUP96YS871I;VX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXQ+#0Y-RPU-38\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R
M/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-S8E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R8C,38P.R8C,38P.R8C,38P.T]T:&5R(&1I9F9E<F5N8V5S(&EN('1A
M>"!B87-I<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X#0H@<V]L:60[)SX-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(S,RPP-#,\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXT+#<T.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$-S8E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L
M;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0W-B4@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SY4;W1A;"!D969E<G)E9"!T87@@87-S971S/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXQ,RPX,S4L-#@S/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY,97-S.B!V86QU871I;VX@
M86QL;W=A;F-E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#<V)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.@T*('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!D:69F97)E;F-E
M(&)E='=E96X@=&AE(&EN8V]M92!T87@@<')O=FES:6]N(&%N9"!T:&4@52Y3
M+B!&961E<F%L('-T871U=&]R>2!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`R-W!T.R<^)B,Q-C`[/"]D:78^#0H\9&EV(&%L
M:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#$T/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#8^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$-CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$96-E;6)E<B`S
M,2P@,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
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M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@R+#@T
M,BPX,3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@Q+#$W,2PR,S`\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^+3,T+C`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG
M;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXY+C`T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXW,S8L-SDV/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C(Q+C,Y/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,BXW.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+C$X
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B4\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXU-BPP,S,\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/D-H86YG92!I;B!V86QU871I;VX@86QL;W=A;F-E
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-3`T+#$U,3PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C,W,RPV-3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ,"XX-3PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M#0H@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@-'!X.R<^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/E!R;W9I<VEO;B!F;W(@:6YC;VUE('1A
M>#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@
M9&]U8FQE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R<^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B0\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X
M(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG
M;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N
M=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?
M.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#(W+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%44I!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VUM:71M96YT
M<R!A;F0@0V]N=&EN9V5N8VEE<R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%B8F]T="!"
M:6]T:&5R87!E=71I8W,@0V]R<"!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DUI;&5S=&]N92!087EM96YT<R!-
M:6QE<W1O;F4@365T:&]D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F(&UI;&5S=&]N
M92!P87EM96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV
M(&%L:6=N/3-$;&5F=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T
M.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1&QE
M9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY-:6QE<W1O;F5S/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-S4P+#`P,#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$
M=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXW-3`L,#`P
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G
M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
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M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C$L-3`P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-S4P
M+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0X."4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH-2D@1FER<W0@8V]M;65R8VEA;"!S
M86QE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^,2PU,#`L,#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.PT*(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B@V*2!A9G1E<B!T:&4@
M9FER<W0@)#$P+#`P,"PP,#`@:6X@;F5T('-A;&5S/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,2PU,#`L,#`P/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO
M9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!A;&EG;CTS1&QE9G0^#0H\
M=&%B;&4@<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^36EL97-T;VYE<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E!A>6UE;G1S/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0X."4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C<U,"PP,#`\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-S4P
M+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0X."4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,RD@=VAE;B!#;VUP86YY(&EN:71I
M871E<R!A(%!H87-E($E)22!#;&EN:6-A;"!4<FEA;"!O9B!A(&QI8V5N<V5D
M('!R;V1U8W0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXQ+#4P,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ
M+#<U,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/C$L-3`P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^*#8I(&%F=&5R('1H
M92!F:7)S="`D,3`L,#`P+#`P,"!I;B!N970-"B!S86QE<SPO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-3`P+#`P,#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^
M#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E>'0M
M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DU32T-#(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^36EL97-T
M;VYE(%!A>6UE;G1S($UI;&5S=&]N92!-971H;V0@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U;6UA
M<GD@;V8@;6EL97-T;VYE('!A>6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$
M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F
M;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/DUI
M;&5S=&]N97,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-
M"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY087EM96YT<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\
M='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*/&1I=B!A;&EG
M;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-S4P+#`P,#PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/C$L-S4P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI
M9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE
M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/DUI;&5S=&]N97,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$
M,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY087EM96YT<SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^,2D@9FEL:6YG(&]F(&%N($YE=R!$<G5G($%P<&QI
M8V%T:6]N("@F(S@R,C`[3D1!)B,X,C(Q.RD@;W(@<F5G=6QA=&]R>2!A<'!R
M;W9A;#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/F9O<B!E86-H(&QI8V5N<V5D('!R;V1U8W0\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^-S4P+#`P,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0X."4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,BD@=7!O
M;B!T:&4@<F5C96EP="!O9B!R96=U;&%T;W)Y(&%P<')O=F%L(&9R;VT@=&AE
M(%4N4RX@1D1!(&9O<B!E86-H/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT
M<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$L-S4P+#`P
M,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B
M;&4^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G9&ES<&QA>3H@8FQO8VL[('1E
M>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\+V1I=CX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X
M.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H
M965T<R]3:&5E=#(X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^4W1O8VL@3W!T:6]N(%!L86X@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&ES8VQO
M<W5R92!O9B!#;VUP96YS871I;VX@4F5L871E9"!#;W-T<RP@4VAA<F4M8F%S
M960@4&%Y;65N=',@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F('-T;V-K(&]P=&EO;B!A
M8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV
M(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X-"CQT86)L
M92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY796EG:'1E9#PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY!=F5R86=E/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY796EG:'1E9#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N
M/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY296UA:6YI;F<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^0V]N=')A8W1U86P\+V9O;G0^/"]D:78^#0H\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@
M<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>&5R8VES92!0<FEC93PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E1E<FT@*&EN('EE87)S*3PO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/E9A;'5E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C
M965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P,3`\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-S,L.#4Y
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG/C$N,CD\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#LD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$
M.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS
M1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H-
M"B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY/=71S=&%N
M9&EN9RP@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-S,L.#4Y/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
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M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
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M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
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M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY'<F%N=&5D/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O
M;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/C(L,#4V+#(W-3PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+CDV/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P
M>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C@N.#D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E#0H@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^3W5T<W1A;F1I;F<L($1E
M8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,BPS
M,S`L,3,T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)#PO9F]N=#X\+V1I=CX-"CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^#0H\9&EV(&%L
M:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+B`Y-CPO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXX+CDQ/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXV.#4L.#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\
M+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?
M8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D
M8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S
M+U-H965T,CDN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4S0D%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/D5Q=6ET>2`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^4W1O
M8VL@3W!T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/E=A<G)A;G0@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA
M<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A
M<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(%-H87)E
M+6)A<V5D($-O;7!E;G-A=&EO;BP@4W1O8VL@3W!T:6]N<RP@06-T:79I='D@
M6U1A8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`R-W!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F
M=#X-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT<CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY796EG:'1E9#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY!
M=F5R86=E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY7
M96EG:'1E9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY296UA:6YI;F<\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N
M/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE
M9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T
M97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^0V]N=')A8W1U86P\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C
M96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>&5R8VES92!0<FEC
M93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P
M>"!S;VQI9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E1E<FT@*&EN('EE87)S*3PO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI
M9#LG(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/E9A;'5E/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O
M;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P
M,3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXR-S,L.#4Y/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG/C$N,CD\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^-2XU,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#LD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I
M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O
M;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/@T*/&1I=B!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^+3PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M-3(E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H-"B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SY/=71S=&%N9&EN9RP@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXR-S,L.#4Y/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C$N,CD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY'<F%N=&5D
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,G!X('-O;&ED.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(L,#4V+#(W-3PO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T
M;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS
M1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I
M9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/C@N.#D\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^
M#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E#0H@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C
M965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^3W5T<W1A
M;F1I;F<L($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L
M93LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
M="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^,BPS,S`L,3,T/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^
M#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN
M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXP+B`Y-CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXX+CDQ/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXV.#4L.#`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CPO
M=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@86QI9VX]
M,T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@<W1Y
M;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`^#0H\='(^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$
M,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY.=6UB97(@;V8\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY5;FET<SPO9F]N=#X\+V1I
M=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO
M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD
M:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
M=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY796EG:'1E9#PO9F]N=#X\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/D%V97)A9V4\+V9O;G0^/"]F;VYT/CPO
M9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY%>&5R
M8VES92!0<FEC93PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L
M:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*
M/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R
M9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@
M,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
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M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SY296UA:6YI;F<\+V9O;G0^/"]F;VYT/CPO9F]N=#X\+V1I
M=CX-"CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
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M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R<'@@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E<CL@;6%R9VEN+6QE
M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)R!C;VQS<&%N/3-$,CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R.R!M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX]
M,T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D%G9W)E9V%T93PO9F]N=#X\
M+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
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M)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0S
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<-"B!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#,^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY/=71S=&%N9&EN9RP@1&5C96UB
M97(@,S$L(#(P,3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXR+#,S,"PQ,S0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C`N
M.38\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I
M;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P
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M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-C@U+#@P
M,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B
M9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG
M;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A
M;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA
M<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z
M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^3W5T<W1A;F1I;F<L($IU;F4@,S`L(#(P,3,\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.PT*('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C(L
M,C@P+#$X-#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXX
M+C0R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+#8P.2PP,S4\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^
M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R8C,38P.SPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$:G5S=&EF
M>2!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V,#L\
M+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I
M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT
M+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV
M(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O
M;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV(&%L:6=N
M/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$8V5N
M=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN
M+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T
M.R!T97AT+6EN9&5N=#H@,'!T.R<^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/@T*/&1I=B!A;&EG
M;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SY!=F5R86=E/"]F;VYT/CPO9F]N=#X\+V9O;G0^/"]F;VYT/CPO
M9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^4F5M86EN:6YG/"]F;VYT/CPO9F]N=#X\
M+V9O;G0^/"]D:78^#0H\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^0V]N=')A
M8W1U86P\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY497)M("AI;B!Y96%R<RD\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV
M(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z
M(#!P=#LG/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@8V]L<W!A;CTS1#,^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#,^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;0T*(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M3W5T<W1A;F1I;F<L($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A
M;&EG;CTS1&QE9G0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT
M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H
M="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R
M:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C0N-#@@/"]F;VYT/CPO
M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXV+#$Q-"PW-C@\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=A<G)A
M;G1S(&5X97)C:7-E9#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG
M;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B@R+#(Q,2PQ-3@\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C$N-C4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O
M;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@
M=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXH,2PP,C,L-S@T
M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/BD\+V9O;G0^/"]D:78^#0H\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y
M;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C8U/"]F;VYT/CPO9&EV/@T*/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$-3(E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI
M9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^3W5T<W1A;F1I
M;F<L($IU;F4@,S`L(#(P,3,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXY+#4S-2PV.30\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C`N-S<\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F
M="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[
M(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXU+C,T,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*
M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E
M;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M.2PV.3$L,S`R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R
M/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X
M934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A
M,&(P+U=O<FMS:&5E=',O4VAE970S,"YH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13)&/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/E=A<G)A;G1S("A486)L97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=A<G)A
M;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4W5M;6%R>2!O9B!W87)R86YT(&ES<W5E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F=#H@,C=P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY$=7)I;F<@=&AE('EE
M87(@96YD960@1&5C96UB97(@,S$L(#(P,3$L('1H92!#;VUP86YY(&%L<V\@
M:7-S=65D('1H92!F;VQL;W=I;F<@=V%R<F%N=',Z/"]F;VYT/CPO9&EV/@T*
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!M87)G:6XM;&5F
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E
M>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1L969T
M/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P/@T*/'1R(&)G8V]L;W(],T0C8V-E969F
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/E=A<G)A;G1S(&ES<W5E9"!W:71H(&-O;G9E<G1I8FQE(&YO=&5S("A3
M964@3F]T92`U*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C(X-RPP-C$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=A<G)A;G1S(&ES
M<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!3=&]C:R!/9F9E<FEN9R`H4V5E($YO
M=&4@.2D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T
M;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXQ+#DW,BPW-C8\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CPO='(^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[0V]N=F5R=&EB;&4@3F]T97,\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ-#,L-3,R/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M3=&]C:R!/9F9E<FEN9R`H4V5E
M($YO=&4@-B!A;F0@3F]T92`Y*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@
M86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\
M9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$
M=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0X."4@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX]
M,T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L
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M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@
M9&]U8FQE.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.PT*(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H
M/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,L,S@Y+#<T,CPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N/3-$;&5F
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.SPO9F]N=#X\+V1I
M=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)VUA<F=I;BUL969T
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X
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M-C`[/"]F;VYT/CPO9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^#0H\=&%B;&4@
M<W1Y;&4],T0G=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`^#0H\='(@8F=C;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI
M9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@
M86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^5V%R<F%N
M=',@:7-S=65D('1O(&EN=F5S=&]R<R!W:71H(%-T;V-K($]F9F5R:6YG("A3
M964@3F]T92`V*3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS
M1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/C(T,BPQ.#D\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=A<G)A;G1S(&ES
M<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!#;VUM;VX@4W1O8VL\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N
M/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXT+#8W."PT.3$\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E
M('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-
M"CQT<B!B9V-O;&]R/3-$=VAI=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$.#@E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q
M-C`[4W1O8VL@3V9F97)I;F<@*%-E92!.;W1E(#8@86YD($YO=&4@.2D\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ,C$L
M,#DT/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED
M=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R
M(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#@X)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL
M93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS
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M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/@T*/&1I=B!A;&EG;CTS1')I9VAT
M('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
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M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$=VAI
M=&4^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$.#@E('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^#0H\9&EV(&%L
M:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=A<G)A;G1S
M(&ES<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!S=&]C:R`F(S@R,3$[(&%C8W)U
M960@9&EV:61E;F0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
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M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)0T*('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[)SX-"CQD:78@86QI
M9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C$X,"PQ,34F
M(S$V,#L\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY4;W1A
M;#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#1P>"!D;W5B;&4[)SX-"CQD:78@86QI9VX],T1R:6=H
M="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C4L-C@Y+#<S-#PO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\9&EV(&%L:6=N
M/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R8C,38P
M.SPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@=V%R<F%N="!A8W1I=FET:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&%L:6=N/3-$
M;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SXF(S$V
M,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$
M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F
M;VYT+7-I>F4Z(#$P<'0[)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/E=E:6=H=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D%V97)A9V4\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E=E:6=H=&5D/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I
M=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/E)E
M;6%I;FEN9SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY!9V=R96=A=&4\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R.R<@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SY.=6UB97(@;V8\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E
M;G1E<B!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D%V97)A9V4\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,-"B!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$
M,CX-"CQD:78@86QI9VX],T1C96YT97(@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT
M+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SY#;VYT<F%C='5A;#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY);G1R:6YS:6,\+V9O;G0^/"]D
M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I
M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M<'@@<V]L:60[)R!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@
M<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SY5;FET<SPO9F]N=#X\+V1I=CX-
M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#)P>"!S;VQI9#LG(&-O;'-P
M86X],T0R/@T*/&1I=B!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/D5X97)C:7-E(%!R:6-E/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^
M#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI
M;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^5&5R;2`H:6X@>65A<G,I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<@8V]L<W!A;CTS1#(^#0H\9&EV
M(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I
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M;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N
M=#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
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M="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\=&0@86QI
M9VX],T1L969T('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV
M(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/D]U='-T
M86YD:6YG+"!$96-E;6)E<B`S,2P@,C`Q,#PO9F]N=#X\+V1I=CX-"CPO=&0^
M#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1R:6=H="!S
M='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/BT\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F=`T*
M('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[
M(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4],T0G
M;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR:6=H
M=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SXM/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A
M;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
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M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A
M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXM/"]F
M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q
M)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I
M;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L
M;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0U,B4@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-
M"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[
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M+6)O='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
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M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^#0H\9&EV(&%L:6=N/3-$
M<FEG:'0@<W1Y;&4],T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUR:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXU+#,V-"PU-3<\+V9O
M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@]
M,T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ
M(#)P>#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL
M969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@
M=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^,"XU,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXV+C<V/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE
M<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS
M1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL
M:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W
M:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG
M;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI
M9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA
M>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$
M;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.@T*(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N
M="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^
M)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS
M1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C
M;VQO<CTS1'=H:71E/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V
M86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M
M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT
M.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I
M<W!L87DZ(&EN;&EN93LG/D]U='-T86YD:6YG+"!$96-E;6)E<B`S,2P@,C`Q
M,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS
M1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-
M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T
M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD
M96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/C4L,S8T+#4U-SPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L
M969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA
M;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D
M(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y
M)2!V86QI9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$<FEG:'0@<W1Y;&4]
M,T0G;6%R9VEN+6QE9G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUR
M:6=H=#H@,'!T.R!T97AT+6EN9&5N=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXP+C4Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@
M=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX]
M,T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\
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M93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@
M<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M
M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
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M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
M:7-P;&%Y.B!I;FQI;F4[)SY'<F%N=&5D/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,G!X('-O;&ED.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@
M;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^#0H\=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@<V]L:60[
M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M
M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[
M(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN
M93LG/C<L-#`V+#`W.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I
M9VAT('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@
M=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D
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M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXQ+C,R/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE
M=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D
M/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#)P>#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$.24@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R<'@[)SX-"CQD
M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=M87)G:6XM;&5F=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[('1E>'0M:6YD96YT
M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/C,N
M-S8\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT
M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`R
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI
M;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!W
M:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6)O
M='1O;3H@,G!X.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H
M/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M
M.B`R<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C
M,38P.R`\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO<CTS1'=H:71E
M/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#4R)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T
M:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[#0H@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES
M<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W
M(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO
M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y
M.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R
M:6=H="!W:61T:#TS1#DE('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M
M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT
M9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T;VT^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM
M97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF
M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q
M-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!W:61T:#TS1#$E
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN
M;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT
M('=I9'1H/3-$.24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L
M:6=N/3-$;&5F="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N
M97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O;G0^/"]T
M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@
M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE
M.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED
M=&@],T0Y)2!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!D:7-P
M;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX]
M,T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R
M;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*
M/"]T<CX-"CQT<B!B9V-O;&]R/3-$(V-C965F9CX-"CQT9"!A;&EG;CTS1&QE
M9G0@=VED=&@],T0U,B4@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M8F]T=&]M.B`T<'@[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$
M)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM<FEG
M:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@
M9&ES<&QA>3H@:6YL:6YE.R<^3W5T<W1A;F1I;F<L($1E8V5M8F5R(#,Q+"`R
M,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I
M9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`T<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG
M/B8C,38P.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@]
M,T0Q)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@-'!X(&1O=6)L93LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@
M:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$<FEG
M:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@-'!X(&1O=6)L93LG/@T*/&1I=B!A;&EG;CTS1')I
M9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^,3(L-S<P+#8S-CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T
M:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\+V9O
M;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI9VX]
M,T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G:6XM
M;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P<'0[
M('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ
M(&EN;&EN93LG/B0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$
M<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
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M,T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O
M;6%N.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\
M=&0@86QI9VX],T1R:6=H="!W:61T:#TS1#$E('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N
M.R!D:7-P;&%Y.B!I;FQI;F4[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@
M86QI9VX],T1L969T('=I9'1H/3-$,24@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/'1D(&%L:6=N/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A
M;&EG;CTS1')I9VAT('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI
M;'DZ('1I;65S(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^-"XT.#PO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('=I9'1H/3-$
M,24@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T
M<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M
M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P
M.R`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('=I9'1H/3-$,24@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`T<'@[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY
M.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L87DZ(&EN;&EN93LG/B8C,38P.R`\
M+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=VED=&@],T0Q)2!V86QI
M9VX],T1B;W1T;VT^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=M87)G
M:6XM;&5F=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+7)I9VAT.B`P
M<'0[('1E>'0M:6YD96YT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE<R!N97<@<F]M86X[(&1I<W!L
M87DZ(&EN;&EN93LG/B0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N
M/3-$<FEG:'0@=VED=&@],T0Y)2!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUB;W1T;VTZ(#1P>#LG/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T
M>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
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M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[(#PO9F]N=#X\
M+W1D/@T*/"]T<CX-"CPO=&%B;&4^#0H\+V1I=CX-"CQD:78@86QI9VX],T1L
M969T('-T>6QE/3-$)VUA<F=I;BUL969T.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM<FEG:'0Z(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ('1I;65S
M(&YE=R!R;VUA;CL@9&ES<&QA>3H@:6YL:6YE.R<^)B,Q-C`[/"]F;VYT/CPO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B
M7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H965T,S$N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5"4T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D1E<V-R:7!T:6]N(&]F
M($)U<VEN97-S(&%N9"!3=6UM87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I
M;F<@4&]L:6-I97,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4W5M;6%R>2!O9B!F;W)T:"!A<W-E=',@86YD(&QI86)I;&ET:65S(&UE87-U
M<F5D(&%T(&9A:7(@=F%L=64@;VX@82!R96-U<G)I;F<@86YD(&YO;B!R96-U
M<G)I;F<@8F%S:7,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&5R:79A=&EV92!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BPY-3<L.3<W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S+#4W-"PY-3@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L-#,Y
M+#8Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3&5V96P@,2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@9F]R=&@@87-S971S(&%N
M9"!L:6%B:6QI=&EE<R!M96%S=7)E9"!A="!F86ER('9A;'5E(&]N(&$@<F5C
M=7)R:6YG(&%N9"!N;VX@<F5C=7)R:6YG(&)A<VES/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F4@;&EA8FEL
M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE=F5L(#(@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM
M87)Y(&]F(&9O<G1H(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@;65A<W5R960@
M870@9F%I<B!V86QU92!O;B!A(')E8W5R<FEN9R!A;F0@;F]N(')E8W5R<FEN
M9R!B87-I<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$97)I=F%T:79E(&QI86)I;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y,979E;"`S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!F;W)T:"!A<W-E=',@86YD
M(&QI86)I;&ET:65S(&UE87-U<F5D(&%T(&9A:7(@=F%L=64@;VX@82!R96-U
M<G)I;F<@86YD(&YO;B!R96-U<G)I;F<@8F%S:7,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV92!L:6%B:6QI
M='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPY-3<L.3<W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`S+#4W-"PY-3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#0L-#,Y+#8Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q
M-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB
M,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H
M965T,S(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$582$%)/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/D1E<V-R:7!T:6]N(&]F($)U<VEN97-S(&%N9"!3=6UM87)Y(&]F(%-I
M9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@*$1E=&%I;',@5&5X='5A
M;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXV($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`R."P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/E-U8G-E<75E;G0@179E;G0@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CY3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^4W1O
M8VL@3W!T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/E=A<G)A;G0@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB
M<CY787)R86YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^5V%R<F%N="!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/D-O;G9E<G1I8FQE($YO=&5S(%!A>6%B;&4@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CY/<'1I
M;VYS($%N9"!787)R86YT<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/D]P=&EO;G,@06YD(%=A
M<G)A;G1S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;BX@,S`L(#(P,3,\8G(^36%C:&EN97)Y(&%N9"!E<75I<&UE;G0@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CY-86-H:6YE<GD@86YD(&5Q=6EP;65N="!;365M8F5R
M73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$S/&)R/D9U<FYI='5R92!A;F0@9FEX='5R97,@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY&
M=7)N:71U<F4@86YD(&9I>'1U<F5S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,C@L(#(P,3(\8G(^06-T:6YI=6T@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^1&5S8W)I<'1I;VX@;V8@0G5S:6YE<W,@86YD(%-U;6UA<GD@
M;V8@4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R`H5&5X='5A;"D\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R
M8V5N=&%G92!O9B!O=VYE<G-H:7`@:6YT97)E<W0@=&\@8F4@86-Q=6ER960@
M8GD@8V]M<&%N>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P
M+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V]M;6]N(%-T;V-K(&ES<W5A8FQE(&EN(&-O;G-I9&5R871I;VX@
M9F]R(&5Q=6ET>2!I;G1E<F5S="!A8W%U:7-I=&EO;CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^.3DN,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@<VAA<F5S
M(&ES<W5E9"!I;B!E>&-H86YG92!O9B!E<75I='D@<V5C=7)I=&EE<R!I;B!P
M97)C96YT86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y!<'!R
M;WAI;6%T96QY(#DY)2!O9B!T:&4@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!C
M;VUM;VX@<W1O8VL@:6UM961I871E;'D@869T97(@=&AE(&-L;W-I;F<@;V8@
M=&AE(%-H87)E($5X8VAA;F=E+"!P87(@=F%L=64@)#`N,#$@<&5R('-H87)E
M+"!O9B!T:&4@0V]M<&%N>2X@5&AE(%-H87)E($5X8VAA;F=E('=A<R!C;&]S
M960@;VX@1&5C96UB97(@,C@L(#(P,3(N/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('!A<B!V
M86QU92!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D('5S969U;"!L
M:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^1FEV92!Y96%R
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/D9I=F4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#Y3979E;B!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/E-E=F5N('EE87)S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@<F5C
M96EV960@8GD@96%C:"!!4$D@<VAA<F5H;VQD97(@;V8@06-T:6YI=6T@8V]M
M;6]N('-T;V-K(&9O<B!E86-H($%022!S:&%R92!E>&-H86YG960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,S,S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0;W1E;G1I86QL>2!I
M<W-U86)L92!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,S,P+#$S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(W,RPX-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XY+#4S-2PV.30\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,34L,C<U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L-S<P+#4Y-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L
M-#0X+#(W-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,C@P+#$X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8L.#0R+#4R.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!/9B!3:&%R
M97,@17AC:&%N9V5D($EN(%-H87)E($5X8VAA;F=E(%!R;V=R86UM93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S@N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V
M,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O
M<FMS:&5E=',O4VAE970S,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13-004<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^1V]I;F<@8V]N8V5R;B`H1&5T86EL<RD@*%531"`D
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0S/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$R/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$U,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XQ-3<@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*
M=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`P,#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`Y/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#@\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`V/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#4\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P,3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1V]I;F<@0V]N8V5R;B`H5&5X='5A;"D\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,BPW.#0L,#$Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,2PU-C(L-3DQ*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,RPT
M-S,L,#,X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,BPT-S$L-3`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H-C<R+#(X-BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#@L,S8Q+#(P-2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#,L
M-#0T+#<Y-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#0V-RPR-C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@S+#0R-2PY.#8I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U+#4W,"PY,#4I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U
M+#8Q-RPU.#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@V+#`U,RPS-C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@T+#4X,"PR,S<I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U+#<S-"PW.3$I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@S+#4S,BPP-#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@S+#$Y,BPS.#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U+#`Y,"PV,C$I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@U-2PW-#,L
M-#8S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H-3DL,C$V+#4P,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('5S960@:6X@;W!E<F%T:6]N
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPS,C<L.#(P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M.#8R+#(S,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@U+#(Q,BPW,3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-3$W+#4Y,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-"PT,#(L-C4X*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0W+#<S,"PT
M-S@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!8V-U;75L871E9"!D969I8VET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4Y+#(Q-BPU,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4Y+#(Q-BPU,#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4U+#<T,RPT
M-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#4U+#<T,RPT-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#4Y+#(Q-BPU,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B
M7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S
M9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T
M<R]3:&5E=#,T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%24)!0SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY296QA=&5D(%!A<G1Y(%1R86YS86-T:6]N<R`H1&5T86EL<RD@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@86-T:79I=&EE<R!R96QA=&5D('1O
M(')E;&%T960@<&%R='D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^475A;&EF:65D(%(F86UP.T0@8V]S=',@:6YC=7)R960@
M8GD@=&AE($-O;7!A;GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-C4U+#<X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5I;6)U<G-E;65N=',@<F5C96EV
M960@9G)O;2!-4TM#0SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R,S<L.#,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Y-C8L,S0Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED
M8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?
M.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970S
M-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P15=01DL^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M4F5L871E9"!087)T>2!4<F%N<V%C=&EO;G,@*$1E=&%I;',@5&5X='5A;"D@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,CXQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#,^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#(W
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@
M,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D9E8BX@,CDL(#(P,3(\8G(^3&EC96YS92P@1&5V96QO<&UE;G0@86YD($-O
M;6UE<F-I86QI>F%T:6]N($%G<F5E;65N="!;365M8F5R73QB<CY.;W1E/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@,S$L(#(P,3(\
M8G(^3&EC96YS92P@1&5V96QO<&UE;G0@86YD($-O;6UE<F-I86QI>F%T:6]N
M($%G<F5E;65N="!;365M8F5R73QB<CY.;W1E/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D%P<BX@,S`L(#(P,3`\8G(^365M;W)I86P@4VQO
M86X@2V5T=&5R:6YG($-A;F-E<B!#96YT97(@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY-96UO
M<FEA;"!3;&]A;B!+971T97)I;F<@0V%N8V5R($-E;G1E<B!;365M8F5R73QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q
M/&)R/DUE;6]R:6%L(%-L;V%N($ME='1E<FEN9R!#86YC97(@0V5N=&5R(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@
M,C<L(#(P,3(\8G(^365M;W)I86P@4VQO86X@2V5T=&5R:6YG($-A;F-E<B!#
M96YT97(@6TUE;6)E<ET\8G(^0VQI;FEC86P@5')I86P@06=R965M96YT(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,3DL(#(P,3$\8G(^4TM)(%M-96UB97)=/&)R/DQI8V5N<V4L($1E=F5L;W!M
M96YT(&%N9"!#;VUM97)C:6%L:7IA=&EO;B!!9W)E96UE;G0@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`S,"P@,C`Q
M,#QB<CY32TD@6TUE;6)E<ET\8G(^3&EC96YS92P@1&5V96QO<&UE;G0@86YD
M($-O;6UE<F-I86QI>F%T:6]N($%G<F5E;65N="!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/E-+
M22!;365M8F5R73QB<CY,:6-E;G-E+"!$979E;&]P;65N="!A;F0@0V]M;65R
M8VEA;&EZ871I;VX@06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,C$L(#(P,3(\8G(^4TM)(%M-96UB
M97)=/&)R/DQI8V5N<V4L($1E=F5L;W!M96YT(&%N9"!#;VUM97)C:6%L:7IA
M=&EO;B!!9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2F%N+B`S,2P@,C`Q,CQB<CY$<BX@4F]S96UA<GD@36%Z
M86YE="!;365M8F5R73QB<CY#;VYS=6QT:6YG(%-E<G9I8V5S($%G<F5E;65N
M="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$R/&)R/D1R+B!2;W-E;6%R>2!-87IA;F5T(%M-96UB97)=
M/&)R/D-O;G-U;'1I;F<@4V5R=FEC97,@06=R965M96YT(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%U9RX@,#<L(#(P,3(\
M8G(^3&%I9&QA=R!A;F0@0V]M<&%N>2!;365M8F5R73QB<CY%;F=A9V5M96YT
M($%G<F5E;65N="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/DQA:61L87<@86YD($-O;7!A;GD@
M6TUE;6)E<ET\8G(^16YG86=E;65N="!!9W)E96UE;G0@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#`Y+"`R,#$Q/&)R
M/DIA;65S<R!#87!I=&%L($=R;W5P($Q,0R!;365M8F5R73QB<CY4<F%N<V%C
M=&EO;B!M86YA9V5M96YT(&%G<F5E;65N="!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D=U86=E
M;G1I("9A;7`[($%S<V]C:6%T97,@3$Q#(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R
M='D@5')A;G-A8W1I;VYS("A497AT=6%L*3PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@4&%T:65N=',@96YR
M;VQL960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U
M;G0@<&%I9"!U;F1E<B!A9W)E96UE;G0@:6X@,C`Q,3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!P86ED('5N9&5R
M(&%G<F5E;65N="!I;B`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!;6]U;G0@<&%I9"!U;F1E<B!A9W)E96UE;G0@:6X@
M,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M36%I;G1E;F%N8V4@9F5E<R!A;F0@<F5S96%R8V@@<&%Y;65N=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO=6YT('!A:60@
M=6YD97(@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!9&1I=&EO;F%L(&%M;W5N="!D=64@=6YD97(@86=R965M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M;VYD:71I;VX@9F]R('1E<FUI;F%T:6]N(&]F(&9O<F)E87)A;F-E('!E<FEO
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^5&AE(&9O<F)E87)A
M;F-E('!E<FEO9"!T97)M:6YA=&5D(&]N($]C=&]B97(@,S`L(#(P,3$L('=H
M96X@=&AE($-O;7!A;GD@<V%T:7-F:65D(&$@9FEN86YC:6YG(&-O;F1I=&EO
M;B!T;R!T:&4@=&5R;6EN871I;VX@;V8@=&AE(&9O<F)E87)A;F-E('!E<FEO
M9"!B>2!R86ES:6YG(&EN(&5X8V5S<R!O9B`D,RPP,#`N,#`P(&EN(&YE=R!E
M<75I='D@9FEN86YC:6YG+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&5R;6EN871I;VX@9&%T92!O9B!F;W)B96%R
M86YC92!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/D]C="`S,"P-"@D),C`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/D]C="`S,"P-"@D),C`Q,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EN:6UU;2!N97<@
M97%U:71Y(&9I;F%N8VEN9R!N965D960@=6YD97(@8V]N9&ET:6]N(&9O<B!T
M97)M:6YA=&EO;B!F;W)B96%R86YC92!P97)I;V0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)G:79E;B!A;6]U;G0@;V8@;V)L
M:6=A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!R96EM8G5R<V5M96YT('!A
M>6UE;G1S(')E8V5I=F5D(&9R;VT@35-+0T,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(S-RPX,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR.3DL,C`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@<F5C96EV86)L92!F
M<F]M($U32T-#/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,W
M+#@S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06UO=6YT('!A:60@=&\@96%C:"!P871I96YT(&%F=&5R($-O;7!L
M971I;F<@8VQI;FEC86P@=')I86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,Q+#$X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4W1A<G0M=7`@9F5E(&9O<B!C;&EN:6-A;"!T<FEA
M;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-SDL-C(S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$=64@
M9&%T92!O9B!S=&%R="UU<"!F964\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/DIU;"`Q,"P-"@D),C`Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3V9F:6-E<G,G($-O;7!E;G-A=&EO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T
M:6]N($5X97)C:7-E(%!R:6-E(%)A;F=E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XP+C<X('1O(#$N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&5R;2!O9B!O<'1I;VYS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XV('EE87)S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-R!Y96%R<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C0@>65A
M<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XW('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@<F5C96EV960@
M=&\@<'5R8VAA<V4@8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY.2PY,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E<V-R:7!T:6]N(&]F(')E8V5I=F%B;&5S
M(&]F('!L86-E;65N="!A9V5N="!F;W(@<V5R=FEC97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/E!L86-E;65N="!A9V5N="!W:6QL(')E8V5I
M=F4@*&$I(&$@8V%S:"!F964@97%U86P@=&\@,3`E(&]F('1H92!G<F]S<R!P
M<F]C965D<R!R86ES960@:6X@=&AE(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R
M:6YG+"`H8BD@82!N;VXM86-C;W5N=&%B;&4@97AP96YS92!R96EM8G5R<V5M
M96YT(&5Q=6%L('1O(#(E(&]F('1H92!G<F]S<R!P<F]C965D<R!R86ES960@
M:6X@=&AE(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG+"!A;F0@*&,I(')E
M:6UB=7)S96UE;G0@;V8@)#$P,"PP,#`@9F]R(&QE9V%L(&5X<&5N<V5S(&EN
M8W5R<F5D(&)Y('1H92!P;&%C96UE;G0@86=E;G0N/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97-C<FEP=&EO;B!O
M9B!W87)R86YT<R!R96-E:79A8FQE<R!B>2!P;&%C96UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/E1H92!P;&%C96UE;G0@86=E;G0@;W(@
M:71S(&1E<VEG;F5E<R!H879E(&%L<V\@<F5C96EV960@=V%R<F%N=',@=&\@
M<'5R8VAA<V4@<VAA<F5S(&]F('1H92!#;VUP86YY)W,@0V]M;6]N(%-T;V-K
M(&EN(&%N(&%M;W5N="!E<75A;"!T;R`Q,"4@;V8@=&AE('-H87)E<R!O9B!C
M;VUM;VX@<W1O8VL@:7-S=65D(&%S('!A<G0@;V8@=&AE('5N:71S('-O;&0@
M:6X@=&AE(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG(&%N9"!T:&4@<VAA
M<F5S(&]F($-O;6UO;B!3=&]C:R!I<W-U86)L92!U<&]N(&5X97)C:7-E(&]F
M('1H92!"('=A<G)A;G1S(&EN8VQU9&5D(&EN('-U8V@@=6YI=',N/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)I
M;V0@;V8@97AE<F-I<V4@;V8@=V%R<F%N=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/E=I=&AI;B`V(&UO;G1H<R!O9B!T:&4@9FEN86P@8VQO
M<VEN9R!O9B!T:&4@,C`Q,B!C;VUM;VX@<W1O8VL@3V9F97)I;F<N/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C
M96YT86=E(&]F('-O;&EC:71A=&EO;B!F964\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y-;VYT:&QY(&9E92!F;W(@9FEN86YC:6%L
M(&%D=FES;W)Y('-E<G9I8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D1E<V-R:7!T:6]N(&]F(&%D9&ET:6]N86P@<F5C96EV
M86)L92!B>2!P;&%C96UE;G0@86=E;G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
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M<75A;"!T;R`Q,"4@;V8@=&AE(&%G9W)E9V%T92!C;VYS:61E<F%T:6]N(&EN
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M;G0N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y787)R86YT(&AE;&0@8GD@<&QA8V5M96YT(&%G96YT('1O('!U<F-H
M87-E(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PR-3$L,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y-;VYT:&QY(&9E92!R96-E:79E9"!B>2!M86YA9V5M
M96YT(&9I<FT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#4P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4&5R8V5N=&%G92!O9B!F=6QL>2!D:6QU=&5D(&-A<&ET86P@<W1O8VL@
M97%U86P@=&\@8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T@86UO=6YT(&]F(&]U="!O9B!P;V-K
M970@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/<&5R871I;F<@;&5A<V4@;6]N=&AL>2!A;6]U;G0@;V8@<F5N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U;G0@<&%I
M9"!T;R!P=7)S=6%N="!L96%S92!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-RPR,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R
M,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y
M8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3
M:&5E=#,V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%,E5!13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY0<F]P97)T>2!A;F0@17%U:7!M96YT("A$971A:6QS*2`H55-$("0I
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@<')O<&5R='D@86YD(&5Q=6EP
M;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y4;W1A;"!P<F]P97)T>2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-3@L-38V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-3<L-#4T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M-34L,#DV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#XH3&5S<RD@06-C=6UU;&%T960@9&5P<F5C:6%T:6]N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-30L-#0T*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$U-"PT-#0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,34S
M+#@V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQO<W,@;VX@9&ES<&]S:71I;VX@;V8@97%U:7!M96YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#$R,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A
M;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS+#`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9I8V4@97%U:7!M96YT(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4W5M;6%R>2!O9B!P<F]P97)T>2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5S969U;"!,:79E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C4@>65A<G,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L('!R;W!E<G1Y+"!P;&%N="!A;F0@97%U:7!M96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3<L,C<T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34V+#$V,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,RPX,#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9U<FYI='5R92!A;F0@9FEX='5R97,@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F('!R;W!E
M<G1Y(&%N9"!E<75I<&UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^57-E9G5L($QI=F5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XW('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^-R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<')O<&5R='DL
M('!L86YT(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PR.3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#$L,CDR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#(Y,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE
M971S+U-H965T,S<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)2D%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E!R;W!E<G1Y(&%N9"!%<75I<&UE;G0@*$1E=&%I;',@5&5X
M='5A;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C8@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E!R;W!E<G1Y(&%N9"!%<75I<&UE;G0@*%1E>'1U86PI/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO
M;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,S$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`U.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#8S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q
M-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D8SEB
M,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S+U-H
M965T,S@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5&-4%%/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R
M;VYG/DYO=&4@4&%Y86)L92!A;F0@0V]N=F5R=&EB;&4@3F]T97,@*$1E=&%I
M;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`R-RP@,C`Q,3QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F('-E;FEO
M<B!S=6)O<F1I;F%T960@=6YS96-U<F5D(&-O;G9E<G1I8FQE('!R;VUI<W-O
M<GD@;F]T97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')I;F-I<&%L(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Y,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S.B!O<FEG:6YA;"!I<W-U86YC92!D
M:7-C;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3&5S<SH@9&ES8V]U;G0@<F5L871E9"!T;R!T:&4@8F5N969I8VEA;"!C
M;VYV97)S:6]N(&9E871U<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,W,BPX-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@=F%L=64@870@1&5C96UB97(@,S$L
M(#(P,3(@86YD(#(P,3$L(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(T+#,V
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^."4@4V5N:6]R(%-U8F]R9&EN871E9"!5;G-E8W5R960@0V]N=F5R=&EB
M;&4@4')O;6ES<V]R>2!.;W1E<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@<V5N:6]R('-U
M8F]R9&EN871E9"!U;G-E8W5R960@8V]N=F5R=&EB;&4@<')O;6ES<V]R>2!N
M;W1E<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<FEN8VEP86P@86UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&5S<SH@;W)I9VEN86P@:7-S=6%N8V4@
M9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$U,"PP
M,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,34P+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DQE<W,Z(&1I<V-O=6YT(')E;&%T960@=&\@9F%I<B!V
M86QU92!O9B!D97)I=F%T:79E('=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S-S<L,34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,W-RPQ-3`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S.B!D:7-C;W5N
M="!R96QA=&5D('1O('1H92!B96YE9FEC:6%L(&-O;G9E<G-I;VX@9F5A='5R
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S<R+#@U,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-S(L
M.#4P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^061D.B!A;6]R=&EZ871I;VX@;V8@9&ES8V]U;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDP,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C0L,S8S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S.B!P
M<FEN8VEP86P@86UO=6YT(&-O;G9E<G1E9"!T;R!S=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH.3`P+#`P,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M87)R>6EN9R!V86QU92!A="!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@,C`Q,2P@
M<F5S<&5C=&EV96QY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$R-"PS-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E
M.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P
M-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E
M=#,Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%159#2SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY.;W1E(%!A>6%B;&4@86YD($-O;G9E<G1I8FQE($YO=&5S("A$971A:6QS
M(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#0^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$U,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ-3<@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIA;BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`Q.2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y/8W0N(#(S+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`R."P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#(W+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&4@
M4&%Y86)L92!A;F0@0V]N=F5R=&EB;&4@3F]T97,@*%1E>'1U86PI/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E<G1I
M8FQE('!R;VUI<W-O<GD@;F]T92!A;6]U;G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@.3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO=6YT(&]F(&]R:6=I;F%L(&ES
M<W5E(&1I<V-O=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M-3`L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')E;6EU;2!F:6YA;F-E(&%G<F5E;65N="!P<FEN8VEP86P@
M86UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y087EM96YT('5N9&5R('!R96UI=6T@9FEN86YC92!A9W)E96UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(X+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36]N=&AL>2!A
M;6]U;G0@<&%Y86)L92!U;F1E<B!P<F5M:75M(&9I;F%N8V4@86=R965M96YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPV,S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1U<F%T
M:6]N(&]F('!E<FEO9&EC('!A>6UE;G1S(&9O<B!P<F5M:75M(&9I;F%N8V4@
M86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XY(&UO
M;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')E;6EU;2!F:6YA;F-E(&%G<F5E;65N="!O=71S=&%N9&EN9R!A
M;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R;VUI<W-O<GD@;F]T92!I;G1E<F5S="!R871E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T('!R;V-E961S(&]F('!R;VUI
M<W-O<GD@;F]T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4&5R8V5N=&%G92!O9B!P<FEN8VEP;&4@86UO=6YT(&EN('=H:6-H
M(&-O;G9E<G1I8FQE(&YO=&4@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX,RXS,R4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E<G1I8FQE(&YO=&4@;6%T=7)I='D@
M=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3VYE('EE87(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D=R;W-S('!R;V-E961S(&EN('-U8G-E<75E;G0@;V9F97)I;F=S(&]F(&-O
M;6UO;B!S=&]C:R!O<B!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D('1O
M(&EN=F5S=&]R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C@W
M+#`V,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^26YV97-T;65N="!W87)R86YT(&=R86YT(&1A=&4@9F%I<B!V86QU
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38U+#<R.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5N
M969I8VEA;"!C;VYV97)S:6]N(&9E871U<F4@9&ES8V]U;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,W,BPX-3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S(L.#4P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S
M:6]N('!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#`N-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-O;G9E<G1I8FQE(&YO=&4@9F%I<B!V86QU92!P97(@<VAA
M<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XQ,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AT
M96YD960@;6%T=7)I='D@4&5R:6]D(&]F(&-O;G9E<G1I8FQE(&YO=&5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XY,"!D87ES/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97-C<FEP
M=&EO;B!O9B!E>'1E;F1E9"!M871U<FET>2!D871E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#Y#;VUP86YY('=A<R!S965K:6YG(&%P<')O=F%L
M('1O(&5X=&5N9"!T:&4@;F]T92!M871U<FET>2!D871E(&9O<B`Y,"!D87ES
M+B!4:&4@0V]M<&%N>2!W87,@86)L92!T;R!O8G1A:6X@87!P<F]V86QS(&9R
M;VT@86QL(&YO=&4@:&]L9&5R<R!A;F0@=&AE(&UA='5R:71Y(&1A=&4@;V8@
M=&AE(&YO=&5S(&AA<R!B965N(&5X=&5N9&5D('1O($IA;G5A<GD@,S$L(#(P
M,3,L($9E8G)U87)Y(#$X+"`R,#$S(&]R($UA<F-H(#(W+"`R,#$S(&9O<B!T
M:&4@,C0@;F]T97,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!N;W1E<R!A;F0@=&AE(&%C8W)U
M960@:6YT97)E<W0@8V]N=F5R=&5D(&EN=&\@8V]M;6]N('-H87)E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ
M871I;VX@;V8@9&5B="!D:7-C;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#4Q+#(V-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<W-2PV,S<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C0L,S8S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDP,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!O9B!D969E<G)E9"!F:6YA;F-I
M;F<@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$T-2PY-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR-3(L,C0X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#`L-#0T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CDR+#8Y,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y,BPV.3(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O
M=VX@<&%Y;65N="!U;F1E<B!I;G-U<F%N8V4@<&]L:6-Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R96UI=6T@;6]N=&AL>2!I
M;G-T86QL;65N="!F;W(@;FEN92!M;VYT:',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R+#8S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F]T97,@<&%Y86)L93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8L.34P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$T,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS-BPY-3`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R:6YC:7!A;"!P87EM96YT
M(&]F(&YO=&5S('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P,RPP-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,#,L,#4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE;G0@06=E;G0@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E
M(%!A>6%B;&4@86YD($-O;G9E<G1I8FQE($YO=&5S("A497AT=6%L*3PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@
M<W1O8VL@<VAA<F5S('!U<F-H87-A8FQE('1H<F]U9V@@=V%R<F%N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T,RPU,S(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E
M('!R:6-E(&]F('=A<G)A;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XW.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^5V%R<F%N=',@97AP:7)A=&EO;B!D871E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*86X@,S$L#0H)"3(P,3D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E
M<G1I8FQE('!R;VUI<W-O<GD@;F]T92!A;6]U;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(Y,BPV.3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.3(L-CDQ/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U;G0@;V8@;W)I
M9VEN86P@:7-S=64@9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N('!E<FEO
M9"!O9B!N;W1E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y/;F4@
M>65A<CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^36%N86=E;65N="!&:7)M(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T92!087EA8FQE(&%N9"!#
M;VYV97)T:6)L92!.;W1E<R`H5&5X='5A;"D\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('-H87)E<R!P
M=7)C:&%S86)L92!T:')O=6=H('=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,C8L.#(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!P<FEC92!O9B!W87)R
M86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A
M<G)A;G1S(&5X<&ER871I;VX@9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^2F%N(#,Q+`T*"0DR,#$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B
M,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C
M.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O
M4VAE970T,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P13560D<^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^1&5R:79A=&EV97,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ-3$@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,34W($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE
M9'5L92!O9B!D97)I=F%T:79E('=A<G)A;G0@:6YS=')U;65N=',@86-T:79I
M='D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F5G:6YN:6YG(&)A;&%N8V4L(%5N:71S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU+#$T-BPS,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS+#,X.2PW-S$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#,X.2PW-S$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E=A<G)A;G1S(&ES<W5E9"!W:71H($-O;G9E<G1I8FQE($YO=&5S
M("A3964@3F]T92`U*2P@56YI=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(X-RPP-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)E8VQA<W-I9FEC871I;VX@=&\@<&%I9"!I;B!C
M87!I=&%L+"!5;FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,RPQ,C(L.#(Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4&QA8V5M96YT(&%G96YT('=A<G)A;G1S(')E;&%T960@
M=&\@:7-S=6%N8V4@;V8@0V]N=F5R=&EB;&4@3F]T97,@*%-E92!.;W1E(#4I
M+"!5;FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30S+#4S
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V%R<F%N=',@:7-S=65D('=I=&@@4W1O8VL@3V9F97)I;F<@*%-E92!.
M;W1E(#DI+"!5;FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C0R+#$Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L.3<R+#<X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4&QA8V5M96YT(&%G96YT('=A<G)A;G1S(')E
M;&%T960@=&\@:7-S=6%N8V4@;V8@4W1O8VL@3V9F97)I;F<@*%-E92!.;W1E
M(#DI+"!5;FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Q
M+#`Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDX-BPS.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&ES<W5E9"!W:71H(#(P,3(@0V]M;6]N
M(%-T;V-K($]F9F5R:6YG("T@02`H4V5E($YO=&4@.2DL(%5N:71S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#$Q."PY.#@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S
M(&ES<W5E9"!W:71H(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG("T@0B`H
M4V5E($YO=&4@.2DL(%5N:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#4U.2PU,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!L86-E;65N="!A9V5N="!W87)R86YT<R!R96QA
M=&5D('1O(#(P,3(@0V]M;6]N(%-T;V-K($]F9F5R:6YG("A3964@3F]T92`Y
M*2P@56YI=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0V-RPX
M-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1R86YS9F5R(&9R;VT@;&EA8FEL:71Y(&-L87-S:69I8V%T:6]N('1O
M(&5Q=6ET>2!C;&%S<VEF:6-A=&EO;BP@56YI=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#,L-S4S+#`U-BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4L(%5N:71S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`R,RPU,3<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#$T-BPS
M,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#,X.2PW-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU+#$T-BPS,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#`R,RPU,3<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)E9VEN;FEN9R!B86QA
M;F-E+"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#,L-3<T+#DU.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-"PT,SDL-C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+#0S.2PV,3,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E8VQA<W-I9FEC871I;VX@=&\@<&%I9"!I;B!C87!I=&%L+"!&86ER
M(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U.3`L,C$W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V%R<F%N=',@:7-S=65D('=I=&@@0V]N=F5R=&EB;&4@3F]T97,@*%-E
M92!.;W1E(#4I+"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS-S<L,34P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE;G0@86=E;G0@=V%R<F%N=',@<F5L
M871E9"!T;R!I<W-U86YC92!O9B!#;VYV97)T:6)L92!.;W1E<R`H4V5E($YO
M=&4@-2DL($9A:7(@5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$X."PU-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&ES<W5E9"!W:71H(%-T;V-K($]F9F5R
M:6YG("A3964@3F]T92`Y*2P@1F%I<B!686QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S$X+#`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3DQ+#DP,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&QA8V5M96YT(&%G
M96YT('=A<G)A;G1S(')E;&%T960@=&\@:7-S=6%N8V4@;V8@4W1O8VL@3V9F
M97)I;F<@*%-E92!.;W1E(#DI+"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-3DL,#0T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR.34L.34P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!I
M<W-U960@=VET:"`R,#$R($-O;6UO;B!3=&]C:R!/9F9E<FEN9R`M($$@*%-E
M92!.;W1E(#DI+"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#0P.2PU-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&ES<W5E9"!W:71H(#(P,3(@
M0V]M;6]N(%-T;V-K($]F9F5R:6YG("T@0B`H4V5E($YO=&4@.2DL($9A:7(@
M5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-C8U+#8Y
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4&QA8V5M96YT(&%G96YT('=A<G)A;G1S(')E;&%T960@=&\@,C`Q,B!#
M;VUM;VX@4W1O8VL@3V9F97)I;F<@*%-E92!.;W1E(#DI+"!&86ER(%9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.3DL-S`W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4<F%N
M<V9E<B!F<F]M(&QI86)I;&ET>2!C;&%S<VEF:6-A=&EO;B!T;R!E<75I='D@
M8VQA<W-I9FEC871I;VXL($9A:7(@5F%L=64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4Y,"PR,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#(S,2PS,C0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#(S
M,2PS,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT+#@R,2PU-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-H86YG92!I;B!F86ER('9A;'5E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-BPW-C0I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C@U+#0R,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,RPY-C8I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y"86QA;F-E+"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(L.34W+#DW-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,RPU-S0L.34X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+#0S.2PV,3,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L
M-3<T+#DU.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,BPY-3<L.3<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED
M8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?
M.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970T
M,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P14DU0D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M1&5R:79A=&EV97,@*$1E=&%I;',@,2D@*%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,3DL(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`R-RP@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*86XN(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@9F%I<B!V86QU97,@
M;V8@9&5R:79A=&EV92!W87)R86YT<R!O;B!B87-I<R!O9B!V86QU871I;VX@
M;6]D96P\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^36%R:V5T('9A;'5E(&]F(&-O;6UO;B!S=&]C:R!O;B!M96%S=7)E;65N
M="!D871E("@Q*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q+C8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C,Y/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C,W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2:7-K(&9R964@
M:6YT97)E<W0@<F%T92`H,BD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`N.30E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2XR-"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+C`U)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$N,S4E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT(&QI=F5S(&EN('EE
M87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XV('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-R!Y
M96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/C0@>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XW('EE87)S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E9"!V;VQA=&EL
M:71Y("@S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38Q+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$U-RXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-30N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,34V+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@9&EV:61E;F0@>6EE
M;&0@*#0I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V)A8FEL:71Y(&]F('-T;V-K(&]F
M9F5R:6YG(&EN(&%N>2!P97)I;V0@;W9E<B`U('EE87)S("@U*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N,#`E/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y286YG92!O9B!P97)C96YT86=E(&]F(&5X:7-T:6YG('-H
M87)E<R!O9F9E<F5D("@V*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S4N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S4N,#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87AI;75M(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4W5M;6%R>2!O9B!F86ER('9A;'5E<R!O9B!D97)I=F%T:79E('=A<G)A
M;G1S(&]N(&)A<VES(&]F('9A;'5A=&EO;B!M;V1E;#PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9&IU<W1E9"!E>&5R8VES
M92!P<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C@S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P+C(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R+C0W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XX,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XR-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4FES:R!F<F5E(&EN
M=&5R97-T(')A=&4@*#(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XP+C<W)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C`N-S<E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y787)R86YT(&QI=F5S(&EN('EE87)S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T
M960@=F]L871I;&ET>2`H,RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$V,2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-C$N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9E<FEN9R!P<FEC92!R86YG92`H-RD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XU-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XV/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y-:6YI;75M(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!F86ER
M('9A;'5E<R!O9B!D97)I=F%T:79E('=A<G)A;G1S(&]N(&)A<VES(&]F('9A
M;'5A=&EO;B!M;V1E;#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!9&IU<W1E9"!E>&5R8VES92!P<FEC93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C0Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C(S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#`N-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)I<VL@9G)E92!I;G1E<F5S="!R871E("@R*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XQ,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C$P)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N
M="!L:79E<R!I;B!Y96%R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^-"!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XT(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@=F]L871I;&ET>2`H,RD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R-2XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C4N,#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/9F9E<FEN9R!P<FEC92!R86YG92`H-RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XQ,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XQ,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XQ.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R
M,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E
M.61C83!B,"]7;W)K<VAE971S+U-H965T-#(N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5(6D%%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D1E<FEV871I=F5S("A$971A:6QS
M(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#$Y+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,C<L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY$97)I=F%T:79E("A497AT=6%L*3PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97-C<FEP=&EO;B!O9B!R:7-K
M(&9R964@:6YT97)E<W0@<F%T92!D971E<FUI;F%T:6]N/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#Y2:7-K+69R964@:6YT97)E<W0@<F%T92!W
M87,@9&5T97)M:6YE9"!B>2!M86YA9V5M96YT('5S:6YG('1H92!A=F5R86=E
M(&]F(#4@86YD(#<@>65A<B!A;F0@=&AE(#,M;6]N=&@@5')E87-U<GD@0FEL
M;"!A<R!O9B!T:&4@<F5S<&5C=&EV92!M96%S=7)E;65N="!D871E+CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP
M96-T960@9&EV:61E;F0@>6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5S8W)I<'1I
M;VX@;V8@<')O8F%B:6QI='D@;V8@<W1O8VL@;V9F97)I;F<\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/E!R;V)A8FEL:71Y(&]F(&$@<W1O8VL@
M;V9F97)I;F<@:7,@,C4E(&9O<B!E86-H('%U87)T97(@;V8@=&AE(&YE>'0@
M9FEV92!Y96%R<RX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)A;F=E(&]F('!E<F-E;G1A9V4@;V8@97AI<W1I;F<@
M<VAA<F5S(&]F9F5R960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,U+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5R:65S($4@4')E
M9F5R<F5D(%-T;V-K(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^1&5R:79A=&EV92`H5&5X='5A;"D\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@
M<')I8V4@;V8@=V%R<F%N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^(#`N,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?
M.#AD8E]B,C$U93ED8V$P8C`O5V]R:W-H965T<R]3:&5E=#0S+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%04I!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY);F-O;64@5&%X
M97,@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1E9F5R<F5D('1A
M>"!A<W-E=',Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!O<&5R871I;F<@;&]S<V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#$S+#8P.2PP,S8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#`X.2PS,30\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E
M+6)A<V5D(&-O;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PT.3<L-34V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S0Q+#0R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@9&EF9F5R96YC97,@:6X@
M=&%X(&)A<VES/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S,L
M,#0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PW-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y4;W1A;"!D969E<G)E9"!T87@@87-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PS,SDL-C,U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L.#,U+#0X,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&5S<SH@=F%L=6%T:6]N(&%L;&]W86YC93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,34L,S,Y+#8S-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,RPX,S4L-#@S*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D
M('1A>"!A<W-E=',L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD
M8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E
M=',O4VAE970T-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q
M=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA
M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P131&044^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^26YC;VUE(%1A>&5S("A$971A:6QS(#$I("A54T0@)"D\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY38VAE9'5L92!O9B!D:69F97)E;F-E(&)E='=E96X@=&AE(&EN8V]M92!T
M87@@<')O=FES:6]N(&%N9"!T:&4@52Y3+B!&961E<F%L('-T871U=&]R>2!R
M871E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9E9&5R86P@:6YC;VUE('1A>&5S(&%T(#,T)3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@R+#@T,BPX,3`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q+#$W,2PR,S`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&961E
M<F%L(&EN8V]M92!T87AE<R!A="`S-"4L(%!E<F-E;G1A9V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,T+C`P)2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-"XP,"4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB
M87-E9"!C;VUP96YS871I;VX@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<U-BPQ,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW,S8L-SDV/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!C;VUP96YS
M871I;VX@8V]S=',L(%!E<F-E;G1A9V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDN,#0E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C$N,SDE/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O
M9B!D97)I=F%T:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C,S+#`T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0L-S0X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T
M:79E<RP@4&5R8V5N=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BXW.24\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP+C$S)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N(&]F(&1E8G0@9&ES8V]U;G1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-#DL-#@P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38L,#,S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!;6]R=&EZ871I;VX@;V8@9&5B="!D:7-C;W5N=',L(%!E<F-E;G1A9V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0N,3@E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,R4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-H
M86YG92!I;B!V86QU871I;VX@86QL;W=A;F-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#4P-"PQ-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S,L-C4S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@=F%L
M=6%T:6]N(&%L;&]W86YC92P@4&5R8V5N=&%G93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3<N.3DE/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`N.#4E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O=FES:6]N(&9O<B!I
M;F-O;64@=&%X/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]V:7-I;VX@9F]R(&EN8V]M92!T
M87@L(%!E<F-E;G1A9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?
M8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D
M8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S
M+U-H965T-#4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$531$%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/DEN8V]M92!487AE<R`H1&5T86EL<R!497AT=6%L*2`H55-$("0I
M/&)R/DEN($UI;&QI;VYS+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M26YC;VUE(%1A>&5S("A497AT=6%L*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;W!E<F%T:6YG(&QO<W-E<R`H(DY/
M3',B*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP
M:7)A=&EO;B!D871E<R!O9B!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y$96,@,S$L#0H)"3(P
M,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E4N4RX@1F5D97)A;"!S=&%T=71O<GD@<F%T93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S0N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?
M.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS
M:&5E=',O4VAE970T-BYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14=604<^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,@*$1E
M=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8F)O='0@0FEO=&AE<F%P975T:6-S
M($-O<G`@6TUE;6)E<ET@?"!0:&%S92!)($-L:6YI8V%L(%1R:6%L(&]F(&$@
M;&EC96YS960@<')O9'5C="!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@;6EL97-T;VYE('!A
M>6UE;G0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^36EL97-T;VYE<R!P87EM96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`W-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`W-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8F)O='0@0FEO=&AE<F%P
M975T:6-S($-O<G`@6TUE;6)E<ET@?"!0:&%S92!)22!#;&EN:6-A;"!4<FEA
M;"!O9B!A(&QI8V5N<V5D('!R;V1U8W0@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(&UI;&5S
M=&]N92!P87EM96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DUI;&5S=&]N97,@<&%Y;65N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-3`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8F)O='0@0FEO=&AE
M<F%P975T:6-S($-O<G`@6TUE;6)E<ET@?"!0:&%S92!)24D@0VQI;FEC86P@
M5')I86P@;V8@82!L:6-E;G-E9"!P<F]D=6-T(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!M
M:6QE<W1O;F4@<&%Y;65N=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y-:6QE<W1O;F5S('!A>6UE;G1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%B8F]T
M="!":6]T:&5R87!E=71I8W,@0V]R<"!;365M8F5R72!\($)I;VQO9VEC86P@
M3&EC96YS92!!<'!L:6-A=&EO;B!F:6QI;F<@=VET:"!5+E,N($9$02!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-U;6UA<GD@;V8@;6EL97-T;VYE('!A>6UE;G0\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36EL97-T;VYE<R!P87EM96YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW
M-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!8F)O='0@0FEO=&AE<F%P975T:6-S($-O<G`@6TUE;6)E<ET@
M?"!&:7)S="!#;VUM97)C:6%L(%-A;&4@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F(&UI;&5S
M=&]N92!P87EM96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DUI;&5S=&]N97,@<&%Y;65N=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-3`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06)B;W1T($)I
M;W1H97)A<&5U=&EC<R!#;W)P(%M-96UB97)=('P@069T97(@1FER<W0@3F5T
M(%-A;&5S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!M:6QE<W1O;F4@<&%Y;65N=#PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6QE<W1O
M;F5S('!A>6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DUE;6]R:6%L(%-L;V%N($ME='1E<FEN9R!#
M86YC97(@0V5N=&5R(%M-96UB97)=('P@3F5W($1R=6<@07!P;&EC871I;VX@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3=6UM87)Y(&]F(&UI;&5S=&]N92!P87EM96YT/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUI;&5S=&]N97,@<&%Y
M;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<U,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y-96UO<FEA;"!3;&]A;B!+971T97)I;F<@0V%N8V5R($-E;G1E
M<B!;365M8F5R72!\(%)E8V5I<'0@;V8@4F5G=6QA=&]R>2!!<'!R;W9A;"!&
M<F]M(%4N4RX@1D1!(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!M:6QE<W1O;F4@<&%Y;65N
M=#PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-
M:6QE<W1O;F5S('!A>6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$L-S4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,2PW-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD
M8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO
M,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E
M=',O4VAE970T-RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q
M=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA
M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P131!4$T^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,@*$1E=&%I
M;',@5&5X='5A;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C`@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ,B!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CXQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XP($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,SXP($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,"!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C`@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D%U9RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^075G+B`P,2P@,C`Q,CQB<CY296YT86P@
M06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^4F5N=&%L($%G<F5E;65N="!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$S/&)R/D%B8F]T="!":6]T:&5R87!E=71I8W,@0V]R<"!;365M8F5R
M73QB<CY0<F]D=6-T($1E=F5L;W!M96YT(&%N9"!0871E;G0@3&EC96YS92!!
M9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY!8F)O='0@0FEO=&AE<F%P975T:6-S
M($-O<G`@6TUE;6)E<ET\8G(^4')O9'5C="!$979E;&]P;65N="!A;F0@4&%T
M96YT($QI8V5N<V4@06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^06)B;W1T($)I
M;W1H97)A<&5U=&EC<R!#;W)P(%M-96UB97)=/&)R/D%F=&5R($9I<G-T($YE
M="!386QE<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D%B8F]T="!":6]T:&5R87!E=71I8W,@
M0V]R<"!;365M8F5R73QB<CY!9G1E<B!&:7)S="!.970@4V%L97,@6TUE;6)E
M<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@
M,C`Q,SQB<CY!8F)O='0@0FEO=&AE<F%P975T:6-S($-O<G`@6TUE;6)E<ET\
M8G(^069T97(@1FER<W0@3F5T(%-A;&5S(%M-96UB97)=/&)R/E!R;V1U8W0@
M1&5V96QO<&UE;G0@86YD(%!A=&5N="!,:6-E;G-E($%G<F5E;65N="!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$R/&)R/D%B8F]T="!":6]T:&5R87!E=71I8W,@0V]R<"!;365M8F5R
M73QB<CY!9G1E<B!&:7)S="!.970@4V%L97,@6TUE;6)E<ET\8G(^4')O9'5C
M="!$979E;&]P;65N="!A;F0@4&%T96YT($QI8V5N<V4@06=R965M96YT(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3,\8G(^06)B;W1T($)I;W1H97)A<&5U=&EC<R!#;W)P(%M-96UB
M97)=/&)R/E!H87-E($D@0VQI;FEC86P@5')I86P@;V8@82!L:6-E;G-E9"!P
M<F]D=6-T(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^06)B;W1T($)I;W1H97)A<&5U=&EC<R!#
M;W)P(%M-96UB97)=/&)R/E!H87-E($D@0VQI;FEC86P@5')I86P@;V8@82!L
M:6-E;G-E9"!P<F]D=6-T(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^06)B;W1T($)I;W1H97)A
M<&5U=&EC<R!#;W)P(%M-96UB97)=/&)R/E!H87-E($D@0VQI;FEC86P@5')I
M86P@;V8@82!L:6-E;G-E9"!P<F]D=6-T(%M-96UB97)=/&)R/E!R;V1U8W0@
M1&5V96QO<&UE;G0@86YD(%!A=&5N="!,:6-E;G-E($%G<F5E;65N="!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(Y
M+"`R,#$R/&)R/DUE;6]R:6%L(%-L;V%N($ME='1E<FEN9R!#86YC97(@0V5N
M=&5R(%M-96UB97)=/&)R/DQI8V5N<V4@86=R965M96YT(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,#(\
M8G(^365M;W)I86P@4VQO86X@2V5T=&5R:6YG($-A;F-E<B!#96YT97(@6TUE
M;6)E<ET\8G(^3&EC96YS92!A9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CY-96UO
M<FEA;"!3;&]A;B!+971T97)I;F<@0V%N8V5R($-E;G1E<B!;365M8F5R73QB
M<CY,:6-E;G-E(&%G<F5E;65N="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/DUE;6]R:6%L(%-L
M;V%N($ME='1E<FEN9R!#86YC97(@0V5N=&5R(%M-96UB97)=/&)R/DQI8V5N
M<V4@86=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,C<L(#(P,3(\8G(^365M;W)I86P@4VQO86X@2V5T
M=&5R:6YG($-A;F-E<B!#96YT97(@6TUE;6)E<ET\8G(^0VQI;FEC86P@5')I
M86P@06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^3V%K(%)I9&=E($YA=&EO;F%L
M($QA8F]R871O<GD@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY/86L@4FED9V4@3F%T:6]N86P@
M3&%B;W)A=&]R>2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y!=6<N(#`V+"`R,#$R/&)R/D%P=&EV(%-O;'5T:6]N<R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!=6<N(#`V
M+"`R,#$R/&)R/D%P=&EV(%-O;'5T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/D%P=&EV
M(%-O;'5T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D%P=&EV(%-O;'5T:6]N<R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#`W/&)R/D%P=&EV(%-O;'5T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!=6<N(#$R+"`R,#$S/&)R/D9R960@
M2'5T8VAI;G-O;B!#86YC97(@4F5S96%R8V@@0V5N=&5R(%M-96UB97)=/&)R
M/FQI8V5N<V4@86YD('-P;VYS;W)E9"!R97-E87)C:"!A9W)E96UE;G0@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`Q
M-2P@,C`Q,CQB<CY&<F5D($AU=&-H:6YS;VX@0V%N8V5R(%)E<V5A<F-H($-E
M;G1E<B!;365M8F5R73QB<CYL:6-E;G-E(&%N9"!S<&]N<V]R960@<F5S96%R
M8V@@86=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DIU;BX@,34L(#(P,3(\8G(^1G)E9"!(=71C:&EN<V]N($-A
M;F-E<B!297-E87)C:"!#96YT97(@6TUE;6)E<ET\8G(^;&EC96YS92!A;F0@
M<W!O;G-O<F5D(')E<V5A<F-H(&%G<F5E;65N="!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/D9R
M960@2'5T8VAI;G-O;B!#86YC97(@4F5S96%R8V@@0V5N=&5R(%M-96UB97)=
M/&)R/FQI8V5N<V4@86YD('-P;VYS;W)E9"!R97-E87)C:"!A9W)E96UE;G0@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`Q-2P@,C`Q,CQB<CY&<F5D($AU=&-H:6YS;VX@0V%N8V5R(%)E<V5A<F-H
M($-E;G1E<B!;365M8F5R73QB<CYL:6-E;G-E(&%N9"!S<&]N<V]R960@<F5S
M96%R8V@@86=R965M96YT(%M-96UB97)=/&)R/DUA>&EM=6T@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`Q-2P@,C`Q
M,CQB<CY&<F5D($AU=&-H:6YS;VX@0V%N8V5R(%)E<V5A<F-H($-E;G1E<B!;
M365M8F5R73QB<CYL:6-E;G-E(&%N9"!S<&]N<V]R960@<F5S96%R8V@@86=R
M965M96YT(%M-96UB97)=/&)R/DUI;FEM=6T@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`Q.2P@,C`Q,CQB<CY&<F5D
M($AU=&-H:6YS;VX@0V%N8V5R(%)E<V5A<F-H($-E;G1E<B!;365M8F5R73QB
M<CY#;&EN:6-A;"!4<FEA;"!!9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^075G+B`R."P@,C`Q,CQB<CY5;FEV
M97)S:71Y(&]F(%1E>&%S($TN1"X@06YD97)S;VX@0V%N8V5R($-E;G1E<B!;
M365M8F5R73QB<CY#;&EN:6-A;"!4<FEA;"!!9W)E96UE;G0@6TUE;6)E<ET\
M8G(^3F]T93QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!=6<N
M(#(X+"`R,#$R/&)R/E5N:79E<G-I='D@;V8@5&5X87,@32Y$+B!!;F1E<G-O
M;B!#86YC97(@0V5N=&5R(%M-96UB97)=/&)R/D-L:6YI8V%L(%1R:6%L($%G
M<F5E;65N="!;365M8F5R73QB<CY.;W1E/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,C8L(#(P,3(\8G(^2F]H;G,@2&]P:VEN<R!5
M;FEV97)S:71Y(%M-96UB97)=/&)R/D-L:6YI8V%L(%1R:6%L($%G<F5E;65N
M="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M97`N(#(V+"`R,#$R/&)R/DIO:&YS($AO<&MI;G,@56YI=F5R<VET>2!;365M
M8F5R73QB<CY#;&EN:6-A;"!4<FEA;"!!9W)E96UE;G0@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^3F]V+B`R,2P@,C`Q,CQB
M<CY5;FEV97)S:71Y(&]F(%!E;FYS>6QV86YI82!;365M8F5R73QB<CY#;&EN
M:6-A;"!4<FEA;"!!9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%Y(#`Y+"`R,#$Q/&)R/DIA;65S<R!#87!I
M=&%L($=R;W5P($Q,0R!;365M8F5R73QB<CY4<F%N<V%C=&EO;B!M86YA9V5M
M96YT(&%G<F5E;65N="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/D9O<FUE<B!#14\@6TUE;6)E
M<ET\8G(^4V5P87)A=&EO;B!A;F0@4V5T=&QE;65N="!!9W)E96UE;G0@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R
M."P@,C`Q,SQB<CY&;W)M97(@0T5/(%M-96UB97)=/&)R/E-E<&%R871I;VX@
M86YD(%-E='1L96UE;G0@06=R965M96YT(%M-96UB97)=/&)R/DYO=&4\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB
M<CY&;W)M97(@0T5/(%M-96UB97)=/&)R/E-E<&%R871I;VX@86YD(%-E='1L
M96UE;G0@06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;6UI=&UE;G1S(&%N9"!#;VYT
M:6YG96YC:65S("A497AT=6%L*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y,:6-E;G-E(&9E92!P87EM96YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,#`P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPP,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y-:6QE<W1O;F5S('!A>6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW+#<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW+#<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!S86QE<R!I;B!M:6QE<W1O;F5S
M('!A>6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6QE<W1O;F4@
M<&%Y;65N="!D871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*
M86X@,S$L#0H)"3(P,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#Y*=6P@,C0L#0H)"3(P,3(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<V-R:7!T:6]N(&]F
M(')O>6%L='D@<&%Y;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^5V4@86=R965D('1O('!A>2!T;R!!8F)O='0@0FEO=&AE<F%P975T:6-S
M($-O<G`@;VX@82!C;W5N=')Y+6)Y+6-O=6YT<GD@8F%S:7,@82!R;WEA;'1Y
M(&]F('5P('1O(#$R)2!O9B!N970@<V%L97,@;V8@86QL(&QI8V5N<V5D('!R
M;V1U8W1S('5N=&EL('1H92!L871E<B!O9CH@*#$I(#$R+C4@>65A<G,@869T
M97(@=&AE(&9I<G-T(&-O;6UE<F-I86P@<V%L92P@;W(@*#(I('=H96X@=&AE
M('!A=&5N=',@97AP:7)E+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/D-O;7!A;GD@<VAA;&P@<&%Y('1O($%B8F]T="!"
M:6]T:&5R87!E=71I8W,@0V]R<"!O;B!A(&-O=6YT<GDM8GDM8V]U;G1R>2!B
M87-I<R!A(')O>6%L='D@;V8@,3(E(&]F(&YE="!S86QE<R!O9B!A;&P@;&EC
M96YS960@<')O9'5C=',@=6YT:6P@=&AE(&QA=&5R(&]F.B`H,2D@,3(N-2!Y
M96%R<R!A9G1E<B!T:&4@9FER<W0@8V]M;65R8VEA;"!S86QE+"!O<B`H,BD@
M=VAE;B!T:&4@<&%T96YT<R!E>'!I<F4N/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^5V4@86=R965S('1O('!A>2!T;R!-
M4TM#0R!O;B!A(&-O=6YT<GDM8GDM8V]U;G1R>2!B87-I<R!A(')O>6%L='D@
M;V8@,B4@;V8@;F5T('-A;&5S(&]F(&%L;"!L:6-E;G-E9"!P<F]D=6-T<R!U
M;G1I;"!T:&4@;&%T97(@;V8Z("@Q*2`Q,"!Y96%R<R!F<F]M('1H92!F:7)S
M="!C;VUM97)C:6%L('-A;&4L(&]R("@R*2!W:&5N('1H92!P871E;G1S(&5X
M<&ER92X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#Y#;VUP86YY('-H86QL('!A>2!T;R!-4TM#0R!O;B!A(&-O=6YT<GDM
M8GDM8V]U;G1R>2!B87-I<R!A(')O>6%L='D@;V8@,B4@;V8@;F5T('-A;&5S
M(&]F(&%L;"!L:6-E;G-E9"!P<F]D=6-T<R!U;G1I;"!T:&4@;&%T97(@;V8Z
M("@Q*2`Q,"!Y96%R<R!F<F]M('1H92!F:7)S="!C;VUM97)C:6%L('-A;&4L
M(&]R("@R*2!W:&5N('1H92!P871E;G1S(&5X<&ER92X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y2;WEA;'1Y('!A>6UE
M;G1S(&]F(#(E(&]F(&YE="!S86QE<R!W:6QL(&)E(&1U92!T;R!&2$-20RX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y2
M;WEA;'1Y('!A>6UE;G1S(&]F(#(E(&]F(&YE="!S86QE<R!W:6QL(&)E(&1U
M92!T;R!&2$-20RX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)O>6%L='D@;V8@3F5T(%-A;&5S(%!E<F-E;G1A9V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+C`P)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1FER<W0@
M8V]M;65R8VEA;"!S86QE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^,3(@>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1E8VAN;VQO9WD@86-C97-S
M(&9E93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!;FYU86P@;6%I;G1E;F%N8V4@9F5E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%N;G5A;"!R97-E87)C:"!F
M=6YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!U<F-H87-E(&]F(')A9&EO86-T:79E(&UA=&5R:6%L('5S960@
M9F]R(')E<V5A<F-H(&%N9"!D979E;&]P;65N=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S,W+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(S,RPQ,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;VIE8W0@97-T:6UA
M=&5D(&-O<W0@9F]R(&-L:6YI8V%L('1R:6%L<R!O9B!D<G5G($%C+3(R-2U(
M=4TQ.34\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3DW+#<S
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L.#4Y+#,S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L.#4Y+#,S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&]W;B!P87EM96YT(&]F('!R;VIE8W0@
M97-T:6UA=&5D(&-O<W0@<&5R8V5N=&%G93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3(N-3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3(N-3`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;W=N('!A>6UE;G0@9F]R('!R
M;VIE8W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,3<S+#DU
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(S.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,SDL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;&EN:6-A;"!T<FEA;"!C;W-T(&9O<B!A<'!R
M;W9A;"!O9B!F;V]D(&%N9"!D<G5G(&%D;6EN:7-T<F%T:6]N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,RPU,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L,C`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1G5N9"!F;W(@1G)E9"!(=71C:&EN<V]N($-A;F-E<B!297-E87)C:"!#96YT
M97(@;&%B("@@4&5R('EE87(@9F]R('1H92!F:7)S="!T=V\@>65A<G,@*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9U;F0@9F]R($9R960@2'5T8VAI;G-O;B!#86YC97(@4F5S96%R8V@@0V5N
M=&5R(&QA8B`H('1H97)E869T97(@*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)O>6%L='D@<&%Y;65N="!F;W(@
M=&AE(&-O;6UE<F-I86P@=7-E(&]F(&1R=6=S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS-RPU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!0871I96YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO=6YT('!A:60@
M=&\@96%C:"!P871I96YT(&%F=&5R($-O;7!L971I;F<@8VQI;FEC86P@=')I
M86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q+#$X-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q+#,V
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0X,2PR,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT.#$L,C`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S@L-3`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S@L-3`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L-S<Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&%R="UU<"!F
M964@9F]R(&-L:6YI8V%L('1R:6%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW.2PV,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ.2PW-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,RPY-#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,RPY-#8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPX-#<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPX-#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T87)T+75P(&1U92!C;W-T('!A:60@9&%T93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^2G5L(#$P+`T*"0DR,#$R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2G5N(#,P+`T*
M"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^2G5N(#,P+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^2G5N(#,P+`T*"0DR,#$S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-;VYT:&QY
M(&9E92!R96-E:79E9"!B>2!M86YA9V5M96YT(&9I<FT\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!F=6QL
M>2!D:6QU=&5D(&-A<&ET86P@<W1O8VL@97%U86P@=&\@8V]M;6]N('-T;V-K
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A
M;G0@97AE<F-I<V%B;&4@;F]T:6-E('!E<FEO9"!D97-C<FEP=&EO;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^5&AE('=A<G)A;G1S(&-O;G1A
M:6X@82!P<F]V:7-I;VX@=VAE<F5I;B!T:&4@:&]L9&5R(&UA>2!W86EV92!T
M:&4@.3`@9&%Y(&5X97)C:7-E(&YO=&EC92!R97%U:7)E;65N="!B>2!G:79I
M;F<@-C4@9&%Y<R!P<FEO<B!N;W1I8V4@;V8@<W5C:"!W86EV97(N/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97-C
M<FEP=&EO;B!O9B!P97)I;V0@;V8@<VAA<F5S(&%V86EL86)I;&ET>2!B>2!E
M>&5R8VES92!O9B!W87)R86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
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M9"!E9F9E8W1I=F4N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y-87AI;75M(&%M;W5N="!O9B!O=70@;V8@<&]C:V5T
M(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F]N("T@<F5F=6YD86)L92!I;G-T:71U=&EO;F%L(&9E93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L-3`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L-3`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;FYU86P@
M<&AA<FUA8WD@9F5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#`R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L,#(U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!;65N9&UE;G0@<')O8V5S<VEN9R!F964\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!P87EA8FQE
M(&EN(&EN<W1A;&QM96YT<R!U;F1E<B!A9W)E96UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!/9B!);G-T86QL
M;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F9O
M<FUA;F-E(&)O;G5S('!A>6%B;&4@=6YD97(@86=R965M96YT(&9O<B!S97)V
M:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E
M;G1A;"!A9W)E96UE;G0@<F5N97=A;"!D97-C<FEP=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^5&AE(&%G<F5E;65N="!A=71O;6%T:6-A
M;&QY(')E;F5W<R!O;B!A(&UO;G1H+71O+6UO;G1H(&)A<VES(&%N9"!R97%U
M:7)E<R!A('1W;R!M;VYT:"!N;W1I8V4@;V8@=&5R;6EN871I;VXN/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y087EM
M96YT(&]F(&9I<G-T(&EN<W1A;&QM96YT(&9O<B!S97)V:6-E<R!B>2!C;VUP
M86YY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C4L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=71S=&%N9&EN9R!P87EM96YT(&]F(&9I;F%L(&EN<W1A;&QM96YT(&9O<B!S
M97)V:6-E<R!B>2!C;VUP86YY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,C4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y087EM96YT(&]F('!E<F9O<FUA;F-E(&)O;G5S(&9O
M<B!S97)V:6-E<R!B>2!C;VUP86YY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#8P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5N="!A9W)E96UE;G0@=&5R;6EN871I;VX@
M9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^2F%N(#,Q+`T*
M"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^2F%N(#,Q+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;W1I8V4@<&5R:6]D(&9O<B!T97)M
M:6YA=&EO;B!O9B!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/C8P(&1A>7,@<')I;W(@=&\@2F%N=6%R>2`Q+"`R,#$S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^5&AE(&%G
M<F5E;65N="!T97)M:6YA=&5D($UA>2`S,2P@,C`Q,RX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?-#8R
M,U\X.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O5V]R
M:W-H965T<R]3:&5E=#0X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-C)"1SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY%<75I='D@*$1E=&%I;',I("A54T0@)"D\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$-#XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S
M,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#`Y/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=&]C:R!/<'1I;VYS(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!S=&]C:R!O
M<'1I;VX@86-T:79I=&EE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@56YI=',L($)E9VEN;FEN9R!B86QA
M;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,S,"PQ,S0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-S,L.#4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C<S+#@U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%N8V5L;&%T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@T.2PY-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(X+#`U,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@97AP:7)E
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L-C$S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB
M97(@;V8@56YI=',L($5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#(X,"PQ.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,S,"PQ,S0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S,L.#4Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<S+#@U
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V5I9VAT960@079E<F%G92!%>&5R8VES92!0<FEC92P@0F5G:6YN:6YG
M(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XY
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,2XR.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2XR.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G92!%>&5R8VES92!0<FEC
M92P@16YD:6YG($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XY-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,"XY-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,2XR.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XR.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G
M92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;2`H:6X@>65A<G,I+"!/=71S
M=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^."!Y96%R
M<R`U(&UO;G1H<R`Q(&1A>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C@@>65A<G,@,3`@;6]N=&AS(#(X(&1A>7,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE
M87)S(#8@;6]N=&AS(#0@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/C4@>65A<G,@-B!M;VYT:',@-"!D87ES/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M9V=R96=A=&4@26YT<FEN<VEC(%9A;'5E+"!"96=I;FYI;F<@8F%L86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V.#4L.#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@26YT<FEN<VEC(%9A;'5E
M+"!%;F1I;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PV,#DL,#,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C@U+#@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V%R<F%N="!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-U;6UA<GD@;V8@<W1O8VL@;W!T:6]N(&%C=&EV:71I
M97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3G5M8F5R(&]F(%5N:71S+"!"96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L-S<P+#8S-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,S8T+#4U-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^=V%R
M<F%N=',@97AE<F-I<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@R+#(Q,2PQ-3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y787)R86YT<R!E>'!I<F5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q+#`R,RPW.#0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@56YI=',L
M($5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XY+#4S-2PV.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,BPW-S`L-C,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PS-C0L-34W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R
M86=E($5X97)C:7-E(%!R:6-E+"!"96=I;FYI;F<@8F%L86YC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+CDW/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C4Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E
M9"!!=F5R86=E($5X97)C:7-E(%!R:6-E+"!E>&5R8VES960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XV-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G
M92!%>&5R8VES92!0<FEC92P@97AP:7)E9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q+C8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E($5X97)C:7-E
M(%!R:6-E+"!%;F1I;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+CDW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C4Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E
M(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M("AI;B!Y96%R<RDL($]U='-T
M86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S
M(#0@;6]N=&AS(#(@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/C0@>65A<G,@-2!M;VYT:',@,C,@9&%Y<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C8@>65A
M<G,@.2!M;VYT:',@-"!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@26YT<FEN<VEC(%9A;'5E
M+"!"96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-BPQ,30L-S8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPR-C$L,S8W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@26YT<FEN<VEC
M(%9A;'5E+"!%;F1I;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Y+#8Y,2PS,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#8L,3$T+#<V.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPR-C$L,S8W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P
M-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I
M;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y
M9&-A,&(P+U=O<FMS:&5E=',O4VAE970T.2YH=&UL#0I#;VYT96YT+51R86YS
M9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z
M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13-'1DL^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0R/CQS=')O;F<^17%U:71Y("A$971A:6QS(%1E>'1U
M86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R-R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#0^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^,3(W($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$U,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$.#XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`P-SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3,\8G(^02!787)R86YT(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA>2`S,2P@,C`Q,SQB<CY3=&]C:R!/
M<'1I;VYS(%M-96UB97)=/&)R/D9O<FUE<B!$:7)E8W1O<B!!;F0@0V]N<W5L
M=&%N=',@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,3QB<CY-86YA9V5M96YT($9I<FT@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CY#;VUM;VX@4W1O8VL@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`P-SQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CY#;VUM
M;VX@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^02!787)R86YT(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/D(@5V%R<F%N=',@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^36%N86=E
M;65N="!&:7)M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^0V]M;6]N(%-T;V-K(%M-96UB97)=
M/&)R/DUA;F%G96UE;G0@1FER;2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D-O;6UO;B!3=&]C
M:R!;365M8F5R73QB<CY,86ED;&%W("9A;7`[($-O(%M-96UB97)=/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/DQA:61L87<@)F%M<#L@0V\@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^3&%I9&QA=R`F
M86UP.R!#;R!;365M8F5R73QB<CY0;&%C96UE;G0@06=E;G0@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CY#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^3&%I9&QA=R`F86UP.R!#
M;R!;365M8F5R73QB<CY0;&%C96UE;G0@06=E;G0@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`Q.2P@,C`Q,CQB<CY3
M97)I97,@12!0<F5F97)R960@4W1O8VL\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^17%U:71Y("A497AT=6%L*3PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@
M<W1O8VL@:7-S=65D(&9O<B!S97)V:6-E<RP@4VAA<F5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV-BPT,#(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-BPT,#(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C
M:R!I<W-U960@9F]R('-E<G9I8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#,Y."PX,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#,Y."PX,3`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,Y."PX,3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S
M(&ES<W5E9"!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL@;V9F97)I;F<\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T,BPQ.3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PY-S(L-S@U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y286ES960@;V9F97)I;F<@;V8@8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#$U,2PT-3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-3DL,S`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPQ.#0L.38W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#(L-S$Q+#<Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(&ES<W5E9"!I;B!S=&]C:R!O9F9E
M<FEN9RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#$Q."PY.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY-C@L-S4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-RPX.3$L,30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PW,#<L,C4Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y386QE(&]F(&-O
M;6UO;B!S=&]C:RP@;F5T(&]F9F5R:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#0V.2PW-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV-C`L,38T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PS-SDL,S8W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE
M;G0@86=E;G0@8V%S:"!F965S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV,3@L,3<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3$L,3$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-S0R+#$Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&QA8V5M96YT(&%G96YT(&-O
M;6UI<W-I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Q-2PQ
M-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW-2PY,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XV,3@L-#DW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE;G0@86=E;G0@97AP96YS92!R96EM
M8G5R<V5M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#,L
M,#(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,34L,3@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3(S+#8Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@:7-S=65D('1O('!U<F-H87-E
M(&-O;6UO;B!S=&]C:RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT-C<L.#0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPQ,3@L.3@X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU-3DL-3`U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW,38L,S0P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY
M-S0L-S<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3(Q+#`Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/CDX-BPS.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU.#@L.30P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ,CDL.3(U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M92!P<FEC92!O9B!W87)R86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$N-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#(N-#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-S@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#`N-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`N,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&5X<&ER871I;VX@=&5R
M;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y96%R<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$R,"!D
M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^-2!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/C<@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XW('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!I<W-U960@=&\@
M<'5R8VAA<V4@8V]M;6]N('-T;V-K+"!F86ER('9A;'5E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT.3DL-S`W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY-3<L-S4T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPQ-3,L-#0R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,34Y+#`T-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$X."PU-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!L86-E;65N="!A9V5N="!S97)V:6-E<R!F965S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX+#`R,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8P
M+#DP-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F%N:R!E<V-R;W<@9F5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D(&)Y(&-O
M;G9E<G-I;VX@;V8@;F]T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PR-3(L-34P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-R=65D(&UA;F%G96UE;G0@9F5E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.38L-S0T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@
M:7-S=65D('1O(&9O<FUE<B!S:&%R96AO;&1E<B!U;F1E<B!S:&%R92!E>&-H
M86YG92!A9W)E96UE;G0L(%-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K(&ES<W5E9"!T;R!F;W)M
M97(@<VAA<F5H;VQD97)S('5N9&5R('-H87)E(&5X8VAA;F=E(&%G<F5E;65N
M="P@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DX
M-BPU-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E5N<F5C;V=N:7IE9"!S:&%R92!B87-E9"!C;VUP96YS871I;VX@
M97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP.#8L
M.#0X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y296-O<F1E9"!O<'1I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.30L,C`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#`L-#$P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@X+#0P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T,"PT,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M
M;W5N="!086ED($9O<B!#86YC96QL871I;VX@3V8@4VAA<F5S($)Y($-O;7!A
M;GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(U+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA
M<F5S(%!U<F-H87-E9"!!9G1E<B!#86YC96QA=&EO;B!/9B!/<'1I;VYS/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.2PY-3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E
M(%!R:6-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-C4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4')O8V5E9',@9G)O;2!787)R86YT($5X97)C:7-E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S+#0V,RPV-#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S-D8SEB,C`V7SAE-3)?
M-#8R,U\X.&1B7V(R,35E.61C83!B,`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`O
M5V]R:W-H965T<R]3:&5E=#4P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%44=!1SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY3=&]C:R!/<'1I;VX@4&QA;B`H1&5T86EL<RD@
M*%-T;V-K($]P=&EO;G,@6TUE;6)E<ETL(%531"`D*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$P/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M=&]C:R!/<'1I;VYS(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4W5M;6%R>2!O9B!S=&]C:R!O<'1I;VX@86-T
M:79I=&EE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.=6UB97(@;V8@56YI=',L($)E9VEN;FEN9R!B86QA;F-E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,S,"PQ,S0\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S,L.#4Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<S
M+#@U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3G5M8F5R(&]F(%5N:71S+"!'<F%N=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#`U-BPR-S4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E
M<B!O9B!5;FET<RP@16YD:6YG($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,C@P+#$X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,S,P+#$S-#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(W,RPX-3D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S,L.#4Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y796EG:'1E9"!!=F5R86=E($5X97)C:7-E(%!R:6-E+"!"96=I;FYI;F<@
M8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+CDV
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q+C(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q+C(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E($5X97)C:7-E(%!R:6-E
M+"!'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I
M8V4L($5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`N.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$N,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,CD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A
M9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E<FT@*&EN('EE87)S*2P@3W5T
M<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C@@>65A
M<G,@-2!M;VYT:',@,2!D87D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XX('EE87)S(#$P(&UO;G1H<R`R."!D87ES/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y
M96%R<R`V(&UO;G1H<R`T(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S(#8@;6]N=&AS(#0@9&%Y<SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V5I9VAT960@079E<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;2`H
M:6X@>65A<G,I+"!'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XX('EE87)S(#$P(&UO;G1H<R`R,2!D87ES/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@26YT
M<FEN<VEC(%9A;'5E+"!"96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`V.#4L.#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!9V=R96=A=&4@26YT<FEN<VEC(%9A;'5E+"!'<F%N=&5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%G9W)E9V%T92!);G1R:6YS:6,@5F%L=64L($5N9&EN9R!"
M86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-C`Y
M+#`S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-C@U+#@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U
M,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B
M,"]7;W)K<VAE971S+U-H965T-3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5$5D9+/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/E-T;V-K($]P=&EO;B!0;&%N("A$971A:6QS
M(%1E>'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,C$^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1F5B+B`R.2P@,C`Q,CQB<CY3=&]C:R!/<'1I;VYS
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3,\8G(^4W1O8VL@3W!T:6]N<R!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/E-T
M;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CY3=&]C:R!/<'1I;VYS(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3`\8G(^4W1O8VL@3W!T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`Y/&)R/E-T;V-K($]P
M=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`P.#QB<CY3=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#<\
M8G(^4W1O8VL@3W!T:6]N<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`V/&)R/E-T;V-K($]P=&EO;G,@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CY-:6YI;75M(%M-96UB97)=/&)R/E-T;V-K($]P=&EO
M;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,#QB<CY-:6YI;75M(%M-96UB97)=/&)R/E-T;V-K($]P
M=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`P.#QB<CY-:6YI;75M(%M-96UB97)=/&)R/E-T;V-K
M($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`P-SQB<CY-:6YI;75M(%M-96UB97)=/&)R/E-T
M;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`P-CQB<CY-:6YI;75M(%M-96UB97)=/&)R
M/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY-87AI;75M(%M-96UB97)=
M/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CY-87AI;75M(%M-96UB
M97)=/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P.#QB<CY-87AI;75M(%M-
M96UB97)=/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-SQB<CY-87AI;75M
M(%M-96UB97)=/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-CQB<CY-87AI
M;75M(%M-96UB97)=/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CXR
M,#`S(%-T;V-K(%!L86X@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CXR,#`S(%-T;V-K(%!L86X@
M6TUE;6)E<ET\8G(^36EN:6UU;2!;365M8F5R73QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/C(P,#,@4W1O8VL@
M4&QA;B!;365M8F5R73QB<CY-87AI;75M(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^,C`Q,B!%
M;7!L;WEE92!3=&]C:R!/<'1I;VX@4&QA;B!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:R!/<'1I
M;VX@4&QA;B`H5&5X='5A;"D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^36%X:6UU;2!G<F%N=&5D(&]P=&EO;B!T;R!P=7)C
M:&%S92!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<U-RPU-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DUA>&EM=6T@9W)A;G1E9"!O<'1I;VX@869T97(@86UE
M;F1M96YT(&EN(#(P,#@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDW."PQ-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-H87)E(&)A<V5D('!A>6UE;G0@87=A<F0@=F5S=&EN9R!P
M97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C0@>65A<G,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XT
M('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^-"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/C0@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XT('EE87)S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y96%R<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C4@>65A<G,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^-2!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/C0@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XU('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92!B87-E9"!P87EM96YT
M(&%W87)D(&UO;G1H;'D@=F5S=&EN9R!P97)C96YT86=E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&5R8V5N=&%G92!O9B!A9V=R
M96=A=&4@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!C;VUM;VX@<VAA<F5S(')E
M<V5R=F5D('5N9&5R(&]F9F5R:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-T;V-K(')E<V5R=F5D(&9O<B!F=71U<F4@:7-S
M=6%N8V4@=6YD97(@15-/4#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.2PT-34L-S<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y);F-R96UE;G0@:6X@;G5M8F5R(&]F('-H87)E<R!U
M;F1E<B!P;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#(Q
M-RPX.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L('-H87)E<R!R97-E<G9E9"!F;W(@:7-S=6%N8V4@=6YD
M97(@<&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPQ-34L
M,C@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=&]C:R!O<'1I;VX@9W)A;G1E9"!T;R!E;7!L;WEE97,@=&\@<'5R
M8VAA<V4@8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#`U-BPR-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS,RPS,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV.2PY-#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3,L,C(P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`V+#`V,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O
M8VL@;W!T:6]N(&=R86YT960@=&\@<'5R8VAA<V4@8V]M;6]N('-T;V-K+"!E
M>&5R8VES92!P<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2XS-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,2XS-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XU/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!O<'1I
M;VX@9W)A;G1E9"!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VLL('1E<FT\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$P('EE87)S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,3`@>65A<G,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ
M,"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/C$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@=F%L=64@;V8@<W1O8VL@
M;W!T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-3$Y
M+#<W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,C0L.3DV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`T-"PQ-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S-RPV-3(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,#4Q+#(X,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&ES
M8V]U;G0@<F%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XX
M,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+C$V)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,N-#8E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RXT-B4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT+C(Y)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@;&EF93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-R!Y96%R<SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C4@>65A<G,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M-2!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/C4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D('9O;&%T:6QI='D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,2XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,SDN,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30S+C`P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U
M-BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-C`N-#0E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,38Q+C0Y)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@9&EV:61E;F1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=&]C:R!O<'1I;VX@8V%N8V5L;&5D(&1U<FEN9R!P97)I;V0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#8Q,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@
M;W!T:6]N(&9O<F9E:71U<F5S(&1U<FEN9R!P97)I;V0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#0Y+#DU,"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C@L,#4P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;7!L;WEE92!S
M=&]C:R!O<'1I;VX@=6YI=',@<F5P<FEC960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(W,RPX-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG('-T;V-K(&]P=&EO
M;B!E>&5R8VES92!P<FEC92!A9G1E<B!R97!R:6-I;F<@;V8@<W1O8VL@;W!T
M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H
M87)E(&)A<V5D(&-O;7!E;G-A=&EO;B!C;W-T(&%F=&5R(')E<')I8VEN9R!O
M9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS-"PX-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E5N<F5C;V=N:7IE9"!S:&%R92!B87-E9"!C;VUP96YS871I
M;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP
M.#8L.#0X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PY.3@L-#,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,30L-3(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-O<F1E9"!O<'1I;VX@97AP96YS
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y-"PR,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0P
M+#0Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,3@X+#0P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,C0P+#0P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C8V+#$W,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3DL.3,U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X
M934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ
M(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A
M,&(P+U=O<FMS:&5E=',O4VAE970U,BYH=&UL#0I#;VYT96YT+51R86YS9F5R
M+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E
M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14E.04,^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^5V%R<F%N=',@*$1E=&%I;',I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4W5M;6%R>2!O9B!W87)R86YT(&ES<W5E9#PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!I<W-U960@=VET:"!C
M;VYV97)T:6)L92!N;W1E<R`H4V5E($YO=&4@-2D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(X-RPP-C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S
M(&ES<W5E9"!T;R!I;G9E<W1O<G,@=VET:"!3=&]C:R!/9F9E<FEN9R`H4V5E
M($YO=&4@-B!A;F0@3F]T92`Y*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C0R+#$X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L.3<R+#<V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@:7-S=65D('1O(&EN
M=F5S=&]R<R!W:71H($-O;6UO;B!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PV-S@L-#DQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE;G0@
M86=E;G0@=V%R<F%N=',@<F5L871E9"!T;R!I<W-U86YC92!O9B!#;VYV97)T
M:6)L92!.;W1E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,30S+#4S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4&QA8V5M96YT(&%G96YT('=A<G)A;G1S(')E
M;&%T960@=&\@:7-S=6%N8V4@;V8@4W1O8VL@3V9F97)I;F<@*%-E92!.;W1E
M(#8@86YD($YO=&4@.2D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R,2PP.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY.#8L,S@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0;&%C96UE;G0@86=E;G0@=V%R<F%N=',@<F5L
M871E9"!T;R!I<W-U86YC92!O9B`R,#$R($-O;6UO;B!3=&]C:R!/9F9E<FEN
M9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8W+#@T-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5V%R<F%N="!I<W-U960@=&\@:6YV97-T;W)S('=I=&@@<W1O
M8VL@+2!A8V-R=65D(&1I=FED96YD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ.#`L,3$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4L-C@Y+#<S-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L,S@Y+#<T,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE
M971S+U-H965T-3,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5564%%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E=A<G)A;G1S("A$971A:6QS(#$I("A787)R86YT(%M-96UB
M97)=+"!54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y(&]F
M('=A<G)A;G1S(&%C=&EV:71I97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3G5M8F5R(&]F(%5N:71S+"!"96=I;FYI;F<@
M8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L-S<P
M+#8S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4L,S8T+#4U-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3G5M8F5R(&]F(%5N:71S+"!'<F%N=&5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#0P-BPP-SD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,V-"PU-3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYU;6)E<B!O9B!5;FET<RP@16YD:6YG($)A;&%N8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/CDL-3,U+#8Y-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#<W,"PV,S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#,V-"PU
M-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I8V4L($)E9VEN;FEN
M9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#`N-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I8V4L($=R
M86YT960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2XS,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,"XU,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V5I9VAT960@079E<F%G92!%>&5R8VES92!0<FEC92P@16YD:6YG
M($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,"XY-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,"XU,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G92!296UA:6YI;F<@0V]N
M=')A8W1U86P@5&5R;2`H:6X@>65A<G,I+"!'<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XS('EE87)S(#D@;6]N=&AS(#0@9&%Y<SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C8@
M>65A<G,@.2!M;VYT:',@-"!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E(%)E;6%I
M;FEN9R!#;VYT<F%C='5A;"!497)M("AI;B!Y96%R<RDL($]U='-T86YD:6YG
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XU('EE87)S(#0@;6]N
M=&AS(#(@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/C0@>65A<G,@-2!M;VYT:',@,C,@9&%Y<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C8@>65A<G,@.2!M
M;VYT:',@-"!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@26YT<FEN<VEC(%9A;'5E+"!"96=I
M;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`V+#$Q-"PW-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#,L,C8Q+#,V-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06=G<F5G871E($EN=')I;G-I8R!6
M86QU92P@16YD:6YG($)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@.2PV.3$L,S`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`V+#$Q-"PW-C@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,C8Q+#,V-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?
M.&4U,E\T-C(S7S@X9&)?8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S-D8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C
M83!B,"]7;W)K<VAE971S+U-H965T-30N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)3D%'/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E=A<G)A;G1S("A$971A:6QS(%1E>'1U
M86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0T/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^5V%R<F%N="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/E=A<G)A;G0@6TUE;6)E<ET\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CY-:6YI;75M(%M-96UB97)=/&)R/E=A<G)A;G0@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CY-
M87AI;75M(%M-96UB97)=/&)R/E=A<G)A;G0@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5V%R<F%N="`H
M5&5X='5A;"D\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V%R<F%N="!G<F%N=&5D('1O($UA;F%G96UE;G0@1FER;2!T;R!P
M=7)C:&%S92!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-S$V+#,T,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L.3<T+#<W-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@9W)A;G1E9"!T
M;R!-86YA9V5M96YT($9I<FT@=&\@<'5R8VAA<V4@8V]M;6]N('-T;V-K+"!E
M>&5R8VES92!P<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P+C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y787)R86YT<R!G<F%N=&5D('1O('!U<F-H87-E(&-O
M;6UO;B!S=&]C:RP@=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^-R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/C<@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@=F%L=64@;V8@=V%R<F%N=',@<F5C
M;W)D960@87,@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.30L,C`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T,"PT,3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$X."PT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(T,"PT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$L.34W+#<U-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPQ-3,L-#0R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E
M8W1E9"!L:69E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XW('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D1I<V-O=6YT(')A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$N.#(E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2XY,B4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C$W)3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96-T960@=F]L871I
M;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C`N-C0E/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C0N
M-S<E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-S`N-S(E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%>'!E8W1E9"!D:79I9&5N9',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S('!E<F-E;G1A
M9V4@;V8@=&]T86P@:7-S=65D(&%N9"!O=71S=&%N9&EN9R!S:&%R97,@;V8@
M8V%P:71A;"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\S9&,Y8C(P-E\X934R7S0V,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V1C.6(R,#9?.&4U,E\T-C(S7S@X
M9&)?8C(Q-64Y9&-A,&(P+U=O<FMS:&5E=',O4VAE970U-2YH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P15-$04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^16UP;&]Y964@1&5F
M:6YE9"!#;VYT<FEB=71I;VX@4&QA;B`H1&5T86EL<RD@*%531"`D*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D5M<&QO>65E($1E9FEN960@0V]N=')I8G5T:6]N(%!L86X@*%1E>'1U86PI
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E
M<V-R:7!T:6]N(&]F(&5M<&QO>65E(&1E9F5R<F5D(&-O;G1R:6)U=&EO;B!P
M;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y4:&4@<&QA;B!R
M97%U:7)E<R`Q,B!C;VYS96-U=&EV92!M;VYT:',@;V8@<V5R=FEC92!A;F0@
M82!M:6YI;75M(&]F(#4P,"!H;W5R<R!O9B!S97)V:6-E(&9O<B!P87)T:6-I
M<&%T:6]N+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4&5R8V5N=&%G92!O9B!E;7!L;WEE<B!M871C:&EN9R!C;VYT
M<FEB=71I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]N=')I8G5T:6]N(&]F('1H92!C;VUP86YY(&EN(&5M<&QO>65E(&1E
M9F5R<F5D(&-O;G1R:6)U=&EO;B!P;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#@L.30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`X+#@X-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T-C(S7S@X9&)?
M8C(Q-64Y9&-A,&(P#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S-D
M8SEB,C`V7SAE-3)?-#8R,U\X.&1B7V(R,35E.61C83!B,"]7;W)K<VAE971S
M+U-H965T-38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5$2D%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/E-U8G-E<75E;G0@179E;G1S("A$971A:6QS*2`H4W5B<V5Q=65N
M="!%=F5N="!;365M8F5R72P@4V5P87)A=&EO;B!A;F0@4V5T=&QE;65N="!!
M9W)E96UE;G0@6TUE;6)E<ETL($9O<FUE<B!#:&EE9B!%>&5C=71I=F4@3V9F
M:6-E<B!;365M8F5R72P@55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C`@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D9E8BX@,C@L(#(P,3,\8G(^3F]T93QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<V5Q=65N="!%=F5N="!;365M
M8F5R72!\(%-E<&%R871I;VX@86YD(%-E='1L96UE;G0@06=R965M96YT(%M-
M96UB97)=('P@1F]R;65R($-H:65F($5X96-U=&EV92!/9F9I8V5R(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4W5B<V5Q=65N="!%=F5N=',@*%1E>'1U86PI/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!I;G-T86QL;65N
M=',@:6X@=VAI8V@@8V]N<VED97)A=&EO;B!I<R!P87EA8FQE/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYS:61E<F%T:6]N('!A>6%B
M;&4@=6YD97(@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!E<F9O<FUA;F-E(&)O;G5S(&EN8VQU9&5D(&EN
M(&%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-C`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)I;V0@
M;V8@<V5R=FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^075G
M=7-T(#$U+"`R,#$R('1O($1E8V5M8F5R(#,Q+"`R,#$R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S9&,Y8C(P-E\X934R7S0V
M,C-?.#AD8E]B,C$U93ED8V$P8C`-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
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M2%)E9CTS1")3:&5E=#`Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970P,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970P-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,#8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#$P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970Q-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970Q-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,3@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,"YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,C$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#(R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,RYH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C0N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#(U+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970R-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C<N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(X+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970R.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,S`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,Q
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,BYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,S,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#,T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S
M-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S8N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,W+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970S."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,SDN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0P+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970T,2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T-#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#0S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T-"YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#4N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#0V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970T-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#@N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0Y+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970U,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T-3$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#4R+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970U,RYH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T-30N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#4U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970U-BYH=&UL
M(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?,V1C.6(R,#9?.&4U,E\T
9-C(S7S@X9&)?8C(Q-64Y9&-A,&(P+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>312</ContextCount>
  <ElementCount>362</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DocumentAndEntityInformation1</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/ConsolidatedBalanceSheetsparenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statement of Changes in Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Consolidatedstatementofchangesinstockholdersequitydeficit</Role>
      <ShortName>Consolidated Statement of Changes in Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Disclosure - Description of Business and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>008 - Disclosure - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Notes11</Role>
      <ShortName>Going Concern</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>009 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/RelatedPartyTransaction</Role>
      <ShortName>Related Party Transactions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>010 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note Payable and Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://cactusventuresinc.com/role/NotePayableAndConvertibleNotes</Role>
      <ShortName>Note Payable and Convertible Notes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>012 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>013 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>015 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>016 - Disclosure - Stock Option Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/StockOptionPlan</Role>
      <ShortName>Stock Option Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>017 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>018 - Disclosure - Employee Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/EmployeeDefinedContributionPlan</Role>
      <ShortName>Employee Defined Contribution Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>019 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Notes13</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>020 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>021 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>022 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/RelatedPartyTransactiontables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>023 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>024 - Disclosure - Note Payable and Convertible Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesTables</Role>
      <ShortName>Note Payable and Convertible Notes (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>025 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>026 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>027 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>028 - Disclosure - Stock Option Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/StockOptionPlanTables</Role>
      <ShortName>Stock Option Plan (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>029 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>030 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>031 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>032 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails1</Role>
      <ShortName>Description of Business and Summary of Significant Accounting Policies (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>033 - Disclosure - Going concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/GoingconcernDetails</Role>
      <ShortName>Going concern (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>034 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/RelatedPartyTransactiondetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>035 - Disclosure - Related Party Transactions (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Relatedpartytransactiondetailstextual</Role>
      <ShortName>Related Party Transactions (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>036 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>037 - Disclosure - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Propertyandequipmentdetailstesxtual</Role>
      <ShortName>Property and Equipment (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>038 - Disclosure - Note Payable and Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetails</Role>
      <ShortName>Note Payable and Convertible Notes (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>039 - Disclosure - Note Payable and Convertible Notes (Details Textual)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://cactusventuresinc.com/role/NotePayableAndConvertibleNotesDetailsTextual</Role>
      <ShortName>Note Payable and Convertible Notes (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>040 - Disclosure - Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DerivativesDetails</Role>
      <ShortName>Derivatives (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>041 - Disclosure - Derivatives (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DerivativesDetails1</Role>
      <ShortName>Derivatives (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>042 - Disclosure - Derivatives (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/DerivativesDetailsTextual</Role>
      <ShortName>Derivatives (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>043 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>044 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>045 - Disclosure - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/IncometaxesdetailsTextual</Role>
      <ShortName>Income Taxes (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>046 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>047 - Disclosure - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Commitmentsandcontingenciesdetailstextual</Role>
      <ShortName>Commitments and Contingencies (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>048 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Equitydetails</Role>
      <ShortName>Equity (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>049 - Disclosure - Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/Equitydetailstextual</Role>
      <ShortName>Equity (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>050 - Disclosure - Stock Option Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/StockOptionPlanDetails</Role>
      <ShortName>Stock Option Plan (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>051 - Disclosure - Stock Option Plan (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/StockOptionPlanDetailsTextual</Role>
      <ShortName>Stock Option Plan (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>052 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>053 - Disclosure - Warrants (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/WarrantsDetails1</Role>
      <ShortName>Warrants (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>054 - Disclosure - Warrants (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/WarrantsDetailsTextual</Role>
      <ShortName>Warrants (Details Textual)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>055 - Disclosure - Employee Defined Contribution Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/EmployeeDefinedContributionPlanDetails</Role>
      <ShortName>Employee Defined Contribution Plan (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>056 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cactusventuresinc.com/role/SubsequenteventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_FairValueAssumptionsExercisePrice had a mix of decimals attribute values: 2 3.</Log>
    <Log type="Info">Element us-gaap_FairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 2 4.</Log>
    <Log type="Info">Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 2 4.</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2002'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2001'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2000'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Consolidated Balance Sheets (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - Consolidated Statements of Operations</Log>
    <Log type="Info">	Process Flow-Through: Removing column '6 Months Ended
Dec. 31, 2000'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2002'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2001'</Log>
    <Log type="Info">Process Flow-Through: 006 - Statement - Statements of Cash Flows</Log>
  </Logs>
  <InputFiles>
    <File>fil-20130630.xml</File>
    <File>fil-20130630.xsd</File>
    <File>fil-20130630_cal.xml</File>
    <File>fil-20130630_def.xml</File>
    <File>fil-20130630_lab.xml</File>
    <File>fil-20130630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQGAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock Option Plan (Details) (Stock Options [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of stock option activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Beginning balance</a></td>
        <td class="nump">2,330,134<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Units, Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,056,275<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Units, Ending Balance</a></td>
        <td class="nump">2,280,184<span></span></td>
        <td class="nump">2,330,134<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="nump">273,859<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Beginning balance</a></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Ending Balance</a></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 0.96<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
        <td class="nump">$ 1.29<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (in years), Outstanding</a></td>
        <td class="text">8 years 5 months 1 day<span></span></td>
        <td class="text">8 years 10 months 28 days<span></span></td>
        <td class="text">5 years 6 months 4 days<span></span></td>
        <td class="text">5 years 6 months 4 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term (in years), Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">8 years 10 months 21 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning balance</a></td>
        <td class="nump">$ 685,800<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
        <td class="nump">$ 1,609,035<span></span></td>
        <td class="nump">$ 685,800<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedWeightedAverageRemainingContractualTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Details Textual) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses ("NOLs")</a></td>
        <td class="nump">$ 43<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Expiration dates of operating loss carryforwards</a></td>
        <td class="text">Dec. 31,
				 2020<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Federal statutory rate</a></td>
        <td class="nump">34.00%<span></span></td>
        <td class="nump">34.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_IncomeTaxesTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_IncomeTaxesTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwardsExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EFCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">23,584,424<span></span></td>
        <td class="nump">21,391,665<span></span></td>
        <td class="nump">13,664,802<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding</a></td>
        <td class="nump">23,584,424<span></span></td>
        <td class="nump">21,391,665<span></span></td>
        <td class="nump">13,664,802<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 6 &#8211; Commitments and Contingencies</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">a.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">Abbott Biotherapeutics Corp.</font> We entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, we made a license fee payment of $3,000,000.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; We agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" style="border-bottom: black 2px solid;" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td style="border-bottom: black 2px solid;" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(5) First commercial sale</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Under the agreement, we agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As of December 31, 2012, we met our first milestone and upon reaching the milestone we paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">b.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">Memorial Sloan Kettering Cancer Center (MSKCC)</font>.&#160;&#160;In February 2002, we entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" style="border-bottom: black 2px;" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td style="border-bottom: black 2px solid;" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) filing of an New Drug Application (&#8220;NDA&#8221;) or regulatory approval </font>for each licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) upon the receipt of regulatory approval from the U.S. FDA for each </font>licensed product</font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Under the agreement, we agreed to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.&#160;&#160;We expect to file the NDA for regulatory approval in 2016.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">c.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">Oak Ridge National Laboratory (ORNL)</font> &#8211; We have contracted to purchase radioactive material to be used for research and development through December 2013. We contracted to purchase $ 337,500 of radioactive material to be used for research and development, with a renewal option at the contract end. &#160;&#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; d.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">AptivSolutions.</font>&#160;&#160;Aptiv Solutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab-A) used in our clinical trials, Phase I and Phase II. &#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &#160;The down payment totaling $239,000 was paid in 2007 and 2012. &#160;The agreement was amended to provide for additional services on August 6, 2012, October 22, 2012 and May 16, 2013. &#160;The total project is now estimated at $ 2,173,955. &#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">e.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">Fred Hutchinson Cancer Research Center (FHCRC)</font>.&#160;&#160;On June 15, 2012, we entered into a license and sponsored research agreement with FHCRC. We will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and we intend to start preparation for a pivotal trial leading to an FDA approval. &#160;We have been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &#160;Under the terms of the sponsored research agreement, we will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.&#160;On August 12, 2013, the Company paid $37,500 to FHCRC.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">f.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">MSKCC</font>.&#160;&#160;On March 27, 2012, we entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &#160;The amount due of $79,623 was paid on July 10, 2012.</font></div>
</td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">g.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">FHCRC</font>.&#160;&#160;On July 19, 2012, we entered into a clinical trial agreement with FHCRC. &#160;We will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, we are required to pay a start-up fee of $19,749. &#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">h.&#160;&#160;</font></div>
</td>
<td valign="top" width="80%">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">The University of Texas M.D. Anderson Cancer Center</font>.&#160;&#160;On August 28, 2012, we entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &#160;The estimated cost is based on treating 24 patients through 2013. &#160;Upon execution of the agreement, we were required to make a payment of $33,946. &#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div>
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" valign="top" width="3%">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">i.&#160;&#160;</font></div>
</td>
<td style="text-align: justify;" valign="top" width="80%">
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">Johns Hopkins University</font>.&#160;&#160;On September 26, 2012, we entered into a clinical trial agreement with Johns Hopkins University. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $38,501 per patient, who has completed the clinical trial. We are required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td style="text-align: left; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" valign="top" width="4%">
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;j.&#160;&#160;</font></div>
</td>
<td style="text-align: left; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" valign="top" width="96%">
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-style: italic; display: inline;">University of Pennsylvania</font>.&#160;&#160;&#160;On November 21, 2012, we entered into a clinical trial agreement with the University of Pennsylvania. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by us and pursuant to an Investigational New Drug Exemption (IND 10807) held by us. &#160;We will pay $31,771 per patient, who has completed the clinical trial. We will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.</font></div>
</td>
</tr>
</table>
</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3rd Floor, New York, NY 10017. &#160;The agreement terminated May 31, 2013. On June 1, 2013The Company entered into a rental agreement for office space at 546 Fifth Avenue, 14 th&#160;&#160;Floor, New York, NY 10036.&#160;&#160;The agreement terminates on December 31, 2013.&#160;&#160;Upon the expiration of the term, the agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &#160;The Company paid a one month refundable deposit.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company paid Mr. Talley $125,000 on March 8, 2013 and a second payment of $125,000 is due to be paid to Mr. Talley on September 1, 2013. The Company also paid Mr. Talley a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012.&#160;&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 8 &#8211; Commitments and Contingencies</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The Company has entered into license and research and development agreements with third parties under which the Company is obligated to make payments in the form of upfront payments as well as milestone and royalty payments. Notable inclusions in this category are:</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">a.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Abbott Biotherapeutics Corp &#8211; The Company entered into a Product Development and Patent License Agreement with Abbott Biotherapeutics Corp. (formerly Facet Biotech formerly known as Protein Design Labs) in 2003 to secure exclusive rights to a specific antibody when conjugated with alpha emitting radioisotopes. Upon execution of the agreement, the Company made a license fee payment of $3,000,000.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The Company agreed to make milestone payments totaling $7,750,000 for the achievement of the following agreed to and contracted milestones:</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1) when Company initiates a Phase I Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) when Company initiates a Phase II Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3) when Company initiates a Phase III Clinical Trial of a licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new
 roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4) Biological License Application filing with U.S. FDA</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(5) First commercial sale</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(6) after the first $10,000,000 in net sales</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,500,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Under the agreement, the Company shall pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.</font></div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">As of December 31, 2012, the Company met its first milestone and upon reaching the milestone the Company paid Abbott Biotherapeutics Corp. a milestone payment of $750,000 on July 24, 2012. &#160;The milestone payment for the Phase I Clinical Trial was recorded as research and development expense.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">b.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">MSKCC &#8211; In February 2002, the Company entered into a license agreement with MSKCC that requires a technology access fee of $50,000 upon execution, an annual maintenance fee of $50,000 and an annual research funding of $50,000 for as long as the agreement is in force.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="border-bottom: black 2px solid;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Milestones</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Payments</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1) filing of an
 New Drug Application (&#8220;NDA&#8221;) or regulatory approval</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">for each licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2) upon the receipt of regulatory approval from the U.S. FDA for each</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">licensed product</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,750,000</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.</font></div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The Company expects to file the NDA for regulatory approval in 2015.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">c.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Oak Ridge National Laboratory (ORNL) &#8211; API has contracted to purchase radioactive material to be used for research and development through December 2012. API is contracted to purchase $233,100 of radioactive material to be used for research and development, with a renewal option at the contract end. &#160;The Company is currently negotiating the 2013 agreement.&#160;&#160;</font></div>
</td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">d.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">AptivSolutions provides project management services for the study of the drug Ac-225-HuM195 (Actimab&#8482;-A) used in the Company clinical trials, Phase I and Phase II. &#160;The total project is estimated to cost $1,859,333 and requires a 12.5% down payment of the total estimated project cost. &#160;The down payment totaling $239,000 was paid in 2007 and 2012. &#160;On August 6, 2012, the agreement was amended to provide for additional services. &#160;The total project is now estimated at $1,997,732. &#160;AptivSolutions bills the Company when services are rendered and the Company records the related expense to research and development costs.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%;
 font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">e.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On June 15, 2012, the Company entered into a license and sponsored research agreement with Fred Hutchinson Cancer Research Center (FHCRC). The Company will build upon previous and ongoing clinical trials, with BC8 (licensed antibody) and eventually develop a clinical trial with Actinium 225. &#160;FHCRC has currently completed Phase I and Phase II of the clinical trial and the Company intends to start preparation for a pivotal trial leading to an FDA approval. &#160;The Company has been granted exclusive rights to the BC8 antibody and related master cell bank developed by FHCRC. &#160;The cost to develop the trial will range from $13.2 million to $23.5 million, depending on the trial design as required by the FDA. &#160;Under the terms of the sponsored research agreement, the Company will fund the FHCRC lab with $150,000 per year for the first two years and $250,000 thereafter. &#160;Payments made toward funding the lab will be credited toward royalty payments owed to FHCRC in the given year. &#160;A milestone payment of $1 million will be due to FHCRC upon FDA approval of the first drug. &#160;Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">f.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On March 27, 2012, the Company entered into a clinical trial agreement with Memorial Sloan Kettering Cancer Center. &#160;The Company will pay $31,185 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $79,623. &#160;The amount due of $79,623 was paid on July 10, 2012.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">g.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On May 9, 2011, Actinium entered into a transaction management agreement with Jamess Capital Group, LLC. (formerly known as Amerasia Capital Group, LLC), a consulting firm affiliated with Mr. Sandesh Seth, a Director of Cactus&#160;Ventures, Inc.&#160;by virtue of his position as a director of Actinium Pharmaceuticals.&#160; Mr. Seth is a Managing Partner of the consulting firm some of whose member interests are held by entities owned by officers and employees of the Placement Agent.&#160; None of Cactus&#8217; current officers or directors had a prior relationship or affiliation with Cactus prior to the closing of the Share Exchange.&#160; Pursuant to the agreement, the management firm was engaged to provide consulting services to Actinium related to the consummation of a going public transaction for Actinium.&#160; The management firm received a monthly fee of $12,500 which is terminable by the Company three months after the effective date of the going public transaction and designees of Jamess, including entities affiliated with Mr. Seth, were issued warrants to purchase common stock equal to 10% of the fully-diluted capital stock of the Company as of the effective date of the going public transaction. The fully diluted shares for this calculation included all issued and outstanding shares as well as those reserved under the Employee Stock Option Plan.&#160; Jamess Capital Group does not retain&#160;beneficial ownership of the warrants as they were&#160;issued to designees of the members in amounts which do not qualify either Jamess or the warrant holders for inclusion in the beneficial ownership table.&#160; The warrants contain&#160;a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.&#160; The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transferred until the earlier of twelve months from the closing date of the Pubco Transaction; or for six months after the planned Registration Statement is declared effective.&#160;The consulting firm is also eligible to be reimbursed upon the submission of proper documentation for ordinary and necessary out-of-pocket expenses not to exceed $5,000 per month.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">h.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On July 19, 2012, the Company entered into a clinical trial agreement with FHCRC. &#160;The Company will pay $31,366 for each patient that has completed the clinical trial. Upon execution of the agreement, the Company is required to pay a start-up fee of $19,749.
 &#160;During the clinical trial additional fees apply and will be invoiced when applicable. &#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">i.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On August 28, 2012, the Company entered into a clinical trial agreement with The University of Texas M.D. Anderson Cancer Center. &#160;The total estimated cost of conducting the clinical trial is $481,204, which includes a non- refundable institutional fee of $14,500. &#160;The estimated cost is based on treating 24 patients through 2013. &#160;Upon execution of the agreement, the Company is required to make a payment of $33,946. &#160;&#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">j.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On September 26, 2012, the Company entered into a clinical trial agreement with Johns Hopkins University. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &#160;The Company will pay $38,501 per patient, who has completed the clinical trial. The Company is required to pay a start-up fee of $22,847, an annual pharmacy fee of $2,025 and an amendment processing fee of $500, when applicable. &#160;The amount due has not been invoiced but accrued by the Company as of December 31, 2012.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="5%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">k.&#160;&#160;</font></div>
</td>
<td width="95%" valign="top" style="text-align: justify;">
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On November 21, 2012, the Company entered into a clinical trial agreement with the University of Pennsylvania. &#160;The Phase I/II clinical trial will be conducted with Actinium 225. &#160;The clinical trial will be conducted under the protocols established by the Company and pursuant to an Investigational New Drug Exemption (IND 10807) held by the Company. &#160;The Company will pay $31,771 per patient, who has completed the clinical trial. The Company will be required to pay a start-up fee of $16,000 and additional administrative fees, when applicable.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; On August 1, 2012, the Company entered into a rental agreement for office space at 501 Fifth Avenue, 3<font style="font-size: 10pt; display: inline;">rd</font> Floor, New York, NY 10017. &#160;The agreement terminates January 31, 2013 unless a Notice of Termination is provided to the landlord 60 days prior to January 1, 2013. &#160;The agreement automatically renews on a month-to-month basis and requires a two month notice of termination. &#160;The Company paid a two month refundable deposit.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EN2EK">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statement of Changes in Stockholders' Equity (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th">
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital</div>
        </th>
        <th class="th">
          <div>Deficit Accumulated During the Development Stage</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Jun. 13, 2000</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of founder shares</a></td>
        <td class="nump">$ 30,000<span></span></td>
        <td class="nump">$ 9,990<span></span></td>
        <td class="nump">$ 20,010<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of founder shares, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">999,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">1,750,000<span></span></td>
        <td class="nump">1,457<span></span></td>
        <td class="nump">1,748,543<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">145,687<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(672,286)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(672,286)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2000</a></td>
        <td class="nump">1,107,714<span></span></td>
        <td class="nump">11,447<span></span></td>
        <td class="nump">1,768,553<span></span></td>
        <td class="num">(672,286)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2000</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,144,687<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">2,250,000<span></span></td>
        <td class="nump">1,873<span></span></td>
        <td class="nump">2,248,127<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">187,313<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,090,621)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,090,621)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2001</a></td>
        <td class="num">(1,732,907)<span></span></td>
        <td class="nump">13,320<span></span></td>
        <td class="nump">4,016,680<span></span></td>
        <td class="num">(5,762,907)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2001</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,332,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">3,250,000<span></span></td>
        <td class="nump">1,804<span></span></td>
        <td class="nump">3,248,196<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">180,375<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(3,192,384)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,192,384)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2002</a></td>
        <td class="num">(1,675,291)<span></span></td>
        <td class="nump">15,124<span></span></td>
        <td class="nump">7,264,876<span></span></td>
        <td class="num">(8,955,291)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2002</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,512,375<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">6,781,250<span></span></td>
        <td class="nump">2,090<span></span></td>
        <td class="nump">6,779,160<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">208,992<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(3,532,044)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,532,044)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2003</a></td>
        <td class="nump">1,573,915<span></span></td>
        <td class="nump">17,214<span></span></td>
        <td class="nump">14,044,036<span></span></td>
        <td class="num">(12,487,335)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2003</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,721,367<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">4,600,000<span></span></td>
        <td class="nump">7,659<span></span></td>
        <td class="nump">4,592,341<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">765,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,734,791)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(5,734,791)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2004</a></td>
        <td class="nump">439,124<span></span></td>
        <td class="nump">24,873<span></span></td>
        <td class="nump">18,636,377<span></span></td>
        <td class="num">(18,222,126)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2004</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,487,267<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">3,900,000<span></span></td>
        <td class="nump">6,494<span></span></td>
        <td class="nump">3,893,506<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">649,350<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">315,388<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">315,388<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(4,580,237)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(4,580,237)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2005</a></td>
        <td class="nump">74,275<span></span></td>
        <td class="nump">31,367<span></span></td>
        <td class="nump">22,845,271<span></span></td>
        <td class="num">(22,802,363)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2005</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,136,617<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">7,550,541<span></span></td>
        <td class="nump">8,390<span></span></td>
        <td class="nump">7,542,151<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">839,042<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">252,308<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">252,308<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(6,053,362)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(6,053,362)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2006</a></td>
        <td class="nump">1,823,762<span></span></td>
        <td class="nump">39,757<span></span></td>
        <td class="nump">30,639,730<span></span></td>
        <td class="num">(28,855,725)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2006</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,975,659<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">6,600,000<span></span></td>
        <td class="nump">7,326<span></span></td>
        <td class="nump">6,592,674<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">732,600<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued for services</a></td>
        <td class="nump">398,810<span></span></td>
        <td class="nump">664<span></span></td>
        <td class="nump">398,146<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">66,402<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">255,061<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">255,061<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,617,581)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(5,617,581)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2007</a></td>
        <td class="nump">3,460,052<span></span></td>
        <td class="nump">47,747<span></span></td>
        <td class="nump">37,885,611<span></span></td>
        <td class="num">(34,473,306)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2007</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,774,661<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">6,000,000<span></span></td>
        <td class="nump">9,990<span></span></td>
        <td class="nump">5,990,010<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">999,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">269,618<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">269,618<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(5,570,905)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(5,570,905)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2008</a></td>
        <td class="nump">4,158,765<span></span></td>
        <td class="nump">57,737<span></span></td>
        <td class="nump">44,145,239<span></span></td>
        <td class="num">(40,044,211)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2008</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,773,661<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">112,382<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">112,382<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(3,425,986)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(3,425,986)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2009</a></td>
        <td class="nump">845,161<span></span></td>
        <td class="nump">57,737<span></span></td>
        <td class="nump">44,257,621<span></span></td>
        <td class="num">(43,470,197)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2009</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,773,661<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">21,166<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">21,166<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(467,266)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(467,266)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2010</a></td>
        <td class="nump">399,061<span></span></td>
        <td class="nump">57,737<span></span></td>
        <td class="nump">44,278,787<span></span></td>
        <td class="num">(43,937,463)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,773,661<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">5,379,367<span></span></td>
        <td class="nump">78,911<span></span></td>
        <td class="nump">5,300,456<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,891,141<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">19,935<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">19,935<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense', window );">Warrant expense</a></td>
        <td class="nump">2,153,442<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,153,442<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants', window );">Fair value of derivative warrants</a></td>
        <td class="num">(3,887,850)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(3,887,850)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Beneficial conversion feature discount</a></td>
        <td class="nump">372,850<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">372,850<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(3,444,795)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(3,444,795)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2011</a></td>
        <td class="nump">992,010<span></span></td>
        <td class="nump">136,648<span></span></td>
        <td class="nump">48,237,620<span></span></td>
        <td class="num">(47,382,258)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,664,802<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of - stock</a></td>
        <td class="nump">5,129,940<span></span></td>
        <td class="nump">40,877<span></span></td>
        <td class="nump">5,089,063<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromIssuanceOfCommonStockShares', window );">Proceeds from issuance of - stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,087,747<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue', window );">Conversion of notes payable and accrued interest to stock</a></td>
        <td class="nump">981,729<span></span></td>
        <td class="nump">12,525<span></span></td>
        <td class="nump">969,204<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares', window );">Conversion of notes payable and accrued interest to stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,252,550<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SharesIssuedAtReverseMergerValue', window );">Shares issued at the reverse merger</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">23,866<span></span></td>
        <td class="num">(23,866)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SharesIssuedAtReverseMergerShares', window );">Shares issued at the reverse merger, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,386,566<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Option expense</a></td>
        <td class="nump">266,172<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">266,172<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense', window );">Warrant expense</a></td>
        <td class="nump">1,957,754<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,957,754<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants', window );">Fair value of derivative warrants</a></td>
        <td class="num">(4,052,089)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(4,052,089)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification', window );">Transfer from liability classification to equity classification</a></td>
        <td class="nump">4,231,324<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">4,231,324<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(8,361,205)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(8,361,205)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2012</a></td>
        <td class="num">$ (1,145,635)<span></span></td>
        <td class="nump">$ 213,916<span></span></td>
        <td class="nump">$ 56,675,181<span></span></td>
        <td class="num">$ (55,713,465)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, Shares at Dec. 31, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">21,391,665<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustments to additional paid in capital fair value of derivative warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdjustmentsToAdditionalPaidInCapitalFairValueOfDerivativeWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustments to additional paid in capital warrant expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdjustmentsToAdditionalPaidInCapitalWarrantExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfNotesPayableAndAccruedInterestToStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion of notes payable and accrued interest to stock, shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ConversionOfNotesPayableAndAccruedInterestToStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ConversionOfNotesPayableAndAccruedInterestToStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion of notes payable and accrued interest to stock, Value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ConversionOfNotesPayableAndAccruedInterestToStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of Transfer from liability classification to equity classification.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FairValueOfTransferFromLiabilityClassificationToEquityClassification</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedsFromIssuanceOfCommonStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of common stock shares</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ProceedsFromIssuanceOfCommonStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SharesIssuedAtReverseMergerShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Shares issued at the reverse merger shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SharesIssuedAtReverseMergerShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SharesIssuedAtReverseMergerValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Shares issued at the reverse merger value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SharesIssuedAtReverseMergerValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 51<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32707879&amp;loc=d3e34017-109320<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Beneficial Conversion Feature<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation related to stock options during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELLAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 5,650,328<span></span></td>
        <td class="nump">$ 5,618,669<span></span></td>
        <td class="nump">$ 5,703,798<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">R&amp;D reimbursement receivable</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">237,834<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">84,270<span></span></td>
        <td class="nump">167,143<span></span></td>
        <td class="nump">5,384<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">252,248<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
        <td class="nump">5,734,598<span></span></td>
        <td class="nump">5,785,812<span></span></td>
        <td class="nump">6,199,264<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,010<span></span></td>
        <td class="nump">1,233<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
        <td class="nump">5,734,598<span></span></td>
        <td class="nump">5,788,822<span></span></td>
        <td class="nump">6,200,497<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
        <td class="nump">793,630<span></span></td>
        <td class="nump">897,044<span></span></td>
        <td class="nump">644,511<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable and accrued expenses - related party</a></td>
        <td class="nump">31,185<span></span></td>
        <td class="nump">31,185<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
        <td class="nump">36,950<span></span></td>
        <td class="nump">140,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible notes payable, net of unamortized discount</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">124,363<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
        <td class="nump">2,957,977<span></span></td>
        <td class="nump">3,574,958<span></span></td>
        <td class="nump">4,439,613<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
        <td class="nump">3,819,742<span></span></td>
        <td class="nump">4,643,187<span></span></td>
        <td class="nump">5,208,487<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
        <td class="nump">3,819,742<span></span></td>
        <td class="nump">4,643,187<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
        <td class="nump">235,844<span></span></td>
        <td class="nump">213,916<span></span></td>
        <td class="nump">136,648<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">60,895,513<span></span></td>
        <td class="nump">56,675,182<span></span></td>
        <td class="nump">48,237,620<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Deficit accumulated during the development stage</a></td>
        <td class="num">(59,216,501)<span></span></td>
        <td class="num">(55,743,463)<span></span></td>
        <td class="num">(47,382,258)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
        <td class="nump">1,914,856<span></span></td>
        <td class="num">(1,145,635)<span></span></td>
        <td class="nump">992,010<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
        <td class="nump">$ 5,734,598<span></span></td>
        <td class="nump">$ 5,788,822<span></span></td>
        <td class="nump">$ 6,200,497<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsAndOtherReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.15(1),(5))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.15)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 15<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph 1, 5<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertibleNotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net amount of current deferred finance costs capitalized at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28555-108399<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredFinanceCostsCurrentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20225523&amp;loc=SL20225862-175312<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDVFK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock Option Plan (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="21">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Feb. 29, 2012

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Minimum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Minimum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>Minimum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>Minimum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006

</div>
          <div>Minimum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Maximum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Maximum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>Maximum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>Maximum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006

</div>
          <div>Maximum [Member]

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>2003 Stock Plan [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>2003 Stock Plan [Member]

</div>
          <div>Minimum [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>2003 Stock Plan [Member]

</div>
          <div>Maximum [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>2012 Employee Stock Option Plan [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionPlanTextualAbstract', window );"><strong>Stock Option Plan (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Maximum granted option to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">757,575<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment', window );">Maximum granted option after amendment in 2008</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">978,154<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award vesting period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">4 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting', window );">Share based payment award monthly vesting percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering', window );">Percentage of aggregate issued and outstanding common shares reserved under offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Stock reserved for future issuance under ESOP</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,455,776<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease', window );">Increment in number of shares under plan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,217,880<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance', window );">Total shares reserved for issuance under plan</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,155,280<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStock', window );">Stock option granted to employees to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,056,275<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">33,300<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">69,941<span></span></td>
        <td class="nump">113,220<span></span></td>
        <td class="nump">206,060<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice', window );">Stock option granted to purchase common stock, exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.90<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.90<span></span></td>
        <td class="nump">$ 1.35<span></span></td>
        <td class="nump">$ 1.35<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife', window );">Stock option granted to purchase common stock, term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of stock option</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,519,777<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 24,996<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 44,159<span></span></td>
        <td class="nump">$ 137,652<span></span></td>
        <td class="nump">$ 1,051,281<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions', window );">Discount rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.80%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2.16%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.46%<span></span></td>
        <td class="nump">3.46%<span></span></td>
        <td class="nump">4.29%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">171.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">139.00%<span></span></td>
        <td class="nump">143.00%<span></span></td>
        <td class="nump">156.00%<span></span></td>
        <td class="nump">160.44%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">161.49%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Stock option cancelled during period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,613<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Stock option forfeitures during period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(49,950)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">128,050<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_EmployeeStockOptionUnitsReprised', window );">Employee stock option units repriced</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">273,859<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption', window );">Outstanding stock option exercise price after repricing of stock option</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.28<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions', window );">Share based compensation cost after repricing of stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">34,879<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_UnrecognizedShareBasedCompensationExpense', window );">Unrecognized share based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,086,848<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,998,435<span></span></td>
        <td class="nump">14,528<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Recorded option expense</a></td>
        <td class="nump">$ 94,200<span></span></td>
        <td class="nump">$ 40,410<span></span></td>
        <td class="nump">$ 188,400<span></span></td>
        <td class="nump">$ 240,400<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 266,172<span></span></td>
        <td class="nump">$ 19,935<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_EmployeeStockOptionUnitsReprised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Employee stock option units reprised.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_EmployeeStockOptionUnitsReprised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum granted option to purchase common stock after amendment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MaximumGrantedOptionToPurchaseCommonStockAfterAmendment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Outstanding stock option exercise price after repricing of stock option.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OutstandingStockOptionExercisePriceAfterRepricingOfStockOption</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of aggregate issued and outstanding common shares reserved under offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfAggregateIssuedAndOutstandingCommonSharesReservedUnderOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation arrangement by share base payment award periodic percentage of award vesting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ShareBasedCompensationArrangementByShareBasePaymentAwardPeriodicPercentageOfAwardVesting</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ShareBasedCompensationCostAfterRepricingOfStockOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation cost after repricing of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ShareBasedCompensationCostAfterRepricingOfStockOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation share based arrangement award shares reserved for issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ShareBasedCompensationShareBasedArrangementAwardSharesReservedForIssuance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStockExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock weighted average contractual life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionPlanTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionPlanTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_UnrecognizedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized share based compensation expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_UnrecognizedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate number of common shares reserved for future issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(v)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3BAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Warrant [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="text-align: center;" colspan="2">Number of</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family:
 times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size:
 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,056,275</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.89</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%"
 valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,330,134</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0. 96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.91</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">685,800</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid; text-align: center; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new
 roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,330,134</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.91</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">685,800</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Cancellation</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(49,950</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,280,184</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.42</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,609,035</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"
 colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">12,770,636</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.97</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.48 </font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6,114,768</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants exercised</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2,211,158</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants expired</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1,023,784</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9,535,694</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.77</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.341</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9,691,302</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of property and equipment</a></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;"></td>
<td width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Lives</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2013</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Office equipment</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,274</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156,162</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Furniture and fixture</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;7 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new
 roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total property and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">158,566</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,454</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: accumulated depreciation</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Loss on disposition of equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4,122</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Property and equipment, net</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,010</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"></td>
<td valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;Lives</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Office equipment</font></div>
</td>
<td width="9%" valign="bottom">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;5 years</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156,162</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">153,804</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Furniture and fixture</font></div>
</td>
<td width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;7 years</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,292</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total property, plant and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157,454</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">155,096</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: accumulated depreciation</font></div>
</td>
<td align="left" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(154,444</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(153,863</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="67%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="67%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Property and equipment</font></div>
</td>
<td align="left" width="9%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,010</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,233</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4FAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Details 1) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Schedule of difference between the income tax provision and the U.S. Federal statutory rate</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal income taxes at 34%</a></td>
        <td class="num">$ (2,842,810)<span></span></td>
        <td class="num">$ (1,171,230)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income taxes at 34%, Percentage</a></td>
        <td class="num">(34.00%)<span></span></td>
        <td class="num">(34.00%)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation costs</a></td>
        <td class="nump">756,136<span></span></td>
        <td class="nump">736,796<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation costs, Percentage</a></td>
        <td class="nump">9.04%<span></span></td>
        <td class="nump">21.39%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in fair value of derivatives</a></td>
        <td class="nump">233,043<span></span></td>
        <td class="nump">4,748<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in fair value of derivatives, Percentage</a></td>
        <td class="nump">2.79%<span></span></td>
        <td class="nump">0.13%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization', window );">Amortization of debt discounts</a></td>
        <td class="nump">349,480<span></span></td>
        <td class="nump">56,033<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization', window );">Amortization of debt discounts, Percentage</a></td>
        <td class="nump">4.18%<span></span></td>
        <td class="nump">1.63%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Change in valuation allowance</a></td>
        <td class="nump">1,504,151<span></span></td>
        <td class="nump">373,653<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Change in valuation allowance, Percentage</a></td>
        <td class="nump">17.99%<span></span></td>
        <td class="nump">10.85%<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income tax</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision for income tax, Percentage</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity-based compensation costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EINAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="4">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Minimum [Member]

</div>
          <div>Warrant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Maximum [Member]

</div>
          <div>Warrant [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantTextualAbstract', window );"><strong>Warrant (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStock', window );">Warrant granted to Management Firm to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,716,340<span></span></td>
        <td class="nump">1,974,774<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice', window );">Warrants granted to Management Firm to purchase common stock, exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife', window );">Warrants granted to purchase common stock, term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Fair value of warrants recorded as stock-based compensation expense</a></td>
        <td class="nump">$ 94,200<span></span></td>
        <td class="nump">$ 40,410<span></span></td>
        <td class="nump">$ 188,400<span></span></td>
        <td class="nump">$ 240,400<span></span></td>
        <td class="nump">$ 1,957,754<span></span></td>
        <td class="nump">$ 2,153,442<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions', window );">Discount rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.82%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.92%<span></span></td>
        <td class="nump">3.17%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">60.64%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">64.77%<span></span></td>
        <td class="nump">70.72%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Warrants percentage of total issued and outstanding shares of capital stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStockExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStockExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock option granted to purchase common stock weighted average contractual life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StockOptionGrantedToPurchaseCommonStockWeightedAverageContractualLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(v)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EEVCK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note Payable and Convertible Notes (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="4">1 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="1">157 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jan. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 19, 2012</div>
        </th>
        <th class="th">
          <div>Oct. 23, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 28, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 27, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotePayableAndConvertibleNotesTextualAbstract', window );"><strong>Note Payable and Convertible Notes (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible promissory note amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 900,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Amount of original issue discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(150,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PremiumFinanceAgreementPrincipalAmount', window );">Premium finance agreement principal amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">140,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentUnderPremiumFinanceAgreement', window );">Payment under premium finance agreement</a></td>
        <td class="nump">28,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodicPaymentUnderPremiumFinanceAgreement', window );">Monthly amount payable under premium finance agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,636<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement', window );">Duration of periodic payments for premium finance agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">9 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PremiumFinanceAgreementOutstandingAmount', window );">Premium finance agreement outstanding amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">140,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Promissory note interest rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProceedsFromConvertibleNotes', window );">Net proceeds of promissory note</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued', window );">Percentage of principle amount in which convertible note issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">83.33%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Convertible note maturity term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">One year<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents', window );">Gross proceeds in subsequent offerings of common stock or equivalents</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeWarrantsIssuedWithConvertibleNotes', window );">Common stock issued to investors</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">287,061<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InvestmentWarrantGrantDateFairValue', window );">Investment warrant grant date fair value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">565,729<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature', window );">Beneficial conversion feature discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">372,850<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">372,850<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DebtInstrumentFairValuePerShare', window );">Convertible note fair value per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.11<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ExtendedMaturityPeriodOfConvertibleNotes', window );">Extended maturity Period of convertible notes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">90 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfExtendedMaturityDate', window );">Description of extended maturity date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Company was seeking approval to extend the note maturity date for 90 days. The Company was able to obtain approvals from all note holders and the maturity date of the notes has been extended to January 31, 2013, February 18, 2013 or March 27, 2013 for the 24 notes.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Convertible notes and the accrued interest converted into common shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">451,267<span></span></td>
        <td class="nump">775,637<span></span></td>
        <td class="nump">124,363<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">145,951<span></span></td>
        <td class="nump">252,248<span></span></td>
        <td class="nump">40,444<span></span></td>
        <td class="nump">292,692<span></span></td>
        <td class="nump">292,692<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InsurancePolicyDownPayment', window );">Down payment under insurance policy</a></td>
        <td class="nump">28,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_InsurancePolicyInstallmentPayment', window );">Premium monthly installment for nine months</a></td>
        <td class="nump">12,636<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">36,950<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">140,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">140,000<span></span></td>
        <td class="nump">36,950<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal payment of notes payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">103,050<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">103,050<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Placement Agent [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotePayableAndConvertibleNotesTextualAbstract', window );"><strong>Note Payable and Convertible Notes (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockPurchaseDueToIssuanceOfWarrants', window );">Common stock shares purchasable through warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">143,532<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price of warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.78<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Warrants expiration date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 31,
				 2019<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Convertible promissory note amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">292,691<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">292,691<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Amount of original issue discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 150,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 150,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmortizationPeriodOfNote', window );">Amortization period of note</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">One year<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Management Firm [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotePayableAndConvertibleNotesTextualAbstract', window );"><strong>Note Payable and Convertible Notes (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockPurchaseDueToIssuanceOfWarrants', window );">Common stock shares purchasable through warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">126,829<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price of warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExpirationDate', window );">Warrants expiration date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 31,
				 2019<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmortizationPeriodOfNote">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amortization period of note.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmortizationPeriodOfNote</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockPurchaseDueToIssuanceOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock shares purchase due to issuance of warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockPurchaseDueToIssuanceOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt instrument discount related to the beneficial conversion feature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DebtInstrumentDiscountRelatedToBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DebtInstrumentFairValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Debt instrument fair value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DebtInstrumentFairValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeWarrantsIssuedWithConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative warrants Issued With Convertible Notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeWarrantsIssuedWithConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfExtendedMaturityDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of extended maturity date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfExtendedMaturityDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Duration of periodic payments for premium finance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DurationOfPeriodicPaymentsForPremiumFinanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ExtendedMaturityPeriodOfConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Extended maturity Period of convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ExtendedMaturityPeriodOfConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross proceeds in subsequent offerings of common stock or equivalents.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GrossProceedsInSubsequentOfferingsOfCommonStockOrEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InsurancePolicyDownPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of down payment of insurance policy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InsurancePolicyDownPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InsurancePolicyInstallmentPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of monthly installment payment of insurance policy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InsurancePolicyInstallmentPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_InvestmentWarrantGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investment warrant grant date fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_InvestmentWarrantGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NotePayableAndConvertibleNotesTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NotePayableAndConvertibleNotesTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentUnderPremiumFinanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Payment under premium finance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PaymentUnderPremiumFinanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of principle amount in which convertible note issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfPrincipleAmountInWhichConvertibleNoteIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodicPaymentUnderPremiumFinanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Periodic amount payable under premium finance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodicPaymentUnderPremiumFinanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PremiumFinanceAgreementOutstandingAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Premium finance agreement outstanding amount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PremiumFinanceAgreementOutstandingAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PremiumFinanceAgreementPrincipalAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Premium finance agreement principal amount.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PremiumFinanceAgreementPrincipalAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProceedsFromConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from senior subordinated unsecured convertible promissory notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ProceedsFromConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price of the warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 13<br><br> -Sentence Column A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>invest_InvestmentWarrantsExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expiration date of warrants held.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 13<br><br> -Sentence Column A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>invest_InvestmentWarrantsExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfDebtDiscountPremium</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 8<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtConversionConvertedInstrumentAmount1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the total principal payments made during the annual reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentAnnualPrincipalPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The price per share of the conversion feature embedded in the debt instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentConvertibleConversionPrice1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face (par) amount of debt instrument at time of issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentFaceAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Contractual interest rate for funds borrowed, under the debt agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentInterestRateStatedPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 22<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22(a)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentMaturityDateDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentUnamortizedDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NotesPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWPFK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party Transactions (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 27, 2012</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Feb. 29, 2012

</div>
          <div>License, Development and Commercialization Agreement [Member]

</div>
          <div>Note</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012

</div>
          <div>License, Development and Commercialization Agreement [Member]

</div>
          <div>Note</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 27, 2012

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 19, 2011

</div>
          <div>SKI [Member]

</div>
          <div>License, Development and Commercialization Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010

</div>
          <div>SKI [Member]

</div>
          <div>License, Development and Commercialization Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>SKI [Member]

</div>
          <div>License, Development and Commercialization Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 21, 2012

</div>
          <div>SKI [Member]

</div>
          <div>License, Development and Commercialization Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012

</div>
          <div>Dr. Rosemary Mazanet [Member]

</div>
          <div>Consulting Services Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Dr. Rosemary Mazanet [Member]

</div>
          <div>Consulting Services Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 07, 2012

</div>
          <div>Laidlaw and Company [Member]

</div>
          <div>Engagement Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Laidlaw and Company [Member]

</div>
          <div>Engagement Agreement [Member]</div>
        </th>
        <th class="th">
          <div>May 09, 2011

</div>
          <div>Jamess Capital Group LLC [Member]

</div>
          <div>Transaction management agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Guagenti &amp; Associates LLC [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RelatedPartyTransactionsTextualAbstract', window );"><strong>Related Party Transactions (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfPatients', window );">Number of Patients enrolled</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidUnderAgreementInYearTwoThousandEleven', window );">Amount paid under agreement in 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 50,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve', window );">Amount paid under agreement in 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen', window );">Amount paid under agreement in 2013</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">250,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MaintenanceFeesAndResearchPayments', window );">Maintenance fees and research payments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidUnderAgreement', window );">Amount paid under agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AdditionalAmountDueUnderAgreement', window );">Additional amount due under agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">150,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfConditionForTerminationOfForbearancePeriod', window );">Condition for termination of forbearance period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The forbearance period terminated on October 30, 2011, when the Company satisfied a financing condition to the termination of the forbearance period by raising in excess of $3,000.000 in new equity financing.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TerminationDateOfForbearanceAgreement', window );">Termination date of forbearance agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Oct. 30,
				 2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Oct. 30,
				 2011<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod', window );">Minimum new equity financing needed under condition for termination forbearance period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,000.000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ForgivenAmountOfObligations', window );">Forgiven amount of obligations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">360,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty', window );">Research and development reimbursement payments received from MSKCC</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">237,834<span></span></td>
        <td class="nump">299,200<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Net receivable from MSKCC</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">237,834<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidToEachPatient', window );">Amount paid to each patient after Completing clinical trial</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,185<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StartUpFeeForClinicalTrial', window );">Start-up fee for clinical trial</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,623<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StartUpDueCostPaidDate', window );">Due date of start-up fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jul. 10,
				 2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Officers' Compensation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OptionExercisePriceRange', window );">Option Exercise Price Range</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">0.78 to 1.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Term of options</a></td>
        <td class="text">6 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">4 years 6 months<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_OptionsReceivedToPurchaseCommonStock', window );">Options received to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">99,900<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfReceivablesOfPlacementAgentForServices', window );">Description of receivables of placement agent for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Placement agent will receive (a) a cash fee equal to 10% of the gross proceeds raised in the 2012 Common Stock Offering, (b) a non-accountable expense reimbursement equal to 2% of the gross proceeds raised in the 2012 Common Stock Offering, and (c) reimbursement of $100,000 for legal expenses incurred by the placement agent.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfWarrantsReceivablesByPlacement', window );">Description of warrants receivables by placement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The placement agent or its designees have also received warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued as part of the units sold in the 2012 Common Stock Offering and the shares of Common Stock issuable upon exercise of the B warrants included in such units.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodOfExerciseOfWarrants', window );">Period of exercise of warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Within 6 months of the final closing of the 2012 common stock Offering.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfSolicitationFee', window );">Percentage of solicitation fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodicFeeForFinancialAdvisoryServices', window );">Monthly fee for financial advisory services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfAdditionalReceivableByPlacementAgent', window );">Description of additional receivable by placement agent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The agreement also provides that (i) if the Company consummates any merger, acquisition, business combination or other transaction (other than the Share Exchange) with any party introduced to it by the placement agent, the placement agent would receive a fee equal to 10% of the aggregate consideration in such transactions, and (ii) if, within a period of 12 months after termination of the advisory services described above, the Company requires a financing or similar advisory transaction the placement agent will have the right to act as the Company's financial advisor and investment banker in such financing or transaction pursuant to a set fee schedule set forth in the August 7, 2012 engagement agreement.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommonStockPurchaseByHoldingOfWarrant', window );">Warrant held by placement agent to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,251,015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodicFeeReceivedByManagementFirm', window );">Monthly fee received by management firm</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock', window );">Percentage of fully diluted capital stock equal to common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MaximumAmountOfOutOfPocketExpenses', window );">Maximum amount of out of pocket expenses</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodicAmountOfRent', window );">Operating lease monthly amount of rent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">300<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidToPursuantLeaseAgreement', window );">Amount paid to pursuant lease agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 7,200<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AdditionalAmountDueUnderAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Additional amount due under agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AdditionalAmountDueUnderAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidToEachPatient">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount to be paid for each Patient that has completed the clinical trial.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidToEachPatient</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidToPursuantLeaseAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid to pursuant lease agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidToPursuantLeaseAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidUnderAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid under agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidUnderAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidUnderAgreementInYearTwoThousandEleven">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid under agreement in year two thousand eleven.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidUnderAgreementInYearTwoThousandEleven</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidUnderAgreementInYearTwoThousandThirteen">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid under agreement in year two thousand thirteen.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidUnderAgreementInYearTwoThousandThirteen</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidUnderAgreementInYearTwoThousandTwelve">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount paid under agreement in year two thousand twelve.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidUnderAgreementInYearTwoThousandTwelve</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommonStockPurchaseByHoldingOfWarrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common stock purchase by holding of warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommonStockPurchaseByHoldingOfWarrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfAdditionalReceivableByPlacementAgent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of additional receivable by placement agent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfAdditionalReceivableByPlacementAgent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfConditionForTerminationOfForbearancePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of condition for termination of forbearance period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfConditionForTerminationOfForbearancePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfReceivablesOfPlacementAgentForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of receivables of placement agent for services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfReceivablesOfPlacementAgentForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfWarrantsReceivablesByPlacement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of warrants receivables by placement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfWarrantsReceivablesByPlacement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ForgivenAmountOfObligations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Forgiven amount of obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ForgivenAmountOfObligations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MaintenanceFeesAndResearchPayments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maintenance fees and research payments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MaintenanceFeesAndResearchPayments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MaximumAmountOfOutOfPocketExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum amount of out of pocket expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MaximumAmountOfOutOfPocketExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Minimum new Equity Financing needed under condition for termination Forbearance period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MinimumNewEquityFinancingNeededUnderConditionForTerminationForbearancePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfPatients">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of patients.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfPatients</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OptionExercisePriceRange">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Option exercise price range.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OptionExercisePriceRange</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_OptionsReceivedToPurchaseCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Options received to purchase common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_OptionsReceivedToPurchaseCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of fully diluted capital stock equal to common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfSolicitationFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of solicitation fee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfSolicitationFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodicAmountOfRent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Periodic amount of rent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodicAmountOfRent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodicFeeForFinancialAdvisoryServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Periodic fee for financial advisory services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodicFeeForFinancialAdvisoryServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodicFeeReceivedByManagementFirm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Periodic fee received by management firm.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodicFeeReceivedByManagementFirm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodOfExerciseOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period of exercise of warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodOfExerciseOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RelatedPartyTransactionsTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_RelatedPartyTransactionsTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research and development prepayments amount received by related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ResearchAndDevelopmentPrepaymentsAmountReceivedByRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StartUpDueCostPaidDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Start-up due cost paid date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StartUpDueCostPaidDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StartUpFeeForClinicalTrial">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Start-up fee for clinical trial.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StartUpFeeForClinicalTrial</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TerminationDateOfForbearanceAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Termination date of forbearance agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_TerminationDateOfForbearanceAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 3<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph k<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.3(a)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExpectedTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expenditures for salaries of officers. Does not include allocated share-based compensation, pension and post-retirement benefit expense or other labor-related non-salary expense. For commercial and industrial companies, excludes any direct and overhead labor that is included in cost of goods sold.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OfficersCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2UAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Summary of property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
        <td class="nump">$ 158,566<span></span></td>
        <td class="nump">$ 157,454<span></span></td>
        <td class="nump">$ 155,096<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">(Less) Accumulated depreciation</a></td>
        <td class="num">(154,444)<span></span></td>
        <td class="num">(154,444)<span></span></td>
        <td class="num">(153,863)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LossOnDispositionOfPropertyAndEquipment', window );">Loss on disposition of equipment</a></td>
        <td class="num">(4,122)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,010<span></span></td>
        <td class="nump">1,233<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Summary of property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
        <td class="nump">157,274<span></span></td>
        <td class="nump">156,162<span></span></td>
        <td class="nump">153,804<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Furniture and fixtures [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Summary of property and equipment</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
        <td class="text">7 years<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
        <td class="nump">$ 1,292<span></span></td>
        <td class="nump">$ 1,292<span></span></td>
        <td class="nump">$ 1,292<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LossOnDispositionOfPropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Loss on disposition of property and equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_LossOnDispositionOfPropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 7 &#8211; Income Taxes</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities at December 31, 2012 and 2011 are as follows:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Deferred tax assets:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Net operating losses</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,609,036</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,089,314</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Share-based compensation</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,497,556</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">741,420</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Other differences in tax basis</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">233,043</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,749</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total deferred tax assets</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">15,339,635</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">13,835,483</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Less: valuation allowance</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(15,339,635</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">(13,835,483</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Deferred tax assets, net</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; As of December 31, 2012, for U.S. federal income tax reporting purposes, the Company has approximately $43 million of unused net operating losses (&#8220;NOLs&#8221;) available for carry forward to future years. The benefit from the carry forward of such NOLs will begin expiring during the year ended December 31, 2020. Because United States tax laws limit the time during which NOL carry forwards may be applied against future taxable income, the Company may be unable to take full advantage of its NOL for federal income tax purposes should the Company generate taxable income. Further, the benefit from utilization of NOLs carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; The difference between the income tax provision and the amount that would result if the U.S. Federal statutory rate of 34% were applied to pre-tax income (loss) for the years ended December 31, 2012 and 2011 are as follows:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="14">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">For the years ended</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;
 </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="6">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="6">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Federal income taxes at 34%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2,842,810</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-34.00</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1,171,230</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-34.00</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Share-based compensation costs</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;
 </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">756,136</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9.04</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">736,796</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">21.39</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value of derivatives</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">233,043</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2.79</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,748</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.13</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Amortization of debt discounts</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">349,480</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.18</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">56,033</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.63</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in valuation allowance</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,504,151</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">17.99</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">373,653</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">10.85</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left"
 width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Provision for income tax</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ScheduleOfWarrantsIssuedTableTextBlock', window );">Summary of warrant issued</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">During the year ended December 31, 2011, the Company also issued the following warrants:</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with convertible notes (See Note 5)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">287,061</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Stock Offering (See Note 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,972,766</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Convertible Notes</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">143,532</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">986,383</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,389,742</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During the year ended December 31, 2012, the Company also issued the following warrants:</font></div>
<div align="justify" style="margin-left: 27pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Stock Offering (See Note 6)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">242,189</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with Common Stock</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,678,491</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of:</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;Stock Offering (See Note 6 and Note 9)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">121,094</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;&#160;2012 Common Stock Offering</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">467,845</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued to investors with stock &#8211; accrued dividend</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%"
 valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">180,115&#160;</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="88%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,689,734</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_SummaryOfWarrantActivitiesTableTextBlock', window );">Summary of warrant activities</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="text-align: center;" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times
 new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left"
 width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,364,557</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.51</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6.76</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,364,557</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6.76</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,261,367</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7,406,079</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.32</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3.76</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">12,770,636</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0. 97</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.48</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6,114,768</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ScheduleOfWarrantsIssuedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrant issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ScheduleOfWarrantsIssuedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_SummaryOfWarrantActivitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Summary of warrant activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_SummaryOfWarrantActivitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHZAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Derivatives (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 19, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 27, 2012</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeTextualAbstract', window );"><strong>Derivative (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfRiskFreeInterestRateDetermination', window );">Description of risk free interest rate determination</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfProbabilityOfStockOffering', window );">Description of probability of stock offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Probability of a stock offering is 25% for each quarter of the next five years.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RangeOfPercentageOfExistingSharesOffered', window );">Range of percentage of existing shares offered</a></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series E Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DerivativeTextualAbstract', window );"><strong>Derivative (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price of warrant</a></td>
        <td class="nump">$ 0.26<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DerivativeTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DerivativeTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfProbabilityOfStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of probability of stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfProbabilityOfStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfRiskFreeInterestRateDetermination">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of risk free interest rate determination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfRiskFreeInterestRateDetermination</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RangeOfPercentageOfExistingSharesOffered">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Range of percentage of existing shares offered.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_RangeOfPercentageOfExistingSharesOffered</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price of the warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 13<br><br> -Sentence Column A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>invest_InvestmentWarrantsExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock Option Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Option Plan</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 10 &#8211; Stock Option Plan</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company has adopted a 2003 Stock Plan under which it may grant up to 757,575 options to purchase common stock. The 2003 Stock Plan was amended in 2008 to increase the number of shares that it may grant up to 978,154. Option awards are generally granted with an exercise price equal to the market price of the Company&#8217;s stock at the date of the grant. However, since the Company is not publicly traded, the fair market value of the stock represents the Board of Directors&#8217; best estimate, based on the information available, on the date of the grant. The awards generally vest over a four or five year period at a rate of approximately 2% per month.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In 2011, the 2003 Stock Plan was amended to increase the number of shares by 3,217,880.&#160;&#160;Total shares reserved for issuance under the Plan will be increased to 6,155,280.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In accordance with the terms of the 2012 Common Stock Offering, the Company adopted a 2012 Employee Stock Option Plan (&#8220;2012 ESOP&#8221;) and reserved 15% of the total issued and outstanding shares as of the final closing of the 2012 Common Stock Offering.&#160;&#160;Total shares reserved for issuance under the 2012 ESOP was 9,455,776 shares.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2006, options to purchase 206,060 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $1,051,281 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 4.29% (2) expected life of 5 years, (3) expected volatility of 156%, and (4) zero expected dividends.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2007, options to purchase 113,220 shares of common stock were granted to several employees at an exercise price of $1.35 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $137,652 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 143%, and (4) zero expected dividends.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2008, options to purchase 69,941 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $44,159 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 3.46% (2) expected life of 5 years, (3) expected volatility of 139%, and (4) zero expected dividends.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2009, 20,613 options to one employee were cancelled as the result of termination of the employment and 128,050 options to one employee were forfeited as the employee deceased during the year.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the year of 2010, options to purchase 33,300 shares of common stock were granted to an employee at an exercise price of $0.90 per share. These options have a term of 10 years and vest over a 4-5 year period. Fair value of $24,996 was calculated using the Black-Scholes option-pricing
 model. Variables used in the Black-Scholes option-pricing model include (1) discount rate of 2.16% (2) expected life of 5 years, (3) expected volatility of 171%, and (4) zero expected dividends.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; In February 2012, the Company re-priced 273,859 units of employee stock options to reflect the current per share fair market value of the Company&#8217;s common stock. The exercise prices of all of the current outstanding stock options were reduced to $1.28 per share. The Company recorded an incremental compensation cost of $34,879 as a result of the re-pricing of options.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During 2012, options to purchase 2,056,275 shares of common stock were issued to several employees and consultants at an exercise price ranging from $0.78 to $1.5 per share.&#160;&#160;These options have a term of 10 years and vest over a 4 year period. The fair value of $1,519,777 was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 1.8% (2) expected life of 7 years, (3) expected volatility of 160.44% &#126; 162.49%, and (4) zero expected dividends.</font></div>
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; The following is a summary of stock option activities for the years ended December 31, 2012 and 2011:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="text-align: center;" colspan="2">Number of</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2010</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"
 style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">273,859</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.29</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.51</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Granted</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">2,056,275</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.89</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,330,134</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0. 96</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.91</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="padding-bottom: 4px;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">685,800</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160; All options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at December 31, 2012 and 2011 were $1,998,435 and $14,528, respectively. During the years ended December 31, 2012 and 2011, the Company recorded option expense of $266,172 and $19,935, respectively.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Derivatives<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivatives [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 5 &#8211; Derivatives</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&#8217;s common stock at prices below such warrants&#8217; respective exercise prices and these provisions could result in modification of the warrants&#8217; exercise price based on a variable that is not an input to the fair value of a &#8220;fixed-for-fixed&#8221; option as defined under FASB ASC Topic No. 815 &#8211; 40. The warrants granted in connection with the issuance of the Company&#8217;s Stock Offering and 2012 Common Stock Offering, the Convertible Notes (previously issued and converted) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &#8220;Lower Price&#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Activities for derivative warrant instruments during the six months ended June 30, 2013 were as follows:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="border-bottom: black 2px solid; text-align: center;" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Fair Value</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,146,338</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new
 roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Reclassification to paid in capital</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3,122,821</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(590,217</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(26,764</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td
 align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, June 30, 2013</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,023,517</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at June 30, 2013 and December 31, 2012.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">June 30,</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2013</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="10%" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Market value of common stock on measurement date (1)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.17</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Adjusted exercise price</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.48 - $0.81</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.50 - $2.475</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Risk free interest rate (2)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10 - $0.77</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.05</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrant lives in years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="text-align: center;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td width="10%" valign="bottom" style="text-align: center;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.5 years</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected volatility (3)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">154</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected dividend yield (4)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The risk-free interest rate was determined by management using the Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3)&#160;&#160;</font></div>
</td>
<td width="95%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr>
<tr>
<td align="left" width="5%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="95%" valign="top"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" width="5%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4)&#160;&#160;</font></div>
</td>
<td align="left" width="95%" valign="top">
<div
 align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 6 &#8211; Derivatives</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; The Company has determined that certain warrants the Company has issued contain provisions that protect holders from future issuances of the Company&#8217;s common stock at prices below such warrants&#8217; respective exercise prices and these provisions could result in modification of the warrants&#8217; exercise price based on a variable that is not an input to the fair value of a &#8220;fixed-for-fixed&#8221; option as defined under FASB ASC Topic No. 815 &#8211; 40. The warrants granted in connection with the issuance of the Company&#8217;s Stock Offering and 2012 Common Stock Offering&#160;(See Note 9), the Convertible Notes (See Note 5) and the placement agent warrants contain anti-dilution provisions that provide for a reduction in the exercise price of such warrants in the event that future common stock (or securities convertible into or exercisable for common stock) is issued (or becomes contractually issuable) at a price per share (a &#8220;Lower Price&#8221;) that is less than the exercise price of such warrant at the time. The amount of any such adjustment is determined in accordance with the provisions of the warrant agreement and depends upon the number of shares of common stock issued (or deemed issued) at the Lower Price and the extent to which the Lower Price is less than the exercise price of the warrant at the time.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;<font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; Activities for derivative warrant instruments during the years ended December 31, 2012 and 2011 were as follows:</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Fair Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2010</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div
 align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">287,061</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">377,150</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of Convertible Notes (See Note 5)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">143,532</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">188,579</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,972,785</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,591,900</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to issuance of stock (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">986,393</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,295,950</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%"
 valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(13,966</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,389,771</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt;
 text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">242,190</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">318,087</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">121,095</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">159,044</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with 2012 Common Stock Offering-A (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,118,988</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,409,554</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants issued with 2012 Common Stock Offering-B (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,559,505</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,665,697</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Placement agent warrants related to 2012 Common Stock Offering (See Note 9)</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">467,845</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">499,707</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Transfer from liability classification to equity classification</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3,753,056</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4,231,324</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Change in fair value</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 2px solid;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 2px solid;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(685,420</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 2px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom" style="padding-bottom: 4px;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Balance, December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5,146,338</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom" style="border-bottom: black 4px double;">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;$</font></div>
</td>
<td align="right" width="9%" valign="bottom" style="border-bottom: black 4px double;">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom" style="padding-bottom: 4px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 19, 2012, as the result of the Share Exchange, it was determined that the floor for resetting the exercise price was met and the exercise price of the certain warrants was set to be $0.26 (before Exchange Ratio adjustment).&#160;Therefore, these warrants were considered indexed to the Company&#8217;s stock and qualified for the scope exception under FASB ASC 815-10 allowing for a transfer from liability classification to equity classification.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The fair values of the warrants issued in the Company&#8217;s stock and Convertible Notes Offering and the warrants issued to the Company&#8217;s placement agent were recognized as derivative warrant instruments at issuance and are measured at fair value at each reporting period. The Company determined the fair values of these warrants using a modified binomial valuation model.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The fair values of the derivative warrants were calculated using a modified binomial valuation model with the following assumptions at each balance sheet date, the transfer date on December 19, 2012, and the date for the new grants in January and December 2012. (The market value of common stock, adjusted exercise price and offering price presented does not reflect the impact of the Share Exchange.)</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">January 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 19,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 27,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">December 31,</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times
 new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="padding-bottom: 2px; text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Market value of common stock on measurement date (1)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.37</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.37</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.39</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Adjusted exercise price</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.24 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.23 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.41 - $0.83</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.22 - $0.26</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.41 - $0.83</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Risk free interest rate (2)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.24</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10% - 0.77</font></td>
<td width="1%"
 nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.94</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.10% - 0.77</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrant lives in years</font></div>
</td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">7 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6 years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td nowrap="nowrap" valign="bottom" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4 months/5years</font></div>
</td>
<td nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected volatility (3)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">156</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">157</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">125% - 161</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Expected dividend yield (4)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Probability of stock offering in any period over 5 years (5)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman;
 display: inline;">25</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Range of percentage of existing shares offered (6)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">35</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">%</font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="40%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Offering price range (7)</font></div>
</td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.18 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.13 - $0.56</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.01 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.12 - $0.60</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td width="1%" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></td>
<td width="9%" valign="bottom" style="text-align: right;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.01 - $0.55</font></td>
<td width="1%" nowrap="nowrap" valign="bottom" style="text-align: left;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div>
<table
 style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="3%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1)&#160;&#160;</font></div>
</td>
<td width="80%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The market value of common stock is based on an enterprise valuation.</font></div>
</td>
</tr>
</table>
</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2)&#160;&#160;</font></div>
</td>
<td align="left" width="96%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The risk-free interest rate was determined by management using the average of 5 and 7 year and the 3-month Treasury Bill as of the respective measurement date.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(3)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Because the Company does not have adequate trading history to determine its historical trading volatility, the volatility factor was estimated by management using the historical volatilities of comparable companies in the same industry and region.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(4)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management determined the dividend yield to be 0% based upon its expectation that it will not pay dividends for the foreseeable future.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(5)&#160;&#160;</font></div>
</td>
<td align="left" width="96%" valign="top">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management has determined that the probability of a stock offering is 25% for each quarter of the next five years.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(6)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Management estimates that the range of percentages of existing shares offered in each stock offering will be between 35% of the shares outstanding.</font></div>
</td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="right" width="4%" valign="top">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(7)&#160;&#160;</font></div>
</td>
<td width="96%" valign="top">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Represents the estimated offering price range in future offerings as determined by management.</font></div>
</td>
</tr>
</table>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4K<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5708775-113959<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4B<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624163-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(n))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4J<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5708773-113959<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 25<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41635-113959<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4H<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624258-113959<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7668309&amp;loc=d3e80748-113994<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4E<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624181-113959<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7668309&amp;loc=d3e80784-113994<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41620-113959<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4D<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624177-113959<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579245-113959<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1B<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5580258-113959<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579240-113959<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41641-113959<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41638-113959<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5624171-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Description Of Business and Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Description of Business and Summary of Significant Accounting Policies</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Nature of Business &#8211;</font> Actinium Pharmaceuticals, Inc. formerly known as Cactus Ventures, Inc. (the &#8220;Company&#8221;, &#8220;Actinium&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that&#160;was in the market for a merger with an appropriate operating company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;API&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange closed on December 28, 2012.&#160;&#160;As a result of the Share Exchange, the former shareholders of API became the controlling shareholders of the Company. At the closing, each API shareholder received 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Actinium common stock for each API share exchanged. At the closing, all of the API shareholders&#8217; options and warrants to purchase API common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Actinium common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein API is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; API, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. API, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;API&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, API launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. API&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of API&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that API&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through API, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On March 20, 2013, in anticipation of the Company changing its name to Actinium Pharmaceuticals, Inc. and its domicile from Nevada to Delaware, the Company&#8217;s subsidiary, Actinium Pharmaceuticals, Inc., changed its name to Actinium Corporation.&#160;&#160;On April 11, 2013, the Company changed its domicile from the State of Nevada to the State of Delaware and changed its name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Basis of Presentation - Unaudited Interim Financial Information &#8211;</font> The accompanying unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary&#160;for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2012 and notes thereto contained in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2012, as filed with the SEC March 29, 2013.</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At June 30, 2013 and December 31, 2012, all of the Company&#8217;s cash was deposited in one bank.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>
</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of June 30, 2013 and December 31. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At June 30, 2013</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%"
 valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and
 development costs.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been antidilutive. For the six months ended June 30, 2013, potentially issuable shares included stock options to purchase 2,280,184 shares and warrants to purchase 9,535,694 shares of the Company&#8217;s common stock. For the six months ended June 30, 2012, potentially issuable shares includes options and warrants&#160;to purchase 6,842,528 shares of the Company&#8217;s common stock and notes payable convertible to 815,275 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160; &#160;<font style="font-weight: bold; display: inline;">Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events through the date the consolidated financial statements were issued for subsequent event disclosure consideration.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 1 &#8211; Description of Business and Summary of Significant Accounting Policies</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Nature of Business &#8211; Actinium Pharmaceuticals, Inc (Formerly</font> Cactus Ventures, Inc.) (the &#8220;Company&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;Actinium&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012 when shareholders representing over 20% of the issued and outstanding shares of Actinium had finished the exchange process.&#160;&#160;On August 22, 2013, shareholders representing 38% of the issued and outstanding shares of Actinium completed the exchange.&#160;&#160;As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. At the closing, each Actinium shareholder shall receive 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Cactus common stock for each Actinium share exchanged. At the closing, all of the Actinium shareholders&#8217; options and warrants to purchase Actinium common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Cactus common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;Actinium&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &#160;Actinium&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font
  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At December 31, 2012 and 2011, all of the Company&#8217;s cash was deposited in one bank.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;<font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div
 style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of December 31, 2012 and 2011. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font
 style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160; Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been anti dilutive. For the year ended December 31, 2012, potentially issuable shares included stock options to purchase 2,330,134 shares and warrants to purchase 12,770,596 shares of the Company&#8217;s common stock. For the year ended December 31, 2011, potentially issuable shares includes options and warrants&#160;to purchase 273,859 shares of the Company&#8217;s common stock and notes payable convertible to 3,448,276 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent:
 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events from January 1, 2013 through March 15, 2013.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EINAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedAbstract', window );"><strong>Summary of warrant issued</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedWithConvertibleNotes', window );">Warrants issued with convertible notes (See Note 5)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">287,061<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedToInvestorsWithStockOffering', window );">Warrants issued to investors with Stock Offering (See Note 6 and Note 9)</a></td>
        <td class="nump">242,189<span></span></td>
        <td class="nump">1,972,766<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssuedToInvestorsWithCommonStock', window );">Warrants issued to investors with Common Stock</a></td>
        <td class="nump">4,678,491<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes', window );">Placement agent warrants related to issuance of Convertible Notes</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">143,532<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering', window );">Placement agent warrants related to issuance of Stock Offering (See Note 6 and Note 9)</a></td>
        <td class="nump">121,094<span></span></td>
        <td class="nump">986,383<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock', window );">Placement agent warrants related to issuance of 2012 Common Stock Offering</a></td>
        <td class="nump">467,845<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantIssuedToInvestorsWithStockAccruedDividend', window );">Warrant issued to investors with stock - accrued dividend</a></td>
        <td class="nump">180,115<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantsIssued', window );">Total</a></td>
        <td class="nump">5,689,734<span></span></td>
        <td class="nump">3,389,742<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent warrants related to issuance of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentWarrantsRelatedToIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent warrants related to issuance of convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentWarrantsRelatedToIssuanceOfConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Placement agent warrants related to issuance of stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PlacementAgentWarrantsRelatedToIssuanceOfStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantIssuedToInvestorsWithStockAccruedDividend">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant issued to investors with stock accrued dividend.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantIssuedToInvestorsWithStockAccruedDividend</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants issued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedToInvestorsWithCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants issued to investors with common Stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedToInvestorsWithCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedToInvestorsWithStockOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants issued to investors with Stock offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedToInvestorsWithStockOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantsIssuedWithConvertibleNotes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants issued with convertible notes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantsIssuedWithConvertibleNotes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4APM">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Details Textual) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="3">0 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="2"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Aug. 31, 2012</div>
        </th>
        <th class="th">
          <div>Aug. 01, 2012

</div>
          <div>Rental Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Rental Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>Product Development and Patent License Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>Product Development and Patent License Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>After First Net Sales [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>After First Net Sales [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>After First Net Sales [Member]

</div>
          <div>Product Development and Patent License Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>After First Net Sales [Member]

</div>
          <div>Product Development and Patent License Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>Phase I Clinical Trial of a licensed product [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>Phase I Clinical Trial of a licensed product [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Abbott Biotherapeutics Corp [Member]

</div>
          <div>Phase I Clinical Trial of a licensed product [Member]

</div>
          <div>Product Development and Patent License Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 29, 2012

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>License agreement [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2002

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>License agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>License agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>License agreement [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 27, 2012

</div>
          <div>Memorial Sloan Kettering Cancer Center [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Oak Ridge National Laboratory [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Oak Ridge National Laboratory [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 06, 2012

</div>
          <div>Aptiv Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 06, 2012

</div>
          <div>Aptiv Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Aptiv Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Aptiv Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007

</div>
          <div>Aptiv Solutions [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 12, 2013

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 15, 2012

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 15, 2012

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 15, 2012

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]

</div>
          <div>Maximum [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 15, 2012

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>license and sponsored research agreement [Member]

</div>
          <div>Minimum [Member]</div>
        </th>
        <th class="th">
          <div>Jul. 19, 2012

</div>
          <div>Fred Hutchinson Cancer Research Center [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 28, 2012

</div>
          <div>University of Texas M.D. Anderson Cancer Center [Member]

</div>
          <div>Clinical Trial Agreement [Member]

</div>
          <div>Note</div>
        </th>
        <th class="th">
          <div>Aug. 28, 2012

</div>
          <div>University of Texas M.D. Anderson Cancer Center [Member]

</div>
          <div>Clinical Trial Agreement [Member]

</div>
          <div>Note</div>
        </th>
        <th class="th">
          <div>Sep. 26, 2012

</div>
          <div>Johns Hopkins University [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 26, 2012

</div>
          <div>Johns Hopkins University [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Nov. 21, 2012

</div>
          <div>University of Pennsylvania [Member]

</div>
          <div>Clinical Trial Agreement [Member]</div>
        </th>
        <th class="th">
          <div>May 09, 2011

</div>
          <div>Jamess Capital Group LLC [Member]

</div>
          <div>Transaction management agreement [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013

</div>
          <div>Former CEO [Member]

</div>
          <div>Separation and Settlement Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2013

</div>
          <div>Former CEO [Member]

</div>
          <div>Separation and Settlement Agreement [Member]

</div>
          <div>Note</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Former CEO [Member]

</div>
          <div>Separation and Settlement Agreement [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CommitmentsAndContingenciesTextualAbstract', window );"><strong>Commitments and Contingencies (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentOfLicenseFee', window );">License fee payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 3,000,000<span></span></td>
        <td class="nump">$ 3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_LongTermPurchaseCommitmentMilestonesPayment', window );">Milestones payments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,750,000<span></span></td>
        <td class="nump">7,750,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Net sales in milestones payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="nump">1,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MilestonePaymentDate', window );">Milestone payment date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jan. 31,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jul. 24,
				 2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfRoyaltyPaymentToRelatedParty', window );">Description of royalty payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">We agreed to pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of up to 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.<span></span></td>
        <td class="text">Company shall pay to Abbott Biotherapeutics Corp on a country-by-country basis a royalty of 12% of net sales of all licensed products until the later of: (1) 12.5 years after the first commercial sale, or (2) when the patents expire.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">We agrees to pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.<span></span></td>
        <td class="text">Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Royalty payments of 2% of net sales will be due to FHCRC.<span></span></td>
        <td class="text">Royalty payments of 2% of net sales will be due to FHCRC.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_RoyaltyOfNetSalesPercentage', window );">Royalty of Net Sales Percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FirstCommercialSalePeriod', window );">First commercial sale period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">12 years 6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TechnologyServicesCosts', window );">Technology access fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaintenanceCosts', window );">Annual maintenance fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ResearchAndDevelopmentArrangement', window );">Annual research funding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="nump">50,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PurchaseOfRadioactiveMaterial', window );">Purchase of radioactive material used for research and development</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">337,500<span></span></td>
        <td class="nump">233,100<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ProjectEstimatedCost', window );">Project estimated cost for clinical trials of drug Ac-225-HuM195</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,997,732<span></span></td>
        <td class="nump">1,859,333<span></span></td>
        <td class="nump">1,859,333<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DownPaymentOfProjectEstimatedCostPercentage', window );">Down payment of project estimated cost percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12.50%<span></span></td>
        <td class="nump">12.50%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DownPaymentForProject', window );">Down payment for project</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,173,955<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">239,000<span></span></td>
        <td class="nump">239,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration', window );">Clinical trial cost for approval of food and drug administration</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">23,500,000<span></span></td>
        <td class="nump">13,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear', window );">Fund for Fred Hutchinson Cancer Research Center lab ( Per year for the first two years )</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">150,000<span></span></td>
        <td class="nump">150,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_FundToRelatedPartyUnderAgreementAfterYearTwo', window );">Fund for Fred Hutchinson Cancer Research Center lab ( thereafter )</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">250,000<span></span></td>
        <td class="nump">250,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty payment for the commercial use of drugs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">37,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfPatients', window );">Number of Patients</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">24<span></span></td>
        <td class="nump">24<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPaidToEachPatient', window );">Amount paid to each patient after Completing clinical trial</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,185<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,366<span></span></td>
        <td class="nump">481,204<span></span></td>
        <td class="nump">481,204<span></span></td>
        <td class="nump">38,501<span></span></td>
        <td class="nump">38,501<span></span></td>
        <td class="nump">31,771<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StartUpFeeForClinicalTrial', window );">Start-up fee for clinical trial</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,623<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,749<span></span></td>
        <td class="nump">33,946<span></span></td>
        <td class="nump">33,946<span></span></td>
        <td class="nump">22,847<span></span></td>
        <td class="nump">22,847<span></span></td>
        <td class="nump">16,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_StartUpDueCostPaidDate', window );">Start-up due cost paid date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jul. 10,
				 2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jun. 30,
				 2013<span></span></td>
        <td class="text">Jun. 30,
				 2013<span></span></td>
        <td class="text">Jun. 30,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PeriodicFeeReceivedByManagementFirm', window );">Monthly fee received by management firm</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock', window );">Percentage of fully diluted capital stock equal to common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_WarrantExercisableNoticePeriodDescription', window );">Warrant exercisable notice period description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The warrants contain a provision wherein the holder may waive the 90 day exercise notice requirement by giving 65 days prior notice of such waiver.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant', window );">Description of period of shares availability by exercise of warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The shares available by exercise of this Warrant are also restricted and may not be sold or otherwise transfered until the earlier of twelve months from the closing date of the Pubco Transaction; or for six months after the planned Registration Statement is declared effective.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_MaximumAmountOfOutOfPocketExpenses', window );">Maximum amount of out of pocket expenses</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NonRefundableInstitutionalFee', window );">Non - refundable institutional fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,500<span></span></td>
        <td class="nump">14,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PharmacyFee', window );">Annual pharmacy fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,025<span></span></td>
        <td class="nump">2,025<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmendmentProcessingFee', window );">Amendment processing fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500<span></span></td>
        <td class="nump">500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AmountPayableInInstallmentsUnderAgreement', window );">Amount payable in installments under agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">250,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NumberOfInstallments', window );">Number Of Installments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PerformanceBonusPayableUnderAgreementForService', window );">Performance bonus payable under agreement for service</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">60,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_AgreementRenewalDescription', window );">Rental agreement renewal description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The agreement automatically renews on a month-to-month basis and requires a two month notice of termination.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentOfFirstInstallmentForServicesByCompany', window );">Payment of first installment for services by company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">125,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentOfFinalInstallmentForServicesByCompany', window );">Outstanding payment of final installment for services by company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">125,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_PaymentOfPerformanceBonusForServicesByCompany', window );">Payment of performance bonus for services by company</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 60,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Rent agreement termination date</a></td>
        <td class="text">Jan. 31,
				 2013<span></span></td>
        <td class="text">Jan. 31,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NoticePeriodForTerminationOfAgreement', window );">Notice period for termination of agreement</a></td>
        <td class="text">60 days prior to January 1, 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The agreement terminated May 31, 2013.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AgreementRenewalDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description regarding renewal of agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AgreementRenewalDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmendmentProcessingFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amendment processing fee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmendmentProcessingFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPaidToEachPatient">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount to be paid for each Patient that has completed the clinical trial.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPaidToEachPatient</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_AmountPayableInInstallmentsUnderAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount payable in installments under agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_AmountPayableInInstallmentsUnderAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Clinical trial cost for approval of food and drug administration.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ClinicalTrialCostForApprovalForFoodAndDrugAdministration</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CommitmentsAndContingenciesTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_CommitmentsAndContingenciesTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfRoyaltyPaymentToRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of royalty payment to related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfRoyaltyPaymentToRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of shares availability by exercise of warrant.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DescriptionOfSharesAvailabilityByExerciseOfWarrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DownPaymentForProject">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Down payment for project.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DownPaymentForProject</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DownPaymentOfProjectEstimatedCostPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of total estimated project cost required for down payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DownPaymentOfProjectEstimatedCostPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FirstCommercialSalePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>First commercial sale period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FirstCommercialSalePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FundToRelatedPartyUnderAgreementAfterYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fund to related party under agreement after year two.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FundToRelatedPartyUnderAgreementAfterYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_FundToRelatedPartyUnderAgreementForFirstTwoYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fund to related party under agreement for first two Year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_FundToRelatedPartyUnderAgreementForFirstTwoYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_LongTermPurchaseCommitmentMilestonesPayment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Long term purchase commitment milestones payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_LongTermPurchaseCommitmentMilestonesPayment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MaximumAmountOfOutOfPocketExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum amount of out of pocket expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MaximumAmountOfOutOfPocketExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_MilestonePaymentDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Milestone payment date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_MilestonePaymentDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NonRefundableInstitutionalFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Non refundable institutional fee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NonRefundableInstitutionalFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NoticePeriodForTerminationOfAgreement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Notice Period for termination of agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NoticePeriodForTerminationOfAgreement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfInstallments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of installments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfInstallments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NumberOfPatients">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of patients.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_NumberOfPatients</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentOfFinalInstallmentForServicesByCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Outstanding payment of final installment for services by company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PaymentOfFinalInstallmentForServicesByCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentOfFirstInstallmentForServicesByCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Payment of first installment for services by company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PaymentOfFirstInstallmentForServicesByCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentOfLicenseFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>License fee payment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PaymentOfLicenseFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PaymentOfPerformanceBonusForServicesByCompany">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Payment of Performance bonus for Services by Company</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PaymentOfPerformanceBonusForServicesByCompany</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of fully diluted capital stock equal to common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PercentageOfFullyDilutedCapitalStockEqualToCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PerformanceBonusPayableUnderAgreementForService">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Performance bonus payable under agreement for service.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PerformanceBonusPayableUnderAgreementForService</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PeriodicFeeReceivedByManagementFirm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Periodic fee received by management firm.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PeriodicFeeReceivedByManagementFirm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PharmacyFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Pharmacy fee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PharmacyFee</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ProjectEstimatedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Project estimated cost.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ProjectEstimatedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_PurchaseOfRadioactiveMaterial">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase of radioactive material.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_PurchaseOfRadioactiveMaterial</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_ResearchAndDevelopmentArrangement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research and development arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_ResearchAndDevelopmentArrangement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_RoyaltyOfNetSalesPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Royalty of net sales percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_RoyaltyOfNetSalesPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StartUpDueCostPaidDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Start-up due cost paid date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StartUpDueCostPaidDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_StartUpFeeForClinicalTrial">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Start-up fee for clinical trial.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_StartUpFeeForClinicalTrial</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_WarrantExercisableNoticePeriodDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant exercisable notice period description.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_WarrantExercisableNoticePeriodDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LeaseExpirationDate1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaintenanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Costs incurred and are directly related to generating maintenance revenues. Also includes cost of maintenance on client contracts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MaintenanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of consideration recognized during the period for the milestone or milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 28<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771982&amp;loc=SL6892177-166501<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TechnologyServicesCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Costs incurred in providing technology services. The services may include training, installation, engineering or consulting. Consulting services often include implementation support, software design or development, or the customization or modification of the licensed software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2(d))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 605<br><br> -Section 25<br><br> -Paragraph 76<br><br> -URI http://asc.fasb.org/extlink&amp;oid=22169047&amp;loc=d3e132428-111767<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TechnologyServicesCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3PAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Going concern (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="3">6 Months Ended</th>
        <th class="th" colspan="12">12 Months Ended</th>
        <th class="th" colspan="1">151 Months Ended</th>
        <th class="th" colspan="1">157 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2000</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2003</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2002</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2001</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_GoingConcernTextualAbstract', window );"><strong>Going Concern (Textual)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,784,011)<span></span></td>
        <td class="num">$ (1,562,591)<span></span></td>
        <td class="num">$ (3,473,038)<span></span></td>
        <td class="num">$ (2,471,500)<span></span></td>
        <td class="num">$ (672,286)<span></span></td>
        <td class="num">$ (8,361,205)<span></span></td>
        <td class="num">$ (3,444,795)<span></span></td>
        <td class="num">$ (467,266)<span></span></td>
        <td class="num">$ (3,425,986)<span></span></td>
        <td class="num">$ (5,570,905)<span></span></td>
        <td class="num">$ (5,617,581)<span></span></td>
        <td class="num">$ (6,053,362)<span></span></td>
        <td class="num">$ (4,580,237)<span></span></td>
        <td class="num">$ (5,734,791)<span></span></td>
        <td class="num">$ (3,532,044)<span></span></td>
        <td class="num">$ (3,192,384)<span></span></td>
        <td class="num">$ (5,090,621)<span></span></td>
        <td class="num">$ (55,743,463)<span></span></td>
        <td class="num">$ (59,216,501)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,327,820)<span></span></td>
        <td class="num">(1,862,232)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,212,710)<span></span></td>
        <td class="num">(517,592)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(44,402,658)<span></span></td>
        <td class="num">(47,730,478)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="nump">$ 59,216,501<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 59,216,501<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 55,743,463<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 55,743,463<span></span></td>
        <td class="nump">$ 59,216,501<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_GoingConcernTextualAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_GoingConcernTextualAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent events</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 8 &#8211; Subsequent Events</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Management has evaluated subsequent events and has concluded no events warrant disclosure.&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 13 &#8211; Subsequent Events</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; In February 28, 2013, the Company entered into a Separation and Settlement Agreement with its former CEO, Jack Talley. Pursuant to the agreement, the Company will pay Mr. Talley in 2 equal installments the aggregate amount of $250,000 and a performance bonus of $60,000 for his service from August 15, 2012 to December 31, 2012. The $60,000 bonus was included in the accounts payable and accrued liabilities on the Company&#8217;s balance sheet at December 31, 2012.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 7 &#8211; Equity</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Stock Option Plan</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The following is a summary of stock options:</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid; text-align: center; margin-left: 0pt; margin-right: 0pt; text-indent: 0pt;" colspan="2">
<div style="text-align: center; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size:
 10pt; font-family: times new roman; display: inline;">Intrinsic</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,330,134</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.91</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">685,800</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Cancellation</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(49,950</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right"
 width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,280,184</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.96</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">8.42</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1,609,035</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; All options issued and outstanding are being amortized over their respective&#160;service periods. The unrecognized compensation expense at June 30, 2013 was $1,086,848.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the three months ended June 30, 2013 and 2012, the Company recorded option expense of $94,200, and $40,410, respectively. During the six months ended June 30, 2013 and 2012, the Company recorded option expense of $188,400 and $240,400, respectively.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">On May 31, 2013, the Company entered into an agreement with its former director and consultant, Dr. Rosemary Mazanet. Pursuant to the agreement, the Company terminated the consulting agreement with Dr. Mazanet and Dr. Mazanet resigned as a director. The Company paid Mazanet cash of $25,000 and cancelled options to purchase 49,950 shares of the Company&#8217;s common stock at $1.50 per share previously granted.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Warrants</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: left; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; The following is a summary of warrants:</font></div>
<div align="justify" style="margin-left: 0pt; display:
 block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Number of</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Units</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Exercise Price</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Weighted</font></font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Average</font></font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Remaining</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Contractual</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Term (in years)</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Aggregate</font></font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Intrinsic</font></font></div>
<font style="font-size: 10pt; font-family: times new roman; display: inline;">Value</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td
 align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="3"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">12,770,636</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.97</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4.48 </font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">6,114,768</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants exercised</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(2,211,158</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Warrants expired</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times
 new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">(1,023,784</font></div>
</td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">)</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">1.65</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Outstanding, June 30, 2013</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9,535,694</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">0.77</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">5.341</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">9,691,302</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; During the six months ended June 30, 2013, the Company issued shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.&#160;&#160;The warrants were exercised at $1.65 per share, resulting in gross proceeds of $3,463,641 received by the Company.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; font-weight: bold; display: inline;">Note 9 &#8211; Equity</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; From inception to December 31, 2010, the Company raised $42,711,791 by issuing 5,707,259 shares of the Company&#8217;s stock and issued 66,402 shares, valued at $398,810, for services.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During 2011, the Company raised $6,184,967 by selling 7,891,141 shares of the Company&#8217;s stock and warrants to purchase 19,972,785 shares of the Company&#8217;s stock through an offering (&#8220;Stock Offering&#8221;).&#160;&#160;A net amount of $5,379,367 was received by the Company in 2011. The Company paid Laidlaw &amp; Company (UK) Ltd. (&#8220;Laidlaw &amp; Co.&#8221;), the placement agent, total cash fees of $742,196, which consisted of placement agent commission of $618,497 and expense reimbursement of $123,699. The Company also issued Laidlaw &amp; Co. warrants to purchase an aggregate of 986,393 shares of the Company&#8217;s common stock, with an exercise price of $0.78 per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $188,579.&#160;In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien PLLC, $60,904 for its services as the placement agent&#8217;s legal counsel and Signature Bank $2,500 for the bank escrow fee.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During 2012, the Company raised $759,300 by selling 968,759 shares and warrants to purchase 242,190 shares of the Company&#8217;s common stock under the Company&#8217;s Stock Offering.&#160;&#160;A net amount of $660,164 was received by the Company in 2012. The Company paid Laidlaw &amp; Co. total cash fees of $91,116, which consisted of placement agent commission of $75,930 and expense reimbursement of $15,186. The Company also issued Laidlaw &amp; Co. warrants to purchase an aggregate of 121,095 shares of the Company&#8217;s common stock, with an exercise price of $0.78&#160;per share and a term of 7 years. These placement agent warrants were valued at their grant date fair value of $159,044. In addition, the Company paid Laidlaw &amp; Co.&#8217;s outside counsel, McCormick &amp; O&#8217;Brien PLLC, $8,020 for its services as the placement agent&#8217;s legal counsel.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; In 2012, the Company also raised $5,151,450 through an offering of 3,118,988 shares of its common stock and &#8220;A Warrants&#8221; to purchase 3,118,988 shares of the Company&#8217;s common stock, exercisable at a price of $1.65 per share for a period of 120 days from the day of the final closing of the offering, and &#8220;B Warrants&#8221; to purchase 1,559,505 shares of the Company&#8217;s common stock, exercisable at a price of $2.48 per share for a period of 5 years from the date of the final closing of the offering. (&#8220;2012 Common Stock Offering&#8221;)&#160;&#160;A net amount of $4,469,776 was received by the Company. Pursuant to the 2012 Common Stock Offering agreement, the Company paid Laidlaw &amp; Co. total cash fees of $618,174, which consisted of placement agent commission of $515,145 and expense reimbursement of $103,029. The Company also issued the placement agent warrants to purchase an aggregate of 467,845 shares of the Company&#8217;s common stock, with an exercise price of $0.78 per share and a term of 5 years. These placement agent warrants were valued at $499,707 and recorded as derivative liabilities.&#160;&#160;In addition, the Company paid the Laidlaw &amp; Co.&#8217;s outside counsel, Richardson &amp; Patel, LLP, $60,000 for its services as the Laidlaw &amp; Co.&#8217;s legal counsel and Signature Bank $3,500 for the bank escrow fee.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; During 2012, the Company&#8217;s convertible notes, plus accrued interest, were converted to 1,252,550 shares of the Company&#8217;s common stock as a result of the 2012 Common Stock Offering.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160; As a result of the Share Exchange described in Note 1, the Company issued 400,000 shares to the original shareholders of the Company and 1,986,566 shares to the former shareholders of Actinium.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">&#160;&#160;&#160; Placement Agent &#8211;</font> In connection with the money raised in 2011, the Company issued Laidlaw &amp; Co. warrants to purchase an aggregate of 1,129,925 shares of common stock, with an exercise price of $0.78 per share.&#160;&#160;With the money raised in 2012, the Company issued Laidlaw &amp; Co. warrants to purchase an aggregate of 588,940 shares of common stock, with an exercise price of $0.78 per share.</font></div>
<div align="justify" style="margin-left: 0pt;
 display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">&#160;&#160;&#160; Management Firm &#8211;</font> In 2011, the Company entered into a&#160;management agreement with Jamess Capital Group, LLC (formerly, AmerAsia Inc., &#8220;Jamess&#8221;) for Jamess to provide consulting services related to funding and Actinium becoming a publicly traded entity.&#160;In 2011, the Company incurred $96,744 in management fees. In addition, Actinium issued Jamess warrants to purchase an aggregate of 1,974,774 shares of common stock, with an exercise price of $0.01 per share. The warrants have a fair value of $2,153,442 (see Note 11) and included a cashless exercise provision.&#160;&#160;In 2012, the Company issued Jamess warrants to purchase 1,716,340 shares of common stock with an exercise price of $0.01 per share. The warrants have a fair value of $1,957,754 (see Note 11) and included a cashless exercise provision.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Summary of activities related to related party</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2012</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2011</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Qualified R&amp;D costs incurred by the Company</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">655,786</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="76%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Reimbursements received from MSKCC</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">237,834</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">966,341</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUOAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Description Of Business and Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Nature of Business</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Nature of Business &#8211;</font> Actinium Pharmaceuticals, Inc. formerly known as Cactus Ventures, Inc. (the &#8220;Company&#8221;, &#8220;Actinium&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that&#160;was in the market for a merger with an appropriate operating company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;API&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange closed on December 28, 2012.&#160;&#160;As a result of the Share Exchange, the former shareholders of API became the controlling shareholders of the Company. At the closing, each API shareholder received 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Actinium common stock for each API share exchanged. At the closing, all of the API shareholders&#8217; options and warrants to purchase API common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Actinium common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein API is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; API, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. API, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;API&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, API launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. API&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of API&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that API&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through API, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; On March 20, 2013, in anticipation of the Company changing its name to Actinium Pharmaceuticals, Inc. and its domicile from Nevada to Delaware, the Company&#8217;s subsidiary, Actinium Pharmaceuticals, Inc., changed its name to Actinium Corporation.&#160;&#160;On April 11, 2013, the Company changed its domicile from the State of Nevada to the State of Delaware and changed its name from Cactus Ventures, Inc. to Actinium Pharmaceuticals, Inc.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Nature of Business &#8211; Actinium Pharmaceuticals, Inc (Formerly</font> Cactus Ventures, Inc.) (the &#8220;Company&#8221;, &#8220;Cactus&#8221;), was incorporated under the laws of the State of Nevada on October 6, 1997. The Company was a shell entity that is in the market for a merger with an appropriate operating company.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On December 28, 2012, the Company entered into a transaction (the &#8220;Share Exchange&#8221;), pursuant to which the Company agreed to acquire 100% of the issued and outstanding equity securities of Actinium Pharmaceuticals, Inc. (&#8220;Actinium&#8221;), in exchange for the issuance of approximately 99% of the issued and outstanding common stock, par value $0.01 per share, of the Company. The Share Exchange was closed on December 28, 2012 when shareholders representing over 20% of the issued and outstanding shares of Actinium had finished the exchange process.&#160;&#160;On August 22, 2013, shareholders representing 38% of the issued and outstanding shares of Actinium completed the exchange.&#160;&#160;As a result of the Share Exchange, the former shareholders of Actinium became the controlling shareholders of the Company. At the closing, each Actinium shareholder shall receive 0.333 shares (the &#8220;Exchange Ratio&#8221;) of Cactus common stock for each Actinium share exchanged. At the closing, all of the Actinium shareholders&#8217; options and warrants to purchase Actinium common stock was exchanged at the Exchange Ratio for new options or warrants, as applicable, to purchase Cactus common stock.&#160;&#160;The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein Actinium is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio established in the merger except otherwise noted.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; Actinium, incorporated on June 13, 2000, is a biotechnology company committed to developing breakthrough therapies for life threatening diseases using its alpha particle immunotherapy (APIT) platform and other related and similar technologies. Actinium, together with its wholly owned subsidiary, MedActinium, Inc. (MAI), (hereinafter referred to collectively as &#8220;Actinium&#8221;) has initiated collaborative efforts with large institutions to establish the proof of concept of alpha particle immunotherapy and has supported one Phase I/Il clinical trial and one Phase I clinical trial at Memorial Sloan-Kettering Cancer Center (MSKCC) under an MSKCC Physician Investigational New Drug Application. In 2012, Actinium launched a multi-center corporate sponsored trial in acute myeloid leukemia (AML) patients. &#160;Actinium&#8217;s objective, through research and development, is to produce reliable cancer fighting products which utilize monoclonal antibodies linked with alpha particle emitters or other appropriate payloads to provide very potent targeted therapies. The initial clinical trials of Actinium&#8217;s compounds have been with patients having acute myeloid leukemia and it is believed that Actinium&#8217;s APIT platform will have wider applicability for different types of cancer where suitable monoclonal antibodies can be found.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font  style="letter-spacing: 9pt;">&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160; As a result of the Share Exchange, the Company is now a holding company operating through Actinium, a clinical-stage biopharmaceutical company developing certain cancer treatments.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation - Unaudited Interim Financial Information</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Basis of Presentation - Unaudited Interim Financial Information &#8211;</font> The accompanying unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary&#160;for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, 2012 and notes thereto contained in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2012, as filed with the SEC March 29, 2013.</font></div><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DevelopmentStageCompanyPolicyTextBlock', window );">Development Stage Company</a></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div><font style="font-weight: bold; display: inline;">Development Stage Company &#8211;</font> The Company is considered a development stage company and has had no commercial revenue to date.</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</font></div><span></span></td>
        <td class="text"><div><font style="font-weight: bold; display: inline;">Principles of Consolidation &#8211;</font> The consolidated financial statements include the Company&#8217;s accounts and those of the Company&#8217;s wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in Financial Statement Presentation</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Use of Estimates in Financial Statement Presentation &#8211;</font> The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</font></div><span></span></td>
        <td class="text"><div><font style="font-weight: bold; display: inline;">Reclassification &#8211;</font> Certain prior period amounts have been reclassified to conform to current period presentation.</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At June 30, 2013 and December 31, 2012, all of the Company&#8217;s cash was deposited in one bank.</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Cash and Cash Equivalents &#8211;</font> The Company considers all highly liquid accounts with original maturities of three months or less to be cash equivalents. Such balances are usually in excess of FDIC insured limits. At December 31, 2012 and 2011, all of the Company&#8217;s cash was deposited in one bank.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Property and Equipment &#8211;</font> Machinery and equipment are recorded at cost and depreciated on a straight-line basis over estimated useful lives of five years. Furniture and fixtures are recorded at cost and depreciated on a straight-line basis over estimated useful lives of seven years. When assets are retired or sold, the cost and related accumulated depreciation are removed from the accounts, and any related gain or loss is reflected in operations. Repairs and maintenance expenditures are charged to operations.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 27pt;">&#160;</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Impairment of Long-Lived Assets &#8211;</font> Management reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be realizable or at a minimum annually during the fourth quarter of the year. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset&#8217;s carrying value to determine if an impairment of such asset is necessary. The effect of any impairment would be to expense the difference between the fair value of such asset and its carrying value.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Derivatives &#8211;</font> All derivatives are recorded at fair value on the balance sheet. Fair values for securities traded in the open market and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>
</div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 45pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of June 30, 2013 and December 31. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At June 30, 2013</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new
 roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Fair Value of Financial Instruments &#8211;</font> Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</font></div>
<div style="text-align: justify; display: block; text-indent: 0pt;">&#160;</div>
<div style="text-align: justify; margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1 Inputs &#8211; Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2 Inputs &#8211; Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 36pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3 Inputs &#8211; Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.</font></div>
<div style="display: block; text-indent: 0pt;">&#160;</div>
<div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">The following tables set forth assets and liabilities measured at fair value on a recurring and non-recurring basis by level within the fair value hierarchy as of December 31, 2012 and 2011. As required by ASC 820, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.</font></div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size:
 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt;
 font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Income Taxes &#8211;</font> The Company uses the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and income tax carrying amounts of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reviews deferred tax assets for a valuation allowance based upon whether it is more likely than not that the deferred tax asset will be fully realized. A valuation allowance, if necessary, is provided against deferred tax assets, based upon management&#8217;s assessment as to their realization.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
        <td class="text"><div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div>
<div style="text-align: justify; margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Research and Development Costs &#8211;</font> Research and development costs are expensed as incurred. Research and development reimbursements and grants are recorded by the Company as a reduction of research and development costs.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Share-Based Payments</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Share-Based Payments &#8211;</font> The Company estimates the fair value of each stock option award at the grant date by using the Black-Scholes option pricing model and value of common shares based on the last common stock valuation done by third party valuation expert of the Company&#8217;s common stock on the date of the share grant. The fair value determined represents the cost for the award and is recognized over the vesting period during which an employee is required to provide service in exchange for the award. As share-based compensation expense is recognized based on awards ultimately expected to vest, the Company reduces the expense for estimated forfeitures based on historical forfeiture rates. Previously recognized compensation costs may be adjusted to reflect the actual forfeiture rate for the entire award at the end of the vesting period. Excess tax benefits, if any, are recognized as an addition to paid-in capital.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">&#160; Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been antidilutive. For the six months ended June 30, 2013, potentially issuable shares included stock options to purchase 2,280,184 shares and warrants to purchase 9,535,694 shares of the Company&#8217;s common stock. For the six months ended June 30, 2012, potentially issuable shares includes options and warrants&#160;to purchase 6,842,528 shares of the Company&#8217;s common stock and notes payable convertible to 815,275 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div><span></span></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;"> Earnings (Loss) Per Common Share &#8211;</font> The Company provides basic and diluted earnings per common share information for each period presented. Basic earnings (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per common share is computed by dividing the net income available to common stockholders&#160;by the weighted average number of common shares outstanding plus dilutive securities. Since the Company has only incurred losses, basic and diluted net loss per common share are the same. &#160;The potentially dilutive securities (options, warrants and convertible instruments) were excluded from the diluted loss per common share calculation because their effect would have been anti dilutive. For the year ended December 31, 2012, potentially issuable shares included stock options to purchase 2,330,134 shares and warrants to purchase 12,770,596 shares of the Company&#8217;s common stock. For the year ended December 31, 2011, potentially issuable shares includes options and warrants&#160;to purchase 273,859 shares of the Company&#8217;s common stock and notes payable convertible to 3,448,276 shares of the Company&#8217;s common stock have been excluded from the calculation.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company.</font></div><span></span></td>
        <td class="text"><div><font style="font-weight: bold; display: inline;">Recent Accounting Pronouncements &#8211;</font> The Company does not expect that any recently issued accounting pronouncements will have a significant impact on the results of operations, financial position, or cash flows of the Company</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Events</a></td>
        <td class="text"><div><font style="font-size: 10pt; font-family: times new roman; display: inline;"><font style="font-weight: bold; display: inline;">Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events through the date the consolidated financial statements were issued for subsequent event disclosure consideration.</font></div><span></span></td>
        <td class="text"><div><font style="font-weight: bold; display: inline;">Subsequent Events &#8211;</font> The Company&#8217;s management reviewed all material events from January 1, 2013 through March 15, 2013.</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DevelopmentStageCompanyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Development Stage Company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DevelopmentStageCompanyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2303973<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 4<br><br> -Subparagraph (a)-(d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f(1))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CompensationRelatedCostsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02, 03<br><br> -Article 3A<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 40<br><br> -Section 45<br><br> -URI http://asc.fasb.org/section&amp;trid=2197723<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2196966<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 325<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197087<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.3A-02)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16385135&amp;loc=d3e33801-111570<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph k<br><br> -Article 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConsolidationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41620-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579245-113959<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5579240-113959<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41638-113959<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(n))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph n<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=d3e41675-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativesPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155942<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section CC<br><br> -Subsection 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PriorPeriodReclassificationAdjustmentDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2127266<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpensePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reporting subsequent events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Actinium Pharmaceuticals, Inc.<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001388320<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">S-1<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Jun. 30,
				 2013<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>fil_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>fil_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Description of Business and Summary of Significant Accounting Policies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Description Of Business and Summary Of Significant Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Summary of set forth assets and liabilities measured at fair value on a recurring and non-recurring basis</a></td>
        <td class="text"><div align="justify" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At June 30, 2013</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display:
 inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">2,957,977</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></div><span></span></td>
        <td class="text"><div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;">&#160;</div>
<div align="left">
<table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0">
<tr>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 1</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 2</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Level 3</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td valign="bottom" style="border-bottom: black 2px solid;" colspan="2">
<div align="center" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Total</font></div>
</td>
<td align="left" valign="bottom" style="padding-bottom: 2px;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr>
<td align="left" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">Derivative liabilities:</font></div>
</td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" valign="bottom" colspan="2"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;</font></td>
<td align="left" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="#cceeff">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2012</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;
 </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">$</font></div>
</td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">3,574,958</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
<tr bgcolor="white">
<td align="left" width="52%" valign="bottom">
<div align="left" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160;&#160;At December 31, 2011</font></div>
</td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">-</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
<td align="right" width="9%" valign="bottom">
<div align="right" style="margin-left: 0pt; display: block; margin-right: 0pt; text-indent: 0pt;"><font style="font-size: 10pt; font-family: times new roman; display: inline;">4,439,613</font></div>
</td>
<td align="left" width="1%" valign="bottom"><font style="font-size: 10pt; font-family: times new roman; display: inline;">&#160; </font></td>
</tr>
</table>
</div>
<div style="display: block; text-indent: 0pt;">&#160;</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring and/or nonrecurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19190-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
